Psyllid ID: psy3347
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | 2.2.26 [Sep-21-2011] | |||||||
| A1Z7T0 | 1190 | Serine/threonine-protein | no | N/A | 0.897 | 0.184 | 0.8 | 1e-113 | |
| Q16513 | 984 | Serine/threonine-protein | yes | N/A | 0.897 | 0.223 | 0.755 | 1e-108 | |
| Q8BWW9 | 983 | Serine/threonine-protein | yes | N/A | 0.897 | 0.223 | 0.751 | 1e-107 | |
| O08874 | 985 | Serine/threonine-protein | yes | N/A | 0.897 | 0.223 | 0.746 | 1e-106 | |
| A7MBL8 | 977 | Serine/threonine-protein | yes | N/A | 0.897 | 0.225 | 0.742 | 1e-106 | |
| P70268 | 946 | Serine/threonine-protein | no | N/A | 0.897 | 0.232 | 0.718 | 1e-102 | |
| A1A4I4 | 944 | Serine/threonine-protein | no | N/A | 0.897 | 0.233 | 0.718 | 1e-102 | |
| Q16512 | 942 | Serine/threonine-protein | no | N/A | 0.897 | 0.233 | 0.714 | 1e-102 | |
| Q63433 | 946 | Serine/threonine-protein | no | N/A | 0.897 | 0.232 | 0.714 | 1e-101 | |
| Q6P5Z2 | 889 | Serine/threonine-protein | no | N/A | 0.897 | 0.247 | 0.579 | 2e-83 |
| >sp|A1Z7T0|PKN_DROME Serine/threonine-protein kinase N OS=Drosophila melanogaster GN=Pkn PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 407 bits (1045), Expect = e-113, Method: Compositional matrix adjust.
Identities = 196/245 (80%), Positives = 207/245 (84%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQ R+ +Y+AIKALKKGDIIARDEVESLLSEKRIFEVAN MRHPFLVNL++CFQTE
Sbjct: 877 VILSQLRSNNQYYAIKALKKGDIIARDEVESLLSEKRIFEVANAMRHPFLVNLYSCFQTE 936
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVF EPRAVFYAACVVLGLQYLHE++IIYR
Sbjct: 937 QHVCFVMEYAAGGDLMMHIHTDVFLEPRAVFYAACVVLGLQYLHENKIIYR--------- 987
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA
Sbjct: 988 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 1031
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1032 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1091
Query: 241 AIMRR 245
A+MRR
Sbjct: 1092 AVMRR 1096
|
Pkc-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. May play a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion and transcription activation signaling processes (By similarity). Plays a role in regulating Rho-mediated dorsal closure during embryogenesis. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1EC: 3 |
| >sp|Q16513|PKN2_HUMAN Serine/threonine-protein kinase N2 OS=Homo sapiens GN=PKN2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1004), Expect = e-108, Method: Compositional matrix adjust.
Identities = 185/245 (75%), Positives = 204/245 (83%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++Y+NT E FAIKALKKGDI+ARDEV+SL+ EKRIFE N++RHPFLVNLFACFQT+
Sbjct: 671 VLLAEYKNTNEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTK 730
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVFSEPRAVFYAACVVLGLQYLHE +I+YR
Sbjct: 731 EHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEHKIVYR--------- 781
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 782 ----------------DLKLDNLLLDTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 825
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLI+EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 826 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAI 885
Query: 241 AIMRR 245
+IMRR
Sbjct: 886 SIMRR 890
|
PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associates with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q8BWW9|PKN2_MOUSE Serine/threonine-protein kinase N2 OS=Mus musculus GN=Pkn2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 388 bits (997), Expect = e-107, Method: Compositional matrix adjust.
Identities = 184/245 (75%), Positives = 204/245 (83%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++Y++T E FAIKALKKGDI+ARDEV+SL+ EKRIFE N++RHPFLVNLFACFQT+
Sbjct: 670 VLLAEYKHTNEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTK 729
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVFSEPRAVFYAACVVLGLQYLHE +I+YR
Sbjct: 730 EHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEHKIVYR--------- 780
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 781 ----------------DLKLDNLLLDTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 824
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLI+EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 825 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAI 884
Query: 241 AIMRR 245
+IMRR
Sbjct: 885 SIMRR 889
|
PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associates with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|O08874|PKN2_RAT Serine/threonine-protein kinase N2 OS=Rattus norvegicus GN=Pkn2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 385 bits (988), Expect = e-106, Method: Compositional matrix adjust.
Identities = 183/245 (74%), Positives = 202/245 (82%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++Y++T E FAIKALKKGDI+ARDEV+SL+ EKRIFE N++RHPFLVNLFACFQT+
Sbjct: 672 VLLAEYKHTNEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTK 731
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVFSEPRAVFYAACVVLGLQYLHE +I+YR
Sbjct: 732 EHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEHKIVYR--------- 782
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTE VKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 783 ----------------DLKLDNLLLDTEASVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 826
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLI+EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 827 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAI 886
Query: 241 AIMRR 245
+IMRR
Sbjct: 887 SIMRR 891
|
PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associates with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|A7MBL8|PKN2_DANRE Serine/threonine-protein kinase N2 OS=Danio rerio GN=pkn2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (986), Expect = e-106, Method: Compositional matrix adjust.
Identities = 182/245 (74%), Positives = 202/245 (82%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L+ Y+ TGE FAIKALKKGDI+ARDEV+SL+ EKRIFE N++RHPFLVNLFACFQT+
Sbjct: 664 VLLADYKTTGEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTK 723
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIHADVFSE R+VFYAACVVLGLQ+LH+ +I+YR
Sbjct: 724 EHVCFVMEYAAGGDLMMHIHADVFSETRSVFYAACVVLGLQFLHDHKIVYR--------- 774
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGF DRT TFCGTPEFLA
Sbjct: 775 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFKDRTSTFCGTPEFLA 818
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP++LS EAI
Sbjct: 819 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPKYLSTEAI 878
Query: 241 AIMRR 245
+IMRR
Sbjct: 879 SIMRR 883
|
Pkc-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. May play a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion and transcription activation signaling processes. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|P70268|PKN1_MOUSE Serine/threonine-protein kinase N1 OS=Mus musculus GN=Pkn1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 371 bits (952), Expect = e-102, Method: Compositional matrix adjust.
Identities = 176/245 (71%), Positives = 197/245 (80%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+LS++R++GE FAIKALKKGDI+ARDEVESL+ EKRI HPFLVNLF CFQT
Sbjct: 633 VLLSEFRSSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTRAGHPFLVNLFGCFQTP 692
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEY+AGGDLM+HIH+DVFSEPRAVFY+ACVVLGLQ+LHE +I+YR
Sbjct: 693 EHVCFVMEYSAGGDLMLHIHSDVFSEPRAVFYSACVVLGLQFLHEHKIVYR--------- 743
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 744 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 787
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLT+TSYTRAVDWWGLGVL++EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 788 PEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAI 847
Query: 241 AIMRR 245
IMRR
Sbjct: 848 GIMRR 852
|
PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170', and GFAP. Able to phosphorylate RPS6 in vitro. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|A1A4I4|PKN1_BOVIN Serine/threonine-protein kinase N1 OS=Bos taurus GN=PKN1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-102, Method: Compositional matrix adjust.
Identities = 176/245 (71%), Positives = 196/245 (80%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+LS++R +GE FAIKALKKGDI+ARDEVESL+ EKRI HPFLVNLF CFQT
Sbjct: 631 VLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTNAGHPFLVNLFGCFQTP 690
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEY+AGGDLM+HIH+DVFSEPRAVFY+ACVVLGLQ+LHE +I+YR
Sbjct: 691 EHVCFVMEYSAGGDLMLHIHSDVFSEPRAVFYSACVVLGLQFLHEHKIVYR--------- 741
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 742 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 785
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLT+TSYTRAVDWWGLGVL++EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 786 PEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAI 845
Query: 241 AIMRR 245
IMRR
Sbjct: 846 GIMRR 850
|
PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170', and GFAP. Able to phosphorylate RPS6 in vitro. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q16512|PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 370 bits (949), Expect = e-102, Method: Compositional matrix adjust.
Identities = 175/245 (71%), Positives = 197/245 (80%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+LS++R +GE FAIKALKKGDI+ARDEVESL+ EKRI + HPFLVNLF CFQT
Sbjct: 629 VLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTP 688
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEY+AGGDLM+HIH+DVFSEPRA+FY+ACVVLGLQ+LHE +I+YR
Sbjct: 689 EHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYR--------- 739
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 740 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 783
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLT+TSYTRAVDWWGLGVL++EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 784 PEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAI 843
Query: 241 AIMRR 245
IMRR
Sbjct: 844 GIMRR 848
|
PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170' of MARCKS, and GFAP. Able to phosphorylate RPS6 in vitro. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q63433|PKN1_RAT Serine/threonine-protein kinase N1 OS=Rattus norvegicus GN=Pkn1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 369 bits (947), Expect = e-101, Method: Compositional matrix adjust.
Identities = 175/245 (71%), Positives = 196/245 (80%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+LS++ ++GE FAIKALKKGDI+ARDEVESL+ EKRI HPFLVNLF CFQT
Sbjct: 633 VLLSEFHSSGELFAIKALKKGDIVARDEVESLMCEKRILATVTRAGHPFLVNLFGCFQTP 692
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEY+AGGDLM+HIH+DVFSEPRAVFY+ACVVLGLQ+LHE +I+YR
Sbjct: 693 EHVCFVMEYSAGGDLMLHIHSDVFSEPRAVFYSACVVLGLQFLHEHKIVYR--------- 743
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRT TFCGTPEFLA
Sbjct: 744 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLA 787
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLT+TSYTRAVDWWGLGVL++EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI
Sbjct: 788 PEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAI 847
Query: 241 AIMRR 245
IMRR
Sbjct: 848 GIMRR 852
|
PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170', and GFAP. Able to phosphorylate RPS6 in vitro. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
| >sp|Q6P5Z2|PKN3_HUMAN Serine/threonine-protein kinase N3 OS=Homo sapiens GN=PKN3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 2e-83, Method: Composition-based stats.
Identities = 142/245 (57%), Positives = 174/245 (71%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L Q++ TG+Y+AIKALKK ++++RDE+ESL EKRI E HPFL++L ACFQT
Sbjct: 573 VLLVQFKGTGKYYAIKALKKQEVLSRDEIESLYCEKRILEAVGCTGHPFLLSLLACFQTS 632
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+H CFV E+ GGDLMM IH DVF EP+A FY ACVVLGLQ+LHE +IIYR
Sbjct: 633 SHACFVTEFVPGGDLMMQIHEDVFPEPQARFYVACVVLGLQFLHEKKIIYRDLKLDNLLL 692
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
D +G++KIADFGLCKEG+GFGDRT TFCGTPEFLA
Sbjct: 693 -------------------------DAQGFLKIADFGLCKEGIGFGDRTSTFCGTPEFLA 727
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLT+ +YTRAVDWWGLGVL++EMLVGE PFPGD EEEVFD IVN + YP FLS++ +
Sbjct: 728 PEVLTQEAYTRAVDWWGLGVLLYEMLVGECPFPGDTEEEVFDCIVNMDAPYPGFLSVQGL 787
Query: 241 AIMRR 245
+++
Sbjct: 788 EFIQK 792
|
Contributes to invasiveness in malignant prostate cancer. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | ||||||
| 350404415 | 1689 | PREDICTED: hypothetical protein LOC10074 | 0.897 | 0.130 | 0.840 | 1e-117 | |
| 307177860 | 1747 | Serine/threonine-protein kinase N2 [Camp | 0.897 | 0.125 | 0.840 | 1e-117 | |
| 380014132 | 1775 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.897 | 0.123 | 0.840 | 1e-117 | |
| 345488814 | 1831 | PREDICTED: hypothetical protein LOC10011 | 0.897 | 0.120 | 0.840 | 1e-117 | |
| 383860305 | 1758 | PREDICTED: serine/threonine-protein kina | 0.897 | 0.125 | 0.836 | 1e-117 | |
| 242022370 | 1059 | conserved hypothetical protein [Pediculu | 0.897 | 0.207 | 0.840 | 1e-116 | |
| 189235408 | 1066 | PREDICTED: similar to protein kinase N2 | 0.897 | 0.206 | 0.840 | 1e-116 | |
| 340716554 | 1712 | PREDICTED: hypothetical protein LOC10064 | 0.897 | 0.128 | 0.836 | 1e-116 | |
| 157120307 | 876 | protein kinase c [Aedes aegypti] gi|1088 | 0.897 | 0.251 | 0.844 | 1e-116 | |
| 347965281 | 1348 | AGAP007587-PA [Anopheles gambiae str. PE | 0.897 | 0.163 | 0.828 | 1e-115 |
| >gi|350404415|ref|XP_003487097.1| PREDICTED: hypothetical protein LOC100743934 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1098), Expect = e-117, Method: Compositional matrix adjust.
Identities = 206/245 (84%), Positives = 211/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN RHPFLVNLFACFQTE
Sbjct: 1376 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANATRHPFLVNLFACFQTE 1435
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVF EPRAVFY+ACVVLGLQYLHESRIIYR
Sbjct: 1436 AHVCFVMEYAAGGDLMMHIHADVFGEPRAVFYSACVVLGLQYLHESRIIYR--------- 1486
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRTGTFCGTPEFLA
Sbjct: 1487 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTGTFCGTPEFLA 1530
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1531 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1590
Query: 241 AIMRR 245
AIMRR
Sbjct: 1591 AIMRR 1595
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307177860|gb|EFN66820.1| Serine/threonine-protein kinase N2 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1098), Expect = e-117, Method: Compositional matrix adjust.
Identities = 206/245 (84%), Positives = 212/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT RHPFLVNLFACFQTE
Sbjct: 1434 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTTRHPFLVNLFACFQTE 1493
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVF EPRAVFY+ACVVLGLQYLHE+RIIYR
Sbjct: 1494 AHVCFVMEYAAGGDLMMHIHADVFGEPRAVFYSACVVLGLQYLHENRIIYR--------- 1544
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRTGTFCGTPEFLA
Sbjct: 1545 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTGTFCGTPEFLA 1588
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1589 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1648
Query: 241 AIMRR 245
AIMRR
Sbjct: 1649 AIMRR 1653
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380014132|ref|XP_003691095.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase N-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-117, Method: Compositional matrix adjust.
Identities = 206/245 (84%), Positives = 211/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN RHPFLVNLFACFQTE
Sbjct: 1462 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANATRHPFLVNLFACFQTE 1521
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVF EPRAVFY+ACVVLGLQYLHESRIIYR
Sbjct: 1522 AHVCFVMEYAAGGDLMMHIHADVFGEPRAVFYSACVVLGLQYLHESRIIYR--------- 1572
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRTGTFCGTPEFLA
Sbjct: 1573 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTGTFCGTPEFLA 1616
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1617 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1676
Query: 241 AIMRR 245
AIMRR
Sbjct: 1677 AIMRR 1681
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345488814|ref|XP_001599463.2| PREDICTED: hypothetical protein LOC100114442 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1094), Expect = e-117, Method: Compositional matrix adjust.
Identities = 206/245 (84%), Positives = 211/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN RHPFLVNLFACFQT+
Sbjct: 1518 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANATRHPFLVNLFACFQTD 1577
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVF EPRAVFY+ACVVLGLQYLHESRIIYR
Sbjct: 1578 AHVCFVMEYAAGGDLMMHIHADVFGEPRAVFYSACVVLGLQYLHESRIIYR--------- 1628
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA
Sbjct: 1629 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 1672
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1673 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1732
Query: 241 AIMRR 245
AIMRR
Sbjct: 1733 AIMRR 1737
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383860305|ref|XP_003705631.1| PREDICTED: serine/threonine-protein kinase N-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1094), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/245 (83%), Positives = 211/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN RHPFLVNLFACFQTE
Sbjct: 1445 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANATRHPFLVNLFACFQTE 1504
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVF EPRAVFY+ACVVLGLQYLHESRIIYR
Sbjct: 1505 AHVCFVMEYAAGGDLMMHIHADVFGEPRAVFYSACVVLGLQYLHESRIIYR--------- 1555
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRTGTFCGTPEFLA
Sbjct: 1556 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTGTFCGTPEFLA 1599
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLT+TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1600 PEVLTDTSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1659
Query: 241 AIMRR 245
AIMRR
Sbjct: 1660 AIMRR 1664
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242022370|ref|XP_002431613.1| conserved hypothetical protein [Pediculus humanus corporis] gi|212516921|gb|EEB18875.1| conserved hypothetical protein [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1091), Expect = e-116, Method: Compositional matrix adjust.
Identities = 206/245 (84%), Positives = 212/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL+QYRNT EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE
Sbjct: 746 VILAQYRNTKEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 805
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIHADVFSEPRA+FYAACVVLGLQYLHES+IIYR
Sbjct: 806 QHVCFVMEYAAGGDLMMHIHADVFSEPRAIFYAACVVLGLQYLHESKIIYR--------- 856
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA
Sbjct: 857 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 900
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 901 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 960
Query: 241 AIMRR 245
AIMRR
Sbjct: 961 AIMRR 965
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189235408|ref|XP_971016.2| PREDICTED: similar to protein kinase N2 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 206/245 (84%), Positives = 214/245 (87%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN++RHPFLVNLFACFQTE
Sbjct: 753 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANSIRHPFLVNLFACFQTE 812
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHE++IIYR
Sbjct: 813 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHENKIIYR--------- 863
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA
Sbjct: 864 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 907
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE+I
Sbjct: 908 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLESI 967
Query: 241 AIMRR 245
AIMRR
Sbjct: 968 AIMRR 972
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340716554|ref|XP_003396762.1| PREDICTED: hypothetical protein LOC100648635 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 205/245 (83%), Positives = 210/245 (85%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN RHPFLVNLFACFQTE
Sbjct: 1399 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANATRHPFLVNLFACFQTE 1458
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
AHVCFVMEYAAGGDLMMHIHADVF E RAVFY+ACVVLGLQYLHESRIIYR
Sbjct: 1459 AHVCFVMEYAAGGDLMMHIHADVFGEARAVFYSACVVLGLQYLHESRIIYR--------- 1509
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMG+GDRTGTFCGTPEFLA
Sbjct: 1510 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTGTFCGTPEFLA 1553
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1554 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1613
Query: 241 AIMRR 245
AIMRR
Sbjct: 1614 AIMRR 1618
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157120307|ref|XP_001653599.1| protein kinase c [Aedes aegypti] gi|108883112|gb|EAT47337.1| AAEL001549-PA, partial [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 207/245 (84%), Positives = 212/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL+QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE
Sbjct: 563 VILAQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 622
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVFSEPRAVFYAACVVLGLQYLHES+IIYR
Sbjct: 623 QHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHESKIIYR--------- 673
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA
Sbjct: 674 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 717
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 718 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 777
Query: 241 AIMRR 245
AIMRR
Sbjct: 778 AIMRR 782
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347965281|ref|XP_308283.5| AGAP007587-PA [Anopheles gambiae str. PEST] gi|333466431|gb|EAA03911.6| AGAP007587-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-115, Method: Compositional matrix adjust.
Identities = 203/245 (82%), Positives = 212/245 (86%), Gaps = 25/245 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL+QY++TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF+CFQT+
Sbjct: 1035 VILAQYKHTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFSCFQTD 1094
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVFSEPRAVFYAACVVLGLQYLHES+IIYR
Sbjct: 1095 QHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHESKIIYR--------- 1145
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA
Sbjct: 1146 ----------------DLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 1189
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240
PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI
Sbjct: 1190 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 1249
Query: 241 AIMRR 245
AIMRR
Sbjct: 1250 AIMRR 1254
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 245 | ||||||
| FB|FBgn0020621 | 1190 | Pkn "Protein kinase related to | 0.481 | 0.099 | 0.855 | 3.3e-101 | |
| UNIPROTKB|F1PHU4 | 845 | PKN2 "Uncharacterized protein" | 0.408 | 0.118 | 0.94 | 7.6e-98 | |
| UNIPROTKB|Q16513 | 984 | PKN2 "Serine/threonine-protein | 0.408 | 0.101 | 0.94 | 8.2e-98 | |
| UNIPROTKB|O44393 | 963 | PRK2 "Protein kinase C-related | 0.481 | 0.122 | 0.822 | 1.5e-97 | |
| UNIPROTKB|F1MFK1 | 981 | PKN2 "Uncharacterized protein" | 0.408 | 0.101 | 0.94 | 2.7e-97 | |
| MGI|MGI:109211 | 983 | Pkn2 "protein kinase N2" [Mus | 0.408 | 0.101 | 0.94 | 2.8e-97 | |
| UNIPROTKB|F1LPA4 | 983 | Pkn2 "Serine/threonine-protein | 0.408 | 0.101 | 0.94 | 2.8e-97 | |
| UNIPROTKB|F1S4D4 | 969 | PKN2 "Uncharacterized protein" | 0.408 | 0.103 | 0.93 | 1.4e-96 | |
| RGD|620146 | 985 | Pkn2 "protein kinase N2" [Ratt | 0.408 | 0.101 | 0.93 | 4.5e-96 | |
| UNIPROTKB|O08874 | 985 | Pkn2 "Serine/threonine-protein | 0.408 | 0.101 | 0.93 | 4.5e-96 |
| FB|FBgn0020621 Pkn "Protein kinase related to protein kinase N" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 3.3e-101, Sum P(2) = 3.3e-101
Identities = 101/118 (85%), Positives = 107/118 (90%)
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET 187
+ EN + ++ + DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET
Sbjct: 979 LHENKIIYRDLKLDNLLLDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET 1038
Query: 188 SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIA+MRR
Sbjct: 1039 SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAVMRR 1096
|
|
| UNIPROTKB|F1PHU4 PKN2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 7.6e-98, Sum P(2) = 7.6e-98
Identities = 94/100 (94%), Positives = 98/100 (98%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 652 DTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 711
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 712 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 751
|
|
| UNIPROTKB|Q16513 PKN2 "Serine/threonine-protein kinase N2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 8.2e-98, Sum P(2) = 8.2e-98
Identities = 94/100 (94%), Positives = 98/100 (98%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 791 DTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 850
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 851 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 890
|
|
| UNIPROTKB|O44393 PRK2 "Protein kinase C-related kinase" [Pisaster ochraceus (taxid:7612)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 1.5e-97, Sum P(2) = 1.5e-97
Identities = 97/118 (82%), Positives = 103/118 (87%)
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET 187
+ EN V ++ + D EG++KIADFGLCKEGMGFGDRT TFCGTPEFLAPEVLTE
Sbjct: 751 LHENNIVYRDLKLDNLLLDQEGFLKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTEA 810
Query: 188 SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAIAIMRR
Sbjct: 811 SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAIAIMRR 868
|
|
| UNIPROTKB|F1MFK1 PKN2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 2.7e-97, Sum P(2) = 2.7e-97
Identities = 94/100 (94%), Positives = 98/100 (98%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 788 DTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 847
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 848 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 887
|
|
| MGI|MGI:109211 Pkn2 "protein kinase N2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 2.8e-97, Sum P(2) = 2.8e-97
Identities = 94/100 (94%), Positives = 98/100 (98%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 790 DTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 849
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 850 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 889
|
|
| UNIPROTKB|F1LPA4 Pkn2 "Serine/threonine-protein kinase N2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 2.8e-97, Sum P(2) = 2.8e-97
Identities = 94/100 (94%), Positives = 98/100 (98%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 790 DTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 849
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 850 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 889
|
|
| UNIPROTKB|F1S4D4 PKN2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 1.4e-96, Sum P(2) = 1.4e-96
Identities = 93/100 (93%), Positives = 98/100 (98%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTEG+VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVL++EM
Sbjct: 776 DTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLVYEM 835
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 836 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 875
|
|
| RGD|620146 Pkn2 "protein kinase N2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 4.5e-96, Sum P(2) = 4.5e-96
Identities = 93/100 (93%), Positives = 96/100 (96%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTE VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 792 DTEASVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 851
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 852 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 891
|
|
| UNIPROTKB|O08874 Pkn2 "Serine/threonine-protein kinase N2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 4.5e-96, Sum P(2) = 4.5e-96
Identities = 93/100 (93%), Positives = 96/100 (96%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
DTE VKIADFGLCKEGMG+GDRT TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI+EM
Sbjct: 792 DTEASVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 851
Query: 206 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
LVGESPFPGDDEEEVFDSIVNDEVRYPRFLS EAI+IMRR
Sbjct: 852 LVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRR 891
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O08874 | PKN2_RAT | 2, ., 7, ., 1, 1, ., 1, 3 | 0.7469 | 0.8979 | 0.2233 | yes | N/A |
| A7MBL8 | PKN2_DANRE | 2, ., 7, ., 1, 1, ., 1, 3 | 0.7428 | 0.8979 | 0.2251 | yes | N/A |
| Q16513 | PKN2_HUMAN | 2, ., 7, ., 1, 1, ., 1, 3 | 0.7551 | 0.8979 | 0.2235 | yes | N/A |
| Q8BWW9 | PKN2_MOUSE | 2, ., 7, ., 1, 1, ., 1, 3 | 0.7510 | 0.8979 | 0.2238 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 245 | |||
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-162 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-119 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-90 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-78 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-77 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-77 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-77 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-74 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-73 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-73 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-71 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-70 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-69 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-68 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-67 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-65 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-65 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-64 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-60 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-60 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-59 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-55 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-55 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-55 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-55 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-52 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-51 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-51 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-50 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-49 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-48 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-47 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-47 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-45 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-44 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-44 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-40 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-39 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-39 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-37 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-37 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-36 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-36 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-35 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-32 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-32 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-32 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-31 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-29 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-29 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-28 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-26 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-25 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-25 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-23 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-19 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.001 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.004 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.004 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.004 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 451 bits (1163), Expect = e-162
Identities = 191/247 (77%), Positives = 207/247 (83%), Gaps = 29/247 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++Y+ TGE +AIKALKKGDIIARDEVESL+ EKRIFE AN+ RHPFLVNLFACFQTE
Sbjct: 15 VLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
HVCFVMEYAAGGDLMMHIH DVFSEPRAVFYAACVVLGLQYLHE++I+YR
Sbjct: 75 DHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR--------- 125
Query: 121 IKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++KL + DTEG+VKIADFGLCKEGMGFGDRT TFCGTPEF
Sbjct: 126 ------------------DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEF 167
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238
LAPEVLTETSYTRAVDWWGLGVLI+EMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS E
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSRE 227
Query: 239 AIAIMRR 245
AI+IMRR
Sbjct: 228 AISIMRR 234
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 342 bits (878), Expect = e-119
Identities = 123/248 (49%), Positives = 164/248 (66%), Gaps = 32/248 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T E +A+K LKK I+ D+VE ++EKR+ +A +HPFL L +CFQT+
Sbjct: 11 VLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFLTQLHSCFQTK 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM HI F EPRA FYAA +VLGLQ+LHE IIYR
Sbjct: 69 DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D+EG++KIADFG+CKEG+ G T TFCGTP+
Sbjct: 121 -------------------DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L+ Y AVDWW LGVL++EML G+SPF GDDE+E+F SI+ DEVRYPR+LS
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSK 221
Query: 238 EAIAIMRR 245
EA +I++
Sbjct: 222 EAKSILKS 229
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 7e-90
Identities = 111/246 (45%), Positives = 149/246 (60%), Gaps = 29/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + ++TG+ +A+K LKK II R EVE L+E+ I + HPF+V L FQTE
Sbjct: 9 VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS---RINHPFIVKLHYAFQTE 65
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V+EYA GG+L H+ FSE RA FYAA +VL L+YLH IIYR
Sbjct: 66 EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYR-------- 117
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN I L D +G++K+ DFGL KE G RT TFCGTPE+L
Sbjct: 118 DLK------PEN--------ILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEVL Y +AVDWW LGVL++EML G+ PF +D +E+++ I+ D +R+P FLS EA
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEA 220
Query: 240 IAIMRR 245
++
Sbjct: 221 RDLISG 226
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 238 bits (608), Expect = 3e-78
Identities = 111/246 (45%), Positives = 156/246 (63%), Gaps = 32/246 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T E+FAIKALKK ++ D+VE + E+R+ +A HPFL +LF FQT+
Sbjct: 11 VMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA--WEHPFLTHLFCTFQTK 68
Query: 61 AHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
H+ FVMEY GGDLM HI + F E RA FYAA ++ GLQ+LH+ IIYR
Sbjct: 69 EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D +G++KIADFG+CKE M + TFCGTP+
Sbjct: 121 -------------------DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L Y +VDWW GVL++EML+G+SPF G+DE+E+FDSI+ND +PR++S
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISK 221
Query: 238 EAIAIM 243
EA +
Sbjct: 222 EAKDCL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 237 bits (605), Expect = 1e-77
Identities = 109/247 (44%), Positives = 156/247 (63%), Gaps = 32/247 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T E +AIK LKK I+ D+V+ ++EKRI +A +HPFL L CFQT+
Sbjct: 11 VMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA--AKHPFLTALHCCFQTK 68
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM I + F EPR+ FYAA V L L +LH +IYR
Sbjct: 69 DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D EG+ K+ADFG+CKEG+ G T TFCGTP+
Sbjct: 121 -------------------DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L E Y +VDWW LGVL++EM+ G+ PF D+E+++F+SI++D+V YP +LS
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSK 221
Query: 238 EAIAIMR 244
EA++I++
Sbjct: 222 EAVSILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 236 bits (603), Expect = 2e-77
Identities = 114/242 (47%), Positives = 149/242 (61%), Gaps = 33/242 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG+Y+A+K LKK IIA+DEV L+E R+ + NT RHPFL L FQT
Sbjct: 11 VILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ--NT-RHPFLTALKYSFQTH 67
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+CFVMEYA GG+L H+ VFSE RA FY A +V L YLH ++YR
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR-------- 119
Query: 120 EIKRIEAKVQENYKVNSSQEIKLT--VNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D +G++KI DFGLCKEG+ G TFCGTPE
Sbjct: 120 -------------------DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
+LAPEVL + Y RAVDWWGLGV+++EM+ G PF D E++F+ I+ +E+R+PR LS
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP 220
Query: 238 EA 239
EA
Sbjct: 221 EA 222
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 6e-77
Identities = 109/245 (44%), Positives = 148/245 (60%), Gaps = 32/245 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T E +AIK LKK II D+VE + EKR+ + + PFL L +CFQT
Sbjct: 16 VMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG--KPPFLTQLHSCFQTM 73
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM HI F EP AVFYAA + +GL +LH IIYR
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D EG++KIADFG+CKE + G T TFCGTP+
Sbjct: 126 -------------------DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE++ Y ++VDWW GVL++EML G+ PF G+DE+E+F SI+ V YP+ LS
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSK 226
Query: 238 EAIAI 242
EA++I
Sbjct: 227 EAVSI 231
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 1e-74
Identities = 111/246 (45%), Positives = 153/246 (62%), Gaps = 32/246 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ + T ++FAIKALKK ++ D+VE + EKR+ +A HPFL +L+ FQT+
Sbjct: 11 VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--WEHPFLTHLYCTFQTK 68
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ FVMEY GGDLM HI + F PRA FYAA ++ GLQ+LH I+YR
Sbjct: 69 ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + DT+G++KIADFG+CKE M +T TFCGTP+
Sbjct: 121 -------------------DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L Y +VDWW GVL++EML+G+SPF G DEEE+F SI D YPR+L+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTR 221
Query: 238 EAIAIM 243
EA I+
Sbjct: 222 EAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 5e-73
Identities = 102/249 (40%), Positives = 146/249 (58%), Gaps = 38/249 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L +++ +G+Y+A+K L K I+ +VE +L+EKRI + RHPFLVNL+ FQ +
Sbjct: 17 VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---RHPFLVNLYGSFQDD 73
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+++ VMEY GG+L H+ + F EP A FYAA VVL L+YLH I+YR P
Sbjct: 74 SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKP---- 129
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + L D++GY+KI DFG K RT T CGTP
Sbjct: 130 -------------EN--------LLL---DSDGYIKITDFGFAKR---VKGRTYTLCGTP 162
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
E+LAPE++ Y +AVDWW LG+LI+EML G PF D+ ++++ I+ +VR+P F S
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFS 222
Query: 237 LEAIAIMRR 245
+A ++R
Sbjct: 223 PDAKDLIRN 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 8e-73
Identities = 106/247 (42%), Positives = 154/247 (62%), Gaps = 32/247 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + +G +A+K LKK I+ D+VE ++EKRI +A HPFL L+ CFQT
Sbjct: 11 VMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQLYCCFQTP 68
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVME+ GGDLM HI + F E RA FYAA + L +LH+ IIYR
Sbjct: 69 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D EG+ K+ADFG+CKEG+ G T TFCGTP+
Sbjct: 121 -------------------DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L E Y +VDWW +GVL++EML G +PF ++E+++F++I+NDEV YP +LS
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ 221
Query: 238 EAIAIMR 244
+A+ I++
Sbjct: 222 DAVDILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 7e-71
Identities = 112/249 (44%), Positives = 157/249 (63%), Gaps = 34/249 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + GEYFA+KALKK ++ D+VE + EKR+ +A +PFL +L+ FQT+
Sbjct: 11 VLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA--WENPFLTHLYCTFQTK 68
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
H+ FVME+ GGDLM HI F RA FYAA +V GLQ+LH IIYR
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTP 176
++KL + D +G++KIADFG+CKE + FGD R TFCGTP
Sbjct: 121 -------------------DLKLDNVMLDRDGHIKIADFGMCKENV-FGDNRASTFCGTP 160
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
+++APE+L YT +VDWW GVL++EML+G+SPF GDDE+E+F+SI D YPR+++
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWIT 220
Query: 237 LEAIAIMRR 245
E+ I+ +
Sbjct: 221 KESKDILEK 229
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 8e-70
Identities = 113/244 (46%), Positives = 153/244 (62%), Gaps = 29/244 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG Y+A+K L+K IIA+DEV ++E R+ + NT RHPFL L FQT
Sbjct: 11 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--NT-RHPFLTALKYAFQTH 67
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+CFVMEYA GG+L H+ + VF+E RA FY A +V L+YLH ++YR
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR-------- 119
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + D +G++KI DFGLCKEG+ G TFCGTPE+L
Sbjct: 120 DIK------LENLML-----------DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEVL + Y RAVDWWGLGV+++EM+ G PF D E +F+ I+ +E+R+PR LS EA
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 222
Query: 240 IAIM 243
+++
Sbjct: 223 KSLL 226
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 2e-69
Identities = 108/245 (44%), Positives = 153/245 (62%), Gaps = 28/245 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T E +AIK LKK +I D+VE + EKR+ + + + PFL L +CFQT
Sbjct: 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQLHSCFQTV 73
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM HI F EP+AVFYAA + +GL +LH IIYR
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+ K+++ + D+EG++KIADFG+CKE M G T TFCGTP+++
Sbjct: 126 -----------DLKLDN------VMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYI 168
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APE++ Y ++VDWW GVL++EML G+ PF G+DE+E+F SI+ V YP+ LS EA
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228
Query: 240 IAIMR 244
++I +
Sbjct: 229 VSICK 233
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 6e-68
Identities = 108/247 (43%), Positives = 151/247 (61%), Gaps = 32/247 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T E +AIK LKK +I D+VE + EKR+ ++ + PFL L +CFQT
Sbjct: 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG--KPPFLTQLHSCFQTM 73
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM I F EP AVFYAA + +GL +LH IIYR
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D+EG++KIADFG+CKE M G T TFCGTP+
Sbjct: 126 -------------------DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE++ Y ++VDWW GVL++EML G++PF G+DE+E+F SI+ V YP+ +S
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 226
Query: 238 EAIAIMR 244
EA+AI +
Sbjct: 227 EAVAICK 233
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 3e-67
Identities = 112/247 (45%), Positives = 151/247 (61%), Gaps = 34/247 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG Y+A+K LKK I+A+DEV L+E R+ + RHPFL L FQT
Sbjct: 11 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ---NSRHPFLTALKYSFQTH 67
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITK 118
+CFVMEYA GG+L H+ + VFSE RA FY A +V L YLH E ++YR
Sbjct: 68 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR------- 120
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLT--VNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++KL + D +G++KI DFGLCKEG+ G TFCGTP
Sbjct: 121 --------------------DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
E+LAPEVL + Y RAVDWWGLGV+++EM+ G PF D E++F+ I+ +E+R+PR LS
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS 220
Query: 237 LEAIAIM 243
EA +++
Sbjct: 221 PEAKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 1e-65
Identities = 88/250 (35%), Positives = 139/250 (55%), Gaps = 34/250 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + ++ FA+K +KK I+ + E + SEK I E N HPF+V L+ F+ +
Sbjct: 9 VELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN---HPFIVKLYRTFKDK 65
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ +MEY GG+L + +F E A FY ACVVL +YLH IIYR
Sbjct: 66 KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR-------- 117
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + D+ GYVK+ DFG K+ + G +T TFCGTPE++
Sbjct: 118 DLK------PENLLL-----------DSNGYVKLVDFGFAKK-LKSGQKTWTFCGTPEYV 159
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE--EVFDSIV--NDEVRYPRFL 235
APE++ Y +VD+W LG+L++E+L G PF DDE+ E+++ I+ N ++ +P ++
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYI 219
Query: 236 SLEAIAIMRR 245
A ++++
Sbjct: 220 DKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-65
Identities = 88/253 (34%), Positives = 136/253 (53%), Gaps = 42/253 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ + TG+ AIK +KK I + + E +L E +I + ++HP +V L+ F+ E
Sbjct: 15 VYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILK---KLKHPNIVRLYDVFEDE 69
Query: 61 AHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ VMEY GGDL + SE A FY ++ L+YLH I++R P+ NI
Sbjct: 70 DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPE-NI 128
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+ D +G+VK+ADFGL ++ + G++ TF GTP
Sbjct: 129 ---------------------------LLDEDGHVKLADFGLARQ-LDPGEKLTTFVGTP 160
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVRYPRF- 234
E++APEVL Y +AVD W LGV+++E+L G+ PFPGDD+ E+F I + +P
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE 220
Query: 235 --LSLEAIAIMRR 245
+S EA ++R+
Sbjct: 221 WDISPEAKDLIRK 233
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-64
Identities = 108/246 (43%), Positives = 153/246 (62%), Gaps = 33/246 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + +G+Y+A+K LKK IIA+DEV L+E R+ + NT RHPFL +L FQT+
Sbjct: 11 VILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK--NT-RHPFLTSLKYSFQTK 67
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+CFVMEY GG+L H+ + VFSE R FY A +V L YLH +I+YR
Sbjct: 68 DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR-------- 119
Query: 120 EIKRIEAKVQENYKVNSSQEIKLT--VNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D +G++KI DFGLCKEG+ TFCGTPE
Sbjct: 120 -------------------DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
+LAPEVL + Y RAVDWWGLGV+++EM+ G PF D E++F+ I+ +++++PR LS
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSA 220
Query: 238 EAIAIM 243
+A +++
Sbjct: 221 DAKSLL 226
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-60
Identities = 97/256 (37%), Positives = 148/256 (57%), Gaps = 41/256 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + + T +A+K +KK + ++++ + +EK +FE A+ HPFLV L +CFQTE
Sbjct: 11 VLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLVGLHSCFQTE 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ + FV+E+ +GGDLM H+ E A FY+A + L L +LHE IIYR
Sbjct: 69 SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D EG++K+ D+G+CKEG+ GD T TFCGTP
Sbjct: 121 -------------------DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF------PGDD---EEEVFDSIVNDE 228
++APE+L Y +VDWW LGVL+FEM+ G SPF D E+ +F I+ +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221
Query: 229 VRYPRFLSLEAIAIMR 244
+R PR LS++A ++++
Sbjct: 222 IRIPRSLSVKASSVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 8e-60
Identities = 92/244 (37%), Positives = 142/244 (58%), Gaps = 28/244 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++++ G+++A+K L+K I+ + E + +++E+ + + ++HPFLV L FQT
Sbjct: 11 VLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV--LLKNVKHPFLVGLHYSFQTA 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FV++Y GG+L H+ + F EPRA FYAA + L YLH IIYR ++ E
Sbjct: 69 DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR---DLKPE 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + D++G+V + DFGLCKEG+ T TFCGTPE+L
Sbjct: 126 NI----------------------LLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEVL + Y R VDWW LG +++EML G PF D E++D+I+N +R +S+ A
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSA 223
Query: 240 IAIM 243
++
Sbjct: 224 RHLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-59
Identities = 82/251 (32%), Positives = 137/251 (54%), Gaps = 39/251 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ ++TG+ +AIK +KK D+I +++V+ +L+E+ I A + P++V L+ FQ +
Sbjct: 9 VFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA---QSPYVVKLYYSFQGK 65
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ VMEY GGDL + E A Y A +VL L+YLH + II+R
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHR-------- 117
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM--------GFGDRTGT 171
++K +N ++S G++K+ DFGL K G+
Sbjct: 118 DLK------PDNILIDS-----------NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 172 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231
GTP+++APEV+ +++ VDWW LG +++E LVG PF G+ EE+F +I+N ++ +
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220
Query: 232 PRFLSL--EAI 240
P + + EAI
Sbjct: 221 PEDVEVSDEAI 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 1e-55
Identities = 89/245 (36%), Positives = 141/245 (57%), Gaps = 28/245 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ ++ G ++A+K L+K I+ + E +++E+ + + ++HPFLV L FQT
Sbjct: 11 VLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV--LLKNLKHPFLVGLHYSFQTA 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FV++Y GG+L H+ + F EPRA FYAA V + YLH IIYR ++ E
Sbjct: 69 EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR---DLKPE 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + D++G+V + DFGLCKEG+ + T TFCGTPE+L
Sbjct: 126 NI----------------------LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEVL + Y R VDWW LG +++EML G PF D +++D+I++ ++ P ++ A
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA 223
Query: 240 IAIMR 244
++
Sbjct: 224 CDLLV 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 3e-55
Identities = 99/256 (38%), Positives = 149/256 (58%), Gaps = 41/256 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + + T +A+K +KK + ++++ + +EK +FE A+ HPFLV L +CFQTE
Sbjct: 11 VLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVGLHSCFQTE 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ + FV+EY GGDLM H+ E A FY+A + L L YLHE IIYR
Sbjct: 69 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D+EG++K+ D+G+CKEG+ GD T TFCGTP
Sbjct: 121 -------------------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF--------PGDDEEE-VFDSIVNDE 228
++APE+L Y +VDWW LGVL+FEM+ G SPF P + E+ +F I+ +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221
Query: 229 VRYPRFLSLEAIAIMR 244
+R PR LS++A ++++
Sbjct: 222 IRIPRSLSVKAASVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 4e-55
Identities = 81/240 (33%), Positives = 130/240 (54%), Gaps = 32/240 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + R + Y+A+K + ++I + + + +EKR+ + + HPF++ LF +
Sbjct: 17 VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK---EVSHPFIIRLFWTEHDQ 73
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ +MEY GG+L ++ FS +FYA+ +V L+YLH I+YR
Sbjct: 74 RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN ++ EG++K+ DFG K+ DRT T CGTPE+L
Sbjct: 126 DLK------PENILLDK-----------EGHIKLTDFGFAKK---LRDRTWTLCGTPEYL 165
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEV+ + +AVDWW LG+LI+EMLVG PF D+ +++ I+ ++ +PR L L A
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYA 225
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 6e-55
Identities = 94/254 (37%), Positives = 146/254 (57%), Gaps = 39/254 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + + + +A+K +KK + ++++ + +EK +FE A++ +PFLV L +CFQT
Sbjct: 11 VLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS--NPFLVGLHSCFQTT 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ + V+EY GGDLM H+ E A FYAA + + L +LHE IIYR
Sbjct: 69 SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR-------- 120
Query: 120 EIKRIEAKVQENYKVNSSQEIKL--TVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++KL + D +G++K+ D+G+CKEG+G GD T TFCGTP
Sbjct: 121 -------------------DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN 161
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF-------PGDDEEEVFDSIVNDEVR 230
++APE+L Y +VDWW LGVL+FEM+ G SPF + E+ +F I+ +R
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR 221
Query: 231 YPRFLSLEAIAIMR 244
PRFLS++A +++
Sbjct: 222 IPRFLSVKASHVLK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 6e-53
Identities = 89/245 (36%), Positives = 139/245 (56%), Gaps = 28/245 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + G+ +A+K L+K ++ R E + +++E+ + + ++HPFLV L FQT
Sbjct: 11 VLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV--LLKNVKHPFLVGLHYSFQTT 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FV+++ GG+L H+ + F EPRA FYAA + L YLH I+YR ++ E
Sbjct: 69 EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR---DLKPE 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + D++G+V + DFGLCKEG+ D T TFCGTPE+L
Sbjct: 126 NI----------------------LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEV+ + Y VDWW LG +++EML G PF D E++D+I++ + SL A
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTA 223
Query: 240 IAIMR 244
+I+
Sbjct: 224 WSILE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-52
Identities = 79/254 (31%), Positives = 123/254 (48%), Gaps = 38/254 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++++ TG+ A+K LKK + ++ E RI + HP +V L F+ +
Sbjct: 15 VYKAKHKGTGKIVAVKILKKRSEK-SKKDQTARREIRIL---RRLSHPNIVRLIDAFEDK 70
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
H+ VMEY GGDL ++ SE A A ++ GL+YLH + II+R
Sbjct: 71 DHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR-------- 122
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K + I L D G VKIADFGL K+ + TF GTP ++
Sbjct: 123 DLK--------------PENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYM 165
Query: 180 APEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFDSIVNDEVRYPRF- 234
APEVL Y VD W LGV+++E+L G+ PF G+ D+ ++ I+ + +
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK 225
Query: 235 ---LSLEAIAIMRR 245
S EA ++++
Sbjct: 226 WSSGSEEAKDLIKK 239
|
Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-52
Identities = 85/242 (35%), Positives = 139/242 (57%), Gaps = 32/242 (13%)
Query: 7 RNTGEYFAIKALKKGDII--ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
+TG+ FA+K LKK I+ +D + +E+ I E ++HPF+V+L FQT +
Sbjct: 21 ADTGKIFAMKVLKKATIVRNQKDTAHTK-AERNILE---AVKHPFIVDLIYAFQTGGKLY 76
Query: 65 FVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKR 123
++EY +GG+L MH+ + +F E A FY + + L L++LH+ IIYR ++ E I
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR---DLKPENI-- 131
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV 183
+ D +G+VK+ DFGLCKE + G T TFCGT E++APE+
Sbjct: 132 --------------------LLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 184 LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIM 243
L + + +AVDWW LG L+++ML G PF ++ ++ D I+ ++ P +L+ EA ++
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL 231
Query: 244 RR 245
++
Sbjct: 232 KK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 4e-52
Identities = 88/262 (33%), Positives = 132/262 (50%), Gaps = 56/262 (21%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + + TG+ FA+K L K ++I R++V+ +L+E+ I T+ HPFL L+A FQTE
Sbjct: 17 VFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA---TLDHPFLPTLYASFQTE 73
Query: 61 AHVCFVMEYAAGGDLMMHIHA-------DVFSEPRAVFYAACVVLGLQYLHESRIIYR-- 111
++C VM+Y GG+L SE A FYAA V+L L+YLH I+YR
Sbjct: 74 TYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129
Query: 112 -P--------------------QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150
P QS++ + + K VNS +E +
Sbjct: 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP--------SETF 181
Query: 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210
+ F R+ +F GT E++APEV++ + AVDWW LG+L++EML G +
Sbjct: 182 SEEPSF-----------RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 211 PFPGDDEEEVFDSIVNDEVRYP 232
PF G + +E F +I+ EV +P
Sbjct: 231 PFKGSNRDETFSNILKKEVTFP 252
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-51
Identities = 84/245 (34%), Positives = 126/245 (51%), Gaps = 34/245 (13%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
Q R+T + FA+K + K + + V ++L+E+RI + + HPFLVNL+ FQ E ++
Sbjct: 20 QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQ---ELNHPFLVNLWYSFQDEENMY 76
Query: 65 FVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKR 123
V++ GGDL H+ FSE + F+ +VL L+YLH II+R +IK
Sbjct: 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR--------DIK- 127
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV 183
+N I L D +G+V I DF + + + T + GTP ++APEV
Sbjct: 128 -----PDN--------ILL---DEQGHVHITDFNIATK-VTPDTLTTSTSGTPGYMAPEV 170
Query: 184 LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD---EEEVFDSIVNDEVRYPRFLSLEAI 240
L Y+ AVDWW LGV +E L G+ P+ G +++ +V YP S EAI
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI 230
Query: 241 -AIMR 244
AI +
Sbjct: 231 DAINK 235
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 6e-51
Identities = 87/240 (36%), Positives = 131/240 (54%), Gaps = 32/240 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +++++ TGEY+AIK LKK +I+ +V+ + EK I + HPF+VN+ FQ E
Sbjct: 34 VRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM---ELSHPFIVNMMCSFQDE 90
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
V F++E+ GG+L H+ A F A FY A +VL +YLH IIYR
Sbjct: 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYR-------- 142
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + D +G+VK+ DFG K+ DRT T CGTPE+L
Sbjct: 143 DLK------PENLLL-----------DNKGHVKVTDFGFAKK---VPDRTFTLCGTPEYL 182
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEV+ + +AVDWW +GVL++E + G PF D +++ I+ +++P + A
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-50
Identities = 85/227 (37%), Positives = 132/227 (58%), Gaps = 28/227 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++++ +++A+K L+K I+ + E + ++SE+ + + ++HPFLV L FQT
Sbjct: 11 VLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNVKHPFLVGLHFSFQTA 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FV++Y GG+L H+ + F EPRA FYAA + L YLH I+YR ++ E
Sbjct: 69 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR---DLKPE 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + D++G++ + DFGLCKE + T TFCGTPE+L
Sbjct: 126 NI----------------------LLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYL 163
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
APEVL + Y R VDWW LG +++EML G PF + E++D+I+N
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-49
Identities = 88/241 (36%), Positives = 132/241 (54%), Gaps = 28/241 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + ++T +A+K L K +I+A+ EV + E+ I PF+V L FQT+
Sbjct: 9 VYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD 68
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ + V +Y +GG+L H+ + FSE RA FY A +VL L++LH+ I+YR ++ E
Sbjct: 69 SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR---DLKPE 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + D G++ + DFGL K + T TFCGT E+L
Sbjct: 126 NI----------------------LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163
Query: 180 APEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR-FLSL 237
APEVL E YT+ VD+W LGVL+FEM G SPF +D ++++ +I +VR+P+ LS
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD 223
Query: 238 E 238
E
Sbjct: 224 E 224
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-49
Identities = 81/227 (35%), Positives = 125/227 (55%), Gaps = 29/227 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
R+T +A+K ++K I++R EV L+E+ + N PF+V L FQ+ + V
Sbjct: 15 RDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC---PFIVPLKFSFQSPEKLYLV 71
Query: 67 MEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+ + GG+L H+ + F RA FY A ++ L+ LH+ +IYR ++ E I
Sbjct: 72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR---DLKPENI---- 124
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185
+ D +G++ + DFGLCK M D+T TFCGTPE+LAPE+L
Sbjct: 125 ------------------LLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 186 ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
YT+AVDWW LGVL++EML G PF ++ E++ I+ + +R+P
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-48
Identities = 76/255 (29%), Positives = 126/255 (49%), Gaps = 26/255 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + T + +AIK L K +I +V+ + EK + N HP ++ L+ FQ E
Sbjct: 17 VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--GHPGIIKLYYTFQDE 74
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
++ FV+EYA G+L+ +I E FYAA ++L L+YLH II+R P+ NI
Sbjct: 75 ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPE-NI 133
Query: 117 TKEEIKRIE------AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
++ I+ AKV + S + T D++ R
Sbjct: 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN-------------RRRFA 180
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230
+F GT E+++PE+L E ++ D W LG +I++ML G+ PF G +E F I+ E
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240
Query: 231 YPRFLSLEAIAIMRR 245
+P +A ++ +
Sbjct: 241 FPPNFPPDAKDLIEK 255
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-47
Identities = 84/239 (35%), Positives = 127/239 (53%), Gaps = 30/239 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ G+ +A+K LKK + RD V + + + EV HPF+V L FQTE + +
Sbjct: 21 PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV----NHPFIVKLHYAFQTEGKLYLI 76
Query: 67 MEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+++ GGDL + +V F+E FY A + L L +LH IIYR ++ E I
Sbjct: 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR---DLKPENI---- 129
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185
+ D EG++K+ DFGL KE + + +FCGT E++APEV+
Sbjct: 130 ------------------LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 186 ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMR 244
+T++ DWW GVL+FEML G PF G D +E I+ ++ P+FLS EA +++R
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-47
Identities = 86/250 (34%), Positives = 132/250 (52%), Gaps = 36/250 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ R+TG+YFAIK LKK D+IA+++V ++ +E+ I + P++ L+ FQ++
Sbjct: 12 VYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLYYSFQSK 69
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ VMEY GGD I E A Y A VVLG++ LH+ II+R
Sbjct: 70 DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR-------- 121
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + D G++K+ DFGL + G+ F GTP++L
Sbjct: 122 DIK------PENLLI-----------DQTGHLKLTDFGLSRNGLENKK----FVGTPDYL 160
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FL 235
APE + + DWW LG +IFE L G PF + + VFD+I++ + +P F
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC 220
Query: 236 SLEAIAIMRR 245
S EA+ ++ R
Sbjct: 221 SPEAVDLINR 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-45
Identities = 87/247 (35%), Positives = 133/247 (53%), Gaps = 36/247 (14%)
Query: 8 NTGEYFAIKALKKGDIIARDEV-ESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ G+ +A+K LKK I+ + + E +E+++ E R PFLV L FQT+ + +
Sbjct: 26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR--RCPFLVTLHYAFQTDTKLHLI 83
Query: 67 MEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
++Y GG+L H+ + F+E Y A +VL L +LH+ IIYR +IK
Sbjct: 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYR--------DIK--- 132
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM-GFGDRTGTFCGTPEFLAPEVL 184
EN I L D+EG+V + DFGL KE + +R +FCGT E++APEV+
Sbjct: 133 ---LEN--------ILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 185 T--ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE----EVFDSIVNDEVRYPRFLSLE 238
+ +AVDWW LGVL FE+L G SPF D E+ E+ I+ + +P+ +S E
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 239 AIAIMRR 245
A +++
Sbjct: 239 ARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 7e-44
Identities = 81/247 (32%), Positives = 123/247 (49%), Gaps = 36/247 (14%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
Q + TG+ +A K L K + R + L+EK+I E ++ F+V+L F+T+ +C
Sbjct: 13 QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS---RFIVSLAYAFETKDDLC 69
Query: 65 FVMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
VM GGDL HI+ F E RA+FYAA ++ GL++LH+ RI+YR ++ E +
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR---DLKPENV 126
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAP 181
+ D G V+I+D GL E + G + GTP ++AP
Sbjct: 127 ----------------------LLDDHGNVRISDLGLAVE-LKGGKKIKGRAGTPGYMAP 163
Query: 182 EVLTETSYTRAVDWWGLGVLIFEMLVGESPF----PGDDEEEVFDSIVNDEVRYPRFLSL 237
EVL Y +VDW+ LG ++EM+ G SPF ++EE+ + V YP S
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSP 223
Query: 238 EAIAIMR 244
EA +
Sbjct: 224 EAKDLCE 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-44
Identities = 88/266 (33%), Positives = 140/266 (52%), Gaps = 51/266 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L +++ T + FA+K + K ++I R++++ + E+ I A +PF+V++F F+T+
Sbjct: 17 VYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE---NPFVVSMFCSFETK 73
Query: 61 AHVCFVMEYAAGGD---LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
H+C VMEY GGD L+ +I A A Y A VL L+YLH I++R
Sbjct: 74 RHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHR------ 125
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM---------GFGDR 168
++K +N + S IKLT DFGL K G+ G ++
Sbjct: 126 --DLK------PDNLLITSMGHIKLT-----------DFGLSKIGLMSLTTNLYEGHIEK 166
Query: 169 -TGTF-----CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD 222
T F CGTPE++APEV+ Y + VDWW +G++++E LVG PF GD EE+F
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 223 SIVNDEVRYP---RFLSLEAIAIMRR 245
+++D++ +P L +A ++ R
Sbjct: 227 QVISDDIEWPEGDEALPADAQDLISR 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 93/279 (33%), Positives = 142/279 (50%), Gaps = 62/279 (22%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + ++TG+ +A+K L+K D+I R+++ + +E+ I A++ P++V L+ FQ E
Sbjct: 17 VWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS---PWIVKLYYSFQDE 73
Query: 61 AHVCFVMEYAAGGDLMMH-IHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
H+ VMEY GGDLM I DVF E A FY A +VL L +H+ I+R
Sbjct: 74 EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT---------- 169
+IK +N + D +G++K+ADFGLCK+ DR
Sbjct: 126 DIK------PDNILI-----------DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 170 -------------------GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210
+ GTP+++APEVL T Y DWW LGV+++EML G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 211 PFPGDDEEEVFDSIVN--DEVRYP--RFLSLEAIAIMRR 245
PF D +E ++ I+N + +R+P +S EAI ++ R
Sbjct: 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-41
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 38/211 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ + TG+ AIK +KK D + +E LL E E+ + HP +V L+ F+ E
Sbjct: 9 VYLARDKKTGKKVAIKIIKKED--SSSLLEELLRE---IEILKKLNHPNIVKLYGVFEDE 63
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSN 115
H+ VMEY GG L ++ + SE + ++ GL+YLH + II+R P N
Sbjct: 64 NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP-EN 122
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
I L ++ G VK+ADFGL K T GT
Sbjct: 123 I-------------------------L-LDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156
Query: 176 PEFLAPEVLT-ETSYTRAVDWWGLGVLIFEM 205
P ++APEVL + Y+ D W LGV+++E+
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 6e-40
Identities = 84/246 (34%), Positives = 139/246 (56%), Gaps = 35/246 (14%)
Query: 8 NTGEYFAIKALKKGDIIARDE-VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+TG+ +A+K L+K ++ + + VE +E+ + E + + PFLV L FQTEA + +
Sbjct: 26 DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE--HVRQSPFLVTLHYAFQTEAKLHLI 83
Query: 67 MEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
++Y +GG++ H++ D FSE FY+ ++L L++LH+ I+YR +I E I
Sbjct: 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYR---DIKLENI---- 136
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMG-FGDRTGTFCGTPEFLAPEVL 184
+ D+EG+V + DFGL KE + +RT +FCGT E++APE++
Sbjct: 137 ------------------LLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 185 -TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE----EVFDSIVNDEVRYPRFLSLEA 239
+ + +AVDWW LG+LIFE+L G SPF + E EV I+ + +P F+ EA
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 240 IAIMRR 245
++ +
Sbjct: 239 QDLLHK 244
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-40
Identities = 87/249 (34%), Positives = 124/249 (49%), Gaps = 39/249 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V Q R TG+ +A K L K + R E + EKRI ++ F+V+L FQT+
Sbjct: 9 VSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR---FIVSLAYAFQTK 65
Query: 61 AHVCFVMEYAAGGDLMMHIHADV------FSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
+C VM GGDL HI+ +V F EPRA FY A ++ GL++LH+ RIIYR
Sbjct: 66 TDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR--- 121
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
++K EN + D +G V+I+D GL E +T + G
Sbjct: 122 -----DLK------PEN-----------VLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVR 230
TP F+APE+L Y +VD++ LGV ++EM+ PF E +E+ I+ND V
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219
Query: 231 YPRFLSLEA 239
YP S +
Sbjct: 220 YPDKFSPAS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-39
Identities = 66/248 (26%), Positives = 109/248 (43%), Gaps = 43/248 (17%)
Query: 1 VILSQYRNTGEYFAIKA--LKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ 58
V L + ++ G+ + +K L R++ L+E +I + HP ++ + F+
Sbjct: 16 VYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKIL---KKLNHPNIIKYYESFE 69
Query: 59 TEAHVCFVMEYAAGGDLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
+ +C VMEYA GGDL I F E + + + + L L+YLH +I++R
Sbjct: 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR-- 127
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
+IK Q I LT + G VK+ DFG+ K D T
Sbjct: 128 ------DIK--------------PQNIFLT---SNGLVKLGDFGISKVLSSTVDLAKTVV 164
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---- 229
GTP +L+PE+ Y D W LG +++E+ + PF G++ E+ I+ +
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP 224
Query: 230 -RYPRFLS 236
+Y L
Sbjct: 225 SQYSSELR 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 78/248 (31%), Positives = 130/248 (52%), Gaps = 35/248 (14%)
Query: 1 VILSQYRNTGEY--FAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ 58
VIL+ Y+N ++ AIK +K II + +V+ + SE++I N + HPF VNL+ F+
Sbjct: 46 VILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL---NYINHPFCVNLYGSFK 101
Query: 59 TEAHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
E+++ V+E+ GG+ + + F FYAA +VL +YL I+YR ++
Sbjct: 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR---DLK 158
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
E + + D +G++K+ DFG K RT T CGTPE
Sbjct: 159 PENL----------------------LLDKDGFIKMTDFGFAKV---VDTRTYTLCGTPE 193
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L + +A DWW LG+ I+E+LVG PF ++ ++ I+ + +P+FL
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN 253
Query: 238 EAIAIMRR 245
+M++
Sbjct: 254 NCKHLMKK 261
|
Length = 340 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-39
Identities = 87/247 (35%), Positives = 123/247 (49%), Gaps = 36/247 (14%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
Q R TG+ +A K L+K I R L+EK+I E N+ F+V+L ++T+ +C
Sbjct: 20 QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS---RFVVSLAYAYETKDALC 76
Query: 65 FVMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
V+ GGDL HI+ F E RAVFYAA + GL+ LH RI+YR ++ E I
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR---DLKPENI 133
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAP 181
+ D G+++I+D GL E + G+ GT ++AP
Sbjct: 134 ----------------------LLDDYGHIRISDLGLAVE-IPEGETIRGRVGTVGYMAP 170
Query: 182 EVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPRFLSL 237
EV+ YT + DWWGLG LI+EM+ G+SPF E EEV + D+ Y S
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSE 230
Query: 238 EAIAIMR 244
A +I R
Sbjct: 231 AARSICR 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 73/253 (28%), Positives = 119/253 (47%), Gaps = 37/253 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L+ ++TGE A+K+++ + +E+E+L E RI ++++HP +V + + E
Sbjct: 16 VYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRIL---SSLQHPNIVRYYGSERDE 71
Query: 61 AHVCF--VMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+EY +GG L + EP Y ++ GL YLH + I++R
Sbjct: 72 EKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR------ 125
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGT 175
+IK I + D++G VK+ADFG K + G+ TG+ GT
Sbjct: 126 --DIK--------------GANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP--GDDEEEVFDSIVNDEVRY-P 232
P ++APEV+ Y RA D W LG + EM G+ P+ G+ ++ + E P
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226
Query: 233 RFLSLEAIAIMRR 245
LS EA +R+
Sbjct: 227 EHLSEEAKDFLRK 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-37
Identities = 68/227 (29%), Positives = 111/227 (48%), Gaps = 32/227 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ ++TGE A+K +KK + +EV +L+E+ I +LV L FQ +
Sbjct: 17 VFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK---SEWLVKLLYAFQDD 73
Query: 61 AHVCFVMEYAAGGDL-MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ MEY GGD + + V SE A FY A + + LHE I+R
Sbjct: 74 EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN+ +++S G++K+ DFGL K + + G+P+++
Sbjct: 126 DLK------PENFLIDAS-----------GHIKLTDFGLSKGIV---TYANSVVGSPDYM 165
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
APEVL Y VD+W LG +++E L G PF G E ++++
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 5e-37
Identities = 80/247 (32%), Positives = 132/247 (53%), Gaps = 36/247 (14%)
Query: 8 NTGEYFAIKALKKGDIIARDEV-ESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
++G+ +A+K LKK I+ + + E +E+++ E + + PFLV L FQT+ + +
Sbjct: 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE--HIRQSPFLVTLHYAFQTDTKLHLI 83
Query: 67 MEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
++Y GG+L H+ F E Y+ +VL L++LH+ IIYR +I E I
Sbjct: 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYR---DIKLENI---- 136
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG-DRTGTFCGTPEFLAPEVL 184
+ D+ G+V + DFGL KE +R +FCGT E++AP+++
Sbjct: 137 ------------------LLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 185 T--ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE----EVFDSIVNDEVRYPRFLSLE 238
+ + +AVDWW +GVL++E+L G SPF D E+ E+ I+ E YP+ +S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 239 AIAIMRR 245
A I++R
Sbjct: 239 AKDIIQR 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-36
Identities = 86/251 (34%), Positives = 124/251 (49%), Gaps = 36/251 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V Q R TG+ +A K L+K I R L+EKRI E N+ F+V+L ++T+
Sbjct: 16 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR---FVVSLAYAYETK 72
Query: 61 AHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+C V+ GGDL HI+ F E RA+FYAA + GL+ L RI+YR ++
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR---DLK 129
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
E I + D G+++I+D GL + + G+ GT
Sbjct: 130 PENI----------------------LLDDRGHIRISDLGLAVQ-IPEGETVRGRVGTVG 166
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPR 233
++APEV+ YT + DWWGLG LI+EM+ G+SPF E EEV + D+ Y
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226
Query: 234 FLSLEAIAIMR 244
S +A +I R
Sbjct: 227 KFSEDAKSICR 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-36
Identities = 83/292 (28%), Positives = 139/292 (47%), Gaps = 79/292 (27%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L Q ++TG +A+K L+K +++ +++V + +E+ I A+ +P++V L+ FQ E
Sbjct: 17 VRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD---NPWVVKLYYSFQDE 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ +MEY GGD+M + + D F+E FY A +L + +H+ I+R
Sbjct: 74 NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK------------------- 160
+IK + L D +G++K++DFGLC
Sbjct: 126 DIK--------------PDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 161 --------EGMGFGDRTGTF-----------CGTPEFLAPEVLTETSYTRAVDWWGLGVL 201
+ M + T+ GTP+++APEV +T Y + DWW LGV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 202 IFEMLVGESPFPGDDEEEVFDSIVN--------DEVRYPRFLSLEAIAIMRR 245
++EMLVG PF D+ +E + I+N DEV LS EA +++R
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP----LSPEAKDLIKR 276
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-35
Identities = 86/249 (34%), Positives = 124/249 (49%), Gaps = 36/249 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V Q R TG+ +A K L+K I R L+EK+I E N+ F+VNL ++T+
Sbjct: 16 VCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ---FVVNLAYAYETK 72
Query: 61 AHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+C V+ GGDL HI+ F E RA+FYAA ++ GL+ LH +YR ++
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR---DLK 129
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
E I + D G+++I+D GL + + G+ GT
Sbjct: 130 PENI----------------------LLDDYGHIRISDLGLAVK-IPEGESIRGRVGTVG 166
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPR 233
++APEVL YT + D+WGLG LI+EM+ G+SPF G E EEV ++ E Y
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226
Query: 234 FLSLEAIAI 242
S EA +I
Sbjct: 227 KFSEEAKSI 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-33
Identities = 77/218 (35%), Positives = 110/218 (50%), Gaps = 38/218 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V Q R TG+ +A K L+K I R L+EK+I E N+ F+V+L ++T+
Sbjct: 16 VCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR---FVVSLAYAYETK 72
Query: 61 AHVCFVMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+C V+ GGDL HI+ F E RAVFYAA + GL+ LH+ RI+YR ++
Sbjct: 73 DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR---DLK 129
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC---KEGMGFGDRTGTFCG 174
E I + D G+++I+D GL EG R GT
Sbjct: 130 PENI----------------------LLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV-- 165
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
++APEV+ YT + DWW LG L++EM+ G+SPF
Sbjct: 166 --GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 34/214 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++++ TG+ AIK +K + ++++ E +++E +I + +HP +V + + +
Sbjct: 16 VYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILK---KCKHPNIVKYYGSYLKK 69
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ VME+ +GG L ++ +E + + ++ GL+YLH + II+R
Sbjct: 70 DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHR------- 122
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+IK + I LT ++G VK+ DFGL + R T GTP +
Sbjct: 123 -DIK--------------AANILLT---SDGEVKLIDFGLSAQLSDTKARN-TMVGTPYW 163
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+APEV+ Y D W LG+ E+ G+ P+
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 76/293 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + +T +A+K L+K D++ R++ + +E+ I A+ ++V L+ FQ +
Sbjct: 17 VCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN---EWVVKLYYSFQDK 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ FVM+Y GGD+M + I +F E A FY A + ++ +H+ I+R
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR-------- 125
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC-------------------K 160
+IK +N + D +G++K+ DFGLC +
Sbjct: 126 DIK------PDNILI-----------DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168
Query: 161 EGMGFGDRTG------------------------TFCGTPEFLAPEVLTETSYTRAVDWW 196
+ M + + GTP ++APEVL T YT+ DWW
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228
Query: 197 GLGVLIFEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRF--LSLEAIAIMRR 245
+GV+++EMLVG+ PF D E ++N + P LS EA ++ R
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR 281
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 47/245 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ TG+ +A+K +KK ++A++ V E+ I ++N+ P++ L FQ + ++ V
Sbjct: 23 KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS---PWIPQLQYAFQDKDNLYLV 79
Query: 67 MEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
MEY GGDL+ ++ + D F E A FY A +VL + +H+ ++R +IK
Sbjct: 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR--------DIK-- 129
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG----LCKEGMGFGDRTGTFCGTPEFLA 180
EN + D G++K+ADFG L M GTP+++A
Sbjct: 130 ----PENVLI-----------DRTGHIKLADFGSAARLTANKMVNSKLP---VGTPDYIA 171
Query: 181 PEVLT------ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF 234
PEVLT + +Y DWW LGV+ +EM+ G SPF + +++I+N + RF
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN----FQRF 227
Query: 235 LSLEA 239
L
Sbjct: 228 LKFPE 232
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-32
Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 36/234 (15%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
Q +NTG+ +A K L K + + + L EK I E N+ PF+VNL F+++ H+C
Sbjct: 13 QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS---PFIVNLAYAFESKTHLC 69
Query: 65 FVMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
VM GGDL HI+ R + Y+A + G+ +LH I+YR ++ E +
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR---DMKPENV 126
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAP 181
+ D +G +++D GL E + G GT ++AP
Sbjct: 127 ----------------------LLDDQGNCRLSDLGLAVE-LKDGKTITQRAGTNGYMAP 163
Query: 182 EVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRY 231
E+L E Y+ VDW+ +G I+EM+ G +PF E EE+ + DEV++
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 73/234 (31%), Positives = 116/234 (49%), Gaps = 39/234 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L +++++ + +A+K L K ++I R + E+ I AN+ ++V L FQ +
Sbjct: 59 VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS---EWIVQLHYAFQDD 115
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
++ VMEY GGDL+ + E A FY A VVL L +H I+R +
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHR--------D 167
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC----KEGMGFGDRTGTFCGTP 176
+K +N ++ S G++K+ADFG C GM R T GTP
Sbjct: 168 VK------PDNMLLDKS-----------GHLKLADFGTCMKMDANGM---VRCDTAVGTP 207
Query: 177 EFLAPEVLT----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
++++PEVL + Y R DWW +GV ++EMLVG++PF D + I++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 41/235 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L +++++ + +A+K L K ++I R + E+ I AN+ P++V LF FQ +
Sbjct: 59 VQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS---PWVVQLFCAFQDD 115
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
++ VMEY GGDL+ + E A FY A VVL L +H +I+R ++ +
Sbjct: 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHR---DVKPDN 172
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG-----TFCGT 175
+ + D G++K+ADFG C + D TG T GT
Sbjct: 173 M----------------------LLDKHGHLKLADFGTCMK----MDETGMVRCDTAVGT 206
Query: 176 PEFLAPEVLTETS----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
P++++PEVL Y R DWW +GV +FEMLVG++PF D + I++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 77/234 (32%), Positives = 117/234 (50%), Gaps = 39/234 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L ++++T + +A+K L K ++I R + E+ I AN+ P++V LF FQ +
Sbjct: 59 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS---PWVVQLFYAFQDD 115
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
++ VMEY GGDL+ + E A FY A VVL L +H I+R ++ +
Sbjct: 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR---DVKPDN 172
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC----KEGMGFGDRTGTFCGTP 176
+ + D G++K+ADFG C KEGM R T GTP
Sbjct: 173 M----------------------LLDKSGHLKLADFGTCMKMNKEGM---VRCDTAVGTP 207
Query: 177 EFLAPEVLTETS----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
++++PEVL Y R DWW +GV ++EMLVG++PF D + I+N
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 73/260 (28%), Positives = 122/260 (46%), Gaps = 76/260 (29%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ +T +A+K L+K D++ R++V + +E+ I A+ + ++V L+ FQ +
Sbjct: 17 VCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD---NEWVVRLYYSFQDK 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ FVM+Y GGD+M + I +F E A FY A + ++ +H+ I+R +I +
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR---DIKPD 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC-------------------K 160
I + D +G++K+ DFGLC +
Sbjct: 131 NI----------------------LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168
Query: 161 EGMGF------------GDR----------------TGTFCGTPEFLAPEVLTETSYTRA 192
+ M F GDR + GTP ++APEVL T YT+
Sbjct: 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228
Query: 193 VDWWGLGVLIFEMLVGESPF 212
DWW +GV+++EMLVG+ PF
Sbjct: 229 CDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-29
Identities = 68/227 (29%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYA 70
+ A+K L K EVE L E +I +A+ P +V L+ FQ E + VMEY
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQI--LASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80
Query: 71 AGGDLMMHIHAD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEA 126
GG L + SE A+F A ++ L+YLH II+R +IK
Sbjct: 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR--------DIK---- 128
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD------RTGTFCGTPEFLA 180
EN + ++ VK+ DFGL K G T GTP ++A
Sbjct: 129 --PEN----------ILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 181 PEVLTETS---YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
PEVL S + + D W LG+ ++E+L G PF G+
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 82/279 (29%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L+ +T +A+K L+K D++ R++V + +E+ I A+ + ++V L+ FQ +
Sbjct: 17 VCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD---NEWVVKLYYSFQDK 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ FVM+Y GGD+M + I +VF E A FY A + L ++ +H+ I+R +I +
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR---DIKPD 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF-------------- 165
I + D +G++K+ DFGLC GF
Sbjct: 131 NI----------------------LIDLDGHIKLTDFGLC---TGFRWTHNSKYYQKGSH 165
Query: 166 --------------------GDRTGT----------------FCGTPEFLAPEVLTETSY 189
GDR T GTP ++APEVL Y
Sbjct: 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225
Query: 190 TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228
T+ DWW +GV++FEMLVG+ PF E ++N E
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-29
Identities = 70/263 (26%), Positives = 127/263 (48%), Gaps = 66/263 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L Q ++TG +A+K L+K D++ +++V + +E+ I A+++ ++V +F FQ +
Sbjct: 17 VRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL---WVVKMFYSFQDK 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ +ME+ GGD+M + + D +E FY A VL + +H+ I+R +I +
Sbjct: 74 LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR---DIKPD 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF------- 172
+ + D++G+VK++DFGLC G+ RT +
Sbjct: 131 NL----------------------LLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSL 167
Query: 173 -----------------------------CGTPEFLAPEVLTETSYTRAVDWWGLGVLIF 203
GTP+++APEV +T Y + DWW LGV+++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 204 EMLVGESPFPGDDEEEVFDSIVN 226
EML+G PF + +E + ++N
Sbjct: 228 EMLIGYPPFCSETPQETYKKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-28
Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 66/263 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L Q ++TG +A+K L+K D++ +++V + +E+ I A+ ++V +F FQ +
Sbjct: 17 VRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG---AWVVKMFYSFQDK 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ +ME+ GGD+M + + D SE FY A VL + +H+ I+R +I +
Sbjct: 74 RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR---DIKPD 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF------- 172
+ + D +G+VK++DFGLC G+ RT +
Sbjct: 131 NL----------------------LLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNP 167
Query: 173 -----------------------------CGTPEFLAPEVLTETSYTRAVDWWGLGVLIF 203
GTP+++APEV +T Y + DWW LGV+++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 204 EMLVGESPFPGDDEEEVFDSIVN 226
EML+G PF + +E + ++N
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 75/283 (26%), Positives = 140/283 (49%), Gaps = 52/283 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L Q ++TG+ +A+K L K ++ +D++ + +E+ + +++ P++V+L+ FQ
Sbjct: 17 VRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS---PWVVSLYYSFQDA 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP------- 112
++ +ME+ GGDLM M I D FSE FY A VL ++ +H+ I+R
Sbjct: 74 QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL 133
Query: 113 ----------------------QSNITKEEIKRIEAKVQENYK----VNSSQEIKLTVND 146
S ++ ++ K + + + V+S I LT++
Sbjct: 134 IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS---INLTMSS 190
Query: 147 TEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML 206
+ +IA + + M + + GTP+++APE+ + Y + DWW LG ++FE L
Sbjct: 191 KD---QIATWKKNRRLMAY-----STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 207 VGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSLEAIAIMRR 245
+G PF ++ E + I+N + + +P LS+EA ++RR
Sbjct: 243 IGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-26
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
TG++ AIK + I + ++S++ E ++ ++HP +V +T + +
Sbjct: 22 LETGDFVAIKQISLEKI-KEEALKSIMQE---IDLLKNLKHPNIVKYIGSIETSDSLYII 77
Query: 67 MEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+EYA G L I F E Y V+ GL YLHE +I+R +IK
Sbjct: 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR--------DIK--- 126
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185
+ I T +G VK+ADFG+ + + GTP ++APEV+
Sbjct: 127 -----------AANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 186 ETSYTRAVDWWGLGVLIFEMLVGESPF 212
+ + A D W LG + E+L G P+
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 70/239 (29%), Positives = 116/239 (48%), Gaps = 36/239 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + +NTG+ +A+K L K +++ R E + E+R V R ++ NL FQ E
Sbjct: 17 VAVVKMKNTGQVYAMKILNKWEMLKRAET-ACFREERDVLVNGDRR--WITNLHYAFQDE 73
Query: 61 AHVCFVMEYAAGGDLMMHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ VM+Y GGDL+ + D E A FY A +VL + +H+ ++R
Sbjct: 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR------- 126
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPE 177
+IK + L D G++++ADFG C + G ++ GTP+
Sbjct: 127 -DIK--------------PDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 178 FLAPEVLTET-----SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231
+++PE+L Y DWW LGV ++EML GE+PF + E + I+N + +
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-26
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 6 YRNTGEYFAIKALK-KGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
++ TG+ AIK + + D+ + ++ E I + P++V + + +
Sbjct: 24 HKETGQVVAIKVVPVEEDL------QEIIKEISILK---QCDSPYIVKYYGSYFKNTDLW 74
Query: 65 FVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
VMEY G + +M I +E + GL+YLH ++ I+R +IK
Sbjct: 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR--------DIK 126
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
+ I L + EG K+ADFG+ + + T GTP ++APE
Sbjct: 127 --------------AGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
V+ E Y D W LG+ EM G+ P+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-25
Identities = 69/245 (28%), Positives = 116/245 (47%), Gaps = 38/245 (15%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVM 67
+TG+ +A+K L K I + L+E+ + + +T PF+V + F T + F++
Sbjct: 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 76
Query: 68 EYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRI 124
+ GGDL H+ VFSE FYAA ++LGL+++H ++YR +NI +E
Sbjct: 77 DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE---- 132
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT-GTFCGTPEFLAPEV 183
G+V+I+D GL + F + GT ++APEV
Sbjct: 133 -----------------------HGHVRISDLGLACD---FSKKKPHASVGTHGYMAPEV 166
Query: 184 LTE-TSYTRAVDWWGLGVLIFEMLVGESPFPG---DDEEEVFDSIVNDEVRYPRFLSLEA 239
L + +Y + DW+ LG ++F++L G SPF D+ E+ + V P S E
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 240 IAIMR 244
+++
Sbjct: 227 RSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +++ TG+ +A+K + + LL E + P++V + F E
Sbjct: 17 VYKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKTLRSCE---SPYVVKCYGAFYKE 71
Query: 61 AHVCFVMEYAAGGDLMMHIHADV------FSEPRAVFYAACVVLGLQYLH-ESRIIYRPQ 113
+ V+EY GG L AD+ EP + A ++ GL YLH + II+R
Sbjct: 72 GEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR-- 124
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
+IK N +NS +G VKIADFG+ K D+ TF
Sbjct: 125 ------DIK------PSNLLINS-----------KGEVKIADFGISKVLENTLDQCNTFV 161
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD 222
GT +++PE + SY+ A D W LG+ + E +G+ PF + F+
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 4e-25
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + R TG+ AIK ++ + + E +++E I +HP +V+ + +
Sbjct: 35 VYKATDRATGKEVAIKKMR----LRKQNKELIINEILIM---KDCKHPNIVDYYDSYLVG 87
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ VMEY GG L ++ + +EP+ + V+ GL+YLH +I+R
Sbjct: 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR------- 140
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+IK S I L+ + G VK+ADFG + + + GTP +
Sbjct: 141 -DIK--------------SDNILLSKD---GSVKLADFGFAAQLTKEKSKRNSVVGTPYW 182
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+APEV+ Y VD W LG++ EM GE P+
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 5e-25
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 47/222 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAHVCFVMEYA 70
A+K LK+G + +E E L E A+ M+ HP +V L + V EY
Sbjct: 32 AVKTLKEGA--SEEEREEFLEE------ASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYM 83
Query: 71 AGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK- 127
GGDL + H + + + A + G++YL ++R ++ A+
Sbjct: 84 PGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHR---DLA--------ARN 132
Query: 128 --VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPEF-LAPEV 183
V EN VKI+DFGL ++ R P +APE
Sbjct: 133 CLVTEN-----------------LVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
L + +T D W GVL++E+ +GE P+PG EEV + +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-25
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 35/210 (16%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVM 67
+TG+ +A+K L K I + L+E+ + + +T PF+V + F T +CF++
Sbjct: 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFIL 76
Query: 68 EYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRI 124
+ GGDL H+ VFSE FYA ++LGL+++H ++YR +NI +E
Sbjct: 77 DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE---- 132
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT-GTFCGTPEFLAPEV 183
G+V+I+D GL + F + GT ++APEV
Sbjct: 133 -----------------------HGHVRISDLGLACD---FSKKKPHASVGTHGYMAPEV 166
Query: 184 LTE-TSYTRAVDWWGLGVLIFEMLVGESPF 212
L + T+Y + DW+ LG ++F++L G SPF
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-24
Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 36/239 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + ++T +A+K L K +++ R E E+ + + ++ L FQ E
Sbjct: 17 VAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ---WITTLHYAFQDE 73
Query: 61 AHVCFVMEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ VM+Y GGDL+ + D E A FY A +VL + +H+ ++R
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR------- 126
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPE 177
+IK + L +N G++++ADFG C + G ++ GTP+
Sbjct: 127 -DIK--------------PDNVLLDMN---GHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 178 FLAPEVLTETS-----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231
+++PE+L Y DWW LGV ++EML GE+PF + E + I+N E R+
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-23
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 9 TGEYFAIKALKKGDIIARDE---VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
TG A+K + + ++ VE+L E R+ + HP ++ + ++H
Sbjct: 24 TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM---ARLNHPHIIRMLGATCEDSHFNL 80
Query: 66 VMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
+E+ AGG + + F E + Y ++ GL YLHE++II+R
Sbjct: 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR------------- 127
Query: 125 EAKVQENYKVNSSQEIK---LTVNDTEGYVKIADFG----LCKEGMGFGDRTGTFCGTPE 177
++K L ++ T ++IADFG L +G G G+ G GT
Sbjct: 128 --------------DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
F+APEVL Y R+ D W +G +I EM + P+ +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-23
Identities = 65/239 (27%), Positives = 115/239 (48%), Gaps = 36/239 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + +N + FA+K L K +++ R E E+ + + + ++ L FQ E
Sbjct: 17 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD---NQWITTLHYAFQDE 73
Query: 61 AHVCFVMEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ VM+Y GGDL+ + D E A FY A +V+ + +H+ ++R +I
Sbjct: 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR---DIKP 130
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPE 177
+ I + D G++++ADFG C + M G ++ GTP+
Sbjct: 131 DNI----------------------LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 178 FLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231
+++PE+L + Y DWW LGV ++EML GE+PF + E + I+N + R+
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 7e-22
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 31/162 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + +N + +A+K +KK D+I ++ V + +E+ ++ + PF+V+L+ Q+
Sbjct: 20 VYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS---KSPFIVHLYYSLQSA 76
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+V VMEY GGD+ ++HI+ F E AV Y + V L L YLH II+R
Sbjct: 77 NNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHR------- 128
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160
++K +N +++ IKLT DFGL K
Sbjct: 129 -DLK------PDNMLISNEGHIKLT-----------DFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 9e-22
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 1 VILSQYRNTGEYFAIKA--LKKGDIIARDEVESLLSE-KRIFEVANTMRHPFLVNLFACF 57
V L ++GE A+K L ++D S+L R + ++H +V
Sbjct: 16 VYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75
Query: 58 QTEAHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
H+ +EY GG + + + F E + ++ GL YLH II+R
Sbjct: 76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHR----- 130
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE------GMGFGDRTG 170
+IK V D +G +KI+DFG+ K+
Sbjct: 131 ---DIKGANILV-----------------DNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213
+ G+ ++APEV+ +TSYTR D W LG L+ EML G+ PFP
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-21
Identities = 60/191 (31%), Positives = 95/191 (49%), Gaps = 30/191 (15%)
Query: 30 ESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI---HADVFSE 86
E S+K + +A M+HP +V FA FQ + VMEY GGDLM I +FSE
Sbjct: 42 EKEASKKEVILLAK-MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE 100
Query: 87 PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146
+ + + + LGL+++H+ +I++R +IK SQ I L+ N
Sbjct: 101 DQILSWFVQISLGLKHIHDRKILHR--------DIK--------------SQNIFLSKN- 137
Query: 147 TEGYV-KIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
G V K+ DFG+ ++ + T GTP +L+PE+ Y D W LG +++E+
Sbjct: 138 --GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
Query: 206 LVGESPFPGDD 216
+ PF G++
Sbjct: 196 CTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-20
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 9 TGEYFAIKA--LKKGDIIARDEVE------SLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
TG A+K L D D+V +LLS+ R + N ++ + +
Sbjct: 25 TGRVVALKIINLDTPD----DDVSDIQREVALLSQLRQSQPPNITKY------YGSYLKG 74
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ +MEYA GG + + A +E V++ L+Y+H+ +I+R +
Sbjct: 75 PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHR--------D 126
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
IK + I +T G VK+ DFG+ + TF GTP ++A
Sbjct: 127 IK--------------AANILVT---NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMA 169
Query: 181 PEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
PEV+TE Y D W LG+ I+EM G P+ D I
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-20
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 38/215 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDII----ARDEVESLLSEKRIFEVANTMRHPFLVNLFAC 56
V + + T + AIK +I A DE+E + E I + R P++ +
Sbjct: 17 VYKAIDKRTNQVVAIK------VIDLEEAEDEIEDIQQE--IQ-FLSQCRSPYITKYYGS 67
Query: 57 FQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
F + + +MEY GG + + E F V+LGL+YLHE I+R
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR----- 122
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+IK + I L+ EG VK+ADFG+ + + TF GTP
Sbjct: 123 ---DIK--------------AANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTP 162
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESP 211
++APEV+ ++ Y D W LG+ E+ GE P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-20
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 35/211 (16%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACFQTEAHV 63
+ G++FA+K + +A D + K++ E+A + ++HP +V + E ++
Sbjct: 22 LDDGDFFAVKEVS----LADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL 77
Query: 64 CFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
+E GG L + F EP Y ++LGL+YLH+ ++R +IK
Sbjct: 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR--------DIK 129
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
V DT G VK+ADFG+ K+ + F +F G+P ++APE
Sbjct: 130 GANILV-----------------DTNGVVKLADFGMAKQVVEF-SFAKSFKGSPYWMAPE 171
Query: 183 VLTET-SYTRAVDWWGLGVLIFEMLVGESPF 212
V+ + Y A D W LG + EM G+ P+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 3e-20
Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 45/242 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCFVMEYAAG 72
A+K LK+ ++E L E RI + HP +V L C + E VMEY G
Sbjct: 32 AVKTLKEDAS--EQQIEEFLREARIM---RKLDHPNVVKLLGVCTEEEPL-YIVMEYMEG 85
Query: 73 GDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIEAKV 128
GDL+ + + S + +A + G++YL I+R N V
Sbjct: 86 GDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL----------V 135
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE---FLAPEVLT 185
EN VKI+DFGL ++ + D G ++APE L
Sbjct: 136 GENLV-----------------VKISDFGLSRD--LYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 186 ETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI-AIM 243
E +T D W GVL++E+ +GE P+PG EEV + + N + +M
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLM 236
Query: 244 RR 245
+
Sbjct: 237 LQ 238
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-20
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 17 ALKKGDI--IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGD 74
ALK+ D+ +++ E E ++E RI N HP +++ F +C VMEYA GD
Sbjct: 29 ALKEVDLGSMSQKEREDAVNEIRILASVN---HPNIISYKEAFLDGNKLCIVMEYAPFGD 85
Query: 75 LMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQ 129
L I + E ++ GLQ LHE +I++R ++K
Sbjct: 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR--------DLK------- 130
Query: 130 ENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY 189
S I L ND VKI D G+ K +T GTP ++APEV Y
Sbjct: 131 -------SANILLVANDL---VKIGDLGISKVLKKNMAKTQI--GTPHYMAPEVWKGRPY 178
Query: 190 TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
+ D W LG L++EM PF +++ + +YP
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-19
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 2 ILSQYRNTGEYFAIKAL---KKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ 58
+L Q+ N+ + +A+K + K + E++L K M+HP +V F+
Sbjct: 17 LLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAK--------MKHPNIVAFKESFE 68
Query: 59 TEAHVCFVMEYAAGGDLMMHI---HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
+ H+ VMEY GGDLM I +F E + + + LG+Q++HE R+++R
Sbjct: 69 ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR---- 124
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
+IK S+ I LT N G VK+ DFG + G T+ GT
Sbjct: 125 ----DIK--------------SKNIFLTQN---GKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
P ++ PE+ Y D W LG +++E+ + PF
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-19
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 8 NTGEYFAIKALKKG--DIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
+TG A+K + + EV +L E ++ ++H +V + C + + +
Sbjct: 25 DTGRELAVKQVPFDPDSPETKKEVNALECE---IQLLKNLQHERIVQYYGCLRDDETLSI 81
Query: 66 VMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
MEY GG + + A +E Y ++ G++YLH + I++R +I I R
Sbjct: 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR---DIKGANILR- 137
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG-------LCKEGMGFGDRTGTFCGTPE 177
D+ G VK+ DFG +C G G + GTP
Sbjct: 138 ---------------------DSAGNVKLGDFGASKRLQTICSSGTGMK----SVTGTPY 172
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+++PEV++ Y R D W +G + EML + P+
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-19
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 39/209 (18%)
Query: 17 ALKKGDI--IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGD 74
A+K+ D+ + R E E + E R+ + +++ + F + + VMEYA GD
Sbjct: 29 AMKQIDLSKMNRREREEAIDEARVLA---KLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85
Query: 75 LMMHIHADV---FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN 131
L + E + + ++LGL +LH +I++R +IK
Sbjct: 86 LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR--------DIK--------- 128
Query: 132 YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT---GTFCGTPEFLAPEVLTETS 188
S + L D VKI D G+ K D T T GTP +L+PE+ +
Sbjct: 129 -----SLNLFLDAYDN---VKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 189 YTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
Y D W LGV+++E G+ PF +++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 65/225 (28%), Positives = 96/225 (42%), Gaps = 49/225 (21%)
Query: 8 NTGEYFAIK--ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH--- 62
+TGE A+K ++ D E+ E ++ E+ ++HP NL + E H
Sbjct: 23 DTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLEL---LKHP---NLVKYYGVEVHREK 73
Query: 63 VCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
V MEY +GG L ++ H + E Y ++ GL YLH I++R +
Sbjct: 74 VYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR--------D 124
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG----LCKEGMGFGDRTGTFCGTP 176
IK N I L N G +K+ DFG L G+ + GTP
Sbjct: 125 IK------PAN--------IFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 177 EFLAPEVLTETSYT---RAVDWWGLGVLIFEMLVGESPFPGDDEE 218
++APEV+T RA D W LG ++ EM G+ P+ D E
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-19
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 40/211 (18%)
Query: 45 MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH-----ADVFSEPRAVFYAACVVLG 99
+ HP +V A F C + EY G DL + SE + + ++LG
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 100 LQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159
+ Y+H+ RI++R ++K ++ I L N +KI DFG+
Sbjct: 119 VHYMHQRRILHR--------DLK--------------AKNIFLKNN----LLKIGDFGVS 152
Query: 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+ MG D TF GTP +++PE L Y D W LG +++EM F G +
Sbjct: 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212
Query: 220 VFDSIVNDEV-----RYPRFLSLEAIAIMRR 245
V IV Y R L+ +IM+
Sbjct: 213 VVLRIVEGPTPSLPETYSRQLN----SIMQS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-19
Identities = 62/242 (25%), Positives = 96/242 (39%), Gaps = 44/242 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK+ + ++E L E RI + HP +V L E + VMEY GG
Sbjct: 32 AVKTLKEDA--SEQQIEEFLREARIM---RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGG 86
Query: 74 DLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIEAKV 128
DL+ ++ S + +A + G++YL I+R N V
Sbjct: 87 DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL----------V 136
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE---FLAPEVLT 185
EN V KI+DFGL ++ + D G ++APE L
Sbjct: 137 GENLVV-----------------KISDFGLSRDL--YDDDYYKVKGGKLPIRWMAPESLK 177
Query: 186 ETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI-AIM 243
E +T D W GVL++E+ +GE P+PG EV + + + +M
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLM 237
Query: 244 RR 245
+
Sbjct: 238 LQ 239
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-19
Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 57/234 (24%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAHVCFVMEYA 70
A+K LK+ + +E + L E A M+ HP +V L E + V+EY
Sbjct: 27 AVKTLKEDA--SEEERKDFLKE------ARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78
Query: 71 AGGDL----------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
GGDL S + +A + G++YL + ++R
Sbjct: 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR--------- 129
Query: 121 IKRIEAKVQENYKVNSSQEIKLTV-N---DTEGYVKIADFGLCKEGMGFGD-RTGTFCGT 175
L N + VKI+DFGL ++ R T
Sbjct: 130 --------------------DLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169
Query: 176 P-EFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND 227
P ++APE L + +T D W GVL++E+ G +P+PG EEV + +
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-19
Identities = 67/240 (27%), Positives = 98/240 (40%), Gaps = 50/240 (20%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF---EVANTMRHPFLVNLFACFQTEA 61
+ +NTG FA+K I D L +K+I E+ + + P++V + F E+
Sbjct: 21 RLKNTGMIFALK------TITTDPNPDL--QKQILRELEINKSCKSPYIVKYYGAFLDES 72
Query: 62 --HVCFVMEYAAGGDL-----MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
+ MEY GG L + E A V+ GL YLH +II+R
Sbjct: 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR--- 129
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
+IK I LT +G VK+ DFG+ E + GTF G
Sbjct: 130 -----DIK--------------PSNILLT---RKGQVKLCDFGVSGELVNSLA--GTFTG 165
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-----EVFDSIVNDEV 229
T ++APE + Y+ D W LG+ + E+ PFP + E E+ IVN
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN 225
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 9e-19
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +Q++ TG A K I + +E+E + E ++ + +HP +V L+ + E
Sbjct: 21 VYKAQHKETG---LFAAAKIIQIESEEELEDFMVE---IDILSECKHPNIVGLYEAYFYE 74
Query: 61 AHVCFVMEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+ ++E+ GG +M+ + +EP+ + ++ L +LH ++I+R
Sbjct: 75 NKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHR------ 127
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++K + I LT+ +G VK+ADFG+ + + TF GTP
Sbjct: 128 --DLK--------------AGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPY 168
Query: 178 FLAPEV-LTETSYTRAVDW----WGLGVLIFEMLVGESP 211
++APEV ET D+ W LG+ + E+ E P
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-18
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA 61
IL + + G+ + IK + + ++ ES ++ V + M+HP +V F+
Sbjct: 17 ILVKSKEDGKQYVIKEINISKMSPKEREES----RKEVAVLSNMKHPNIVQYQESFEENG 72
Query: 62 HVCFVMEYAAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ VM+Y GGDL I+A +F E + + + + L L+++H+ +I++R
Sbjct: 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR------- 125
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+IK SQ I LT +G +K+ DFG+ + + T GTP +
Sbjct: 126 -DIK--------------SQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
L+PE+ Y D W LG +++EM + F
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 34/199 (17%)
Query: 17 ALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+KK D+ + E L +E I MR HP +V +++ + + VME+ GG
Sbjct: 48 AVKKMDLRKQQRRELLFNEVVI------MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 74 DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYK 133
L + +E + V+ L +LH +I+R +IK
Sbjct: 102 ALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR--------DIK----------- 142
Query: 134 VNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAV 193
S I LT + G VK++DFG C + R + GTP ++APEV++ Y V
Sbjct: 143 ---SDSILLTSD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 194 DWWGLGVLIFEMLVGESPF 212
D W LG+++ EM+ GE P+
Sbjct: 197 DIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-18
Identities = 61/215 (28%), Positives = 87/215 (40%), Gaps = 43/215 (20%)
Query: 9 TGEYFAIKA--LKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
E AIK L+K V+ L E + + HP +V + F + V
Sbjct: 25 NNEKVAIKRIDLEKCQT----SVDELRKE---VQAMSQCNHPNVVKYYTSFVVGDELWLV 77
Query: 67 MEYAAGG---DLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
M Y +GG D+M + E V+ GL+YLH + I+R +IK
Sbjct: 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR--------DIK 129
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG----TFCGTPEF 178
+ I L +G VKIADFG+ GDRT TF GTP +
Sbjct: 130 --------------AGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 179 LAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPF 212
+APEV+ + Y D W G+ E+ G +P+
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 60/211 (28%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
TGE AIK +K + D+ E + E + RHP +V F + + V
Sbjct: 25 IATGELVAIKVIK---LEPGDDFEIIQQEISML---KECRHPNIVAYFGSYLRRDKLWIV 78
Query: 67 MEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
MEY GG L + + SE + + + GL YLHE+ I+R +IK
Sbjct: 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR--------DIK-- 128
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE-GMGFGDRTGTFCGTPEFLAPEV 183
I LT +G VK+ADFG+ + R +F GTP ++APEV
Sbjct: 129 ------------GANILLT---EDGDVKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172
Query: 184 LTETS---YTRAVDWWGLGVLIFEMLVGESP 211
Y D W LG+ E+ + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-17
Identities = 50/187 (26%), Positives = 78/187 (41%), Gaps = 42/187 (22%)
Query: 41 VANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVV 97
V M+ +P + L+ T +M+Y GDL ++ SE +V
Sbjct: 61 VHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLV 119
Query: 98 LGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN--YKVNSSQEIKLTVNDTEGYVKIAD 155
L LH+ II+ N +IK EN Y + + + D
Sbjct: 120 EALNDLHKHNIIH----N----DIK------LENVLYDRAKDR------------IYLCD 153
Query: 156 FGLCKEGMGFGDRTGTFC---GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+GLCK GT GT ++ +PE + +Y + DWW +GVL +E+L G+ PF
Sbjct: 154 YGLCK-------IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
Query: 213 PGDDEEE 219
D++EE
Sbjct: 207 KEDEDEE 213
|
Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-17
Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 35/177 (19%)
Query: 41 VANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEP---RAVFYAAC-- 95
V +HP +VN + + VMEY AGG L DV +E A C
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL-----TDVVTETCMDEGQIAAVCRE 123
Query: 96 VVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155
+ L++LH +++I+R +IK S I L + +G VK+ D
Sbjct: 124 CLQALEFLHSNQVIHR--------DIK--------------SDNILLGM---DGSVKLTD 158
Query: 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
FG C + + T GTP ++APEV+T +Y VD W LG++ EM+ GE P+
Sbjct: 159 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 30/175 (17%)
Query: 44 TMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD----VFSEPRAVFYAACVVLG 99
++H +V ME GG L + + +E +FY ++ G
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 100 LQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159
L+YLH+++I++R +IK +N + VN G VKI+DFG
Sbjct: 121 LKYLHDNQIVHR--------DIK------GDN----------VLVNTYSGVVKISDFGTS 156
Query: 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPF 212
K G T TF GT +++APEV+ + Y D W LG I EM G+ PF
Sbjct: 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 7e-17
Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 1 VILSQYRNTGEYFAIKALKK-----GDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA 55
V L++ + TGE AIK +KK + + EV+SL HP +V L
Sbjct: 15 VYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE---------HPNIVKLKE 65
Query: 56 CFQTEAHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
F+ + FV EY G LM FSE ++ GL ++H+ +R
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR-- 123
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
++K EN V S E+ VKIADFGL +E T +
Sbjct: 124 ------DLK------PENLLV-SGPEV----------VKIADFGLAREIRSRPPYT-DYV 159
Query: 174 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
T + APE+L TSY+ VD W LG ++ E+ FPG E
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-17
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +++ +++G A+K + D+ + E L +E I +H +V ++ +
Sbjct: 37 VCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR---DYQHQNVVEMYKSYLVG 90
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ +ME+ GG L + +E + V+ L YLH +I+R +
Sbjct: 91 EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR--------D 142
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
IK S I LT+ +G VK++DFG C + + + GTP ++A
Sbjct: 143 IK--------------SDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
PEV++ T Y VD W LG+++ EM+ GE P+ D
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 45/226 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKG---DIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF 57
V ++ + TGE AIK +K + I + + + K + HP ++ L F
Sbjct: 15 VYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE-------LNHPNIIKLLDVF 67
Query: 58 QTEAHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---P 112
+ + + V E+ DL ++ E Y ++ GL + H I++R P
Sbjct: 68 RHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKP 126
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
N+ + +TEG +K+ADFGL + +
Sbjct: 127 -ENL---------------------------LINTEGVLKLADFGLARSFGSPVRPYTHY 158
Query: 173 CGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
T + APE+L + Y+ VD W +G + E+L FPG E
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-16
Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 35/177 (19%)
Query: 41 VANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEP---RAVFYAAC-- 95
V +++P +VN F + VMEY AGG L DV +E A A C
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL-----TDVVTETCMDEAQIAAVCRE 123
Query: 96 VVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155
+ L++LH +++I+R +IK S + L + +G VK+ D
Sbjct: 124 CLQALEFLHANQVIHR--------DIK--------------SDNVLLGM---DGSVKLTD 158
Query: 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
FG C + + T GTP ++APEV+T +Y VD W LG++ EM+ GE P+
Sbjct: 159 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 4e-16
Identities = 63/225 (28%), Positives = 93/225 (41%), Gaps = 55/225 (24%)
Query: 7 RNTGEYFAIKALKKGD------IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
+ TGE A+K ++ + A E+ SLL E ++HP +V L TE
Sbjct: 21 KKTGEIVALKKIRLDNEEEGIPSTALREI-SLLKE---------LKHPNIVKLLDVIHTE 70
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ V EY DL + S ++ GL Y H RI++R
Sbjct: 71 RKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHR------- 122
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE- 177
++K Q I + + G +K+ADFGL + FG T+ T E
Sbjct: 123 -DLK--------------PQNILINRD---GVLKLADFGLARA---FGIPLRTY--THEV 159
Query: 178 ----FLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
+ APE+L Y+ AVD W +G + EM+ G+ FPGD E
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-16
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ ++TG+ A+K K D+ + E L +E I H +V+++ +
Sbjct: 38 VCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMR---DYHHENVVDMYNSYLVG 91
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ VME+ GG L + +E + V+ L YLH +I+R +
Sbjct: 92 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR--------D 143
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
IK S I LT ++G +K++DFG C + + + GTP ++A
Sbjct: 144 IK--------------SDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
PEV++ Y VD W LG+++ EM+ GE P+
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 5e-16
Identities = 61/222 (27%), Positives = 87/222 (39%), Gaps = 47/222 (21%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC-- 64
+ TG+ AIK + DII DE E + E I + HP + + F +
Sbjct: 28 KKTGQLVAIKIM---DIIE-DEEEEIKEEYNI--LRKYSNHPNIATFYGAFIKKNPPGND 81
Query: 65 ----FVMEYAAGG---DLMMHIHADVFSEPRAVFYAAC--VVLGLQYLHESRIIYRPQSN 115
VME GG DL+ + + GL YLHE+++I+R
Sbjct: 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR---- 137
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
+IK Q I LT VK+ DFG+ + R TF GT
Sbjct: 138 ----DIK--------------GQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176
Query: 176 PEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPF 212
P ++APEV+ + SY D W LG+ E+ G+ P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 42/192 (21%)
Query: 46 RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADV-----FSEPRA--VFYAACVVL 98
H +V F F+++ + +MEY +GGDL I + F E +FY +VL
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQ--IVL 180
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
L +H ++++R ++K S I L G +K+ DFG
Sbjct: 181 ALDEVHSRKMMHR--------DLK--------------SANIFLM---PTGIIKLGDFGF 215
Query: 159 CKEGMGFGDRTG-----TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213
K+ + D +FCGTP +LAPE+ Y++ D W LGV+++E+L PF
Sbjct: 216 SKQ---YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
Query: 214 GDDEEEVFDSIV 225
G + E+ ++
Sbjct: 273 GPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-16
Identities = 52/165 (31%), Positives = 75/165 (45%), Gaps = 32/165 (19%)
Query: 63 VCFVMEYAAGGDLMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+ V++YA GDL I F E A V+L + ++H +I+R
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR------ 167
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGT 175
+IK S I L N G VK+ DFG K D TFCGT
Sbjct: 168 --DIK--------------SANILLCSN---GLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220
P ++APE+ Y++ D + LGVL++E+L + PF G++ EEV
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV 253
|
Length = 496 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-15
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
TG+ AIK + ++ + + E +++E V ++P +VN + + VME
Sbjct: 43 TGQEVAIKQM---NLQQQPKKELIINE---ILVMRENKNPNIVNYLDSYLVGDELWVVME 96
Query: 69 YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
Y AGG L + E + + L +LH +++I+R +IK
Sbjct: 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR--------DIK------ 142
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETS 188
S I L + +G VK+ DFG C + + T GTP ++APEV+T +
Sbjct: 143 --------SDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 189 YTRAVDWWGLGVLIFEMLVGESPF 212
Y VD W LG++ EM+ GE P+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-15
Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 54/233 (23%)
Query: 7 RNTGEYFAIKALKK------GDIIARDEVESLLSEKRIFEVANTMRHPFLVNL----FAC 56
+ TGE A+K ++ I A E+ LL + +RHP +V L +
Sbjct: 21 KKTGELVALKKIRMENEKEGFPITAIREI-KLLQK---------LRHPNIVRLKEIVTSK 70
Query: 57 FQTEAHVCFVMEYAAGGDLM-MHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
+ + V EY DL + +V F+E + Y ++ GLQYLH + I++R
Sbjct: 71 GKGS--IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHR--- 124
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTF 172
+IK S + +N+ +G +K+ADFGL + D T
Sbjct: 125 -----DIK-------------GSN---ILINN-DGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 173 CGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
T + PE+L T Y VD W +G ++ E+ +G+ F G E E + I
Sbjct: 163 I-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 28/187 (14%)
Query: 25 ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVF 84
A DE+E + E + ++ P++ + + + +MEY GG + + A F
Sbjct: 42 AEDEIEDIQQEITVLSQCDS---PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF 98
Query: 85 SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
E + ++ GL YLH + I+R +IK + E
Sbjct: 99 DEFQIATMLKEILKGLDYLHSEKKIHR--------DIKAANVLLSE-------------- 136
Query: 145 NDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFE 204
+G VK+ADFG+ + + TF GTP ++APEV+ +++Y D W LG+ E
Sbjct: 137 ---QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
Query: 205 MLVGESP 211
+ GE P
Sbjct: 194 LAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 54/220 (24%), Positives = 82/220 (37%), Gaps = 41/220 (18%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA-CFQTEAHV 63
+ ++ G+ K + G + E + L+SE I ++HP +V +
Sbjct: 20 RRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILR---ELKHPNIVRYYDRIIDRSNQT 75
Query: 64 CF-VMEYAAGGDLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLH-----ESRIIYRP 112
+ VMEY GGDL I E ++L L H + +++R
Sbjct: 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHR- 134
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
++K I L D VK+ DFGL K T+
Sbjct: 135 -------DLK--------------PANIFL---DANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
GTP +++PE L SY D W LG LI+E+ PF
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 44/238 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVE--SLLSEKRIFEVANTMRHPFLVNLFACFQ 58
V +R TG+ A+K ++ + +E +L E ++ + P++V + F
Sbjct: 17 VSKVLHRPTGKIMAVKTIR----LEINEAIQKQILRE---LDILHKCNSPYIVGFYGAFY 69
Query: 59 TEAHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESR-IIYRPQSN 115
+ MEY GG D ++ E A V+ GL YLHE II+R
Sbjct: 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR---- 125
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
++K N VNS +IKL DFG+ + + TF GT
Sbjct: 126 ----DVK------PSNILVNSRGQIKLC-----------DFGVSGQLVN--SLAKTFVGT 162
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-----EVFDSIVNDE 228
++APE + Y+ D W LG+ + E+ G P+P +++ E+ IVN+
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-15
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 30/205 (14%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVM 67
T E AIK + + A DE+E + E + ++ P++ + + + +M
Sbjct: 27 RTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS---PYITRYYGSYLKGTKLWIIM 81
Query: 68 EYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
EY GG + + E ++ GL YLH R I+R +IK
Sbjct: 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR--------DIKAANVL 133
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET 187
+ E +G VK+ADFG+ + + TF GTP ++APEV+ ++
Sbjct: 134 LSE-----------------QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 188 SYTRAVDWWGLGVLIFEMLVGESPF 212
+Y D W LG+ E+ GE P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-15
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 25/167 (14%)
Query: 46 RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHE 105
++P +VN + + VMEY AGG L + E + + L++LH
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 106 SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165
+++I+R +IK S I L + +G VK+ DFG C +
Sbjct: 135 NQVIHR--------DIK--------------SDNILLGM---DGSVKLTDFGFCAQITPE 169
Query: 166 GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+ T GTP ++APEV+T +Y VD W LG++ EM+ GE P+
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-15
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +Q + TG A K + D + +E+E + E ++ + HP +V L F E
Sbjct: 21 VYKAQNKETGVLAAAKVI---DTKSEEELEDYMVE---IDILASCDHPNIVKLLDAFYYE 74
Query: 61 AHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ ++E+ AGG D +M +EP+ + L YLHE++II+R
Sbjct: 75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR------- 127
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++K + I T+ +G +K+ADFG+ + R +F GTP +
Sbjct: 128 -DLK--------------AGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 169
Query: 179 LAPE-VLTETSYTRAVDW----WGLGVLIFEMLVGESP 211
+APE V+ ETS R D+ W LG+ + EM E P
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 38/231 (16%)
Query: 8 NTGEYFAIKALKKGDIIARD----EVESLLSEKRIFE--VANTMRHPFLVNLFACFQTEA 61
N G + G I+AR E++ + + I E V + P++V + F ++
Sbjct: 13 NGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72
Query: 62 HVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESR-IIYRPQSNITK 118
+ ME+ GG D ++ A E + V+ GL YL E I++R
Sbjct: 73 EISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKIMHR------- 124
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++K N VNS EIKL DFG+ G +F GT +
Sbjct: 125 -DVK------PSNILVNSRGEIKL-----------CDFGV--SGQLIDSMANSFVGTRSY 164
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV 229
++PE L T YT D W LG+ + EM +G P P D +E+ +++ V
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPV 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 1 VILSQYRNTGEYFAIKALKKGDI-IARDEVE-SLLSE-KRIFEVANTMRHPFLVNLFACF 57
V ++ + TG AIK +K G+ A+D + + L E K + E ++HP ++ L F
Sbjct: 16 VYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPNIIGLLDVF 71
Query: 58 QTEAHVCFVMEYAAGGDLMMHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
++++ V E+ DL I + V + Y + GL+YLH + I++R
Sbjct: 72 GHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHR---- 126
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADFGLCKEGMGFGDRTGTF 172
+ K N N ++G +K+ADFGL + FG
Sbjct: 127 ---------------DLKPN---------NLLIASDGVLKLADFGLARS---FGSPNRKM 159
Query: 173 CGTPE-----FLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
T + + APE+L Y VD W +G + E+L+ PGD +
Sbjct: 160 --THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ +++G+ A+K K D+ + E L +E I +H +V ++ +
Sbjct: 36 VCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR---DYQHENVVEMYNSYLVG 89
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ VME+ GG L + +E + V+ L LH +I+R +
Sbjct: 90 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR--------D 141
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
IK S I LT +G VK++DFG C + R + GTP ++A
Sbjct: 142 IK--------------SDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
PE+++ Y VD W LG+++ EM+ GE P+
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 28/187 (14%)
Query: 25 ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVF 84
A DE+E + E + ++ P++ + + + + +MEY GG + +
Sbjct: 42 AEDEIEDIQQEITVLSQCDS---PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL 98
Query: 85 SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
E + ++ GL YLH + I+R +IK + E+
Sbjct: 99 DETQIATILREILKGLDYLHSEKKIHR--------DIKAANVLLSEH------------- 137
Query: 145 NDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFE 204
G VK+ADFG+ + + TF GTP ++APEV+ +++Y D W LG+ E
Sbjct: 138 ----GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
Query: 205 MLVGESP 211
+ GE P
Sbjct: 194 LAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ + TG A+ A K + + +E+E + E E+ T HP++V L F +
Sbjct: 28 VYKAKNKETG---ALAAAKVIETKSEEELEDYMVE---IEILATCNHPYIVKLLGAFYWD 81
Query: 61 AHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ ++E+ GG D +M +EP+ ++ LQYLH +II+R
Sbjct: 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR------- 134
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++K + + LT+ +G +K+ADFG+ + + R +F GTP +
Sbjct: 135 -DLK--------------AGNVLLTL---DGDIKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 179 LAPEV-----LTETSYTRAVDWWGLGVLIFEMLVGESP 211
+APEV + +T Y D W LG+ + EM E P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-14
Identities = 44/196 (22%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 24 IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHA-- 81
+ +DE + +E ++ ++ + HP ++ + F + + VMEYA GG L +I
Sbjct: 38 MTKDERLAAQNECQVLKLLS---HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC 94
Query: 82 -DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140
+ E + + ++L L ++H I++R + K Q N ++ + +
Sbjct: 95 NSLLDEDTILHFFVQILLALHHVHTKLILHR-------------DLKTQ-NILLDKHKMV 140
Query: 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGV 200
VKI DFG+ K + + T GTP +++PE+ Y + D W LG
Sbjct: 141 ----------VKIGDFGISKI-LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189
Query: 201 LIFEMLVGESPFPGDD 216
+++E+ + F +
Sbjct: 190 VLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 30/69 (43%), Positives = 44/69 (63%), Gaps = 3/69 (4%)
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP- 232
GTP++LAPE+L + AVDWW LGV +FE L G PF + ++VF +I+N ++ +P
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601
Query: 233 --RFLSLEA 239
LS+ A
Sbjct: 602 GEEKLSVNA 610
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-14
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 53/228 (23%)
Query: 1 VILSQYRNTGEYFAIK---------ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLV 51
V+ +++ TG+ AIK +KK IA E+ L +RH LV
Sbjct: 17 VMKCKHKETGQIVAIKKFLESEDDKMVKK---IAMREIRML----------KQLRHENLV 63
Query: 52 NLFACFQTEAHVCFVMEYAAG---GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRI 108
NL F+ + + V E+ DL + + S R + ++ G+++ H I
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ--ILRGIEFCHSHNI 121
Query: 109 IYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168
I+R +IK EN V+ S G VK+ DFG + G+
Sbjct: 122 IHR--------DIK------PENILVSQS-----------GVVKLCDFGFARTLAAPGEV 156
Query: 169 TGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
+ T + APE+L +T Y RAVD W +G L+ EML GE FPGD
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-14
Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 50/237 (21%)
Query: 1 VILSQYRNTGEYFAIKAL---KKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF 57
V ++ R TGE A+K + + I L E + +HP++V L F
Sbjct: 16 VFKAKDRETGETVALKKVALRRLEGGIP----NQALRE---IKALQACQHPYVVKLLDVF 68
Query: 58 QTEAHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
+ VMEY DL ++ E + Y ++ G+ Y+H + I++R
Sbjct: 69 PHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR---- 123
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIK---LTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
++K L ++ G +KIADFGL + R +
Sbjct: 124 -----------------------DLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSH 159
Query: 173 -CGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE----VFDS 223
T + APE+L Y VD W +G + E+L G FPG+++ E VF +
Sbjct: 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 43/230 (18%)
Query: 1 VILSQYRNTGEYFAIK-------ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNL 53
V L+ TGE A+K + D +D V++L SE E + H +V
Sbjct: 17 VYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE---IETLKDLDHLNIVQY 73
Query: 54 FACFQTEAHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
TE ++ +EY GG + + + F E F+ V+ GL YLH I++R
Sbjct: 74 LGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGLAYLHSKGILHR 132
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRT 169
++K +N V D +G KI+DFG+ K + + D+
Sbjct: 133 --------DLK------ADNLLV-----------DADGICKISDFGISKKSDDIYDNDQN 167
Query: 170 GTFCGTPEFLAPEV--LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
+ G+ ++APEV Y+ VD W LG ++ EM G P+ D+E
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW-SDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 69/264 (26%), Positives = 107/264 (40%), Gaps = 62/264 (23%)
Query: 8 NTGEYFAIKALKKGDIIARDEV-----ESLLSEKRIFEVANTMRH---PFLVNLFACFQT 59
N G +K + G ++A+ V S+ K+I M P++V+ + F
Sbjct: 17 NGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 60 EAHVCFVMEYAAGGDL------MMHIHADVFSEPRAVFYAACVVLGLQYLH-ESRIIYRP 112
E ++C ME+ G L I ++ + A VV GL YL+ RI++R
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-----IAVAVVEGLTYLYNVHRIMHR- 128
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
+IK N VNS +IKL DFG+ E + TF
Sbjct: 129 -------DIK------PSNILVNSRGQIKL-----------CDFGVSGELIN--SIADTF 162
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF---PGDDEEE-----VFD-- 222
GT +++PE + YT D W LG+ I E+ +G+ PF DD+ + + D
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222
Query: 223 -SIVNDEVRYPRFLSLEAIAIMRR 245
IV + PR S + +R
Sbjct: 223 QQIVQEPP--PRLPSSDFPEDLRD 244
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-13
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 8 NTGEYFAIK--ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
N G+ A+K L +++A ++ L E+ ++ +++H +V + +
Sbjct: 22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEE--VDLLKSLKHVNIVQYLGTCLDDNTISI 79
Query: 66 VMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
ME+ GG + ++ EP Y ++ G+ YLH + +++R +IK
Sbjct: 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR--------DIK-- 129
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC-------GTPE 177
+ L N G +K+ DFG C + + GT GTP
Sbjct: 130 ------------GNNVMLMPN---GIIKLIDFG-CARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
++APEV+ E+ Y R D W +G +FEM G+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-13
Identities = 62/232 (26%), Positives = 90/232 (38%), Gaps = 58/232 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + TG AIK L +S + KR + E+ M H ++ L F
Sbjct: 31 VCSAFDTKTGRKVAIKKL-------SRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83
Query: 58 QTEAH------VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ V V G DL + S+ F ++ GL+Y+H + II+R
Sbjct: 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHR 142
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL---CKEGMGF 165
P SNI VN E +KI DFGL + M
Sbjct: 143 DLKP-SNIA----------------VNEDCE-----------LKILDFGLARHTDDEM-- 172
Query: 166 GDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216
TG + T + APE+ L Y + VD W +G ++ E+L G++ FPG D
Sbjct: 173 ---TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-13
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 28 EVESLLSEKRIFEVANTMRHPFLVNLFACFQ--TEAHVCFVMEYAAGGDLMMHIHA-DVF 84
EV +L E ++ + ++H +V + C + E + MEY GG + + A
Sbjct: 47 EVSALECEIQLLK---NLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL 103
Query: 85 SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
+E Y ++ G+ YLH + I++R +I I R
Sbjct: 104 TESVTRKYTRQILEGMSYLHSNMIVHR---DIKGANILR--------------------- 139
Query: 145 NDTEGYVKIADFG-------LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWG 197
D+ G VK+ DFG +C G G TGT P +++PEV++ Y R D W
Sbjct: 140 -DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT----PYWMSPEVISGEGYGRKADVWS 194
Query: 198 LGVLIFEMLVGESPF 212
LG + EML + P+
Sbjct: 195 LGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 61/195 (31%), Positives = 88/195 (45%), Gaps = 47/195 (24%)
Query: 45 MRHPFLVNLFACFQTEA--HVCFVMEY-----AAGGDLMMHIHADVFSEPRAVFYAACVV 97
+RHP +V L + + VMEY A+ D M FSE + C++
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP----TPFSESQV----KCLM 114
Query: 98 L----GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153
L GLQYLHE+ II+R + KV++ L + D G +KI
Sbjct: 115 LQLLRGLQYLHENFIIHR-------------------DLKVSN-----LLLTDK-GCLKI 149
Query: 154 ADFGLCKE-GMGFGDRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESP 211
ADFGL + G+ T T + APE+L T+YT A+D W +G ++ E+L +
Sbjct: 150 ADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL 208
Query: 212 FPGDDEEEVFDSIVN 226
PG E E D I+
Sbjct: 209 LPGKSEIEQLDLIIQ 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-12
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 42/235 (17%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
Y N A+K LK G + V++ L E + + T++H LV L+A E +
Sbjct: 26 YYNNSTKVAVKTLKPGTM----SVQAFLEEANLMK---TLQHDKLVRLYAVVTKEEPIYI 78
Query: 66 VMEYAAGGDLMMHIHADVFSE---PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
+ EY A G L+ + +D + P+ + ++A + G+ Y+ I+R +++
Sbjct: 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR--------DLR 130
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTP-EFL 179
V E+ KIADFGL + E + R G P ++
Sbjct: 131 AANVLVSESL-----------------MCKIADFGLARVIEDNEYTAREGA--KFPIKWT 171
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRYPR 233
APE + S+T D W G+L++E++ G+ P+PG +V S + R PR
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-SALQRGYRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 49/212 (23%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSE-KRIFEVANTMRHPFLVNLFACF--QTEAHVC 64
NTGE A+K+L E S+ +R E+ T+ H +V +
Sbjct: 31 NTGEQVAVKSLN------HSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84
Query: 65 FVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEE 120
+MEY G L ++ H D + R + +++ + G+ YL R I+R + NI
Sbjct: 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI---- 140
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-----EGMGFGDRTGTFCGT 175
+ ++E VKI+DFGL K + + G
Sbjct: 141 -----------------------LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES--- 174
Query: 176 PEF-LAPEVLTETSYTRAVDWWGLGVLIFEML 206
P F APE L + ++ A D W GV ++E+
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 8 NTGEYFAIKALKKGDIIARD----EVESLLSEK--RIFEVANTMRHPFLVNLFACFQTEA 61
N G F + G I+AR E++ + + R +V + P++V + F ++
Sbjct: 17 NGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76
Query: 62 HVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ ME+ GG L + A E + V+ GL YL E + I +
Sbjct: 77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-------KHKIMHRD 129
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
+K N VNS EIKL DFG+ G +F GT +++
Sbjct: 130 VK------PSNILVNSRGEIKL-----------CDFGV--SGQLIDSMANSFVGTRSYMS 170
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220
PE L T Y+ D W +G+ + EM +G P P D +E+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-12
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 40/205 (19%)
Query: 33 LSEKRIFEVANT------MRHPFLVNLFACFQTEAHVCFVMEYAAGGDL---MMHIHADV 83
LSEK + N ++HP ++ + F + + MEYA GG L ++ +
Sbjct: 38 LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL 97
Query: 84 FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLT 143
F E ++Y +V + Y+H++ I++R +IK + I LT
Sbjct: 98 FEEEMVLWYLFQIVSAVSYIHKAGILHR--------DIK--------------TLNIFLT 135
Query: 144 VNDTEGYVKIADFGLCKEGMGFGDRTG---TFCGTPEFLAPEVLTETSYTRAVDWWGLGV 200
G +K+ DFG+ K G T GTP +++PE+ Y D W LG
Sbjct: 136 ---KAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGC 189
Query: 201 LIFEMLVGESPFPGDDEEEVFDSIV 225
+++E+L + F + + IV
Sbjct: 190 VLYELLTLKRTFDATNPLNLVVKIV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 37/190 (19%)
Query: 37 RIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAV------ 90
R +V + P++V + F ++ + ME+ GG L V E + +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-----DQVLKEAKRIPEEILG 106
Query: 91 FYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150
+ V+ GL YL E K +I + K N VNS EIKL
Sbjct: 107 KVSIAVLRGLAYLRE------------KHQIMHRDVK-PSNILVNSRGEIKL-------- 145
Query: 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210
DFG+ G +F GT +++PE L T Y+ D W +G+ + E+ +G
Sbjct: 146 ---CDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY 200
Query: 211 PFPGDDEEEV 220
P P D +E+
Sbjct: 201 PIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-11
Identities = 50/177 (28%), Positives = 74/177 (41%), Gaps = 36/177 (20%)
Query: 47 HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI-HAD----VFSEPRAVFYAACVVLGLQ 101
HP ++ A F + V+E A GDL I H + E Y + L+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 102 YLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161
++H RI++R +IK + +T G VK+ D GL
Sbjct: 121 HMHSKRIMHR--------DIK--------------PANVFITAT---GVVKLGDLGL--- 152
Query: 162 GMGFGDRTG---TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
G F +T + GTP +++PE + E Y D W LG L++EM +SPF GD
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-11
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 15 IKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGD 74
ALKK I + ++ + ++ + HP ++ +A F + + V+E A GD
Sbjct: 29 PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 88
Query: 75 LMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQ 129
L I + E Y + L+++H R+++R +IK
Sbjct: 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR--------DIK------P 134
Query: 130 ENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG---TFCGTPEFLAPEVLTE 186
N + ++ G VK+ D GL G F +T + GTP +++PE + E
Sbjct: 135 ANVFITAT-----------GVVKLGDLGL---GRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 187 TSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
Y D W LG L++EM +SPF GD
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 54/201 (26%), Positives = 78/201 (38%), Gaps = 36/201 (17%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
T E AIK + + ++ + ++ E R +RHP + C+ E VME
Sbjct: 39 TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFL---QQLRHPNTIEYKGCYLREHTAWLVME 95
Query: 69 YAAG-GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
Y G ++ +H E + GL YLH I+R +IK
Sbjct: 96 YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR--------DIK----- 142
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV---L 184
+ I LT G VK+ADFG +F GTP ++APEV +
Sbjct: 143 ---------AGNILLTEP---GTVKLADFG----SASLVSPANSFVGTPYWMAPEVILAM 186
Query: 185 TETSYTRAVDWWGLGVLIFEM 205
E Y VD W LG+ E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 57/250 (22%), Positives = 107/250 (42%), Gaps = 34/250 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L ++R G+ + IK L + R E +E+ ++ + ++HP +V ++ E
Sbjct: 16 VSLVRHRTDGKQYVIKKLNLRNASRR---ERKAAEQEA-QLLSQLKHPNIVAYRESWEGE 71
Query: 61 AHVCF-VMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
+ + VM + GGDL + + E + V + + + LQYLHE I++R
Sbjct: 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR----- 126
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++K +Q + LT + +K+ D G+ + D T GTP
Sbjct: 127 ---DLK--------------TQNVFLTRTNI---IKVGDLGIARVLENQCDMASTLIGTP 166
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFL 235
+++PE+ + Y D W LG ++EM + F D + I+ ++ P+
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226
Query: 236 SLEAIAIMRR 245
S E ++
Sbjct: 227 SPELGELIAT 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-11
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 28 EVESLLSEKRIFEVANTMRHPFLVNLFACFQ--TEAHVCFVMEYAAGGDLMMHIHA-DVF 84
EV +L E ++ + +RH +V + C + E + +EY GG + + A
Sbjct: 47 EVNALECEIQLLK---NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGAL 103
Query: 85 SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
+E Y ++ G+ YLH + I++R +I I R
Sbjct: 104 TENVTRRYTRQILQGVSYLHSNMIVHR---DIKGANILR--------------------- 139
Query: 145 NDTEGYVKIADFG-------LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWG 197
D+ G VK+ DFG +C G G TGT P +++PEV++ Y R D W
Sbjct: 140 -DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT----PYWMSPEVISGEGYGRKADVWS 194
Query: 198 LGVLIFEMLVGESPF 212
+ + EML + P+
Sbjct: 195 VACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 42/219 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ TGE AIK K + D+ + + R +V +RH +VNL F+ + + V
Sbjct: 23 KATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78
Query: 67 MEYAAGGDLMMHIHADVFSEPRAVFYAAC------VVLGLQYLHESRIIYRPQSNITKEE 120
EY + + + P + A ++ + Y H II+R +
Sbjct: 79 FEYVE-----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHR--------D 125
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT-FCGTPEFL 179
IK EN V+ S G +K+ DFG + T + T +
Sbjct: 126 IK------PENILVSES-----------GVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 180 APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
APE+L +T+Y + VD W +G ++ E+L GE FPGD +
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 6e-11
Identities = 67/268 (25%), Positives = 101/268 (37%), Gaps = 81/268 (30%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + + TG AIK K ++ + L+ KRI E+ +RH ++ L
Sbjct: 16 VCSAVDKRTGRKVAIK--KISNVF-----DDLIDAKRILREIKLLRHLRHENIIGLLDIL 68
Query: 58 QTEAHVCF-----VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL-GLQYLHESRIIYR 111
+ + F V E DL I + + Y +L GL+YLH + +I+R
Sbjct: 69 RPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHR 127
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168
P SNI VNS+ + +KI DFGL + D
Sbjct: 128 DLKP-SNIL----------------VNSNCD-----------LKICDFGLARGVDPDED- 158
Query: 169 TGTFCGTPEFL----------APEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDD- 216
FL APE+L +S YT+A+D W +G + E+L + FPG D
Sbjct: 159 ------EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212
Query: 217 --------------EEEVFDSIVNDEVR 230
EE I +++ R
Sbjct: 213 IDQLNLIVEVLGTPSEEDLKFITSEKAR 240
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-11
Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 62/247 (25%)
Query: 1 VILSQYRNTGEYFAIKALK----KGDIIAR----DEVESLLSEKRIFEVANTMRHPFLVN 52
V + TG+ AIK +K D+ + R ++ N ++H ++
Sbjct: 25 VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84
Query: 53 LFACFQTEAHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVL----GLQYLHESR 107
L + + VM+ A DL + + +E C++L GL LH+
Sbjct: 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTES----QVKCILLQILNGLNVLHKWY 139
Query: 108 IIYRPQS--NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE---G 162
++R S NI +++G KIADFGL +
Sbjct: 140 FMHRDLSPANI---------------------------FINSKGICKIADFGLARRYGYP 172
Query: 163 MGFGDRTGTFCGTP-EFLAPEVLT-----------ETSYTRAVDWWGLGVLIFEMLVGES 210
+ E + +V+T Y AVD W +G + E+L G+
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 211 PFPGDDE 217
FPG++E
Sbjct: 233 LFPGENE 239
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQTEAHVC 64
R TGE A+K I D E S I E++ ++H +V L TE +
Sbjct: 22 RTTGEIVALKE------IHLDAEEGTPSTA-IREISLMKELKHENIVRLHDVIHTENKLM 74
Query: 65 FVMEYAAGGDLMMHIHADVFSEPRAV------FYAACVVLGLQYLHESRIIYRPQSNITK 118
V EY DL ++ D A+ + ++ G+ + HE+R+++R
Sbjct: 75 LVFEYMDK-DLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR------- 124
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG---T 175
++K +N +N G +K+ADFGL FG TF T
Sbjct: 125 -DLK------PQNLLINK-----------RGELKLADFGL---ARAFGIPVNTFSNEVVT 163
Query: 176 PEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
+ AP+VL + +Y+ ++D W +G ++ EM+ G FPG + E+ I
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 52/254 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK D +D + L+SE + ++ +H ++NL E + V+EYAA G
Sbjct: 46 AVKMLK-DDATEKD-LSDLVSEMEMMKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHG 101
Query: 74 DL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
+L + ++ V +A V G+++L + I+R
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD---- 157
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV-KIADFGLCKE--GMGFGDRTGTFC 173
+ A+ N V TE +V KIADFGL ++ + + +T
Sbjct: 158 -------LAAR---NVLV------------TEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFE-MLVGESPFPGDDEEEVFDSIVNDE-VRY 231
+++APE L + YT D W GVL++E +G SP+PG EE+F + +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEK 255
Query: 232 PRFLSLEAIAIMRR 245
P+ + E +MR
Sbjct: 256 PQNCTQELYHLMRD 269
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 40/181 (22%)
Query: 47 HPFLVNLFACF-----QTEAHVCFVMEYAAGG---DLM--MHIHADVFSEPRAVFYAACV 96
HP +V + + + + V+E GG DL+ + EP +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 97 VLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156
++GLQ+LH ++ I+R ++K I LT TEG VK+ DF
Sbjct: 134 LMGLQHLHVNKTIHR--------DVK--------------GNNILLT---TEGGVKLVDF 168
Query: 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESP 211
G+ + R T GTP ++APEV+ +++Y D W LG+ E+ G+ P
Sbjct: 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 212 F 212
Sbjct: 229 L 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 39/210 (18%)
Query: 8 NTGEYFAIKALK--KGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
NTGE AIK +K G+ A + E ++ + +H +V F + +
Sbjct: 32 NTGELAAIKVIKLEPGEDFAVVQQEIIMMKD--------CKHSNIVAYFGSYLRRDKLWI 83
Query: 66 VMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
ME+ GG L H SE + + + + GL YLH ++R +IK
Sbjct: 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR--------DIK-- 133
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL 184
I LT N G+VK+ADFG+ + + +F GTP ++APEV
Sbjct: 134 ------------GANILLTDN---GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 185 T---ETSYTRAVDWWGLGVLIFEMLVGESP 211
+ Y + D W +G+ E+ + P
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 66/240 (27%), Positives = 93/240 (38%), Gaps = 75/240 (31%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVE----------SLLSEKRIFEVANTMRHPFLVNLFAC 56
+ TGE I ALKK I E E SLL E + HP +V L
Sbjct: 21 KLTGE---IVALKK--IRLETEDEGVPSTAIREISLLKE---------LNHPNIVRLLDV 66
Query: 57 FQTEAHVCFVMEYAAGGDL-----MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
+E + V E+ DL M P Y ++ G+ Y H R+++R
Sbjct: 67 VHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR 123
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168
PQ+ L + D EG +K+ADFGL + FG
Sbjct: 124 DLKPQN---------------------------LLI-DREGALKLADFGLAR---AFGVP 152
Query: 169 TGTFCGTPE-----FLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVF 221
T+ T E + APE+L Y+ VD W +G + EM+ FPGD E +++F
Sbjct: 153 VRTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 51/213 (23%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK D ++ L+SE + ++ +H ++NL + + ++EYA+ G
Sbjct: 51 AVKMLK--DDATEKDLSDLVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 74 DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN-- 131
+L ++ A P + Y+ + + + ++ ++ + T + + +E +
Sbjct: 107 NLREYLRA---RRPPGMEYS----YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI 159
Query: 132 YKVNSSQEIKLTVNDTEGYVKIADFGLCKE--GMGFGDRTGTFCGTPEFLAPEVLTETSY 189
++ +++ + +T N+ +KIADFGL ++ + + +T +++APE L + Y
Sbjct: 160 HRDLAARNVLVTENNV---MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
Query: 190 TRAVDWWGLGVLIFEML-VGESPFPGDDEEEVF 221
T D W GVL++E+ +G SP+PG EE+F
Sbjct: 217 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 36/207 (17%)
Query: 17 ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL- 75
ALKK I + ++ + ++ + HP ++ F + + V+E A GDL
Sbjct: 31 ALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLS 90
Query: 76 --MMHIHADVFSEPRAVFYAACVVL--GLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN 131
+ + P + V L ++++H R+++R +IK N
Sbjct: 91 QMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR--------DIK------PAN 136
Query: 132 YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG---TFCGTPEFLAPEVLTETS 188
+ ++ G VK+ D GL G F +T + GTP +++PE + E
Sbjct: 137 VFITAT-----------GVVKLGDLGL---GRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 189 YTRAVDWWGLGVLIFEMLVGESPFPGD 215
Y D W LG L++EM +SPF GD
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 49/228 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK D ++ L+SE + ++ +H ++NL E + ++EYAA G
Sbjct: 48 AVKMLK--DNATDKDLADLISEMELMKLIG--KHKNIINLLGVCTQEGPLYVIVEYAAKG 103
Query: 74 DLMMHIHA-------DVFSEPRA----------VFYAACVVLGLQYLHESRIIYRPQSNI 116
+L + A F + V A V G++YL R I+R +
Sbjct: 104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA-- 161
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCG 174
++ + +T ++ +KIADFGL + + + +T
Sbjct: 162 --------------------ARNVLVTEDNV---MKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVF 221
+++APE L + YT D W G+L++E+ +G SP+PG EE+F
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 55/202 (27%), Positives = 81/202 (40%), Gaps = 42/202 (20%)
Query: 26 RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC-----FVMEYAAGGDLM---- 76
D E + +E I + HP +V + F + V+E GG +
Sbjct: 59 SDVDEEIEAEYNILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116
Query: 77 -MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135
+ I E + +LGLQ+LH +RII+R + K N
Sbjct: 117 GLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR-------------------DVKGN 157
Query: 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYT 190
+ I LT TEG VK+ DFG+ + R T GTP ++APEV+ + SY
Sbjct: 158 N---ILLT---TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYD 211
Query: 191 RAVDWWGLGVLIFEMLVGESPF 212
D W LG+ E+ G+ P
Sbjct: 212 ARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 28 EVESLLSEKRIFEVANTMRHPFLVNLFACFQ--TEAHVCFVMEYAAGGDLMMHIHA-DVF 84
EV +L E ++ + + H +V + C + E + ME+ GG + + +
Sbjct: 47 EVNALECEIQLLK---NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL 103
Query: 85 SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
+E Y ++ G+ YLH + I++R +I I R
Sbjct: 104 TENVTRKYTRQILEGVSYLHSNMIVHR---DIKGANILR--------------------- 139
Query: 145 NDTEGYVKIADFG-------LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWG 197
D+ G VK+ DFG +C G G TGT P +++PEV++ Y R D W
Sbjct: 140 -DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT----PYWMSPEVISGEGYGRKADIWS 194
Query: 198 LGVLIFEMLVGESPF 212
+G + EML + P+
Sbjct: 195 VGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-10
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 5 QYRNTGE-YFAIK-------ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFAC 56
+ +N G+ A+K A K + ++SE I + +RHP +V +
Sbjct: 20 RKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI--IKEQLRHPNIVRYYKT 77
Query: 57 FQTEAHVCFVMEYAAGGDLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLH-ESRIIY 110
F + VM+ G L H ++ F+E R +VL L+YLH E RI++
Sbjct: 78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVH 137
Query: 111 RPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
R + N+ I L +D V I DFGL K+ +
Sbjct: 138 R-------------------DLTPNN---IMLGEDDK---VTITDFGLAKQ-KQPESKLT 171
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+ GT + PE++ Y D W G ++++M + PF
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-10
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA-CFQTEAHVCFVMEYAAG 72
A+K L+KG E + L E + + HP +V L C E +ME G
Sbjct: 30 AVKTLRKGATD--QEKKEFLKEAHLM---SNFNHPNIVKLLGVCLLNEP-QYIIMELMEG 83
Query: 73 GDLMMHIH-ADVFSEPRAVF-----YAAC--VVLGLQYLHESRIIYRPQSNITKEEIKRI 124
GDL+ ++ A V + C V G YL + I+R +
Sbjct: 84 GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA---------- 133
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE--GMGFGDRTGTFCGTPEFLAPE 182
N V+ D + VKI DFGL ++ + + G ++APE
Sbjct: 134 ----ARNCLVSEKG------YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE 183
Query: 183 VLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEV 220
L + +T D W GVL++E+L +G+ P+P + +EV
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 56/247 (22%), Positives = 89/247 (36%), Gaps = 61/247 (24%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
AIK +++G +SE E A M HP LV L+ + + V EY
Sbjct: 32 AIKMIREG----------AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81
Query: 71 AGGDLMMHIHADVFSEPRAVFYAAC--VVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
A G L+ ++ C V ++YL + I+R + A+
Sbjct: 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD-----------LAAR- 129
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGL----------CKEGMGFGDRTGTFCGTPEF 178
N V + VK++DFGL +G F + +
Sbjct: 130 --NCLVGE-----------DNVVKVSDFGLARYVLDDQYTSSQGTKFPVK---------W 167
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRY-PRFLS 236
PEV + ++ D W GVL++E+ G+ P+ EV +S+ Y P+
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP 227
Query: 237 LEAIAIM 243
E IM
Sbjct: 228 TEVYTIM 234
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 36/202 (17%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVM 67
+T E A+K + ++ + ++ E + + ++HP + C+ E VM
Sbjct: 44 HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ---QLKHPNTIEYKGCYLKEHTAWLVM 100
Query: 68 EYAAG-GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEA 126
EY G ++ +H E + GL YLH +I+R +IK
Sbjct: 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR--------DIK---- 148
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV--- 183
+ I LT G VK+ADFG +F GTP ++APEV
Sbjct: 149 ----------AGNILLT---EPGQVKLADFG----SASKSSPANSFVGTPYWMAPEVILA 191
Query: 184 LTETSYTRAVDWWGLGVLIFEM 205
+ E Y VD W LG+ E+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 36/208 (17%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
T E AIK + + ++ + ++ E + + ++HP + C+ E VME
Sbjct: 49 TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ---RIKHPNSIEYKGCYLREHTAWLVME 105
Query: 69 YAAG-GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
Y G ++ +H E + GL YLH +I+R +IK
Sbjct: 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR--------DIK----- 152
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV---L 184
+ I LT G VK+ADFG +F GTP ++APEV +
Sbjct: 153 ---------AGNILLT---EPGQVKLADFG----SASIASPANSFVGTPYWMAPEVILAM 196
Query: 185 TETSYTRAVDWWGLGVLIFEMLVGESPF 212
E Y VD W LG+ E+ + P
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 39/129 (30%), Positives = 53/129 (41%), Gaps = 32/129 (24%)
Query: 99 GLQYLHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155
G+ +LH RI++R PQ N V S +G VKIAD
Sbjct: 119 GVDFLHSHRIVHRDLKPQ-----------------NILVTS-----------DGQVKIAD 150
Query: 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
FGL + F + T + APEVL ++SY VD W +G + E+ F G
Sbjct: 151 FGLARI-YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209
Query: 216 DEEEVFDSI 224
E + D I
Sbjct: 210 SEADQLDKI 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 45/218 (20%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF------QTEAH 62
TG+ AIK + + DE E + E + + + R+ + + F +
Sbjct: 30 TGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRN--IATYYGAFIKKNPPGMDDQ 83
Query: 63 VCFVMEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ VME+ G DL+ + + E + ++ GL +LH+ ++I+R
Sbjct: 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR-------- 135
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK Q + LT N VK+ DFG+ + R TF GTP ++
Sbjct: 136 DIK--------------GQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 180 APEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPF 212
APEV+ + +Y D W LG+ EM G P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 68/221 (30%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQTEAHVC 64
+ TGE + ALKK I E E + S I E++ + HP +V L TE +
Sbjct: 22 KLTGE---VVALKK--IRLDTETEGVPSTA-IREISLLKELNHPNIVKLLDVIHTENKLY 75
Query: 65 FVMEYAAGGDLMMHIHADVFSE---PRAVFYAACVVLGLQYLHESRIIYR---PQSNITK 118
V E+ DL + A S P Y ++ GL + H R+++R PQ+
Sbjct: 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN---- 130
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF-CGTPE 177
L +N TEG +K+ADFGL + G RT T T
Sbjct: 131 -----------------------LLIN-TEGAIKLADFGLAR-AFGVPVRTYTHEVVTLW 165
Query: 178 FLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
+ APE+L Y+ AVD W LG + EM+ + FPGD E
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 15/221 (6%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L +++ T E+F KA+ + R++ + ++ V ++H +V F +
Sbjct: 29 VFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE----VNVMRELKHKNIVRYIDRFLNK 84
Query: 61 AH--VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
A+ + +ME+ GDL +I + + A V + Q LH + +
Sbjct: 85 ANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNG 143
Query: 119 EEIKRIEAKVQENYKVNSSQEI-KLTV--NDTEG--YVKIADFGLCKEGMGFGDRTGTFC 173
E + + K Q + + I K+T N+ G KI DFGL K +G +
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN-IGIESMAHSCV 202
Query: 174 GTPEFLAPEVLT-ET-SYTRAVDWWGLGVLIFEMLVGESPF 212
GTP + +PE+L ET SY D W LG +I+E+ G++PF
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 45/218 (20%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------H 62
TG+ AIK + + DE E + E + + + R+ + + F ++
Sbjct: 40 TGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRN--IATYYGAFIKKSPPGHDDQ 93
Query: 63 VCFVMEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ VME+ G DL+ + + E + ++ GL +LH ++I+R
Sbjct: 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHR-------- 145
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK Q + LT N VK+ DFG+ + R TF GTP ++
Sbjct: 146 DIK--------------GQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188
Query: 180 APEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPF 212
APEV+ + +Y D W LG+ EM G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 59/248 (23%), Positives = 102/248 (41%), Gaps = 61/248 (24%)
Query: 3 LSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFA-CFQ 58
LSQ + A+K +K DI E+E LSE A M+ HP ++ L CF+
Sbjct: 20 LSQDDGSQLKVAVKTMKL-DIHTYSEIEEFLSE------AACMKDFDHPNVMKLIGVCFE 72
Query: 59 TEAHVCF-----VMEYAAGGDLMMHIHADVFSEPRA-----------VFYAACVVLGLQY 102
+ ++ + GDL H+ + + + + LG++Y
Sbjct: 73 ASSLQKIPKPMVILPFMKHGDL----HSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128
Query: 103 LHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG 162
L I+R ++ ++E+ V +ADFGL K+
Sbjct: 129 LSNRNFIHR--------DLAARNCMLREDMTVC-----------------VADFGLSKK- 162
Query: 163 MGFGD--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEE 218
+ GD R G P +++A E L + YT D W GV ++E+ G++P+PG +
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
Query: 219 EVFDSIVN 226
E++D + +
Sbjct: 223 EIYDYLRH 230
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 54/221 (24%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK D ++ L+SE + ++ +H ++NL + + ++EYA+ G
Sbjct: 48 AVKMLK--DDATDKDLSDLVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 74 DLMMHIHADVFSEPRAVFYA--ACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN 131
+L ++ A P + Y+ C + P+ +T +++ +V
Sbjct: 104 NLREYLRA---RRPPGMDYSFDTCKL--------------PEEQLTFKDLVSCAYQVARG 146
Query: 132 YKVNSSQEI--------KLTVNDTEGYVKIADFGLCKE--GMGFGDRTGTFCGTPEFLAP 181
+ +SQ+ + V + + +KIADFGL ++ + + +T +++AP
Sbjct: 147 MEYLASQKCIHRDLAARNVLVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205
Query: 182 EVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVF 221
E L + YT D W GVL++E+ +G SP+PG EE+F
Sbjct: 206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 63/237 (26%), Positives = 95/237 (40%), Gaps = 55/237 (23%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L YR G+ A+K LK A ++ L+E V T+RHP LV L
Sbjct: 22 VMLGDYR--GQKVAVKCLKDDSTAA----QAFLAEA---SVMTTLRHPNLVQLLGVVLQG 72
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAAC-------VVLGLQYLHESRIIYR-- 111
+ V EY A G L+ ++ S RAV A V G++YL E ++R
Sbjct: 73 NPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
N+ E + K++DFGL KE G +G
Sbjct: 129 AARNVLVSE---------------------------DLVAKVSDFGLAKEA-SQGQDSGK 160
Query: 172 FCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVN 226
P ++ APE L E ++ D W G+L++E+ G P+P ++V +
Sbjct: 161 L---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK+ + EVE L E + + ++HP LV L E + E+ G
Sbjct: 35 AVKTLKEDTM----EVEEFLKEAAVMK---EIKHPNLVQLLGVCTREPPFYIITEFMTYG 87
Query: 74 DLMMHIHADVFSEPRAV---FYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
+L+ ++ E AV + A + ++YL + I+R ++ V E
Sbjct: 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR--------DLAARNCLVGE 139
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP---EFLAPEVLTET 187
N+ VK+ADFGL + + GD G ++ APE L
Sbjct: 140 NH-----------------LVKVADFGLSR--LMTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 188 SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND 227
++ D W GVL++E+ G SP+PG D +V++ +
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 53/203 (26%), Positives = 74/203 (36%), Gaps = 49/203 (24%)
Query: 48 PFLVNLFACFQTEAHVCFVMEYAAGGDL----MMHIHADVFSEPRAVFYAACVVLGLQYL 103
P++V+ + F E V MEY G L + + E VV GL++L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 104 HESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM 163
E + NI ++K N VN G VK+ DFG+ G
Sbjct: 119 KE-------EHNIIHRDVK------PTNVLVN-----------GNGQVKLCDFGV--SGN 152
Query: 164 GFGDRTGTFCGTPEFLAPE---VLTET---SYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
T G ++APE +YT D W LG+ I EM +G P+P
Sbjct: 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---- 208
Query: 218 EEVFDSIVNDEVRYPRFLSLEAI 240
E + +I F L AI
Sbjct: 209 PETYANI---------FAQLSAI 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 36/169 (21%)
Query: 48 PFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSE-PRAVF--YAACVVLGLQYLH 104
P+++ + F E + E+ GG L DV+ + P V A VV GL YL
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLW 112
Query: 105 ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMG 164
+I++R ++K N VN T G VK+ DFG+ + +
Sbjct: 113 SLKILHR--------DVK------PSNMLVN-----------TRGQVKLCDFGVSTQLVN 147
Query: 165 FGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213
T+ GT ++APE ++ Y D W LG+ E+ +G P+P
Sbjct: 148 --SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 56/232 (24%), Positives = 87/232 (37%), Gaps = 48/232 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK D ++ L E I +++ H L+ L+ T + V E A G
Sbjct: 27 AVKCLK--SDKLSDIMDDFLKEAAIM---HSLDHENLIRLYGVVLTHP-LMMVTELAPLG 80
Query: 74 DLM--MHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ + A F YA + G++YL R I+R +
Sbjct: 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLA---------------- 124
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF--------LAPE 182
++ I L +D VKI DFGL + + + E APE
Sbjct: 125 ------ARNILLASDDK---VKIGDFGLMR-ALPQNED----HYVMEEHLKVPFAWCAPE 170
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRYPR 233
L +++ A D W GV ++EM GE P+ G ++ I + R R
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 49/228 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK D +D + L+SE + ++ +H ++NL + + ++EYA+ G
Sbjct: 54 AVKMLKS-DATEKD-LSDLISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 74 DLMMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
+L ++ A + S V A V G++YL + I+R ++
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR---DL 166
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE--GMGFGDRTGTFCG 174
+ E V +KIADFGL ++ + + +T
Sbjct: 167 AARNVLVTEDNV----------------------MKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVF 221
+++APE L + YT D W GVL++E+ +G SP+PG EE+F
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 64/225 (28%), Positives = 90/225 (40%), Gaps = 55/225 (24%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K LK G + E+ L E A M RH LV L+A C + E + V EY
Sbjct: 34 AVKTLKPGTM----SPEAFLQE------AQIMKKLRHDKLVQLYAVCSEEEP-IYIVTEY 82
Query: 70 AAGGDLMMHIHADVFS---EPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRI 124
+ G L+ + + P+ V AA + G+ YL I+R NI
Sbjct: 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL------- 135
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGT-FCGTP-EFLA 180
V EN KIADFGL + E + R G F P ++ A
Sbjct: 136 ---VGENL-----------------VCKIADFGLARLIEDDEYTAREGAKF---PIKWTA 172
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
PE +T D W G+L+ E++ G P+PG EV + +
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 71/239 (29%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR----HPFLVNLFAC 56
V+ +Q R TG+Y+AIK +KK + ++V +L E + +R HP ++ L
Sbjct: 15 VLKAQSRKTGKYYAIKCMKK-HFKSLEQVNNL-REIQ------ALRRLSPHPNILRLIEV 66
Query: 57 F--QTEAHVCFVMEYAAGGDLM-MHI------HADVFSEPRAVFYAACVVLGLQYLHESR 107
+ + V E LM M++ E R Y ++ L ++H +
Sbjct: 67 LFDRKTGRLALVFE------LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 108 IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD 167
I +R +IK EN + +I +K+ADFG C+
Sbjct: 121 IFHR--------DIK------PENILIK--DDI----------LKLADFGSCR------- 147
Query: 168 RTGTFCGTP--EFL------APE-VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
G + P E++ APE +LT+ Y +D W +G + FE+L FPG +E
Sbjct: 148 --GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-09
Identities = 51/208 (24%), Positives = 79/208 (37%), Gaps = 36/208 (17%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
E AIK + + ++ + ++ E R + +RHP + C+ E VME
Sbjct: 39 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ---KLRHPNTIQYRGCYLREHTAWLVME 95
Query: 69 YAAG-GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
Y G ++ +H E + GL YLH +I+R ++K
Sbjct: 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR--------DVK----- 142
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV---L 184
+ I L+ G VK+ DFG F GTP ++APEV +
Sbjct: 143 ---------AGNILLS---EPGLVKLGDFG----SASIMAPANXFVGTPYWMAPEVILAM 186
Query: 185 TETSYTRAVDWWGLGVLIFEMLVGESPF 212
E Y VD W LG+ E+ + P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 54/241 (22%), Positives = 97/241 (40%), Gaps = 39/241 (16%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK E E+L+SE +I +++ H +VNL + + EY G
Sbjct: 69 AVKMLKP--TAHSSEREALMSELKI--MSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 74 DLMMHIH--ADVFSEPRAVF-YAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
DL+ + + F + ++ V G+ +L I+R ++ + K+
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHR---DLAARNVLLTHGKI-- 179
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM---GFGDRTGTFCGTPEFLAPEVLTET 187
VKI DFGL ++ M + + +++APE +
Sbjct: 180 --------------------VKICDFGLARDIMNDSNYVVKGNARLPV-KWMAPESIFNC 218
Query: 188 SYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRY--PRFLSLEAIAIMR 244
YT D W G+L++E+ +G +P+PG + F ++ + R P E IM+
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278
Query: 245 R 245
Sbjct: 279 T 279
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-09
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 44/217 (20%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFE---VANTMRHPFLVNLFACFQ-----TE 60
TG A+K L + +S++ KR + + M+H ++ L F E
Sbjct: 41 TGLRVAVKKLSR-------PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ +++ + G DL + ++ F ++ GL+Y+H + II+R +
Sbjct: 94 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR--------D 145
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
+K N VN E+K I DFGL + D + T + A
Sbjct: 146 LK------PSNLAVNEDCELK-----------ILDFGLARHT---DDEMTGYVATRWYRA 185
Query: 181 PEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216
PE+ L Y + VD W +G ++ E+L G + FPG D
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 60/216 (27%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF-- 65
NTGE A+K L+ E L +R E+ +++H +V VC+
Sbjct: 31 NTGEVVAVKKLQ------HSTAEHLRDFEREIEILKSLQHDNIVKYKG-------VCYSA 77
Query: 66 -------VMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQS 114
VMEY G L ++ H + + + YA+ + G++YL R ++R
Sbjct: 78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
NI E +E VKI DFGL K + D+
Sbjct: 138 NILVE---------------------------SENRVKIGDFGLTK--VLPQDKEYYKVR 168
Query: 175 TPE-----FLAPEVLTETSYTRAVDWWGLGVLIFEM 205
P + APE LTE+ ++ A D W GV+++E+
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 37/204 (18%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF--QTEAHVCFV 66
TGE A+K LK+ K+ + T+ H +V C Q + +
Sbjct: 32 TGEMVAVKTLKRECGQQNTS-----GWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86
Query: 67 MEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEA 126
MEY G L ++ + + + +A + G+ YLH I+R
Sbjct: 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDL------------- 133
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGTPEF-LAPE 182
+++ + L D + VKI DFGL K EG + R +P F A E
Sbjct: 134 ---------AARNVLL---DNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDSPVFWYAVE 180
Query: 183 VLTETSYTRAVDWWGLGVLIFEML 206
L E ++ A D W GV ++E+L
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 51/228 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEK---RIFEVANTMRHPFLVNLFACFQTEAHVCF----- 65
A+K +K I R E+E LSE + F+ N MR + C QT +
Sbjct: 30 AVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRL-----IGVCLQTVESEGYPSPVV 83
Query: 66 VMEYAAGGDLMMHI-HADVFSEPR------AVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ + GDL + ++ + P+ V + + G++YL I+R
Sbjct: 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR------- 136
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTP 176
++ + EN V +ADFGL K+ + GD R G P
Sbjct: 137 -DLAARNCMLNENMNVC-----------------VADFGLSKK-IYNGDYYRQGRIAKMP 177
Query: 177 -EFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFD 222
+++A E L + YT D W GV ++E+ G++P+PG + E++D
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 50/212 (23%), Positives = 77/212 (36%), Gaps = 48/212 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
A+K LK+ I A +K A+ M HP +V L + E + VME A
Sbjct: 27 AVKTLKQEHIAA--------GKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELA 77
Query: 71 AGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIEAK 127
G L+ ++ A V +G+ YL ++R N+
Sbjct: 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNV----------- 126
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD---RTGTFCGTP-EFLAPEV 183
L VN KI+DFG+ + +G G R T P ++ APE
Sbjct: 127 --------------LLVN--RHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPG 214
+ ++ D W GV ++E G P+
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 59/263 (22%), Positives = 105/263 (39%), Gaps = 63/263 (23%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCFVMEYAAG 72
A+K LK+ + E+ LLSE F + + HP ++ L+ AC Q + ++EYA
Sbjct: 34 AVKMLKENA--SSSELRDLLSE---FNLLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKY 87
Query: 73 GDLMMHIHADVFSEPRAVF-------------------------YAACVVLGLQYLHESR 107
G L + P + +A + G+QYL E +
Sbjct: 88 GSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147
Query: 108 IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMG 164
+++R ++ + E + +KI+DFGL + E
Sbjct: 148 LVHR---DLAARNVLVAEGRK----------------------MKISDFGLSRDVYEEDS 182
Query: 165 FGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDS 223
+ R+ +++A E L + YT D W GVL++E++ +G +P+PG E +F+
Sbjct: 183 YVKRSKGRIPV-KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 224 I-VNDEVRYPRFLSLEAIAIMRR 245
+ + P S E +M
Sbjct: 242 LKTGYRMERPENCSEEMYNLMLT 264
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
AIK LK D++ + + E + + +RH L++LFA V + E G
Sbjct: 34 AIKILKSDDLLKQQD---FQKEVQALK---RLRHKHLISLFAVCSVGEPVYIITELMEKG 87
Query: 74 DLMMHI---HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ + V + A V G+ YL E I+R + A+
Sbjct: 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD-----------LAAR--- 133
Query: 131 NYKVNSSQEIKLTVNDTEGYV-KIADFGLC---KEGMGFGDRTGTFCGTP-EFLAPEVLT 185
N V E V K+ADFGL KE + P ++ APE +
Sbjct: 134 NILVG------------EDLVCKVADFGLARLIKEDVYLSSDKKI----PYKWTAPEAAS 177
Query: 186 ETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
+++ D W G+L++EM G+ P+PG + EV+D I
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 38/124 (30%), Positives = 55/124 (44%), Gaps = 37/124 (29%)
Query: 100 LQYLHESRIIYRPQ--SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157
L+Y+H +I+R SNI +NS + VK+ADFG
Sbjct: 120 LKYIHSGNVIHRDLKPSNIL----------------LNS-----------DCRVKLADFG 152
Query: 158 LCK------EGMGFGDRTGTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGES 210
L + E T + T + APE+L T YT+ VD W +G ++ EML+G+
Sbjct: 153 LARSLSELEENPENPVLT-DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
Query: 211 PFPG 214
FPG
Sbjct: 212 LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 39/204 (19%)
Query: 8 NTGEYFAIKALK--KGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
+TGE A+K +K GD + L ++ IF V +H +V F + + +
Sbjct: 32 HTGELAAVKIIKLEPGDDFS-------LIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWI 83
Query: 66 VMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
MEY GG L H SE + + + GL YLH ++R +IK
Sbjct: 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR--------DIK-- 133
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL 184
I LT N G VK+ADFG+ + + +F GTP ++APEV
Sbjct: 134 ------------GANILLTDN---GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
Query: 185 T---ETSYTRAVDWWGLGVLIFEM 205
Y + D W +G+ E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 52/184 (28%)
Query: 63 VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
V V EY DL + SE A + ++ GL+Y+H + +++R ++K
Sbjct: 91 VYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHR--------DLK 141
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-------------EGMGFGDRT 169
N +N+ + +KI DFGL + EG+
Sbjct: 142 ------PANVFINTEDLV----------LKIGDFGLARIVDPHYSHKGYLSEGL-----V 180
Query: 170 GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE----VFDSI- 224
+ +P L L+ +YT+A+D W G + EML G+ F G E E + +S+
Sbjct: 181 TKWYRSPRLL----LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 225 VNDE 228
V E
Sbjct: 237 VVRE 240
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 48/209 (22%), Positives = 74/209 (35%), Gaps = 60/209 (28%)
Query: 42 ANTMRH---PFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI--------HADVFSEP--- 87
A+ M+ +V L T VME A GDL ++ + P
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 88 RAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147
+ + AA + G+ YL + ++R + N V
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLA--------------ARNCMVAE----------- 154
Query: 148 EGYVKIADFGLC----------KEGMGFGDRTGTFCGTP-EFLAPEVLTETSYTRAVDWW 196
+ VKI DFG+ K G G P ++APE L + +T D W
Sbjct: 155 DLTVKIGDFGMTRDIYETDYYRKGGKGL---------LPVRWMAPESLKDGVFTTKSDVW 205
Query: 197 GLGVLIFEML-VGESPFPGDDEEEVFDSI 224
GV+++EM + E P+ G EEV +
Sbjct: 206 SFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 4/70 (5%)
Query: 151 VKIADFGLCKEGMGFGDRTGT---FCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEML 206
+KI DFGL + D TG + T + APE+ L YT+A+D W +G ++ EML
Sbjct: 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
Query: 207 VGESPFPGDD 216
FPG D
Sbjct: 205 SNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 46/220 (20%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFE---VANTMRHPFLVNLFACFQTEAHV 63
R TG AIK L + +S L KR + + M+H ++ L F + +
Sbjct: 37 RRTGAKVAIKKLYR-------PFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89
Query: 64 ------CFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
VM + G DL + + SE R F ++ GL+Y+H + II+R
Sbjct: 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHR------ 142
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++K N VN E+K I DFGL ++ + TG + T
Sbjct: 143 --DLK------PGNLAVNEDCELK-----------ILDFGLARQTDS--EMTG-YVVTRW 180
Query: 178 FLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216
+ APEV L YT+ VD W +G ++ EML G+ F G D
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 49/221 (22%)
Query: 41 VANTMRHPFLVNLFACFQTEAHVCFVM-EYAAGGDLMMHIHA-------DVFSEPRAVFY 92
+ + HP ++ L F C ++ Y DL ++ A D+ + R+V
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLR 193
Query: 93 AACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152
A +QYLHE+RII+R +IK EN +N G V
Sbjct: 194 A------IQYLHENRIIHR--------DIK------AENIFINHP-----------GDVC 222
Query: 153 IADFGL-CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGE-S 210
+ DFG C ++ + GT APE+L Y AVD W G+++FEM S
Sbjct: 223 LGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
Query: 211 PFPGD------DEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
F D D + I+ +P ++A A +
Sbjct: 283 LFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE 323
|
Length = 391 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 57/249 (22%), Positives = 94/249 (37%), Gaps = 55/249 (22%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----H 62
+G+ AIK + A D R ++ +H ++ + +
Sbjct: 27 TRSGKKVAIKKIPH----AFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82
Query: 63 VCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
V VM+ DL IH+D +E ++ ++ GL+Y+H + +I+R ++
Sbjct: 83 VYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHR--------DL 133
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF----CGTPE 177
K N VN E++ I DFG+ + F T
Sbjct: 134 K------PSNLLVNEDCELR-----------IGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 178 FLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDD---------------EEEVF 221
+ APE+L + YT A+D W +G + EML FPG + EEV
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 222 DSIVNDEVR 230
+ I +D VR
Sbjct: 237 NRIGSDRVR 245
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 40/211 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L T + F +K L+K S S +R+ + + + P +V L +E
Sbjct: 9 VLLVMDTRTQQTFILKGLRKS---------SEYSRERLTIIPHCV--PNMVCLHKYIVSE 57
Query: 61 AHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
V V+++A GG L HI + E +AA +V+ L LH I+ R +
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN----- 112
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
N ++ I+LT + ++ D E + +C
Sbjct: 113 ---------PNNILLDDRGHIQLTYFSR--WSEVED-SCDGEAV-----ENMYC------ 149
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGES 210
APEV + T A DWW LG ++FE+L G++
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 53/234 (22%), Positives = 91/234 (38%), Gaps = 48/234 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA-CFQTEAHVCFVMEYAAG 72
+KAL+K + +R ++ + H +V L C + E H ++EY
Sbjct: 39 LVKALQK-----TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH-YMILEYTDL 92
Query: 73 GDLMMHIHADV----------FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
GDL + A S + V + LG+ +L +R ++R +
Sbjct: 93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLA-------- 144
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFL 179
N V+S +E VK++ L K+ + P +L
Sbjct: 145 ------ARNCLVSSQRE-----------VKVSLLSLSKD--VYNSEYYKLRNALIPLRWL 185
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRYP 232
APE + E ++ D W GVL++E+ GE PF G +EEV + + ++ P
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 43/219 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK G + + + L+E +I + +RHP L+ L+A E + V E G
Sbjct: 34 AVKTLKPGTM----DPKDFLAEAQIMK---KLRHPKLIQLYAVCTLEEPIYIVTELMKYG 86
Query: 74 DLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ ++ P+ + AA V G+ YL I+R + A+
Sbjct: 87 SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRD-----------LAAR--- 132
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLC---KEGMGFGDRTGTFCGTP-EFLAPEVLTE 186
N V + K+ADFGL KE + + R G P ++ APE
Sbjct: 133 NVLVGEN-----------NICKVADFGLARVIKEDI-YEAREGA--KFPIKWTAPEAALY 178
Query: 187 TSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
++ D W G+L+ E++ G P+PG EV +
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 6e-08
Identities = 60/255 (23%), Positives = 98/255 (38%), Gaps = 66/255 (25%)
Query: 9 TGEYFAIKALK---KGD---IIARDEVESLLSEKRIFEVANTMRHPFLVNL--FACFQTE 60
TGE A+K LK + + I + E+ LL ++HP +V +
Sbjct: 29 TGEIVALKKLKMEKEKEGFPITSLREINILLK----------LQHPNIVTVKEVVVGSNL 78
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNI 116
+ VMEY DL +M F + ++ G+ +LH++ I++R SN+
Sbjct: 79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNL 137
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+N+ G +KI DFGL +E +G + T
Sbjct: 138 L----------------LNNR-----------GILKICDFGLARE---YGSPLKPY--TQ 165
Query: 177 E-----FLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN---- 226
+ APE+L Y+ A+D W +G + E+L + FPG E + + I
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225
Query: 227 -DEVRYPRFLSLEAI 240
E +P F L
Sbjct: 226 PTEKIWPGFSELPGA 240
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 36/204 (17%)
Query: 30 ESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSE 86
E +SE+ E A M HP LV L+ + +C V E+ G L ++ A
Sbjct: 38 EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKF 97
Query: 87 PRAVFYAAC--VVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
+ C V G+ YL S +I+R + N V +Q
Sbjct: 98 SQETLLGMCLDVCEGMAYLESSNVIHRDLA--------------ARNCLVGENQ------ 137
Query: 145 NDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP---EFLAPEVLTETSYTRAVDWWGLGVL 201
VK++DFG+ + D+ + GT ++ +PEV + + Y+ D W GVL
Sbjct: 138 -----VVKVSDFGMTR--FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVL 190
Query: 202 IFEMLV-GESPFPGDDEEEVFDSI 224
++E+ G++P+ EV ++I
Sbjct: 191 MWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 41/131 (31%), Positives = 52/131 (39%), Gaps = 43/131 (32%)
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIAD 155
G+ YLHE+ I++R +IK N D +G +KIAD
Sbjct: 127 GINYLHENHILHR---------------------------DIK-AANILIDNQGILKIAD 158
Query: 156 FGLC----------KEGMGFGDRTGTFCG-TPEFLAPE-VLTETSYTRAVDWWGLGVLIF 203
FGL K G G G R T T + PE +L E YT AVD WG+G +
Sbjct: 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218
Query: 204 EMLVGESPFPG 214
EM G
Sbjct: 219 EMFTRRPILQG 229
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 37/141 (26%), Positives = 54/141 (38%), Gaps = 26/141 (18%)
Query: 96 VVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155
++ GL+YLH RII+R ++K EN +N V I D
Sbjct: 166 ILEGLRYLHAQRIIHR--------DVK------TENIFIND-----------VDQVCIGD 200
Query: 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
G + + G GT E APEVL Y D W G+++FEML S D
Sbjct: 201 LGAAQFPVVAPAFLG-LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259
Query: 216 DEEEVFDSIVNDEVRYPRFLS 236
+ + + + +S
Sbjct: 260 PPSTPEEYVKSCHSHLLKIIS 280
|
Length = 357 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 73/285 (25%), Positives = 121/285 (42%), Gaps = 56/285 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVANTMRHPFLVNLF-ACFQTEAHVC 64
+++ A+K LK+G + E ++L+SE +I + N H +VNL AC + +
Sbjct: 34 KSSCNTVAVKMLKEGATAS--EHKALMSELKILIHIGN---HLNVVNLLGACTKPNGPLM 88
Query: 65 FVMEYAAGGDLMMHIHA--DVFS-------EPRAVFYA---------------ACVVLGL 100
++E+ G+L + A + FS + R F A A V+
Sbjct: 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSR 148
Query: 101 QYLHESRIIYRPQ-------SNITKEEIKRIEAKVQENYKVNSSQE----------IKLT 143
S PQ S +T E++ +V + +S++ I L+
Sbjct: 149 FQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS 208
Query: 144 VNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 201
N+ VKI DFGL ++ D R G+ +++APE + + YT D W GVL
Sbjct: 209 ENNV---VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVL 265
Query: 202 IFEML-VGESPFPGDDEEEVFDSIVND--EVRYPRFLSLEAIAIM 243
++E+ +G SP+PG E F + D +R P + E IM
Sbjct: 266 LWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIM 310
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 30 ESLLSEKRIFE---VANTMRHPFLVNLFACFQTEAHV-----CFVMEYAAGGDLMMHIHA 81
+SL+ +R + + M+H ++ L F + +++ G DL +
Sbjct: 53 QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC 112
Query: 82 DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIK 141
S+ F ++ GL+Y+H + II+R ++K N VN E++
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHR--------DLK------PSNVAVNEDCELR 158
Query: 142 LTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGV 200
I DFGL ++ D + T + APE+ L Y + VD W +G
Sbjct: 159 -----------ILDFGLARQA---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 204
Query: 201 LIFEMLVGESPFPGDD 216
++ E+L G++ FPG+D
Sbjct: 205 IMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 38/213 (17%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
+R TG +A+K + D V + R E+ + HP +V F +
Sbjct: 95 HRPTGRLYALKVIYGNH---EDTVRRQIC--REIEILRDVNHPNVVKCHDMFDHNGEIQV 149
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
++E+ GG L AD E A ++ G+ YLH I++R +IK
Sbjct: 150 LLEFMDGGSLEGTHIAD---EQFLADVARQILSGIAYLHRRHIVHR--------DIK--- 195
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE-VL 184
N +NS++ VKIADFG+ + D + GT +++PE +
Sbjct: 196 ---PSNLLINSAKN-----------VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
Query: 185 TETSYTR----AVDWWGLGVLIFEMLVGESPFP 213
T+ ++ A D W LGV I E +G PF
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 54/234 (23%), Positives = 82/234 (35%), Gaps = 35/234 (14%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF-VM 67
TG AIK L+ A +E +R + + HP +V L + + F V
Sbjct: 2 TGHEVAIKLLR---TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58
Query: 68 EYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEA 126
EY G L + AD V+ L H I++R ++K
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHR--------DLK---- 106
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-------RTGTFCGTPEFL 179
Q I ++ + K+ DFG+ G D RT GTP +
Sbjct: 107 ----------PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYC 156
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV-FDSIVNDEVRYP 232
APE L T D + G++ E L G+ G E+ + + +V P
Sbjct: 157 APEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP 210
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
AIK LK G + E+ L E +V +RH LV L+A +E + V EY + G
Sbjct: 34 AIKTLKPGTM----SPEAFLQEA---QVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG 85
Query: 74 DLMMHI---HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ + P+ V AA + G+ Y+ ++R +++ V E
Sbjct: 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR--------DLRAANILVGE 137
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTPEFLAPEVLTETS 188
N K+ADFGL + E + R G ++ APE
Sbjct: 138 NL-----------------VCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGR 179
Query: 189 YTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
+T D W G+L+ E+ G P+PG EV D +
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-07
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK G + ES L E +I + +RH LV L+A +E + V EY + G
Sbjct: 34 AVKTLKPGTM----SPESFLEEAQIMK---KLRHDKLVQLYAVV-SEEPIYIVTEYMSKG 85
Query: 74 DLMMHI---HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ + P V AA V G+ Y+ I+R +++ V +
Sbjct: 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR--------DLRSANILVGD 137
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTP-EFLAPEVLTET 187
KIADFGL + E + R G P ++ APE
Sbjct: 138 GL-----------------VCKIADFGLARLIEDNEYTARQGA--KFPIKWTAPEAALYG 178
Query: 188 SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
+T D W G+L+ E++ G P+PG + EV + +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 41/184 (22%)
Query: 45 MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH--ADVFSEPRAVFYAACVVLGLQY 102
++H +V L TE + V EY DL ++ ++ S + ++ GL Y
Sbjct: 60 LKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 103 LHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159
H+ +I++R PQ+ L +N+ +G +K+ADFGL
Sbjct: 119 CHKRKILHRDLKPQN---------------------------LLINE-KGELKLADFGLA 150
Query: 160 KEGMGFGDRTGTFCG---TPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
+ T T+ T + P+VL T Y+ +D WG+G +++EM G FPG
Sbjct: 151 RAK---SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207
Query: 216 DEEE 219
+E
Sbjct: 208 TVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 58/245 (23%), Positives = 96/245 (39%), Gaps = 48/245 (19%)
Query: 10 GEY-FAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCF 65
G+Y AIK +K+G +SE E A M H LV L+ + +
Sbjct: 27 GQYDVAIKMIKEGS----------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAAC--VVLGLQYLHESRIIYRPQSNITKEEIKR 123
V EY + G L+ ++ + C V G+ YL + I+R +
Sbjct: 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA--------- 127
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP---EFLA 180
N V+ +G VK++DFGL + + D + G+ +
Sbjct: 128 -----ARNCLVDD-----------QGCVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSP 169
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRY-PRFLSLE 238
PEVL + ++ D W GVL++E+ +G+ P+ + E + + Y P S +
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK 229
Query: 239 AIAIM 243
AIM
Sbjct: 230 VYAIM 234
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 61/218 (27%), Positives = 89/218 (40%), Gaps = 47/218 (21%)
Query: 9 TGEYFAIKALKK---GDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA---- 61
TGE AIK L + +I A+ L K M+H ++ L F +
Sbjct: 39 TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH-------MQHENVIGLLDVFTSAVSGDE 91
Query: 62 --HVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
VM Y DL I SE + + ++ GL+Y+H + II+R
Sbjct: 92 FQDFYLVMPYMQT-DLQ-KIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHR-------- 141
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K N VN E+K I DFGL + + TG + T +
Sbjct: 142 DLK------PGNLAVNEDCELK-----------ILDFGLARHADA--EMTG-YVVTRWYR 181
Query: 180 APEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216
APEV L Y + VD W +G ++ EML G++ F G D
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 52/227 (22%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAH 62
Y N AIK+LK+G + E+ L+E AN M+ HP LV L+A T+
Sbjct: 26 YYNGHTKVAIKSLKQGSM----SPEAFLAE------ANLMKQLQHPRLVRLYAVV-TQEP 74
Query: 63 VCFVMEYAAGGDLMMHIHADVFSE---PRAVFYAACVVLGLQYLHESRIIYRP--QSNIT 117
+ + EY G L+ + + + + AA + G+ ++ I+R +NI
Sbjct: 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGT 175
E KIADFGL + E + R G
Sbjct: 135 VSE---------------------------TLCCKIADFGLARLIEDNEYTAREGA--KF 165
Query: 176 P-EFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEV 220
P ++ APE + ++T D W G+L+ E++ G P+PG EV
Sbjct: 166 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 49/219 (22%)
Query: 17 ALKKGDIIARDE-VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75
ALKK + DE V S + R + M+H +V L +E + V EY DL
Sbjct: 31 ALKKIRLEQEDEGVPS--TAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DL 85
Query: 76 MMHIHADVFSE----PRAV-FYAACVVLGLQYLHESRIIYR---PQSNITKEEIKRIEAK 127
+ H D + PR + Y ++ G+ Y H R+++R PQ+
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN------------- 132
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG---TPEFLAPEVL 184
L ++ +K+ADFGL + FG TF T + APE+L
Sbjct: 133 --------------LLIDRRTNALKLADFGLAR---AFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 185 TET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVF 221
+ Y+ VD W +G + EM+ + FPGD E +E+F
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 47/194 (24%), Positives = 72/194 (37%), Gaps = 35/194 (18%)
Query: 27 DEVESLLSEKRIFEVANTMRHPFLVNLFA-CFQTEAHVCFVMEYAAGGDLMMHIHADVFS 85
D L E I HP +V L C Q + + VME GG L+ +
Sbjct: 34 DLKRKFLQEAEI---LKQYDHPNIVKLIGVCVQKQP-IYIVMELVPGGSLLTFLRKKKNR 89
Query: 86 EPRAVFYAACV--VLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLT 143
+ G++YL I+R ++ V EN
Sbjct: 90 LTVKKLLQMSLDAAAGMEYLESKNCIHR--------DLAARNCLVGEN------------ 129
Query: 144 VNDTEGYVKIADFGLCKE--GMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 201
+KI+DFG+ +E G + G ++ APE L YT D W G+L
Sbjct: 130 -----NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGIL 184
Query: 202 IFEML-VGESPFPG 214
++E +G++P+PG
Sbjct: 185 LWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 47/197 (23%), Positives = 75/197 (38%), Gaps = 41/197 (20%)
Query: 44 TMRHPFLVNLFA-CFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAV-----------F 91
H +V L F+ ++E AGGDL + + PR F
Sbjct: 65 KFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRE---NRPRPERPSSLTMKDLLF 120
Query: 92 YAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151
A V G +YL E+ I+R I A+ LT
Sbjct: 121 CARDVAKGCKYLEENHFIHRD-----------IAAR-----------NCLLTCKGPGRVA 158
Query: 152 KIADFGLCKE--GMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VG 208
KIADFG+ ++ + + G +++ PE + +T D W GVL++E+ +G
Sbjct: 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG 218
Query: 209 ESPFPGDDEEEVFDSIV 225
P+PG +EV + +
Sbjct: 219 YMPYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-07
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 32/185 (17%)
Query: 45 MRHPFLVNLFACFQTEAH-VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYL 103
+RH +++L F + + FV E G DL + + + ++ ++ GL+Y+
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 104 HESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM 163
H + +++R ++K + EN + KI DFGL + +
Sbjct: 125 HSAGVVHR--------DLKPSNILINENCDL-----------------KICDFGLAR--I 157
Query: 164 GFGDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD 222
TG + T + APE+ LT Y VD W G + EML G+ FPG D F
Sbjct: 158 QDPQMTG-YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF- 215
Query: 223 SIVND 227
SI+ D
Sbjct: 216 SIITD 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 51/200 (25%), Positives = 75/200 (37%), Gaps = 62/200 (31%)
Query: 37 RIFEVANTMRHPFLVNLFACF------QTEAHVCFVMEYAAGGDLMMH-----IHADVFS 85
R + + H ++ L F + V VME LM I D+
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDH 117
Query: 86 EPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIEAKVQENYKVNSSQEIKLT 143
E R + ++ G+++LH + II+R SNI
Sbjct: 118 E-RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI--------------------------- 149
Query: 144 VNDTEGYVKIADFGLCKEGMGFGDRT--GTFCGTPE-----FLAPEVLTETSYTRAVDWW 196
V ++ +KI DFGL RT +F TP + APEV+ Y VD W
Sbjct: 150 VVKSDCTLKILDFGLA--------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 201
Query: 197 GLGVLIFEMLVGESPFPGDD 216
+G ++ EM+ G FPG D
Sbjct: 202 SVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 31/82 (37%), Positives = 41/82 (50%), Gaps = 11/82 (13%)
Query: 142 LTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE-----FLAPEVLT-ETSYTRAVDW 195
L V+ +G +KIAD GL G F ++ T E + APEVL T Y+ VD
Sbjct: 141 LLVDKQKGLLKIADLGL---GRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDI 195
Query: 196 WGLGVLIFEMLVGESPFPGDDE 217
W +G + EM + FPGD E
Sbjct: 196 WSVGCIFAEMSRKQPLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-06
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 45/218 (20%)
Query: 47 HPFLVNLFACFQTEAHVCFVMEYAAGGDLM-----------------MHIHADVFSEPRA 89
HP ++NL + ++ +EYA G+L+ + A S +
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 90 VFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149
+ +AA V G+ YL + + I+R ++ V ENY
Sbjct: 115 LHFAADVARGMDYLSQKQFIHR--------DLAARNILVGENYVA--------------- 151
Query: 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VG 208
KIADFGL + + +T ++A E L + YT D W GVL++E++ +G
Sbjct: 152 --KIADFGLSRGQEVYVKKTMGRLPV-RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208
Query: 209 ESPFPGDDEEEVFDSIVND-EVRYPRFLSLEAIAIMRR 245
+P+ G E+++ + + P E +MR+
Sbjct: 209 GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQ 246
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 48/187 (25%), Positives = 73/187 (39%), Gaps = 32/187 (17%)
Query: 32 LLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH--ADVFSEPRA 89
LSE RI + + HP +V L + VME GGD + + D +
Sbjct: 39 FLSEARILKQYD---HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL 95
Query: 90 VFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149
V +A G+ YL I+R ++ V EN
Sbjct: 96 VKFALDAAAGMAYLESKNCIHR--------DLAARNCLVGEN-----------------N 130
Query: 150 YVKIADFGLCK-EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-V 207
+KI+DFG+ + E G +G ++ APE L Y+ D W G+L++E +
Sbjct: 131 VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSL 190
Query: 208 GESPFPG 214
G P+PG
Sbjct: 191 GVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 57/260 (21%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVE----SLLSEKRIFEVANTMRHPFLVNLF-ACFQT-- 59
+N G + A+K ++ + E S + E + T HP +V LF C +
Sbjct: 24 KNGGRFVALKRVR-----VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78
Query: 60 --EAHVCFVMEYAAGGDLMMHIHADVFSEP-------RAVFYAACVVLGLQYLHESRIIY 110
E + V E+ D + + D EP + + + ++ GL +LH R+++
Sbjct: 79 DRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMFQ--LLRGLDFLHSHRVVH 133
Query: 111 RPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
R ++K +N V SS +IKL ADFGL + F
Sbjct: 134 R--------DLK------PQNILVTSSGQIKL-----------ADFGLARI-YSFQMALT 167
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE----VFDSI-V 225
+ T + APEVL ++SY VD W +G + EM + F G + + + D I +
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227
Query: 226 NDEVRYPRFLSLEAIAIMRR 245
E +PR ++L A +
Sbjct: 228 PGEEDWPRDVALPRQAFHSK 247
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 41/184 (22%)
Query: 45 MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH--ADVFSEPRAVFYAACVVLGLQY 102
++H +V L TE + V EY DL ++ + + + ++ GL Y
Sbjct: 61 LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 103 LHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159
H ++++R PQ+ L +N+ G +K+ADFGL
Sbjct: 120 CHRRKVLHRDLKPQN---------------------------LLINE-RGELKLADFGLA 151
Query: 160 KEGMGFGDRTGTFCG---TPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
+ T T+ T + P++L T Y+ +D WG+G + +EM G FPG
Sbjct: 152 RAK---SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208
Query: 216 DEEE 219
EE
Sbjct: 209 TVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEV-ESLLSEKRIFEVANTMRHPFLVNLFACFQT 59
V+ +++ T E AIK K + +EV E+ L E ++ T++ +V L F+
Sbjct: 17 VLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLR---TLKQENIVELKEAFRR 71
Query: 60 EAHVCFVMEYAAGGDL-MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ V EY L ++ + + Y ++ + + H++ I++R
Sbjct: 72 RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR------- 124
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT-FCGTPE 177
+IK EN ++ + +KL DFG + + T + T
Sbjct: 125 -DIK------PENLLISHNDVLKL-----------CDFGFARNLSEGSNANYTEYVATRW 166
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
+ +PE+L Y +AVD W +G ++ E+ G+ FPG+ E
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 37/225 (16%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
AIK LK G + + LSE I H ++ L + EY G
Sbjct: 37 AIKTLKPG--YTEKQRQDFLSEASIM---GQFSHHNIIRLEGVVTKFKPAMIITEYMENG 91
Query: 74 --DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN 131
D + H FS + V + G++YL + ++R + N
Sbjct: 92 ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA--------------ARN 137
Query: 132 YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP---EFLAPEVLTETS 188
VNS+ E K++DFGL + + T T G + APE +
Sbjct: 138 ILVNSNLE-----------CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 189 YTRAVDWWGLGVLIFE-MLVGESPFPGDDEEEVFDSIVNDEVRYP 232
+T A D W G++++E M GE P+ EV +I ND R P
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 39/226 (17%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
AIK L++ + + +L E + ++ HP +V L + + + G
Sbjct: 40 AIKVLREET--SPKANKEILDEAYVMA---SVDHPHVVRLLGICLSSQV-QLITQLMPLG 93
Query: 74 DLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN 131
L+ ++ H D + + + G+ YL E R+++R + A+ N
Sbjct: 94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR-----------DLAAR---N 139
Query: 132 YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG--TP-EFLAPEVLTETS 188
V + Q +VKI DFGL K + ++ G P +++A E +
Sbjct: 140 VLVKTPQ-----------HVKITDFGLAKL-LDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 189 YTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRYPR 233
YT D W GV ++E++ G P+ G E+ D + E R P+
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-06
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
AIK LK G ++ E+ L E +I + +RH LV L+A +E + V E+ G
Sbjct: 34 AIKTLKPGTMMP----EAFLQEAQIMK---KLRHDKLVPLYAVV-SEEPIYIVTEFMGKG 85
Query: 74 DLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ + P+ V AA + G+ Y+ I+R +++ V +
Sbjct: 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR--------DLRAANILVGD 137
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTP-EFLAPEVLTET 187
N KIADFGL + E + R G P ++ APE
Sbjct: 138 NL-----------------VCKIADFGLARLIEDNEYTARQGA--KFPIKWTAPEAALYG 178
Query: 188 SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
+T D W G+L+ E++ G P+PG EV + +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-06
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 40/188 (21%)
Query: 45 MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQY 102
++H +V L T+ + V EY DL ++ H + ++ GL Y
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 103 LHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159
+H+ I++R PQ+ L ++DT G +K+ADFGL
Sbjct: 119 IHQRYILHRDLKPQN---------------------------LLISDT-GELKLADFGLA 150
Query: 160 KEGMGFGDRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPG---- 214
+ T + P+VL T Y+ +D WG+G + EM+ G + FPG
Sbjct: 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
Query: 215 -DDEEEVF 221
D E +F
Sbjct: 211 QDQLERIF 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 29/178 (16%)
Query: 45 MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH--ADVFSEPRAVFYAACVVLGLQY 102
++H +V L T+ + V EY DL ++ ++ S + ++ GL Y
Sbjct: 61 LKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 103 LHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG 162
H ++++R ++K +N +N E+KL ADFGL +
Sbjct: 120 CHRRKVLHR--------DLK------PQNLLINERGELKL-----------ADFGLARAK 154
Query: 163 MGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
T + P+VL +S Y+ +D WG+G + FEM G FPG E+
Sbjct: 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-06
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
AIKA+ +G +SE+ E A M HP LV L+ + + V E+
Sbjct: 32 AIKAINEGA----------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81
Query: 71 AGGDLMMHIHADVFSEPRAVFYAAC--VVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
G L+ ++ + + + C V G++YL + I+R +
Sbjct: 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA-------------- 127
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP---EFLAPEVLT 185
N V+S G VK++DFG+ + + D + G ++ PEV
Sbjct: 128 ARNCLVSS-----------TGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFN 174
Query: 186 ETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
+ Y+ D W GVL++E+ G+ PF EV + I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 151 VKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-V 207
VKI DFGL ++ D R G +++APE + + YT D W GVL++E+ +
Sbjct: 212 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271
Query: 208 GESPFPGDDEEEVFDSIVNDEVRY--PRFLSLEAIAIM 243
G SP+PG +E F + + R P + + E +IM
Sbjct: 272 GASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIM 309
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 147 TEGYV-KIADFGLCKEGMGFGDRTGTFCGTP----EFLAPEVLTETSYTRAVDWWGLGVL 201
T+G V KI DFGL ++ M D G +++APE + + YT D W G+L
Sbjct: 246 TDGRVAKICDFGLARDIMN--DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 303
Query: 202 IFEML-VGESPFPGDDEEEVFDSIVND--EVRYPRFLSLEAIAIMR 244
++E+ +G+SP+PG F +V ++ P F E +IM+
Sbjct: 304 LWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK 349
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K +K G + VE+ L+E + + T++H LV L A E + + E+ A G
Sbjct: 34 AVKTMKPGSM----SVEAFLAEANVMK---TLQHDKLVKLHAVVTKEP-IYIITEFMAKG 85
Query: 74 DLMMHIHADVFSE---PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130
L+ + +D S+ P+ + ++A + G+ ++ + I+R ++ I + V
Sbjct: 86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR---DLRAANILVSASLV-- 140
Query: 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTP-EFLAPEVLTET 187
KIADFGL + E + R G P ++ APE +
Sbjct: 141 --------------------CKIADFGLARVIEDNEYTAREGA--KFPIKWTAPEAINFG 178
Query: 188 SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224
S+T D W G+L+ E++ G P+PG EV ++
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 53/246 (21%)
Query: 3 LSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFAC-FQ 58
L + + A+K LK DI + ++E L E A M+ HP ++ L +
Sbjct: 20 LKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLRE------AACMKEFDHPNVIKLIGVSLR 72
Query: 59 TEAH-----VCFVMEYAAGGDL-----MMHIHADVFSEPRAVF--YAACVVLGLQYLHES 106
+ A ++ + GDL M I + F+ P + + G++YL
Sbjct: 73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK 132
Query: 107 RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG 166
I+R ++ + EN V +ADFGL K+ + G
Sbjct: 133 NFIHR--------DLAARNCMLNENMTVC-----------------VADFGLSKK-IYSG 166
Query: 167 D--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFE-MLVGESPFPGDDEEEVFD 222
D R G P ++LA E L + YT D W GV ++E M G++P+ G + E+++
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
Query: 223 SIVNDE 228
++
Sbjct: 227 YLIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 46/197 (23%)
Query: 47 HPFLVNLFACFQTEAHVCFVMEYAAGGDLM-----------------MHIHADVFSEPRA 89
HP ++NL + ++ +EYA G+L+ + A S +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 90 VFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149
+ +AA V G+ YL + + I+R ++ V ENY
Sbjct: 127 LHFAADVARGMDYLSQKQFIHR--------DLAARNILVGENY----------------- 161
Query: 150 YVKIADFGLCKEGMGFGDRT-GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-V 207
KIADFGL + + +T G ++A E L + YT D W GVL++E++ +
Sbjct: 162 VAKIADFGLSRGQEVYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219
Query: 208 GESPFPGDDEEEVFDSI 224
G +P+ G E+++ +
Sbjct: 220 GGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 37/147 (25%)
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
GL +LH + I++R ++K EN V S G VK+ADFGL
Sbjct: 120 GLDFLHANCIVHR--------DLK------PENILVTSG-----------GQVKLADFGL 154
Query: 159 CK---EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
+ M T + APEVL +++Y VD W +G + EM + F G+
Sbjct: 155 ARIYSCQMALTPVVVTLW----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210
Query: 216 DEEE----VFDSI-VNDEVRYPRFLSL 237
E + +FD I + E +PR ++L
Sbjct: 211 SEADQLGKIFDLIGLPPEDDWPRDVTL 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 47/220 (21%)
Query: 46 RHPFLVNLFACFQTEAHVCFVMEYAAGGDLM-----------------MHIHADVFSEPR 88
HP ++NL + ++ +EYA G+L+ H A + +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 89 AVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148
+ +A+ V G+QYL E + I+R ++ V EN
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHR--------DLAARNVLVGENLAS-------------- 158
Query: 149 GYVKIADFGLCKEGMGFGDRT-GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML- 206
KIADFGL + + +T G ++A E L + YT D W GVL++E++
Sbjct: 159 ---KIADFGLSRGEEVYVKKTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
Query: 207 VGESPFPGDDEEEVFDSIVND-EVRYPRFLSLEAIAIMRR 245
+G +P+ G E+++ + + PR E +MR+
Sbjct: 214 LGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQ 253
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 28/74 (37%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 151 VKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-V 207
VKI DFGL ++ D R G +++APE + + YT D W GVL++E+ +
Sbjct: 218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
Query: 208 GESPFPGDDEEEVF 221
G SP+PG +E F
Sbjct: 278 GASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 53/221 (23%)
Query: 7 RNTGEYFAIK---------ALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF 57
R TG+ AIK +KK IA E+ L ++HP LVNL F
Sbjct: 23 RETGQIVAIKKFVESEDDPVIKK---IALREIRML----------KQLKHPNLVNLIEVF 69
Query: 58 QTEAHVCFVMEY---AAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
+ + + V EY +L + + + + + + + H+ I+R
Sbjct: 70 RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--TLQAVNFCHKHNCIHR--- 124
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
++K EN + +IKL DFG + G GD +
Sbjct: 125 -----DVK------PENILITKQGQIKL-----------CDFGFARILTGPGDDYTDYVA 162
Query: 175 TPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
T + APE+L +T Y VD W +G + E+L G+ +PG
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 55/237 (23%), Positives = 89/237 (37%), Gaps = 64/237 (27%)
Query: 7 RNTGEYFAIKALKKGDIIARDE-VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
R T E I ALK+ + DE V S S R + ++H +V L+ ++ +
Sbjct: 22 RETHE---IVALKRVRLDDDDEGVPS--SALREICLLKELKHKNIVRLYDVLHSDKKLTL 76
Query: 66 VMEY----------AAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---P 112
V EY + GD+ I + ++ GL + H +++R P
Sbjct: 77 VFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ---------LLKGLAFCHSHNVLHRDLKP 127
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
Q N +N + E+KL ADFGL + FG +
Sbjct: 128 Q-----------------NLLINKNGELKL-----------ADFGLAR---AFGIPVRCY 156
Query: 173 CG---TPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESP-FPGDDEEEVFDSI 224
T + P+VL Y+ ++D W G + E+ P FPG+D ++ I
Sbjct: 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 43/187 (22%)
Query: 44 TMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQ 101
++H +V L T+ + V EY DL M S + ++ GL
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 102 YLHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
Y H+ R+++R PQ+ L +++ G +K+ADFGL
Sbjct: 118 YCHQRRVLHRDLKPQN---------------------------LLISER-GELKLADFGL 149
Query: 159 CKEGMGFGDRTGTFCG---TPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
+ + T+ T + P+VL T Y+ ++D WG+G + +EM G FPG
Sbjct: 150 ARAK---SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206
Query: 215 --DDEEE 219
D E++
Sbjct: 207 STDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 29/173 (16%)
Query: 45 MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQY 102
++H +V L T+ + FV EY DL ++ H + ++ GL Y
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 103 LHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG 162
+H I++R + K Q N ++ E+KL ADFGL +
Sbjct: 119 IHGQHILHR-------------DLKPQ-NLLISYLGELKL-----------ADFGLARAK 153
Query: 163 MGFGDRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
+ T + P+VL T Y+ A+D WG G + EML G+ FPG
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 2/65 (3%)
Query: 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGE 209
+K+ DFG K + G R+ ++ + + APE+ L T+YT +D W LG +I EM++G
Sbjct: 210 LKLCDFGSAKNLLA-GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 210 SPFPG 214
F G
Sbjct: 269 PIFSG 273
|
Length = 440 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 26/119 (21%)
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
GL+Y+H + +++R ++K N +N++ ++ KI DFGL
Sbjct: 120 GLKYIHSANVLHR--------DLK------PSNLLLNANCDL-----------KICDFGL 154
Query: 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDD 216
+ GD + T + APE+L S YT A+D W +G + E+L + FPG D
Sbjct: 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 39/206 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
AIK LK + + + ++ E E+ + + +P++V + + EA + VME A+GG
Sbjct: 26 AIKVLKNEN--EKSVRDEMMREA---EIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGG 79
Query: 74 DLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQEN 131
L + D + V V +G++YL ++R ++ +
Sbjct: 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR---DLAARNV---------- 126
Query: 132 YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD---RTGTFCGTP-EFLAPEVLTET 187
L VN + Y KI+DFGL K +G D + + P ++ APE +
Sbjct: 127 ----------LLVN--QHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 188 SYTRAVDWWGLGVLIFEML-VGESPF 212
++ D W G+ ++E G+ P+
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 47/220 (21%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L YR G A+K +K D A ++ L+E V +RH LV L E
Sbjct: 22 VMLGDYR--GNKVAVKCIKN-DATA----QAFLAEA---SVMTQLRHSNLVQLLGVIVEE 71
Query: 61 AHVCF-VMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQS 114
+ V EY A G L+ ++ + V + ++ V ++YL + ++R
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR 131
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
N+ E + K++DFGL KE D TG
Sbjct: 132 NVLVSE---------------------------DNVAKVSDFGLTKEASSTQD-TGKL-- 161
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFP 213
++ APE L E ++ D W G+L++E+ G P+P
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-05
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 41/219 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K+ + + + D L E RI + + HP +V L + + VME GG
Sbjct: 24 AVKSCR--ETLPPDLKAKFLQEARILKQYS---HPNIVRLIGVCTQKQPIYIVMELVQGG 78
Query: 74 DLMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
D + + V + V AA G++YL I+R +
Sbjct: 79 DFLTFLRTEGPRLKVKELIQMVENAAA---GMEYLESKHCIHRDLA-------------- 121
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-EGMGFGDRTGTFCGTP-EFLAPEVLTE 186
++ +T + +KI+DFG+ + E G TG P ++ APE L
Sbjct: 122 --------ARNCLVTEKNV---LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 187 TSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
Y+ D W G+L++E +G P+ ++ ++I
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 151 VKIADFGLCKEGM---GFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML- 206
VKI DFGL ++ M + + TF +++APE + YT D W G+L++E+
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPL-KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
Query: 207 VGESPFPGDDEEEVFDSIVNDEVRY--PRFLSLEAIAIMRR 245
+G +P+P E F + + R P S E IM++
Sbjct: 337 LGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 24/68 (35%), Positives = 40/68 (58%), Gaps = 5/68 (7%)
Query: 151 VKIADFGLCKEGM---GFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML- 206
VKI DFGL ++ M + + TF +++APE + + YT D W G+L++E+
Sbjct: 276 VKICDFGLARDIMHDSNYVSKGSTFLPV-KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
Query: 207 VGESPFPG 214
+G +P+PG
Sbjct: 335 LGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
TG+ A+K +K D+ A ++ L E V + H LV L + VME
Sbjct: 28 TGQKVAVKNIK-CDVTA----QAFLEET---AVMTKLHHKNLVRLLGVILHNG-LYIVME 78
Query: 69 YAAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKR 123
+ G+L+ + + S + + ++ V G++YL ++++R + NI E
Sbjct: 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--- 135
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV 183
+G K++DFGL + G D + ++ APE
Sbjct: 136 ------------------------DGVAKVSDFGLARVGSMGVDNSKL---PVKWTAPEA 168
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
L ++ D W GVL++E+ G +P+P +EV + +
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 55/232 (23%), Positives = 89/232 (38%), Gaps = 67/232 (28%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVE------------SLLSEKRIFEVANTMRHPFLVNLF 54
+ TG+ A+K + R E E SLL E ++HP +V L
Sbjct: 22 KKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKE---------LQHPNIVCLQ 65
Query: 55 ACFQTEAHVCFVMEYAAGGDLMMH---IHADVFSEPRAV-FYAACVVLGLQYLHESRIIY 110
E+ + + E+ + DL + + + + V Y ++ G+ + H R+++
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 111 R---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD 167
R PQ+ + D +G +K+ADFGL + G
Sbjct: 125 RDLKPQNLLI----------------------------DNKGVIKLADFGLAR-AFGIPV 155
Query: 168 RTGTF-CGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
R T T + APEVL Y+ VD W +G + EM + F GD E
Sbjct: 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 26/108 (24%)
Query: 151 VKIADFGLCKEGMGFGDRTGT-----FCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIF 203
+KI DFGL + + F D + T + APE+ + YT A+D W +G +
Sbjct: 142 LKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 199
Query: 204 EMLVGESPFPGDD---------------EEEVFDSIVNDEVRYPRFLS 236
E+L G+ FPG + E + N++ R R+LS
Sbjct: 200 EVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR--RYLS 245
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 13/81 (16%)
Query: 151 VKIADFGLCKEGMGFGDRTGT-FCGTPE-----FLAPEVLTETSYTRAVDWWGLGVLIFE 204
+KI DFGL + GT F TP + APEV+ Y VD W +G ++ E
Sbjct: 165 LKILDFGLARTA-------GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 205 MLVGESPFPGDDEEEVFDSIV 225
M+ G FPG D + ++ ++
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 59/226 (26%), Positives = 88/226 (38%), Gaps = 42/226 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAHVCFVMEYA 70
A+K K + E + + A MR HP +V L TE V VME A
Sbjct: 38 AVKTCKNCTSPSVRE--------KFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELA 88
Query: 71 AGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
G+L ++ + + Y+ + L YL R ++R I A+
Sbjct: 89 PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRD-----------IAAR- 136
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP-EFLAPEVLTET 187
N V+S +KL DFGL + + P +++APE +
Sbjct: 137 --NVLVSSPDCVKL-----------GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 188 SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRYP 232
+T A D W GV ++E+L+ G PF G +V I N E R P
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLP 228
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 57/240 (23%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
++ TG A+K +++ ++E + +L + + V + P++V + F T++ V
Sbjct: 36 FKKTGHVMAVKQMRRTG--NKEENKRILMDLDV--VLKSHDCPYIVKCYGYFITDSDVFI 91
Query: 66 VMEYAAGGDLMMHIHADVFSE------PRAVF--YAACVVLGLQYLHESR-IIYR---PQ 113
ME +M D + P + +V L YL E +I+R P
Sbjct: 92 CME-------LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKP- 143
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
SNI + D G VK+ DFG+ + +T +
Sbjct: 144 SNI---------------------------LLDASGNVKLCDFGISGRLVDSKAKTRS-A 175
Query: 174 GTPEFLAPEVLT----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDE 228
G ++APE + Y D W LG+ + E+ G+ P+ E EV I+ +E
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 10/106 (9%)
Query: 147 TEGYV-KIADFGLCKEGMGFGDRTGTFCGTP----EFLAPEVLTETSYTRAVDWWGLGVL 201
T G + KI DFGL ++ D G +++APE + YT D W G+L
Sbjct: 248 THGRITKICDFGLARDIRN--DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 305
Query: 202 IFEML-VGESPFPGDDEEEVFDSIVNDEVRY--PRFLSLEAIAIMR 244
++E+ +G SP+PG + F ++ + R P E IM+
Sbjct: 306 LWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK 351
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 36/123 (29%), Positives = 57/123 (46%), Gaps = 30/123 (24%)
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
GL+Y+H + +++R ++K N VN+ E+ KI DFGL
Sbjct: 117 GLKYIHSANVLHR--------DLK------PGNLLVNADCEL-----------KICDFGL 151
Query: 159 ---CKEGMGFGDRTGT-FCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFP 213
E G T + T + APE+ L+ SYT+A+D W +G ++ E+L + F
Sbjct: 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
Query: 214 GDD 216
G D
Sbjct: 212 GKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 39/132 (29%), Positives = 53/132 (40%), Gaps = 36/132 (27%)
Query: 100 LQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL- 158
+ Y+H II+R +IK EN VN ++I L DFG
Sbjct: 273 IDYIHGEGIIHR--------DIK------TENVLVNGPEDICL-----------GDFGAA 307
Query: 159 CKEGMGFGDRTGTF----CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF-- 212
C G + F GT + APEVL YT +VD W G++IFE V +
Sbjct: 308 C---FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364
Query: 213 -PGDDEEEVFDS 223
DE +D+
Sbjct: 365 ASRGDERRPYDA 376
|
Length = 461 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 152 KIADFGLCKEGMGFGDRTGTFCG-TP-EFLAPEVLTETSYTRAVDWWGLGVLIFE-MLVG 208
K++DFGL + T G P + APE + +T A D W G++++E M G
Sbjct: 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYG 205
Query: 209 ESPFPGDDEEEVFDSIVNDEVRYP 232
E P+ ++V ++ D R P
Sbjct: 206 ERPYWDMSNQDVIKAV-EDGYRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 39/231 (16%)
Query: 5 QYRNTGEYFAIKALKK--GDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH 62
+ + + + A+K LK D +DE LL E + + + +P++V + + E+
Sbjct: 17 KMKKSEKTVAVKILKNDNNDPALKDE---LLREANVMQQLD---NPYIVRMIGICEAESW 70
Query: 63 VCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
+ VME A G L + + +E V +G++YL E+ ++R +
Sbjct: 71 M-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLA------- 122
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGTPEF 178
++ + L T+ Y KI+DFGL K + ++
Sbjct: 123 ---------------ARNVLLV---TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDE 228
APE + ++ D W GVL++E G+ P+ G EV I + E
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 47/182 (25%), Positives = 71/182 (39%), Gaps = 37/182 (20%)
Query: 40 EVANTMRHPFLVNLFACFQTEAHVCFVM-EYAAGGDLMMHIHADVFSEP---RAVFYAAC 95
++ T+ H ++NL ++ ++ VC VM +Y DL ++ S P
Sbjct: 138 DILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--DLFTYVDR---SGPLPLEQAITIQR 192
Query: 96 VVLG-LQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154
+L L YLH II+R ++K EN I L D +
Sbjct: 193 RLLEALAYLHGRGIIHR--------DVK------TEN--------IFL---DEPENAVLG 227
Query: 155 DFGL-CKEGMG-FGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
DFG CK + + GT E +PE+L Y D W G+++FEM V
Sbjct: 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
Query: 213 PG 214
G
Sbjct: 288 FG 289
|
Length = 392 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 49/230 (21%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQTEAHVC 64
G+ +AIK K E + +S+ E+A ++H +V+L F A
Sbjct: 24 GKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78
Query: 65 --FVMEYAAGGDLM----MHIHADVFSEPRAVFYAACVVL--GLQYLHESRIIYRPQSNI 116
+ +YA DL H A S P ++ + + G+ YLH + +++R
Sbjct: 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR----- 132
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-GYVKIADFGLCK------EGMGFGDRT 169
++K I + E G VKI D GL + + + D
Sbjct: 133 ---DLK--------------PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 170 GTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218
T + APE+L YT+A+D W +G + E+L E F G + +
Sbjct: 176 VV---TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 56/241 (23%), Positives = 89/241 (36%), Gaps = 35/241 (14%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+K LK AR + R E+ ++H +V + + V EY G
Sbjct: 39 AVKTLKDASDNARKDFH------REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 74 DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYK 133
DL + A P AV A + +T+ ++ I ++
Sbjct: 93 DLNKFLRA---HGPDAVLMAEG---------------NRPAELTQSQMLHIAQQIAAGMV 134
Query: 134 VNSSQEIK----LTVNDTEG---YVKIADFGLCKEGMGFGD-RTGTFCGTP-EFLAPEVL 184
+SQ T N G VKI DFG+ ++ R G P ++ PE +
Sbjct: 135 YLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194
Query: 185 TETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPRFLSLEAIAI 242
+T D W LGV+++E+ G+ P+ EV + I V + PR E +
Sbjct: 195 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDL 254
Query: 243 M 243
M
Sbjct: 255 M 255
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 8e-04
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 43/209 (20%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCF 65
NTGE A+K+LK + + L K+ E+ + H +V + +
Sbjct: 31 NTGEQVAVKSLKPES--GGNHIADL---KKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85
Query: 66 VMEYAAGGDLMMHIHADV--FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKR 123
+ME+ G L ++ + + + + YA + G+ YL + ++R +
Sbjct: 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA--------- 136
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC-----GTPEF 178
N V S E VKI DFGL K + +P F
Sbjct: 137 -----ARNVLVES-----------EHQVKIGDFGLTK---AIETDKEYYTVKDDLDSPVF 177
Query: 179 -LAPEVLTETSYTRAVDWWGLGVLIFEML 206
APE L ++ + A D W GV ++E+L
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 45/186 (24%)
Query: 50 LVNLFA---CFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHES 106
L+N+F + V VME +L IH ++ E R + ++ G+++LH +
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLCGIKHLHSA 142
Query: 107 RIIYR--PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMG 164
II+R SNI V ++ +KI DFGL +
Sbjct: 143 GIIHRDLKPSNI---------------------------VVKSDCTLKILDFGLARTA-- 173
Query: 165 FGDRTGTFCGTPE-----FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
F TP + APEV+ Y VD W +G ++ E++ G F G D +
Sbjct: 174 ----CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
Query: 220 VFDSIV 225
++ ++
Sbjct: 230 QWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 50/214 (23%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA-CFQTEAHVCFVMEYAAG 72
A+K+L + I +EVE L E I + HP +++L C +E V+ Y
Sbjct: 27 AVKSLNR--ITDLEEVEQFLKEGIIMK---DFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81
Query: 73 GDLMMHIHADVFSEPR------AVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEA 126
GDL I SE + + V G++YL + ++R ++
Sbjct: 82 GDLRNFIR----SETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR--------DLAARNC 129
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC-----KEGMGFGDRTGTFCGTP-EFLA 180
+ E++ VK+ADFGL KE + TG P +++A
Sbjct: 130 MLDESF-----------------TVKVADFGLARDIYDKEYYSVHNHTGA--KLPVKWMA 170
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFP 213
E L +T D W GVL++E++ G P+P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 8e-04
Identities = 49/205 (23%), Positives = 77/205 (37%), Gaps = 46/205 (22%)
Query: 41 VANTMRHPFLVNLFA-CF--------QTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVF 91
+ +M HP LV L C Q H C +++Y +H H D +
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGC-LLDY-------VHEHKDNIGSQLLLN 113
Query: 92 YAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151
+ + G+ YL E R+++R + N V S +V
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLA--------------ARNVLVKSPN-----------HV 148
Query: 152 KIADFGLCKEGMGFGDRTGTFCGTP--EFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-G 208
KI DFGL + G G +++A E + +T D W GV I+E++ G
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208
Query: 209 ESPFPGDDEEEVFDSIVNDEVRYPR 233
P+ G E+ D + E R P+
Sbjct: 209 GKPYDGIPTREIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 1/75 (1%)
Query: 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210
+KI DFGL + G + T + APEV+ Y VD W +G ++ EM+ +
Sbjct: 158 LKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
Query: 211 PFPGDDEEEVFDSIV 225
FPG D + ++ ++
Sbjct: 217 LFPGRDYIDQWNKVI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 54/233 (23%)
Query: 14 AIKALKKGDIIA-RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAG 72
AIK LK+ + E ++ E+ + ++HP +V L E C + EY A
Sbjct: 39 AIKTLKENAEPKVQQEF------RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH 92
Query: 73 GDL----MMHI-HADVFSE------------PRAVFYAACVVLGLQYLHESRIIYRPQSN 115
GDL + + H+DV +E + A + G++YL ++R +
Sbjct: 93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLA- 151
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
N V LTV KI+DFGL ++ D +
Sbjct: 152 -------------ARNCLVGE----GLTV-------KISDFGLSRDIYS-ADYYRVQSKS 186
Query: 176 P---EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
++ PE + +T D W GV+++E+ G P+ G +EV + I
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 38/224 (16%)
Query: 12 YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAA 71
+ AIK LK G + LSE I HP +++L V + E+
Sbjct: 34 FVAIKTLKSG--YTEKQRRDFLSEASIM---GQFDHPNIIHLEGVVTKSRPVMIITEFME 88
Query: 72 GG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQ 129
G D + + F+ + V + G++YL E ++R +
Sbjct: 89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA--------------A 134
Query: 130 ENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGT-P-EFLAPEVL 184
N VNS+ K++DFGL + + T + G P + APE +
Sbjct: 135 RNILVNSNL-----------VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 185 TETSYTRAVDWWGLGVLIFE-MLVGESPFPGDDEEEVFDSIVND 227
+T A D W G++++E M GE P+ ++V ++I D
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 34/110 (30%), Positives = 46/110 (41%), Gaps = 27/110 (24%)
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
GL+YLH + I++R +IK N VNS+ + KI DFGL
Sbjct: 115 GLKYLHSAGILHR--------DIK------PGNLLVNSNCVL-----------KICDFGL 149
Query: 159 C-KEGMGFGDRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEML 206
E T + APE+L YT AVD W +G + E+L
Sbjct: 150 ARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 25/94 (26%), Positives = 37/94 (39%), Gaps = 22/94 (23%)
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC--GTPEFLAPEVLTE 186
Q ++ V+ ++ L +D F + G C G EF PE+ T
Sbjct: 145 QNSFLVSDDSKVVLVDSD--------SFQINANGTLH------LCPVGVSEFTPPELQTL 190
Query: 187 TSYTRA-----VDWWGLGVLIFEMLVGES-PFPG 214
S+ D +GL VLIF +L G P+ G
Sbjct: 191 PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224
|
Length = 637 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 51/238 (21%), Positives = 94/238 (39%), Gaps = 54/238 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFE--VANTMRHPFLVNLFACFQTEAHVCFVMEYAA 71
AIK LK D+ E L E+ E + + ++HP +V L E + + Y +
Sbjct: 39 AIKTLK-------DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91
Query: 72 GGDL-----MMHIHADVFS-----------EPRAVFY-AACVVLGLQYLHESRIIYRPQS 114
DL M H+DV S EP + + G+++L ++++
Sbjct: 92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHK--- 148
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE--GMGFGDRTGTF 172
++ + + K+N VKI+D GL +E + G
Sbjct: 149 DLATRNVLVFD-------KLN---------------VKISDLGLFREVYAADYYKLMGNS 186
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEV 229
+++PE + ++ D W GV+++E+ G P+ G ++V + I N +V
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.004
Identities = 16/38 (42%), Positives = 22/38 (57%)
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESP 211
P F+APEV+ SYT D + LG+ ++E L E P
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 17/67 (25%), Positives = 33/67 (49%), Gaps = 3/67 (4%)
Query: 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205
+ + + + +C M G GTP+++APE L + + D + LGV++++M
Sbjct: 168 EDLLDIDVDERNICYSSM---TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 206 LVGESPF 212
L P+
Sbjct: 225 LTLSFPY 231
|
Length = 932 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG0584|consensus | 632 | 100.0 | ||
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| KOG4645|consensus | 1509 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| KOG4278|consensus | 1157 | 99.98 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0671|consensus | 415 | 99.97 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0669|consensus | 376 | 99.97 | ||
| KOG0666|consensus | 438 | 99.97 | ||
| KOG1094|consensus | 807 | 99.97 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0596|consensus | 677 | 99.97 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG2345|consensus | 302 | 99.97 | ||
| KOG0603|consensus | 612 | 99.97 | ||
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608|consensus | 1034 | 99.97 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151|consensus | 775 | 99.97 | ||
| KOG0665|consensus | 369 | 99.97 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0200|consensus | 609 | 99.96 | ||
| KOG2052|consensus | 513 | 99.96 | ||
| KOG1152|consensus | 772 | 99.96 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0670|consensus | 752 | 99.96 | ||
| KOG3653|consensus | 534 | 99.96 | ||
| KOG0664|consensus | 449 | 99.96 | ||
| KOG1025|consensus | 1177 | 99.96 | ||
| KOG1035|consensus | 1351 | 99.95 | ||
| KOG0668|consensus | 338 | 99.95 | ||
| KOG1290|consensus | 590 | 99.95 | ||
| KOG1027|consensus | 903 | 99.94 | ||
| KOG0576|consensus | 829 | 99.93 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1024|consensus | 563 | 99.93 | ||
| KOG1345|consensus | 378 | 99.91 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1167|consensus | 418 | 99.86 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603|consensus | 612 | 99.82 | ||
| KOG0195|consensus | 448 | 99.82 | ||
| KOG1164|consensus | 322 | 99.81 | ||
| KOG4158|consensus | 598 | 99.81 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG0590|consensus | 601 | 99.79 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1163|consensus | 341 | 99.76 | ||
| KOG0606|consensus | 1205 | 99.74 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1165|consensus | 449 | 99.73 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG1023|consensus | 484 | 99.66 | ||
| KOG1240|consensus | 1431 | 99.66 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| KOG1166|consensus | 974 | 99.56 | ||
| KOG1033|consensus | 516 | 99.55 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.42 | |
| KOG1243|consensus | 690 | 99.41 | ||
| KOG0590|consensus | 601 | 99.4 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.31 | |
| KOG1266|consensus | 458 | 99.19 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG0606|consensus | 1205 | 99.11 | ||
| KOG0601|consensus | 524 | 99.0 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| KOG3741|consensus | 655 | 98.95 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG3087|consensus | 229 | 98.68 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.59 | |
| KOG0601|consensus | 524 | 98.53 | ||
| KOG2137|consensus | 700 | 98.36 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.2 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.13 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.87 | |
| KOG0576|consensus | 829 | 97.78 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.68 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.97 | |
| KOG1035|consensus | 1351 | 96.77 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.56 | |
| KOG1826|consensus | 2724 | 96.49 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.43 | |
| KOG1235|consensus | 538 | 96.24 | ||
| KOG1093|consensus | 725 | 96.01 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.24 | |
| KOG2270|consensus | 520 | 95.24 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 95.16 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.97 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.63 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.62 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 91.69 | |
| KOG2268|consensus | 465 | 88.85 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 88.68 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 88.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 85.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 85.0 | |
| PLN02236 | 344 | choline kinase | 84.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 83.43 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=330.42 Aligned_cols=217 Identities=32% Similarity=0.578 Sum_probs=201.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||.|++..+|+.||+|++.+.........+.+.+| +++.+++.|||||+++++|++.+++|+|.|+|..++|..+++
T Consensus 34 cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~E---IeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K 110 (592)
T KOG0575|consen 34 CYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNE---IEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK 110 (592)
T ss_pred EEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHH---HHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH
Confidence 69999999999999999998777776677777666 788899999999999999999999999999999999999986
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+.+++|++++.+++||+.||.|||+++|+|| |+|..|| +++++.++||+|||+|
T Consensus 111 rrk~ltEpEary~l~QIv~GlkYLH~~~IiHR---DLKLGNl----------------------fL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 111 RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHR---DLKLGNL----------------------FLNENMNVKIGDFGLA 165 (592)
T ss_pred hcCCCCcHHHHHHHHHHHHHHHHHHhcCceec---ccchhhe----------------------eecCcCcEEeccccee
Confidence 4689999999999999999999999999999 7777777 8888899999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
.....+.+...+.|||+.|.|||++....++..+||||+||+||.|+.|++||...+-.+....|....+.+|+.++.++
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A 245 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEA 245 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHH
Confidence 98888888889999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+|||++
T Consensus 246 ~dLI~~ 251 (592)
T KOG0575|consen 246 KDLIRK 251 (592)
T ss_pred HHHHHH
Confidence 999863
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=314.40 Aligned_cols=219 Identities=31% Similarity=0.559 Sum_probs=181.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.++.+||||.+..... +.+.++.+..| +.+|+.++|||||++++++..++++|+|||||.||+|.++++
T Consensus 26 Vykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~E---i~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~ 101 (429)
T KOG0595|consen 26 VYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSE---IKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR 101 (429)
T ss_pred EEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHH---HHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH
Confidence 89999999999999999987643 44555666555 777889999999999999999999999999999999999996
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++..++.++.|++.||++||+++|+|| |+||.|| ++..+. ..+..-.+||+|||++
T Consensus 102 ~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHR---DLKPQNi-----LLs~~~-----------~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 102 RRGRLPEATARHFMQQLASALQFLHENNIIHR---DLKPQNI-----LLSTTA-----------RNDTSPVLKIADFGFA 162 (429)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---cCCcceE-----EeccCC-----------CCCCCceEEecccchh
Confidence 5 589999999999999999999999999999 5555555 444211 0000146899999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLS 236 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~ 236 (245)
+.. ..+....+.||++.|||||++..+.|+.|+|+||+|+++|++++|+.||...+..+.+..+..+... +|..++
T Consensus 163 R~L-~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 163 RFL-QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred hhC-CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 974 3445577889999999999999999999999999999999999999999999999999988766543 345666
Q ss_pred hhHHhhh
Q psy3347 237 LEAIAIM 243 (245)
Q Consensus 237 ~~~~~li 243 (245)
+..++|+
T Consensus 242 ~~~~~Ll 248 (429)
T KOG0595|consen 242 NPLRELL 248 (429)
T ss_pred Cchhhhh
Confidence 6655554
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=306.36 Aligned_cols=212 Identities=29% Similarity=0.518 Sum_probs=186.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-eEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-HVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+|+.|++-+|+|++... ......+.+ .+|+++++.++||+||.++|+|..++ .++++||||++|+|..++
T Consensus 95 V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi---~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~ 169 (364)
T KOG0581|consen 95 VYKVRHKPTGKIYALKVILLN--IDPALQKQI---LRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDIL 169 (364)
T ss_pred EEEEEEcCCCeEEEEEeeccc--CCHHHHHHH---HHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHH
Confidence 799999999999999999532 122223334 45578888999999999999999999 599999999999999999
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+. +.++++...+++.++++||.|||+ ++|+|| ||||+|| +++..|.+||||||
T Consensus 170 k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHR---DIKPsNl----------------------LvNskGeVKicDFG 224 (364)
T KOG0581|consen 170 KRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHR---DIKPSNL----------------------LVNSKGEVKICDFG 224 (364)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeec---cCCHHHe----------------------eeccCCCEEecccc
Confidence 64 789999999999999999999995 999999 9999999 88999999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCcc-cC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-----DEEEVFDSIVNDEV-RY 231 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-----~~~~~~~~~~~~~~-~~ 231 (245)
.|....+. ...+++||..|||||-+.+..|+.++||||||++++|+++|++||... +..+.+.+|+.+.+ ..
T Consensus 225 VS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l 302 (364)
T KOG0581|consen 225 VSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL 302 (364)
T ss_pred ccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC
Confidence 99876555 467889999999999999999999999999999999999999999764 67899999988655 46
Q ss_pred CCC-CChhHHhhhc
Q psy3347 232 PRF-LSLEAIAIMR 244 (245)
Q Consensus 232 p~~-~~~~~~~li~ 244 (245)
|.. +|+++++++.
T Consensus 303 P~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVS 316 (364)
T ss_pred CcccCCHHHHHHHH
Confidence 776 9999999985
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=302.77 Aligned_cols=217 Identities=44% Similarity=0.850 Sum_probs=198.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|+.++.++||+.||+|++++..+....+.+....|+.+ |..++||.|+.++-.|++....|+|+||+.||.|...++
T Consensus 41 V~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~I---L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~ 117 (357)
T KOG0598|consen 41 VFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNI---LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ 117 (357)
T ss_pred EEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHH---HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH
Confidence 78999999999999999999887777677777777555 456889999999999999999999999999999999886
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..++.++.+|+.||.|||+.||+|| |+||+|| ++|.+|.++|+|||++
T Consensus 118 ~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyR---DlKPENI----------------------LLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 118 REGRFSEDRARFYLAEIVLALGYLHSKGIIYR---DLKPENI----------------------LLDEQGHIKLTDFGLC 172 (357)
T ss_pred hcCCcchhHHHHHHHHHHHHHHHHHhCCeeec---cCCHHHe----------------------eecCCCcEEEeccccc
Confidence 5679999999999999999999999999999 9999999 9999999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc-ccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~p~~~~~~ 238 (245)
+.....+....+.|||+.|||||++.+..|+..+|.||||+++|||++|.+||.+.+..+..+.+..+. ..+|..++++
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ 252 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEE 252 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHH
Confidence 977777777888999999999999999999999999999999999999999999999999999999988 4556679999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
++|++++
T Consensus 253 ardll~~ 259 (357)
T KOG0598|consen 253 ARDLLKK 259 (357)
T ss_pred HHHHHHH
Confidence 9999864
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=289.41 Aligned_cols=214 Identities=42% Similarity=0.851 Sum_probs=197.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|.+++++.+|..+|+|++++..+..-.+++...+|.+++ +.+.||.++++.+-|.+.++.++||||.+||-|..+++
T Consensus 60 V~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL---~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr 136 (355)
T KOG0616|consen 60 VHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVL---KAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR 136 (355)
T ss_pred EEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHH---hhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH
Confidence 678999999999999999998888888888888887765 45669999999999999999999999999999999985
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.++++++.++.++.||+.||+|||+++|++| |+||+|| ++|.+|.+||.|||++
T Consensus 137 k~~rF~e~~arFYAAeivlAleylH~~~iiYR---DLKPENi----------------------LlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 137 KSGRFSEPHARFYAAEIVLALEYLHSLDIIYR---DLKPENL----------------------LLDQNGHIKITDFGFA 191 (355)
T ss_pred hcCCCCchhHHHHHHHHHHHHHHHHhcCeeec---cCChHHe----------------------eeccCCcEEEEeccce
Confidence 4789999999999999999999999999999 9999999 9999999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+... ...-+.|||+-|+|||++...+++.++|-||||+.+|||+.|.+||...++....++|+.+...+|+.+++++
T Consensus 192 K~v~---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~ 268 (355)
T KOG0616|consen 192 KRVS---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDA 268 (355)
T ss_pred EEec---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHH
Confidence 8632 2366789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+||+++
T Consensus 269 kdLl~~ 274 (355)
T KOG0616|consen 269 KDLLKK 274 (355)
T ss_pred HHHHHH
Confidence 999863
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=317.52 Aligned_cols=218 Identities=80% Similarity=1.317 Sum_probs=207.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|++|+.+.+++.||||++++..+...++++....|.|++.+.. +||.+++++..|+...++|.||||+.||++..+.+
T Consensus 384 V~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~--~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~ 461 (694)
T KOG0694|consen 384 VLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN--RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH 461 (694)
T ss_pred EEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc--cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe
Confidence 7899999999999999999999999999999999999998887 89999999999999999999999999999777777
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
.+.++++.++.++..|+.||+|||++||++| |+|.+|| ++|.+|.+||+|||+++
T Consensus 462 ~~~F~e~rarfyaAev~l~L~fLH~~~IIYR---DlKLdNi----------------------LLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 462 TDVFSEPRARFYAAEVVLGLQFLHENGIIYR---DLKLDNL----------------------LLDTEGHVKIADFGLCK 516 (694)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhcCceee---ecchhhe----------------------EEcccCcEEeccccccc
Confidence 7889999999999999999999999999999 7777777 89999999999999999
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHH
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 240 (245)
..+..+...+++|||+-|+|||++.+..|+.++|.||||+.||||+.|..||++.++.+++..|+...+.+|..+|.+..
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI 596 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence 88878888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhcC
Q psy3347 241 AIMRR 245 (245)
Q Consensus 241 ~li~~ 245 (245)
++|++
T Consensus 597 ~il~~ 601 (694)
T KOG0694|consen 597 AIMRR 601 (694)
T ss_pred HHHHH
Confidence 99874
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=310.82 Aligned_cols=218 Identities=34% Similarity=0.598 Sum_probs=195.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|++|+++.+++.||||++.+.-+..+..++-..+|...+..|. +||.|++++--|+++...|+|+||+++|+|.++++
T Consensus 89 V~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~--~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~ 166 (604)
T KOG0592|consen 89 VVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS--GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK 166 (604)
T ss_pred EEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh--CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH
Confidence 7999999999999999999877666666666677766666554 89999999999999999999999999999999995
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..++.++.+|+.||+|||++||+|| |+||+|| ++|++|+++|.|||.+
T Consensus 167 K~Gsfde~caR~YAAeIldAleylH~~GIIHR---DlKPENI----------------------LLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 167 KYGSFDETCARFYAAEILDALEYLHSNGIIHR---DLKPENI----------------------LLDKDGHIKITDFGSA 221 (604)
T ss_pred HhCcchHHHHHHHHHHHHHHHHHHHhcCceec---cCChhhe----------------------eEcCCCcEEEeecccc
Confidence 5789999999999999999999999999999 9999999 9999999999999998
Q ss_pred cCCCCCCC-----------C--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 160 KEGMGFGD-----------R--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 160 ~~~~~~~~-----------~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+....... . ...++||..|.+||.+.....++.+|+|+||||+|+|+.|.+||.+.++.-.++.|+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 74322111 1 1458999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCChhHHhhhcC
Q psy3347 227 DEVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 227 ~~~~~p~~~~~~~~~li~~ 245 (245)
..+.+|+.++++++||++|
T Consensus 302 l~y~fp~~fp~~a~dLv~K 320 (604)
T KOG0592|consen 302 LDYEFPEGFPEDARDLIKK 320 (604)
T ss_pred hcccCCCCCCHHHHHHHHH
Confidence 9999999999999999875
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=315.07 Aligned_cols=216 Identities=27% Similarity=0.517 Sum_probs=190.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
|-+|+|.+||+.+|||++.+...........+.+ ++-+|+-+.|||+++++++++.+.+.|+|.||+++|-|.+++
T Consensus 28 vrlakh~~TGqlaaiKii~k~~~~s~s~~~~Ier---EIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv 104 (786)
T KOG0588|consen 28 VRLAKHAETGQLAAIKIIPKRSELSSSQPAGIER---EIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV 104 (786)
T ss_pred ehhhhcccccceeEEEeeccccccccccccchhh---hhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH
Confidence 4468999999999999998753333333334444 477788889999999999999999999999999999998887
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+.+++++.++.+++.||+.|+.|||..+|+|| |+||+|+ ++|..+++||+|||+|
T Consensus 105 ~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHR---DLKpENl----------------------LLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 105 RKGPLPEREAAHFFRQILDGVSYCHAFNICHR---DLKPENL----------------------LLDVKNNIKIADFGMA 159 (786)
T ss_pred hhCCCCCHHHHHHHHHHHHHHHHHhhhcceec---cCCchhh----------------------hhhcccCEeeecccee
Confidence 56889999999999999999999999999999 8888888 7778888999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
.. ...+....+.||+++|.+||++.|.+|. .++||||+|+|+|.|++|+.||++.+-..++.++..+...+|..++++
T Consensus 160 sL-e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~e 238 (786)
T KOG0588|consen 160 SL-EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSE 238 (786)
T ss_pred ec-ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHH
Confidence 75 3344557788999999999999999985 789999999999999999999999999999999999999999999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
++|||+|
T Consensus 239 aQdLLr~ 245 (786)
T KOG0588|consen 239 AQDLLRR 245 (786)
T ss_pred HHHHHHH
Confidence 9999975
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=301.21 Aligned_cols=219 Identities=32% Similarity=0.579 Sum_probs=190.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
|++|++..+|+.||+|++.+....... .....+..|++.+++.++ ||||+++++++.....+++||||+.||.|.+++
T Consensus 33 V~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i 111 (370)
T KOG0583|consen 33 VKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYI 111 (370)
T ss_pred EEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHH
Confidence 789999999999999988775332122 112222235578888888 999999999999999999999999999999998
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-CceEEeecC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-GYVKIADFG 157 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~kl~Dfg 157 (245)
.. +++.+..++++++|++.|++|||++||+|| |+||+|| +++.+ +++||+|||
T Consensus 112 ~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HR---DLK~ENi----------------------lld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 112 VNKGRLKEDEARKYFRQLISAVAYCHSRGIVHR---DLKPENI----------------------LLDGNEGNLKLSDFG 166 (370)
T ss_pred HHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeC---CCCHHHE----------------------EecCCCCCEEEeccc
Confidence 65 789999999999999999999999999999 8888888 77788 999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETS-YT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 235 (245)
++...........+.+||+.|+|||++.+.. |+ .++||||||+++|.|++|..||...+.......+..+...+|..+
T Consensus 167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence 9986433445677889999999999999877 85 789999999999999999999999888888899999999999999
Q ss_pred -ChhHHhhhcC
Q psy3347 236 -SLEAIAIMRR 245 (245)
Q Consensus 236 -~~~~~~li~~ 245 (245)
++++++|+++
T Consensus 247 ~S~~~~~Li~~ 257 (370)
T KOG0583|consen 247 LSPEARSLIEK 257 (370)
T ss_pred CCHHHHHHHHH
Confidence 9999999864
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=299.18 Aligned_cols=222 Identities=29% Similarity=0.515 Sum_probs=180.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh-hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD-EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
|-+|..+.||+.||||++++....-.. .......-++++++|++++|||||+++++|......|+||||++||.|.+++
T Consensus 188 Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v 267 (475)
T KOG0615|consen 188 VKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV 267 (475)
T ss_pred EEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH
Confidence 457999999999999999875433221 1223333456688999999999999999999999999999999999999988
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
- ++.+.+..-+-+++|++.|+.|||++||+|| ||||+|| ++. ..+.+..+||+|||+
T Consensus 268 v~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HR---DiKPeNI-----Ll~--------------~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 268 VANKYLREDLGKLLFKQLLTAVKYLHSQGIIHR---DIKPENI-----LLS--------------NDAEDCLLKITDFGL 325 (475)
T ss_pred HhccccccchhHHHHHHHHHHHHHHHHcCcccc---cCCcceE-----Eec--------------cCCcceEEEecccch
Confidence 4 5667888888999999999999999999999 6666666 333 222447799999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCC--C-CcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCcccC-C-
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETS--Y-TRAVDWWGLGVLIFEMLVGESPFPGDDEEE-VFDSIVNDEVRY-P- 232 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~-p- 232 (245)
|+.. .......+.|||+.|.|||++.+.. + ..++|+||+||++|-+++|.+||++..... ..++|..+.+.+ |
T Consensus 326 AK~~-g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 326 AKVS-GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhcc-ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 9863 3455678999999999999997643 3 348999999999999999999998876554 888999988765 2
Q ss_pred --CCCChhHHhhhcC
Q psy3347 233 --RFLSLEAIAIMRR 245 (245)
Q Consensus 233 --~~~~~~~~~li~~ 245 (245)
..++++.++||++
T Consensus 405 ~w~~Iseea~dlI~~ 419 (475)
T KOG0615|consen 405 QWDRISEEALDLINW 419 (475)
T ss_pred hhhhhhHHHHHHHHH
Confidence 5789999999874
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=299.32 Aligned_cols=196 Identities=27% Similarity=0.430 Sum_probs=169.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++..||+-||+|++.-.... .+..+-..|++.+|++++||||+++.++.... +.+|||||||++ +|.-+
T Consensus 133 VYkAr~~~tgkivALKKvr~d~~~----~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GL 207 (560)
T KOG0600|consen 133 VYKARDLETGKIVALKKVRFDNEK----EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGL 207 (560)
T ss_pred eeEeeecccCcEEEEEEeecccCC----CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhh
Confidence 899999999999999999864321 12333345668899999999999999988765 799999999988 78777
Q ss_pred hhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+... .+++++++-+++|++.||+|||++||+|| |||.+|| ++|.+|.+||+||
T Consensus 208 l~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHR---DIK~SNi----------------------Lidn~G~LKiaDF 262 (560)
T KOG0600|consen 208 LSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHR---DIKGSNI----------------------LIDNNGVLKIADF 262 (560)
T ss_pred hcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeec---cccccce----------------------EEcCCCCEEeccc
Confidence 7654 68999999999999999999999999999 9999999 9999999999999
Q ss_pred CCccCCCCCCC-CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 157 GLCKEGMGFGD-RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 157 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|++++...... .....+-|.+|+|||.+.|. .|+.++|+||+||||.||++|++.|+|.++.+++..|..
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 99996544433 35556779999999999985 699999999999999999999999999999999998865
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=287.13 Aligned_cols=215 Identities=26% Similarity=0.424 Sum_probs=187.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeE-EEeeCCe-EEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA-CFQTEAH-VCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~ 78 (245)
||+|++..+|..+|.|.+.-.. .+..+.+.+..| +.+|++++||||+++++ .|..++. .++|||+|.+|+|...
T Consensus 35 vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~E---i~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqm 110 (375)
T KOG0591|consen 35 VYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKE---ISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQM 110 (375)
T ss_pred eEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHH---HHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHH
Confidence 7999999999999999998433 334444555444 78899999999999999 5655555 8999999999999888
Q ss_pred hhh-----cCCChHHHHHHHHHHHHHHHHhhh--cC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 79 IHA-----DVFSEPRAVFYAACVVLGLQYLHE--SR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 79 ~~~-----~~l~~~~~~~i~~~i~~~l~~lH~--~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
+++ ..++++.+++++.|++.||.+||+ .+ |+|| ||||.|| +++.+|
T Consensus 111 Ik~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHR---DIKPaNI----------------------Fl~~~g 165 (375)
T KOG0591|consen 111 IKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHR---DIKPANI----------------------FLTANG 165 (375)
T ss_pred HHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeec---cCcchhe----------------------EEcCCC
Confidence 753 358999999999999999999999 55 9999 9999999 889999
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~ 229 (245)
.+||+|||+++...+........+||++||+||.+.+.+|+.++||||+||++|||..-.+||.+.+-.++-.+|.++..
T Consensus 166 vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 99999999999877777777889999999999999999999999999999999999999999999999999999999877
Q ss_pred c-CC-CCCChhHHhhhc
Q psy3347 230 R-YP-RFLSLEAIAIMR 244 (245)
Q Consensus 230 ~-~p-~~~~~~~~~li~ 244 (245)
+ .| +..|.+++.||+
T Consensus 246 ~~~p~~~YS~~l~~li~ 262 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELIN 262 (375)
T ss_pred CCCcHHHhhhHHHHHHH
Confidence 5 56 678888888774
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=290.24 Aligned_cols=220 Identities=86% Similarity=1.426 Sum_probs=195.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++..........+.+.+|.++++.++.++||||+++++++..+++.|+||||+++++|...++
T Consensus 15 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~ 94 (324)
T cd05589 15 VLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH 94 (324)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh
Confidence 79999999999999999987544444556777888888888888999999999999999999999999999999998888
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
.+.+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||++.
T Consensus 95 ~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr---dlkp~Ni----------------------ll~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 95 TDVFSEPRAVFYAACVVLGLQYLHENKIVYR---DLKLDNL----------------------LLDTEGFVKIADFGLCK 149 (324)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCeEec---CCCHHHe----------------------EECCCCcEEeCcccCCc
Confidence 7789999999999999999999999999999 8888888 88889999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHH
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAI 240 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 240 (245)
............+|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..+++++.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 229 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 54333334456678999999999998889999999999999999999999999988888888888888888999999999
Q ss_pred hhhcC
Q psy3347 241 AIMRR 245 (245)
Q Consensus 241 ~li~~ 245 (245)
++|++
T Consensus 230 ~li~~ 234 (324)
T cd05589 230 SIMRR 234 (324)
T ss_pred HHHHH
Confidence 98864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=290.83 Aligned_cols=214 Identities=28% Similarity=0.500 Sum_probs=178.4
Q ss_pred CEeEEEecCCcE-EEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-eEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEY-FAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-HVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++ |+. ||+|++......... .+.+.+| +.+|.+++||||++++|++.... ..++||||+++|+|..+
T Consensus 57 V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E---~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~ 130 (362)
T KOG0192|consen 57 VYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRRE---ASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVL 130 (362)
T ss_pred EEEEEeC--CceeEEEEEecchhcChHH-HHHHHHH---HHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHH
Confidence 6888777 777 999999876544333 4455444 77788899999999999998877 79999999999999999
Q ss_pred hhh---cCCChHHHHHHHHHHHHHHHHhhhcC-ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEE
Q psy3347 79 IHA---DVFSEPRAVFYAACVVLGLQYLHESR-IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKI 153 (245)
Q Consensus 79 ~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~-i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl 153 (245)
+.. ..++...+.+++.||+.||.|||+++ |+|| |+|++|+ +++.++ .+||
T Consensus 131 l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHr---DLK~~Ni----------------------Lv~~~~~~~KI 185 (362)
T KOG0192|consen 131 LHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHR---DLKSDNI----------------------LVDLKGKTLKI 185 (362)
T ss_pred HhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeec---ccChhhE----------------------EEcCCCCEEEE
Confidence 954 57999999999999999999999999 9999 7777777 778887 9999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCcccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT--ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-- 229 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-- 229 (245)
+|||+++.............||..|||||.+. ...|+.|+||||||+++|||+||+.||.+.....+...+.....
T Consensus 186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99999986433222333468999999999999 55899999999999999999999999999888777777764433
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|..+++.+..||++
T Consensus 266 ~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMER 281 (362)
T ss_pred CCCccCCHHHHHHHHH
Confidence 4577899999999864
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=297.90 Aligned_cols=214 Identities=30% Similarity=0.506 Sum_probs=190.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||.|+...+++.||||++.... +...+-+.+| +.+|+..+|+|||.+++.|...+..++||||++||+|.+.+.
T Consensus 289 vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnE---i~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt 362 (550)
T KOG0578|consen 289 VYVARKISTKQEVAIKRMDLRK---QPKKELLLNE---ILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT 362 (550)
T ss_pred eeeeeeccCCceEEEEEEEecc---CCchhhhHHH---HHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh
Confidence 7999999999999999997642 3333445555 778899999999999999988899999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++.++..++++++.||+|||.+||+|| |||.+|| +++.+|.+||+|||++.
T Consensus 363 ~~~~~E~qIA~Icre~l~aL~fLH~~gIiHr---DIKSDnI----------------------LL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 363 KTRMTEGQIAAICREILQGLKFLHARGIIHR---DIKSDNI----------------------LLTMDGSVKLTDFGFCA 417 (550)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhcceeee---cccccee----------------------EeccCCcEEEeeeeeee
Confidence 8889999999999999999999999999999 6666666 77788999999999998
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
.......+..+.+||++|||||......|+++.||||||++.+||+.|++||...++..++..|.+.+.+ .|+.+|+
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 7766666788899999999999999999999999999999999999999999999999999988776543 4799999
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
+++||++|
T Consensus 498 ~~kdFL~~ 505 (550)
T KOG0578|consen 498 ELKDFLDR 505 (550)
T ss_pred HHHHHHHH
Confidence 99999864
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=296.42 Aligned_cols=214 Identities=29% Similarity=0.511 Sum_probs=190.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||||+.+.|.+.||+|.+.+.. .+..+.+++.+ ++++++.++||||+.+++.|+...++++|.||+.| +|..++.
T Consensus 18 VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~---ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~ 92 (808)
T KOG0597|consen 18 VYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQ---EVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE 92 (808)
T ss_pred eeecccccceeEEEEEEehhcC-CchHHHHHHHH---HHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH
Confidence 8999999999999999998754 33444555554 47778899999999999999999999999999988 9999995
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++..+..++.+++.||.|||+++|+|| |+||.|| +++++|.+|+||||++
T Consensus 93 ~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhr---d~kPqni----------------------Ll~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 93 QDGKLPEEQVRAIAYDLVSALYYLHSNRILHR---DMKPQNI----------------------LLEKGGTLKLCDFGLA 147 (808)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhcCcccc---cCCccee----------------------eecCCCceeechhhhh
Confidence 4 679999999999999999999999999999 8888888 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............-||+.|||||...+++|+..+|+||+||++||+++|++||...+-.+....|......+|..++.++
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f 227 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSF 227 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHH
Confidence 86544444455667999999999999999999999999999999999999999998889999999999999999999998
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
+.+++
T Consensus 228 ~nfl~ 232 (808)
T KOG0597|consen 228 VNFLQ 232 (808)
T ss_pred HHHHH
Confidence 88774
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=286.86 Aligned_cols=217 Identities=50% Similarity=0.907 Sum_probs=186.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++............+ .+++++++.++||||+++++++..++..|+||||+++++|..++.
T Consensus 11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~---~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 87 (323)
T cd05571 11 VILVREKATGKYYAMKILKKEVIIAKDEVAHT---LTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHH---HHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986533333333333 345677888999999999999999999999999999999988885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kl~DfG~a 142 (323)
T cd05571 88 RERVFSEDRARFYGAEIVSALGYLHSCDVVYR---DLKLENL----------------------MLDKDGHIKITDFGLC 142 (323)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC---CCCHHHE----------------------EECCCCCEEEeeCCCC
Confidence 4578999999999999999999999999999 8888888 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+|+..|+|||.+.+..++.++|||||||++|||++|+.||.+.+.......+......+|..+++++
T Consensus 143 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05571 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred cccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 75433333344567899999999998888999999999999999999999999988888888888888888899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 223 ~~li~~ 228 (323)
T cd05571 223 KSLLAG 228 (323)
T ss_pred HHHHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=277.93 Aligned_cols=197 Identities=26% Similarity=0.428 Sum_probs=172.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+++++.||+-||||++..+. ....++. -..|++.+|+++.|||+|.++++|......++|||||+..-|.+.-+
T Consensus 18 V~KCrnk~TgqIVAIKkF~Ese--dd~~VkK--IAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~ 93 (396)
T KOG0593|consen 18 VMKCRNKDTGQIVAIKKFVESE--DDPVVKK--IALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELER 93 (396)
T ss_pred EEEeccCCcccEEEEEeeccCC--ccHHHHH--HHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHh
Confidence 7999999999999999997542 2223332 34677899999999999999999999999999999998866655544
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..++...++.++.|++.|+.|||+++++|| ||||+|| ++..+|.+||||||+|
T Consensus 94 ~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHR---DIKPENI----------------------Lit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 94 YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHR---DIKPENI----------------------LITQNGVVKLCDFGFA 148 (396)
T ss_pred ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecc---cCChhhe----------------------EEecCCcEEeccchhh
Confidence 3 468999999999999999999999999999 8888888 8888999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+.....++....++.|.+|+|||.+.+ .+|++++||||+||+++||++|.+.|+|.+..+++..|..
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 987667777788899999999999988 6799999999999999999999999999998888877754
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=268.15 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=171.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+|.+||+.||||+++.......-. ....||+..|+.++|+||+.++|+|.+.....+|+||++. +|...++
T Consensus 18 Vyka~d~~t~~~VAIKKIkl~~~kdGi~----~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIk 92 (318)
T KOG0659|consen 18 VYKARDTETGKRVAIKKIKLGNAKDGIN----RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIK 92 (318)
T ss_pred EEEEEecCCCcEEEEEEeeccccccCcc----HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhc
Confidence 7999999999999999999764322111 2345668888899999999999999999999999999965 8998886
Q ss_pred hc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 AD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. .++..+++.++.++++|++|||++.|+|| |+||+|+ +++.+|.+||+|||+
T Consensus 93 d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHR---DlKPnNL----------------------Lis~~g~lKiADFGL 147 (318)
T KOG0659|consen 93 DKNIILSPADIKSYMLMTLKGLAYCHSKWILHR---DLKPNNL----------------------LISSDGQLKIADFGL 147 (318)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcc---cCCccce----------------------EEcCCCcEEeecccc
Confidence 54 57899999999999999999999999999 9999999 999999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND 227 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (245)
++...+........+-|.+|+|||.+.|. .|+...||||.|||++||+.|.+.|+|.+..+++..|...
T Consensus 148 Ar~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 148 ARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA 217 (318)
T ss_pred hhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence 99766555544455779999999999884 5899999999999999999999999999999998888653
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=287.99 Aligned_cols=217 Identities=35% Similarity=0.665 Sum_probs=191.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|+-+.||+.+|+|+++++......+++..+.|+.++. ..++|.||+++-.|++..+.||||||++||++..++
T Consensus 157 VrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~---~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~ 233 (550)
T KOG0605|consen 157 VRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILA---EVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM 233 (550)
T ss_pred EEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhh---hcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH
Confidence 8999999999999999999998888889999998877654 468999999999999999999999999999999888
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+.+.|++..++.++.+.+.|+..+|+.|++|| ||||+|+ ++|..|++||+|||+|
T Consensus 234 ~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHR---DIKPdNl----------------------LiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 234 RKDTLTEDWARFYIAETVLAIESIHQLGYIHR---DIKPDNL----------------------LIDAKGHIKLSDFGLS 288 (550)
T ss_pred hcCcCchHHHHHHHHHHHHHHHHHHHcCcccc---cCChhhe----------------------eecCCCCEeecccccc
Confidence 45789999999999999999999999999999 9999999 9999999999999998
Q ss_pred cCCCC---------------------CCCCC--------------------------CcccCCCCccccccccCCCCCcc
Q psy3347 160 KEGMG---------------------FGDRT--------------------------GTFCGTPEFLAPEVLTETSYTRA 192 (245)
Q Consensus 160 ~~~~~---------------------~~~~~--------------------------~~~~~~~~y~aPE~~~~~~~~~~ 192 (245)
..... ..... ...+||+-|+|||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 52211 00000 12458999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCC--CCCChhHHhhhcC
Q psy3347 193 VDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYP--RFLSLEAIAIMRR 245 (245)
Q Consensus 193 ~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p--~~~~~~~~~li~~ 245 (245)
+|.||||||||||+.|.+||.+.++.+...+|+... ..+| ..++++++|||.|
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITR 425 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHH
Confidence 999999999999999999999999999999998754 4555 5678999999964
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=282.22 Aligned_cols=217 Identities=37% Similarity=0.711 Sum_probs=186.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|+++............+ .+++++++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 9 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 85 (312)
T cd05585 9 VMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT---LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ 85 (312)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHH---HHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH
Confidence 79999999999999999986433233333333 344677888899999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||.|||++|++|| |++|+|| +++.++.++|+|||++
T Consensus 86 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~Hr---Dlkp~Ni----------------------li~~~~~~kl~Dfg~~ 140 (312)
T cd05585 86 REGRFDLSRARFYTAELLCALENLHKFNVIYR---DLKPENI----------------------LLDYQGHIALCDFGLC 140 (312)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC---CCCHHHe----------------------EECCCCcEEEEECccc
Confidence 4578999999999999999999999999999 8888888 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++
T Consensus 141 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (312)
T cd05585 141 KLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDA 220 (312)
T ss_pred ccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHH
Confidence 75433333344567899999999999888999999999999999999999999988888888888888888899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 221 ~~li~~ 226 (312)
T cd05585 221 KDLLIG 226 (312)
T ss_pred HHHHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=281.74 Aligned_cols=217 Identities=50% Similarity=0.909 Sum_probs=185.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++............+ .+++++++.++||||++++++|...+..|+||||+++++|..++.
T Consensus 11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 87 (323)
T cd05595 11 VILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHH---HHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986533333333333 344677888999999999999999999999999999999988875
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 88 RERVFTEERARFYGAEIVSALEYLHSRDVVYR---DIKLENL----------------------MLDKDGHIKITDFGLC 142 (323)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHE----------------------EEcCCCCEEecccHHh
Confidence 4 568999999999999999999999999999 8888888 7888899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..............|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++
T Consensus 143 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05595 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred ccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence 75333333334567899999999998888999999999999999999999999988888888888887888899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 223 ~~li~~ 228 (323)
T cd05595 223 KSLLAG 228 (323)
T ss_pred HHHHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=285.53 Aligned_cols=210 Identities=28% Similarity=0.496 Sum_probs=176.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||.|+++. ...||+|.++....+. +.+. +++++|++++|+|||+++++|+.++.+|||||||+.|+|.++++
T Consensus 222 V~~g~~~~-~~~vavk~ik~~~m~~----~~f~---~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr 293 (468)
T KOG0197|consen 222 VWLGKWNG-STKVAVKTIKEGSMSP----EAFL---REAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLR 293 (468)
T ss_pred EEEEEEcC-CCcccceEEeccccCh----hHHH---HHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhh
Confidence 78888872 3389999998754332 3343 45888999999999999999999889999999999999999997
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..++.++.+.++.||++||+||.+++++|| |+-.-|| +++.+..+||+|||
T Consensus 294 ~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR---DLAARNi----------------------LV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 294 TREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR---DLAARNI----------------------LVDEDLVVKISDFG 348 (468)
T ss_pred hcCCCccchHHHHHHHHHHHHHHHHHHhCCccch---hhhhhhe----------------------eeccCceEEEcccc
Confidence 5 468899999999999999999999999999 4444455 88888999999999
Q ss_pred CccCCCCCCCCCCccc--CCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cCCC
Q psy3347 158 LCKEGMGFGDRTGTFC--GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~p~ 233 (245)
+++. ..+........ -+..|+|||.+....|+.++||||||++||||+| |+.||.+.+..++.+.+..+.. +.|+
T Consensus 349 LAr~-~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 349 LARL-IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE 427 (468)
T ss_pred cccc-cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC
Confidence 9994 33322211111 1467999999999999999999999999999999 9999999999999999988754 6789
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.||+++.++|+
T Consensus 428 ~CP~~vY~lM~ 438 (468)
T KOG0197|consen 428 GCPDEVYELMK 438 (468)
T ss_pred CCCHHHHHHHH
Confidence 99999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=281.80 Aligned_cols=217 Identities=48% Similarity=0.908 Sum_probs=185.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.............+.+ ++++++.++||||+++.+++...+..++||||+++++|..++.
T Consensus 11 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~---E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 87 (328)
T cd05593 11 VILVREKASGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS 87 (328)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHH---HHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence 7999999999999999998654333333344443 4667888899999999999999999999999999999988875
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 88 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dikp~NI----------------------ll~~~~~~kL~DfG~~ 142 (328)
T cd05593 88 RERVFSEDRTRFYGAEIVSALDYLHSGKIVYR---DLKLENL----------------------MLDKDGHIKITDFGLC 142 (328)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEec---ccCHHHe----------------------EECCCCcEEEecCcCC
Confidence 4 568999999999999999999999999999 8888888 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++
T Consensus 143 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 222 (328)
T cd05593 143 KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADA 222 (328)
T ss_pred ccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHH
Confidence 75333333334567899999999998888999999999999999999999999988888888888777778899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 223 ~~li~~ 228 (328)
T cd05593 223 KSLLSG 228 (328)
T ss_pred HHHHHH
Confidence 998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=277.82 Aligned_cols=214 Identities=36% Similarity=0.717 Sum_probs=183.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+. +++++++.++||||+++++++.+++..+++|||+.+++|.+++.
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (291)
T cd05612 17 VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR 93 (291)
T ss_pred EEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHH---HHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH
Confidence 799999999999999999764322222333333 44777889999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~NI----------------------li~~~~~~kl~Dfg~~ 148 (291)
T cd05612 94 NSGRFSNSTGLFYASEIVCALEYLHSKEIVYR---DLKPENI----------------------LLDKEGHIKLTDFGFA 148 (291)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCHHHe----------------------EECCCCCEEEEecCcc
Confidence 4568999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+..+.+..+...+|..+++++
T Consensus 149 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 225 (291)
T cd05612 149 KKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYA 225 (291)
T ss_pred hhccC---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHH
Confidence 75322 223456889999999998888999999999999999999999999998888888888888888899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 226 ~~li~~ 231 (291)
T cd05612 226 KDLIKK 231 (291)
T ss_pred HHHHHH
Confidence 999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.55 Aligned_cols=214 Identities=37% Similarity=0.753 Sum_probs=184.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++..........+.+.+ ++++++.++||||+++++++..++..+++|||+.+++|.+++.
T Consensus 34 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 110 (329)
T PTZ00263 34 VRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ---EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110 (329)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHH---HHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH
Confidence 7999999999999999998643333233344444 4677888999999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||++
T Consensus 111 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~---dlkp~NI----------------------ll~~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 111 KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYR---DLKPENL----------------------LLDNKGHVKVTDFGFA 165 (329)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCHHHE----------------------EECCCCCEEEeeccCc
Confidence 4 568999999999999999999999999999 8888888 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..+...+|..+++++
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 242 (329)
T PTZ00263 166 KKVPD---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242 (329)
T ss_pred eEcCC---CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHH
Confidence 75322 223457899999999999888999999999999999999999999988888888888888888898899999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 243 ~~li~~ 248 (329)
T PTZ00263 243 RDLVKG 248 (329)
T ss_pred HHHHHH
Confidence 998863
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=270.93 Aligned_cols=197 Identities=27% Similarity=0.385 Sum_probs=169.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|+|+.|++-||+|+++-+... ...-+..+|++.+|.+++|||||.+.++.... +.+|+|||||++ +|...
T Consensus 92 VYRakdk~t~eIVALKr~kmekek----~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl 166 (419)
T KOG0663|consen 92 VYRAKDKKTDEIVALKRLKMEKEK----EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSL 166 (419)
T ss_pred EEEeccCCcceeEEeeeccccccc----CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHH
Confidence 899999999999999999865311 12223345668888899999999999987544 479999999987 77766
Q ss_pred hhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. .++...+++-++.|++.|++|||.+.|+|| |+|++|+ ++...|.+||+||
T Consensus 167 ~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHR---DLK~SNL----------------------Lm~~~G~lKiaDF 221 (419)
T KOG0663|consen 167 METMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHR---DLKTSNL----------------------LLSHKGILKIADF 221 (419)
T ss_pred HHhccCCCchHHHHHHHHHHHHHHHHHhhceeEec---ccchhhe----------------------eeccCCcEEeccc
Confidence 642 478899999999999999999999999999 8889898 8888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND 227 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (245)
|+|+...+........+-|.+|+|||.+.+. .|+.+.||||+|||++||+++++.|+|..+.++...|...
T Consensus 222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l 293 (419)
T KOG0663|consen 222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL 293 (419)
T ss_pred chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence 9999866666666777889999999999985 5899999999999999999999999999999999998653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=277.62 Aligned_cols=217 Identities=47% Similarity=0.946 Sum_probs=183.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|++.+.........+....|.+ .+..+ +||||+++++++...+..|+||||+++++|..++
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~---~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i 87 (320)
T cd05590 11 VMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKR---ILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI 87 (320)
T ss_pred EEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHH---HHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHH
Confidence 7999999999999999998653333333444444433 34333 6999999999999999999999999999998887
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 88 ~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~---dlkp~NI----------------------li~~~~~~kL~DfG~ 142 (320)
T cd05590 88 QKSRRFDEARARFYAAEITSALMFLHDKGIIYR---DLKLDNV----------------------LLDHEGHCKLADFGM 142 (320)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC---CCCHHHe----------------------EECCCCcEEEeeCCC
Confidence 4 4578999999999999999999999999999 8888888 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+..............|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (320)
T cd05590 143 CKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQD 222 (320)
T ss_pred CeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 87533333334456789999999999888899999999999999999999999999988888888888888888889999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
++++|++
T Consensus 223 ~~~li~~ 229 (320)
T cd05590 223 AVDILKA 229 (320)
T ss_pred HHHHHHH
Confidence 9998863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=277.61 Aligned_cols=218 Identities=49% Similarity=0.953 Sum_probs=183.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++..........+....|.+++.. ..+||||+++++++..++..|+||||+++++|...+.
T Consensus 11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~--~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 88 (321)
T cd05591 11 VMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILAL--AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ 88 (321)
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHh--ccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986543333344444455433322 2379999999999999999999999999999988774
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dikp~Ni----------------------ll~~~~~~kL~Dfg~~ 143 (321)
T cd05591 89 RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR---DLKLDNI----------------------LLDAEGHCKLADFGMC 143 (321)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHe----------------------EECCCCCEEEeecccc
Confidence 4568999999999999999999999999999 8888888 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..............|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......+|..+++++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 223 (321)
T cd05591 144 KEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEA 223 (321)
T ss_pred eecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 75433333344567899999999998888999999999999999999999999999988988888888888888899999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.++|++
T Consensus 224 ~~ll~~ 229 (321)
T cd05591 224 VSILKA 229 (321)
T ss_pred HHHHHH
Confidence 988863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=283.30 Aligned_cols=194 Identities=27% Similarity=0.419 Sum_probs=168.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCC-eEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEA-HVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~ 78 (245)
||+|+.+++|+.||||++++...+ .+...+ +|++..|++++ ||||+++.+++.+.+ ..++|||||+. +|.+.
T Consensus 26 V~la~~~~~~~~VAIK~MK~Kf~s----~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqL 99 (538)
T KOG0661|consen 26 VYLAKSKETGELVAIKKMKKKFYS----WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQL 99 (538)
T ss_pred EEEeeecCCCceeeHHHHHhhhcc----HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHH
Confidence 899999999999999999986533 233333 46678889998 999999999998887 99999999977 88888
Q ss_pred hh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
++ +..+++..++.|+.||++||+|+|.+|++|| |+||+|| ++.+...+||+||
T Consensus 100 mK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR---DlKPENi----------------------Li~~~~~iKiaDF 154 (538)
T KOG0661|consen 100 MKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR---DLKPENI----------------------LISGNDVIKIADF 154 (538)
T ss_pred HhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc---cCChhhe----------------------EecccceeEeccc
Confidence 85 3578999999999999999999999999999 8888888 7777788999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|+|+...+. .....++.|.+|+|||++.. .-|+.+.|||++|||++|+++-++.|+|.++.+...+|..
T Consensus 155 GLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 155 GLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred ccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 999975443 34667789999999999976 5689999999999999999999999999999988888754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=275.63 Aligned_cols=218 Identities=50% Similarity=0.971 Sum_probs=181.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|+++..........+....+.+++ ....+||||+++++++..+++.++||||+++++|..+++
T Consensus 11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l--~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~ 88 (316)
T cd05592 11 VMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVL--ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ 88 (316)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHH--HhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999999999999999864322223333344443332 223489999999999999999999999999999988885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.|||++||+|| |++|+|| +++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kL~Dfg~a 143 (316)
T cd05592 89 SSGRFDEARARFYAAEIICGLQFLHKKGIIYR---DLKLDNV----------------------LLDKDGHIKIADFGMC 143 (316)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeC---CCCHHHe----------------------EECCCCCEEEccCcCC
Confidence 4 568999999999999999999999999999 8888888 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
.............+|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.+|..+++++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 223 (316)
T cd05592 144 KENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEA 223 (316)
T ss_pred eECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 75433333344567899999999999888999999999999999999999999998888888888777777888899999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.++|++
T Consensus 224 ~~ll~~ 229 (316)
T cd05592 224 KDCLSK 229 (316)
T ss_pred HHHHHH
Confidence 998863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=277.09 Aligned_cols=218 Identities=42% Similarity=0.835 Sum_probs=182.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.............+..+. ..+++.++||||+++++.+...+..++||||+++++|..++.
T Consensus 11 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~--~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 88 (323)
T cd05575 11 VLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAER--NVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ 88 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHH--HHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH
Confidence 799999999999999999864332222333333332 234577899999999999999999999999999999988885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~---dikp~NI----------------------ll~~~~~~kl~Dfg~~ 143 (323)
T cd05575 89 RERSFPEPRARFYAAEIASALGYLHSLNIIYR---DLKPENI----------------------LLDSQGHVVLTDFGLC 143 (323)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC---CCCHHHe----------------------EECCCCcEEEeccCCC
Confidence 4 568999999999999999999999999999 8888888 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
.............+|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+..+++++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 223 (323)
T cd05575 144 KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSA 223 (323)
T ss_pred cccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 75433333344567899999999999888999999999999999999999999998888888888887777777889998
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.++|++
T Consensus 224 ~~li~~ 229 (323)
T cd05575 224 RHLLEG 229 (323)
T ss_pred HHHHHH
Confidence 888763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=278.52 Aligned_cols=220 Identities=33% Similarity=0.554 Sum_probs=182.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh--------HHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeec
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE--------VESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~ 70 (245)
|-+|++..+|+.||||++.+........ .-.+.+-.+++.+|++|.|||||+++++..+. ..+|||+|||
T Consensus 113 VkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~ 192 (576)
T KOG0585|consen 113 VKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYC 192 (576)
T ss_pred EEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEec
Confidence 4589999999999999998754322211 11123445668899999999999999999765 4899999999
Q ss_pred cCCchhhhhhhcC-CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 71 AGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 71 ~~~~L~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
..|.+...--..+ +++.+++.++++++.||+|||.+||+|| ||||+|+ +++.+|
T Consensus 193 s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR---DIKPsNL----------------------Ll~~~g 247 (576)
T KOG0585|consen 193 SKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHR---DIKPSNL----------------------LLSSDG 247 (576)
T ss_pred cCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeecc---ccchhhe----------------------EEcCCC
Confidence 9888765444444 8999999999999999999999999999 9999999 889999
Q ss_pred ceEEeecCCccCC-----CCCCCCCCcccCCCCccccccccC---CCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy3347 150 YVKIADFGLCKEG-----MGFGDRTGTFCGTPEFLAPEVLTE---TSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220 (245)
Q Consensus 150 ~~kl~Dfg~~~~~-----~~~~~~~~~~~~~~~y~aPE~~~~---~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~ 220 (245)
++||+|||.+... .+........+||+.|+|||.+.+ ..+ +.+.||||+|+++|.|+.|+.||.+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999988643 122223445789999999999977 333 4789999999999999999999999999999
Q ss_pred HHHHhcCcccCCCC--CChhHHhhhcC
Q psy3347 221 FDSIVNDEVRYPRF--LSLEAIAIMRR 245 (245)
Q Consensus 221 ~~~~~~~~~~~p~~--~~~~~~~li~~ 245 (245)
..+|+.....+|+. +.++++|||.|
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~ 354 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKR 354 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHH
Confidence 99999999999865 79999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=279.37 Aligned_cols=217 Identities=31% Similarity=0.626 Sum_probs=178.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++...........+.+ +..++..++||||+++++.+.+.+..|+||||+++|+|.+++.
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (363)
T cd05628 17 VRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRA---ERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93 (363)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHH---HHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH
Confidence 7999999999999999998643322233333433 4667778899999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 94 ~~~~l~~~~~~~~~~qi~~aL~~lH~~givHr---DlKp~NI----------------------Li~~~~~vkL~DFGla 148 (363)
T cd05628 94 KKDTLTEEETQFYIAETVLAIDSIHQLGFIHR---DIKPDNL----------------------LLDSKGHVKLSDFGLC 148 (363)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEec---CCCHHHe----------------------EECCCCCEEEeeccCc
Confidence 4678999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCC-----------------------------------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHH
Q psy3347 160 KEGMGFG-----------------------------------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFE 204 (245)
Q Consensus 160 ~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 204 (245)
+...... ......+||..|+|||.+.+..++.++|+|||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 6422110 00123578999999999998889999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhcC--cccCCC--CCChhHHhhhcC
Q psy3347 205 MLVGESPFPGDDEEEVFDSIVND--EVRYPR--FLSLEAIAIMRR 245 (245)
Q Consensus 205 l~~g~~pf~~~~~~~~~~~~~~~--~~~~p~--~~~~~~~~li~~ 245 (245)
|++|+.||.+.+..+....+... ...+|. .++++++++|.+
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 273 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILR 273 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHH
Confidence 99999999988888888877653 233453 468899988753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=278.33 Aligned_cols=214 Identities=36% Similarity=0.745 Sum_probs=182.4
Q ss_pred CEeEEEecCC-cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTG-EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.++.++ ..||+|++...........+.+.+| +++++.++||||+++++++..++..++||||+++|+|..++
T Consensus 46 Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i 122 (340)
T PTZ00426 46 VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE---RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL 122 (340)
T ss_pred EEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHH---HHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 7999887665 6899999976443333334444444 66778889999999999999999999999999999999988
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..+..++.|++.||.|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 123 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---DLkp~NI----------------------Ll~~~~~ikL~DFG~ 177 (340)
T PTZ00426 123 RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR---DLKPENL----------------------LLDKDGFIKMTDFGF 177 (340)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc---CCCHHHE----------------------EECCCCCEEEecCCC
Confidence 5 4578999999999999999999999999999 8888888 788899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+..... ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.....+.+..+...+|..++++
T Consensus 178 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 254 (340)
T PTZ00426 178 AKVVDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254 (340)
T ss_pred CeecCC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 875322 23355789999999999888899999999999999999999999999888888888888888889999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
++++|++
T Consensus 255 ~~~li~~ 261 (340)
T PTZ00426 255 CKHLMKK 261 (340)
T ss_pred HHHHHHH
Confidence 9998864
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=274.40 Aligned_cols=214 Identities=34% Similarity=0.514 Sum_probs=172.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--eEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+.++|+.+|+|.+.... ....+.+. +++.+|++++|||||+++|...... .+++.|||+++|+|.++
T Consensus 33 V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~---~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~ 106 (313)
T KOG0198|consen 33 VYLATNKKTGELMAVKSVELED---SPTSESLE---REIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDL 106 (313)
T ss_pred EEEEEecCCCcceeeeeeeccc---chhHHHHH---HHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHH
Confidence 7999999999999999998652 12234444 4477788889999999999855444 69999999999999999
Q ss_pred hhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-CCceEEee
Q psy3347 79 IHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-EGYVKIAD 155 (245)
Q Consensus 79 ~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~kl~D 155 (245)
+++. .++++.++++++|+++||.|||++|++|+ ||||+|| +++. ++.+||+|
T Consensus 107 ~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~---DiK~~Ni----------------------Ll~~~~~~~KlaD 161 (313)
T KOG0198|consen 107 IKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHC---DIKPANI----------------------LLDPSNGDVKLAD 161 (313)
T ss_pred HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc---CcccceE----------------------EEeCCCCeEEecc
Confidence 9653 69999999999999999999999999999 8888888 7777 79999999
Q ss_pred cCCccCCCCCC---CCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcC--c
Q psy3347 156 FGLCKEGMGFG---DRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVND--E 228 (245)
Q Consensus 156 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~-~~~~~~~~~~~~~--~ 228 (245)
||++....... .......||+.|||||++..+ ...+++|||||||++.||+||+.||.. ....+..-.+... .
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL 241 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC
Confidence 99887544211 224457899999999999853 334699999999999999999999987 4444444444433 3
Q ss_pred ccCCCCCChhHHhhhcC
Q psy3347 229 VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~~ 245 (245)
+.+|+.+|++.+++|++
T Consensus 242 P~ip~~ls~~a~~Fl~~ 258 (313)
T KOG0198|consen 242 PEIPDSLSDEAKDFLRK 258 (313)
T ss_pred CCCCcccCHHHHHHHHH
Confidence 56799999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=274.35 Aligned_cols=217 Identities=49% Similarity=0.920 Sum_probs=182.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|++++.........+....+.++ +..+ .|++|+++++++...+..++||||+++|+|..++
T Consensus 16 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~---l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~ 92 (323)
T cd05616 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRV---LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI 92 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH---HHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHH
Confidence 79999999999999999986533233333344444333 3333 5899999999999999999999999999998887
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~kL~DfG~ 147 (323)
T cd05616 93 QQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR---DLKLDNV----------------------MLDSEGHIKIADFGM 147 (323)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec---CCCHHHe----------------------EECCCCcEEEccCCC
Confidence 5 4578999999999999999999999999999 8888888 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 227 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHH
Confidence 87533333334456789999999999988999999999999999999999999999888888888888888889999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++++++
T Consensus 228 ~~~li~~ 234 (323)
T cd05616 228 AVAICKG 234 (323)
T ss_pred HHHHHHH
Confidence 9988863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=279.99 Aligned_cols=217 Identities=50% Similarity=0.904 Sum_probs=184.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++............+ .+++++++.++||||+++.+++..++..|+||||+++++|..++.
T Consensus 11 V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~---~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 87 (325)
T cd05594 11 VILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87 (325)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHH---HHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986543333333333 344667788899999999999999999999999999999988875
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||+ +|++|| |+||+|| +++.++.+||+|||+
T Consensus 88 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr---Dikp~NI----------------------ll~~~~~~kL~Dfg~ 142 (325)
T cd05594 88 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYR---DLKLENL----------------------MLDKDGHIKITDFGL 142 (325)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec---CCCCCeE----------------------EECCCCCEEEecCCC
Confidence 4 568999999999999999999997 799999 8888888 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+..............|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 222 (325)
T cd05594 143 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 222 (325)
T ss_pred CeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 87533333333455789999999999888899999999999999999999999998888888888888888889999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 223 ~~~li~~ 229 (325)
T cd05594 223 AKSLLSG 229 (325)
T ss_pred HHHHHHH
Confidence 9998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=272.76 Aligned_cols=208 Identities=31% Similarity=0.588 Sum_probs=181.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|-+|++...|+.||||.+++..+...+..-.+ +|++++|..++||||++++++|+..+.+.+||||..+|.|.+++.
T Consensus 69 Vk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhI---RREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS 145 (668)
T KOG0611|consen 69 VKLAYEHKSGREVAIKSIRKDKIKDEQDLVHI---RREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS 145 (668)
T ss_pred eeehhhccCCcEeehhhhhhhhcccHHHHHHH---HHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH
Confidence 44677778899999999998766655444444 555888999999999999999999999999999999999999994
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
++.+++..++++++||..|+.|||.++++|| |+|.+|| ++|.++++||+|||++
T Consensus 146 er~~LsErEaRhfFRQIvSAVhYCHknrVvHR---DLKLENI----------------------LLD~N~NiKIADFGLS 200 (668)
T KOG0611|consen 146 ERGSLSEREARHFFRQIVSAVHYCHKNRVVHR---DLKLENI----------------------LLDQNNNIKIADFGLS 200 (668)
T ss_pred HhccccHHHHHHHHHHHHHHHHHHhhccceec---ccchhhe----------------------eecCCCCeeeeccchh
Confidence 6789999999999999999999999999999 7777777 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCCh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 237 (245)
... .......++||++.|.+||++.|.+|. +.+|.||||+.+|.++.|..||+|.+......+|..+.++-|+.-++
T Consensus 201 Nly-~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSd 278 (668)
T KOG0611|consen 201 NLY-ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSD 278 (668)
T ss_pred hhh-ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCch
Confidence 753 344457789999999999999999984 78999999999999999999999999999999999998876654443
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=273.82 Aligned_cols=217 Identities=55% Similarity=1.016 Sum_probs=183.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|++++...........+.+|.++ +..+ +||||+++++++...++.|+||||+++++|..++
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i---l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 87 (318)
T cd05570 11 VLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRV---LALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI 87 (318)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHH---HHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHH
Confidence 79999999999999999986543333344445555443 4334 7999999999999999999999999999998888
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 88 ~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kl~Dfg~ 142 (318)
T cd05570 88 QRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR---DLKLDNV----------------------LLDSEGHIKIADFGM 142 (318)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEcc---CCCHHHe----------------------EECCCCcEEecccCC
Confidence 54 479999999999999999999999999999 8888888 788889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 143 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (318)
T cd05570 143 CKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222 (318)
T ss_pred CeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHH
Confidence 87533333334455789999999999998999999999999999999999999998888888888888888888899999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 223 ~~~li~~ 229 (318)
T cd05570 223 AKSILKS 229 (318)
T ss_pred HHHHHHH
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=274.94 Aligned_cols=218 Identities=39% Similarity=0.781 Sum_probs=181.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++.............+..+ +..+++.++||||+++++++...+..++||||+++++|..++.
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e--~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 88 (325)
T cd05602 11 VLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE--RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ 88 (325)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHH--HHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986432222222333333 2334677899999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHr---Dlkp~Ni----------------------li~~~~~~kl~DfG~a 143 (325)
T cd05602 89 RERCFLEPRARFYAAEIASALGYLHSLNIVYR---DLKPENI----------------------LLDSQGHIVLTDFGLC 143 (325)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHe----------------------EECCCCCEEEccCCCC
Confidence 4 568888999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......++..+++++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 223 (325)
T cd05602 144 KENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 223 (325)
T ss_pred cccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHH
Confidence 75433333344567899999999999888999999999999999999999999988888888888777666777888888
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 224 ~~li~~ 229 (325)
T cd05602 224 RHLLEG 229 (325)
T ss_pred HHHHHH
Confidence 888763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=263.96 Aligned_cols=218 Identities=30% Similarity=0.541 Sum_probs=184.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh-hhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM-MHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~ 79 (245)
|+++.++.||+.+|+|++........ .++.+.+| +.+++.++||||+++.+.+...++.|+|||+++|++|. +..
T Consensus 27 VrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rE---arIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV 102 (355)
T KOG0033|consen 27 VRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLERE---ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 102 (355)
T ss_pred HHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHH---HHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH
Confidence 46677889999999999987655443 56677666 45566778999999999999999999999999999985 555
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+..+++..+..+++||+++|.|||.+||+|| |+||.|+ ++- ..+..--+|++|||++
T Consensus 103 ~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHR---DvkP~nl-----lLA--------------SK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 103 AREFYSEADASHCIQQILEALAYCHSNGIVHR---DLKPENL-----LLA--------------SKAKGAAVKLADFGLA 160 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCceec---cCChhhe-----eee--------------eccCCCceeecccceE
Confidence 67778999999999999999999999999999 5555555 433 3344556999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----CCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p----~~~ 235 (245)
.... ++..-...+|++.|||||++...+|+.++|||++|+++|-++.|.+||.+.+...+.++|..+.+.+| +.+
T Consensus 161 i~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 161 IEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred EEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcC
Confidence 8654 55445567899999999999999999999999999999999999999999999999999999988765 478
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
+++.++|++|
T Consensus 240 s~~Ak~Lvrr 249 (355)
T KOG0033|consen 240 TPEAKSLIRR 249 (355)
T ss_pred CHHHHHHHHH
Confidence 9999999875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=272.90 Aligned_cols=218 Identities=49% Similarity=0.930 Sum_probs=181.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++..........+....|.+.+. ...+||||+++++++..+++.|+||||+.+++|..++.
T Consensus 11 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~--~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~ 88 (316)
T cd05620 11 VLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA--LAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ 88 (316)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHH--hccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH
Confidence 7999999999999999998643222233344444433322 23489999999999999999999999999999988885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr---Dlkp~Ni----------------------l~~~~~~~kl~Dfg~~ 143 (316)
T cd05620 89 DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR---DLKLDNV----------------------MLDRDGHIKIADFGMC 143 (316)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHe----------------------EECCCCCEEeCccCCC
Confidence 4 578999999999999999999999999999 8888888 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+....+.+|..+++++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (316)
T cd05620 144 KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKES 223 (316)
T ss_pred eecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 74322223344567899999999999888999999999999999999999999988888888888777777888899999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 224 ~~li~~ 229 (316)
T cd05620 224 KDILEK 229 (316)
T ss_pred HHHHHH
Confidence 998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=272.35 Aligned_cols=217 Identities=49% Similarity=0.906 Sum_probs=181.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCC-CceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRH-PFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|+++..........+.+..| .+.+..++| ++|+++++++...+..|+||||+++++|..++
T Consensus 16 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e---~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~ 92 (324)
T cd05587 16 VMLAERKGTDELYAIKILKKDVIIQDDDVECTMVE---KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 92 (324)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH---HHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence 79999999999999999986533333334444444 444555655 56889999999999999999999999998888
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kL~Dfg~ 147 (324)
T cd05587 93 QQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR---DLKLDNV----------------------MLDAEGHIKIADFGM 147 (324)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHe----------------------EEcCCCCEEEeecCc
Confidence 5 4568999999999999999999999999999 8888888 788889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+.............+|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 86432222233455789999999999998899999999999999999999999999988888888888888889999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+.+++++
T Consensus 228 ~~~li~~ 234 (324)
T cd05587 228 AVSICKG 234 (324)
T ss_pred HHHHHHH
Confidence 9988763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=273.29 Aligned_cols=218 Identities=41% Similarity=0.807 Sum_probs=181.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.+...........+..| +..+++.++||||+++++++...+..++||||+++++|...+.
T Consensus 11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e--~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 88 (321)
T cd05603 11 VLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAE--RNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ 88 (321)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHH--HHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence 79999999999999999986533222233333333 2335678899999999999999999999999999999988775
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kl~Dfg~~ 143 (321)
T cd05603 89 RERCFLEPRARFYAAEVASAIGYLHSLNIIYR---DLKPENI----------------------LLDSQGHVVLTDFGLC 143 (321)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---cCCHHHe----------------------EECCCCCEEEccCCCC
Confidence 4 568899999999999999999999999999 8888888 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
.............+|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+......+|...+.++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 223 (321)
T cd05603 144 KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA 223 (321)
T ss_pred ccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence 75333333344567899999999998888999999999999999999999999988888888888877777788888888
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.++|++
T Consensus 224 ~~li~~ 229 (321)
T cd05603 224 CDLLVG 229 (321)
T ss_pred HHHHHH
Confidence 888753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=272.85 Aligned_cols=216 Identities=50% Similarity=0.920 Sum_probs=181.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++++.........+.+..|. .++..+ +|++|+++++++...+..|+||||+++++|..++
T Consensus 16 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i 92 (323)
T cd05615 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK---RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI 92 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH---HHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHH
Confidence 799999999999999999864332333334444443 344444 4678889999999999999999999999999888
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. ..+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.++|+|||+
T Consensus 93 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHr---Dikp~Ni----------------------ll~~~~~ikL~Dfg~ 147 (323)
T cd05615 93 QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR---DLKLDNV----------------------MLDSEGHIKIADFGM 147 (323)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHe----------------------EECCCCCEEEecccc
Confidence 54 578999999999999999999999999999 8888888 788899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++.............|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.....+.+......+|..++++
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 227 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 87533333333455689999999999888899999999999999999999999999888888888888888888899999
Q ss_pred HHhhhc
Q psy3347 239 AIAIMR 244 (245)
Q Consensus 239 ~~~li~ 244 (245)
++++++
T Consensus 228 ~~~li~ 233 (323)
T cd05615 228 AVSICK 233 (323)
T ss_pred HHHHHH
Confidence 888875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=274.45 Aligned_cols=217 Identities=41% Similarity=0.793 Sum_probs=180.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.............+..|. ..+++.++||||+++++++...+..++||||+++++|..++.
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~--~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 88 (325)
T cd05604 11 VLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER--NVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ 88 (325)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH--HHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence 799999999999999999864332223333333332 234677899999999999999999999999999999988774
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qi~~al~~lH~~givH~---Dlkp~NI----------------------ll~~~~~~kL~DfG~~ 143 (325)
T cd05604 89 RERSFPEPRARFYAAEIASALGYLHSINIVYR---DLKPENI----------------------LLDSQGHVVLTDFGLC 143 (325)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCHHHe----------------------EECCCCCEEEeecCCc
Confidence 4578999999999999999999999999999 8888888 7888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
.............+|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.......+...+.++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (325)
T cd05604 144 KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTA 223 (325)
T ss_pred ccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHH
Confidence 75333333344567899999999999888999999999999999999999999988888888888777666666788887
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.++|+
T Consensus 224 ~~ll~ 228 (325)
T cd05604 224 WSILE 228 (325)
T ss_pred HHHHH
Confidence 77765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=271.88 Aligned_cols=218 Identities=38% Similarity=0.763 Sum_probs=181.7
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++. .+|+.||+|+++....... ........+++++++.++||||++++++|..++..|++|||+.+++|.+
T Consensus 12 V~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (323)
T cd05584 12 VFQVRKVTGADTGKIFAMKVLKKATIVRN--QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 89 (323)
T ss_pred EEEEEEcccCCCCCEEEEEEEEHHHHHhh--hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHH
Confidence 6888763 5789999999986432211 1112222344677888999999999999999999999999999999998
Q ss_pred hhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
++.. +.+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+||
T Consensus 90 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~Df 144 (323)
T cd05584 90 HLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR---DLKPENI----------------------LLDAQGHVKLTDF 144 (323)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EECCCCCEEEeeC
Confidence 8854 567888999999999999999999999999 8888888 7888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~ 236 (245)
|+++.............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..+...+|..++
T Consensus 145 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (323)
T cd05584 145 GLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT 224 (323)
T ss_pred cCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 99875333333344567899999999998888899999999999999999999999998888888888888888889999
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
++++++|++
T Consensus 225 ~~~~~li~~ 233 (323)
T cd05584 225 PEARDLLKK 233 (323)
T ss_pred HHHHHHHHH
Confidence 999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=273.17 Aligned_cols=217 Identities=42% Similarity=0.838 Sum_probs=177.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|+++............+..| ..++..+ +||||++++++|...+..|+||||+++++|..++
T Consensus 11 V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e---~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~ 87 (329)
T cd05588 11 VLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTE---KHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87 (329)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH---HHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHH
Confidence 79999999999999999987543333333444444 4445455 6999999999999999999999999999998887
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. .+.+++..+..++.|++.||.|||++|++|| |++|+|| +++.++.++|+|||+
T Consensus 88 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------li~~~~~~kL~Dfg~ 142 (329)
T cd05588 88 QRQRKLPEEHARFYSAEISLALNFLHERGIIYR---DLKLDNV----------------------LLDAEGHIKLTDYGM 142 (329)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHe----------------------EECCCCCEEECcCcc
Confidence 4 4579999999999999999999999999999 8888888 788889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcCcc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD---------DEEEVFDSIVNDEV 229 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~---------~~~~~~~~~~~~~~ 229 (245)
++............+|+..|+|||.+.+..++.++|+|||||++|+|++|+.||... ......+.+.....
T Consensus 143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (329)
T cd05588 143 CKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222 (329)
T ss_pred ccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC
Confidence 875333333345567899999999999888999999999999999999999999521 12234455666677
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|..+++++.++|++
T Consensus 223 ~~p~~~~~~~~~li~~ 238 (329)
T cd05588 223 RIPRSLSVKASSVLKG 238 (329)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 7888999999988864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=270.64 Aligned_cols=217 Identities=50% Similarity=0.931 Sum_probs=180.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHh-hcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN-TMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+++.||+|+++..........+....|. ..+. ..+||||+++++++...+..++||||+++++|..++
T Consensus 11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l 87 (316)
T cd05619 11 VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEK---RVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI 87 (316)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHH---HHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999999999999999865322223333344443 3343 358999999999999999999999999999999888
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. ..+++..+..++.|++.||.|||++|++|| |++|+|| +++.++.++|+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHr---dikp~Ni----------------------l~~~~~~~kl~Dfg~ 142 (316)
T cd05619 88 QSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR---DLKLDNI----------------------LLDTDGHIKIADFGM 142 (316)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC---CCCHHHE----------------------EECCCCCEEEccCCc
Confidence 64 568999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+....+.+|..++.+
T Consensus 143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05619 143 CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTRE 222 (316)
T ss_pred ceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 87432222233455789999999999888899999999999999999999999998888888888877777778889999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++++.+
T Consensus 223 ~~~li~~ 229 (316)
T cd05619 223 AKDILVK 229 (316)
T ss_pred HHHHHHH
Confidence 9988863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=276.77 Aligned_cols=217 Identities=34% Similarity=0.622 Sum_probs=175.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+.+| +++++.++||||+++++++...++.++||||+++|+|.+++.
T Consensus 17 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E---~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (381)
T cd05626 17 VCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAE---RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93 (381)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHH---HHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH
Confidence 79999999999999999986543333334444444 667788899999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||++
T Consensus 94 ~~~~~~e~~~~~~~~qi~~aL~~LH~~givHr---DlKp~Ni----------------------li~~~~~~kL~DFGl~ 148 (381)
T cd05626 94 RMEVFPEVLARFYIAELTLAIESVHKMGFIHR---DIKPDNI----------------------LIDLDGHIKLTDFGLC 148 (381)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---CCcHHHE----------------------EECCCCCEEEeeCcCC
Confidence 4 568999999999999999999999999999 8888888 7888899999999987
Q ss_pred cCCCCCC-----------------------------------------------CCCCcccCCCCccccccccCCCCCcc
Q psy3347 160 KEGMGFG-----------------------------------------------DRTGTFCGTPEFLAPEVLTETSYTRA 192 (245)
Q Consensus 160 ~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (245)
....... ......+||..|+|||.+.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 5211000 00123478999999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cccCC--CCCChhHHhhhcC
Q psy3347 193 VDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EVRYP--RFLSLEAIAIMRR 245 (245)
Q Consensus 193 ~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~p--~~~~~~~~~li~~ 245 (245)
+|||||||++|||++|+.||...+..+....+... ...+| ..+++++++||++
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ 285 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK 285 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999887766665555432 23344 3688999998863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=276.26 Aligned_cols=217 Identities=34% Similarity=0.674 Sum_probs=177.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||||++.............+.+ ++++++.++||||++++++|..+++.|+||||+++|+|.+++.
T Consensus 17 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~---E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~ 93 (364)
T cd05599 17 VRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA---ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM 93 (364)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHH---HHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH
Confidence 7999999999999999998643333333333433 4677788899999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 94 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~---Dlkp~NI----------------------l~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 94 KKDTFTEEETRFYIAETILAIDSIHKLGYIHR---DIKPDNL----------------------LLDAKGHIKLSDFGLC 148 (364)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---cCCHHHe----------------------EECCCCCEEEeecccc
Confidence 4568999999999999999999999999999 8888888 8888999999999988
Q ss_pred cCCCCCCC--------------------------------------CCCcccCCCCccccccccCCCCCcchhHHHHHHH
Q psy3347 160 KEGMGFGD--------------------------------------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 201 (245)
Q Consensus 160 ~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 201 (245)
........ .....+||+.|+|||.+.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 64211100 0112468999999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcCcc--cCCC--CCChhHHhhhcC
Q psy3347 202 IFEMLVGESPFPGDDEEEVFDSIVNDEV--RYPR--FLSLEAIAIMRR 245 (245)
Q Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~p~--~~~~~~~~li~~ 245 (245)
+|+|++|..||.+.+..+....+..... .+|. .+++++++||++
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 276 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR 276 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHH
Confidence 9999999999998888777777765432 3343 568899998863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=270.25 Aligned_cols=217 Identities=43% Similarity=0.851 Sum_probs=176.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|++++...........+.+| ..++..+ +||||+++++++...+..++||||+++++|..++
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~ 87 (329)
T cd05618 11 VLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTE---KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 87 (329)
T ss_pred EEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHH---HHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHH
Confidence 79999999999999999987543333344444444 3344443 7999999999999999999999999999998877
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 88 ~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~---Dikp~Ni----------------------li~~~~~~kL~DfG~ 142 (329)
T cd05618 88 QRQRKLPEEHARFYSAEISLALNYLHERGIIYR---DLKLDNV----------------------LLDSEGHIKLTDYGM 142 (329)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCCHHHE----------------------EECCCCCEEEeeCCc
Confidence 4 4578999999999999999999999999999 8888888 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcCcc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG---------DDEEEVFDSIVNDEV 229 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~---------~~~~~~~~~~~~~~~ 229 (245)
++.............|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.. .......+.+.....
T Consensus 143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 222 (329)
T cd05618 143 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222 (329)
T ss_pred cccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC
Confidence 87533333334456789999999999988899999999999999999999999942 112234445566677
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|..+++++.++|++
T Consensus 223 ~~p~~~~~~~~~ll~~ 238 (329)
T cd05618 223 RIPRSLSVKAASVLKS 238 (329)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 7899999999888864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=276.50 Aligned_cols=217 Identities=33% Similarity=0.625 Sum_probs=175.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+.+ ++++++.++||||++++++|..+++.|+||||+++++|..++.
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (377)
T cd05629 17 VRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA---ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI 93 (377)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHH---HHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH
Confidence 7999999999999999997643333333344444 4667788899999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||++
T Consensus 94 ~~~~~~~~~~~~~~~ql~~aL~~LH~~givHr---Dlkp~NI----------------------ll~~~~~~kl~DfGla 148 (377)
T cd05629 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR---DIKPDNI----------------------LIDRGGHIKLSDFGLS 148 (377)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHE----------------------EECCCCCEEEeecccc
Confidence 4568899999999999999999999999999 8888888 7788899999999988
Q ss_pred cCCCCCC-------------C----------------------------------CCCcccCCCCccccccccCCCCCcc
Q psy3347 160 KEGMGFG-------------D----------------------------------RTGTFCGTPEFLAPEVLTETSYTRA 192 (245)
Q Consensus 160 ~~~~~~~-------------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (245)
+...... . .....+||+.|+|||.+.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 5211100 0 0012468999999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cccCCC--CCChhHHhhhcC
Q psy3347 193 VDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EVRYPR--FLSLEAIAIMRR 245 (245)
Q Consensus 193 ~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~p~--~~~~~~~~li~~ 245 (245)
+|||||||++|||++|..||.+.+..+....+... ...+|. .+++++++||++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~ 285 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999888877777776643 233444 578888888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=275.64 Aligned_cols=216 Identities=33% Similarity=0.609 Sum_probs=175.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++...........+.+.+| +++++.++||||+++++.+..+++.|+||||+++|+|..++.
T Consensus 17 Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E---~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (382)
T cd05625 17 VCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAE---RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93 (382)
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHH---HHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986433333334444444 667788899999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.++|+|||++
T Consensus 94 ~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHr---DlKp~NI----------------------Ll~~~g~~kL~DFGla 148 (382)
T cd05625 94 RMGIFPEDLARFYIAELTCAVESVHKMGFIHR---DIKPDNI----------------------LIDRDGHIKLTDFGLC 148 (382)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EECCCCCEEEeECCCC
Confidence 4 568899999999999999999999999999 8888888 8888999999999987
Q ss_pred cCCCCCC-----------------------------------------------CCCCcccCCCCccccccccCCCCCcc
Q psy3347 160 KEGMGFG-----------------------------------------------DRTGTFCGTPEFLAPEVLTETSYTRA 192 (245)
Q Consensus 160 ~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (245)
....... ......+||+.|+|||.+.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 4211000 00123468999999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCC--CCCChhHHhhhc
Q psy3347 193 VDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYP--RFLSLEAIAIMR 244 (245)
Q Consensus 193 ~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p--~~~~~~~~~li~ 244 (245)
+|||||||++|||++|+.||.+.+..+....+.... ..+| ..++++.+++|.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 284 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLII 284 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHH
Confidence 999999999999999999999888777666665432 2333 467899998875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=274.13 Aligned_cols=217 Identities=32% Similarity=0.583 Sum_probs=178.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.+.........+.+.+ +..+++.++||||+++++++.++++.++||||+++|+|..+++
T Consensus 59 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~ 135 (370)
T cd05596 59 VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS 135 (370)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHH---HHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH
Confidence 7999999999999999997643222222333333 4667788899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++||+|| |++|+|| +++.++.+||+|||++.
T Consensus 136 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr---DLkp~NI----------------------Ll~~~~~~kL~DfG~~~ 190 (370)
T cd05596 136 NYDIPEKWARFYTAEVVLALDAIHSMGFIHR---DVKPDNM----------------------LLDKSGHLKLADFGTCM 190 (370)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHE----------------------EEcCCCCEEEEecccee
Confidence 7789999999999999999999999999999 8888888 88889999999999987
Q ss_pred CCCCCCC-CCCcccCCCCccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCCC
Q psy3347 161 EGMGFGD-RTGTFCGTPEFLAPEVLTET----SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYPR 233 (245)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p~ 233 (245)
....... .....+|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+.......+.... ..+|.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 5332221 23355789999999998653 37889999999999999999999999888877777776643 34454
Q ss_pred --CCChhHHhhhcC
Q psy3347 234 --FLSLEAIAIMRR 245 (245)
Q Consensus 234 --~~~~~~~~li~~ 245 (245)
.+++++++||++
T Consensus 271 ~~~~s~~~~~li~~ 284 (370)
T cd05596 271 DIEISKQAKDLICA 284 (370)
T ss_pred cCCCCHHHHHHHHH
Confidence 578899988863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.70 Aligned_cols=217 Identities=41% Similarity=0.834 Sum_probs=177.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+++.||+|+++..........+.+.+| ..++..+ +||||+++++++...+..|+||||+++++|..++
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e---~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 87 (327)
T cd05617 11 VLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTE---KHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM 87 (327)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH---HHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 79999999999999999987544333444445555 3444444 6999999999999999999999999999998877
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||+
T Consensus 88 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr---Dlkp~Ni----------------------li~~~~~~kl~Dfg~ 142 (327)
T cd05617 88 QRQRKLPEEHARFYAAEICIALNFLHERGIIYR---DLKLDNV----------------------LLDADGHIKLTDYGM 142 (327)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHE----------------------EEeCCCCEEEecccc
Confidence 5 4579999999999999999999999999999 8888888 788889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcCcccC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-------DEEEVFDSIVNDEVRY 231 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-------~~~~~~~~~~~~~~~~ 231 (245)
+.............+|+..|+|||.+.+..++.++|+||||+++|+|++|+.||... ......+.+.....++
T Consensus 143 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (327)
T cd05617 143 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI 222 (327)
T ss_pred ceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC
Confidence 875333333344567899999999999889999999999999999999999999532 2233445555666678
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|..+++.+.++|++
T Consensus 223 p~~~~~~~~~li~~ 236 (327)
T cd05617 223 PRFLSVKASHVLKG 236 (327)
T ss_pred CCCCCHHHHHHHHH
Confidence 88899999888764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=262.20 Aligned_cols=217 Identities=37% Similarity=0.626 Sum_probs=175.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|.+...........+.+. .++++++.++||||+++.+++..++..+++|||+++++|...+.
T Consensus 9 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~---~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 85 (280)
T cd05608 9 VSACQMRATGKLYACKKLNKKRLKKRKGYEGAM---VEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIY 85 (280)
T ss_pred EEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHH---HHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHH
Confidence 799999999999999999865333222333333 44667888899999999999999999999999999999987662
Q ss_pred -----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 -----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 -----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 86 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~~l~d 140 (280)
T cd05608 86 NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR---DLKPENV----------------------LLDNDGNVRISD 140 (280)
T ss_pred hccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEEee
Confidence 2458999999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCcccC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRY 231 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~ 231 (245)
||++..............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+......+
T Consensus 141 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 220 (280)
T cd05608 141 LGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY 220 (280)
T ss_pred CccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC
Confidence 99987543333333445788999999999988999999999999999999999999976432 23344444455556
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|..+++++++++++
T Consensus 221 ~~~~~~~~~~li~~ 234 (280)
T cd05608 221 PDKFSPASKSFCEA 234 (280)
T ss_pred cccCCHHHHHHHHH
Confidence 77889998888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=251.29 Aligned_cols=215 Identities=30% Similarity=0.558 Sum_probs=191.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||.|+.++++.-||+|++-++.+...+ .-.+..|++++-..++||||++++++|.+....|+++||+.+|.+...+.
T Consensus 38 vYlarekks~~IvalKVlfKsqi~~~~---v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~ 114 (281)
T KOG0580|consen 38 VYLAREKKSLFIVALKVLFKSQILKTQ---VEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQ 114 (281)
T ss_pred EeEeeeccCCcEEEEeeeeHHHHHHhc---chhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHH
Confidence 899999999999999999876533322 22334566888889999999999999999999999999999999988886
Q ss_pred ---hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 ---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
...++++.+..+++|++.||.|||..+|+|| ||||+|+ +++..+.+||+|||
T Consensus 115 ~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhR---diKpenl----------------------Llg~~~~lkiAdfG 169 (281)
T KOG0580|consen 115 EGRMKRFDEQRAATYIKQLANALLYCHLKRVIHR---DIKPENL----------------------LLGSAGELKIADFG 169 (281)
T ss_pred hcccccccccchhHHHHHHHHHHHHhccCCcccC---CCCHHHh----------------------ccCCCCCeeccCCC
Confidence 2458999999999999999999999999999 9999999 88899999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCCh
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 237 (245)
.+... +.....+.|||.-|.|||...+..++..+|+|++|+..||++.|.+||.+.+..+..+.|......+|+.++.
T Consensus 170 wsV~~--p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~ 247 (281)
T KOG0580|consen 170 WSVHA--PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISG 247 (281)
T ss_pred ceeec--CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccCh
Confidence 88642 2345678899999999999999999999999999999999999999999988899999999999999999999
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
+++|+|.+
T Consensus 248 ~a~dlI~~ 255 (281)
T KOG0580|consen 248 GAADLISR 255 (281)
T ss_pred hHHHHHHH
Confidence 99999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=273.75 Aligned_cols=216 Identities=33% Similarity=0.617 Sum_probs=177.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++.+.........+.+. ++..+++.++||||+++++++..++..|+||||+++|+|.++++
T Consensus 59 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~ 135 (370)
T cd05621 59 VQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW---EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135 (370)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHH---HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999999999999999754322222223333 34667778899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++.
T Consensus 136 ~~~~~~~~~~~~~~qil~aL~~LH~~~IvHr---DLKp~NI----------------------Ll~~~~~~kL~DFG~a~ 190 (370)
T cd05621 136 NYDVPEKWAKFYTAEVVLALDAIHSMGLIHR---DVKPDNM----------------------LLDKHGHLKLADFGTCM 190 (370)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHE----------------------EECCCCCEEEEecccce
Confidence 7789999999999999999999999999999 8888888 78889999999999987
Q ss_pred CCCCCCC-CCCcccCCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCCC
Q psy3347 161 EGMGFGD-RTGTFCGTPEFLAPEVLTETS----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYPR 233 (245)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p~ 233 (245)
....... .....+||+.|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+.... ..+|.
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence 5322221 223567899999999996543 6789999999999999999999999888777777776543 34554
Q ss_pred --CCChhHHhhhc
Q psy3347 234 --FLSLEAIAIMR 244 (245)
Q Consensus 234 --~~~~~~~~li~ 244 (245)
.+++.+++++.
T Consensus 271 ~~~~s~~~~~li~ 283 (370)
T cd05621 271 DVEISKHAKNLIC 283 (370)
T ss_pred cccCCHHHHHHHH
Confidence 46888888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=262.31 Aligned_cols=216 Identities=36% Similarity=0.603 Sum_probs=173.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+.............+ .+++++++.++|+||+++.+++..++..+++|||+++++|...+.
T Consensus 16 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~---~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 92 (285)
T cd05631 16 VCACQVRATGKMYACKKLEKKRIKKRKGEAMA---LNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 92 (285)
T ss_pred EEEEEEecCCceEEEEEeeHhhhhhhhhHHHH---HHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHH
Confidence 79999999999999999976533222222233 344677888999999999999999999999999999999987763
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~---dikp~Ni----------------------ll~~~~~~kl~Dfg 147 (285)
T cd05631 93 NMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR---DLKPENI----------------------LLDDRGHIRISDLG 147 (285)
T ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeC---CCCHHHE----------------------EECCCCCEEEeeCC
Confidence 2 358899999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE----EVFDSIVNDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~----~~~~~~~~~~~~~p~ 233 (245)
++..... ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .....+......++.
T Consensus 148 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 148 LAVQIPE-GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226 (285)
T ss_pred CcEEcCC-CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc
Confidence 9875322 12223456899999999999889999999999999999999999999875432 233333444456777
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++++.+||++
T Consensus 227 ~~s~~~~~li~~ 238 (285)
T cd05631 227 KFSEDAKSICRM 238 (285)
T ss_pred cCCHHHHHHHHH
Confidence 889999888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=270.43 Aligned_cols=216 Identities=38% Similarity=0.721 Sum_probs=181.5
Q ss_pred CEeEEE---ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQY---RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||++++ +.+|+.||+|++....... ....+..++++++++++||||+++++++..++..|+||||+++++|..
T Consensus 12 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 87 (318)
T cd05582 12 VFLVRKITGPDAGQLYAMKVLKKATLKV----RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 87 (318)
T ss_pred EEEEEEeccCCCCCEEEEEEEEHHHhhh----hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHH
Confidence 677766 4579999999998643211 111223345677889999999999999999999999999999999998
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
++. ...+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.++|+||
T Consensus 88 ~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kL~Df 142 (318)
T cd05582 88 RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR---DLKPENI----------------------LLDEEGHIKLTDF 142 (318)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CCCHHHe----------------------EECCCCcEEEeec
Confidence 885 4568999999999999999999999999999 8888888 7888899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~ 236 (245)
|++..............|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++
T Consensus 143 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~ 222 (318)
T cd05582 143 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLS 222 (318)
T ss_pred cCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 99875433323344567899999999998888899999999999999999999999988888888888887778899999
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
+++++||++
T Consensus 223 ~~~~~li~~ 231 (318)
T cd05582 223 PEAQSLLRA 231 (318)
T ss_pred HHHHHHHHH
Confidence 999998863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=269.29 Aligned_cols=214 Identities=33% Similarity=0.581 Sum_probs=176.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|+++............+.+ ++++++.++||||+++++++..++..|+||||+++++|.+++.
T Consensus 17 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~---e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (333)
T cd05600 17 VFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT---ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN 93 (333)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHH---HHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence 7999999999999999998653222223333443 4667788899999999999999999999999999999999985
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.|||++|++|| |++|+|| +++.++.+||+|||++
T Consensus 94 ~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kL~Dfg~a 148 (333)
T cd05600 94 NLGVLSEDHARFYMAEMFEAVDALHELGYIHR---DLKPENF----------------------LIDASGHIKLTDFGLS 148 (333)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EECCCCCEEEEeCcCC
Confidence 4 568999999999999999999999999999 8888888 7888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--cCCC----
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--RYPR---- 233 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~p~---- 233 (245)
..... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+..... ..|.
T Consensus 149 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 225 (333)
T cd05600 149 KGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225 (333)
T ss_pred ccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcc
Confidence 75322 23456789999999999888999999999999999999999999998887777666654221 1221
Q ss_pred --CCChhHHhhhcC
Q psy3347 234 --FLSLEAIAIMRR 245 (245)
Q Consensus 234 --~~~~~~~~li~~ 245 (245)
.+++++++||++
T Consensus 226 ~~~~s~~~~~li~~ 239 (333)
T cd05600 226 RFNLSDEAWDLITK 239 (333)
T ss_pred ccccCHHHHHHHHH
Confidence 458888888763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=261.92 Aligned_cols=217 Identities=37% Similarity=0.694 Sum_probs=184.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+.+.++..+|+|++.+..........+...| -++|..++||.+..++..|+.+...|++||||+||+|....+
T Consensus 93 VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE---~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrq 169 (459)
T KOG0610|consen 93 VYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTE---REILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQ 169 (459)
T ss_pred EEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHH---HHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHh
Confidence 89999999999999999998765544444444444 556778899999999999999999999999999999998885
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.+ .+++..++.++.+++.||+|||-.||++| |+||+|| ++..+|.+.|+||.
T Consensus 170 kQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYR---DLKPENI----------------------LvredGHIMLsDFD 224 (459)
T KOG0610|consen 170 KQPGKRFSESAARFYAAEVLLALEYLHMLGIVYR---DLKPENI----------------------LVREDGHIMLSDFD 224 (459)
T ss_pred hCCCCccchhhHHHHHHHHHHHHHHHHhhceeec---cCCccee----------------------EEecCCcEEeeecc
Confidence 43 58999999999999999999999999999 8888888 78888999999998
Q ss_pred CccCCC----------------------------------CCC----------------------CCCCcccCCCCcccc
Q psy3347 158 LCKEGM----------------------------------GFG----------------------DRTGTFCGTPEFLAP 181 (245)
Q Consensus 158 ~~~~~~----------------------------------~~~----------------------~~~~~~~~~~~y~aP 181 (245)
++.... ... .....++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 763110 000 112245788899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCC--CCChhHHhhhcC
Q psy3347 182 EVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSLEAIAIMRR 245 (245)
Q Consensus 182 E~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~ 245 (245)
|++.|...+.++|.|+||+.+|||+.|+.||.|.+..+.+.+|+.....+|. .++-.++|||++
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999988884 568899999974
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=272.60 Aligned_cols=217 Identities=32% Similarity=0.632 Sum_probs=177.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.............+.+ +..++..++||||+++++.+..+++.|+||||+++++|.+++.
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (360)
T cd05627 17 VRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRA---ERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93 (360)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHH---HHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH
Confidence 7999999999999999998643322333334443 4566778899999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 94 ~~~~l~~~~~~~~~~qi~~~L~~lH~~givHr---DLkp~NI----------------------li~~~~~vkL~DfG~~ 148 (360)
T cd05627 94 KKDTLSEEATQFYIAETVLAIDAIHQLGFIHR---DIKPDNL----------------------LLDAKGHVKLSDFGLC 148 (360)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc---CCCHHHE----------------------EECCCCCEEEeeccCC
Confidence 4578999999999999999999999999999 8888888 7888999999999987
Q ss_pred cCCCCCC-----------------------------------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHH
Q psy3347 160 KEGMGFG-----------------------------------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFE 204 (245)
Q Consensus 160 ~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 204 (245)
....... ......+||+.|+|||.+.+..++.++|+|||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 6321110 00123468999999999998899999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhcCc--ccCCC--CCChhHHhhhcC
Q psy3347 205 MLVGESPFPGDDEEEVFDSIVNDE--VRYPR--FLSLEAIAIMRR 245 (245)
Q Consensus 205 l~~g~~pf~~~~~~~~~~~~~~~~--~~~p~--~~~~~~~~li~~ 245 (245)
|++|+.||.+.+..+....+.... ..+|. .+++++++||.+
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 273 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR 273 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHH
Confidence 999999999888888777776532 33443 478889888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=271.55 Aligned_cols=216 Identities=34% Similarity=0.611 Sum_probs=177.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++...........+.+. ++..+++.++||||+++++.+..++..++||||+++++|..+++
T Consensus 59 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~---~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~ 135 (371)
T cd05622 59 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW---EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 135 (371)
T ss_pred EEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHH---HHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999999999999999754322222223333 34566778899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++.
T Consensus 136 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---DLkp~NI----------------------ll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 136 NYDVPEKWARFYTAEVVLALDAIHSMGFIHR---DVKPDNM----------------------LLDKSGHLKLADFGTCM 190 (371)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeC---CCCHHHE----------------------EECCCCCEEEEeCCcee
Confidence 7789999999999999999999999999999 8888888 78889999999999987
Q ss_pred CCCCCCC-CCCcccCCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCC-
Q psy3347 161 EGMGFGD-RTGTFCGTPEFLAPEVLTETS----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYP- 232 (245)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p- 232 (245)
....... .....+||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+.... ..+|
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 5432221 233557899999999996532 7789999999999999999999999888877777776543 3344
Q ss_pred -CCCChhHHhhhc
Q psy3347 233 -RFLSLEAIAIMR 244 (245)
Q Consensus 233 -~~~~~~~~~li~ 244 (245)
..++++++++|.
T Consensus 271 ~~~~s~~~~~li~ 283 (371)
T cd05622 271 DNDISKEAKNLIC 283 (371)
T ss_pred cCCCCHHHHHHHH
Confidence 357888888875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=274.15 Aligned_cols=217 Identities=34% Similarity=0.613 Sum_probs=174.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+.+ ++++++.++||||+++++.+..++..|+||||+++++|.+++.
T Consensus 17 V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~---E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~ 93 (376)
T cd05598 17 VCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93 (376)
T ss_pred EEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHH---HHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 7999999999999999997643322223333444 4677888999999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||++
T Consensus 94 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHr---Dlkp~Ni----------------------ll~~~~~ikL~DFG~a 148 (376)
T cd05598 94 RLGIFEEDLARFYIAELTCAIESVHKMGFIHR---DIKPDNI----------------------LIDRDGHIKLTDFGLC 148 (376)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC---CCCHHHE----------------------EECCCCCEEEEeCCCC
Confidence 4 567889999999999999999999999999 8888888 7888899999999987
Q ss_pred cCCCCC-------------------------------------------CCCCCcccCCCCccccccccCCCCCcchhHH
Q psy3347 160 KEGMGF-------------------------------------------GDRTGTFCGTPEFLAPEVLTETSYTRAVDWW 196 (245)
Q Consensus 160 ~~~~~~-------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 196 (245)
...... .......+|++.|+|||.+.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 421000 0001134689999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--cCC--CCCChhHHhhhcC
Q psy3347 197 GLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--RYP--RFLSLEAIAIMRR 245 (245)
Q Consensus 197 slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~p--~~~~~~~~~li~~ 245 (245)
||||++|+|++|+.||.+.+..+....+..... .+| ..+++++.++|.+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 281 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR 281 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHH
Confidence 999999999999999998887776666654322 233 3678888888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=270.10 Aligned_cols=220 Identities=40% Similarity=0.708 Sum_probs=177.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++................+.+++.....-+||||+++++++...+..++||||+.+++|..++.
T Consensus 9 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 88 (330)
T cd05586 9 VYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ 88 (330)
T ss_pred EEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH
Confidence 79999999999999999976433333333333344333322222279999999999999999999999999999988875
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||++
T Consensus 89 ~~~~~~~~~~~~~~~qil~al~~LH~~~ivHr---Dlkp~Ni----------------------li~~~~~~kl~Dfg~a 143 (330)
T cd05586 89 KEGRFSEDRAKFYIAELVLALEHLHKYDIVYR---DLKPENI----------------------LLDATGHIALCDFGLS 143 (330)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---cCCHHHe----------------------EECCCCCEEEecCCcC
Confidence 4568999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCC-CCCh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR-FLSL 237 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~-~~~~ 237 (245)
.............+|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+..+...+|. .+++
T Consensus 144 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 223 (330)
T cd05586 144 KANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD 223 (330)
T ss_pred cCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 7533333334456789999999999764 4789999999999999999999999988888888888777766664 5788
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
+++++|++
T Consensus 224 ~~~~li~~ 231 (330)
T cd05586 224 EGRQFVKG 231 (330)
T ss_pred HHHHHHHH
Confidence 88888764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.49 Aligned_cols=219 Identities=31% Similarity=0.536 Sum_probs=186.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.||+.+|+|++.+.........+.+.+| +++|+.+. ||||+.+.++|+.....++|||++.||.|.+.+
T Consensus 51 v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~E---v~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i 127 (382)
T KOG0032|consen 51 VYLCREKSTGKEVACKVIPKRKLRGKEDREDVRRE---VAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRI 127 (382)
T ss_pred EEEEEecCCCceeEEEEeehhhccccccHHHHHHH---HHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHH
Confidence 68999999999999999988765554555666666 56666776 999999999999999999999999999999888
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-CCCCceEEeecCC
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN-DTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~kl~Dfg~ 158 (245)
....+++.++..+++|++.++.|||+.|++|| |+||+|+ ++. .. +.++.++++|||+
T Consensus 128 ~~~~~sE~da~~~~~~il~av~~lH~~gvvHr---DlKpEN~-----L~~--------------~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 128 VKKHYSERDAAGIIRQILEAVKYLHSLGVVHR---DLKPENL-----LLA--------------SKDEGSGRIKLIDFGL 185 (382)
T ss_pred HHccCCHHHHHHHHHHHHHHHHHHHhCCceec---cCCHHHe-----eec--------------cccCCCCcEEEeeCCC
Confidence 54359999999999999999999999999999 6766666 322 11 1236899999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----CC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RF 234 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p----~~ 234 (245)
+..... +......+||+.|+|||.+.+.+|+..+||||+|+++|.|+.|.+||.+.+..+...++..+.+.++ +.
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 987544 5567788999999999999989999999999999999999999999999999999999999887664 45
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
++..+++++++
T Consensus 265 is~~akd~i~~ 275 (382)
T KOG0032|consen 265 ISESAKDFIRK 275 (382)
T ss_pred cCHHHHHHHHH
Confidence 68888888763
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=257.89 Aligned_cols=196 Identities=24% Similarity=0.372 Sum_probs=165.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCc-eeeeeEEEeeCC------eEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPF-LVNLFACFQTEA------HVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~n-i~~~~~~~~~~~------~~~lv~e~~~~~ 73 (245)
||+|+++.+|+.||+|+++.+... +..-.. ..|++-+++.++|+| |+++.+++...+ ..++||||+..
T Consensus 27 Vykar~~~~g~~VALKkirl~~~~-EG~P~t---aiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~- 101 (323)
T KOG0594|consen 27 VYKARSKRTGKFVALKKIRLEFEE-EGVPST---AIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR- 101 (323)
T ss_pred EEEEEEecCCCEEEEEEEeccccc-cCCCch---hhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-
Confidence 899999999999999999865321 111122 245578888999999 999999998876 78999999954
Q ss_pred chhhhhhh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 74 DLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 74 ~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
+|..++.. ..++...++.+++|++.||+|||++||+|| |+||.|| +++++
T Consensus 102 DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHR---DLKPQNl----------------------Li~~~ 156 (323)
T KOG0594|consen 102 DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHR---DLKPQNL----------------------LISSS 156 (323)
T ss_pred cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecc---cCCcceE----------------------EECCC
Confidence 89888853 247778899999999999999999999999 8888888 88889
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|.+||+|||+++...-+.......++|.+|+|||.+.+. .|+...||||+|||++||+++++.|++.++.+....|..
T Consensus 157 G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 157 GVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred CcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 999999999998543344445666789999999999986 689999999999999999999999999999888888754
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=259.26 Aligned_cols=216 Identities=50% Similarity=0.943 Sum_probs=198.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|.+++.+.+|+.||+|+++++-+.+.+++..-..|.|+ |..++||.+..+.-.|+.++..|+||||+.||.|.-.+.
T Consensus 184 VIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RV---L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs 260 (516)
T KOG0690|consen 184 VILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRV---LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS 260 (516)
T ss_pred EEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHH---HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh
Confidence 56789999999999999999888888777777667655 457789999999999999999999999999999987775
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+ ..+++.-++.+-..|+.||.|||+++|++| |+|.+|+ ++|++|.+||.|||++
T Consensus 261 rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYR---DlKLENL----------------------lLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 261 RERVFSEDRTRFYGAEIVSALGYLHSRNIVYR---DLKLENL----------------------LLDKDGHIKITDFGLC 315 (516)
T ss_pred hhhcccchhhhhhhHHHHHHhhhhhhCCeeee---echhhhh----------------------eeccCCceEeeecccc
Confidence 4 568999999999999999999999999999 7777777 8899999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+.....+....++|||+.|+|||++...-|+.++|.|.+|++||||+.|+.||...+...++..|+.....+|+.++++.
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eA 395 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEA 395 (516)
T ss_pred hhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHH
Confidence 98888888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
+.|++
T Consensus 396 ktLLs 400 (516)
T KOG0690|consen 396 KTLLS 400 (516)
T ss_pred HHHHH
Confidence 99875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=270.90 Aligned_cols=217 Identities=40% Similarity=0.731 Sum_probs=179.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|+++............+.. +.+++..++||||+++++++.++++.++||||+++++|.+++.
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 93 (350)
T cd05573 17 VWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA---ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI 93 (350)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHH---HHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHH
Confidence 7999999999999999998654333233334443 4667788899999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||++
T Consensus 94 ~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~---Dlkp~NI----------------------ll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 94 RKDVFPEETARFYIAELVLALDSVHKLGFIHR---DIKPDNI----------------------LIDADGHIKLADFGLC 148 (350)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHe----------------------EECCCCCEEeecCCCC
Confidence 4 578999999999999999999999999999 8888888 7888999999999998
Q ss_pred cCCCCCC-----------------------------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q psy3347 160 KEGMGFG-----------------------------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210 (245)
Q Consensus 160 ~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 210 (245)
....... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7543322 12334568899999999998899999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhc--CcccCCC--CCChhHHhhhcC
Q psy3347 211 PFPGDDEEEVFDSIVN--DEVRYPR--FLSLEAIAIMRR 245 (245)
Q Consensus 211 pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~ 245 (245)
||.+....+....+.. ....+|. .+++++++||++
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ 267 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR 267 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHH
Confidence 9998887777777766 3334443 358899888863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=260.10 Aligned_cols=196 Identities=26% Similarity=0.445 Sum_probs=166.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~L 75 (245)
|+.|.++.||+.||||++.... +..-..++-.|++.+|+.++|+||+.+.+++.. -+.+|+|+|+| +.+|
T Consensus 38 VcsA~~~~t~~~VAIKKi~~~F----~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL 112 (359)
T KOG0660|consen 38 VCSAKDKRTGEKVAIKKILNPF----ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDL 112 (359)
T ss_pred EEEEEEcCCCCEeehhhhhhhh----hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHH
Confidence 6889999999999999998532 222344555667888889999999999999966 24689999999 5599
Q ss_pred hhhhhhcC-CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
...++.+. ++...+..++.|++.||.|+|+.+|+|| |+||+|+ +++.+..+|||
T Consensus 113 ~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHR---DLKPsNl----------------------l~n~~c~lKI~ 167 (359)
T KOG0660|consen 113 HQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHR---DLKPSNL----------------------LLNADCDLKIC 167 (359)
T ss_pred HHHHHcCccccHHHHHHHHHHHHHhcchhhccccccc---ccchhhe----------------------eeccCCCEEec
Confidence 99998776 9999999999999999999999999999 8888888 88889999999
Q ss_pred ecCCccCCCC--CCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMG--FGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||+++...+ .....+.++.|.+|+|||.+.. ..|+.+.||||+|||++||++|++.|+|.+..+.++.+..
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 9999996432 1233567788999999999965 6799999999999999999999999999887777777654
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=261.59 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=174.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||||++..+... .+.+.+ +++.+.|+.++||||++++..|..+...|+||.||.+|++.+.++
T Consensus 42 V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l---~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik 116 (516)
T KOG0582|consen 42 VYLARCIPTNEVVAIKIINLEKCN--NDLDAL---RKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIK 116 (516)
T ss_pred eeeeeecccCCEEEEEEeehhhhh--hhHHHH---HHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHH
Confidence 799999999999999999876532 234555 455888999999999999999999999999999999999999986
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..|.+++++||.|||++|-+|| |+|+.|| +++.+|.+||+|||
T Consensus 117 ~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHR---dvKAgnI----------------------Li~~dG~VkLadFg 171 (516)
T KOG0582|consen 117 TYYPDGLEEASIATILREVLKALDYLHQNGHIHR---DVKAGNI----------------------LIDSDGTVKLADFG 171 (516)
T ss_pred HHccccccHHHHHHHHHHHHHHHHHHHhcCceec---ccccccE----------------------EEcCCCcEEEcCce
Confidence 4 468999999999999999999999999999 9999999 99999999999999
Q ss_pred CccCCCCCCCCC----CcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC
Q psy3347 158 LCKEGMGFGDRT----GTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231 (245)
Q Consensus 158 ~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (245)
.+......+... .+.+|+++|||||.+.+ ..|+.|+||||||++..||++|..||....+.+++-.-+++.++.
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 876554444432 45689999999999644 578999999999999999999999999999988877777777654
Q ss_pred C
Q psy3347 232 P 232 (245)
Q Consensus 232 p 232 (245)
|
T Consensus 252 ~ 252 (516)
T KOG0582|consen 252 L 252 (516)
T ss_pred c
Confidence 3
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=266.47 Aligned_cols=215 Identities=26% Similarity=0.493 Sum_probs=186.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCe-EEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH-VCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~ 79 (245)
++.++++..++.+++|.+.-......+. +. ..+++.+++++.||||+.+.+.|..++. .||+|+||+||++.+.+
T Consensus 20 a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~---A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i 95 (426)
T KOG0589|consen 20 ALLVRHKSDDKLYVLKKINLEKLTEPER-RS---AIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLI 95 (426)
T ss_pred hhhhhhccCCceEEEEEEeccccCchhh-HH---HHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHH
Confidence 3567888889999999998765433222 23 3455788889999999999999998887 99999999999999988
Q ss_pred hh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+. ..+++..+..|+.|++.|+.|||+++|+|| |+|++|| +..+++.++|+||
T Consensus 96 ~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHR---DlK~~Ni----------------------fltk~~~VkLgDf 150 (426)
T KOG0589|consen 96 KEQKGVLFPEERILKWFVQILLAVNYLHENRVLHR---DLKCANI----------------------FLTKDKKVKLGDF 150 (426)
T ss_pred HHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcc---cchhhhh----------------------hccccCceeecch
Confidence 53 357999999999999999999999999999 8888888 6777888999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
|+++..........+.+||+.|++||.+.+.+|+.|+|+|||||++|||.+-+++|.+.+......++..+. .+.|...
T Consensus 151 GlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y 230 (426)
T KOG0589|consen 151 GLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY 230 (426)
T ss_pred hhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc
Confidence 999976555546778899999999999999999999999999999999999999999999999999998876 5678889
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
+.+++.||+
T Consensus 231 s~el~~lv~ 239 (426)
T KOG0589|consen 231 SSELRSLVK 239 (426)
T ss_pred cHHHHHHHH
Confidence 998888774
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.87 Aligned_cols=202 Identities=28% Similarity=0.432 Sum_probs=164.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh---cCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT---MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~---~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
|.+|.|..|++.||||+++..... ......|.++++.|++ -+.-|+|+++|+|.+.+|.|||+|.+ ..+|.+
T Consensus 202 Vvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYe 276 (586)
T KOG0667|consen 202 VVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYE 276 (586)
T ss_pred eEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHH
Confidence 679999999999999999975322 2233445666666662 22349999999999999999999987 459999
Q ss_pred hhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 78 HIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 78 ~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. +++...++.++.||+.||.+||+.||+|. |+||+|| |+.. - ....+||+
T Consensus 277 llK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHc---DLKPENI-----LL~~--------------~-~r~~vKVI 333 (586)
T KOG0667|consen 277 LLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHC---DLKPENI-----LLKD--------------P-KRSRIKVI 333 (586)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---cCChhhe-----eecc--------------C-CcCceeEE
Confidence 99753 58899999999999999999999999999 6666666 3331 1 12379999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCC
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~ 233 (245)
|||+|..... ....++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|+|.++.+++..|......+|.
T Consensus 334 DFGSSc~~~q---~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 334 DFGSSCFESQ---RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ecccccccCC---cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999986322 223778899999999999999999999999999999999999999999999999998775544443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=255.10 Aligned_cols=212 Identities=18% Similarity=0.237 Sum_probs=171.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+ +|+.||+|+++..........+.+. +++..+++++||||+++++++.+ ....+++|||+.+|+|.
T Consensus 36 v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~ 110 (283)
T PHA02988 36 IYKGIF--NNKEVIIRTFKKFHKGHKVLIDITE---NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLR 110 (283)
T ss_pred EEEEEE--CCEEEEEEeccccccccHHHHHHHH---HHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHH
Confidence 678876 6999999999865322222233443 44778889999999999999876 34789999999999999
Q ss_pred hhhhh-cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA-DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++....+++.|++.||.|+|+. +++|| |++|+|+ +++.++.+||+
T Consensus 111 ~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hr---dlkp~ni----------------------ll~~~~~~kl~ 165 (283)
T PHA02988 111 EVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK---NLTSVSF----------------------LVTENYKLKII 165 (283)
T ss_pred HHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCC---cCChhhE----------------------EECCCCcEEEc
Confidence 99854 5688899999999999999999984 89999 8888888 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--cc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~ 230 (245)
|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+..+....+.... .+
T Consensus 166 dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 166 CHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242 (283)
T ss_pred ccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99998753221 223467888999999976 678999999999999999999999999888888777775543 34
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|..+++++.+||++
T Consensus 243 ~~~~~~~~l~~li~~ 257 (283)
T PHA02988 243 LPLDCPLEIKCIVEA 257 (283)
T ss_pred CCCcCcHHHHHHHHH
Confidence 566789999999864
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=265.65 Aligned_cols=215 Identities=28% Similarity=0.518 Sum_probs=186.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
|-+|+|.-||+.||||++.+..... -.-..+++| ...|+-.+|||||+++++...+-..|+++|.-.+|+|.+++
T Consensus 34 VKLArHVFTGekVAVKviDKTKlD~-~st~hlfqE---VRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyIm 109 (864)
T KOG4717|consen 34 VKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQE---VRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIM 109 (864)
T ss_pred hhhhhhhcccceeEEEEecccccch-hhhhHHHHH---HHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHH
Confidence 3468999999999999999876433 233445555 56677789999999999999999999999998899999998
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
+ ...+++..+++++.||+.|+.|||+..++|| |+||+|+ ++..+-|-+||.|||+
T Consensus 110 KHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHR---DLKPENV---------------------VFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 110 KHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHR---DLKPENV---------------------VFFEKLGLVKLTDFGF 165 (864)
T ss_pred hhhccccHHHHHHHHHHHHHHHHHHhhhhhhcc---cCCccee---------------------EEeeecCceEeeeccc
Confidence 3 4579999999999999999999999999999 6666666 3455668999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCCh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 237 (245)
+..+ .++.+..+.||+..|-|||++.|..|+ +++||||||+|+|-++.|.+||...+..+.+..|+.+.+..|+.++.
T Consensus 166 SNkf-~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~ 244 (864)
T KOG4717|consen 166 SNKF-QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSK 244 (864)
T ss_pred cccC-CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhH
Confidence 8653 345567889999999999999999987 78999999999999999999999988899999999999999999999
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
+++|||+
T Consensus 245 eCrdLI~ 251 (864)
T KOG4717|consen 245 ECRDLIQ 251 (864)
T ss_pred HHHHHHH
Confidence 9999986
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=248.23 Aligned_cols=217 Identities=24% Similarity=0.493 Sum_probs=181.2
Q ss_pred eEEEecCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 3 LSQYRNTGEYFAIKALKKGDI--IARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 3 ~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
++.++.||+.+|+|++.-... +.....+....-.++..+|+++ .||+|+.+.|+|+.+.++++|+|.|+.|-|.+++
T Consensus 35 Rci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL 114 (411)
T KOG0599|consen 35 RCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL 114 (411)
T ss_pred hhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh
Confidence 467889999999999874321 1112222222235567777766 7999999999999999999999999999999999
Q ss_pred hhc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
... .+++...++|++|+++|+.|||.++|+|| |+||+|| ++|.+.+++|+|||+
T Consensus 115 ts~VtlSEK~tR~iMrqlfegVeylHa~~IVHR---DLKpENI----------------------Llddn~~i~isDFGF 169 (411)
T KOG0599|consen 115 TSKVTLSEKETRRIMRQLFEGVEYLHARNIVHR---DLKPENI----------------------LLDDNMNIKISDFGF 169 (411)
T ss_pred hhheeecHHHHHHHHHHHHHHHHHHHHhhhhhc---ccChhhe----------------------eeccccceEEeccce
Confidence 654 68999999999999999999999999999 8889898 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC-
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE------TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY- 231 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 231 (245)
+.. ...+++....|||+.|+|||.+.. ..|+...|+|++|+|||.++.|.+||.-+...-.+..|..+.+.+
T Consensus 170 a~~-l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 170 ACQ-LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred eec-cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 986 445667888999999999999953 357889999999999999999999998877777778888888876
Q ss_pred -C--CCCChhHHhhhcC
Q psy3347 232 -P--RFLSLEAIAIMRR 245 (245)
Q Consensus 232 -p--~~~~~~~~~li~~ 245 (245)
| ...+.+.+|||+|
T Consensus 249 speWadis~~~KdLIsr 265 (411)
T KOG0599|consen 249 SPEWADISATVKDLISR 265 (411)
T ss_pred CcchhhccccHHHHHHH
Confidence 3 4678889999875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=270.25 Aligned_cols=214 Identities=27% Similarity=0.418 Sum_probs=184.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..|++.||||++.-+. ...+++++.+| +..+..++++||.++++.|..+...+++||||.||++.+.++
T Consensus 29 Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqe---i~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~ 103 (467)
T KOG0201|consen 29 VYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQE---ISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK 103 (467)
T ss_pred eeeeeeccccceEEEEEechhh--cchhhHHHHHH---HHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc
Confidence 8999999999999999998653 34455666555 777889999999999999999999999999999999999998
Q ss_pred hcCC-ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 ADVF-SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~~l-~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+ .+..+.-++++++.|+.|+|..+.+|| |||++|| ++..+|.+|++|||.+
T Consensus 104 ~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHr---DIKaani----------------------l~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 104 SGNILDEFEIAVILREVLKGLDYLHSEKKIHR---DIKAANI----------------------LLSESGDVKLADFGVA 158 (467)
T ss_pred cCCCCccceeeeehHHHHHHhhhhhhcceecc---cccccce----------------------eEeccCcEEEEeccee
Confidence 7665 888888999999999999999999999 8888777 6666799999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-CCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~p~~~~~~ 238 (245)
...........+++||+.|||||++.+..|+.+|||||||++.+||++|.+|+....++.++..|-...++ ....+++.
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~ 238 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPP 238 (467)
T ss_pred eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHH
Confidence 87777777778999999999999999889999999999999999999999999988886666555444333 34577888
Q ss_pred HHhhhc
Q psy3347 239 AIAIMR 244 (245)
Q Consensus 239 ~~~li~ 244 (245)
+++||+
T Consensus 239 ~kEFV~ 244 (467)
T KOG0201|consen 239 FKEFVE 244 (467)
T ss_pred HHHHHH
Confidence 888874
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.81 Aligned_cols=217 Identities=31% Similarity=0.586 Sum_probs=174.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++.+...........+. ++..++..++|+||+++++++..++..|+||||+.+|+|..++.
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~ 93 (331)
T cd05624 17 VAVVKMKHTERIYAMKILNKWEMLKRAETACFR---EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLS 93 (331)
T ss_pred EEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHH---HHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 799999999999999999754322222222333 33566778899999999999999999999999999999999985
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 94 ~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHr---Dlkp~Ni----------------------ll~~~~~~kl~DfG~ 148 (331)
T cd05624 94 KFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHR---DIKPDNV----------------------LLDMNGHIRLADFGS 148 (331)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---cCchHHE----------------------EEcCCCCEEEEeccc
Confidence 4 568999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--c
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--R 230 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~ 230 (245)
+........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+..... +
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 149 CLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ 228 (331)
T ss_pred eeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc
Confidence 875433222 1233568999999999865 4578899999999999999999999998887777777765432 3
Q ss_pred CCC---CCChhHHhhhcC
Q psy3347 231 YPR---FLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~---~~~~~~~~li~~ 245 (245)
+|. .++++++++|++
T Consensus 229 ~p~~~~~~~~~~~~li~~ 246 (331)
T cd05624 229 FPSHITDVSEEAKDLIQR 246 (331)
T ss_pred CCCccccCCHHHHHHHHH
Confidence 343 468889988853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=253.96 Aligned_cols=216 Identities=37% Similarity=0.605 Sum_probs=173.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|++.............+. +++++++.++||||+++++.+..+++.+++|||+++++|..++.
T Consensus 16 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 92 (285)
T cd05605 16 VCACQVRATGKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred EEEEEEcCCCceEEEEEEehhhhhhhhhHHHHH---HHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHH
Confidence 799999999999999999764322222222233 34677888999999999999999999999999999999987773
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~~l~Dfg 147 (285)
T cd05605 93 NMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR---DLKPENI----------------------LLDDYGHIRISDLG 147 (285)
T ss_pred hcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec---CCCHHHE----------------------EECCCCCEEEeeCC
Confidence 2 358999999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV----FDSIVNDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~----~~~~~~~~~~~p~ 233 (245)
++..... ........|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+...... ...+......+|.
T Consensus 148 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05605 148 LAVEIPE-GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE 226 (285)
T ss_pred CceecCC-CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc
Confidence 9875322 2222334688899999999888899999999999999999999999987655332 2333344445677
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++.+++||++
T Consensus 227 ~~~~~~~~li~~ 238 (285)
T cd05605 227 KFSEAARSICRQ 238 (285)
T ss_pred ccCHHHHHHHHH
Confidence 789999888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=259.59 Aligned_cols=217 Identities=33% Similarity=0.631 Sum_probs=173.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++.+.........+.+.+| ..++..++|+||+++++++..+++.|+||||+.+++|..++.
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e---~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (331)
T cd05597 17 VAVVKMKNTGQVYAMKILNKWEMLKRAETACFREE---RDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLS 93 (331)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHH---HHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHH
Confidence 79999999999999999975432222333334443 556677899999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kl~Dfg~ 148 (331)
T cd05597 94 KFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHR---DIKPDNV----------------------LLDKNGHIRLADFGS 148 (331)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEC---CCCHHHE----------------------EECCCCCEEEEECCc
Confidence 4 468999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--c
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--R 230 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~ 230 (245)
+........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 149 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 149 CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ 228 (331)
T ss_pred eeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence 865332222 1223468999999999963 3577899999999999999999999988877777666654332 2
Q ss_pred CC---CCCChhHHhhhcC
Q psy3347 231 YP---RFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p---~~~~~~~~~li~~ 245 (245)
+| ..++++++++|++
T Consensus 229 ~~~~~~~~~~~~~~li~~ 246 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRR 246 (331)
T ss_pred CCCccCCCCHHHHHHHHH
Confidence 33 3478888888863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=269.62 Aligned_cols=214 Identities=24% Similarity=0.451 Sum_probs=177.5
Q ss_pred CEeEEEecC-CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNT-GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.+..+ ++.||+|.+... .......+ .+++++++.++||||+++++++..+++.|+||||+++|+|.+++
T Consensus 83 vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~---~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l 156 (478)
T PTZ00267 83 AFVATRGSDPKEKVVAKFVMLN---DERQAAYA---RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI 156 (478)
T ss_pred EEEEEEcCCCCeEEEEEEcccC---CHHHHHHH---HHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHH
Confidence 689988887 788999977543 22222233 34577888999999999999999999999999999999998876
Q ss_pred hh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 80 HA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 80 ~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+. .++++..+..++.|++.||.|||++||+|| |+||+|| +++.++.+||+
T Consensus 157 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kL~ 211 (478)
T PTZ00267 157 KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR---DLKSANI----------------------FLMPTGIIKLG 211 (478)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEEC---CcCHHhE----------------------EECCCCcEEEE
Confidence 42 358889999999999999999999999999 8888888 78888999999
Q ss_pred ecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cC
Q psy3347 155 DFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RY 231 (245)
Q Consensus 155 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~ 231 (245)
|||+++....... .....+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..+.. ++
T Consensus 212 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291 (478)
T ss_pred eCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999875432211 23455789999999999888899999999999999999999999998888888888776654 46
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|..++++++++|++
T Consensus 292 ~~~~s~~~~~li~~ 305 (478)
T PTZ00267 292 PCPVSSGMKALLDP 305 (478)
T ss_pred CccCCHHHHHHHHH
Confidence 77899999998863
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=259.93 Aligned_cols=217 Identities=32% Similarity=0.612 Sum_probs=175.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.+|+|++.+...........+.. +..++..++|+||+++++++...++.++||||+.+|+|.++++
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~ 93 (332)
T cd05623 17 VAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLS 93 (332)
T ss_pred EEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHH---HHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHH
Confidence 7999999999999999997533222222233333 3566778899999999999999999999999999999999986
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 94 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHr---Dlkp~Ni----------------------li~~~~~~kL~DfG~ 148 (332)
T cd05623 94 KFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR---DIKPDNI----------------------LMDMNGHIRLADFGS 148 (332)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCHHHE----------------------EECCCCCEEEeecch
Confidence 4 468999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--c
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--R 230 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~ 230 (245)
+........ .....+|+..|+|||.+. ...++.++|||||||++|||++|+.||.+.+..+....+..... +
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 149 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 228 (332)
T ss_pred heecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc
Confidence 865332222 223457899999999986 24578899999999999999999999998888888887766543 2
Q ss_pred CC---CCCChhHHhhhcC
Q psy3347 231 YP---RFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p---~~~~~~~~~li~~ 245 (245)
+| ..+++++++||++
T Consensus 229 ~p~~~~~~s~~~~~li~~ 246 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRR 246 (332)
T ss_pred CCCccccCCHHHHHHHHH
Confidence 33 3578999998864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=252.36 Aligned_cols=193 Identities=24% Similarity=0.439 Sum_probs=157.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|+++.... ......+. +++++++.++||||+++++++..++..++||||+.+ +|..++.
T Consensus 21 Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 94 (288)
T cd07871 21 VFKGRSKLTENLVALKEIRLEHE--EGAPCTAI---REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD 94 (288)
T ss_pred EEEEEECCCCCEEEEEEeccccc--CCcchhHH---HHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHH
Confidence 79999999999999999975421 11122333 446778889999999999999999999999999975 8887774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~DfG~ 149 (288)
T cd07871 95 NCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR---DLKPQNL----------------------LINEKGELKLADFGL 149 (288)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EECCCCCEEECcCcc
Confidence 3 347888999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+..............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8753322223344567889999999865 56889999999999999999999999887766655544
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=250.58 Aligned_cols=214 Identities=44% Similarity=0.886 Sum_probs=181.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|++...........+.+. +++++++.++||||+++++++..++..+++|||+++++|.+++.
T Consensus 17 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 93 (290)
T cd05580 17 VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL---NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR 93 (290)
T ss_pred EEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHH---HHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH
Confidence 689999999999999999865433333334444 44777888999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 94 ~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~---dl~p~ni----------------------li~~~~~~kl~dfg~~ 148 (290)
T cd05580 94 KSGRFPEPVARFYAAQVVLALEYLHSLDIVYR---DLKPENL----------------------LLDSDGYIKITDFGFA 148 (290)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CCCHHHE----------------------EECCCCCEEEeeCCCc
Confidence 4568999999999999999999999999999 8888888 7888899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..+.+..+...+|..+++.+
T Consensus 149 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 225 (290)
T cd05580 149 KRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDA 225 (290)
T ss_pred cccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHH
Confidence 754322 33456788999999998888889999999999999999999999888777777777777777888889999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 226 ~~li~~ 231 (290)
T cd05580 226 KDLIRN 231 (290)
T ss_pred HHHHHH
Confidence 998864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=271.54 Aligned_cols=203 Identities=26% Similarity=0.456 Sum_probs=166.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+.. ++.||||+++.- .| -.++.|++++||||+.+.|+|+...-+||+||||..|-|...++
T Consensus 140 VF~Grl~--netVAVKKV~el------------kE-TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk 204 (904)
T KOG4721|consen 140 VFLGRLH--NETVAVKKVREL------------KE-TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK 204 (904)
T ss_pred eeeeecc--CceehhHHHhhh------------hh-hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh
Confidence 6777665 889999988631 11 12678899999999999999999999999999999999999997
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. .++.....+.|..+|+.||.|||.+.|+|| |+|.-|| ++..+..+||+|||.+
T Consensus 205 a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHR---DLKSPNi----------------------LIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 205 AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHR---DLKSPNI----------------------LISYDDVVKISDFGTS 259 (904)
T ss_pred ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhh---ccCCCce----------------------EeeccceEEeccccch
Confidence 5 468888899999999999999999999999 4444444 6666778999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cccCCCCCCh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSL 237 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~p~~~~~ 237 (245)
+..... .....++||..|||||++..++.+.|+||||||+++|||+||+.||...+...+.--+-.. ..+.|+.||+
T Consensus 260 ~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 260 KELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred Hhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence 753332 3345678999999999999999999999999999999999999999877664443333222 3357899999
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
.++-||+
T Consensus 339 GfklL~K 345 (904)
T KOG4721|consen 339 GFKLLLK 345 (904)
T ss_pred HHHHHHH
Confidence 9988876
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=255.35 Aligned_cols=188 Identities=28% Similarity=0.479 Sum_probs=156.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L 75 (245)
||.|...++++.||||++-...... .+|+++|+.++||||+++.-+|.... ...+||||++. +|
T Consensus 40 Vyq~~~~e~~~~vAIKKv~~d~r~k----------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL 108 (364)
T KOG0658|consen 40 VYQAKLRETEEEVAIKKVLQDKRYK----------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TL 108 (364)
T ss_pred EEEEEEcCCCceeEEEEecCCCCcC----------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HH
Confidence 7999999999999999886543221 24577888999999999999986543 34699999987 88
Q ss_pred hhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-C
Q psy3347 76 MMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-G 149 (245)
Q Consensus 76 ~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 149 (245)
..+++ +..++.-.++-++.|+++||.|||+.||+|| ||||.|| ++|.+ |
T Consensus 109 ~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHR---DIKPqNl----------------------LvD~~tg 163 (364)
T KOG0658|consen 109 YRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHR---DIKPQNL----------------------LVDPDTG 163 (364)
T ss_pred HHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccC---CCChheE----------------------EEcCCCC
Confidence 77776 3568888899999999999999999999999 8888888 66665 9
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
.+||||||.|+... .++.+..+..|..|+|||.+.|. .|+.+.||||.||+++||+-|.+.|+|.+..+++..|.
T Consensus 164 ~LKicDFGSAK~L~-~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi 239 (364)
T KOG0658|consen 164 VLKICDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII 239 (364)
T ss_pred eEEeccCCcceeec-cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH
Confidence 99999999998643 33445666779999999999885 69999999999999999999999999998877766654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=248.73 Aligned_cols=216 Identities=32% Similarity=0.572 Sum_probs=169.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|.+............... .++++++.++||||+++.+++..+++.+++|||+++++|..++.
T Consensus 9 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~---~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~ 85 (277)
T cd05607 9 VCAVQVKNTGKMYACKKLDKKRLKKKSGEKMAL---LEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIY 85 (277)
T ss_pred EEEEEEccCCcEEEEEEEcHHHhhcchhhHHHH---HHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHH
Confidence 799999999999999999754322211222222 34677888999999999999999999999999999999987774
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---dikp~Ni----------------------li~~~~~~~l~Dfg 140 (277)
T cd05607 86 NVGERGLEMERVIHYSAQITCGILHLHSMDIVYR---DMKPENV----------------------LLDDQGNCRLSDLG 140 (277)
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEc---cCChHhE----------------------EEcCCCCEEEeece
Confidence 3 357888899999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCcccC-C
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRY-P 232 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~-p 232 (245)
++....... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .+............ .
T Consensus 141 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd05607 141 LAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH 219 (277)
T ss_pred eeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc
Confidence 887533221 22334678899999999888899999999999999999999999975432 23333333333333 2
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 220 ~~~~~~~~~li~~ 232 (277)
T cd05607 220 QNFTEESKDICRL 232 (277)
T ss_pred ccCCHHHHHHHHH
Confidence 5688899988864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=250.89 Aligned_cols=193 Identities=23% Similarity=0.405 Sum_probs=158.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|+++.... .....+.+. +++++++.++||||+++++++..++..++||||++++++..+..
T Consensus 17 v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 92 (287)
T cd07848 17 VLKCRHKETKEIVAIKKFKDSEE-NEEVKETTL---RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE 92 (287)
T ss_pred EEEEEECCCCcEEEEEEEecccc-cccchhhHH---HHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh
Confidence 79999999999999999976422 122223333 44777889999999999999999999999999999877765554
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~---dlkp~Ni----------------------ll~~~~~~kl~Dfg~~ 147 (287)
T cd07848 93 MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR---DIKPENL----------------------LISHNDVLKLCDFGFA 147 (287)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EEcCCCcEEEeeccCc
Confidence 3468899999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy3347 160 KEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD 222 (245)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~ 222 (245)
....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 7542221 12234568889999999988889999999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=255.35 Aligned_cols=217 Identities=39% Similarity=0.718 Sum_probs=171.8
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccch-hhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIAR-DEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+|+.||+|++.+...... ...+.+. +++++++.+ +||||+++++++..++..+++|||+.+++|
T Consensus 16 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 92 (332)
T cd05614 16 VFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR---TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM 92 (332)
T ss_pred EEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHH---HHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcH
Confidence 6777664 5799999999976432211 1222333 345566666 599999999999999999999999999999
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
.+++. +..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr---Dlkp~Ni----------------------li~~~~~~kl~ 147 (332)
T cd05614 93 FTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYR---DIKLENI----------------------LLDSEGHVVLT 147 (332)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec---CCCHHHe----------------------EECCCCCEEEe
Confidence 88884 4578999999999999999999999999999 8888888 78888999999
Q ss_pred ecCCccCCCCCC-CCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCc
Q psy3347 155 DFGLCKEGMGFG-DRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVNDE 228 (245)
Q Consensus 155 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~~~ 228 (245)
|||+++...... ......+|+..|+|||.+.+. .++.++|||||||++|+|++|+.||... ........+....
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 227 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC
Confidence 999987532222 223345789999999999765 4788999999999999999999999642 3344555566666
Q ss_pred ccCCCCCChhHHhhhcC
Q psy3347 229 VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~~ 245 (245)
.++|..++++++++|++
T Consensus 228 ~~~~~~~~~~~~~li~~ 244 (332)
T cd05614 228 PPFPSFIGPEAQDLLHK 244 (332)
T ss_pred CCCCCCCCHHHHHHHHH
Confidence 77788899999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=260.03 Aligned_cols=216 Identities=31% Similarity=0.588 Sum_probs=175.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++.......+..+.+.+ +..+++.++||||+++++++...+..++||||+++++|.++++
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 93 (330)
T cd05601 17 VQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93 (330)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHH---HHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHH
Confidence 7999999999999999998654322233333333 4566778899999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|| |++|+|| +++.++.+||+|||+
T Consensus 94 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~---Dlkp~NI----------------------ll~~~~~~kL~Dfg~ 148 (330)
T cd05601 94 RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR---DIKPENV----------------------LIDRTGHIKLADFGS 148 (330)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc---cCchHhe----------------------EECCCCCEEeccCCC
Confidence 4 478999999999999999999999999999 8888888 788899999999999
Q ss_pred ccCCCCCCCC-CCcccCCCCcccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--c
Q psy3347 159 CKEGMGFGDR-TGTFCGTPEFLAPEVLT------ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--V 229 (245)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~ 229 (245)
+......... .....|+..|+|||.+. ...++.++|||||||++|+|++|+.||...+..+....+.... .
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred CeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 8754332221 22346889999999986 3557789999999999999999999998888777777776543 2
Q ss_pred cCC--CCCChhHHhhhc
Q psy3347 230 RYP--RFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p--~~~~~~~~~li~ 244 (245)
.+| ..+++++++||+
T Consensus 229 ~~~~~~~~~~~~~~li~ 245 (330)
T cd05601 229 KFPEDPKVSSDFLDLIQ 245 (330)
T ss_pred CCCCCCCCCHHHHHHHH
Confidence 234 357888888875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.53 Aligned_cols=215 Identities=31% Similarity=0.554 Sum_probs=190.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|.+|++..||..||||.+.++... ....+.+ .++++.|+.++||||++++.+...+...|+||||+.+|.+.+++.
T Consensus 72 V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~---~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~ 147 (596)
T KOG0586|consen 72 VKLARHILTGTEVAIKIIDKTQLN-PSKRQKL---GREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV 147 (596)
T ss_pred EEeeEecCCCceEEEEEehhcccC-hHHHHHH---HHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH
Confidence 678999999999999999986533 2233334 455788889999999999999999999999999999999999984
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+...+..+..++.|++.|++|||+++|+|| |+|.+|| +++.+.++||+|||++
T Consensus 148 ~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHr---dLk~eNi----------------------lL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 148 KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHR---DLKAENI----------------------LLDENMNIKIADFGFS 202 (596)
T ss_pred hcccchhhhhhhhhHHHHHHHHHHhhcceecc---ccchhhc----------------------ccccccceeeeccccc
Confidence 5678889999999999999999999999999 8888888 7888889999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
.++. ......+++|++.|.|||.+.+..| ++.+|+||+|+++|.|+.|..||.+.+-.+....++.+..++|-.++-+
T Consensus 203 ~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~d 281 (596)
T KOG0586|consen 203 TFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCD 281 (596)
T ss_pred eeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeech
Confidence 8654 4556778899999999999999887 5789999999999999999999999999999999999999999999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||+|
T Consensus 282 ce~lLrk 288 (596)
T KOG0586|consen 282 CEDLLRK 288 (596)
T ss_pred hHHHHHH
Confidence 9999874
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=273.69 Aligned_cols=206 Identities=24% Similarity=0.427 Sum_probs=171.6
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc------
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD------ 82 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------ 82 (245)
+...||||.++... ..+..++|.+| ++++..++|||||+++|+|..++..|+|||||..|+|.+|++..
T Consensus 515 ~~~lVAVK~LKd~a--~~~~~~dF~RE---aeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~ 589 (774)
T KOG1026|consen 515 DEQLVAVKALKDKA--ENQARQDFRRE---AELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADK 589 (774)
T ss_pred cceehhHhhhcccc--cHHHHHHHHHH---HHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCcccc
Confidence 45689999998653 33345566554 88899999999999999999999999999999999999999521
Q ss_pred -----C----CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 83 -----V----FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 83 -----~----l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
. ++..+.+.|+.||+.||.||-++.++||||. .+.+++..+..|||
T Consensus 590 ~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLA-------------------------TRNCLVge~l~VKI 644 (774)
T KOG1026|consen 590 LASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLA-------------------------TRNCLVGENLVVKI 644 (774)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchh-------------------------hhhceeccceEEEe
Confidence 2 7788999999999999999999999999443 23347778889999
Q ss_pred eecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-
Q psy3347 154 ADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV- 229 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~- 229 (245)
+|||+++...+... ......-+.+|||||.+..+.|+.++||||||+++||+++ |+.||.+.++.++.+.+..++.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL 724 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence 99999985322211 1112233679999999999999999999999999999998 9999999999999999988765
Q ss_pred cCCCCCChhHHhhhc
Q psy3347 230 RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~~~~~~~~~li~ 244 (245)
+-|+.||+++.+||.
T Consensus 725 ~~Pe~CP~~vY~LM~ 739 (774)
T KOG1026|consen 725 SCPENCPTEVYSLML 739 (774)
T ss_pred cCCCCCCHHHHHHHH
Confidence 568999999999996
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=245.79 Aligned_cols=218 Identities=31% Similarity=0.563 Sum_probs=174.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|.+................+..+++.++..+||||+++.+++...+..++||||+.+++|..++.
T Consensus 10 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~ 89 (278)
T cd05606 10 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 89 (278)
T ss_pred EEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH
Confidence 79999999999999999986543322222334445555666777789999999999999999999999999999988884
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..++.++.|++.||.|||+++++|+ |++|+|| +++.++.++|+|||++
T Consensus 90 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~---di~p~ni----------------------li~~~~~~kl~dfg~~ 144 (278)
T cd05606 90 QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR---DLKPANI----------------------LLDEHGHVRISDLGLA 144 (278)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC---CCCHHHE----------------------EECCCCCEEEccCcCc
Confidence 4568999999999999999999999999999 8888888 7788899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCcccCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFDSIVNDEVRYPRFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~---~~~~~~~~~~~~~~~~p~~~ 235 (245)
...... ......|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+. ...............+|..+
T Consensus 145 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (278)
T cd05606 145 CDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222 (278)
T ss_pred cccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcC
Confidence 743222 22344688899999999754 6889999999999999999999999765 33333333444455677778
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+++++
T Consensus 223 s~~~~~li~~ 232 (278)
T cd05606 223 SPELRSLLEG 232 (278)
T ss_pred CHHHHHHHHH
Confidence 8888888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=273.94 Aligned_cols=214 Identities=30% Similarity=0.469 Sum_probs=178.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||-|+|..|+...|||-+... ..+..+-+..| +.+-++++|.|||+++|.+..+|++-+.||-.+||+|...++
T Consensus 591 VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEE---IaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLr 664 (1226)
T KOG4279|consen 591 VYAARDMDTQVRIAIKEIPEK---DSREVQPLHEE---IALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLR 664 (1226)
T ss_pred EEeeccccceeEEEeeecccc---cchhhccHHHH---HHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHH
Confidence 799999999999999999754 23333444333 677789999999999999999999999999999999999996
Q ss_pred h--cCC--ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 81 A--DVF--SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 81 ~--~~l--~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
. +++ ++.....+.+||++||.|||++.|+|| |||-+|+++. .-.|.+||+||
T Consensus 665 skWGPlKDNEstm~fYtkQILeGLkYLHen~IVHR--------DIKGDNVLvN----------------TySGvlKISDF 720 (1226)
T KOG4279|consen 665 SKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHR--------DIKGDNVLVN----------------TYSGVLKISDF 720 (1226)
T ss_pred hccCCCccchhHHHHHHHHHHHHhhhhhhcceeec--------cccCCcEEEe----------------eccceEEeccc
Confidence 5 577 788899999999999999999999999 5666665544 33689999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH--hcCcccC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSI--VNDEVRY 231 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~pf~~~-~~~~~~~~~--~~~~~~~ 231 (245)
|.++..-.......++.||..|||||++..+ .|++++|||||||++.||.||++||... ++..++-++ ....+++
T Consensus 721 GTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~i 800 (1226)
T KOG4279|consen 721 GTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPI 800 (1226)
T ss_pred ccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCC
Confidence 9998777777778899999999999999764 5899999999999999999999999643 334444443 4556788
Q ss_pred CCCCChhHHhhhc
Q psy3347 232 PRFLSLEAIAIMR 244 (245)
Q Consensus 232 p~~~~~~~~~li~ 244 (245)
|++++.+++.+|-
T Consensus 801 Peelsaeak~Fil 813 (1226)
T KOG4279|consen 801 PEELSAEAKNFIL 813 (1226)
T ss_pred cHHHHHHHHHHHH
Confidence 9999999998874
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=239.71 Aligned_cols=219 Identities=24% Similarity=0.452 Sum_probs=174.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|++||+|.+....... ..........++++.++.++||||+++++++..+...++++||+++++|.+++.
T Consensus 18 vy~~~~~~~~~~~~lk~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 96 (263)
T cd06625 18 VYLCYDVDTGRELAVKQVPFDPDSP-ETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK 96 (263)
T ss_pred EEEEEEcCCCcEEEEEEEeecccch-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH
Confidence 6899999999999999987543221 111222233445778889999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|+|||++
T Consensus 97 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~---dl~p~ni----------------------lv~~~~~~~l~dfg~~ 151 (263)
T cd06625 97 AYGALTETVTRKYTRQILEGVEYLHSNMIVHR---DIKGANI----------------------LRDSAGNVKLGDFGAS 151 (263)
T ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEeecccc
Confidence 4568899999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCC---CcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cccCCCC
Q psy3347 160 KEGMGFGDRT---GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EVRYPRF 234 (245)
Q Consensus 160 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~p~~ 234 (245)
.......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+... ....|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCcc
Confidence 6432211111 2345678899999999888999999999999999999999999776665554444433 3346778
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.++|++
T Consensus 232 ~~~~~~~li~~ 242 (263)
T cd06625 232 VSPDARNFLRR 242 (263)
T ss_pred CCHHHHHHHHH
Confidence 89999888863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=241.03 Aligned_cols=216 Identities=38% Similarity=0.777 Sum_probs=179.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|++...........+.+.+| ++.++.++||||+++++.+..++..+++|||+++++|.+++.
T Consensus 9 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 85 (262)
T cd05572 9 VELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSE---KEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR 85 (262)
T ss_pred EEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHH---HHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHh
Confidence 69999999999999999986544433344445444 667788899999999999999999999999999999999985
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.|+|++|++|+ |++|+|| +++.++.++|+|||.+
T Consensus 86 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~---dl~~~ni----------------------lv~~~~~~~l~df~~~ 140 (262)
T cd05572 86 DRGLFDEYTARFYIACVVLAFEYLHNRGIIYR---DLKPENL----------------------LLDSNGYVKLVDFGFA 140 (262)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccC---CCCHHHE----------------------EEcCCCCEEEeeCCcc
Confidence 4 467889999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh--cCcccCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD--EEEVFDSIV--NDEVRYPRFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~--~~~~~~~~~--~~~~~~p~~~ 235 (245)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+. .....+|..+
T Consensus 141 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (262)
T cd05572 141 KKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYI 219 (262)
T ss_pred cccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCccc
Confidence 7543322 2334467888999999988888999999999999999999999997766 666667666 3455677778
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
+++++++|++
T Consensus 220 ~~~~~~~i~~ 229 (262)
T cd05572 220 DKAAKDLIKQ 229 (262)
T ss_pred CHHHHHHHHH
Confidence 8899888863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=262.40 Aligned_cols=216 Identities=28% Similarity=0.463 Sum_probs=176.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--------eEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--------HVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--------~~~lv~e~~~~ 72 (245)
||+|++..+|+.||+|++...... ..... +..+++..+..++|+|++++.+.+...+ ..++||||+.+
T Consensus 48 Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~---~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~ 123 (496)
T PTZ00283 48 VLCAKRVSDGEPFAVKVVDMEGMS-EADKN---RAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANA 123 (496)
T ss_pred EEEEEEcCCCCEEEEEEEecccCC-HHHHH---HHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCC
Confidence 799999999999999999765322 22222 3344577788899999999998775432 47899999999
Q ss_pred Cchhhhhhh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 73 GDLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 73 ~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
|+|.++++. ..+++..+..++.|++.||.|+|++||+|| |+||+|| +++.
T Consensus 124 gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr---DLKP~NI----------------------Ll~~ 178 (496)
T PTZ00283 124 GDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR---DIKSANI----------------------LLCS 178 (496)
T ss_pred CcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EEeC
Confidence 999988753 358899999999999999999999999999 8888888 7888
Q ss_pred CCceEEeecCCccCCCCC--CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 148 EGYVKIADFGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++.+||+|||+++..... .......+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 899999999998753221 122345678999999999998889999999999999999999999999888888877777
Q ss_pred cCcc-cCCCCCChhHHhhhcC
Q psy3347 226 NDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 226 ~~~~-~~p~~~~~~~~~li~~ 245 (245)
.+.. +.|..+++++.++|++
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~ 279 (496)
T PTZ00283 259 AGRYDPLPPSISPEMQEIVTA 279 (496)
T ss_pred cCCCCCCCCCCCHHHHHHHHH
Confidence 6544 4678899999988763
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.25 Aligned_cols=216 Identities=26% Similarity=0.441 Sum_probs=174.6
Q ss_pred CEeEEEecCCc---E-EEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGE---Y-FAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|+.+..+. . ||+|..+.+.....++...+.+| +++|+.++||||++++|+...+..+++|||+|.||+|.
T Consensus 173 V~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~E---ArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~ 249 (474)
T KOG0194|consen 173 VFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKE---ARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLD 249 (474)
T ss_pred EEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHH---HHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHH
Confidence 68887776422 3 89999987544555666666666 66678899999999999999999999999999999999
Q ss_pred hhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++++.. .++..+..+++.+.+.||+|||+++++|| ||=..|+ ++..++.+||+
T Consensus 250 ~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHR--------DIAARNc-----------------L~~~~~~vKIS 304 (474)
T KOG0194|consen 250 DYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHR--------DIAARNC-----------------LYSKKGVVKIS 304 (474)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcch--------hHhHHHh-----------------eecCCCeEEeC
Confidence 999654 49999999999999999999999999999 5544444 55566778999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCccc--C
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVR--Y 231 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~--~ 231 (245)
|||+++............--+.+|+|||.+....|+.++||||||+++||+++ |..||++....++...|.....+ +
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 99999854322221211123678999999998899999999999999999998 89999999999999999665544 5
Q ss_pred CCCCChhHHhhhc
Q psy3347 232 PRFLSLEAIAIMR 244 (245)
Q Consensus 232 p~~~~~~~~~li~ 244 (245)
|...++++..++.
T Consensus 385 ~~~~p~~~~~~~~ 397 (474)
T KOG0194|consen 385 PSKTPKELAKVMK 397 (474)
T ss_pred CCCCHHHHHHHHH
Confidence 6777777777764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=241.68 Aligned_cols=218 Identities=31% Similarity=0.578 Sum_probs=171.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.+|+|.+...............++...+.++...+||||+.+.+.+..++..++||||+.+++|..++.
T Consensus 10 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 89 (279)
T cd05633 10 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 89 (279)
T ss_pred EEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH
Confidence 79999999999999999976543322222333444444556666789999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.++++|||++
T Consensus 90 ~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~---dikp~Ni----------------------l~~~~~~~~l~dfg~~ 144 (279)
T cd05633 90 QHGVFSEKEMRFYATEIILGLEHMHNRFVVYR---DLKPANI----------------------LLDEHGHVRISDLGLA 144 (279)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCC---CCCHHHE----------------------EECCCCCEEEccCCcc
Confidence 4578999999999999999999999999999 8888888 7788899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCcccCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDD---EEEVFDSIVNDEVRYPRFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~---~~~~~~~~~~~~~~~p~~~ 235 (245)
...... ......|+..|+|||.+.. ..++.++|+||||+++|+|++|..||.... ...............|..+
T Consensus 145 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd05633 145 CDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSF 222 (279)
T ss_pred eecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCcccc
Confidence 643221 1233468889999999864 568899999999999999999999996532 2222222333444567788
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
+++++++|++
T Consensus 223 ~~~~~~li~~ 232 (279)
T cd05633 223 SPELKSLLEG 232 (279)
T ss_pred CHHHHHHHHH
Confidence 9999988864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=243.90 Aligned_cols=216 Identities=34% Similarity=0.585 Sum_probs=170.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.............+.+ ++.+++.++|+|++++.+.+...++.|++|||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~---E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 92 (285)
T cd05630 16 VCACQVRATGKMYACKKLEKKRIKKRKGESMALN---EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred EEEEEEcCCCceEEEEEEehhhccchHHHHHHHH---HHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHH
Confidence 6899999999999999997643332222233333 4667888999999999999999999999999999999988874
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 93 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~---dikp~Ni----------------------l~~~~~~~~l~Dfg 147 (285)
T cd05630 93 HMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR---DLKPENI----------------------LLDDHGHIRISDLG 147 (285)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeC---CCCHHHE----------------------EECCCCCEEEeecc
Confidence 2 358899999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh-cCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE---EEVFDSIV-NDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~---~~~~~~~~-~~~~~~p~ 233 (245)
++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+. .....++.
T Consensus 148 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05630 148 LAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226 (285)
T ss_pred ceeecCCC-ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc
Confidence 88643222 122234688999999999888899999999999999999999999976432 12222222 22334567
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++++++|+++
T Consensus 227 ~~~~~~~~li~~ 238 (285)
T cd05630 227 KFSPDARSLCKM 238 (285)
T ss_pred cCCHHHHHHHHH
Confidence 788888888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=251.55 Aligned_cols=212 Identities=25% Similarity=0.360 Sum_probs=163.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++.... .....+.+. +++++++.++|+||+++++++...+..+++|||+.+++|...
T Consensus 90 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-- 162 (353)
T PLN00034 90 VYKVIHRPTGRLYALKVIYGNH--EDTVRRQIC---REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-- 162 (353)
T ss_pred EEEEEECCCCCEEEEEEEecCC--cHHHHHHHH---HHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc--
Confidence 7999999999999999996532 122223343 447778889999999999999999999999999999998653
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||++.
T Consensus 163 -~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 163 -HIADEQFLADVARQILSGIAYLHRRHIVHR---DIKPSNL----------------------LINSAKNVKIADFGVSR 216 (353)
T ss_pred -ccCCHHHHHHHHHHHHHHHHHHHHCCEeec---CCCHHHE----------------------EEcCCCCEEEcccccce
Confidence 235677788999999999999999999999 8888888 77888999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc-CcccC
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE---EEVFDSIVN-DEVRY 231 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~---~~~~~~~~~-~~~~~ 231 (245)
.............|+..|+|||.+.. ...+.++|||||||++|||++|+.||..... ......+.. .....
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEA 296 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCC
Confidence 54333222345578999999998843 2235689999999999999999999964322 222222222 23345
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
+..+++++++||++
T Consensus 297 ~~~~~~~l~~li~~ 310 (353)
T PLN00034 297 PATASREFRHFISC 310 (353)
T ss_pred CCccCHHHHHHHHH
Confidence 67788999998863
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=242.80 Aligned_cols=215 Identities=36% Similarity=0.581 Sum_probs=171.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.+.............+. +++++++.++|+|++++.+.+..++..|++|||+.+++|..++.
T Consensus 16 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 92 (285)
T cd05632 16 VCACQVRATGKMYACKRLEKKRIKKRKGESMAL---NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY 92 (285)
T ss_pred EEEEEECCCCcEEEEEEeehhhhhhhhHHHHHH---HHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHH
Confidence 699999999999999999764332222222333 34677888999999999999999999999999999999987774
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||++||+|+ |++|+|+ +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~---dikp~Ni----------------------li~~~~~~kl~Dfg 147 (285)
T cd05632 93 NMGNPGFEEERALFYAAEILCGLEDLHRENTVYR---DLKPENI----------------------LLDDYGHIRISDLG 147 (285)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---CCCHHHE----------------------EECCCCCEEEecCC
Confidence 2 358999999999999999999999999999 8888888 77788899999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS----IVNDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~----~~~~~~~~p~ 233 (245)
++...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.+......... +......++.
T Consensus 148 ~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05632 148 LAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226 (285)
T ss_pred cceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc
Confidence 88643221 122344688999999999888899999999999999999999999987655433222 2333344567
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.+++++.+|+.
T Consensus 227 ~~~~~~~~li~ 237 (285)
T cd05632 227 KFSEEAKSICK 237 (285)
T ss_pred cCCHHHHHHHH
Confidence 78888888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.53 Aligned_cols=185 Identities=23% Similarity=0.407 Sum_probs=150.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++..... ....... .+++.+++.++||||+++++++..+...++||||+.+ +|.+++.
T Consensus 21 V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 94 (303)
T cd07869 21 VYKGKSKVNGKLVALKVIRLQEE--EGTPFTA---IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMD 94 (303)
T ss_pred EEEEEECCCCCEEEEEEeccccc--cccchhH---HHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCc-CHHHHHH
Confidence 79999999999999999975321 1111222 3457778899999999999999999999999999964 6766664
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kl~Dfg~ 149 (303)
T cd07869 95 KHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR---DLKPQNL----------------------LISDTGELKLADFGL 149 (303)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCCEEECCCCc
Confidence 3 468889999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
+..............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 8643222222344567889999999866 457889999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=244.00 Aligned_cols=214 Identities=28% Similarity=0.473 Sum_probs=172.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.+..... ...+.+.+| +..++.++|||++++++.+..+++.|+||||+++++|.+++.
T Consensus 36 v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e---~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 109 (296)
T cd06654 36 VYTAMDVATGQEVAIRQMNLQQQ---PKKELIINE---ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109 (296)
T ss_pred EEEEEECCCCcEEEEEEEecCCc---chHHHHHHH---HHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH
Confidence 69999999999999999976432 222334333 667778899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||+.|++|+ |++|+|| +++.++.++|+|||.+.
T Consensus 110 ~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~---dLkp~Ni----------------------ll~~~~~~kl~dfg~~~ 164 (296)
T cd06654 110 ETCMDEGQIAAVCRECLQALEFLHSNQVIHR---DIKSDNI----------------------LLGMDGSVKLTDFGFCA 164 (296)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EEcCCCCEEECccccch
Confidence 7778999999999999999999999999999 8888888 77888999999999887
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc-c--cCCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-V--RYPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~--~~p~~~~~ 237 (245)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.... + ..|..+++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (296)
T ss_pred hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCH
Confidence 53222222334567889999999988888999999999999999999999998776544433333222 1 23566788
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
.+.++|+|
T Consensus 245 ~l~~li~~ 252 (296)
T cd06654 245 IFRDFLNR 252 (296)
T ss_pred HHHHHHHH
Confidence 88888753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.16 Aligned_cols=189 Identities=24% Similarity=0.409 Sum_probs=151.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||+|++..... .......+ .+++++++.++||||+++++++... ...|+||||++ ++|
T Consensus 16 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 90 (338)
T cd07859 16 VCSAIDTHTGEKVAIKKINDVFE-HVSDATRI---LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDL 90 (338)
T ss_pred EEEEEECCCCCEEEEEEechhhc-cchhHHHH---HHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCH
Confidence 79999999999999999874321 11122233 4457778889999999999988543 25899999996 578
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..++. ...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+
T Consensus 91 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---dlkp~NI----------------------ll~~~~~~kL~ 145 (338)
T cd07859 91 HQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR---DLKPKNI----------------------LANADCKLKIC 145 (338)
T ss_pred HHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EECCCCcEEEc
Confidence 77775 4568999999999999999999999999999 8888888 78889999999
Q ss_pred ecCCccCCCCCCC---CCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy3347 155 DFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219 (245)
Q Consensus 155 Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~ 219 (245)
|||+++....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 9999874322211 1234568899999999865 578899999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=251.20 Aligned_cols=215 Identities=27% Similarity=0.463 Sum_probs=162.7
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC-CeEEEEEeeccCC
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE-AHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~-~~~~lv~e~~~~~ 73 (245)
||+|.+ ..+++.||+|+++... .....+.+.+| +.++..+ +||||+++++++... +..+++|||+++|
T Consensus 23 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g 97 (338)
T cd05102 23 VVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSE---LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97 (338)
T ss_pred EEEEEEeccCCcccchhhheecccccc--chHHHHHHHHH---HHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCC
Confidence 788875 2456789999997532 22233444444 5566666 799999999988754 4689999999999
Q ss_pred chhhhhhh---------------------------------------------------------------cCCChHHHH
Q psy3347 74 DLMMHIHA---------------------------------------------------------------DVFSEPRAV 90 (245)
Q Consensus 74 ~L~~~~~~---------------------------------------------------------------~~l~~~~~~ 90 (245)
+|.+++.. .++++..+.
T Consensus 98 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 177 (338)
T cd05102 98 NLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLI 177 (338)
T ss_pred cHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHH
Confidence 99888743 136677888
Q ss_pred HHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCC--C
Q psy3347 91 FYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--R 168 (245)
Q Consensus 91 ~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~ 168 (245)
.++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||+++....... .
T Consensus 178 ~~~~qi~~aL~~LH~~~ivHr---DiKp~Ni----------------------l~~~~~~~kl~DfG~a~~~~~~~~~~~ 232 (338)
T cd05102 178 CYSFQVARGMEFLASRKCIHR---DLAARNI----------------------LLSENNVVKICDFGLARDIYKDPDYVR 232 (338)
T ss_pred HHHHHHHHHHHHHHHCCEECC---CCccceE----------------------EEcCCCcEEEeecccccccccCcchhc
Confidence 999999999999999999999 8888888 778889999999999875322211 1
Q ss_pred CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 169 TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE-VFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~-~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+ ....+..+ ....|..+++++++||.+
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 223345678999999988889999999999999999997 999998755433 33333333 234577888899888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=243.91 Aligned_cols=198 Identities=24% Similarity=0.373 Sum_probs=158.2
Q ss_pred CEeEEEec-CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccCCc
Q psy3347 1 VILSQYRN-TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~ 74 (245)
||+|++.. +|+.||+|+++...... .......+|..++..++.++||||+++++++.. ....+++|||+. ++
T Consensus 17 Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 94 (290)
T cd07862 17 VFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD 94 (290)
T ss_pred EEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CC
Confidence 79999865 47899999987543221 122344556666666667789999999999853 456899999996 48
Q ss_pred hhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 75 LMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 75 L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
|..++.. ..+++..+..++.|++.||.|||++|++|+ |+||+|| +++.++.+
T Consensus 95 l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~---dlkp~Ni----------------------l~~~~~~~ 149 (290)
T cd07862 95 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR---DLKPQNI----------------------LVTSSGQI 149 (290)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCCHHHE----------------------EEcCCCCE
Confidence 8877743 358899999999999999999999999999 8888888 77888999
Q ss_pred EEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 152 KIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+|+|||++..... ........|+..|+|||.+.+..++.++|||||||++|+|++|++||.+.+..+....+..
T Consensus 150 kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 150 KLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred EEccccceEeccC-CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 9999999875322 2233455688999999999888899999999999999999999999998877776666643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=242.83 Aligned_cols=214 Identities=28% Similarity=0.485 Sum_probs=175.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+.... ....+.+.+ +++.++.++|||++++++.+...+..++++||+.+++|..++.
T Consensus 35 vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 108 (296)
T cd06655 35 VFTAIDVATGQEVAIKQINLQK---QPKKELIIN---EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT 108 (296)
T ss_pred EEEEEEcCCCcEEEEEEEeccc---CchHHHHHH---HHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH
Confidence 6899999999999999987532 122233433 4667788899999999999999999999999999999999988
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 109 ~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~---dL~p~Ni----------------------li~~~~~~kl~dfg~~~ 163 (296)
T cd06655 109 ETCMDEAQIAAVCRECLQALEFLHANQVIHR---DIKSDNV----------------------LLGMDGSVKLTDFGFCA 163 (296)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEEccCccch
Confidence 7789999999999999999999999999999 8888888 77888999999999887
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~~~ 237 (245)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+..+....+..... ..|..+++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCH
Confidence 543332223345678889999999888899999999999999999999999988776655554443322 24567888
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
.++++|++
T Consensus 244 ~~~~li~~ 251 (296)
T cd06655 244 IFRDFLNR 251 (296)
T ss_pred HHHHHHHH
Confidence 88888864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=243.24 Aligned_cols=217 Identities=34% Similarity=0.705 Sum_probs=175.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.||+|.+...........+.+.+ +++.++.++||||+++++.+..+++.+++|||+++++|..+++
T Consensus 17 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (305)
T cd05609 17 VYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV---ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK 93 (305)
T ss_pred EEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHH---HHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH
Confidence 6999999999999999987643222222333433 4667788899999999999999999999999999999999985
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.++++|||++
T Consensus 94 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~NI----------------------ll~~~~~~~l~dfg~~ 148 (305)
T cd05609 94 NIGALPVDMARMYFAETVLALEYLHNYGIVHR---DLKPDNL----------------------LITSMGHIKLTDFGLS 148 (305)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCchHHE----------------------EECCCCCEEEeeCCCc
Confidence 4 568899999999999999999999999999 8888888 7888899999999987
Q ss_pred cCCCCCC---------------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 160 KEGMGFG---------------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 160 ~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 6310000 0011235677899999998888999999999999999999999999988888878877
Q ss_pred hcCcccCCC---CCChhHHhhhcC
Q psy3347 225 VNDEVRYPR---FLSLEAIAIMRR 245 (245)
Q Consensus 225 ~~~~~~~p~---~~~~~~~~li~~ 245 (245)
.......|. .++++++++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~ 252 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISR 252 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHH
Confidence 766544432 578888888864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=246.49 Aligned_cols=187 Identities=25% Similarity=0.480 Sum_probs=157.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|..+|+|++.... .....+.+. ++++.++.++||||+++++++..++..++||||+++++|.++++
T Consensus 21 V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 95 (331)
T cd06649 21 VTKVQHKPSGLIMARKLIHLEI--KPAIRNQII---RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 95 (331)
T ss_pred EEEEEECCCCcEEEEEEeeccc--CHHHHHHHH---HHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH
Confidence 7999999999999999997532 222223343 44777889999999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||+. +++|+ |++|+|| +++.++.++|+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~ 150 (331)
T cd06649 96 EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR---DVKPSNI----------------------LVNSRGEIKLCDFGV 150 (331)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcC---CCChhhE----------------------EEcCCCcEEEccCcc
Confidence 4 5689999999999999999999986 69999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~ 219 (245)
+..... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 151 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 151 SGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred cccccc--cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 875322 12334568899999999988889999999999999999999999997655443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=238.27 Aligned_cols=216 Identities=24% Similarity=0.430 Sum_probs=177.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.|++|.+...... ....+.+.+ +++.++.++|||++++++++..++..+++|||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 91 (256)
T cd08529 16 VFKVVRKADKRVYAMKQIDLSKMN-RREREEAID---EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK 91 (256)
T ss_pred EEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHH---HHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHH
Confidence 699999999999999998754322 223333433 4667888999999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 92 ~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~---dl~~~ni----------------------li~~~~~~~l~df~ 146 (256)
T cd08529 92 MQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR---DIKSLNL----------------------FLDAYDNVKIGDLG 146 (256)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCcceE----------------------EEeCCCCEEEcccc
Confidence 4 367888999999999999999999999999 8888888 78888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLS 236 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~ 236 (245)
++..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+.. +++..++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08529 147 VAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYS 226 (256)
T ss_pred cceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 887543333333345678889999999888889999999999999999999999988877776666665543 3556788
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
+++.++|++
T Consensus 227 ~~~~~~i~~ 235 (256)
T cd08529 227 QQLAQLIDQ 235 (256)
T ss_pred HHHHHHHHH
Confidence 888888763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=253.03 Aligned_cols=217 Identities=50% Similarity=0.940 Sum_probs=193.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|.+|..+-|.+.||||++++.-+.....++.-..|.|++.+.. +-|.+++++.+|+.-+..|.||||+.||+|...++
T Consensus 365 VlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~--kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ 442 (683)
T KOG0696|consen 365 VLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG--KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ 442 (683)
T ss_pred eeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCC--CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH
Confidence 5678788889999999999876666667777777877775443 46899999999999999999999999999988885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+.++.++.++.+|+.||-|||++||++| |+|.+|+ ++|++|.+||.|||++
T Consensus 443 Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYR---DLKLDNv----------------------mLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 443 QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYR---DLKLDNV----------------------MLDSEGHIKIADFGMC 497 (683)
T ss_pred HhcccCCchhhhhhHHHHHHhhhhhcCCeeee---eccccce----------------------EeccCCceEeeecccc
Confidence 4789999999999999999999999999999 6666666 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+...-......+++||+-|+|||++..++|+..+|.||+|+.+|||+.|.+||.+.++.++++.|......+|.++|.+.
T Consensus 498 KEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEA 577 (683)
T KOG0696|consen 498 KENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEA 577 (683)
T ss_pred cccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHH
Confidence 87666666678899999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.++.+
T Consensus 578 v~ick 582 (683)
T KOG0696|consen 578 VAICK 582 (683)
T ss_pred HHHHH
Confidence 87753
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=238.56 Aligned_cols=214 Identities=28% Similarity=0.475 Sum_probs=176.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|.+.... .......+. ++++.++.++|+|++++.+++..+...++++||+++++|.+++.
T Consensus 17 v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 91 (274)
T cd06609 17 VYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQ---QEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK 91 (274)
T ss_pred EEEEEECCCCeEEEEEEeeccc--cchHHHHHH---HHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHh
Confidence 6999999999999999997542 122233343 44677888899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
..++++..+..++.|++.|+.|+|+++++|+ |++|+|+ +++.++.++|+|||+++
T Consensus 92 ~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~---dl~p~ni----------------------~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 92 PGKLDETYIAFILREVLLGLEYLHEEGKIHR---DIKAANI----------------------LLSEEGDVKLADFGVSG 146 (274)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EECCCCCEEEcccccce
Confidence 7789999999999999999999999999999 8888888 78889999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCC-CChh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRF-LSLE 238 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~-~~~~ 238 (245)
.............++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..... ..+.. ++++
T Consensus 147 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (274)
T cd06609 147 QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKP 226 (274)
T ss_pred eecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHH
Confidence 643332334455678889999999888899999999999999999999999987766665555544432 33444 7888
Q ss_pred HHhhhc
Q psy3347 239 AIAIMR 244 (245)
Q Consensus 239 ~~~li~ 244 (245)
+.++++
T Consensus 227 ~~~~l~ 232 (274)
T cd06609 227 FKDFVS 232 (274)
T ss_pred HHHHHH
Confidence 888875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=240.00 Aligned_cols=216 Identities=36% Similarity=0.642 Sum_probs=177.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|++...........+.+.+| ++.+++++||||+++++.+..++..++++||+.+++|..++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 92 (258)
T cd05578 16 VCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNE---RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS 92 (258)
T ss_pred EEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHH---HHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHH
Confidence 69999999999999999986543333334444444 677888999999999999999999999999999999999986
Q ss_pred hc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 AD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.. ++++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||.+
T Consensus 93 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~---dl~~~ni----------------------l~~~~~~~~l~d~~~~ 147 (258)
T cd05578 93 QKVKFSEEQVKFWICEIVLALEYLHSKGIIHR---DIKPDNI----------------------LLDEQGHVHITDFNIA 147 (258)
T ss_pred hcCCcCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHe----------------------EEcCCCCEEEeecccc
Confidence 54 88999999999999999999999999999 8888888 7888899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCcccCCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD---EEEVFDSIVNDEVRYPRFLS 236 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~---~~~~~~~~~~~~~~~p~~~~ 236 (245)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+ .....+.........|..++
T Consensus 148 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T cd05578 148 TKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS 226 (258)
T ss_pred cccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCc
Confidence 7533222 2234457788999999988888999999999999999999999998766 34444433435556778888
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
+++.++|++
T Consensus 227 ~~~~~~i~~ 235 (258)
T cd05578 227 TEAIDAINK 235 (258)
T ss_pred HHHHHHHHH
Confidence 999888864
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=238.23 Aligned_cols=215 Identities=27% Similarity=0.519 Sum_probs=177.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.++... .....+.+.+| +..++.++||||+++++.+..+++.+++|||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 90 (255)
T cd08219 16 ALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKE---AVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK 90 (255)
T ss_pred EEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHH---HHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHH
Confidence 6899999999999999987532 12233444444 566788899999999999999999999999999999988774
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++++|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~---dl~p~ni----------------------li~~~~~~~l~dfg 145 (255)
T cd08219 91 LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR---DIKSKNI----------------------FLTQNGKVKLGDFG 145 (255)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccC---CCCcceE----------------------EECCCCcEEEcccC
Confidence 3 357889999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLS 236 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~ 236 (245)
.+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..+.. +.|..++
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (255)
T cd08219 146 SARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYS 225 (255)
T ss_pred cceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 987543333333445688899999999888899999999999999999999999988877776666665544 3577788
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
.+++++|++
T Consensus 226 ~~~~~li~~ 234 (255)
T cd08219 226 YELRSLIKQ 234 (255)
T ss_pred HHHHHHHHH
Confidence 888888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=239.58 Aligned_cols=214 Identities=26% Similarity=0.430 Sum_probs=173.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.... .....+.+. ++++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 20 vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 94 (277)
T cd06640 20 VFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQ---QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR 94 (277)
T ss_pred EEEEEEccCCEEEEEEEEeccc--cHHHHHHHH---HHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh
Confidence 6999999999999999987542 122233343 44677888999999999999999999999999999999999988
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
..++++..+..++.|++.||+|+|+++++|+ |++|+|| +++.++.++++|||++.
T Consensus 95 ~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~---dl~p~Ni----------------------l~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 95 AGPFDEFQIATMLKEILKGLDYLHSEKKIHR---DIKAANV----------------------LLSEQGDVKLADFGVAG 149 (277)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCccCc---CCChhhE----------------------EEcCCCCEEEcccccce
Confidence 7889999999999999999999999999999 8888888 77888999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc-ccCCCCCChhH
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSLEA 239 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~ 239 (245)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.... ...+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPF 229 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHH
Confidence 54333222334467788999999988889999999999999999999999998777666555443332 23345667777
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.++|+
T Consensus 230 ~~li~ 234 (277)
T cd06640 230 KEFID 234 (277)
T ss_pred HHHHH
Confidence 77765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=238.23 Aligned_cols=217 Identities=21% Similarity=0.354 Sum_probs=170.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|.++............+.+ +++.++.++||||+++++++...+..+++|||+++++|..++.
T Consensus 18 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 94 (267)
T cd08228 18 VYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK 94 (267)
T ss_pred EEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHH---HHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHH
Confidence 7999999999999999887543333333334444 4677889999999999999999999999999999999987773
Q ss_pred -----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 -----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 -----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~---dl~~~ni----------------------l~~~~~~~~l~d 149 (267)
T cd08228 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR---DIKPANV----------------------FITATGVVKLGD 149 (267)
T ss_pred HhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC---CCCHHHE----------------------EEcCCCCEEECc
Confidence 2347888999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCcc-cC-
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD--DEEEVFDSIVNDEV-RY- 231 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~--~~~~~~~~~~~~~~-~~- 231 (245)
||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||... +..+....+..... +.
T Consensus 150 ~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08228 150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP 229 (267)
T ss_pred cccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC
Confidence 998875433322233456788899999998888899999999999999999999998644 23444444444332 22
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
+...+.+++++|++
T Consensus 230 ~~~~~~~~~~li~~ 243 (267)
T cd08228 230 TEHYSEKLRELVSM 243 (267)
T ss_pred hhhcCHHHHHHHHH
Confidence 24567788888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=238.31 Aligned_cols=214 Identities=17% Similarity=0.254 Sum_probs=169.9
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++ ..+..||+|.++... .....+.+. ++++.++.++||||+++++++..+++.++||||+++++|..
T Consensus 21 V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (266)
T cd05064 21 LCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFL---AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95 (266)
T ss_pred EEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHH---HHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHH
Confidence 6888765 456799999998642 122223333 44677888899999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++++|
T Consensus 96 ~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~---dikp~ni----------------------li~~~~~~~l~d 150 (266)
T cd05064 96 FLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK---GLAAHKV----------------------LVNSDLVCKISG 150 (266)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---cccHhhE----------------------EEcCCCcEEECC
Confidence 8854 468999999999999999999999999999 7888787 777889999999
Q ss_pred cCCccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 156 FGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
||.+........ ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.+..+....+..+. .+.|
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence 997754221111 1112234567999999988889999999999999999875 999999888877777766543 3456
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..++..+.+++.
T Consensus 231 ~~~~~~~~~li~ 242 (266)
T cd05064 231 RNCPNLLHQLML 242 (266)
T ss_pred CCCCHHHHHHHH
Confidence 778888888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=239.43 Aligned_cols=216 Identities=37% Similarity=0.635 Sum_probs=172.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+.............+.. ++++++.++||||+++.+++...+..|++|||+++++|.+++.
T Consensus 9 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 85 (277)
T cd05577 9 VCACQVKATGKMYACKKLDKKRLKKRKGEQMALN---EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY 85 (277)
T ss_pred EEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHH---HHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHH
Confidence 7999999999999999997643222222333333 4677888899999999999999999999999999999998884
Q ss_pred h-c--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A-D--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~-~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. . .+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~---di~p~Ni----------------------l~~~~~~~~l~dfg 140 (277)
T cd05577 86 NVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR---DLKPENV----------------------LLDDHGNVRISDLG 140 (277)
T ss_pred HcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EECCCCCEEEccCc
Confidence 3 3 58899999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~p~ 233 (245)
.+..... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+.......|.
T Consensus 141 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd05577 141 LAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD 219 (277)
T ss_pred chhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc
Confidence 8865322 2222334567789999999888899999999999999999999999976533 2333333444445677
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.++++++++|++
T Consensus 220 ~~~~~~~~li~~ 231 (277)
T cd05577 220 KFSPEAKDLCEA 231 (277)
T ss_pred cCCHHHHHHHHH
Confidence 789999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=243.40 Aligned_cols=193 Identities=23% Similarity=0.423 Sum_probs=155.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|.++.... ......+ .+++++++.++||||+++++++..++..++||||+++ +|..++.
T Consensus 22 Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 95 (309)
T cd07872 22 VFKGRSKLTENLVALKEIRLEHE--EGAPCTA---IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMD 95 (309)
T ss_pred EEEEEecCCCCeEEEEEeecccc--CCcchhH---HHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHH
Confidence 79999999999999999975431 1111223 3447778889999999999999999999999999976 7776664
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|| |++|+|| +++.++.++|+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kl~Dfg~ 150 (309)
T cd07872 96 DCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR---DLKPQNL----------------------LINERGELKLADFGL 150 (309)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCCEEECcccc
Confidence 3 347888999999999999999999999999 8888888 788889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 8753322222334567889999999865 45789999999999999999999999887665554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=237.36 Aligned_cols=217 Identities=36% Similarity=0.729 Sum_probs=179.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.+|+|.+...........+.+.+ +++.++.++||||+++++.+..++..|++||++.+++|..++.
T Consensus 9 vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~---e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 85 (265)
T cd05579 9 VFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT---ERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE 85 (265)
T ss_pred EEEEEECCCCCEEEEEEecchhhhhhhHHHHHHH---HHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHH
Confidence 6999999999999999997654322233344444 4667788899999999999999999999999999999998886
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 86 ~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~---di~~~ni----------------------l~~~~~~~~l~dfg~~ 140 (265)
T cd05579 86 NVGSLDEDVARIYIAEIVLALEYLHSNGIIHR---DLKPDNI----------------------LIDSNGHLKLTDFGLS 140 (265)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHcCeecC---CCCHHHe----------------------EEcCCCCEEEEecccc
Confidence 4 578999999999999999999999999999 8888888 7888899999999988
Q ss_pred cCCCCCCC--------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC
Q psy3347 160 KEGMGFGD--------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231 (245)
Q Consensus 160 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (245)
........ ......++..|+|||......++.++|+||||+++|++++|+.||......+....+..+...+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (265)
T cd05579 141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220 (265)
T ss_pred hhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC
Confidence 64322211 2234456788999999988888899999999999999999999999888888888887766667
Q ss_pred CCCC--ChhHHhhhcC
Q psy3347 232 PRFL--SLEAIAIMRR 245 (245)
Q Consensus 232 p~~~--~~~~~~li~~ 245 (245)
|..+ ++++.++|++
T Consensus 221 ~~~~~~~~~~~~~i~~ 236 (265)
T cd05579 221 PEDVEVSDEAIDLISK 236 (265)
T ss_pred CccccCCHHHHHHHHH
Confidence 7665 8888888763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=238.42 Aligned_cols=213 Identities=25% Similarity=0.465 Sum_probs=173.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.+... .....+.+.+ +++.++.++||||+++++.+..++..++||||+++++|..++.
T Consensus 21 v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (280)
T cd06611 21 VYKAQHKETGLFAAAKIIQIE---SEEELEDFMV---EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIML 94 (280)
T ss_pred EEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHH---HHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHH
Confidence 799999989999999999753 2223334444 4677888999999999999999999999999999999998885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|+ +++.++.++|+|||.
T Consensus 95 ~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~---dl~p~ni----------------------li~~~~~~~l~d~g~ 149 (280)
T cd06611 95 ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR---DLKAGNI----------------------LLTLDGDVKLADFGV 149 (280)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCChhhE----------------------EECCCCCEEEccCcc
Confidence 4 468999999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--- 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (245)
+..............++..|+|||.+. +.+++.++|+||||+++|+|++|+.||...+..+....+.....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 150 SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred chhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 765333333334456788999999984 345678999999999999999999999888777766666655332
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..++.++.++|+
T Consensus 230 ~~~~~~~~~~~li~ 243 (280)
T cd06611 230 QPSKWSSSFNDFLK 243 (280)
T ss_pred CcccCCHHHHHHHH
Confidence 35677888888876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=236.63 Aligned_cols=213 Identities=24% Similarity=0.379 Sum_probs=166.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|+++... ......+. +++..++.++||||+++++.+...+..+++|||+++++|.+++.
T Consensus 25 v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~---~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 98 (267)
T cd06645 25 VYKARNVNTGELAAIKVIKLEP---GEDFAVVQ---QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH 98 (267)
T ss_pred EEEEEEcCCCcEEEEEEEecCc---hhHHHHHH---HHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH
Confidence 6899999999999999987542 12223333 34677888899999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 99 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~ni----------------------li~~~~~~~l~dfg~~ 153 (267)
T cd06645 99 VTGPLSESQIAYVSRETLQGLYYLHSKGKMHR---DIKGANI----------------------LLTDNGHVKLADFGVS 153 (267)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCCEEECcceee
Confidence 4578999999999999999999999999999 8888888 7788899999999988
Q ss_pred cCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
..............|+..|+|||.+. ...++.++|+|||||++|+|++|+.||....+..............|
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 65433333334557889999999984 34578899999999999999999999865544433333322222211
Q ss_pred -CCCChhHHhhhc
Q psy3347 233 -RFLSLEAIAIMR 244 (245)
Q Consensus 233 -~~~~~~~~~li~ 244 (245)
..+++.++++|+
T Consensus 234 ~~~~~~~~~~li~ 246 (267)
T cd06645 234 KMKWSNSFHHFVK 246 (267)
T ss_pred cCCCCHHHHHHHH
Confidence 245667777765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=242.78 Aligned_cols=213 Identities=24% Similarity=0.465 Sum_probs=173.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.... ....+.+.+| +..++.++|||++++++++..++..+++|||+++++|..++.
T Consensus 37 v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e---~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 110 (297)
T cd06659 37 VCIAREKHSGRQVAVKMMDLRK---QQRRELLFNE---VVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 110 (297)
T ss_pred EEEEEEcCCCCEEEEEEEEecc---cchHHHHHHH---HHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh
Confidence 6899999999999999986532 1222334443 667788899999999999999999999999999999998887
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 111 ~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~---dl~p~Ni----------------------ll~~~~~~kL~dfg~~~ 165 (297)
T cd06659 111 QTRLNEEQIATVCESVLQALCYLHSQGVIHR---DIKSDSI----------------------LLTLDGRVKLSDFGFCA 165 (297)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHe----------------------EEccCCcEEEeechhHh
Confidence 7788999999999999999999999999999 8888888 77888999999999886
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+...... .+..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06659 166 QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP 245 (297)
T ss_pred hcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCH
Confidence 4333322334456888999999998888999999999999999999999999877766665555433222 2345677
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
++.++|+
T Consensus 246 ~l~~~i~ 252 (297)
T cd06659 246 VLRDFLE 252 (297)
T ss_pred HHHHHHH
Confidence 7777775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=235.23 Aligned_cols=220 Identities=29% Similarity=0.484 Sum_probs=175.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccch---hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR---DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+..+++.+|+|.+........ ...+......+++++++.++||||+++++++...+..+++|||+++++|..
T Consensus 16 v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06628 16 VYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA 95 (267)
T ss_pred EEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHH
Confidence 68999998999999998876433222 111122333455778889999999999999999999999999999999999
Q ss_pred hhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 96 ~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~---di~p~ni----------------------l~~~~~~~~l~df 150 (267)
T cd06628 96 LLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHR---DIKGANI----------------------LVDNKGGIKISDF 150 (267)
T ss_pred HHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccc---cCCHHHE----------------------EEcCCCCEEeccc
Confidence 8854 568889999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCC------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-cc
Q psy3347 157 GLCKEGMGFG------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND-EV 229 (245)
Q Consensus 157 g~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~ 229 (245)
|.++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+.......+... ..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC
Confidence 9887543211 1122345778899999998888899999999999999999999999876665554444443 34
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
..|..++.++.++|++
T Consensus 231 ~~~~~~~~~~~~li~~ 246 (267)
T cd06628 231 EIPSNISSEAIDFLEK 246 (267)
T ss_pred cCCcccCHHHHHHHHH
Confidence 5677888888888863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=242.25 Aligned_cols=217 Identities=40% Similarity=0.747 Sum_probs=176.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+...........+.+ .++++.++.++||||+++++.+...+..|++|||+.+++|.+++.
T Consensus 17 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (316)
T cd05574 17 VFLVRLKGTGKLFALKVLDKKEMIKRNKVKRV---LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ 93 (316)
T ss_pred EEEEEEcCCCcEEEEEEEeccccchHHHHHHH---HHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHH
Confidence 79999999999999999987543322233333 344677888899999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 94 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~~l~dfg 148 (316)
T cd05574 94 RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR---DLKPENI----------------------LLHESGHIMLSDFD 148 (316)
T ss_pred hCCCCccCHHHHHHHHHHHHHHHHHHHHCCeecc---CCChHHe----------------------EEcCCCCEEEeecc
Confidence 4 458899999999999999999999999999 8888888 78888999999999
Q ss_pred CccCCCCCCC-----------------------------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC
Q psy3347 158 LCKEGMGFGD-----------------------------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG 208 (245)
Q Consensus 158 ~~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g 208 (245)
++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 8764321110 01134678889999999888899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhcCcccCCCC--CChhHHhhhcC
Q psy3347 209 ESPFPGDDEEEVFDSIVNDEVRYPRF--LSLEAIAIMRR 245 (245)
Q Consensus 209 ~~pf~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~li~~ 245 (245)
+.||.+.+..+....+......+|.. .+++++++|++
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 267 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRK 267 (316)
T ss_pred CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHH
Confidence 99999888777777776655555543 68888888863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.70 Aligned_cols=197 Identities=27% Similarity=0.439 Sum_probs=172.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||-|+|..+.+.||||+++.+.....+..+++..| +..|++++|||++.+.|+|-.+...++|||||-| +..+.+
T Consensus 42 VYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKE---VrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlle 117 (948)
T KOG0577|consen 42 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKE---VRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLE 117 (948)
T ss_pred eEEeeccCccceeeeeeccccccccHHHHHHHHHH---HHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHH
Confidence 89999999999999999998776666666777666 5567788999999999999999899999999966 666666
Q ss_pred -hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 -HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 -~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...++.+-.+..|+.+.+.||+|||+.+.+|| |||..|| ++...|.||++|||.
T Consensus 118 VhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHR---DiKAGNI----------------------LLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 118 VHKKPLQEVEIAAITHGALQGLAYLHSHNRIHR---DIKAGNI----------------------LLSEPGLVKLADFGS 172 (948)
T ss_pred HHhccchHHHHHHHHHHHHHHHHHHHHhhHHhh---hccccce----------------------EecCCCeeeeccccc
Confidence 45689999999999999999999999999999 7777777 777889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (245)
+.. ......++||++|||||++.. +.|+.++||||||+++.|+...++|+...+.+.++..|.....+
T Consensus 173 Asi----~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP 243 (948)
T KOG0577|consen 173 ASI----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 243 (948)
T ss_pred hhh----cCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC
Confidence 763 344668899999999999964 67999999999999999999999999999999999999876544
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=241.01 Aligned_cols=214 Identities=26% Similarity=0.411 Sum_probs=172.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+.... .....+.+.+ +++.++.++||||+++++++..++..++||||+++++|..++.
T Consensus 20 vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (277)
T cd06642 20 VYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQ---EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK 94 (277)
T ss_pred EEEEEEcCCCeEEEEEEecccc--chHHHHHHHH---HHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh
Confidence 7999999999999999987432 1223334443 4677888999999999999999999999999999999999988
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.|+.|||++|++|+ |++|+|| +++.++.++++|||++.
T Consensus 95 ~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~---dl~p~ni----------------------~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 95 PGPLEETYIATILREILKGLDYLHSERKIHR---DIKAANV----------------------LLSEQGDVKLADFGVAG 149 (277)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhcCCeecc---CCChheE----------------------EEeCCCCEEEccccccc
Confidence 7789999999999999999999999999999 8888888 77788999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCChhH
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSLEA 239 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~ 239 (245)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+..... ..+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF 229 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHH
Confidence 543322222334578889999999888899999999999999999999999976665555444433322 2345677777
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.++++
T Consensus 230 ~~li~ 234 (277)
T cd06642 230 KEFVE 234 (277)
T ss_pred HHHHH
Confidence 77775
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=266.51 Aligned_cols=216 Identities=19% Similarity=0.243 Sum_probs=165.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...........+.+.+ ++++++.++||||+++++++..++..+++|||++|++|.+++.
T Consensus 18 VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflr---Ei~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~ 94 (932)
T PRK13184 18 VYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR---EAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLK 94 (932)
T ss_pred EEEEEECCCCcEEEEEEECcccccCHHHHHHHHH---HHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHH
Confidence 7999999999999999997643222222333444 4677888999999999999999999999999999999988874
Q ss_pred h------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 81 A------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 81 ~------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
. ...+...+..++.|++.||+|||++||+|| |+||+|| +++.+
T Consensus 95 s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHR---DLKPeNI----------------------LLd~d 149 (932)
T PRK13184 95 SVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHR---DLKPDNI----------------------LLGLF 149 (932)
T ss_pred HhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcccc---CCchheE----------------------EEcCC
Confidence 2 124556778999999999999999999999 8888888 88888
Q ss_pred CceEEeecCCccCCCCCC------------------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q psy3347 149 GYVKIADFGLCKEGMGFG------------------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 210 (245)
+.++|+|||++....... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 999999999987531100 01123468999999999998899999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhc-Cccc--CCCCCChhHHhhhc
Q psy3347 211 PFPGDDEEEVFDSIVN-DEVR--YPRFLSLEAIAIMR 244 (245)
Q Consensus 211 pf~~~~~~~~~~~~~~-~~~~--~p~~~~~~~~~li~ 244 (245)
||...+..+....... .... ....+++.+.+++.
T Consensus 230 PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~ 266 (932)
T PRK13184 230 PYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAM 266 (932)
T ss_pred CCCCcchhhhhhhhhccChhhccccccCCHHHHHHHH
Confidence 9977554433222111 1111 12356677776664
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=241.21 Aligned_cols=214 Identities=28% Similarity=0.463 Sum_probs=172.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+..... ...+.+.+ ++..++.++||||+++++++..++..++||||+++++|..++.
T Consensus 35 v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 108 (297)
T cd06656 35 VYTAIDIATGQEVAIKQMNLQQQ---PKKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108 (297)
T ss_pred EEEEEECCCCCEEEEEEEecCcc---chHHHHHH---HHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH
Confidence 69999999999999999975422 12233333 3667788899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|+|||.+.
T Consensus 109 ~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~---dL~p~Ni----------------------li~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 109 ETCMDEGQIAAVCRECLQALDFLHSNQVIHR---DIKSDNI----------------------LLGMDGSVKLTDFGFCA 163 (297)
T ss_pred hCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEECcCccce
Confidence 7788999999999999999999999999999 8888888 77888999999999886
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~~~ 237 (245)
.............++..|+|||.+.+..++.++|+||||+++|++++|+.||.+.+.......+..... ..|..+++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA 243 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCH
Confidence 533222223345678899999999888899999999999999999999999977655443333322221 23566788
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
.+++++++
T Consensus 244 ~~~~li~~ 251 (297)
T cd06656 244 VFRDFLNR 251 (297)
T ss_pred HHHHHHHH
Confidence 88888753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=237.87 Aligned_cols=214 Identities=28% Similarity=0.465 Sum_probs=172.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..++..+|+|.+.... ....+.+.+ +++.++.++|||++++++++..++..+++|||+++++|..++.
T Consensus 21 v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~---e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 94 (282)
T cd06643 21 VYKAQNKETGVLAAAKVIDTKS---EEELEDYMV---EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 94 (282)
T ss_pred EEEEEECCCCeEEEEEEeCCCC---HHHHHHHHH---HHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHH
Confidence 6899999999999999986532 223344444 4677888899999999999999999999999999999988774
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
..++++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|+|||+
T Consensus 95 ~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~---dlkp~ni----------------------li~~~~~~kl~dfg~ 149 (282)
T cd06643 95 ELERPLTEPQIRVVCKQTLEALNYLHENKIIHR---DLKAGNI----------------------LFTLDGDIKLADFGV 149 (282)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCcccE----------------------EEccCCCEEEccccc
Confidence 3568999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---c
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---R 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~ 230 (245)
+..............++..|+|||.+. +..++.++|+||||+++|+|++|+.||...+..+....+..... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd06643 150 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA 229 (282)
T ss_pred cccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC
Confidence 875433333334456788999999984 34577899999999999999999999988777666666544322 2
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|..++.+++++|++
T Consensus 230 ~~~~~~~~~~~li~~ 244 (282)
T cd06643 230 QPSRWSSEFKDFLKK 244 (282)
T ss_pred CccccCHHHHHHHHH
Confidence 356688889988863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=249.59 Aligned_cols=194 Identities=23% Similarity=0.312 Sum_probs=155.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L 75 (245)
||+|.+..+|+.||+|++.... ......+.+ .+++++++.++||||+++++++...+ ..|+||||+.+ +|
T Consensus 16 V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 90 (372)
T cd07853 16 VWSVTDPRDGKRVALKKMPNVF-QNLVSCKRV---FRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DL 90 (372)
T ss_pred EEEEEECCCCCEEEEEeccccc-cchHHHHHH---HHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecccc-CH
Confidence 7999999999999999986532 111222333 44577788899999999999998776 78999999975 67
Q ss_pred hhhh-hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
...+ ....+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+
T Consensus 91 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~---dlkp~Ni----------------------li~~~~~~kL~ 145 (372)
T cd07853 91 HKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR---DIKPGNL----------------------LVNSNCVLKIC 145 (372)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCChHHE----------------------EECCCCCEEec
Confidence 6666 44578999999999999999999999999999 8888888 88889999999
Q ss_pred ecCCccCCCCCC-CCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 155 DFGLCKEGMGFG-DRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|||+++...... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 146 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 146 DFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred cccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 999987532221 122334678899999999774 4789999999999999999999999887766555444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=234.45 Aligned_cols=216 Identities=24% Similarity=0.462 Sum_probs=174.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-CCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-EAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.++.+++.||+|.+..... .....+.+ .++++.++.++|+|++++.+.+.. ++..+++|||+++++|.+++
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l 91 (257)
T cd08223 16 VSLVRHRTDGKQYVIKKLNLRNA-SRRERKAA---EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL 91 (257)
T ss_pred EEEEEEcCCCcEEEEEEEehhhc-CHHHHHHH---HHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHH
Confidence 68999999999999999975432 12222333 344677888999999999998764 55789999999999999888
Q ss_pred hh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
.. ..+++..+..++.|++.|++++|++|++|+ |++|+|| +++.++.++|+||
T Consensus 92 ~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~---di~p~ni----------------------l~~~~~~~~l~df 146 (257)
T cd08223 92 KEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR---DLKTQNV----------------------FLTRTNIIKVGDL 146 (257)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCchhE----------------------EEecCCcEEEecc
Confidence 53 358999999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFL 235 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~ 235 (245)
|++..............++..|+|||.+.+..++.++|+||||+++++|++|+.||.+.+.......+..+.. ..|...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd08223 147 GIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226 (257)
T ss_pred cceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCcccc
Confidence 9987543333334455678899999999888899999999999999999999999988776666655555433 456678
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+++++
T Consensus 227 ~~~~~~li~~ 236 (257)
T cd08223 227 SPELGELIAT 236 (257)
T ss_pred CHHHHHHHHH
Confidence 8888888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.50 Aligned_cols=196 Identities=26% Similarity=0.370 Sum_probs=156.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||+|.++...... .......+|.+++..++.++||||+++++++.. ....+++||++.+ +|
T Consensus 16 v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 93 (288)
T cd07863 16 VYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DL 93 (288)
T ss_pred EEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CH
Confidence 7999999999999999987542211 112233455556666667789999999999864 3468999999975 78
Q ss_pred hhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 76 MMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 76 ~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
..++.. ..+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---dikp~Ni----------------------li~~~~~~k 148 (288)
T cd07863 94 RTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR---DLKPENI----------------------LVTSGGQVK 148 (288)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EECCCCCEE
Confidence 777743 348999999999999999999999999999 8888888 788889999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++|++||.+....+....+
T Consensus 149 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 149 LADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219 (288)
T ss_pred ECccCccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence 9999998753222 2233456788999999998888999999999999999999999999877665555444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=241.02 Aligned_cols=213 Identities=24% Similarity=0.462 Sum_probs=172.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||||.+.... ....+.+.+| +..++.++|||++++++.+..++..+++|||+++++|..++.
T Consensus 38 v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e---~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 111 (292)
T cd06658 38 VCIATEKHTGKQVAVKKMDLRK---QQRRELLFNE---VVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111 (292)
T ss_pred EEEEEECCCCCEEEEEEEecch---HHHHHHHHHH---HHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh
Confidence 6899999899999999986532 2223334444 667788899999999999999999999999999999999887
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 112 ~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kL~dfg~~~ 166 (292)
T cd06658 112 HTRMNEEQIATVCLSVLRALSYLHNQGVIHR---DIKSDSI----------------------LLTSDGRIKLSDFGFCA 166 (292)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---CCCHHHE----------------------EEcCCCCEEEccCcchh
Confidence 7789999999999999999999999999999 8888888 77888999999999886
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
.............++..|+|||.+.+..++.++|+||||+++|||++|+.||.+.+..+....+...... .+...++
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCH
Confidence 5333332233456788999999998888999999999999999999999999877766655544332211 1235677
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
.+.++|+
T Consensus 247 ~~~~li~ 253 (292)
T cd06658 247 VLRGFLD 253 (292)
T ss_pred HHHHHHH
Confidence 7777765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=238.22 Aligned_cols=215 Identities=22% Similarity=0.377 Sum_probs=172.1
Q ss_pred CEeEEEecCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTG-----EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+...+ +.||+|.+.... .....+.+.+ +++.++.++||||+++++++...+..+++|||+++++|
T Consensus 21 Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~---ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L 95 (283)
T cd05048 21 VYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQ---EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95 (283)
T ss_pred EEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHH---HHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcH
Confidence 6888776554 789999987532 2222333444 46778888999999999999999999999999999999
Q ss_pred hhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 76 MMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 76 ~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~---dlkp~Ni----------------- 155 (283)
T cd05048 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHR---DLAARNC----------------- 155 (283)
T ss_pred HHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---ccccceE-----------------
Confidence 988853 346778889999999999999999999999 8888887
Q ss_pred chhccccCCCCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGD 215 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~ 215 (245)
+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 156 -----l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 156 -----LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred -----EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 77788999999999987432211 11223355778999999988889999999999999999998 99999988
Q ss_pred CHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 216 DEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 216 ~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
+..+....+..+.. ..|..+++++.+|+.+
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~ 261 (283)
T cd05048 231 SNQEVIEMIRSRQLLPCPEDCPARVYALMIE 261 (283)
T ss_pred CHHHHHHHHHcCCcCCCcccCCHHHHHHHHH
Confidence 88888777766543 4578899999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=236.00 Aligned_cols=213 Identities=24% Similarity=0.398 Sum_probs=173.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.||+|.+.... ...+.+.+ +++.++.++||||+++++++..++..+++|||+++++|.+++.
T Consensus 22 v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (263)
T cd05052 22 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 94 (263)
T ss_pred EEEEEEecCCceEEEEEecCCc----hHHHHHHH---HHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHH
Confidence 6899999999999999987532 12233444 4667778899999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 95 ~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~---dlkp~ni----------------------l~~~~~~~kl~df~ 149 (263)
T cd05052 95 ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR---DLAARNC----------------------LVGENHLVKVADFG 149 (263)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec---ccCcceE----------------------EEcCCCcEEeCCCc
Confidence 3 357888999999999999999999999999 8888888 77788999999999
Q ss_pred CccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 158 LCKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+... ....|..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 150 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG 229 (263)
T ss_pred cccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 98754322111 111223457999999988889999999999999999998 99999988877777776654 3456788
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.+++++
T Consensus 230 ~~~~~~~li~~ 240 (263)
T cd05052 230 CPPKVYELMRA 240 (263)
T ss_pred CCHHHHHHHHH
Confidence 89999988864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=254.23 Aligned_cols=187 Identities=23% Similarity=0.365 Sum_probs=148.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--------CeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--------AHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--------~~~~lv~e~~~~ 72 (245)
||+|.+..+++.||||++.... ... .+++.+++.++||||++++++|... ...++||||+++
T Consensus 82 Vy~~~~~~~~~~vAiK~i~~~~-------~~~---~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~ 151 (440)
T PTZ00036 82 VYEAICIDTSEKVAIKKVLQDP-------QYK---NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ 151 (440)
T ss_pred EEEEEECCCCCEEEEEEEecCc-------chH---HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc
Confidence 7999999999999999886432 111 2346778889999999999987432 257799999976
Q ss_pred Cchhhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 73 GDLMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 73 ~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
++..++. ...+++..++.++.|++.||+|||++||+|| |+||+|| +++.
T Consensus 152 -~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHr---DLKp~NI----------------------Ll~~ 205 (440)
T PTZ00036 152 -TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHR---DLKPQNL----------------------LIDP 205 (440)
T ss_pred -cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CcCHHHE----------------------EEcC
Confidence 5655542 3468899999999999999999999999999 8888887 6664
Q ss_pred C-CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 148 E-GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 148 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+ +.+||+|||+++..... .......|++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+....+
T Consensus 206 ~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred CCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4 47999999999754322 223345778999999998764 6899999999999999999999999987766555444
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=233.43 Aligned_cols=214 Identities=38% Similarity=0.707 Sum_probs=171.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++................+.. ......+|||++++++++..++..++++||+++++|..+++
T Consensus 12 v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~--~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 89 (260)
T cd05611 12 VYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERA--IMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK 89 (260)
T ss_pred EEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHH--HHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH
Confidence 6999999999999999997643322222333333322 22345589999999999999999999999999999999886
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.|+|+.+++|+ |++|+|| +++.++.++|+|||++
T Consensus 90 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~dfg~~ 144 (260)
T cd05611 90 TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR---DIKPENL----------------------LIDQTGHLKLTDFGLS 144 (260)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EECCCCcEEEeecccc
Confidence 4 578999999999999999999999999999 8888888 7778899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC----CCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY----PRFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----p~~~ 235 (245)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......+ +..+
T Consensus 145 ~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd05611 145 RNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC 220 (260)
T ss_pred eeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccC
Confidence 74322 234457788999999988778999999999999999999999998887777666665544332 3457
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.++|++
T Consensus 221 ~~~~~~~i~~ 230 (260)
T cd05611 221 SPEAVDLINR 230 (260)
T ss_pred CHHHHHHHHH
Confidence 8888888763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=249.64 Aligned_cols=214 Identities=27% Similarity=0.447 Sum_probs=163.4
Q ss_pred CEeEEEecCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTG-----EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|++..+| +.||+|.++... .....+.+.+| +++++.+ +||||+++++++...+..+++|||+.+|+
T Consensus 54 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~ 128 (374)
T cd05106 54 VVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSE---LKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGD 128 (374)
T ss_pred EEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHH---HHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCc
Confidence 6888865444 579999997542 12233444444 5667677 79999999999999999999999999999
Q ss_pred hhhhhhh-----------------------------------------------------------------------cC
Q psy3347 75 LMMHIHA-----------------------------------------------------------------------DV 83 (245)
Q Consensus 75 L~~~~~~-----------------------------------------------------------------------~~ 83 (245)
|.+++.. .+
T Consensus 129 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (374)
T cd05106 129 LLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWP 208 (374)
T ss_pred HHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCC
Confidence 9888742 13
Q ss_pred CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCC
Q psy3347 84 FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM 163 (245)
Q Consensus 84 l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 163 (245)
+++..+.+++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+++...
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHr---DLkp~Ni----------------------l~~~~~~~kL~DfGla~~~~ 263 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHR---DVAARNV----------------------LLTDGRVAKICDFGLARDIM 263 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEec---cCchheE----------------------EEeCCCeEEEeeceeeeecc
Confidence 5677889999999999999999999999 8888887 77788899999999987533
Q ss_pred CCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc--ccCCCCCChh
Q psy3347 164 GFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE--VRYPRFLSLE 238 (245)
Q Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~--~~~p~~~~~~ 238 (245)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.... ...|..++++
T Consensus 264 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred CCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 2211 1112234567999999988889999999999999999997 999998765444333333332 2346677888
Q ss_pred HHhhhc
Q psy3347 239 AIAIMR 244 (245)
Q Consensus 239 ~~~li~ 244 (245)
+.++|+
T Consensus 344 l~~li~ 349 (374)
T cd05106 344 IYSIMK 349 (374)
T ss_pred HHHHHH
Confidence 888875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=232.78 Aligned_cols=215 Identities=20% Similarity=0.361 Sum_probs=170.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.+|+|.+.... ..+....+.+ ++++++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 11 vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 85 (252)
T cd05084 11 VFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQ---EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 85 (252)
T ss_pred EEEEEEecCCceEEEEecCccC--CHHHHHHHHH---HHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHH
Confidence 7999999999999999886432 2222334444 4667788899999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||.
T Consensus 86 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~kl~dfg~ 140 (252)
T cd05084 86 TEGPRLKVKELIQMVENAAAGMEYLESKHCIHR---DLAARNC----------------------LVTEKNVLKISDFGM 140 (252)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc---ccchheE----------------------EEcCCCcEEECcccc
Confidence 4 358899999999999999999999999999 8888787 777888999999998
Q ss_pred ccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 159 CKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
+......... ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+... ....|..
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 220 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPEL 220 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCccc
Confidence 8643211110 011122456999999988889999999999999999998 99999877766665555443 3345677
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
++..+.+++++
T Consensus 221 ~~~~~~~li~~ 231 (252)
T cd05084 221 CPDAVYRLMER 231 (252)
T ss_pred CCHHHHHHHHH
Confidence 88888888763
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=235.49 Aligned_cols=214 Identities=23% Similarity=0.357 Sum_probs=166.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++.... ......+. +++..++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 25 vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~---~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 98 (267)
T cd06646 25 VYKARNLHTGELAAVKIIKLEP---GDDFSLIQ---QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH 98 (267)
T ss_pred EEEEEECCCCeEEEEEEEecCc---cchHHHHH---HHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 7999999999999999997532 12222333 34677888999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|+ +++.++.++|+|||++
T Consensus 99 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~ni----------------------ll~~~~~~~l~dfg~~ 153 (267)
T cd06646 99 VTGPLSELQIAYVCRETLQGLAYLHSKGKMHR---DIKGANI----------------------LLTDNGDVKLADFGVA 153 (267)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EECCCCCEEECcCccc
Confidence 4578999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC-----
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY----- 231 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----- 231 (245)
..............++..|+|||.+. ...++.++|+||||+++|+|++|+.||......+....+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06646 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233 (267)
T ss_pred eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence 75432222233456788999999984 3457789999999999999999999986554443332222222221
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
+..++.++.++|++
T Consensus 234 ~~~~~~~~~~li~~ 247 (267)
T cd06646 234 KTKWSSTFHNFVKI 247 (267)
T ss_pred ccccCHHHHHHHHH
Confidence 23467788888763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=235.47 Aligned_cols=217 Identities=24% Similarity=0.378 Sum_probs=171.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.+|+|.+...........+.+.+ ++..++.++||||+++++++..++..+++|||+++++|..++.
T Consensus 18 v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~---e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 94 (267)
T cd08229 18 VYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 94 (267)
T ss_pred EEEEeecCCCceEEEEeeeehhhhhHHHHHHHHH---HHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHH
Confidence 7999999999999999887643333333344444 4677888899999999999999999999999999999988774
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~---dl~p~ni----------------------li~~~~~~~l~d 149 (267)
T cd08229 95 HFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR---DIKPANV----------------------FITATGVVKLGD 149 (267)
T ss_pred HhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EEcCCCCEEECc
Confidence 2 357889999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCccc-C-
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE--EEVFDSIVNDEVR-Y- 231 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~--~~~~~~~~~~~~~-~- 231 (245)
||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... .+....+.....+ .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08229 150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 229 (267)
T ss_pred chhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC
Confidence 99887543332223345678899999999888889999999999999999999999965432 3333344333222 2
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
+..+++++++++.+
T Consensus 230 ~~~~~~~~~~li~~ 243 (267)
T cd08229 230 SDHYSEELRQLVNM 243 (267)
T ss_pred cccccHHHHHHHHH
Confidence 34577888888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=233.82 Aligned_cols=213 Identities=27% Similarity=0.395 Sum_probs=171.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|++.... ....+.+. +++++++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 19 v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~---~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~ 92 (262)
T cd06613 19 VYKARDIATGELVAIKVIKLEP---GDDFEIIQ---QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ 92 (262)
T ss_pred EEEeEecCCCCEEEEEEEEcCc---hhhHHHHH---HHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 6899999999999999998642 12233443 44778889999999999999999999999999999999998885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||.
T Consensus 93 ~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~---dl~p~ni----------------------~i~~~~~~~l~d~g~ 147 (262)
T cd06613 93 VTRGPLSELQIAYVCRETLKGLAYLHETGKIHR---DIKGANI----------------------LLTEDGDVKLADFGV 147 (262)
T ss_pred hhccCCCHHHHHHHHHHHHHHHHHHHhCCceec---CCChhhE----------------------EECCCCCEEECcccc
Confidence 3 578999999999999999999999999999 8888888 788889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC----
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET---SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY---- 231 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 231 (245)
+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 87543333233445678889999999776 78899999999999999999999998776555544444332221
Q ss_pred -CCCCChhHHhhhc
Q psy3347 232 -PRFLSLEAIAIMR 244 (245)
Q Consensus 232 -p~~~~~~~~~li~ 244 (245)
+...++++.++|+
T Consensus 228 ~~~~~~~~~~~li~ 241 (262)
T cd06613 228 DKEKWSPVFHDFIK 241 (262)
T ss_pred chhhhhHHHHHHHH
Confidence 2345667777775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=232.53 Aligned_cols=215 Identities=25% Similarity=0.393 Sum_probs=169.0
Q ss_pred CEeEEE--ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQY--RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+ ..+++.+|+|+++.... .....+.+.+| +.+++.++||||+++++++. ....+++|||+++++|..+
T Consensus 11 v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 85 (257)
T cd05116 11 VKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLRE---ANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKF 85 (257)
T ss_pred eEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHH---HHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHH
Confidence 688854 45688999999875431 22223334433 66778889999999999885 4467899999999999998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||+|+|++|++|+ |++|+|+ +++.++.++|+|||
T Consensus 86 l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~---dlkp~ni----------------------ll~~~~~~kl~Dfg 140 (257)
T cd05116 86 LQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR---DLAARNV----------------------LLVTQHYAKISDFG 140 (257)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---ccchhhE----------------------EEcCCCeEEECCCc
Confidence 854 568999999999999999999999999999 7777777 67778899999999
Q ss_pred CccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 158 LCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
++......... .....++..|+|||.+....++.++|+||||+++|||++ |..||.+....+....+..+. .+.|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 220 (257)
T cd05116 141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP 220 (257)
T ss_pred cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 98754322211 112223468999999987888999999999999999998 999998887777777776543 3567
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++.++|++
T Consensus 221 ~~~~~~l~~li~~ 233 (257)
T cd05116 221 QRCPPEMYDLMKL 233 (257)
T ss_pred CCCCHHHHHHHHH
Confidence 8899999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=230.94 Aligned_cols=215 Identities=23% Similarity=0.406 Sum_probs=176.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||.+++..+++.+++|.+....... .....+. ++++++++++|+||+++++++...+..+++|||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~---~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~ 91 (256)
T cd08221 16 ATLYRRTEDDSLVVWKEVNLTRLSE-KERRDAL---NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV 91 (256)
T ss_pred EEEEEEcCCCcEEEEEEEeecccch-hHHHHHH---HHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHH
Confidence 5788999999999999987543222 2233343 44777888999999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~---dl~p~ni----------------------~~~~~~~~kl~d~~ 146 (256)
T cd08221 92 RQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR---DIKTLNI----------------------FLTKAGLIKLGDFG 146 (256)
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHhCCcccc---CCChHhE----------------------EEeCCCCEEECcCc
Confidence 4 357899999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-CCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLS 236 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~p~~~~ 236 (245)
.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+... .+..++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08221 147 ISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYS 226 (256)
T ss_pred ceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 8875433332334456788999999998878889999999999999999999999888877777777665543 346678
Q ss_pred hhHHhhhc
Q psy3347 237 LEAIAIMR 244 (245)
Q Consensus 237 ~~~~~li~ 244 (245)
.++.++|+
T Consensus 227 ~~~~~~i~ 234 (256)
T cd08221 227 SELISLVH 234 (256)
T ss_pred HHHHHHHH
Confidence 88888775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=234.18 Aligned_cols=214 Identities=25% Similarity=0.433 Sum_probs=175.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.... .....+.+ .+++..++.++||||+++++.+..++..++||||+++++|..++.
T Consensus 20 vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~ 94 (277)
T cd06641 20 VFKGIDNRTQKVVAIKIIDLEE--AEDEIEDI---QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE 94 (277)
T ss_pred EEEEEECCCCcEEEEEEecccc--chHHHHHH---HHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh
Confidence 7999999899999999886432 12222333 344677788999999999999999999999999999999999988
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.|+.+||++|++|+ |++|+|+ +++.++.++|+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~---dl~p~Ni----------------------~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 95 PGPLDETQIATILREILKGLDYLHSEKKIHR---DIKAANV----------------------LLSEHGEVKLADFGVAG 149 (277)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHccCCeecC---CCCHHhE----------------------EECCCCCEEEeecccce
Confidence 7789999999999999999999999999999 8888888 77888999999999886
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCChhH
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSLEA 239 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~ 239 (245)
.............++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..... ..+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 229 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHH
Confidence 543322223344678889999999888889999999999999999999999987776666665544433 3556778888
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.+++.
T Consensus 230 ~~~i~ 234 (277)
T cd06641 230 KEFVE 234 (277)
T ss_pred HHHHH
Confidence 88875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=236.88 Aligned_cols=214 Identities=27% Similarity=0.475 Sum_probs=170.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.+|+|.+... .....+.+.+ +++.++.++||||+++++.+..++..++||||+++++|..++.
T Consensus 28 vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 101 (292)
T cd06644 28 VYKAKNKETGALAAAKVIETK---SEEELEDYMV---EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML 101 (292)
T ss_pred EEEEEECCCCceEEEEEeccC---CHHHHHHHHH---HHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHH
Confidence 799999999999999999754 2223334433 4667788999999999999999999999999999999987764
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 102 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~kl~dfg~ 156 (292)
T cd06644 102 ELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR---DLKAGNV----------------------LLTLDGDIKLADFGV 156 (292)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeec---CCCcceE----------------------EEcCCCCEEEccCcc
Confidence 3468999999999999999999999999999 8888888 777889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---c
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---R 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~ 230 (245)
+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 7653333222344567888999999853 4467889999999999999999999987666555555544322 2
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|..++.++.++|++
T Consensus 237 ~~~~~~~~~~~li~~ 251 (292)
T cd06644 237 QPSKWSMEFRDFLKT 251 (292)
T ss_pred CCcccCHHHHHHHHH
Confidence 356677888888763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=241.29 Aligned_cols=185 Identities=25% Similarity=0.476 Sum_probs=154.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.+|+|.+.... .....+.+. +++++++.++||||++++++|..+++.++||||+.+++|.++++
T Consensus 21 V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 95 (333)
T cd06650 21 VFKVSHKPSGLIMARKLIHLEI--KPAIRNQII---RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 95 (333)
T ss_pred EEEEEECCCCcEEEEEEeeccc--CHHHHHHHH---HHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH
Confidence 7999999999999999987542 122223344 44777888899999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++ +++|+ |+||+|| +++.++.+||+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~---dlkp~Ni----------------------li~~~~~~kL~Dfg~ 150 (333)
T cd06650 96 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR---DVKPSNI----------------------LVNSRGEIKLCDFGV 150 (333)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec---CCChhhE----------------------EEcCCCCEEEeeCCc
Confidence 4 5688999999999999999999985 79999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
+...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 151 SGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred chhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 8643221 12344688899999999888899999999999999999999999975543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=232.72 Aligned_cols=214 Identities=23% Similarity=0.394 Sum_probs=167.6
Q ss_pred CEeEEEe--cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYR--NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+. .++..||+|++.... .....+.+.+| ++++++++||||+++++++. ....++||||+++++|.++
T Consensus 11 v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E---~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~ 84 (257)
T cd05115 11 VKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMRE---AEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKF 84 (257)
T ss_pred EEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHH---HHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHH
Confidence 6888765 456679999987542 12222334444 66778889999999999985 4578999999999999998
Q ss_pred hh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+. ...+++..+.+++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 85 l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~ni----------------------l~~~~~~~kl~df 139 (257)
T cd05115 85 LSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR---DLAARNV----------------------LLVNQHYAKISDF 139 (257)
T ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeec---ccchheE----------------------EEcCCCcEEeccC
Confidence 85 3468999999999999999999999999999 7777777 7778889999999
Q ss_pred CCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccC
Q psy3347 157 GLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRY 231 (245)
Q Consensus 157 g~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~ 231 (245)
|++......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+....+....+..+. ...
T Consensus 140 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05115 140 GLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC 219 (257)
T ss_pred CccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence 998743222211 111122467999999988889999999999999999996 999998888777777666544 345
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|..+++++.++|.+
T Consensus 220 ~~~~~~~l~~li~~ 233 (257)
T cd05115 220 PAECPPEMYALMKD 233 (257)
T ss_pred CCCCCHHHHHHHHH
Confidence 78889999998863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=235.52 Aligned_cols=214 Identities=25% Similarity=0.471 Sum_probs=174.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|++.... ....+.+.+ ++..++.++|||++++++++...+..++++||+++++|.+++.
T Consensus 35 v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~---e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 108 (285)
T cd06648 35 VCIATDKSTGRQVAVKKMDLRK---QQRRELLFN---EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT 108 (285)
T ss_pred EEEEEECCCCCEEEEEEEeccc---hhHHHHHHH---HHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHH
Confidence 6899999999999999886432 222233333 3667888899999999999999999999999999999999987
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|+|++|++|+ +++|+|| +++.++.++|+|||.+.
T Consensus 109 ~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 109 HTRMNEEQIATVCLAVLKALSFLHAQGVIHR---DIKSDSI----------------------LLTSDGRVKLSDFGFCA 163 (285)
T ss_pred hCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCChhhE----------------------EEcCCCcEEEcccccch
Confidence 7788999999999999999999999999999 8888888 77888999999999876
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC---CCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY---PRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---p~~~~~ 237 (245)
.............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....+. +..+++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCH
Confidence 54333322334567889999999988889999999999999999999999998877766666665543222 334778
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
.+.++|++
T Consensus 244 ~l~~li~~ 251 (285)
T cd06648 244 RLRSFLDR 251 (285)
T ss_pred HHHHHHHH
Confidence 88888763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=231.51 Aligned_cols=217 Identities=24% Similarity=0.441 Sum_probs=172.2
Q ss_pred CEeEEEecCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDI--IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+.||+|.+..... ...+....+ .++++.++.++||||+++++++... +..+++|||+++++|.
T Consensus 18 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~---~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~ 94 (264)
T cd06653 18 VYLCYDADTGRELAVKQVPFDPDSQETSKEVNAL---ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK 94 (264)
T ss_pred EEEEEEcCCCCEEEEEEEecCcccchhhHHHHHH---HHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHH
Confidence 69999999999999998864321 112222333 4457788899999999999998654 5688999999999999
Q ss_pred hhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++.. ..+++..+.+++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~---dl~p~ni----------------------~i~~~~~~~l~d 149 (264)
T cd06653 95 DQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHR---DIKGANI----------------------LRDSAGNVKLGD 149 (264)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EEcCCCCEEECc
Confidence 88854 568899999999999999999999999999 8888888 777888999999
Q ss_pred cCCccCCCCCC---CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--cc
Q psy3347 156 FGLCKEGMGFG---DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VR 230 (245)
Q Consensus 156 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~ 230 (245)
||.++...... .......++..|+|||.+.+..++.++|+||||+++|++++|+.||......+...++.... +.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM 229 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCC
Confidence 99987532211 11123457888999999988888999999999999999999999998776666555554332 34
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|..+++++.++|++
T Consensus 230 ~p~~~~~~~~~~i~~ 244 (264)
T cd06653 230 LPDGVSDACRDFLKQ 244 (264)
T ss_pred CCcccCHHHHHHHHH
Confidence 688899999988863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=237.95 Aligned_cols=206 Identities=21% Similarity=0.360 Sum_probs=157.4
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc-------
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD------- 82 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------- 82 (245)
+..||+|++.... .......+.+ +++.+..++||||+++++++...+..+++|||+++++|.+++...
T Consensus 46 ~~~vaiK~~~~~~--~~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 120 (304)
T cd05096 46 PLLVAVKILRPDA--NKNARNDFLK---EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120 (304)
T ss_pred ceEEEEEEecCCC--CHHHHHHHHH---HHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccc
Confidence 4579999987542 1222334444 467788889999999999999999999999999999998887432
Q ss_pred -------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 83 -------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 83 -------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
.+++..+.+++.|++.||.|||++|++|+ |+||+|| +++.++
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~---dlkp~Ni----------------------ll~~~~ 175 (304)
T cd05096 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR---DLATRNC----------------------LVGENL 175 (304)
T ss_pred ccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc---Ccchhhe----------------------EEcCCc
Confidence 25667888999999999999999999999 8888888 778889
Q ss_pred ceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHh
Q psy3347 150 YVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV--GESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~pf~~~~~~~~~~~~~ 225 (245)
.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ +..||.+.+..+....+.
T Consensus 176 ~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 255 (304)
T cd05096 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAG 255 (304)
T ss_pred cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHH
Confidence 999999999874322111 1223345678999999988889999999999999999986 678887766655554432
Q ss_pred c---C-----cccCCCCCChhHHhhhcC
Q psy3347 226 N---D-----EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 226 ~---~-----~~~~p~~~~~~~~~li~~ 245 (245)
. . ....|..+++.+.+||.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (304)
T cd05096 256 EFFRDQGRQVYLFRPPPCPQGLYELMLQ 283 (304)
T ss_pred HHhhhccccccccCCCCCCHHHHHHHHH
Confidence 1 1 112356788888888753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=232.13 Aligned_cols=219 Identities=23% Similarity=0.408 Sum_probs=171.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+ .+|+.+|+|.+...........+......++++.++.++|+||+++++++...+..+++|||+++++|.+++.
T Consensus 16 v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 94 (265)
T cd06631 16 VYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN 94 (265)
T ss_pred EEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH
Confidence 688876 4789999999875432222222222333445778889999999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. .++++..+..++.|++.||+|+|+.|++|+ |++|+|| +++.++.++|+|||++
T Consensus 95 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~dfg~~ 149 (265)
T cd06631 95 RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR---DIKGNNV----------------------MLMPNGIIKLIDFGCA 149 (265)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CcCHHhE----------------------EECCCCeEEeccchhh
Confidence 4 578999999999999999999999999999 8888888 7788899999999988
Q ss_pred cCCCCC------CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---ccc
Q psy3347 160 KEGMGF------GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND---EVR 230 (245)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~~ 230 (245)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... .++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 643211 11122345788899999998888899999999999999999999999876655544444332 234
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|..+++++.++|++
T Consensus 230 ~~~~~~~~~~~~i~~ 244 (265)
T cd06631 230 LPDSFSAAAIDFVTS 244 (265)
T ss_pred CCCCCCHHHHHHHHH
Confidence 567788888888863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=233.52 Aligned_cols=217 Identities=26% Similarity=0.427 Sum_probs=170.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+.... .....+.+.+|.+++..++...|||++++++++..+...+++|||+.+++|.++++
T Consensus 17 v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (277)
T cd06917 17 VYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK 94 (277)
T ss_pred EEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence 6899999999999999987532 22233445555444444444459999999999999999999999999999999987
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||.|||+.|++|+ +++|+|| +++.++.++|+|||.+.
T Consensus 95 ~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~---dl~p~ni----------------------~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 95 AGPIAEKYISVIIREVLVALKYIHKVGVIHR---DIKAANI----------------------LVTNTGNVKLCDFGVAA 149 (277)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CcCHHHE----------------------EEcCCCCEEEccCCcee
Confidence 7789999999999999999999999999999 8888888 77788999999999887
Q ss_pred CCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCC-CCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPR-FLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~-~~~~ 237 (245)
.............|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..... .++. ..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence 64443333445568889999999865 4578899999999999999999999987766554444333222 2333 3677
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
++.++|+
T Consensus 230 ~~~~~i~ 236 (277)
T cd06917 230 LLREFVA 236 (277)
T ss_pred HHHHHHH
Confidence 8888775
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.93 Aligned_cols=176 Identities=26% Similarity=0.375 Sum_probs=148.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|.... +.+. +++++++.++||||++++++|..++..+++||++. ++|..++.
T Consensus 108 V~~~~d~~~~~~vaiK~~~~---------~~~~---~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~ 174 (391)
T PHA03212 108 AFACIDNKTCEHVVIKAGQR---------GGTA---TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA 174 (391)
T ss_pred EEEEEECCCCCEEEEechhh---------hhhH---HHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH
Confidence 79999999999999997542 1223 34677889999999999999999999999999985 57777764
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||++
T Consensus 175 ~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHr---DiKP~NI----------------------ll~~~~~vkL~DFG~a 229 (391)
T PHA03212 175 AKRNIAICDILAIERSVLRAIQYLHENRIIHR---DIKAENI----------------------FINHPGDVCLGDFGAA 229 (391)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCChHhE----------------------EEcCCCCEEEEeCCcc
Confidence 4568999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 160 KEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 6432221 123345789999999999888899999999999999999999987643
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=233.45 Aligned_cols=219 Identities=25% Similarity=0.452 Sum_probs=168.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...........+......++++.++.++|+||+++++++.+.++.+++|||+.+++|.++++
T Consensus 16 v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 95 (268)
T cd06630 16 CYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS 95 (268)
T ss_pred EEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH
Confidence 68999999999999999975432222222222333445778888999999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~ 158 (245)
. .++++..+..++.|++.||.|||++|++|+ +++|+|| +++.++ .++|+|||.
T Consensus 96 ~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~---~i~~~ni----------------------l~~~~~~~~~l~dfg~ 150 (268)
T cd06630 96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHR---DVKGANL----------------------LIDSTGQRLRIADFGA 150 (268)
T ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEEccccc
Confidence 4 568999999999999999999999999999 8888888 555554 699999998
Q ss_pred ccCCCCCCC----CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh--cCcc
Q psy3347 159 CKEGMGFGD----RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE---EVFDSIV--NDEV 229 (245)
Q Consensus 159 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~---~~~~~~~--~~~~ 229 (245)
+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .....+. ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 875433211 122345778899999998888899999999999999999999999654322 2222222 1233
Q ss_pred cCCCCCChhHHhhhc
Q psy3347 230 RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~~~~~~~~~li~ 244 (245)
..|..+++++.+++.
T Consensus 231 ~~~~~~~~~~~~~i~ 245 (268)
T cd06630 231 SIPEHLSPGLRDVTL 245 (268)
T ss_pred CCchhhCHHHHHHHH
Confidence 456778888888775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.90 Aligned_cols=216 Identities=25% Similarity=0.439 Sum_probs=168.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIA--RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+.||+|.+....... ....+.+.+| ++.++.++||||+++++++... +.++++|||+++++|.
T Consensus 18 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~ 94 (265)
T cd06652 18 VYLCYDADTGRELAVKQVQFDPESPETSKEVNALECE---IQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK 94 (265)
T ss_pred EEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHH---HHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHH
Confidence 6899999999999999886432111 2233444444 6777888999999999998663 5788999999999999
Q ss_pred hhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~D 149 (265)
T cd06652 95 DQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHR---DIKGANI----------------------LRDSVGNVKLGD 149 (265)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EecCCCCEEECc
Confidence 88854 568888999999999999999999999999 8888888 777889999999
Q ss_pred cCCccCCCCCC---CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--cc
Q psy3347 156 FGLCKEGMGFG---DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VR 230 (245)
Q Consensus 156 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~ 230 (245)
||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+............ ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV 229 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCC
Confidence 99887432211 11223457788999999988888999999999999999999999997765554444443322 23
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|...+..+.++|+
T Consensus 230 ~~~~~~~~~~~~i~ 243 (265)
T cd06652 230 LPPHVSDHCRDFLK 243 (265)
T ss_pred CchhhCHHHHHHHH
Confidence 46667777777775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=243.48 Aligned_cols=191 Identities=24% Similarity=0.427 Sum_probs=155.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|.+..+++.||+|++..... .....+.+ .++++.++.++||||+++++++... ...|++++++ +++
T Consensus 31 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 105 (343)
T cd07878 31 VCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRT---YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GAD 105 (343)
T ss_pred EEEEEECCCCCEEEEEEeCchhh-hhHHHHHH---HHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCC
Confidence 79999999999999999975421 11122223 3457778889999999999988543 3579999987 678
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|..+++...+++..+..++.|++.||+|||++||+|| |++|+|| +++.++.+||+
T Consensus 106 l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr---dikp~Ni----------------------l~~~~~~~kl~ 160 (343)
T cd07878 106 LNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHR---DLKPSNV----------------------AVNEDCELRIL 160 (343)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---cCChhhE----------------------EECCCCCEEEc
Confidence 9888887789999999999999999999999999999 8888888 78888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|||++..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 161 Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 161 DFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999875322 2334578899999999976 46889999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=243.67 Aligned_cols=191 Identities=24% Similarity=0.374 Sum_probs=153.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||+|++..+|+.||+|++..... .......+ .+++.+++.++||||+++++++...+ ..|++|||+++ +
T Consensus 37 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 111 (359)
T cd07876 37 VCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRA---YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-N 111 (359)
T ss_pred EEEEEEcCCCceeEEEEeccccc-chhHHHHH---HHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-C
Confidence 79999999999999999975421 12222333 34577788899999999999986543 57999999976 5
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+...+. ..+++..+..++.|++.||.|||++||+|| |++|+|| +++.++.++|+
T Consensus 112 l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHr---Dlkp~NI----------------------l~~~~~~~kl~ 165 (359)
T cd07876 112 LCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 165 (359)
T ss_pred HHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EECCCCCEEEe
Confidence 555543 348888899999999999999999999999 8888888 78889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
|||+++..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 166 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~ 233 (359)
T cd07876 166 DFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK 233 (359)
T ss_pred cCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99998753222 223345678899999999988899999999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=263.55 Aligned_cols=231 Identities=24% Similarity=0.374 Sum_probs=167.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++..+++.||+|++..... .......+.+ ++.+++.++||||++++++|.. .+.+|+||||+++++|..+
T Consensus 29 VYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~---EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~l 104 (1021)
T PTZ00266 29 VFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVI---EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRN 104 (1021)
T ss_pred EEEEEECCCCeEEEEEEEecccc-CHHHHHHHHH---HHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHH
Confidence 79999999999999999976432 2223344444 4677888999999999998854 4579999999999999988
Q ss_pred hhh-----cCCChHHHHHHHHHHHHHHHHhhhc-------CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 79 IHA-----DVFSEPRAVFYAACVVLGLQYLHES-------RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 79 ~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~-------~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
+.. ..+++..++.|+.||+.||+|||+. +|+|+ ||||+|| ++.................+
T Consensus 105 L~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHR---DLKPeNI-----LL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 105 IQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHR---DLKPQNI-----FLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceec---cCcHHHe-----EeecCccccccccccccccC
Confidence 853 4689999999999999999999984 49999 5555555 44321110000000111234
Q ss_pred CCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 147 TEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
..+.+||+|||++..... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........
T Consensus 177 g~~iVKLsDFGlAr~l~~-~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~ 255 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGI-ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255 (1021)
T ss_pred CCCceEEccCCccccccc-cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHH
Confidence 456799999999875322 222334578999999999964 45789999999999999999999999866555444444
Q ss_pred hcCcccCC-CCCChhHHhhhc
Q psy3347 225 VNDEVRYP-RFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~~~~~p-~~~~~~~~~li~ 244 (245)
+...+.+| ...++++.+||+
T Consensus 256 lk~~p~lpi~~~S~eL~dLI~ 276 (1021)
T PTZ00266 256 LKRGPDLPIKGKSKELNILIK 276 (1021)
T ss_pred HhcCCCCCcCCCCHHHHHHHH
Confidence 44444433 457888888875
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=236.61 Aligned_cols=192 Identities=22% Similarity=0.415 Sum_probs=155.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|.++.... ......+. ++++.++.++||||+++++++..++..+++|||+++ +|..++.
T Consensus 22 vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~---~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 95 (301)
T cd07873 22 VYKGRSKLTDNLVALKEIRLEHE--EGAPCTAI---REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD 95 (301)
T ss_pred EEEEEEcCCCcEEEEEEEecccc--cCchhHHH---HHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHH
Confidence 79999999999999999875421 11122233 346778889999999999999999999999999975 7877774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~dfg~ 150 (301)
T cd07873 96 DCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR---DLKPQNL----------------------LINERGELKLADFGL 150 (301)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCCHHHE----------------------EECCCCcEEECcCcc
Confidence 3 458889999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
+..............++..|+|||.+.+. .++.++||||||+++|+|++|++||.+.+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~ 216 (301)
T cd07873 151 ARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216 (301)
T ss_pred hhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 87533222223344567889999998664 478899999999999999999999988776555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=234.86 Aligned_cols=215 Identities=24% Similarity=0.405 Sum_probs=171.8
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+. .+++.||+|.++... ..+..+.+.+| +++++.++||||+++++++...+..+++|||+++++|
T Consensus 21 v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 95 (280)
T cd05049 21 VFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFERE---AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95 (280)
T ss_pred EeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHH---HHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCH
Confidence 6888764 346899999987542 22233444444 6778888999999999999999999999999999999
Q ss_pred hhhhhhc---------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 76 MMHIHAD---------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 76 ~~~~~~~---------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
.+++... .+++..+..++.|++.|++|+|++|++|+ |++|+||
T Consensus 96 ~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~---dlkp~ni------------------- 153 (280)
T cd05049 96 NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHR---DLATRNC------------------- 153 (280)
T ss_pred HHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecc---ccccceE-------------------
Confidence 9988532 36788899999999999999999999999 8888887
Q ss_pred hccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDE 217 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~ 217 (245)
+++.++.++|+|||++........ ......++..|+|||.+.+..+++++||||||+++|+|++ |+.||.+.+.
T Consensus 154 ---li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 154 ---LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred ---EEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 778889999999999864322111 1223345678999999998889999999999999999998 9999988887
Q ss_pred HHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 218 EEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 218 ~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
.+....+..+.. .+|..++.+++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 259 (280)
T cd05049 231 EEVIECITQGRLLQRPRTCPSEVYDIMLG 259 (280)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 777777766544 3467788899888863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=233.93 Aligned_cols=190 Identities=23% Similarity=0.371 Sum_probs=152.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|+++.... .....+.+.+ ++..++.++||||+++++++..++..++||||++ ++|..++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~ 90 (285)
T cd07861 16 VYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIR---EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLD 90 (285)
T ss_pred EEEEEECCCCcEEEEEEeccccc-cCCchHHHHH---HHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHh
Confidence 79999999999999999875321 1112233333 4677888899999999999999999999999997 47777664
Q ss_pred h----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 81 A----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 81 ~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~df 145 (285)
T cd07861 91 SLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR---DLKPQNL----------------------LIDNKGVIKLADF 145 (285)
T ss_pred cCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeec---CCCHHHE----------------------EEcCCCcEEECcc
Confidence 2 458899999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~ 220 (245)
|++..............++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+.
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 146 GLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred cceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9987432222222334567889999988654 578899999999999999999999987655433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=263.93 Aligned_cols=214 Identities=26% Similarity=0.467 Sum_probs=173.1
Q ss_pred CEeEEEecC-Cc----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNT-GE----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~-~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||.|....- |. .||+|.+++. ...+++..+.+| ..+|+.++||||++++|++-+.+..++++|||++|+|
T Consensus 708 VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~E---a~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL 782 (1025)
T KOG1095|consen 708 VYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKE---ALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDL 782 (1025)
T ss_pred eEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHH---HHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcH
Confidence 788876653 33 4899988864 344555555544 7778999999999999999999999999999999999
Q ss_pred hhhhhhc--------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 76 MMHIHAD--------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 76 ~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
..|++.. .++..+...++.||++|+.||++++.+|| |+-.-|. +++.
T Consensus 783 ~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR---DLAaRNC----------------------LL~~ 837 (1025)
T KOG1095|consen 783 LSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR---DLAARNC----------------------LLDE 837 (1025)
T ss_pred HHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc---chhhhhe----------------------eecc
Confidence 9999643 37788999999999999999999999999 3333333 7778
Q ss_pred CCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy3347 148 EGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~ 224 (245)
...+||+|||+|+....... ......-+.+|||||.+..+.|+.|+||||||+++||++| |..||.+.++.+++..+
T Consensus 838 ~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 838 RRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred cCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence 88999999999983211111 1111223568999999999999999999999999999999 99999999999999977
Q ss_pred hcC-cccCCCCCChhHHhhhc
Q psy3347 225 VND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~-~~~~p~~~~~~~~~li~ 244 (245)
+.+ ..+.|+.|++.+.++|.
T Consensus 918 ~~ggRL~~P~~CP~~ly~lM~ 938 (1025)
T KOG1095|consen 918 LEGGRLDPPSYCPEKLYQLML 938 (1025)
T ss_pred HhCCccCCCCCCChHHHHHHH
Confidence 655 45678999999999986
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=234.63 Aligned_cols=214 Identities=20% Similarity=0.350 Sum_probs=169.3
Q ss_pred CEeEEEe----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYR----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+. .+++.+|+|.+.... ..+....+.+ +++.++.++||||+++++++..++..|++|||+.+++|.
T Consensus 21 vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 95 (283)
T cd05090 21 IYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQ---EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLH 95 (283)
T ss_pred eEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHH---HHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHH
Confidence 6888753 456899999997532 2233344444 467788899999999999999999999999999999999
Q ss_pred hhhhh------------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 77 MHIHA------------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 77 ~~~~~------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|+
T Consensus 96 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~---dlkp~ni----------------- 155 (283)
T cd05090 96 EFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK---DLAARNI----------------- 155 (283)
T ss_pred HHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehh---ccccceE-----------------
Confidence 88742 136778889999999999999999999999 7777777
Q ss_pred chhccccCCCCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGD 215 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~ 215 (245)
+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.
T Consensus 156 -----li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 156 -----LIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred -----EEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 77788899999999987532211 11233345667999999988889999999999999999998 99999888
Q ss_pred CHHHHHHHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 216 DEEEVFDSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 216 ~~~~~~~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
...+..+.+.... .+.|..++++++++|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (283)
T cd05090 231 SNQEVIEMVRKRQLLPCSEDCPPRMYSLMT 260 (283)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 7777777665544 3456788888888875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=230.86 Aligned_cols=217 Identities=25% Similarity=0.405 Sum_probs=171.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.++..........+.+.+| ++.++.++|+|++++++.+...+..+++|||+++++|..++.
T Consensus 18 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e---i~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 94 (267)
T cd08224 18 VYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE---IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK 94 (267)
T ss_pred EEEEEEcCCCCEEEEEEeecccccchhhHHHHHHH---HHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHH
Confidence 79999999999999999875433333334445444 677888999999999999999999999999999999988774
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ..+++..+..++.+++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~---dl~p~ni----------------------l~~~~~~~~l~d 149 (267)
T cd08224 95 HFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR---DIKPANV----------------------FITATGVVKLGD 149 (267)
T ss_pred HhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecC---CcChhhE----------------------EECCCCcEEEec
Confidence 2 347889999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCcc-cCC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD--DEEEVFDSIVNDEV-RYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~--~~~~~~~~~~~~~~-~~p 232 (245)
||++..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||... +..+....+..+.. +.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08224 150 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229 (267)
T ss_pred cceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC
Confidence 998875433332233456788899999998888999999999999999999999999644 23344444444332 234
Q ss_pred C-CCChhHHhhhcC
Q psy3347 233 R-FLSLEAIAIMRR 245 (245)
Q Consensus 233 ~-~~~~~~~~li~~ 245 (245)
. ..+.+++++|++
T Consensus 230 ~~~~~~~~~~~i~~ 243 (267)
T cd08224 230 ADHYSEELRDLVSR 243 (267)
T ss_pred hhhcCHHHHHHHHH
Confidence 3 677788888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=234.99 Aligned_cols=214 Identities=22% Similarity=0.400 Sum_probs=170.9
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||++.+ ..++..+|+|.+.... ....+.+.+ +++.+++++||||+++++++...+..+++|||+++++|
T Consensus 21 v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (288)
T cd05093 21 VFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHR---EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 94 (288)
T ss_pred EEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHH---HHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCH
Confidence 577765 3356779999887532 222334444 46778889999999999999999999999999999999
Q ss_pred hhhhhhc--------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchh
Q psy3347 76 MMHIHAD--------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIK 141 (245)
Q Consensus 76 ~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~ 141 (245)
.+++... .+++..+..++.|++.||+|||++|++|| |++|+||
T Consensus 95 ~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~---dlkp~Ni-------------------- 151 (288)
T cd05093 95 NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHR---DLATRNC-------------------- 151 (288)
T ss_pred HHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---ccCcceE--------------------
Confidence 9888532 37899999999999999999999999999 8888888
Q ss_pred ccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy3347 142 LTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEE 218 (245)
Q Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~ 218 (245)
+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....
T Consensus 152 --li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 152 --LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred --EEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 778889999999999874322111 1222334668999999988889999999999999999998 99999888777
Q ss_pred HHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 219 EVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 219 ~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
+....+..+.. ..++.+++++.+|+.+
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~l~~li~~ 257 (288)
T cd05093 230 EVIECITQGRVLQRPRTCPKEVYDLMLG 257 (288)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 77777776653 4567788899888753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=230.57 Aligned_cols=217 Identities=49% Similarity=0.896 Sum_probs=182.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.+|+|.+.............+..| ++.++.++|||++++++.+..++..+++||++++++|.+++.
T Consensus 9 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 85 (250)
T cd05123 9 VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTE---RNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS 85 (250)
T ss_pred EEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHH---HHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHH
Confidence 68999988899999999987544333334444444 566778889999999999999999999999999999999886
Q ss_pred hc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 AD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.. .+++..+..++.|++.|+.|+|+++++|+ +++|+|| +++.++.++|+|||.+
T Consensus 86 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~---~l~p~ni----------------------~~~~~~~~~l~d~~~~ 140 (250)
T cd05123 86 KEGRFSEERARFYAAEIVLALEYLHSLGIIYR---DLKPENI----------------------LLDADGHIKLTDFGLA 140 (250)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCCcceE----------------------EEcCCCcEEEeecCcc
Confidence 54 68999999999999999999999999999 8888888 7788899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..............++..|+|||...+..++.++|+||||+++|++++|..||...+..+....+.....++|..++.++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 220 (250)
T cd05123 141 KELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEA 220 (250)
T ss_pred eecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHH
Confidence 75433322344456778899999998888889999999999999999999999888777777777777777888899999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.++|++
T Consensus 221 ~~~i~~ 226 (250)
T cd05123 221 RDLISG 226 (250)
T ss_pred HHHHHH
Confidence 998864
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=238.07 Aligned_cols=214 Identities=26% Similarity=0.448 Sum_probs=165.4
Q ss_pred CEeEEEecCCcE--EEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEY--FAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+|.. +|+|.++.. ......+.+.+| ++.+..+ +||||+++++++..++..+++|||+++++|.+
T Consensus 23 V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E---i~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (303)
T cd05088 23 VLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGE---LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97 (303)
T ss_pred EEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHH---HHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHH
Confidence 799999888765 466666532 122233344444 5666777 79999999999999999999999999999998
Q ss_pred hhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 78 HIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 78 ~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
+++.. .+++..+..++.|++.||+|||++|++|+ |++|+|+
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~---dlkp~Ni------------------- 155 (303)
T cd05088 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR---DLAARNI------------------- 155 (303)
T ss_pred HHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCcccc---ccchheE-------------------
Confidence 88532 46788999999999999999999999999 7777777
Q ss_pred hccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~ 219 (245)
+++.++.++|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 156 ---li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 156 ---LVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred ---EecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 77788999999999886321111 1111223567999999988888999999999999999998 999998877777
Q ss_pred HHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 220 VFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 220 ~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
....+... ....|..+++++.+||.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~li~~ 258 (303)
T cd05088 232 LYEKLPQGYRLEKPLNCDDEVYDLMRQ 258 (303)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHH
Confidence 66666544 223566678888888763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.52 Aligned_cols=214 Identities=28% Similarity=0.501 Sum_probs=169.9
Q ss_pred CEeEEEe----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYR----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+. ..+..|+||.++.. ...+..+.+.++ ++.+++++||||++++|++...+..++||||+.+|+|.
T Consensus 15 v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e---~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~ 89 (259)
T PF07714_consen 15 VYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNE---IQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLD 89 (259)
T ss_dssp EEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHH---HHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHH
T ss_pred EEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeec---cccccccccccccccccccccccccccccccccccccc
Confidence 6788777 45779999999643 233334555444 67788889999999999999888899999999999999
Q ss_pred hhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 77 MHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 77 ~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
+++... .+++..+..|+.|++.||.|||+++++|+ +++++|| +++.++.+||
T Consensus 90 ~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~---~l~~~ni----------------------ll~~~~~~Kl 144 (259)
T PF07714_consen 90 DYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHG---NLSPSNI----------------------LLDSNGQVKL 144 (259)
T ss_dssp HHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEES---T-SGGGE----------------------EEETTTEEEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccc----------------------cccccccccc
Confidence 999654 78999999999999999999999999999 7777777 8888999999
Q ss_pred eecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-
Q psy3347 154 ADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV- 229 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~- 229 (245)
+|||++........ ..........|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+.....
T Consensus 145 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~ 224 (259)
T PF07714_consen 145 SDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL 224 (259)
T ss_dssp ESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999875422111 1223345678999999988889999999999999999999 7899998888888888865544
Q ss_pred cCCCCCChhHHhhhc
Q psy3347 230 RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~~~~~~~~~li~ 244 (245)
+.|..++..+.++|+
T Consensus 225 ~~~~~~~~~~~~li~ 239 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQ 239 (259)
T ss_dssp TSBTTSBHHHHHHHH
T ss_pred eeccchhHHHHHHHH
Confidence 457788999988875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=231.92 Aligned_cols=210 Identities=23% Similarity=0.422 Sum_probs=164.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.... .....+.+.+| ++.++.++||||+++++.+..++..+++|||+++++|..+
T Consensus 17 v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-- 89 (279)
T cd06619 17 VYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSE---LEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-- 89 (279)
T ss_pred EEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHH---HHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh--
Confidence 7999999999999999997542 22223344444 6677888999999999999999999999999999988654
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 90 -~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------ll~~~~~~~l~dfg~~~ 143 (279)
T cd06619 90 -RKIPEHVLGRIAVAVVKGLTYLWSLKILHR---DVKPSNM----------------------LVNTRGQVKLCDFGVST 143 (279)
T ss_pred -hcCCHHHHHHHHHHHHHHHHHHHHCCEeeC---CCCHHHE----------------------EECCCCCEEEeeCCcce
Confidence 347888899999999999999999999999 8888888 77888999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCc-ccC-
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD-------EEEVFDSIVNDE-VRY- 231 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~-------~~~~~~~~~~~~-~~~- 231 (245)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+.... ...
T Consensus 144 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (279)
T cd06619 144 QLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221 (279)
T ss_pred ecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence 53221 2334578889999999988889999999999999999999999996422 122223332222 222
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
....+++++++|.+
T Consensus 222 ~~~~~~~~~~li~~ 235 (279)
T cd06619 222 VGQFSEKFVHFITQ 235 (279)
T ss_pred CCcCCHHHHHHHHH
Confidence 24567788888753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=244.80 Aligned_cols=214 Identities=25% Similarity=0.419 Sum_probs=162.6
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.+ ..++..||+|+++... .....+.+.+| +++++.+ +||||+++++++..++..++||||+++|+
T Consensus 51 V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E---i~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~ 125 (375)
T cd05104 51 VVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSE---LKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125 (375)
T ss_pred EEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHH---HHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCc
Confidence 677753 4567799999997542 12233444444 5666667 79999999999999999999999999999
Q ss_pred hhhhhhhc------------------------------------------------------------------------
Q psy3347 75 LMMHIHAD------------------------------------------------------------------------ 82 (245)
Q Consensus 75 L~~~~~~~------------------------------------------------------------------------ 82 (245)
|..+++..
T Consensus 126 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (375)
T cd05104 126 LLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILE 205 (375)
T ss_pred HHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHh
Confidence 98887431
Q ss_pred ----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 83 ----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 83 ----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++|+|||+
T Consensus 206 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dlkp~Ni----------------------ll~~~~~~kl~DfG~ 260 (375)
T cd05104 206 EDELALDTEDLLSFSYQVAKGMSFLASKNCIHR---DLAARNI----------------------LLTHGRITKICDFGL 260 (375)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCchhhE----------------------EEECCCcEEEecCcc
Confidence 35677888999999999999999999999 8888887 777788899999999
Q ss_pred ccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc--ccCCC
Q psy3347 159 CKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE--VRYPR 233 (245)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~--~~~p~ 233 (245)
++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.............. ...|.
T Consensus 261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE 340 (375)
T ss_pred ceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence 875322221 1122334567999999988889999999999999999998 899998765443333333332 23456
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
..+.++++||+
T Consensus 341 ~~~~~l~~li~ 351 (375)
T cd05104 341 CAPSEMYDIMK 351 (375)
T ss_pred CCCHHHHHHHH
Confidence 67888888875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=258.15 Aligned_cols=214 Identities=23% Similarity=0.374 Sum_probs=179.6
Q ss_pred CEeEEEecCC---cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTG---EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
|++|+-+..| ..||||.++.. ..+.+..+|..| +-+|.+.+||||+++-|+.+.....+|+.|||++|+|..
T Consensus 645 Vc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~E---AsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDs 719 (996)
T KOG0196|consen 645 VCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSE---ASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDS 719 (996)
T ss_pred eecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhh---hhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHH
Confidence 5677776655 48999999975 455666677666 677889999999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
|++. +.+...+++.+.+.|+.||+||-+.|.+|| |+-.-|| +++.+-.+|++|
T Consensus 720 FLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHR---DLAARNI----------------------LVNsnLvCKVsD 774 (996)
T KOG0196|consen 720 FLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHR---DLAARNI----------------------LVNSNLVCKVSD 774 (996)
T ss_pred HHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhh---hhhhhhe----------------------eeccceEEEecc
Confidence 9964 468888999999999999999999999999 3333344 666777899999
Q ss_pred cCCccCCCCCCCCCC-cccC--CCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 156 FGLCKEGMGFGDRTG-TFCG--TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~~~-~~~~--~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
||+++...++.+... +..| +.+|+|||.+....|+.++||||+|++|||.++ |+-||...++.++.+.|..+- .+
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP 854 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP 854 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence 999997766664332 3333 368999999999999999999999999999887 999999999999999998874 46
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
+|-.||..+.+||.
T Consensus 855 pPmDCP~aL~qLMl 868 (996)
T KOG0196|consen 855 PPMDCPAALYQLML 868 (996)
T ss_pred CCCCCcHHHHHHHH
Confidence 67889999999984
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=229.09 Aligned_cols=216 Identities=25% Similarity=0.468 Sum_probs=175.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++++..+|+.||+|.+...... ....+.+. +++..++.++||||+++.+++...++.+++|||+.+++|..++.
T Consensus 16 ~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 91 (256)
T cd08218 16 AILVKSKEDGKQYVIKEINISKMS-PKEREESR---KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKIN 91 (256)
T ss_pred EEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHH---HHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHH
Confidence 588999999999999999754322 22223343 34677889999999999999999999999999999999988875
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||++|++|+ +++|+|| +++.++.++++|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~---~l~~~ni----------------------l~~~~~~~~l~d~~ 146 (256)
T cd08218 92 AQRGVLFPEDQILDWFVQICLALKHVHDRKILHR---DIKSQNI----------------------FLTKDGTIKLGDFG 146 (256)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EEcCCCCEEEeecc
Confidence 3 257888999999999999999999999999 8888888 77788899999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLS 236 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~ 236 (245)
.+..............++..|+|||.+.+..++.++|+||||+++++|++|+.||......+....+..+.. +.|..++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08218 147 IARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYS 226 (256)
T ss_pred ceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCC
Confidence 887543322222334577889999999888889999999999999999999999988777777777666544 4577888
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
.++.++|++
T Consensus 227 ~~~~~li~~ 235 (256)
T cd08218 227 YDLRNLVSQ 235 (256)
T ss_pred HHHHHHHHH
Confidence 888888863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.25 Aligned_cols=215 Identities=20% Similarity=0.315 Sum_probs=167.5
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.++ .+++.||+|++.... .......+. +++..++.++||||+++++++..+++.+++|||+++++|
T Consensus 22 v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~---~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L 96 (277)
T cd05062 22 VYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFL---NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 96 (277)
T ss_pred EEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHH---HHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCH
Confidence 6777764 246789999986432 112222333 346677888999999999999999999999999999999
Q ss_pred hhhhhhc-----------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 76 MMHIHAD-----------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 76 ~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
.+++... .+++..+..++.|++.||.|||++|++|+ |++|+|| +
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~---dlkp~Ni----------------------l 151 (277)
T cd05062 97 KSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHR---DLAARNC----------------------M 151 (277)
T ss_pred HHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CcchheE----------------------E
Confidence 9888531 24567788899999999999999999999 8888888 7
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+..
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~ 231 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231 (277)
T ss_pred EcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 78889999999998864322111 1112244678999999988889999999999999999999 79999888877777
Q ss_pred HHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 222 DSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
..+..... ..|..+++++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~ 256 (277)
T cd05062 232 RFVMEGGLLDKPDNCPDMLFELMRM 256 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 76665543 4577888888888764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=243.63 Aligned_cols=194 Identities=24% Similarity=0.390 Sum_probs=157.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|++..+++.||||++..... .......+. +++.+++.++||||+++++++... ...|+||||+++ +
T Consensus 40 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~---~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 114 (364)
T cd07875 40 VCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAY---RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-N 114 (364)
T ss_pred EEEEEECCCCcEEEEEEeCcccc-CchhHHHHH---HHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-C
Confidence 78999999999999999975421 122223333 446778888999999999988543 357999999976 6
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|...+.. .+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 115 l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kL~ 168 (364)
T cd07875 115 LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 168 (364)
T ss_pred HHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecC---CCCHHHE----------------------EECCCCcEEEE
Confidence 6665543 48888899999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||+++.... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 169 DfG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 169 DFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred eCCCccccCC-CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999875322 2223345788999999999988899999999999999999999999998887777666654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=233.92 Aligned_cols=213 Identities=24% Similarity=0.444 Sum_probs=172.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++... .......+.+| +..++.++|+|++++++.+..+++.+++|||+++++|.+++.
T Consensus 36 v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 109 (292)
T cd06657 36 VCIATVKSSGKLVAVKKMDLR---KQQRRELLFNE---VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 109 (292)
T ss_pred EEEEEEcCCCeEEEEEEeccc---chhHHHHHHHH---HHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh
Confidence 689999999999999988643 22223334434 667888999999999999999999999999999999999887
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 110 ~~~~~~~~~~~~~~ql~~~l~~lH~~givH~---dl~p~Ni----------------------lv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 110 HTRMNEEQIAAVCLAVLKALSVLHAQGVIHR---DIKSDSI----------------------LLTHDGRVKLSDFGFCA 164 (292)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCCEEEcccccce
Confidence 7778999999999999999999999999999 8888888 78888999999999876
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
.............++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..+....+.....+ .+..+++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06657 165 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSP 244 (292)
T ss_pred ecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCH
Confidence 5433222233456788899999998888899999999999999999999999887766655544332221 2345678
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
++.++|+
T Consensus 245 ~l~~li~ 251 (292)
T cd06657 245 SLKGFLD 251 (292)
T ss_pred HHHHHHH
Confidence 8887775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=237.86 Aligned_cols=189 Identities=23% Similarity=0.349 Sum_probs=151.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++...... ....+.+. +++++++.++||||++++++|..++..++||||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~---~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 91 (327)
T cd08227 16 VNLARYKPTGEYVTVRRINLEACT-NEMVTFLQ---GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 91 (327)
T ss_pred EEEEeecccCcEEEEEEechhhcc-HHHHHHHH---HHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHH
Confidence 689999999999999999764321 12223333 34677888899999999999999999999999999999998884
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |+||+|| +++.++.++++||+
T Consensus 92 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~---dlkp~Ni----------------------l~~~~~~~~l~~~~ 146 (327)
T cd08227 92 THFMDGMSELAIAYILQGVLKALDYIHHMGYVHR---SVKASHI----------------------LISVDGKVYLSGLR 146 (327)
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CCChhhE----------------------EEecCCcEEEcccc
Confidence 3 358899999999999999999999999999 8888888 77788899999998
Q ss_pred CccCCCCCCC-------CCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy3347 158 LCKEGMGFGD-------RTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218 (245)
Q Consensus 158 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~ 218 (245)
.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 216 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 216 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 6543221111 1122345667999999975 45889999999999999999999999765443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=228.38 Aligned_cols=218 Identities=25% Similarity=0.445 Sum_probs=169.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+|+.||+|++........ ..+......+++++++.++||||+++++++.. .+..+++|||+++++|.++
T Consensus 18 vy~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 96 (266)
T cd06651 18 VYLCYDVDTGRELAAKQVQFDPESPE-TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ 96 (266)
T ss_pred EEEEEEcCCCcEEEEEEeecCcCCch-hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHH
Confidence 69999999999999999875432211 11222223445778889999999999999865 3678999999999999988
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++.....++.|++.||+|||+++++|+ +++|+|| +++.++.++|+|||
T Consensus 97 l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~---~l~p~ni----------------------l~~~~~~~~l~dfg 151 (266)
T cd06651 97 LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHR---DIKGANI----------------------LRDSAGNVKLGDFG 151 (266)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCCHHHE----------------------EECCCCCEEEccCC
Confidence 854 568889999999999999999999999999 8888888 77888899999999
Q ss_pred CccCCCCCC---CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cccCC
Q psy3347 158 LCKEGMGFG---DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EVRYP 232 (245)
Q Consensus 158 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~p 232 (245)
++....... .......++..|+|||.+.+..++.++|+|||||++|++++|+.||......+........ .+.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 886432111 1112345778899999998888999999999999999999999999766554444433322 33456
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++.++++++
T Consensus 232 ~~~~~~~~~li~ 243 (266)
T cd06651 232 SHISEHARDFLG 243 (266)
T ss_pred hhcCHHHHHHHH
Confidence 778888888774
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.51 Aligned_cols=215 Identities=25% Similarity=0.438 Sum_probs=176.3
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+... +..||+|.+....... ..+.+.+ +++.++.++|+|++++++++...+..+++|||+++++|.+
T Consensus 11 v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (262)
T cd00192 11 VYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLK---EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLD 85 (262)
T ss_pred EEEEEEecCCCCCceEEeEeeccccchh--HHHHHHH---HHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHH
Confidence 688988865 8999999998653221 2344444 4667778889999999999999999999999999999999
Q ss_pred hhhh----------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 78 HIHA----------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 78 ~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~---di~p~ni----------------------li~~ 140 (262)
T cd00192 86 YLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR---DLAARNC----------------------LVGE 140 (262)
T ss_pred HHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC---ccCcceE----------------------EECC
Confidence 9854 568999999999999999999999999999 8888888 8888
Q ss_pred CCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy3347 148 EGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSI 224 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~ 224 (245)
++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 141 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 220 (262)
T cd00192 141 DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220 (262)
T ss_pred CCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 8999999999987543322 12333456778999999988889999999999999999999 69999988888877777
Q ss_pred hcCc-ccCCCCCChhHHhhhcC
Q psy3347 225 VNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 225 ~~~~-~~~p~~~~~~~~~li~~ 245 (245)
.... ...|..+++++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~ 242 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLS 242 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHH
Confidence 6543 34577888998888753
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=231.21 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=172.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++. ++.+|+|++..... ...+.+.. +++.++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 22 vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (261)
T cd05148 22 VWEGLWKN-RVRVAIKILKSDDL---LKQQDFQK---EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR 94 (261)
T ss_pred EEEeEecC-CCcEEEEeccccch---hhHHHHHH---HHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHh
Confidence 79999987 89999999876432 12233333 4677888999999999999999999999999999999999985
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+.+++.|++.||+|||++|++|+ |++|+|+ +++.++.++|+|||
T Consensus 95 ~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~---dl~~~ni----------------------lv~~~~~~kl~d~g 149 (261)
T cd05148 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR---DLAARNI----------------------LVGEDLVCKVADFG 149 (261)
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---ccCcceE----------------------EEcCCceEEEcccc
Confidence 3 357889999999999999999999999999 8888887 78888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFL 235 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~~ 235 (245)
.+..............++..|+|||.+....++.++|+||||+++|+|++ |+.||.+.+..+....+... ..+.|..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05148 150 LARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229 (261)
T ss_pred chhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCC
Confidence 88754332222223344567999999988889999999999999999998 89999888777777766654 33456788
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.++|.
T Consensus 230 ~~~~~~~i~ 238 (261)
T cd05148 230 PQEIYKIML 238 (261)
T ss_pred CHHHHHHHH
Confidence 888888875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=228.98 Aligned_cols=212 Identities=23% Similarity=0.389 Sum_probs=168.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ ++..+|+|.+...... ...+.+ +++.++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 20 v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 91 (256)
T cd05059 20 VHLGKWR-GKIDVAIKMIREGAMS----EDDFIE---EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR 91 (256)
T ss_pred EEEeEec-CCccEEEEEeccCCCC----HHHHHH---HHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHH
Confidence 6889876 5678999998753221 123333 4667788899999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 92 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dl~p~ni----------------------~i~~~~~~kl~dfg~ 146 (256)
T cd05059 92 ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR---DLAARNC----------------------LVGEDNVVKVSDFGL 146 (256)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCcccc---cccHhhE----------------------EECCCCcEEECCccc
Confidence 3 357899999999999999999999999999 8888887 778889999999998
Q ss_pred ccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCCC
Q psy3347 159 CKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~~ 235 (245)
++...+.... .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+....+... ....|..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05059 147 ARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA 226 (256)
T ss_pred ceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 8753222111 111123457999999988889999999999999999999 89999887777766666554 33456778
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+++.+
T Consensus 227 ~~~~~~li~~ 236 (256)
T cd05059 227 PTEVYTIMYS 236 (256)
T ss_pred CHHHHHHHHH
Confidence 8999988853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.79 Aligned_cols=194 Identities=26% Similarity=0.403 Sum_probs=157.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++..... .....+.+. +++++++.++|||++++++++...+..+++|||+++++|..+..
T Consensus 17 v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~---~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 92 (286)
T cd07847 17 VFKCRNRETGQIVAIKKFVESED-DPVIKKIAL---REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK 92 (286)
T ss_pred EEEEEECCCCcEEEEEEEeeccc-CccccHHHH---HHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh
Confidence 69999999999999999875421 111112233 34677888999999999999999999999999999988887764
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 93 ~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~dfg~~ 147 (286)
T cd07847 93 NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHR---DVKPENI----------------------LITKQGQIKLCDFGFA 147 (286)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCChhhE----------------------EEcCCCcEEECccccc
Confidence 3 468999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
..............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 754333323334567788999999876 4578899999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=233.37 Aligned_cols=217 Identities=35% Similarity=0.604 Sum_probs=180.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.++.+|+.||+|++...........+.+.+| .++++.++ ||||+++++++..++..+++||++++++|.+++
T Consensus 17 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e---~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 93 (280)
T cd05581 17 VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE---KEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI 93 (280)
T ss_pred EEEEEEcCCCCEEEEEEechHhccchHHHHHHHHH---HHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHH
Confidence 69999999999999999986443333333344433 56677777 999999999999999999999999999999988
Q ss_pred hhc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
... .+++..+..++.|++.||.+||++|++|+ |++|+|| +++.++.++++|||+
T Consensus 94 ~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~---dl~~~ni----------------------~i~~~~~~~l~df~~ 148 (280)
T cd05581 94 RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR---DLKPENI----------------------LLDKDMHIKITDFGT 148 (280)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCHHHe----------------------EECCCCCEEecCCcc
Confidence 654 78999999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCC--------------------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy3347 159 CKEGMGFG--------------------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218 (245)
Q Consensus 159 ~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~ 218 (245)
+....... .......++..|+|||...+..++.++|+||||++++++++|..||...+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 87533222 1122345678899999998888889999999999999999999999888777
Q ss_pred HHHHHHhcCcccCCCCCChhHHhhhcC
Q psy3347 219 EVFDSIVNDEVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 219 ~~~~~~~~~~~~~p~~~~~~~~~li~~ 245 (245)
...+.+......+|..+++.+.++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~ 255 (280)
T cd05581 229 LTFQKILKLEYSFPPNFPPDAKDLIEK 255 (280)
T ss_pred HHHHHHHhcCCCCCCccCHHHHHHHHH
Confidence 777777777777888899999988863
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=234.23 Aligned_cols=211 Identities=27% Similarity=0.464 Sum_probs=164.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC----CeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE----AHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~----~~~~lv~e~~~~~~L~ 76 (245)
|-.+.++.||+.+|+|++.-. +...+|.+ + .+..-.|||||+++|+|... .-..+|||.|+||.|.
T Consensus 78 V~~C~~k~T~ekfALKvL~Ds--------~KARrEVe-L-Hw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf 147 (400)
T KOG0604|consen 78 VVQCVHKRTQEKFALKVLLDS--------PKARREVE-L-HWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF 147 (400)
T ss_pred eEEEEeccchhhhHHHHHhcC--------HHHHhHhh-h-hhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence 456788999999999999743 22223322 1 12334799999999999543 3567999999999999
Q ss_pred hhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 77 MHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 77 ~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
..++. ..+.+.++..|++||..|+.|||+.+|.|| |+||+|+ +.. -...+-.+||
T Consensus 148 sriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHR---DlKpENL-----Lyt--------------~t~~na~lKL 205 (400)
T KOG0604|consen 148 SRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHR---DLKPENL-----LYT--------------TTSPNAPLKL 205 (400)
T ss_pred HHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhc---cCChhhe-----eee--------------cCCCCcceEe
Confidence 88853 358999999999999999999999999999 6666666 333 2234567999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCcc
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD----EEEVFDSIVNDEV 229 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~----~~~~~~~~~~~~~ 229 (245)
+|||+++.... .....+.+.|++|.|||++..+.|+..+|+||+|++||-|+.|.+||.+.. .......|..+++
T Consensus 206 tDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 206 TDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred cccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 99999986433 223456678999999999988889999999999999999999999996542 3455567888999
Q ss_pred cCC----CCCChhHHhhhc
Q psy3347 230 RYP----RFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p----~~~~~~~~~li~ 244 (245)
.|| +.+|++.+|+|+
T Consensus 285 ~FP~pEWs~VSe~aKdlIR 303 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIR 303 (400)
T ss_pred cCCChhHhHHHHHHHHHHH
Confidence 998 357888888886
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=229.08 Aligned_cols=213 Identities=24% Similarity=0.399 Sum_probs=164.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC------CeEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE------AHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~------~~~~lv~e~~~~~ 73 (245)
||+|++..+++.||+|.+.... .....+.+| +..++.+ +|||++++++++... ...+++|||+.++
T Consensus 22 vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e---~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~ 94 (272)
T cd06637 22 VYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQE---INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 94 (272)
T ss_pred EEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHH---HHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCC
Confidence 7999999999999999997542 122334444 4455555 699999999998653 4689999999999
Q ss_pred chhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 74 DLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 74 ~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|..++.. ..+++..+..++.|++.||+|||+++++|+ |++|+|| +++.++.
T Consensus 95 ~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~---dl~~~ni----------------------li~~~~~ 149 (272)
T cd06637 95 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR---DIKGQNV----------------------LLTENAE 149 (272)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC---CCCHHHE----------------------EECCCCC
Confidence 99988854 357889999999999999999999999999 8888888 7788899
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++|+|||++..............|+..|+|||.+. +..++.++|+||||+++|+|++|+.||.............
T Consensus 150 ~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~ 229 (272)
T cd06637 150 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229 (272)
T ss_pred EEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 99999999875332222334456788999999986 3357889999999999999999999997665544444333
Q ss_pred cCcc--cCCCCCChhHHhhhcC
Q psy3347 226 NDEV--RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 226 ~~~~--~~p~~~~~~~~~li~~ 245 (245)
.... ..+..++.++++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~ 251 (272)
T cd06637 230 RNPAPRLKSKKWSKKFQSFIES 251 (272)
T ss_pred cCCCCCCCCCCcCHHHHHHHHH
Confidence 3222 1235678888888863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=232.51 Aligned_cols=213 Identities=26% Similarity=0.435 Sum_probs=168.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|.++... .......+.+ +++.++.++||||+++++.+..++..+++|||+++++|..++.
T Consensus 17 v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 91 (286)
T cd06622 17 VYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIM---ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYA 91 (286)
T ss_pred EEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHH---HHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHH
Confidence 6899999999999999987532 2222334444 4677788899999999999999999999999999999988886
Q ss_pred hc----CCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 AD----VFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~~----~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.. .+++..+..++.|++.||.|||+ .+++|+ |++|+|| +++.++.++|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~d 146 (286)
T cd06622 92 GGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR---DVKPTNV----------------------LVNGNGQVKLCD 146 (286)
T ss_pred hccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeC---CCCHHHE----------------------EECCCCCEEEee
Confidence 53 68999999999999999999997 599999 8888888 777889999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET------SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS---IVN 226 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~---~~~ 226 (245)
||.+...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........... +..
T Consensus 147 fg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 224 (286)
T cd06622 147 FGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224 (286)
T ss_pred cCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence 9988653222 22334577889999998543 347899999999999999999999976554443333 233
Q ss_pred C-cccCCCCCChhHHhhhcC
Q psy3347 227 D-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 227 ~-~~~~p~~~~~~~~~li~~ 245 (245)
. ....|..++++++++|++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~ 244 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAK 244 (286)
T ss_pred cCCCCCCcccCHHHHHHHHH
Confidence 2 234566788999988863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=231.59 Aligned_cols=214 Identities=20% Similarity=0.327 Sum_probs=169.4
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+.. +++.||+|+++... .....+.+. ++..++..++||||+++++++...+..++++||+.+++|
T Consensus 21 V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l 95 (283)
T cd05091 21 VYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFK---HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95 (283)
T ss_pred EEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHH---HHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcH
Confidence 68887754 36789999997532 111223333 345677788999999999999999999999999999999
Q ss_pred hhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 76 MMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 76 ~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
..++.. ..+++..+.+++.|++.||+|+|++|++|| |+||+|+
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~---dlkp~Ni----------------- 155 (283)
T cd05091 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHK---DLATRNV----------------- 155 (283)
T ss_pred HHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcccc---ccchhhe-----------------
Confidence 888732 236778889999999999999999999999 7777777
Q ss_pred chhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGD 215 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~ 215 (245)
+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 156 -----l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 156 -----LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred -----EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 667778899999998874322111 1223345678999999988889999999999999999998 89999888
Q ss_pred CHHHHHHHHhcCcc-cCCCCCChhHHhhhc
Q psy3347 216 DEEEVFDSIVNDEV-RYPRFLSLEAIAIMR 244 (245)
Q Consensus 216 ~~~~~~~~~~~~~~-~~p~~~~~~~~~li~ 244 (245)
...+....+..... +.|..+++++.+++.
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 260 (283)
T cd05091 231 SNQDVIEMIRNRQVLPCPDDCPAWVYTLML 260 (283)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 88888888777654 457889999888875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=242.22 Aligned_cols=182 Identities=30% Similarity=0.435 Sum_probs=150.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-eEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-HVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.-.. |+.||||++....... ...+.+| ++.+.+++|||+++++|+|.+.+ +.+||+||+++|+|.+++
T Consensus 91 VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~E---i~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L 163 (361)
T KOG1187|consen 91 VYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNE---VEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHL 163 (361)
T ss_pred EEEEEECC-CCEEEEEEecCCCCcc---hhHHHHH---HHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHh
Confidence 78887664 4899999887643211 2335444 78888999999999999999888 599999999999999998
Q ss_pred hh--c-CCChHHHHHHHHHHHHHHHHhhhcC---ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 80 HA--D-VFSEPRAVFYAACVVLGLQYLHESR---IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 80 ~~--~-~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
.. . +++|..+.+|+.+++.||+|||... |+|| |||++|| ++|.++.+||
T Consensus 164 ~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr---DiKssNI----------------------LLD~~~~aKl 218 (361)
T KOG1187|consen 164 HGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHR---DIKSSNI----------------------LLDEDFNAKL 218 (361)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecC---CCCHHHe----------------------eECCCCCEEc
Confidence 54 2 7899999999999999999999854 9999 8888888 8999999999
Q ss_pred eecCCccCCCCCCCCCCcc-cCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 154 ADFGLCKEGMGFGDRTGTF-CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
+|||+++............ .||..|+|||+...+..+.++||||||+++.|+++|+.+.+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 9999997532211111222 789999999999888899999999999999999999988764
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=233.92 Aligned_cols=186 Identities=26% Similarity=0.472 Sum_probs=155.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.+|+|.+.... .......+. +++++++.++||||+++++++..++..+++|||+++++|.++++
T Consensus 17 v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~ 91 (308)
T cd06615 17 VTKVLHRPSGLIMARKLIHLEI--KPAIRNQII---RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 91 (308)
T ss_pred EEEEEEcCCCeEEEEEEecccc--CHHHHHHHH---HHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH
Confidence 6899999999999999987532 122223333 44777888999999999999999999999999999999999985
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||+ .+++|+ |++|+|| +++.++.++|+|||+
T Consensus 92 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~dfg~ 146 (308)
T cd06615 92 KAGRIPENILGKISIAVLRGLTYLREKHKIMHR---DVKPSNI----------------------LVNSRGEIKLCDFGV 146 (308)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEEC---CCChHHE----------------------EEecCCcEEEccCCC
Confidence 4 568999999999999999999998 589999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~ 218 (245)
+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 147 SGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred ccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 8643221 233456788999999998888899999999999999999999999765433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=228.88 Aligned_cols=214 Identities=30% Similarity=0.480 Sum_probs=166.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.... ....+.+.+| +++++.++|+||+++++++..++..++++||+++++|..++.
T Consensus 24 v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 97 (268)
T cd06624 24 VYAARDLSTQVRIAIKEIPERD---SRYVQPLHEE---IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR 97 (268)
T ss_pred EEEeEecCCCcEEEEEEecCCC---HHHHHHHHHH---HHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHH
Confidence 7999999999999999887542 2233344444 677788899999999999999999999999999999999886
Q ss_pred h--cCC--ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-CCceEEee
Q psy3347 81 A--DVF--SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-EGYVKIAD 155 (245)
Q Consensus 81 ~--~~l--~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~kl~D 155 (245)
. ..+ ++..+..++.|++.||+|||++|++|+ |++|+|| +++. ++.++|+|
T Consensus 98 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~---dl~p~ni----------------------l~~~~~~~~~l~d 152 (268)
T cd06624 98 SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR---DIKGDNV----------------------LVNTYSGVVKISD 152 (268)
T ss_pred HhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeec---CCCHHHE----------------------EEcCCCCeEEEec
Confidence 4 345 778888999999999999999999999 8888888 5554 67899999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH--hcCccc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSI--VNDEVR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~--~~~~~~ 230 (245)
||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ...... ......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06624 153 FGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232 (268)
T ss_pred chhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCC
Confidence 99886543322223344578889999998654 3788999999999999999999999754322 111111 233445
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|..+++++++++++
T Consensus 233 ~~~~~~~~~~~li~~ 247 (268)
T cd06624 233 IPESLSAEAKNFILR 247 (268)
T ss_pred CCcccCHHHHHHHHH
Confidence 677888999888863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=226.66 Aligned_cols=216 Identities=29% Similarity=0.525 Sum_probs=173.0
Q ss_pred CEeEEEecCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII--ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+++.||+|.+...... ..+..+.+ .++++.++.++|+||+++++++..++..++++||+++++|.++
T Consensus 16 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~---~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (258)
T cd06632 16 VYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQL---EQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKL 92 (258)
T ss_pred EEEEEEcCCCcEEEEEEEEEccccccchHHHHHH---HHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHH
Confidence 689999989999999998753211 11223333 3447788899999999999999999999999999999999998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||+|||++|++|+ +++|+|| +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~~~ni----------------------~~~~~~~~kl~d~~ 147 (258)
T cd06632 93 LKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR---DIKGANI----------------------LVDTNGVVKLADFG 147 (258)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEEccCc
Confidence 854 458899999999999999999999999999 8888888 77788999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CcccCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~--~~~~~p~~ 234 (245)
.+....... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......+....+.. ....+|..
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T cd06632 148 MAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH 226 (258)
T ss_pred cceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCC
Confidence 887543322 233456788899999997665 88999999999999999999999977665555544443 22345677
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.++|++
T Consensus 227 ~~~~~~~li~~ 237 (258)
T cd06632 227 LSDEAKDFILK 237 (258)
T ss_pred cCHHHHHHHHH
Confidence 88888888763
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=231.00 Aligned_cols=215 Identities=23% Similarity=0.351 Sum_probs=171.1
Q ss_pred CEeEEEecC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNT-----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.++.. +..||+|.+.... .......+. ++++.++.++||||+++++++...+..+++|||+++++|
T Consensus 22 v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~---~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (277)
T cd05032 22 VYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFL---NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDL 96 (277)
T ss_pred EEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHH---HHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCH
Confidence 688877643 4899999986432 112222333 346778888999999999999999999999999999999
Q ss_pred hhhhhhc-----------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 76 MMHIHAD-----------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 76 ~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
..++... .+++..+..++.|++.||.|||++|++|+ |++|+|| +
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---di~p~ni----------------------l 151 (277)
T cd05032 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR---DLAARNC----------------------M 151 (277)
T ss_pred HHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc---ccChheE----------------------E
Confidence 9888431 25677889999999999999999999999 8888888 7
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||.+.+..+..
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 152 VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred EcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence 88889999999999874322211 1223345678999999988889999999999999999998 99999888888877
Q ss_pred HHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 222 DSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
+.+.... ...|..++.++.++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~ 256 (277)
T cd05032 232 KFVIDGGHLDLPENCPDKLLELMRM 256 (277)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 7776543 34677889999988863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.02 Aligned_cols=214 Identities=29% Similarity=0.483 Sum_probs=170.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+.... ....+.+.+| +..++.++|||++++++++...+..++|+||+++++|..++.
T Consensus 35 v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e---~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 108 (293)
T cd06647 35 VYTAIDVATGQEVAIKQMNLQQ---QPKKELIINE---ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108 (293)
T ss_pred EEEEEEcCCCCEEEEEEecccc---chHHHHHHHH---HHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh
Confidence 6899998899999999986432 1222334333 567788899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 109 ~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~---dL~p~Ni----------------------li~~~~~~kL~dfg~~~ 163 (293)
T cd06647 109 ETCMDEGQIAAVCRECLQALEFLHSNQVIHR---DIKSDNI----------------------LLGMDGSVKLTDFGFCA 163 (293)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCEeec---cCCHHHE----------------------EEcCCCCEEEccCccee
Confidence 7778999999999999999999999999999 8888887 77788899999999876
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-ccc--CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND-EVR--YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~--~p~~~~~ 237 (245)
.............++..|+|||.+....++.++|+||||+++|++++|+.||...+..+....+... ... .+..+++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence 5433333334456788899999998888899999999999999999999999876654443333222 222 2345677
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
.++++|++
T Consensus 244 ~l~~li~~ 251 (293)
T cd06647 244 IFRDFLNR 251 (293)
T ss_pred HHHHHHHH
Confidence 88888753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=241.70 Aligned_cols=192 Identities=24% Similarity=0.367 Sum_probs=154.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|++..+++.||+|++..... .......+ .+++.+++.++||||+++++++... ...+++|||+++ +
T Consensus 33 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 107 (355)
T cd07874 33 VCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRA---YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-N 107 (355)
T ss_pred EEEEEecCCCceEEEEEeCCccc-ChHHHHHH---HHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-c
Confidence 79999999999999999975421 11222333 3446778888999999999998654 357999999976 5
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+...+.. .+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+
T Consensus 108 l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHr---Dikp~Ni----------------------ll~~~~~~kl~ 161 (355)
T cd07874 108 LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 161 (355)
T ss_pred HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCChHHE----------------------EECCCCCEEEe
Confidence 6555543 48888899999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|||+++... .........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus 162 Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (355)
T cd07874 162 DFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_pred eCcccccCC-CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999987532 222234457889999999998888999999999999999999999999887765554444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=228.42 Aligned_cols=216 Identities=22% Similarity=0.361 Sum_probs=167.8
Q ss_pred CEeEEEecCCc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccC
Q psy3347 1 VILSQYRNTGE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~ 72 (245)
||+|.+..+++ .+|+|.++.... .....+.+.+| ++.++.++||||+++++++... ...+++|||+.+
T Consensus 15 V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 90 (272)
T cd05075 15 VMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSE---AVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKH 90 (272)
T ss_pred EEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHH---HHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCC
Confidence 79999887775 699998876421 22334444444 6677888999999999987432 257899999999
Q ss_pred Cchhhhhhh-------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 73 GDLMMHIHA-------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 73 ~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
++|..++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| ++
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~ 145 (272)
T cd05075 91 GDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR---DLAARNC----------------------ML 145 (272)
T ss_pred CcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc---ccchhhe----------------------EE
Confidence 999887631 247889999999999999999999999999 7777777 77
Q ss_pred CCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy3347 146 DTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFD 222 (245)
Q Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~ 222 (245)
+.++.++|+|||+++....... ......++..|+|||...+..++.++|+||||+++|+|++ |+.||.+....+...
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 225 (272)
T cd05075 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225 (272)
T ss_pred cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 7788999999999875322211 1122245667999999988889999999999999999999 899998887777777
Q ss_pred HHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 223 SIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 223 ~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
.+..+.. +.+..+++++.++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~ 249 (272)
T cd05075 226 YLRQGNRLKQPPDCLDGLYSLMSS 249 (272)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHH
Confidence 7766543 4567788888888763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=230.63 Aligned_cols=213 Identities=29% Similarity=0.456 Sum_probs=166.8
Q ss_pred EEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-hh
Q psy3347 4 SQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI-HA 81 (245)
Q Consensus 4 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~ 81 (245)
+....||.+||||++.+.. .-...+..+| .+++.++ +|+||++++++|+++..+|+|||.|.||+|...+ ++
T Consensus 97 cv~i~t~~EYAVKiidKq~---gHsR~RvfRE---Ve~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~ 170 (463)
T KOG0607|consen 97 CVSIQTGKEYAVKIIDKQP---GHSRSRVFRE---VETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR 170 (463)
T ss_pred eeeeccchhhhhhhhhcCC---chHHHHHHHH---HHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh
Confidence 4667899999999998753 2233455555 5556565 5999999999999999999999999999998777 56
Q ss_pred cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 82 DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 82 ~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
..+++.++.+++++|+.||.|||.+||.|| |+||+|| +... -+.-.-+|||||.++..
T Consensus 171 ~~F~E~EAs~vvkdia~aLdFlH~kgIAHR---DlKPENi-----LC~~--------------pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 171 KHFNEREASRVVKDIASALDFLHTKGIAHR---DLKPENI-----LCES--------------PNKVSPVKICDFDLGSG 228 (463)
T ss_pred hhccHHHHHHHHHHHHHHHHHHhhcCcccc---cCCccce-----eecC--------------CCCcCceeeeccccccc
Confidence 789999999999999999999999999999 6666666 3331 12223489999988753
Q ss_pred CCCC-------CCCCCcccCCCCcccccccc---C--CCCCcchhHHHHHHHHHHHHhCCCCCCCC--------------
Q psy3347 162 GMGF-------GDRTGTFCGTPEFLAPEVLT---E--TSYTRAVDWWGLGVLIFEMLVGESPFPGD-------------- 215 (245)
Q Consensus 162 ~~~~-------~~~~~~~~~~~~y~aPE~~~---~--~~~~~~~DvwslG~~l~el~~g~~pf~~~-------------- 215 (245)
.... .....+.+|+..|||||+.. + .-|+.++|.||||+|+|=|+.|.+||.|.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 2111 11234678999999999984 2 35789999999999999999999999764
Q ss_pred -CHHHHHHHHhcCcccCCC----CCChhHHhhhc
Q psy3347 216 -DEEEVFDSIVNDEVRYPR----FLSLEAIAIMR 244 (245)
Q Consensus 216 -~~~~~~~~~~~~~~~~p~----~~~~~~~~li~ 244 (245)
-...++..|..+.++||+ .+|.+.+|+++
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis 342 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS 342 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH
Confidence 245677778899999995 46788888875
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=229.07 Aligned_cols=215 Identities=22% Similarity=0.341 Sum_probs=168.0
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.++. .+|+|.++... .....+.+.+| +..++.++||||+++++++..++..+++|||+++++|.+
T Consensus 20 v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (267)
T cd05066 20 VCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSE---ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94 (267)
T ss_pred eEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHH---HHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHH
Confidence 68998876544 79999987532 22233444444 667788899999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|+ +++.++.++++|
T Consensus 95 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~---dlkp~ni----------------------li~~~~~~~l~d 149 (267)
T cd05066 95 FLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR---DLAARNI----------------------LVNSNLVCKVSD 149 (267)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeh---hhchhcE----------------------EECCCCeEEeCC
Confidence 9854 357889999999999999999999999999 7777776 677788999999
Q ss_pred cCCccCCCCCCCCC---CcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 156 FGLCKEGMGFGDRT---GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
||.+.......... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+.... .+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC
Confidence 99987543322111 11122457999999988889999999999999999886 999998877766666665542 23
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.+..+++++.+++.+
T Consensus 230 ~~~~~~~~~~~li~~ 244 (267)
T cd05066 230 APMDCPAALHQLMLD 244 (267)
T ss_pred CCCCCCHHHHHHHHH
Confidence 456678888888763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=231.23 Aligned_cols=186 Identities=33% Similarity=0.588 Sum_probs=158.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|++......... .... .+++..++.++||||+++++++......+++||++.+++|.+++.
T Consensus 15 v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~---~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~ 90 (260)
T PF00069_consen 15 VYKAKNKKNGQKVAVKIIDKSEIEEEE-REEN---IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ 90 (260)
T ss_dssp EEEEEETTTTEEEEEEEEESTTHHHHH-HHHH---HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH
T ss_pred EEEEEECCCCeEEEEEEeccccccccc-cchh---hhhhhcccccccccccccccccccccccccccccccccccccccc
Confidence 799999999999999999875422211 1112 234667777889999999999999999999999999999999986
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||++||++|++|+ |++|+|| +++.++.++|+|||.+
T Consensus 91 ~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~---dikp~NI----------------------l~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 91 KNKPLSEEEILKIAYQILEALAYLHSKGIVHR---DIKPENI----------------------LLDENGEVKLIDFGSS 145 (260)
T ss_dssp HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEES---SBSGGGE----------------------EESTTSEEEESSGTTT
T ss_pred cccccccccccccccccccccccccccccccc---ccccccc----------------------cccccccccccccccc
Confidence 6789999999999999999999999999999 9999999 8889999999999998
Q ss_pred cCCCCCCCCCCcccCCCCcccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
..............++..|+|||... +..++.++|+||||+++|+|++|..||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 146 VKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp EESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 64322333344566788999999998 778899999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=241.06 Aligned_cols=214 Identities=24% Similarity=0.426 Sum_probs=163.6
Q ss_pred CEeEEEecC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNT-----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.+... +..||+|++.... .....+.+.+| ++.++.++ ||||+++++++...+..|+||||+++|+
T Consensus 53 Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E---i~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~ 127 (400)
T cd05105 53 VVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSE---LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGD 127 (400)
T ss_pred EEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHH---HHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCc
Confidence 688876433 4579999997542 22333445444 66677775 9999999999999999999999999999
Q ss_pred hhhhhhh-------------------------------------------------------------------------
Q psy3347 75 LMMHIHA------------------------------------------------------------------------- 81 (245)
Q Consensus 75 L~~~~~~------------------------------------------------------------------------- 81 (245)
|.+++..
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (400)
T cd05105 128 LVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSN 207 (400)
T ss_pred HHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCc
Confidence 9887632
Q ss_pred ------------------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcc
Q psy3347 82 ------------------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSS 137 (245)
Q Consensus 82 ------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~ 137 (245)
..+++..+..++.|++.||+|||+++++|+ |++|+||
T Consensus 208 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~---dikp~Ni---------------- 268 (400)
T cd05105 208 YDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHR---DLAARNV---------------- 268 (400)
T ss_pred ccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCChHhE----------------
Confidence 136677788999999999999999999999 8888888
Q ss_pred cchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3347 138 QEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPG 214 (245)
Q Consensus 138 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~ 214 (245)
+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 269 ------ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 269 ------LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred ------EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 777888999999999875332221 1223345678999999988889999999999999999997 9999987
Q ss_pred CCHHHHH-HHHhcC-cccCCCCCChhHHhhhc
Q psy3347 215 DDEEEVF-DSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 215 ~~~~~~~-~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
....... ..+..+ ..+.|..+++++.++|.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 374 (400)
T cd05105 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMV 374 (400)
T ss_pred cchhHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 6443333 333332 23456778888888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=227.62 Aligned_cols=212 Identities=25% Similarity=0.413 Sum_probs=169.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++. +..+|+|.+...... .+.+.+| ++.++.++||||+++++++..++..+++|||+++++|.+++.
T Consensus 20 vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 91 (256)
T cd05114 20 VHLGKWRA-QIKVAIKAINEGAMS----EEDFIEE---AKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR 91 (256)
T ss_pred EEEEEecc-CceEEEEecccCCcc----HHHHHHH---HHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHH
Confidence 68887764 568999988754221 2334444 667788899999999999999999999999999999998885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|+ +++.++.++|+|||.
T Consensus 92 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~ni----------------------~i~~~~~~kl~d~g~ 146 (256)
T cd05114 92 QRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR---DLAARNC----------------------LVSSTGVVKVSDFGM 146 (256)
T ss_pred hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc---ccCcceE----------------------EEcCCCeEEECCCCC
Confidence 3 458889999999999999999999999999 7778777 777888999999998
Q ss_pred ccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cCCCCC
Q psy3347 159 CKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~p~~~ 235 (245)
++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+..+.. ..|...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA 226 (256)
T ss_pred ccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 8753222211 112234557999999988889999999999999999999 9999988888887777776543 346667
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+++++
T Consensus 227 ~~~~~~li~~ 236 (256)
T cd05114 227 SMTVYEVMYS 236 (256)
T ss_pred CHHHHHHHHH
Confidence 7888887753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=229.81 Aligned_cols=215 Identities=24% Similarity=0.390 Sum_probs=167.1
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+.. ++..||+|.+.... .......+.+ ++..++.++|+||+++++++...+..+++|||+.+++|
T Consensus 22 vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L 96 (277)
T cd05036 22 VYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLM---EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL 96 (277)
T ss_pred EEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHH---HHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCH
Confidence 78998887 78899999886432 1222233433 46778889999999999999888899999999999999
Q ss_pred hhhhhhc--------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 76 MMHIHAD--------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 76 ~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
.+++... .+++..+.+++.|++.||+|||+++++|+ |++|+|| +++.
T Consensus 97 ~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~---dlkp~ni----------------------l~~~ 151 (277)
T cd05036 97 KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR---DIAARNC----------------------LLTC 151 (277)
T ss_pred HHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---ccchheE----------------------EEec
Confidence 9988542 47888999999999999999999999999 7777776 4443
Q ss_pred C---CceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 148 E---GYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 148 ~---~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
+ ..++|+|||+++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 3 3689999999875321111 1112233567999999988889999999999999999997 99999988877777
Q ss_pred HHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 222 DSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
..+... ...+|..+++.+.++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~i~~ 256 (277)
T cd05036 232 EFVTGGGRLDPPKGCPGPVYRIMTD 256 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 666543 334577888888888763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=226.84 Aligned_cols=214 Identities=22% Similarity=0.315 Sum_probs=168.9
Q ss_pred CEeEEEecCC---cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTG---EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+..++ ..+|+|.+...... ...+.+.+ +++.++.++|||++++++++. .+..+++|||+.+++|.+
T Consensus 11 v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~ 84 (257)
T cd05060 11 VVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLR---EASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLK 84 (257)
T ss_pred EEEeEeeccCCCcceEEEEecccccch--HHHHHHHH---HHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHH
Confidence 6888776654 79999999865322 22233433 467778889999999999875 456899999999999999
Q ss_pred hhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
++.. ..+++..+..++.|++.||+|||+++++|+ |++|+|+ +++.++.++|+||
T Consensus 85 ~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~---di~p~ni----------------------li~~~~~~kl~df 139 (257)
T cd05060 85 YLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR---DLAARNV----------------------LLVNRHQAKISDF 139 (257)
T ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeecc---CcccceE----------------------EEcCCCcEEeccc
Confidence 9965 458999999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCC---CcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cC
Q psy3347 157 GLCKEGMGFGDRT---GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RY 231 (245)
Q Consensus 157 g~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~ 231 (245)
|.++......... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..... +.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05060 140 GMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR 219 (257)
T ss_pred cccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCC
Confidence 9987542222111 11122357999999988889999999999999999998 9999988877777777655533 45
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|..+++.++++|++
T Consensus 220 ~~~~~~~l~~li~~ 233 (257)
T cd05060 220 PEECPQEIYSIMLS 233 (257)
T ss_pred CCCCCHHHHHHHHH
Confidence 77888899888863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=228.13 Aligned_cols=214 Identities=21% Similarity=0.342 Sum_probs=170.9
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+ ...||+|.++... .......+.+| +..++.++||||+++++.+...+..+++|||+++++|.+
T Consensus 20 vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 94 (266)
T cd05033 20 VCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTE---ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94 (266)
T ss_pred EEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHH---HHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHH
Confidence 789988654 4589999987542 22233344444 667788899999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. +.+++..+.+++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~---di~p~ni----------------------li~~~~~~~l~d 149 (266)
T cd05033 95 FLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR---DLAARNI----------------------LVNSNLVCKVSD 149 (266)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCcceE----------------------EEcCCCCEEECc
Confidence 8854 468999999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccC
Q psy3347 156 FGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRY 231 (245)
Q Consensus 156 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~ 231 (245)
||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+... ..+.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP 229 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9998764311111 112234567999999988889999999999999999998 99999877777777766654 3345
Q ss_pred CCCCChhHHhhhc
Q psy3347 232 PRFLSLEAIAIMR 244 (245)
Q Consensus 232 p~~~~~~~~~li~ 244 (245)
|..+++++.+++.
T Consensus 230 ~~~~~~~l~~li~ 242 (266)
T cd05033 230 PMDCPSALYQLML 242 (266)
T ss_pred CCCCCHHHHHHHH
Confidence 6778888888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=234.09 Aligned_cols=213 Identities=22% Similarity=0.344 Sum_probs=164.6
Q ss_pred CEeEEEecCCcE----EEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEY----FAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..+|+. ||+|+++... .....+.+.+ ++..++.++||||+++++++... ..++++||+.+|+|.
T Consensus 23 Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~ 96 (316)
T cd05108 23 VYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILD---EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLL 96 (316)
T ss_pred EEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHH---HHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHH
Confidence 799988776664 8999987432 1222333433 36677888999999999998764 578999999999999
Q ss_pred hhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++... .+++..+.+++.|++.||+|||++|++|| |+||+|| +++.++.+||+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~---dlkp~Ni----------------------ll~~~~~~kl~ 151 (316)
T cd05108 97 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR---DLAARNV----------------------LVKTPQHVKIT 151 (316)
T ss_pred HHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecc---ccchhhe----------------------EecCCCcEEEc
Confidence 988643 57888899999999999999999999999 8888888 77788899999
Q ss_pred ecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+....+.... .+
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 99999754322221 111223567999999988889999999999999999998 999998877666555444332 24
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..++.++.++|.
T Consensus 232 ~~~~~~~~~~~li~ 245 (316)
T cd05108 232 QPPICTIDVYMIMV 245 (316)
T ss_pred CCCCCCHHHHHHHH
Confidence 46678888888775
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=229.55 Aligned_cols=212 Identities=28% Similarity=0.496 Sum_probs=171.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|++..... ..+.+.+ +++.++.++|+|++++++++...+..++++||+++++|.+++.
T Consensus 35 v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (286)
T cd06614 35 VYKATDRATGKEVAIKKMRLRKQ----NKELIIN---EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT 107 (286)
T ss_pred EEEEEEccCCcEEEEEEEecCch----hHHHHHH---HHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHH
Confidence 68999998999999999976422 2233433 4677889999999999999999999999999999999999996
Q ss_pred hc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 AD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. .+++..+..++.|++.||+|||+.|++|+ +++|+|| +++.++.++|+|||.
T Consensus 108 ~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~---dl~p~ni----------------------~i~~~~~~~l~d~~~ 162 (286)
T cd06614 108 QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR---DIKSDNI----------------------LLSKDGSVKLADFGF 162 (286)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCChhhE----------------------EEcCCCCEEECccch
Confidence 54 78999999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-C--CCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-Y--PRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~--p~~~ 235 (245)
+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+ . +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence 764332222223345677899999998888999999999999999999999999877766555555443322 2 2347
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
+.+++++|+
T Consensus 243 ~~~l~~li~ 251 (286)
T cd06614 243 SPEFKDFLN 251 (286)
T ss_pred CHHHHHHHH
Confidence 788888875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=229.16 Aligned_cols=214 Identities=21% Similarity=0.379 Sum_probs=168.6
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|+.. .++..+|+|.+.... ....+.+.+ +++.++.++|+||+++++++...+..+++|||+++++|
T Consensus 21 v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (280)
T cd05092 21 VFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQR---EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94 (280)
T ss_pred EEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHH---HHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCH
Confidence 6777542 357789999887542 222334444 46778889999999999999999999999999999999
Q ss_pred hhhhhhc----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccc
Q psy3347 76 MMHIHAD----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQE 139 (245)
Q Consensus 76 ~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~ 139 (245)
.+++... .+++..+..++.|++.|++|||++|++|+ |++|+||
T Consensus 95 ~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~---dlkp~ni------------------ 153 (280)
T cd05092 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHR---DLATRNC------------------ 153 (280)
T ss_pred HHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecc---cccHhhE------------------
Confidence 9888542 37888999999999999999999999999 7778777
Q ss_pred hhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy3347 140 IKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDD 216 (245)
Q Consensus 140 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~ 216 (245)
+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||....
T Consensus 154 ----l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 154 ----LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred ----EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 777789999999998864322111 1222334678999999988889999999999999999998 999998777
Q ss_pred HHHHHHHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 217 EEEVFDSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 217 ~~~~~~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
..+....+..+. ...|..+++.+.++|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 259 (280)
T cd05092 230 NTEAIECITQGRELERPRTCPPEVYAIMQG 259 (280)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHH
Confidence 777666665543 34577889999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=226.86 Aligned_cols=211 Identities=25% Similarity=0.435 Sum_probs=169.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.+.... ..+.+.+ +++.++.++||||+++++.+..+...|+++|++.+++|.+++.
T Consensus 19 v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~---e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~ 90 (256)
T cd06612 19 VYKAIHKETGQVVAIKVVPVEE-----DLQEIIK---EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK 90 (256)
T ss_pred EEEEEEcCCCcEEEEEEeecHH-----HHHHHHH---HHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHH
Confidence 6899999889999999997532 1334444 4667778899999999999999999999999999999999884
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||+.+++|+ +++|+|| +++.++.++|+|||+
T Consensus 91 ~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~---dl~~~ni----------------------~~~~~~~~~l~dfg~ 145 (256)
T cd06612 91 ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR---DIKAGNI----------------------LLNEEGQAKLADFGV 145 (256)
T ss_pred hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCcceE----------------------EECCCCcEEEccccc
Confidence 3568999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~ 235 (245)
+..............++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.+....+..... ..|..+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW 225 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhc
Confidence 87543332223344577889999999888899999999999999999999999987666554444333221 234456
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.++|+
T Consensus 226 ~~~~~~~i~ 234 (256)
T cd06612 226 SPEFNDFVK 234 (256)
T ss_pred CHHHHHHHH
Confidence 777888775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=231.57 Aligned_cols=214 Identities=23% Similarity=0.392 Sum_probs=169.1
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .++..+++|.+.... ....+.+. ++++.+++++||||+++++++...+..++||||+++++|
T Consensus 21 vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (291)
T cd05094 21 VFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQ---REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94 (291)
T ss_pred EEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHH---HHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcH
Confidence 5777754 345679999887542 12223343 346778889999999999999999999999999999999
Q ss_pred hhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 76 MMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 76 ~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
.+++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 95 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~---dlkp~Ni----------------- 154 (291)
T cd05094 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR---DLATRNC----------------- 154 (291)
T ss_pred HHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---ccCcceE-----------------
Confidence 9988532 26888999999999999999999999999 8888888
Q ss_pred chhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGD 215 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~ 215 (245)
+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 155 -----l~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 155 -----LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred -----EEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 778889999999999864322211 1223455778999999988889999999999999999999 99999887
Q ss_pred CHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 216 DEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 216 ~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
+..+..+.+..+.. ..+..++.++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 260 (291)
T cd05094 230 SNTEVIECITQGRVLERPRVCPKEVYDIMLG 260 (291)
T ss_pred CHHHHHHHHhCCCCCCCCccCCHHHHHHHHH
Confidence 77777776665544 3456778888888753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=224.39 Aligned_cols=214 Identities=23% Similarity=0.409 Sum_probs=173.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.+...... ....+.+.+| ++.++.++|||++++++.+..++..++||||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e---~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 91 (256)
T cd08220 16 VHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNE---CQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ 91 (256)
T ss_pred EEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHH---HHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHH
Confidence 689999999999999999765332 2233444444 677888899999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceEEeec
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVKIADF 156 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|+|++|++|+ |++|+|| +++ .++.++++||
T Consensus 92 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~---dl~~~ni----------------------l~~~~~~~~~l~d~ 146 (256)
T cd08220 92 KRCNSLLDEDTILHFFVQILLALHHVHTKLILHR---DLKTQNI----------------------LLDKHKMVVKIGDF 146 (256)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEEccC
Confidence 4 347889999999999999999999999999 7888887 554 3456899999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
|.+...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+.......+.... ..+|..+
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08220 147 GISKILSSK-SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY 225 (256)
T ss_pred CCceecCCC-ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCc
Confidence 998753222 22234567888999999988888999999999999999999999998877766666665543 3467778
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++++++.
T Consensus 226 ~~~l~~li~ 234 (256)
T cd08220 226 SPDLRQLIL 234 (256)
T ss_pred CHHHHHHHH
Confidence 888888875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=225.26 Aligned_cols=215 Identities=26% Similarity=0.435 Sum_probs=175.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+|+.||+|.+..... .....+.+.+ +++.++.++||||+++++++.. +...+++|||+++++|..+
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~ 91 (265)
T cd08217 16 VRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVS---EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQL 91 (265)
T ss_pred EEEeeecCCCCEEEEEEEecccC-CHHHHHHHHH---HHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHH
Confidence 69999999999999999976432 2223333433 4677889999999999998753 4578999999999999988
Q ss_pred hhh-----cCCChHHHHHHHHHHHHHHHHhh-----hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 79 IHA-----DVFSEPRAVFYAACVVLGLQYLH-----ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 79 ~~~-----~~l~~~~~~~i~~~i~~~l~~lH-----~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
+.. .++++..+..++.|++.||.|+| +.+++|+ |++|+|| +++.+
T Consensus 92 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~---dl~p~ni----------------------li~~~ 146 (265)
T cd08217 92 IQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHR---DLKPANI----------------------FLDAN 146 (265)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceec---CCCHHHE----------------------EEecC
Confidence 843 46888999999999999999999 8999999 8888888 77888
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (245)
+.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..+.+..+.
T Consensus 147 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 226 (265)
T cd08217 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK 226 (265)
T ss_pred CCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC
Confidence 99999999998754333322344567889999999988888999999999999999999999998887767666666554
Q ss_pred c-cCCCCCChhHHhhhc
Q psy3347 229 V-RYPRFLSLEAIAIMR 244 (245)
Q Consensus 229 ~-~~p~~~~~~~~~li~ 244 (245)
. .+|...++++.++++
T Consensus 227 ~~~~~~~~~~~~~~l~~ 243 (265)
T cd08217 227 FRRIPYRYSSELNEVIK 243 (265)
T ss_pred CCCCccccCHHHHHHHH
Confidence 3 457788888888876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=226.47 Aligned_cols=213 Identities=25% Similarity=0.424 Sum_probs=169.1
Q ss_pred CEeEEEec-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRN-TGE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+.. .++ .||+|.++..... ...+.+. ++++.+++++||||+++++++.. +..+++|||+++++|..
T Consensus 11 v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~ 84 (257)
T cd05040 11 VRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFL---KEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84 (257)
T ss_pred EEeeeEecCCCCceEEEEeecCCcccH--HHHHHHH---HHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHH
Confidence 78998866 333 6999999875432 3333444 44777889999999999999988 89999999999999999
Q ss_pred hhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 78 HIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 78 ~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~---di~p~ni----------------------l~~~~~~~kl~ 139 (257)
T cd05040 85 RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHR---DLAARNI----------------------LLASDDKVKIG 139 (257)
T ss_pred HHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCcccc---ccCcccE----------------------EEecCCEEEec
Confidence 88543 57899999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc--
Q psy3347 155 DFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-- 228 (245)
Q Consensus 155 Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-- 228 (245)
|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 140 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05040 140 DFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219 (257)
T ss_pred cccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc
Confidence 9998875432111 1112345678999999988889999999999999999998 999998777777666665332
Q ss_pred ccCCCCCChhHHhhhc
Q psy3347 229 VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~ 244 (245)
...|..++.++.+++.
T Consensus 220 ~~~~~~~~~~~~~li~ 235 (257)
T cd05040 220 LERPEACPQDIYNVML 235 (257)
T ss_pred CCCCccCCHHHHHHHH
Confidence 2345677888888875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=238.13 Aligned_cols=211 Identities=26% Similarity=0.433 Sum_probs=177.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|.|+++|+.+|||.+.-. ...+.+..| +-++.+|..|++|+++|.|-.....++|||||.-|++.+.+
T Consensus 49 V~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKE---ISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R 120 (502)
T KOG0574|consen 49 VHKAIHRESGHVLAIKKVPVD-----TDLQEIIKE---ISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR 120 (502)
T ss_pred HHHHHHhccCcEEEEEecCcc-----chHHHHHHH---HHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH
Confidence 789999999999999998743 233444444 66778999999999999998888999999999999999888
Q ss_pred -hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 -HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 -~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
++.++++..+..+.+.-+.||+|||...-+|| |||..|| +++.+|..|++|||.
T Consensus 121 ~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHR---DIKAGNI----------------------LLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 121 ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHR---DIKAGNI----------------------LLNTDGIAKLADFGV 175 (502)
T ss_pred HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHh---hcccccE----------------------EEcccchhhhhhccc
Confidence 46789999999999999999999999999999 7777777 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~ 235 (245)
+....+.-.+.++..||+.|||||++..-.|+.++||||||++..||..|++||....++.+.-.+-+..++ -|+.-
T Consensus 176 AGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 176 AGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEW 255 (502)
T ss_pred cchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhh
Confidence 987776666788899999999999998778999999999999999999999999887776654444443322 14555
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
|.+.-|+++
T Consensus 256 S~~F~DFi~ 264 (502)
T KOG0574|consen 256 SSEFNDFIR 264 (502)
T ss_pred hhHHHHHHH
Confidence 666666664
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=249.67 Aligned_cols=215 Identities=23% Similarity=0.390 Sum_probs=172.7
Q ss_pred CEeEEEecCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--eEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII-ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~ 77 (245)
||+|.|..+|..||.-.++..... ..+..+.+ ..++.+|+.|+||||+++++.+.+.. .+-+|+|.+..|+|..
T Consensus 56 VYka~De~~giEVAWnqvk~~d~~q~~~~leR~---~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~ 132 (632)
T KOG0584|consen 56 VYKAFDEEEGIEVAWNQVKIRDVTQSPEELERL---YSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLRE 132 (632)
T ss_pred eeeccccccchhhHHHHHhHHHhhcChHHHHHH---HHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHH
Confidence 899999999999998877654332 22233444 45588999999999999999997654 4789999999999999
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+.+ .+.++...++.|++||+.||.|||++. |+|| |+|++|| ++-...|.|||+
T Consensus 133 Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHR---DLKCDNI---------------------FinG~~G~VKIG 188 (632)
T KOG0584|consen 133 YRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHR---DLKCDNI---------------------FVNGNLGEVKIG 188 (632)
T ss_pred HHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCcccc---ccccceE---------------------EEcCCcCceeec
Confidence 995 467899999999999999999999985 8999 8999999 234456999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCccc--C
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVNDEVR--Y 231 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~--~ 231 (245)
|+|+|+...... ....+||+-|||||... ..|+..+|||||||+|.||+|+..||+. .++..+.+++..+..| +
T Consensus 189 DLGLAtl~r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 189 DLGLATLLRKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred chhHHHHhhccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 999998533222 23368999999999995 6799999999999999999999999975 5667777777776543 2
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
..--.|++++||.+
T Consensus 266 ~kV~dPevr~fIek 279 (632)
T KOG0584|consen 266 SKVKDPEVREFIEK 279 (632)
T ss_pred hccCCHHHHHHHHH
Confidence 23346888888864
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=228.37 Aligned_cols=214 Identities=26% Similarity=0.447 Sum_probs=166.2
Q ss_pred CEeEEEecCCc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|. .+|+|.++... .....+.+.+| ++.+.++ +||||+++++++...+..+++|||+++++|.+
T Consensus 11 v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (270)
T cd05047 11 VLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGE---LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85 (270)
T ss_pred EEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHH---HHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHH
Confidence 79999988876 46888876421 22233444444 5566667 79999999999999999999999999999998
Q ss_pred hhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 78 HIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 78 ~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
++... .+++..+..++.|++.||+|||++|++|+ |++|+|+
T Consensus 86 ~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~---dikp~ni------------------- 143 (270)
T cd05047 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR---DLAARNI------------------- 143 (270)
T ss_pred HHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---ccccceE-------------------
Confidence 88532 36788999999999999999999999999 8888887
Q ss_pred hccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~ 219 (245)
+++.++.++++|||++....... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+
T Consensus 144 ---li~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 144 ---LVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred ---EEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence 77888999999999875321111 1111223557999999988889999999999999999997 999998877777
Q ss_pred HHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 220 VFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 220 ~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
....+... ..+.|..++.++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (270)
T cd05047 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQ 246 (270)
T ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence 66666554 234566778888888753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=227.05 Aligned_cols=214 Identities=22% Similarity=0.321 Sum_probs=168.6
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+++ .+|+|.++... .....+.+.+| ++.++.++|||++++.+++...+..+++|||+++++|..
T Consensus 21 vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (268)
T cd05063 21 VFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSE---ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95 (268)
T ss_pred EEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHH---HHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHH
Confidence 68999887665 79999887532 12223344444 667888899999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++. ..+++..+..++.|++.|++|||++|++|+ |++|+|| +++.++.++++|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~kl~d 150 (268)
T cd05063 96 YLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR---DLAARNI----------------------LVNSNLECKVSD 150 (268)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---ccchhhE----------------------EEcCCCcEEECC
Confidence 8854 468899999999999999999999999999 7778777 777888999999
Q ss_pred cCCccCCCCCCCCCC---cccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 156 FGLCKEGMGFGDRTG---TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
||++........... ....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.... .+
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 999875432221111 1122456999999988888999999999999999997 999998877777777765543 23
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.+..++.++.+++.
T Consensus 231 ~~~~~~~~~~~li~ 244 (268)
T cd05063 231 APMDCPSAVYQLML 244 (268)
T ss_pred CCCCCCHHHHHHHH
Confidence 45567888888775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.62 Aligned_cols=205 Identities=38% Similarity=0.771 Sum_probs=185.8
Q ss_pred EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh-hcCCChHHHH
Q psy3347 12 YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH-ADVFSEPRAV 90 (245)
Q Consensus 12 ~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~ 90 (245)
-+|+|.+++..+....+.+....|.+++. .++.|.|++++.-|.++.++|++||-|-||.|...++ ++.+....++
T Consensus 447 ~fAlKilkK~hIVdtkQqeHv~sEr~Im~---~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tar 523 (732)
T KOG0614|consen 447 TFALKILKKKHIVDTKQQEHVFSERNIMM---ECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTAR 523 (732)
T ss_pred HHHHHHHhHhhccchhHHHHHHhHHHHHH---hcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhh
Confidence 48999999888888888888999977754 5669999999999999999999999999999988884 6789999999
Q ss_pred HHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCC
Q psy3347 91 FYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170 (245)
Q Consensus 91 ~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 170 (245)
.++..+++|++|||++||++| |+||+|+ ++|.+|.+||.|||+++. ...+.+.-
T Consensus 524 F~~acv~EAfeYLH~k~iIYR---DLKPENl----------------------lLd~~Gy~KLVDFGFAKk-i~~g~KTw 577 (732)
T KOG0614|consen 524 FYVACVLEAFEYLHRKGIIYR---DLKPENL----------------------LLDNRGYLKLVDFGFAKK-IGSGRKTW 577 (732)
T ss_pred hhHHHHHHHHHHHHhcCceec---cCChhhe----------------------eeccCCceEEeehhhHHH-hccCCcee
Confidence 999999999999999999999 8889888 899999999999999986 44556678
Q ss_pred cccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCCCCCChhHHhhhcC
Q psy3347 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~ 245 (245)
++|||+.|.|||++.....+.++|.||||+.+||+++|.+||++.+++...+.|+.+- ..+|+.++....+||++
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 8999999999999999999999999999999999999999999999999999999874 46899999998888864
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.56 Aligned_cols=187 Identities=29% Similarity=0.448 Sum_probs=153.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||++++++||+.||||+++.... ....+.. .+++++|++++|||||+++++=.... ...++||||.||+
T Consensus 29 V~rgrnketG~~vAvK~~~~~~~--~r~~e~~---~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGs 103 (732)
T KOG4250|consen 29 VYRGRNKETGRLVAVKTFNKESS--LRPRERW---CREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGS 103 (732)
T ss_pred eeeecccccccchhHHhhhhhcc--cchHHHH---HHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCc
Confidence 89999999999999999987542 2233333 44588999999999999999865433 5789999999999
Q ss_pred hhhhhhh----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 75 LMMHIHA----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 75 L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
|...++. ..+++..+..+..++..||.|||++||+|| |+||.|| ++. .-.|+.-.
T Consensus 104 L~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHR---DlKP~NI-----vl~-------------~Gedgq~I 162 (732)
T KOG4250|consen 104 LRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHR---DLKPGNI-----VLQ-------------IGEDGQSI 162 (732)
T ss_pred HHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceec---cCCCCcE-----EEe-------------ecCCCceE
Confidence 9999964 369999999999999999999999999999 7777777 211 01123334
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCcccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
.||+|||.|+... ++......+||..|++||... +..|+..+|.|||||++|+.+||+.||-.
T Consensus 163 yKLtDfG~Arel~-d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 163 YKLTDFGAARELD-DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred EeeecccccccCC-CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 7999999999743 334566789999999999997 47788999999999999999999999943
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=231.09 Aligned_cols=215 Identities=27% Similarity=0.458 Sum_probs=166.9
Q ss_pred CEeEEEec-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYRN-------TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++.. ++..+|+|.++... .......+.+| ++.++.+ +||||+++++++...+..+++|||+++
T Consensus 34 V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e---~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (307)
T cd05098 34 VVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISE---MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 108 (307)
T ss_pred EEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHH---HHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCC
Confidence 67887643 33579999997532 22223334444 5666677 799999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
++|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 109 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~---dlkp~Ni-------------- 171 (307)
T cd05098 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR---DLAARNV-------------- 171 (307)
T ss_pred CcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc---cccHHhe--------------
Confidence 9999888532 37788899999999999999999999999 8888887
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus 172 --------ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 172 --------LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred --------EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 7778899999999998753221111 112223467999999988889999999999999999998 99999
Q ss_pred CCCCHHHHHHHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
.+.+..+....+.... ...|..++.++.+|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 277 (307)
T cd05098 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD 277 (307)
T ss_pred CcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 8877777666665543 35677888999888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=214.92 Aligned_cols=196 Identities=22% Similarity=0.369 Sum_probs=165.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++++|++-||+|.++... +.+-+. -...|++-+++.+.|.||++++++...++...+|+|||. ++|..++.
T Consensus 18 vfkarn~~t~eivalkrvrldd--ddegvp--ssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfd 92 (292)
T KOG0662|consen 18 VFKARNRETHEIVALKRVRLDD--DDEGVP--SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFD 92 (292)
T ss_pred eEecccCCccceEEEEEEeccC--CCCCCc--HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHH
Confidence 7999999999999999998643 222222 233566888999999999999999999999999999994 48887774
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
++.+.....+.++.|++.||.|||+++++|| |+||.|+ +++++|.+|++|||+
T Consensus 93 slng~~d~~~~rsfmlqllrgl~fchshnvlhr---dlkpqnl----------------------lin~ngelkladfgl 147 (292)
T KOG0662|consen 93 SLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHR---DLKPQNL----------------------LINRNGELKLADFGL 147 (292)
T ss_pred hcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhc---cCCcceE----------------------EeccCCcEEecccch
Confidence 4678888999999999999999999999999 7788777 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~ 226 (245)
++.+.-...+.+..+-|.+|++|..+.+. -|+...|+||.|||++|+.. |++.|++.+-.+....|..
T Consensus 148 arafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred hhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 98654444445556678999999999885 48899999999999999997 9999999998888888753
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=273.38 Aligned_cols=216 Identities=28% Similarity=0.447 Sum_probs=179.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||-|-+.+||+-.|+|-++..... ..-++...+|..+ +..++|||+++++|+=.+....+|.||||++|+|.+.+.
T Consensus 1251 VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~v---lE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~ 1326 (1509)
T KOG4645|consen 1251 VYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKV---LEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE 1326 (1509)
T ss_pred eEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHH---HHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH
Confidence 799999999999999998875543 3444555666444 556679999999999999999999999999999999997
Q ss_pred hcC-CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 ADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~~-l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+. .++.....+..|++.|++|||++||+|| ||||+|| +++.+|.+|.+|||.|
T Consensus 1327 ~gri~dE~vt~vyt~qll~gla~LH~~gIVHR---DIK~aNI----------------------~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1327 HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHR---DIKPANI----------------------LLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred hcchhhhhHHHHHHHHHHHHHHHHHhcCceec---CCCccce----------------------eeecCCcEEeecccce
Confidence 664 5667777899999999999999999999 9999999 8888899999999999
Q ss_pred cCCCCCCC----CCCcccCCCCccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC-ccc
Q psy3347 160 KEGMGFGD----RTGTFCGTPEFLAPEVLTET---SYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSIVND-EVR 230 (245)
Q Consensus 160 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~~g~~pf~~~-~~~~~~~~~~~~-~~~ 230 (245)
....+... ......||+.|||||.+.+. ....++|||||||+..||+||+-||... ++..++.++..+ .+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 86544321 12356799999999999763 4568899999999999999999999765 456777788665 556
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|+.++++.+|+|++
T Consensus 1462 ~P~~ls~~g~dFle~ 1476 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEH 1476 (1509)
T ss_pred CchhhhHhHHHHHHH
Confidence 899999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=227.34 Aligned_cols=206 Identities=25% Similarity=0.468 Sum_probs=161.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++.++.+|+.+|+|.+....... . +.....+++ +|||++++++.|..++..++||||+++++|.++++
T Consensus 32 v~~~~~~~~~~~~~~k~~~~~~~~~---~-----e~~~~~~~~--~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~ 101 (267)
T PHA03390 32 VSVLKHKPTQKLFVQKIIKAKNFNA---I-----EPMVHQLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK 101 (267)
T ss_pred EEEEEEcCCCcEEEEEEEehhhcch---h-----hHHHHHHhh--cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHH
Confidence 6899999999999999997642211 1 111112222 69999999999999999999999999999999986
Q ss_pred hc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEeecCC
Q psy3347 81 AD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIADFGL 158 (245)
Q Consensus 81 ~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~ 158 (245)
.. .+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++ .++|+|||+
T Consensus 102 ~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 102 KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN---DIKLENV----------------------LYDRAKDRIYLCDYGL 156 (267)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCCHHHE----------------------EEeCCCCeEEEecCcc
Confidence 54 78999999999999999999999999999 8888887 666666 899999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCcccCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE----VFDSIVNDEVRYPRF 234 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~p~~ 234 (245)
+..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ..........+.++.
T Consensus 157 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T PHA03390 157 CKIIGT----PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN 232 (267)
T ss_pred ceecCC----CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccc
Confidence 875322 223457888999999988889999999999999999999999997543222 111222333345667
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++.+.++|++
T Consensus 233 ~~~~~~~li~~ 243 (267)
T PHA03390 233 VSKNANDFVQS 243 (267)
T ss_pred cCHHHHHHHHH
Confidence 88998888753
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=223.99 Aligned_cols=214 Identities=29% Similarity=0.491 Sum_probs=173.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...... ...+.+.+| +..+..++|+|++++++++..++..+++|||+++++|.+++.
T Consensus 17 v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 91 (264)
T cd06623 17 VYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRE---LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK 91 (264)
T ss_pred EEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHH---HHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHH
Confidence 689999999999999998764321 223334444 666777889999999999999999999999999999999986
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++.....++.|++.|++|+|+ .|++|+ +++|+|| +++.++.++|+|||.
T Consensus 92 ~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~---~l~~~ni----------------------~~~~~~~~~l~df~~ 146 (264)
T cd06623 92 KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR---DIKPSNL----------------------LINSKGEVKIADFGI 146 (264)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHhccCCCccC---CCCHHHE----------------------EECCCCCEEEccCcc
Confidence 4 678999999999999999999999 999999 8888888 788889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcC-cccCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~---~~~~~~~~~~~~-~~~~p~~ 234 (245)
+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||... ...+....+... ....+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence 876443333333456788899999998888899999999999999999999999766 444555555433 2334555
Q ss_pred -CChhHHhhhc
Q psy3347 235 -LSLEAIAIMR 244 (245)
Q Consensus 235 -~~~~~~~li~ 244 (245)
++..+.++|+
T Consensus 227 ~~~~~l~~li~ 237 (264)
T cd06623 227 EFSPEFRDFIS 237 (264)
T ss_pred cCCHHHHHHHH
Confidence 7888888775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=231.47 Aligned_cols=191 Identities=21% Similarity=0.356 Sum_probs=151.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|.++..... ......+.+ +++.++.++||||+++++++.+.+..++++||+++ +|..++.
T Consensus 16 vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~---ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 90 (284)
T cd07839 16 VFKAKNRETHEIVALKRVRLDDDD-EGVPSSALR---EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFD 90 (284)
T ss_pred EEEEEECCCCcEEEEEEeeccccc-ccCccchhH---HHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHH
Confidence 699999999999999999754211 111223333 46778888999999999999999999999999975 7776664
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 91 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~---dl~~~ni----------------------l~~~~~~~~l~dfg~ 145 (284)
T cd07839 91 SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR---DLKPQNL----------------------LINKNGELKLADFGL 145 (284)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CCCHHHE----------------------EEcCCCcEEECccch
Confidence 3568999999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCC-CCCCHHHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPF-PGDDEEEVF 221 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf-~~~~~~~~~ 221 (245)
+..............++..|+|||.+.+. .++.++|+||||+++|+|++|..|| .+.+..+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred hhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 87533222223344567889999998764 4789999999999999999988775 444444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=231.11 Aligned_cols=214 Identities=26% Similarity=0.435 Sum_probs=167.5
Q ss_pred CEeEEEecCCc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+|. .+++|.++... .....+.+.+| ++.+.++ +||||+++++++...+..+++|||+++++|.+
T Consensus 18 v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E---~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (297)
T cd05089 18 VIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGE---LEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92 (297)
T ss_pred EEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHH---HHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHH
Confidence 68898887765 46888877421 22223344444 5666666 69999999999999999999999999999998
Q ss_pred hhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 78 HIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 78 ~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
++... .+++..+..++.|++.||+|||++|++|+ |++|+|+
T Consensus 93 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~---dlkp~Ni------------------- 150 (297)
T cd05089 93 FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHR---DLAARNV------------------- 150 (297)
T ss_pred HHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---cCCcceE-------------------
Confidence 88532 37788899999999999999999999999 8888888
Q ss_pred hccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~ 219 (245)
+++.++.+||+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 151 ---ll~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 151 ---LVGENLASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred ---EECCCCeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 777889999999998864211111 111223456999999988889999999999999999997 999998888777
Q ss_pred HHHHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 220 VFDSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 220 ~~~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
....+..+. ...|..+++++++||++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~li~~ 253 (297)
T cd05089 227 LYEKLPQGYRMEKPRNCDDEVYELMRQ 253 (297)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 777766543 34567789999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=227.95 Aligned_cols=213 Identities=23% Similarity=0.394 Sum_probs=163.1
Q ss_pred CEeEEEecCCcE----EEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEY----FAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..+|+. +++|.+.... ...... ....++..++.++||||+++++++. +...++++||+.+++|.
T Consensus 23 vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~---~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~ 96 (279)
T cd05111 23 VHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQ---EITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLL 96 (279)
T ss_pred eEEEEEcCCCCceeeEEEEeeccccc--chHHHH---HHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHH
Confidence 799998877774 6667664321 111222 2334456678889999999999875 45678999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.+||+
T Consensus 97 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~---dlkp~ni----------------------li~~~~~~kl~ 151 (279)
T cd05111 97 DHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR---NLAARNI----------------------LLKSDSIVQIA 151 (279)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecc---ccCcceE----------------------EEcCCCcEEEc
Confidence 99853 468999999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-c
Q psy3347 155 DFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-R 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~ 230 (245)
|||.++....... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.+....+..+.+..+.. .
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05111 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA 231 (279)
T ss_pred CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC
Confidence 9999875322211 1223345678999999988889999999999999999998 9999988777666555544433 3
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..++.++.+++.
T Consensus 232 ~~~~~~~~~~~li~ 245 (279)
T cd05111 232 QPQICTIDVYMVMV 245 (279)
T ss_pred CCCCCCHHHHHHHH
Confidence 35667777777664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.19 Aligned_cols=191 Identities=30% Similarity=0.470 Sum_probs=155.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|.+....... ...+.+.+ +++.++.++||||+++++++..++..+++|||+++++|..+..
T Consensus 17 vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 92 (286)
T cd07846 17 VMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMR---EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK 92 (286)
T ss_pred EEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHH---HHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh
Confidence 6999999999999999987543221 12233333 4677888899999999999999999999999999988887764
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||+.|++|+ +++|+|| +++.++.++|+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~---~l~p~ni----------------------~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 93 YPNGLDESRVRKYLFQILRGIEFCHSHNIIHR---DIKPENI----------------------LVSQSGVVKLCDFGFA 147 (286)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EECCCCcEEEEeeeee
Confidence 3 468999999999999999999999999999 8888888 7788899999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~ 220 (245)
..............++..|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+..+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~ 209 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ 209 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 754333333334567888999999865 3467899999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=226.14 Aligned_cols=211 Identities=24% Similarity=0.375 Sum_probs=168.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. +++.||+|.++.... ..+.+.+ +++.+++++||||+++++++...+..+++|||+++++|.+++.
T Consensus 22 v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (261)
T cd05068 22 VWEGLWN-NTTPVAVKTLKPGTM----DPKDFLA---EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ 93 (261)
T ss_pred EEEEEec-CCeEEEEEeeCCCcc----cHHHHHH---HHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHh
Confidence 6888865 457899999875432 1233333 4677888899999999999999999999999999999999985
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. .+++..+..++.|++.|+.+||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~~l~dfg 148 (261)
T cd05068 94 GGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR---DLAARNV----------------------LVGENNICKVADFG 148 (261)
T ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---cCCcceE----------------------EEcCCCCEEECCcc
Confidence 42 58899999999999999999999999999 8888888 78888999999999
Q ss_pred CccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
++......... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+....+.... .+.|..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05068 149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG 228 (261)
T ss_pred eEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 98754322111 111122357999999988889999999999999999999 999999888777777665442 234567
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
+++++.+++.
T Consensus 229 ~~~~~~~li~ 238 (261)
T cd05068 229 CPKELYDIML 238 (261)
T ss_pred CCHHHHHHHH
Confidence 7888888875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=231.12 Aligned_cols=211 Identities=25% Similarity=0.383 Sum_probs=166.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+........+..+.+.+| ++.++.++||||+++.+++..++..++||||+.+ ++.+++.
T Consensus 31 vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~E---i~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~ 106 (307)
T cd06607 31 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE---VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILE 106 (307)
T ss_pred EEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHH---HHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHH
Confidence 68999999999999999976543333444444444 6778889999999999999999999999999975 6655553
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 107 ~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~---dl~p~nI----------------------l~~~~~~~kL~dfg~ 161 (307)
T cd06607 107 VHKKPLQEVEIAAICHGALQGLAYLHSHERIHR---DIKAGNI----------------------LLTEPGTVKLADFGS 161 (307)
T ss_pred HcccCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCCcccE----------------------EECCCCCEEEeecCc
Confidence 4568999999999999999999999999999 8888888 788889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cC-CC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RY-PR 233 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~-p~ 233 (245)
+..... .....++..|+|||.+. ...++.++||||||+++|+|++|+.||.+.+.......+..... .. +.
T Consensus 162 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (307)
T cd06607 162 ASLVSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN 237 (307)
T ss_pred ceecCC----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCch
Confidence 864321 22446778899999884 35678899999999999999999999987776665555443322 22 34
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.++++++++|+
T Consensus 238 ~~~~~~~~li~ 248 (307)
T cd06607 238 DWSDYFRNFVD 248 (307)
T ss_pred hhCHHHHHHHH
Confidence 56777787775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=223.78 Aligned_cols=214 Identities=22% Similarity=0.381 Sum_probs=170.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+.. ++.||+|.++..... ...+.+.+ +++.++.++||||+++++++...+..+++|||+.+++|.+++.
T Consensus 11 v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~ 84 (251)
T cd05041 11 VYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQ---EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLR 84 (251)
T ss_pred EEEEEEeC-CCcEEEEeccccCCH--HHHHHHHH---HHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHH
Confidence 68998887 999999998764322 22333443 4677888999999999999999999999999999999999884
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..++......++.+++.||+|||+++++|+ |++|+|| +++.++.++|+|||.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~---di~p~ni----------------------li~~~~~~~l~d~g~ 139 (251)
T cd05041 85 KKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR---DLAARNC----------------------LVGENNVLKISDFGM 139 (251)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehh---hcCcceE----------------------EEcCCCcEEEeeccc
Confidence 3 457888899999999999999999999999 8888777 778889999999998
Q ss_pred ccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 159 CKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
+......... ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+... ....|..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 219 (251)
T cd05041 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQL 219 (251)
T ss_pred cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence 8743211111 111223456999999988889999999999999999999 89999887776666666544 2345678
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
++.++.++|++
T Consensus 220 ~~~~~~~li~~ 230 (251)
T cd05041 220 CPEEIYRLMLQ 230 (251)
T ss_pred CCHHHHHHHHH
Confidence 88999988863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=225.24 Aligned_cols=212 Identities=25% Similarity=0.415 Sum_probs=167.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. ++..||+|.+..... ..+.+.+ ++.+++.++|+||+++++++...+..+++|||+++++|.++++
T Consensus 22 v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 93 (261)
T cd05072 22 VWMGYYN-NSTKVAVKTLKPGTM----SVQAFLE---EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK 93 (261)
T ss_pred EEEEEec-CCceEEEEEccCCch----hHHHHHH---HHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHH
Confidence 6899865 567899999875321 2233443 4667788899999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||+++++|+ |++|+|| +++.++.++|+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~---dl~p~ni----------------------li~~~~~~~l~dfg 148 (261)
T cd05072 94 SDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR---DLRAANV----------------------LVSESLMCKIADFG 148 (261)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---ccchhhE----------------------EecCCCcEEECCCc
Confidence 3 357888889999999999999999999999 8888887 77788999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+....+....+.... .+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05072 149 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228 (261)
T ss_pred cceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 9875322211 1112234567999999988889999999999999999998 999998877777666665442 233456
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
++.++.+++.+
T Consensus 229 ~~~~~~~li~~ 239 (261)
T cd05072 229 CPDELYDIMKT 239 (261)
T ss_pred CCHHHHHHHHH
Confidence 78888888753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=226.82 Aligned_cols=214 Identities=22% Similarity=0.369 Sum_probs=168.7
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+|+ .||+|.++... .....+.+..| ++.++.++||||+++++++..++..+++|||+++++|..
T Consensus 20 vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e---~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (269)
T cd05065 20 VCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE---ASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94 (269)
T ss_pred EEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHH---HHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHH
Confidence 68999887765 69999987532 22233444444 677788899999999999999999999999999999998
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. +.+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++++|
T Consensus 95 ~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~---dl~p~ni----------------------li~~~~~~kl~d 149 (269)
T cd05065 95 FLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR---DLAARNI----------------------LVNSNLVCKVSD 149 (269)
T ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---ccChheE----------------------EEcCCCcEEECC
Confidence 8854 457889999999999999999999999999 8888787 778889999999
Q ss_pred cCCccCCCCCCCC--CCccc---CCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-c
Q psy3347 156 FGLCKEGMGFGDR--TGTFC---GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-E 228 (245)
Q Consensus 156 fg~~~~~~~~~~~--~~~~~---~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~ 228 (245)
||++......... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||...+..+....+... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~ 229 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR 229 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9988653222111 11111 1346999999988889999999999999999886 99999888777777776543 2
Q ss_pred ccCCCCCChhHHhhhc
Q psy3347 229 VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~ 244 (245)
.+.|..+++++.+++.
T Consensus 230 ~~~~~~~~~~~~~li~ 245 (269)
T cd05065 230 LPPPMDCPTALHQLML 245 (269)
T ss_pred CCCcccCCHHHHHHHH
Confidence 3445678888888774
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=226.70 Aligned_cols=213 Identities=26% Similarity=0.439 Sum_probs=166.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCC------eEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEA------HVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~------~~~lv~e~~~~~ 73 (245)
||+|.++.+++.+++|++.... ...+.+.+| +++++.+ +|+||+++++++...+ ..+++|||++++
T Consensus 22 v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e---~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 94 (275)
T cd06608 22 VYKARHKKTGQLVAIKIMDIIE----DEEEEIKEE---YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGG 94 (275)
T ss_pred EEEEEECCCCcEEEEEEEecCc----hhHHHHHHH---HHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCC
Confidence 6899999999999999987542 122344444 5666666 6999999999996644 589999999999
Q ss_pred chhhhhhh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 74 DLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 74 ~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
+|.+++.. ..+++..+..++.|++.||+|||++|++|+ +++|+|| +++.+
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~---~l~p~ni----------------------~~~~~ 149 (275)
T cd06608 95 SVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHR---DIKGQNI----------------------LLTKN 149 (275)
T ss_pred cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC---CCCHHHE----------------------EEccC
Confidence 99887742 468899999999999999999999999999 8888888 77888
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
+.++|+|||++..............++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........
T Consensus 150 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 150 AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229 (275)
T ss_pred CeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence 99999999988754333333445567888999998854 2467889999999999999999999987665555555
Q ss_pred HhcCccc---CCCCCChhHHhhhcC
Q psy3347 224 IVNDEVR---YPRFLSLEAIAIMRR 245 (245)
Q Consensus 224 ~~~~~~~---~p~~~~~~~~~li~~ 245 (245)
+.....+ .+...+++++++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~ 254 (275)
T cd06608 230 IPRNPPPTLKSPENWSKKFNDFISE 254 (275)
T ss_pred hhccCCCCCCchhhcCHHHHHHHHH
Confidence 5443321 234467788888763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=226.01 Aligned_cols=211 Identities=24% Similarity=0.384 Sum_probs=167.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++.. +..+|+|.+...... .+.+.+ +++.+++++||||+++++++...+..+++|||+.+++|.+++.
T Consensus 20 vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~ 91 (256)
T cd05113 20 VKYGKWRG-QYDVAIKMIKEGSMS----EDEFIE---EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR 91 (256)
T ss_pred EEEEEecC-CCcEEEEEcCCCccc----HHHHHH---HHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHH
Confidence 68887653 456999998754321 233444 4677888999999999999998889999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|||.
T Consensus 92 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~ni----------------------li~~~~~~kl~d~g~ 146 (256)
T cd05113 92 EHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR---DLAARNC----------------------LVDDQGCVKVSDFGL 146 (256)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---ccCcceE----------------------EEcCCCCEEECCCcc
Confidence 4 358899999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCccc-CCCCC
Q psy3347 159 CKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVR-YPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~-~p~~~ 235 (245)
++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+..+... .|...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05113 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226 (256)
T ss_pred ceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 8753322211 111234567999999988889999999999999999998 99999887777777777665433 46667
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++.+++++.
T Consensus 227 ~~~~~~li~ 235 (256)
T cd05113 227 SEKVYAIMY 235 (256)
T ss_pred CHHHHHHHH
Confidence 888888875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=230.84 Aligned_cols=215 Identities=24% Similarity=0.431 Sum_probs=165.1
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.+ ..++..+|+|.++... .....+.+.+| ++.++++ +||||+++++++...+..+++|||+.+++
T Consensus 51 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 125 (302)
T cd05055 51 VVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSE---LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125 (302)
T ss_pred EEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHH---HHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCc
Confidence 577764 3356789999987542 12223344444 6677788 79999999999999999999999999999
Q ss_pred hhhhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 75 LMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 75 L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
|..+++.. .+++..+..++.|++.||+|||+++++|+ |++|+|| +++.++.+
T Consensus 126 L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~ 180 (302)
T cd05055 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHR---DLAARNV----------------------LLTHGKIV 180 (302)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehh---hhccceE----------------------EEcCCCeE
Confidence 99988542 37899999999999999999999999999 7777777 66778889
Q ss_pred EEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc
Q psy3347 152 KIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE 228 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~ 228 (245)
+++|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.........
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 9999999875433221 1122345677999999988889999999999999999998 999998776555444444333
Q ss_pred c--cCCCCCChhHHhhhcC
Q psy3347 229 V--RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~--~~p~~~~~~~~~li~~ 245 (245)
. ..|...++++.+++++
T Consensus 261 ~~~~~~~~~~~~~~~li~~ 279 (302)
T cd05055 261 YRMAQPEHAPAEIYDIMKT 279 (302)
T ss_pred CcCCCCCCCCHHHHHHHHH
Confidence 2 2355678888888763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=225.87 Aligned_cols=216 Identities=22% Similarity=0.359 Sum_probs=168.5
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeecc
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAA 71 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~ 71 (245)
||+|.+.. ++..||+|.++..... ....+.+.+| ++.++.++||||+++++++.... ..+++|||++
T Consensus 15 v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~ 90 (273)
T cd05035 15 VMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSE---AACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMK 90 (273)
T ss_pred EEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHH---HHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccC
Confidence 68887765 3488999999754322 2233344444 67788899999999999886544 3799999999
Q ss_pred CCchhhhhhh-------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 72 GGDLMMHIHA-------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 72 ~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
+++|..++.. ..+++..+..++.|++.||+|||+++++|+ |++|+|| +
T Consensus 91 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~---dlkp~Ni----------------------l 145 (273)
T cd05035 91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR---DLAARNC----------------------M 145 (273)
T ss_pred CCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc---ccchheE----------------------E
Confidence 9999877732 257888999999999999999999999999 8888887 7
Q ss_pred cCCCCceEEeecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.++|+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+..
T Consensus 146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05035 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225 (273)
T ss_pred ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 778889999999998753222111 111234567999999988889999999999999999999 99999888877777
Q ss_pred HHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 222 DSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
+.+..+ ....|..+++++.++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~li~~ 250 (273)
T cd05035 226 DYLRHGNRLKQPEDCLDELYDLMYS 250 (273)
T ss_pred HHHHcCCCCCCCcCCCHHHHHHHHH
Confidence 777654 334677888888888764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=249.96 Aligned_cols=214 Identities=26% Similarity=0.445 Sum_probs=182.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.++-..|.|++... ..++.+++.-| +++|..|+||+|+++++.|...+..+++.|||+||-....+-
T Consensus 48 VyKA~nket~~lAAaKvIetk---seEELEDylVE---IeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaiml 121 (1187)
T KOG0579|consen 48 VYKAVNKETKLLAAAKVIETK---SEEELEDYLVE---IEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIML 121 (1187)
T ss_pred hhhhhcccchhhhhhhhhccc---chhHHhhhhhh---hhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHH
Confidence 799999999999999999764 45667777666 777889999999999999999999999999999998877663
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+.++++.-+++|++.||.|||+++|+|| |+|..|| +..-+|.++|+|||.
T Consensus 122 EL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHR---DLKAGNi----------------------L~TldGdirLADFGV 176 (1187)
T KOG0579|consen 122 ELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHR---DLKAGNI----------------------LLTLDGDIRLADFGV 176 (1187)
T ss_pred HhccccchHHHHHHHHHHHHHHHHHhhcchhhh---hccccce----------------------EEEecCcEeeecccc
Confidence 4679999999999999999999999999999 7777777 677789999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--- 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (245)
+............+.||++|||||+.. ..+|+.++||||||+++.||..+++|-..-+++.++-+|....++
T Consensus 177 SAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 177 SAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred cccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 876555555567889999999999884 468999999999999999999999999988999888888765544
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
-|+.-+..++|++.+
T Consensus 257 qPS~Ws~~F~DfLk~ 271 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKR 271 (1187)
T ss_pred CcchhhhHHHHHHHH
Confidence 266667777777753
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=222.65 Aligned_cols=214 Identities=22% Similarity=0.378 Sum_probs=168.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. +++.+|+|.+.... .......+.+ +++.++.++||||+++++++...+..+++|||+++++|..++.
T Consensus 11 vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 84 (250)
T cd05085 11 VFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLS---EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR 84 (250)
T ss_pred EEEEEec-CCcEEEEEecCCcC--CHHHHHHHHH---HHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHH
Confidence 7899765 68899999987542 2222223444 4667778899999999999999999999999999999998885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|+|++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 85 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~---dl~p~ni----------------------li~~~~~~~l~d~g~ 139 (250)
T cd05085 85 KKKDELKTKQLVKFALDAAAGMAYLESKNCIHR---DLAARNC----------------------LVGENNVLKISDFGM 139 (250)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---ccChheE----------------------EEcCCCeEEECCCcc
Confidence 3 357889999999999999999999999999 8888887 777889999999998
Q ss_pred ccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 159 CKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
+......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+.... ...|..+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (250)
T cd05085 140 SRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKC 219 (250)
T ss_pred ceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 8643221111 112233567999999988888999999999999999998 999998877766666665442 2446678
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+++.+
T Consensus 220 ~~~~~~li~~ 229 (250)
T cd05085 220 PDDVYKVMQR 229 (250)
T ss_pred CHHHHHHHHH
Confidence 8888888753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=227.80 Aligned_cols=215 Identities=21% Similarity=0.321 Sum_probs=166.4
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.++. .+..||+|.++.... ......+ .+++..++.++||||+++++++..++..+++|||+++|+|
T Consensus 22 Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 96 (288)
T cd05061 22 VYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEF---LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96 (288)
T ss_pred EEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHH---HHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCH
Confidence 68886653 355899998864321 1111223 3446778888999999999999999999999999999999
Q ss_pred hhhhhhc-----------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 76 MMHIHAD-----------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 76 ~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
.++++.. ..+...+..++.|++.||.|||++|++|+ |++|+|| +
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~---dikp~ni----------------------l 151 (288)
T cd05061 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR---DLAARNC----------------------M 151 (288)
T ss_pred HHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC---CCChheE----------------------E
Confidence 9988531 23456778899999999999999999999 8888888 7
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+..
T Consensus 152 i~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred EcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 78889999999999874322111 1122234667999999988889999999999999999998 89999888877777
Q ss_pred HHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 222 DSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
..+..+. .+.|..+++++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~ 256 (288)
T cd05061 232 KFVMDGGYLDQPDNCPERVTDLMRM 256 (288)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 7666543 34577788888888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=230.98 Aligned_cols=195 Identities=26% Similarity=0.435 Sum_probs=158.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIA--RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+|+.||+|.++...... ......+ ..+++.++.++|+||+++++++..++..++||||+ +++|..+
T Consensus 16 vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~---~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 91 (298)
T cd07841 16 VYKARDKETGRIVAIKKIKLGERKEAKDGINFTA---LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKV 91 (298)
T ss_pred EEEEEECCCCcEEEEEEEeccccccccchhhHHH---HHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHH
Confidence 6999999999999999998654321 1112222 33467788889999999999999999999999999 8899998
Q ss_pred hhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 92 i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~---dl~p~ni----------------------ll~~~~~~~l~df 146 (298)
T cd07841 92 IKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHR---DLKPNNL----------------------LIASDGVLKLADF 146 (298)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---CCChhhE----------------------EEcCCCCEEEccc
Confidence 8654 58999999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|++..............++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 147 GLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred eeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 998754333333334456778999999855 45788999999999999999999888877665554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=228.08 Aligned_cols=191 Identities=28% Similarity=0.451 Sum_probs=156.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.||+|+++.... .....+.+.+ +++.++.++|+||+++++++..++..+++|||++++.+..+..
T Consensus 17 v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~ 92 (288)
T cd07833 17 VLKCRNKATGEIVAIKKFKESED-DEDVKKTALR---EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA 92 (288)
T ss_pred EEEEEeCCCCcEEEEehhhhhcc-cccchhHHHH---HHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh
Confidence 68999999999999999875421 1222233444 4677888899999999999999999999999999877766554
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||.+
T Consensus 93 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~---dl~~~ni----------------------~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 93 SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHR---DIKPENI----------------------LVSESGVLKLCDFGFA 147 (288)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EECCCCCEEEEeeecc
Confidence 3 468999999999999999999999999999 8888888 7788999999999998
Q ss_pred cCCCCCCC-CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy3347 160 KEGMGFGD-RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220 (245)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~ 220 (245)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 210 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 75433322 23345678889999999887 788999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=228.55 Aligned_cols=192 Identities=28% Similarity=0.423 Sum_probs=153.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|.++..... ......+. ++++.+++++||||+++++++..++..+++|||+. ++|..++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~ 90 (284)
T cd07860 16 VYKARNKLTGEVVALKKIRLDTET-EGVPSTAI---REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMD 90 (284)
T ss_pred EEEEEECCCCCEEEEEEccccccc-cccchHHH---HHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHH
Confidence 699999999999999998754311 11222333 34777889999999999999999999999999996 57877764
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ +++|+|| +++.++.++|+|||
T Consensus 91 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~---~l~p~ni----------------------ll~~~~~~~l~dfg 145 (284)
T cd07860 91 ASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR---DLKPQNL----------------------LINTEGAIKLADFG 145 (284)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCCEEEeecc
Confidence 3 468899999999999999999999999999 8888888 78888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD 222 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~ 222 (245)
++..............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 146 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred chhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 8864322222223345677899999987644 5888999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=226.23 Aligned_cols=212 Identities=27% Similarity=0.483 Sum_probs=169.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.+|+|.+.... .....+.+.+ +++.++.++||||+++++.+..++..++++||+++++|.+++.
T Consensus 17 v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 91 (265)
T cd06605 17 VSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILR---ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILK 91 (265)
T ss_pred EEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHH---HHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHH
Confidence 6999999999999999998643 1223333444 4677788889999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|+|+ .|++|+ |++|+|| +++.++.++|+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~---dl~~~ni----------------------~~~~~~~~~l~d~g 146 (265)
T cd06605 92 EVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR---DVKPSNI----------------------LVNSRGQIKLCDFG 146 (265)
T ss_pred HccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecC---CCCHHHE----------------------EECCCCCEEEeecc
Confidence 4 568899999999999999999999 999999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCc-ccC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-----DEEEVFDSIVNDE-VRY 231 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-----~~~~~~~~~~~~~-~~~ 231 (245)
.+....... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||... ...+..+.+.... +..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (265)
T cd06605 147 VSGQLVNSL--AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL 224 (265)
T ss_pred cchhhHHHH--hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC
Confidence 886432211 11256778899999998888999999999999999999999999654 2334444444432 234
Q ss_pred CCC-CChhHHhhhc
Q psy3347 232 PRF-LSLEAIAIMR 244 (245)
Q Consensus 232 p~~-~~~~~~~li~ 244 (245)
|.. ++++++++|+
T Consensus 225 ~~~~~~~~~~~li~ 238 (265)
T cd06605 225 PSGKFSPDFQDFVN 238 (265)
T ss_pred ChhhcCHHHHHHHH
Confidence 444 7888888876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=227.99 Aligned_cols=214 Identities=24% Similarity=0.433 Sum_probs=166.7
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+.. ....+|+|.+.... .....+.+.+ +++.++.++||||+++++.+..++..+++|||+.+++|
T Consensus 16 vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (290)
T cd05045 16 VVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLS---EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90 (290)
T ss_pred eEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHH---HHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCH
Confidence 68887753 23579999887542 1223344444 46778888999999999999999999999999999999
Q ss_pred hhhhhh-------------------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhh
Q psy3347 76 MMHIHA-------------------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130 (245)
Q Consensus 76 ~~~~~~-------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~ 130 (245)
.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+||
T Consensus 91 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~---dikp~ni--------- 158 (290)
T cd05045 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR---DLAARNV--------- 158 (290)
T ss_pred HHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh---hhhhheE---------
Confidence 988742 236788889999999999999999999999 6666666
Q ss_pred ccccCcccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-
Q psy3347 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV- 207 (245)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~- 207 (245)
+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 159 -------------ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 159 -------------LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred -------------EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhc
Confidence 667788999999999874322211 1122344668999999988889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhcC-cccCCCCCChhHHhhhc
Q psy3347 208 GESPFPGDDEEEVFDSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 208 g~~pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
|..||.+....+..+.+... ....|..++.+++++++
T Consensus 226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 263 (290)
T cd05045 226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLML 263 (290)
T ss_pred CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 99999988877776665543 33457778888888875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=223.36 Aligned_cols=208 Identities=27% Similarity=0.466 Sum_probs=168.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. |+.||+|.+..... ..+.+.+ ++..++.++|+||+++++++...+..+++|||+++++|.++++
T Consensus 22 v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 92 (256)
T cd05039 22 VMLGDYR--GQKVAVKCLKDDST----AAQAFLA---EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR 92 (256)
T ss_pred EEEEEec--CcEEEEEEeccchh----HHHHHHH---HHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHH
Confidence 6888764 89999999975421 2333444 4677888999999999999998899999999999999999985
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. .+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~---di~p~Ni----------------------li~~~~~~~l~d~g 147 (256)
T cd05039 93 SRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHR---DLAARNV----------------------LVSEDLVAKVSDFG 147 (256)
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccch---hcccceE----------------------EEeCCCCEEEcccc
Confidence 43 58999999999999999999999999999 8888787 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFL 235 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~~ 235 (245)
.+....... .....+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+..+ ....|..+
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 148 LAKEASQGQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGC 224 (256)
T ss_pred ccccccccc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCC
Confidence 987542111 12234567999999988888999999999999999997 99999888777766666544 23456778
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.++|++
T Consensus 225 ~~~~~~li~~ 234 (256)
T cd05039 225 PPEVYKVMKD 234 (256)
T ss_pred CHHHHHHHHH
Confidence 8888888763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=226.12 Aligned_cols=212 Identities=26% Similarity=0.398 Sum_probs=162.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC-----CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE-----AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.+|+|++..... ..+.+.+| +..++.+ +|||++++++++... +..++||||+++++
T Consensus 38 vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e---~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~s 110 (291)
T cd06639 38 VYKVTNKKDGSLAAVKILDPISD----VDEEIEAE---YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS 110 (291)
T ss_pred EEEEEECCCCCEEEEEEeccccc----HHHHHHHH---HHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCc
Confidence 68999999999999999875321 12233334 4445555 799999999998653 46899999999999
Q ss_pred hhhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 75 LMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 75 L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
|.++++ ...+++..+..++.|++.||.|||++|++|+ |++|+|+ +++.++
T Consensus 111 L~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---dlkp~ni----------------------li~~~~ 165 (291)
T cd06639 111 VTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR---DVKGNNI----------------------LLTTEG 165 (291)
T ss_pred HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHE----------------------EEcCCC
Confidence 988774 2468899999999999999999999999999 8888888 777888
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-----SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
.++|+|||++..............++..|+|||.+... .++.++|+||||+++|+|++|+.||......+....+
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 99999999887543332223345678889999998543 3678999999999999999999999877665544444
Q ss_pred hcCcc---cCCCCCChhHHhhhc
Q psy3347 225 VNDEV---RYPRFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~~~---~~p~~~~~~~~~li~ 244 (245)
..... ..|+..+.++.++|.
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~ 268 (291)
T cd06639 246 PRNPPPTLLHPEKWCRSFNHFIS 268 (291)
T ss_pred hcCCCCCCCcccccCHHHHHHHH
Confidence 43322 124556677777775
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=261.33 Aligned_cols=217 Identities=35% Similarity=0.622 Sum_probs=182.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|.+++++.|++.||.|++++-....+..-..|..| |- +|...+.+=|++++-.|.++++.|+||||++||+|...+.
T Consensus 91 V~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EE-RD--imv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlS 167 (1317)
T KOG0612|consen 91 VALVRHKSTEKVYAMKILNKWEMLKRAETACFREE-RD--IMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLS 167 (1317)
T ss_pred eEEEEeeccccchhHHHhhHHHHhhchhHHHHHHH-hH--HHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHh
Confidence 67889999999999999987443333333344333 33 3445567889999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +++|+.-++.++..++.||.-+|+.|.+|| ||||+|+ ++|..|++||+|||.+
T Consensus 168 k~~~~pE~~ArFY~aEiVlAldslH~mgyVHR---DiKPDNv----------------------Lld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 168 KFDRLPEDWARFYTAEIVLALDSLHSMGYVHR---DIKPDNV----------------------LLDKSGHIKLADFGSC 222 (1317)
T ss_pred hcCCChHHHHHHHHHHHHHHHHHHHhccceec---cCCccee----------------------EecccCcEeeccchhH
Confidence 4 469999999999999999999999999999 8999888 9999999999999988
Q ss_pred cCCCCCCC-CCCcccCCCCcccccccc----C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cccC
Q psy3347 160 KEGMGFGD-RTGTFCGTPEFLAPEVLT----E-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EVRY 231 (245)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~~~ 231 (245)
-....++. .....+|||-|.+||++. + +.|++.+|.||+|+++|||+.|..||...+-.+...+|+.. ...|
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 76544444 356789999999999995 3 56899999999999999999999999998888888999876 4456
Q ss_pred C--CCCChhHHhhhcC
Q psy3347 232 P--RFLSLEAIAIMRR 245 (245)
Q Consensus 232 p--~~~~~~~~~li~~ 245 (245)
| -.+|+++++||++
T Consensus 303 P~~~~VSeeakdLI~~ 318 (1317)
T KOG0612|consen 303 PDETDVSEEAKDLIEA 318 (1317)
T ss_pred CcccccCHHHHHHHHH
Confidence 7 5689999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=224.07 Aligned_cols=214 Identities=27% Similarity=0.430 Sum_probs=170.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..++..+|+|++...... ...+.+.+| ++.++.++|+|++++++.+...+..+++||++++++|.+++.
T Consensus 17 v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~ 91 (267)
T cd06610 17 VYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKE---VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK 91 (267)
T ss_pred EEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHH---HHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHH
Confidence 689998889999999999754322 233444444 667888899999999999999999999999999999999885
Q ss_pred h----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 81 A----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 81 ~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|||++|++|+ +++|+|| +++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~---~l~p~ni----------------------~~~~~~~~~l~df 146 (267)
T cd06610 92 SSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR---DIKAGNI----------------------LLGEDGSVKIADF 146 (267)
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHhE----------------------EEcCCCCEEEccc
Confidence 4 357899999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCC----CCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-
Q psy3347 157 GLCKEGMGFGDR----TGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR- 230 (245)
Q Consensus 157 g~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~- 230 (245)
|++......... .....++..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+..........+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd06610 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS 226 (267)
T ss_pred chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC
Confidence 988654332221 2334678889999999766 6889999999999999999999999877766655555444322
Q ss_pred CC-----CCCChhHHhhhc
Q psy3347 231 YP-----RFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p-----~~~~~~~~~li~ 244 (245)
.+ ..++++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06610 227 LETGADYKKYSKSFRKMIS 245 (267)
T ss_pred cCCccccccccHHHHHHHH
Confidence 22 256778888875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=236.80 Aligned_cols=215 Identities=38% Similarity=0.619 Sum_probs=181.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
|+-++-+.||+-||+|.+.++++....-.....+|.. +|..++.+.||.+--.|+..+..|+|+..|.||+|.-.+
T Consensus 201 V~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~---iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiy 277 (591)
T KOG0986|consen 201 VCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQ---ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIY 277 (591)
T ss_pred eeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHH---HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEee
Confidence 5667888899999999998877666555555555644 455677899999999999999999999999999997665
Q ss_pred hh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 80 HA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 80 ~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+. +.++++.++.++.+|+.||++||+.+|++| |+||+|| ++|..|+++|+|+|
T Consensus 278 n~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR---DLKPeNI----------------------LLDd~GhvRISDLG 332 (591)
T KOG0986|consen 278 NHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR---DLKPENI----------------------LLDDHGHVRISDLG 332 (591)
T ss_pred ccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec---cCChhhe----------------------eeccCCCeEeeccc
Confidence 32 369999999999999999999999999999 9999999 99999999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD----EEEVFDSIVNDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~----~~~~~~~~~~~~~~~p~ 233 (245)
++... ..+......+||..|||||++..+.|+..+|.|||||++|||+.|..||...- .+++-..+++....+|+
T Consensus 333 LAvei-~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~ 411 (591)
T KOG0986|consen 333 LAVEI-PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD 411 (591)
T ss_pred eEEec-CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc
Confidence 99853 33333444589999999999999899999999999999999999999997653 23555556777888999
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
..|+++++|.+
T Consensus 412 kFS~eakslc~ 422 (591)
T KOG0986|consen 412 KFSEEAKSLCE 422 (591)
T ss_pred ccCHHHHHHHH
Confidence 99999998864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=225.94 Aligned_cols=213 Identities=24% Similarity=0.407 Sum_probs=162.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEee------CCeEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQT------EAHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~------~~~~~lv~e~~~~~ 73 (245)
||+|++..+++.+|+|++.... .....+..| +..++.+ +||||+++++++.. .+..+++|||++++
T Consensus 32 v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e---~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~ 104 (282)
T cd06636 32 VYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLE---INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG 104 (282)
T ss_pred EEEEEEcCCCcEEEEEEEecCh----HHHHHHHHH---HHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCC
Confidence 6999999999999999986532 222334444 3444455 69999999999853 45889999999999
Q ss_pred chhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 74 DLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 74 ~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|..++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.
T Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~---dl~~~ni----------------------li~~~~~ 159 (282)
T cd06636 105 SVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHR---DIKGQNV----------------------LLTENAE 159 (282)
T ss_pred cHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCC
Confidence 99988853 347888889999999999999999999999 8888888 7788899
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++|+|||++..............++..|+|||.+. ...++.++|+||||+++|+|++|+.||......+....+.
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 99999998865322222233456788999999985 3457789999999999999999999997665544333333
Q ss_pred cCcc-c-CCCCCChhHHhhhcC
Q psy3347 226 NDEV-R-YPRFLSLEAIAIMRR 245 (245)
Q Consensus 226 ~~~~-~-~p~~~~~~~~~li~~ 245 (245)
.... . .+..+++++.++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~ 261 (282)
T cd06636 240 RNPPPKLKSKKWSKKFIDFIEG 261 (282)
T ss_pred hCCCCCCcccccCHHHHHHHHH
Confidence 2221 1 234578888888863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=223.86 Aligned_cols=207 Identities=24% Similarity=0.443 Sum_probs=164.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe-eCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-TEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|... |+.+|+|.++... ..+.+.+ ++..++.++|+|++++++++. .++..+++|||+++++|.+++
T Consensus 22 v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 91 (256)
T cd05082 22 VMLGDYR--GNKVAVKCIKNDA-----TAQAFLA---EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 91 (256)
T ss_pred EEEEEEc--CCcEEEEEeCCCc-----hHHHHHH---HHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHH
Confidence 5777654 8889999986432 1233444 466788889999999999764 456789999999999999988
Q ss_pred hhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~ni----------------------l~~~~~~~kl~df 146 (256)
T cd05082 92 RSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR---DLAARNV----------------------LVSEDNVAKVSDF 146 (256)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc---ccchheE----------------------EEcCCCcEEecCC
Confidence 542 37888999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
|++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+..+ ....++.
T Consensus 147 g~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05082 147 GLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 223 (256)
T ss_pred ccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 9887432221 22234567999999988889999999999999999997 99999887777776666544 3345678
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++.++++|++
T Consensus 224 ~~~~~~~li~~ 234 (256)
T cd05082 224 CPPVVYDVMKQ 234 (256)
T ss_pred CCHHHHHHHHH
Confidence 89999988763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=226.05 Aligned_cols=213 Identities=26% Similarity=0.462 Sum_probs=167.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++.... .....+.+.+ ++++++.++||||+++++.+...+..++||||+++++|..++.
T Consensus 21 v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 95 (284)
T cd06620 21 VSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILR---ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK 95 (284)
T ss_pred EEEEEEcCCCcEEEEEEEEecC--cchHHHHHHH---HHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH
Confidence 6899999999999999987542 1222334444 4677888899999999999999999999999999999988875
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. +.+++..+..++.+++.||.|||+ .+++|+ +++|+|+ +++.++.++|+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~---dl~p~ni----------------------l~~~~~~~~l~d~gl 150 (284)
T cd06620 96 KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR---DIKPSNI----------------------LVNSRGQIKLCDFGV 150 (284)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHhcCeecc---CCCHHHE----------------------EECCCCcEEEccCCc
Confidence 4 568999999999999999999997 689999 8888888 777889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-----------EVFDSIVND 227 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~-----------~~~~~~~~~ 227 (245)
+...... ......++..|+|||.+.+..++.++|+|||||++|++++|+.||...... +....+...
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 151 SGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred ccchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 7643221 123456888999999998888899999999999999999999999754431 233333332
Q ss_pred c-ccCCC-CCChhHHhhhcC
Q psy3347 228 E-VRYPR-FLSLEAIAIMRR 245 (245)
Q Consensus 228 ~-~~~p~-~~~~~~~~li~~ 245 (245)
. ..++. .++.++.+|+++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~ 248 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDA 248 (284)
T ss_pred cCCCCCchhcCHHHHHHHHH
Confidence 2 22333 377788888753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=221.53 Aligned_cols=216 Identities=28% Similarity=0.542 Sum_probs=177.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|++..... .....+.+.+ +++.++.++|||++++.+.+..++..++++|++++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~---e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 91 (258)
T cd08215 16 VYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALN---EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK 91 (258)
T ss_pred EEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHH---HHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHH
Confidence 68999999999999999976432 1223333433 4677888899999999999999999999999999999998885
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ..+++..+..++.+++.||.+||++|++|+ |++|+|| +++.++.++|+|
T Consensus 92 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~---dl~~~ni----------------------l~~~~~~~~l~d 146 (258)
T cd08215 92 KQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR---DIKPQNI----------------------FLTSNGLVKLGD 146 (258)
T ss_pred HhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecc---cCChHHe----------------------EEcCCCcEEECC
Confidence 4 568999999999999999999999999999 8888888 777889999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRF 234 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~ 234 (245)
||.+..............++..|+|||...+..++.++|+||+|+++++|++|+.||...+..+.......... ..|..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T cd08215 147 FGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ 226 (258)
T ss_pred ccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCC
Confidence 99887543333233445678889999999888899999999999999999999999988777777776665533 45677
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
++.++.++|++
T Consensus 227 ~~~~~~~~i~~ 237 (258)
T cd08215 227 YSSELRNLVSS 237 (258)
T ss_pred CCHHHHHHHHH
Confidence 88888888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=222.81 Aligned_cols=202 Identities=26% Similarity=0.377 Sum_probs=158.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|.++.... ..++. ..+....||||+++++++...+..+++|||+++++|.+++.
T Consensus 9 v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~---~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 9 VLLVMDTRTQQTFILKGLRKSSE--------YSRER---LTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred EEEEEEccCCcEEEEEeecchhh--------hhhHH---HHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 79999999999999999986421 11121 22234469999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.++++|||.+
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~~l~df~~~ 132 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCR---DLNPNNI----------------------LLDDRGHIQLTYFSRW 132 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHE----------------------EEcCCCCEEEecccch
Confidence 4568999999999999999999999999999 8888888 7888899999999977
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
...... .....++..|+|||...+..+++++|+||+|+++|+|++|+.||....... . ......+|..+++.+
T Consensus 133 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~~~~~~~~ 205 (237)
T cd05576 133 SEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIPEWVSEEA 205 (237)
T ss_pred hccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCcccCCHHH
Confidence 543221 223345667999999988888999999999999999999998875432210 0 011234567788888
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 206 ~~li~~ 211 (237)
T cd05576 206 RSLLQQ 211 (237)
T ss_pred HHHHHH
Confidence 887753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=223.56 Aligned_cols=211 Identities=25% Similarity=0.400 Sum_probs=167.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++ +++.||+|.+..... ..+.+.+ ++++++.++||||+++++++. .+..+++|||+.+++|.+++.
T Consensus 22 v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~---E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~ 92 (260)
T cd05067 22 VWMGYYN-GHTKVAIKSLKQGSM----SPEAFLA---EANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK 92 (260)
T ss_pred EEeeecC-CCceEEEEEecCCCC----cHHHHHH---HHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHH
Confidence 6889765 578899999875432 1233433 467788899999999999874 557899999999999998874
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|+ +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~---dl~p~ni----------------------~i~~~~~~~l~dfg 147 (260)
T cd05067 93 TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR---DLRAANI----------------------LVSETLCCKIADFG 147 (260)
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecc---cccHHhE----------------------EEcCCCCEEEccCc
Confidence 3 357888999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
++....... .......++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+....+..+. .+.|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDN 227 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Confidence 987543111 11222344668999999988889999999999999999998 999998887777666665442 345677
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
++.++.++|++
T Consensus 228 ~~~~~~~li~~ 238 (260)
T cd05067 228 CPEELYELMRL 238 (260)
T ss_pred CCHHHHHHHHH
Confidence 88888888864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.37 Aligned_cols=209 Identities=21% Similarity=0.330 Sum_probs=148.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHh---hcCCCceeeeeEEEeeC-CeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN---TMRHPFLVNLFACFQTE-AHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..+++.||||+++... ........|.++++.++ ..+|++++.+.++|... ++.|+|||++ +++|.
T Consensus 145 V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~ 219 (467)
T PTZ00284 145 VVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLL 219 (467)
T ss_pred EEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHH
Confidence 7999999999999999997432 11122233333333332 23466799999998764 5899999988 55777
Q ss_pred hhh-hhcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHI-HADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++ +.+.+++..+..++.|++.||+|||+ .||+|| ||||+|| ++.......... .........+.+||+
T Consensus 220 ~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHr---DlKP~NI-----Ll~~~~~~~~~~-~~~~~~~~~~~vkl~ 290 (467)
T PTZ00284 220 DWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHT---DLKPENI-----LMETSDTVVDPV-TNRALPPDPCRVRIC 290 (467)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecC---CCCHHHE-----EEecCCcccccc-cccccCCCCceEEEC
Confidence 766 45679999999999999999999998 599999 6666666 433211000000 000011122469999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||.+... .......+||..|+|||.+.+..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 291 DfG~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 291 DLGGCCDE---RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCccccC---ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99987532 1223456789999999999999999999999999999999999999998877666555533
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=228.20 Aligned_cols=215 Identities=28% Similarity=0.482 Sum_probs=168.5
Q ss_pred CEeEEEecC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNT-----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.++.. ...+|+|.+.... ..+....+.+| ++.++.+ +|+||+++++++..++..+++|||+++++
T Consensus 28 v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~ 102 (293)
T cd05053 28 VVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSE---MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102 (293)
T ss_pred EEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHH---HHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCc
Confidence 688887643 3789999987542 22233344444 6667777 79999999999999999999999999999
Q ss_pred hhhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcc
Q psy3347 75 LMMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSS 137 (245)
Q Consensus 75 L~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~ 137 (245)
|..+++. ..+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 103 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~---dlkp~Ni---------------- 163 (293)
T cd05053 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR---DLAARNV---------------- 163 (293)
T ss_pred HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccc---ccceeeE----------------
Confidence 9988842 247788899999999999999999999999 7777777
Q ss_pred cchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy3347 138 QEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPG 214 (245)
Q Consensus 138 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~ 214 (245)
+++.++.++|+|||.++....... ......++..|+|||.+.+..++.++|||||||++|++++ |..||.+
T Consensus 164 ------l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 164 ------LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred ------EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 777889999999999875322211 1112234567999999988889999999999999999997 9999988
Q ss_pred CCHHHHHHHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 215 DDEEEVFDSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 215 ~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
....+..+.+.... ...|..+++++.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 269 (293)
T cd05053 238 IPVEELFKLLKEGYRMEKPQNCTQELYHLMRD 269 (293)
T ss_pred CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 87777777665543 34567788888888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=226.48 Aligned_cols=213 Identities=26% Similarity=0.433 Sum_probs=161.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEe-----eCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQ-----TEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~~ 74 (245)
||+|.++.+|+.+|+|+++... ...+.+.+| +.+++.+ +||||+++++++. .++..+++|||+++++
T Consensus 34 vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e---~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 106 (286)
T cd06638 34 VFKVLNKKNGSKAAVKILDPIH----DIDEEIEAE---YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS 106 (286)
T ss_pred EEEEEECCCCceeEEEeecccc----chHHHHHHH---HHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCC
Confidence 6899999999999999886432 111333344 4455566 6999999999874 3457999999999999
Q ss_pred hhhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 75 LMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 75 L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
|..++. ...+++..+..++.|++.||.|||+++++|+ |++|+|| +++.++
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~ni----------------------li~~~~ 161 (286)
T cd06638 107 VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR---DVKGNNI----------------------LLTTEG 161 (286)
T ss_pred HHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCcccc---CCCHHhE----------------------EECCCC
Confidence 988763 2357888899999999999999999999999 8888888 777888
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
.++|+|||++..............|+..|+|||.+.. ..++.++|+||||+++|+|++|+.||...........+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 9999999998754332222334468889999999853 44788999999999999999999999776654444333
Q ss_pred hcCcc---cCCCCCChhHHhhhcC
Q psy3347 225 VNDEV---RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 225 ~~~~~---~~p~~~~~~~~~li~~ 245 (245)
..... ..|..++.++.++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~ 265 (286)
T cd06638 242 PRNPPPTLHQPELWSNEFNDFIRK 265 (286)
T ss_pred cccCCCcccCCCCcCHHHHHHHHH
Confidence 32221 1245567778888753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=229.84 Aligned_cols=215 Identities=28% Similarity=0.470 Sum_probs=166.9
Q ss_pred CEeEEEec-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYRN-------TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++.. .+..+|+|.++... .......+.+| ++.++.+ +||||+++++++..++..+++|||+.+
T Consensus 28 vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 102 (314)
T cd05099 28 VVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISE---MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAK 102 (314)
T ss_pred EEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHH---HHHHHhccCCCCeeeEEEEEccCCceEEEEecCCC
Confidence 67887532 35579999987532 22334444444 5566677 699999999999999999999999999
Q ss_pred Cchhhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
++|..++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|+
T Consensus 103 g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~---dlkp~Ni-------------- 165 (314)
T cd05099 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR---DLAARNV-------------- 165 (314)
T ss_pred CcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec---cccceeE--------------
Confidence 999988843 237788889999999999999999999999 7777777
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.++|+|||.++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus 166 --------ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 166 --------LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred --------EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 7778889999999998753221111 112223457999999988889999999999999999999 89999
Q ss_pred CCCCHHHHHHHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
.+.+..+....+.... ...|..++.++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 271 (314)
T cd05099 238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRE 271 (314)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 8888777777766543 34567788888888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=226.25 Aligned_cols=215 Identities=26% Similarity=0.393 Sum_probs=168.4
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .++..+|+|.+.... .......+. ++++.++.++||||+++++++..+++.+++|||+++++|
T Consensus 21 v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~---~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 95 (288)
T cd05050 21 VFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQ---REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95 (288)
T ss_pred EEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHH---HHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCH
Confidence 6888764 367899999987542 122223333 347778889999999999999999999999999999999
Q ss_pred hhhhhhc-----------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhcc
Q psy3347 76 MMHIHAD-----------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENY 132 (245)
Q Consensus 76 ~~~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~ 132 (245)
.+++... .+++..+..++.|++.||+|+|+++++|+ |++|+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~---dl~p~ni----------- 161 (288)
T cd05050 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR---DLATRNC----------- 161 (288)
T ss_pred HHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc---cccHhhe-----------
Confidence 9888521 36778889999999999999999999999 7777777
Q ss_pred ccCcccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q psy3347 133 KVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GE 209 (245)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~ 209 (245)
+++.++.++|+|||.+........ .......+..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 162 -----------l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~ 230 (288)
T cd05050 162 -----------LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230 (288)
T ss_pred -----------EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence 677889999999998864322111 1112234567999999988889999999999999999997 88
Q ss_pred CCCCCCCHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 210 SPFPGDDEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 210 ~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
.||.+....+....+..+.. +.|..+++++.+||.+
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 267 (288)
T cd05050 231 QPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRL 267 (288)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 99988777777777665543 3467788888888763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=226.95 Aligned_cols=194 Identities=25% Similarity=0.395 Sum_probs=155.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+|+.+|+|.++..... ......+ .++++.++.++||||+++.+++... +..|++|||+.+ +|..+
T Consensus 21 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~---~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~ 95 (293)
T cd07843 21 VYRARDKKTGEIVALKKLKMEKEK-EGFPITS---LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSL 95 (293)
T ss_pred EEEEEECCCCcEEEEEEEeecccc-ccchhhH---HHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHH
Confidence 799999999999999999864322 1111122 3346778888999999999998877 899999999975 88877
Q ss_pred hhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 96 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~---dl~p~ni----------------------li~~~~~~~l~d~ 150 (293)
T cd07843 96 METMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR---DLKTSNL----------------------LLNNRGILKICDF 150 (293)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---cCCHHHE----------------------EECCCCcEEEeec
Confidence 743 358999999999999999999999999999 8888888 7888899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 151 GLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred CceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9887543332223344567889999998764 4688999999999999999999999877665555443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=222.31 Aligned_cols=216 Identities=27% Similarity=0.497 Sum_probs=170.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|..+|+|.+....... ...+.+. ++++.++.++|+||+++++.+..++..++++||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~---~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 91 (257)
T cd08225 16 IYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASK---KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRIN 91 (257)
T ss_pred EEEEEEcCCCceEEEEEeeHhhccc-hhhHHHH---HHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHH
Confidence 6899999999999999987643211 2223333 34677888899999999999999999999999999999998885
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEeec
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIADF 156 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Df 156 (245)
.. .+++..+..++.|++.||+|||+++++|+ |++|+|| +++.++ .++++||
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~---dl~~~ni----------------------l~~~~~~~~~l~d~ 146 (257)
T cd08225 92 RQRGVLFSEDQILSWFVQISLGLKHIHDRKILHR---DIKSQNI----------------------FLSKNGMVAKLGDF 146 (257)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---cCCHHHE----------------------EEcCCCCeEEeccc
Confidence 42 47889999999999999999999999999 7888887 665554 5799999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFL 235 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~ 235 (245)
|.+..............|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..... +.+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd08225 147 GIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF 226 (257)
T ss_pred ccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCC
Confidence 9887543333333344578889999999888899999999999999999999999987776666555554433 344567
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
+.+++++|++
T Consensus 227 ~~~~~~~i~~ 236 (257)
T cd08225 227 SRDLRSLISQ 236 (257)
T ss_pred CHHHHHHHHH
Confidence 7788888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=228.20 Aligned_cols=212 Identities=25% Similarity=0.388 Sum_probs=167.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.+|+|.+........+....+. ++++.++.++|||++++++++..++..+++|||+.+ ++.+.+.
T Consensus 41 v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~ 116 (317)
T cd06635 41 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII---KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLE 116 (317)
T ss_pred EEEEEEcCCCcEEEEEEEecCCCCchHHHHHHH---HHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHH
Confidence 689999999999999999765333333333443 447778889999999999999999999999999975 6666553
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
..++++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 117 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~---dL~p~Ni----------------------l~~~~~~~kl~dfg~ 171 (317)
T cd06635 117 VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR---DIKAGNI----------------------LLTEPGQVKLADFGS 171 (317)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCcccE----------------------EECCCCCEEEecCCC
Confidence 3568899999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-C-CC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-Y-PR 233 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~-p~ 233 (245)
+.... ......++..|+|||.+. ...++.++|+||||+++|+|++|+.||...........+.....+ . +.
T Consensus 172 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 172 ASIAS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN 247 (317)
T ss_pred ccccC----CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCc
Confidence 76421 123446788899999984 356889999999999999999999999877766666666554332 2 34
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
..++.++++|++
T Consensus 248 ~~~~~l~~li~~ 259 (317)
T cd06635 248 EWSDYFRNFVDS 259 (317)
T ss_pred cccHHHHHHHHH
Confidence 567778887753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=225.86 Aligned_cols=193 Identities=24% Similarity=0.428 Sum_probs=155.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|+++.... ....+.+.+ +++.++.++||||+++++++...+..+++|||+++ +|..++.
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 89 (284)
T cd07836 16 VYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIR---EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMD 89 (284)
T ss_pred EEEEEECCCCeEEEEEEeccccc--ccchHHHHH---HHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHH
Confidence 69999999999999999976432 112233333 46777888999999999999999999999999986 7877764
Q ss_pred h----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 81 A----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 81 ~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|+|+.|++|+ |++|+|| +++.++.++++||
T Consensus 90 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~---dl~p~ni----------------------~~~~~~~~~l~d~ 144 (284)
T cd07836 90 THGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR---DLKPQNL----------------------LINKRGELKLADF 144 (284)
T ss_pred hcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCCHHHE----------------------EECCCCcEEEeec
Confidence 3 358999999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|++..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 145 GLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred chhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9887532222222344567889999998664 4688999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=220.98 Aligned_cols=215 Identities=28% Similarity=0.467 Sum_probs=168.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.++..... ....+.+.+| ++.++.++|+||+++++++...+..++++||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e---~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 91 (264)
T cd06626 16 VYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADE---MKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE 91 (264)
T ss_pred EEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHH---HHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHh
Confidence 688999889999999999865432 2334444444 677888999999999999999999999999999999999886
Q ss_pred hc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 AD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||.+
T Consensus 92 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~---dl~~~ni----------------------l~~~~~~~kl~d~g~~ 146 (264)
T cd06626 92 HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR---DIKPANI----------------------FLDHNGVIKLGDFGCA 146 (264)
T ss_pred hcCCCChHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEEcccccc
Confidence 54 57888999999999999999999999999 8888888 7778899999999988
Q ss_pred cCCCCCCCCC----CcccCCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC-ccc
Q psy3347 160 KEGMGFGDRT----GTFCGTPEFLAPEVLTETS---YTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSIVND-EVR 230 (245)
Q Consensus 160 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g~~pf~~~-~~~~~~~~~~~~-~~~ 230 (245)
.......... ....++..|+|||.+.+.. ++.++||||||+++|++++|..||.+. ........+... ...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP 226 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC
Confidence 7532222111 1245678899999997765 788999999999999999999999755 333333333332 233
Q ss_pred CCCC--CChhHHhhhc
Q psy3347 231 YPRF--LSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~--~~~~~~~li~ 244 (245)
+|.. +++.+.++|+
T Consensus 227 ~~~~~~~~~~~~~li~ 242 (264)
T cd06626 227 IPDSLQLSPEGKDFLD 242 (264)
T ss_pred CCcccccCHHHHHHHH
Confidence 4544 3788888875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=228.63 Aligned_cols=215 Identities=27% Similarity=0.451 Sum_probs=167.4
Q ss_pred CEeEEEe-------cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYR-------NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++. .++..||+|.+.... .....+.+.+| +..++.+ +||||+++++++...+..+++|||+.+
T Consensus 31 Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (304)
T cd05101 31 VVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSE---MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105 (304)
T ss_pred EEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHH---HHHHHhhccCCCchheeEEEecCCceEEEEecCCC
Confidence 6778653 235589999887532 22333445444 5566677 799999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
++|..++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~---dlkp~Ni-------------- 168 (304)
T cd05101 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR---DLAARNV-------------- 168 (304)
T ss_pred CcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec---ccccceE--------------
Confidence 9999888531 36677889999999999999999999999 8888887
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.++|+|||.++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 169 --------li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 169 --------LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred --------EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 7778899999999998754322211 222334567999999988889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
.+.+..+....+..... ..|..++.++++|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (304)
T cd05101 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD 274 (304)
T ss_pred ccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 88888787777655433 3567788888888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=225.23 Aligned_cols=213 Identities=23% Similarity=0.360 Sum_probs=164.6
Q ss_pred CEeEEEecCCc----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGE----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+ .||+|+++... .....+.+.+| ...++.++||||+++++++.. ...++++||+++|+|.
T Consensus 23 vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e---~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~ 96 (279)
T cd05109 23 VYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDE---AYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLL 96 (279)
T ss_pred EEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHH---HHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHH
Confidence 79999887776 48999987532 22223334444 556778899999999999865 4578999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++++. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~---dlkp~Ni----------------------l~~~~~~~kL~ 151 (279)
T cd05109 97 DYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR---DLAARNV----------------------LVKSPNHVKIT 151 (279)
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---ccccceE----------------------EEcCCCcEEEC
Confidence 88854 358999999999999999999999999999 7778777 66778889999
Q ss_pred ecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.... .+
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP 231 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC
Confidence 99998754322111 111223567999999988889999999999999999998 999998777666666555443 34
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.+++.
T Consensus 232 ~~~~~~~~~~~li~ 245 (279)
T cd05109 232 QPPICTIDVYMIMV 245 (279)
T ss_pred CCccCCHHHHHHHH
Confidence 45678888888775
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=248.78 Aligned_cols=209 Identities=21% Similarity=0.355 Sum_probs=165.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEE-ee---C---CeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACF-QT---E---AHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~-~~---~---~~~~lv~e~~~~ 72 (245)
||+|++...|..||+|++-.. +....+.+.+| +++|+.|. |+|||.++|.. .. + ..++|+||||.|
T Consensus 53 VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~E---I~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~g 126 (738)
T KOG1989|consen 53 VYLAQDVKGGKKYALKRMYVN---DEEALNAVKRE---IDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKG 126 (738)
T ss_pred EEEEEecCCCceeeeeeeecC---CHHHHHHHHHH---HHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccC
Confidence 899999998899999988653 44455566666 66666664 99999999932 11 1 257899999999
Q ss_pred Cchhhhhh---hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 73 GDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 73 ~~L~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
|.|.++++ ...|++.++++|+.++++|+++||... |+|| |||.+|+ ++..
T Consensus 127 g~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHR---DLKiENv----------------------Lls~ 181 (738)
T KOG1989|consen 127 GSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHR---DLKIENV----------------------LLSA 181 (738)
T ss_pred CcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchh---hhhhhhe----------------------EEcC
Confidence 99999985 346999999999999999999999987 9999 6666666 7778
Q ss_pred CCceEEeecCCccCCCCCCCC---------CCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 148 EGYVKIADFGLCKEGMGFGDR---------TGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
+|..||||||.+......... ......|+.|+|||.+. +.+.+.|+|||+|||+||-|+....||...
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 899999999988743332211 11234588999999994 678899999999999999999999999755
Q ss_pred CHHHHHHHHhcCcccCCC--CCChhHHhhhc
Q psy3347 216 DEEEVFDSIVNDEVRYPR--FLSLEAIAIMR 244 (245)
Q Consensus 216 ~~~~~~~~~~~~~~~~p~--~~~~~~~~li~ 244 (245)
-. -.|+.+.+.+|. ..+..+.+||+
T Consensus 262 g~----laIlng~Y~~P~~p~ys~~l~~LI~ 288 (738)
T KOG1989|consen 262 GK----LAILNGNYSFPPFPNYSDRLKDLIR 288 (738)
T ss_pred cc----eeEEeccccCCCCccHHHHHHHHHH
Confidence 22 247788887774 57778888875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=230.75 Aligned_cols=192 Identities=20% Similarity=0.329 Sum_probs=151.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++..... ..+..+.+.+ +..+++.++||||++++++|..+++.+++|||+.++++.+++.
T Consensus 16 v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~---e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~ 91 (328)
T cd08226 16 VYLARHTPTGTLVTVRITDLENC-TEEHLKALQN---EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLK 91 (328)
T ss_pred EEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHH---HHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHH
Confidence 79999999999999999875432 2223334443 4566778899999999999999999999999999999998885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+ ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.++++||+
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~~~~~~~ 146 (328)
T cd08226 92 TYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR---NIKASHI----------------------LISGDGLVSLSGLS 146 (328)
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEeCCCcEEEechH
Confidence 4 358889999999999999999999999999 8888888 77788999999997
Q ss_pred CccCCCCCCCC-------CCcccCCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy3347 158 LCKEGMGFGDR-------TGTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221 (245)
Q Consensus 158 ~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~ 221 (245)
.+......... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 54321111110 0112235569999999763 4788999999999999999999999876554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=224.87 Aligned_cols=217 Identities=37% Similarity=0.681 Sum_probs=168.3
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccch-hhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIAR-DEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+|+.||+|++........ ...+.+. +++++++.+ +|+||+++++.+..++..++||||+++++|
T Consensus 16 v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~---~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (290)
T cd05613 16 VFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL 92 (290)
T ss_pred EEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHH---HHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcH
Confidence 5788764 4799999999975432111 1122333 345666677 589999999999999999999999999999
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
.+++. ...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+
T Consensus 93 ~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~kl~ 147 (290)
T cd05613 93 FTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYR---DIKLENI----------------------LLDSNGHVVLT 147 (290)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHe----------------------EECCCCCEEEe
Confidence 98885 4568889999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCC-CCCCcccCCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcC
Q psy3347 155 DFGLCKEGMGFG-DRTGTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVND 227 (245)
Q Consensus 155 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~~ 227 (245)
|||++....... .......|+..|+|||.+.+. .++.++|+||||+++|+|++|+.||... ...+....+...
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence 999887532221 122345678889999999653 4678899999999999999999999632 334455555556
Q ss_pred cccCCCCCChhHHhhhcC
Q psy3347 228 EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 228 ~~~~p~~~~~~~~~li~~ 245 (245)
..++|..+++.+.+++++
T Consensus 228 ~~~~~~~~~~~~~~ll~~ 245 (290)
T cd05613 228 EPPYPQEMSALAKDIIQR 245 (290)
T ss_pred CCCCCccCCHHHHHHHHH
Confidence 667788888888888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=218.58 Aligned_cols=215 Identities=28% Similarity=0.496 Sum_probs=175.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|.+...... ....+.+ .++++.++.++|||++++++++..++..+++||++++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 91 (254)
T cd06627 16 VYKGLNLETGDFVAIKQISLEKIK-EEALKSI---MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK 91 (254)
T ss_pred EEEEEEcCCCcEEEEEEecccccC-HHHHHHH---HHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHH
Confidence 688999989999999999875422 2233344 444777888899999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.++|++|++|+ |++|+|| +++.++.++|+|||.+
T Consensus 92 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~ni----------------------~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 92 KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR---DIKAANI----------------------LTTKDGVVKLADFGVA 146 (254)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHhhCCcccC---CCCHHHE----------------------EECCCCCEEEeccccc
Confidence 4 578999999999999999999999999999 8888888 7777899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN-DEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~-~~~~~p~~~~~~ 238 (245)
..............++..|+|||...+..++.++|+||||+++|+|++|..||...+.......+.. ....+|..++++
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPE 226 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHH
Confidence 7543333223345678889999999877788999999999999999999999987666555555443 334567788888
Q ss_pred HHhhhc
Q psy3347 239 AIAIMR 244 (245)
Q Consensus 239 ~~~li~ 244 (245)
++++++
T Consensus 227 ~~~~i~ 232 (254)
T cd06627 227 LKDFLM 232 (254)
T ss_pred HHHHHH
Confidence 888875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=222.71 Aligned_cols=212 Identities=26% Similarity=0.410 Sum_probs=169.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. .++.+|+|.+..... ..+.+.+| +..++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 22 v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~ 93 (261)
T cd05034 22 VWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQE---AQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK 93 (261)
T ss_pred EEEEEEc-CCceEEEEEecCCcc----CHHHHHHH---HHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHh
Confidence 6889875 457899999875432 12334444 677788899999999999998889999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.|+.|||++|++|+ |++|+|| +++.++.++++|||
T Consensus 94 ~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~---di~p~ni----------------------li~~~~~~~l~d~g 148 (261)
T cd05034 94 SGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR---DLAARNI----------------------LVGENLVCKIADFG 148 (261)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CcchheE----------------------EEcCCCCEEECccc
Confidence 4 357889999999999999999999999999 8888888 78888999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
.+........ ......++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+....+... ..+.|..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05034 149 LARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN 228 (261)
T ss_pred cceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 8875332111 1112223567999999988889999999999999999998 99999988877777777654 2345667
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.+++.+
T Consensus 229 ~~~~~~~~i~~ 239 (261)
T cd05034 229 CPEELYDLMLQ 239 (261)
T ss_pred CCHHHHHHHHH
Confidence 78888888753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=225.83 Aligned_cols=215 Identities=24% Similarity=0.420 Sum_probs=167.1
Q ss_pred CEeEEEecCC------cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTG------EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|++..++ +.+|+|.+.... .......+. ++++.++.++||||+++++++...+..+++|||+++++
T Consensus 11 vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (269)
T cd05044 11 VYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFL---KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGD 85 (269)
T ss_pred EEeeeecccccCcccceeehhhhhhccc--chhhHHHHH---HHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCc
Confidence 6888876544 789999886432 112233333 44777889999999999999999999999999999999
Q ss_pred hhhhhhh--------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 75 LMMHIHA--------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 75 L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
|.+++.. ..+++..+..++.|++.||+|+|+++++|+ |++|+|| +++
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~---dl~p~ni----------------------l~~ 140 (269)
T cd05044 86 LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHR---DLAARNC----------------------LVS 140 (269)
T ss_pred HHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccC---CCChheE----------------------EEe
Confidence 9988853 236788899999999999999999999999 7777777 555
Q ss_pred CCC-----ceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy3347 147 TEG-----YVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEE 218 (245)
Q Consensus 147 ~~~-----~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~ 218 (245)
.++ .++++|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 141 ~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~ 220 (269)
T cd05044 141 EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220 (269)
T ss_pred cCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH
Confidence 555 89999999886432111 11122344578999999988889999999999999999998 99999887777
Q ss_pred HHHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 219 EVFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 219 ~~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
+....+..+ ....+..+++++.++|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (269)
T cd05044 221 EVLQHVTAGGRLQKPENCPDKIYQLMTN 248 (269)
T ss_pred HHHHHHhcCCccCCcccchHHHHHHHHH
Confidence 777666544 334567888899888864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=224.07 Aligned_cols=213 Identities=23% Similarity=0.349 Sum_probs=168.1
Q ss_pred CEeEEEecCCc----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGE----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.++.+|+ .+|+|.+..... ......+. ++++.++.++||||+++++++.. ...+++|||+++++|.
T Consensus 23 v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~ 96 (279)
T cd05057 23 VYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEIL---DEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLL 96 (279)
T ss_pred EEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHH---HHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHH
Confidence 68898887765 689998875431 22223333 44677888899999999999876 7899999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~---di~p~ni----------------------l~~~~~~~kL~ 151 (279)
T cd05057 97 DYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR---DLAARNV----------------------LVKTPQHVKIT 151 (279)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEec---ccCcceE----------------------EEcCCCeEEEC
Confidence 98854 368899999999999999999999999999 8888787 77788899999
Q ss_pred ecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||.++........ .....++..|+|||.+....++.++|+||||+++||+++ |+.||.+....+..+.+..+. .+
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP 231 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 99998754322111 111123457999999988888999999999999999998 999999888777777776543 34
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..++.++.+++.
T Consensus 232 ~~~~~~~~~~~~~~ 245 (279)
T cd05057 232 QPPICTIDVYMVLV 245 (279)
T ss_pred CCCCCCHHHHHHHH
Confidence 56677888877765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=220.97 Aligned_cols=215 Identities=27% Similarity=0.444 Sum_probs=172.9
Q ss_pred CEeEEEecCC----cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTG----EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..++ ..||+|++.... .....+.+..| ++.++.++|+||+++++++...+..+++||++++++|.
T Consensus 15 v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~ 89 (258)
T smart00219 15 VYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLRE---ARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLL 89 (258)
T ss_pred eEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHH---HHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHH
Confidence 6889888766 899999997542 11133444444 66677889999999999999999999999999999999
Q ss_pred hhhhhc-C--CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 77 MHIHAD-V--FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 77 ~~~~~~-~--l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
+++... . +++..+..++.|++.||++||+.|++|+ |++|+|| +++.++.++|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~---dl~~~ni----------------------l~~~~~~~~l 144 (258)
T smart00219 90 DYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHR---DLAARNC----------------------LVGENLVVKI 144 (258)
T ss_pred HHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeec---ccccceE----------------------EEccCCeEEE
Confidence 988543 2 8999999999999999999999999999 8888888 7888899999
Q ss_pred eecCCccCCCCCCCCCC-cccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-c
Q psy3347 154 ADFGLCKEGMGFGDRTG-TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-R 230 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~ 230 (245)
+|||.+........... ...++..|+|||.+.+..++.++|+||||+++++|++ |..||.+.+.....+.+..... .
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 224 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP 224 (258)
T ss_pred cccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99999875332211111 1235678999999977888999999999999999998 8999988887777777765543 4
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|..++.++.+++++
T Consensus 225 ~~~~~~~~~~~~i~~ 239 (258)
T smart00219 225 KPENCPPEIYKLMLQ 239 (258)
T ss_pred CCCcCCHHHHHHHHH
Confidence 567788888888753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=223.52 Aligned_cols=211 Identities=26% Similarity=0.388 Sum_probs=164.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+ ..||+|.++.... ..+.+.+ +++.++.++||||+++++.+. .+..+++|||+++++|.+++.
T Consensus 22 v~~~~~~~~-~~valK~~~~~~~----~~~~~~~---E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~ 92 (262)
T cd05071 22 VWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQ---EAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK 92 (262)
T ss_pred EEEEEecCC-ceEEEEecccCcc----CHHHHHH---HHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHh
Confidence 789988765 4699999985332 1123333 467788889999999999874 456899999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|+|+++++|+ |++|+|| +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~---dl~p~Ni----------------------ll~~~~~~~L~dfg 147 (262)
T cd05071 93 GEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR---DLRAANI----------------------LVGENLVCKVADFG 147 (262)
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHHCCcccc---ccCcccE----------------------EEcCCCcEEeccCC
Confidence 4 347889999999999999999999999999 8888887 77788999999999
Q ss_pred CccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
.+......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+....+.... .+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd05071 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 227 (262)
T ss_pred ceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccc
Confidence 88643222111 112335667999999988889999999999999999999 899998877776666665442 234566
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.++|++
T Consensus 228 ~~~~l~~li~~ 238 (262)
T cd05071 228 CPESLHDLMCQ 238 (262)
T ss_pred cCHHHHHHHHH
Confidence 78888888753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=222.78 Aligned_cols=214 Identities=26% Similarity=0.426 Sum_probs=175.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.+|+|.+....... .....+ .++++.++.++|+||+++.+++......+++|||+++++|..++.
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 91 (256)
T cd08530 16 VYKVKRLSDNQFYALKEVDLGSMSQ-KEREDA---VNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS 91 (256)
T ss_pred EEEEEECCCCCEEEEEEEehhhccH-HHHHHH---HHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHH
Confidence 6899999999999999998654322 222333 344677888999999999999999999999999999999998885
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ..+++..+..++.|++.||+|||+.|++|+ +++|+|| +++.++.++++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~---~l~~~ni----------------------~~~~~~~~kl~d 146 (256)
T cd08530 92 KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR---DLKSANI----------------------LLVANDLVKIGD 146 (256)
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccC---CCCcceE----------------------EEecCCcEEEee
Confidence 4 468888999999999999999999999999 8888888 777788999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRF 234 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~ 234 (245)
||++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..... +.+..
T Consensus 147 ~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08530 147 LGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224 (256)
T ss_pred ccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchh
Confidence 9988753322 23334578889999999888889999999999999999999999998887777777665543 35667
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
.+.+++++|++
T Consensus 225 ~~~~~~~li~~ 235 (256)
T cd08530 225 YSQDLQNFIRS 235 (256)
T ss_pred hCHHHHHHHHH
Confidence 88888888763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=224.02 Aligned_cols=191 Identities=26% Similarity=0.410 Sum_probs=153.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...... ....+.+.+| ++.++.++|||++++++++..++..+++|||++ ++|..++.
T Consensus 15 vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E---~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~ 89 (283)
T cd07835 15 VYKARDKLTGEIVALKKIRLETED-EGVPSTAIRE---ISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMD 89 (283)
T ss_pred EEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHH---HHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHh
Confidence 699999999999999999754321 1122334444 677888899999999999999999999999995 58888875
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. .+++..+..++.|++.||+|||+++++|+ |++|+|| +++.++.++|+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~---dl~p~ni----------------------l~~~~~~~~l~df~ 144 (283)
T cd07835 90 SSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR---DLKPQNL----------------------LIDREGALKLADFG 144 (283)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC---CCCHHHE----------------------EEcCCCcEEEeecc
Confidence 43 58999999999999999999999999999 8888888 77778999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~ 221 (245)
.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 209 (283)
T cd07835 145 LARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209 (283)
T ss_pred cccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 986432222222333567889999988664 5788999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=223.66 Aligned_cols=194 Identities=26% Similarity=0.448 Sum_probs=157.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...... ....+.+.+ ++..++.++||||+++++++..++..++||||+ +++|..++.
T Consensus 16 v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~ 90 (286)
T cd07832 16 VFKAKDRETGETVALKKVALRRLE-GGIPNQALR---EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLR 90 (286)
T ss_pred EEEEEECCCCceEEEEEEEccccc-chhhHHHHH---HHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHH
Confidence 699999999999999999864321 122233433 466778889999999999999999999999999 999998874
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||.
T Consensus 91 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~ni----------------------~~~~~~~~~l~dfg~ 145 (286)
T cd07832 91 DEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR---DLKPANL----------------------LISADGVLKIADFGL 145 (286)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CcCHHHE----------------------EEcCCCcEEEeeeee
Confidence 3 468999999999999999999999999999 8888888 777889999999998
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+..+....+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 146 ARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred cccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence 875433221 12345678899999998654 4688999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=235.64 Aligned_cols=215 Identities=25% Similarity=0.425 Sum_probs=165.2
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|++. .+++.||+|+++... .....+.+.+| ++++..++ ||||+++++++...++.++||||+.+|+
T Consensus 53 Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E---~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~ 127 (401)
T cd05107 53 VVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSE---LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGD 127 (401)
T ss_pred EEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHH---HHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCc
Confidence 7888853 456789999997542 22223344444 66677776 9999999999999999999999999999
Q ss_pred hhhhhhhc------------------------------------------------------------------------
Q psy3347 75 LMMHIHAD------------------------------------------------------------------------ 82 (245)
Q Consensus 75 L~~~~~~~------------------------------------------------------------------------ 82 (245)
|.++++..
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (401)
T cd05107 128 LVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESS 207 (401)
T ss_pred HHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhcc
Confidence 98887431
Q ss_pred ---------------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 83 ---------------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 83 ---------------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
.+++..+..++.|++.||+|||+++++|+ |++|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr---dlkp~Ni-------------- 270 (401)
T cd05107 208 NYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR---DLAARNV-------------- 270 (401)
T ss_pred CcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc---cCCcceE--------------
Confidence 24556678899999999999999999999 8888777
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||
T Consensus 271 --------Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 271 --------LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred --------EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 777788999999999875322211 1223356778999999988889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHhcCc--ccCCCCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVNDE--VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~ 245 (245)
......+......... .+.|..+++++.+||++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~ 377 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQK 377 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 8766555444444333 24567788888888863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=232.32 Aligned_cols=214 Identities=27% Similarity=0.462 Sum_probs=161.1
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEee-CCeEEEEEeeccCC
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQT-EAHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~-~~~~~lv~e~~~~~ 73 (245)
||+|.+. .+++.||+|+++... .....+.+.+ +++.+..+ +|+||+++++++.. ++..+++|||++++
T Consensus 23 Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~---E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~ 97 (337)
T cd05054 23 VIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMT---ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97 (337)
T ss_pred EEeccccccccccccceeeeeeccCCC--CHHHHHHHHH---HHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCC
Confidence 6777643 356899999997532 1222333433 46666677 79999999998864 46789999999999
Q ss_pred chhhhhhh--------------------------------------------------------------cCCChHHHHH
Q psy3347 74 DLMMHIHA--------------------------------------------------------------DVFSEPRAVF 91 (245)
Q Consensus 74 ~L~~~~~~--------------------------------------------------------------~~l~~~~~~~ 91 (245)
+|.+++.. .++++..+..
T Consensus 98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 177 (337)
T cd05054 98 NLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLIS 177 (337)
T ss_pred CHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHH
Confidence 99887742 2578888999
Q ss_pred HHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCC--CC
Q psy3347 92 YAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RT 169 (245)
Q Consensus 92 i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~ 169 (245)
++.|++.||+|||++||+|| |+||+|| +++.++.++|+|||++........ ..
T Consensus 178 ~~~qi~~aL~~lH~~~ivHr---Dikp~Ni----------------------ll~~~~~vkL~DfG~a~~~~~~~~~~~~ 232 (337)
T cd05054 178 YSFQVARGMEFLASRKCIHR---DLAARNI----------------------LLSENNVVKICDFGLARDIYKDPDYVRK 232 (337)
T ss_pred HHHHHHHHHHHHHhCCeecC---CCCcceE----------------------EEeCCCcEEEeccccchhcccCcchhhc
Confidence 99999999999999999999 8888888 777889999999999875422221 12
Q ss_pred CcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--cccCCCCCChhHHhhhc
Q psy3347 170 GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND--EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~ 244 (245)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+........ ....|...++++.+++.
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 310 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML 310 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHH
Confidence 23345678999999988899999999999999999998 99999875543333333322 22346677788888775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=222.19 Aligned_cols=211 Identities=26% Similarity=0.407 Sum_probs=166.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. ++..+|+|.++..... .+.+.+ ++..++.++|+|++++++++. .+..+++|||+++++|.+++.
T Consensus 22 v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~---E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~ 92 (260)
T cd05070 22 VWMGTWN-GNTKVAVKTLKPGTMS----PESFLE---EAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK 92 (260)
T ss_pred EEEEEec-CCceeEEEEecCCCCC----HHHHHH---HHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHH
Confidence 6888765 5677999999764321 133434 467788899999999999875 456899999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~---di~p~Ni----------------------li~~~~~~~l~dfg 147 (260)
T cd05070 93 DGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR---DLRSANI----------------------LVGDGLVCKIADFG 147 (260)
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCccceE----------------------EEeCCceEEeCCce
Confidence 3 348899999999999999999999999999 8888888 77788999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+....+... ..+.|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05070 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD 227 (260)
T ss_pred eeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 9875322111 1112234567999999988889999999999999999999 99999888777777776654 3345677
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
.+.++.+|+++
T Consensus 228 ~~~~~~~li~~ 238 (260)
T cd05070 228 CPISLHELMLQ 238 (260)
T ss_pred CCHHHHHHHHH
Confidence 88888888764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=222.95 Aligned_cols=214 Identities=25% Similarity=0.373 Sum_probs=167.7
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+..+ ...||+|...... .....+.+.+| +..++.++||||+++++++.. +..+++|||+++++|.+
T Consensus 22 v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e---~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~ 95 (270)
T cd05056 22 VYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQE---AYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRS 95 (270)
T ss_pred EEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHH---HHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHH
Confidence 688887654 4579999887542 12233344444 667888899999999999865 46789999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. ..+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.++|+|
T Consensus 96 ~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~---dl~p~ni----------------------li~~~~~~~l~d 150 (270)
T cd05056 96 YLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR---DIAARNV----------------------LVSSPDCVKLGD 150 (270)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---ccChheE----------------------EEecCCCeEEcc
Confidence 9864 347899999999999999999999999999 8888888 777888999999
Q ss_pred cCCccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 156 FGLCKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
||++......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||.+.+..+....+..+. .+.|
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05056 151 FGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230 (270)
T ss_pred CceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 9988754332211 112223457999999988889999999999999999986 999998887777776665543 3457
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..++++++++|++
T Consensus 231 ~~~~~~~~~li~~ 243 (270)
T cd05056 231 PNCPPTLYSLMTK 243 (270)
T ss_pred CCCCHHHHHHHHH
Confidence 7889999988763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=221.41 Aligned_cols=214 Identities=21% Similarity=0.338 Sum_probs=157.3
Q ss_pred CEeEEEec--CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRN--TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.... ....+|+|.+.... .......+.+ +++.++.++||||+++++.+...+..+++|||+++++|.++
T Consensus 11 v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~---e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~ 85 (269)
T cd05042 11 VLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQ---EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNY 85 (269)
T ss_pred EEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHH---HHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHH
Confidence 68885443 34578888776432 2222233333 46677888999999999999999999999999999999998
Q ss_pred hhhc------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 79 IHAD------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 79 ~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
+... ..++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+|
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------ll~~~~~~k 140 (269)
T cd05042 86 LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHS---DLALRNC----------------------QLTADLSVK 140 (269)
T ss_pred HHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecc---cccHhhe----------------------EecCCCcEE
Confidence 8542 23567788999999999999999999999 8888888 778889999
Q ss_pred EeecCCccCCCCCCC--CCCcccCCCCccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy3347 153 IADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFD 222 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~ 222 (245)
|+|||++........ ......++..|+|||.+.. ..++.++|||||||++|+|++ |..||......+...
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~ 220 (269)
T cd05042 141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220 (269)
T ss_pred EeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 999998864222111 1122334567999998742 356789999999999999999 889998777666655
Q ss_pred HHhcCc-cc-----CCCCCChhHHhhhc
Q psy3347 223 SIVNDE-VR-----YPRFLSLEAIAIMR 244 (245)
Q Consensus 223 ~~~~~~-~~-----~p~~~~~~~~~li~ 244 (245)
.+.... .+ .+..+++.+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (269)
T cd05042 221 QVVREQDIKLPKPQLDLKYSDRWYEVMQ 248 (269)
T ss_pred HHhhccCccCCCCcccccCCHHHHHHHH
Confidence 554332 22 23456677776654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=225.72 Aligned_cols=211 Identities=45% Similarity=0.893 Sum_probs=182.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|..+++++|.+-||+|+++++-.-..+.+.....|..+++... +||.++.++.+|..+...++|.||..||+|.-.++
T Consensus 266 vl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as--n~pflvglhscfqtesrlffvieyv~ggdlmfhmq 343 (593)
T KOG0695|consen 266 VLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS--NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ 343 (593)
T ss_pred hhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc--CCCeEEehhhhhcccceEEEEEEEecCcceeeehh
Confidence 4578899999999999999876666666666777766666544 79999999999999999999999999999987774
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+..+++..++.+...|..||.|||++||++| |+|.+|+ ++|..|.+|+.|+|++
T Consensus 344 rqrklpeeharfys~ei~lal~flh~rgiiyr---dlkldnv----------------------lldaeghikltdygmc 398 (593)
T KOG0695|consen 344 RQRKLPEEHARFYSAEICLALNFLHERGIIYR---DLKLDNV----------------------LLDAEGHIKLTDYGMC 398 (593)
T ss_pred hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeee---eccccce----------------------EEccCCceeecccchh
Confidence 4579999999999999999999999999999 6655555 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC-------CC-CHHHHHHHHhcCcccC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP-------GD-DEEEVFDSIVNDEVRY 231 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~-------~~-~~~~~~~~~~~~~~~~ 231 (245)
+....++...++++||+.|.|||++.+..|+..+|.|+||+.|+||+.|+.||+ .. ++.-+++-|+..+.++
T Consensus 399 ke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 399 KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred hcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 987788888999999999999999999999999999999999999999999994 12 3344556668889999
Q ss_pred CCCCChh
Q psy3347 232 PRFLSLE 238 (245)
Q Consensus 232 p~~~~~~ 238 (245)
|+++|--
T Consensus 479 prslsvk 485 (593)
T KOG0695|consen 479 PRSLSVK 485 (593)
T ss_pred cceeehh
Confidence 9988754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=223.04 Aligned_cols=215 Identities=22% Similarity=0.308 Sum_probs=167.7
Q ss_pred CEeEEEec----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L 75 (245)
||+|.+.. ++..|++|++... ......+.+.+| +..++.++||||+++++++.. +...++++||+++++|
T Consensus 22 V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e---~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L 96 (280)
T cd05043 22 IFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQE---SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNL 96 (280)
T ss_pred EEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHH---HHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcH
Confidence 68898876 3688999988743 223333444444 667888899999999998765 4678999999999999
Q ss_pred hhhhhh---------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 76 MMHIHA---------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 76 ~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
..++.. ..+++..+..++.|++.||+|||+++++|+ |++|+|+ +++
T Consensus 97 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~---di~p~ni----------------------l~~ 151 (280)
T cd05043 97 KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK---DIAARNC----------------------VID 151 (280)
T ss_pred HHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec---ccCHhhE----------------------EEc
Confidence 988843 347899999999999999999999999999 8888777 777
Q ss_pred CCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy3347 147 TEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDS 223 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~ 223 (245)
.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....
T Consensus 152 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 231 (280)
T cd05043 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231 (280)
T ss_pred CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 789999999999874322111 1122344667999999988889999999999999999999 9999988877777666
Q ss_pred HhcCcc-cCCCCCChhHHhhhcC
Q psy3347 224 IVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 224 ~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
+..+.. ..+..+++++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~ 254 (280)
T cd05043 232 LKDGYRLAQPINCPDELFAVMAC 254 (280)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHH
Confidence 655432 3456678888888753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=221.04 Aligned_cols=214 Identities=22% Similarity=0.335 Sum_probs=163.4
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe-eCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-TEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~-~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+.. ++..+|+|.+.... .....+.+.+ +...++.++||||+++++++. .++..+++|||+.+++|.
T Consensus 11 v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 85 (262)
T cd05058 11 VYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLK---EGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR 85 (262)
T ss_pred EEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHH---HHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHH
Confidence 68888654 34689999886421 2223334433 466788899999999999765 456789999999999999
Q ss_pred hhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++... .+++..+..++.|++.||+|||+++++|+ |++|+|| +++.++.++|+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlk~~ni----------------------li~~~~~~kl~ 140 (262)
T cd05058 86 NFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR---DLAARNC----------------------MLDESFTVKVA 140 (262)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc---ccCcceE----------------------EEcCCCcEEEC
Confidence 998542 45677788899999999999999999999 7788777 77788999999
Q ss_pred ecCCccCCCCCCC----CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc
Q psy3347 155 DFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~ 229 (245)
|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+..+..
T Consensus 141 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (262)
T cd05058 141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220 (262)
T ss_pred CccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9998874322111 1112334667999999988889999999999999999999 6778887777777766665533
Q ss_pred -cCCCCCChhHHhhhc
Q psy3347 230 -RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 -~~p~~~~~~~~~li~ 244 (245)
..|..+++.+.++|.
T Consensus 221 ~~~~~~~~~~~~~li~ 236 (262)
T cd05058 221 LLQPEYCPDPLYEVML 236 (262)
T ss_pred CCCCCcCCHHHHHHHH
Confidence 346677888888775
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=229.69 Aligned_cols=185 Identities=24% Similarity=0.362 Sum_probs=141.6
Q ss_pred CEeEEEe--cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYR--NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++ .+++.||+|.+...... .... +++++++.++||||+++++++.. +...+++|||+++ +|.
T Consensus 17 Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (317)
T cd07868 17 VYKAKRKDGKDDRDYALKQIEGTGIS-----MSAC---REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW 87 (317)
T ss_pred EEEEEEccCCCCceEEEEEECCCCCc-----HHHH---HHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHH
Confidence 7999876 46789999998754211 2223 34677888999999999999854 4578999999865 676
Q ss_pred hhhhh----------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 77 MHIHA----------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 77 ~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
.++.. ..+++..++.++.|++.||+|||++||+|| |+||+|| ++.. ..+
T Consensus 88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHr---Dlkp~Ni-----l~~~-------------~~~ 146 (317)
T cd07868 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR---DLKPANI-----LVMG-------------EGP 146 (317)
T ss_pred HHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcC---CCCHHHE-----EEec-------------CCC
Confidence 65531 247888999999999999999999999999 7777777 2210 014
Q ss_pred CCCceEEeecCCccCCCCCCC---CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 147 TEGYVKIADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
.++.+||+|||+++....... ......+|..|+|||.+.+. .++.++||||+||++|+|++|++||.+.
T Consensus 147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 567899999999875432211 22345778999999999774 5789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=220.32 Aligned_cols=219 Identities=23% Similarity=0.402 Sum_probs=169.7
Q ss_pred CEeEEEec-CCcEEEEEEeecccccch----hhHHHHHHHHHHHHHHh-hcCCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRN-TGEYFAIKALKKGDIIAR----DEVESLLSEKRIFEVAN-TMRHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~-~~~~vaiK~~~~~~~~~~----~~~~~~~~e~~~~~~l~-~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.++. +++.+|+|.+........ .....+....+++.++. .++||||+++++++..++..+++|||+++++
T Consensus 16 v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (269)
T cd08528 16 VYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP 95 (269)
T ss_pred EEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCc
Confidence 68999887 688999998864321110 11122222333455554 4789999999999999999999999999999
Q ss_pred hhhhhh-----hcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 75 LMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 75 L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
|.+++. ...+++..++.++.|++.||.|||+ .|++|+ |++|+|| +++.+
T Consensus 96 l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~---dl~~~ni----------------------l~~~~ 150 (269)
T cd08528 96 LGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHR---DLTPNNI----------------------MLGED 150 (269)
T ss_pred HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeec---CCCHHHE----------------------EECCC
Confidence 987762 2358889999999999999999996 789999 8888888 77888
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (245)
+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+....
T Consensus 151 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 151 DKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred CcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 999999999987532222 3344567888999999988889999999999999999999999998777666666665544
Q ss_pred cc-CCC-CCChhHHhhhcC
Q psy3347 229 VR-YPR-FLSLEAIAIMRR 245 (245)
Q Consensus 229 ~~-~p~-~~~~~~~~li~~ 245 (245)
.. .+. ..++++.++|++
T Consensus 230 ~~~~~~~~~~~~l~~li~~ 248 (269)
T cd08528 230 YEPLPEGMYSEDVTDVITS 248 (269)
T ss_pred CCcCCcccCCHHHHHHHHH
Confidence 33 233 678888888864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=221.09 Aligned_cols=219 Identities=27% Similarity=0.474 Sum_probs=166.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh----hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD----EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..+|+.+|+|.+......... .........++++.++.++|||++++++++...+..++||||+.+++|.
T Consensus 17 vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 96 (272)
T cd06629 17 VYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIG 96 (272)
T ss_pred EEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHH
Confidence 799999989999999988643211111 1111112234467788999999999999999999999999999999999
Q ss_pred hhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.++.. ..+++..+..++.|++.||.|+|+++++|+ |++|+|| +++.++.++++|
T Consensus 97 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~~~ni----------------------l~~~~~~~~l~d 151 (272)
T cd06629 97 SCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHR---DLKADNL----------------------LVDADGICKISD 151 (272)
T ss_pred HHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeec---CCChhhE----------------------EEcCCCeEEEee
Confidence 88854 578888999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCC--CCCCCcccCCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--cc
Q psy3347 156 FGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND--EV 229 (245)
Q Consensus 156 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~~ 229 (245)
||++...... ........++..|+|||.+.... ++.++|+||||+++|++++|..||......+....+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence 9988753221 11123345778899999987644 788999999999999999999999766554433333222 22
Q ss_pred cCCC----CCChhHHhhhc
Q psy3347 230 RYPR----FLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~----~~~~~~~~li~ 244 (245)
.+|. .++.+++++|+
T Consensus 232 ~~~~~~~~~~~~~~~~li~ 250 (272)
T cd06629 232 PIPPDVSMNLSPVALDFLN 250 (272)
T ss_pred cCCccccccCCHHHHHHHH
Confidence 2332 45778888775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=211.07 Aligned_cols=197 Identities=24% Similarity=0.396 Sum_probs=162.1
Q ss_pred eEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh--
Q psy3347 3 LSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH-- 80 (245)
Q Consensus 3 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-- 80 (245)
+.++..+|.-.|+|.+... .+.++.+.+.++..+ .++....|.+++++|.+...+..++.||.|. .||..+.+
T Consensus 64 kmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi--~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v 138 (282)
T KOG0984|consen 64 KMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDI--IMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKV 138 (282)
T ss_pred heeeccCCeEEEEeeehhh--cChHHHHHHHHhhhh--hccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHH
Confidence 5688999999999999864 344555555555333 2355579999999999999999999999985 48876663
Q ss_pred ---hcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 81 ---ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 81 ---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
...+++..+-+|+..++.||.|||++ .++|| |+||+|| +++.+|++|+|||
T Consensus 139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHR---DvKPsNi----------------------LIn~~GqVKiCDF 193 (282)
T KOG0984|consen 139 LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHR---DVKPSNI----------------------LINYDGQVKICDF 193 (282)
T ss_pred HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhc---cCCcceE----------------------EEccCCcEEEccc
Confidence 35789999999999999999999987 79999 9999999 9999999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCccc
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVNDEVR 230 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~ 230 (245)
|.|....++.... ...|+..|||||.+.. ..|+.++||||||+++.||++++.||.. .++.+++.+++....+
T Consensus 194 GIsG~L~dSiAkt-~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 194 GISGYLVDSIAKT-MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred ccceeehhhhHHH-HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 9998765555433 2457788999999953 3688999999999999999999999975 4788999999887654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=222.11 Aligned_cols=214 Identities=21% Similarity=0.321 Sum_probs=161.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|+++..... .....+..+. ...++..+||||+++++++..++..+++|||++ ++|..++.
T Consensus 17 v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~--~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~ 91 (283)
T cd06617 17 VDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDL--DISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYK 91 (283)
T ss_pred EEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHH--HHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHH
Confidence 799999999999999999764221 1222333332 223567789999999999999999999999997 47766553
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
. ..+++..+..++.|++.||+|||++ +++|+ |++|+|| +++.++.+||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~---dlkp~ni----------------------l~~~~~~~kl~ 146 (283)
T cd06617 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHR---DVKPSNV----------------------LINRNGQVKLC 146 (283)
T ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecC---CCCHHHE----------------------EECCCCCEEEe
Confidence 2 3588999999999999999999997 99999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC-c
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE----TSYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSIVND-E 228 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~~g~~pf~~~-~~~~~~~~~~~~-~ 228 (245)
|||.+....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... ...+....+... .
T Consensus 147 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd06617 147 DFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225 (283)
T ss_pred eccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC
Confidence 999987532221 1223457788999999865 45688999999999999999999999643 233333344333 2
Q ss_pred ccCC-CCCChhHHhhhcC
Q psy3347 229 VRYP-RFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~~~p-~~~~~~~~~li~~ 245 (245)
...| ..+++++.++|++
T Consensus 226 ~~~~~~~~~~~l~~li~~ 243 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNK 243 (283)
T ss_pred CCCCccccCHHHHHHHHH
Confidence 2333 4578888888753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=240.44 Aligned_cols=215 Identities=32% Similarity=0.516 Sum_probs=174.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||-|+++++|+.||||++.+-++...++ ..+.+| .++|..+.||.|+.+--.|+....+++|||.+.|.-|...+.
T Consensus 580 VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~E---VaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILS 655 (888)
T KOG4236|consen 580 VYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNE---VAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILS 655 (888)
T ss_pred eecceecccCceeeeeeeecccCCCchH-HHHHHH---HHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHH
Confidence 7999999999999999999877655443 445555 667778899999999999999999999999997766777774
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.+.+++...+.++.||+.||.|||-.+|+|. |+||+|+ ++. ..+.--.+||||||+
T Consensus 656 sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHC---DLKPENV-----LLa--------------s~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 656 SEKGRLPERITKFLVTQILVALRYLHFKNIVHC---DLKPENV-----LLA--------------SASPFPQVKLCDFGF 713 (888)
T ss_pred hhcccchHHHHHHHHHHHHHHHHHhhhcceeec---cCCchhe-----eec--------------cCCCCCceeeccccc
Confidence 3579999999999999999999999999999 5555555 544 223445799999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----CC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RF 234 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p----~~ 234 (245)
++. ..........+||+.|+|||.+....|...-||||.|+|+|--++|.+||... +++-.+|.+...-+| ..
T Consensus 714 ARi-IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 714 ARI-IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred eee-cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhh
Confidence 986 33334466789999999999999999999999999999999999999999643 344555655554343 56
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
++++..|||+
T Consensus 791 is~~AidlIn 800 (888)
T KOG4236|consen 791 ISPEAIDLIN 800 (888)
T ss_pred cCHHHHHHHH
Confidence 8899999886
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=223.85 Aligned_cols=185 Identities=24% Similarity=0.418 Sum_probs=149.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|.+...... ...... .+++++++.++||||+++++++..+++.++||||+.+ +|..++.
T Consensus 21 vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~---~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~ 94 (291)
T cd07844 21 VYKGRSKLTGQLVALKEIRLEHEE--GAPFTA---IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMD 94 (291)
T ss_pred EEEEEEcCCCcEEEEEEEeccccc--CCchhH---HHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHH
Confidence 799999999999999998754211 111122 3457788899999999999999999999999999985 8888774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~kl~dfg~ 149 (291)
T cd07844 95 DCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR---DLKPQNL----------------------LISERGELKLADFGL 149 (291)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---cCCHHHE----------------------EEcCCCCEEECcccc
Confidence 3 357889999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
++.............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 8643222222223345778999999876 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=223.96 Aligned_cols=206 Identities=20% Similarity=0.374 Sum_probs=158.9
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc-------
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD------- 82 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------- 82 (245)
+..||+|.+.... .....+.+.+| ++.++.++||||+++++++..++..+++||++.+++|..++...
T Consensus 46 ~~~va~K~~~~~~--~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 120 (296)
T cd05051 46 PVLVAVKVLRPDA--SDNAREDFLKE---VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120 (296)
T ss_pred ceeEEEEEecCcc--CHHHHHHHHHH---HHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc
Confidence 3568999987542 12233444444 66777889999999999999999999999999999999888542
Q ss_pred -----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 83 -----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 83 -----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 121 ~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~---dlkp~Ni----------------------li~~~~~~~l~dfg 175 (296)
T cd05051 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHR---DLATRNC----------------------LVGKNYTIKIADFG 175 (296)
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccc---ccchhce----------------------eecCCCceEEcccc
Confidence 47889999999999999999999999999 8888887 77788999999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcC------
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV--GESPFPGDDEEEVFDSIVND------ 227 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~pf~~~~~~~~~~~~~~~------ 227 (245)
.++....... ......++..|+|||.+.+..++.++||||||+++|+|++ +..||...+..+....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
T cd05051 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR 255 (296)
T ss_pred ceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccc
Confidence 9874322211 1223345678999999988889999999999999999998 78888776665555544321
Q ss_pred c--ccCCCCCChhHHhhhcC
Q psy3347 228 E--VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 228 ~--~~~p~~~~~~~~~li~~ 245 (245)
. .+.|..+++++.+++.+
T Consensus 256 ~~~~~~~~~~~~~l~~li~~ 275 (296)
T cd05051 256 QIYLPRPPNCPKDIYELMLE 275 (296)
T ss_pred cccCCCccCCCHHHHHHHHH
Confidence 1 12345677888888753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=224.33 Aligned_cols=211 Identities=23% Similarity=0.400 Sum_probs=166.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...........+.+.+ +++.++.++|||++++++++..+...+++|||+.+ ++..++.
T Consensus 37 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 112 (313)
T cd06633 37 VYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK---EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLE 112 (313)
T ss_pred EEEEEECCCCcEEEEEEEeccccCchHHHHHHHH---HHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Confidence 6999999999999999997654333333344444 46778888999999999999999999999999965 6666663
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
..++++..+..++.|++.|+.|||++|++|+ +++|+|| +++.++.++|+|||+
T Consensus 113 ~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~---dl~p~ni----------------------li~~~~~~kL~dfg~ 167 (313)
T cd06633 113 VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR---DIKAGNI----------------------LLTEPGQVKLADFGS 167 (313)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCChhhE----------------------EECCCCCEEEeecCC
Confidence 3468899999999999999999999999999 8888888 777889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-C-CC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-Y-PR 233 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~-p~ 233 (245)
+.... ......++..|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+.....+ . ..
T Consensus 168 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
T cd06633 168 ASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSN 243 (313)
T ss_pred CcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 76421 123456788899999984 356788999999999999999999999887766655555443322 1 23
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
..+..+++||+
T Consensus 244 ~~~~~l~~li~ 254 (313)
T cd06633 244 EWTDSFRGFVD 254 (313)
T ss_pred ccCHHHHHHHH
Confidence 46677787775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=220.94 Aligned_cols=211 Identities=26% Similarity=0.382 Sum_probs=164.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+ ..+|+|.+..... ..+.+.+ +++.++.++|||++++++++. .+..+++|||+.+++|.+++.
T Consensus 22 v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~---E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~ 92 (260)
T cd05069 22 VWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQ---EAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLK 92 (260)
T ss_pred EEEEEEcCC-ceEEEEEcccCCc----cHHHHHH---HHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHh
Confidence 688877654 4699998875421 1133333 466778889999999999875 456899999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|+ +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~---dl~~~Ni----------------------ll~~~~~~~l~dfg 147 (260)
T cd05069 93 EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR---DLRAANI----------------------LVGDNLVCKIADFG 147 (260)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec---ccCcceE----------------------EEcCCCeEEECCCc
Confidence 4 247888999999999999999999999999 7888787 77888999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
.+........ ......++..|+|||...+..++.++|+||||+++|+|++ |+.||.+....+....+.... .+.|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQG 227 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 9865322111 1112234567999999988889999999999999999999 999998887777666665542 344667
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
.+..+++++++
T Consensus 228 ~~~~~~~li~~ 238 (260)
T cd05069 228 CPESLHELMKL 238 (260)
T ss_pred cCHHHHHHHHH
Confidence 88888888763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=240.53 Aligned_cols=211 Identities=20% Similarity=0.359 Sum_probs=163.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+| .| .||||++.-..... +..+.|++| ...+++.+|.||+-+.|+|..++. .||+..|+|.+|..+++
T Consensus 408 V~Rg~w--hG-dVAVK~Lnv~~pt~-~qlqaFKnE---Va~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlH 479 (678)
T KOG0193|consen 408 VYRGRW--HG-DVAVKLLNVDDPTP-EQLQAFKNE---VAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLH 479 (678)
T ss_pred eeeccc--cc-ceEEEEEecCCCCH-HHHHHHHHH---HHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhcc
Confidence 788876 35 59999998765443 356667666 778899999999999999998887 99999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+.....+.|++|++.||.|||.++|+|| |+|..|| ++.++++|||+|||+
T Consensus 480 v~etkfdm~~~idIAqQiaqGM~YLHAK~IIHr---DLKSnNI----------------------Fl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 480 VQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHR---DLKSNNI----------------------FLHEDLKVKIGDFGL 534 (678)
T ss_pred chhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhh---hccccce----------------------EEccCCcEEEecccc
Confidence 3 467788899999999999999999999999 6666677 777789999999999
Q ss_pred ccCC--CCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC--
Q psy3347 159 CKEG--MGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY-- 231 (245)
Q Consensus 159 ~~~~--~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 231 (245)
+..- -+........-|...|||||++.- .+|+..+||||||+++|||++|..||.......+.-.+-.+...+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 8521 111112334457788999999953 589999999999999999999999999555444333333331111
Q ss_pred ---CCCCChhHHhhhc
Q psy3347 232 ---PRFLSLEAIAIMR 244 (245)
Q Consensus 232 ---p~~~~~~~~~li~ 244 (245)
-..++.++++|+.
T Consensus 615 s~~~s~~pk~mk~Ll~ 630 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLS 630 (678)
T ss_pred hhhhccCHHHHHHHHH
Confidence 1456667777763
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=216.33 Aligned_cols=216 Identities=31% Similarity=0.536 Sum_probs=173.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++.+|+.|++|++...... ....+.+. ++++.+++++||||+++++.+... +..++++|++.+++|.++
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (260)
T cd06606 16 VYLALDKDTGELMAVKSVELSGDS-EEELEALE---REIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSL 91 (260)
T ss_pred EEEEEECCCCcEEEEEEeeccccc-hHHHHHHH---HHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHH
Confidence 689999999999999999865322 22334443 447778889999999999999888 899999999999999998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||+|||+.|++|+ |++|+|| +++.++.++|+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~---dl~p~ni----------------------~i~~~~~~~l~d~~ 146 (260)
T cd06606 92 LKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR---DIKGANI----------------------LVDSDGVVKLADFG 146 (260)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EEcCCCCEEEcccc
Confidence 854 378999999999999999999999999999 8888888 77778999999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CcccCC
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDSIVN--DEVRYP 232 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~-~~~~~~~~~~--~~~~~p 232 (245)
.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||.... .......+.. ....+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 8875433321 1334567788999999988888999999999999999999999997665 3333333332 233467
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..++++++++|++
T Consensus 227 ~~~~~~l~~~i~~ 239 (260)
T cd06606 227 EHLSEEAKDFLRK 239 (260)
T ss_pred cccCHHHHHHHHH
Confidence 7788888888763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=231.10 Aligned_cols=193 Identities=26% Similarity=0.422 Sum_probs=155.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||+|.+..... .......+. +++.+++.++||||++++++|... .+.|+||||+.+ +
T Consensus 32 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 106 (353)
T cd07850 32 VCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAY---RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-N 106 (353)
T ss_pred EEEEEECCCCCEEEEEecCcccc-ChhHHHHHH---HHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-C
Confidence 68999999999999999875321 122223333 346778889999999999998643 357999999965 7
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|...+... +++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 107 l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~---dlkp~Ni----------------------l~~~~~~~kL~ 160 (353)
T cd07850 107 LCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 160 (353)
T ss_pred HHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCCHHHE----------------------EECCCCCEEEc
Confidence 77776544 8889999999999999999999999999 8888888 78889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||++..... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 161 Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 230 (353)
T cd07850 161 DFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230 (353)
T ss_pred cCccceeCCC-CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999875322 222334467888999999988889999999999999999999999998877655555543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=225.64 Aligned_cols=196 Identities=30% Similarity=0.426 Sum_probs=155.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++.+|+.||+|+++...... ...... .+++++++.++|+|++++++++... +..++||||+++ +|..+
T Consensus 23 v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~---~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 97 (309)
T cd07845 23 VYRARDTTSGEIVALKKVRMDNERD-GIPISS---LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASL 97 (309)
T ss_pred EEEEEECCCCcEEEEEEEEeccCCC-CCcchh---hHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHH
Confidence 7999999999999999997543211 111122 2346778889999999999998754 568999999975 77776
Q ss_pred hhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 98 l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~kL~df 152 (309)
T cd07845 98 LDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHR---DLKVSNL----------------------LLTDKGCLKIADF 152 (309)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EECCCCCEEECcc
Confidence 643 568999999999999999999999999999 8888888 7788899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.+.+..+....+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 998754332222223345678999999866 4578999999999999999999999998887777666543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=222.17 Aligned_cols=179 Identities=24% Similarity=0.377 Sum_probs=144.4
Q ss_pred EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhhhhhcC
Q psy3347 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMHIHADV 83 (245)
Q Consensus 6 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~ 83 (245)
...+++.||+|.++... .....+.+.+ +++.++.++||||+++++++... ...+++|||+.+++|.+++....
T Consensus 29 ~~~~~~~vaiK~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 103 (283)
T cd05080 29 NDGTGEMVAVKTLKREC--GQQNTSGWKK---EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK 103 (283)
T ss_pred cCCCCceEEEEEecccc--ChHHHHHHHH---HHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC
Confidence 44578899999997542 1122233443 46778889999999999988653 46899999999999999998778
Q ss_pred CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCC
Q psy3347 84 FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM 163 (245)
Q Consensus 84 l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~ 163 (245)
+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+++...
T Consensus 104 l~~~~~~~i~~~l~~~l~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 104 LNLAQLLLFAQQICEGMAYLHSQHYIHR---DLAARNV----------------------LLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecc---ccChheE----------------------EEcCCCcEEEeecccccccC
Confidence 9999999999999999999999999999 8888888 77788999999999987532
Q ss_pred CCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 164 GFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 164 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 22110 1122345679999999888899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=220.88 Aligned_cols=214 Identities=22% Similarity=0.316 Sum_probs=158.3
Q ss_pred CEeEEEe--cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYR--NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+. .++..+|+|.++... .......+. +++..++.++||||+++++++......++||||+++++|.++
T Consensus 11 Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 85 (269)
T cd05087 11 VILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFL---EEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGY 85 (269)
T ss_pred EEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHH---HHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHH
Confidence 6888754 356789999887542 112222333 346778889999999999999988899999999999999988
Q ss_pred hhhc------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 79 IHAD------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 79 ~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
+... ..++..+..++.|++.|++|||++|++|+ |++|+|| +++.++.++
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~---dlkp~ni----------------------l~~~~~~~k 140 (269)
T cd05087 86 LRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHS---DLALRNC----------------------LLTADLTVK 140 (269)
T ss_pred HHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEecc---ccCcceE----------------------EEcCCCcEE
Confidence 8531 34566778899999999999999999999 7777777 777788999
Q ss_pred EeecCCccCCCCCCC--CCCcccCCCCccccccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy3347 153 IADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTET-------SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFD 222 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~ 222 (245)
|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|||++ |+.||......+...
T Consensus 141 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 220 (269)
T cd05087 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT 220 (269)
T ss_pred ECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 999998864322111 11233567789999998532 35789999999999999996 999998766655544
Q ss_pred HHhcC-cccC-----CCCCChhHHhhhc
Q psy3347 223 SIVND-EVRY-----PRFLSLEAIAIMR 244 (245)
Q Consensus 223 ~~~~~-~~~~-----p~~~~~~~~~li~ 244 (245)
..... ...+ +..+++.+.++|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (269)
T cd05087 221 YTVREQQLKLPKPRLKLPLSDRWYEVMQ 248 (269)
T ss_pred HHhhcccCCCCCCccCCCCChHHHHHHH
Confidence 43322 2222 2346777777775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=235.71 Aligned_cols=174 Identities=24% Similarity=0.319 Sum_probs=144.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|..... ... +++++++.++|+||+++++++..++..+++||++. ++|..++.
T Consensus 185 Vy~a~~~~~~~~vavK~~~~~---------~~~---~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~ 251 (461)
T PHA03211 185 VFESSHPDYPQRVVVKAGWYA---------SSV---HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLG 251 (461)
T ss_pred EEEEEECCCCCEEEEeccccc---------CHH---HHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHH
Confidence 799999999999999964321 122 34677888999999999999999999999999985 57777774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.++|+|||+
T Consensus 252 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr---DLKP~NI----------------------Ll~~~~~vkL~DFGl 306 (461)
T PHA03211 252 ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHR---DIKTENV----------------------LVNGPEDICLGDFGA 306 (461)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC---cCCHHHE----------------------EECCCCCEEEcccCC
Confidence 3 468999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy3347 159 CKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf 212 (245)
++....... ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 875322211 122356899999999999888999999999999999999976554
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=232.45 Aligned_cols=178 Identities=25% Similarity=0.400 Sum_probs=147.4
Q ss_pred CEeEEEe--cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYR--NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|... .+++.||+|.+.... ... +++++++.++||||+++++++...+..|++||++. ++|..+
T Consensus 108 Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~---~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~ 175 (392)
T PHA03207 108 VFVCTKHGDEQRKKVIVKAVTGGK--------TPG---REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTY 175 (392)
T ss_pred EEEEEEcCCccceeEEEEeccccc--------cHH---HHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHH
Confidence 6888653 457899999886531 122 34677888999999999999999999999999986 477777
Q ss_pred hh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+. ...+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.++|+|||
T Consensus 176 l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr---Dlkp~Ni----------------------ll~~~~~~~l~DfG 230 (392)
T PHA03207 176 VDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR---DVKTENI----------------------FLDEPENAVLGDFG 230 (392)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EEcCCCCEEEccCc
Confidence 74 4578999999999999999999999999999 8888888 77888999999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9864322211 223457899999999998888999999999999999999999999764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=227.25 Aligned_cols=214 Identities=28% Similarity=0.458 Sum_probs=165.6
Q ss_pred CEeEEEecC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYRNT-------GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++... +..||+|.++... .....+.+.+| ++.++++ +||||+++++++..++..+++|||+++
T Consensus 28 v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 102 (334)
T cd05100 28 VVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSE---MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102 (334)
T ss_pred EEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHH---HHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCC
Confidence 688876432 3378999887431 22233444444 6667777 799999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
++|.+++... .++...+..++.|++.||+|||++|++|+ |++|+||
T Consensus 103 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~---dlkp~Ni-------------- 165 (334)
T cd05100 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR---DLAARNV-------------- 165 (334)
T ss_pred CcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc---ccccceE--------------
Confidence 9999888531 36677888999999999999999999999 8888888
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 166 --------ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 166 --------LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred --------EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 7778899999999998753222111 112223457999999988889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHhcCcc-cCCCCCChhHHhhhc
Q psy3347 213 PGDDEEEVFDSIVNDEV-RYPRFLSLEAIAIMR 244 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~ 244 (245)
.+.+..+....+..... ..|..++.++.++|.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMR 270 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 98888777777665433 456777888888775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=214.15 Aligned_cols=212 Identities=25% Similarity=0.463 Sum_probs=169.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.+++|++..... ...+.+. ++++.++.++|||++++.+.+..++..++++||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 89 (253)
T cd05122 16 VYKARHKRTGKEVAIKVIKLESK---EKKEKII---NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK 89 (253)
T ss_pred EEEEEECCCCcEEEEEEecccch---hHHHHHH---HHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHh
Confidence 68999998999999999986432 2233343 44677888899999999999999999999999999999999885
Q ss_pred hc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 AD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. .+++..+..++.|++.||++||++|++|+ |++|+|| +++.++.++|+|||.
T Consensus 90 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~---dl~p~ni----------------------~i~~~~~~~l~d~~~ 144 (253)
T cd05122 90 STNQTLTESQIAYVCKELLKGLEYLHSNGIIHR---DIKAANI----------------------LLTSDGEVKLIDFGL 144 (253)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecC---CCCHHHE----------------------EEccCCeEEEeeccc
Confidence 53 78999999999999999999999999999 8888888 777889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc-ccCCC--CC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-VRYPR--FL 235 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~p~--~~ 235 (245)
+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+......... ...+. .+
T Consensus 145 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (253)
T cd05122 145 SAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW 223 (253)
T ss_pred ccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCccccc
Confidence 875332221 334567788999999988888899999999999999999999998775555444443322 22332 23
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
+.++.++|+
T Consensus 224 ~~~~~~~i~ 232 (253)
T cd05122 224 SDEFKDFLK 232 (253)
T ss_pred CHHHHHHHH
Confidence 777888775
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=223.34 Aligned_cols=204 Identities=20% Similarity=0.378 Sum_probs=155.6
Q ss_pred EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc---------
Q psy3347 12 YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD--------- 82 (245)
Q Consensus 12 ~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------- 82 (245)
.||+|.++... .....+.+.+ +++.++.++|||++++++++...+..+++|||+.+++|.+++...
T Consensus 46 ~vavK~~~~~~--~~~~~~~~~~---ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 120 (295)
T cd05097 46 LVAVKMLRADV--TKTARNDFLK---EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120 (295)
T ss_pred EEEEEecCCCC--CHHHHHHHHH---HHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhcccccccccc
Confidence 58999987542 1222333444 477788999999999999999999999999999999999887432
Q ss_pred ----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 83 ----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 83 ----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.+++..+..++.|++.||+|||++|++|+ |++|+|+ +++.++.+||+|||+
T Consensus 121 ~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~---dlkp~Ni----------------------ll~~~~~~kl~dfg~ 175 (295)
T cd05097 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHR---DLATRNC----------------------LVGNHYTIKIADFGM 175 (295)
T ss_pred ccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc---ccChhhE----------------------EEcCCCcEEeccccc
Confidence 25778889999999999999999999999 8888887 777788999999998
Q ss_pred ccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc-----Cc-
Q psy3347 159 CKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV--GESPFPGDDEEEVFDSIVN-----DE- 228 (245)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~pf~~~~~~~~~~~~~~-----~~- 228 (245)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ +..||...+..+....+.. ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T cd05097 176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ 255 (295)
T ss_pred ccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc
Confidence 864322111 1122344668999999988889999999999999999998 6788887666555444321 11
Q ss_pred --ccCCCCCChhHHhhhcC
Q psy3347 229 --VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 --~~~p~~~~~~~~~li~~ 245 (245)
...+..+++.+.+|+.+
T Consensus 256 ~~~~~~~~~~~~l~~li~~ 274 (295)
T cd05097 256 IYLSQTPLCPSPVFKLMMR 274 (295)
T ss_pred ccCCCCCCCCHHHHHHHHH
Confidence 12345677888888763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=223.40 Aligned_cols=194 Identities=25% Similarity=0.352 Sum_probs=150.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|.+..... .....+.+.+ +++.++.++||||+++++++..+++.++||||+++ +|..++.
T Consensus 18 v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 92 (294)
T PLN00009 18 VYKARDRVTNETIALKKIRLEQE-DEGVPSTAIR---EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMD 92 (294)
T ss_pred EEEEEecCCCcEEEEEehhhccc-cccchHHHHH---HHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHH
Confidence 68999999999999999865421 1112223333 46778888999999999999999999999999965 7766663
Q ss_pred h-c--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceEEeec
Q psy3347 81 A-D--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVKIADF 156 (245)
Q Consensus 81 ~-~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~kl~Df 156 (245)
. . .+++..+..++.|++.||+|||++|++|+ +++|+|| +++ .++.+||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~---dl~p~ni----------------------ll~~~~~~~kl~df 147 (294)
T PLN00009 93 SSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR---DLKPQNL----------------------LIDRRTNALKLADF 147 (294)
T ss_pred hCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCCcceE----------------------EEECCCCEEEEccc
Confidence 3 2 25678888999999999999999999999 8888888 565 4567999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|++..............++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+..+...++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 148 GLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred ccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998643222222233456788999999866 45788999999999999999999999877665554443
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=217.56 Aligned_cols=212 Identities=25% Similarity=0.417 Sum_probs=167.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. .++.+|+|.+...... ...+.+ +++.++.++|||++++++++......+++|||+.+++|.+++.
T Consensus 20 v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 91 (256)
T cd05112 20 VWLGYWL-EKRKVAIKTIREGAMS----EEDFIE---EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR 91 (256)
T ss_pred EEEEEEe-CCCeEEEEECCCCCCC----HHHHHH---HHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHH
Confidence 6888775 4778999998754321 123433 4667788899999999999999999999999999999998885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.|+++||+++++|+ |++|+|| +++.++.++|+|||.
T Consensus 92 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~---dl~p~ni----------------------~i~~~~~~~l~d~g~ 146 (256)
T cd05112 92 AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR---DLAARNC----------------------LVGENQVVKVSDFGM 146 (256)
T ss_pred hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc---ccccceE----------------------EEcCCCeEEECCCcc
Confidence 3 457889999999999999999999999999 8888888 777888999999998
Q ss_pred ccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cCCCCC
Q psy3347 159 CKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~p~~~ 235 (245)
+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..+.+..+.. ..|...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05112 147 TRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA 226 (256)
T ss_pred eeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCC
Confidence 8743222111 112234567999999988889999999999999999998 9999988877777776655432 346667
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+|+++
T Consensus 227 ~~~~~~l~~~ 236 (256)
T cd05112 227 SQSVYELMQH 236 (256)
T ss_pred CHHHHHHHHH
Confidence 8888888753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=217.03 Aligned_cols=213 Identities=23% Similarity=0.428 Sum_probs=172.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+++++.+|.-+|||.+.+.. +.++.+++....+++ ++.-+.|.||+.+|+|..+..+++.||.|. ..+...++
T Consensus 108 V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv--~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlk 182 (391)
T KOG0983|consen 108 VWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVV--LKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLK 182 (391)
T ss_pred eEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHH--hhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHH
Confidence 7999999999999999999764 455555554443332 333358999999999999999999999884 35555554
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.+++++..+-++...++.||.||-++ ||+|| |+||+|| ++|..|++|+||||
T Consensus 183 rik~piPE~ilGk~tva~v~AL~YLKeKH~viHR---DvKPSNI----------------------LlDe~GniKlCDFG 237 (391)
T KOG0983|consen 183 RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHR---DVKPSNI----------------------LLDERGNIKLCDFG 237 (391)
T ss_pred HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeec---ccCccce----------------------EEccCCCEEeeccc
Confidence 35799999999999999999999975 89999 9999999 99999999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCccc-CC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSIVNDEVR-YP 232 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~-~~~~~~~~~~~~~~~-~p 232 (245)
.+....+... .+...|++.|||||-+.- ..|+.++||||||++++|++||..||.+. +..+.+..+++..++ .|
T Consensus 238 IsGrlvdSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~ 316 (391)
T KOG0983|consen 238 ISGRLVDSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP 316 (391)
T ss_pred ccceeecccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC
Confidence 9976554443 445578999999999954 35888999999999999999999999874 678999999986654 23
Q ss_pred --CCCChhHHhhhc
Q psy3347 233 --RFLSLEAIAIMR 244 (245)
Q Consensus 233 --~~~~~~~~~li~ 244 (245)
..+|++..+++.
T Consensus 317 ~~~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVK 330 (391)
T ss_pred cccCcCHHHHHHHH
Confidence 347888888764
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=219.55 Aligned_cols=212 Identities=29% Similarity=0.485 Sum_probs=162.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+++.+|+|.+.... .......+.+ +++.++.++||||++++++|.. .+..+++|||+++++|.++
T Consensus 17 v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (287)
T cd06621 17 VTKCRLKNTGMIFALKTITTDP--NPDLQKQILR---ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSI 91 (287)
T ss_pred EEEEEECCCCeEEEEEEEecCC--chHHHHHHHH---HHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHH
Confidence 6899999999999999997542 1122334444 4677888999999999998854 3478999999999999877
Q ss_pred hh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 79 IH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 79 ~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
+. ...+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|
T Consensus 92 l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~---dl~~~ni----------------------l~~~~~~~~l 146 (287)
T cd06621 92 YKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR---DIKPSNI----------------------LLTRKGQVKL 146 (287)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EEecCCeEEE
Confidence 63 2357888999999999999999999999999 8888888 7778889999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCc
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-----DEEEVFDSIVNDE 228 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-----~~~~~~~~~~~~~ 228 (245)
+|||++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||... ...+....+....
T Consensus 147 ~dfg~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 147 CDFGVSGELVNS--LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred eecccccccccc--ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 999988643221 122345678899999998888999999999999999999999999754 2344444444322
Q ss_pred c-cCCC------CCChhHHhhhc
Q psy3347 229 V-RYPR------FLSLEAIAIMR 244 (245)
Q Consensus 229 ~-~~p~------~~~~~~~~li~ 244 (245)
. .+++ ..+++++++|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~ 247 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIK 247 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHH
Confidence 1 1221 23456777765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=222.14 Aligned_cols=217 Identities=17% Similarity=0.302 Sum_probs=158.0
Q ss_pred CEeEEEecCCc-------EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCC
Q psy3347 1 VILSQYRNTGE-------YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 73 (245)
||+|.++.++. ++|+|.+.... ....+.+.. +..+++.++|||++++++++..++..++||||+.++
T Consensus 11 Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~---e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g 84 (258)
T cd05078 11 IFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFE---AASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFG 84 (258)
T ss_pred heeeeecccccccccccchhhHHhhcchh---HHHHHHHHH---HHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCC
Confidence 78898866544 48888876432 122223333 356677889999999999999989999999999999
Q ss_pred chhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 74 DLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 74 ~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
+|..++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| ++..... ......+.+
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~---dlkp~ni-----li~~~~~---------~~~~~~~~~ 147 (258)
T cd05078 85 SLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHG---NVCAKNV-----LLIREED---------RKTGNPPFI 147 (258)
T ss_pred cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCccceE-----EEecccc---------cccCCCceE
Confidence 99999854 357889999999999999999999999999 6666666 3321100 000112347
Q ss_pred EEeecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCcc
Q psy3347 152 KIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVG-ESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g-~~pf~~~~~~~~~~~~~~~~~ 229 (245)
+++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++| ..||...+...... +.....
T Consensus 148 ~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~ 222 (258)
T cd05078 148 KLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH 222 (258)
T ss_pred EecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc
Confidence 9999998764321 223456778999999976 4578899999999999999998 57776655544333 334455
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|...++++.+||++
T Consensus 223 ~~~~~~~~~~~~li~~ 238 (258)
T cd05078 223 QLPAPKWTELANLINQ 238 (258)
T ss_pred cCCCCCcHHHHHHHHH
Confidence 6777778888888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=223.27 Aligned_cols=213 Identities=23% Similarity=0.368 Sum_probs=161.7
Q ss_pred CEeEEEecCCc----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGE----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.++.+|+ .+|+|.+.... .......+. ++..+++.++||||+++++++... ..++++||+++|+|.
T Consensus 23 vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~ 96 (303)
T cd05110 23 VYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFM---DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLL 96 (303)
T ss_pred EEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHH---HHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHH
Confidence 79999988876 46888876432 112222333 346677888999999999998654 578999999999999
Q ss_pred hhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~---dikp~Ni----------------------ll~~~~~~kL~ 151 (303)
T cd05110 97 DYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR---DLAARNV----------------------LVKSPNHVKIT 151 (303)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc---cccccee----------------------eecCCCceEEc
Confidence 888543 57888999999999999999999999999 7777777 66777889999
Q ss_pred ecCCccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++........ .....++..|+|||.+.+..++.++||||||+++||+++ |..||.+....+....+..+. .+
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 99998754322211 112234568999999988889999999999999999997 999998776655555544433 23
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.+..++.++.++|.
T Consensus 232 ~~~~~~~~~~~li~ 245 (303)
T cd05110 232 QPPICTIDVYMVMV 245 (303)
T ss_pred CCCCCCHHHHHHHH
Confidence 34567777777764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=219.73 Aligned_cols=191 Identities=27% Similarity=0.421 Sum_probs=149.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC--CeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+++.||+|+++...... .. ... .+++..+.++ +|||++++++++.++ +..+++|||+++ ++.+
T Consensus 15 v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~---~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 88 (282)
T cd07831 15 VLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNN---LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYE 88 (282)
T ss_pred EEEEEEcCCCcEEEEEEehhccCCc-hh-hhH---HHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHH
Confidence 6999999999999999987542111 11 112 2335556666 499999999999887 899999999975 7766
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++. +.++|+|
T Consensus 89 ~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~---dl~p~ni----------------------~l~~-~~~kl~d 142 (282)
T cd07831 89 LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR---DIKPENI----------------------LIKD-DILKLAD 142 (282)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceec---ccCHHHE----------------------EEcC-CCeEEEe
Confidence 6643 468999999999999999999999999999 8888887 6667 8999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
||.+........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 143 FGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred cccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 999875433222 233457888999998754 45788999999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=222.97 Aligned_cols=212 Identities=24% Similarity=0.376 Sum_probs=166.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.+|+|.+.............+. ++++.++.++|+|++++.+++...+..++||||+.+ ++.+.+.
T Consensus 31 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 106 (308)
T cd06634 31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII---KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLE 106 (308)
T ss_pred EEEEEEcCCCcEEEEEEEecccccChHHHHHHH---HHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHH
Confidence 699999999999999998754333333333443 347778889999999999999999999999999974 6766553
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||+++++|+ |++|+|| +++.++.++|+|||+
T Consensus 107 ~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~---dl~p~ni----------------------l~~~~~~~kl~dfg~ 161 (308)
T cd06634 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR---DVKAGNI----------------------LLSEPGLVKLGDFGS 161 (308)
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHhE----------------------EECCCCcEEECCccc
Confidence 3468889999999999999999999999999 8888888 777889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc--CCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--YPR 233 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~p~ 233 (245)
+..... .....++..|+|||.+. ...++.++||||||+++|+|++|..||...+..+....+.....+ .+.
T Consensus 162 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06634 162 ASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237 (308)
T ss_pred ceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcc
Confidence 764321 22446778899999984 345788999999999999999999999776665555555443322 234
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
..+..++++|++
T Consensus 238 ~~~~~~~~li~~ 249 (308)
T cd06634 238 HWSEYFRNFVDS 249 (308)
T ss_pred cccHHHHHHHHH
Confidence 677788888763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=220.25 Aligned_cols=217 Identities=39% Similarity=0.700 Sum_probs=168.3
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccch-hhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIAR-DEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+++.||+|+++....... ...+.+. ++++++..+ +||||+++++.+..++..++||||+.+++|
T Consensus 16 vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~---~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (288)
T cd05583 16 VFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR---TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL 92 (288)
T ss_pred EEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHH---HHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcH
Confidence 5777653 4688999999985432211 1122233 346667777 599999999999999999999999999999
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..++. ...+++..+..++.|++.||+|||+.|++|+ |++|.|| +++.++.++|+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~---dl~p~ni----------------------l~~~~~~~~l~ 147 (288)
T cd05583 93 FTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYR---DIKLENI----------------------LLDSEGHVVLT 147 (288)
T ss_pred HHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHe----------------------EECCCCCEEEE
Confidence 88885 4568899999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCC-CCCcccCCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcC
Q psy3347 155 DFGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVND 227 (245)
Q Consensus 155 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~~ 227 (245)
|||++........ ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||... ...+....+...
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence 9998875332221 122345788999999987654 678999999999999999999999533 234444555566
Q ss_pred cccCCCCCChhHHhhhcC
Q psy3347 228 EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 228 ~~~~p~~~~~~~~~li~~ 245 (245)
..+.|..++++++++|++
T Consensus 228 ~~~~~~~~~~~l~~li~~ 245 (288)
T cd05583 228 KPPFPKTMSAEARDFIQK 245 (288)
T ss_pred CCCCCcccCHHHHHHHHH
Confidence 667778888998888763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=236.22 Aligned_cols=214 Identities=26% Similarity=0.385 Sum_probs=171.5
Q ss_pred CEeEEEecC----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNT----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+... .--||||+-+... ..+..+.+.+| .-+|+.++||||++++|+|.. ...++|||.++.|-|.
T Consensus 405 Vy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqE---a~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr 478 (974)
T KOG4257|consen 405 VYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQE---ASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELR 478 (974)
T ss_pred eeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHH---HHHHHhCCCcchhheeeeeec-cceeEEEecccchhHH
Confidence 577754432 2368889888743 22335566655 567889999999999999965 4799999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
.+++. ..++......++.|+..||+|||+.+.+|| ||-.-|| ++.+...+|++
T Consensus 479 ~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHR---DIAaRNi----------------------LVsSp~CVKLa 533 (974)
T KOG4257|consen 479 EYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHR---DIAARNI----------------------LVSSPQCVKLA 533 (974)
T ss_pred HHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhh---hhhhhhe----------------------eecCcceeeec
Confidence 99965 358888899999999999999999999999 4433344 55566789999
Q ss_pred ecCCccCCCCCCCCCCc-ccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cC
Q psy3347 155 DFGLCKEGMGFGDRTGT-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RY 231 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~ 231 (245)
|||+++...+....... ..-+..|||||.+...+|+.++|||.||++|||++. |..||.+-.+.++...+.++.. +.
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~ 613 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC 613 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC
Confidence 99999975444332222 223567999999999999999999999999999987 9999999988888888888755 56
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|+.|||.+..||.|
T Consensus 614 P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 614 PPNCPPALYSLMSK 627 (974)
T ss_pred CCCCChHHHHHHHH
Confidence 99999999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=224.31 Aligned_cols=184 Identities=25% Similarity=0.421 Sum_probs=150.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-CCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-EAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.++.+|+.||+|++..... .....+.+.+ ++++++.++||||+++.++|.. .+..+++|||+ +++|..++
T Consensus 26 v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~---E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 100 (328)
T cd07856 26 VCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYR---ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLL 100 (328)
T ss_pred EEEEEECCCCCEEEEEEeccccc-ccchhHHHHH---HHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHH
Confidence 68999999999999998865321 1222233433 4677888899999999999865 56789999998 45888888
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+..++++..+..++.|++.||+|||++|++|+ +++|+|+ +++.++.++|+|||.+
T Consensus 101 ~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~---dl~p~Ni----------------------li~~~~~~~l~dfg~~ 155 (328)
T cd07856 101 TSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR---DLKPSNI----------------------LINENCDLKICDFGLA 155 (328)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------eECCCCCEEeCccccc
Confidence 87788888999999999999999999999999 8888888 7778899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+...
T Consensus 156 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 156 RIQD---PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred cccC---CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7421 12233456788999999866 5688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=222.00 Aligned_cols=205 Identities=21% Similarity=0.377 Sum_probs=155.9
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc-------
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD------- 82 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------- 82 (245)
+..+|+|++.... .......+.+ +++.++.++|+||+++++++..++..+++|||+.+++|..++...
T Consensus 46 ~~~~a~K~~~~~~--~~~~~~~~~~---E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 120 (296)
T cd05095 46 PVLVAVKMLREDA--NKNARNDFLK---EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120 (296)
T ss_pred eeEEEEEeccccC--CHHHHHHHHH---HHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccc
Confidence 4579999987532 1222233444 467788889999999999999999999999999999999888542
Q ss_pred -----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 83 -----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 83 -----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 121 ~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~~l~dfg 175 (296)
T cd05095 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHR---DLATRNC----------------------LVGKNYTIKIADFG 175 (296)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHHCCeecc---cCChheE----------------------EEcCCCCEEeccCc
Confidence 25667899999999999999999999999 8888888 77788999999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc-------
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV--GESPFPGDDEEEVFDSIVN------- 226 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~pf~~~~~~~~~~~~~~------- 226 (245)
++........ ......++..|+|||...+..++.++|+|||||++|||++ |..||...+..+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
T cd05095 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR 255 (296)
T ss_pred ccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc
Confidence 9874322111 1222334567999999888889999999999999999998 7899977665554443311
Q ss_pred -CcccCCCCCChhHHhhhc
Q psy3347 227 -DEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 227 -~~~~~p~~~~~~~~~li~ 244 (245)
...+.|..+++.+.+||.
T Consensus 256 ~~~~~~~~~~~~~~~~li~ 274 (296)
T cd05095 256 QVYLPKPALCPDSLYKLML 274 (296)
T ss_pred cccCCCCCCCCHHHHHHHH
Confidence 112335667888888875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=227.58 Aligned_cols=190 Identities=25% Similarity=0.437 Sum_probs=151.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||+|++...... ....+.+ .++++.++.++||||+++++++... +..+++++++ +++
T Consensus 33 v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~---~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~ 107 (345)
T cd07877 33 VCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRT---YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD 107 (345)
T ss_pred EEEEEEcCCCeEEEEEEecCcchh-hHHHHHH---HHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccC
Confidence 689999999999999999753211 1112233 3456778889999999999998643 3578899877 678
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|..+++...+++..+..++.|++.||+|||++|++|+ +++|+|| +++.++.++|+
T Consensus 108 L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---dlkp~NI----------------------ll~~~~~~kl~ 162 (345)
T cd07877 108 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR---DLKPSNL----------------------AVNEDCELKIL 162 (345)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCChHHE----------------------EEcCCCCEEEe
Confidence 9888877789999999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
|||++.... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......
T Consensus 163 dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 163 DFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred ccccccccc---ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999987532 12234467888999999866 4678899999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=225.03 Aligned_cols=185 Identities=24% Similarity=0.363 Sum_probs=140.6
Q ss_pred CEeEEEec--CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRN--TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++. +++.||+|.+...... ..+ .+++++++.++||||+++++++.. ++..+++|||+++ +|.
T Consensus 17 Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (317)
T cd07867 17 VYKAKRKDGKDEKEYALKQIEGTGIS-----MSA---CREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLW 87 (317)
T ss_pred EEEEEecCCCccceEEEEEecCCCCc-----HHH---HHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHH
Confidence 79998664 6789999998754211 223 344777888999999999999853 5678999999876 665
Q ss_pred hhhhh----------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 77 MHIHA----------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 77 ~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
+++.. ..+++..+..++.|++.||+|||++|++|| |+||+|| ++.. ..+
T Consensus 88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~---Dlkp~Ni-----l~~~-------------~~~ 146 (317)
T cd07867 88 HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHR---DLKPANI-----LVMG-------------EGP 146 (317)
T ss_pred HHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcC---CCCHHHE-----EEcc-------------CCC
Confidence 55421 247888899999999999999999999999 7777777 2110 014
Q ss_pred CCCceEEeecCCccCCCCCCC---CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 147 TEGYVKIADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
.++.+||+|||+++....... ......++..|+|||.+.+. .++.++|||||||++|+|++|++||...
T Consensus 147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 567899999999875332211 12345678899999999764 5789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=218.41 Aligned_cols=207 Identities=18% Similarity=0.276 Sum_probs=147.8
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhh--cCCChH
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHA--DVFSEP 87 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~ 87 (245)
...+|+|++.... ......+ .+++..++.++||||+++++++..+...+++|||+++++|..++.. ..+++.
T Consensus 32 ~~~v~~k~~~~~~---~~~~~~~---~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~ 105 (262)
T cd05077 32 EIKVILKVLDPSH---RDISLAF---FETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP 105 (262)
T ss_pred ceeEEEeecChhh---hhHHHHH---HHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHH
Confidence 3368888876532 1112222 3346778888999999999999998899999999999999888753 468999
Q ss_pred HHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCC
Q psy3347 88 RAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD 167 (245)
Q Consensus 88 ~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 167 (245)
.+..++.|++.||+|||++|++|+ |++|+|| ++...- ........++++|||.+.....
T Consensus 106 ~~~~i~~qi~~~l~~lH~~~ivH~---dlkp~Ni-----ll~~~~----------~~~~~~~~~~l~d~g~~~~~~~--- 164 (262)
T cd05077 106 WKFKVAKQLASALSYLEDKDLVHG---NVCTKNI-----LLAREG----------IDGECGPFIKLSDPGIPITVLS--- 164 (262)
T ss_pred HHHHHHHHHHHHHHHhhhCCeECC---CCCcccE-----EEecCC----------ccCCCCceeEeCCCCCCccccC---
Confidence 999999999999999999999999 6666666 332110 0001122489999998864322
Q ss_pred CCCcccCCCCcccccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHHhhhcC
Q psy3347 168 RTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 168 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~-~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 245 (245)
.....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+... ............++++.+||++
T Consensus 165 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 242 (262)
T cd05077 165 -RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSCKELADLMTH 242 (262)
T ss_pred -cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCChHHHHHHHHH
Confidence 12345677899999986 466889999999999999997 5899987665444322 2233333334455677777753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=219.54 Aligned_cols=206 Identities=17% Similarity=0.254 Sum_probs=150.4
Q ss_pred cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhh--cCCChHH
Q psy3347 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHA--DVFSEPR 88 (245)
Q Consensus 11 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~ 88 (245)
..||+|++.... ......+ .+++++++.++||||+++++++..++..++||||+++++|..++.. +.+++..
T Consensus 45 ~~v~~k~~~~~~---~~~~~~~---~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 118 (274)
T cd05076 45 LRVVLKVLDPSH---RDIALAF---FETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW 118 (274)
T ss_pred eeEEEEecChHH---HHHHHHH---HHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHH
Confidence 468899886432 1112223 3346678889999999999999999999999999999999988853 4688999
Q ss_pred HHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCC
Q psy3347 89 AVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168 (245)
Q Consensus 89 ~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 168 (245)
+..++.|++.||+|||++|++|+ |++|+|| ++...- ...+....++++|||.+......
T Consensus 119 ~~~i~~qi~~~l~~lH~~~iiH~---dlkp~Ni-----ll~~~~----------~~~~~~~~~kl~d~g~~~~~~~~--- 177 (274)
T cd05076 119 KITVAQQLASALSYLEDKNLVHG---NVCAKNI-----LLARLG----------LAEGTSPFIKLSDPGVSFTALSR--- 177 (274)
T ss_pred HHHHHHHHHHHHHHHHcCCccCC---CCCcccE-----EEeccC----------cccCccceeeecCCccccccccc---
Confidence 99999999999999999999999 6666666 332110 00112345899999987643221
Q ss_pred CCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHHhhhcC
Q psy3347 169 TGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 169 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~-~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 245 (245)
....++..|+|||.+.+ ..++.++|+||||+++||++ +|+.||.+....+... ........|...++++.++|++
T Consensus 178 -~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 254 (274)
T cd05076 178 -EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPEPSCKELATLISQ 254 (274)
T ss_pred -cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCCCCChHHHHHHHH
Confidence 12346677999999865 56789999999999999995 6999998765544333 3333445566666778887753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=225.96 Aligned_cols=188 Identities=24% Similarity=0.417 Sum_probs=150.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|.+..+|+.||+|+++... .......+ .++++.++.++||||+++++++... ...++++||+++ ++
T Consensus 21 vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 94 (336)
T cd07849 21 VCSATHKPTGVKVAIKKISPFE--HQTFCQRT---LREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DL 94 (336)
T ss_pred EEEEEEcCCCCeEEEEEecccc--cchhHHHH---HHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CH
Confidence 7999999999999999986421 11222233 3457778888999999999987544 358999999975 78
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
...+....+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 95 ~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~---dlkp~Ni----------------------ll~~~~~~kl~d 149 (336)
T cd07849 95 YKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHR---DLKPSNL----------------------LLNTNCDLKICD 149 (336)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHE----------------------EECCCCCEEECc
Confidence 877777789999999999999999999999999999 8888888 778889999999
Q ss_pred cCCccCCCCCCC---CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy3347 156 FGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219 (245)
Q Consensus 156 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~ 219 (245)
||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 998864322211 1223467889999998755 468899999999999999999999997765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=216.69 Aligned_cols=206 Identities=23% Similarity=0.416 Sum_probs=162.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++. .+++.||+|.++... ..+.+.+ ++..++.++|||++++++++..+ ..+++|||+.+++|.+++.
T Consensus 22 v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~ 90 (254)
T cd05083 22 VLQGE--YTGQKVAVKNIKCDV-----TAQAFLE---ETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLR 90 (254)
T ss_pred eEecc--cCCCceEEEeecCcc-----hHHHHHH---HHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHH
Confidence 56664 468899999986431 1233333 46778889999999999998655 4799999999999999885
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. .+++..+..++.|++.||.|+|++|++|+ |++|+|+ +++.++.++|+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~---dl~p~ni----------------------li~~~~~~kl~Dfg 145 (254)
T cd05083 91 TRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR---DLAARNI----------------------LVSEDGVAKVSDFG 145 (254)
T ss_pred hcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---ccCcceE----------------------EEcCCCcEEECCCc
Confidence 42 47888999999999999999999999999 8888787 77788999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
++...... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+..+. ...+..+
T Consensus 146 ~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (254)
T cd05083 146 LARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC 222 (254)
T ss_pred cceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcC
Confidence 88642211 112233567999999988889999999999999999998 999998888777766665543 2345678
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++++++++
T Consensus 223 ~~~~~~li~~ 232 (254)
T cd05083 223 PADVYVLMTS 232 (254)
T ss_pred CHHHHHHHHH
Confidence 8888888753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-31 Score=224.71 Aligned_cols=190 Identities=28% Similarity=0.445 Sum_probs=152.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||+|++.... ......+.+. ++++.++.++||||+++++++..+. .+++||||+ +++
T Consensus 31 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 105 (343)
T cd07880 31 VCSALDRRTGAKVAIKKLYRPF-QSELFAKRAY---RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTD 105 (343)
T ss_pred EEEEEECCCCcEEEEEEecccc-cchHHHHHHH---HHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCC
Confidence 6899999999999999986532 1112223333 4467788999999999999987553 469999998 668
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|..++....+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++++
T Consensus 106 l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~---dlkp~Ni----------------------ll~~~~~~kl~ 160 (343)
T cd07880 106 LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHR---DLKPGNL----------------------AVNEDCELKIL 160 (343)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEe
Confidence 9888877789999999999999999999999999999 8888888 77788999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
|||++..... ......++..|+|||.+.+ ..++.++|+||||+++|++++|+.||.+.+.......
T Consensus 161 dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 161 DFGLARQTDS---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred eccccccccc---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999875322 1223456788999999876 4578899999999999999999999987765444333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-31 Score=219.91 Aligned_cols=194 Identities=24% Similarity=0.341 Sum_probs=149.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCe-----EEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAH-----VCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~-----~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||+|.++.... .......+.+| ++.++.+ +||||+++++++..... .+++|||+++ +
T Consensus 17 vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E---~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 91 (295)
T cd07837 17 VYKARDKNTGKLVALKKTRLEMD-EEGIPPTALRE---ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-D 91 (295)
T ss_pred EEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHH---HHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-C
Confidence 79999999999999999875421 11122333344 5666677 46999999999876655 8999999986 7
Q ss_pred hhhhhhh------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-
Q psy3347 75 LMMHIHA------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT- 147 (245)
Q Consensus 75 L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~- 147 (245)
|..++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.
T Consensus 92 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~---dl~~~ni----------------------l~~~~ 146 (295)
T cd07837 92 LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHR---DLKPQNL----------------------LVDKQ 146 (295)
T ss_pred HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCChHHE----------------------EEecC
Confidence 7776632 347899999999999999999999999999 8888888 6666
Q ss_pred CCceEEeecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 148 EGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 147 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 147 KGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred CCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 789999999988753222222233356778999998865 45789999999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=220.03 Aligned_cols=185 Identities=25% Similarity=0.395 Sum_probs=148.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|.+..... ......+. ++++.++.++|+||+++.+++..++..|++|||+. +++..++.
T Consensus 21 v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~---~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~ 94 (291)
T cd07870 21 VYKGISRINGQLVALKVISMKTE--EGVPFTAI---REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMI 94 (291)
T ss_pred EEEEEEcCCCcEEEEEEecccCc--CCCcHHHH---HHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHH
Confidence 79999999999999999975421 11111223 34677888899999999999999999999999996 56665553
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~~l~Dfg~ 149 (291)
T cd07870 95 QHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR---DLKPQNL----------------------LISYLGELKLADFGL 149 (291)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCChHHE----------------------EEcCCCcEEEecccc
Confidence 2 457788889999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
++.............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 87533222223344568889999998764 47889999999999999999999997554
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=217.26 Aligned_cols=206 Identities=20% Similarity=0.285 Sum_probs=153.5
Q ss_pred CEeEEEecCC----------cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeec
Q psy3347 1 VILSQYRNTG----------EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~ 70 (245)
||+|.+..++ ..+++|.+..... ....+ .+++++++.++||||+++++++.. +..+++|||+
T Consensus 11 v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~ 82 (259)
T cd05037 11 IYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAF---FETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYV 82 (259)
T ss_pred EEEEEEeccCCccccCCccceeeeeeccccchh----hHHHH---HHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcC
Confidence 7899998777 3588887764321 12333 344677889999999999999887 7789999999
Q ss_pred cCCchhhhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 71 AGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 71 ~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++++|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.+
T Consensus 83 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~---dlkp~Ni----------------------ll~~~ 137 (259)
T cd05037 83 KFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHG---NVCGKNI----------------------LVARY 137 (259)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecc---cCccceE----------------------EEecC
Confidence 999999988643 58889999999999999999999999999 7777776 55555
Q ss_pred C-------ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy3347 149 G-------YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIFEMLV-GESPFPGDDEE 218 (245)
Q Consensus 149 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~ 218 (245)
+ .++|+|||++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..
T Consensus 138 ~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 138 GLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred ccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 5 799999999875322 2233456779999999776 68899999999999999999 68888665433
Q ss_pred HHHHHHhcCcccCCCCCChhHHhhhc
Q psy3347 219 EVFDSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 219 ~~~~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
+...... .....|.....++.++|+
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~~li~ 238 (259)
T cd05037 214 EKERFYQ-DQHRLPMPDCAELANLIN 238 (259)
T ss_pred hHHHHHh-cCCCCCCCCchHHHHHHH
Confidence 3322222 222223322356666664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=219.09 Aligned_cols=197 Identities=26% Similarity=0.373 Sum_probs=157.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCe-----EEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH-----VCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~-----~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||+|.++.... .......+.+|..++..++.++|||++++++++...+. .+++||++.+ +|
T Consensus 15 v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l 92 (287)
T cd07838 15 VYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DL 92 (287)
T ss_pred EEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CH
Confidence 69999998999999999975432 11122334455555566666789999999999987766 9999999975 78
Q ss_pred hhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 76 MMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 76 ~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
..++.. ..+++..+..++.|++.||+|||+.|++|+ +++|+|+ +++.++.++
T Consensus 93 ~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~---~l~~~ni----------------------li~~~~~~~ 147 (287)
T cd07838 93 ATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHR---DLKPQNI----------------------LVTSDGQVK 147 (287)
T ss_pred HHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---cCChhhE----------------------EEccCCCEE
Confidence 777743 248999999999999999999999999999 8888888 788889999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|+|||.+...... .......++..|+|||.+.+..++.++|+||||+++|+|++|.+||.+....+....+.
T Consensus 148 l~dfg~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 148 IADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred EeccCcceeccCC-cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence 9999988653222 12223356788999999988889999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=227.67 Aligned_cols=190 Identities=23% Similarity=0.393 Sum_probs=151.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|.++.+|+.||+|++..... .......+. +++.+++.++||||+++++++.. .+..++||||++ ++|.
T Consensus 21 v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 95 (334)
T cd07855 21 VCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTL---RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLH 95 (334)
T ss_pred EEEEEEcCCCCEEEEEEeccccc-cccchHHHH---HHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHH
Confidence 68999999999999999975421 112223333 34677888899999999998853 357899999996 4888
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.++. ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 96 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~d 150 (334)
T cd07855 96 HIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHR---DLKPSNL----------------------LVNEDCELRIGD 150 (334)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EEcCCCcEEecc
Confidence 8874 4568999999999999999999999999999 8888888 788899999999
Q ss_pred cCCccCCCCCCCC----CCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy3347 156 FGLCKEGMGFGDR----TGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220 (245)
Q Consensus 156 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~ 220 (245)
||++......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~ 220 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH
Confidence 9998753322211 123467889999999865 4578999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=219.08 Aligned_cols=215 Identities=23% Similarity=0.376 Sum_probs=159.6
Q ss_pred CEeEEE----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCc
Q psy3347 1 VILSQY----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~ 74 (245)
||+|++ +.+++.||+|.++... .....+.+ .++++.++.++|||++++.+++... ...+++|||+++++
T Consensus 20 v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~ 94 (284)
T cd05079 20 VELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADL---KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94 (284)
T ss_pred EEEEEEccCCCCccceEEEEEcCccc--cHHHHHHH---HHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCC
Confidence 577763 4678999999987542 22222333 4457778889999999999998765 57899999999999
Q ss_pred hhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++.. ..+++..+..++.|++.||+|+|++|++|+ |++|+|| +++.++.++
T Consensus 95 L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~---dlkp~Ni----------------------l~~~~~~~~ 149 (284)
T cd05079 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR---DLAARNV----------------------LVESEHQVK 149 (284)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---ccchheE----------------------EEcCCCCEE
Confidence 9999854 357899999999999999999999999999 7778777 777889999
Q ss_pred EeecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------------
Q psy3347 153 IADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-------------- 215 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-------------- 215 (245)
|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|+++..|+...
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence 999999875322211 122345567799999998888999999999999999999977654211
Q ss_pred -CHHHHHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 216 -DEEEVFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 216 -~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
........+..+ ..+.+..+++++.+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (284)
T cd05079 230 MTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK 261 (284)
T ss_pred ccHHHHHHHHHcCccCCCCCCCCHHHHHHHHH
Confidence 011111112222 223456788888888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=218.42 Aligned_cols=182 Identities=26% Similarity=0.421 Sum_probs=144.0
Q ss_pred CEeEE----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCc
Q psy3347 1 VILSQ----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~ 74 (245)
||+|. +..+++.||+|.+.... ....+.+.+| ++.++.++||||+++++++.. ....+++|||+++++
T Consensus 20 v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 93 (284)
T cd05081 20 VELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFERE---IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93 (284)
T ss_pred EEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHH---HHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCC
Confidence 57776 45678999999987542 2233444444 677888999999999998754 346899999999999
Q ss_pred hhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++
T Consensus 94 L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~---dlkp~ni----------------------li~~~~~~~ 148 (284)
T cd05081 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHR---DLATRNI----------------------LVESENRVK 148 (284)
T ss_pred HHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceec---cCCHhhE----------------------EECCCCeEE
Confidence 9998853 458899999999999999999999999999 8888888 778889999
Q ss_pred EeecCCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 153 IADFGLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|..++.
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9999998754322211 111223446999999988889999999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=223.26 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=154.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh-----hHH---HHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD-----EVE---SLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~-----~~~---~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|.++.+|+.||+|+++........ ... ......++++.++.++||||+++++++..++..+++|||+.
T Consensus 25 vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 103 (335)
T PTZ00024 25 VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA- 103 (335)
T ss_pred EEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-
Confidence 799999999999999999754322110 000 00112345778889999999999999999999999999997
Q ss_pred Cchhhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 73 GDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 73 ~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
++|.+++.. ..+++.....++.|++.||+|||++|++|+ |++|+|| +++.++.+
T Consensus 104 ~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~---dl~~~ni----------------------ll~~~~~~ 158 (335)
T PTZ00024 104 SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHR---DLSPANI----------------------FINSKGIC 158 (335)
T ss_pred cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---cccHHHe----------------------EECCCCCE
Confidence 488877754 468999999999999999999999999999 8888887 77788999
Q ss_pred EEeecCCccCCCCC--------------CCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 152 KIADFGLCKEGMGF--------------GDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 152 kl~Dfg~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
+|+|||++...... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999988643211 1111223457789999999764 46889999999999999999999998877
Q ss_pred HHHHHHHH
Q psy3347 217 EEEVFDSI 224 (245)
Q Consensus 217 ~~~~~~~~ 224 (245)
..+....+
T Consensus 239 ~~~~~~~i 246 (335)
T PTZ00024 239 EIDQLGRI 246 (335)
T ss_pred HHHHHHHH
Confidence 66655544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=223.88 Aligned_cols=192 Identities=27% Similarity=0.463 Sum_probs=152.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC--CeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+..+|+.+|+|++..... .......+. ++++.++.+ +||||+++++++... ...++||||+.+ +|..
T Consensus 23 v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~---~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~ 97 (337)
T cd07852 23 VWKAIDRRTKEVVALKKIFDAFR-NATDAQRTF---REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHA 97 (337)
T ss_pred EEEEEEcCCCeEEEEEeeccccC-cchhhhhhh---HHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHH
Confidence 68999999999999998864321 222223333 346778888 999999999998643 468999999975 8888
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
++....+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 98 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~---dl~p~ni----------------------ll~~~~~~kl~d~g 152 (337)
T cd07852 98 VIRANILEDVHKRYIMYQLLKALKYIHSGNVIHR---DLKPSNI----------------------LLNSDCRVKLADFG 152 (337)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EEcCCCcEEEeecc
Confidence 8876678889999999999999999999999999 8888888 88889999999999
Q ss_pred CccCCCCCC-----CCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy3347 158 LCKEGMGFG-----DRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD 222 (245)
Q Consensus 158 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~ 222 (245)
.+....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 887432221 11223467888999998865 457889999999999999999999998765544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=215.71 Aligned_cols=211 Identities=26% Similarity=0.405 Sum_probs=164.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. .+..+|+|.+.... ...+.+.+ ++++++.++|+||+++.+++.. ...+++|||+++++|.+++.
T Consensus 22 vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~ 92 (260)
T cd05073 22 VWMATYN-KHTKVAVKTMKPGS----MSVEAFLA---EANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLK 92 (260)
T ss_pred EEEEEec-CCccEEEEecCCCh----hHHHHHHH---HHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHH
Confidence 6888755 45679999887532 12234444 4667888999999999999877 77899999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||.|+|++|++|+ |++|+|+ +++.++.++|+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~---dl~p~ni----------------------~i~~~~~~~l~d~~ 147 (260)
T cd05073 93 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR---DLRAANI----------------------LVSASLVCKIADFG 147 (260)
T ss_pred hCCccccCHHHHHHHHHHHHHHHHHHHhCCcccc---ccCcceE----------------------EEcCCCcEEECCCc
Confidence 4 246788889999999999999999999999 8888887 77888999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
.+........ ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..+....+..+. .+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 227 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCccc
Confidence 8864322111 1122234567999999988888999999999999999998 999998877766666655442 234567
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
.+.++.+++.+
T Consensus 228 ~~~~~~~~i~~ 238 (260)
T cd05073 228 CPEELYNIMMR 238 (260)
T ss_pred CCHHHHHHHHH
Confidence 78888888753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=219.23 Aligned_cols=215 Identities=23% Similarity=0.388 Sum_probs=168.3
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|+++. +.+.+|+|.+.... .....+.+.+| ++.+++++||||+++++++...+..++||||+++++|
T Consensus 21 v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 95 (275)
T cd05046 21 VFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRE---LDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95 (275)
T ss_pred EEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHH---HHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcH
Confidence 68888764 35689999886432 11123344444 6677888999999999999998999999999999999
Q ss_pred hhhhhh-c---------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 76 MMHIHA-D---------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 76 ~~~~~~-~---------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
.+++.. . .+++..+..++.|++.||+|||++|++|+ |++|+|+ ++
T Consensus 96 ~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~---dlkp~Ni----------------------li 150 (275)
T cd05046 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR---DLAARNC----------------------LV 150 (275)
T ss_pred HHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC---cCccceE----------------------EE
Confidence 998853 2 48899999999999999999999999999 8888777 77
Q ss_pred CCCCceEEeecCCccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy3347 146 DTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDS 223 (245)
Q Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~ 223 (245)
+.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...........
T Consensus 151 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 151 SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 8889999999998764322111 1223345667999999988788899999999999999998 8999987777777776
Q ss_pred HhcCccc--CCCCCChhHHhhhcC
Q psy3347 224 IVNDEVR--YPRFLSLEAIAIMRR 245 (245)
Q Consensus 224 ~~~~~~~--~p~~~~~~~~~li~~ 245 (245)
+..+... .+..+++.+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~i~~ 254 (275)
T cd05046 231 LQAGKLELPVPEGCPSRLYKLMTR 254 (275)
T ss_pred HHcCCcCCCCCCCCCHHHHHHHHH
Confidence 6655433 356788888888763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=219.29 Aligned_cols=194 Identities=27% Similarity=0.420 Sum_probs=157.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.+|+|.+...... ......+. ++++.++.++|+||+++++++..++..+++|||+++ ++..++.
T Consensus 15 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~ 89 (283)
T cd05118 15 VYKARDKLTGEIVAIKKIKLRFES-EGIPKTAL---REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIK 89 (283)
T ss_pred EEEEEcCCCCcEEEEEEecccccc-chhHHHHH---HHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHH
Confidence 689999989999999998764322 11223333 346778888999999999999999999999999976 7777775
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||+++++|+ |++|+|| +++.++.++|+|||.
T Consensus 90 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~---dl~p~ni----------------------li~~~~~~~l~df~~ 144 (283)
T cd05118 90 DRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR---DLKPENL----------------------LINTEGVLKLADFGL 144 (283)
T ss_pred hhcccCCHHHHHHHHHHHHHHHHHHHHCCeeec---CcCHHHE----------------------EECCCCcEEEeeeee
Confidence 4 478999999999999999999999999999 8888888 778889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 145 ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred eEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 87543332222334567889999999776 6889999999999999999999999877765554443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=232.43 Aligned_cols=211 Identities=26% Similarity=0.401 Sum_probs=173.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||.+.|++..-.||||.++... -+++.|..| ..+|+.+.|||+|+++|+|+.+..+||++|||..|+|.++++
T Consensus 283 VYeGvWKkyslTvAVKtLKEDt----MeveEFLkE---AAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLR 355 (1157)
T KOG4278|consen 283 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKE---AAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLR 355 (1157)
T ss_pred eeeeeeeccceeeehhhhhhcc----hhHHHHHHH---HHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHH
Confidence 7999999999999999998642 344555444 778889999999999999999999999999999999999995
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..++.-..+.++.||..||.||..++++|| |+--.| +++..+..+|++|||
T Consensus 356 ecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHR--------DLAARN-----------------CLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 356 ECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHR--------DLAARN-----------------CLVGENHIVKVADFG 410 (1157)
T ss_pred HhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhh--------hhhhhh-----------------ccccccceEEeeccc
Confidence 3 346666777899999999999999999999 443333 366777889999999
Q ss_pred CccCCCCCCCCCCc-ccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCccc--CCC
Q psy3347 158 LCKEGMGFGDRTGT-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVR--YPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~--~p~ 233 (245)
+++....+...... .-=++.|+|||.+....|+.|+|||+||+.+||+.| |-.||+|.+-..+...+.. +++ -|+
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~Pe 489 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPE 489 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCC
Confidence 99986655432211 111457999999999999999999999999999998 9999999987776665544 444 589
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.|++.+..||+
T Consensus 490 GCPpkVYeLMr 500 (1157)
T KOG4278|consen 490 GCPPKVYELMR 500 (1157)
T ss_pred CCCHHHHHHHH
Confidence 99999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=221.67 Aligned_cols=188 Identities=19% Similarity=0.327 Sum_probs=152.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++++..+|+.||+|+++.... .....+.+. ++++.++.++||||+++++++..++..+++|||+++++|.+++.
T Consensus 16 v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~---~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 16 VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQ---QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred EEEEEecCCCCEEEEEEEecccc-chhHHHHHH---HHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 57888888999999999976421 223334444 44777888899999999999999999999999999999998885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||+++|+|+ |++|+|| +++.++.++++|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~---dlk~~Ni----------------------li~~~~~~kl~d~~ 146 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHR---SVKASHI----------------------LLSGDGKVVLSGLR 146 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCcceE----------------------EEecCCceEEecCc
Confidence 3 358889999999999999999999999999 8888888 78888999999999
Q ss_pred CccCCCCCCC-------CCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 158 LCKEGMGFGD-------RTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 158 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~ 215 (314)
T cd08216 147 YSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215 (314)
T ss_pred cceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8764322111 1123345668999999865 3578899999999999999999999976544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=224.95 Aligned_cols=187 Identities=25% Similarity=0.422 Sum_probs=150.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|++..+|+.||+|.+..... .......+. +++++++.++||||+++++++... ...++++||+. ++|
T Consensus 21 vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~---~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 95 (337)
T cd07858 21 VCSAKNSETNEKVAIKKIANAFD-NRIDAKRTL---REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDL 95 (337)
T ss_pred EEEEEecCCCCeEEEEEeccccc-ccchhHHHH---HHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCH
Confidence 68999999999999999875421 222223333 446778888999999999988644 35899999996 578
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..+++ ...+++..+..++.|++.||.|||+++++|+ |++|+|| +++.++.++|+
T Consensus 96 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kL~ 150 (337)
T cd07858 96 HQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHR---DLKPSNL----------------------LLNANCDLKIC 150 (337)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EEcCCCCEEEC
Confidence 77774 4578999999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
|||++..............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 151 DFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred cCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 99998754333233344567889999998865 4588999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=225.24 Aligned_cols=196 Identities=26% Similarity=0.418 Sum_probs=158.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L 75 (245)
||+|++..+|+.||+|++..... .....+.+. ++++.++.++||||+++.+++...+ ..|++|||+++ +|
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 90 (330)
T cd07834 16 VCSAVDKRTGRKVAIKKISNVFD-DLIDAKRIL---REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DL 90 (330)
T ss_pred EEEEEeCCCCcEEEEEeeccccc-cchhhhhHH---HHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hH
Confidence 69999998999999999976421 122233343 3467788889999999999987764 78999999975 78
Q ss_pred hhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 91 ~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~---dlkp~ni----------------------li~~~~~~~L~ 145 (330)
T cd07834 91 HKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHR---DLKPSNI----------------------LVNSNCDLKIC 145 (330)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEc
Confidence 777754 478999999999999999999999999999 8888888 78888999999
Q ss_pred ecCCccCCCCCC---CCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMGFG---DRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||++....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+..
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 999987543322 123344678889999999877 788999999999999999999999988876665555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-31 Score=215.63 Aligned_cols=214 Identities=19% Similarity=0.319 Sum_probs=156.6
Q ss_pred CEeEEEecC--CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNT--GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|+.... ...+++|.++... .....+.+.+| ...++.++||||+++++.+....+.++||||+++++|..+
T Consensus 11 v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e---~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 85 (268)
T cd05086 11 VLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQ---GDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSY 85 (268)
T ss_pred EEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHH---HHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHH
Confidence 688865433 2356666665432 12223344443 5667788999999999999999999999999999999998
Q ss_pred hhhc-----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 79 IHAD-----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 79 ~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
+... ..++..+..++.|++.||+|||+++++|+ |++|+|| +++.++.++|
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~---dikp~ni----------------------l~~~~~~~~l 140 (268)
T cd05086 86 LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHS---DLALRNC----------------------FLTSDLTVKV 140 (268)
T ss_pred HHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeecc---CCccceE----------------------EEcCCccEEe
Confidence 8542 34566778899999999999999999999 8888888 7778899999
Q ss_pred eecCCccCCCCCC--CCCCcccCCCCccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy3347 154 ADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDS 223 (245)
Q Consensus 154 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~ 223 (245)
+|||++....... .......++..|+|||.+.. ..++.++||||||+++|||++ |..||...+..+....
T Consensus 141 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~ 220 (268)
T cd05086 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH 220 (268)
T ss_pred cccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999876422111 11234467788999998843 245678999999999999997 6889987777666666
Q ss_pred HhcCc-cc-----CCCCCChhHHhhhc
Q psy3347 224 IVNDE-VR-----YPRFLSLEAIAIMR 244 (245)
Q Consensus 224 ~~~~~-~~-----~p~~~~~~~~~li~ 244 (245)
+.... .. ++...++.+.++|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (268)
T cd05086 221 VIKDQQVKLFKPQLELPYSERWYEVLQ 247 (268)
T ss_pred HHhhcccccCCCccCCCCcHHHHHHHH
Confidence 54432 11 23345667776664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=220.37 Aligned_cols=193 Identities=23% Similarity=0.347 Sum_probs=150.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--------eEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--------HVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--------~~~lv~e~~~~ 72 (245)
||+|++..+|+.||+|.+....... ...... .++++.++.++||||+++++++...+ ..++||||+++
T Consensus 28 v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 103 (310)
T cd07865 28 VFKARHKKTKQIVALKKVLMENEKE-GFPITA---LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH 103 (310)
T ss_pred EEEEEECCCCcEEEEEEEeccCCcC-CchhHH---HHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc
Confidence 7999999999999999987542111 111122 23467788899999999999986543 46999999975
Q ss_pred Cchhhhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 73 GDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 73 ~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|...+... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.
T Consensus 104 -~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~ 157 (310)
T cd07865 104 -DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHR---DMKAANI----------------------LITKDGI 157 (310)
T ss_pred -CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHE----------------------EECCCCc
Confidence 777666443 68999999999999999999999999999 8888888 7788899
Q ss_pred eEEeecCCccCCCCCCC----CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 151 VKIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999998874322111 12234567889999998764 468899999999999999999999987766544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=226.83 Aligned_cols=174 Identities=26% Similarity=0.386 Sum_probs=144.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|+..... .. .+..+++.++||||+++++++...+..++|||++.+ +|..++.
T Consensus 82 Vy~~~~~~~~~~valK~~~~~~---------~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 148 (357)
T PHA03209 82 VFVATKPGQPDPVVLKIGQKGT---------TL---IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLT 148 (357)
T ss_pred EEEEEECCCCceEEEEeCCccc---------cH---HHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHH
Confidence 7999999999999999865431 11 235677889999999999999999999999999954 7777764
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.++|+|||+
T Consensus 149 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~kl~DfG~ 203 (357)
T PHA03209 149 KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR---DVKTENI----------------------FINDVDQVCIGDLGA 203 (357)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCCEEEecCcc
Confidence 3468999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG-ESPFP 213 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~pf~ 213 (245)
++..... .......|+..|+|||.+.+..++.++|||||||++|||+++ ..+|.
T Consensus 204 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 204 AQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 8743222 122345688999999999988899999999999999999984 55554
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=224.34 Aligned_cols=214 Identities=27% Similarity=0.463 Sum_probs=158.2
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC-CeEEEEEeeccCC
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE-AHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~-~~~~lv~e~~~~~ 73 (245)
||+|.+ ..+++.||+|+++... .......+.+| ++.+..+ +||||+++++++... +..+++|||+++|
T Consensus 23 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g 97 (343)
T cd05103 23 VIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSE---LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97 (343)
T ss_pred EEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHH---HHHHHhccCCccHhhhcceeecCCCceEEEEeccCCC
Confidence 688874 3568899999997532 12233344444 5666677 689999999988654 5689999999999
Q ss_pred chhhhhhhc--------------------------------------------------------------------CCC
Q psy3347 74 DLMMHIHAD--------------------------------------------------------------------VFS 85 (245)
Q Consensus 74 ~L~~~~~~~--------------------------------------------------------------------~l~ 85 (245)
+|.+++... .++
T Consensus 98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (343)
T cd05103 98 NLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLT 177 (343)
T ss_pred cHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCC
Confidence 998887431 256
Q ss_pred hHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCC
Q psy3347 86 EPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165 (245)
Q Consensus 86 ~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 165 (245)
+..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++......
T Consensus 178 ~~~~~~~~~qi~~al~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~kl~dfg~~~~~~~~ 232 (343)
T cd05103 178 LEDLICYSFQVAKGMEFLASRKCIHR---DLAARNI----------------------LLSENNVVKICDFGLARDIYKD 232 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecC---CCccCeE----------------------EEcCCCcEEEEecccccccccC
Confidence 67778899999999999999999999 8888888 7778899999999998753222
Q ss_pred CC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcC-cccCCCCCChhHH
Q psy3347 166 GD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE-VFDSIVND-EVRYPRFLSLEAI 240 (245)
Q Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~-~~~~~~~~-~~~~p~~~~~~~~ 240 (245)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..... ....+..+ ..+.|..+++++.
T Consensus 233 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (343)
T cd05103 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 312 (343)
T ss_pred cchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHH
Confidence 21 1122334567999999988889999999999999999997 999997654332 33333332 2344666777777
Q ss_pred hhhc
Q psy3347 241 AIMR 244 (245)
Q Consensus 241 ~li~ 244 (245)
++|.
T Consensus 313 ~~~~ 316 (343)
T cd05103 313 QTML 316 (343)
T ss_pred HHHH
Confidence 7764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-31 Score=216.94 Aligned_cols=213 Identities=23% Similarity=0.362 Sum_probs=159.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||++.+..+|+.+|+|.+...... .....+.+| +..+.++. ||||+++++++..++..+++|||+.. ++..+.
T Consensus 20 vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e---~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~ 93 (288)
T cd06616 20 VNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMD---LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFY 93 (288)
T ss_pred EEEEEECCCCCEEEEEEehhccCh--HHHHHHHHH---HHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHH
Confidence 799999999999999998754321 223344444 55566664 99999999999999999999999864 443322
Q ss_pred ------hhcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 80 ------HADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 80 ------~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
....+++..+..++.|++.||+|||+. +++|+ |++|+|| +++.++.++
T Consensus 94 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~---dlkp~Ni----------------------l~~~~~~~k 148 (288)
T cd06616 94 KYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHR---DVKPSNI----------------------LLDRNGNIK 148 (288)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeecc---CCCHHHE----------------------EEccCCcEE
Confidence 134688999999999999999999975 99999 8888888 777888999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCc
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET---SYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDSIVNDE 228 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~ 228 (245)
|+|||++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .+....+....
T Consensus 149 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 227 (288)
T cd06616 149 LCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD 227 (288)
T ss_pred EeecchhHHhccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC
Confidence 999999875433222 2233577889999999765 588999999999999999999999976542 23333333222
Q ss_pred c-cC----CCCCChhHHhhhcC
Q psy3347 229 V-RY----PRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~-~~----p~~~~~~~~~li~~ 245 (245)
. .. +..+++++.+||++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~ 249 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINL 249 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHH
Confidence 2 22 23478888888753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=218.80 Aligned_cols=194 Identities=28% Similarity=0.420 Sum_probs=157.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.||+|++.... ......+.+.+ +++.++.++|+|++++++++...+..+++|||+++ +|.+++.
T Consensus 15 vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~---e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~ 89 (282)
T cd07829 15 VYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR---EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD 89 (282)
T ss_pred EEEeeecCCCcEEEEEEecccc-ccccccHHHHH---HHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHH
Confidence 6899999999999999998653 11122233333 46777888899999999999999999999999975 8998886
Q ss_pred hc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 AD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. .+++..+..++.|++.||+|||++|++|+ +++|+|| +++.++.++|+|||.
T Consensus 90 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~---~l~~~ni----------------------~~~~~~~~~l~d~g~ 144 (282)
T cd07829 90 KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHR---DLKPQNI----------------------LINRDGVLKLADFGL 144 (282)
T ss_pred hhccCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCChheE----------------------EEcCCCCEEEecCCc
Confidence 54 78999999999999999999999999999 8888888 778889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+..............++..|+|||.+.+. .++.++|+||||+++|++++|..||.+.+..+....+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 145 ARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred ccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 87543333223334556789999999766 7889999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-31 Score=217.22 Aligned_cols=185 Identities=26% Similarity=0.407 Sum_probs=148.3
Q ss_pred CEeEEEe----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCc
Q psy3347 1 VILSQYR----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~ 74 (245)
||+|.+. .+++.+|+|+++..... ...+.+.+ +++.++.++||||+++++++.. ....+++|||+++++
T Consensus 20 v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~---ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 94 (284)
T cd05038 20 VELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFER---EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94 (284)
T ss_pred EEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHH---HHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCC
Confidence 6888754 35889999999864321 22334444 4677888899999999999877 558999999999999
Q ss_pred hhhhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~~~ 149 (284)
T cd05038 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR---DLAARNI----------------------LVESEDLVK 149 (284)
T ss_pred HHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHhE----------------------EEcCCCCEE
Confidence 99998654 48999999999999999999999999999 8888888 778889999
Q ss_pred EeecCCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 153 IADFGLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 9999998754322111 11223455699999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=224.64 Aligned_cols=191 Identities=26% Similarity=0.449 Sum_probs=154.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCe------EEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH------VCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~------~~lv~e~~~~~~ 74 (245)
||+|++..+++.||+|++...... ....+.+. +++..++.++|||++++.+++...+. .++|+||+ +++
T Consensus 31 vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 105 (343)
T cd07851 31 VCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTY---RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GAD 105 (343)
T ss_pred EEEEEECCCCcEEEEEecccccch-hhHHHHHH---HHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCC
Confidence 689999999999999998753211 12223333 34677888999999999998866544 89999998 569
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|.+++...++++..+..++.|++.||+|||+.|++|+ +++|+|| +++.++.++|+
T Consensus 106 L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~---dlkp~Ni----------------------ll~~~~~~kL~ 160 (343)
T cd07851 106 LNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHR---DLKPSNI----------------------AVNEDCELKIL 160 (343)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EECCCCCEEEc
Confidence 9998887789999999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|||++..... ......++..|+|||.+.+ ..++.++||||||+++|++++|+.||.+.+..+....+
T Consensus 161 dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 161 DFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred cccccccccc---cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999875322 1334467788999999865 35788999999999999999999999877666555544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-31 Score=214.28 Aligned_cols=215 Identities=21% Similarity=0.351 Sum_probs=163.5
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeecc
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAA 71 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~ 71 (245)
||+|.++. +++.||+|++..... .....+.+. ++++.++.++||||+++++++.... ..++++||+.
T Consensus 15 v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (273)
T cd05074 15 VREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFL---REAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMK 90 (273)
T ss_pred EEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHH---HHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCC
Confidence 68887543 578999999975432 222233343 3467788999999999999886432 3478999999
Q ss_pred CCchhhhhhh-------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 72 GGDLMMHIHA-------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 72 ~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
+++|..++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +
T Consensus 91 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~---dikp~ni----------------------l 145 (273)
T cd05074 91 HGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR---DLAARNC----------------------M 145 (273)
T ss_pred CCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec---ccchhhE----------------------E
Confidence 9999877631 146788899999999999999999999999 8888777 7
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.++++|||+++....... ......++..|++||.+.+..++.++||||||+++|+|++ |+.||.+.+..+..
T Consensus 146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05074 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225 (273)
T ss_pred EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH
Confidence 77888999999998875322211 1122334567999999988888999999999999999999 99999888777766
Q ss_pred HHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 222 DSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
..+.... ...+...++.+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~l~~ 249 (273)
T cd05074 226 NYLIKGNRLKQPPDCLEDVYELMC 249 (273)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHH
Confidence 6665443 3445667788888875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=215.94 Aligned_cols=218 Identities=27% Similarity=0.461 Sum_probs=169.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..++..+++|+++......... .......++..+++.++||||+++++.+......+++|||+++++|..++.
T Consensus 16 v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 94 (260)
T cd08222 16 VYLVKDKKAVAEERLKVLKEIPVGELNP-NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLE 94 (260)
T ss_pred EEEEEecCCCCcceEEEeccccccccCc-chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHH
Confidence 6899998888888888876533211111 111222344677888999999999999998889999999999999987764
Q ss_pred -----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 -----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 -----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
...+++..+..++.|++.||.|||++|++|+ +++|+|+ +++. +.++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~---~l~~~ni----------------------li~~-~~~~l~d 148 (260)
T cd08222 95 ELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHR---DLKAKNI----------------------FLKN-NLLKIGD 148 (260)
T ss_pred HHhhcccccCHHHHHHHHHHHHHHHHHHHHcCcccc---CCChhhe----------------------Eeec-CCEeecc
Confidence 2468999999999999999999999999999 7777777 4443 5699999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRF 234 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~ 234 (245)
||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+....+..+.. ..|..
T Consensus 149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T cd08222 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPET 228 (260)
T ss_pred cCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcch
Confidence 99887544433334445678889999999888888999999999999999999999987777666666655433 34667
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.++|++
T Consensus 229 ~~~~~~~li~~ 239 (260)
T cd08222 229 YSRQLNSIMQS 239 (260)
T ss_pred hcHHHHHHHHH
Confidence 88888888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=223.41 Aligned_cols=192 Identities=24% Similarity=0.393 Sum_probs=150.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--------------CeEEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--------------AHVCFV 66 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--------------~~~~lv 66 (245)
||+|.+..+|+.||+|.+..... ...+.+. ++++.++.++||||+++++++... ...+++
T Consensus 21 vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~---~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv 94 (342)
T cd07854 21 VFSAVDSDCDKRVAVKKIVLTDP---QSVKHAL---REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94 (342)
T ss_pred EEEEEECCCCcEEEEEEEecCCC---chHHHHH---HHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEE
Confidence 79999999999999999876432 2233333 346778889999999999876543 357999
Q ss_pred EeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 67 MEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 67 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
|||+++ +|..++....+++..++.++.|++.||.|||++|++|+ |++|+|| +++
T Consensus 95 ~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~---dikp~Ni----------------------li~ 148 (342)
T cd07854 95 QEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHR---DLKPANV----------------------FIN 148 (342)
T ss_pred eecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EEc
Confidence 999974 88888877789999999999999999999999999999 7777777 554
Q ss_pred -CCCceEEeecCCccCCCCCCC---CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy3347 147 -TEGYVKIADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221 (245)
Q Consensus 147 -~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~ 221 (245)
.++.++++|||.+........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+....+..
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 456789999998864322111 1122356778999998754 45788999999999999999999999876655544
Q ss_pred HHH
Q psy3347 222 DSI 224 (245)
Q Consensus 222 ~~~ 224 (245)
..+
T Consensus 229 ~~~ 231 (342)
T cd07854 229 QLI 231 (342)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-31 Score=216.16 Aligned_cols=195 Identities=27% Similarity=0.450 Sum_probs=156.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+..+|+.+|+|++.... ........+.+ +++.++.++|||++++++++... +..+++|||+++ +|..+
T Consensus 15 vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 89 (287)
T cd07840 15 VYKARNKKTGELVALKKIRMEN-EKEGFPITAIR---EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGL 89 (287)
T ss_pred EEEEEECCCCeEEEEEEEeccc-ccccchHHHHH---HHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHH
Confidence 6999999999999999998653 12222233443 46777888999999999999887 899999999975 88877
Q ss_pred hhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. ..+++..+..++.|++.||+|||+.|++|+ |++|+|| +++.++.++|+||
T Consensus 90 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~---dl~p~ni----------------------l~~~~~~~~l~d~ 144 (287)
T cd07840 90 LDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHR---DIKGSNI----------------------LINNDGVLKLADF 144 (287)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceec---cCcHHHe----------------------EEcCCCCEEEccc
Confidence 754 368999999999999999999999999999 8888888 7888999999999
Q ss_pred CCccCCCCCCC-CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 157 GLCKEGMGFGD-RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 157 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~ 215 (287)
T cd07840 145 GLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215 (287)
T ss_pred cceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 98875433221 1223355778999998765 457899999999999999999999998777665555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=217.93 Aligned_cols=194 Identities=24% Similarity=0.345 Sum_probs=151.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----------eEEEEEeec
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----------HVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----------~~~lv~e~~ 70 (245)
||+|.++.+|+.||+|+++...... .....+ .+++++++.++|||++++++++.... ..++++||+
T Consensus 23 v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~---~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 98 (302)
T cd07864 23 VYKARDKDTGELVALKKVRLDNEKE-GFPITA---IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM 98 (302)
T ss_pred EEEEEECCCCcEEEEEEEeeccccc-CchHHH---HHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEccc
Confidence 7999999999999999997542111 111223 33477788899999999999986644 799999999
Q ss_pred cCCchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 71 AGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 71 ~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++ ++...+.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.+
T Consensus 99 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~---dl~p~ni----------------------li~~~ 152 (302)
T cd07864 99 DH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHR---DIKCSNI----------------------LLNNK 152 (302)
T ss_pred Cc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EECCC
Confidence 87 56555543 368999999999999999999999999999 8888888 78888
Q ss_pred CceEEeecCCccCCCCCCC-CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 149 GYVKIADFGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 153 GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred CcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999998875432221 1222345678999998865 45788999999999999999999999876655444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-33 Score=226.10 Aligned_cols=217 Identities=20% Similarity=0.282 Sum_probs=158.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC---CCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~---h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
|-.+.|.+++..||+|+++.... ..+....|.+.++.+..-+ ---++++.++|...++.|+|+|.+ |.|+.+
T Consensus 105 V~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~d 179 (415)
T KOG0671|consen 105 VVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFD 179 (415)
T ss_pred eEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHH
Confidence 45678888999999999986432 2233344555555553222 113889999999999999999987 668999
Q ss_pred hhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhc---cccCCCCce
Q psy3347 78 HIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKL---TVNDTEGYV 151 (245)
Q Consensus 78 ~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 151 (245)
+++.+ +++...+..++.|++++++|||+.+++|. |+||+|| ++....-......... .-.-.+-.+
T Consensus 180 Flk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HT---DLKPENI-----Lfvss~~~~~~~~k~~~~~~r~~ks~~I 251 (415)
T KOG0671|consen 180 FLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHT---DLKPENI-----LFVSSEYFKTYNPKKKVCFIRPLKSTAI 251 (415)
T ss_pred HhccCCccccchHHHHHHHHHHHHHHHHHHhcceeec---CCChheE-----EEeccceEEEeccCCccceeccCCCcce
Confidence 99653 57888999999999999999999999999 5555555 5553321111111110 112234569
Q ss_pred EEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC
Q psy3347 152 KIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (245)
+++|||.+++ +....+..+.|.+|+|||++.+.+++.++||||+|||+.|+++|...|++.+..+.+..+..-..++
T Consensus 252 ~vIDFGsAtf---~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~ 328 (415)
T KOG0671|consen 252 KVIDFGSATF---DHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPI 328 (415)
T ss_pred EEEecCCcce---eccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCC
Confidence 9999999986 3333567788999999999999999999999999999999999999999888766554443333355
Q ss_pred CC
Q psy3347 232 PR 233 (245)
Q Consensus 232 p~ 233 (245)
|.
T Consensus 329 P~ 330 (415)
T KOG0671|consen 329 PS 330 (415)
T ss_pred cH
Confidence 54
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=236.99 Aligned_cols=115 Identities=34% Similarity=0.593 Sum_probs=97.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|+++............+..| +.+++.++||||+++++++...++.|+||||+.+++|..++.
T Consensus 20 Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E---~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~ 96 (669)
T cd05610 20 VYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE---RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH 96 (669)
T ss_pred EEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHH---HHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH
Confidence 79999999999999999986543333333444444 566777889999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHH
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~i 121 (245)
.+.+++..++.++.|++.||+|||++||+|| ||||+||
T Consensus 97 ~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHr---DLKP~NI 135 (669)
T cd05610 97 IYGYFDEEMAVKYISEVALALDYLHRHGIIHR---DLKPDNM 135 (669)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeC---CccHHHE
Confidence 3568899999999999999999999999999 7777777
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=217.51 Aligned_cols=196 Identities=23% Similarity=0.366 Sum_probs=155.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--------CCeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--------EAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--------~~~~~lv~e~~~~ 72 (245)
||+|+.+++|+.||+|++--+.... ..-..+.|++.+|..+.|+|++.++++|.. ...+|+||++|++
T Consensus 33 VFkAr~~n~~kkvalkkvlmeneKe----GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh 108 (376)
T KOG0669|consen 33 VFKARSKNTGKKVALKKVLMENEKE----GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH 108 (376)
T ss_pred HHHHhhcCccchhHHHHHHHhcccc----CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh
Confidence 6899999999999999764322111 111234555666777789999999998843 2469999999987
Q ss_pred Cchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 73 GDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 73 ~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|.-.+.+ -.++...+++++.+++.||.|+|++.|+|| |+|++|+ +++++|.
T Consensus 109 -DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHR---DmKaaNv----------------------LIt~dgi 162 (376)
T KOG0669|consen 109 -DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHR---DMKAANV----------------------LITKDGI 162 (376)
T ss_pred -hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhh---cccHhhE----------------------EEcCCce
Confidence 77777744 358889999999999999999999999999 8888888 8999999
Q ss_pred eEEeecCCccCCC-CC---CCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 151 VKIADFGLCKEGM-GF---GDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 151 ~kl~Dfg~~~~~~-~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+||+|||+++.+. +. .....+.+-|.+|++||.+.|. .|+++.|+|..||++.||+++.+.|++.++......|.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999996432 11 1123344558899999999984 58999999999999999999999999998887777764
Q ss_pred c
Q psy3347 226 N 226 (245)
Q Consensus 226 ~ 226 (245)
.
T Consensus 243 ~ 243 (376)
T KOG0669|consen 243 Q 243 (376)
T ss_pred H
Confidence 3
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=218.19 Aligned_cols=185 Identities=26% Similarity=0.375 Sum_probs=148.7
Q ss_pred CEeEEEecC--Cc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNT--GE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L 75 (245)
||+|..+++ ++ .+|||.++.+.-...-+ ....|++.+++.+.|||++.+..+|-. +..+++++||+++ +|
T Consensus 40 VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS----~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL 114 (438)
T KOG0666|consen 40 VYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS----MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DL 114 (438)
T ss_pred eeEeeeccCCcccchhhHHHHHhccCCCCCcC----HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hH
Confidence 789955554 23 79999998763211111 233566889999999999999999865 7899999999988 77
Q ss_pred hhhhhh------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-
Q psy3347 76 MMHIHA------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE- 148 (245)
Q Consensus 76 ~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~- 148 (245)
...++. ..++...++.|+-||+.|+.|||++=|+|| |+||+|| ++..+
T Consensus 115 ~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHR---DLKPaNI----------------------lvmgdg 169 (438)
T KOG0666|consen 115 WHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHR---DLKPANI----------------------LVMGDG 169 (438)
T ss_pred HHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeec---cCCcceE----------------------EEeccC
Confidence 766642 248889999999999999999999999999 8888888 55555
Q ss_pred ---CceEEeecCCccCCCCCCCC---CCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 149 ---GYVKIADFGLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 149 ---~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
|++||+|||+++...+.-.. ....+-|.+|+|||.+.|.. |+++.|||+.|||++||++-++.|.+.
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999999965444332 23456689999999999865 899999999999999999999999765
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=228.02 Aligned_cols=206 Identities=22% Similarity=0.372 Sum_probs=164.8
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc--C-CC
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD--V-FS 85 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~-l~ 85 (245)
.+..||+|+++..... .....+.+| ++.|.+|+||||++++|+|..+..+|+++||+++|+|.+|+... + +.
T Consensus 561 g~lkVAVK~Lr~~a~~--~~r~~F~kE---IkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~ 635 (807)
T KOG1094|consen 561 GPLKVAVKILRPDATK--NARNDFLKE---IKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAE 635 (807)
T ss_pred CceEEEEeecCcccch--hHHHHHHHH---HHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccc
Confidence 3689999999976422 223445544 67788889999999999999999999999999999999999654 2 24
Q ss_pred hHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCC
Q psy3347 86 EPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165 (245)
Q Consensus 86 ~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 165 (245)
...-.+|+.||+.||+||-+.+++|| |+.+-|+ ++|+++++||+|||+++...+.
T Consensus 636 t~~~vsi~tqiasgmaYLes~nfVHr---d~a~rNc----------------------Lv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 636 TAPGVSICTQIASGMAYLESLNFVHR---DLATRNC----------------------LVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred cchhHHHHHHHHHHHHHHHhhchhhc---cccccce----------------------eecCcccEEecCcccccccccC
Confidence 45667899999999999999999999 5555565 9999999999999999854332
Q ss_pred CC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHH---hcCcc-----cCCC
Q psy3347 166 GD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV--GESPFPGDDEEEVFDSI---VNDEV-----RYPR 233 (245)
Q Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~pf~~~~~~~~~~~~---~~~~~-----~~p~ 233 (245)
.. .....+-+.+|||+|.+.-+.|+.++|+|+||+++||+++ .+.||...+.+++.+.. ..++. ..|.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 22 2334556789999999999999999999999999999976 78999877766665553 33333 2478
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
-|+.++.++|-
T Consensus 771 ~cp~~lyelml 781 (807)
T KOG1094|consen 771 ACPQGLYELML 781 (807)
T ss_pred cCcHHHHHHHH
Confidence 89999888874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=220.83 Aligned_cols=190 Identities=27% Similarity=0.434 Sum_probs=149.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||+|++.+.... ......+ .+++++++.++||||+++++++... ..+++++||+.. +
T Consensus 31 v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 105 (342)
T cd07879 31 VCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRA---YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-D 105 (342)
T ss_pred EEEEEeCCCCcEEEEEEecCcccc-ccchhHH---HHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-C
Confidence 689999999999999998753211 1112233 3446778889999999999998654 256999999864 6
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|.... ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 106 l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~---dlkp~NI----------------------ll~~~~~~kL~ 159 (342)
T cd07879 106 LQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHR---DLKPGNL----------------------AVNEDCELKIL 159 (342)
T ss_pred HHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEEe
Confidence 66554 3468899999999999999999999999999 8888888 77888999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|||+++... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus 160 dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 160 DFGLARHAD---AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred eCCCCcCCC---CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999987421 12234466788999999866 45788999999999999999999999887655544443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=230.40 Aligned_cols=214 Identities=26% Similarity=0.416 Sum_probs=168.9
Q ss_pred CEeEEEecC-Cc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT-GE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.|..- |+ .||||.++...... ...+|++| ..+|.+++|||+++++|+..+ ....+|||.++.|+|.+
T Consensus 126 V~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrE---as~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLld 199 (1039)
T KOG0199|consen 126 VKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLRE---ASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLD 199 (1039)
T ss_pred EeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHH---HHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHH
Confidence 677777653 43 78999998654332 44566555 677889999999999999866 67999999999999999
Q ss_pred hhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 78 HIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 78 ~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
.++. ..+.......++.||+.||+||-+++++|| |+-.-|+ ++-+...+||+
T Consensus 200 rLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHR---DLAARNl----------------------llasprtVKI~ 254 (1039)
T KOG0199|consen 200 RLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHR---DLAARNL----------------------LLASPRTVKIC 254 (1039)
T ss_pred HHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhh---hhhhhhh----------------------eecccceeeee
Confidence 9854 467788899999999999999999999999 3333344 44456679999
Q ss_pred ecCCccCCCCCCCCC---CcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-c
Q psy3347 155 DFGLCKEGMGFGDRT---GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-V 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~ 229 (245)
|||+.+......... ...--++.|.|||.+....|+.++|||+||++||||++ |+.||.|.....+++.|-.+. .
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL 334 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL 334 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC
Confidence 999998642222111 11112457999999999999999999999999999999 999999999999999987443 3
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
+.|..|++++.++|.+
T Consensus 335 pRPk~csedIY~imk~ 350 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKN 350 (1039)
T ss_pred CCCCCChHHHHHHHHH
Confidence 5688999999999863
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-33 Score=215.39 Aligned_cols=212 Identities=24% Similarity=0.386 Sum_probs=167.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|++..|+.+|+.+|||.++.... ..+.+.+..|... .++.-+.||||+++|++-.++--++.||.|. .||..+.+
T Consensus 80 V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~--~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk 154 (361)
T KOG1006|consen 80 VNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDT--VMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYK 154 (361)
T ss_pred hhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHH--HHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHH
Confidence 67888999999999999987542 3444555544322 4556679999999999989999999999994 47766553
Q ss_pred ------hcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 81 ------ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 81 ------~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
...+++..+-.|+.-.+.||.||-.. .|+|| |+||+|| ++|+.|.+||
T Consensus 155 ~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHR---DvKPSNI----------------------Lldr~G~vKL 209 (361)
T KOG1006|consen 155 RVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHR---DVKPSNI----------------------LLDRHGDVKL 209 (361)
T ss_pred HHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhc---cCChhhe----------------------EEecCCCEee
Confidence 34689998889998899999999865 79999 9999999 9999999999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCccc
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDSIVNDEVR 230 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~~~ 230 (245)
||||.+....++.... .-.|+..|||||-+.. ..|+.++||||||+++||++||+.||.+++. .++..+++.+.++
T Consensus 210 CDFGIcGqLv~SiAkT-~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp 288 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKT-VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP 288 (361)
T ss_pred ecccchHhHHHHHHhh-hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC
Confidence 9999987655544433 3467888999999954 4588999999999999999999999988754 5777777777765
Q ss_pred C---CCC---CChhHHhhh
Q psy3347 231 Y---PRF---LSLEAIAIM 243 (245)
Q Consensus 231 ~---p~~---~~~~~~~li 243 (245)
. +.. .+..++.+|
T Consensus 289 ~l~~~~~~~~~s~~~~~fi 307 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFI 307 (361)
T ss_pred eecCcccccccCHHHHHHH
Confidence 3 222 455555554
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=217.66 Aligned_cols=187 Identities=26% Similarity=0.365 Sum_probs=146.7
Q ss_pred CEeEEEec--CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchh
Q psy3347 1 VILSQYRN--TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~ 76 (245)
||+|.++. +|+.||+|.+...........+... +++++++.++||||+++++++... +..++||||+++ ++.
T Consensus 16 v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 91 (316)
T cd07842 16 VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC---REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLW 91 (316)
T ss_pred EEEEEecCCCCCCeEEEEEeccccccccCccHHHH---HHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHH
Confidence 68999988 8999999999864321122223333 346778889999999999999888 789999999976 555
Q ss_pred hhhhh------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---
Q psy3347 77 MHIHA------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT--- 147 (245)
Q Consensus 77 ~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~--- 147 (245)
..+.. ..+++..+..++.|++.||+|||+.+++|+ |++|+|| +++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~---dlkp~Ni----------------------l~~~~~~ 146 (316)
T cd07842 92 QIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR---DLKPANI----------------------LVMGEGP 146 (316)
T ss_pred HHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeC---CCCHHHE----------------------EEcCCCC
Confidence 44421 257889999999999999999999999999 8888887 6666
Q ss_pred -CCceEEeecCCccCCCCCCC---CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 148 -EGYVKIADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 148 -~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
++.+||+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+..
T Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 147 ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 88999999998875322211 12234567889999988764 57899999999999999999999997553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=213.13 Aligned_cols=214 Identities=24% Similarity=0.424 Sum_probs=158.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|.++.... ......+..+... +.+..+||||+++++++..++..+++|||+++ ++.....
T Consensus 31 v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~--~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~ 105 (296)
T cd06618 31 VYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDV--VLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLK 105 (296)
T ss_pred EEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHH--HHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHH
Confidence 68999999999999999975421 1222233333221 23333699999999999999999999999854 6665553
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
...+++..+..++.|++.||+|||+ .|++|+ |++|+|| +++.++.++|+|||
T Consensus 106 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~---dl~p~ni----------------------ll~~~~~~kL~dfg 160 (296)
T cd06618 106 RIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR---DVKPSNI----------------------LLDASGNVKLCDFG 160 (296)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC---CCcHHHE----------------------EEcCCCCEEECccc
Confidence 3468889999999999999999997 599999 8888888 77888999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCc-ccC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETS----YTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDSIVNDE-VRY 231 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~pf~~~~-~~~~~~~~~~~~-~~~ 231 (245)
++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... ..+....+.... ...
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 161 ISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred cchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 8865322221 22334677899999997543 7889999999999999999999997532 344455554433 223
Q ss_pred C--CCCChhHHhhhcC
Q psy3347 232 P--RFLSLEAIAIMRR 245 (245)
Q Consensus 232 p--~~~~~~~~~li~~ 245 (245)
+ ..+++++++||++
T Consensus 240 ~~~~~~~~~l~~li~~ 255 (296)
T cd06618 240 PPNEGFSPDFCSFVDL 255 (296)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 3 3468888888763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=210.85 Aligned_cols=217 Identities=13% Similarity=0.120 Sum_probs=152.0
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHH-----HHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEe
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVES-----LLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVME 68 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~-----~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e 68 (245)
||+|++..+ +..+|+|+..........+... ...+...+..+..++|+|++++++++.... ..++++|
T Consensus 28 Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~ 107 (294)
T PHA02882 28 VYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLE 107 (294)
T ss_pred EEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEe
Confidence 799998877 7778888654322111111100 011222334456778999999999875543 4578888
Q ss_pred eccCCchhhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 69 YAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 69 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
++.. ++.+.++. ...++..+..++.|++.||+|||+++++|| |+||+|| +++.
T Consensus 108 ~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr---DiKp~Ni----------------------ll~~ 161 (294)
T PHA02882 108 KLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG---DIKPENI----------------------MVDG 161 (294)
T ss_pred hhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcC
Confidence 7644 55555543 346788889999999999999999999999 8888888 7788
Q ss_pred CCceEEeecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HH
Q psy3347 148 EGYVKIADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EE 219 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~ 219 (245)
++.++|+|||+++....... ......||+.|+|||...+..++.++|||||||++|+|++|+.||.+... ..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 89999999999875322111 11234689999999999988999999999999999999999999976632 11
Q ss_pred --------HHHHHhcCcccCCCCCChhHHhhhc
Q psy3347 220 --------VFDSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 220 --------~~~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
....+...... +..+++++.++|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 273 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIK-IKNANKFIYDFIE 273 (294)
T ss_pred HHHHhHHHHHHHhhhhhhc-cCCCCHHHHHHHH
Confidence 12222222222 3456777877775
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=224.39 Aligned_cols=212 Identities=20% Similarity=0.369 Sum_probs=149.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||++.... .+-||+|++.-.. .+......+.+| +.+|.++ +|.+|++++|+=..++.+|+||| ++.-+|..++
T Consensus 377 V~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nE---I~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE-~Gd~DL~kiL 450 (677)
T KOG0596|consen 377 VFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNE---IALLNKLKGHDKIIQLYDYEVTDGYLYMVME-CGDIDLNKIL 450 (677)
T ss_pred eeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHH---HHHHHHhcCCceEEEEeeeeccCceEEEEee-cccccHHHHH
Confidence 67776654 3456666554322 123344556666 5555555 58999999999888999999999 5566999999
Q ss_pred hhcCCCh--HHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 80 HADVFSE--PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 80 ~~~~l~~--~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+...... -.++.+..|++.++.++|++||+|. |+||+|. ++. .|.+||+|||
T Consensus 451 ~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHS---DLKPANF-----LlV------------------kG~LKLIDFG 504 (677)
T KOG0596|consen 451 KKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHS---DLKPANF-----LLV------------------KGRLKLIDFG 504 (677)
T ss_pred HhccCCCchHHHHHHHHHHHHHHHHHHHhceeec---CCCcccE-----EEE------------------eeeEEeeeec
Confidence 7654322 3788999999999999999999999 6666555 222 5789999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTET-----------SYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDS 223 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~ 223 (245)
.+.....+.- .....+||..|||||.+... ..++++||||||||+|+|+.|++||..... ..-+..
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~a 584 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHA 584 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHh
Confidence 9976443322 23456899999999999532 256889999999999999999999965432 222233
Q ss_pred HhcC--cccCCCCCChh-HHhhhc
Q psy3347 224 IVND--EVRYPRFLSLE-AIAIMR 244 (245)
Q Consensus 224 ~~~~--~~~~p~~~~~~-~~~li~ 244 (245)
|..- ..++|+.-+.. +.++|+
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK 608 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMK 608 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHH
Confidence 3322 23566655444 666664
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=211.74 Aligned_cols=191 Identities=30% Similarity=0.432 Sum_probs=153.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.+..+++.||||.+...... ...... .+++..++.++ |||++++++++..++..++||||+ +++|.+.+
T Consensus 15 v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~---~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~ 88 (283)
T cd07830 15 VYLARNKETGELVAIKKMKKKFYS--WEECMN---LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLM 88 (283)
T ss_pred EEEEEECCCCcEEEEEEehhhccc--hhHHHH---HHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHH
Confidence 799999989999999998754211 111111 23466677888 999999999999999999999999 77888777
Q ss_pred hh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
.. ..+++..+..++.|++.+|.|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~---dl~~~ni----------------------~i~~~~~~~l~d~ 143 (283)
T cd07830 89 KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR---DLKPENL----------------------LVSGPEVVKIADF 143 (283)
T ss_pred HhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCChhhE----------------------EEcCCCCEEEeec
Confidence 43 267999999999999999999999999999 8888888 8888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
|.+....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+....+....
T Consensus 144 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 144 GLAREIRSRP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred ccceeccCCC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 9987532222 2234567888999998854 4578999999999999999999999987665544433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=208.42 Aligned_cols=213 Identities=22% Similarity=0.315 Sum_probs=159.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||++++..+++.||+|++.-. .. +.....+++++..++.+|||++++++....+ ...|++++|...|+|
T Consensus 37 v~LV~~~s~~~~YAlKkI~c~---~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl 110 (302)
T KOG2345|consen 37 VDLVKGLSTGHLYALKKILCH---SQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSL 110 (302)
T ss_pred eeeecccCcccchhhheeecc---ch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccH
Confidence 688899999999999999743 22 3333445668888999999999999976332 358999999999999
Q ss_pred hhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 76 MMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 76 ~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
.+.+. ...+++.+...|+.++++||++||+.. ..|| |+||+|| +..+.
T Consensus 111 ~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~---DiKP~NI----------------------Lls~~ 165 (302)
T KOG2345|consen 111 LDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHR---DIKPANI----------------------LLSDS 165 (302)
T ss_pred HHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCccccc---CCCccee----------------------EecCC
Confidence 88773 236899999999999999999999998 9999 8888888 66678
Q ss_pred CceEEeecCCccCCCCCCCC---------CCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 149 GYVKIADFGLCKEGMGFGDR---------TGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
+.+++.|||.++...-.... -.....|..|+|||.+.- ...+.++|||||||++|+|+.|..||...-
T Consensus 166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 99999999987642111000 012345788999999954 456789999999999999999999995321
Q ss_pred H--HHHHHHHhcCcccCCC--CCChhHHhhhc
Q psy3347 217 E--EEVFDSIVNDEVRYPR--FLSLEAIAIMR 244 (245)
Q Consensus 217 ~--~~~~~~~~~~~~~~p~--~~~~~~~~li~ 244 (245)
. ..+.-++.+++..+|+ ..|+.+.++|+
T Consensus 246 ~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik 277 (302)
T KOG2345|consen 246 QQGGSLALAVQNAQISIPNSSRYSEALHQLIK 277 (302)
T ss_pred hcCCeEEEeeeccccccCCCCCccHHHHHHHH
Confidence 1 1122234455666663 35666666654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=225.74 Aligned_cols=204 Identities=28% Similarity=0.437 Sum_probs=161.9
Q ss_pred eEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc
Q psy3347 3 LSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD 82 (245)
Q Consensus 3 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 82 (245)
.+.+..+++.+++|++.+....+.++. . -.+..-+||||+++.+++.++-+.++|||.+.|+-+.+.+...
T Consensus 340 ~~~~~~t~~~~~vkii~~~~~~~~~e~-------~--~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~ 410 (612)
T KOG0603|consen 340 YCESSPTDQEPAVKIISKRADDNQDEI-------P--ISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK 410 (612)
T ss_pred eeeccccccchhheecccccccccccc-------c--hhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc
Confidence 456778899999999987522222211 1 1223447999999999999999999999999988777766555
Q ss_pred CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-CCCCceEEeecCCccC
Q psy3347 83 VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN-DTEGYVKIADFGLCKE 161 (245)
Q Consensus 83 ~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~kl~Dfg~~~~ 161 (245)
+.....+..|+++++.++.|||++|++|| |++|+|| +. +..|.++|+|||.++.
T Consensus 411 ~~~~~e~~~w~~~lv~Av~~LH~~gvvhR---DLkp~NI----------------------L~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 411 PEFCSEASQWAAELVSAVDYLHEQGVVHR---DLKPGNI----------------------LLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred chhHHHHHHHHHHHHHHHHHHHhcCeeec---CCChhhe----------------------eecCCCCcEEEEEechhhh
Confidence 44447888999999999999999999999 8889999 66 6889999999999876
Q ss_pred CCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCcccCCCCCChhHH
Q psy3347 162 GMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVRYPRFLSLEAI 240 (245)
Q Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~ 240 (245)
.... ....+-|..|.|||.+....|+.++|+||||+++|+|++|..||...+.. ++...+.... +...+|++++
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--~s~~vS~~AK 540 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--FSECVSDEAK 540 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc--cccccCHHHH
Confidence 4333 22335577899999999899999999999999999999999999877655 4444444333 3488999999
Q ss_pred hhhcC
Q psy3347 241 AIMRR 245 (245)
Q Consensus 241 ~li~~ 245 (245)
||+++
T Consensus 541 dLl~~ 545 (612)
T KOG0603|consen 541 DLLQQ 545 (612)
T ss_pred HHHHH
Confidence 99874
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=214.05 Aligned_cols=194 Identities=27% Similarity=0.408 Sum_probs=150.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--------CeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--------AHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--------~~~~lv~e~~~~ 72 (245)
||+|.++.+|+.+|+|++....... ....... ++++.++.++||||+++++++... ...+++|||+.+
T Consensus 24 v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~ 99 (311)
T cd07866 24 VYKARQIKTGRVVALKKILMHNEKD-GFPITAL---REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH 99 (311)
T ss_pred EEEEEECCCCcEEEEEEEEeccCCC-CcchhHH---HHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc
Confidence 7999999999999999987543211 1112233 447778889999999999987443 357999999876
Q ss_pred Cchhhhhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 73 GDLMMHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 73 ~~L~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
++...+. ...+++..+..++.|+++||+|||++|++|+ |++|+|| +++.++.
T Consensus 100 -~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~---dl~p~ni----------------------l~~~~~~ 153 (311)
T cd07866 100 -DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHR---DIKAANI----------------------LIDNQGI 153 (311)
T ss_pred -CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EECCCCC
Confidence 5655553 2468999999999999999999999999999 8888888 7888899
Q ss_pred eEEeecCCccCCCCCCCC-----------CCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy3347 151 VKIADFGLCKEGMGFGDR-----------TGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~ 218 (245)
++|+|||++......... .....++..|+|||.+.+. .++.++||||||+++|+|++|++||.+.+..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999988743221111 1123457789999988654 5789999999999999999999999887766
Q ss_pred HHHHHH
Q psy3347 219 EVFDSI 224 (245)
Q Consensus 219 ~~~~~~ 224 (245)
.....+
T Consensus 234 ~~~~~~ 239 (311)
T cd07866 234 DQLHLI 239 (311)
T ss_pred HHHHHH
Confidence 555544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=202.14 Aligned_cols=213 Identities=41% Similarity=0.706 Sum_probs=169.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.+|+|++........ .+.+.+| ++.++.++|+|++++++.+......++++|++++++|..++.
T Consensus 5 v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e---~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 5 VYLARDKKTGKLVAIKVIKKEKIKKK--RERILRE---ISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred EEEEEECCCCcEEEEEEecccccccH--HHHHHHH---HHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 68999998899999999986532211 3444444 666778899999999999999899999999999999999886
Q ss_pred hcC-CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 ADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~~-l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
... ++...+..++.+++.++.+||+.+++|+ +++|+|| +++.++.++++|||.+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~---~i~~~ni----------------------~~~~~~~~~l~d~~~~ 134 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHR---DLKPENI----------------------LLDEDGHVKLADFGLA 134 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecC---CcCHHHe----------------------EECCCCcEEEccccce
Confidence 543 8889999999999999999999999999 8888888 7778899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCcccCCCC---C
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVNDEVRYPRF---L 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~~p~~---~ 235 (245)
....... ......++..|+|||...+..++.++|+||||++++++++|..||.. .......+.+.......+.. +
T Consensus 135 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 135 RQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred eeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccC
Confidence 7533221 23345677889999999888888999999999999999999999977 44455555444444333222 6
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
+.++.++++
T Consensus 214 ~~~~~~~i~ 222 (244)
T smart00220 214 SPEAKDLIR 222 (244)
T ss_pred CHHHHHHHH
Confidence 777777664
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=225.88 Aligned_cols=217 Identities=35% Similarity=0.656 Sum_probs=181.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
|-+++-..|...||.|.+.+.....+.++...+.|+.++ ...+++=||+++-.|.+.+.+|+||||.+||++..++
T Consensus 645 V~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDIL---AEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 645 VCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDIL---AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred eEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhH---hhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH
Confidence 456777778889999999998888888888888886654 4667899999999999999999999999999998777
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+-+-+++..++.++.++..|+++.|..|++|| ||||+|| ++|.+|.+||.|||++
T Consensus 722 rmgIFeE~LARFYIAEltcAiesVHkmGFIHR---DiKPDNI----------------------LIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 722 RMGIFEEDLARFYIAELTCAIESVHKMGFIHR---DIKPDNI----------------------LIDRDGHIKLTDFGLC 776 (1034)
T ss_pred HhccCHHHHHHHHHHHHHHHHHHHHhccceec---ccCccce----------------------EEccCCceeeeecccc
Confidence 55778999999999999999999999999999 9999999 9999999999999998
Q ss_pred cCCC----------CCCC--------------------------------CCCcccCCCCccccccccCCCCCcchhHHH
Q psy3347 160 KEGM----------GFGD--------------------------------RTGTFCGTPEFLAPEVLTETSYTRAVDWWG 197 (245)
Q Consensus 160 ~~~~----------~~~~--------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 197 (245)
..+. ++.. .....+||+.|+|||++....|+.-+|.||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 5210 0000 011246899999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc--CC--CCCChhHHhhhcC
Q psy3347 198 LGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--YP--RFLSLEAIAIMRR 245 (245)
Q Consensus 198 lG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~p--~~~~~~~~~li~~ 245 (245)
.|+|+|||+.|..||...++.+....+.+..-. +| ..+++++.+||+|
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~k 908 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQK 908 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHH
Confidence 999999999999999877776666666554322 33 5789999999874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=213.39 Aligned_cols=193 Identities=21% Similarity=0.337 Sum_probs=148.9
Q ss_pred CEeEEEecC--CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC----CeEEEEEeeccCC
Q psy3347 1 VILSQYRNT--GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE----AHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~----~~~~lv~e~~~~~ 73 (245)
||+|++..+ ++.||+|.+.... ......+.+.+| ++.++.+ +||||+++++.+... ...++++|+++ +
T Consensus 16 vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~ 90 (332)
T cd07857 16 VCSARNAETSEEETVAIKKITNVF-SKKILAKRALRE---LKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-A 90 (332)
T ss_pred EEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHH---HHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-C
Confidence 689999888 9999999987532 111222333344 5556666 599999999975432 46789999986 5
Q ss_pred chhhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 74 DLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 74 ~L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
+|..++. ...+++..++.++.|++.||+|||++|++|+ |++|+|| +++.++.++
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~---dlkp~Ni----------------------li~~~~~~k 145 (332)
T cd07857 91 DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHR---DLKPGNL----------------------LVNADCELK 145 (332)
T ss_pred CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHe----------------------EEcCCCCEE
Confidence 7887774 4578999999999999999999999999999 8888888 778889999
Q ss_pred EeecCCccCCCCCCC----CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy3347 153 IADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~ 223 (245)
|+|||.+........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~ 221 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHH
Confidence 999999874322111 1233467889999998865 5688999999999999999999999987665444443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=218.86 Aligned_cols=223 Identities=28% Similarity=0.442 Sum_probs=172.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHH-HHHHHHHHHHhhcCCCceeeeeEEEeeC-CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESL-LSEKRIFEVANTMRHPFLVNLFACFQTE-AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~-~~e~~~~~~l~~~~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.|...++.||+|+-.....|..+..++. +...|+..+-+.++||-||+++|+|+.+ ..+|-|+|||+|.+|.-+
T Consensus 479 VyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFY 558 (775)
T KOG1151|consen 479 VYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFY 558 (775)
T ss_pred HHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHH
Confidence 79999999999999999876665665554443 3456667778899999999999999865 579999999999999998
Q ss_pred hhhc-CCChHHHHHHHHHHHHHHHHhhhc--CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 79 IHAD-VFSEPRAVFYAACVVLGLQYLHES--RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 79 ~~~~-~l~~~~~~~i~~~i~~~l~~lH~~--~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. .+++..++.|+-||+.||.||.+. .|+|- |+||.|| ++. .-...|.+||.|
T Consensus 559 LKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHY---DLKPgNI-----LLv--------------~GtacGeIKITD 616 (775)
T KOG1151|consen 559 LKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHY---DLKPGNI-----LLV--------------NGTACGEIKITD 616 (775)
T ss_pred HHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeee---ccCCccE-----EEe--------------cCcccceeEeee
Confidence 8764 579999999999999999999976 58999 6666666 322 223357899999
Q ss_pred cCCccCCCCCCC-------CCCcccCCCCccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Q psy3347 156 FGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTET----SYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDS 223 (245)
Q Consensus 156 fg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~~g~~pf~~~-~~~~~~~~ 223 (245)
||+++...++.. ..+...||.+|+|||.+... ..+.++||||.|+|+|+.+.|+.||-.. +..++++.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999986433222 24556799999999999643 3568999999999999999999999533 33344433
Q ss_pred --HhcC-cccCC--CCCChhHHhhhcC
Q psy3347 224 --IVND-EVRYP--RFLSLEAIAIMRR 245 (245)
Q Consensus 224 --~~~~-~~~~p--~~~~~~~~~li~~ 245 (245)
|+.. ...|| ..++.+.+++|+|
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRR 723 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRR 723 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHH
Confidence 3332 33344 5789999999975
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=211.47 Aligned_cols=193 Identities=24% Similarity=0.385 Sum_probs=161.7
Q ss_pred eEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCchh
Q psy3347 3 LSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGDLM 76 (245)
Q Consensus 3 ~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~L~ 76 (245)
.|.|.-++++||+|++... ..+ .....+..|++.++..++|+||++++.+|+... .+|+|||+|.. +|.
T Consensus 34 ~a~D~v~~~~v~ikk~~~p-f~n---~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~ 108 (369)
T KOG0665|consen 34 AAFDQVLGRPVAIKKLSRP-FQN---QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLC 108 (369)
T ss_pred ecchhhccCceehhhhcCc-ccc---CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHH
Confidence 4566678999999999875 222 345566677788999999999999999997654 57999999954 787
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
.... -.+....+..++.|++.|++|+|+.||+|| |+||+|| ++..++.+||.||
T Consensus 109 ~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihR---dLkPsni----------------------vv~~~~~lKi~df 162 (369)
T KOG0665|consen 109 QVIL-MELDHETISYILYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVNSDCTLKILDF 162 (369)
T ss_pred HHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeec---ccCcccc----------------------eecchhheeeccc
Confidence 7765 346677889999999999999999999999 8889888 8888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND 227 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (245)
|+++....+ -..+.++.+..|.|||.+.+..+...+||||+||++.||++|+..|+|.+..+...++..-
T Consensus 163 g~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 163 GLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred hhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 999853222 2456677888999999999988999999999999999999999999999988888887653
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=226.48 Aligned_cols=213 Identities=25% Similarity=0.404 Sum_probs=166.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~L 75 (245)
||+++++.+|+..|+|+.... .+..+.+..|.++++. ..+|||++.++++|.. ++.++||||||.+||.
T Consensus 35 v~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~--~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSV 108 (953)
T KOG0587|consen 35 VYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKK--YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSV 108 (953)
T ss_pred EEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHh--ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccH
Confidence 799999999999999999763 2222344445454443 3379999999999864 4589999999999999
Q ss_pred hhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 76 MMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 76 ~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
.+.+++ ..+.|..+.-|++.++.|+++||.+.++|| |+|=.|| +++.++.+|
T Consensus 109 TDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHR---DikG~Ni----------------------LLT~e~~VK 163 (953)
T KOG0587|consen 109 TDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHR---DIKGQNV----------------------LLTENAEVK 163 (953)
T ss_pred HHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeee---cccCceE----------------------EEeccCcEE
Confidence 998864 468888999999999999999999999999 5555555 777889999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND 227 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (245)
++|||.+....+......+.+||+.|||||++.. ..|+..+|+||||++-.||..|.+|+-...+..++-.|-..
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 9999999887777777888999999999999964 24668899999999999999999999877776665544433
Q ss_pred ccc---CCCCCChhHHhhhc
Q psy3347 228 EVR---YPRFLSLEAIAIMR 244 (245)
Q Consensus 228 ~~~---~p~~~~~~~~~li~ 244 (245)
.++ -|..=+..+.|+|+
T Consensus 244 PPPkLkrp~kWs~~FndFIs 263 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFIS 263 (953)
T ss_pred CCccccchhhHHHHHHHHHH
Confidence 322 12333445555543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=221.96 Aligned_cols=151 Identities=18% Similarity=0.289 Sum_probs=124.6
Q ss_pred HHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcC------CChHHHHHHHHHHHHHHHHhhhcCcc
Q psy3347 36 KRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADV------FSEPRAVFYAACVVLGLQYLHESRII 109 (245)
Q Consensus 36 ~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------l~~~~~~~i~~~i~~~l~~lH~~~i~ 109 (245)
.+++++++.++||||+++++++...+..+++++++.+ +|..++.... .....+..++.|++.||+|||++||+
T Consensus 211 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi 289 (501)
T PHA03210 211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI 289 (501)
T ss_pred HHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4457788899999999999999999999999998854 6666553322 23456778999999999999999999
Q ss_pred ccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCC-CCCcccCCCCccccccccCCC
Q psy3347 110 YRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETS 188 (245)
Q Consensus 110 H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 188 (245)
|| |+||+|| +++.++.+||+|||++........ ......|+..|+|||.+.+..
T Consensus 290 Hr---DLKP~NI----------------------Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 290 HR---DIKLENI----------------------FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred cC---CCCHHHE----------------------EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC
Confidence 99 8888888 778889999999999975433222 233457899999999999888
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCC
Q psy3347 189 YTRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 189 ~~~~~DvwslG~~l~el~~g~~pf 212 (245)
++.++|||||||++|||++|..++
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999987543
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=223.71 Aligned_cols=205 Identities=25% Similarity=0.464 Sum_probs=163.8
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcC-----
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADV----- 83 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----- 83 (245)
...||+|.++... ...+.+.+..| ++.|+.+ .||||+.++|+++..+..++++||+..|+|..+++...
T Consensus 328 ~~~VaVK~~k~~~--~~~~~~~~~~E---l~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~ 402 (609)
T KOG0200|consen 328 YVTVAVKMLKENA--SSSEKKDLMSE---LNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESI 402 (609)
T ss_pred eEEEEEEeccccc--CcHHHHHHHHH---HHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccc
Confidence 5589999998653 22455666666 5555555 59999999999999999999999999999999996554
Q ss_pred ------------CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 84 ------------FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 84 ------------l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
++..+...++.||+.|++||++..++||| +-..| +++..+..+
T Consensus 403 ~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD--------LAaRN-----------------VLi~~~~~~ 457 (609)
T KOG0200|consen 403 DGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD--------LAARN-----------------VLITKNKVI 457 (609)
T ss_pred cccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh--------hhhhh-----------------EEecCCCEE
Confidence 88899999999999999999999999993 32222 267777889
Q ss_pred EEeecCCccCCCCCCCCC-Cccc--CCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHhc
Q psy3347 152 KIADFGLCKEGMGFGDRT-GTFC--GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDD-EEEVFDSIVN 226 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~-~~~~~~~~~~ 226 (245)
||+|||+++......... .... -+..|||||.+....|+.++||||||+++||+++ |..||++.. ..++.+.+..
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~ 537 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE 537 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence 999999998543332221 1111 2567999999999899999999999999999999 999999865 6677666666
Q ss_pred Ccc-cCCCCCChhHHhhhc
Q psy3347 227 DEV-RYPRFLSLEAIAIMR 244 (245)
Q Consensus 227 ~~~-~~p~~~~~~~~~li~ 244 (245)
+.. ..|..|++++.++|+
T Consensus 538 G~r~~~P~~c~~eiY~iM~ 556 (609)
T KOG0200|consen 538 GNRMEQPEHCSDEIYDLMK 556 (609)
T ss_pred CCCCCCCCCCCHHHHHHHH
Confidence 654 679999999999986
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=210.72 Aligned_cols=190 Identities=24% Similarity=0.404 Sum_probs=151.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|+++ |+.||||++... +.+.+++|.++++.. .++|+||+.+++.-..++ +.+||++|.+.|||.
T Consensus 227 VwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTv-mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~ 297 (513)
T KOG2052|consen 227 VWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTV-MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLY 297 (513)
T ss_pred eeecccc--CCceEEEEeccc------chhhhhhHHHHHHHH-HhccchhhhhhhccccCCCceEEEEEeeecccCCcHH
Confidence 7999887 999999999742 236778888888765 578999999999876554 689999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhh--------cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHE--------SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--------~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
+++++..++.....+++..++.||+|||- ..|.|| |+|..|| ++.++
T Consensus 298 DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHR---DlKSKNI----------------------LVKkn 352 (513)
T KOG2052|consen 298 DYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHR---DLKSKNI----------------------LVKKN 352 (513)
T ss_pred HHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcc---ccccccE----------------------EEccC
Confidence 99999999999999999999999999995 358999 6666566 77788
Q ss_pred CceEEeecCCccCCCCC----CCCCCcccCCCCccccccccCC----CCC--cchhHHHHHHHHHHHHhC----------
Q psy3347 149 GYVKIADFGLCKEGMGF----GDRTGTFCGTPEFLAPEVLTET----SYT--RAVDWWGLGVLIFEMLVG---------- 208 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~----~~~--~~~DvwslG~~l~el~~g---------- 208 (245)
|.+.|+|+|++....+. ....+..+||.+|||||++... -|. ..+||||||.++||++..
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999998643322 1235667999999999999542 232 569999999999998752
Q ss_pred CCCCCC----CCHHHHHHHH
Q psy3347 209 ESPFPG----DDEEEVFDSI 224 (245)
Q Consensus 209 ~~pf~~----~~~~~~~~~~ 224 (245)
.+||.+ .+..+.+..+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkV 452 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKV 452 (513)
T ss_pred cCCcccCCCCCCCHHHHhcc
Confidence 357743 3455665555
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=220.63 Aligned_cols=187 Identities=29% Similarity=0.461 Sum_probs=155.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHH-----HHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeecc-CCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVES-----LLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAA-GGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~-----~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~-~~~ 74 (245)
||+|.|++....|+||.+.++++....++++ .-.|..++..++.-.|+||++++++|++++++|++||... +-+
T Consensus 577 V~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gID 656 (772)
T KOG1152|consen 577 VNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGID 656 (772)
T ss_pred EEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcc
Confidence 7999999999999999999887665554443 2335444444444459999999999999999999999874 568
Q ss_pred hhhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 75 LMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 75 L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
|.+++.. ..+++..++-|++|++.|+++||+.||+|| |||-+|+ .++++|.+||
T Consensus 657 LFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhr---dikdenv----------------------ivd~~g~~kl 711 (772)
T KOG1152|consen 657 LFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHR---DIKDENV----------------------IVDSNGFVKL 711 (772)
T ss_pred hhhhhhccCccchHHHHHHHHHHHhccccccccCceec---ccccccE----------------------EEecCCeEEE
Confidence 8899964 569999999999999999999999999999 6666666 8899999999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
+|||.+....+. .-..++||.-|.|||.+.|.+| +..-|||++|+.+|.++..+.||..
T Consensus 712 idfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999988754332 2456789999999999999888 5678999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=192.23 Aligned_cols=199 Identities=36% Similarity=0.559 Sum_probs=160.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+++.+|+|.+...... ...+.+.+ +++.++.++|+|++++++.+......++++|++++++|..++.
T Consensus 15 v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~---e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 89 (225)
T smart00221 15 VYLARDKGTGELVAVKVLKKEKTE--KQREEFLR---EIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLR 89 (225)
T ss_pred EEEEEEcCCCcEEEEEeeccccch--HHHHHHHH---HHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHH
Confidence 689999988999999999865322 12334443 4667778899999999999988899999999999999999986
Q ss_pred hc-C-CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 AD-V-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~~-~-l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. . +++..+..++.+++.++.++|+++++|+ |++|+|+ +++.++.++|+|||.
T Consensus 90 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~---di~~~ni----------------------~v~~~~~~~l~d~g~ 144 (225)
T smart00221 90 KKGGKLSEEEARFYLRQILEALEYLHSLGIVHR---DLKPENI----------------------LLGMDGLVKLADFGL 144 (225)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEeeCce
Confidence 54 3 8899999999999999999999999999 8888888 777778999999998
Q ss_pred ccCCCCCC-CCCCcccCCCCccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCC-C-CHHHHHHHHhcCcc
Q psy3347 159 CKEGMGFG-DRTGTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPG-D-DEEEVFDSIVNDEV 229 (245)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~g~~pf~~-~-~~~~~~~~~~~~~~ 229 (245)
+....... .......++..|++||.+ ....++.++|+|+||+++++|++|+.||.+ . +...+.+.+..+.+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 145 ARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred eeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 87543321 122345667789999998 667788899999999999999999999987 3 44466666666653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=235.06 Aligned_cols=172 Identities=21% Similarity=0.334 Sum_probs=142.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++....... .++++.+++++||||+++++++..++..++||||+++|+|.++++
T Consensus 706 Vy~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 775 (968)
T PLN00113 706 SYKGKSIKNGMQFVVKEINDVNSIP----------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775 (968)
T ss_pred EEEEEECCCCcEEEEEEccCCcccc----------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh
Confidence 7999999999999999987432111 122566788899999999999999999999999999999999986
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhh---hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLH---ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. +++..+.+++.|++.||+|+| +.+++|| |+||+|| +++.++..++. +|
T Consensus 776 ~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~---dlkp~Ni----------------------l~~~~~~~~~~-~~ 827 (968)
T PLN00113 776 N--LSWERRRKIAIGIAKALRFLHCRCSPAVVVG---NLSPEKI----------------------IIDGKDEPHLR-LS 827 (968)
T ss_pred c--CCHHHHHHHHHHHHHHHHHhccCCCCCeecC---CCCHHhE----------------------EECCCCceEEE-ec
Confidence 3 888999999999999999999 6799999 8888888 67777777765 55
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 828 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 828 LPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 5432211 1223678899999999888899999999999999999999999853
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=217.48 Aligned_cols=199 Identities=20% Similarity=0.391 Sum_probs=157.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC------CCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR------HPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~------h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
|.+|+|..-|..||||+|.... -..+..++++++|++|+ --|+++++..|.+.+|+|||||.+ .-+
T Consensus 448 Vvra~D~~r~~~vAiKIIRnNE-------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slN 519 (752)
T KOG0670|consen 448 VVRARDQARGQEVAIKIIRNNE-------VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLN 519 (752)
T ss_pred eeeccccCCCCeeEEEEeecch-------HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hch
Confidence 5678888889999999998632 11222345566666663 248999999999999999999977 448
Q ss_pred hhhhhhh----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 75 LMMHIHA----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 75 L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
|.+.++. -.|....+..++.|++.||.+|-..||+|. ||||+|| ++. .+...
T Consensus 520 LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHa---DIKPDNi-----LVN----------------E~k~i 575 (752)
T KOG0670|consen 520 LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHA---DIKPDNI-----LVN----------------ESKNI 575 (752)
T ss_pred HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeec---ccCccce-----Eec----------------cCcce
Confidence 8888853 257788889999999999999999999999 6666666 332 23456
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (245)
+||||||.|... +..+..+ +.-+..|.|||++.|-+|+...|+||.||+|||++||+..|+|.++...+...+....+
T Consensus 576 LKLCDfGSA~~~-~eneitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 576 LKLCDFGSASFA-SENEITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeeccCcccccc-ccccccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 899999988753 3333333 33466799999999999999999999999999999999999999998888887776666
Q ss_pred CCC
Q psy3347 231 YPR 233 (245)
Q Consensus 231 ~p~ 233 (245)
+|.
T Consensus 654 ~p~ 656 (752)
T KOG0670|consen 654 FPN 656 (752)
T ss_pred CcH
Confidence 663
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=209.31 Aligned_cols=176 Identities=24% Similarity=0.349 Sum_probs=143.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|+.. ++.||||++.. ++.+.+.+|.+++.+. .+.|+||++++++-.... .++||++|.+.|+|.
T Consensus 226 V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp-~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~ 296 (534)
T KOG3653|consen 226 VWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLP-GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLC 296 (534)
T ss_pred eehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhcc-CccchhHHHhhchhccCCccccceeEEeeeccCCcHH
Confidence 7888775 79999999964 4567788887777655 678999999999865544 799999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhh---------cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHE---------SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---------~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
++++...+++....+++..++.||+|||+ ..|+|| |+|..|+ ++.+
T Consensus 297 dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHR---DlkSkNV----------------------LvK~ 351 (534)
T KOG3653|consen 297 DYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHR---DLKSKNV----------------------LVKN 351 (534)
T ss_pred HHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccc---cccccce----------------------EEcc
Confidence 99999999999999999999999999996 368999 5555555 7778
Q ss_pred CCceEEeecCCccCCCCC--CCCCCcccCCCCccccccccCCC-CC-----cchhHHHHHHHHHHHHhCCC
Q psy3347 148 EGYVKIADFGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETS-YT-----RAVDWWGLGVLIFEMLVGES 210 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~~l~el~~g~~ 210 (245)
++.+.|+|||+|...... .......+||.+|||||.+.+.. +. .+.||||+|.++|||+++..
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 999999999999754322 12244579999999999997631 22 57999999999999998543
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-31 Score=206.51 Aligned_cols=195 Identities=23% Similarity=0.343 Sum_probs=155.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L 75 (245)
||...|..+|+.||+|++.... +....-++.-+++.++...+|.|++..+|+....+ .+|+++|.|.. +|
T Consensus 69 VWsVTDPRdgrrvalkK~pnvf----q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DL 143 (449)
T KOG0664|consen 69 VWSVTDPRSGKRVALKKMPNVF----QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DL 143 (449)
T ss_pred EEeccCCCCccchhHhhcchHH----HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hh
Confidence 6888899999999999987532 22233334445577788889999999999986654 46888998855 77
Q ss_pred hhhh-hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
...+ ...+++...++-+..||++||+|||+.||+|| ||||.|+ +++++..+|||
T Consensus 144 HKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHR---DIKPGNL----------------------LVNSNCvLKIC 198 (449)
T KOG0664|consen 144 HKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHR---DIKPGNL----------------------LVNSNCILKIC 198 (449)
T ss_pred hheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhc---cCCCccE----------------------EeccCceEEec
Confidence 7766 44678889999999999999999999999999 8888888 88888999999
Q ss_pred ecCCccCCCCCCC-CCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||+++....+.. .....+-|.+|+|||++.|. .|+.+.||||.|||+.|++-.+..|....+.+.++.|.
T Consensus 199 DFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 199 DFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred ccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 9999985332222 23344567899999999885 58999999999999999999999998777766666553
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=217.92 Aligned_cols=213 Identities=23% Similarity=0.317 Sum_probs=166.9
Q ss_pred CEeEEEecC----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNT----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+.-. +.+||||++..... .+....+ ++++-.|.+++|||++++++++..+. ..||++++++|+|.
T Consensus 712 V~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~---LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~Ll 785 (1177)
T KOG1025|consen 712 VYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIEL---LDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLL 785 (1177)
T ss_pred EEeeeEecCCceecceeEEEEeeccCC--chhhHHH---HHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHH
Confidence 567765533 55899998876432 1122233 33466788999999999999997665 88999999999999
Q ss_pred hhhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++++ +..+.....+.|..||++||.|||.++++|| ||--.|+ ++.+-..+||.
T Consensus 786 Dyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHr--------dLaaRNV-----------------LVksP~hvkit 840 (1177)
T KOG1025|consen 786 DYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHR--------DLAARNV-----------------LVKSPNHVKIT 840 (1177)
T ss_pred HHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhh--------hhhhhhe-----------------eecCCCeEEEE
Confidence 9995 4578889999999999999999999999999 4443443 55666789999
Q ss_pred ecCCccCCCCCCCCCCcccC--CCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCG--TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++....+........| ++.|||-|.+....|+.++||||||+++||++| |..||.+.+..++-..+..+. .+
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs 920 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS 920 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC
Confidence 99999865444433222222 457999999999999999999999999999999 999999999888877776554 35
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
-|+.|+-++..+|.
T Consensus 921 qPpiCtiDVy~~mv 934 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMV 934 (1177)
T ss_pred CCCCccHHHHHHHH
Confidence 68899998887764
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=222.01 Aligned_cols=142 Identities=30% Similarity=0.519 Sum_probs=111.4
Q ss_pred EEEEEeeccCCchhhhhhhcCCC--hHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 63 VCFVMEYAAGGDLMMHIHADVFS--EPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 63 ~~lv~e~~~~~~L~~~~~~~~l~--~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
.||-||||+..++.+++.++.+. ....++++++|++||+|+|+.||+|| |+||.||
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHR---DLKP~NI------------------- 728 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHR---DLKPRNI------------------- 728 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeec---cCCccee-------------------
Confidence 47889999998888888777664 77899999999999999999999999 9999999
Q ss_pred hccccCCCCceEEeecCCccCCC-----------------CC-CCCCCcccCCCCccccccccCC---CCCcchhHHHHH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGM-----------------GF-GDRTGTFCGTPEFLAPEVLTET---SYTRAVDWWGLG 199 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~-----------------~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG 199 (245)
++|.++.|||+|||++.... +. .......+||.-|+|||.+.+. .|+.|+||||||
T Consensus 729 ---FLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLG 805 (1351)
T KOG1035|consen 729 ---FLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLG 805 (1351)
T ss_pred ---EEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHH
Confidence 88899999999999987411 00 0023456899999999999764 499999999999
Q ss_pred HHHHHHHhCCCCCCCC-CHHHHHHHHhcCcccCC
Q psy3347 200 VLIFEMLVGESPFPGD-DEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 200 ~~l~el~~g~~pf~~~-~~~~~~~~~~~~~~~~p 232 (245)
++++||+. ||... ........+..+..+.|
T Consensus 806 IVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 806 IVLFEMLY---PFGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred HHHHHHhc---cCCchHHHHHHHHhcccCCCCCC
Confidence 99999974 46433 23344444554554444
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=186.77 Aligned_cols=190 Identities=19% Similarity=0.340 Sum_probs=146.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||.|.+..+.++++||+++... .+.+.+|.++++-|+ +||||++++++..+. ....+++||..+.+....
T Consensus 54 VFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~--gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~l 125 (338)
T KOG0668|consen 54 VFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLR--GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQL 125 (338)
T ss_pred HhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhcc--CCCCeeehhhhhcCccccCchhHhhhhccccHHHH
Confidence 6778888899999999998642 345666655554443 599999999998765 367899999988777665
Q ss_pred hhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 79 IHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 79 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. +.++-.+++.++.+++.||.|||+.||.|| |+||-|+ ++. .....++|+|+|+
T Consensus 126 y--~tl~d~dIryY~~elLkALdyCHS~GImHR---DVKPhNv-----mId----------------h~~rkLrlIDWGL 179 (338)
T KOG0668|consen 126 Y--PTLTDYDIRYYIYELLKALDYCHSMGIMHR---DVKPHNV-----MID----------------HELRKLRLIDWGL 179 (338)
T ss_pred h--hhhchhhHHHHHHHHHHHHhHHHhcCcccc---cCCccee-----eec----------------hhhceeeeeecch
Confidence 5 457888899999999999999999999999 5555555 333 2345799999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPF-PGDDEEEVFDSIV 225 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf-~~~~~~~~~~~~~ 225 (245)
+.+.... ...+..+.+..|-.||.+.. +.|+..-|+|||||++++|+..+.|| .|.++.+++-.|.
T Consensus 180 AEFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 180 AEFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred HhhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 9874333 23445567888999999976 55889999999999999999977665 6777766665553
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=197.06 Aligned_cols=113 Identities=25% Similarity=0.379 Sum_probs=91.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC--C---CceeeeeEEEeeCC----eEEEEEeecc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--H---PFLVNLFACFQTEA----HVCFVMEYAA 71 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--h---~ni~~~~~~~~~~~----~~~lv~e~~~ 71 (245)
||+|+|..+.+.||+|+.+.. +..-+....|.++++.++.-+ | .+||+++|.|...+ |+|+|+|++.
T Consensus 94 VWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLG 169 (590)
T KOG1290|consen 94 VWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLG 169 (590)
T ss_pred eEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhh
Confidence 899999999999999999853 444455566766666665444 4 37999999997643 8999999995
Q ss_pred CCchhhhhh---hcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHH
Q psy3347 72 GGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEI 121 (245)
Q Consensus 72 ~~~L~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~i 121 (245)
. +|..+++ ...++...++.|++|++.||.|||+ .||+|. |+||+|+
T Consensus 170 d-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT---DlKPENv 219 (590)
T KOG1290|consen 170 D-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT---DLKPENV 219 (590)
T ss_pred h-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc---CCCccee
Confidence 5 6666553 3569999999999999999999997 499999 9999988
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=210.83 Aligned_cols=211 Identities=25% Similarity=0.319 Sum_probs=151.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|... |+.||||.+-.+. +...+|+++.|+.. +||||+++++.=.++++.|+..|.|.. +|.+++
T Consensus 526 Vf~G~ye--~R~VAVKrll~e~---------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dli 593 (903)
T KOG1027|consen 526 VFRGVYE--GREVAVKRLLEEF---------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLI 593 (903)
T ss_pred EEEEeeC--CceehHHHHhhHh---------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHH
Confidence 6777775 8999999886532 22234556666554 699999999998999999999999976 899888
Q ss_pred hhc--C---CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 80 HAD--V---FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 80 ~~~--~---l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
... . ......+.+..|++.||++||+.+|+|| |+|| +||++..+ .-+...+++|+
T Consensus 594 e~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHR---DLkP-----QNILI~~~------------~~~~~~ra~iS 653 (903)
T KOG1027|consen 594 ESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHR---DLKP-----QNILISVP------------SADGTLRAKIS 653 (903)
T ss_pred hccccchhhcccccHHHHHHHHHHHHHHHHhcccccc---cCCC-----ceEEEEcc------------CCCcceeEEec
Confidence 652 1 1124567889999999999999999999 5544 44454411 01234578999
Q ss_pred ecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCccc
Q psy3347 155 DFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 230 (245)
|||+++....... ......||-.|+|||++...+-+.++||+|+||++|+.++ |..||-.. .+...+|+.+...
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~ 731 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYT 731 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccc
Confidence 9999985433222 3456678899999999988888889999999999999998 69999533 3333456666554
Q ss_pred CCCC-CCh--hHHhhhcC
Q psy3347 231 YPRF-LSL--EAIAIMRR 245 (245)
Q Consensus 231 ~p~~-~~~--~~~~li~~ 245 (245)
.... .-+ +.+|||++
T Consensus 732 L~~L~~~~d~eA~dLI~~ 749 (903)
T KOG1027|consen 732 LVHLEPLPDCEAKDLISR 749 (903)
T ss_pred eeeeccCchHHHHHHHHH
Confidence 3210 011 66777653
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-27 Score=204.00 Aligned_cols=201 Identities=27% Similarity=0.442 Sum_probs=165.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+|+.+++..|+|+++-. +...+..+.+| +.+++.++||||+.+++.|-.....+++||||.+|+|.+..+
T Consensus 31 vyKaRd~~s~elaavkvVkLe---p~dd~~~iqqe---i~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~ 104 (829)
T KOG0576|consen 31 VYKARDKRSGELAAVKVVKLE---PGDDFSGIQQE---IGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH 104 (829)
T ss_pred hhhhcccccCchhhheeeecc---CCccccccccc---eeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee
Confidence 799999999999999999865 33334444433 667889999999999999988889999999999999999886
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +++++.++...+++.+.|++|+|+.|-+|| |||=.|| ++...|.+|+.|||.+
T Consensus 105 ~TgplselqiayvcRetl~gl~ylhs~gk~hR---diKGani----------------------lltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 105 VTGPLSELQIAYVCRETLQGLKYLHSQGKIHR---DIKGANI----------------------LLTDEGDVKLADFGVS 159 (829)
T ss_pred ecccchhHHHHHHHhhhhccchhhhcCCcccc---cccccce----------------------eecccCceeecccCch
Confidence 4 689999999999999999999999999999 6666677 7777899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
........+...+.||++|||||+-.- +.|...+|+|++|++..|+..-.+|...-.++.+...+-.-.+.+|
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 765555556678899999999999853 4578899999999999999887888666666666555544444333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=199.74 Aligned_cols=178 Identities=17% Similarity=0.204 Sum_probs=122.9
Q ss_pred CEeEEEecC----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEE------EeeCCeEEEEEeec
Q psy3347 1 VILSQYRNT----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFAC------FQTEAHVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~------~~~~~~~~lv~e~~ 70 (245)
||+|.+..+ ++.||+|++.... ..+....+ .++...+.++..+... ...+...++|+||+
T Consensus 148 VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e-----~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~ 217 (566)
T PLN03225 148 VYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE-----RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYE 217 (566)
T ss_pred EEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH-----HHHhhchhhHHHHHHhhhcccccccCCceEEEEEec
Confidence 799999998 9999999886432 11111111 1112122222222221 23456899999999
Q ss_pred cCCchhhhhhhcCC---------------------ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhh
Q psy3347 71 AGGDLMMHIHADVF---------------------SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQ 129 (245)
Q Consensus 71 ~~~~L~~~~~~~~l---------------------~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~ 129 (245)
++++|.+++..... ....+..++.|++.||.|||+++|+|| |+||+||
T Consensus 218 ~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR---DLKP~NI-------- 286 (566)
T PLN03225 218 GESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR---DVKPQNI-------- 286 (566)
T ss_pred CCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC---cCCHHHE--------
Confidence 99999888854321 123456799999999999999999999 8888888
Q ss_pred hccccCcccchhccccCC-CCceEEeecCCccCCCCC-CCCCCcccCCCCccccccccCC--------------------
Q psy3347 130 ENYKVNSSQEIKLTVNDT-EGYVKIADFGLCKEGMGF-GDRTGTFCGTPEFLAPEVLTET-------------------- 187 (245)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~-~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-------------------- 187 (245)
+++. ++.+||+|||+++..... ........+++.|+|||.+...
T Consensus 287 --------------Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 287 --------------IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred --------------EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 5654 578999999999753222 2223456788999999976422
Q ss_pred --CCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 188 --SYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 188 --~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
.++.++|||||||++|||+++..++.
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 12345699999999999998766643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=189.77 Aligned_cols=209 Identities=16% Similarity=0.154 Sum_probs=135.0
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHH-----------HHHHHHHhhcCCC-----ceeeeeEEEee--------CCeEE
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSE-----------KRIFEVANTMRHP-----FLVNLFACFQT--------EAHVC 64 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e-----------~~~~~~l~~~~h~-----ni~~~~~~~~~--------~~~~~ 64 (245)
.++.||||.+....... .+++.++ ..++..+..++|. ++++++++|.. .+..+
T Consensus 185 ~~r~VAVK~l~~~~~~~---~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~ 261 (507)
T PLN03224 185 KKRRVVLKRVNMDRQGV---RQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQW 261 (507)
T ss_pred cCceEEEEEecccchhh---HHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceE
Confidence 46789999987532111 1111110 1122334444444 34777777753 35689
Q ss_pred EEEeeccCCchhhhhhhc-------------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHH
Q psy3347 65 FVMEYAAGGDLMMHIHAD-------------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119 (245)
Q Consensus 65 lv~e~~~~~~L~~~~~~~-------------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~ 119 (245)
+||||+++++|.++++.. .+++..+..++.|++.||.|+|+.+++|| |+||+
T Consensus 262 LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHr---DLKp~ 338 (507)
T PLN03224 262 LVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHR---DIKPE 338 (507)
T ss_pred EEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCchH
Confidence 999999999998877531 12456678899999999999999999999 88888
Q ss_pred HHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCC-CCcccCCCCccccccccCCC----------
Q psy3347 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR-TGTFCGTPEFLAPEVLTETS---------- 188 (245)
Q Consensus 120 ~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~---------- 188 (245)
|| +++.++.++|+|||++......... .....+++.|+|||.+....
T Consensus 339 NI----------------------Ll~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~ 396 (507)
T PLN03224 339 NL----------------------LVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAM 396 (507)
T ss_pred hE----------------------EECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhh
Confidence 88 7778889999999998643222111 11223467899999985321
Q ss_pred ----------CC--cchhHHHHHHHHHHHHhCCC-CCCCCCHH----H-------HHHHHhcCcccCC--CCCChhHHhh
Q psy3347 189 ----------YT--RAVDWWGLGVLIFEMLVGES-PFPGDDEE----E-------VFDSIVNDEVRYP--RFLSLEAIAI 242 (245)
Q Consensus 189 ----------~~--~~~DvwslG~~l~el~~g~~-pf~~~~~~----~-------~~~~~~~~~~~~p--~~~~~~~~~l 242 (245)
++ .+.|+||+||++++|+++.. ||.+.... . ....+......++ +..++..+||
T Consensus 397 ~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dL 476 (507)
T PLN03224 397 AALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDL 476 (507)
T ss_pred hhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHH
Confidence 11 24699999999999999875 76532111 1 1111122223332 5678888888
Q ss_pred hcC
Q psy3347 243 MRR 245 (245)
Q Consensus 243 i~~ 245 (245)
+.+
T Consensus 477 i~~ 479 (507)
T PLN03224 477 ACK 479 (507)
T ss_pred HHH
Confidence 753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-24 Score=166.29 Aligned_cols=175 Identities=38% Similarity=0.634 Sum_probs=142.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++.+..+|+.+++|++....... ..+.+. ++++.++.+.|++++++++++......+++||++.+++|..++.
T Consensus 9 v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~---~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~ 83 (215)
T cd00180 9 VYLARDKKTGKKVAIKIIKKEDSSS--LLEELL---REIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK 83 (215)
T ss_pred EEEEEecCCCcEEEEEEeccccchh--HHHHHH---HHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHH
Confidence 6889998889999999998653211 223343 44667778889999999999999899999999999899999986
Q ss_pred hc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-CCceEEeecC
Q psy3347 81 AD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-EGYVKIADFG 157 (245)
Q Consensus 81 ~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~kl~Dfg 157 (245)
.. .++...+..++.+++.++++||+.|++|+ |++|.|| +++. ++.++|+|||
T Consensus 84 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~---dl~~~ni----------------------~~~~~~~~~~l~d~~ 138 (215)
T cd00180 84 ENEGKLSEDEILRILLQILEGLEYLHSNGIIHR---DLKPENI----------------------LLDSDNGKVKLADFG 138 (215)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHhhE----------------------EEeCCCCcEEEecCC
Confidence 54 68999999999999999999999999999 7777777 6666 7899999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHH
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEM 205 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el 205 (245)
.+..............+...|++||.+... .++.+.|+|++|++++++
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 139 LSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 887532222112334567789999999776 778899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-25 Score=179.50 Aligned_cols=202 Identities=20% Similarity=0.287 Sum_probs=155.0
Q ss_pred EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-CeEEEEEeeccCCchhhhhh-----h----
Q psy3347 12 YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-AHVCFVMEYAAGGDLMMHIH-----A---- 81 (245)
Q Consensus 12 ~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~-----~---- 81 (245)
.|-+|.++... .+.++..+..| -.++....|||+.++.+++..+ ...+.++.++.-|+|..|+. .
T Consensus 316 ~v~vKTvk~~A--S~iQv~~~L~e---s~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~a 390 (563)
T KOG1024|consen 316 EVLVKTVKQHA--SQIQVNLLLQE---SMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYA 390 (563)
T ss_pred HHHHHHHHhcc--cHHHHHHHHHH---HHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccc
Confidence 44455555321 12233334333 4566778899999999988654 57788899998899999986 1
Q ss_pred cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 82 DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 82 ~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
..++..+.+.++.|++.|++|+|++|++|. ||--. .+++|..-++||+|=.+++.
T Consensus 391 qtvtt~qlV~masQla~am~hlh~~~ViHk--------DiAaR-----------------NCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 391 QTVTTIQLVLMASQLAMAMEHLHNHGVIHK--------DIAAR-----------------NCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred cchhHHHHHHHHHHHHHHHHHHHhcCcccc--------hhhhh-----------------cceehhheeEEeccchhccc
Confidence 246778899999999999999999999999 44322 33777778899999999984
Q ss_pred C--CCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cCCCCCCh
Q psy3347 162 G--MGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPRFLSL 237 (245)
Q Consensus 162 ~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~ 237 (245)
. .+......+...+..||+||.+....|+.++|+||||+.+|||+| |+.||...++.+....+..+.. ..|-.||+
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPD 525 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPD 525 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcH
Confidence 2 233322333345678999999999999999999999999999999 9999999999998888777644 45889999
Q ss_pred hHHhhh
Q psy3347 238 EAIAIM 243 (245)
Q Consensus 238 ~~~~li 243 (245)
++-.+|
T Consensus 526 eLf~vM 531 (563)
T KOG1024|consen 526 ELFTVM 531 (563)
T ss_pred HHHHHH
Confidence 988776
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=170.36 Aligned_cols=179 Identities=22% Similarity=0.384 Sum_probs=133.7
Q ss_pred EeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeE-EEeeCCeEEEEEeeccCCchhhhh
Q psy3347 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFA-CFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 2 ~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~-~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
.+|+|+.++..+++|.+.+.. ...+++.+| +..--.+ .|.||+.-++ .|+..+.+.+++||++.|+|..-+
T Consensus 41 lL~eHr~s~t~ivlKavp~p~----tt~~dF~rE---fhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv 113 (378)
T KOG1345|consen 41 LLAEHRQSKTRIVLKAVPRPQ----TTQADFVRE---FHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV 113 (378)
T ss_pred EeeeccCCceEEEeeccCcch----hhHHHHHHH---hccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc
Confidence 478999999999999987642 223344333 3211122 4889998887 577888999999999999999888
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
....+.+..-++++.|+++|+.|||+.+++|| |||.+|+++. -....++|+||||.+
T Consensus 114 ~~~GigE~~~K~v~~ql~SAi~fMHsknlVHR--------dlK~eNiLif---------------~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 114 EAAGIGEANTKKVFAQLLSAIEFMHSKNLVHR--------DLKAENILIF---------------DADFYRVKLCDFGLT 170 (378)
T ss_pred CcccccHHHHHHHHHHHHHHHHHhhccchhhc--------ccccceEEEe---------------cCCccEEEeeecccc
Confidence 77789999999999999999999999999999 5555555544 223458999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC---CC--CCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE---TS--YTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~--~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
+......+.. -....|-+||.+.. +. ..+..|+|.||++++..+||++||.
T Consensus 171 ~k~g~tV~~~---~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 171 RKVGTTVKYL---EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred cccCceehhh---hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 7532222211 11334788888743 22 4578999999999999999999995
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=201.21 Aligned_cols=163 Identities=15% Similarity=0.145 Sum_probs=114.4
Q ss_pred hhcCC-CceeeeeEEE-------eeCCeEEEEEeeccCCchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccC
Q psy3347 43 NTMRH-PFLVNLFACF-------QTEAHVCFVMEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112 (245)
Q Consensus 43 ~~~~h-~ni~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~ 112 (245)
+.++| +||.+++|.| .....++.+||++ +++|.+++.. ..+++..++.+++||+.||.|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr- 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH- 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec-
Confidence 44556 6888888887 2234677888977 5599999954 358999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhhhcc--ccCcccchhccccCCCCceEEeecCCccCCCCCC----------------CCCCcccC
Q psy3347 113 QSNITKEEIKRIEAKVQENY--KVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG----------------DRTGTFCG 174 (245)
Q Consensus 113 ~~~i~~~~ik~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~~ 174 (245)
|+||+|| ++...- +.......+....+.++.+|++|||+++...... ......+|
T Consensus 105 --DlKP~Ni-----Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 105 --NVRPSCF-----VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred --cCCchhE-----EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 6666665 442110 0000000000011345678889999876321100 00112457
Q ss_pred CCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 175 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
|++|+|||.+.+..++.++|||||||++|||++|.+|+..
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 8899999999988999999999999999999999888753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=155.91 Aligned_cols=106 Identities=24% Similarity=0.290 Sum_probs=89.2
Q ss_pred Cchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 73 GDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 73 ~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
|+|.++++. .++++..+..++.|++.||+|||+++ ||+|| +++.++.
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Ni----------------------l~~~~~~ 49 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNI----------------------LLTWDGL 49 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccE----------------------eEcCccc
Confidence 588888853 46999999999999999999999987 56666 7778888
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
+++ ||++...... ...|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 50 ~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 50 LKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred eee--ccceEeeccc-----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 998 9988753221 2257899999999999999999999999999999999999996543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=166.19 Aligned_cols=180 Identities=24% Similarity=0.367 Sum_probs=136.2
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+.. .++.||+|.+..... -..+.+|.+.+..+. .+.||+++.+++..+++.++|+||+++....+
T Consensus 52 v~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~g--G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~ 124 (418)
T KOG1167|consen 52 VYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLG--GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRD 124 (418)
T ss_pred hhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhc--cchhhhcchhhhccCCeeEEEecccCccCHHH
Confidence 56776666 688999999976532 234555544444333 58899999999999999999999999988888
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
++.. ++.+.+..+++.++.||+++|.+||+|| |+||+|+ +.. ...++-.|.|||
T Consensus 125 l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHR---DiKpsNF-----L~n----------------~~t~rg~LvDFg 178 (418)
T KOG1167|consen 125 LYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHR---DIKPSNF-----LYN----------------RRTQRGVLVDFG 178 (418)
T ss_pred HHhc--CCHHHHHHHHHHHHHHhhhhhccCcccc---CCCcccc-----ccc----------------cccCCceEEech
Confidence 8754 6788999999999999999999999999 6666666 333 123456788888
Q ss_pred CccCCC---------C------CC-----------------------------CCCCcccCCCCccccccccCC-CCCcc
Q psy3347 158 LCKEGM---------G------FG-----------------------------DRTGTFCGTPEFLAPEVLTET-SYTRA 192 (245)
Q Consensus 158 ~~~~~~---------~------~~-----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~ 192 (245)
++.... . .+ .......||+.|.|||++... ..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 875100 0 00 001123488999999999764 46899
Q ss_pred hhHHHHHHHHHHHHhCCCCCC
Q psy3347 193 VDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 193 ~DvwslG~~l~el~~g~~pf~ 213 (245)
.||||.|+|+..++++..||.
T Consensus 259 iDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred cceeeccceeehhhccccccc
Confidence 999999999999999999984
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-19 Score=150.12 Aligned_cols=197 Identities=36% Similarity=0.585 Sum_probs=153.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCC-ceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHP-FLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~-ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.+. ..+++|.+.............+.++ ...+..+.|+ +++++.+.+...+..+++++++.++++..+.
T Consensus 16 v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 89 (384)
T COG0515 16 VYLARDR---KLVALKVLAKKLESKSKEVERFLRE---IQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL 89 (384)
T ss_pred EEEEEec---cEEEEEeechhhccchhHHHHHHHH---HHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHH
Confidence 5667666 7789999987543332234444444 5567778887 7999999998888899999999999999777
Q ss_pred hhc----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEe
Q psy3347 80 HAD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIA 154 (245)
Q Consensus 80 ~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~ 154 (245)
... .++......++.|++.++.|+|+.+++|| |++|+|+ +++..+ .++++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hr---d~kp~ni----------------------l~~~~~~~~~l~ 144 (384)
T COG0515 90 KKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR---DIKPENI----------------------LLDRDGRVVKLI 144 (384)
T ss_pred HhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHe----------------------eecCCCCeEEEe
Confidence 654 58889999999999999999999999999 8888888 666666 69999
Q ss_pred ecCCccCCCCCCC------CCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Q psy3347 155 DFGLCKEGMGFGD------RTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVF 221 (245)
Q Consensus 155 Dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~----~~~~ 221 (245)
|||.+........ ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||..... ....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~ 224 (384)
T COG0515 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224 (384)
T ss_pred ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence 9998874322221 2356688999999999987 5678899999999999999999999876653 4444
Q ss_pred HHHhcCc
Q psy3347 222 DSIVNDE 228 (245)
Q Consensus 222 ~~~~~~~ 228 (245)
..+....
T Consensus 225 ~~~~~~~ 231 (384)
T COG0515 225 KIILELP 231 (384)
T ss_pred HHHHhcC
Confidence 4444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=159.57 Aligned_cols=159 Identities=15% Similarity=0.110 Sum_probs=110.8
Q ss_pred CEeEEEec-CCcEEEEEEeecccc--cchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRN-TGEYFAIKALKKGDI--IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++. +|+.+|||++..... ......+.+. +++++++.++|+|+++.+.. .+..++||||++|++|..
T Consensus 34 Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~---~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~ 107 (365)
T PRK09188 34 VERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAA---REIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL 107 (365)
T ss_pred EEEEEEcCCCCeEEEEEEecccccccccHHHHHHHH---HHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH
Confidence 79999887 688889998763211 0112233344 44777888899999853322 246899999999999963
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCC-CHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI-TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i-~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
... .. ...++.|++.||.|||++||+|| |+ ||+|| +++.++.++|+||
T Consensus 108 ~~~---~~---~~~~~~~i~~aL~~lH~~gIiHr---DL~KP~NI----------------------Lv~~~~~ikLiDF 156 (365)
T PRK09188 108 ARP---HG---DPAWFRSAHRALRDLHRAGITHN---DLAKPQNW----------------------LMGPDGEAAVIDF 156 (365)
T ss_pred hCc---cc---hHHHHHHHHHHHHHHHHCCCeeC---CCCCcceE----------------------EEcCCCCEEEEEC
Confidence 211 11 24678999999999999999999 88 88888 7777889999999
Q ss_pred CCccCCCCCCCC--------CCcccCCCCccccccccCC------CCCcchhHH
Q psy3347 157 GLCKEGMGFGDR--------TGTFCGTPEFLAPEVLTET------SYTRAVDWW 196 (245)
Q Consensus 157 g~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~------~~~~~~Dvw 196 (245)
|+++........ ..+..++..|+|||.+... ..+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999854322210 1244567789999999532 223446666
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-21 Score=168.75 Aligned_cols=198 Identities=37% Similarity=0.671 Sum_probs=161.7
Q ss_pred cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhh-cCCC
Q psy3347 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHA-DVFS 85 (245)
Q Consensus 8 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~ 85 (245)
..|..+|.|++++......... .-..+..+ +..++ ||.++++.-.++.++..++++++..+|.+...+.. ..+.
T Consensus 20 da~~~yamkvl~k~t~~~~~~~-~t~~er~i---l~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~ 95 (612)
T KOG0603|consen 20 DAGHLYAMKVLKKATLKVRDRT-HTKQERII---LAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFD 95 (612)
T ss_pred cccchhhhhccccccccccccc-ccccHHHH---HhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchH
Confidence 4578899999887554332222 22333333 33444 99999999999999999999999999999887754 4566
Q ss_pred hHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCC
Q psy3347 86 EPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165 (245)
Q Consensus 86 ~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 165 (245)
+.....+...++.+++++|..+++|| ++|++|| +++.+|.+++.|||+++.....
T Consensus 96 ~~~~~~~~aelaLald~lh~l~iiyr---d~k~eni----------------------lld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 96 ELDVAFYLAELALALDHLHKLGIAYR---DYKLENV----------------------LLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred HHHHHHHHHHHHHHHhhcchhHHHHh---cccccce----------------------eecccCccccCCchhhhHhHhh
Confidence 77788888999999999999999999 8888888 8889999999999999864433
Q ss_pred CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHHhhhc
Q psy3347 166 GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
... ||+..|||||++. .....+|.||||++++||++|..||.+ +....|......+|+.++.++++++.
T Consensus 151 ~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 151 KIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFR 219 (612)
T ss_pred hhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHH
Confidence 322 8999999999997 566789999999999999999999987 77788888899999999999998875
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-20 Score=149.09 Aligned_cols=206 Identities=21% Similarity=0.329 Sum_probs=149.6
Q ss_pred EeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhh
Q psy3347 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHA 81 (245)
Q Consensus 2 ~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 81 (245)
|++++. |..++.|++.-.....+.+ .++ .+++-.|+-..||||..+++.|....+..++..||+.|+|...++.
T Consensus 207 wrgrwq--gndivakil~vr~~t~ris-rdf---neefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe 280 (448)
T KOG0195|consen 207 WRGRWQ--GNDIVAKILNVREVTARIS-RDF---NEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE 280 (448)
T ss_pred cccccc--Ccchhhhhhhhhhcchhhc-chh---hhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc
Confidence 666664 7778888887543333222 222 2234455666799999999999999999999999999999999975
Q ss_pred c---CCChHHHHHHHHHHHHHHHHhhhcCc-cccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE--ee
Q psy3347 82 D---VFSEPRAVFYAACVVLGLQYLHESRI-IYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI--AD 155 (245)
Q Consensus 82 ~---~l~~~~~~~i~~~i~~~l~~lH~~~i-~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl--~D 155 (245)
+ .....++++++.+++.|++|||+..- +-| ...+...+++|.+.+.+| +|
T Consensus 281 ~t~vvvd~sqav~faldiargmaflhslep~ipr------------------------~~lns~hvmidedltarismad 336 (448)
T KOG0195|consen 281 QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPR------------------------FYLNSKHVMIDEDLTARISMAD 336 (448)
T ss_pred CccEEEecchHHHHHHHHHhhHHHHhhcchhhhh------------------------hhcccceEEecchhhhheeccc
Confidence 4 35778999999999999999998742 222 122334457777766665 23
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--c
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYT---RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--R 230 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~ 230 (245)
--++.. ......++.|++||.+...+-+ .++|+|||++.+||+.|.+.||...++++.-.++.-.+. .
T Consensus 337 ~kfsfq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ 409 (448)
T KOG0195|consen 337 TKFSFQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH 409 (448)
T ss_pred ceeeee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc
Confidence 222211 1112336779999999765543 579999999999999999999999999998888855443 4
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
+|..+++.+-.||+
T Consensus 410 ippgis~hm~klm~ 423 (448)
T KOG0195|consen 410 IPPGISRHMNKLMN 423 (448)
T ss_pred CCCCccHHHHHHHH
Confidence 78999998888875
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-18 Score=143.98 Aligned_cols=192 Identities=22% Similarity=0.214 Sum_probs=140.3
Q ss_pred CEeEEEecCC-cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEE-eeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTG-EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACF-QTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+..++ +.+|+|.......... ..+..|..++..+... ..+++..+++.+ ..+.+.++||+.+ |.+|.+
T Consensus 34 V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~d 109 (322)
T KOG1164|consen 34 VYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLED 109 (322)
T ss_pred EEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHH
Confidence 6899888775 6888888775421111 1344554444444321 235899999999 5788999999976 668888
Q ss_pred hhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 78 HIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 78 ~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+.+. +.++...+.+++.|++.+|.++|+.|++|| ||||+|+ ++...- -.....+.+.
T Consensus 110 l~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHR---DiKp~N~-----~~g~~~------------~~~~~~~~ll 169 (322)
T KOG1164|consen 110 LRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHR---DIKPENF-----VVGQSS------------RSEVRTLYLL 169 (322)
T ss_pred HHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccC---CcCHHHe-----eecCCC------------CcccceEEEE
Confidence 7742 468899999999999999999999999999 6666666 322100 0011468999
Q ss_pred ecCCcc--CCC-CCCC------C-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 155 DFGLCK--EGM-GFGD------R-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 155 Dfg~~~--~~~-~~~~------~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
|||+++ ... ..+. . .....||.+|+++....+...+++.|+||++.++.++..|..||.+..
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 999998 321 1111 1 224559999999999999999999999999999999999999997654
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.2e-20 Score=150.98 Aligned_cols=175 Identities=19% Similarity=0.263 Sum_probs=130.5
Q ss_pred CCCceeeeeEEEeeC---------------------------CeEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHH
Q psy3347 46 RHPFLVNLFACFQTE---------------------------AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL 98 (245)
Q Consensus 46 ~h~ni~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~ 98 (245)
.||||+++.++|.++ ...|+||..... +|..++-....+.....-+..|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 699999999988441 257899987655 8999997777888888999999999
Q ss_pred HHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-CCCCceEEeecCCccCCCCCCC------CCCc
Q psy3347 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN-DTEGYVKIADFGLCKEGMGFGD------RTGT 171 (245)
Q Consensus 99 ~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~kl~Dfg~~~~~~~~~~------~~~~ 171 (245)
|+.|||.+||.|| |+|++||+++ +. |.--.+.|+|||++-...+.+- ....
T Consensus 353 av~hL~~hgvAhR--------DlKSDNiL~E--------------lddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd 410 (598)
T KOG4158|consen 353 AVTHLHKHGVAHR--------DLKSDNILLE--------------LDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVD 410 (598)
T ss_pred HHHHHHHccchhh--------cccccceEEE--------------ecCCCCcEEEEcccceeeecccccccccccccccc
Confidence 9999999999999 6677777766 22 2234567899998753222221 1223
Q ss_pred ccCCCCccccccccCCCC------CcchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCcccCCCCCChhHHhhh
Q psy3347 172 FCGTPEFLAPEVLTETSY------TRAVDWWGLGVLIFEMLVGESPFPGDD--EEEVFDSIVNDEVRYPRFLSLEAIAIM 243 (245)
Q Consensus 172 ~~~~~~y~aPE~~~~~~~------~~~~DvwslG~~l~el~~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~li 243 (245)
..|....||||+....+- -.++|.|+.|.+-||++....||.++- ..+...+-....+..|+.+++.+++++
T Consensus 411 ~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 411 LGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHH
Confidence 456778999999965321 268999999999999999999997632 233334334445667999999998876
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=137.25 Aligned_cols=132 Identities=16% Similarity=0.173 Sum_probs=94.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh------HHHH--------------HHHHHHHHHHhhcCCCceeeeeEEEeeC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE------VESL--------------LSEKRIFEVANTMRHPFLVNLFACFQTE 60 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~------~~~~--------------~~e~~~~~~l~~~~h~ni~~~~~~~~~~ 60 (245)
||+|.+. +|++||+|+++......... ...+ ....++++.+..+.++++.....+. ..
T Consensus 13 Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~-~~ 90 (190)
T cd05147 13 VYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPIL-LK 90 (190)
T ss_pred EEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEE-ec
Confidence 7999987 89999999998653211110 0011 0112345666666666664433332 22
Q ss_pred CeEEEEEeeccCCchhhh-hhhcCCChHHHHHHHHHHHHHHHHh-hhcCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 61 AHVCFVMEYAAGGDLMMH-IHADVFSEPRAVFYAACVVLGLQYL-HESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 61 ~~~~lv~e~~~~~~L~~~-~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
+ .++||||++++++... +...+++...+..++.|++.+|.++ |+.||+|| |+||+||
T Consensus 91 ~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr---DlkP~NI----------------- 149 (190)
T cd05147 91 S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHA---DLSEYNL----------------- 149 (190)
T ss_pred C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE-----------------
Confidence 2 3899999998777544 4556788999999999999999999 79999999 8888888
Q ss_pred chhccccCCCCceEEeecCCccC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++ ++.++|+|||++..
T Consensus 150 -----li~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 150 -----LYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred -----EEE-CCcEEEEEcccccc
Confidence 665 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-20 Score=168.46 Aligned_cols=150 Identities=25% Similarity=0.432 Sum_probs=124.8
Q ss_pred HHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCH
Q psy3347 40 EVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118 (245)
Q Consensus 40 ~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~ 118 (245)
..-..+.|||++..++.+.+.....-.||||++ +|..++... .+...++--+++|++.|++|+|+.||.|| |+|+
T Consensus 373 ~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahr---dlK~ 448 (601)
T KOG0590|consen 373 CIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHR---DLKL 448 (601)
T ss_pred eecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceec---cCcc
Confidence 334577899998888887766555555999999 998888665 78888999999999999999999999999 8888
Q ss_pred HHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCC----CCCCcccCCCCccccccccCCCCCc-ch
Q psy3347 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG----DRTGTFCGTPEFLAPEVLTETSYTR-AV 193 (245)
Q Consensus 119 ~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~-~~ 193 (245)
+|+ ++..+|.+||+|||.+....-.. ......+|+..|+|||.+.+..|.+ ..
T Consensus 449 enl----------------------l~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~v 506 (601)
T KOG0590|consen 449 ENL----------------------LVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAV 506 (601)
T ss_pred ccE----------------------EEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchh
Confidence 888 88888999999999876332221 2345678899999999999999975 69
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q psy3347 194 DWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 194 DvwslG~~l~el~~g~~pf~~~ 215 (245)
||||.|+++..|.+|+.||...
T Consensus 507 DiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 507 DVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred hhhhccceEEEEecCCCccccc
Confidence 9999999999999999999543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-19 Score=140.14 Aligned_cols=158 Identities=15% Similarity=0.136 Sum_probs=110.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHH---HHHHHHHHHhhcCCCceeeeeEEEeeC--------CeEEEEEee
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLL---SEKRIFEVANTMRHPFLVNLFACFQTE--------AHVCFVMEY 69 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~e~~~~~~l~~~~h~ni~~~~~~~~~~--------~~~~lv~e~ 69 (245)
||++.+ +++.+|+|++...........+.+. ...++++.+.+++||+|..+.+++... +..+++|||
T Consensus 47 v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEy 124 (232)
T PRK10359 47 VSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEY 124 (232)
T ss_pred EEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEE
Confidence 577544 4778999999865433333323311 023446667788999999999986543 358999999
Q ss_pred ccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 70 AAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 70 ~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
++|.+|.++. .+++ ....+++.++..+|+.|++|+ |++|+|+ +++.+|
T Consensus 125 i~G~tL~~~~---~~~~----~~~~~i~~~l~~lH~~gi~H~---Dikp~Ni----------------------li~~~g 172 (232)
T PRK10359 125 IEGVELNDMP---EISE----DVKAKIKASIESLHQHGMVSG---DPHKGNF----------------------IVSKNG 172 (232)
T ss_pred ECCccHHHhh---hccH----HHHHHHHHHHHHHHHcCCccC---CCChHHE----------------------EEeCCC
Confidence 9999997763 2332 345689999999999999999 8889888 777778
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHH
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEM 205 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 205 (245)
++++|||.+........ . ........+..++|+||||+++.-.
T Consensus 173 -i~liDfg~~~~~~e~~a--~----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA--K----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -EEEEECCCcccccchhh--H----------HHHHHHhHhcccccccceeEeehHH
Confidence 99999998764211110 0 1123344567789999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-18 Score=132.26 Aligned_cols=132 Identities=16% Similarity=0.158 Sum_probs=96.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh------------------HHH--HHHHHHHHHHHhhcCCCceeeeeEEEeeC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE------------------VES--LLSEKRIFEVANTMRHPFLVNLFACFQTE 60 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~------------------~~~--~~~e~~~~~~l~~~~h~ni~~~~~~~~~~ 60 (245)
||+|.+. +|+.||||+++......... ... .....++.+.+..+.|+++.....+....
T Consensus 13 Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 91 (190)
T cd05145 13 VYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKK 91 (190)
T ss_pred EEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecC
Confidence 7999887 89999999998653111000 000 01113446667777788875555444333
Q ss_pred CeEEEEEeeccCCchhh-hhhhcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 61 AHVCFVMEYAAGGDLMM-HIHADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 61 ~~~~lv~e~~~~~~L~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
.++||||++|+++.. .+....++...+..++.|++.++.++|+ +|++|+ |++|+||
T Consensus 92 --~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr---DlkP~NI----------------- 149 (190)
T cd05145 92 --NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG---DLSEYNI----------------- 149 (190)
T ss_pred --CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecC---CCChhhE-----------------
Confidence 489999999875533 3455668888999999999999999999 999999 8888888
Q ss_pred chhccccCCCCceEEeecCCccC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++ ++.++|+|||++..
T Consensus 150 -----ll~-~~~~~liDFG~a~~ 166 (190)
T cd05145 150 -----LYH-DGKPYIIDVSQAVE 166 (190)
T ss_pred -----EEE-CCCEEEEEccccee
Confidence 666 68899999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=133.30 Aligned_cols=187 Identities=18% Similarity=0.236 Sum_probs=143.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
+|.|.+..+|+.||||+-+.... ...+..|.++..+|+. ...|..+.-++....+-.+|||.+ |-+|.+.+.
T Consensus 31 Iy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~--g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfn 102 (341)
T KOG1163|consen 31 IYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQG--GVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFN 102 (341)
T ss_pred eeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhcc--CCCCchhhhhccccccceeeeecc-CccHHHHHH
Confidence 48899999999999998875432 2345566777777763 456777777888888999999977 668988774
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...++......++-|++.-++|+|.++.+|| ||||+|. +-- +-....++-++|||+
T Consensus 103 fC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHR---DIKPdNF-----LMG--------------lgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 103 FCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHR---DIKPDNF-----LMG--------------LGRHCNKLYLIDFGL 160 (341)
T ss_pred HHhhhhhHHhHHHHHHHHHHHHHHHHhhccccc---cCCccce-----eec--------------cccccceEEEEeccc
Confidence 3567888899999999999999999999999 6666555 322 111234578999999
Q ss_pred ccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 159 CKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 159 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
|+..-+... ......||.+|.+--...+...+...|+-|+|.++...-.|..||.+..+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 975433222 13356799999988877777788999999999888888889999988644
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-18 Score=156.12 Aligned_cols=177 Identities=34% Similarity=0.732 Sum_probs=131.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||..+|+.|.+++|+|+-+.. . +.+. ++...++|.++ |+-...++
T Consensus 99 vylvrh~~trqrfa~kiNkq~-l--------ilRn-----ilt~a~npfvv---------------------gDc~tllk 143 (1205)
T KOG0606|consen 99 VYLVRHKETRQRFAMKINKQN-L--------ILRN-----ILTFAGNPFVV---------------------GDCATLLK 143 (1205)
T ss_pred eeeeeccccccchhhcccccc-h--------hhhc-----cccccCCccee---------------------chhhhhcc
Confidence 788999999999999433321 0 0000 23333444443 34344443
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ++++... +.+++|+|+-||+|| |+||+|+ ++..-|.+|+.|||++
T Consensus 144 ~~g~lPvdm--------vla~Eylh~ygivhr---dlkpdnl----------------------lIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 144 NIGPLPVDM--------VLAVEYLHSYGIVHR---DLKPDNL----------------------LITSMGHIKLTDFGLS 190 (1205)
T ss_pred cCCCCcchh--------hHHhHhhccCCeecC---CCCCCcc----------------------eeeecccccccchhhh
Confidence 3 3454322 789999999999999 8888888 8888899999999988
Q ss_pred cCC-CCCC--------C------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 160 KEG-MGFG--------D------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 160 ~~~-~~~~--------~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+.. +... + .....+||+.|+|||++.-+.|+..+|.|++|+|+||.+-|+.||.+.++++++.++
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 621 1110 0 112358999999999999999999999999999999999999999999999999999
Q ss_pred hcCcccCCC---CCChhHHhhhcC
Q psy3347 225 VNDEVRYPR---FLSLEAIAIMRR 245 (245)
Q Consensus 225 ~~~~~~~p~---~~~~~~~~li~~ 245 (245)
+.....+|+ .+++|+++++++
T Consensus 271 isd~i~wpE~dea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 271 ISDDIEWPEEDEALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccccccCcCCCHHHHHHHHH
Confidence 998888874 467888888763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-18 Score=140.62 Aligned_cols=210 Identities=21% Similarity=0.248 Sum_probs=119.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-------CCceeeeeEEEeeC------------C
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-------HPFLVNLFACFQTE------------A 61 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-------h~ni~~~~~~~~~~------------~ 61 (245)
||.+.|.+||+++|+|+............+.+++|.-.+..+.... |-.++-.++...-. +
T Consensus 28 v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~ 107 (288)
T PF14531_consen 28 VFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQS 107 (288)
T ss_dssp EEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTE
T ss_pred EEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCc
Confidence 6899999999999999887654333334555544421111111111 11234444443221 1
Q ss_pred -----eEEEEEeeccCCchhhhhh----hcCC----ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHh
Q psy3347 62 -----HVCFVMEYAAGGDLMMHIH----ADVF----SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128 (245)
Q Consensus 62 -----~~~lv~e~~~~~~L~~~~~----~~~l----~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~ 128 (245)
..+++|+-+. ++|.+++. .... .......+..|++..++++|+.|++|+ |++|+|+
T Consensus 108 ~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg---di~~~nf------- 176 (288)
T PF14531_consen 108 IYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG---DIKPENF------- 176 (288)
T ss_dssp EEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES---T-SGGGE-------
T ss_pred cceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec---ccceeeE-------
Confidence 2367888774 47766653 1222 122334567899999999999999999 8888887
Q ss_pred hhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC--------CCCcchhHHHHHH
Q psy3347 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET--------SYTRAVDWWGLGV 200 (245)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwslG~ 200 (245)
+++.+|.+.|+||+..... +........+..|.|||..... .++.+.|.|+||+
T Consensus 177 ---------------ll~~~G~v~Lg~F~~~~r~---g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 177 ---------------LLDQDGGVFLGDFSSLVRA---GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp ---------------EE-TTS-EEE--GGGEEET---TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ---------------EEcCCCCEEEcChHHHeec---CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 8899999999999865431 1111112334668999987432 4678899999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHH-HHhcCcccCCCCCChhHHhhhc
Q psy3347 201 LIFEMLVGESPFPGDDEEEVFD-SIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 201 ~l~el~~g~~pf~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~li~ 244 (245)
++|.|+.+..||.......... ....+ ..+|+.+++||+
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~~f~~C-----~~~Pe~v~~LI~ 278 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEWDFSRC-----RDMPEPVQFLIR 278 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGGGGTTS-----S---HHHHHHHH
T ss_pred HHHHHHHccCCCCCCCccccccccchhc-----CCcCHHHHHHHH
Confidence 9999999999997554322111 11111 156667777764
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=133.05 Aligned_cols=197 Identities=21% Similarity=0.291 Sum_probs=149.3
Q ss_pred EeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh-
Q psy3347 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH- 80 (245)
Q Consensus 2 ~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~- 80 (245)
+.|.+.-++++||||.-.... +...+..|-|...+|. ..++|.+.+-+...+-+..||+|.+ |-||.+.+.
T Consensus 45 f~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~--g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~ 116 (449)
T KOG1165|consen 45 FLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLG--GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL 116 (449)
T ss_pred ecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHc--CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH
Confidence 567777889999999776542 2345566777777776 5678888887777777899999977 668888773
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...++...+..++.|++.-++++|++.+++| ||||+|+++... --.....+-++|||++
T Consensus 117 CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYR--------DIKPdNFLIGrp------------~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 117 CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYR--------DIKPDNFLIGRP------------GTKDANVIHIIDFGMA 176 (449)
T ss_pred hcCcccHHhHHHHHHHHHHHHHHHHhcceeec--------ccCccceeecCC------------CCCCCceEEEEeccch
Confidence 4578999999999999999999999999999 455555555531 1112345889999999
Q ss_pred cCCCCCCCC-------CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhc
Q psy3347 160 KEGMGFGDR-------TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFDSIVN 226 (245)
Q Consensus 160 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~---~~~~~~~~~~~ 226 (245)
+...+.... .....||.+||+-..-.|...+.+.|+-|||-++...+.|..||.|- +..+-.++|-.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 865443322 22456899999999889999999999999998888888999999774 44455555543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=122.57 Aligned_cols=170 Identities=15% Similarity=0.119 Sum_probs=114.6
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCCChH
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEP 87 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~ 87 (245)
.+++++.+.+.....+...-... ...+|+++|++++ |+++.+++++ +..+++|||+.|.+|......
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~--l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------ 91 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWW--LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------ 91 (218)
T ss_pred CCceeeecccccchhhhhhHHHH--HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------
Confidence 57788888777643221111111 2244577777884 5788888886 346999999999888654321
Q ss_pred HHHHHHHHHHHHHHHhhhcCccccCCCCC-CHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCC
Q psy3347 88 RAVFYAACVVLGLQYLHESRIIYRPQSNI-TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG 166 (245)
Q Consensus 88 ~~~~i~~~i~~~l~~lH~~~i~H~~~~~i-~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 166 (245)
....++.|++.+|.++|++||+|+ |+ +|+|| +++.++.++|+|||++.......
T Consensus 92 ~~~~~~~qi~~~L~~lH~~GIvHr---DL~kp~NI----------------------Lv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 92 GDLAYFRAARRLLQQLHRCGVAHN---DLAKEANW----------------------LVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred hhHHHHHHHHHHHHHHHHCcCccC---CCCCcceE----------------------EEcCCCCEEEEECCCceecCCcc
Confidence 124578899999999999999999 88 67888 77788899999999997432222
Q ss_pred CC----C---------CcccCCCCccccccccC-CCCC-cchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 167 DR----T---------GTFCGTPEFLAPEVLTE-TSYT-RAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 167 ~~----~---------~~~~~~~~y~aPE~~~~-~~~~-~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
.. . .-...++.|+.|+.-.. ...+ ...+.++.|+-+|.++|+..|+.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0 00112445666655533 2455 4456669999999999998887544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.4e-16 Score=122.37 Aligned_cols=123 Identities=12% Similarity=0.106 Sum_probs=88.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-----CCCceeeeeEEEeeC---Ce-EEEEEee--
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-----RHPFLVNLFACFQTE---AH-VCFVMEY-- 69 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-----~h~ni~~~~~~~~~~---~~-~~lv~e~-- 69 (245)
||. |..++.. +||++..... ...+.+.+| +..++.+ +||||++++|++.++ +. +.+|+||
T Consensus 18 Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rE---i~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G 88 (210)
T PRK10345 18 CYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRE---LKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDG 88 (210)
T ss_pred EEE--CCCCcCe-EEEEEecccc---chHHHHHHH---HHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCC
Confidence 563 7777776 6998875421 223445555 4455555 689999999999876 34 3488999
Q ss_pred ccCCchhhhhhhcCCChHHHHHHHHHHHHHH-HHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC--
Q psy3347 70 AAGGDLMMHIHADVFSEPRAVFYAACVVLGL-QYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-- 146 (245)
Q Consensus 70 ~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-- 146 (245)
+.+++|.+++++..+++. ..++.|++.++ +|||+++|+|| |+||+|| +++
T Consensus 89 ~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~Ivhr---DlKp~NI----------------------Ll~~~ 141 (210)
T PRK10345 89 KPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTM---ELKPQNI----------------------LCQRI 141 (210)
T ss_pred CcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeec---CCCHHHE----------------------EEecc
Confidence 447899999977666655 45678888777 99999999999 7777777 443
Q ss_pred --CCCceEEeecCCc
Q psy3347 147 --TEGYVKIADFGLC 159 (245)
Q Consensus 147 --~~~~~kl~Dfg~~ 159 (245)
.++.++|+|++.+
T Consensus 142 ~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 142 SESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCCcEEEEECCCC
Confidence 3457999995544
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-16 Score=135.17 Aligned_cols=160 Identities=21% Similarity=0.311 Sum_probs=123.6
Q ss_pred HhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCc-cccCCCCCCH
Q psy3347 42 ANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRI-IYRPQSNITK 118 (245)
Q Consensus 42 l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i-~H~~~~~i~~ 118 (245)
|+.+.|.|+.+++|.+.+++..+.|.+||..|+|.+.+... .+++-....++++++.||+|+|...| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg------- 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHG------- 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeee-------
Confidence 35678999999999999999999999999999999999654 46677778899999999999999877 788
Q ss_pred HHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCC--CCCCCCcccCCCCccccccccCC---C----C
Q psy3347 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMG--FGDRTGTFCGTPEFLAPEVLTET---S----Y 189 (245)
Q Consensus 119 ~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~---~----~ 189 (245)
++++. .+++|....+|++|||+...... .............|.|||.+.+. . .
T Consensus 74 -~l~s~-----------------nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 74 -ALKSS-----------------NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred -eeccc-----------------cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccc
Confidence 33333 33778888999999998765322 11112222334579999999763 1 3
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhc
Q psy3347 190 TRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVN 226 (245)
Q Consensus 190 ~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~ 226 (245)
+.++|+||||++++|+++.+.||... .+.+....+..
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence 56799999999999999999999652 33456666655
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=150.70 Aligned_cols=181 Identities=19% Similarity=0.261 Sum_probs=128.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
|.+|+|++ | .|+||++-+.. .....+.+.+..++++ ...+++||++++.-+-..+.-.|+|=+|..+ +|.+.+.
T Consensus 39 v~r~k~~e-G-~vVvKVFvk~~--p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlS 112 (1431)
T KOG1240|consen 39 VARAKDRE-G-LVVVKVFVKQD--PTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLS 112 (1431)
T ss_pred hhhccCCC-c-eEEEEEEeccC--CCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhc
Confidence 34666664 4 49999987653 2333444555444454 4566899999998887777777888888865 8888886
Q ss_pred hc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 AD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
-. .+...+.+.|+-|++.||.-||..||+|+ |||.+|| ++.+=.-+-|+||...
T Consensus 113 TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHG---DIKsENI----------------------LiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 113 TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHG---DIKSENI----------------------LITSWNWLYLTDFASF 167 (1431)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHcCcccc---ccccceE----------------------EEeeechhhhhccccc
Confidence 44 46777888999999999999999999999 6655555 4445455788999876
Q ss_pred cCC---CCCCCCCCcccCC----CCccccccccC----------CC-CCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 160 KEG---MGFGDRTGTFCGT----PEFLAPEVLTE----------TS-YTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 160 ~~~---~~~~~~~~~~~~~----~~y~aPE~~~~----------~~-~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+.. .+++.....+..| ..|.|||-+.. .+ .+++.||+|+||+++|+++ |.+||
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 531 1112111112222 35999998842 12 5688999999999999988 89999
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.9e-15 Score=116.48 Aligned_cols=130 Identities=19% Similarity=0.187 Sum_probs=98.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHH--HHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVE--SLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~--~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++ +|..+++|+.........+... ...+..++++.+..+.|+++.....++...+..+++|||++|++|.++
T Consensus 12 vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~ 89 (211)
T PRK14879 12 IYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDL 89 (211)
T ss_pred EEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHH
Confidence 688877 6889999987643221111111 112234456667777888888888887777888999999999999988
Q ss_pred hhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 79 IHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 79 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
+..... ....++.+++.+|.++|+.|++|+ |++|.|| +++ ++.++++|||.
T Consensus 90 ~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~---Dl~p~Ni----------------------l~~-~~~~~liDf~~ 140 (211)
T PRK14879 90 INSNGM---EELELSREIGRLVGKLHSAGIIHG---DLTTSNM----------------------ILS-GGKIYLIDFGL 140 (211)
T ss_pred HHhccH---HHHHHHHHHHHHHHHHHhCCcccC---CCCcccE----------------------EEE-CCCEEEEECCc
Confidence 854321 778899999999999999999999 8888888 565 67899999998
Q ss_pred ccC
Q psy3347 159 CKE 161 (245)
Q Consensus 159 ~~~ 161 (245)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-15 Score=120.15 Aligned_cols=133 Identities=16% Similarity=0.153 Sum_probs=91.2
Q ss_pred CEeEE-EecCCcEEEEEEeecccccchh-----------------hHH-HHHHHHHHHHHHhhcCCCceeeeeEEEeeCC
Q psy3347 1 VILSQ-YRNTGEYFAIKALKKGDIIARD-----------------EVE-SLLSEKRIFEVANTMRHPFLVNLFACFQTEA 61 (245)
Q Consensus 1 V~~a~-~~~~~~~vaiK~~~~~~~~~~~-----------------~~~-~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~ 61 (245)
||+|. +..+|+.||+|+++........ ..+ ......++++.+..+.+ +.+.+..++...
T Consensus 44 Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~-~~i~~p~~~~~~- 121 (237)
T smart00090 44 VYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE-AGVPVPKPIAWR- 121 (237)
T ss_pred EEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCeeeEec-
Confidence 79998 6678999999999864311000 000 00111334555555544 233333333333
Q ss_pred eEEEEEeeccCCchhhhh-hhcCCChHHHHHHHHHHHHHHHHhhhcC-ccccCCCCCCHHHHHHHHHHhhhccccCcccc
Q psy3347 62 HVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESR-IIYRPQSNITKEEIKRIEAKVQENYKVNSSQE 139 (245)
Q Consensus 62 ~~~lv~e~~~~~~L~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~-i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~ 139 (245)
..++||||+++.+|.... .........+..++.|++.+++++|+.| ++|+ |++|+||
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~---Dikp~NI------------------ 180 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHG---DLSEYNI------------------ 180 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeC---CCChhhE------------------
Confidence 348999999998886654 4445566677899999999999999999 9999 8888888
Q ss_pred hhccccCCCCceEEeecCCccC
Q psy3347 140 IKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 140 ~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++ ++.++|+|||.+..
T Consensus 181 ----li~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 181 ----LVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred ----EEE-CCCEEEEEChhhhc
Confidence 666 67899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=113.39 Aligned_cols=127 Identities=18% Similarity=0.128 Sum_probs=91.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh--hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD--EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+ +|+.+++|+.........+ ......+..++++.++.+.|+++.....++...+..+++|||++|++|.+.
T Consensus 10 vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~ 87 (199)
T TIGR03724 10 IYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDV 87 (199)
T ss_pred EEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHH
Confidence 688874 5889999986643211111 111112223446666677777765555555566778999999999999887
Q ss_pred hhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 79 IHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 79 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
+..... .++.+++.+|.++|+.|++|+ |++|.|+ +++ ++.++++|||+
T Consensus 88 ~~~~~~------~~~~~i~~~l~~lH~~gi~H~---Dl~~~Ni----------------------l~~-~~~~~liDfg~ 135 (199)
T TIGR03724 88 IEEGND------ELLREIGRLVGKLHKAGIVHG---DLTTSNI----------------------IVR-DDKLYLIDFGL 135 (199)
T ss_pred HhhcHH------HHHHHHHHHHHHHHHCCeecC---CCCcceE----------------------EEE-CCcEEEEECCC
Confidence 644211 789999999999999999999 8888777 666 68899999998
Q ss_pred ccC
Q psy3347 159 CKE 161 (245)
Q Consensus 159 ~~~ 161 (245)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.9e-15 Score=135.54 Aligned_cols=186 Identities=20% Similarity=0.256 Sum_probs=135.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+.+ |+.||+|+=+....|.- .+- .++.+.|+..--+.|..+..++...+..++|+||.+.|+|.++++
T Consensus 714 vy~a~~~~-~~~~alK~e~P~~~WEf-----YI~-~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N 786 (974)
T KOG1166|consen 714 VYVATHSN-GKLVALKVEKPPNPWEF-----YIC-LQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN 786 (974)
T ss_pred EEEeecCC-CcEEEEEeecCCCceee-----eeh-HHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc
Confidence 79998887 99999999887654421 111 111122221112467777777777888999999999999999996
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++.....++.|++.-++++|..+|+|+ |||| +|+++..... .....--++|+|||.+
T Consensus 787 ~~~~m~e~lv~~~~~qml~ive~lH~~~IIHg---DiKP-----DNfll~~~~~----------~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 787 TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHG---DIKP-----DNFLLRREIC----------ADSDSKGLYLIDFGRS 848 (974)
T ss_pred cCCCCCchhhhHHHHHHHHHHHHHHhcceecc---cCCc-----ceeEeecccC----------CCCcccceEEEecccc
Confidence 4 467899999999999999999999999999 5555 4445543221 1112345899999988
Q ss_pred cCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy3347 160 KEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESP 211 (245)
Q Consensus 160 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~p 211 (245)
.-..-.+. .-....+|-.+-.+|...|++++..+|.|.|+.+++.|+.|+..
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 64322222 22334566678889999999999999999999999999998753
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.3e-16 Score=131.08 Aligned_cols=118 Identities=20% Similarity=0.304 Sum_probs=98.7
Q ss_pred eEEEEEeeccCCchhhhhhhc----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcc
Q psy3347 62 HVCFVMEYAAGGDLMMHIHAD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSS 137 (245)
Q Consensus 62 ~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~ 137 (245)
+.++.|++|...+|.+|+.+. ..+......++.|++.|++| ++.+|+ |++|.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihr---dlkp~ni---------------- 387 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHR---DLKPSNI---------------- 387 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhh---hcccccc----------------
Confidence 589999999999999999643 34566788899999999999 999999 8888888
Q ss_pred cchhccccCCCCceEEeecCCccCCCCCC------CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh
Q psy3347 138 QEIKLTVNDTEGYVKIADFGLCKEGMGFG------DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV 207 (245)
Q Consensus 138 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~ 207 (245)
....+..+||.|||+........ ......+||.+||+||++.+..|+.++||||||.+++|++.
T Consensus 388 ------f~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 388 ------FFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ------ccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 44445589999999876543322 13456789999999999999999999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-13 Score=124.01 Aligned_cols=126 Identities=19% Similarity=0.144 Sum_probs=91.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccch--hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR--DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+. ++.+++|+......... .......+..++++.++.++|+++.....++......++||||+++++|.++
T Consensus 349 Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~ 426 (535)
T PRK09605 349 IKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDV 426 (535)
T ss_pred EEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHH
Confidence 6887664 44555554432211111 1101112234557778888899998888877777778999999999999887
Q ss_pred hhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 79 IHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 79 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
+. ....++.+++.+|.+||+.|++|| |++|+|| ++ .++.++|+|||+
T Consensus 427 l~-------~~~~~~~~i~~~L~~lH~~giiHr---Dlkp~NI----------------------Ll-~~~~~~liDFGl 473 (535)
T PRK09605 427 LE-------GNPELVRKVGEIVAKLHKAGIVHG---DLTTSNF----------------------IV-RDDRLYLIDFGL 473 (535)
T ss_pred HH-------HHHHHHHHHHHHHHHHHhCCCccC---CCChHHE----------------------EE-ECCcEEEEeCcc
Confidence 75 356789999999999999999999 8888888 55 467899999999
Q ss_pred ccC
Q psy3347 159 CKE 161 (245)
Q Consensus 159 ~~~ 161 (245)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=3e-13 Score=108.78 Aligned_cols=130 Identities=15% Similarity=0.212 Sum_probs=89.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccch---hh--H--HHHHHHHHHHHHHhhcCCCce--eeeeEEEeeC-C---eEEEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR---DE--V--ESLLSEKRIFEVANTMRHPFL--VNLFACFQTE-A---HVCFVM 67 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~---~~--~--~~~~~e~~~~~~l~~~~h~ni--~~~~~~~~~~-~---~~~lv~ 67 (245)
||.+... +..+++|.+.+...... .. . ....+..++++++..++|+++ ...+++.... + ..++||
T Consensus 48 v~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~ 125 (239)
T PRK01723 48 TWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI 125 (239)
T ss_pred EEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence 3555443 78899998875432111 00 0 111223445667777777764 6677764332 2 235999
Q ss_pred eeccC-CchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 68 EYAAG-GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 68 e~~~~-~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
|+++| .+|.+++....++.. .+.+++.++.+||++||+|+ |++|.|| +++
T Consensus 126 e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~Hr---Dlkp~NI----------------------Lv~ 176 (239)
T PRK01723 126 ERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHA---DLNAHNI----------------------LLD 176 (239)
T ss_pred EecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCC---CCCchhE----------------------EEc
Confidence 99997 689888876666543 35789999999999999999 8888888 777
Q ss_pred CCCceEEeecCCccC
Q psy3347 147 TEGYVKIADFGLCKE 161 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~ 161 (245)
.++.++|+|||.+..
T Consensus 177 ~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 PDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCEEEEECCCccc
Confidence 778899999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-13 Score=106.53 Aligned_cols=126 Identities=17% Similarity=0.132 Sum_probs=87.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh------HH----------HHHHHHHHHHHHhhcCCCc--eeeeeEEEeeCCe
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE------VE----------SLLSEKRIFEVANTMRHPF--LVNLFACFQTEAH 62 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~------~~----------~~~~e~~~~~~l~~~~h~n--i~~~~~~~~~~~~ 62 (245)
||+|.+. +|+.||||++.......... .. ......+++..+..+.|++ +...++ .+.
T Consensus 31 Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~ 105 (198)
T cd05144 31 VYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNR 105 (198)
T ss_pred EEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCC
Confidence 6888775 79999999987532110000 00 0011233455555665653 333333 234
Q ss_pred EEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhc
Q psy3347 63 VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKL 142 (245)
Q Consensus 63 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~ 142 (245)
.+++|||+++++|...... .....++.+++.++.++|+.|++|+ |++|+|+
T Consensus 106 ~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~---Dl~p~Ni--------------------- 156 (198)
T cd05144 106 HAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHG---DLSEFNI--------------------- 156 (198)
T ss_pred ceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcC---CCCcccE---------------------
Confidence 5899999999888664321 3456788999999999999999999 8888888
Q ss_pred cccCCCCceEEeecCCccC
Q psy3347 143 TVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 143 ~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++.++.++|+|||.+..
T Consensus 157 -ll~~~~~~~liDfg~~~~ 174 (198)
T cd05144 157 -LVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred -EEcCCCcEEEEECCcccc
Confidence 778889999999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-12 Score=100.19 Aligned_cols=129 Identities=16% Similarity=0.172 Sum_probs=82.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHH------------------HHHHHHHHHHhhcCCC--ceeeeeEEEeeC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESL------------------LSEKRIFEVANTMRHP--FLVNLFACFQTE 60 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------~~e~~~~~~l~~~~h~--ni~~~~~~~~~~ 60 (245)
||+|.+. +|+.||||++.............. .....+.+.+..+.+. .+.++++.
T Consensus 13 Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~---- 87 (187)
T cd05119 13 VYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL---- 87 (187)
T ss_pred EEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----
Confidence 7899887 899999999876432111111100 0001223333333222 23444433
Q ss_pred CeEEEEEeeccCCchhhh-hhhcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 61 AHVCFVMEYAAGGDLMMH-IHADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 61 ~~~~lv~e~~~~~~L~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
...+++|||++++++... +...... ..+..++.+++.++.++|+ +|++|+ |++|+||
T Consensus 88 ~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~---Dl~p~Ni----------------- 146 (187)
T cd05119 88 NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHG---DLSEYNI----------------- 146 (187)
T ss_pred CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcC---CCChhhE-----------------
Confidence 235899999998544221 1111111 5678899999999999999 999999 8888888
Q ss_pred chhccccCCCCceEEeecCCccC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++ ++.++++|||.+..
T Consensus 147 -----li~-~~~~~liDfg~a~~ 163 (187)
T cd05119 147 -----LVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred -----EEE-CCcEEEEECccccc
Confidence 666 78899999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-12 Score=113.84 Aligned_cols=168 Identities=20% Similarity=0.359 Sum_probs=117.8
Q ss_pred EEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcC
Q psy3347 4 SQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADV 83 (245)
Q Consensus 4 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 83 (245)
|.-+.++.+|.+.+++.... +..+.. .+.++.|+.++||||+++++.+..++..|+|+|-+. .|..+++.
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~---~~~~~~---~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNG---EVTELA---KRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred cceeccCCceEEEEEeCCCc---hhhHHH---HHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--
Confidence 55677899999999987542 222222 345788899999999999999999999999999764 55555543
Q ss_pred CChHHHHHHHHHHHHHHHHhh-hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCC
Q psy3347 84 FSEPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG 162 (245)
Q Consensus 84 l~~~~~~~i~~~i~~~l~~lH-~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~ 162 (245)
+......-.+.||+.||.||| +.+++|+ +++.+. ++++..|.-||++|..+...
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHg---Nv~~~S----------------------VfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHG---NVCKDS----------------------VFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeec---cEeeee----------------------EEEcCCCcEEEeeeEEEecc
Confidence 224445566889999999997 6689999 443333 38889999999999876543
Q ss_pred CCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC
Q psy3347 163 MGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG 208 (245)
Q Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g 208 (245)
...........--..|..|+.+.... -..|.|.|||.+++++.|
T Consensus 156 ~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 156 SGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 22221111111122355666552222 347999999999999999
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.8e-14 Score=126.63 Aligned_cols=177 Identities=29% Similarity=0.447 Sum_probs=134.4
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-hhc--CCC
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI-HAD--VFS 85 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~--~l~ 85 (245)
...+|.|.+.... ......+....+ ...-+.+. |+|++++++.....+..++.+++..++++.... ... ..+
T Consensus 46 ~~~~a~~~~s~~~-~~~~~~~~i~~e---~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~ 121 (601)
T KOG0590|consen 46 ESSSATKPISIPP-KSEDSSEHIDTE---TDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTS 121 (601)
T ss_pred cceeeccCCCCCC-CccchhhhcCcc---ccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCC
Confidence 4456666665443 111222222222 22233444 999999999999999999999999999998877 433 467
Q ss_pred hHHHHHHHHHHHHHHHHhh-hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEeecCCccCCC
Q psy3347 86 EPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIADFGLCKEGM 163 (245)
Q Consensus 86 ~~~~~~i~~~i~~~l~~lH-~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~ 163 (245)
...+.+++.|+..++.|+| ..++.|+ +++|+|. +++..+ ..++.|||++....
T Consensus 122 ~~~~~~~~~ql~s~l~~~H~~~~~~h~---~ikP~n~----------------------~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 122 SSSASRYLPQLNSGLSYLHPENGVTHR---DIKPSNS----------------------LLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcchhhhhhhhccCccccCcccccccC---CCCCccc----------------------hhccCCCcccCCCchhhcccc
Confidence 7888999999999999999 9999999 8888877 777777 89999999998654
Q ss_pred C-CCC--CCCcccC-CCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 164 G-FGD--RTGTFCG-TPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 164 ~-~~~--~~~~~~~-~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
. .+. .....+| ++.|+|||...+.. ..+..|+||+|+++..+.+|..|+...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 4 222 2334567 89999999998854 467899999999999999999998543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.5e-11 Score=89.90 Aligned_cols=122 Identities=17% Similarity=0.129 Sum_probs=90.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++.+. ++.+++|....... ...+.+|...+..++.. ..++.++++++..++..+++|||+.++.+...
T Consensus 14 v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~-~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-- 83 (155)
T cd05120 14 VYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARK-GLPVPKVLASGESDGWSYLLMEWIEGETLDEV-- 83 (155)
T ss_pred eEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHc-CCCCCeEEEEcCCCCccEEEEEecCCeecccC--
Confidence 5777764 47899999875421 23444454444444332 25888898888888899999999988777544
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhc---CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHES---RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+......++.+++.+++++|.. +++|+ |++|+|+ +++..+.+++.|||
T Consensus 84 ----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~---Dl~~~Ni----------------------l~~~~~~~~l~Df~ 134 (155)
T cd05120 84 ----SEEEKEDIAEQLAELLAKLHQLPLLVLCHG---DLHPGNI----------------------LVDDGKILGIIDWE 134 (155)
T ss_pred ----CHHHHHHHHHHHHHHHHHHhCCCceEEEec---CCCcceE----------------------EEECCcEEEEEecc
Confidence 4556677889999999999985 79999 7777777 66667889999999
Q ss_pred CccC
Q psy3347 158 LCKE 161 (245)
Q Consensus 158 ~~~~ 161 (245)
.+..
T Consensus 135 ~~~~ 138 (155)
T cd05120 135 YAGY 138 (155)
T ss_pred cccC
Confidence 8763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.2e-12 Score=102.65 Aligned_cols=145 Identities=24% Similarity=0.317 Sum_probs=104.9
Q ss_pred HhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCchhhhhhh-----cCCChHHHHHHHHHHHHHHHHhhhcC--cc
Q psy3347 42 ANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLHESR--II 109 (245)
Q Consensus 42 l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~--i~ 109 (245)
+-.+.|.|+++++.++.+.. ...++.||+..|++..++++ ..+......+|+.||+.||.|||+.. ++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 33557999999999986643 47899999999999999964 24778888999999999999999874 78
Q ss_pred ccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCC--C--CCCCCcccCCCCcccccccc
Q psy3347 110 YRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMG--F--GDRTGTFCGTPEFLAPEVLT 185 (245)
Q Consensus 110 H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~--~~~~~~~~~~~~y~aPE~~~ 185 (245)
|+ +.+++-+ .+..+|-+|++--.......+ . ........+-+.|.+||.-.
T Consensus 201 hg---nlTc~ti----------------------fiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 201 HG---NLTCDTI----------------------FIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cC---Ccchhhe----------------------eecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc
Confidence 88 5555555 556677777654332221000 0 00111223456788999876
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCC
Q psy3347 186 ETSYTRAVDWWGLGVLIFEMLVGESP 211 (245)
Q Consensus 186 ~~~~~~~~DvwslG~~l~el~~g~~p 211 (245)
.-..+.++|||+||+...+|..++.-
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHheec
Confidence 66677889999999999999887764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.4e-10 Score=99.72 Aligned_cols=85 Identities=15% Similarity=0.118 Sum_probs=61.2
Q ss_pred eeeeEEEe-eCCeEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHH-HHHHhhhcCccccCCCCCCHHHHHHHHHHh
Q psy3347 51 VNLFACFQ-TEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL-GLQYLHESRIIYRPQSNITKEEIKRIEAKV 128 (245)
Q Consensus 51 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~-~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~ 128 (245)
+.+..++. ..+..++||||++|++|.+......... ....++.+++. .+..+|..|++|+ |++|.||
T Consensus 220 v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H~---D~hPgNi------- 288 (437)
T TIGR01982 220 VYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFHA---DLHPGNI------- 288 (437)
T ss_pred EEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCceeC---CCCcccE-------
Confidence 44444442 2445799999999999987764221111 23456666655 4688999999999 8888888
Q ss_pred hhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++.++.++++|||++..
T Consensus 289 ---------------lv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 289 ---------------FVLKDGKIIALDFGIVGR 306 (437)
T ss_pred ---------------EECCCCcEEEEeCCCeeE
Confidence 778889999999999865
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-09 Score=82.71 Aligned_cols=94 Identities=11% Similarity=0.109 Sum_probs=65.9
Q ss_pred HHHHHhhcC--CCceeeeeEEEeeCCeEEEEEeeccCCchh-hhhhhcCCChHHHHHHHHHHHHHHHHh-hhcCccccCC
Q psy3347 38 IFEVANTMR--HPFLVNLFACFQTEAHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYL-HESRIIYRPQ 113 (245)
Q Consensus 38 ~~~~l~~~~--h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~i~H~~~ 113 (245)
|+..|+++. .-++..++++ +..++||||++++.+. ..++...++...+..+..+++.+|..+ |+.|++|+
T Consensus 76 E~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG-- 149 (197)
T cd05146 76 EMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHA-- 149 (197)
T ss_pred HHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecC--
Confidence 344444442 2355556654 4568999999875442 233444455666778889999999988 89999999
Q ss_pred CCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 114 ~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
|+++.|| +++ ++.+.++|||.+..
T Consensus 150 -DLs~~NI----------------------L~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 -DLSEYNM----------------------LWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred -CCCHHHE----------------------EEE-CCcEEEEECCCcee
Confidence 8888888 554 46799999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.5e-11 Score=110.46 Aligned_cols=174 Identities=30% Similarity=0.527 Sum_probs=130.3
Q ss_pred CCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc-CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHH
Q psy3347 47 HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125 (245)
Q Consensus 47 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~ 125 (245)
+|.++...--+......+++++|+.+++|...++.- ..+..-++.....+..++++||+..+.|+ +.+|.++
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~---~~~p~~~---- 935 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHR---DLKPDSL---- 935 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcc---cccccch----
Confidence 344444333344556789999999999998888654 46666677778889999999999999999 6666666
Q ss_pred HHhhhccccCcccchhccccCCCCceEEeecCCccCC--C-------------------------CCC----CCCCcccC
Q psy3347 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG--M-------------------------GFG----DRTGTFCG 174 (245)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~--~-------------------------~~~----~~~~~~~~ 174 (245)
++..+|..++.|||..... . ... .......+
T Consensus 936 ------------------l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 997 (1205)
T KOG0606|consen 936 ------------------LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVG 997 (1205)
T ss_pred ------------------hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccC
Confidence 4445566666666522100 0 000 01223467
Q ss_pred CCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC---CCCChhHHhhhcC
Q psy3347 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---RFLSLEAIAIMRR 245 (245)
Q Consensus 175 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---~~~~~~~~~li~~ 245 (245)
+.-|.+||...+....+.+|.|++|.++.|.++|.+||....+...++.+..+..++| ...++++++++.+
T Consensus 998 t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ 1071 (1205)
T KOG0606|consen 998 TPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINR 1071 (1205)
T ss_pred CCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhh
Confidence 8899999999999999999999999999999999999999999999999999988875 5678888887753
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.3e-10 Score=97.91 Aligned_cols=182 Identities=20% Similarity=0.170 Sum_probs=127.4
Q ss_pred CEeEEE--ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQY--RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||.++. ..++..+|+|.-+....... ..+.. .+++..-+.. .|+|.++....+...+..++-+|.+. .+|..
T Consensus 132 ~~~~~~~~~~s~~~~a~k~s~~p~s~p~---~~~~k-~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~ 206 (524)
T KOG0601|consen 132 VFKSRCTNSESPHKFAVKKSKIPFSPPL---DSKRK-LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQS 206 (524)
T ss_pred eecccCCcccCCcccccccccCCCCCcc---ccccc-cchhhcccccCccccccccCcccccCCcceeeecccc-chhHH
Confidence 466666 77899999998543221111 11111 1223222223 48999998899999999999999885 57766
Q ss_pred hhh--hcCCChHHHHHHHHHHHH----HHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-Cc
Q psy3347 78 HIH--ADVFSEPRAVFYAACVVL----GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-GY 150 (245)
Q Consensus 78 ~~~--~~~l~~~~~~~i~~~i~~----~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 150 (245)
+-. ...++...++....+... |+.++|+++++|. +++|+|+ ....+ ..
T Consensus 207 ~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~---~~kp~~i----------------------~~~~~~~s 261 (524)
T KOG0601|consen 207 YCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHD---DLKPANI----------------------FTTSDWTS 261 (524)
T ss_pred hhhcccccCCchhhhhHHhhhhhcccccccccCCCccccc---ccchhhe----------------------ecccccce
Confidence 653 234778888888889988 9999999999999 8888888 45555 67
Q ss_pred eEEeecCCccCCCCCCCC-----CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 151 VKIADFGLCKEGMGFGDR-----TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
++++|||+.....+..-. .....|...|++||...+ .++...|++++|.++.+..++..+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 888999876532221111 112246677999999844 47788999999999999988766553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.98 E-value=1e-09 Score=97.23 Aligned_cols=83 Identities=12% Similarity=0.103 Sum_probs=55.0
Q ss_pred CCceeeeeEEEee-CCeEEEEEeeccCCchhhh--hhhcCC-----ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCH
Q psy3347 47 HPFLVNLFACFQT-EAHVCFVMEYAAGGDLMMH--IHADVF-----SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118 (245)
Q Consensus 47 h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~--~~~~~l-----~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~ 118 (245)
+.+.+.+..++.+ ....++||||+.|+++.+. +..... .+..+..++.| +.+.|++|+ |++|
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHa---DpHP 288 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHA---DMHP 288 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeC---CCCh
Confidence 3444555555532 4567899999999999764 232222 22233333444 446999999 8888
Q ss_pred HHHHHHHHHhhhccccCcccchhccccCCCC----ceEEeecCCccC
Q psy3347 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEG----YVKIADFGLCKE 161 (245)
Q Consensus 119 ~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~kl~Dfg~~~~ 161 (245)
.|| +++.+| ++++.|||+...
T Consensus 289 GNI----------------------lv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 289 GNI----------------------FVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHe----------------------EEecCCCCCCeEEEEecceEEE
Confidence 888 666666 899999998864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.8e-09 Score=78.27 Aligned_cols=117 Identities=21% Similarity=0.130 Sum_probs=76.0
Q ss_pred CcEEEEEEeecccccchhhHHHH-----HHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCC
Q psy3347 10 GEYFAIKALKKGDIIARDEVESL-----LSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVF 84 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~-----~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l 84 (245)
|.++++|.=-++..-..+-.+.+ .+|.+++..++.. .|.-..-++.+.+...++|||.+|..|.+.+...
T Consensus 19 g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~---GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-- 93 (204)
T COG3642 19 GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA---GVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-- 93 (204)
T ss_pred CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc---CCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--
Confidence 66666664433322222222222 3344444444433 3333333444677788999999998988887554
Q ss_pred ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 85 SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 85 ~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
...+++.+-.-+.-||.+||+|+ |++++|+ .+.+ +.+.++|||++..
T Consensus 94 ----~~~~~r~vG~~vg~lH~~givHG---DLTtsNi----------------------Il~~-~~i~~IDfGLg~~ 140 (204)
T COG3642 94 ----RPDLLREVGRLVGKLHKAGIVHG---DLTTSNI----------------------ILSG-GRIYFIDFGLGEF 140 (204)
T ss_pred ----chHHHHHHHHHHHHHHhcCeecC---CCccceE----------------------EEeC-CcEEEEECCcccc
Confidence 24567778888899999999999 8888888 5544 3499999999875
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=87.76 Aligned_cols=161 Identities=16% Similarity=0.205 Sum_probs=113.8
Q ss_pred EeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccC-Cchh
Q psy3347 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAG-GDLM 76 (245)
Q Consensus 2 ~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~-~~L~ 76 (245)
|+|...-+|..|++|++...+.-.... .....+.++++.|+|+|++.++|.. +...++|++|.++ ++|.
T Consensus 293 yk~~s~~DG~~YvLkRlhg~r~~~~nk------~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 293 YKATSNVDGNAYVLKRLHGDRDQSTNK------DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred EeeeeccCCceeeeeeeccccccCccc------chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 789899999999999995432111111 1233677889999999999999863 3478999999985 6776
Q ss_pred hhhh-h---------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 77 MHIH-A---------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 77 ~~~~-~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
+..- . ...++..++.++.|+..||.++|+.|+.-+ -+.+.+|
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck---~L~~~kI------------------- 424 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACK---TLDLKKI------------------- 424 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceee---cccHhHe-------------------
Confidence 5441 1 125678899999999999999999999777 5555555
Q ss_pred hccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGES 210 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 210 (245)
+++++.+++|+..|.......++ + |.+.+. .+-|.=.||.++..|.+|..
T Consensus 425 ---lv~G~~RIriS~C~i~Dvl~~d~-------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 425 ---LVTGKMRIRISGCGIMDVLQEDP-------T-------EPLESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ---EeeCcceEEEecccceeeecCCC-------C-------cchhHH---hhhhHHHHHHHHHHHhhccc
Confidence 77777778887777543221111 0 111111 34699999999999999854
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.8e-09 Score=78.80 Aligned_cols=117 Identities=14% Similarity=0.142 Sum_probs=76.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+++.. |+.|++|+...... .......|.+.++.+... ..+.+++... ....++|||+++|.++...
T Consensus 14 vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~--~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~-- 81 (170)
T cd05151 14 NYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEA--GIGPKLYYFD--PETGVLITEFIEGSELLTE-- 81 (170)
T ss_pred eEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHh--CCCCceEEEe--CCCCeEEEEecCCCccccc--
Confidence 5777654 88999998865421 112234444444444322 1234455443 3335799999999877543
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCc-----cccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRI-----IYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i-----~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
... ...+..+++.+|+.||+.++ +|+ |++|+|+ +++ ++.++++|
T Consensus 82 --~~~---~~~~~~~l~~~l~~LH~~~~~~~~~~Hg---D~~~~Ni----------------------l~~-~~~~~liD 130 (170)
T cd05151 82 --DFS---DPENLEKIAKLLKKLHSSPLPDLVPCHN---DLLPGNF----------------------LLD-DGRLWLID 130 (170)
T ss_pred --ccc---CHHHHHHHHHHHHHHhCCCCCCceeecC---CCCcCcE----------------------EEE-CCeEEEEe
Confidence 111 13456789999999999985 999 8888888 666 56799999
Q ss_pred cCCcc
Q psy3347 156 FGLCK 160 (245)
Q Consensus 156 fg~~~ 160 (245)
|+.+.
T Consensus 131 f~~a~ 135 (170)
T cd05151 131 WEYAG 135 (170)
T ss_pred ccccc
Confidence 99875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.9e-07 Score=75.20 Aligned_cols=132 Identities=10% Similarity=-0.014 Sum_probs=83.9
Q ss_pred cCCcEEEEEEeecccccchhhHH----------HHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccC
Q psy3347 8 NTGEYFAIKALKKGDIIARDEVE----------SLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAG 72 (245)
Q Consensus 8 ~~~~~vaiK~~~~~~~~~~~~~~----------~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~ 72 (245)
..|+.|.||....... . +-++ ...+|.+.+..|...+- .+..++.++.. ....++|||++++
T Consensus 43 ~~g~~~~vKr~~~~~~-~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GI-ptP~pVa~~e~~~~~~~~~s~LVte~l~~ 119 (268)
T PRK15123 43 LAGKSYFLKWHRGTGW-G-EIFKNLLSLRMPVLGADREWRAIHRLHEVGV-DTMTGVAFGERGSNPATRTSFIITEDLAP 119 (268)
T ss_pred ECCEEEEEEEecCCcH-H-HHhhhhcccccccHHHHHHHHHHHHHHHcCC-CCCCeeEEEEecCCCccceeEEEEeeCCC
Confidence 3578899997754321 1 0111 24456555555544432 33445555533 2357899999987
Q ss_pred C-chhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 73 G-DLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 73 ~-~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
. +|.+++.. .+.+......++.+++..+.-||+.||+|+ |+++.|| ++.... ..-+.+
T Consensus 120 ~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~Hg---DL~~~Ni-----Ll~~~~----------~~~~~~ 181 (268)
T PRK15123 120 TISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHR---DCYICHF-----LLHLPF----------PGREED 181 (268)
T ss_pred CccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccC---CCChhhE-----EEeccc----------cCCCCC
Confidence 5 78888752 344556777899999999999999999999 7777777 221000 000124
Q ss_pred CceEEeecCCcc
Q psy3347 149 GYVKIADFGLCK 160 (245)
Q Consensus 149 ~~~kl~Dfg~~~ 160 (245)
+.+.++||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 678999999775
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.5e-08 Score=73.80 Aligned_cols=129 Identities=19% Similarity=0.187 Sum_probs=73.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh--------------------hHHHHHHHHHHHHHHhhcCCC--ceeeeeEEEe
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD--------------------EVESLLSEKRIFEVANTMRHP--FLVNLFACFQ 58 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~--------------------~~~~~~~e~~~~~~l~~~~h~--ni~~~~~~~~ 58 (245)
||.|... .|+.+|+|+.+.....-.. .........+|...|..+..- ++.+++++.
T Consensus 2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 7888775 5789999999754211100 000112234556666666544 455555442
Q ss_pred eCCeEEEEEeecc--CCchhhhhhhcCCChHHHHHHHHHHHHHHHH-hhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 59 TEAHVCFVMEYAA--GGDLMMHIHADVFSEPRAVFYAACVVLGLQY-LHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 59 ~~~~~~lv~e~~~--~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
..++||||++ |..+.. +....++......++.+++..+.. +|+.|++|+ |+.+.||
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHG---DLs~~NI-------------- 138 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHG---DLSEYNI-------------- 138 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEES---S-STTSE--------------
T ss_pred ---CCEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceec---CCChhhE--------------
Confidence 2369999998 544443 333333355667788888885555 579999999 5555566
Q ss_pred cccchhccccCCCCceEEeecCCccC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++.+ .+.++|||.+..
T Consensus 139 --------lv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 139 --------LVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp --------EEETT-CEEE--GTTEEE
T ss_pred --------Eeecc-eEEEEecCccee
Confidence 66554 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.9e-07 Score=69.07 Aligned_cols=128 Identities=17% Similarity=0.092 Sum_probs=78.0
Q ss_pred CCcEEEEEEeecccccchh-----hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccC-Cchhhhhhhc
Q psy3347 9 TGEYFAIKALKKGDIIARD-----EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAG-GDLMMHIHAD 82 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~ 82 (245)
.|+.+.||.--.+..-... ...+-.+| ...+.++.--.|.-..-++.+.+.-++.|||.+| .++.+++...
T Consensus 29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~E---ar~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~ 105 (229)
T KOG3087|consen 29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQE---ARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILST 105 (229)
T ss_pred CCceeEEeecccccccchHHHHHHHHHHHHHH---HHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHH
Confidence 4888888843322211111 12223344 4444444333444444466677778899999977 4667776431
Q ss_pred ---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 83 ---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 83 ---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.........+++.+-+.+.-||+++++|+ |++.+|| ++. ..+....+-++|||++
T Consensus 106 ~~~~~~d~~~~~~~~~iG~~igklH~ndiiHG---DLTTSNi-----ll~--------------~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 106 MEDESEDEGLAELARRIGELIGKLHDNDIIHG---DLTTSNI-----LLR--------------SDGNQITPILIDFGLS 163 (229)
T ss_pred ccCcccchhHHHHHHHHHHHHHHhhhCCeecc---cccccce-----EEe--------------cCCCcCceEEEeecch
Confidence 22223336788999999999999999999 7778788 111 1222234579999998
Q ss_pred cC
Q psy3347 160 KE 161 (245)
Q Consensus 160 ~~ 161 (245)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.7e-07 Score=72.12 Aligned_cols=104 Identities=15% Similarity=0.148 Sum_probs=70.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC---CeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE---AHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~---~~~~lv~e~~~~~~L~~ 77 (245)
||++.... |+.+++|........ .....+.+|.+.++.++.. +.++.+++.+.... +..+++||+++|.++..
T Consensus 14 ~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~-~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~ 89 (223)
T cd05154 14 TYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGT-GVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRD 89 (223)
T ss_pred EEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCC-CCCCCCEEEECCCCCccCCceEEEEEeCCEecCC
Confidence 57776543 688999988654221 1233455565555555442 33456677766543 36789999999988877
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCc
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRI 108 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i 108 (245)
......+++.....++.+++.+|..||+...
T Consensus 90 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 120 (223)
T cd05154 90 RLLRPELSPEERRALARALADTLAALHSVDP 120 (223)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhCCCh
Confidence 5533457788888999999999999998653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=4e-08 Score=85.79 Aligned_cols=173 Identities=17% Similarity=0.213 Sum_probs=117.8
Q ss_pred cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh-hcCCCh
Q psy3347 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH-ADVFSE 86 (245)
Q Consensus 8 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~ 86 (245)
.++..|++|-+..........+..+ ...+..-....|.+++++...+....+.++-.|||++++...... ...+.+
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl---~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~ 365 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSL---GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDE 365 (524)
T ss_pred CCCceEeChhhhccccchHhhhcch---hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCc
Confidence 4667788887765432222221111 111111122258889998888888778889999999988876652 234677
Q ss_pred HHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-CceEEeecCCccCCCCC
Q psy3347 87 PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-GYVKIADFGLCKEGMGF 165 (245)
Q Consensus 87 ~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~kl~Dfg~~~~~~~~ 165 (245)
...+++..|++.++.++|+..++|+ |++|+|| .+.++ +..+++|||+.......
T Consensus 366 ~~~~~~~~q~~~~l~~i~s~~~~~~---d~~psni----------------------~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 366 DPRLRLTAQILTALNVIHSKLFVHL---DVKPSNI----------------------LISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhhHHHHHhccccccchhhhcc---cccccce----------------------eeccchhhhhcccccccccccee
Confidence 7889999999999999999999999 8888888 33333 67889999987631111
Q ss_pred CCCCCcccCCCCcc--ccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy3347 166 GDRTGTFCGTPEFL--APEVLTETSYTRAVDWWGLGVLIFEMLVGESP 211 (245)
Q Consensus 166 ~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslG~~l~el~~g~~p 211 (245)
.......-++. ++.......+..++|++|||..+.+.+++...
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 11222233344 45555556788999999999999999987654
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.7e-08 Score=85.21 Aligned_cols=98 Identities=35% Similarity=0.499 Sum_probs=74.2
Q ss_pred HHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCC---
Q psy3347 93 AACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR--- 168 (245)
Q Consensus 93 ~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 168 (245)
+.+++.|+.|+|++ +++|+ +|.|++| .++.++..||+.|+.+....+..+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~---ni~p~~i----------------------~~na~~~wkl~Gf~f~v~~~~~~~~p~~ 159 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHG---NIQPEAI----------------------VVNANGDWKLAGFSFCVNANGPTEYPFS 159 (700)
T ss_pred hhcccchhhhhccCcceeec---ccchhhe----------------------eeccCcceeeccchhhhccCCCCccccc
Confidence 34566899999976 79999 8888888 8889999999999987643332111
Q ss_pred ------CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHH-hCCCCCCCC
Q psy3347 169 ------TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGD 215 (245)
Q Consensus 169 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~-~g~~pf~~~ 215 (245)
.........|.|||.+.+...++++|++|+|+.+|.+. .|+..+...
T Consensus 160 ~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 160 EYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhcc
Confidence 11112235699999998877789999999999999999 477776443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.7e-06 Score=69.95 Aligned_cols=127 Identities=23% Similarity=0.286 Sum_probs=95.3
Q ss_pred EEEEEeeccC-Cchhhhhh----h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhcccc
Q psy3347 63 VCFVMEYAAG-GDLMMHIH----A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKV 134 (245)
Q Consensus 63 ~~lv~e~~~~-~~L~~~~~----~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~ 134 (245)
.-+.|....+ ..+.++++ + ....++.+.+.++.++.+.+-+|.+|-.=+ |++++++
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vG---DVn~~~~------------- 148 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVG---DVNQNSF------------- 148 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCccc---ccCccce-------------
Confidence 6678887765 34555553 1 246789999999999999999999998767 8888777
Q ss_pred CcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHh-C
Q psy3347 135 NSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLV-G 208 (245)
Q Consensus 135 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~-g 208 (245)
++..++.+.+.|=..... ...+....+.+|...|++||.-.- ..-+...|.+.||+.+++++. |
T Consensus 149 ---------lVsd~~~V~LVdsDsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~gg 218 (637)
T COG4248 149 ---------LVSDDSKVVLVDSDSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGG 218 (637)
T ss_pred ---------eeecCceEEEEcccceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcC
Confidence 777888888887543322 223334556788999999998752 233467899999999999987 5
Q ss_pred CCCCCCC
Q psy3347 209 ESPFPGD 215 (245)
Q Consensus 209 ~~pf~~~ 215 (245)
..||+|.
T Consensus 219 rHPysGI 225 (637)
T COG4248 219 RHPYSGI 225 (637)
T ss_pred CCCCCcc
Confidence 9999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.1e-05 Score=61.84 Aligned_cols=104 Identities=13% Similarity=0.080 Sum_probs=75.0
Q ss_pred HHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccC-Cchhhhhhh-cCCChHHHHHHHHHHHHHHHHhhh
Q psy3347 32 LLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAG-GDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHE 105 (245)
Q Consensus 32 ~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~ 105 (245)
..+|.+.+..|...+ -.+..++.+..... ..++++|++++ .+|.+++.. ...+......++.+++..+.-||+
T Consensus 58 a~~E~~~~~~L~~~G-i~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 58 AKREWRNLQRLREAG-IPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHcC-CCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 444555555555432 34566666665422 46899999987 488888865 335666778899999999999999
Q ss_pred cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC---ceEEeecCCccC
Q psy3347 106 SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG---YVKIADFGLCKE 161 (245)
Q Consensus 106 ~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~kl~Dfg~~~~ 161 (245)
+|+.|+ |+++.|| +++.++ .+.++||+-++.
T Consensus 137 ~gi~H~---Dl~~~NI----------------------Lv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 137 AGIYHG---DLNPSNI----------------------LVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CcCCCC---CCCcccE----------------------EEeCCCCceeEEEEcchhcee
Confidence 999999 7777777 555554 788999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.8e-05 Score=59.83 Aligned_cols=124 Identities=13% Similarity=0.167 Sum_probs=71.9
Q ss_pred EEEecCCcEEEEEEeecccccchhhHHHHHH---HHHHHHHHhhc---CCCceeeeeEEEee-----CCeEEEEEeeccC
Q psy3347 4 SQYRNTGEYFAIKALKKGDIIARDEVESLLS---EKRIFEVANTM---RHPFLVNLFACFQT-----EAHVCFVMEYAAG 72 (245)
Q Consensus 4 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~---e~~~~~~l~~~---~h~ni~~~~~~~~~-----~~~~~lv~e~~~~ 72 (245)
|.-.-.|+.+.+|..+......+..+.++.+ ..+.+..+..+ +-.....++-+... ....+++|||++|
T Consensus 48 alIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG 127 (229)
T PF06176_consen 48 ALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEG 127 (229)
T ss_pred EEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecC
Confidence 3333457788888877654333333333321 11222222222 22233333333322 2345689999999
Q ss_pred CchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 73 GDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 73 ~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
..|.+... +++ .+...+.+++.-+|+.|++|+ |..|.|+ ++.. +.++
T Consensus 128 ~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HG---D~hpgNF----------------------lv~~-~~i~ 174 (229)
T PF06176_consen 128 VELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHG---DPHPGNF----------------------LVSN-NGIR 174 (229)
T ss_pred eecccchh---cCH----HHHHHHHHHHHHHHHcCCccC---CCCcCcE----------------------EEEC-CcEE
Confidence 88765431 222 244567788999999999999 6666666 5554 4499
Q ss_pred EeecCCcc
Q psy3347 153 IADFGLCK 160 (245)
Q Consensus 153 l~Dfg~~~ 160 (245)
+.|++..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998655
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00013 Score=57.19 Aligned_cols=106 Identities=14% Similarity=0.080 Sum_probs=75.7
Q ss_pred hHHHHHHHHHHHHHHhhcCCCceeeeeEEEe-e--C--CeEEEEEeeccC-CchhhhhhhcCC---ChHHHHHHHHHHHH
Q psy3347 28 EVESLLSEKRIFEVANTMRHPFLVNLFACFQ-T--E--AHVCFVMEYAAG-GDLMMHIHADVF---SEPRAVFYAACVVL 98 (245)
Q Consensus 28 ~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~-~--~--~~~~lv~e~~~~-~~L~~~~~~~~l---~~~~~~~i~~~i~~ 98 (245)
....+.+|.+.++.|...+=| +.++. ++. . + ...+||+|-+++ .+|.+++....+ +......+..+++.
T Consensus 62 g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~ 139 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVAL 139 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHH
Confidence 346677887777777766555 55555 332 1 1 257899998765 688888865444 55666789999999
Q ss_pred HHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc--eEEeecCCcc
Q psy3347 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY--VKIADFGLCK 160 (245)
Q Consensus 99 ~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~kl~Dfg~~~ 160 (245)
.+.-||+.|+.|+ +..+-|| +++.++. ++++||.-++
T Consensus 140 ~ia~LH~~Gv~Hg---dly~khI----------------------ll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 140 AFKKMHSVNRQHG---CCYVRHI----------------------YVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred HHHHHHHCCCcCC---CCCHhhe----------------------eecCCCCeeEEEEEhhccc
Confidence 9999999999999 5555555 5554455 8999998665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0001 Score=59.56 Aligned_cols=126 Identities=17% Similarity=0.163 Sum_probs=80.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh------h----------HHHHHHHHHHHHHHhhcCCC--ceeeeeEEEeeCCe
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD------E----------VESLLSEKRIFEVANTMRHP--FLVNLFACFQTEAH 62 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~------~----------~~~~~~e~~~~~~l~~~~h~--ni~~~~~~~~~~~~ 62 (245)
||.|.+. .|.++|+|.-+....+... . .-.-...+++++.|..+... .+...+++ +.
T Consensus 107 VY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nR 181 (304)
T COG0478 107 VYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NR 181 (304)
T ss_pred EEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----cc
Confidence 6888776 5899999977654321110 0 11123345667777766432 34444443 44
Q ss_pred EEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhc
Q psy3347 63 VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKL 142 (245)
Q Consensus 63 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~ 142 (245)
-++|||+.+|..|...- +....+..++..|++-+.-.-..|++|+ |+.+=||
T Consensus 182 HaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHG---DlSefNI--------------------- 233 (304)
T COG0478 182 HAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHG---DLSEFNI--------------------- 233 (304)
T ss_pred ceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCcccc---CCchheE---------------------
Confidence 67999999886664332 1234445555666666666668999999 6666677
Q ss_pred cccCCCCceEEeecCCcc
Q psy3347 143 TVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 143 ~~~~~~~~~kl~Dfg~~~ 160 (245)
+++.+|.+.++||--+.
T Consensus 234 -lV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 234 -LVTEDGDIVVIDWPQAV 250 (304)
T ss_pred -EEecCCCEEEEeCcccc
Confidence 89999999999997554
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.78 E-value=1.5e-05 Score=70.98 Aligned_cols=144 Identities=23% Similarity=0.262 Sum_probs=102.9
Q ss_pred HHHHHhhcCCCc-eeeeeEEEeeCCeEEEEEeeccCC-chhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCC
Q psy3347 38 IFEVANTMRHPF-LVNLFACFQTEAHVCFVMEYAAGG-DLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113 (245)
Q Consensus 38 ~~~~l~~~~h~n-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~ 113 (245)
++++|.+++||| .+..++-+..+....+.++++.++ +-...... -.+.+.+...+.+.-.++++++|+.--+|++
T Consensus 283 ~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d- 361 (829)
T KOG0576|consen 283 AIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD- 361 (829)
T ss_pred HHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc-
Confidence 467899999999 777777777778899999999876 33222211 1233444555666678889999988656772
Q ss_pred CCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcch
Q psy3347 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAV 193 (245)
Q Consensus 114 ~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 193 (245)
| ....++..+..||+........ .......+++.++|||......+....
T Consensus 362 ------~-----------------------~l~s~~~~~~~~~~v~~~L~~~-~~~~t~~~~~~~~~pev~~~~~~~~~p 411 (829)
T KOG0576|consen 362 ------N-----------------------ILGSEEEVKLLDFAVPPQLTRT-MKPRTAIGTPEPLAPEVIQENTIDGCP 411 (829)
T ss_pred ------c-----------------------ccccccccccccccCCcccCcc-cccccCCCCCCCCCchhhcccccccCC
Confidence 1 2233466888999976643222 235566789999999999888899999
Q ss_pred hHHHHHHHHHHHHhCCCCC
Q psy3347 194 DWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 194 DvwslG~~l~el~~g~~pf 212 (245)
|.|++|.--.++.-|.+|-
T Consensus 412 ~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 412 DSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CccCCCcchhhcCCCCCCC
Confidence 9999998777777777664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00029 Score=56.26 Aligned_cols=74 Identities=15% Similarity=0.103 Sum_probs=52.5
Q ss_pred eEEEEEeeccCC-chhhhhhhcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccc
Q psy3347 62 HVCFVMEYAAGG-DLMMHIHADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQE 139 (245)
Q Consensus 62 ~~~lv~e~~~~~-~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~ 139 (245)
...|||||.+.. .-.-.++.-++...++..+..+++..+.-|-. .|++|+ |+..=||
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHg---DLSEyNi------------------ 198 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHG---DLSEYNI------------------ 198 (268)
T ss_pred CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccc---cchhhhe------------------
Confidence 346999999753 22333333334444678888899999988887 899999 4444466
Q ss_pred hhccccCCCCceEEeecCCccC
Q psy3347 140 IKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 140 ~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+.. ++.+-|+|+|-+..
T Consensus 199 ----L~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 199 ----LVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred ----EEE-CCeEEEEECccccc
Confidence 555 78899999997764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00065 Score=60.47 Aligned_cols=83 Identities=16% Similarity=0.228 Sum_probs=55.6
Q ss_pred eeeeEEE-eeCCeEEEEEeeccCCchhhh--hhhcCCChHHHHHHHHHHHHH-HHHhhhcCccccCCCCCCHHHHHHHHH
Q psy3347 51 VNLFACF-QTEAHVCFVMEYAAGGDLMMH--IHADVFSEPRAVFYAACVVLG-LQYLHESRIIYRPQSNITKEEIKRIEA 126 (245)
Q Consensus 51 ~~~~~~~-~~~~~~~lv~e~~~~~~L~~~--~~~~~l~~~~~~~i~~~i~~~-l~~lH~~~i~H~~~~~i~~~~ik~~~~ 126 (245)
+.+-.+| +..+.-.++|||+.|..+.+. ++....+. +.++..++.+ +..+-..|++|. |.-|.||
T Consensus 228 v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~dgffHa---DpHpGNi----- 296 (517)
T COG0661 228 VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLRDGFFHA---DPHPGNI----- 296 (517)
T ss_pred eEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhcCcccc---CCCccce-----
Confidence 3444444 345678899999999888766 34445553 2333333222 344556899999 5555577
Q ss_pred HhhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++.+|++.+.|||+...
T Consensus 297 -----------------~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 297 -----------------LVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred -----------------EEecCCcEEEEcCcceec
Confidence 888889999999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0035 Score=48.84 Aligned_cols=104 Identities=15% Similarity=0.170 Sum_probs=66.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccch------------------hhHHHHHHHHHHHHHHhhcCCCce--eeeeEEEeeC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR------------------DEVESLLSEKRIFEVANTMRHPFL--VNLFACFQTE 60 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~------------------~~~~~~~~e~~~~~~l~~~~h~ni--~~~~~~~~~~ 60 (245)
||+++. .|+.||+|+.+.-..... ....-+..|.|.+..|+..++.++ ++.+|+....
T Consensus 54 V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~ 131 (207)
T PF13095_consen 54 VFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLT 131 (207)
T ss_pred EEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEc
Confidence 566655 488999999332110000 122346778888999998888888 9999987332
Q ss_pred ------------------CeEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHH
Q psy3347 61 ------------------AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121 (245)
Q Consensus 61 ------------------~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~i 121 (245)
....||.||..... .+.. +-+.++++-+..+|..||+-+ |+++.|.
T Consensus 132 ~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k~gI~~~---Dv~~~ny 195 (207)
T PF13095_consen 132 EDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHKLGIVPR---DVKPRNY 195 (207)
T ss_pred hHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHHCCeeec---cCccccc
Confidence 02357777765432 2232 334566777788999999988 5544444
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0022 Score=49.70 Aligned_cols=92 Identities=14% Similarity=0.157 Sum_probs=65.8
Q ss_pred HHhhcCC-CceeeeeEEEeeCCeEEEEEeeccCCchhh----hhhhcCCChHHHHHHHHHHHHHHHHhhhc--CccccCC
Q psy3347 41 VANTMRH-PFLVNLFACFQTEAHVCFVMEYAAGGDLMM----HIHADVFSEPRAVFYAACVVLGLQYLHES--RIIYRPQ 113 (245)
Q Consensus 41 ~l~~~~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~i~H~~~ 113 (245)
++..+++ +++.+++|.|. .+++.|+.+.+++.. ..+....++..+.+++.++++.+.+++.. |-+|.
T Consensus 12 ll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~l-- 85 (188)
T PF12260_consen 12 LLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYL-- 85 (188)
T ss_pred HHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEE--
Confidence 3444443 58999999992 357889998665531 11112467899999999999999999874 22332
Q ss_pred CCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 114 ~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
.|++++|+ .++.+|++|+.|.....
T Consensus 86 cDv~~~nf----------------------gv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 86 CDVSPDNF----------------------GVNDDGRLKLIDLDDVF 110 (188)
T ss_pred eecchHHe----------------------EEeCCCcEEEEechhcc
Confidence 47777777 77788999999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0086 Score=48.15 Aligned_cols=91 Identities=11% Similarity=0.002 Sum_probs=57.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+.... +..+.+|...... .....+|.+.+..+... --+.+++++...++..++|||+++|.++.....
T Consensus 15 v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~--~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~ 84 (244)
T cd05150 15 VYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGK--LPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE 84 (244)
T ss_pred EEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhc--CCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence 4555432 4678888776432 22344565556555532 346677777766667899999999987754321
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHES 106 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~ 106 (245)
......++.+++..+..+|+.
T Consensus 85 -----~~~~~~~~~~l~~~l~~lH~i 105 (244)
T cd05150 85 -----ELEPERLVDALAEALRRLHAL 105 (244)
T ss_pred -----ccCHHHHHHHHHHHHHHHhcC
Confidence 122345677788888888875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0093 Score=57.19 Aligned_cols=151 Identities=21% Similarity=0.205 Sum_probs=98.4
Q ss_pred HHHHHhhcCCCceeeeeEEEeeCCe----EEEEEeeccCCchhhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccC
Q psy3347 38 IFEVANTMRHPFLVNLFACFQTEAH----VCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112 (245)
Q Consensus 38 ~~~~l~~~~h~ni~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~ 112 (245)
+++.+....|+|+..++.+-...-. ..+..+++...++...+. -..++....+.+..++.+|+.++|+..+.|.-
T Consensus 232 e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~ 311 (1351)
T KOG1035|consen 232 ELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVV 311 (1351)
T ss_pred HHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeE
Confidence 3566677889999999998754322 224455777767766664 35678888889999999999999999766551
Q ss_pred CCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe--ecCCccCCCCCCCCCCcccCCCCccccccccCCCCC
Q psy3347 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA--DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYT 190 (245)
Q Consensus 113 ~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 190 (245)
+. .........+..+...++ ||+.+....+ .........+.-+.++|......++
T Consensus 312 L~----------------------~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d-~~~~~~~~~~~~~~~~e~~~~~~~~ 368 (1351)
T KOG1035|consen 312 LS----------------------ASSSKESTVDGEGVVAISLSDFDSSKPLPD-NEKSFSDLLAEIRNADEDLKENTAK 368 (1351)
T ss_pred Ee----------------------cccccccccCccceeecchhhhcccccCCC-cccchhhcCccccccccccccccch
Confidence 10 000112244555666666 8887764322 2222222334457788887665554
Q ss_pred c--chhHHHHHHHHHHHHhCCCC
Q psy3347 191 R--AVDWWGLGVLIFEMLVGESP 211 (245)
Q Consensus 191 ~--~~DvwslG~~l~el~~g~~p 211 (245)
. ..|+|++|.....+..|..+
T Consensus 369 ~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 369 KSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred hhhhhHHHHHHHHHhhhhhcCcc
Confidence 4 47999999999888876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.038 Score=43.12 Aligned_cols=84 Identities=15% Similarity=0.227 Sum_probs=58.4
Q ss_pred HHHHHHHHHHHHh---hcCCCceeeeeEEEeeCCeEEEEEeeccC--C----chhhhhhhcCCChHHHHHHHHHHHHHHH
Q psy3347 31 SLLSEKRIFEVAN---TMRHPFLVNLFACFQTEAHVCFVMEYAAG--G----DLMMHIHADVFSEPRAVFYAACVVLGLQ 101 (245)
Q Consensus 31 ~~~~e~~~~~~l~---~~~h~ni~~~~~~~~~~~~~~lv~e~~~~--~----~L~~~~~~~~l~~~~~~~i~~~i~~~l~ 101 (245)
...+|.+....+. ...+.+|.+++|+.+++-..-+|+|...+ | +|.++++.+.++. .....+.++ .+
T Consensus 57 ~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~L~~f---~~ 132 (199)
T PF10707_consen 57 QNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQALDEF---KR 132 (199)
T ss_pred HHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHHHHHH---HH
Confidence 3444555454444 33578999999999998888999997643 2 6677887777766 444444444 47
Q ss_pred HhhhcCccccCCCCCCHHHH
Q psy3347 102 YLHESRIIYRPQSNITKEEI 121 (245)
Q Consensus 102 ~lH~~~i~H~~~~~i~~~~i 121 (245)
+|-+++|+.+ |++|.||
T Consensus 133 ~l~~~~Iv~~---dl~~~NI 149 (199)
T PF10707_consen 133 YLLDHHIVIR---DLNPHNI 149 (199)
T ss_pred HHHHcCCeec---CCCcccE
Confidence 7788999988 7777776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.047 Score=43.53 Aligned_cols=88 Identities=14% Similarity=0.063 Sum_probs=52.1
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCc-hhhhhhhcCCChHH
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGD-LMMHIHADVFSEPR 88 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~-L~~~~~~~~l~~~~ 88 (245)
|..+++|...... ......+|.+.+..+.... --+.+.+++....+...++||+++|.+ +..... .+...
T Consensus 22 ~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~g-lpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~---~~~~~ 92 (226)
T TIGR02172 22 TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLG-IPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIIS---DNPSR 92 (226)
T ss_pred CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcC-CCCCceEEEEecCCeeeeeeeecCCccchhhhhc---CCHHH
Confidence 5567888876422 1233455655555554322 234667777777777889999999863 322221 22233
Q ss_pred HHHHHHHHHHHHHHhhhc
Q psy3347 89 AVFYAACVVLGLQYLHES 106 (245)
Q Consensus 89 ~~~i~~~i~~~l~~lH~~ 106 (245)
...++.+++..+.-+|+.
T Consensus 93 ~~~l~~~la~~l~~lH~~ 110 (226)
T TIGR02172 93 LEEIAKIFAEMAKKLHST 110 (226)
T ss_pred HHHHHHHHHHHHHHHhCC
Confidence 445667777777777764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.00064 Score=66.61 Aligned_cols=146 Identities=14% Similarity=0.049 Sum_probs=97.7
Q ss_pred HhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhhhhh-----cCCChHHHHHHHHHHHHHHHHhhhc-C----cc
Q psy3347 42 ANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMHIHA-----DVFSEPRAVFYAACVVLGLQYLHES-R----II 109 (245)
Q Consensus 42 l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~-~----i~ 109 (245)
++...|+++.....-... ...-+..++++.+|.+...+-. .++...-......+.+.+..-+|+. + .+
T Consensus 1283 ~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v 1362 (2724)
T KOG1826|consen 1283 LREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNV 1362 (2724)
T ss_pred hhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccch
Confidence 344578887766654432 3356889999999999887732 2233222222333336666666654 2 24
Q ss_pred ccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCC
Q psy3347 110 YRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY 189 (245)
Q Consensus 110 H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 189 (245)
|+ .+|+.| +++..+.+++++++|+.+............++++.|+.|++...-.+
T Consensus 1363 ~~--------~Lkf~l-----------------pmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~ 1417 (2724)
T KOG1826|consen 1363 SK--------SLKFTL-----------------PMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF 1417 (2724)
T ss_pred hh--------hhhhhc-----------------cceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh
Confidence 44 333322 36778889999999999843444444556677888999999877788
Q ss_pred CcchhHHHHHHHHHHHHhCCCCC
Q psy3347 190 TRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 190 ~~~~DvwslG~~l~el~~g~~pf 212 (245)
+.++|+|..|+.+|+...|..+|
T Consensus 1418 t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1418 TKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhHHHHHHHHHHHHHHhcccHHH
Confidence 88899999999999988887776
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.038 Score=42.16 Aligned_cols=117 Identities=21% Similarity=0.148 Sum_probs=70.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++.+. |..+|+|+=+..+ ...++..|.++++++.... --.+++.+. . ..+.|||..|-.|...-.
T Consensus 38 Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~--~~p~vy~yg--~--~~i~me~i~G~~L~~~~~ 104 (201)
T COG2112 38 VYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEG--VTPEVYFYG--E--DFIRMEYIDGRPLGKLEI 104 (201)
T ss_pred EEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcC--CCceEEEec--h--hhhhhhhhcCcchhhhhh
Confidence 5777765 7799999887542 3466777777777665432 122333332 2 234499998878766543
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
.. + .+-...+++..--|-..||-|+.+ +.+...+++ +++.+-|+||..++
T Consensus 105 ~~-----~-rk~l~~vlE~a~~LD~~GI~H~El-----------------------~~~~k~vlv-~~~~~~iIDFd~At 154 (201)
T COG2112 105 GG-----D-RKHLLRVLEKAYKLDRLGIEHGEL-----------------------SRPWKNVLV-NDRDVYIIDFDSAT 154 (201)
T ss_pred cc-----c-HHHHHHHHHHHHHHHHhccchhhh-----------------------cCCceeEEe-cCCcEEEEEccchh
Confidence 21 1 222334556655566789999833 223333333 44489999999876
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.058 Score=48.31 Aligned_cols=88 Identities=16% Similarity=0.155 Sum_probs=52.9
Q ss_pred eeeeEEEee-CCeEEEEEeeccCCchhh--hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHH
Q psy3347 51 VNLFACFQT-EAHVCFVMEYAAGGDLMM--HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127 (245)
Q Consensus 51 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~ 127 (245)
+.+-.++.+ .....|+|||++|..+.+ .+....++...+..-..+... .-+-..|.+|.|=| |.|| +
T Consensus 264 V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPH---PGNi-----l 333 (538)
T KOG1235|consen 264 VLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPH---PGNI-----L 333 (538)
T ss_pred eeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCC---CCcE-----E
Confidence 335555533 456899999999987754 445566776554443333322 33445789999433 3355 2
Q ss_pred hhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+..+ -..++.+.+-|||+...
T Consensus 334 v~~~-------------~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 334 VRPN-------------PEGDEEIVLLDHGLYAV 354 (538)
T ss_pred EecC-------------CCCCccEEEEccccccc
Confidence 1100 02578899999998764
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.026 Score=50.05 Aligned_cols=44 Identities=18% Similarity=0.184 Sum_probs=33.6
Q ss_pred HHHHhhcCCCceeeeeEEEeeC-CeEEEEEeeccCCchhhhhhhcC
Q psy3347 39 FEVANTMRHPFLVNLFACFQTE-AHVCFVMEYAAGGDLMMHIHADV 83 (245)
Q Consensus 39 ~~~l~~~~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~ 83 (245)
++.++.+.|+|.-+++++.... ....+|||++ +.++.+..+.+.
T Consensus 33 ~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 33 FQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred hHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 5778888999999999987543 3578999988 448888775543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.19 Score=47.93 Aligned_cols=91 Identities=12% Similarity=0.209 Sum_probs=56.2
Q ss_pred cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCc--eeeeeEEEeeC---CeEEEEEeeccCCchhhhhhhcCCC
Q psy3347 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPF--LVNLFACFQTE---AHVCFVMEYAAGGDLMMHIHADVFS 85 (245)
Q Consensus 11 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~n--i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~l~ 85 (245)
..+++|+....... .....+.+|.+.+..+.. |++ +.+++.++.+. +..|+|||+++|..+.+.. -..++
T Consensus 66 ~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~--~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~-~~~~~ 140 (822)
T PLN02876 66 KRYVLRKKPPGKLL--QSAHAVEREYQVLRALGE--HTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPK-LPGVA 140 (822)
T ss_pred eeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhh--cCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCcc-CCCCC
Confidence 46777766432211 112345555555444432 444 46777777654 4678999999986543211 12355
Q ss_pred hHHHHHHHHHHHHHHHHhhhc
Q psy3347 86 EPRAVFYAACVVLGLQYLHES 106 (245)
Q Consensus 86 ~~~~~~i~~~i~~~l~~lH~~ 106 (245)
......+..+++..|..||+.
T Consensus 141 ~~~r~~l~~~l~~~La~LH~v 161 (822)
T PLN02876 141 PERRRAIYRATAKVLAALHSA 161 (822)
T ss_pred HHHHHHHHHHHHHHHHHHhCC
Confidence 667788999999999999985
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.28 Score=42.03 Aligned_cols=72 Identities=18% Similarity=0.141 Sum_probs=50.6
Q ss_pred EEEEEeeccC-CchhhhhhhcCCChHHHHHHHHHHHHHHHHhh-hcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 63 VCFVMEYAAG-GDLMMHIHADVFSEPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 63 ~~lv~e~~~~-~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
..|||+|++. |-..-.++...++...+..+-.+++.-|.-|. .++++|.||+ --|+
T Consensus 239 hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLS---EfN~------------------- 296 (520)
T KOG2270|consen 239 HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLS---EFNL------------------- 296 (520)
T ss_pred ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchh---hhhh-------------------
Confidence 4699999974 33345556667888888888888888777665 5689999443 2233
Q ss_pred hccccCCCCceEEeecCCcc
Q psy3347 141 KLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~ 160 (245)
+--+|.+-|+|.+-|.
T Consensus 297 ----LyhdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 ----LYHDGKLYIIDVSQSV 312 (520)
T ss_pred ----eEECCEEEEEEccccc
Confidence 2235789999988765
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.24 Score=41.22 Aligned_cols=86 Identities=9% Similarity=-0.024 Sum_probs=53.8
Q ss_pred EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee---CCeEEEEEeeccCCchhhhhhhcCCChHH
Q psy3347 12 YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT---EAHVCFVMEYAAGGDLMMHIHADVFSEPR 88 (245)
Q Consensus 12 ~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~l~~~~ 88 (245)
.+.+|..+.. .....+..|.+.+..+....--.+.++++++.. .+..++|||++++.++.+. ......
T Consensus 39 ~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~----~~~~~~ 109 (297)
T PRK10593 39 NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP----ARTPER 109 (297)
T ss_pred CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC----CCCHHH
Confidence 4666764421 012355566555655554322356667766644 4678999999999877651 123334
Q ss_pred HHHHHHHHHHHHHHhhhc
Q psy3347 89 AVFYAACVVLGLQYLHES 106 (245)
Q Consensus 89 ~~~i~~~i~~~l~~lH~~ 106 (245)
...+..+++.+|+-||+.
T Consensus 110 ~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 110 WEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred HHHHHHHHHHHHHHHhCC
Confidence 556778888999999985
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.21 Score=41.30 Aligned_cols=60 Identities=15% Similarity=0.168 Sum_probs=32.9
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeE------EEeeCCeEEEEEeeccCCchh
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA------CFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~------~~~~~~~~~lv~e~~~~~~L~ 76 (245)
+..+++|+.... . .+....|.+.++.+...+-| +.+++. +....+..+.++++++|..+.
T Consensus 37 ~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~-vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~ 102 (296)
T cd05153 37 SGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLP-VPRPIADRDGEYLSELAGKPAALVEFLAGEHLT 102 (296)
T ss_pred CCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCC-CCccccCCCCcEeeeeCCceEEEEEeCCCCCCC
Confidence 457888887641 1 12333444445555433322 444433 123345678999999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.62 Score=36.50 Aligned_cols=94 Identities=17% Similarity=0.120 Sum_probs=60.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEE---eeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF---QTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~---~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+.... +..+++|..... .....+.+|...++.+....- -+.+++... ...+..+++|++++|..+..
T Consensus 13 ~~~v~~~--~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~-pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 13 VYRVTTD--DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGI-PVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEET--TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTS-BS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred EEEEEEC--CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCC-CCceEEeecccccccccceEEEEEeccccccc
Confidence 3555444 358999987643 233445556555665654322 355555533 33456899999999987766
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcC
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 107 (245)
..+......++.+++..+..||+..
T Consensus 85 -----~~~~~~~~~~~~~~~~~l~~lh~~~ 109 (239)
T PF01636_consen 85 -----ELSPEQRPELLRQLGRALAQLHQVP 109 (239)
T ss_dssp -----TSTHHHHHHHHHHHHHHHHHHHHSH
T ss_pred -----cccccccccccccchhhhhhccccc
Confidence 4566777888889999999999873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.18 Score=40.32 Aligned_cols=86 Identities=9% Similarity=-0.015 Sum_probs=46.0
Q ss_pred cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC---CeEEEEEeeccCCchhhhhhhcCCChH
Q psy3347 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE---AHVCFVMEYAAGGDLMMHIHADVFSEP 87 (245)
Q Consensus 11 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~l~~~ 87 (245)
..+++|..... .....+.+|.+.+..+...----+.++++..... +..+++|++++|.++.... ..
T Consensus 19 ~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~~~~----~~-- 87 (235)
T cd05155 19 DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETATAAA----LS-- 87 (235)
T ss_pred CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCCccc----cC--
Confidence 35667765432 1223556665556555431001223333333221 2458899999998875431 11
Q ss_pred HHHHHHHHHHHHHHHhhhcC
Q psy3347 88 RAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 88 ~~~~i~~~i~~~l~~lH~~~ 107 (245)
....+..+++..+.-||+..
T Consensus 88 ~~~~l~~~la~~l~~LH~i~ 107 (235)
T cd05155 88 DPSEFAEDLADFLAALRQID 107 (235)
T ss_pred CHHHHHHHHHHHHHHHhCCC
Confidence 12356777788788888653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.85 Score=38.02 Aligned_cols=17 Identities=18% Similarity=0.221 Sum_probs=12.9
Q ss_pred ccCCCCceEEeecCCcc
Q psy3347 144 VNDTEGYVKIADFGLCK 160 (245)
Q Consensus 144 ~~~~~~~~kl~Dfg~~~ 160 (245)
+.+.++.+.|+||+.+.
T Consensus 200 l~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 200 LFDGDSVKGVIDFYFAC 216 (307)
T ss_pred EEECCceEEEeeccccc
Confidence 66666666899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.54 Score=39.54 Aligned_cols=89 Identities=13% Similarity=0.135 Sum_probs=45.7
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--eEEEEEeeccCCchhhhhhhcCCChH
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCFVMEYAAGGDLMMHIHADVFSEP 87 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~l~~~ 87 (245)
+++++++ ... ............+|.+++..+....= -+...+++|..+. ..+.||++.+|..+..........
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~v-P~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~-- 122 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDV-PVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLG-- 122 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCC-CCcccccccccCCCCCceEEEEEecceeccCcCCcccch--
Confidence 6777777 221 22233444555555444444433211 2344455554443 679999999886443322111111
Q ss_pred HHHHHHH-HHHHHHHHhhh
Q psy3347 88 RAVFYAA-CVVLGLQYLHE 105 (245)
Q Consensus 88 ~~~~i~~-~i~~~l~~lH~ 105 (245)
.+.+. .++..|.-||+
T Consensus 123 --~~~~~~~l~~~La~LH~ 139 (321)
T COG3173 123 --RQFALDALADFLAELHS 139 (321)
T ss_pred --HHHHHHHHHHHHHHHhC
Confidence 22333 67777777775
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.64 Score=37.57 Aligned_cols=88 Identities=13% Similarity=0.070 Sum_probs=43.0
Q ss_pred EeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhh
Q psy3347 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHA 81 (245)
Q Consensus 2 ~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 81 (245)
|+.. .+|+.+++|........- . -+..+|.+.+..+...+- ..+++... . -.+||||++|..+....
T Consensus 13 y~~~--~~~~~~vlR~~~~~~~~~--~-~~r~~E~~~l~~l~~~g~--~P~~i~~~--~--~~~v~e~i~G~~~~~~~-- 79 (256)
T TIGR02721 13 WRIE--HPGISFVWRPQSPVCKAL--G-VDRQREYQILQALSALGL--APKPILVN--E--HWLLVEWLEGEVITLDQ-- 79 (256)
T ss_pred EEEE--eCCccEEEeeCCcccccc--c-CcHHHHHHHHHHHHhcCC--CCceEEEe--C--CEEEEEeccCccccccc--
Confidence 5443 357788888765421110 0 122345455555543221 22333332 2 25899999986653210
Q ss_pred cCCChHHHHHHHHHHHHHHHHhhhcC
Q psy3347 82 DVFSEPRAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 82 ~~l~~~~~~~i~~~i~~~l~~lH~~~ 107 (245)
+.. .....++++.|.-+|+..
T Consensus 80 --~~~---~~~~~~la~~l~~lH~~~ 100 (256)
T TIGR02721 80 --FVA---LDLLLELAALLHQLHSQP 100 (256)
T ss_pred --ccC---chhHHHHHHHHHHHhCCC
Confidence 000 123455666666677654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.97 E-value=1.8 Score=36.19 Aligned_cols=17 Identities=6% Similarity=0.055 Sum_probs=13.1
Q ss_pred eCCeEEEEEeeccCCch
Q psy3347 59 TEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 59 ~~~~~~lv~e~~~~~~L 75 (245)
..+..++++++.+|..+
T Consensus 93 ~~g~~~~l~~~l~G~~~ 109 (319)
T PRK05231 93 LAGKPAAIVTFLEGKWP 109 (319)
T ss_pred eCCEEEEEEEecCCCCC
Confidence 35678999999988643
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.69 E-value=2.7 Score=36.61 Aligned_cols=80 Identities=11% Similarity=0.059 Sum_probs=45.6
Q ss_pred CEeEEEecCCcEEEEEEeeccccc--c--hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCc-h
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII--A--RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGD-L 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~--~--~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~-L 75 (245)
||++.+...++.+.||.-...-.. . .-..+....|.+.+..+....-.++.+++.+ +....++|||++++.. +
T Consensus 42 VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~~l 119 (401)
T PRK09550 42 VFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHKIL 119 (401)
T ss_pred EEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCccHH
Confidence 677777644468999985421100 0 1123444555555555544433456666666 3456889999998643 4
Q ss_pred hhhhhhc
Q psy3347 76 MMHIHAD 82 (245)
Q Consensus 76 ~~~~~~~ 82 (245)
...+..+
T Consensus 120 r~~Ll~g 126 (401)
T PRK09550 120 RKGLIDG 126 (401)
T ss_pred HHHHhcC
Confidence 5555433
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=88.85 E-value=0.34 Score=40.88 Aligned_cols=69 Identities=17% Similarity=0.167 Sum_probs=47.4
Q ss_pred CeEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 61 ~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
+..|+|||+..+..|....+- ..+..+...+..-+--|-.+|++|+ |.+--||
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHg---DFNEFNi------------------- 233 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHG---DFNEFNI------------------- 233 (465)
T ss_pred cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceec---ccchhee-------------------
Confidence 456899999988887654321 1223344444444555668999999 6666666
Q ss_pred hccccCCCCceEEeecCCc
Q psy3347 141 KLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~ 159 (245)
+++.++.++++||--.
T Consensus 234 ---mv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 234 ---MVKDDDKIVVIDFPQM 249 (465)
T ss_pred ---EEecCCCEEEeechHh
Confidence 7777889999999743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=88.68 E-value=4.5 Score=35.40 Aligned_cols=97 Identities=12% Similarity=-0.018 Sum_probs=51.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh----hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccC--Cc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD----EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAG--GD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~--~~ 74 (245)
||+..+ .++.++||.-...-..... ...+...|.+.++.+.......+.+++.++. ...+++||++++ ..
T Consensus 48 VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~~~~i 123 (418)
T PLN02756 48 VYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLEPPHII 123 (418)
T ss_pred EEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecCCccee
Confidence 466655 3456889876522111111 1223333444444444433346777777775 457888999976 34
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHH
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQ 101 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~ 101 (245)
+...+-.+......+..+...++..|-
T Consensus 124 lr~~Ll~G~~~p~~a~~ig~~la~tLf 150 (418)
T PLN02756 124 LRKGLIAGIEYPLLAEHMSDYMAKTLF 150 (418)
T ss_pred hhhhhccCCCCHHHHHHHHHHHHHHHh
Confidence 555553333334455556555555543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=88.60 E-value=7.5 Score=31.39 Aligned_cols=60 Identities=18% Similarity=0.280 Sum_probs=41.3
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
..+|-+|.-.+ +....+..|..-++.|.+.+--.+.+++.+....++.|+||||++-+.+
T Consensus 39 ~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 39 TDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred CcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 34666665543 2334455555556666665556788888888889999999999987554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.02 E-value=2.8 Score=36.16 Aligned_cols=87 Identities=22% Similarity=0.237 Sum_probs=49.7
Q ss_pred cCCCceeeeeEEEeeCC-eEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHH
Q psy3347 45 MRHPFLVNLFACFQTEA-HVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIK 122 (245)
Q Consensus 45 ~~h~ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik 122 (245)
+.-++..+.+-+-.+++ +.|++|++. |+++... +. -...++..++.+.+.-+.-+-.. ..=|| ++.-+||
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i-k~--~~~~e~lsff~s~~sil~~lekkf~fehr---nlt~~ni- 353 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPISII-KA--DRSEEELSFFWSCISILDILEKKFPFEHR---NLTLDNI- 353 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Cceeeee-ec--ccHHHHHHHHHHHHHHHhhhhhcCCcccc---cccccce-
Confidence 34444444444432332 567888865 4444321 11 23455666666665544433333 24577 5555566
Q ss_pred HHHHHhhhccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++ +|++.|+||-+++.
T Consensus 354 ---------------------LId-~GnvtLIDfklsRl 370 (488)
T COG5072 354 ---------------------LID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ---------------------eee-cCceEEEEeeeeec
Confidence 777 89999999999984
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=85.07 E-value=5.1 Score=31.68 Aligned_cols=91 Identities=14% Similarity=0.183 Sum_probs=46.6
Q ss_pred CEeEEEec-CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRN-TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
+|+..... .++.|++|+....... .-+..+|.+.+..+... .-..+++..+. + .++|||++|.++....
T Consensus 14 ~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~--gl~P~v~~~~~--~--~~l~e~i~G~~l~~~~ 83 (235)
T cd05157 14 LVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKH--GLAPKLYATFQ--N--GLIYEFIPGRTLEPED 83 (235)
T ss_pred EEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhC--CCCCeEEEEeC--C--cEEEEeeCCCcCCHHH
Confidence 35443332 2568889977643211 11122344444444322 22344444332 2 3799999986654221
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRI 108 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i 108 (245)
+.. ..++.+++..|.-+|+...
T Consensus 84 ----~~~---~~~~~~la~~l~~lH~~~~ 105 (235)
T cd05157 84 ----LRN---PKIYRLIARELAKLHSIKP 105 (235)
T ss_pred ----ccC---hHHHHHHHHHHHHHhcccc
Confidence 111 2356678888888997654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=85.00 E-value=15 Score=36.24 Aligned_cols=64 Identities=13% Similarity=0.221 Sum_probs=32.7
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh----cCCCceeeeeE-----EEee-CC--eEEEEEeeccCCchh
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT----MRHPFLVNLFA-----CFQT-EA--HVCFVMEYAAGGDLM 76 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~----~~h~ni~~~~~-----~~~~-~~--~~~lv~e~~~~~~L~ 76 (245)
+|+.+++|+..... .. .....+.+.+..|.. +.-|.+++-.+ .... ++ ..+-+++|++|..+.
T Consensus 47 ~g~~yVLKi~~~~~--~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~ 121 (1013)
T PRK06148 47 DGADYILKIVNPSE--PR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLA 121 (1013)
T ss_pred CCCeEEEEEcCCcc--ch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHH
Confidence 57789999998642 11 122223334444432 22334333221 1111 22 567789999987765
Q ss_pred h
Q psy3347 77 M 77 (245)
Q Consensus 77 ~ 77 (245)
+
T Consensus 122 ~ 122 (1013)
T PRK06148 122 E 122 (1013)
T ss_pred h
Confidence 4
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=84.76 E-value=5.1 Score=34.09 Aligned_cols=56 Identities=20% Similarity=0.182 Sum_probs=29.6
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
++.|++|+..... +.+-+-.+|.+++..+...+ --.++++.+. ++ .+.+|+++.++
T Consensus 65 ~~~~v~Ri~g~~t----~~~idR~~E~~~~~~l~~~g--l~P~~~~~~~-~g---~v~efi~g~~l 120 (344)
T PLN02236 65 GRKVLVRIYGEGV----ELFFDRDDEIRTFECMSRHG--QGPRLLGRFP-NG---RVEEFIHARTL 120 (344)
T ss_pred CCeEEEEEccCCC----CeeechHHHHHHHHHHHHcC--CCCceEEEEC-Cc---eEEEeeCCCCC
Confidence 4688999886532 11112244555555554332 1234455552 22 57899877555
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=83.43 E-value=7.5 Score=32.26 Aligned_cols=79 Identities=14% Similarity=0.135 Sum_probs=45.1
Q ss_pred cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCCChH
Q psy3347 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEP 87 (245)
Q Consensus 8 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~ 87 (245)
.+++.+-+|+-.... ...+..|.+-++.|.+..--.+.+++++...++..+++|||++.+. .+..
T Consensus 38 ~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~---------~~~~ 102 (288)
T PF03881_consen 38 TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGS---------PSPP 102 (288)
T ss_dssp TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----------------CC
T ss_pred CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCC---------CCch
Confidence 568889999876321 2344555555666655555678899999888888899999997541 1111
Q ss_pred HHHHHHHHHHHHHHHhhh
Q psy3347 88 RAVFYAACVVLGLQYLHE 105 (245)
Q Consensus 88 ~~~~i~~~i~~~l~~lH~ 105 (245)
. ...+...|+-||+
T Consensus 103 ~----~~~lg~~LA~LH~ 116 (288)
T PF03881_consen 103 D----WEELGRQLAALHQ 116 (288)
T ss_dssp H----HHHHHHHHHHHHH
T ss_pred h----HHHHHHHHHHHhh
Confidence 1 2456677788998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 245 | ||||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-55 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-55 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-55 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-54 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-54 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-54 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-54 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-54 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-54 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-54 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-53 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-53 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-53 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-53 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-53 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-53 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-52 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-52 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-46 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-46 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-46 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-46 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-43 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-43 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-43 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-43 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-42 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-42 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-42 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-42 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-42 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-42 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-42 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-42 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-42 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-42 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-42 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-42 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-42 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-42 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-42 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-42 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-42 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-42 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-42 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-42 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-42 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-42 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-42 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-42 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-42 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-42 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-42 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-42 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-41 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-41 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-41 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-41 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-41 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-41 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-41 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-41 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-41 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-41 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-41 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-41 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-41 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-40 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-39 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-37 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-37 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-37 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-37 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-36 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-30 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-24 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-24 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-23 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-23 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-23 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-23 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-23 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-22 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-21 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-21 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-04 |
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-130
Identities = 111/246 (45%), Positives = 154/246 (62%), Gaps = 28/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++++ T ++FAIKALKK ++ D+VE + EKR+ +A HPFL ++F FQT+
Sbjct: 33 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW--EHPFLTHMFCTFQTK 90
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
++ FVMEY GGDLM HI F RA FYAA ++LGLQ+LH I+YR
Sbjct: 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR-------- 142
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N I L D +G++KIADFG+CKE M +T TFCGTP+++
Sbjct: 143 DLK------LDN--------ILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 185
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APE+L Y +VDWW GVL++EML+G+SPF G DEEE+F SI D YPR+L EA
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245
Query: 240 IAIMRR 245
++ +
Sbjct: 246 KDLLVK 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 365 bits (939), Expect = e-128
Identities = 108/246 (43%), Positives = 152/246 (61%), Gaps = 28/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+LS+ + T E +A+K LKK +I D+VE + EKR+ + + PFL L +CFQT
Sbjct: 36 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFLTQLHSCFQTM 93
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM HI F EP AVFYAA + +GL +L IIYR
Sbjct: 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR-------- 145
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N + L D+EG++KIADFG+CKE + G T TFCGTP+++
Sbjct: 146 DLK------LDN--------VML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APE++ Y ++VDWW GVL++EML G++PF G+DE+E+F SI+ V YP+ +S EA
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248
Query: 240 IAIMRR 245
+AI +
Sbjct: 249 VAICKG 254
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-126
Identities = 109/246 (44%), Positives = 156/246 (63%), Gaps = 28/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ + TG+ +A+K LKK I+ D+VE ++EKRI +A HPFL LF CFQT
Sbjct: 39 VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFLTQLFCCFQTP 96
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVME+ GGDLM HI + F E RA FYAA ++ L +LH+ IIYR
Sbjct: 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR-------- 148
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N + L D EG+ K+ADFG+CKEG+ G T TFCGTP+++
Sbjct: 149 DLK------LDN--------VLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI 191
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APE+L E Y AVDWW +GVL++EML G +PF ++E+++F++I+NDEV YP +L +A
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDA 251
Query: 240 IAIMRR 245
I++
Sbjct: 252 TGILKS 257
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 359 bits (925), Expect = e-126
Identities = 112/246 (45%), Positives = 151/246 (61%), Gaps = 29/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG Y+A+K L+K IIA+DEV ++E R+ + RHPFL L FQT
Sbjct: 21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ---NTRHPFLTALKYAFQTH 77
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+CFVMEYA GG+L H+ VF+E RA FY A +V L+YLH ++YR
Sbjct: 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR-------- 129
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + L D +G++KI DFGLCKEG+ G TFCGTPE+L
Sbjct: 130 DIK------LEN--------LML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEVL + Y RAVDWWGLGV+++EM+ G PF D E +F+ I+ +E+R+PR LS EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 240 IAIMRR 245
+++
Sbjct: 233 KSLLAG 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 370 bits (951), Expect = e-125
Identities = 108/246 (43%), Positives = 152/246 (61%), Gaps = 28/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+LS+ + T E +A+K LKK +I D+VE + EKR+ + + PFL L +CFQT
Sbjct: 357 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFLTQLHSCFQTM 414
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ FVMEY GGDLM HI F EP AVFYAA + +GL +L IIYR
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR-------- 466
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N + L D+EG++KIADFG+CKE + G T TFCGTP+++
Sbjct: 467 DLK------LDN--------VML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 509
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APE++ Y ++VDWW GVL++EML G++PF G+DE+E+F SI+ V YP+ +S EA
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 240 IAIMRR 245
+AI +
Sbjct: 570 VAICKG 575
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-121
Identities = 98/255 (38%), Positives = 150/255 (58%), Gaps = 37/255 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + + T +A++ +KK + ++++ + +EK +FE A+ HPFLV L +CFQTE
Sbjct: 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS--NHPFLVGLHSCFQTE 125
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ + FV+EY GGDLM H+ E A FY+A + L L YLHE IIYR
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR-------- 177
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N + L D+EG++K+ D+G+CKEG+ GD T TFCGTP ++
Sbjct: 178 DLK------LDN--------VLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI 220
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP---------GDDEEEVFDSIVNDEVR 230
APE+L Y +VDWW LGVL+FEM+ G SPF + E+ +F I+ ++R
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 231 YPRFLSLEAIAIMRR 245
PR LS++A ++++
Sbjct: 281 IPRSLSVKAASVLKS 295
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 346 bits (891), Expect = e-121
Identities = 99/255 (38%), Positives = 150/255 (58%), Gaps = 37/255 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + + T +A+K +KK + ++++ + +EK +FE A+ HPFLV L +CFQTE
Sbjct: 25 VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS--NHPFLVGLHSCFQTE 82
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ + FV+EY GGDLM H+ E A FY+A + L L YLHE IIYR
Sbjct: 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR-------- 134
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N + L D+EG++K+ D+G+CKEG+ GD T TFCGTP ++
Sbjct: 135 DLK------LDN--------VLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI 177
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP---------GDDEEEVFDSIVNDEVR 230
APE+L Y +VDWW LGVL+FEM+ G SPF + E+ +F I+ ++R
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237
Query: 231 YPRFLSLEAIAIMRR 245
PR LS++A ++++
Sbjct: 238 IPRSLSVKAASVLKS 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-120
Identities = 89/249 (35%), Positives = 137/249 (55%), Gaps = 34/249 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++++ ++A+K L+K I+ + E + ++SE+ + ++HPFLV L FQT
Sbjct: 54 VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL--LKNVKHPFLVGLHFSFQTA 111
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ FV++Y GG+L H+ + F EPRA FYAA + L YLH I+YR P
Sbjct: 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKP---- 167
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN I L D++G++ + DFGLCKE + T TFCGTP
Sbjct: 168 -------------EN--------ILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
E+LAPEVL + Y R VDWW LG +++EML G PF + E++D+I+N ++ ++
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263
Query: 237 LEAIAIMRR 245
A ++
Sbjct: 264 NSARHLLEG 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-120
Identities = 112/247 (45%), Positives = 152/247 (61%), Gaps = 30/247 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG Y+A+K LKK I+A+DEV L+E R+ + RHPFL L FQT
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ---NSRHPFLTALKYSFQTH 220
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESR-IIYRPQSNITK 118
+CFVMEYA GG+L H+ + VFSE RA FY A +V L YLH + ++YR
Sbjct: 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR------- 273
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++K EN + L D +G++KI DFGLCKEG+ G TFCGTPE+
Sbjct: 274 -DLK------LEN--------LML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 315
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238
LAPEVL + Y RAVDWWGLGV+++EM+ G PF D E++F+ I+ +E+R+PR L E
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375
Query: 239 AIAIMRR 245
A +++
Sbjct: 376 AKSLLSG 382
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-117
Identities = 89/250 (35%), Positives = 140/250 (56%), Gaps = 33/250 (13%)
Query: 1 VILSQY---RNTGEYFAIKALKKGDIIAR-DEVESLLSEKRIFEVANTMRHPFLVNLFAC 56
V + NTG+ FA+K LKK I+ + +E+ I E ++HPF+V+L
Sbjct: 33 VFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE---EVKHPFIVDLIYA 89
Query: 57 FQTEAHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
FQT + ++EY +GG+L M + + +F E A FY A + + L +LH+ IIYR
Sbjct: 90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYR---- 145
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
++K EN I L + +G+VK+ DFGLCKE + G T TFCGT
Sbjct: 146 ----DLK------PEN--------IML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGT 184
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235
E++APE+L + + RAVDWW LG L+++ML G PF G++ ++ D I+ ++ P +L
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 236 SLEAIAIMRR 245
+ EA ++++
Sbjct: 245 TQEARDLLKK 254
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-112
Identities = 87/240 (36%), Positives = 128/240 (53%), Gaps = 30/240 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ + +A+K LKK + RD V + E+ I N HPF+V L FQTE + +
Sbjct: 49 SDARQLYAMKVLKKATLKVRDRVRTK-MERDILVEVN---HPFIVKLHYAFQTEGKLYLI 104
Query: 67 MEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+++ GGDL + +V F+E FY A + L L +LH IIYR ++K
Sbjct: 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR--------DLK--- 153
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185
EN I L D EG++K+ DFGL KE + + +FCGT E++APEV+
Sbjct: 154 ---PEN--------ILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 186 ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMRR 245
+T++ DWW GVL+FEML G PF G D +E I+ ++ P+FLS EA +++R
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-112
Identities = 79/254 (31%), Positives = 120/254 (47%), Gaps = 37/254 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V Q + TG+ +A K L K + R + + EK+I + F+V+L F+T+
Sbjct: 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH---SRFIVSLAYAFETK 257
Query: 61 AHVCFVMEYAAGGDLMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
+C VM GGD+ HI+ F EPRA+FY A +V GL++LH+ IIYR
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR---- 313
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
++K EN + L D +G V+I+D GL E +T + GT
Sbjct: 314 ----DLK------PEN--------VLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRY 231
P F+APE+L Y +VD++ LGV ++EM+ PF E +E+ ++ V Y
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412
Query: 232 PRFLSLEAIAIMRR 245
P S +
Sbjct: 413 PDKFSPASKDFCEA 426
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = e-108
Identities = 84/252 (33%), Positives = 121/252 (48%), Gaps = 36/252 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V Q R TG+ +A K L+K I R L+EK+I E N F+V+L ++T+
Sbjct: 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN---SRFVVSLAYAYETK 256
Query: 61 AHVCFVMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+C V+ GGDL HI+ F E RAVFYAA + GL+ LH RI+YR
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR------ 310
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++K EN I L D G+++I+D GL + G GT
Sbjct: 311 --DLK------PEN--------ILL---DDHGHIRISDLGLAVH-VPEGQTIKGRVGTVG 350
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPR 233
++APEV+ YT + DWW LG L++EM+ G+SPF + EEV + Y
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410
Query: 234 FLSLEAIAIMRR 245
S +A ++ +
Sbjct: 411 RFSPQARSLCSQ 422
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 304 bits (779), Expect = 1e-99
Identities = 71/250 (28%), Positives = 118/250 (47%), Gaps = 32/250 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + +TG+ +A+K L K I + L+E+ + + +T PF+V + F T
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ F+++ GGDL H+ VFSE FYAA ++LGL+++H ++YR
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR-------- 316
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K N I L D G+V+I+D GL + + GT ++
Sbjct: 317 DLK------PAN--------ILL---DEHGHVRISDLGLACDFS--KKKPHASVGTHGYM 357
Query: 180 APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPF---PGDDEEEVFDSIVNDEVRYPRFL 235
APEVL +Y + DW+ LG ++F++L G SPF D+ E+ + V P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417
Query: 236 SLEAIAIMRR 245
S E +++
Sbjct: 418 SPELRSLLEG 427
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-99
Identities = 85/248 (34%), Positives = 132/248 (53%), Gaps = 36/248 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDE-VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
+TG+ +A+K LKK I+ + + E +E+++ E + PFLV L FQTE +
Sbjct: 79 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYAFQTETKLHL 136
Query: 66 VMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
+++Y GG+L H+ + F+E Y +VL L++LH+ IIYR +IK
Sbjct: 137 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR--------DIK-- 186
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM-GFGDRTGTFCGTPEFLAPEV 183
EN I L D+ G+V + DFGL KE + +R FCGT E++AP++
Sbjct: 187 ----LEN--------ILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 184 LTETS--YTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPRFLSL 237
+ + +AVDWW LGVL++E+L G SPF D E E+ I+ E YP+ +S
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 238 EAIAIMRR 245
A +++R
Sbjct: 292 LAKDLIQR 299
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-98
Identities = 84/249 (33%), Positives = 129/249 (51%), Gaps = 38/249 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + R+ G Y+A+K LKK ++ +VE E+ + + HPF++ ++ FQ
Sbjct: 22 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS---IVTHPFIIRMWGTFQDA 78
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ +M+Y GG+L + + F P A FYAA V L L+YLH IIYR P
Sbjct: 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP---- 134
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN I L D G++KI DFG K D T T CGTP
Sbjct: 135 -------------EN--------ILL---DKNGHIKITDFGFAKYV---PDVTYTLCGTP 167
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
+++APEV++ Y +++DWW G+LI+EML G +PF + + ++ I+N E+R+P F +
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 227
Query: 237 LEAIAIMRR 245
+ ++ R
Sbjct: 228 EDVKDLLSR 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 2e-94
Identities = 72/251 (28%), Positives = 119/251 (47%), Gaps = 37/251 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ T +AIK L+K II ++V + E+ + + HPF V L+ FQ +
Sbjct: 46 VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS---RLDHPFFVKLYFTFQDD 102
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ F + YA G+L+ +I F E FY A +V L+YLH II+R P
Sbjct: 103 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP---- 158
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM--GFGDRTGTFCG 174
EN I L + + +++I DFG K R +F G
Sbjct: 159 -------------EN--------ILL---NEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF 234
T ++++PE+LTE S ++ D W LG +I++++ G PF +E +F I+ E +P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 235 LSLEAIAIMRR 245
+A ++ +
Sbjct: 255 FFPKARDLVEK 265
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-94
Identities = 91/249 (36%), Positives = 135/249 (54%), Gaps = 38/249 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L +++ +G ++A+K L K ++ ++E L+EKRI + N PFLV L F+
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKLEFSFKDN 113
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+++ VMEY AGG++ H+ FSEP A FYAA +VL +YLH +IYR P
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP---- 169
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + + D +GY+++ DFG K RT T CGTP
Sbjct: 170 -------------EN--------LLI---DQQGYIQVTDFGFAKR---VKGRTWTLCGTP 202
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
E LAPE++ Y +AVDWW LGVLI+EM G PF D ++++ IV+ +VR+P S
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 237 LEAIAIMRR 245
+ ++R
Sbjct: 263 SDLKDLLRN 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 3e-89
Identities = 72/252 (28%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + Q +T + +A+K + K + R+EV ++ E +I + HPFLVNL+ FQ E
Sbjct: 31 VCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE---HPFLVNLWYSFQDE 87
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V++ GGDL H+ F E + +V+ L YL RII+R
Sbjct: 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR-------- 139
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K +N I L D G+V I DF + + + T GT ++
Sbjct: 140 DMK------PDN--------ILL---DEHGHVHITDFNIAAM-LPRETQITTMAGTKPYM 181
Query: 180 APEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPG---DDEEEVFDSIVNDEVRYPR 233
APE+ + Y+ AVDWW LGV +E+L G P+ +E+ + V YP
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 234 FLSLEAIAIMRR 245
S E ++++++
Sbjct: 242 AWSQEMVSLLKK 253
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 5e-88
Identities = 71/260 (27%), Positives = 117/260 (45%), Gaps = 43/260 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + + TG+ +A+K + K D++ R EV E+ + + ++ L FQ E
Sbjct: 77 VAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD---RRWITQLHFAFQDE 133
Query: 61 AHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ VMEY GGDL+ + + A FY A +V+ + +H ++R
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR------- 186
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPE 177
+IK +N I L D G++++ADFG C + G R+ GTP+
Sbjct: 187 -DIK------PDN--------ILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 178 FLAPEVLT-------ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230
+L+PE+L SY DWW LGV +EM G++PF D E + IV+ +
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288
Query: 231 -----YPRFLSLEAIAIMRR 245
+ EA ++R
Sbjct: 289 LSLPLVDEGVPEEARDFIQR 308
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 1e-85
Identities = 70/258 (27%), Positives = 121/258 (46%), Gaps = 41/258 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + +N + FA+K L K +++ R E E+ + + ++ L FQ +
Sbjct: 90 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD---SKWITTLHYAFQDD 146
Query: 61 AHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ VM+Y GGDL+ + D E A FY A +V+ + +H+ ++R
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR------- 199
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPE 177
+IK +N I + D G++++ADFG C + M G ++ GTP+
Sbjct: 200 -DIK------PDN--------ILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 178 FLAPEVLTETS-----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-- 230
+++PE+L Y DWW LGV ++EML GE+PF + E + I+N + R
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301
Query: 231 ---YPRFLSLEAIAIMRR 245
+S A ++RR
Sbjct: 302 FPTQVTDVSENAKDLIRR 319
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-83
Identities = 81/254 (31%), Positives = 127/254 (50%), Gaps = 37/254 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L ++++T + +A+K L K ++I R + E+ I AN P++V LF FQ +
Sbjct: 85 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN---SPWVVQLFYAFQDD 141
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
++ VMEY GGDL+ + E A FY A VVL L +H I+R +
Sbjct: 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR--------D 193
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG-DRTGTFCGTPEFL 179
+K +N + L D G++K+ADFG C + G R T GTP+++
Sbjct: 194 VK------PDN--------MLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 180 APEVLT----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR 233
+PEVL + Y R DWW +GV ++EMLVG++PF D + I+N + + +P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296
Query: 234 --FLSLEAIAIMRR 245
+S EA ++
Sbjct: 297 DNDISKEAKNLICA 310
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-67
Identities = 65/246 (26%), Positives = 107/246 (43%), Gaps = 31/246 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ + A+K L K + L E I +RHP ++ ++ F
Sbjct: 30 VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS---HLRHPNILRMYNYFHDR 86
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ ++E+A G+L + F E R+ + + L Y HE ++I+R
Sbjct: 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHR-------- 138
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + + +G +KIADFG R T CGT ++L
Sbjct: 139 DIK------PEN--------LLM---GYKGELKIADFGWSV--HAPSLRRRTMCGTLDYL 179
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
PE++ ++ VD W GVL +E LVG PF E IVN ++++P FLS +
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 240 IAIMRR 245
++ +
Sbjct: 240 KDLISK 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-65
Identities = 68/246 (27%), Positives = 104/246 (42%), Gaps = 31/246 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ + + A+K L K + L E I +RHP ++ L+ F
Sbjct: 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS---HLRHPNILRLYGYFHDA 81
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
V ++EYA G + + F E R Y + L Y H R+I+R
Sbjct: 82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHR-------- 133
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + L + G +KIADFG R CGT ++L
Sbjct: 134 DIK------PEN--------LLL---GSAGELKIADFGWSV--HAPSSRRTDLCGTLDYL 174
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
PE++ + VD W LGVL +E LVG+ PF + +E + I E +P F++ A
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 240 IAIMRR 245
++ R
Sbjct: 235 RDLISR 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-55
Identities = 53/242 (21%), Positives = 85/242 (35%), Gaps = 36/242 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + G +A+K +D L+E +HP V L ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGS--HEKVGQHPCCVRLEQAWEEG 129
Query: 61 AHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ E G L H A E + Y +L L +LH +++
Sbjct: 130 GILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD------ 182
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+K I L G K+ DFGL E +G G P +
Sbjct: 183 --VK--------------PANIFLGPR---GRCKLGDFGLLVE-LGTAGAGEVQEGDPRY 222
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGES-PFPGDDEEEVFDSIVNDEVRYPRFLSL 237
+APE+L + SY A D + LG+ I E+ P G+ +++ + E + LS
Sbjct: 223 MAPELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE--FTAGLSS 279
Query: 238 EA 239
E
Sbjct: 280 EL 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-50
Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 33/249 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
IL + G + IK + + + E E E + M+HP +V F+
Sbjct: 40 AILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLA---NMKHPNIVQYRESFEEN 95
Query: 61 AHVCFVMEYAAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+ VM+Y GGDL I+A +F E + + + + L L+++H+ +I++R
Sbjct: 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR------ 149
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
+IK SQ I LT +G V++ DFG+ + + GTP
Sbjct: 150 --DIK--------------SQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLS 236
+L+PE+ Y D W LG +++E+ + F + + I++ S
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250
Query: 237 LEAIAIMRR 245
+ +++ +
Sbjct: 251 YDLRSLVSQ 259
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-49
Identities = 42/250 (16%), Positives = 84/250 (33%), Gaps = 51/250 (20%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIF---------EVA--NTMRHPFLVNLFA 55
+++A+K +K + + + ++K E+ +++ + +
Sbjct: 51 EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 56 CFQTEAHVCFVMEYAAGGDLMMHI---------HADVFSEPRAVFYAACVVLGLQYLHES 106
V + EY ++ + V+ Y+H
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 107 R-IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165
+ I +R ++K N I + D G VK++DFG + +
Sbjct: 171 KNICHR--------DVK------PSN--------ILM---DKNGRVKLSDFGESEYMV-- 203
Query: 166 GDRTGTFCGTPEFLAPEVLT--ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFD 222
+ GT EF+ PE + + VD W LG+ ++ M PF E+F+
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 223 SIVNDEVRYP 232
+I + YP
Sbjct: 264 NIRTKNIEYP 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-49
Identities = 65/243 (26%), Positives = 114/243 (46%), Gaps = 35/243 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+T E FA K + K ++ + E + E + ++ H +V F+ V V
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSME---ISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 67 MEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+E L+ +H +EP A +Y +VLG QYLH +R+I+R
Sbjct: 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR-------------- 165
Query: 126 AKVQENYKVNSSQEIKLTVN---DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
++KL N + + VKI DFGL + G+R CGTP ++APE
Sbjct: 166 -------------DLKLG-NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAI 242
VL++ ++ VD W +G +++ +LVG+ PF +E + I +E P+ ++ A ++
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 271
Query: 243 MRR 245
+++
Sbjct: 272 IQK 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-49
Identities = 60/247 (24%), Positives = 115/247 (46%), Gaps = 30/247 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ +TG AIK + K + V+ + +E + ++ ++HP ++ L+ F+
Sbjct: 27 VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE--V-KIHCQLKHPSILELYNYFEDS 83
Query: 61 AHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+V V+E G++ ++ FSE A + ++ G+ YLH I++R
Sbjct: 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR------- 136
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++ N + L +KIADFGL + ++ T CGTP +
Sbjct: 137 -DLT------LSN--------LLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238
++PE+ T +++ D W LG + + +L+G PF D + + +V + P FLS+E
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238
Query: 239 AIAIMRR 245
A ++ +
Sbjct: 239 AKDLIHQ 245
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-49
Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 35/241 (14%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
T E FA K + K ++ + E + E + ++ H +V F+ V V+E
Sbjct: 39 TKEVFAGKIVPKSLLLKPHQREKMSME---ISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95
Query: 69 YAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
L+ +H +EP A +Y +VLG QYLH +R+I+R
Sbjct: 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR---------------- 139
Query: 128 VQENYKVNSSQEIKLTVN---DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL 184
++KL N + + VKI DFGL + G+R CGTP ++APEVL
Sbjct: 140 -----------DLKLG-NLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 185 TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMR 244
++ ++ VD W +G +++ +LVG+ PF +E + I +E P+ ++ A ++++
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247
Query: 245 R 245
+
Sbjct: 248 K 248
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 2e-47
Identities = 33/221 (14%), Positives = 73/221 (33%), Gaps = 28/221 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ F +K K + E + ++ + V
Sbjct: 92 AKNKQKFVLKVQKPANPW---EFYIGTQLMERL---KPSMQHMFMKFYSAHLFQNGSVLV 145
Query: 67 MEYAAGGDLMMHIHA------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
E + G L+ I+ V + + +A ++ ++ +H+ II+
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD-------- 197
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF--GDRTGTFCGTPEF 178
IK +N+ + + + +D + + D G + F G C T F
Sbjct: 198 IK------PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF 251
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
E+L+ + +D++G+ ++ ML G ++ E
Sbjct: 252 QCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-44
Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 37/243 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + G A+K ++ D++ + E + + + HP ++ +A F +
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK---QLNHPNVIKYYASFIED 104
Query: 61 AHVCFVMEYAAGGDLMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
+ V+E A GDL I + E Y + L+++H R+++R
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR---- 160
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
+IK + +T G VK+ D GL + + GT
Sbjct: 161 ----DIK--------------PANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGT 199
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE--EVFDSIVNDEVRYPR 233
P +++PE + E Y D W LG L++EM +SPF GD + I + YP
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPP 257
Query: 234 FLS 236
S
Sbjct: 258 LPS 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-44
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 32/253 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
+ ++ G+ K L G + E + L+SE + ++HP +V +
Sbjct: 22 CQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLR---ELKHPNIVRYYDRIIDR 77
Query: 61 A--HVCFVMEYAAGGDLMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
+ VMEY GGDL I E + + L L+ H
Sbjct: 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS---DGG 134
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
+ ++K + L VK+ DFGL + TF
Sbjct: 135 HTVLHRDLK--------------PANVFLDGK---QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYP 232
GTP +++PE + SY D W LG L++E+ PF ++E+ I + R P
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237
Query: 233 RFLSLEAIAIMRR 245
S E I+ R
Sbjct: 238 YRYSDELNEIITR 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 29/230 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
++TG +A K +KK A +R + + HP ++ L ++ V +
Sbjct: 34 KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93
Query: 67 MEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
+E +GG+L + SE A + ++ G+ YLH +I + P
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP---------- 143
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + N ++K+ DFGL E + G GTPEF+APE
Sbjct: 144 -------ENIMLLDK-------NIPIPHIKLIDFGLAHE-IEDGVEFKNIFGTPEFVAPE 188
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
++ D W +GV+ + +L G SPF GD ++E +I +
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-43
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
++TG +A K +KK A S +R + + H ++ L ++ V +
Sbjct: 34 KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93
Query: 67 MEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
+E +GG+L + SE A + ++ G+ YLH +I + P
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP---------- 143
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + N ++K+ DFGL E + G GTPEF+APE
Sbjct: 144 -------ENIMLLDK-------NIPIPHIKLIDFGLAHE-IEDGVEFKNIFGTPEFVAPE 188
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
++ D W +GV+ + +L G SPF GD ++E +I + +
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-43
Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ TG+ +A K +KK + + S +R + +RHP ++ L F+ + V +
Sbjct: 27 KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86
Query: 67 MEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
+E +GG+L + +E A + ++ G+ YLH RI + P
Sbjct: 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKP---------- 136
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + N +K+ DFG+ + + G+ GTPEF+APE
Sbjct: 137 -------ENIMLLDK-------NVPNPRIKLIDFGIAHK-IEAGNEFKNIFGTPEFVAPE 181
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
++ D W +GV+ + +L G SPF G+ ++E +I +
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR----HPFLVNLFACFQTEAH 62
++TG+ +A K LKK +D +L E + + P ++NL ++ +
Sbjct: 51 KSTGQEYAAKFLKK-RRRGQDCRAEILHEIAV------LELAKSCPRVINLHEVYENTSE 103
Query: 63 VCFVMEYAAGGDLMMHIHADV---FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ ++EYAAGG++ ++ SE + ++ G+ YLH++ I++ P
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP---- 159
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+N I L+ G +KI DFG+ ++ +G GTP
Sbjct: 160 -------------QN--------ILLSSIYPLGDIKIVDFGMSRK-IGHACELREIMGTP 197
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
E+LAPE+L T A D W +G++ + +L SPF G+D +E + +I V Y
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 51/247 (20%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-- 58
V +++ TG+ FAIK V+ + E FEV + H +V LFA +
Sbjct: 25 VFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMRE---FEVLKKLNHKNIVKLFAIEEET 79
Query: 59 TEAHVCFVMEYAAGGDLMMHI----HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--- 111
T H +ME+ G L + +A E + VV G+ +L E+ I++R
Sbjct: 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
P NI +++ D + K+ DFG +E + ++ +
Sbjct: 140 PG-NI-----------------------MRVIGEDGQSVYKLTDFGAARE-LEDDEQFVS 174
Query: 172 FCGTPEFLAPEVLT--------ETSYTRAVDWWGLGVLIFEMLVGESPF----PGDDEEE 219
GT E+L P++ + Y VD W +GV + G PF +E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 220 VFDSIVN 226
V I+
Sbjct: 235 VMYKIIT 241
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-42
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 51/249 (20%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-- 58
V +++ TG+ FAIK + V+ + E FEV + H +V LFA +
Sbjct: 25 VFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMRE---FEVLKKLNHKNIVKLFAIEEET 79
Query: 59 TEAHVCFVMEYAAGGDLMMHI----HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--- 111
T H +ME+ G L + +A E + VV G+ +L E+ I++R
Sbjct: 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
P NI +++ D + K+ DFG +E + ++ +
Sbjct: 140 PG-NI-----------------------MRVIGEDGQSVYKLTDFGAARE-LEDDEQFVS 174
Query: 172 FCGTPEFLAPEVLT--------ETSYTRAVDWWGLGVLIFEMLVGESPF----PGDDEEE 219
GT E+L P++ + Y VD W +GV + G PF +E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 220 VFDSIVNDE 228
V I+ +
Sbjct: 235 VMYKIITGK 243
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 42/233 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQTEAHVC 64
TG A K +K + ++EV++ E++ N + H L+ L+ F+++ +
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKN--------EISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 65 FVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
VMEY GG+L I + +E + + + G++++H+ I++ P+ NI
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE-NI--- 218
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
L VN +KI DFGL + ++ GTPEFL
Sbjct: 219 ----------------------LCVNRDAKQIKIIDFGLARR-YKPREKLKVNFGTPEFL 255
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
APEV+ + D W +GV+ + +L G SPF GD++ E ++I+
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 44/245 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+ +++TGE AIK ++ ++ ++ E E ++ + HP +V+
Sbjct: 30 VLRWIHQDTGEQVAIKQCRQ-ELSPKNR-ERWCLE---IQIMKKLNHPNVVSAREVPDGL 84
Query: 61 AHV------CFVMEYAAGGDLMMHI----HADVFSEPRAVFYAACVVLGLQYLHESRIIY 110
+ MEY GGDL ++ + E + + L+YLHE+RII+
Sbjct: 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH 144
Query: 111 R---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD 167
R P EN I L KI D G KE + G+
Sbjct: 145 RDLKP-----------------EN--------IVLQPGPQRLIHKIIDLGYAKE-LDQGE 178
Query: 168 RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND 227
F GT ++LAPE+L + YT VD+W G L FE + G PF + + + V +
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 228 EVRYP 232
+
Sbjct: 239 KSNEH 243
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 42/233 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQTEAHVC 64
+ TG F K + + + V++ E++ N + HP L+NL F+ + +
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKN--------EISIMNQLHHPKLINLHDAFEDKYEMV 124
Query: 65 FVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
++E+ +GG+L I A+ SE + Y GL+++HE I++ P+ NI
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE-NI--- 180
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+ VKI DFGL + + + T EF
Sbjct: 181 ----------------------MCETKKASSVKIIDFGLATK-LNPDEIVKVTTATAEFA 217
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
APE++ D W +GVL + +L G SPF G+D+ E ++ + +
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
++TG +A K +KK + S +R + ++HP ++ L ++ + V +
Sbjct: 33 KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92
Query: 67 MEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
+E AGG+L + +E A + ++ G+ YLH +I + P
Sbjct: 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP---------- 142
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + N + +KI DFGL + + FG+ GTPEF+APE
Sbjct: 143 -------ENIMLLDR-------NVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFVAPE 187
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
++ D W +GV+ + +L G SPF GD ++E ++ +
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 63/250 (25%), Positives = 115/250 (46%), Gaps = 32/250 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG+ A+K + K + + + ESLL E ++ + + HP ++ L+ F+ +
Sbjct: 42 VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK---QLDHPNIMKLYEFFEDK 98
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V E GG+L I + FSE A V+ G+ Y+H+++I++R
Sbjct: 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHR-------- 150
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + L + ++I DFGL + GT ++
Sbjct: 151 DLK------PEN--------LLLESKSKDANIRIIDFGLSTH-FEASKKMKDKIGTAYYI 195
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FL 235
APEVL +Y D W GV+++ +L G PF G +E ++ + + + +
Sbjct: 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 236 SLEAIAIMRR 245
S A ++R+
Sbjct: 255 SESAKDLIRK 264
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-41
Identities = 50/232 (21%), Positives = 92/232 (39%), Gaps = 39/232 (16%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
++ + + K +K + + E I N RH +++L F++ + +
Sbjct: 27 TSSKKTYMAKFVKV----KGTDQVLVKKEISIL---NIARHRNILHLHESFESMEELVMI 79
Query: 67 MEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEI 121
E+ +G D+ I+ +E V Y V LQ+LH I + P+ NI
Sbjct: 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE-NI----- 133
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAP 181
+ +KI +FG ++ + GD PE+ AP
Sbjct: 134 --------------------IYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLFTAPEYYAP 172
Query: 182 EVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
EV + A D W LG L++ +L G +PF + +++ ++I+N E +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 8e-41
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 42/234 (17%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQTEAHVC 64
R TG FA K + ++ V E+ + +RHP LVNL F+ + +
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRK--------EIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 65 FVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
+ E+ +GG+L + + SE AV Y V GL ++HE+ ++ P+ NI
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE-NI--- 286
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+ +K+ DFGL + GT EF
Sbjct: 287 ----------------------MFTTKRSNELKLIDFGLTAH-LDPKQSVKVTTGTAEFA 323
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
APEV D W +GVL + +L G SPF G++++E ++ + +
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 377
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-40
Identities = 54/269 (20%), Positives = 95/269 (35%), Gaps = 70/269 (26%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-- 58
V+ ++ Y+AIK ++ +++ ++LSE + ++ H ++V +A +
Sbjct: 22 VVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLL---ASLNHQYVVRYYAAWLER 74
Query: 59 -----------TEAHVCFVMEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHE 105
++ + MEY G L IH+ ++ L Y+H
Sbjct: 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 106 SRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-- 160
II+R P N I + D VKI DFGL K
Sbjct: 135 QGIIHRDLKP-----------------MN--------IFI---DESRNVKIGDFGLAKNV 166
Query: 161 ------------EGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLV 207
G D + GT ++A EVL T Y +D + LG++ FEM+
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 208 GESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
G + + + + + +P
Sbjct: 227 P--FSTGMERVNILKKLRSVSIEFPPDFD 253
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-40
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ TG FA K + + ARD + L E RI ++HP +V L Q E+ V
Sbjct: 28 KTTGLEFAAKIINTKKLSARD-FQKLEREARIC---RKLQHPNIVRLHDSIQEESFHYLV 83
Query: 67 MEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
+ GG+L I A + +SE A ++ + Y H + I++R P
Sbjct: 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP---------- 133
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + L VK+ADFGL E + + F GTP +L+PE
Sbjct: 134 -------EN--------LLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFAGTPGYLSPE 177
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
VL + Y++ VD W GV+++ +LVG PF +D+ ++ I YP
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-40
Identities = 65/235 (27%), Positives = 96/235 (40%), Gaps = 44/235 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ T FA+K + K +E+E LL +HP ++ L + +V V
Sbjct: 44 KATNMEFAVKIIDKSKRDPTEEIEILLRY---------GQHPNIITLKDVYDDGKYVYVV 94
Query: 67 MEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
E GG+L+ I FSE A + ++YLH +++R P SNI
Sbjct: 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP-SNI------ 147
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGY--VKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
L V+++ ++I DFG K+ T C T F+A
Sbjct: 148 -------------------LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPF---PGDDEEEVFDSIVNDEVRYP 232
PEVL Y A D W LGVL++ ML G +PF P D EE+ I + +
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-40
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ TG FA K + + ARD + L E RI ++HP +V L Q E+ V
Sbjct: 51 KTTGLEFAAKIINTKKLSARD-FQKLEREARIC---RKLQHPNIVRLHDSIQEESFHYLV 106
Query: 67 MEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
+ GG+L I A + +SE A ++ + Y H + I++R P
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKP---------- 156
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + L VK+ADFGL E + + F GTP +L+PE
Sbjct: 157 -------EN--------LLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFAGTPGYLSPE 200
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
VL + Y++ VD W GV+++ +LVG PF +D+ ++ I YP
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L + + T AIK ++K + LL E + + + HP ++ L+ F+ +
Sbjct: 53 VLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLK---LLDHPNIMKLYDFFEDK 108
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ VME GG+L I F+E A V+ G+ YLH+ I++R
Sbjct: 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHR-------- 160
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + L + + +KI DFGL + GT ++
Sbjct: 161 DLK------PEN--------LLLESKEKDALIKIVDFGLSAV-FENQKKMKERLGTAYYI 205
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FL 235
APEVL + Y D W +GV++F +L G PF G ++E+ + + + +
Sbjct: 206 APEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264
Query: 236 SLEAIAIMRR 245
S A ++++
Sbjct: 265 SEGAKDLIKQ 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-39
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 43/256 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + R++G IK + K + +E + +E + ++ HP ++ +F F+
Sbjct: 38 VHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVL---KSLDHPNIIKIFEVFEDY 92
Query: 61 AHVCFVMEYAAGGDLMMHIHADV-----FSEPRAVFYAACVVLGLQYLHESRIIYR---P 112
++ VME GG+L+ I + SE ++ L Y H ++++ P
Sbjct: 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
EN I +KI DFGL + + +
Sbjct: 153 -----------------EN--------ILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNA 186
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--- 229
GT ++APEV T D W GV+++ +L G PF G EEV E
Sbjct: 187 AGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245
Query: 230 RYPRFLSLEAIAIMRR 245
R L+ +A+ ++++
Sbjct: 246 VECRPLTPQAVDLLKQ 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-39
Identities = 46/264 (17%), Positives = 95/264 (35%), Gaps = 59/264 (22%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +++R G+ + IK +K + A EV+ L++ + H +V+ C+
Sbjct: 27 VFKAKHRIDGKTYVIKRVKYNNEKAEREVK-ALAK---------LDHVNIVHYNGCWDGF 76
Query: 61 AH----------------VCFVMEYAAGGDLMMHIH---ADVFSEPRAVFYAACVVLGLQ 101
+ + ME+ G L I + + A+ + G+
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD 136
Query: 102 YLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161
Y+H ++I R ++K I L VKI DFGL
Sbjct: 137 YIHSKKLINR--------DLK--------------PSNIFLVDT---KQVKIGDFGLVTS 171
Query: 162 GMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221
+ + GT +++PE ++ Y + VD + LG+++ E+L + + F
Sbjct: 172 -LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV--CDTAFETSKFF 228
Query: 222 DSIVNDEVRYPRFLSLEAIAIMRR 245
+ + + ++++
Sbjct: 229 TDLRD--GIISDIFDKKEKTLLQK 250
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-39
Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 33/250 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+ + R T + +A+K + K +D ++L E + + + HP ++ LF +
Sbjct: 38 VLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLK---KLDHPNIMKLFEILEDS 93
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V E GG+L I FSE A V G+ Y+H+ I++R
Sbjct: 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR-------- 145
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN I L + + +KI DFGL + GT ++
Sbjct: 146 DLK------PEN--------ILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRIGTAYYI 190
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FL 235
APEVL +Y D W GV+++ +L G PF G +E ++ + + + +
Sbjct: 191 APEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249
Query: 236 SLEAIAIMRR 245
S +A ++R+
Sbjct: 250 SDDAKDLIRK 259
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 41/262 (15%), Positives = 91/262 (34%), Gaps = 56/262 (21%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHP--FLVNLFACFQTEAHV 63
+ +AIK + + + ++S +E N ++ ++ L+ T+ ++
Sbjct: 48 LNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYL---NKLQQHSDKIIRLYDYEITDQYI 103
Query: 64 CFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
VME DL + Y ++ + +H+ I++ P N
Sbjct: 104 YMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA-NF--- 158
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTPE 177
L V+ G +K+ DFG+ + + GT
Sbjct: 159 ----------------------LIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 178 FLAPEVLTETS-----------YTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIV 225
++ PE + + S + D W LG +++ M G++PF + +I+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 226 ND--EVRYPRFLSLEAIAIMRR 245
+ E+ +P + +++
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKC 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 67/239 (28%), Positives = 108/239 (45%), Gaps = 41/239 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQ 58
V L + R TG+ FA+K +KK +E+ E+A ++H +V L ++
Sbjct: 25 VFLVKQRLTGKLFALKCIKKSPAFRDSSLEN--------EIAVLKKIKHENIVTLEDIYE 76
Query: 59 TEAHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQS 114
+ H VM+ +GG+L I V++E A V+ ++YLHE+ I++R P
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP-- 134
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
EN + + + I DFGL K M T CG
Sbjct: 135 ---------------EN--------LLYLTPEENSKIMITDFGLSK--MEQNGIMSTACG 169
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
TP ++APEVL + Y++AVD W +GV+ + +L G PF + E ++F+ I +
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 67/239 (28%), Positives = 102/239 (42%), Gaps = 31/239 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQ 58
V L+ R T + AI+ + K E+ + E+ + HP ++ + F
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210
Query: 59 TEAHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
E V+E GG+L + E Y ++L +QYLHE+ II+R
Sbjct: 211 AE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR------ 263
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++K EN + L+ + + +KI DFG K +G T CGTP
Sbjct: 264 --DLK------PEN--------VLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCGTPT 306
Query: 178 FLAPEVLTET---SYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDSIVNDEVRYP 232
+LAPEVL Y RAVD W LGV++F L G PF + + D I + + +
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 41/263 (15%), Positives = 90/263 (34%), Gaps = 58/263 (22%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFL--VNLFACFQTEAHV 63
+ +AIK + + + ++S +E N ++ + L+ T+ ++
Sbjct: 29 LNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYL---NKLQQHSDKIIRLYDYEITDQYI 84
Query: 64 CFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
VME DL + Y ++ + +H+ I++ P N
Sbjct: 85 YMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA-NF--- 139
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGTP 176
L V+ G +K+ DFG+ + + GT
Sbjct: 140 ----------------------LIVD---GMLKLIDFGIANQMQPDTTSVVKD-SQVGTV 173
Query: 177 EFLAPEVLTETS-----------YTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSI 224
++ PE + + S + D W LG +++ M G++PF + +I
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 225 VND--EVRYPRFLSLEAIAIMRR 245
++ E+ +P + +++
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLKC 256
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-38
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+ + R T + +A+K + K +D ++L E + + + HP ++ LF +
Sbjct: 38 VLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLK---KLDHPNIMKLFEILEDS 93
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V E GG+L I FSE A V G+ Y+H+ I++R
Sbjct: 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHR-------- 145
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN I L + + +KI DFGL + GT ++
Sbjct: 146 DLK------PEN--------ILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRIGTAYYI 190
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
APEVL +Y D W GV+++ +L G PF G +E ++ + + +
Sbjct: 191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-38
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 7 RNTGEYFAIKALKKGDIIARD--EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
R TG+ FA+K + + E L E I + ++HP +V L + ++ +
Sbjct: 46 RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC---HMLKHPHIVELLETYSSDGMLY 102
Query: 65 FVMEYAAGGDLMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
V E+ G DL I V+SE A Y ++ L+Y H++ II+R P
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKP---- 158
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+ L + VK+ FG+ + G G GTP
Sbjct: 159 -------------HC--------VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
F+APEV+ Y + VD WG GV++F +L G PF +E +F+ I+ + +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF-YGTKERLFEGIIKGKYKMNP 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-38
Identities = 40/262 (15%), Positives = 88/262 (33%), Gaps = 56/262 (21%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFL--VNLFACFQTEAHV 63
+ +AIK + + ++S +E N ++ + L+ T+ ++
Sbjct: 76 LNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYL---NKLQQHSDKIIRLYDYEITDQYI 131
Query: 64 CFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
VME DL + Y ++ + +H+ I++ P N
Sbjct: 132 YMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA-NF--- 186
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTPE 177
L V+ G +K+ DFG+ + + G
Sbjct: 187 ----------------------LIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 178 FLAPEVLTETS-----------YTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIV 225
++ PE + + S + D W LG +++ M G++PF + +I+
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 226 ND--EVRYPRFLSLEAIAIMRR 245
+ E+ +P + +++
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKC 303
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-38
Identities = 69/292 (23%), Positives = 106/292 (36%), Gaps = 79/292 (27%)
Query: 7 RNTGEYFAIKALKKGDIIARD--EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
T AIK + K I + +VE + +E + + HP + L+ ++ E ++C
Sbjct: 48 NQTRAIRAIKIMNKNKIRQINPKDVERIKTE---VRLMKKLHHPNIARLYEVYEDEQYIC 104
Query: 65 FVMEYAAGGDLMMHIHA-----------------------------------------DV 83
VME GG L+ ++ V
Sbjct: 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFV 164
Query: 84 FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLT 143
E + L YLH I +R +IK EN+ L
Sbjct: 165 QREKLISNIMRQIFSALHYLHNQGICHR--------DIK------PENF---------LF 201
Query: 144 VNDTEGYVKIADFGLCKE----GMGFGDRTGTFCGTPEFLAPEVL--TETSYTRAVDWWG 197
+ +K+ DFGL KE G T GTP F+APEVL T SY D W
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 198 LGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSLEAIAIMRR 245
GVL+ +L+G PFPG ++ + ++N ++ + LS A ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 71/247 (28%), Positives = 120/247 (48%), Gaps = 32/247 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L+++ TG AIK + K + ++ L E RI + + HP +V LF +TE
Sbjct: 31 VKLARHILTGREVAIKIIDKTQLNPTS-LQKLFREVRIMK---ILNHPNIVKLFEVIETE 86
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ +MEYA+GG++ ++ A E A +V +QY H+ RI++R
Sbjct: 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR-------- 138
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + L D + +KIADFG E G + FCG P +
Sbjct: 139 DLK------AEN--------LLL---DADMNIKIADFGFSNE-FTVGGKLDAFCGAPPYA 180
Query: 180 APEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238
APE+ Y VD W LGV+++ ++ G PF G + +E+ + ++ + R P ++S +
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240
Query: 239 AIAIMRR 245
+++R
Sbjct: 241 CENLLKR 247
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 33/237 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V G+ +A + ++ + + L E RI ++HP +V L E
Sbjct: 27 VRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARIC---RLLKHPNIVRLHDSISEE 82
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
H + + GG+L I A + +SE A ++ + + H+ +++R P
Sbjct: 83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKP---- 138
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + L VK+ADFGL E G F GTP
Sbjct: 139 -------------EN--------LLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
+L+PEVL + Y + VD W GV+++ +LVG PF +D+ ++ I +P
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS 234
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 61/257 (23%), Positives = 109/257 (42%), Gaps = 36/257 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEV----ANTMR---HPFLVNL 53
V+L + +N AIK +KK + + ++ E + ++ HP ++ L
Sbjct: 52 VLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111
Query: 54 FACFQTEAHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
F F+ + + V E+ GG+L I F E A ++ G+ YLH+ I++R
Sbjct: 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHR- 170
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
+IK EN I L ++ +KI DFGL +
Sbjct: 171 -------DIK------PEN--------ILLENKNSLLNIKIVDFGLSSF-FSKDYKLRDR 208
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
GT ++APEVL + Y D W GV+++ +L G PF G +++++ + + +
Sbjct: 209 LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 233 R----FLSLEAIAIMRR 245
+S EA +++
Sbjct: 268 FNDWKNISDEAKELIKL 284
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-37
Identities = 60/253 (23%), Positives = 102/253 (40%), Gaps = 41/253 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ + T A K + K + ++V+ E I + ++ HP ++ L+ F+
Sbjct: 25 VKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMK---SLDHPNIIRLYETFEDN 78
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ VME GG+L + VF E A V+ + Y H+ + +R P
Sbjct: 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP---- 134
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + + +K+ DFGL G T GTP
Sbjct: 135 -------------EN--------FLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTKVGTP 172
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--- 233
+++P+VL E Y D W GV+++ +L G PF + EV I +P
Sbjct: 173 YYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231
Query: 234 -FLSLEAIAIMRR 245
+S +A +++RR
Sbjct: 232 LNVSPQAESLIRR 244
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-37
Identities = 50/228 (21%), Positives = 81/228 (35%), Gaps = 29/228 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V R G +AIK KK + DE +L + ++ A +H +V F+ + +
Sbjct: 27 VFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL---REVYAHAVLGQHSHVVRYFSAWAED 83
Query: 61 AHVCFVMEYAAGGDLMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---P 112
H+ EY GG L I F E V GL+Y+H +++ P
Sbjct: 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP 143
Query: 113 QSNI--TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
NI ++ I ++ + S++ + KI D G
Sbjct: 144 S-NIFISRTSIPNAASEEGDEDDWASNKVM----------FKIGDLGHVTR----ISSPQ 188
Query: 171 TFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
G FLA EVL E ++ D + L + + E D+
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 2e-36
Identities = 36/275 (13%), Positives = 70/275 (25%), Gaps = 68/275 (24%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSE-------------------KRIFEV 41
+ + + TGE F + + + ++ + E R
Sbjct: 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153
Query: 42 ANTMRHPFLVNLFACFQTEAHVCFVMEY----AAGGDLMMHIHA--------DVFSEPRA 89
+ ++ P + E + + + +L
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 90 VFYAACVVLGLQYLHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146
+ V+ L LH +++ P + + D
Sbjct: 214 LQLTLQVIRLLASLHHYGLVHTYLRP-----------------VDIVL-----------D 245
Query: 147 TEGYVKIADFGLCK-EGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGV 200
G V + F +G G PE A +L T T A D W LG+
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 201 LIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235
I+ + + P D + I P+ +
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPV 340
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 39/238 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + T + +A+K LKK + + + +E + + HP ++ L F+T
Sbjct: 69 VYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLL---RLSHPNIIKLKEIFETP 120
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ V+E GG+L I +SE A ++ + YLHE+ I++R P
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP---- 176
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + + +KIADFGL K + T CGTP
Sbjct: 177 -------------EN--------LLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGTP 214
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSIVNDEVRYPR 233
+ APE+L +Y VD W +G++ + +L G PF + ++ +F I+N E +
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS 272
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-36
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 52/272 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT---------------- 44
V L+ N Y+A+K L K +I + +
Sbjct: 29 VKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88
Query: 45 ----MRHPFLVNLFACFQ--TEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL 98
+ HP +V L E H+ V E G +M SE +A FY ++
Sbjct: 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIK 148
Query: 99 GLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158
G++YLH +II+R +IK N L V +G++KIADFG+
Sbjct: 149 GIEYLHYQKIIHR--------DIK------PSN----------LLV-GEDGHIKIADFGV 183
Query: 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETS--YT-RAVDWWGLGVLIFEMLVGESPFPGD 215
E G GTP F+APE L+ET ++ +A+D W +GV ++ + G+ PF +
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 216 DEEEVFDSIVNDEVRYPRF--LSLEAIAIMRR 245
+ I + + +P ++ + ++ R
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITR 275
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-36
Identities = 56/237 (23%), Positives = 91/237 (38%), Gaps = 44/237 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ + + FA+K II++ + E + HP +V L F + H V
Sbjct: 33 KKSNQAFAVK------IISKRMEANTQKEITALK--LCEGHPNIVKLHEVFHDQLHTFLV 84
Query: 67 MEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIK 122
ME GG+L I FSE A + +V + ++H+ +++R P
Sbjct: 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP---------- 134
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
EN + T + +KI DFG + T C T + APE
Sbjct: 135 -------EN--------LLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 183 VLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-------EEVFDSIVNDEVRYP 232
+L + Y + D W LGV+++ ML G+ PF D E+ I + +
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 68/242 (28%), Positives = 100/242 (41%), Gaps = 37/242 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQ 58
V L+ R T + AIK + K E+ + E+ + HP ++ + F
Sbjct: 26 VKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85
Query: 59 TEAHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQS 114
E V+E GG+L + E Y ++L +QYLHE+ II+R P
Sbjct: 86 AE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP-- 142
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
EN + L+ + + +KI DFG K +G T CG
Sbjct: 143 ---------------EN--------VLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLCG 178
Query: 175 TPEFLAPEVLTET---SYTRAVDWWGLGVLIFEMLVGESPFPGD-DEEEVFDSIVNDEVR 230
TP +LAPEVL Y RAVD W LGV++F L G PF + + D I + +
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238
Query: 231 YP 232
+
Sbjct: 239 FI 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-35
Identities = 46/243 (18%), Positives = 92/243 (37%), Gaps = 47/243 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR----HPFLVNLFACFQTEAH 62
+ T + +A+K + + E + + + +R HP ++ L ++T
Sbjct: 39 KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98
Query: 63 VCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITK 118
V + G+L ++ V SE ++ + LH+ I++R P
Sbjct: 99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP------ 152
Query: 119 EEIKRIEAKVQEN--YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + + +K+ DFG + + G++ CGTP
Sbjct: 153 -----------ENILLDDDMN-------------IKLTDFGFSCQ-LDPGEKLREVCGTP 187
Query: 177 EFLAPEVL------TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230
+LAPE++ Y + VD W GV+++ +L G PF + + I++ +
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247
Query: 231 YPR 233
+
Sbjct: 248 FGS 250
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 37/250 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA--NTMRHPFLVNLFACFQ 58
V + + + +K +KK ++ +E K E+A + + H ++ + F+
Sbjct: 40 VWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99
Query: 59 TEAHVCFVMEYAA-GGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
+ VME G DL I EP A + +V + YL II+R
Sbjct: 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR----- 154
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+IK EN I + + +K+ DFG + G TFCGT
Sbjct: 155 ---DIK------DEN--------IVI---AEDFTIKLIDFGSAAY-LERGKLFYTFCGTI 193
Query: 177 EFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235
E+ APEVL Y ++ W LGV ++ ++ E+PF + + V + P +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF--CE----LEETVEAAIHPPYLV 247
Query: 236 SLEAIAIMRR 245
S E ++++
Sbjct: 248 SKELMSLVSG 257
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-35
Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 37/250 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVAN--TMRHPFLVNLFACF 57
V + +++ TG A+K I+ R ++ SL +I E+ N RHP ++ L+
Sbjct: 27 VKIGEHQLTGHKVAVK------ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 58 QTEAHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
T VMEY +GG+L +I E A ++ + Y H +++R
Sbjct: 81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHR----- 135
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++K EN + L D KIADFGL M G+ T CG+P
Sbjct: 136 ---DLK------PEN--------VLL---DAHMNAKIADFGLSNM-MSDGEFLRTSCGSP 174
Query: 177 EFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235
+ APEV++ Y VD W GV+++ +L G PF + +F I P +L
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL 234
Query: 236 SLEAIAIMRR 245
+ ++
Sbjct: 235 NRSVATLLMH 244
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-34
Identities = 36/281 (12%), Positives = 71/281 (25%), Gaps = 77/281 (27%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRI---------------------- 38
+ + + TGE F + + + ++ + E
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 39 FEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAA------GGDLMMHIHADVFSEPRAV 90
F++ + ++ + + F+ G L+ H A
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 91 FYAAC-VVLGLQYLHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146
V+ L LH +++ P +I V D
Sbjct: 209 LQLTLQVIRLLASLHHYGLVHTYLRPV-DI---------------------------VLD 240
Query: 147 TEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL-----------TETSYTRAVDW 195
G V + F + F PE+ T T + D
Sbjct: 241 QRGGVFLTGFEHLVR----DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 196 WGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
W LG++I+ + + P D + I P+ +
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVR 337
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 69/256 (26%), Positives = 111/256 (43%), Gaps = 45/256 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVAN--TMRHPFLVNLFACF 57
L + + T E A+K +++G I ++ + E+ N ++RHP +V
Sbjct: 36 ARLMRDKLTKELVAVKYIERGAAI----------DENVQREIINHRSLRHPNIVRFKEVI 85
Query: 58 QTEAHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
T H+ +MEYA+GG+L I +A FSE A F+ ++ G+ Y H +I +R
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHR----- 140
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++K EN L +KI DFG K + + GTP
Sbjct: 141 ---DLK------LENT---------LLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTP 181
Query: 177 EFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVF----DSIVNDEVRY 231
++APEVL Y + D W GV ++ MLVG PF +E + I++ +
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI 241
Query: 232 PR--FLSLEAIAIMRR 245
P +S E ++ R
Sbjct: 242 PDDIRISPECCHLISR 257
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 52/242 (21%), Positives = 94/242 (38%), Gaps = 46/242 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACFQTEAHV 63
R TG FA+K ++ E + E E + HP ++ L +++ + +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 64 CFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKE 119
V + G+L ++ V SE ++ + +LH + I++R P
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP------- 228
Query: 120 EIKRIEAKVQEN--YKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
EN N ++++DFG + G++ CGTP
Sbjct: 229 ----------ENILLDDNMQ-------------IRLSDFGFSCH-LEPGEKLRELCGTPG 264
Query: 178 FLAPEVL------TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231
+LAPE+L T Y + VD W GV++F +L G PF + + I+ + ++
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 232 PR 233
Sbjct: 325 SS 326
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 49/257 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA------NTMRHPFLVNLF 54
V AIK + + ++ + ++ EVA HP ++ L
Sbjct: 47 VFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL--EVALLWKVGAGGGHPGVIRLL 104
Query: 55 ACFQTEAHVCFVMEYAA-GGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
F+T+ V+E DL +I E + + VV +Q+ H +++R
Sbjct: 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHR- 163
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC---KEGMGFGDRT 169
+IK EN + ++ G K+ DFG +
Sbjct: 164 -------DIK------DEN----------ILIDLRRGCAKLIDFGSGALLHDEP-----Y 195
Query: 170 GTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228
F GT + PE ++ Y W LG+L+++M+ G+ PF D E I+ E
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE 249
Query: 229 VRYPRFLSLEAIAIMRR 245
+ +P +S + A++RR
Sbjct: 250 LHFPAHVSPDCCALIRR 266
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 47/228 (20%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH---- 62
R TG+ A+K L + EV+ P +V + ++ H
Sbjct: 51 RRTGQKCALKLLYDSPKARQ-EVDHHWQA---------SGGPHIVCILDVYENMHHGKRC 100
Query: 63 VCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ +ME GG+L I F+E A + +Q+LH I +R P
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP---- 156
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + T + + +K+ DFG KE + T C TP
Sbjct: 157 -------------EN--------LLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTP 193
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
++APEVL Y ++ D W LGV+++ +L G PF + + + +
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-32
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 42/221 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ AIK + + D + L E + + ++H +V F +
Sbjct: 44 LSNQVRIAIKEIPERD---SRYSQPLHEEIALHK---HLKHKNIVQYLGSFSENGFIKIF 97
Query: 67 MEYAAGG---DLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
ME GG L+ +E FY ++ GL+YLH+++I++R
Sbjct: 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR----------- 146
Query: 123 RIEAKVQENYKVNSSQEIK---LTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK + +N G +KI+DFG K G T TF GT +++
Sbjct: 147 ----------------DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 180 APEVL--TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218
APE++ Y +A D W LG I EM G+ PF E
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-32
Identities = 50/253 (19%), Positives = 96/253 (37%), Gaps = 43/253 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRH--PFLVNLFACFQ 58
V + AIK ++K I E+ + + + ++ L F+
Sbjct: 59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118
Query: 59 TEAHVCFVMEYAAG-GDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
++E DL I E A + V+ +++ H +++R
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR----- 173
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC---KEGMGFGDRTGTFC 173
+IK EN + ++ G +K+ DFG K+ + F
Sbjct: 174 ---DIK------DEN----------ILIDLNRGELKLIDFGSGALLKDTV-----YTDFD 209
Query: 174 GTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
GT + PE + Y R+ W LG+L+++M+ G+ PF + +EE I+ +V +
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEE----IIRGQVFFR 263
Query: 233 RFLSLEAIAIMRR 245
+ +S E ++R
Sbjct: 264 QRVSSECQHLIRW 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 38/250 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVAN--TMRHPFLVNLFACF 57
V L+ + T + A+K I+R ++ R+ E++ +RHP ++ L+
Sbjct: 25 VKLATHYKTQQKVALK------FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78
Query: 58 QTEAHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
T + V+EY AGG+L +I +E + ++ ++Y H +I++R
Sbjct: 79 TTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR----- 132
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++K EN + L D VKIADFGL M G+ T CG+P
Sbjct: 133 ---DLK------PEN--------LLL---DDNLNVKIADFGLSNI-MTDGNFLKTSCGSP 171
Query: 177 EFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235
+ APEV+ Y VD W G++++ MLVG PF + +F + + P FL
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231
Query: 236 SLEAIAIMRR 245
S A +++RR
Sbjct: 232 SPGAQSLIRR 241
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 43/253 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVAN--TMRHPFLVNLFACF 57
V + ++ TG A+K I+ R ++ SL +I E+ N RHP ++ L+
Sbjct: 32 VKVGKHELTGHKVAVK------ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 58 QTEAHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQ 113
T + + VMEY +GG+L +I E + ++ G+ Y H +++R P
Sbjct: 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP- 144
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
EN + L D KIADFGL M G+ T C
Sbjct: 145 ----------------EN--------VLL---DAHMNAKIADFGLSNM-MSDGEFLRTSC 176
Query: 174 GTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
G+P + APEV++ Y VD W GV+++ +L G PF D +F I + P
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236
Query: 233 RFLSLEAIAIMRR 245
++L+ I++++
Sbjct: 237 QYLNPSVISLLKH 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 61/254 (24%), Positives = 89/254 (35%), Gaps = 55/254 (21%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR----HPFLVNLFACFQTEAH 62
T + +A+K ++K R V EV + H ++ L F+ E
Sbjct: 35 LITSQEYAVKIIEKQPGHIRSRVFR--------EVE-MLYQCQGHRNVLELIEFFEEEDR 85
Query: 63 VCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITK 118
V E GG ++ HIH F+E A V L +LH I +R P
Sbjct: 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKP------ 139
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL---CKEGMGFGDRTG----T 171
EN I + VKI DF L K + T
Sbjct: 140 -----------EN--------ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 172 FCGTPEFLAPEVL-----TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
CG+ E++APEV+ + Y + D W LGV+++ +L G PF G +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 227 DEVRYPRFLSLEAI 240
L E+I
Sbjct: 241 ACPACQNML-FESI 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-32
Identities = 41/254 (16%), Positives = 84/254 (33%), Gaps = 53/254 (20%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + + G ++A+K + + + + E E ++ HP ++ L A E
Sbjct: 45 VDLVEGLHDGHFYALKRILCHE---QQDREEAQRE---ADMHRLFNHPNILRLVAYCLRE 98
Query: 61 A----HVCFVMEYAAGGDLMMHI-----HADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
++ + G L I + +E + ++ + GL+ +H +R
Sbjct: 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR 158
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---------EG 162
++K N I L + D G
Sbjct: 159 --------DLK------PTN--------ILLGDEGQ---PVLMDLGSMNQACIHVEGSRQ 193
Query: 163 MGFGDRTGTFCGTPEFLAPEVLTETSY---TRAVDWWGLGVLIFEMLVGESPFPGDDEE- 218
T + APE+ + S+ D W LG +++ M+ GE P+ ++
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 219 EVFDSIVNDEVRYP 232
+ V +++ P
Sbjct: 254 DSVALAVQNQLSIP 267
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-31
Identities = 55/253 (21%), Positives = 100/253 (39%), Gaps = 35/253 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF--ACFQ 58
V T A+K LKK + E+ + K+ ++ +RH ++ L +
Sbjct: 21 VKEVLDSETLCRRAVKILKKKKLRRIPNGEANV--KKEIQLLRRLRHKNVIQLVDVLYNE 78
Query: 59 TEAHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
+ + VMEY G +++ + F +A Y ++ GL+YLH I+++
Sbjct: 79 EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK----- 133
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC--KEGMGFGDRTGTFCG 174
+IK N + L T G +KI+ G+ D T G
Sbjct: 134 ---DIK------PGN--------LLL---TTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 175 TPEFLAPEVLT-ETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
+P F PE+ +++ VD W GV ++ + G PF GD+ ++F++I P
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP 233
Query: 233 RFLSLEAIAIMRR 245
+++
Sbjct: 234 GDCGPPLSDLLKG 246
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 59/241 (24%), Positives = 89/241 (36%), Gaps = 50/241 (20%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAH 62
+ T E FA+K L+ R EVE + P +V + ++
Sbjct: 84 KRTQEKFALKMLQDCPKARR-EVELHW---------RASQCPHIVRIVDVYENLYAGRKC 133
Query: 63 VCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ VME GG+L I F+E A + +QYLH I +R P
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP---- 189
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
EN + T +K+ DFG KE + T C TP
Sbjct: 190 -------------EN--------LLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTP 227
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD----EEEVFDSIVNDEVRYP 232
++APEVL Y ++ D W LGV+++ +L G PF + + I + +P
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 233 R 233
Sbjct: 288 N 288
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 59/255 (23%), Positives = 103/255 (40%), Gaps = 43/255 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L+ R T E A+K + + D E++ K+ + + H +V + +
Sbjct: 23 VQLAVNRVTEEAVAVKIVDMKRAV--DCPENI---KKEICINKMLNHENVVKFYGHRREG 77
Query: 61 AHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+EY +GG+L I D+ EP A + ++ G+ YLH I +R
Sbjct: 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR-------- 129
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG---TFCGTP 176
+IK EN + L D +KI+DFGL + +R CGT
Sbjct: 130 DIK------PEN--------LLL---DERDNLKISDFGLATV-FRYNNRERLLNKMCGTL 171
Query: 177 EFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEV---FDSIVNDEVRYP 232
++APE+L + VD W G+++ ML GE P+ D + + +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLN 229
Query: 233 RF--LSLEAIAIMRR 245
+ + +A++ +
Sbjct: 230 PWKKIDSAPLALLHK 244
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-31
Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 47/257 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN--TMRHPFLVNLFACFQ 58
V L+ R T E A+K + + D E++ K+ E+ + H +V + +
Sbjct: 23 VQLAVNRVTEEAVAVKIVDMKRAV--DCPENI---KK--EICINKMLNHENVVKFYGHRR 75
Query: 59 TEAHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+EY +GG+L I D+ EP A + ++ G+ YLH I +R
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR------ 129
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG---TFCG 174
+IK EN + L D +KI+DFGL + +R CG
Sbjct: 130 --DIK------PEN--------LLL---DERDNLKISDFGLATV-FRYNNRERLLNKMCG 169
Query: 175 TPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEV---FDSIVNDEVR 230
T ++APE+L + VD W G+++ ML GE P+ D + + +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTY 227
Query: 231 YPRF--LSLEAIAIMRR 245
+ + +A++ +
Sbjct: 228 LNPWKKIDSAPLALLHK 244
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-31
Identities = 43/255 (16%), Positives = 88/255 (34%), Gaps = 62/255 (24%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ + +AIK ++ + E ++ E + + HP +V F + +
Sbjct: 21 VFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALA---KLEHPGIVRYFNAWLEK 75
Query: 61 ------------AHVCFVMEYAAGGDLMMHIHA----DVFSEPRAVFYAACVVLGLQYLH 104
++ M+ +L ++ + + + +++LH
Sbjct: 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135
Query: 105 ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---- 160
+++R ++K I T++ VK+ DFGL
Sbjct: 136 SKGLMHR--------DLK--------------PSNIFFTMD---DVVKVGDFGLVTAMDQ 170
Query: 161 --------EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
M R GT +++PE + SY+ VD + LG+++FE+L PF
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227
Query: 213 PGDDE-EEVFDSIVN 226
E + N
Sbjct: 228 STQMERVRTLTDVRN 242
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 42/218 (19%), Positives = 72/218 (33%), Gaps = 51/218 (23%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ TG A+K ++ +E+ + + P +V L+ + V
Sbjct: 80 KQTGFQCAVKKVRLEVFR-VEEL-VACAG---------LSSPRIVPLYGAVREGPWVNIF 128
Query: 67 MEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKR 123
ME GG L+ + E RA++Y + GL+YLH RI++
Sbjct: 129 MELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHG------------ 174
Query: 124 IEAKVQENYKVNSSQEIK---LTVNDTEGYVKIADFGLCK-----EGMGFGDRTGTFCGT 175
++K + ++ + DFG GT
Sbjct: 175 ---------------DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213
+APEV+ VD W ++ ML G P+
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 56/273 (20%), Positives = 99/273 (36%), Gaps = 64/273 (23%)
Query: 7 RNTGEYFAIKALKKGDI-IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
G A+K + IA E++ LL+E + HP ++ + T+ +
Sbjct: 36 SFQGRPVAVKRMLIDFCDIALMEIK-LLTE--------SDDHPNVIRYYCSETTDRFLYI 86
Query: 66 VMEYAAGGDLMMHI--------HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQS 114
+E +L + + + E + + G+ +LH +II+R PQ
Sbjct: 87 ALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ- 144
Query: 115 NI---TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK----EGMGFGD 167
NI T + EN ++ I+DFGLCK F
Sbjct: 145 NILVSTSSRFTADQQTGAENLRI-----------------LISDFGLCKKLDSGQSSFRT 187
Query: 168 RTGTFCGTPEFLAPEVLTETS-------YTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219
GT + APE+L E++ TR++D + +G + + +L G+ PF E
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 220 VFDSIVNDEVRYPRF-------LSLEAIAIMRR 245
+I+ L EA ++ +
Sbjct: 248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-30
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 26/225 (11%)
Query: 10 GEYFAIKALKKG-DIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
G+ A+KA + D +E++ E ++F ++HP ++ L E ++C VME
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFA---MLKHPNIIALRGVCLKEPNLCLVME 86
Query: 69 YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESR---IIYRPQSNITKEEIKRIE 125
+A GG L + V +A + G+ YLH+ II+R ++K
Sbjct: 87 FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR--------DLKS-- 136
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185
N + E N +KI DFGL +E + G ++APEV+
Sbjct: 137 ----SNILILQKVENGDLSNKI---LKITDFGLAREWHR--TTKMSAAGAYAWMAPEVIR 187
Query: 186 ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230
+ +++ D W GVL++E+L GE PF G D V + +++
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-30
Identities = 50/243 (20%), Positives = 85/243 (34%), Gaps = 41/243 (16%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF----QTEAH 62
T A L+ + + E + E E+ ++HP +V + + + +
Sbjct: 48 TETTVEVAWCELQDRKL-TKSERQRFKEE---AEMLKGLQHPNIVRFYDSWESTVKGKKC 103
Query: 63 VCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKE 119
+ V E G L ++ V + ++ GLQ+LH II+R ++ +
Sbjct: 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR---DLKCD 160
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + G VKI D GL + GTPEF+
Sbjct: 161 NI---------------------FITGPTGSVKIGDLGLAT--LKRASFAKAVIGTPEFM 197
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLS 236
APE+ E Y +VD + G+ + EM E P+ V V+ + +
Sbjct: 198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 237 LEA 239
E
Sbjct: 257 PEV 259
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 48/249 (19%), Positives = 80/249 (32%), Gaps = 49/249 (19%)
Query: 7 RNTGEYFAIKALKKGDI-IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
A+K + A EV+ LL E + HP ++ F +
Sbjct: 45 MFDNRDVAVKRILPECFSFADREVQ-LLRE--------SDEHPNVIRYFCTEKDRQFQYI 95
Query: 66 VMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEE 120
+E L ++ + GL +LH I++R P NI
Sbjct: 96 AIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH-NIL--- 150
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGTPE 177
I + + I+DFGLCK G R GT
Sbjct: 151 -------------------ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 178 FLAPEVLTETS---YTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVN---DEVR 230
++APE+L+E T VD + G + + ++ G PF + + + D +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 231 YPRFLSLEA 239
+ + A
Sbjct: 252 PEKHEDVIA 260
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + TG+ AI+ + ++ + + E +++E + ++P +VN +
Sbjct: 36 VYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR---ENKNPNIVNYLDSYLVG 89
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ VMEY AGG L + E + + L++LH +++I+R +
Sbjct: 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR--------D 141
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
IK S I L +G VK+ DFG C + + T GTP ++A
Sbjct: 142 IK--------------SDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
PEV+T +Y VD W LG++ EM+ GE P+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 30/207 (14%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
T + AIK + + A DE+E + E V + P++ + + + +
Sbjct: 43 DNRTQKVVAIKIIDLEE--AEDEIEDIQQE---ITVLSQCDSPYVTKYYGSYLKDTKLWI 97
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+MEY GG + + E + ++ GL YLH + I+R +IK
Sbjct: 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR--------DIK--- 146
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185
+ + L+ G VK+ADFG+ + + TF GTP ++APEV+
Sbjct: 147 -----------AANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 186 ETSYTRAVDWWGLGVLIFEMLVGESPF 212
+++Y D W LG+ E+ GE P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPH 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-30
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ +++G A+K + D+ + E L +E + +H +V ++ +
Sbjct: 61 VCLAREKHSGRQVAVKMM---DLRKQQRRELLFNE---VVIMRDYQHFNVVEMYKSYLVG 114
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ +ME+ GG L + +E + V+ L YLH +I+R +
Sbjct: 115 EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHR--------D 166
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
IK S I LT +G VK++DFG C + + + GTP ++A
Sbjct: 167 IK--------------SDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
PEV++ + Y VD W LG+++ EM+ GE P+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 35/214 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + ++ TG+ AIK + +++ ++ E + P +V + +
Sbjct: 45 VYKAIHKETGQIVAIKQ-----VPVESDLQEIIKE---ISIMQQCDSPHVVKYYGSYFKN 96
Query: 61 AHVCFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ VMEY G + ++ + +E + GL+YLH R I+R
Sbjct: 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR------- 149
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+IK + I L TEG+ K+ADFG+ + + T GTP +
Sbjct: 150 -DIK--------------AGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFW 191
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+APEV+ E Y D W LG+ EM G+ P+
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCFVMEYAAG 72
A+K L + D A + V L E I + +RHP +V A Q ++ V EY +
Sbjct: 64 AVKILMEQDFHA-ERVNEFLREVAIMK---RLRHPNIVLFMGAVTQ-PPNLSIVTEYLSR 118
Query: 73 GDLMMHIH----ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEA 126
G L +H + E R + A V G+ YLH I++R +K
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR--------NLK---- 166
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE 186
S + + T VK+ DFGL + + + GTPE++APEVL +
Sbjct: 167 ----------SPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 187 TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230
D + GV+++E+ + P+ + +V ++ R
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-28
Identities = 32/259 (12%), Positives = 59/259 (22%), Gaps = 60/259 (23%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRI---------------------FEVANTM 45
E FA+K G +R E+E L +
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 46 RHPFLVNLFACFQTEA--HVCFVMEYAAG------GDLMMHIHADVFSEPRAVFYAAC-V 96
P L A + +M A+ L A+ +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 97 VLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156
+ L +++ +N + +G + + D
Sbjct: 204 IRLAANLQSKGLVHG--------HFTP------DNLFI-----------MPDGRLMLGDV 238
Query: 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLT--ETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
+ G R + E L ++T A++ W LG+ I+ + PF
Sbjct: 239 SALWK---VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 215 DDEEEVFDSIVNDEVRYPR 233
Sbjct: 296 VTPGIKGSWKRPSLRVPGT 314
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-28
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
+ + TG A K + + + +E+E + E E+ T HP++V L + + +
Sbjct: 39 KNKETGALAAAKVI---ETKSEEELEDYIVE---IEILATCDHPYIVKLLGAYYHDGKLW 92
Query: 65 FVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
++E+ GG + +M +EP+ ++ L +LH RII+R ++K
Sbjct: 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR--------DLK 144
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPE 182
+ + +T EG +++ADFG+ + + + +F GTP ++APE
Sbjct: 145 --------------AGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 183 VLT-----ETSYTRAVDWWGLGVLIFEMLVGESP 211
V+ +T Y D W LG+ + EM E P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 45/222 (20%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF------Q 58
++ TG+ AIK + + DE E + E I + H + + F
Sbjct: 44 RHVKTGQLAAIKVMD----VTGDEEEEIKQE--INMLKKYSHHRNIATYYGAFIKKNPPG 97
Query: 59 TEAHVCFVMEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
+ + VME+ G DL+ + + E + ++ GL +LH+ ++I+R
Sbjct: 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR---- 153
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
+IK Q + LT VK+ DFG+ + R TF GT
Sbjct: 154 ----DIK--------------GQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 176 PEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPF 212
P ++APEV+ + +Y D W LG+ EM G P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 50/210 (23%), Positives = 78/210 (37%), Gaps = 36/210 (17%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
E AIK + + ++ + ++ E +RHP + C+ E V
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKE---VRFLQKLRHPNTIQYRGCYLREHTAWLV 132
Query: 67 MEYAAGGDL-MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
MEY G ++ +H E + GL YLH +I+R ++K
Sbjct: 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR--------DVK--- 181
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV-- 183
+ I L+ G VK+ DFG +F GTP ++APEV
Sbjct: 182 -----------AGNILLS---EPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVIL 223
Query: 184 -LTETSYTRAVDWWGLGVLIFEMLVGESPF 212
+ E Y VD W LG+ E+ + P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 38/219 (17%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSE-KRIFEVANTMRHPFLVNLF-ACFQTEAHV 63
AIK+L GD E+ E +R + + + HP +V L+
Sbjct: 40 LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---P 96
Query: 64 CFVMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKE 119
VME+ GDL + A + + LG++Y+ I++R
Sbjct: 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR-------- 148
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEG--YVKIADFGLCKEGMGFGDRTGTFCGTPE 177
+++ S I L D K+ADFGL ++ G +
Sbjct: 149 DLR--------------SPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQ 191
Query: 178 FLAPEVLT--ETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
++APE + E SYT D + ++++ +L GE PF
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 45/227 (19%), Positives = 82/227 (36%), Gaps = 47/227 (20%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR---HPFLVNLFACF 57
V L++Y+ TGEY ++ + + + + V L E + + HP +V A F
Sbjct: 43 VNLARYKPTGEYVTVRRINL-EACSNEMVTFLQGE------LHVSKLFNHPNIVPYRATF 95
Query: 58 QTEAHVCFVMEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
+ + V + A G DL+ D +E + V+ L Y+H ++R
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHR--- 152
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT--- 171
+K + I ++ +G V ++ + G R
Sbjct: 153 -----SVK--------------ASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 172 ----FCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPF 212
+L+PEVL + Y D + +G+ E+ G PF
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 44/228 (19%), Positives = 87/228 (38%), Gaps = 44/228 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCFVMEYAAG 72
A+K L ++++ +E + RH ++ T + V ++ G
Sbjct: 50 AVKMLNVTAPTP-QQLQAFKNEVGVLR---KTRHVNILLFMGYS--TAPQLAIVTQWCEG 103
Query: 73 GDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIEAKV 128
L H+HA F + + A G+ YLH II+R +NI +
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF----------L 153
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGL--CKEGMGFGDRTGTFCGTPEFLAPEVLTE 186
E+ V KI DFGL K + G+ ++APEV+
Sbjct: 154 HEDNTV-----------------KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 187 TS---YTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVNDEVR 230
Y+ D + G++++E++ G+ P+ ++ +++ + + +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-26
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 52/216 (24%)
Query: 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCFVME 68
+ AIK ++ E ++ + E R + + HP +V L+ AC VC VME
Sbjct: 31 AKDVAIKQIESES-----ERKAFIVELRQL---SRVNHPNIVKLYGACLN---PVCLVME 79
Query: 69 YAAGGDLMMHIH----ADVFSEPRAVFYAACVVLGLQYLHESR---IIYR---PQSNITK 118
YA GG L +H ++ A+ + G+ YLH + +I+R P N+
Sbjct: 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP-PNLL- 137
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+ V +KI DFG + G+ +
Sbjct: 138 ---------LVAGGTV----------------LKICDFGTACD---IQTHMTNNKGSAAW 169
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
+APEV ++Y+ D + G++++E++ PF
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 49/224 (21%)
Query: 6 YRNTGEYFAIKA--LKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHV 63
E AIK L+K ++ LL E + + HP +V+ + F + +
Sbjct: 36 CAPKKEKVAIKRINLEKCQ----TSMDELLKE---IQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 64 CFVMEYAAGG---DLMMHIHAD------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
VM+ +GG D++ HI A V E V+ GL+YLH++ I+R
Sbjct: 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR--- 145
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG---- 170
++K + I L +G V+IADFG+ GD T
Sbjct: 146 -----DVK--------------AGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 171 -TFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPF 212
TF GTP ++APEV+ + Y D W G+ E+ G +P+
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-25
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 42/238 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF---EVANTMRHPFLVNLFACF 57
V ++ +G A K +I + ++ +I +V + P++V + F
Sbjct: 49 VFKVSHKPSGLVMARK------LIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGAF 100
Query: 58 QTEAHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLH-ESRIIYRPQS 114
++ + ME+ GG D ++ E + V+ GL YL + +I++R
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHR--- 156
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
++K N VNS G +K+ DFG+ G +F G
Sbjct: 157 -----DVK------PSNILVNS-----------RGEIKLCDFGVS--GQLIDSMANSFVG 192
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
T +++PE L T Y+ D W +G+ + EM VG P P D +E+
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-24
Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 44/239 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++R TG A+K +++ ++E + +L + + V + P++V F F T
Sbjct: 41 VWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDV--VLKSHDCPYIVQCFGTFITN 96
Query: 61 AHVCFVMEYAAGG-DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESR-IIYR---PQSN 115
V ME + + E +V L YL E +I+R P SN
Sbjct: 97 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP-SN 155
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
I + D G +K+ DFG+ + + G
Sbjct: 156 I---------------------------LLDERGQIKLCDFGISGRLVDDKAKD-RSAGC 187
Query: 176 PEFLAPEVL-----TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDE 228
++APE + T+ Y D W LG+ + E+ G+ P+ + EV ++ +E
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 43/227 (18%), Positives = 74/227 (32%), Gaps = 52/227 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCFVMEYAAG 72
AI+ + D++++ E + RH +V AC H+ + G
Sbjct: 59 AIRLIDIERDNE-DQLKAFKREVMAY---RQTRHENVVLFMGACMSPP-HLAIITSLCKG 113
Query: 73 GDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIEAKV 128
L + V + A +V G+ YLH I+++ N+
Sbjct: 114 RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV------------ 161
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-----EGMGFGDRTGTFCGTPEFLAPEV 183
N V I DFGL + D+ G LAPE+
Sbjct: 162 -------------FYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 184 LTETS---------YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221
+ + S +++ D + LG + +E+ E PF E +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-24
Identities = 47/241 (19%), Positives = 84/241 (34%), Gaps = 46/241 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ +G+ A+K ++ + E + LL + I T+ PF V + E
Sbjct: 23 VEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDI--SMRTVDCPFTVTFYGALFRE 78
Query: 61 AHVCFVMEYAAGG--DLMMHI--HADVFSEPRAVFYAACVVLGLQYLH-ESRIIYR---P 112
V ME + E A +V L++LH + +I+R P
Sbjct: 79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
SN+ L + G VK+ DFG+ + +
Sbjct: 139 -SNV-------------------------LI--NALGQVKMCDFGISGYLVDDVAKD-ID 169
Query: 173 CGTPEFLAPEV----LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVND 227
G ++APE L + Y+ D W LG+ + E+ + P+ + +V +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229
Query: 228 E 228
Sbjct: 230 P 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-24
Identities = 29/194 (14%), Positives = 59/194 (30%), Gaps = 50/194 (25%)
Query: 43 NTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI----HADVFSEPRAVFYAACVVL 98
+ V + ++ M+ +L + + + +
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175
Query: 99 GLQYLHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155
+++LH +++R P NI + VK+ D
Sbjct: 176 AVEFLHSKGLMHRDLKPS-NIF------------------------F---TMDDVVKVGD 207
Query: 156 FGLCKEGMGFGDRTGTF------------CGTPEFLAPEVLTETSYTRAVDWWGLGVLIF 203
FGL + GT +++PE + +Y+ VD + LG+++F
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 204 EMLVGESPFPGDDE 217
E+L F E
Sbjct: 268 ELLY---SFSTQME 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-23
Identities = 43/227 (18%), Positives = 78/227 (34%), Gaps = 44/227 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQT-EAHVCFVMEYAA 71
+K LK D R + E HP ++ + AC H + +
Sbjct: 37 VVKVLKVRDWSTRKSRD-FNEECPRLR---IFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 72 GGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLH--ESRIIYRPQSNITKEEIKRIEA 126
G L +H V + +AV +A + G+ +LH E I +
Sbjct: 93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH--------ALN---- 140
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT- 185
S+ + + + T +I+ + + P ++APE L
Sbjct: 141 ----------SRSVMIDEDMT---ARISMADVKFSFQ-----SPGRMYAPAWVAPEALQK 182
Query: 186 --ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230
E + R+ D W VL++E++ E PF E+ + + +R
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-23
Identities = 52/247 (21%), Positives = 80/247 (32%), Gaps = 71/247 (28%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT- 59
V+ + T E FA+K L+ R EVE + P +V + ++
Sbjct: 34 VLQIFNKRTQEKFALKMLQDCPKARR-EVELHWR---------ASQCPHIVRIVDVYENL 83
Query: 60 ---EAHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYR-- 111
+ VME GG+L I F+E A + +QYLH I +R
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 112 -PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
P EN + T +K+ DFG
Sbjct: 144 KP-----------------EN--------LLYTSKRPNAILKLTDFG------------- 165
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD----EEEVFDSIVN 226
A E E Y ++ D W LGV+++ +L G PF + + I
Sbjct: 166 --------FAKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216
Query: 227 DEVRYPR 233
+ +P
Sbjct: 217 GQYEFPN 223
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-23
Identities = 53/232 (22%), Positives = 86/232 (37%), Gaps = 51/232 (21%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
I +R TGE +K L + D + + L E ++ + HP ++ +
Sbjct: 26 AIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVM---RCLEHPNVLKFIGVLYKD 79
Query: 61 AHVCFVMEYAAGGDLMMHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNI 116
+ F+ EY GG L I + + V +A + G+ YLH II+R N
Sbjct: 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC 139
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL------------CKEGMG 164
V+EN V +ADFGL +
Sbjct: 140 L----------VRENKN-----------------VVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 165 FGDRTG--TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
DR T G P ++APE++ SY VD + G+++ E++ + P
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 49/242 (20%), Positives = 89/242 (36%), Gaps = 47/242 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ +G+ A+K ++ + E + LL + + V + P++V + E
Sbjct: 38 VNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDV--VMRSSDCPYIVQFYGALFRE 93
Query: 61 AHVCFVMEYAAGG-----DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESR-IIYR--- 111
ME + + + DV E V L +L E+ II+R
Sbjct: 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
P SNI L D G +K+ DFG+ + + +T
Sbjct: 154 P-SNI-------------------------LL--DRSGNIKLCDFGISGQLVDSIAKT-R 184
Query: 172 FCGTPEFLAPEVL----TETSYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDSIVN 226
G ++APE + + Y D W LG+ ++E+ G P+P + + +V
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 227 DE 228
+
Sbjct: 245 GD 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-22
Identities = 47/268 (17%), Positives = 82/268 (30%), Gaps = 70/268 (26%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR----HPFLVNLFAC 56
V +Q +G +A+K L + + EV M+ HP +V +
Sbjct: 44 VYEAQDVGSGREYALKRLLSNEEEKNRAIIQ--------EV-CFMKKLSGHPNIVQFCSA 94
Query: 57 FQTEAH--------VCFVMEYAAGG---DLMMHIHADVFSEPRAVFYAACVVLGLQYLHE 105
+ E G L S + +Q++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 106 SR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC---- 159
+ II+R ++K EN + L +G +K+ DFG
Sbjct: 155 QKPPIIHR--------DLKV------EN--------LLL---SNQGTIKLCDFGSATTIS 189
Query: 160 --------KEGMGFGDRTGTFCGTPEFLAPEVLTETS---YTRAVDWWGLGVLIFEMLVG 208
+ + T TP + PE++ S D W LG +++ +
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
Query: 209 ESPFPGDDEEEVFDSIVNDEVRYPRFLS 236
+ PF E+ IVN + P +
Sbjct: 250 QHPF----EDGAKLRIVNGKYSIPPHDT 273
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-21
Identities = 44/225 (19%), Positives = 81/225 (36%), Gaps = 38/225 (16%)
Query: 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA----CFQTEAHVCF 65
GE A+K I + E S E I++ +RH ++ A T +
Sbjct: 65 GEEVAVK------IFSSREERSWFREAEIYQTVM-LRHENILGFIAADNKDNGTWTQLWL 117
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
V +Y G L +++ + + A GL +LH + + + I ++K
Sbjct: 118 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK--- 174
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF----CGTPEFLAP 181
S+ I + G IAD GL D GT ++AP
Sbjct: 175 -----------SKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 182 EVLTETS------YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220
EVL ++ + D + +G++ +E+ S ++ ++
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-21
Identities = 43/225 (19%), Positives = 79/225 (35%), Gaps = 38/225 (16%)
Query: 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFAC----FQTEAHVCF 65
GE A+K + E S E I++ MRH ++ A + +
Sbjct: 60 GEKVAVK------VFFTTEEASWFRETEIYQTVL-MRHENILGFIAADIKGTGSWTQLYL 112
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+ +Y G L ++ + + A V GL +LH + + I ++K
Sbjct: 113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK--- 169
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR----TGTFCGTPEFLAP 181
S+ I + G IAD GL + + + T GT ++ P
Sbjct: 170 -----------SKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 182 EVLTETS------YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220
EVL E+ D + G++++E+ +E ++
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 5e-21
Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 46/232 (19%)
Query: 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFAC-----FQTEAHVC 64
A+K + ++ ++EK I+ V M H +
Sbjct: 36 ERPVAVKVFSFAN------RQNFINEKNIYRVPL-MEHDNIARFIVGDERVTADGRMEYL 88
Query: 65 FVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITKEEIKR 123
VMEY G L ++ + A V GL YLH E + I+ ++
Sbjct: 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN- 147
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL-CKEGMGFGDRTG-------TFCGT 175
S+ + + +G I+DFGL + R G + GT
Sbjct: 148 -------------SRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 176 PEFLAPEVLTET-------SYTRAVDWWGLGVLIFEMLVG-ESPFPGDDEEE 219
++APEVL S + VD + LG++ +E+ + FPG+ E
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-20
Identities = 43/225 (19%), Positives = 77/225 (34%), Gaps = 38/225 (16%)
Query: 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH----VCF 65
GE A+K I + + +S E ++ +RH ++ A T H +
Sbjct: 31 GENVAVK------IFSSRDEKSWFRETELYNTVM-LRHENILGFIASDMTSRHSSTQLWL 83
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
+ Y G L ++ + + GL +LH + + I ++K
Sbjct: 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK--- 140
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL----CKEGMGFGDRTGTFCGTPEFLAP 181
S+ I + N IAD GL + GT ++AP
Sbjct: 141 -----------SKNILVKKNGQ---CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 182 EVLTET------SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220
EVL ET + VD W G++++E+ ++ +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 49/231 (21%), Positives = 82/231 (35%), Gaps = 55/231 (23%)
Query: 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFAC----FQTEAHVCF 65
EY A+K D +S +E ++ + M+H ++ + +
Sbjct: 47 NEYVAVKIFPIQD------KQSWQNEYEVYSLPG-MKHENILQFIGAEKRGTSVDVDLWL 99
Query: 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHES----------RIIYRPQSN 115
+ + G L + A+V S A + GL YLHE I +R
Sbjct: 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRD--- 156
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL---CKEGMGFGDRTGTF 172
IK S+ + L IADFGL + G GD G
Sbjct: 157 -----IK--------------SKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQ- 193
Query: 173 CGTPEFLAPEVL-----TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218
GT ++APEVL + +D + +G++++E+ + G +E
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 46/241 (19%), Positives = 79/241 (32%), Gaps = 57/241 (23%)
Query: 14 AIKALKKGDIIARDE--VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF-----V 66
+K L + D ++E++ + HP +V +F + V
Sbjct: 110 VLKGLVH----SGDAEAQAMAMAERQF---LAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162
Query: 67 MEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIKR 123
MEY G L A+ Y ++ L YLH ++Y P+ NI
Sbjct: 163 MEYVGGQSLKRSK-GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPE-NIML----- 215
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEV 183
TE +K+ D G + G GTP F APE+
Sbjct: 216 -----------------------TEEQLKLIDLGAVSRI----NSFGYLYGTPGFQAPEI 248
Query: 184 LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIM 243
+ T T A D + +G + + + G + + + D+ + S + +
Sbjct: 249 VR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----DDPVLKTYDSYGRL-LR 302
Query: 244 R 244
R
Sbjct: 303 R 303
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-19
Identities = 58/252 (23%), Positives = 92/252 (36%), Gaps = 60/252 (23%)
Query: 7 RNTGEYFAIKALKKGD------IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
T E AIK ++ A EV SLL E ++H ++ L +
Sbjct: 56 TVTNETVAIKRIRLEHEEEGVPGTAIREV-SLLKE---------LQHRNIIELKSVIHHN 105
Query: 61 AHVCFVMEYAAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ + EYA DL ++ S + ++ G+ + H R ++R PQ
Sbjct: 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ--- 161
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
N ++ S + +KI DFGL + FG F T
Sbjct: 162 --------------NLLLSVSDASE------TPVLKIGDFGLARA---FGIPIRQF--TH 196
Query: 177 EFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN---- 226
E + PE+L Y+ +VD W + + EML+ FPGD E + I
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 227 -DEVRYPRFLSL 237
D+ +P +L
Sbjct: 257 PDDTTWPGVTAL 268
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 60/235 (25%)
Query: 1 VILSQYRNTGEYFAIKALK----KG-DIIARDEVESLLSEKRIFEVANTMRHPFLVNLFA 55
V + + T A+K ++ +G A EV SLL + ++H +V L
Sbjct: 18 VYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV-SLLKD---------LKHANIVTLHD 67
Query: 56 CFQTEAHVCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR-- 111
TE + V EY DL + ++ + + ++ GL Y H ++++R
Sbjct: 68 IIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126
Query: 112 -PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
PQ N+ + G +K+ADFGL + T
Sbjct: 127 KPQ-NLLI---------------------------NERGELKLADFGLARA---KSIPTK 155
Query: 171 TFCGTPEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
T+ E + P++L T Y+ +D WG+G + +EM G FPG EE
Sbjct: 156 TY--DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-18
Identities = 47/230 (20%), Positives = 83/230 (36%), Gaps = 61/230 (26%)
Query: 7 RNTGEYFAIKALKKGD------IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
R+TG+ AIK + + IA E+ +L + ++HP LVNL F+ +
Sbjct: 25 RDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQ---------LKHPNLVNLLEVFRRK 74
Query: 61 AHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSN 115
+ V EY ++ + + E + + + H+ I+R P+ N
Sbjct: 75 RRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPE-N 132
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
I L +K+ DFG + + +
Sbjct: 133 I-------------------------LI--TKHSVIKLCDFGFARL---LTGPSDYY--D 160
Query: 176 PEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
E +PE+L +T Y VD W +G + E+L G +PG + +
Sbjct: 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 3e-18
Identities = 50/236 (21%), Positives = 85/236 (36%), Gaps = 62/236 (26%)
Query: 7 RNTGEYFAIKALKKGD------IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
R T E A+K ++ D A E+ LL E ++H +V L ++
Sbjct: 24 RETHEIVALKRVRLDDDDEGVPSSALREI-CLLKE---------LKHKNIVRLHDVLHSD 73
Query: 61 AHVCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSN 115
+ V E+ DL + ++ GL + H +++R PQ N
Sbjct: 74 KKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ-N 131
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
L +N G +K+A+FGL + FG + +
Sbjct: 132 --------------------------LLINR-NGELKLANFGLARA---FGIPVRCY--S 159
Query: 176 PEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESP-FPGDDEEEVFDSI 224
E + P+VL Y+ ++D W G + E+ P FPG+D ++ I
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 68/235 (28%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVE-----------SLLSEKRIFEVANTMRHPFLVNLFA 55
+NT + AIK +K G R E + LL E + HP ++ L
Sbjct: 32 KNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQE---------LSHPNIIGLLD 79
Query: 56 CFQTEAHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR-- 111
F ++++ V ++ DL + I ++ V + Y + GL+YLH+ I++R
Sbjct: 80 AFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 138
Query: 112 -PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
P N L +++ G +K+ADFGL K FG
Sbjct: 139 KPN-N--------------------------LLLDE-NGVLKLADFGLAKS---FGSPNR 167
Query: 171 TFCGTPEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+ T + + APE+L Y VD W +G ++ E+L+ PGD + +
Sbjct: 168 AY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-18
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 65/234 (27%)
Query: 7 RNTGEYFAIKALKKGD-----IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA 61
+ TG Y A+K +K A E+ SL+ E ++H +V L+ TE
Sbjct: 27 KTTGVYVALKEVKLDSEEGTPSTAIREI-SLMKE---------LKHENIVRLYDVIHTEN 76
Query: 62 HVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACV-------VLGLQYLHESRIIYR--- 111
+ V E+ DL ++ + V + GL + HE++I++R
Sbjct: 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
PQ N L +N G +K+ DFGL + FG T
Sbjct: 136 PQ-N--------------------------LLINK-RGQLKLGDFGLARA---FGIPVNT 164
Query: 172 FCGTPEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
F + E + AP+VL +Y+ ++D W G ++ EM+ G+ FPG ++EE
Sbjct: 165 F--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 3e-18
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 61/229 (26%)
Query: 8 NTGEYFAIKALKKGD------IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA 61
N GE FA+K ++ E+ S+L E ++H +V L+ T+
Sbjct: 24 NYGETFALKKIRLEKEDEGIPSTTIREI-SILKE---------LKHSNIVKLYDVIHTKK 73
Query: 62 HVCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNI 116
+ V E+ DL + + A + ++ G+ Y H+ R+++R PQ N+
Sbjct: 74 RLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ-NL 131
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
L + EG +KIADFGL + FG + T
Sbjct: 132 -------------------------LI--NREGELKIADFGLARA---FGIPVRKY--TH 159
Query: 177 EFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
E + AP+VL Y+ +D W +G + EM+ G FPG E +
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-18
Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 7 RNTGEYFAIKALKKGD------IIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
++TG AIK + D IA E+ LL + +RH LVNL + +
Sbjct: 47 KDTGRIVAIKKFLESDDDKMVKKIAMREI-KLLKQ---------LRHENLVNLLEVCKKK 96
Query: 61 AHVCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
V E+ ++ + + + Y ++ G+ + H II+R
Sbjct: 97 KRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR------- 148
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+IK EN + V+ G VK+ DFG + + E
Sbjct: 149 -DIKP------EN----------ILVSQ-SGVVKLCDFGFART---LAAPGEVY--DDEV 185
Query: 179 L-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
APE+L + Y +AVD W +G L+ EM +GE FPGD + +
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 69/233 (29%)
Query: 8 NTGEYFAIKALKKGDIIARDEVE----------SLLSEKRIFEVANTMRHPFLVNLFACF 57
+ G I ALK+ I E E SLL E + HP +V+L
Sbjct: 43 SQGR---IVALKR--IRLDAEDEGIPSTAIREISLLKE---------LHHPNIVSLIDVI 88
Query: 58 QTEAHVCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---P 112
+E + V E+ DL + + + + Y ++ G+ + H+ RI++R P
Sbjct: 89 HSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
Q N L +N +G +K+ADFGL + FG ++
Sbjct: 148 Q-N--------------------------LLINS-DGALKLADFGLARA---FGIPVRSY 176
Query: 173 CGTPEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
T E + AP+VL Y+ +VD W +G + EM+ G+ FPG +++
Sbjct: 177 --THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 47/230 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK L++ + +L E A M +P + L C + V + +
Sbjct: 48 AIKELREATS--PKANKEILDE------AYVMASVDNPHVCRLLGIC--LTSTVQLITQL 97
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G L+ ++ H D + + + G+ YL + R+++R + A+
Sbjct: 98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD-----------LAAR 146
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFLAPEVL 184
N V + Q +VKI DFGL K +G ++ G P +++A E +
Sbjct: 147 ---NVLVKTPQ-----------HVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESI 191
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
YT D W GV ++E++ G P+ G E+ + E R P+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-18
Identities = 49/245 (20%), Positives = 83/245 (33%), Gaps = 64/245 (26%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFAC--FQTEAH 62
NTGE A+K L+ + + E + +H +V +
Sbjct: 37 NTGEVVAVKKLQHS---TEEHLRDFERE------IEILKSLQHDNIVKYKGVCYSAGRRN 87
Query: 63 VCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITK 118
+ +MEY G L + H + + + Y + + G++YL R I+R NI
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL- 146
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTP 176
V+ VKI DFGL K + + +P
Sbjct: 147 ---------VENEN-----------------RVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 177 EF-LAPEVLTETSYTRAVDWWGLGVLIFEML----------------VGESPFPGDDEEE 219
F APE LTE+ ++ A D W GV+++E+ +G
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 220 VFDSI 224
+ + +
Sbjct: 241 LIELL 245
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 49/245 (20%), Positives = 84/245 (34%), Gaps = 64/245 (26%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFAC--FQTEAH 62
NTGE A+K L+ + + E + +H +V +
Sbjct: 68 NTGEVVAVKKLQHS---TEEHLRDFERE------IEILKSLQHDNIVKYKGVCYSAGRRN 118
Query: 63 VCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITK 118
+ +MEY G L ++ H + + + Y + + G++YL R I+R NI
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL- 177
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTP 176
V+ VKI DFGL K + + +P
Sbjct: 178 ---------VENEN-----------------RVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 177 EF-LAPEVLTETSYTRAVDWWGLGVLIFEML----------------VGESPFPGDDEEE 219
F APE LTE+ ++ A D W GV+++E+ +G
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 220 VFDSI 224
+ + +
Sbjct: 272 LIELL 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 49/233 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K LK + + ++ + E N M H L+ L+ + V E
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIRE------VNAMHSLDHRNLIRLYGVV--LTPPMKMVTEL 101
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIE 125
A G L+ + H F YA V G+ YL R I+R N+
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL-------- 153
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAP 181
+ VKI DFGL + + D + AP
Sbjct: 154 --LATRDL-----------------VKIGDFGLMRA-LPQNDDHYVMQEHRKVPFAWCAP 193
Query: 182 EVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
E L +++ A D W GV ++EM G+ P+ G + ++ I + R PR
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 54/243 (22%), Positives = 82/243 (33%), Gaps = 49/243 (20%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAH- 62
NTG A+K L+ D+ E + F+V +
Sbjct: 50 NTGALVAVKQLQHS---GPDQQRDFQRE------IQILKALHSDFIVKYRGVSYGPGRQS 100
Query: 63 VCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITK 118
+ VMEY G L + H R + Y++ + G++YL R ++R NI
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL- 159
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTP 176
V+ +VKIADFGL K D +P
Sbjct: 160 ---------VESEA-----------------HVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 177 EF-LAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPRF 234
F APE L++ ++R D W GV+++E+ + E D R
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 235 LSL 237
L L
Sbjct: 254 LEL 256
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 41/209 (19%), Positives = 75/209 (35%), Gaps = 40/209 (19%)
Query: 14 AIKALKKGDIIARDE--VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAA 71
A+K + + ++ D + E R A ++ P +V + + + + M
Sbjct: 63 ALKLMSET--LSSDPVFRTRMQREART---AGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117
Query: 72 GGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYR---PQSNITKEEIKRIEAK 127
G DL + + PRAV + L H + +R P+ NI
Sbjct: 118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE-NI----------- 165
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTE 186
+ + + + DFG+ + G GT ++APE +E
Sbjct: 166 ----------------LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 187 TSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
+ T D + L +++E L G P+ GD
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGD 238
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 47/234 (20%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACF 57
V ++ A+K LK+ + EVE L E A M +HP LV L
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKE------AAVMKEIKHPNLVQLLGVC 285
Query: 58 QTEAHVCFVMEYAAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
E + E+ G+L+ ++ S ++ A + ++YL + I+R +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 115 --NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
N V EN+ VK+ADFGL + G
Sbjct: 346 ARNCL----------VGENHL-----------------VKVADFGLSRLMTGDTYTAHAG 378
Query: 173 CGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
P ++ APE L ++ D W GVL++E+ G SP+PG D +V++ +
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-17
Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 27/171 (15%)
Query: 47 HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHE 105
H +V++ + + VMEY G L +I + S A+ + ++ G+++ H+
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 106 SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165
RI++R +IK Q I + + +KI DFG+ K
Sbjct: 130 MRIVHR--------DIK--------------PQNILID---SNKTLKIFDFGIAKALSET 164
Query: 166 G-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
+T GT ++ +PE + D + +G++++EMLVGE PF G+
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-17
Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 47/230 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK L++ + + +L E A M +P + L C + V + +
Sbjct: 48 AIKELREAT--SPKANKEILDE------AYVMASVDNPHVCRLLGIC--LTSTVQLITQL 97
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G L+ ++ H D + + + G+ YL + R+++R + A+
Sbjct: 98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD-----------LAAR 146
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFLAPEVL 184
N V + Q +VKI DFGL K +G ++ G P +++A E +
Sbjct: 147 ---NVLVKTPQ-----------HVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALESI 191
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
YT D W GV ++E++ G P+ G E+ + E R P+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 48/231 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K+ ++ + D L E A + HP +V L C Q + + VME
Sbjct: 143 AVKSCRET--LPPDLKAKFLQE------ARILKQYSHPNIVRLIGVCTQKQ-PIYIVMEL 193
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
GGD + + + G++YL I+R + A+
Sbjct: 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD-----------LAAR 242
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N V +KI+DFG+ +E G + APE
Sbjct: 243 ---NCLVTEKNV-----------LKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEA 286
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
L Y+ D W G+L++E +G SP+P ++ + + R P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPC 336
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-16
Identities = 52/259 (20%), Positives = 75/259 (28%), Gaps = 45/259 (17%)
Query: 1 VILSQYRNTGEYFAIK---ALKKGDIIARDEVESLLSEKRIFEVA-NTMRHPFLVNLFAC 56
V LS ++ A+K + + A DE+ L K + N +V L
Sbjct: 53 VWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL---KSVRNSDPNDPNREMVVQLLDD 109
Query: 57 FQTE----AHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLH-ESRI 108
F+ H+C V E G L+ I P V+ GL YLH + RI
Sbjct: 110 FKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI 168
Query: 109 I------------------------YRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144
I N
Sbjct: 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPK 228
Query: 145 NDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIF 203
N + VKIAD G + + T ++ + EVL + Y D W + F
Sbjct: 229 NAEKLKVKIADLG----NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAF 284
Query: 204 EMLVGESPFPGDDEEEVFD 222
E+ G+ F EE
Sbjct: 285 ELATGDYLFEPHSGEEYTR 303
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 49/242 (20%), Positives = 76/242 (31%), Gaps = 60/242 (24%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAH- 62
TGE A+KALK E + + H ++ C A
Sbjct: 58 GTGEMVAVKALKADA--GPQHRSGWKQE------IDILRTLYHEHIIKYKGCCEDAGAAS 109
Query: 63 VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEE 120
+ VMEY G L ++ + + +A + G+ YLH I+R N+
Sbjct: 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVL--- 166
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEF 178
+ + VKI DFGL K + R +P F
Sbjct: 167 -------LDNDRL-----------------VKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 179 -LAPEVLTETSYTRAVDWWGLGVLIFEML---------------VGESPFPGDDEEEVFD 222
APE L E + A D W GV ++E+L + + +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 223 SI 224
+
Sbjct: 263 LL 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 50/225 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK+L + +VE+ L E M HP ++ L E ++ Y
Sbjct: 53 AIKSLSRI--TEMQQVEAFLRE------GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRIE 125
GDL+ I + + + V G++YL E + ++R N
Sbjct: 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCM-------- 156
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL-----A 180
+ E++ VK+ADFGL ++ + + L A
Sbjct: 157 --LDESFT-----------------VKVADFGLARD-ILDREYYSVQQHRHARLPVKWTA 196
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
E L +T D W GVL++E+L G P+ D ++ +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-16
Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 50/225 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K+L + EV L+E M HP +++L C ++E V+ Y
Sbjct: 121 AVKSLNRI--TDIGEVSQFLTE------GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKRIE 125
GDL I + + + V G+++L + ++R + N
Sbjct: 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM-------- 224
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL-----A 180
+ E + VK+ADFGL ++ M + T L A
Sbjct: 225 --LDEKFT-----------------VKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMA 264
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
E L +T D W GVL++E++ G P+P + ++ +
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-16
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 33/177 (18%)
Query: 47 HPFLVNLF----ACFQTEAHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQ 101
HP +V ++ A VMEY G L +H + + RA+ A L
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 102 YLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161
+ H++ II+R ++K I ++ VK+ DFG+ +
Sbjct: 131 FSHQNGIIHR--------DVK--------------PANIMIS---ATNAVKVMDFGIARA 165
Query: 162 GMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215
G+ +T GT ++L+PE S D + LG +++E+L GE PF GD
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-16
Identities = 43/232 (18%), Positives = 84/232 (36%), Gaps = 51/232 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
IK ++ R +++ + H +V L C + + V +Y
Sbjct: 46 CIKVIEDKS--GRQSFQAVTDH------MLAIGSLDHAHIVRLLGLC--PGSSLQLVTQY 95
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKRIE 125
G L+ H+ H + + + G+ YL E +++R + N+
Sbjct: 96 LPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL-------- 147
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFLAPE 182
++ + V++ADFG+ + D+ + P +++A E
Sbjct: 148 --LKSPSQ-----------------VQVADFGVADL-LPPDDKQLLYSEAKTPIKWMALE 187
Query: 183 VLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
+ YT D W GV ++E++ G P+ G EV D + E R +
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQ 238
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-16
Identities = 47/225 (20%), Positives = 84/225 (37%), Gaps = 59/225 (26%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K +K ++ L+E A+ M RH LV L + + + V EY
Sbjct: 48 AVKCIKNDA-----TAQAFLAE------ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96
Query: 70 AAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKRI 124
A G L+ ++ + V + ++ V ++YL + ++R N+
Sbjct: 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL------- 149
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LA 180
V E+ K++DFGL KE + + A
Sbjct: 150 ---VSEDNV-----------------AKVSDFGLTKE--ASSTQDTG-----KLPVKWTA 182
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
PE L E ++ D W G+L++E+ G P+P ++V +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 6e-16
Identities = 58/221 (26%), Positives = 83/221 (37%), Gaps = 48/221 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
AIK LK G + E+ L E A M RH LV L+A +E + V EY
Sbjct: 295 AIKTLKPGTM----SPEAFLQE------AQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYM 343
Query: 71 AGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKRIE 125
+ G L+ + + P+ V AA + G+ Y+ ++R NI
Sbjct: 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL-------- 395
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP-EFLAPEVL 184
V EN K+ADFGL + P ++ APE
Sbjct: 396 --VGENLVC-----------------KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+T D W G+L+ E+ G P+PG EV D +
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-16
Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 59/225 (26%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K +K ++ L+E A+ M RH LV L + + + V EY
Sbjct: 220 AVKCIKNDA-----TAQAFLAE------ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268
Query: 70 AAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKRI 124
A G L+ ++ + V + ++ V ++YL + ++R + N+
Sbjct: 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL------- 321
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LA 180
V E+ K++DFGL KE + + A
Sbjct: 322 ---VSEDN-----------------VAKVSDFGLTKE--ASSTQDTG-----KLPVKWTA 354
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
PE L E ++ D W G+L++E+ G P+P ++V +
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 50/227 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K+L + EV L+E M HP +++L C ++E V+ Y
Sbjct: 57 AVKSLNRI--TDIGEVSQFLTE------GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKRIE 125
GDL I + + + V G++YL + ++R + N
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM-------- 160
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL-----A 180
+ E + VK+ADFGL ++ M + T L A
Sbjct: 161 --LDEKFT-----------------VKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMA 200
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVN 226
E L +T D W GVL++E++ G P+P + ++ ++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 46/245 (18%), Positives = 84/245 (34%), Gaps = 62/245 (25%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAH 62
NTGE A+K+LK + + L E + H +V C + +
Sbjct: 47 DNTGEQVAVKSLKPES--GGNHIADLKKE------IEILRNLYHENIVKYKGICTEDGGN 98
Query: 63 -VCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNIT 117
+ +ME+ G L ++ + + + + + YA + G+ YL + ++R N+
Sbjct: 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 158
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGT 175
V+ + VKI DFGL K + +
Sbjct: 159 ----------VESEH-----------------QVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 176 PEF-LAPEVLTETSYTRAVDWWGLGVLIFEML---------------VGESPFPGDDEEE 219
P F APE L ++ + A D W GV + E+L +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 220 VFDSI 224
+ +++
Sbjct: 252 LVNTL 256
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 53/251 (21%), Positives = 91/251 (36%), Gaps = 66/251 (26%)
Query: 4 SQYRNTGEYFAIKALKKGDI--IARDEVESLLSEKRIFEVANTMRHPFLVNLFACF--QT 59
+ + +A+K ++ I A E+ LL E ++HP +++L F
Sbjct: 42 RKDGKDDKDYALKQIEGTGISMSACREIA-LLRE---------LKHPNVISLQKVFLSHA 91
Query: 60 EAHVCFVMEYAAGGDLM--MHIHADVFSEPRAVFYAACVV--------LGLQYLHESRII 109
+ V + +YA DL + H + + V +V G+ YLH + ++
Sbjct: 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150
Query: 110 YR---PQSN--ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMG 164
+R P N + E +R G VKIAD G +
Sbjct: 151 HRDLKPA-NILVMGEGPER-------------------------GRVKIADMGFARL--- 181
Query: 165 FGDRTGTFC-GTPEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
F P + APE+L YT+A+D W +G + E+L E F E
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241
Query: 218 EEVFDSIVNDE 228
+ + + +
Sbjct: 242 DIKTSNPYHHD 252
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 53/237 (22%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACF 57
V ++ A+K LK+ + EVE L E A M +HP LV L
Sbjct: 29 VYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKE------AAVMKEIKHPNLVQLLGVC 78
Query: 58 QTEAHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
E + E+ G+L+ ++ S ++ A + ++YL + I+R +
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 115 --NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
N V EN+ VK+ADFGL + T T
Sbjct: 139 ARNCL----------VGENHL-----------------VKVADFGLSRL---MTGDTYTA 168
Query: 173 CGTPEF----LAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+F APE L ++ D W GVL++E+ G SP+PG D +V++ +
Sbjct: 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-15
Identities = 56/219 (25%), Positives = 82/219 (37%), Gaps = 44/219 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
AIK LK G + E+ L E A M RH LV L+A +E + V EY
Sbjct: 212 AIKTLKPGTM----SPEAFLQE------AQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYM 260
Query: 71 AGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
+ G L+ + + P+ V AA + G+ Y+ ++R + A
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD-----------LRA- 308
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP-EFLAPEVLTE 186
N V K+ADFGL + P ++ APE
Sbjct: 309 --ANILVGE-----------NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 187 TSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+T D W G+L+ E+ G P+PG EV D +
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 51/239 (21%), Positives = 83/239 (34%), Gaps = 72/239 (30%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVE----------SLLSEKRIFEVANTMRHPFLVNLFAC 56
+N G ALK+ + + E ++L T HP +V LF
Sbjct: 34 KNGGR---FVALKR--VRVQTGEEGMPLSTIREVAVLRH------LETFEHPNVVRLFDV 82
Query: 57 FQT-----EAHVCFVMEYAAGGDLM--MHIHADVFSEPRAV-FYAACVVLGLQYLHESRI 108
E + V E+ DL + + + ++ GL +LH R+
Sbjct: 83 CTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV 141
Query: 109 IYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165
++R PQ N + V G +K+ADFGL + +
Sbjct: 142 VHRDLKPQ-N--------------------------ILVTS-SGQIKLADFGLARI---Y 170
Query: 166 GDRTGTFCGTPEFL-----APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+ T + APEVL ++SY VD W +G + EM + F G + +
Sbjct: 171 SFQM-AL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 45/238 (18%), Positives = 81/238 (34%), Gaps = 41/238 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDI---IARDEVESL--LSEKRIFEVANTMRHPFLVNLFA 55
V L++ + A+K ++ + A DE++ L +++ + + + ++ L
Sbjct: 35 VWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN-HILKLLD 93
Query: 56 CFQ----TEAHVCFVME------YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHE 105
F HV V E L+ + ++LGL Y+H
Sbjct: 94 HFNHKGPNGVHVVMVFEVLGENLL----ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 149
Query: 106 SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165
+ I +IK EN + + +KIAD G +
Sbjct: 150 -------RCGIIHTDIK------PENVLMEIVDS-----PENLIQIKIADLG---NACWY 188
Query: 166 GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS 223
+ T E+ +PEVL + D W LIFE++ G+ F D+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 58/222 (26%), Positives = 79/222 (35%), Gaps = 49/222 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK K + E L E A TM HP +V L TE V +ME
Sbjct: 422 AIKTCKNCT--SDSVREKFLQE------ALTMRQFDHPHIVKLIGVI--TENPVWIIMEL 471
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G+L + + YA + L YL R ++R I A+
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR-----------DIAAR 520
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N V+S VK+ DFGL + D T + +APE
Sbjct: 521 ---NVLVSS-----------NDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPES 563
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ +T A D W GV ++E+L G PF G +V I
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 53/236 (22%), Positives = 93/236 (39%), Gaps = 59/236 (25%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTE-----AHVC 64
A+K LK DIIA ++E L E A M HP + L ++
Sbjct: 55 AVKMLKA-DIIASSDIEEFLRE------AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107
Query: 65 FVMEYAAGGDLMMHI-------HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
++ + GDL + + V + + G++YL I+R
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRD----- 162
Query: 118 KEEIKRIEAK---VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTF 172
+ A+ + E+ V +ADFGL ++ + GD R G
Sbjct: 163 ------LAARNCMLAEDMT-----------------VCVADFGLSRK-IYSGDYYRQGCA 198
Query: 173 CGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVN 226
P ++LA E L + YT D W GV ++E++ G++P+ G + E+++ ++
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-14
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 58/226 (25%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
A+K+LK+G + ++ L+E AN M +H LV L+A T+ + + EY
Sbjct: 41 AVKSLKQGSM----SPDAFLAE------ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYM 89
Query: 71 AGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQS--NITKEEIKRIE 125
G L+ + + + + AA + G+ ++ E I+R NI
Sbjct: 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL-------- 141
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTPEF----L 179
V + KIADFGL + E + R G +F
Sbjct: 142 --VSDTLS-----------------CKIADFGLARLIEDNEYTAREGA-----KFPIKWT 177
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
APE + ++T D W G+L+ E++ G P+PG EV ++
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 37/223 (16%), Positives = 73/223 (32%), Gaps = 47/223 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
+K L K R+ ES A+ M H LV + C + V E+
Sbjct: 44 LLKVLDKA---HRNYSESFFEA------ASMMSKLSHKHLVLNYGVCVCGD-ENILVQEF 93
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G L ++ + + + + A + + +L E+ +I+ + AK
Sbjct: 94 VKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGN-----------VCAK 142
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N + ++ K +K++D G+ + + + PE
Sbjct: 143 ---NILLIREEDRKTGNPPF---IKLSDPGISIT---VLPKDIL-----QERIPWVPPEC 188
Query: 184 LTET-SYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ + A D W G ++E+ G+ P D +
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-14
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 50/222 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK +++G + E + E A M HP LV L+ C + +C V E+
Sbjct: 36 AIKTIREGAM----SEEDFIEE------AEVMMKLSHPKLVQLYGVCLEQA-PICLVTEF 84
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G L ++ +F+ + V G+ YL E+ +I+R + A+
Sbjct: 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD-----------LAAR 133
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N V +K++DFG+ + D T +F +PEV
Sbjct: 134 ---NCLVGE-----------NQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKWASPEV 176
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ + Y+ D W GVL++E+ G+ P+ EV + I
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 54/249 (21%), Positives = 88/249 (35%), Gaps = 83/249 (33%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLF-ACFQTEAHVCFVME 68
A+K LK+G E +L+SE + H +VNL AC + + ++E
Sbjct: 61 AVKMLKEG--ATHSEHRALMSE------LKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112
Query: 69 YAAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ G+L ++ D + + Y+ V G+++L + I+R
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGY-VKIADFGLCKEG 162
D +E VKI DFGL ++
Sbjct: 173 ----------------------------------DLAARNILLSEKNVVKICDFGLARDI 198
Query: 163 MGFGDRTGTFCGTPEFL-----APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPG-D 215
D L APE + + YT D W GVL++E+ +G SP+PG
Sbjct: 199 YKDPDYVRKGDA---RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 216 DEEEVFDSI 224
+EE +
Sbjct: 256 IDEEFCRRL 264
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 54/222 (24%), Positives = 85/222 (38%), Gaps = 47/222 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK LK+G + + E ++ E A M +P++V L C + VME
Sbjct: 367 AIKVLKQGT--EKADTEEMMRE------AQIMHQLDNPYIVRLIGVC--QAEALMLVMEM 416
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
A GG L + + V +G++YL E ++R + A+
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR-----------NLAAR 465
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N + + Y KI+DFGL K +G D T ++ APE
Sbjct: 466 ---NVLLVN-----------RHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPEC 510
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ ++ D W GV ++E L G+ P+ EV I
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-14
Identities = 59/257 (22%), Positives = 89/257 (34%), Gaps = 64/257 (24%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA-----NTMRHPFLVNLFACFQTEA 61
++G ALK + L + EVA HP +V L T
Sbjct: 31 PHSGH---FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87
Query: 62 H-----VCFVMEYAAGGDL---MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR-- 111
V V E+ DL + + GL +LH + I++R
Sbjct: 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 146
Query: 112 -PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
P+ NI L + G VK+ADFGL + + +
Sbjct: 147 KPE-NI-------------------------LV--TSGGTVKLADFGLARI---YSYQM- 174
Query: 171 TFCGTPEFL-----APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225
TP + APEVL +++Y VD W +G + EM + F G+ E + I
Sbjct: 175 AL--TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 226 N-----DEVRYPRFLSL 237
+ E +PR +SL
Sbjct: 233 DLIGLPPEDDWPRDVSL 249
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-14
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 45/221 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K LK + LL+E AN M +P++V + C VME
Sbjct: 48 AVKILKNEAN-DPALKDELLAE------ANVMQQLDNPYIVRMIGIC--EAESWMLVMEM 98
Query: 70 AAGGDLMMHI-HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
A G L ++ + + V +G++YL ES ++R + A+
Sbjct: 99 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD-----------LAAR- 146
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEVL 184
N + + + Y KI+DFGL K + + ++ APE +
Sbjct: 147 --NVLLVT-----------QHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 192
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
++ D W GVL++E G+ P+ G EV +
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 43/229 (18%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
AIKALK G + LSE A+ M HP ++ L V EY
Sbjct: 81 AIKALKAGY--TERQRRDFLSE------ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132
Query: 71 AGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
G L + H F+ + V V G++YL + ++R + A+
Sbjct: 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR-----------DLAAR- 180
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFLAPEVLT 185
N V+S K++DFGL + D T G P + APE +
Sbjct: 181 --NVLVDS-----------NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 186 ETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
+++ A D W GV+++E+L GE P+ +V S+ R P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-RLPA 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-14
Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 48/231 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK LK+G + + E ++ E A M +P++V L C + VME
Sbjct: 41 AIKVLKQGT--EKADTEEMMRE------AQIMHQLDNPYIVRLIGVC--QAEALMLVMEM 90
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
A GG L + + V +G++YL E ++R + A+
Sbjct: 91 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR-----------DLAAR 139
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N + + Y KI+DFGL K +G D T ++ APE
Sbjct: 140 ---NVLLVN-----------RHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPEC 184
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVRYPR 233
+ ++ D W GV ++E L G+ P+ EV I + R
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMEC 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 50/222 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
A+K +K G + VE+ L+E AN M +H LV L A T+ + + E+
Sbjct: 216 AVKTMKPGSM----SVEAFLAE------ANVMKTLQHDKLVKLHAVV-TKEPIYIITEFM 264
Query: 71 AGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
A G L+ + +D P+ + ++A + G+ ++ + I+R + A
Sbjct: 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD-----------LRA- 312
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N V++ KIADFGL + D T +F APE
Sbjct: 313 --ANILVSA-----------SLVCKIADFGLARV---IEDNEYTAREGAKFPIKWTAPEA 356
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ S+T D W G+L+ E++ G P+PG EV ++
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-14
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 44/221 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK LK G + L E A M H ++ L + + + + EY
Sbjct: 77 AIKTLKAGY--TEKQRVDFLGE------AGIMGQFSHHNIIRLEGVISKYKP-MMIITEY 127
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G L + FS + V + G++YL ++R + A+
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR-----------DLAAR 176
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFLAPEVL 184
N VNS K++DFGL + + T T G P + APE +
Sbjct: 177 ---NILVNS-----------NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ +T A D W G++++E++ GE P+ EV +I
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 55/245 (22%), Positives = 93/245 (37%), Gaps = 77/245 (31%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY 69
A+K LK ++ L+SE M +H ++NL + + ++EY
Sbjct: 117 AVKMLKDD--ATEKDLSDLVSE------MEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168
Query: 70 AAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
A+ G+L + + + + V + G++YL + I+R
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR- 227
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGY-VKIADFGLCKEGM 163
D TE +KIADFGL ++ +
Sbjct: 228 ---------------------------------DLAARNVLVTENNVMKIADFGLARD-I 253
Query: 164 GFGD--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEE 219
D + T P +++APE L + YT D W GVL++E+ +G SP+PG EE
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 220 VFDSI 224
+F +
Sbjct: 314 LFKLL 318
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-13
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 50/222 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK +K+G + + + E A M H LV L+ C + + + EY
Sbjct: 52 AIKMIKEGSM----SEDEFIEE------AKVMMNLSHEKLVQLYGVCTKQR-PIFIITEY 100
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
A G L+ ++ F + + V ++YL + ++R + A+
Sbjct: 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD-----------LAAR 149
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N VN +G VK++DFGL + D T +F PEV
Sbjct: 150 ---NCLVND-----------QGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
L + ++ D W GVL++E+ +G+ P+ E + I
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-13
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 48/221 (21%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYA 70
A+K +K+G + + E A TM HP LV + E + V EY
Sbjct: 36 AVKMIKEGSM----SEDEFFQE------AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85
Query: 71 AGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128
+ G L+ ++ H + + V G+ +L + I+R + A+
Sbjct: 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD-----------LAAR- 133
Query: 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEVL 184
N V+ + VK++DFG+ + D +F APEV
Sbjct: 134 --NCLVDR-----------DLCVKVSDFGMTRY---VLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
Y+ D W G+L++E+ +G+ P+ EV +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 55/245 (22%), Positives = 93/245 (37%), Gaps = 77/245 (31%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY 69
A+K LK ++ L+SE M +H ++NL + + ++EY
Sbjct: 71 AVKMLKDD--ATEKDLSDLVSE------MEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 122
Query: 70 AAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
A+ G+L + + + + V + G++YL + I+R
Sbjct: 123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR- 181
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGY-VKIADFGLCKEGM 163
D TE +KIADFGL ++ +
Sbjct: 182 ---------------------------------DLAARNVLVTENNVMKIADFGLARD-I 207
Query: 164 GFGD--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEE 219
D + T P +++APE L + YT D W GVL++E+ +G SP+PG EE
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 220 VFDSI 224
+F +
Sbjct: 268 LFKLL 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 49/242 (20%), Positives = 84/242 (34%), Gaps = 73/242 (30%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVE----------SLLSEKRIFEVANTMRHPFLVNLFAC 56
R TG+ ALKK ++ +E E +L ++H +VNL
Sbjct: 39 RKTGQ---KVALKK--VLMENEKEGFPITALREIKILQL---------LKHENVVNLIEI 84
Query: 57 FQTEAHVCF--------VMEYAAGGDLM--MHIHADVFSEPRAVFYAACVVLGLQYLHES 106
+T+A V ++ DL + F+ ++ GL Y+H +
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143
Query: 107 RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADFGLCKEGM 163
+I++R ++K N +G +K+ADFGL +
Sbjct: 144 KILHR--------DMK--------------------AANVLITRDGVLKLADFGLARA-F 174
Query: 164 GFGDRTGTFCGTPEFL-----APEVLT-ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
+ T + PE+L E Y +D WG G ++ EM G+ E
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 218 EE 219
+
Sbjct: 235 QH 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-13
Identities = 50/229 (21%), Positives = 82/229 (35%), Gaps = 48/229 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K L + + + L E A + H +V Q+ +ME
Sbjct: 64 AVKTLPEV--CSEQDELDFLME------ALIISKFNHQNIVRCIGVSLQSL-PRFILMEL 114
Query: 70 AAGGDL--------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
AGGDL + + A + G QYL E+ I+R
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD--------- 165
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTP-EF 178
I A+ N + KI DFG+ ++ + R G P ++
Sbjct: 166 --IAAR---NCLLTCPGP-----GRV---AKIGDFGMARD-IYRASYYRKGGCAMLPVKW 211
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVN 226
+ PE E +T D W GVL++E+ +G P+P +EV + + +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 58/222 (26%), Positives = 79/222 (35%), Gaps = 49/222 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK K + E L E A TM HP +V L TE V +ME
Sbjct: 47 AIKTCKNCT--SDSVREKFLQE------ALTMRQFDHPHIVKLIGVI--TENPVWIIMEL 96
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G+L + + YA + L YL R ++R I A+
Sbjct: 97 CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR-----------DIAAR 145
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N V+S VK+ DFGL + D T + +APE
Sbjct: 146 ---NVLVSS-----------NDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPES 188
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ +T A D W GV ++E+L G PF G +V I
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 44/221 (19%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK LK G + L E A+ M HP ++ L +++ V V EY
Sbjct: 77 AIKTLKVGY--TEKQRRDFLGE------ASIMGQFDHPNIIRLEGVVTKSKP-VMIVTEY 127
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G L + H F+ + V + G++YL + ++R + A+
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR-----------DLAAR 176
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT--P-EFLAPEVL 184
N +NS K++DFGL + + T G P + +PE +
Sbjct: 177 ---NILINS-----------NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 185 TETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+T A D W G++++E++ GE P+ ++V ++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 57/241 (23%), Positives = 89/241 (36%), Gaps = 69/241 (28%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY 69
A+K LK ++ L+SE M +H ++NL + + ++EY
Sbjct: 105 AVKMLKSDA--TEKDLSDLISE------MEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 156
Query: 70 AAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR- 111
A+ G+L H + S V A V G++YL + I+R
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 216
Query: 112 -PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
N+ V E+ +KIADFGL ++
Sbjct: 217 LAARNVL----------VTEDNV-----------------MKIADFGLARDIH----HID 245
Query: 171 TFCGTPEFL------APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDS 223
+ T APE L + YT D W GVL++E+ +G SP+PG EE+F
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 224 I 224
+
Sbjct: 306 L 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 68/239 (28%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY 69
AIK +K+ ++D+ E + HP ++NL + ++ +EY
Sbjct: 56 AIKRMKEY--ASKDDHRDFAGE------LEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107
Query: 70 AAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
A G+L + + A S + + +AA V G+ YL + + I+R
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167
Query: 113 QS--NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
+ NI V ENY KIADFGL + + +T
Sbjct: 168 LAARNIL----------VGENYV-----------------AKIADFGLSRGQEVYVKKTM 200
Query: 171 TFCGTPEF----LAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+A E L + YT D W GVL++E++ +G +P+ G E+++ +
Sbjct: 201 G-----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 46/245 (18%), Positives = 85/245 (34%), Gaps = 82/245 (33%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCF---- 65
A+K +K D ++ E+E LSE A M HP ++ L C + +
Sbjct: 66 AVKTMKL-DNSSQREIEEFLSE------AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118
Query: 66 VMEYAAGGDL-------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ + GDL + + + + LG++YL ++R
Sbjct: 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD------ 172
Query: 119 EEIKRIEAK---VQENYKVNSSQEIKLTVNDTEGYVKIADFGL----------CKEGMGF 165
+ A+ ++++ V +ADFGL + +
Sbjct: 173 -----LAARNCMLRDDMT-----------------VCVADFGLSKKIYSGDYYRQGRIA- 209
Query: 166 GDRTGTFCGTPEFL-----APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEE 219
+ A E L + YT D W GV ++E+ G +P+PG E
Sbjct: 210 ------------KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
Query: 220 VFDSI 224
++D +
Sbjct: 258 MYDYL 262
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-13
Identities = 49/229 (21%), Positives = 82/229 (35%), Gaps = 48/229 (20%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K L + + + L E A + H +V Q+ ++E
Sbjct: 105 AVKTLPEV--CSEQDELDFLME------ALIISKFNHQNIVRCIGVSLQSL-PRFILLEL 155
Query: 70 AAGGDL--------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEI 121
AGGDL + + A + G QYL E+ I+R
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD--------- 206
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTP-EF 178
I A+ N + KI DFG+ ++ + R G P ++
Sbjct: 207 --IAAR---NCLLTCPGP-----GRV---AKIGDFGMARD-IYRAGYYRKGGCAMLPVKW 252
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVN 226
+ PE E +T D W GVL++E+ +G P+P +EV + + +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 49/234 (20%), Positives = 87/234 (37%), Gaps = 58/234 (24%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK + + + E L+E A+ M +V L Q + +ME
Sbjct: 59 AIKTVNEA--ASMRERIEFLNE------ASVMKEFNCHHVVRLLGVVSQGQ-PTLVIMEL 109
Query: 70 AAGGDL-----------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNI 116
GDL + S + + A + G+ YL+ ++ ++R N
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCG 174
V E++ VKI DFG+ ++ + D R G
Sbjct: 170 M----------VAEDFT-----------------VKIGDFGMTRD-IYETDYYRKGGKGL 201
Query: 175 TP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVN 226
P +++PE L + +T D W GV+++E+ + E P+ G E+V ++
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-13
Identities = 50/237 (21%), Positives = 81/237 (34%), Gaps = 64/237 (27%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+KALK+ AR + E A + +H +V F C + + V EY
Sbjct: 75 AVKALKEASESARQD---FQRE------AELLTMLQHQHIVRFFGVCTEGR-PLLMVFEY 124
Query: 70 AAGGDL----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
GDL + + + A+ V G+ YL ++R
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184
Query: 114 S--NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RT 169
+ N V + VKI DFG+ ++ + D R
Sbjct: 185 ATRNCL----------VGQGLV-----------------VKIGDFGMSRD-IYSTDYYRV 216
Query: 170 GTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
G P ++ PE + +T D W GV+++E+ G+ P+ E D I
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 53/237 (22%), Positives = 86/237 (36%), Gaps = 48/237 (20%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + AIK L ++ KR + E+ + H ++ L F
Sbjct: 41 VCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 93
Query: 58 QTEAH------VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ V VME +L I + R + ++ G+++LH + II+R
Sbjct: 94 TPQKSLEEFQDVYIVMELM-DANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 112 PQ--SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT 169
SNI V S +KI DFGL + T
Sbjct: 152 DLKPSNIV----------------VKSDCT-----------LKILDFGLARTAGTSFMMT 184
Query: 170 GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
+ T + APEV+ Y VD W +G ++ EM+ G FPG D + ++ ++
Sbjct: 185 P-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-12
Identities = 48/222 (21%), Positives = 78/222 (35%), Gaps = 49/222 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+K KK + D E +SE A M HP +V L E +ME
Sbjct: 44 AVKTCKKDCTL--DNKEKFMSE------AVIMKNLDHPHIVKLIGII--EEEPTWIIMEL 93
Query: 70 AAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAK 127
G+L ++ + + V Y+ + + YL ++R I +
Sbjct: 94 YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD-----------IAVR 142
Query: 128 VQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF----LAPEV 183
N V S VK+ DFGL + D ++PE
Sbjct: 143 ---NILVAS-----------PECVKLGDFGLSRY---IEDEDYYKASVTRLPIKWMSPES 185
Query: 184 LTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
+ +T A D W V ++E+L G+ PF + ++V +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 49/238 (20%), Positives = 81/238 (34%), Gaps = 65/238 (27%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
A+KALK + AR + E A + +H +V + C + + V EY
Sbjct: 49 AVKALKDPTLAARKD---FQRE------AELLTNLQHEHIVKFYGVCGDGDP-LIMVFEY 98
Query: 70 AAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
GDL + + A+ + G+ YL ++R
Sbjct: 99 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158
Query: 113 QS--NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--R 168
+ N V N VKI DFG+ ++ + D R
Sbjct: 159 LATRNCL----------VGANLL-----------------VKIGDFGMSRD-VYSTDYYR 190
Query: 169 TGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
G P ++ PE + +T D W GV+++E+ G+ P+ EV + I
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-12
Identities = 57/255 (22%), Positives = 98/255 (38%), Gaps = 86/255 (33%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLF-ACFQTEAHVCFVMEY 69
A+K LK+ + E+ LLSE N + HP ++ L+ AC Q + ++EY
Sbjct: 57 AVKMLKEN--ASPSELRDLLSE------FNVLKQVNHPHVIKLYGACSQDG-PLLLIVEY 107
Query: 70 AAGGDL-------------------------MMHIHADVFSEPRAVFYAACVVLGLQYLH 104
A G L + H + + +A + G+QYL
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167
Query: 105 ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGY-VKIAD 155
E ++++R D EG +KI+D
Sbjct: 168 EMKLVHR----------------------------------DLAARNILVAEGRKMKISD 193
Query: 156 FGLCKEGMGFGD--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESP 211
FGL ++ + D + P +++A E L + YT D W GVL++E++ +G +P
Sbjct: 194 FGLSRD-VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 212 FPGDDEEEVFDSIVN 226
+PG E +F+ +
Sbjct: 253 YPGIPPERLFNLLKT 267
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-12
Identities = 52/222 (23%), Positives = 82/222 (36%), Gaps = 50/222 (22%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACFQTEAH- 62
AIK K ++ KR + E+ + H +++L F +
Sbjct: 84 AVLDRNVAIK--KLSRPF-----QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 63 -----VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR---PQS 114
V VME +L I ++ R + ++ G+++LH + II+R P S
Sbjct: 137 EEFQDVYLVMELM-DANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHSAGIIHRDLKP-S 193
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
NI V S +KI DFGL + T +
Sbjct: 194 NIV----------------VKSDCT-----------LKILDFGLARTAGTSFMMTP-YVV 225
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216
T + APEV+ Y VD W +G ++ EM+ + FPG D
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-12
Identities = 48/251 (19%), Positives = 75/251 (29%), Gaps = 86/251 (34%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY 69
A+K LK E E+L+SE + H +VNL + EY
Sbjct: 57 AVKMLKPSA--HLTEREALMSE------LKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108
Query: 70 AAGGDL-------------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIY 110
GDL +M + ++ V G+ +L I+
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168
Query: 111 RPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGYV-KIADFGLCKE 161
R D T G + KI DFGL ++
Sbjct: 169 R----------------------------------DLAARNILLTHGRITKICDFGLARD 194
Query: 162 GMGFGDRTGTFCGTPEFL------APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPG 214
+ APE + YT D W G+ ++E+ +G SP+PG
Sbjct: 195 IK----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 215 -DDEEEVFDSI 224
+ + + I
Sbjct: 251 MPVDSKFYKMI 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 51/261 (19%), Positives = 86/261 (32%), Gaps = 61/261 (23%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEV--ESLLSEKRIF-EVA--NTMRHPFLVNLFA 55
+ + + G AIK + R KR+ E+ N HP ++ L
Sbjct: 37 AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96
Query: 56 CFQTEAHVCF-----VMEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRI 108
F V E DL IH V S ++ ++LGL LHE+ +
Sbjct: 97 IFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGV 155
Query: 109 IYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF 165
++R P NI + + + + I DF L +E
Sbjct: 156 VHRDLHP-GNIL----------------LADNND-----------ITICDFNLAREDTAD 187
Query: 166 GDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD-------- 216
++T + + APE+ + +T+ VD W G ++ EM ++ F G
Sbjct: 188 ANKTH-YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
Query: 217 -------EEEVFDSIVNDEVR 230
+ E + R
Sbjct: 247 VEVVGTPKIEDVVMFSSPSAR 267
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-12
Identities = 54/268 (20%), Positives = 93/268 (34%), Gaps = 75/268 (27%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + ++ TGE AIK K + + L R E+ +H ++ +F
Sbjct: 27 VCSATHKPTGEIVAIK---KIEPF-----DKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 58 QTEAHVCF-----VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR- 111
+ ++ F + E DL I + S+ ++ + ++ LH S +I+R
Sbjct: 79 RPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 112 --PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT 169
P SN+ +NS+ + +K+ DFGL +
Sbjct: 138 LKP-SNLL----------------INSNCD-----------LKVCDFGLARIIDESAADN 169
Query: 170 GTFCGTPEFL----------APEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD-- 216
G + APEV LT Y+RA+D W G ++ E+ + FPG D
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229
Query: 217 --------------EEEVFDSIVNDEVR 230
+ I + R
Sbjct: 230 HQLLLIFGIIGTPHSDNDLRCIESPRAR 257
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-12
Identities = 66/258 (25%), Positives = 99/258 (38%), Gaps = 67/258 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + TG AIK K +S L KR + E+ MRH ++ L F
Sbjct: 41 VCSAVDGRTGAKVAIK--KLYRPF-----QSELFAKRAYRELRLLKHMRHENVIGLLDVF 93
Query: 58 QTEA------HVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ VM + G DL + + E R F ++ GL+Y+H + II+R
Sbjct: 94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR 152
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168
P N+ VN E +KI DFGL ++ +
Sbjct: 153 DLKP-GNLA----------------VNEDCE-----------LKILDFGLARQ--ADSEM 182
Query: 169 TGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD----------- 216
TG + T + APEV L YT+ VD W +G ++ EM+ G++ F G D
Sbjct: 183 TG-YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241
Query: 217 ----EEEVFDSIVNDEVR 230
E + +DE +
Sbjct: 242 TGTPPAEFVQRLQSDEAK 259
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 9e-12
Identities = 26/227 (11%), Positives = 54/227 (23%), Gaps = 67/227 (29%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73
A+ + ++ D ++ LS + + P + + T A V E+ GG
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTL---RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116
Query: 74 DLMMHIHADVFSEP----RAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQ 129
L +V A+ + H + +
Sbjct: 117 SL-----QEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALS--------IDHP------ 157
Query: 130 ENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY 189
++++ +G V +A +
Sbjct: 158 SR--------VRVS---IDGDVVLAYPA--------------------TMPDA------- 179
Query: 190 TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI---VNDEVRYPR 233
D G+G ++ +LV P P + P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 44/254 (17%), Positives = 80/254 (31%), Gaps = 58/254 (22%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA---NTMRHPFLVNLFAC 56
V + E +K LK + +K+I E+ N P ++ L
Sbjct: 52 VFEAINITNNEKVVVKILK------------PVKKKKIKREIKILENLRGGPNIITLADI 99
Query: 57 FQTEAH--VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--- 111
+ V E+ D ++ FY ++ L Y H I++R
Sbjct: 100 VKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
P N+ ++ +++ D+GL + +
Sbjct: 158 PH-NV--------------------------MIDHEHRKLRLIDWGLAEFYHPGQEYNV- 189
Query: 172 FCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESP-FPGDDEEEVFDSIVN--- 226
+ F PE+L Y ++D W LG ++ M+ + P F G D + I
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249
Query: 227 --DEVRYPRFLSLE 238
D Y ++E
Sbjct: 250 TEDLYDYIDKYNIE 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 55/248 (22%), Positives = 84/248 (33%), Gaps = 84/248 (33%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLF-ACFQTEAHVCFVME 68
A+K LK DE E+L+SE M +H +VNL AC V + E
Sbjct: 80 AVKMLKSTA--HADEKEALMSE------LKIMSHLGQHENIVNLLGACTHGG-PVLVITE 130
Query: 69 YAAGGDL---------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
Y GDL I S + +++ V G+ +L I+R
Sbjct: 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR-- 188
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGYV-KIADFGLCKEGMG 164
D T G+V KI DFGL ++ M
Sbjct: 189 --------------------------------DVAARNVLLTNGHVAKIGDFGLARDIM- 215
Query: 165 FGDRTGTFCGTPEFL------APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDD- 216
+ APE + + YT D W G+L++E+ +G +P+PG
Sbjct: 216 ---NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 217 EEEVFDSI 224
+ + +
Sbjct: 273 NSKFYKLV 280
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 43/241 (17%), Positives = 88/241 (36%), Gaps = 47/241 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDII---ARDEVESLLSEKRIFEVANTMRHPFLVNLFACF 57
V+L Q+ + +Y+A+K ++ A+ E + L K+I + +V F
Sbjct: 51 VLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADIL---KKIQNDDINNNN--IVKYHGKF 105
Query: 58 QTEAHVCFVME------YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIY- 110
H+C + E Y +++ + + F Y ++ L YL + + +
Sbjct: 106 MYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT 161
Query: 111 --RPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168
+P+ NI ++ ++ + + + T +K+ DFG
Sbjct: 162 DLKPE-NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG--IKLIDFG----------- 207
Query: 169 TGTFCGTPEFL----------APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE 218
TF ++ APEV+ + + D W G ++ E+ G F +
Sbjct: 208 CATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 219 E 219
E
Sbjct: 266 E 266
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-11
Identities = 46/239 (19%), Positives = 82/239 (34%), Gaps = 81/239 (33%)
Query: 7 RNTGEYFAIKALKKGDIIARDEV-E-SLLSEKRIFEVANTMRHPFLVNLFACFQT----- 59
+ E A+KK R + E ++ ++HP +V+L A F +
Sbjct: 62 VESDEV----AIKKVLQDKRFKNRELQIMRI---------VKHPNVVDLKAFFYSNGDKK 108
Query: 60 -EAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL-------GLQYLHESRIIYR 111
E + V+EY ++ + +++ + + L L Y+H I +R
Sbjct: 109 DEVFLNLVLEYV---PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR 168
PQ N L ++ G +K+ DFG K
Sbjct: 166 DIKPQ---------------------N------LLLDPPSGVLKLIDFGSAK-------- 190
Query: 169 TGTFCGTPEFL---------APEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
+ APE+ T+YT +D W G ++ E++ G+ FPG+
Sbjct: 191 --ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-11
Identities = 54/255 (21%), Positives = 81/255 (31%), Gaps = 86/255 (33%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLF-ACFQTEAHVCFVMEY 69
A+K LK+ + D E A M +P +V L C + +C + EY
Sbjct: 81 AVKMLKEE--ASADMQADFQRE------AALMAEFDNPNIVKLLGVCAVGK-PMCLLFEY 131
Query: 70 AAGGDL-------------------------MMHIHADVFSEPRAVFYAACVVLGLQYLH 104
A GDL + S + A V G+ YL
Sbjct: 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 191
Query: 105 ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGY-VKIAD 155
E + ++R D E VKIAD
Sbjct: 192 ERKFVHR----------------------------------DLATRNCLVGENMVVKIAD 217
Query: 156 FGLCKEGMGFGD--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESP 211
FGL + + D + P ++ PE + YT D W GV+++E+ G P
Sbjct: 218 FGLSRN-IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 212 FPGDDEEEVFDSIVN 226
+ G EEV + +
Sbjct: 277 YYGMAHEEVIYYVRD 291
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 51/246 (20%), Positives = 85/246 (34%), Gaps = 82/246 (33%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEV-E-SLLSEKRIFEVANTMRHPFLVNLFACFQ 58
V ++ ++GE AIK K R + E ++ + + H +V L F
Sbjct: 70 VYQAKLCDSGELVAIK---KVLQDKRFKNRELQIMRK---------LDHCNIVRLRYFFY 117
Query: 59 T------EAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL-------GLQYLHE 105
+ E ++ V++Y ++ A +S + V L L Y+H
Sbjct: 118 SSGEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 106 SRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG 162
I +R PQ N L ++ +K+ DFG K+
Sbjct: 175 FGICHRDIKPQ---------------------N------LLLDPDTAVLKLCDFGSAKQ- 206
Query: 163 MGFGDRTGTFCGTPEFL----------APEV-LTETSYTRAVDWWGLGVLIFEMLVGESP 211
E APE+ T YT ++D W G ++ E+L+G+
Sbjct: 207 ----------LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256
Query: 212 FPGDDE 217
FPGD
Sbjct: 257 FPGDSG 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-11
Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 51/224 (22%)
Query: 9 TGEYFAIKALKKGDII---ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
++ A+K ++ A +E+ L + + + +++ F H+C
Sbjct: 121 VHQHVALKMVRNEKRFHRQAAEEIRIL---EHLRKQDKDNTMNV-IHMLENFTFRNHICM 176
Query: 66 VME------YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIY---RPQSNI 116
E Y +L+ FS P +A ++ L LH++RII+ +P+ NI
Sbjct: 177 TFELLSMNLY----ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE-NI 231
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL-CKEGMGFGDRTGTFCGT 175
L +K+ DFG C E R T+ +
Sbjct: 232 -------------------------LLKQQGRSGIKVIDFGSSCYEH----QRVYTYIQS 262
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+ APEV+ Y +D W LG ++ E+L G PG+DE +
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-11
Identities = 59/253 (23%), Positives = 92/253 (36%), Gaps = 65/253 (25%)
Query: 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACFQTEA 61
TG A+K L +S++ KR + E+ M+H ++ L F
Sbjct: 49 FDTKTGLRVAVKKL-------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101
Query: 62 H------VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ-- 113
V V G DL + ++ F ++ GL+Y+H + II+R
Sbjct: 102 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 160
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
SN+ VN E+ KI DFGL + TG +
Sbjct: 161 SNLA----------------VNEDCEL-----------KILDFGLARHTADE--MTG-YV 190
Query: 174 GTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD---------------E 217
T + APE+ L Y + VD W +G ++ E+L G + FPG D
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 218 EEVFDSIVNDEVR 230
E+ I ++ R
Sbjct: 251 AELLKKISSESAR 263
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 9e-11
Identities = 45/250 (18%), Positives = 74/250 (29%), Gaps = 88/250 (35%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFA-CFQTEAHVCFVMEY 69
AIK LK E E A +HP +V L + + + + Y
Sbjct: 43 AIKTLKDKA--EGPLREEFRHE------AMLRARLQHPNVVCLLGVVTKDQ-PLSMIFSY 93
Query: 70 AAGGDL-----------------MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP 112
+ GDL P V A + G++YL ++++
Sbjct: 94 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 153
Query: 113 QS--NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL----------CK 160
+ N+ V + VKI+D GL
Sbjct: 154 LATRNVL----------VYDKLN-----------------VKISDLGLFREVYAADYYKL 186
Query: 161 EGMGFGDRTGTFCGTPEFL-----APEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPG 214
G L APE + ++ D W GV+++E+ G P+ G
Sbjct: 187 LGNS-------------LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 215 DDEEEVFDSI 224
++V + I
Sbjct: 234 YSNQDVVEMI 243
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 58/257 (22%), Positives = 97/257 (37%), Gaps = 66/257 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + + +GE AIK K +S + KR + E+ M+H ++ L F
Sbjct: 40 VCSAIDKRSGEKVAIK--KLSRPF-----QSEIFAKRAYRELLLLKHMQHENVIGLLDVF 92
Query: 58 QTEAH------VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ VM + DL + FSE + + ++ GL+Y+H + +++R
Sbjct: 93 TPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-FSEEKIQYLVYQMLKGLKYIHSAGVVHR 150
Query: 112 PQ--SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT 169
N+ VN E+ KI DFGL + + T
Sbjct: 151 DLKPGNLA----------------VNEDCEL-----------KILDFGLARH--ADAEMT 181
Query: 170 GTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD------------ 216
G + T + APEV L+ Y + VD W +G ++ EML G++ F G D
Sbjct: 182 G-YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 217 ---EEEVFDSIVNDEVR 230
E + + +
Sbjct: 241 GVPGTEFVQKLNDKAAK 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 43/229 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDII---ARDEVESLLSEKRIFEVANTMRHPFLVNLFACF 57
V+ + R E+ AIK +K A+ EV L + + + M++ ++V+L F
Sbjct: 70 VVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL---ELMNKHDTEMKY-YIVHLKRHF 125
Query: 58 QTEAHVCFVME------YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR 111
H+C V E Y DL+ + + S +A + L +L +
Sbjct: 126 MFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL--- 178
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG-LCKEGMGFGDRTG 170
+I ++K EN I L N +KI DFG C+ G R
Sbjct: 179 ---SIIHCDLK------PEN--------I-LLCNPKRSAIKIVDFGSSCQLG----QRIY 216
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+ + + +PEVL Y A+D W LG ++ EM GE F G +E +
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 51/260 (19%), Positives = 90/260 (34%), Gaps = 67/260 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + AIK + E +R E+ RH ++ +
Sbjct: 43 VCSAYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 58 QTEAHVCF-----VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR- 111
+ V + DL + S ++ ++ GL+Y+H + +++R
Sbjct: 95 RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 112 --PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRT 169
P SN+ +N++ + +KI DFGL + D T
Sbjct: 154 LKP-SNLL----------------LNTTCD-----------LKICDFGLARVADPDHDHT 185
Query: 170 GTFCG---TPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD--------- 216
G T + APE+ L YT+++D W +G ++ EML FPG
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 217 ------EEEVFDSIVNDEVR 230
+E + I+N + R
Sbjct: 246 GILGSPSQEDLNCIINLKAR 265
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 64/276 (23%), Positives = 100/276 (36%), Gaps = 82/276 (29%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMR-HPFLVNLFAC 56
V S R TGE A+K K D ++ +R F E+ + H +VNL
Sbjct: 25 VWKSIDRRTGEVVAVK--KIFDAF-----QNSTDAQRTFREIMILTELSGHENIVNLLNV 77
Query: 57 FQTEA--HVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--- 111
+ + V V +Y DL I A++ + ++ ++YLH +++R
Sbjct: 78 LRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK 136
Query: 112 PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC-----------K 160
P SNI +N+ E +VK+ADFGL
Sbjct: 137 P-SNIL----------------LNA-----------ECHVKVADFGLSRSFVNIRRVTNN 168
Query: 161 EGMGFGDRTGTFCGTPEFL----------APEV-LTETSYTRAVDWWGLGVLIFEMLVGE 209
+ + T F L APE+ L T YT+ +D W LG ++ E+L G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 210 SPFPGDD---------------EEEVFDSIVNDEVR 230
FPG E +SI + +
Sbjct: 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAK 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-10
Identities = 55/262 (20%), Positives = 94/262 (35%), Gaps = 59/262 (22%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLF-ACFQTEAHVCFVME 68
A+K LK+G E +L+SE + H +VNL AC + + ++E
Sbjct: 56 AVKMLKEG--ATHSEHRALMSE------LKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107
Query: 69 YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHE------SRIIYRPQSNITK---E 119
+ G+L ++ + A G Y+ R+ S +
Sbjct: 108 FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVND--------------------------------T 147
++ + V+E + LT+ +
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 227
Query: 148 EGY-VKIADFGLCKEGMGFGD-RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFE 204
E VKI DFGL ++ D P +++APE + + YT D W GVL++E
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287
Query: 205 ML-VGESPFPG-DDEEEVFDSI 224
+ +G SP+PG +EE +
Sbjct: 288 IFSLGASPYPGVKIDEEFCRRL 309
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-10
Identities = 53/253 (20%), Positives = 84/253 (33%), Gaps = 85/253 (33%)
Query: 14 AIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY 69
A+K LK+ E E+L+SE M H +VNL + + EY
Sbjct: 79 AVKMLKEK--ADSSEREALMSE------LKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 130
Query: 70 AAGGDL------------------------MMHIHADVFSEPRAVFYAACVVLGLQYLHE 105
GDL +V + + +A V G+++L
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190
Query: 106 SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--------TEGYV-KIADF 156
++R D T G V KI DF
Sbjct: 191 KSCVHR----------------------------------DLAARNVLVTHGKVVKICDF 216
Query: 157 GLCKEGMGFGD--RTGTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPF 212
GL ++ + P +++APE L E YT D W G+L++E+ +G +P+
Sbjct: 217 GLARD-IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 213 PG-DDEEEVFDSI 224
PG + + I
Sbjct: 276 PGIPVDANFYKLI 288
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-10
Identities = 51/237 (21%), Positives = 83/237 (35%), Gaps = 58/237 (24%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + ++TG AIK + + E +I + + HP +V L + F T
Sbjct: 39 VQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91
Query: 61 AHVCF-------VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVL-------GLQYLHES 106
VMEY +H + + + + + LH
Sbjct: 92 GERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 107 --RIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161
+ +R P N + VN+ +G +K+ DFG K+
Sbjct: 149 SVNVCHRDIKPH---------------------N------VLVNEADGTLKLCDFGSAKK 181
Query: 162 GMGFGDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217
C + + APE+ YT AVD W +G + EM++GE F GD+
Sbjct: 182 LSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 50/240 (20%), Positives = 84/240 (35%), Gaps = 61/240 (25%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + + + AIK K I+ D K E+ + H +V +F
Sbjct: 27 VFSAVDNDCDKRVAIK---K--IVLTDPQSV----KHALREIKIIRRLDHDNIVKVFEIL 77
Query: 58 QTEAH--------------VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYL 103
V V EY DL + E A + ++ GL+Y+
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRGLKYI 136
Query: 104 HESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160
H + +++R P +N+ +N + +KI DFGL +
Sbjct: 137 HSANVLHRDLKP-ANL--------------------------FINTEDLVLKIGDFGLAR 169
Query: 161 EGMGFGDRTGTFCG---TPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216
G T + +P + L+ +YT+A+D W G + EML G++ F G
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-10
Identities = 43/229 (18%), Positives = 79/229 (34%), Gaps = 40/229 (17%)
Query: 7 RNTGEYFAIKALKKGDII---ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHV 63
A+K ++ AR E+ L K+I E + V + F H+
Sbjct: 42 ARGKSQVALKIIRNVGKYREAARLEINVL---KKIKEKDKENKFLC-VLMSDWFNFHGHM 97
Query: 64 CFVME------YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIY---RPQS 114
C E + + + + + P A + L++LHE+++ + +P+
Sbjct: 98 CIAFELLGKNTF----EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPE- 152
Query: 115 NI---TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG-LCKEGMGFGDRTG 170
NI E K + I++ DFG + +
Sbjct: 153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRV----------A-DFGSATFDH----EHHT 197
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
T T + PEV+ E + + D W +G ++FE G + F + E
Sbjct: 198 TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 52/196 (26%), Positives = 71/196 (36%), Gaps = 59/196 (30%)
Query: 46 RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEP--------RAVFYAACVV 97
RHP LV+L + + +Y G+L H++ AA
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA--- 149
Query: 98 LGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157
GL YLH II+R ++K S I L D KI DFG
Sbjct: 150 RGLHYLHTRAIIHR--------DVK--------------SINILL---DENFVPKITDFG 184
Query: 158 LCKEGMGFGDRT-------GTFCGTPEFLAPE-----VLTETSYTRAVDWWGLGVLIFEM 205
+ K+G D+T GT G ++ PE LTE S D + GV++FE+
Sbjct: 185 ISKKGTE-LDQTHLSTVVKGTL-G---YIDPEYFIKGRLTEKS-----DVYSFGVVLFEV 234
Query: 206 LVGESPF-PGDDEEEV 220
L S E V
Sbjct: 235 LCARSAIVQSLPREMV 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 29/123 (23%), Positives = 50/123 (40%), Gaps = 32/123 (26%)
Query: 99 GLQYLHESRIIYR---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155
+ ++H I +R PQ N L VN + +K+ D
Sbjct: 153 AVGFIHSLGICHRDIKPQ---------------------N------LLVNSKDNTLKLCD 185
Query: 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214
FG K+ + C + + APE+ L T YT ++D W +G + E+++G+ F G
Sbjct: 186 FGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244
Query: 215 DDE 217
+
Sbjct: 245 ETS 247
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-09
Identities = 47/231 (20%), Positives = 79/231 (34%), Gaps = 72/231 (31%)
Query: 14 AIKALKKGDIIA--------RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
A+K L I E++ ++++ +H LV L +C
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIK-VMAK---------CQHENLVELLGFSSDGDDLCL 107
Query: 66 VMEYAAGGDLMMHIHADVFSEP-------RAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
V Y G L+ + + P + AA G+ +LHE+ I+R
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN---GINFLHENHHIHR------- 157
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADFGLCKEGMGFGDRT------ 169
+IK S+ N D KI+DFGL + +T
Sbjct: 158 -DIK-------------SA-------NILLDEAFTAKISDFGLARAS-EKFAQTVMTSRI 195
Query: 170 -GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
GT ++APE L ++ D + GV++ E++ G E +
Sbjct: 196 VGTT-A---YMAPEALRGEITPKS-DIYSFGVVLLEIITGLPAVDEHREPQ 241
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 53/267 (19%), Positives = 85/267 (31%), Gaps = 87/267 (32%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V + + AIK + E L+ KRI E+A N + H +V +
Sbjct: 69 VCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121
Query: 58 QTEAHVCF-----VMEYAAGGDLMMHIHADVF-SEPRAVFYAACVVLGLQYLHESRIIYR 111
+ F V+E A D V+ +E +++G++Y+H + I++R
Sbjct: 122 IPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL---------- 158
P +N VN + VK+ DFGL
Sbjct: 181 DLKP-ANCL----------------VNQ-----------DCSVKVCDFGLARTVDYPENG 212
Query: 159 -------CKEGMGFGDRTGTFCGTPEFL----------APEV-LTETSYTRAVDWWGLGV 200
+E L APE+ L + +YT A+D W +G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 201 LIFEMLVGESP-----------FPGDD 216
+ E+L FPG
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSS 299
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 44/236 (18%), Positives = 87/236 (36%), Gaps = 54/236 (22%)
Query: 7 RNTGEYFAIKALKKGDI---IARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHV 63
+ G + A+K +K D AR E++ L + + V + F+ H+
Sbjct: 37 KAGGRHVAVKIVKNVDRYCEAARSEIQVL---EHLNTTDPNSTFRC-VQMLEWFEHHGHI 92
Query: 64 CFVME------YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIY---RPQS 114
C V E Y D + F A + + +LH +++ + +P+
Sbjct: 93 CIVFELLGLSTY----DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE- 147
Query: 115 NI---TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT 171
NI + + K++ + + + +IK+ + DFG + T
Sbjct: 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKV----------V-DFG-----------SAT 185
Query: 172 FCGTPEFL--------APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+ APEV+ +++ D W +G ++ E +G + FP D +E
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 55/262 (20%), Positives = 92/262 (35%), Gaps = 82/262 (31%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIF-EVA--NTMRHPFLVNLFACF 57
V L+ +NT + AIK K + E L+ KRI E+ N ++ +++ L+
Sbjct: 42 VYLAYDKNTEKNVAIK--KVNRMF-----EDLIDCKRILREITILNRLKSDYIIRLYDLI 94
Query: 58 QTEAHVCF-----VMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ + F V+E A DL + +E ++LG ++HES II+R
Sbjct: 95 IPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 112 ---PQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL---------- 158
P +N +N + VK+ DFGL
Sbjct: 154 DLKP-ANCL----------------LNQ-----------DCSVKVCDFGLARTINSEKDT 185
Query: 159 --CKEGMGFGDRTGTFCGTPEFL----------APEV-LTETSYTRAVDWWGLGVLIFEM 205
+ + + L APE+ L + +YT+++D W G + E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 206 LVGESP-----------FPGDD 216
L FPG
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSS 267
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 53/225 (23%), Positives = 79/225 (35%), Gaps = 65/225 (28%)
Query: 10 GEYFAIKALKKGDIIARD-----EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVC 64
G A+K LK+ + EVE + + H L+ L T
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMI----------SMAVHRNLLRLRGFCMTPTERL 103
Query: 65 FVMEYAAGGDLMMHIHADVFSEPR---------AVFYAACVVLGLQYLHES---RIIYRP 112
V Y A G + + S+P A+ A GL YLH+ +II+R
Sbjct: 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR----GLAYLHDHCDPKIIHR- 158
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT- 171
++K + I L D E + DFGL K D T
Sbjct: 159 -------DVK--------------AANILL---DEEFEAVVGDFGLAK----LMDYKDTH 190
Query: 172 ----FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212
GT +APE L+ + D +G GV++ E++ G+ F
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.74 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.58 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 93.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.49 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 90.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 87.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 80.94 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=357.08 Aligned_cols=217 Identities=32% Similarity=0.578 Sum_probs=193.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++.+.........+.+.+| +++++.++||||++++++|.+++.+|+|||||+||+|.++++
T Consensus 48 V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E---~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~ 124 (311)
T 4aw0_A 48 VVLARELATSREYAIKILEKRHIIKENKVPYVTRE---RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124 (311)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH---HHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHH---HHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 89999999999999999987544333444455444 777889999999999999999999999999999999999985
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+|
T Consensus 125 ~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHR---DlKPeNI----------------------Ll~~~g~vKl~DFGla 179 (311)
T 4aw0_A 125 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHR---DLKPENI----------------------LLNEDMHIQITDFGTA 179 (311)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccC---CCCHHHe----------------------EEcCCCCEEEEEcCCc
Confidence 4689999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCC--CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCCh
Q psy3347 160 KEGMGF--GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237 (245)
Q Consensus 160 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 237 (245)
+..... .....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..+...+|+.+|+
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~ 259 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP 259 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCH
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCH
Confidence 864322 223556799999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
++++||++
T Consensus 260 ~~~dli~~ 267 (311)
T 4aw0_A 260 KARDLVEK 267 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=352.40 Aligned_cols=214 Identities=24% Similarity=0.435 Sum_probs=188.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.||+.||||++...... ..+.+.+ |+++|+.++||||++++++|.+++.+|+|||||+||+|.+++.
T Consensus 90 V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~---Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~ 163 (346)
T 4fih_A 90 VCIATVRSSGKLVAVKKMDLRKQQ---RRELLFN---EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 163 (346)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCS---SGGGGHH---HHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEecCchh---HHHHHHH---HHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 899999999999999999764322 2233444 4777889999999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++||+|| ||||+|| +++.+|.+||+|||+|+
T Consensus 164 ~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR---DlKp~NI----------------------Ll~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 164 HTRMNEEQIAAVCLAVLQALSVLHAQGVIHR---DIKSDSI----------------------LLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCCTTCE
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---cCCHHHE----------------------EECCCCCEEEecCcCce
Confidence 8899999999999999999999999999999 9999999 88999999999999998
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.....+ .+..+|+
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 298 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP 298 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCH
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCH
Confidence 6555555566789999999999999999999999999999999999999999999999988888765432 2457899
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
++++||++
T Consensus 299 ~~~dli~~ 306 (346)
T 4fih_A 299 SLKGFLDR 306 (346)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=339.77 Aligned_cols=215 Identities=31% Similarity=0.534 Sum_probs=177.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|+++.+|+.||+|++.+.........+.+.+| +++++.++||||+++++++.+++..|+||||+ +|+|.+++
T Consensus 29 V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---i~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~ 104 (275)
T 3hyh_A 29 VKLAYHTTTGQKVALKIINKKVLAKSDMQGRIERE---ISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV 104 (275)
T ss_dssp EEEEECTTTCCEEEEEEEECC------CHHHHHHH---HHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHH---HHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH
Confidence 79999999999999999987654443334445444 77788899999999999999999999999999 56888777
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
+++.+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+|
T Consensus 105 ~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHR---DiKP~NI----------------------Ll~~~~~vkl~DFGla 159 (275)
T 3hyh_A 105 QRDKMSEQEARRFFQQIISAVEYCHRHKIVHR---DLKPENL----------------------LLDEHLNVKIADFGLS 159 (275)
T ss_dssp HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCTTTE----------------------EECTTCCEEECCSSCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---cCChHHe----------------------EECCCCCEEEeecCCC
Confidence 45689999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+..+...+|+.+|++
T Consensus 160 ~~~~-~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (275)
T 3hyh_A 160 NIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPG 238 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred eecC-CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 7532 2333456789999999999998876 5799999999999999999999999999999999999988999999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 239 ~~~li~~ 245 (275)
T 3hyh_A 239 AAGLIKR 245 (275)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=351.37 Aligned_cols=216 Identities=24% Similarity=0.455 Sum_probs=187.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++...... ....+.+. +|+++++.++||||++++++|.+++.+|+|||||+||+|.+++.
T Consensus 40 V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~---~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~ 115 (350)
T 4b9d_A 40 AILVKSTEDGRQYVIKEINISRMS-SKEREESR---REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115 (350)
T ss_dssp EEEEEETTTCCEEEEEEEECTTSC-HHHHHHHH---HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEehHHCC-HHHHHHHH---HHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 899999999999999999875432 23344444 45777889999999999999999999999999999999999985
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..++.++.|++.||+|||++||+|| ||||+|| +++.+|.+||+|||
T Consensus 116 ~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHR---DlKp~NI----------------------Ll~~~g~vKl~DFG 170 (350)
T 4b9d_A 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHR---DIKSQNI----------------------FLTKDGTVQLGDFG 170 (350)
T ss_dssp HTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEET---TCCGGGE----------------------EECTTCCEEECSTT
T ss_pred HcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---cCCHHHE----------------------EECCCCCEEEcccc
Confidence 3 346899999999999999999999999999 9999999 88899999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLS 236 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~ 236 (245)
+|+............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...++..+.. +.|..+|
T Consensus 171 la~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s 250 (350)
T 4b9d_A 171 IARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250 (350)
T ss_dssp EESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred cceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCC
Confidence 998643332233456899999999999999999999999999999999999999999999999999988765 4578899
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
+++++||++
T Consensus 251 ~~~~~li~~ 259 (350)
T 4b9d_A 251 YDLRSLVSQ 259 (350)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=347.13 Aligned_cols=216 Identities=38% Similarity=0.700 Sum_probs=185.6
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++. .+++.||+|++++....... ...+. +|+++++.++||||++++++|.+++..|+|||||+||+|.+
T Consensus 40 Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~---~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~ 115 (304)
T 3ubd_A 40 VFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTK---MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115 (304)
T ss_dssp EEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC---------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHH
T ss_pred EEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHH---HHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHH
Confidence 7999874 47899999999875433222 22333 34677889999999999999999999999999999999999
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+++ .+.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+||
T Consensus 116 ~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR---DlKp~NI----------------------Ll~~~g~vKl~DF 170 (304)
T 3ubd_A 116 RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR---DLKPENI----------------------LLDEEGHIKLTDF 170 (304)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---SCCGGGE----------------------EECTTSCEEEESS
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCC---CCCHHHe----------------------EEcCCCCEEeccc
Confidence 985 4679999999999999999999999999999 9999999 8889999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 236 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~ 236 (245)
|+|+............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.....++|+.+|
T Consensus 171 Gla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s 250 (304)
T 3ubd_A 171 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250 (304)
T ss_dssp EEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCC
Confidence 99986544444556778999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHhhhcC
Q psy3347 237 LEAIAIMRR 245 (245)
Q Consensus 237 ~~~~~li~~ 245 (245)
+++++||++
T Consensus 251 ~~~~~li~~ 259 (304)
T 3ubd_A 251 PEAQSLLRM 259 (304)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=354.28 Aligned_cols=214 Identities=25% Similarity=0.449 Sum_probs=189.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.||+.||||++..... ...+.+.+| +++|+.++||||++++++|.+++.+|+|||||+||+|.++++
T Consensus 167 V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~E---i~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~ 240 (423)
T 4fie_A 167 VCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNE---VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 240 (423)
T ss_dssp EEEEEETTTCCEEEEEEEESTTC---SSGGGHHHH---HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeccch---hHHHHHHHH---HHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh
Confidence 89999999999999999986432 223344444 777889999999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++||+|| ||||+|| +++.+|.+||+|||+|+
T Consensus 241 ~~~l~e~~~~~~~~qil~aL~ylH~~~IiHR---DiKp~NI----------------------Ll~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 241 HTRMNEEQIAAVCLAVLQALSVLHAQGVIHR---DIKSDSI----------------------LLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSTTTE----------------------EECTTCCEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCCeecc---cCCHHHE----------------------EEcCCCCEEEecCccce
Confidence 8899999999999999999999999999999 9999999 88999999999999998
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+.....+ .+..+|+
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 375 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP 375 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCH
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCH
Confidence 6555555566789999999999999999999999999999999999999999999999988888765432 3567899
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
++++||++
T Consensus 376 ~~~dli~~ 383 (423)
T 4fie_A 376 SLKGFLDR 383 (423)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=340.38 Aligned_cols=209 Identities=22% Similarity=0.318 Sum_probs=179.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||+++..... .+++.+++.++||||++++++|.+++..|+|||||+||+|.++++
T Consensus 74 Vy~a~~~~~g~~vAiK~i~~~~~~-----------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~ 142 (336)
T 4g3f_A 74 VHRMKDKQTGFQCAVKKVRLEVFR-----------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142 (336)
T ss_dssp EEEEEETTTCCEEEEEEEETTTCC-----------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEECHHHhH-----------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH
Confidence 899999999999999999864211 235778899999999999999999999999999999999999995
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEeecCC
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIADFGL 158 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~ 158 (245)
.+.+++..+..++.|++.||+|||++||+|| ||||+|| +++.+| .+||+|||+
T Consensus 143 ~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR---DlKp~NI----------------------Ll~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 143 QMGCLPEDRALYYLGQALEGLEYLHTRRILHG---DVKADNV----------------------LLSSDGSRAALCDFGH 197 (336)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECS---CCCGGGE----------------------EECTTSCCEEECCCTT
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---ccCHHHE----------------------EEeCCCCEEEEeeCCC
Confidence 4679999999999999999999999999999 9999999 888877 699999999
Q ss_pred ccCCCCCCC-----CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---
Q psy3347 159 CKEGMGFGD-----RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--- 230 (245)
Q Consensus 159 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (245)
|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.....+
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 277 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh
Confidence 985432221 123457999999999999999999999999999999999999999988777777778776543
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|..+++++++||++
T Consensus 278 ~~~~~s~~~~~li~~ 292 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQE 292 (336)
T ss_dssp SCTTSCHHHHHHHHH
T ss_pred cCccCCHHHHHHHHH
Confidence 578899999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=324.00 Aligned_cols=213 Identities=23% Similarity=0.390 Sum_probs=175.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++.+|+.||+|++...... ....+.+. +++++++.++||||++++++|.. ++.+|+|||||++|+|.
T Consensus 42 Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~---~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~ 117 (290)
T 3fpq_A 42 VYKGLDTETTVEVAWCELQDRKLT-KSERQRFK---EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117 (290)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHH---HHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHH
T ss_pred EEEEEECCCCeEEEEEEEchhhCC-HHHHHHHH---HHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHH
Confidence 899999999999999999865422 23334444 45788889999999999999865 35689999999999999
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceE
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVK 152 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~k 152 (245)
++++ .+.+++..+..++.|++.||+|||++| |+|| |+||+|| +++ .+|.+|
T Consensus 118 ~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHR---DlKp~NI----------------------Ll~~~~g~vK 172 (290)
T 3fpq_A 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR---DLKCDNI----------------------FITGPTGSVK 172 (290)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCC---CCCGGGE----------------------EESSTTSCEE
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEec---ccChhhe----------------------eEECCCCCEE
Confidence 9995 467999999999999999999999999 9999 9999998 776 478999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCcc--
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDSIVNDEV-- 229 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~~-- 229 (245)
|+|||+|+... .......+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+... ......+..+..
T Consensus 173 l~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 173 IGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp ECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EEeCcCCEeCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC
Confidence 99999997532 223456789999999999865 699999999999999999999999976544 455555555433
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|..+++++++||++
T Consensus 250 ~~~~~~~~~~~~li~~ 265 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEG 265 (290)
T ss_dssp GGGGCCCHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHH
Confidence 3467889999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=330.11 Aligned_cols=214 Identities=22% Similarity=0.405 Sum_probs=181.7
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+|+.||||+++... ....+.+. +|++++++++||||++++|+|.+++..|+|||||++|+|
T Consensus 29 Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~---~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L 102 (299)
T 4asz_A 29 VFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFH---REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 102 (299)
T ss_dssp EEEEEECSCC----CEEEEEEEECSCC---HHHHHHHH---HHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred EEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHH---HHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcH
Confidence 7999875 468899999997542 23334454 457889999999999999999999999999999999999
Q ss_pred hhhhhh--------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchh
Q psy3347 76 MMHIHA--------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIK 141 (245)
Q Consensus 76 ~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~ 141 (245)
.++++. ..+++..+..++.|++.||+|||+++|+|| |+||+||
T Consensus 103 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR---DlKp~NI-------------------- 159 (299)
T 4asz_A 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHR---DLATRNC-------------------- 159 (299)
T ss_dssp HHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE--------------------
T ss_pred HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---ccCHhhE--------------------
Confidence 999853 258999999999999999999999999999 9999998
Q ss_pred ccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy3347 142 LTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEE 218 (245)
Q Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~ 218 (245)
+++.++.+||+|||+|+....... ......||+.|||||.+.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 160 --Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 160 --LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp --EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred --EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 888899999999999974322211 1234568999999999999999999999999999999998 99999999999
Q ss_pred HHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 219 EVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 219 ~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
++...+..+.. +.|+.+|+++.+||.+
T Consensus 238 ~~~~~i~~~~~~~~p~~~~~~~~~li~~ 265 (299)
T 4asz_A 238 EVIECITQGRVLQRPRTCPQEVYELMLG 265 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHH
Confidence 99999887654 5789999999999863
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=328.66 Aligned_cols=214 Identities=24% Similarity=0.392 Sum_probs=175.7
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|+++ .+|+.||||+++.. .....+.+. +|+++|++++||||++++|+|.+++..|+|||||++|+|
T Consensus 57 Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~---~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L 130 (329)
T 4aoj_A 57 VFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQ---REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130 (329)
T ss_dssp EEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHH---HHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred EEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHH---HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence 7999865 46899999999754 223334454 447888999999999999999999999999999999999
Q ss_pred hhhhhh----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccc
Q psy3347 76 MMHIHA----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQE 139 (245)
Q Consensus 76 ~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~ 139 (245)
.++++. .++++..+..++.|++.||+|||+++|+|| |+||+||
T Consensus 131 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR---DLKp~NI------------------ 189 (329)
T 4aoj_A 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR---DLATRNC------------------ 189 (329)
T ss_dssp HHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE------------------
T ss_pred HHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecc---cccHhhE------------------
Confidence 998853 258899999999999999999999999999 9999999
Q ss_pred hhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy3347 140 IKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDD 216 (245)
Q Consensus 140 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~ 216 (245)
+++.++.+||+|||+++....... .....+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+
T Consensus 190 ----Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 190 ----LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp ----EEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred ----EECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 888999999999999985422221 2335678999999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 217 EEEVFDSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 217 ~~~~~~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
..++...+..+. .+.|+.+++++.+||++
T Consensus 266 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~ 295 (329)
T 4aoj_A 266 NTEAIDCITQGRELERPRACPPEVYAIMRG 295 (329)
T ss_dssp HHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccccHHHHHHHHH
Confidence 999988887764 46789999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=325.66 Aligned_cols=215 Identities=22% Similarity=0.364 Sum_probs=180.5
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+++.||||+++... .....+.+.+| +.++++++||||++++|+|..++..++|||||++|+|
T Consensus 42 Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E---~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L 116 (308)
T 4gt4_A 42 VYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHE---AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116 (308)
T ss_dssp EEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHH---HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBH
T ss_pred EEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHH---HHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcH
Confidence 7999853 468899999997542 22233445444 7778899999999999999999999999999999999
Q ss_pred hhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCccc
Q psy3347 76 MMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQ 138 (245)
Q Consensus 76 ~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~ 138 (245)
.+++.. ..+++..+.+++.|++.||+|||+++|+|| |+||+||
T Consensus 117 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHR---DLK~~NI----------------- 176 (308)
T 4gt4_A 117 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHK---DLATRNV----------------- 176 (308)
T ss_dssp HHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE-----------------
T ss_pred HHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCC---Cccccce-----------------
Confidence 999842 248899999999999999999999999999 9999998
Q ss_pred chhccccCCCCceEEeecCCccCCCCC--CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3347 139 EIKLTVNDTEGYVKIADFGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGD 215 (245)
Q Consensus 139 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~ 215 (245)
+++.++.+||+|||+++..... .......+||+.|||||.+.+..|+.++|||||||++|||+| |..||.+.
T Consensus 177 -----Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 177 -----LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp -----EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred -----EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 8889999999999999754222 122445678999999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 216 DEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 216 ~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
+..++...+..+.. +.|+.+|+++.+||.+
T Consensus 252 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~ 282 (308)
T 4gt4_A 252 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIE 282 (308)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCcccchHHHHHHHHH
Confidence 99999998887654 5688999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=345.73 Aligned_cols=218 Identities=31% Similarity=0.569 Sum_probs=191.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.||+.||+|++.+.............+|.+++.+++.++||||++++++|.+.+.+|+||||+.||+|..++.
T Consensus 205 V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~ 284 (689)
T 3v5w_A 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284 (689)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence 89999999999999999987655444555666777788889999999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..++.++.||+.||+|||++||+|| |+||+|| +++.+|.+||+|||+|
T Consensus 285 ~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHR---DLKPeNI----------------------Lld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYR---DLKPANI----------------------LLDEHGHVRISDLGLA 339 (689)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCchHHe----------------------EEeCCCCEEeccccee
Confidence 4679999999999999999999999999999 9999999 8999999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCcccCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFDSIVNDEVRYPRFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~---~~~~~~~~~~~~~~~~p~~~ 235 (245)
+.... ....+.+||+.|||||++.. ..|+.++|+|||||++|||++|.+||.+. +..+....+......+|..+
T Consensus 340 ~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~ 417 (689)
T 3v5w_A 340 CDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417 (689)
T ss_dssp EECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred eecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence 85432 23456799999999999964 57999999999999999999999999753 44566677778888899999
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
|+++++||++
T Consensus 418 S~~a~dLI~~ 427 (689)
T 3v5w_A 418 SPELRSLLEG 427 (689)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 9999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=315.31 Aligned_cols=212 Identities=20% Similarity=0.347 Sum_probs=167.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ ..||||+++.... ..+..+.+. ++++++++++||||++++|++.. +..++|||||++|+|.+++.
T Consensus 52 Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~---~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~ 123 (307)
T 3omv_A 52 VYKGKWH---GDVAVKILKVVDP-TPEQFQAFR---NEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLH 123 (307)
T ss_dssp EEEEESS---SEEEEEECCCSSC-CHHHHHHHH---HHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHH
T ss_pred EEEEEEC---CcEEEEEEEecCC-CHHHHHHHH---HHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHh
Confidence 7999764 3599999975432 233344454 44788899999999999999864 56899999999999999985
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||+++|+|| |+||+|| +++.++.+||+|||+
T Consensus 124 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHR---DlKp~NI----------------------Ll~~~~~~Ki~DFGl 178 (307)
T 3omv_A 124 VQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR---DMKSNNI----------------------FLHEGLTVKIGDFGL 178 (307)
T ss_dssp TSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS---CCCSSSE----------------------EEETTEEEEECCCSS
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC---ccCHHHE----------------------EECCCCcEEEeeccC
Confidence 3 469999999999999999999999999999 9999998 888999999999999
Q ss_pred ccCCCCC--CCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc----
Q psy3347 159 CKEGMGF--GDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---- 229 (245)
Q Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---- 229 (245)
|+..... .......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||.+.+.......+.....
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 9753221 222445689999999999964 4689999999999999999999999988766555555443322
Q ss_pred --cCCCCCChhHHhhhcC
Q psy3347 230 --RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 --~~p~~~~~~~~~li~~ 245 (245)
..|..+|+++.+||.+
T Consensus 259 ~~~~~~~~~~~l~~li~~ 276 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVAD 276 (307)
T ss_dssp STTSCTTSCHHHHHHHHH
T ss_pred cccccccchHHHHHHHHH
Confidence 2356789999998863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=319.20 Aligned_cols=196 Identities=22% Similarity=0.373 Sum_probs=164.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee------CCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT------EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~------~~~~~lv~e~~~~~~ 74 (245)
||+|+++.||+.||||+++.... .....+.+ .+++++|+.++||||+++++++.. .++.|+|||||+ |+
T Consensus 70 V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~---~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~ 144 (398)
T 4b99_A 70 VSSARRRLTGQQVAIKKIPNAFD-VVTNAKRT---LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SD 144 (398)
T ss_dssp EEEEEETTTCCEEEEEEETTTTS-SHHHHHHH---HHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EE
T ss_pred EEEEEECCCCCEEEEEEECcccc-chHHHHHH---HHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CC
Confidence 89999999999999999976432 22223333 455788889999999999999864 357999999996 57
Q ss_pred hhhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 75 LMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 75 L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
|.+++. .+.+++..++.+++|++.||+|||++||+|| ||||+|| +++.+|.+||
T Consensus 145 L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHR---DlKP~NI----------------------l~~~~~~~Ki 199 (398)
T 4b99_A 145 LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHR---DLKPSNL----------------------LVNENCELKI 199 (398)
T ss_dssp HHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTCCEEE
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCC---CcCcccc----------------------ccCCCCCEEE
Confidence 887774 5679999999999999999999999999999 9999999 8889999999
Q ss_pred eecCCccCCCCC----CCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 154 ADFGLCKEGMGF----GDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 154 ~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+|||+++..... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+.+..|..
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999999854322 2234567899999999999875 468999999999999999999999999998888887754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=312.94 Aligned_cols=214 Identities=27% Similarity=0.457 Sum_probs=173.4
Q ss_pred CEeEEEecC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCC-CceeeeeEEEeeC-CeEEEEEeeccCC
Q psy3347 1 VILSQYRNT-----GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRH-PFLVNLFACFQTE-AHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h-~ni~~~~~~~~~~-~~~~lv~e~~~~~ 73 (245)
||+|++..+ ++.||||+++... .....+.+.+| +++|++++| |||++++|+|... +.+++|||||++|
T Consensus 80 Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E---~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G 154 (353)
T 4ase_A 80 VIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSE---LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154 (353)
T ss_dssp EEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTE
T ss_pred EEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHH---HHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCC
Confidence 799988754 4689999997643 22334445555 666777765 8999999998764 5789999999999
Q ss_pred chhhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCc
Q psy3347 74 DLMMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNS 136 (245)
Q Consensus 74 ~L~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~ 136 (245)
+|.++++. ..+++..+..++.|++.||+|||+++|+|| |+||+||
T Consensus 155 ~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHR---DLK~~NI--------------- 216 (353)
T 4ase_A 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR---DLAARNI--------------- 216 (353)
T ss_dssp EHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE---------------
T ss_pred CHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecC---ccCccce---------------
Confidence 99999853 237889999999999999999999999999 9999998
Q ss_pred ccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy3347 137 SQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFP 213 (245)
Q Consensus 137 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~ 213 (245)
+++.++.+||+|||+|+....... .....+||+.|||||.+.+..|+.++|||||||++|||+| |+.||.
T Consensus 217 -------Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 217 -------LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp -------EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred -------eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 888899999999999986433322 2345678999999999999999999999999999999998 999998
Q ss_pred CCCHH-HHHHHHhcC-cccCCCCCChhHHhhhc
Q psy3347 214 GDDEE-EVFDSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 214 ~~~~~-~~~~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
+.... .+...+..+ ..+.|+.+++++.+||.
T Consensus 290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~ 322 (353)
T 4ase_A 290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 322 (353)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 86544 444445444 34578999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=326.99 Aligned_cols=213 Identities=28% Similarity=0.446 Sum_probs=183.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.... ....+.+. +++++|+.++||||++++++|.+++.+|+|||||+||+|.+++.
T Consensus 173 V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~ 246 (573)
T 3uto_A 173 VHRVTERATGNNFAAKFVMTPH---ESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246 (573)
T ss_dssp EEEEEETTTCCEEEEEEEECCS---HHHHHHHH---HHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHT
T ss_pred EEEEEECCCCCEEEEEEEeccc---hhhHHHHH---HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHH
Confidence 7999999999999999998643 22233444 44777888999999999999999999999999999999999884
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC--CCceEEeec
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT--EGYVKIADF 156 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~kl~Df 156 (245)
.+.+++..++.+++||+.||+|||++||+|| |+||+|| +++. .+.+||+||
T Consensus 247 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHR---DlKp~Ni----------------------ll~~~~~~~vKl~DF 301 (573)
T 3uto_A 247 DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL---DLKPENI----------------------MFTTKRSNELKLIDF 301 (573)
T ss_dssp CTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSSSCCCEEECCC
T ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---cCChhhc----------------------cccCCCCCCEEEeec
Confidence 3579999999999999999999999999999 8999888 5543 488999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+......+|
T Consensus 302 G~a~~~~-~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 302 GLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp SSCEECC-TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred cceeEcc-CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence 9998642 22334466899999999999999999999999999999999999999999999999999988766554
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 381 ~~~s~~~~dli~~ 393 (573)
T 3uto_A 381 SGISEDGKDFIRK 393 (573)
T ss_dssp TTSCHHHHHHHHT
T ss_pred cCCCHHHHHHHHH
Confidence 5789999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=303.73 Aligned_cols=211 Identities=19% Similarity=0.308 Sum_probs=156.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------------eEEEEEe
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------------HVCFVME 68 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------------~~~lv~e 68 (245)
||+|+++.+|+.||||+++... .....+.+. +|+++++.++||||++++++|...+ +.|+|||
T Consensus 21 V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~---~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE 95 (299)
T 4g31_A 21 VFEAKNKVDDCNYAIKRIRLPN--RELAREKVM---REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ 95 (299)
T ss_dssp EEEEEETTTCCEEEEEEEEECS--SHHHHHHHH---HHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEE
T ss_pred EEEEEECCCCCEEEEEEEeccC--CHHHHHHHH---HHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEe
Confidence 8999999999999999997543 222233444 4578889999999999999986543 4799999
Q ss_pred eccCCchhhhhhhc-C---CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 69 YAAGGDLMMHIHAD-V---FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 69 ~~~~~~L~~~~~~~-~---l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
||++|+|.++++.. . .++..++.++.|++.||+|||++||+|| |+||+|| +
T Consensus 96 ~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHR---DlKp~NI----------------------L 150 (299)
T 4g31_A 96 LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR---DLKPSNI----------------------F 150 (299)
T ss_dssp CCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------E
T ss_pred cCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccc---cCcHHHe----------------------E
Confidence 99999999999643 2 3445688999999999999999999999 9999999 8
Q ss_pred cCCCCceEEeecCCccCCCCCCC------------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD------------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf 212 (245)
++.+|.+||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||
T Consensus 151 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf 227 (299)
T 4g31_A 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227 (299)
T ss_dssp ECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred ECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC
Confidence 88999999999999975432211 1234579999999999999999999999999999999996 77
Q ss_pred CCCCH-HHHHHHHhcCccc-CCCCCChhHHhhhc
Q psy3347 213 PGDDE-EEVFDSIVNDEVR-YPRFLSLEAIAIMR 244 (245)
Q Consensus 213 ~~~~~-~~~~~~~~~~~~~-~p~~~~~~~~~li~ 244 (245)
.+... ......+.....+ .+...+++..+||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~ 261 (299)
T 4g31_A 228 STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ 261 (299)
T ss_dssp SSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHH
T ss_pred CCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 64322 2233333333221 12345566666664
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=298.15 Aligned_cols=217 Identities=50% Similarity=0.928 Sum_probs=190.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++.........+.+.+| ..+++.++||||+++++++...+..|+||||+++|+|..++.
T Consensus 21 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 97 (337)
T 1o6l_A 21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE---SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH---HHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHH---HHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986543333334444444 666778899999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||++
T Consensus 98 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYR---DIKLENL----------------------MLDKDGHIKITDFGLC 152 (337)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---cCCHHHE----------------------EECCCCCEEEeeccch
Confidence 4578999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+.+..+....+......+|..+++++
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 232 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred hhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 86444444456678999999999999888999999999999999999999999999888888889888888999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 233 ~~li~~ 238 (337)
T 1o6l_A 233 KSLLAG 238 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=301.27 Aligned_cols=217 Identities=48% Similarity=0.950 Sum_probs=184.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++++.........+...+|.+ +++.+ +||||+++++++...+..|+||||+++|+|..++
T Consensus 39 V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~---il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 115 (353)
T 3txo_A 39 VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR---ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115 (353)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHH---HHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred EEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHH---HHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 7999999999999999998754434444455555544 44444 6999999999999999999999999999999888
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 116 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr---Dlkp~NI----------------------Ll~~~g~ikL~DFG~ 170 (353)
T 3txo_A 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYR---DLKLDNV----------------------LLDHEGHCKLADFGM 170 (353)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTT
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc---CCCHHHE----------------------EECCCCCEEEccccc
Confidence 5 4679999999999999999999999999999 9999999 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+.+..+....+......+|..++++
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 250 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred eeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 98644444445667899999999999888899999999999999999999999999999999999999998999999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 251 ~~~li~~ 257 (353)
T 3txo_A 251 ATGILKS 257 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=299.84 Aligned_cols=189 Identities=24% Similarity=0.397 Sum_probs=151.9
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++ .+++.||+|++.... ....+.+| +++++.+ +||||++++++|.+.+++|+||||+++++|.
T Consensus 37 Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E---~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~ 108 (361)
T 4f9c_A 37 VYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAE---LQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFL 108 (361)
T ss_dssp EEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHH---HHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHH
T ss_pred EEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHH---HHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHH
Confidence 7999886 368899999987542 12233344 5666666 6999999999999999999999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-CceEEee
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-GYVKIAD 155 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~kl~D 155 (245)
++++ .+++..++.+++|++.||+|||++||+|| ||||+|| +++.+ +.+||+|
T Consensus 109 ~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHR---DiKPeNi----------------------Ll~~~~~~~kl~D 161 (361)
T 4f9c_A 109 DILN--SLSFQEVREYMLNLFKALKRIHQFGIVHR---DVKPSNF----------------------LYNRRLKKYALVD 161 (361)
T ss_dssp HHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEETTTTEEEECC
T ss_pred HHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeC---cCCHHHe----------------------EEeCCCCeEEECc
Confidence 9884 59999999999999999999999999999 9999998 66655 7999999
Q ss_pred cCCccCCCCCC----------------------------CCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHH
Q psy3347 156 FGLCKEGMGFG----------------------------DRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEML 206 (245)
Q Consensus 156 fg~~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~ 206 (245)
||+|+...... ......+||+.|+|||++.+.+ ++.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 99997432211 1123457999999999998764 889999999999999999
Q ss_pred hCCCCCC-CCCHHHHHHHH
Q psy3347 207 VGESPFP-GDDEEEVFDSI 224 (245)
Q Consensus 207 ~g~~pf~-~~~~~~~~~~~ 224 (245)
+|+.||. +.+..+.+..+
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I 260 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQI 260 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHH
Confidence 9999984 44555554444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=295.38 Aligned_cols=217 Identities=49% Similarity=0.935 Sum_probs=188.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++++.........+....|.++ +..+ +||||+++++++.+.+..|+||||+++|+|..++
T Consensus 33 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~i---l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 109 (345)
T 1xjd_A 33 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV---LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109 (345)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHH---HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHH---HHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 79999999999999999987543333344555555444 4333 8999999999999999999999999999999988
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. +.+++..+..++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 110 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR---DLKLDNI----------------------LLDKDGHIKIADFGM 164 (345)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTT
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC---CCChhhE----------------------EECCCCCEEEeEChh
Confidence 54 679999999999999999999999999999 9999999 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (345)
T 1xjd_A 165 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244 (345)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred hhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHH
Confidence 97543333445567899999999999998899999999999999999999999999999999999988888899999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 245 ~~~li~~ 251 (345)
T 1xjd_A 245 AKDLLVK 251 (345)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=295.26 Aligned_cols=217 Identities=48% Similarity=0.899 Sum_probs=189.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++++.........+.+.+| ..++..+ +||||+++++++...+..|+||||+++|+|..++
T Consensus 36 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E---~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 112 (353)
T 2i0e_A 36 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE---KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112 (353)
T ss_dssp EEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHH---HHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHH---HHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 79999999999999999987543333344445545 4455555 7999999999999999999999999999999988
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. +.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr---Dlkp~NI----------------------ll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR---DLKLDNV----------------------MLDSEGHIKIADFGM 167 (353)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec---cCCHHHE----------------------EEcCCCcEEEEeCCc
Confidence 54 679999999999999999999999999999 9999999 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+.+..+....+......+|..++++
T Consensus 168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 247 (353)
T 2i0e_A 168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247 (353)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 98644444445567899999999999988999999999999999999999999999999999999999888899999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 248 ~~~li~~ 254 (353)
T 2i0e_A 248 AVAICKG 254 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=291.40 Aligned_cols=215 Identities=30% Similarity=0.584 Sum_probs=187.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++..... .....+.+. +++++++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 31 V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~ 106 (328)
T 3fe3_A 31 VKLARHILTGREVAIKIIDKTQL-NPTSLQKLF---REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV 106 (328)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHH---HHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH
Confidence 79999999999999999986532 223333444 45777888999999999999999999999999999999999884
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 107 ~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 107 AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR---DLKAENL----------------------LLDADMNIKIADFGFS 161 (328)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTSCEEECSTTCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecc---CCCHHHE----------------------EEcCCCCEEEeeccCc
Confidence 5679999999999999999999999999999 9999999 8889999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
..... .......+||+.|+|||.+.+..++ .++|||||||++|+|++|+.||.+.+..+....+..+...+|..++++
T Consensus 162 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 240 (328)
T 3fe3_A 162 NEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240 (328)
T ss_dssp GGGSS-SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred eecCC-CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 75322 2334566899999999999887765 789999999999999999999999999999999999988999999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+.+||++
T Consensus 241 ~~~li~~ 247 (328)
T 3fe3_A 241 CENLLKR 247 (328)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=292.87 Aligned_cols=178 Identities=22% Similarity=0.321 Sum_probs=145.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|++ +|+.||||+++... .+.+.+| +++..+..++||||+++++++..++ ..|+|||||++|+|.
T Consensus 19 Vy~~~~--~g~~VAvK~l~~~~------~~~~~~e-~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~ 89 (303)
T 3hmm_A 19 VWRGKW--RGEEVAVKIFSSRE------ERSWFRE-AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 89 (303)
T ss_dssp EEEEEE--TTEEEEEEEECGGG------HHHHHHH-HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHH
T ss_pred EEEEEE--CCEEEEEEEECccc------hhhHHHH-HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHH
Confidence 799987 59999999997531 1222333 3455567889999999999997654 689999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhhc--------CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHES--------RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++++..++++..+.+++.|++.||+|||++ +|+|| |+||+|| +++.+
T Consensus 90 ~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR---DlKp~NI----------------------Ll~~~ 144 (303)
T 3hmm_A 90 DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR---DLKSKNI----------------------LVKKN 144 (303)
T ss_dssp HHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS---CCCGGGE----------------------EECTT
T ss_pred HHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec---cCCcccE----------------------EECCC
Confidence 999988999999999999999999999987 99999 9999999 89999
Q ss_pred CceEEeecCCccCCCCCCC----CCCcccCCCCccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCC
Q psy3347 149 GYVKIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTET------SYTRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g~~pf 212 (245)
+.+||+|||+++....... .....+||+.|||||++.+. .++.++|||||||++|||+||.+||
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 9999999999875322221 12345799999999999754 3667999999999999999997765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=290.58 Aligned_cols=214 Identities=37% Similarity=0.760 Sum_probs=187.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++.........+.+.+ +..+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 22 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~---E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 98 (318)
T 1fot_A 22 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 98 (318)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHH---HHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHH---HHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence 7999999999999999998653322233344444 4666778899999999999999999999999999999999985
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||++
T Consensus 99 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 99 KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR---DLKPENI----------------------LLDKNGHIKITDFGFA 153 (318)
T ss_dssp HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCCGGGE----------------------EECTTSCEEECCCSSC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCChheE----------------------EEcCCCCEEEeecCcc
Confidence 4 578999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+... ......+||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+......+|..+++++
T Consensus 154 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 230 (318)
T 1fot_A 154 KYVP---DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 230 (318)
T ss_dssp EECS---SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred eecC---CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 7532 2234568899999999999888999999999999999999999999999988999999988888999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 231 ~~li~~ 236 (318)
T 1fot_A 231 KDLLSR 236 (318)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=290.79 Aligned_cols=217 Identities=43% Similarity=0.853 Sum_probs=184.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++++.........+.+.+| ..++..+ +||||+++++++...+..|+||||+++++|..++
T Consensus 25 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E---~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l 101 (345)
T 3a8x_A 25 VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE---KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 101 (345)
T ss_dssp EEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHH---HHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHH---HHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 79999999999999999987654444445555555 4445555 7999999999999999999999999999999888
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 102 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYR---DLKLDNV----------------------LLDSEGHIKLTDYGM 156 (345)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCGGG
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCCHHHE----------------------EECCCCCEEEEeccc
Confidence 5 4679999999999999999999999999999 9999999 888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcCcc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG---------DDEEEVFDSIVNDEV 229 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~---------~~~~~~~~~~~~~~~ 229 (245)
++............+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.. .......+.+.....
T Consensus 157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred cccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 97544444445667899999999999988899999999999999999999999965 234455666777778
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|..+++++++||++
T Consensus 237 ~~p~~~s~~~~~li~~ 252 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKS 252 (345)
T ss_dssp CCCTTSCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHH
Confidence 8899999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=295.89 Aligned_cols=217 Identities=42% Similarity=0.854 Sum_probs=183.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++++.........+.+.+|.++ +..+ +||||++++++|...+..++||||+++|+|..++
T Consensus 68 V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~i---l~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 144 (396)
T 4dc2_A 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV---FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144 (396)
T ss_dssp EEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHH---HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHH---HHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence 79999999999999999987654444444555555444 4333 7999999999999999999999999999999888
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 145 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHr---DLKp~NI----------------------Ll~~~g~ikL~DFGl 199 (396)
T 4dc2_A 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYR---DLKLDNV----------------------LLDSEGHIKLTDYGM 199 (396)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTT
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEec---cCCHHHE----------------------EECCCCCEEEeecce
Confidence 5 4679999999999999999999999999999 9999999 889999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcCcc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD---------DEEEVFDSIVNDEV 229 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~---------~~~~~~~~~~~~~~ 229 (245)
++............+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+. ......+.+.....
T Consensus 200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp CBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred eeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 986444445566778999999999999999999999999999999999999999532 23446666777888
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.+|..+++++++||++
T Consensus 280 ~~p~~~s~~~~~li~~ 295 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKS 295 (396)
T ss_dssp CCCTTSCHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHH
Confidence 8999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.89 Aligned_cols=218 Identities=39% Similarity=0.799 Sum_probs=184.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++++...........+.+|..+ +++.++||||++++++|...+..|+||||+++|+|..++.
T Consensus 54 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~--ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 131 (373)
T 2r5t_A 54 VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ 131 (373)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGBC-------------C--CBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHH--HHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999987654433333444444221 2567899999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||++
T Consensus 132 ~~~~~~~~~~~~~~~qi~~aL~~LH~~givHr---Dlkp~NI----------------------ll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYR---DLKPENI----------------------LLDSQGHIVLTDFGLC 186 (373)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEECCCCBC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCCHHHE----------------------EECCCCCEEEeeCccc
Confidence 4578999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+||+.|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+....+......+|..+++++
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 266 (373)
T 2r5t_A 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 266 (373)
T ss_dssp GGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHH
T ss_pred cccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Confidence 75444444456778999999999999989999999999999999999999999999999999999988888899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 267 ~~li~~ 272 (373)
T 2r5t_A 267 RHLLEG 272 (373)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=292.24 Aligned_cols=214 Identities=40% Similarity=0.787 Sum_probs=187.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+. +++.+++.++||||+++++++.+.+..|+||||+++++|.+++.
T Consensus 57 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 133 (350)
T 1rdq_E 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHH---HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhHHhccHHHHHHHH---HHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999999999999999865433333334444 44677888999999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. +.+++..+..++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||++
T Consensus 134 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~g~~kL~DFg~a 188 (350)
T 1rdq_E 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR---DLKPENL----------------------LIDQQGYIQVTDFGFA 188 (350)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---cCccceE----------------------EECCCCCEEEcccccc
Confidence 4 679999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+.... .....+||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+..+...+|..+++++
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 265 (350)
T 1rdq_E 189 KRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265 (350)
T ss_dssp EECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHH
T ss_pred eeccC---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 75322 234567899999999999888999999999999999999999999999999999999998888999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 266 ~~li~~ 271 (350)
T 1rdq_E 266 KDLLRN 271 (350)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=281.23 Aligned_cols=214 Identities=27% Similarity=0.462 Sum_probs=182.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++...... ..+.+. +++..++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 36 V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 109 (297)
T 3fxz_A 36 VYTAMDVATGQEVAIRQMNLQQQP---KKELII---NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109 (297)
T ss_dssp EEEEEBTTTCCEEEEEEEEGGGCS---CHHHHH---HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEeeccccc---HHHHHH---HHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHh
Confidence 799999999999999999764322 223333 34677888999999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||++.
T Consensus 110 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---Dlkp~Ni----------------------l~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 110 ETCMDEGQIAAVCRECLQALEFLHSNQVIHR---DIKSDNI----------------------LLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCCTTCE
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCceeC---CCCHHHE----------------------EECCCCCEEEeeCCCce
Confidence 8889999999999999999999999999999 9999998 88889999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~~~ 237 (245)
.............|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+..... ..|..+++
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T 3fxz_A 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (297)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCH
T ss_pred ecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCH
Confidence 654444445566899999999999999999999999999999999999999998887766666544322 34677888
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
++++||++
T Consensus 245 ~~~~li~~ 252 (297)
T 3fxz_A 245 IFRDFLNR 252 (297)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 89888863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=299.01 Aligned_cols=217 Identities=49% Similarity=0.903 Sum_probs=182.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++............+ .+++.+++.++||||+++++++...+..++||||+++++|..++.
T Consensus 164 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~ 240 (446)
T 4ejn_A 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 240 (446)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHH---HHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH
Confidence 79999999999999999986533333333333 344677888999999999999999999999999999999988885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||+|||+ +||+|| |+||+|| +++.++.+||+|||+
T Consensus 241 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr---Dlkp~NI----------------------ll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 241 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYR---DLKLENL----------------------MLDKDGHIKITDFGL 295 (446)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC---CCCGGGE----------------------EECSSSCEEECCCCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC---CCCHHHE----------------------EECCCCCEEEccCCC
Confidence 4678999999999999999999998 999999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..++++
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 375 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 97644444445567899999999999999999999999999999999999999999999999999988888899999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 376 ~~~li~~ 382 (446)
T 4ejn_A 376 AKSLLSG 382 (446)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=296.72 Aligned_cols=217 Identities=35% Similarity=0.617 Sum_probs=183.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++.........+.+.+| ..+++.++||||++++++|.+.+..|+||||+++|+|.++++
T Consensus 85 V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~ 161 (410)
T 3v8s_A 85 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE---RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161 (410)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHH---HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHH---HHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986433222223334444 566778899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+++
T Consensus 162 ~~~~~e~~~~~~~~qi~~aL~~LH~~givHr---DLKp~NI----------------------Ll~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIHR---DVKPDNM----------------------LLDKSGHLKLADFGTCM 216 (410)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTCE
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---cCCHHHe----------------------eECCCCCEEEeccceeE
Confidence 8889999999999999999999999999999 9999999 88999999999999997
Q ss_pred CCCCCCC-CCCcccCCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--ccCC-
Q psy3347 161 EGMGFGD-RTGTFCGTPEFLAPEVLTETS----YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VRYP- 232 (245)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~p- 232 (245)
....... .....+||+.|+|||.+.+.. ++.++|+|||||++|||++|+.||.+.+..+....+.... ..+|
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 5433221 234668999999999997655 7889999999999999999999999999888888887653 3444
Q ss_pred -CCCChhHHhhhcC
Q psy3347 233 -RFLSLEAIAIMRR 245 (245)
Q Consensus 233 -~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 297 ~~~~s~~~~~li~~ 310 (410)
T 3v8s_A 297 DNDISKEAKNLICA 310 (410)
T ss_dssp TCCCCHHHHHHHHH
T ss_pred cccccHHHHHHHHH
Confidence 4789999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=286.13 Aligned_cols=216 Identities=27% Similarity=0.451 Sum_probs=182.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh---hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD---EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||+|+++........ ..+.+.+ ++.+++.++||||++++++|...+..++||||+++++|.+
T Consensus 28 V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~---E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~ 104 (361)
T 2yab_A 28 VKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER---EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD 104 (361)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHH---HHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EEEEEECCCCCEEEEEEEEccccccccchhHHHHHHH---HHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHH
Confidence 799999999999999999875432211 1234444 4777889999999999999999999999999999999999
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC----ceE
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG----YVK 152 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~k 152 (245)
++. ...+++..+..++.|++.||.|||++||+|| |+||+|| +++.++ .+|
T Consensus 105 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr---Dlkp~NI----------------------ll~~~~~~~~~vk 159 (361)
T 2yab_A 105 FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF---DLKPENI----------------------MLLDKNIPIPHIK 159 (361)
T ss_dssp HHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESCTTSSSCCEE
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EEeCCCCCccCEE
Confidence 985 4578999999999999999999999999999 8888888 565555 799
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
|+|||++..... .......+||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 160 l~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 160 LIDFGLAHEIED-GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238 (361)
T ss_dssp ECCCSSCEECCT-TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EEecCCceEcCC-CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999999975332 2234456799999999999988999999999999999999999999999999898888888776654
Q ss_pred ----CCCChhHHhhhcC
Q psy3347 233 ----RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ----~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 239 ~~~~~~~s~~~~~li~~ 255 (361)
T 2yab_A 239 EEFFSQTSELAKDFIRK 255 (361)
T ss_dssp HHHHTTSCHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHH
Confidence 6789999998863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=295.26 Aligned_cols=217 Identities=32% Similarity=0.618 Sum_probs=182.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++.........+.+.+| ..++..++||||++++++|.+++..|+||||+++|+|.+++.
T Consensus 90 V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E---~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~ 166 (437)
T 4aw2_A 90 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREE---RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS 166 (437)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHH---HHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHH---HHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHH
Confidence 79999999999999999986433222233334444 556677899999999999999999999999999999999996
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 167 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHr---DLKp~NI----------------------Ll~~~g~vkL~DFGl 221 (437)
T 4aw2_A 167 KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR---DIKPDNI----------------------LMDMNGHIRLADFGS 221 (437)
T ss_dssp TTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTT
T ss_pred HccCCCCHHHHHHHHHHHHHHHHHHHhCCeEec---ccCHHHe----------------------eEcCCCCEEEcchhh
Confidence 4 579999999999999999999999999999 9999999 889999999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--cc
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE--VR 230 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~ 230 (245)
++....... .....+||+.|+|||.+. ...++.++|||||||++|||++|+.||.+.+..+....+.... ..
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence 975433322 234468999999999996 4568899999999999999999999999999888888887543 34
Q ss_pred CCC---CCChhHHhhhcC
Q psy3347 231 YPR---FLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~---~~~~~~~~li~~ 245 (245)
+|. .+++++++||++
T Consensus 302 ~p~~~~~~s~~~~dLi~~ 319 (437)
T 4aw2_A 302 FPTQVTDVSENAKDLIRR 319 (437)
T ss_dssp CCSSCCCSCHHHHHHHHT
T ss_pred CCcccccCCHHHHHHHHH
Confidence 453 589999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=282.19 Aligned_cols=217 Identities=39% Similarity=0.762 Sum_probs=177.7
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIA-RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++. .+|+.||+|+++...... ......+ .+++++++.++||||+++++++..++..|+||||+++++|.
T Consensus 33 V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (327)
T 3a62_A 33 VFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT---KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 109 (327)
T ss_dssp EEEEEECSSTTTTCEEEEEEECCC-----------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHH
T ss_pred EEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHH---HHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHH
Confidence 7889885 689999999998653221 1122233 34467788889999999999999999999999999999999
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++. .+.+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.+||+|
T Consensus 110 ~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---Dlkp~Ni----------------------ll~~~~~~kl~D 164 (327)
T 3a62_A 110 MQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYR---DLKPENI----------------------MLNHQGHVKLTD 164 (327)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCTTTE----------------------EECTTSCEEECC
T ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcc---cCCHHHe----------------------EECCCCcEEEEe
Confidence 8885 4578999999999999999999999999999 8999898 888899999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 235 (245)
||+++............+|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......+|..+
T Consensus 165 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~ 244 (327)
T 3a62_A 165 FGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244 (327)
T ss_dssp CSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTS
T ss_pred CCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 99987543333344566789999999999888899999999999999999999999999998888888988888889999
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++++||++
T Consensus 245 ~~~~~~li~~ 254 (327)
T 3a62_A 245 TQEARDLLKK 254 (327)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 9999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=286.45 Aligned_cols=216 Identities=31% Similarity=0.604 Sum_probs=182.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+.+ ++++++.++||||++++++|...+..|+||||+.+|+|..++.
T Consensus 31 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~---E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~ 107 (384)
T 4fr4_A 31 VCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK---ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ 107 (384)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHH---HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEehhhcccHHHHHHHHH---HHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH
Confidence 7999999999999999998654333334444444 4677888999999999999999999999999999999999886
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..++.++.|++.||.|||++||+|| |+||+|| +++.+|.+||+|||++
T Consensus 108 ~~~~l~~~~~~~~~~qi~~aL~~LH~~givHr---Dlkp~NI----------------------ll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHR---DMKPDNI----------------------LLDEHGHVHITDFNIA 162 (384)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---cCcHHHe----------------------EECCCCCEEEecccee
Confidence 4 479999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCcccCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPG---DDEEEVFDSIVNDEVRYPR 233 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~---~~~~~~~~~~~~~~~~~p~ 233 (245)
.... ........+||+.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+ ....+....+......+|.
T Consensus 163 ~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~ 241 (384)
T 4fr4_A 163 AMLP-RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241 (384)
T ss_dssp EECC-TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred eecc-CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence 7532 2233456789999999999964 4588999999999999999999999964 3445666666777778899
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++++.+||++
T Consensus 242 ~~s~~~~~li~~ 253 (384)
T 4fr4_A 242 AWSQEMVSLLKK 253 (384)
T ss_dssp TSCHHHHHHHHH
T ss_pred cCCHHHHHHHHH
Confidence 999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.01 Aligned_cols=217 Identities=48% Similarity=0.899 Sum_probs=190.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||||++++.........+....| ..++..+ +||||+++++++.+.+..|+||||+++|+|..++
T Consensus 357 V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E---~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l 433 (674)
T 3pfq_A 357 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE---KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433 (674)
T ss_dssp EEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHH---HHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHH
T ss_pred EEEEEECCCCcEEEEEEEeccccccHHHHHHHHHH---HHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHH
Confidence 79999999999999999986543333444455555 3445444 7999999999999999999999999999999988
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. +.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 434 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHr---DLKp~NI----------------------Ll~~~g~ikL~DFGl 488 (674)
T 3pfq_A 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR---DLKLDNV----------------------MLDSEGHIKIADFGM 488 (674)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECC---CCCSTTE----------------------EECSSSCEEECCCTT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEec---cCChhhE----------------------EEcCCCcEEEeecce
Confidence 54 679999999999999999999999999999 9999999 889999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
++............+||+.|+|||++.+..++.++|+||||+++|||++|+.||.+.+..+..+.+......+|..++++
T Consensus 489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 568 (674)
T 3pfq_A 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 568 (674)
T ss_dssp CEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHH
T ss_pred eeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 98544444456677899999999999989999999999999999999999999999999999999999999999999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 569 ~~~li~~ 575 (674)
T 3pfq_A 569 AVAICKG 575 (674)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.11 Aligned_cols=217 Identities=32% Similarity=0.588 Sum_probs=181.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++.........+.+.+| ..++..++||||++++++|.+.+..|+||||+++|+|..++.
T Consensus 77 V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E---~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~ 153 (412)
T 2vd5_A 77 VAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE---RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS 153 (412)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHH---HHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHH---HHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHH
Confidence 79999999999999999986443333334445444 555677899999999999999999999999999999999986
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+
T Consensus 154 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHr---DLKp~NI----------------------Lld~~g~vkL~DFGl 208 (412)
T 2vd5_A 154 KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR---DIKPDNI----------------------LLDRCGHIRLADFGS 208 (412)
T ss_dssp HHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---ccCHHHe----------------------eecCCCCEEEeechh
Confidence 4 479999999999999999999999999999 9999999 889999999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCcccccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLT-------ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-- 228 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-- 228 (245)
++....... .....+||+.|+|||.+. +..++.++|+|||||++|||++|+.||.+.+..+....+....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 975433222 233468999999999997 3568899999999999999999999999998888888887532
Q ss_pred ccCC---CCCChhHHhhhcC
Q psy3347 229 VRYP---RFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~~~p---~~~~~~~~~li~~ 245 (245)
..+| ..+++++++||++
T Consensus 289 ~~~p~~~~~~s~~~~dli~~ 308 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQR 308 (412)
T ss_dssp CCCC----CCCHHHHHHHHT
T ss_pred cCCCccccCCCHHHHHHHHH
Confidence 2333 6799999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=297.51 Aligned_cols=217 Identities=34% Similarity=0.614 Sum_probs=185.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.+.........+.+.+| .++++.++||||+++++++...+..|+||||++||+|..++.
T Consensus 201 Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~ 277 (543)
T 3c4z_A 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE---KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277 (543)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH---HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHH---HHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHH
Confidence 79999999999999999986543333334445444 566778899999999999999999999999999999998885
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|
T Consensus 278 ~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHr---DLKP~NI----------------------Ll~~~g~vkL~D 332 (543)
T 3c4z_A 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR---DLKPENV----------------------LLDDDGNVRISD 332 (543)
T ss_dssp TSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTSCEEECC
T ss_pred HhhcccccccHHHHHHHHHHHHHHHHHHHHcCCccc---CCChHHE----------------------EEeCCCCEEEee
Confidence 3 358999999999999999999999999999 9999999 889999999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCcccC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVNDEVRY 231 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~~~~~~ 231 (245)
||+++............+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+. ...+....+......+
T Consensus 333 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~ 412 (543)
T 3c4z_A 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY 412 (543)
T ss_dssp CTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC
T ss_pred cceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC
Confidence 999976443333344568999999999999989999999999999999999999999765 3466777777777888
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|..+++++++||++
T Consensus 413 p~~~s~~~~~li~~ 426 (543)
T 3c4z_A 413 PDKFSPASKDFCEA 426 (543)
T ss_dssp CTTSCHHHHHHHHH
T ss_pred CcccCHHHHHHHHH
Confidence 99999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.71 Aligned_cols=216 Identities=26% Similarity=0.464 Sum_probs=184.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++...... ....+.+. +++++++.++||||+++++++..++..++||||+.+|+|.+.+.
T Consensus 27 V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~---~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~ 102 (444)
T 3soa_A 27 VRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102 (444)
T ss_dssp EEEEEETTTTEEEEEEEEESCSCH-HHHHHHHH---HHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEEcccCC-HHHHHHHH---HHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH
Confidence 799999999999999999875432 22233444 44777888899999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC---CCCceEEeec
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND---TEGYVKIADF 156 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~kl~Df 156 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++ .++.+||+||
T Consensus 103 ~~~~~~e~~~~~i~~qil~aL~~lH~~givHr---DlKp~NI----------------------ll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 103 AREYYSEADASHCIQQILEAVLHCHQMGVVHR---NLKPENL----------------------LLASKLKGAAVKLADF 157 (444)
T ss_dssp HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCSSTTE----------------------EESBSSTTCCEEECCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EEeccCCCCcEEEccC
Confidence 4679999999999999999999999999999 8888888 554 4678999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++..............||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+..+...+|
T Consensus 158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp SSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred ceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 9997654444444566899999999999888899999999999999999999999999999999999888776654
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 238 ~~~s~~~~~li~~ 250 (444)
T 3soa_A 238 DTVTPEAKDLINK 250 (444)
T ss_dssp TTSCHHHHHHHHH
T ss_pred ccCCHHHHHHHHH
Confidence 3689999998863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=285.78 Aligned_cols=215 Identities=29% Similarity=0.500 Sum_probs=180.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|++..+|+.||+|++.............+. +++..++.++||||+++++++...+..++||||+ +|+|.+++
T Consensus 25 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~ 100 (336)
T 3h4j_B 25 VKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV 100 (336)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHH---HHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEehHHccchhHHHHHH---HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH
Confidence 799999999999999999864322222223343 4477888999999999999999999999999999 56787766
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
....+++..+..++.|++.||.|||++|++|| |+||+|| +++.++.+||+|||++
T Consensus 101 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~---Dlkp~NI----------------------ll~~~~~~kl~DFG~s 155 (336)
T 3h4j_B 101 EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR---DLKPENL----------------------LLDDNLNVKIADFGLS 155 (336)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCC---CCSTTTE----------------------EECTTCCEEECCSSCT
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCchhhE----------------------EEcCCCCEEEEEeccc
Confidence 45679999999999999999999999999999 9999998 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
.... ........+||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||.+....+....+..+...+|..++++
T Consensus 156 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 234 (336)
T 3h4j_B 156 NIMT-DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234 (336)
T ss_dssp BTTT-TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHH
T ss_pred eecc-CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHH
Confidence 7533 2333456689999999999988776 6899999999999999999999988766665556666666788999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 235 ~~~li~~ 241 (336)
T 3h4j_B 235 AQSLIRR 241 (336)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 9999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=273.39 Aligned_cols=217 Identities=24% Similarity=0.367 Sum_probs=176.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|++...........+.+ .+++..++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 103 (294)
T 4eqm_A 27 VYLAEDTILNIKVAIKAIFIPPREKEETLKRF---EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103 (294)
T ss_dssp EEEEEETTTCSEEEEEEEECCSSCCHHHHHHH---HHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEECCCCCeEEEEEeccCccccHHHHHHH---HHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH
Confidence 79999999999999999976543333333444 445778889999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+++++..+..++.|++.||+|||++|++|+ |+||+|| +++.++.+||+|||++
T Consensus 104 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---Dlkp~Ni----------------------l~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 104 SHGPLSVDTAINFTNQILDGIKHAHDMRIVHR---DIKPQNI----------------------LIDSNKTLKIFDFGIA 158 (294)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEECCCSSS
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCCEEEEeCCCc
Confidence 4579999999999999999999999999999 9999999 8888999999999998
Q ss_pred cCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-----CCC
Q psy3347 160 KEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-----YPR 233 (245)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-----~p~ 233 (245)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+..........+ .+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence 7543222 1233457899999999999988999999999999999999999999988877666555544332 346
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++.+.++|.+
T Consensus 239 ~~~~~l~~li~~ 250 (294)
T 4eqm_A 239 DIPQSLSNVILR 250 (294)
T ss_dssp TSCHHHHHHHHH
T ss_pred CCCHHHHHHHHH
Confidence 788888888753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=280.57 Aligned_cols=215 Identities=29% Similarity=0.518 Sum_probs=180.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++...... ....+.+. +++++++.++||||+++++++.+.+..++||||+.+++|.+++.
T Consensus 45 V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~---~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 120 (362)
T 2bdw_A 45 VRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120 (362)
T ss_dssp EEEEEETTTCCEEEEEEEETTTCC-HHHHHHHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT
T ss_pred EEEEEECCCCCEEEEEEEEcccCC-HHHHHHHH---HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 799999999999999999865432 23334444 44777888899999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCceEEeec
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGYVKIADF 156 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~kl~Df 156 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++. ++.+||+||
T Consensus 121 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 121 AREFYSEADASHCIQQILESIAYCHSNGIVHR---NLKPENL----------------------LLASKAKGAAVKLADF 175 (362)
T ss_dssp TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCSGGGE----------------------EESCSSTTCCEEECCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---cCchHHE----------------------EEecCCCCCCEEEeec
Confidence 4578999999999999999999999999999 8888888 5544 356999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++..... ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+..+...+|
T Consensus 176 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 254 (362)
T 2bdw_A 176 GLAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254 (362)
T ss_dssp TTCBCCTT-CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG
T ss_pred CcceEecC-CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 99975432 2233456789999999999888899999999999999999999999999988888888888776655
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 255 ~~~~~~~~~li~~ 267 (362)
T 2bdw_A 255 DTVTPEAKSLIDS 267 (362)
T ss_dssp GGSCHHHHHHHHH
T ss_pred cCCCHHHHHHHHH
Confidence 3578899998863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=292.93 Aligned_cols=216 Identities=29% Similarity=0.526 Sum_probs=186.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+. ++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 32 V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~---~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 108 (476)
T 2y94_A 32 VKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC 108 (476)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHH---HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT
T ss_pred EEEEEECCCCCEEEEEEEEhhhccCHHHHHHHH---HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 799999999999999999864332222233444 45778889999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 109 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr---DLkp~NI----------------------ll~~~~~vkL~DFG~a 163 (476)
T 2y94_A 109 KNGRLDEKESRRLFQQILSGVDYCHRHMVVHR---DLKPENV----------------------LLDAHMNAKIADFGLS 163 (476)
T ss_dssp SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECS---CCSGGGE----------------------EECTTCCEEECCCSSC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcc---cccHHHE----------------------EEecCCCeEEEeccch
Confidence 4579999999999999999999999999999 9999999 8888999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
.... ........+|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+..+....+..+....|..++++
T Consensus 164 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 242 (476)
T 2y94_A 164 NMMS-DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS 242 (476)
T ss_dssp EECC-TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHH
T ss_pred hhcc-ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHH
Confidence 7532 2233456689999999999988765 6899999999999999999999998888888888888888889999999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 243 ~~~Li~~ 249 (476)
T 2y94_A 243 VISLLKH 249 (476)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=276.11 Aligned_cols=216 Identities=26% Similarity=0.455 Sum_probs=180.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh---hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD---EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||+|++......... ..+.+.+ ++.+++.++||||+++++++...+..++||||+++++|.+
T Consensus 27 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 103 (326)
T 2y0a_A 27 VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER---EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103 (326)
T ss_dssp EEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHH---HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EEEEEECCCCcEEEEEEEEccccccccchhhHHHHHH---HHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHH
Confidence 799999999999999999865432211 2334444 4677888899999999999999999999999999999999
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC----ceE
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG----YVK 152 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~k 152 (245)
++. ...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++ .+|
T Consensus 104 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~~~k 158 (326)
T 2y0a_A 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF---DLKPENI----------------------MLLDRNVPKPRIK 158 (326)
T ss_dssp HHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESCSSSSSCCEE
T ss_pred HHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcC---CCCHHHE----------------------EEecCCCCCCCEE
Confidence 985 4578999999999999999999999999999 8888888 666666 799
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
|+|||++..... ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+......++
T Consensus 159 l~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 159 IIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237 (326)
T ss_dssp ECCCTTCEECCT-TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCeECCC-CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence 999999875322 2233456789999999999888899999999999999999999999999888888887776655543
Q ss_pred ----CCCChhHHhhhcC
Q psy3347 233 ----RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ----~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 238 ~~~~~~~~~~~~~li~~ 254 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRR 254 (326)
T ss_dssp HHHHTTSCHHHHHHHHH
T ss_pred ccccccCCHHHHHHHHH
Confidence 5788888888763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=272.78 Aligned_cols=217 Identities=29% Similarity=0.521 Sum_probs=178.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHHHhhcCCCceeeeeEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR-----------------------DEVESLLSEKRIFEVANTMRHPFLVNLFACF 57 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~ 57 (245)
||+|+++.+|+.||+|++........ ...+.+ .+++++++.++||||+++++++
T Consensus 29 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~ 105 (298)
T 2zv2_A 29 VKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV---YQEIAILKKLDHPNVVKLVEVL 105 (298)
T ss_dssp EEEEEETTTTEEEEEEEEECC-------------------------------CHH---HHHHHHHHTCCCTTBCCEEEEE
T ss_pred EEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH---HHHHHHHHhCCCCCCCeEEEEE
Confidence 79999999999999999986532211 112233 4457788899999999999999
Q ss_pred ee--CCeEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 58 QT--EAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 58 ~~--~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
.. .+..++||||+++++|.++.....+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 106 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dlkp~Ni-------------- 168 (298)
T 2zv2_A 106 DDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHR---DIKPSNL-------------- 168 (298)
T ss_dssp ECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE--------------
T ss_pred EcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHE--------------
Confidence 86 5689999999999999988877789999999999999999999999999999 9999999
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETS---YTRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g~~pf 212 (245)
+++.++.+||+|||++..............||..|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 169 --------l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 169 --------LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp --------EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred --------EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 888899999999999875443333344567899999999997654 367899999999999999999999
Q ss_pred CCCCHHHHHHHHhcCcccCC--CCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVNDEVRYP--RFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~ 245 (245)
.+.........+......+| ..+++++++||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 275 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITR 275 (298)
T ss_dssp CCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHH
T ss_pred CCccHHHHHHHHhcccCCCCCccccCHHHHHHHHH
Confidence 98888777777766655554 4788999998863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=274.86 Aligned_cols=213 Identities=24% Similarity=0.442 Sum_probs=181.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++..... ...+.+.+ ++..++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 61 V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 134 (321)
T 2c30_A 61 VCLAREKHSGRQVAVKMMDLRKQ---QRRELLFN---EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 134 (321)
T ss_dssp EEEEEETTTCCEEEEEEEETTTC---CSHHHHHH---HHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT
T ss_pred EEEEEECCCCcEEEEEEEeccch---hHHHHHHH---HHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH
Confidence 79999999999999999976432 22233443 4777889999999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|||++.
T Consensus 135 ~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 135 QVRLNEEQIATVCEAVLQALAYLHAQGVIHR---DIKSDSI----------------------LLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCCTTCE
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EECCCCcEEEeeeeeee
Confidence 8889999999999999999999999999999 9999999 88889999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---CCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR---YPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~---~p~~~~~ 237 (245)
.............||..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+.....+ .+..+++
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSP 269 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCH
T ss_pred ecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCH
Confidence 5444333345667899999999998888999999999999999999999999988887777777655432 2345788
Q ss_pred hHHhhhc
Q psy3347 238 EAIAIMR 244 (245)
Q Consensus 238 ~~~~li~ 244 (245)
+++++|+
T Consensus 270 ~l~~li~ 276 (321)
T 2c30_A 270 VLRDFLE 276 (321)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=278.29 Aligned_cols=216 Identities=30% Similarity=0.539 Sum_probs=174.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccch--hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR--DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++.+|+.||+|++........ ...+.+.+| +++++.++||||+++++++..++..++||||+++++|.+.
T Consensus 40 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~ 116 (351)
T 3c0i_A 40 VRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE---ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116 (351)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHH---HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHH---HHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHH
Confidence 79999999999999999975432111 123344444 6777888999999999999999999999999999999877
Q ss_pred hhh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC---Cc
Q psy3347 79 IHA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE---GY 150 (245)
Q Consensus 79 ~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 150 (245)
+.. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.+ +.
T Consensus 117 l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHr---Dlkp~NI----------------------l~~~~~~~~~ 171 (351)
T 3c0i_A 117 IVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHR---DVKPHCV----------------------LLASKENSAP 171 (351)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECSSSTTCC
T ss_pred HHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceec---cCChHHe----------------------EEecCCCCCc
Confidence 632 248999999999999999999999999999 8888888 55544 44
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (245)
+||+|||++.............+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+. ..+....+..+...
T Consensus 172 vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYK 250 (351)
T ss_dssp EEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCC
T ss_pred EEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCC
Confidence 99999999976444333344567899999999999888999999999999999999999999875 45566666666554
Q ss_pred CC----CCCChhHHhhhcC
Q psy3347 231 YP----RFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p----~~~~~~~~~li~~ 245 (245)
++ ..+++++++||++
T Consensus 251 ~~~~~~~~~s~~~~~li~~ 269 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRR 269 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHH
T ss_pred CCccccccCCHHHHHHHHH
Confidence 43 5788999988863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=275.19 Aligned_cols=212 Identities=25% Similarity=0.440 Sum_probs=180.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++.... ...+.+. +++++++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 21 Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (321)
T 1tki_A 21 VHRCVETSSKKTYMAKFVKVKG----TDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN 93 (321)
T ss_dssp EEEEEETTTTEEEEEEEECCCT----HHHHHHH---HHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT
T ss_pred EEEEEECCCCcEEEEEEEecCc----ccHHHHH---HHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHH
Confidence 7999999999999999997532 2223344 44677888899999999999999999999999999999999986
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC--CCceEEeec
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT--EGYVKIADF 156 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||.|||++|++|| |+||+|| +++. ++.+||+||
T Consensus 94 ~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~---Dlkp~NI----------------------l~~~~~~~~~kl~Df 148 (321)
T 1tki_A 94 TSAFELNEREIVSYVHQVCEALQFLHSHNIGHF---DIRPENI----------------------IYQTRRSSTIKIIEF 148 (321)
T ss_dssp SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSSSCCCEEECCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC---CCCHHHE----------------------EEccCCCCCEEEEEC
Confidence 4 368999999999999999999999999999 8888888 5554 789999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++..... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 149 g~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (321)
T 1tki_A 149 GQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp TTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCC-CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh
Confidence 99975322 2223455789999999999888889999999999999999999999999999888888888776655
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 228 ~~~s~~~~~li~~ 240 (321)
T 1tki_A 228 KEISIEAMDFVDR 240 (321)
T ss_dssp TTSCHHHHHHHHT
T ss_pred ccCCHHHHHHHHH
Confidence 4789999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=293.58 Aligned_cols=216 Identities=35% Similarity=0.578 Sum_probs=182.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.+.........+.+.+| .++++.++||||+++++++.+.+..|+||||++||+|..++.
T Consensus 200 Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~ 276 (576)
T 2acx_A 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE---KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 276 (576)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH---HHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHH---HHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHH
Confidence 79999999999999999986543333333444444 666778899999999999999999999999999999998885
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. .+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||
T Consensus 277 ~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHr---DLKPeNI----------------------Lld~~g~vKL~DFG 331 (576)
T 2acx_A 277 HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR---DLKPENI----------------------LLDDHGHIRISDLG 331 (576)
T ss_dssp SSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTSCEEECCCT
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEecc---CCchheE----------------------EEeCCCCeEEEecc
Confidence 42 48999999999999999999999999999 9999999 88899999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCcccCCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVNDEVRYPR 233 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~~~~~~p~ 233 (245)
++...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+. ...+....+......+|.
T Consensus 332 la~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~ 410 (576)
T 2acx_A 332 LAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410 (576)
T ss_dssp TCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT
T ss_pred cceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc
Confidence 99753222 2234458999999999999888999999999999999999999999765 345566666777777889
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++++++||++
T Consensus 411 ~~s~~~~dLI~~ 422 (576)
T 2acx_A 411 RFSPQARSLCSQ 422 (576)
T ss_dssp TSCHHHHHHHHH
T ss_pred cCCHHHHHHHHH
Confidence 999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.98 Aligned_cols=213 Identities=28% Similarity=0.470 Sum_probs=180.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|+++.... ...+.+. +++++++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 105 Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 178 (373)
T 2x4f_A 105 VHKCEETATGLKLAAKIIKTRGM---KDKEEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178 (373)
T ss_dssp EEEEEETTTCCEEEEEEEECCSH---HHHHHHH---HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHH
T ss_pred EEEEEEcCCCcEEEEEEEccccc---ccHHHHH---HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 79999999999999999986432 2233343 45778889999999999999999999999999999999988874
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc--CCCCceEEeec
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN--DTEGYVKIADF 156 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| ++ +.++.+||+||
T Consensus 179 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 179 DESYNLTELDTILFMKQICEGIRHMHQMYILHL---DLKPENI----------------------LCVNRDAKQIKIIDF 233 (373)
T ss_dssp HTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EEEETTTTEEEECCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---cCCHHHE----------------------EEecCCCCcEEEEeC
Confidence 3 468999999999999999999999999999 8888888 55 56788999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|+++..... ......+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......++
T Consensus 234 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 312 (373)
T 2x4f_A 234 GLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF 312 (373)
T ss_dssp SSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred CCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh
Confidence 999753322 223455789999999999888899999999999999999999999999988888888877665543
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 313 ~~~~~~~~~li~~ 325 (373)
T 2x4f_A 313 QDISEEAKEFISK 325 (373)
T ss_dssp TTSCHHHHHHHHT
T ss_pred ccCCHHHHHHHHH
Confidence 5688999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=266.49 Aligned_cols=216 Identities=28% Similarity=0.497 Sum_probs=186.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++...........+.+.+ +++.++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 31 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 107 (294)
T 2rku_A 31 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 107 (294)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHH---HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCceEEEEEechhhccCHHHHHHHHH---HHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH
Confidence 7999999999999999998654333334444444 4677888999999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 108 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 108 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR---DLKLGNL----------------------FLNEDLEVKIGDFGLA 162 (294)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCChHhE----------------------EEcCCCCEEEEeccCc
Confidence 4 578999999999999999999999999999 9999998 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.+....+....+.......|..+++++
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 242 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHH
Confidence 75443333344567899999999998888999999999999999999999999988888887788777778888999999
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.++|+
T Consensus 243 ~~li~ 247 (294)
T 2rku_A 243 ASLIQ 247 (294)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=271.13 Aligned_cols=214 Identities=27% Similarity=0.449 Sum_probs=170.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++ +|+.||+|++..... .....+.+. +++++++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 53 V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 126 (309)
T 3p86_A 53 VHRAEW--HGSDVAVKILMEQDF-HAERVNEFL---REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126 (309)
T ss_dssp EEEEEE--TTEEEEEEEECCCCC-SHHHHHHHH---HHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHH
T ss_pred EEEEEE--CCCcEEEEEecCCCC-CHHHHHHHH---HHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHh
Confidence 788976 588999999976532 223334444 44777888899999999999999999999999999999999986
Q ss_pred hc----CCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 81 AD----VFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 81 ~~----~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
.. .+++..+..++.|++.||+|||++| ++|| |+||+|| +++.++.+||+
T Consensus 127 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~---Dikp~NI----------------------ll~~~~~~kL~ 181 (309)
T 3p86_A 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR---NLKSPNL----------------------LVDKKYTVKVC 181 (309)
T ss_dssp STTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCT---TCCGGGE----------------------EECTTCCEEEC
T ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECC---CCChhhE----------------------EEeCCCcEEEC
Confidence 43 3899999999999999999999999 9999 9999998 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CcccCC
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN--DEVRYP 232 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~--~~~~~p 232 (245)
|||+++.............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+.. ....+|
T Consensus 182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261 (309)
T ss_dssp CCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred CCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 999987543333334456789999999999998899999999999999999999999998888877777643 344578
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++.+||++
T Consensus 262 ~~~~~~l~~li~~ 274 (309)
T 3p86_A 262 RNLNPQVAAIIEG 274 (309)
T ss_dssp TTSCHHHHHHHHH
T ss_pred ccCCHHHHHHHHH
Confidence 8999999998863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.13 Aligned_cols=217 Identities=28% Similarity=0.499 Sum_probs=187.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|++...........+.+.+ ++.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 57 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 133 (335)
T 2owb_A 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM---EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 133 (335)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHH---HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEechhhhcCHHHHHHHHH---HHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh
Confidence 7999999999999999998654333334444444 4677888999999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---dlkp~NI----------------------l~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 134 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR---DLKLGNL----------------------FLNEDLEVKIGDFGLA 188 (335)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EECTTCCEEECCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCCEec---CCCchhE----------------------EEcCCCCEEEeeccCc
Confidence 4 679999999999999999999999999999 9999998 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+....+....+......+|..+++++
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 268 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred eecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHH
Confidence 75443333344567899999999998888999999999999999999999999988888887778777778889999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.+||++
T Consensus 269 ~~li~~ 274 (335)
T 2owb_A 269 ASLIQK 274 (335)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=269.32 Aligned_cols=217 Identities=27% Similarity=0.513 Sum_probs=158.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++...........+.+ .++++.++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 27 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 103 (278)
T 3cok_A 27 VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRV---QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK 103 (278)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHH---HHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH
T ss_pred EEEEEEccCCceEEEEEeehhhhhhhhHHHHH---HHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHh
Confidence 79999999999999999975432222222333 445778889999999999999999999999999999999999886
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 104 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------li~~~~~~kl~dfg~ 158 (278)
T 3cok_A 104 NRVKPFSENEARHFMHQIITGMLYLHSHGILHR---DLTLSNL----------------------LLTRNMNIKIADFGL 158 (278)
T ss_dssp TCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECS---SCCGGGE----------------------EECTTCCEEECCCTT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EEcCCCCEEEEeecc
Confidence 4 568999999999999999999999999999 8999998 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
+..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.......|..++++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIE 238 (278)
T ss_dssp CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHH
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHH
Confidence 87543333333455788999999999888899999999999999999999999987766666666666666778889999
Q ss_pred HHhhhcC
Q psy3347 239 AIAIMRR 245 (245)
Q Consensus 239 ~~~li~~ 245 (245)
+++||++
T Consensus 239 ~~~li~~ 245 (278)
T 3cok_A 239 AKDLIHQ 245 (278)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=266.30 Aligned_cols=215 Identities=30% Similarity=0.568 Sum_probs=182.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|++.............+ .++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~ 101 (279)
T 3fdn_A 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQL---RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101 (279)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHTCHHHH---HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEEccCCcEEEEEEEeccccchhhHHHHH---HHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH
Confidence 79999999999999999976432222222333 345778889999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 102 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~---dlkp~Ni----------------------li~~~~~~~l~Dfg~~ 156 (279)
T 3fdn_A 102 KLSKFDEQRTATYITELANALSYCHSKRVIHR---DIKPENL----------------------LLGSAGELKIADFGWS 156 (279)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHTTTCEEC---CCCGGGE----------------------EECTTSCEEECSCCEE
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecc---cCChHhE----------------------EEcCCCCEEEEecccc
Confidence 4678999999999999999999999999999 9999998 8888999999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......+|..+++++
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T 3fdn_A 157 VHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234 (279)
T ss_dssp SCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred ccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHH
Confidence 64322 2234557899999999998888999999999999999999999999999988888888888888899999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 235 ~~li~~ 240 (279)
T 3fdn_A 235 RDLISR 240 (279)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=272.22 Aligned_cols=210 Identities=26% Similarity=0.457 Sum_probs=154.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++.... .....+ ++..++.+. ||||+++++++.+++..++||||+++++|.+++
T Consensus 27 V~~~~~~~~~~~vavK~~~~~~------~~~~~~---e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 97 (325)
T 3kn6_A 27 CRKCVHKKSNQAFAVKIISKRM------EANTQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI 97 (325)
T ss_dssp EEEEEETTTCCEEEEEEEEGGG------HHHHHH---HHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred EEEEEECCCCCEEEEEEEChhh------hhhHHH---HHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHH
Confidence 7999999999999999997531 123333 355666665 999999999999999999999999999999988
Q ss_pred hh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC---ceEEee
Q psy3347 80 HA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG---YVKIAD 155 (245)
Q Consensus 80 ~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~kl~D 155 (245)
.. ..+++..+..++.|++.||+|||++||+|| |++|+|| +++.++ .+||+|
T Consensus 98 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~~kl~D 152 (325)
T 3kn6_A 98 KKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR---DLKPENL----------------------LFTDENDNLEIKIID 152 (325)
T ss_dssp HHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EEEC----CEEEECC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeec---CCCHHHE----------------------EEecCCCcccEEEec
Confidence 54 569999999999999999999999999999 8888888 554444 899999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcCc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-------DEEEVFDSIVNDE 228 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-------~~~~~~~~~~~~~ 228 (245)
||+++............+||..|+|||.+.+..++.++||||||+++|+|++|+.||.+. ...+....+..+.
T Consensus 153 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp CTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred cccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 999975444333445667899999999999889999999999999999999999999764 3356677777766
Q ss_pred ccCC----CCCChhHHhhhc
Q psy3347 229 VRYP----RFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~~p----~~~~~~~~~li~ 244 (245)
..++ ..+++++++||+
T Consensus 233 ~~~~~~~~~~~s~~~~~li~ 252 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQ 252 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHH
T ss_pred CCCCcccccCCCHHHHHHHH
Confidence 6554 358899998886
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=273.44 Aligned_cols=217 Identities=26% Similarity=0.361 Sum_probs=172.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+.||+|++.............+ .++++.++.++||||+++++++...+ ..|+||||+++++|.
T Consensus 28 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~ 104 (311)
T 3ork_A 28 VHLARDLRDHRDVAVKVLRADLARDPSFYLRF---RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 104 (311)
T ss_dssp EEEEEETTTTEEEEEEEECTTTTTSHHHHHHH---HHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHH
T ss_pred EEEEEECCCCceEEEEEeCccccCCHHHHHHH---HHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHH
Confidence 79999999999999999987543333333344 44577788999999999999987654 459999999999999
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++++ .+.+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|
T Consensus 105 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~D 159 (311)
T 3ork_A 105 DIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---DVKPANI----------------------MISATNAVKVMD 159 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EEETTSCEEECC
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC---CCCHHHE----------------------EEcCCCCEEEee
Confidence 9985 4679999999999999999999999999999 9999998 888889999999
Q ss_pred cCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC-
Q psy3347 156 FGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY- 231 (245)
Q Consensus 156 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 231 (245)
||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+....+...........+
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 999875322211 2334568999999999998899999999999999999999999999988877777666554433
Q ss_pred ---CCCCChhHHhhhcC
Q psy3347 232 ---PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 ---p~~~~~~~~~li~~ 245 (245)
+..+++++.++|++
T Consensus 240 ~~~~~~~~~~l~~li~~ 256 (311)
T 3ork_A 240 SARHEGLSADLDAVVLK 256 (311)
T ss_dssp HHHSTTCCHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHH
Confidence 35688999888753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=264.47 Aligned_cols=214 Identities=29% Similarity=0.562 Sum_probs=183.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|++...........+.+ .++++.++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 30 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 106 (284)
T 2vgo_A 30 VYLAREKQNKFIMALKVLFKSQLEKEGVEHQL---RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ 106 (284)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHH---HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEEcCCCcEEEEEEEcccccchHHHHHHH---HHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHH
Confidence 79999999999999999976432222222333 344777889999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 107 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~kl~Dfg~~ 161 (284)
T 2vgo_A 107 KHGRFDEQRSATFMEELADALHYCHERKVIHR---DIKPENL----------------------LMGYKGELKIADFGWS 161 (284)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCSGGGE----------------------EECTTCCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCCHHHE----------------------EEcCCCCEEEeccccc
Confidence 4578999999999999999999999999999 9999998 8888899999999988
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+......+|..+++++
T Consensus 162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 2vgo_A 162 VHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239 (284)
T ss_dssp EECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred ccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHH
Confidence 643222 233457889999999999888999999999999999999999999988888888888888888889999999
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
+++|+
T Consensus 240 ~~li~ 244 (284)
T 2vgo_A 240 KDLIS 244 (284)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99886
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=275.01 Aligned_cols=213 Identities=28% Similarity=0.436 Sum_probs=179.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++.... ......+ .+++++++.++||||+++++++...+..++||||+.+++|.+++.
T Consensus 67 Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~---~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 140 (387)
T 1kob_A 67 VHRCVEKATGRVFVAKFINTPY---PLDKYTV---KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140 (387)
T ss_dssp EEEEEETTTCCEEEEEEEECCS---HHHHHHH---HHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT
T ss_pred EEEEEECCCCCEEEEEEecccc---hhhHHHH---HHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHH
Confidence 7999999999999999997642 1222333 345778889999999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC--CCCceEEeec
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--TEGYVKIADF 156 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++ .++.+||+||
T Consensus 141 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr---Dlkp~NI----------------------ll~~~~~~~vkL~DF 195 (387)
T 1kob_A 141 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL---DIKPENI----------------------MCETKKASSVKIIDF 195 (387)
T ss_dssp CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSTTCCCEEECCC
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---ccchHHe----------------------EEecCCCCceEEEec
Confidence 4 368999999999999999999999999999 8888888 554 4578999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+......++
T Consensus 196 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 274 (387)
T 1kob_A 196 GLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274 (387)
T ss_dssp TTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred ccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 999753222 223345789999999999988899999999999999999999999999888888888877655443
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 275 ~~~s~~~~~li~~ 287 (387)
T 1kob_A 275 SSVSPEAKDFIKN 287 (387)
T ss_dssp TTSCHHHHHHHHT
T ss_pred ccCCHHHHHHHHH
Confidence 5688999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=268.38 Aligned_cols=216 Identities=26% Similarity=0.429 Sum_probs=181.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh---hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD---EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||+|++......... ..+.+.+ +++.++.++||||+++++++...+..++||||+++++|.+
T Consensus 28 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (321)
T 2a2a_A 28 VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER---EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104 (321)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHH---HHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred EEEEEECCCCeEEEEEEEecccccccccchhHHHHHH---HHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHH
Confidence 799999999999999999865432211 2334444 4677888899999999999999999999999999999999
Q ss_pred hhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC----ceE
Q psy3347 78 HIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG----YVK 152 (245)
Q Consensus 78 ~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~k 152 (245)
++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++ .++
T Consensus 105 ~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~---dikp~NI----------------------l~~~~~~~~~~~k 159 (321)
T 2a2a_A 105 FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHF---DLKPENI----------------------MLLDKNIPIPHIK 159 (321)
T ss_dssp HHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESCTTSSSCCEE
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCChHHE----------------------EEecCCCCcCCEE
Confidence 9864 568999999999999999999999999999 8888888 666666 799
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
|+|||++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 160 l~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 160 LIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp ECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EccCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 9999998754332 223455789999999999988899999999999999999999999999888888888877665544
Q ss_pred ----CCCChhHHhhhcC
Q psy3347 233 ----RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ----~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 239 ~~~~~~~~~~~~~li~~ 255 (321)
T 2a2a_A 239 EEFFSHTSELAKDFIRK 255 (321)
T ss_dssp HHHHTTCCHHHHHHHHT
T ss_pred hhhhcccCHHHHHHHHH
Confidence 6788899998864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.17 Aligned_cols=195 Identities=27% Similarity=0.468 Sum_probs=159.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCC--eEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEA--HVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+|+.||+|++.... ......+... +++..++.+. ||||+++++++...+ ..|+||||++ ++|..
T Consensus 25 V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~---~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~ 99 (388)
T 3oz6_A 25 VWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTF---REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHA 99 (388)
T ss_dssp EEEEEETTTCCEEEEEEECC---CCHHHHHHHH---HHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHH
T ss_pred EEEEEECCCCCEEEEEEecccc-cChHHHHHHH---HHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHH
Confidence 7999999999999999997532 2222333333 4466677776 999999999997554 7999999997 58999
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+++...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 100 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kl~DFG 154 (388)
T 3oz6_A 100 VIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHR---DMKPSNI----------------------LLNAECHVKVADFG 154 (388)
T ss_dssp HHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEECCCT
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeC---CCCHHHe----------------------EEcCCCCEEecCCc
Confidence 8888889999999999999999999999999999 9999999 88899999999999
Q ss_pred CccCCCCC---------------------CCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 158 LCKEGMGF---------------------GDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 158 ~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
+++..... .......+||+.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99743221 112334578999999999977 57899999999999999999999999999
Q ss_pred CHHHHHHHHh
Q psy3347 216 DEEEVFDSIV 225 (245)
Q Consensus 216 ~~~~~~~~~~ 225 (245)
+..+....+.
T Consensus 235 ~~~~~~~~i~ 244 (388)
T 3oz6_A 235 STMNQLERII 244 (388)
T ss_dssp SHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 8887777765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=268.65 Aligned_cols=194 Identities=24% Similarity=0.448 Sum_probs=162.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++... .....+.+. +++++++.++||||+++++++..++..++||||+++ +|.+++.
T Consensus 21 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~ 94 (317)
T 2pmi_A 21 VYKGLNKTTGVYVALKEVKLDS--EEGTPSTAI---REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMD 94 (317)
T ss_dssp EEEEECSSSCCEEEEEEEECCS--TTCSCHHHH---HHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHH
T ss_pred EEEEEECCCCcEEEEEEeeccc--ccccHHHHH---HHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHH
Confidence 7999999999999999997643 111223333 447788899999999999999999999999999985 8888774
Q ss_pred h-------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 81 A-------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 81 ~-------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~---Dlkp~NI----------------------l~~~~~~~kl 149 (317)
T 2pmi_A 95 SRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHR---DLKPQNL----------------------LINKRGQLKL 149 (317)
T ss_dssp HHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEE
T ss_pred hccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCChHHe----------------------EEcCCCCEEE
Confidence 3 248899999999999999999999999999 9999999 8888999999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+|||++..............+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999998754333333445678999999999976 468999999999999999999999999988877766664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=276.22 Aligned_cols=195 Identities=22% Similarity=0.340 Sum_probs=161.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...... ....+.+. +++.+++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 43 V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 118 (389)
T 3gni_B 43 VNLARYKPTGEYVTVRRINLEACS-NEMVTFLQ---GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118 (389)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHH---HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEecccccC-hHHHHHHH---HHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHh
Confidence 799999999999999999865322 23333443 45777888999999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 119 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kl~dfg 173 (389)
T 3gni_B 119 THFMDGMNELAIAYILQGVLKALDYIHHMGYVHR---SVKASHI----------------------LISVDGKVYLSGLR 173 (389)
T ss_dssp HTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCGG
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEcccc
Confidence 4 568999999999999999999999999999 9999999 88889999999999
Q ss_pred CccCCCCCC-------CCCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 158 LCKEGMGFG-------DRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
.+....... ......+|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 875322111 11233478889999999987 57899999999999999999999999876555444433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.51 Aligned_cols=210 Identities=29% Similarity=0.446 Sum_probs=172.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++....... .+| ++.+..+ +||||+++++++.+++..|+||||+++|+|.+++
T Consensus 38 V~~~~~~~~~~~~avK~~~~~~~~~-------~~E---~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i 107 (342)
T 2qr7_A 38 CKRCIHKATNMEFAVKIIDKSKRDP-------TEE---IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107 (342)
T ss_dssp EEEEEETTTTEEEEEEEEETTTCCC-------HHH---HHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEcccCCh-------HHH---HHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 7999999999999999998653211 122 3344444 7999999999999999999999999999999888
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-CCC---CceEEe
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN-DTE---GYVKIA 154 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~kl~ 154 (245)
. ...+++..+..++.|++.||+|||++||+|| |+||+|| ++ +.+ +.+||+
T Consensus 108 ~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr---Dlkp~NI----------------------l~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 108 LRQKFFSEREASAVLFTITKTVEYLHAQGVVHR---DLKPSNI----------------------LYVDESGNPESIRIC 162 (342)
T ss_dssp HTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EESSSSCSGGGEEEC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec---cCCHHHE----------------------EEecCCCCcCeEEEE
Confidence 5 4568999999999999999999999999999 8888888 43 332 359999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCcccC
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG---DDEEEVFDSIVNDEVRY 231 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~---~~~~~~~~~~~~~~~~~ 231 (245)
|||++.............+||+.|+|||.+.+..++.++|||||||++|+|++|..||.+ .+..+....+..+...+
T Consensus 163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242 (342)
T ss_dssp CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred ECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence 999998644444445566889999999999887889999999999999999999999975 45667777777766654
Q ss_pred C----CCCChhHHhhhcC
Q psy3347 232 P----RFLSLEAIAIMRR 245 (245)
Q Consensus 232 p----~~~~~~~~~li~~ 245 (245)
+ ..+++++++||++
T Consensus 243 ~~~~~~~~s~~~~~li~~ 260 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSK 260 (342)
T ss_dssp CSTTTTTSCHHHHHHHHH
T ss_pred CccccccCCHHHHHHHHH
Confidence 4 5689999998863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=285.41 Aligned_cols=215 Identities=28% Similarity=0.517 Sum_probs=181.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...........+.+.+| +++++.++||||+++++++...+..++||||+.+++|.+++.
T Consensus 42 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 118 (484)
T 3nyv_A 42 VILCKDKITGQECAVKVISKRQVKQKTDKESLLRE---VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118 (484)
T ss_dssp EEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHH---HHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHH---HHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 79999999999999999986544333344445444 777889999999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEeec
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADF 156 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~Df 156 (245)
...+++..+..++.|++.||.|||++||+|| |+||+|| ++ +.++.+||+||
T Consensus 119 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 119 SRKRFSEVDAARIIRQVLSGITYMHKNKIVHR---DLKPENL----------------------LLESKSKDANIRIIDF 173 (484)
T ss_dssp TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EESSSSTTCCEEECCT
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCCHHHE----------------------EEecCCCCCcEEEEee
Confidence 4679999999999999999999999999999 8888888 55 46788999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++...... ......+||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++
T Consensus 174 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 174 GLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251 (484)
T ss_dssp THHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred eeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 998753222 22345578999999999966 689999999999999999999999999999999998887765543
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 252 ~~~s~~~~~li~~ 264 (484)
T 3nyv_A 252 KKVSESAKDLIRK 264 (484)
T ss_dssp GGSCHHHHHHHHH
T ss_pred ccCCHHHHHHHHH
Confidence 4688999998863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=263.17 Aligned_cols=196 Identities=20% Similarity=0.323 Sum_probs=160.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++..... .....+.+ .++++.++.++||||+++++++..++..++||||++++.+..+..
T Consensus 18 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 93 (292)
T 3o0g_A 18 VFKAKNRETHEIVALKRVRLDDD-DEGVPSSA---LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93 (292)
T ss_dssp EEEEEETTTCCEEEEEEEESSCS-STTHHHHH---HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred EEEEEECCCCceEEEEeeeccCC-cCCcchHH---HHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHh
Confidence 79999999999999999986542 22222333 345788889999999999999999999999999998744444443
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||++
T Consensus 94 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~---dikp~Ni----------------------l~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR---DLKPQNL----------------------LINRNGELKLANFGLA 148 (292)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEcCCCCEEEeecccc
Confidence 4679999999999999999999999999999 9999999 8888999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESP-FPGDDEEEVFDSIV 225 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~p-f~~~~~~~~~~~~~ 225 (245)
..............||..|+|||.+.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred eecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 76443444455667899999999997765 79999999999999999987666 66666666666654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=259.51 Aligned_cols=211 Identities=26% Similarity=0.469 Sum_probs=178.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.+|+|++..... ...+.+.+ +++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 25 V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 98 (277)
T 3f3z_A 25 VKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQ---EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV 98 (277)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGC---SCHHHHHH---HHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEeCCCCcEEEEEeehhhcc---chHHHHHH---HHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH
Confidence 79999999999999999986432 22334444 4777888999999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEeec
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADF 156 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~Df 156 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| ++ +.++.++|+||
T Consensus 99 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 99 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHR---DLKPENF----------------------LFLTDSPDSPLKLIDF 153 (277)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESSSSTTCCEEECCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCccCC---CCCHHHE----------------------EEecCCCCCcEEEEec
Confidence 4678999999999999999999999999999 8888888 55 67889999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCC---
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--- 233 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~--- 233 (245)
|++..... ........|++.|+|||.+.+. ++.++||||||+++|+|++|+.||.+.+..+....+..+...+|.
T Consensus 154 g~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T 3f3z_A 154 GLAARFKP-GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231 (277)
T ss_dssp TTCEECCT-TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred ccceeccC-ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh
Confidence 99875322 2234455789999999998654 889999999999999999999999999888888888887776663
Q ss_pred -CCChhHHhhhc
Q psy3347 234 -FLSLEAIAIMR 244 (245)
Q Consensus 234 -~~~~~~~~li~ 244 (245)
.+++++++||+
T Consensus 232 ~~~~~~~~~li~ 243 (277)
T 3f3z_A 232 LNVSPQAESLIR 243 (277)
T ss_dssp TTSCHHHHHHHH
T ss_pred hcCCHHHHHHHH
Confidence 68999998886
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.55 Aligned_cols=212 Identities=31% Similarity=0.514 Sum_probs=164.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++....... +.+. +++..++.++||||+++++++...+..++||||+.+++|.+++.
T Consensus 36 V~~~~~~~~~~~vavK~~~~~~~~~----~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 108 (361)
T 3uc3_A 36 ARLMRDKLTKELVAVKYIERGAAID----ENVQ---REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC 108 (361)
T ss_dssp EEEEEETTTCCEEEEEEEESSTTSC----HHHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEecCcccc----HHHH---HHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH
Confidence 7999999999999999998643221 2333 44677888999999999999999999999999999999998884
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc--eEEeecC
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY--VKIADFG 157 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~kl~Dfg 157 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++. +||+|||
T Consensus 109 ~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~---Dlkp~Ni----------------------ll~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 109 NAGRFSEDEARFFFQQLLSGVSYCHSMQICHR---DLKLENT----------------------LLDGSPAPRLKICDFG 163 (361)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSC---CCCGGGE----------------------EECSSSSCCEEECCCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EEcCCCCceEEEeecC
Confidence 4679999999999999999999999999999 8889888 6665554 9999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCcccCC
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIFEMLVGESPFPGDD----EEEVFDSIVNDEVRYP 232 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~g~~pf~~~~----~~~~~~~~~~~~~~~p 232 (245)
+++.... ........||+.|+|||.+.+..++.+ +|||||||++|+|++|+.||.+.. .......+......+|
T Consensus 164 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (361)
T 3uc3_A 164 YSKSSVL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP 242 (361)
T ss_dssp CC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC
T ss_pred ccccccc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC
Confidence 9874222 222345578999999999988877655 899999999999999999997643 3455555666555555
Q ss_pred C--CCChhHHhhhcC
Q psy3347 233 R--FLSLEAIAIMRR 245 (245)
Q Consensus 233 ~--~~~~~~~~li~~ 245 (245)
. .+++++++||++
T Consensus 243 ~~~~~s~~~~~li~~ 257 (361)
T 3uc3_A 243 DDIRISPECCHLISR 257 (361)
T ss_dssp TTSCCCHHHHHHHHH
T ss_pred CcCCCCHHHHHHHHH
Confidence 4 689999998863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=259.68 Aligned_cols=214 Identities=29% Similarity=0.529 Sum_probs=178.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++..... .....+.+. ++++.++.++||||+++++++..++..+++|||+++++|.+.+.
T Consensus 22 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 97 (284)
T 3kk8_A 22 VRRCVHKTTGLEFAAKIINTKKL-SARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97 (284)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEEcCCCceEEEEEeecccC-CHHHHHHHH---HHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH
Confidence 79999999999999999986542 223334444 44777888899999999999999999999999999999987774
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC---ceEEeec
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG---YVKIADF 156 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~kl~Df 156 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++ .++|+||
T Consensus 98 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 98 AREFYSEADASHCIQQILESIAYCHSNGIVHR---NLKPENL----------------------LLASKAKGAAVKLADF 152 (284)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EESSSSTTCCEEECCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcC---CCCHHHE----------------------EEecCCCCCcEEEeec
Confidence 5678999999999999999999999999999 8888888 665444 4999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++..... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..+...+|
T Consensus 153 g~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T 3kk8_A 153 GLAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 231 (284)
T ss_dssp TTCEECCS-SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred eeeEEccc-CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh
Confidence 99875332 2223456789999999999988899999999999999999999999999988888888877665544
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++++||+
T Consensus 232 ~~~~~~~~~li~ 243 (284)
T 3kk8_A 232 DTVTPEAKSLID 243 (284)
T ss_dssp TTSCHHHHHHHH
T ss_pred cccCHHHHHHHH
Confidence 467889988875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=260.84 Aligned_cols=215 Identities=28% Similarity=0.497 Sum_probs=174.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++...........+.+. ++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 103 (276)
T 2h6d_A 27 VKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC 103 (276)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHH---HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEECCCCceEEEEEeccccccchhHHHHHH---HHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHh
Confidence 799999999999999999764322222233443 44777888999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 104 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 104 KHGRVEEMEARRLFQQILSAVDYCHRHMVVHR---DLKPENV----------------------LLDAHMNAKIADFGLS 158 (276)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCC---CCCGGGE----------------------EECTTSCEEECCCCGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccC---CCChhhE----------------------EECCCCCEEEeecccc
Confidence 4578999999999999999999999999999 9999898 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLE 238 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 238 (245)
..... ........++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||.+....+....+......+|..++++
T Consensus 159 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2h6d_A 159 NMMSD-GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237 (276)
T ss_dssp GCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cccCC-CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHH
Confidence 75322 222334568889999999987765 6899999999999999999999998888888888887777788889999
Q ss_pred HHhhhc
Q psy3347 239 AIAIMR 244 (245)
Q Consensus 239 ~~~li~ 244 (245)
+.++|+
T Consensus 238 l~~li~ 243 (276)
T 2h6d_A 238 VATLLM 243 (276)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=272.52 Aligned_cols=214 Identities=26% Similarity=0.462 Sum_probs=176.5
Q ss_pred CEeEEEe-------cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYR-------NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++. .++..||+|+++... .....+.+.+| +++++.+ +||||+++++++...+..|+||||+++
T Consensus 97 Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~ 171 (370)
T 2psq_A 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSE---MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171 (370)
T ss_dssp EEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHH---HHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHH---HHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 7899875 356689999998642 23334444444 6677788 899999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
|+|.+++... .+++..+..++.|++.||+|||++||+|| |+||+||
T Consensus 172 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~NI-------------- 234 (370)
T 2psq_A 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR---DLAARNV-------------- 234 (370)
T ss_dssp CBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE--------------
T ss_pred CCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc---ccchhhE--------------
Confidence 9999998542 37888999999999999999999999999 9999999
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 235 --------ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 235 --------LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp --------EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred --------EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 888899999999999975332221 2233456778999999998899999999999999999999 99999
Q ss_pred CCCCHHHHHHHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 213 PGDDEEEVFDSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
.+.+..+....+..+. ...|..+++++.++|+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 339 (370)
T 2psq_A 307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 339 (370)
T ss_dssp TTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 9888887777776654 3567889999999886
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=262.08 Aligned_cols=214 Identities=24% Similarity=0.421 Sum_probs=182.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++..... ....+.+.+ ++..++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 38 V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 112 (303)
T 3a7i_A 38 VFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQ---EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE 112 (303)
T ss_dssp EEEEEETTTCCEEEEEEEETTTC--STTHHHHHH---HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT
T ss_pred EEEEEECCCCcEEEEEEeccccc--HHHHHHHHH---HHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh
Confidence 79999999999999999976532 223344444 4677888899999999999999999999999999999999998
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
.+.+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||++.
T Consensus 113 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 113 PGPLDETQIATILREILKGLDYLHSEKKIHR---DIKAANV----------------------LLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTCE
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCCccC---CCChheE----------------------EECCCCCEEEeecccce
Confidence 8889999999999999999999999999999 8999888 88889999999999987
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc-cCCCCCChhH
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSLEA 239 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~ 239 (245)
.............|+..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+..... ..+..+++++
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 247 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 247 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHH
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHH
Confidence 543333334456788999999999888899999999999999999999999998887777766655433 4567889999
Q ss_pred Hhhhc
Q psy3347 240 IAIMR 244 (245)
Q Consensus 240 ~~li~ 244 (245)
.+||+
T Consensus 248 ~~li~ 252 (303)
T 3a7i_A 248 KEFVE 252 (303)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=267.74 Aligned_cols=211 Identities=24% Similarity=0.386 Sum_probs=174.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||||++...........+.+. ++++.++.++||||+++++++..++..++||||+.| +|.+++.
T Consensus 70 Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~ 145 (348)
T 1u5q_A 70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII---KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLE 145 (348)
T ss_dssp EEEEEETTTTEEEEEEEEESCSSCHHHHHHHHH---HHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH
T ss_pred EEEEEEccCCeEEEEEEEccccccchHHHHHHH---HHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHH
Confidence 799999999999999999865433333334444 447778888999999999999999999999999974 7776663
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||+
T Consensus 146 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 146 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR---DVKAGNI----------------------LLSEPGLVKLGDFGS 200 (348)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCSGGGE----------------------EEETTTEEEECCCTT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCCHHHE----------------------EECCCCCEEEeeccC
Confidence 4578999999999999999999999999999 9999998 888889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc--CCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--YPR 233 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~p~ 233 (245)
+..... .....|++.|+|||.+. ...++.++|||||||++|+|++|+.||.+.+..+....+.....+ .+.
T Consensus 201 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 276 (348)
T 1u5q_A 201 ASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 276 (348)
T ss_dssp CBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred ceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Confidence 875322 23457899999999985 467889999999999999999999999988877777666655433 346
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.+++++++||+
T Consensus 277 ~~~~~l~~li~ 287 (348)
T 1u5q_A 277 HWSEYFRNFVD 287 (348)
T ss_dssp TSCHHHHHHHH
T ss_pred CCCHHHHHHHH
Confidence 78888888875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.53 Aligned_cols=199 Identities=25% Similarity=0.370 Sum_probs=165.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIA--RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~ 73 (245)
||+|+++.+|+.||+|++....... ........+|.+++..++.++||||+++++++.... ..+++||++.+
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~- 103 (308)
T 3g33_A 25 VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ- 103 (308)
T ss_dssp EEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-
T ss_pred EEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-
Confidence 7999999999999999997543211 111234556666677777778999999999997754 68999999974
Q ss_pred chhhhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 74 DLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 74 ~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|.+++... .+++..+..++.|++.||+|||++|++|+ |+||+|| +++.++.
T Consensus 104 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~~ 158 (308)
T 3g33_A 104 DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR---DLKPENI----------------------LVTSGGT 158 (308)
T ss_dssp BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCTTTE----------------------EECTTSC
T ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EEcCCCC
Confidence 998888643 38999999999999999999999999999 9999898 8888999
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+||+|||+++... .........||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 159 ~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYS-YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp EEECSCSCTTTST-TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred EEEeeCccccccC-CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999987532 22334456789999999999988999999999999999999999999999888877777653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=280.04 Aligned_cols=215 Identities=27% Similarity=0.464 Sum_probs=178.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccch----------hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeec
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR----------DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~ 70 (245)
||+|+++.+++.||+|++........ ...+.+ .+++++++.++||||+++++++...+..++||||+
T Consensus 52 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 128 (504)
T 3q5i_A 52 VLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI---YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128 (504)
T ss_dssp EEEEEETTTCCEEEEEEEEC----------------CTHHHH---HHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHH---HHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecC
Confidence 79999999999999999986542211 112233 44577888999999999999999999999999999
Q ss_pred cCCchhhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC
Q psy3347 71 AGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG 149 (245)
Q Consensus 71 ~~~~L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (245)
++++|.+++. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++
T Consensus 129 ~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~ 183 (504)
T 3q5i_A 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHR---DIKPENI----------------------LLENKN 183 (504)
T ss_dssp TTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EESSTT
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC---CCcHHHE----------------------EEecCC
Confidence 9999988774 5679999999999999999999999999999 8888888 565554
Q ss_pred ---ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 150 ---YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 150 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
.+||+|||++...... ......+||+.|+|||.+. ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 6999999999754322 2344567899999999986 4689999999999999999999999999999999999888
Q ss_pred CcccCC----CCCChhHHhhhcC
Q psy3347 227 DEVRYP----RFLSLEAIAIMRR 245 (245)
Q Consensus 227 ~~~~~p----~~~~~~~~~li~~ 245 (245)
+...++ ..+++++++||++
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~ 284 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKL 284 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHH
T ss_pred CCCCCCccccCCCCHHHHHHHHH
Confidence 776554 6789999998863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.39 Aligned_cols=208 Identities=28% Similarity=0.482 Sum_probs=162.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHH-hhcCCCceeeeeEEEee----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA-NTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||||++... ....+| ++.+ +..+||||++++++|.. .++.|+||||+++|+|
T Consensus 78 V~~~~~~~~~~~vAiK~~~~~--------~~~~~E---~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L 146 (400)
T 1nxk_A 78 VLQIFNKRTQEKFALKMLQDC--------PKARRE---VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146 (400)
T ss_dssp EEEEEETTTCCEEEEEEEECS--------HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred EEEEEECCCCCEEEEEEeCcc--------hhHHHH---HHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcH
Confidence 799999999999999999742 122333 3333 45589999999999876 5679999999999999
Q ss_pred hhhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CC
Q psy3347 76 MMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EG 149 (245)
Q Consensus 76 ~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 149 (245)
.+++... .+++..+..++.|++.||.|||++||+|| |+||+|| +++. ++
T Consensus 147 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~~ 201 (400)
T 1nxk_A 147 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR---DVKPENL----------------------LYTSKRPNA 201 (400)
T ss_dssp HHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSSSTTC
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CcCcceE----------------------EEecCCCCc
Confidence 9998642 58999999999999999999999999999 8888888 6665 78
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE----EVFDSIV 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~----~~~~~~~ 225 (245)
.+||+|||+++..... ......+||..|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus 202 ~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred cEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 8999999999753322 2234567899999999998889999999999999999999999999765432 2344455
Q ss_pred cCcccCC----CCCChhHHhhhcC
Q psy3347 226 NDEVRYP----RFLSLEAIAIMRR 245 (245)
Q Consensus 226 ~~~~~~p----~~~~~~~~~li~~ 245 (245)
.+...+| ..+++++++||++
T Consensus 281 ~~~~~~~~~~~~~~s~~~~~li~~ 304 (400)
T 1nxk_A 281 MGQYEFPNPEWSEVSEEVKMLIRN 304 (400)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred cCcccCCCcccccCCHHHHHHHHH
Confidence 5555444 5689999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=280.04 Aligned_cols=214 Identities=28% Similarity=0.494 Sum_probs=176.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|+++.+|+.||+|++....... .....+. +++++++.++||||+++++++...+..++||||+.+++|.+.+
T Consensus 38 V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 113 (486)
T 3mwu_A 38 VLKCKDRITQQEYAVKVINKASAKN-KDTSTIL---REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113 (486)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEecccccc-hHHHHHH---HHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH
Confidence 7999999999999999997543221 2233444 4477788899999999999999999999999999999998877
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEeec
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADF 156 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~Df 156 (245)
....+++..+..++.|++.||.|||++||+|| |+||+|| ++ +.++.+||+||
T Consensus 114 ~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 114 KRKRFSEHDAARIIKQVFSGITYMHKHNIVHR---DLKPENI----------------------LLESKEKDCDIKIIDF 168 (486)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EESSSSTTCCEEECSC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---cCchHHE----------------------EEecCCCCCCEEEEEC
Confidence 45679999999999999999999999999999 8888888 55 34567999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++...... ......+||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++
T Consensus 169 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (486)
T 3mwu_A 169 GLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (486)
T ss_dssp SCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred CcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 998753222 23445678999999999975 589999999999999999999999999999999888887765543
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 247 ~~~s~~~~~li~~ 259 (486)
T 3mwu_A 247 RTISDDAKDLIRK 259 (486)
T ss_dssp GGSCHHHHHHHHH
T ss_pred CCCCHHHHHHHHH
Confidence 4688999998863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=258.56 Aligned_cols=216 Identities=26% Similarity=0.470 Sum_probs=176.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh---hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD---EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||+|+++........ ..+.+.+ +++.++.++||||+++++++...+..++||||+++++|.+
T Consensus 21 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (283)
T 3bhy_A 21 VRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER---EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97 (283)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHH---HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EEEEEEcCCCCeeehHHhhhccccccccchHHHHHHH---HHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHH
Confidence 799999999999999999865432221 2334444 4677888899999999999999999999999999999999
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC----ceE
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG----YVK 152 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~k 152 (245)
++. ...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++ .++
T Consensus 98 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~~~~~k 152 (283)
T 3bhy_A 98 FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF---DLKPENI----------------------MLLDKNVPNPRIK 152 (283)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EESCSSSSSCCEE
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCChHHE----------------------EEecCCCCCCceE
Confidence 885 4679999999999999999999999999999 8888888 665555 799
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
|+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......++
T Consensus 153 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 153 LIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231 (283)
T ss_dssp ECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred EEecccceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence 9999998753222 223345688899999999888899999999999999999999999999888888777766554443
Q ss_pred ----CCCChhHHhhhcC
Q psy3347 233 ----RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ----~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 232 ~~~~~~~~~~~~~li~~ 248 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRR 248 (283)
T ss_dssp HHHHTTCCHHHHHHHHT
T ss_pred chhcccCCHHHHHHHHH
Confidence 6788888888864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=271.46 Aligned_cols=192 Identities=27% Similarity=0.448 Sum_probs=162.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||||++.... ......+.+ .+++++++.++||||+++++++...+ .+|+||||+ +++
T Consensus 41 V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~---~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~ 115 (367)
T 1cm8_A 41 VCSAVDGRTGAKVAIKKLYRPF-QSELFAKRA---YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD 115 (367)
T ss_dssp EEEEEETTTCCEEEEEECSSTT-SSHHHHHHH---HHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEE
T ss_pred EEEEEECCCCCEEEEEEeCccc-cCHHHHHHH---HHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCC
Confidence 7999999999999999997542 122222333 45577888899999999999997653 469999999 779
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|.++++...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 116 L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kl~ 170 (367)
T 1cm8_A 116 LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR---DLKPGNL----------------------AVNEDCELKIL 170 (367)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CcCHHHE----------------------EEcCCCCEEEE
Confidence 9999988889999999999999999999999999999 9999999 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||+++.... .....++|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 171 Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 171 DFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp CCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999975322 2345678999999999977 678999999999999999999999999988777666654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=267.21 Aligned_cols=214 Identities=24% Similarity=0.346 Sum_probs=176.3
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..+|+ .||||+++... .....+.+.+ ++++++.++||||+++++++..++..++||||+++++|.+
T Consensus 65 V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 139 (325)
T 3kul_A 65 VCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLS---EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139 (325)
T ss_dssp EEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHH---HHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHH
T ss_pred EEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHH---HHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHH
Confidence 79999986655 49999998542 2233344444 4778889999999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++. ..+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.++|+|
T Consensus 140 ~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kl~D 194 (325)
T 3kul_A 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR---DLAARNV----------------------LVDSNLVCKVSD 194 (325)
T ss_dssp HHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECC
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCC---CCCcceE----------------------EECCCCCEEECC
Confidence 9853 478999999999999999999999999999 9999998 888899999999
Q ss_pred cCCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-ccc
Q psy3347 156 FGLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~ 230 (245)
||+++........ .....+|..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+ ..+
T Consensus 195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 9999754332221 122334668999999988889999999999999999999 99999999888888887765 345
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.+||+
T Consensus 275 ~~~~~~~~l~~li~ 288 (325)
T 3kul_A 275 APMGCPHALHQLML 288 (325)
T ss_dssp CCTTCCHHHHHHHH
T ss_pred CCCCcCHHHHHHHH
Confidence 67889999999885
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=268.70 Aligned_cols=211 Identities=30% Similarity=0.494 Sum_probs=162.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+++.||+|+++... ..+.+. ++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 69 Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 140 (349)
T 2w4o_A 69 VYRCKQKGTQKPYALKVLKKTV-----DKKIVR---TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV 140 (349)
T ss_dssp EEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT
T ss_pred EEEEEECCCCcEEEEEEeccch-----hHHHHH---HHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH
Confidence 7999999999999999998542 122333 34677788899999999999999999999999999999998885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCceEEeec
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGYVKIADF 156 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||.|||++|++|| |++|+|| +++. ++.+||+||
T Consensus 141 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dikp~NI----------------------ll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 141 EKGYYSERDAADAVKQILEAVAYLHENGIVHR---DLKPENL----------------------LYATPAPDAPLKIADF 195 (349)
T ss_dssp TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EESSSSTTCCEEECCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec---CCCcccE----------------------EEecCCCCCCEEEccC
Confidence 4 568999999999999999999999999999 8888888 5543 789999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCcccCC---
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVRYP--- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~p--- 232 (245)
|+++.... ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .....+......++
T Consensus 196 g~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 196 GLSKIVEH-QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp C-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred ccccccCc-ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 99875322 22234567899999999999888999999999999999999999999765544 35566666554332
Q ss_pred -CCCChhHHhhhcC
Q psy3347 233 -RFLSLEAIAIMRR 245 (245)
Q Consensus 233 -~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 275 ~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 275 WDEVSLNAKDLVRK 288 (349)
T ss_dssp TTTSCHHHHHHHHT
T ss_pred hhhCCHHHHHHHHH
Confidence 5688899998864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=278.43 Aligned_cols=214 Identities=28% Similarity=0.505 Sum_probs=177.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|+++.+|+.||+|++....... .....+. +++.+++.++||||++++++|...+..++||||+.+++|.+.+
T Consensus 53 V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 128 (494)
T 3lij_A 53 VLLCRDKVTHVERAIKIIRKTSVST-SSNSKLL---EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128 (494)
T ss_dssp EEEEEETTTCCEEEEEEEEC------CTTHHHH---HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEeccccCc-hHHHHHH---HHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH
Confidence 7999999999999999998654222 1223343 4477888999999999999999999999999999999998877
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCceEEeec
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGYVKIADF 156 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~kl~Df 156 (245)
+...+++..+..++.|++.||+|||++||+|| |+||+|| +++. ++.+||+||
T Consensus 129 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~~~~~~kl~Df 183 (494)
T 3lij_A 129 HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHR---DLKPENL----------------------LLESKEKDALIKIVDF 183 (494)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EESCSSTTCCEEECCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---cCChhhE----------------------EEeCCCCCCcEEEEEC
Confidence 45679999999999999999999999999999 8888888 5544 456999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++...... ......+||+.|+|||.+. ..++.++|||||||++|+|++|..||.+.+..+....+..+...++
T Consensus 184 G~a~~~~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 261 (494)
T 3lij_A 184 GLSAVFENQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW 261 (494)
T ss_dssp TTCEECBTT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG
T ss_pred CCCeECCCC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc
Confidence 998754322 2344567999999999985 4689999999999999999999999999999999998887766543
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++++||++
T Consensus 262 ~~~s~~~~~li~~ 274 (494)
T 3lij_A 262 KNVSEGAKDLIKQ 274 (494)
T ss_dssp TTSCHHHHHHHHH
T ss_pred ccCCHHHHHHHHH
Confidence 4688999998863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=274.81 Aligned_cols=215 Identities=20% Similarity=0.358 Sum_probs=177.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++... .....+.+ .+++++++.++||||+++++++..++..++||||+++++|.++++
T Consensus 130 V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 204 (377)
T 3cbl_A 130 VFSGRLRADNTLVAVKSCRETL--PPDLKAKF---LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204 (377)
T ss_dssp EEEEEETTTCCEEEEEECCTTS--CHHHHTTT---THHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred EEEEEEecCCeEEEEEEccccC--CHHHHHHH---HHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHH
Confidence 7999999999999999997542 22222333 345778889999999999999999999999999999999999985
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||+
T Consensus 205 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr---Dlkp~Ni----------------------l~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 205 TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR---DLAARNC----------------------LVTEKNVLKISDFGM 259 (377)
T ss_dssp HHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECCGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCc---ccCHHHE----------------------EEcCCCcEEECcCCC
Confidence 4 358999999999999999999999999999 9999998 888899999999999
Q ss_pred ccCCCCCCCC--CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 159 CKEGMGFGDR--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 159 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..+. .+.|..
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 8753221111 112234567999999988889999999999999999998 999999988888877776553 456788
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.+||++
T Consensus 340 ~~~~l~~li~~ 350 (377)
T 3cbl_A 340 CPDAVFRLMEQ 350 (377)
T ss_dssp CCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999998863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=268.59 Aligned_cols=215 Identities=25% Similarity=0.400 Sum_probs=177.9
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+++.||+|+++... .....+.+. ++++.++.++||||+++++++..++..++||||+++++|
T Consensus 63 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 137 (343)
T 1luf_A 63 VFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQ---REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137 (343)
T ss_dssp EEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHH---HHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHH---HHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcH
Confidence 7999987 456899999998642 222333444 447778889999999999999999999999999999999
Q ss_pred hhhhhh-------------------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhh
Q psy3347 76 MMHIHA-------------------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130 (245)
Q Consensus 76 ~~~~~~-------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~ 130 (245)
.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+||
T Consensus 138 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~---Dlkp~NI--------- 205 (343)
T 1luf_A 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR---DLATRNC--------- 205 (343)
T ss_dssp HHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE---------
T ss_pred HHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCcceE---------
Confidence 999864 468899999999999999999999999999 9999888
Q ss_pred ccccCcccchhccccCCCCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-
Q psy3347 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV- 207 (245)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~- 207 (245)
+++.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 206 -------------l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 206 -------------LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp -------------EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -------------EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 78888999999999986432111 12234466888999999988889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 208 GESPFPGDDEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 208 g~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
|..||.+.+..+....+..+.. ..|..+++++.+||++
T Consensus 273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (343)
T 1luf_A 273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 311 (343)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHH
Confidence 9999999888888888776654 4678899999998863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=260.04 Aligned_cols=211 Identities=31% Similarity=0.550 Sum_probs=176.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++..... ..+.+. ++++.++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 25 V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 98 (304)
T 2jam_A 25 VFLVKQRLTGKLFALKCIKKSPAF---RDSSLE---NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL 98 (304)
T ss_dssp EEEEEETTTCCEEEEEEEECC---------HHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeccccc---chHHHH---HHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH
Confidence 799999999999999999864321 122333 44677888899999999999999999999999999999988874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEeec
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIADF 156 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~Df 156 (245)
.+.+++..+..++.|++.||+|||++|++|+ |++|+|| ++ +.++.++|+||
T Consensus 99 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dikp~NI----------------------l~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 99 ERGVYTEKDASLVIQQVLSAVKYLHENGIVHR---DLKPENL----------------------LYLTPEENSKIMITDF 153 (304)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---SCCGGGC----------------------EESSSSTTCCEEBCSC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCCHHHE----------------------EEecCCCCCCEEEccC
Confidence 5678999999999999999999999999999 8888888 55 67889999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC----C
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY----P 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----p 232 (245)
|++..... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..+...+ +
T Consensus 154 g~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (304)
T 2jam_A 154 GLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW 231 (304)
T ss_dssp STTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT
T ss_pred CcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 99874322 22344568999999999998889999999999999999999999999988888888887765443 3
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++++||+
T Consensus 232 ~~~~~~~~~li~ 243 (304)
T 2jam_A 232 DDISESAKDFIC 243 (304)
T ss_dssp TTSCHHHHHHHH
T ss_pred ccCCHHHHHHHH
Confidence 568889988876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=265.75 Aligned_cols=213 Identities=23% Similarity=0.351 Sum_probs=168.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++... .....+.+. ++++.++.++||||+++++++.+++..++||||+++++|.++++
T Consensus 26 V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 99 (310)
T 3s95_A 26 AIKVTHRETGEVMVMKELIRF---DEETQRTFL---KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK 99 (310)
T ss_dssp EEEEEETTTCCEEEEEEESCC---CHHHHHHHH---HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEeccC---CHHHHHHHH---HHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHH
Confidence 799999999999999998653 233334444 44778889999999999999999999999999999999999996
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|||+
T Consensus 100 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 100 SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR---DLNSHNC----------------------LVRENKNVVVADFGL 154 (310)
T ss_dssp HCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSTTSE----------------------EECTTSCEEECCCTT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCCcCeE----------------------EECCCCCEEEeeccc
Confidence 5 568999999999999999999999999999 8999888 888899999999999
Q ss_pred ccCCCCCCCC--------------CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Q psy3347 159 CKEGMGFGDR--------------TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD-- 222 (245)
Q Consensus 159 ~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~-- 222 (245)
+......... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence 8753222111 114578999999999999999999999999999999999999986532211000
Q ss_pred HHh-cCcccCCCCCChhHHhhhc
Q psy3347 223 SIV-NDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 223 ~~~-~~~~~~p~~~~~~~~~li~ 244 (245)
.+. ......|..+++++.++|+
T Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~ 257 (310)
T 3s95_A 235 NVRGFLDRYCPPNCPPSFFPITV 257 (310)
T ss_dssp CHHHHHHHTCCTTCCTTHHHHHH
T ss_pred hhhccccccCCCCCCHHHHHHHH
Confidence 000 0011245677777777765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=260.81 Aligned_cols=217 Identities=19% Similarity=0.261 Sum_probs=167.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++...........+.+. +++..++.++||||+++++++..++..+++|||+++++|.+++.
T Consensus 50 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 126 (309)
T 2h34_A 50 VYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ---REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR 126 (309)
T ss_dssp EEEEEETTTTEEEEEEECGGGGGGSHHHHHHHH---HHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH
T ss_pred EEEEEEcCCCeEEEEEecCcccccCHHHHHHHH---HHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH
Confidence 799999999999999999865433333334444 44777889999999999999999999999999999999999885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 127 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dlkp~NI----------------------l~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 127 RQGPLAPPRAVAIVRQIGSALDAAHAAGATHR---DVKPENI----------------------LVSADDFAYLVDFGIA 181 (309)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTSCEEECSCCC-
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcC---CCChHHE----------------------EEcCCCCEEEecCccC
Confidence 4 579999999999999999999999999999 8999998 8888899999999998
Q ss_pred cCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCC
Q psy3347 160 KEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFL 235 (245)
Q Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~ 235 (245)
....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+..... ..+..+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI 261 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTC
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCC
Confidence 7532221 123345688899999999888899999999999999999999999987765544444433322 235678
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.++|++
T Consensus 262 ~~~l~~li~~ 271 (309)
T 2h34_A 262 PVAFDAVIAR 271 (309)
T ss_dssp CTHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 8888888753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=262.70 Aligned_cols=194 Identities=23% Similarity=0.395 Sum_probs=155.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. +|+.||+|++..... .......+ .+++++++.++||||+++++++..++..++||||+++ +|.+++.
T Consensus 37 V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~---~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 110 (311)
T 3niz_A 37 VYKAKDS-QGRIVALKRIRLDAE-DEGIPSTA---IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD 110 (311)
T ss_dssp EEEEEET-TSCEEEEEEEC-------CHHHHH---HHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHH
T ss_pred EEEEEEC-CCCEEEEEEEecccc-cchhhHHH---HHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHH
Confidence 7999985 599999999975431 11122333 3457778889999999999999999999999999986 7776664
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 111 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~---Dikp~NI----------------------l~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHR---DLKPQNL----------------------LINSDGALKLADFGL 165 (311)
T ss_dssp TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEECCCTT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCchHhE----------------------EECCCCCEEEccCcC
Confidence 3 358999999999999999999999999999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9754333333445578999999999976 568999999999999999999999998876665555553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=264.94 Aligned_cols=214 Identities=24% Similarity=0.403 Sum_probs=169.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++...... ...+.+. +++.+++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 23 V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 97 (323)
T 3tki_A 23 VQLAVNRVTEEAVAVKIVDMKRAV--DCPENIK---KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 97 (323)
T ss_dssp EEEEEETTTCCEEEEEEEECC---------CHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB
T ss_pred EEEEEECCCCcEEEEEEEEccccc--chHHHHH---HHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh
Confidence 799999999999999999754321 1223333 44677788899999999999999999999999999999999886
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|||++
T Consensus 98 ~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~---Dlkp~NI----------------------ll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 98 PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR---DIKPENL----------------------LLDERDNLKISDFGLA 152 (323)
T ss_dssp TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---ccchHHE----------------------EEeCCCCEEEEEeecc
Confidence 4 469999999999999999999999999999 9999998 8888999999999998
Q ss_pred cCCCCC--CCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCccc--CCC
Q psy3347 160 KEGMGF--GDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVR--YPR 233 (245)
Q Consensus 160 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~--~p~ 233 (245)
...... .......+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.... ............ ...
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGG
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccc
Confidence 743211 122345678999999999987765 77899999999999999999999765442 222223222222 225
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.+++++.+||+
T Consensus 233 ~~~~~~~~li~ 243 (323)
T 3tki_A 233 KIDSAPLALLH 243 (323)
T ss_dssp GSCHHHHHHHH
T ss_pred cCCHHHHHHHH
Confidence 67888888875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.83 Aligned_cols=219 Identities=23% Similarity=0.451 Sum_probs=177.9
Q ss_pred CEeEEEecCCcEEEEEEeeccccc-chhhHH-HHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII-ARDEVE-SLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~-~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||||++...... .....+ ......+++..++.+ +||||+++++++...+..++||||+++++|.+
T Consensus 110 Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~ 189 (365)
T 2y7j_A 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189 (365)
T ss_dssp EEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHH
T ss_pred EEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHH
Confidence 799999999999999999764311 111111 112223446667777 79999999999999999999999999999999
Q ss_pred hhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
++.. ..+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|+||
T Consensus 190 ~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~---Dlkp~NI----------------------l~~~~~~ikl~Df 244 (365)
T 2y7j_A 190 YLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHR---DLKPENI----------------------LLDDNMQIRLSDF 244 (365)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EECCCCCEEEEec
Confidence 8854 579999999999999999999999999999 9999999 8888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE------TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (245)
|++..... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..+...
T Consensus 245 G~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 323 (365)
T 2y7j_A 245 GFSCHLEP-GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ 323 (365)
T ss_dssp TTCEECCT-TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CcccccCC-CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 98875332 223445678999999999863 35788999999999999999999999988888887877776655
Q ss_pred CC----CCCChhHHhhhcC
Q psy3347 231 YP----RFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p----~~~~~~~~~li~~ 245 (245)
++ ..+++++.+||++
T Consensus 324 ~~~~~~~~~~~~~~~li~~ 342 (365)
T 2y7j_A 324 FSSPEWDDRSSTVKDLISR 342 (365)
T ss_dssp CCHHHHSSSCHHHHHHHHH
T ss_pred CCCcccccCCHHHHHHHHH
Confidence 43 5688888888763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=267.16 Aligned_cols=217 Identities=30% Similarity=0.494 Sum_probs=171.6
Q ss_pred CEeEEEecCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII--ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++..+++.||+|++...... .....+.+. +++++++.++||||+++++++...+..++||||+++++|.++
T Consensus 42 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 118 (345)
T 3hko_A 42 VRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118 (345)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHH---HHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred EEEEEECCCCceEEEeehhhhhhcccCHHHHHHHH---HHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHH
Confidence 799999999999999999864321 122334444 447778888999999999999999999999999999999988
Q ss_pred hhh-----------------------------------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCC
Q psy3347 79 IHA-----------------------------------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117 (245)
Q Consensus 79 ~~~-----------------------------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~ 117 (245)
+.. ..+++..+..++.|++.||+|||++|++|+ |++
T Consensus 119 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~---Dlk 195 (345)
T 3hko_A 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR---DIK 195 (345)
T ss_dssp EEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECC---CCC
T ss_pred HHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc---CCC
Confidence 741 113566788899999999999999999999 888
Q ss_pred HHHHHHHHHHhhhccccCcccchhccccCCCC--ceEEeecCCccCCCCCCC----CCCcccCCCCccccccccC--CCC
Q psy3347 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG--YVKIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTE--TSY 189 (245)
Q Consensus 118 ~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~ 189 (245)
|+|| +++.++ .+||+|||++........ ......|++.|+|||.+.+ ..+
T Consensus 196 p~NI----------------------ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 196 PENF----------------------LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp GGGE----------------------EESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred hhhE----------------------EEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 8888 665555 899999999874322111 2345578999999999965 678
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----CCCChhHHhhhcC
Q psy3347 190 TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSLEAIAIMRR 245 (245)
Q Consensus 190 ~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 245 (245)
+.++||||||+++|+|++|+.||.+....+....+......++ ..+++++++||++
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHH
Confidence 8999999999999999999999999988888888877665443 3478899988863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.62 Aligned_cols=194 Identities=24% Similarity=0.371 Sum_probs=156.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|++..+|+.||||++.... ......+. ..+++.+++.++||||+++++++... +..|+||||++++
T Consensus 78 V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~---~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~- 152 (464)
T 3ttj_A 78 VCAAYDAVLDRNVAIKKLSRPF-QNQTHAKR---AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN- 152 (464)
T ss_dssp EEEEEETTTTEEEEEEEEESGG-GSHHHHHH---HHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-
T ss_pred EEEEEECCCCCEEEEEEECccc-cChHHHHH---HHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-
Confidence 7999999999999999998642 22222333 34557788889999999999999654 4689999999764
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+...+.. .+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 153 l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHr---Dlkp~NI----------------------ll~~~~~~kl~ 206 (464)
T 3ttj_A 153 LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 206 (464)
T ss_dssp HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEEC
T ss_pred HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCChHhE----------------------EEeCCCCEEEE
Confidence 5555543 48999999999999999999999999999 9999999 88899999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||+++.... .......+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 207 DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 207 DFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp CCCCC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEeeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999975322 2234556889999999999999999999999999999999999999999988777776644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=260.01 Aligned_cols=194 Identities=25% Similarity=0.400 Sum_probs=156.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++ .+|+.||+|++...... ....+.+. ++++.++.++||||+++++++..++..++||||+++ +|.+++.
T Consensus 18 V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (288)
T 1ob3_A 18 VYKAQN-NYGETFALKKIRLEKED-EGIPSTTI---REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD 91 (288)
T ss_dssp EEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHH---HHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHH
T ss_pred EEEEEc-CCCCEEEEEEEeccccc-cccchhHH---HHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHH
Confidence 799998 67999999999764321 11123333 457888899999999999999999999999999976 8888775
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. +.+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR---DLKPQNL----------------------LINREGELKIADFGL 146 (288)
T ss_dssp TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTSCEEECCTTH
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHE----------------------EEcCCCCEEEeECcc
Confidence 3 568999999999999999999999999999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+..............+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 147 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 214 (288)
T 1ob3_A 147 ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (288)
T ss_dssp HHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 87533222233445789999999999764 58999999999999999999999999887776666553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=265.76 Aligned_cols=196 Identities=21% Similarity=0.285 Sum_probs=154.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|+++..... ....+. ..+++++++.++||||+++++++..++..++||||+++ +|.+++.
T Consensus 50 V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~ 124 (329)
T 3gbz_A 50 VYKAIDTVTNETVAIKRIRLEHEE-EGVPGT---AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD 124 (329)
T ss_dssp EEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH
T ss_pred EEEEEECCCCceEEEEEEcccccc-cccchh---HHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHh
Confidence 799999999999999999764321 111222 24557888999999999999999999999999999985 8888885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-----CCCCceEEe
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN-----DTEGYVKIA 154 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~kl~ 154 (245)
. ..+++..+..++.|++.||+|||++||+|+ |+||+|| ++ +.++.+||+
T Consensus 125 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR---DLKPQNL----------------------LLSVSDASETPVLKIG 179 (329)
T ss_dssp HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EEEC-----CCEEEEC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECC---CCCHHHE----------------------EEecCCCCccceEEEC
Confidence 4 579999999999999999999999999999 8888888 55 445679999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||++..............+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 999987533333334455779999999999874 489999999999999999999999999888777776643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.06 Aligned_cols=210 Identities=16% Similarity=0.183 Sum_probs=163.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeee-------EEEeeCC------------
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-------ACFQTEA------------ 61 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~-------~~~~~~~------------ 61 (245)
||+|+++.+|+.||||++...........+.+.+|.++++.++.++||||++++ +++...+
T Consensus 89 V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (377)
T 3byv_A 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168 (377)
T ss_dssp EEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC-----
T ss_pred EEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCC
Confidence 799999999999999999865444445556677776666778888999999998 7776554
Q ss_pred -----eEEEEEeeccCCchhhhhhh-cCCCh-------HHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHh
Q psy3347 62 -----HVCFVMEYAAGGDLMMHIHA-DVFSE-------PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128 (245)
Q Consensus 62 -----~~~lv~e~~~~~~L~~~~~~-~~l~~-------~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~ 128 (245)
..|++|||+ +|+|.+++.. ..+++ ..+..++.|++.||+|||++||+|| |+||+||
T Consensus 169 ~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dikp~NI------- 237 (377)
T 3byv_A 169 DMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT---YLRPVDI------- 237 (377)
T ss_dssp -CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE-------
T ss_pred ceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE-------
Confidence 389999999 5799998853 33444 7777899999999999999999999 9999999
Q ss_pred hhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-----------CCCcchhHHH
Q psy3347 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-----------SYTRAVDWWG 197 (245)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dvws 197 (245)
+++.++.+||+|||+++.. .......+| ..|+|||.+.+. .++.++||||
T Consensus 238 ---------------ll~~~~~~kL~DFG~a~~~---~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 238 ---------------VLDQRGGVFLTGFEHLVRD---GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp ---------------EECTTCCEEECCGGGCEET---TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred ---------------EEcCCCCEEEEechhheec---CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 8888999999999998752 222345567 899999999877 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHHhhhc
Q psy3347 198 LGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 198 lG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
|||++|+|++|+.||.+....+....+. ..+..+++++++||+
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~ 341 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLE 341 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHH
Confidence 9999999999999997665433322222 233667888888875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=260.14 Aligned_cols=195 Identities=24% Similarity=0.357 Sum_probs=157.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++..... .....+.+ .++++.++.++||||+++++++...+..++||||+++++|..+..
T Consensus 19 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 94 (311)
T 4agu_A 19 VFKCRNRDTGQIVAIKKFLESED-DPVIKKIA---LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR 94 (311)
T ss_dssp EEEEEETTTCCEEEEEEECCCCC--HHHHHHH---HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred EEEEEeCCCCcEEEEEEeecccc-chHHHHHH---HHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh
Confidence 79999999999999999876432 11222333 345777888999999999999999999999999999999988875
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 95 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 95 YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHR---DVKPENI----------------------LITKHSVIKLCDFGFA 149 (311)
T ss_dssp TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCC---CCChhhE----------------------EEcCCCCEEEeeCCCc
Confidence 4568999999999999999999999999999 9999998 8888999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
..............|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp EECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 764433333445678899999999976 56899999999999999999999999988776665554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=266.29 Aligned_cols=209 Identities=26% Similarity=0.439 Sum_probs=171.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCC-c
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR-----DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG-D 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~-~ 74 (245)
||+|+++.+|+.||+|++........ ...+.+ .+++++++.++||||+++++++...+..++|||++.+| +
T Consensus 40 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~ 116 (335)
T 3dls_A 40 VWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV---TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD 116 (335)
T ss_dssp EEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEE---EHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCB
T ss_pred EEEEEECCCCcEEEEEEEehhhcccccccchHHHHHH---HHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCcc
Confidence 79999999999999999987543221 112223 33477788999999999999999999999999999766 9
Q ss_pred hhhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 75 LMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 75 L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
|..++.. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||
T Consensus 117 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kL 171 (335)
T 3dls_A 117 LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHR---DIKDENI----------------------VIAEDFTIKL 171 (335)
T ss_dssp HHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTSCEEE
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEe---ccCHHHE----------------------EEcCCCcEEE
Confidence 9988865 479999999999999999999999999999 9999999 8888999999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
+|||++..... ........||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.... .........|
T Consensus 172 ~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~ 244 (335)
T 3dls_A 172 IDFGSAAYLER-GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPP 244 (335)
T ss_dssp CCCTTCEECCT-TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCS
T ss_pred eecccceECCC-CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCC
Confidence 99999875332 223445678999999999988776 789999999999999999999997532 2333444567
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++++||+
T Consensus 245 ~~~~~~l~~li~ 256 (335)
T 3dls_A 245 YLVSKELMSLVS 256 (335)
T ss_dssp SCCCHHHHHHHH
T ss_pred cccCHHHHHHHH
Confidence 778888888875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.79 Aligned_cols=214 Identities=28% Similarity=0.481 Sum_probs=177.1
Q ss_pred CEeEEEecC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYRNT-------GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++..+ +..||+|+++... .....+.+.+| +++++.+ +||||+++++++..++..++||||+++
T Consensus 85 Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~ 159 (382)
T 3tt0_A 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISE---MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 159 (382)
T ss_dssp EEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHH---HHHHHHhcCCchhhhheeeeccCCceEEEEEecCC
Confidence 789987643 3589999997642 23333444444 6666677 899999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
++|.+++... .+++..+..++.|++.||+|||++||+|| |+||+||
T Consensus 160 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI-------------- 222 (382)
T 3tt0_A 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR---DLAARNV-------------- 222 (382)
T ss_dssp CBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE--------------
T ss_pred CcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCcceE--------------
Confidence 9999998643 38999999999999999999999999999 9999999
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 223 --------ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 223 --------LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp --------EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred --------EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 88889999999999987543221 12334456778999999999899999999999999999999 99999
Q ss_pred CCCCHHHHHHHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 213 PGDDEEEVFDSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
.+.+..+....+..+. ...|..+++++.+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 327 (382)
T 3tt0_A 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 327 (382)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 9998888888776653 3567889999999886
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=269.44 Aligned_cols=214 Identities=22% Similarity=0.342 Sum_probs=173.6
Q ss_pred CEeEE-----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQ-----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|+ +..+++.||+|+++... .......+.+ ++.+++.++||||+++++++...+..++||||+++++|
T Consensus 87 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 161 (367)
T 3l9p_A 87 VYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLM---EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161 (367)
T ss_dssp EEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEH
T ss_pred EEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHH---HHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCH
Confidence 78998 55678899999997532 2223333444 46678888999999999999999999999999999999
Q ss_pred hhhhhhc--------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 76 MMHIHAD--------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 76 ~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
.++++.. .+++..+..++.|++.||+|||++||+|| |+||+|| +++.
T Consensus 162 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~ 216 (367)
T 3l9p_A 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR---DIAARNC----------------------LLTC 216 (367)
T ss_dssp HHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EESC
T ss_pred HHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC---CCChhhE----------------------EEec
Confidence 9998542 48889999999999999999999999999 8888888 6664
Q ss_pred C---CceEEeecCCccCCCC--CCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 148 E---GYVKIADFGLCKEGMG--FGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 148 ~---~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
+ ..+||+|||+++.... .........+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4 4599999999863211 1122334567889999999988899999999999999999998 99999999988888
Q ss_pred HHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 222 DSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
..+..+. ...|..+++++.+||+
T Consensus 297 ~~i~~~~~~~~~~~~~~~l~~li~ 320 (367)
T 3l9p_A 297 EFVTSGGRMDPPKNCPGPVYRIMT 320 (367)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHH
Confidence 8887764 3567889999999886
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=261.69 Aligned_cols=196 Identities=28% Similarity=0.417 Sum_probs=159.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++..... .....+.+ .++++.++.++||||+++++++...+..++||||+++++|..+..
T Consensus 41 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 116 (331)
T 4aaa_A 41 VMKCRNKDTGRIVAIKKFLESDD-DKMVKKIA---MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL 116 (331)
T ss_dssp EEEEEETTTCCEEEEEEEESCSS-CHHHHHHH---HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred EEEEEECCCCceEEEEEEecCCC-chHHHHHH---HHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh
Confidence 79999999999999999976432 22222233 345777888999999999999999999999999999999988764
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 117 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 117 FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR---DIKPENI----------------------LVSQSGVVKLCDFGFA 171 (331)
T ss_dssp STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEECCCTTC
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHCCEEcc---CcChheE----------------------EEcCCCcEEEEeCCCc
Confidence 4579999999999999999999999999999 9999998 8888999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
..............|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 7543333334456789999999999775 68899999999999999999999999887766655543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=255.57 Aligned_cols=211 Identities=25% Similarity=0.439 Sum_probs=175.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. +++.||+|++...... .+.+. ++++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 26 V~~~~~~-~~~~vavK~~~~~~~~----~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 97 (269)
T 4hcu_A 26 VHLGYWL-NKDKVAIKTIREGAMS----EEDFI---EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR 97 (269)
T ss_dssp EEEEEET-TTEEEEEEEECTTSBC----HHHHH---HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHH
T ss_pred EEEEEec-CCCeEEEEEecccccC----HHHHH---HHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHH
Confidence 7999887 4778999999864322 23344 34777888999999999999999999999999999999999985
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 98 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 98 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR---DLAARNC----------------------LVGENQVIKVSDFGM 152 (269)
T ss_dssp TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECGGGCEEECCTTG
T ss_pred hcCcccCHHHHHHHHHHHHHHHHHHHhCCeecC---CcchheE----------------------EEcCCCCEEeccccc
Confidence 4 458999999999999999999999999999 8999888 778889999999999
Q ss_pred ccCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCCC
Q psy3347 159 CKEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~~ 235 (245)
+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+... ....|..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 153 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 232 (269)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred cccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence 87532211 11223445678999999988889999999999999999999 99999999888888888766 34457788
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.++|+
T Consensus 233 ~~~~~~li~ 241 (269)
T 4hcu_A 233 STHVYQIMN 241 (269)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 999988875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=254.79 Aligned_cols=212 Identities=27% Similarity=0.457 Sum_probs=170.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.+|+|++..... ....+.+.+ +++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 38 V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~---E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 112 (285)
T 3is5_A 38 VHLVEERSSGLERVIKTINKDRS--QVPMEQIEA---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV 112 (285)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHH---HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHH
T ss_pred EEEEEEccCCceEEEEEeecccc--chhHHHHHH---HHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHH
Confidence 79999999999999999986532 222344444 4777889999999999999999999999999999999988773
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceE
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVK 152 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~k 152 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| ++ +.++.++
T Consensus 113 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~---dikp~NI----------------------l~~~~~~~~~~k 167 (285)
T 3is5_A 113 SAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK---DLKPENI----------------------LFQDTSPHSPIK 167 (285)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCSGGGE----------------------EESSSSTTCCEE
T ss_pred hhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEEC---CCCHHHE----------------------EEecCCCCCCEE
Confidence 2 568999999999999999999999999999 8888888 55 4567899
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
|+|||++...... .......|+..|+|||.+. ..++.++||||||+++|+|++|+.||.+.+..+....+......++
T Consensus 168 l~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (285)
T 3is5_A 168 IIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245 (285)
T ss_dssp ECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEeeecceecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc
Confidence 9999998753222 2234557899999999985 4688999999999999999999999999888877777765554433
Q ss_pred ---CCCChhHHhhhc
Q psy3347 233 ---RFLSLEAIAIMR 244 (245)
Q Consensus 233 ---~~~~~~~~~li~ 244 (245)
..+++++.+||+
T Consensus 246 ~~~~~~~~~~~~li~ 260 (285)
T 3is5_A 246 VECRPLTPQAVDLLK 260 (285)
T ss_dssp C--CCCCHHHHHHHH
T ss_pred cccCcCCHHHHHHHH
Confidence 447888888875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=258.91 Aligned_cols=216 Identities=26% Similarity=0.420 Sum_probs=176.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|+++.+|+.||+|++...... ....+.+.+ +++.++.++||||+++++++.. .+..++||||+++++|.++
T Consensus 22 V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (279)
T 2w5a_A 22 CQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVS---EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASV 97 (279)
T ss_dssp EEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHH---HHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHH
T ss_pred EEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHH---HHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHH
Confidence 799999999999999999865322 223334444 4677888899999999998854 5789999999999999998
Q ss_pred hhh-----cCCChHHHHHHHHHHHHHHHHhhhcC-----ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 79 IHA-----DVFSEPRAVFYAACVVLGLQYLHESR-----IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 79 ~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
+.. ..+++..+..++.|++.||+|||++| ++|+ |++|+|| +++.+
T Consensus 98 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~---dl~p~NI----------------------l~~~~ 152 (279)
T 2w5a_A 98 ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR---DLKPANV----------------------FLDGK 152 (279)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCC---CCSGGGE----------------------EECSS
T ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEe---ccchhhE----------------------EEcCC
Confidence 853 24899999999999999999999999 9999 9999998 88889
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (245)
+.++|+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..+.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp SCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 99999999998753322222234568899999999988889999999999999999999999999888888877777665
Q ss_pred c-cCCCCCChhHHhhhcC
Q psy3347 229 V-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~-~~p~~~~~~~~~li~~ 245 (245)
. .+|..+++++.++|++
T Consensus 233 ~~~~~~~~~~~l~~li~~ 250 (279)
T 2w5a_A 233 FRRIPYRYSDELNEIITR 250 (279)
T ss_dssp CCCCCTTSCHHHHHHHHH
T ss_pred cccCCcccCHHHHHHHHH
Confidence 4 5678899999998863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=267.67 Aligned_cols=214 Identities=21% Similarity=0.311 Sum_probs=166.4
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++ .++..||||+++... .....+.+.+ ++++++.++||||+++++++...+..++||||+++++|.+
T Consensus 61 Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~ 135 (373)
T 2qol_A 61 VCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135 (373)
T ss_dssp EEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHH---HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHH---HHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHH
Confidence 7899887 567889999997642 2233344444 4777889999999999999999999999999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+|
T Consensus 136 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kl~D 190 (373)
T 2qol_A 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR---DLAARNI----------------------LINSNLVCKVSD 190 (373)
T ss_dssp HHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEECC
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC---CCCcceE----------------------EEcCCCCEEECc
Confidence 9964 368999999999999999999999999999 9999999 888899999999
Q ss_pred cCCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 156 FGLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+..+. .+
T Consensus 191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998754332211 112234668999999988899999999999999999998 999999888888887776653 34
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.+||.
T Consensus 271 ~~~~~~~~l~~li~ 284 (373)
T 2qol_A 271 PPMDCPAALYQLML 284 (373)
T ss_dssp CCTTCBHHHHHHHH
T ss_pred CCccccHHHHHHHH
Confidence 56778888888875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=264.33 Aligned_cols=195 Identities=29% Similarity=0.478 Sum_probs=157.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--eEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~~ 78 (245)
||+|++..+|+.||+|++..... ....+.+. +++++++.++||||+++++++...+ +.++||||+++++|.++
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 99 (319)
T 4euu_A 25 VFRGRHKKTGDLFAIKVFNNISF--LRPVDVQM---REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTV 99 (319)
T ss_dssp EEEEEETTTCCEEEEEEECGGGG--GSCHHHHH---HHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHH
T ss_pred EEEEEECCCCcEEEEEEeccccc--cchHHHHH---HHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHH
Confidence 79999999999999999985432 12233333 4477788889999999999998765 88999999999999999
Q ss_pred hhhc----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc----CCCCc
Q psy3347 79 IHAD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN----DTEGY 150 (245)
Q Consensus 79 ~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 150 (245)
+... .+++..+..++.|++.||+|||++||+|+ |+||+|| ++ +.++.
T Consensus 100 l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~~ 154 (319)
T 4euu_A 100 LEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR---NIKPGNI----------------------MRVIGEDGQSV 154 (319)
T ss_dssp HHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEEECTTSCEE
T ss_pred HHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CCCHHHE----------------------EEeccCCCCce
Confidence 8542 38999999999999999999999999999 8888888 55 66778
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCcccccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CHH
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT--------ETSYTRAVDWWGLGVLIFEMLVGESPFPGD----DEE 218 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~~g~~pf~~~----~~~ 218 (245)
+||+|||+++..... .......|+..|+|||.+. +..++.++|||||||++|+|++|+.||... ...
T Consensus 155 ~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 233 (319)
T 4euu_A 155 YKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233 (319)
T ss_dssp EEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred EEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence 999999999754332 2234557899999999986 467889999999999999999999999643 234
Q ss_pred HHHHHHhc
Q psy3347 219 EVFDSIVN 226 (245)
Q Consensus 219 ~~~~~~~~ 226 (245)
+....+..
T Consensus 234 ~~~~~~~~ 241 (319)
T 4euu_A 234 EVMYKIIT 241 (319)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhc
Confidence 45555544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=259.76 Aligned_cols=214 Identities=29% Similarity=0.474 Sum_probs=167.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh-cCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT-MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+|+.||+|++..... ...+.+.+| ++.+.+ .+||||+++++++..++..++||||+++++|.+++
T Consensus 29 V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (316)
T 2ac3_A 29 VQTCINLITSQEYAVKIIEKQPG---HIRSRVFRE---VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI 102 (316)
T ss_dssp EEEEECSSSCCEEEEEEEECCSS---CCHHHHHHH---HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred EEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHH---HHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence 79999999999999999976431 223344444 555666 47999999999999999999999999999999988
Q ss_pred h-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc---eEEee
Q psy3347 80 H-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY---VKIAD 155 (245)
Q Consensus 80 ~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~kl~D 155 (245)
. ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++. +||+|
T Consensus 103 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 103 HKRRHFNELEASVVVQDVASALDFLHNKGIAHR---DLKPENI----------------------LCEHPNQVSPVKICD 157 (316)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EESCSSSSCSEEECC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCceeC---CCCHHHE----------------------EEccCCCcCceEEEE
Confidence 5 4678999999999999999999999999999 8888888 6666554 99999
Q ss_pred cCCccCCCCCCC-------CCCcccCCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------
Q psy3347 156 FGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIFEMLVGESPFPGDD------- 216 (245)
Q Consensus 156 fg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~pf~~~~------- 216 (245)
||++........ .....+|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999874321111 1223468999999999965 457899999999999999999999997653
Q ss_pred --------HHHHHHHHhcCcccCC----CCCChhHHhhhcC
Q psy3347 217 --------EEEVFDSIVNDEVRYP----RFLSLEAIAIMRR 245 (245)
Q Consensus 217 --------~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 245 (245)
.......+..+...+| ..+++++++||++
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 278 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred ccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHH
Confidence 2345556666666655 4688899988863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=260.08 Aligned_cols=214 Identities=25% Similarity=0.428 Sum_probs=176.2
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+. .+++.||+|++.... .....+.+. ++++.++.++||||+++++++...+..++||||+++++|
T Consensus 39 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 113 (314)
T 2ivs_A 39 VVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLL---SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113 (314)
T ss_dssp EEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHH---HHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHH---HHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCH
Confidence 7899884 456899999997542 223334444 457788899999999999999999999999999999999
Q ss_pred hhhhhhc-------------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhh
Q psy3347 76 MMHIHAD-------------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130 (245)
Q Consensus 76 ~~~~~~~-------------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~ 130 (245)
.+++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 114 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---dikp~NI--------- 181 (314)
T 2ivs_A 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR---DLAARNI--------- 181 (314)
T ss_dssp HHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE---------
T ss_pred HHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc---ccchheE---------
Confidence 9998542 27888999999999999999999999999 9999998
Q ss_pred ccccCcccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-
Q psy3347 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV- 207 (245)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~- 207 (245)
+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 182 -------------li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 182 -------------LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp -------------EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred -------------EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 888889999999999875322221 1233456778999999988889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 208 GESPFPGDDEEEVFDSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 208 g~~pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
|..||.+.+..+....+.... ...|..+++++.++|+
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 286 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLML 286 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHH
Confidence 999999888877777776653 3567889999999886
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=267.07 Aligned_cols=192 Identities=24% Similarity=0.443 Sum_probs=148.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|++..+|+.||||++..... .....+.+ .+++++++.++||||+++++++... +..+++||++ +++
T Consensus 45 V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~---~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~ 119 (367)
T 2fst_X 45 VCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRT---YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD 119 (367)
T ss_dssp EEEEEETTTTEEEEEEECSSTTS-SHHHHHHH---HHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEE
T ss_pred EEEEEECCCCCEEEEEEeCcccc-CHHHHHHH---HHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCC
Confidence 79999999999999999975421 22222333 4557778889999999999999654 5689999998 679
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|..+++...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 120 L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~---Dlkp~NI----------------------ll~~~~~~kL~ 174 (367)
T 2fst_X 120 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR---DLKPSNL----------------------AVNEDCELKIL 174 (367)
T ss_dssp CC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCCHhhE----------------------EECCCCCEEEe
Confidence 9999888889999999999999999999999999999 9999999 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||+++.... .....+||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 175 DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 243 (367)
T 2fst_X 175 DFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243 (367)
T ss_dssp C------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999875322 2345678999999999977 678999999999999999999999999988777666654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=260.00 Aligned_cols=214 Identities=29% Similarity=0.480 Sum_probs=172.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++...... ......+.+| +..++.+ .||||+++++++...+..++||||+.+++|.+++
T Consensus 45 V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e---~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 120 (327)
T 3lm5_A 45 VRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHE---IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120 (327)
T ss_dssp EEEEEETTTCCEEEEEEEESEETT-EECHHHHHHH---HHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGG
T ss_pred EEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHH---HHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHH
Confidence 799999999999999999864322 1223444444 4455555 5799999999999999999999999999999988
Q ss_pred hh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCceEE
Q psy3347 80 HA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGYVKI 153 (245)
Q Consensus 80 ~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~kl 153 (245)
.. ..+++..+..++.|++.||+|||++|++|| |++|+|| +++. ++.++|
T Consensus 121 ~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~---Dikp~NI----------------------l~~~~~~~~~~kL 175 (327)
T 3lm5_A 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL---DLKPQNI----------------------LLSSIYPLGDIKI 175 (327)
T ss_dssp SSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EESCBTTBCCEEE
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC---cCChHHE----------------------EEecCCCCCcEEE
Confidence 43 568999999999999999999999999999 8888888 6555 789999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC--
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY-- 231 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 231 (245)
+|||++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......+
T Consensus 176 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 176 VDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp CCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 999998753222 22344578999999999998899999999999999999999999999988887777776554433
Q ss_pred --CCCCChhHHhhhc
Q psy3347 232 --PRFLSLEAIAIMR 244 (245)
Q Consensus 232 --p~~~~~~~~~li~ 244 (245)
+..+++++++||+
T Consensus 255 ~~~~~~~~~~~~li~ 269 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQ 269 (327)
T ss_dssp TTTTTSCHHHHHHHH
T ss_pred hhhcccCHHHHHHHH
Confidence 3568888888875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=253.96 Aligned_cols=213 Identities=26% Similarity=0.451 Sum_probs=164.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIA-RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++. |+.||+|++....... ....+.+ .++++.++.++||||+++++++..++..++||||+++++|.+++
T Consensus 23 V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 97 (271)
T 3dtc_A 23 VYRAFWI--GDEVAVKAARHDPDEDISQTIENV---RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 97 (271)
T ss_dssp EEEEEET--TEEEEEEEC----------CHHHH---HHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHH
T ss_pred EEEEEEc--CCeEEEEEEecCCcccHHHHHHHH---HHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHh
Confidence 7889874 8999999997643221 1122333 34477788889999999999999999999999999999999999
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcC---ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC--------C
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESR---IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT--------E 148 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 148 (245)
+...+++..+..++.|++.||+|||++| ++|+ |++|+|| +++. +
T Consensus 98 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~---dikp~Ni----------------------l~~~~~~~~~~~~ 152 (271)
T 3dtc_A 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR---DLKSSNI----------------------LILQKVENGDLSN 152 (271)
T ss_dssp TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCS---CCSGGGE----------------------EESSCCSSSCCSS
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec---CCchHHE----------------------EEecccccccccC
Confidence 8888999999999999999999999999 8899 8888888 4443 6
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (245)
+.++|+|||++....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred cceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 789999999987532222 234568899999999988889999999999999999999999999888877777766554
Q ss_pred c--cCCCCCChhHHhhhcC
Q psy3347 229 V--RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~--~~p~~~~~~~~~li~~ 245 (245)
. +.|..+++++.++|++
T Consensus 231 ~~~~~~~~~~~~~~~li~~ 249 (271)
T 3dtc_A 231 LALPIPSTCPEPFAKLMED 249 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHH
Confidence 3 4578899999998863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=264.17 Aligned_cols=209 Identities=21% Similarity=0.299 Sum_probs=165.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+|+.||+|++..... .+.+.+| ++.++.+ +||||+++++++..++..++||||+ +++|.+++
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E---~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 95 (330)
T 2izr_A 25 LRLGKNLYTNEYVAIKLEPMKSR-----APQLHLE---YRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLF 95 (330)
T ss_dssp EEEEEETTTTEEEEEEEEETTCS-----SCCHHHH---HHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred EEEEEECCCCcEEEEEEeccccc-----hHHHHHH---HHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHH
Confidence 79999999999999999875421 1234444 5556667 8999999999999999999999999 88999998
Q ss_pred h--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc-----eE
Q psy3347 80 H--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY-----VK 152 (245)
Q Consensus 80 ~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~k 152 (245)
. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++. ++
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHr---Dlkp~Ni----------------------ll~~~~~~~~~~~k 150 (330)
T 2izr_A 96 DLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR---DVKPENF----------------------LIGRPGNKTQQVIH 150 (330)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECCGGGTCTTSEE
T ss_pred HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCCHHHe----------------------eeccCCCCCCceEE
Confidence 6 3679999999999999999999999999999 8888888 7777666 99
Q ss_pred EeecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Q psy3347 153 IADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFD 222 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~---~~~~~~~ 222 (245)
|+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+. ...+...
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 999999975322221 124567899999999999989999999999999999999999999874 3344444
Q ss_pred HHhcCcccCC-----CCCChhHHhhhc
Q psy3347 223 SIVNDEVRYP-----RFLSLEAIAIMR 244 (245)
Q Consensus 223 ~~~~~~~~~p-----~~~~~~~~~li~ 244 (245)
.+.....+.| ..++ ++.++|+
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~ 256 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLR 256 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHH
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHH
Confidence 4433332222 2233 6666654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=253.85 Aligned_cols=218 Identities=22% Similarity=0.374 Sum_probs=176.5
Q ss_pred CEeEEEecCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII---ARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++.+|+.||+|++...... ............++++.++.+. ||||+++++++..++..++||||+++++|.
T Consensus 33 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (298)
T 1phk_A 33 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 112 (298)
T ss_dssp EEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred EEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHH
Confidence 799999999999999999764311 1111111222344566677774 999999999999999999999999999999
Q ss_pred hhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 113 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~kl~d 167 (298)
T 1phk_A 113 DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR---DLKPENI----------------------LLDDDMNIKLTD 167 (298)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECC
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCcceE----------------------EEcCCCcEEEec
Confidence 99854 578999999999999999999999999999 8999898 888899999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCcccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLT------ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~ 229 (245)
||++..... ........++..|+|||.+. ...++.++||||||+++|+|++|..||.+.+..+....+..+..
T Consensus 168 fg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 168 FGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CTTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ccchhhcCC-CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999875322 22334557889999999985 34678899999999999999999999998888888777777655
Q ss_pred cCC----CCCChhHHhhhc
Q psy3347 230 RYP----RFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p----~~~~~~~~~li~ 244 (245)
.++ ..+++++.+||+
T Consensus 247 ~~~~~~~~~~~~~l~~li~ 265 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVS 265 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHH
T ss_pred ccCcccccccCHHHHHHHH
Confidence 443 357888888875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=277.72 Aligned_cols=212 Identities=26% Similarity=0.420 Sum_probs=177.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.||||+++.... ..+.+.+ ++++++.++||||+++++++...+..++||||+++++|.++++
T Consensus 236 Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~ 308 (495)
T 1opk_A 236 VYEGVWKKYSLTVAVKTLKEDTM----EVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308 (495)
T ss_dssp EEEEEEGGGTEEEEEEECCSSSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred EEEEEEcCCCeEEEEEEecCccc----chHHHHH---HHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHH
Confidence 79999999999999999986431 2344444 4677888899999999999999999999999999999999986
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++||+|| |++|+|| +++.++.+||+|||
T Consensus 309 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kl~DFG 363 (495)
T 1opk_A 309 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR---NLAARNC----------------------LVGENHLVKVADFG 363 (495)
T ss_dssp HSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECGGGCEEECCTT
T ss_pred hcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCChhhE----------------------EECCCCcEEEeecc
Confidence 4 358899999999999999999999999999 8999888 78888999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..+ ..+.|..
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 9985432221 1223345678999999988889999999999999999999 99999988877777766554 3356788
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
+++++.+||+
T Consensus 444 ~~~~l~~li~ 453 (495)
T 1opk_A 444 CPEKVYELMR 453 (495)
T ss_dssp CCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 9999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=254.97 Aligned_cols=216 Identities=24% Similarity=0.383 Sum_probs=165.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++...........+.+.+ ++..++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 48 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 124 (310)
T 2wqm_A 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124 (310)
T ss_dssp EEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHH---HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEEcCCCceEEEEeeehhhccCHHHHHHHHH---HHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHH
Confidence 7999999999999999998644333334444444 4777888999999999999999999999999999999998885
Q ss_pred h-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 A-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 125 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~---dl~p~NI----------------------l~~~~~~~kl~D 179 (310)
T 2wqm_A 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR---DIKPANV----------------------FITATGVVKLGD 179 (310)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEECC
T ss_pred HhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCC---CCcHHHE----------------------EEcCCCCEEEEe
Confidence 2 458999999999999999999999999999 8999998 888899999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCccc-C-
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD--DEEEVFDSIVNDEVR-Y- 231 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~--~~~~~~~~~~~~~~~-~- 231 (245)
||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||.+. ........+.....+ .
T Consensus 180 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T 2wqm_A 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 259 (310)
T ss_dssp C------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC
T ss_pred ccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc
Confidence 999875433333334557889999999998888999999999999999999999999754 334455555544332 2
Q ss_pred CCCCChhHHhhhc
Q psy3347 232 PRFLSLEAIAIMR 244 (245)
Q Consensus 232 p~~~~~~~~~li~ 244 (245)
+..+++++.+||+
T Consensus 260 ~~~~~~~l~~li~ 272 (310)
T 2wqm_A 260 SDHYSEELRQLVN 272 (310)
T ss_dssp TTTSCHHHHHHHH
T ss_pred ccccCHHHHHHHH
Confidence 3678888988875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=257.21 Aligned_cols=211 Identities=26% Similarity=0.437 Sum_probs=176.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+..+|+.||+|++.... ..+.+.+ ++..++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 45 Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 116 (314)
T 3com_A 45 VYKAIHKETGQIVAIKQVPVES-----DLQEIIK---EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR 116 (314)
T ss_dssp EEEEEETTTCCEEEEEEEETTS-----CCHHHHH---HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEecCchH-----HHHHHHH---HHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHH
Confidence 7999999999999999997542 1233433 4677888999999999999999999999999999999999885
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||+.|++|+ |++|+|| +++.++.++|+|||+
T Consensus 117 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~kl~dfg~ 171 (314)
T 3com_A 117 LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR---DIKAGNI----------------------LLNTEGHAKLADFGV 171 (314)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCCTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC---CcCHHHE----------------------EECCCCCEEEeeccc
Confidence 4578999999999999999999999999999 9999998 888889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~ 235 (245)
+..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..... ..|..+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T 3com_A 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251 (314)
T ss_dssp CEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred chhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence 87543333334456788999999999888899999999999999999999999988777665555544322 235567
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.+||+
T Consensus 252 ~~~l~~li~ 260 (314)
T 3com_A 252 SDNFTDFVK 260 (314)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 888888875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=263.44 Aligned_cols=197 Identities=26% Similarity=0.430 Sum_probs=160.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh--hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD--EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++..+|+.||+|++......... ..+.+ .+++++++.++||||+++++++...+..++||||+++ +|..+
T Consensus 26 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~ 101 (346)
T 1ua2_A 26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA---LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI 101 (346)
T ss_dssp EEEEECSSCCSEEEEEEC------------CTHH---HHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHH
T ss_pred EEEEEECCCCcEEEEEEEecCCcchhhhhhhHHH---HHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHH
Confidence 799999999999999999754321111 11223 3457778889999999999999999999999999986 78777
Q ss_pred hhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+||
T Consensus 102 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~~~kl~Df 156 (346)
T 1ua2_A 102 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR---DLKPNNL----------------------LLDENGVLKLADF 156 (346)
T ss_dssp HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTCCEEECCC
T ss_pred HHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECC---CCCHHHE----------------------EEcCCCCEEEEec
Confidence 754 358899999999999999999999999999 9999999 8888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|+++.............+|+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9997644433344556789999999999764 578999999999999999999999999888777776643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=255.91 Aligned_cols=212 Identities=25% Similarity=0.409 Sum_probs=177.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+++.||+|++.... ...+.+.+ +++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 29 V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 101 (288)
T 3kfa_A 29 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 101 (288)
T ss_dssp EEEEEEGGGTEEEEEEEECSCS----THHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHH
T ss_pred EEEeEecCCCEEEEEEecCcCH----HHHHHHHH---HHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHH
Confidence 7999999999999999997542 22344444 4677888899999999999999999999999999999999985
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 102 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 102 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR---DLAARNC----------------------LVGENHLVKVADFG 156 (288)
T ss_dssp HCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCS---CCSGGGE----------------------EECGGGCEEECCCC
T ss_pred hcccCCccHhHHHHHHHHHHHHHHHHHHCCccCC---CCCcceE----------------------EEcCCCCEEEccCc
Confidence 4 358999999999999999999999999999 8999888 77888899999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+... ....|..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence 9875433221 1223445678999999988889999999999999999999 99999988877777766554 3456788
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
+++++.+||+
T Consensus 237 ~~~~l~~li~ 246 (288)
T 3kfa_A 237 CPEKVYELMR 246 (288)
T ss_dssp CCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 9999998886
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.18 Aligned_cols=216 Identities=21% Similarity=0.352 Sum_probs=163.1
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeE------EEEEeecc
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHV------CFVMEYAA 71 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~------~lv~e~~~ 71 (245)
||+|+++.+++ .||+|+++..... ....+.+ .++++.++.++||||+++++++...+.. +++|||+.
T Consensus 39 Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~ 114 (323)
T 3qup_A 39 VREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEF---LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114 (323)
T ss_dssp EEEEEC-------CEEEEEEC-------CHHHHHH---HHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCT
T ss_pred EEEEEEcccCCcceeEEEEEecccccC-HHHHHHH---HHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEecc
Confidence 79999888775 8999999764322 2233444 4457788899999999999999876654 99999999
Q ss_pred CCchhhhhhhc-------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 72 GGDLMMHIHAD-------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 72 ~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
+++|.+++... .+++..+..++.|++.||+|||++|++|+ |+||+|| +
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~---Dikp~NI----------------------l 169 (323)
T 3qup_A 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR---DLAARNC----------------------M 169 (323)
T ss_dssp TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------E
T ss_pred CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccC---CCCcceE----------------------E
Confidence 99999888432 58899999999999999999999999999 9999999 8
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 249 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence 88899999999999875322211 1223345678999999988889999999999999999999 99999998888888
Q ss_pred HHHhcCc-ccCCCCCChhHHhhhcC
Q psy3347 222 DSIVNDE-VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~~-~~~p~~~~~~~~~li~~ 245 (245)
..+..+. ...|..+++++.+||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~ 274 (323)
T 3qup_A 250 NYLIGGNRLKQPPECMEEVYDLMYQ 274 (323)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred HHHhcCCCCCCCCccCHHHHHHHHH
Confidence 8776654 45678899999998863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=266.18 Aligned_cols=214 Identities=27% Similarity=0.468 Sum_probs=169.3
Q ss_pred CEeEE-----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCC-eEEEEEeeccCC
Q psy3347 1 VILSQ-----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEA-HVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~-~~~lv~e~~~~~ 73 (245)
||+|+ +..+++.||+|+++... .....+.+.+| ++.++.+ +||||+++++++...+ ..++||||+++|
T Consensus 38 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g 112 (359)
T 3vhe_A 38 VIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSE---LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 112 (359)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTE
T ss_pred EEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHH---HHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCC
Confidence 78998 55677999999997642 22333445555 5566666 7999999999997754 589999999999
Q ss_pred chhhhhhhcC-------------------------------------------------------------------CCh
Q psy3347 74 DLMMHIHADV-------------------------------------------------------------------FSE 86 (245)
Q Consensus 74 ~L~~~~~~~~-------------------------------------------------------------------l~~ 86 (245)
+|.++++... +++
T Consensus 113 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 192 (359)
T 3vhe_A 113 NLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192 (359)
T ss_dssp EHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCH
T ss_pred cHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCH
Confidence 9999885421 788
Q ss_pred HHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCC
Q psy3347 87 PRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG 166 (245)
Q Consensus 87 ~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 166 (245)
..+..++.|++.||+|||++||+|+ |+||+|| +++.++.++|+|||++.......
T Consensus 193 ~~~~~~~~ql~~aL~~LH~~~ivH~---Dikp~NI----------------------ll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 193 EHLICYSFQVAKGMEFLASRKCIHR---DLAARNI----------------------LLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECGGGCEEECCCGGGSCTTSCT
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccC---CCChhhE----------------------EEcCCCcEEEEeccceeeecccc
Confidence 8999999999999999999999999 9999998 78888999999999987542222
Q ss_pred C--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHhcC-cccCCCCCChhHHh
Q psy3347 167 D--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF-DSIVND-EVRYPRFLSLEAIA 241 (245)
Q Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~-~~~~~~-~~~~p~~~~~~~~~ 241 (245)
. ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+.. ..+... ....|..+++++.+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2 2334567888999999988889999999999999999998 99999877644333 333333 34567889999999
Q ss_pred hhc
Q psy3347 242 IMR 244 (245)
Q Consensus 242 li~ 244 (245)
+|+
T Consensus 328 li~ 330 (359)
T 3vhe_A 328 TML 330 (359)
T ss_dssp HHH
T ss_pred HHH
Confidence 885
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=263.47 Aligned_cols=195 Identities=23% Similarity=0.417 Sum_probs=155.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++..... ......+ .+++++++.++||||+++++++...+..++||||+++ +|.+++.
T Consensus 18 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (324)
T 3mtl_A 18 VYKGKSKLTDNLVALKEIRLEHE--EGAPCTA---IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD 91 (324)
T ss_dssp EEEEEETTTCCEEEEEEECC--------CCCC---CCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEecccc--cccchhH---HHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHH
Confidence 79999999999999999975421 1111122 2347778899999999999999999999999999975 8887775
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|+ |++|+|| +++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~---Dikp~NI----------------------l~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 92 DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR---DLKPQNL----------------------LINERGELKLADFGL 146 (324)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES---SCCGGGE----------------------EECTTCCEEECSSSE
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC---CcCHHHE----------------------EECCCCCEEEccCcc
Confidence 3 458999999999999999999999999999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+..............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 147 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 147 ARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp EECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8754333333445578999999999976 5689999999999999999999999999888777766644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.65 Aligned_cols=207 Identities=25% Similarity=0.457 Sum_probs=171.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-eEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-HVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.+. |+.||||+++... ..+.+.+| +.+++.++||||+++++++.... ..++||||+++|+|.+++
T Consensus 209 V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l 278 (450)
T 1k9a_A 209 VMLGDYR--GNKVAVKCIKNDA-----TAQAFLAE---ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278 (450)
T ss_dssp EEEEEET--TEEEEEEEESSCT-----TSHHHHHH---HHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHH
T ss_pred EEEEEec--CCeEEEEEeCCch-----HHHHHHHH---HHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHH
Confidence 7888775 8899999998642 22344444 67788999999999999987654 799999999999999999
Q ss_pred hhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+.. .+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+||
T Consensus 279 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~kl~Df 333 (450)
T 1k9a_A 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR---DLAARNV----------------------LVSEDNVAKVSDF 333 (450)
T ss_dssp HHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EECTTSCEEECCC
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCCHhhE----------------------EECCCCCEEEeeC
Confidence 642 36889999999999999999999999999 9999998 8888999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
|+++..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+..+ ..+.|..
T Consensus 334 G~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~ 410 (450)
T 1k9a_A 334 GLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410 (450)
T ss_dssp TTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred CCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 998743221 223356788999999999999999999999999999998 99999988877777777665 3456889
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.+||++
T Consensus 411 ~~~~l~~li~~ 421 (450)
T 1k9a_A 411 CPPAVYDVMKN 421 (450)
T ss_dssp CCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=259.72 Aligned_cols=214 Identities=25% Similarity=0.445 Sum_probs=173.7
Q ss_pred CEeEEEecCCcEE--EEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYF--AIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.+ |+|.++... .....+.+.+ +++.++.+ +||||+++++++...+..++||||+++++|.+
T Consensus 41 Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~---E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 115 (327)
T 1fvr_A 41 VLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAG---ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115 (327)
T ss_dssp EEEEEEEETTEEEEEEEEEEECC--------CHHHH---HHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred EEEEEEccCCcccceeeeeecccc--chHHHHHHHH---HHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHH
Confidence 7999999999866 999887532 2222334444 46778888 89999999999999999999999999999999
Q ss_pred hhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 78 HIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 78 ~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 116 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---dlkp~NI------------------- 173 (327)
T 1fvr_A 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR---DLAARNI------------------- 173 (327)
T ss_dssp HHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE-------------------
T ss_pred HHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCccceE-------------------
Confidence 88543 58999999999999999999999999999 9999888
Q ss_pred hccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~ 219 (245)
+++.++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 174 ---l~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 174 ---LVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp ---EECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ---EEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 7788899999999998742211 12233456778999999988889999999999999999998 999999988888
Q ss_pred HHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 220 VFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 220 ~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
....+..+ ....|..+++++.+||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~li~~ 276 (327)
T 1fvr_A 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQ 276 (327)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHH
Confidence 88777665 335677889999998863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=251.50 Aligned_cols=211 Identities=21% Similarity=0.342 Sum_probs=174.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ +++.||+|+++..... .+.+.+ +++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 24 V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 95 (268)
T 3sxs_A 24 VKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQ---EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR 95 (268)
T ss_dssp EEEEEET-TTEEEEEEEECBTTBC----HHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHH
T ss_pred EEEEEec-CceeEEEEEeccCCCc----HHHHHH---HHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHH
Confidence 7899776 5778999999864322 233433 4677888899999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 96 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR---DLAARNC----------------------LVDRDLCVKVSDFGM 150 (268)
T ss_dssp HHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEES---SCSGGGE----------------------EECTTCCEEECCTTC
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CcCcceE----------------------EECCCCCEEEccCcc
Confidence 4 358999999999999999999999999999 9999998 888899999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cCCCCC
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~p~~~ 235 (245)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..... ..|..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T 3sxs_A 151 TRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA 230 (268)
T ss_dssp EEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTS
T ss_pred ceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcC
Confidence 875332221 1223345667999999988889999999999999999999 9999998888888777766544 457778
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.++|+
T Consensus 231 ~~~l~~li~ 239 (268)
T 3sxs_A 231 SDTIYQIMY 239 (268)
T ss_dssp CHHHHHHHH
T ss_pred hHHHHHHHH
Confidence 888888875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=257.74 Aligned_cols=214 Identities=20% Similarity=0.316 Sum_probs=176.7
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.++ .+++.||+|++.... .......+ .+++..++.++||||+++++++...+..++||||+++++|
T Consensus 41 Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~---~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 115 (322)
T 1p4o_A 41 VYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEF---LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115 (322)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHH---HHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEeeeecCccCCCCceEEEEEeccccc--CHHHHHHH---HHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcH
Confidence 7888887 468899999997542 22222333 3457888999999999999999999999999999999999
Q ss_pred hhhhhh-----------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 76 MMHIHA-----------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 76 ~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
.+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +
T Consensus 116 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dikp~NI----------------------l 170 (322)
T 1p4o_A 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR---DLAARNC----------------------M 170 (322)
T ss_dssp HHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS---CCSGGGE----------------------E
T ss_pred HHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccC---CCccceE----------------------E
Confidence 998853 356889999999999999999999999999 9999998 8
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 88899999999999874322211 1223355778999999988889999999999999999999 89999998888888
Q ss_pred HHHhcCcc-cCCCCCChhHHhhhc
Q psy3347 222 DSIVNDEV-RYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~~~-~~p~~~~~~~~~li~ 244 (245)
..+..+.. ..|..+++++.+||+
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~ 274 (322)
T 1p4o_A 251 RFVMEGGLLDKPDNCPDMLFELMR 274 (322)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHH
Confidence 87766543 467889999998886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=255.51 Aligned_cols=208 Identities=18% Similarity=0.298 Sum_probs=165.4
Q ss_pred CEeEEEecCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCC
Q psy3347 1 VILSQYRNTG-------EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 73 (245)
||+|+++.++ +.||+|++.... ....+.+. ++++.++.++||||+++++++..++..++||||++++
T Consensus 24 V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 97 (289)
T 4fvq_A 24 IFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFF---EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFG 97 (289)
T ss_dssp EEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHH---HHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTC
T ss_pred EEEEEEecccccccccchhhhhhhccccc---HHHHHHHH---HHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCC
Confidence 7999999887 479999997542 22233444 4477788999999999999999999999999999999
Q ss_pred chhhhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc-
Q psy3347 74 DLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY- 150 (245)
Q Consensus 74 ~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 150 (245)
+|.+++... .+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.
T Consensus 98 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~ 152 (289)
T 4fvq_A 98 SLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHG---NVCAKNI----------------------LLIREEDR 152 (289)
T ss_dssp BHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EEEECCBG
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECC---CcCcceE----------------------EEecCCcc
Confidence 999999643 38999999999999999999999999999 8888888 5555554
Q ss_pred -------eEEeecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 151 -------VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 151 -------~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
++|+|||++..... .....++..|+|||.+.+ ..++.++||||||+++|+|++ +.+||...+.....
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred cccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 99999999864321 223457888999999987 678999999999999999999 55666555544443
Q ss_pred HHHhcCcccCCCCCChhHHhhhc
Q psy3347 222 DSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
.........|...++++.+||+
T Consensus 229 -~~~~~~~~~~~~~~~~l~~li~ 250 (289)
T 4fvq_A 229 -QFYEDRHQLPAPKAAELANLIN 250 (289)
T ss_dssp -HHHHTTCCCCCCSSCTTHHHHH
T ss_pred -HHhhccCCCCCCCCHHHHHHHH
Confidence 3444455667777888888775
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.51 Aligned_cols=188 Identities=20% Similarity=0.377 Sum_probs=155.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee---------------------
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--------------------- 59 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--------------------- 59 (245)
||+|++..+|+.||+|++....... .+++++++.++||||++++++|..
T Consensus 23 V~~a~~~~~~~~vAiK~~~~~~~~~----------~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (383)
T 3eb0_A 23 VCEVFDIESGKRFALKKVLQDPRYK----------NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGK 92 (383)
T ss_dssp EEEEEETTTCCEEEEEEEECCTTSC----------CHHHHHHTTCCCTTBCCEEEEEEEC--------------------
T ss_pred EEEEEECCCCCEEEEEEEecCcchH----------HHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccc
Confidence 7999999999999999997542111 234778889999999999999844
Q ss_pred -----------------CCeEEEEEeeccCCchhhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCC
Q psy3347 60 -----------------EAHVCFVMEYAAGGDLMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117 (245)
Q Consensus 60 -----------------~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~ 117 (245)
..+.++||||+++ +|.+.+. ...+++..++.++.|++.||+|||++||+|| |+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~---Dik 168 (383)
T 3eb0_A 93 NNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR---DIK 168 (383)
T ss_dssp -----------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS---CCC
T ss_pred ccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC---ccC
Confidence 3358999999985 7665553 3578999999999999999999999999999 899
Q ss_pred HHHHHHHHHHhhhccccCcccchhccccC-CCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhH
Q psy3347 118 KEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDW 195 (245)
Q Consensus 118 ~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv 195 (245)
|+|| +++ .++.+||+|||+++..... .......++..|+|||.+.+. .++.++||
T Consensus 169 p~Ni----------------------l~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 169 PQNL----------------------LVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp GGGE----------------------EEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHE----------------------EEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 9888 665 5789999999999753222 234456789999999999775 48999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 196 WGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 196 wslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||||++|+|++|+.||.+.+..+....+.
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~~~~i~ 255 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQLVRII 255 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999999999999988877776664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=259.59 Aligned_cols=211 Identities=20% Similarity=0.331 Sum_probs=159.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHh--hcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVAN--TMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++..+|+.||+|+++... ...+....|.+++..+. .++||||+++++++...++.++|||++ +++|.++
T Consensus 51 V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~ 125 (360)
T 3llt_A 51 VLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEI 125 (360)
T ss_dssp EEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHH
T ss_pred EEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHH
Confidence 7999999999999999997431 22333444443333332 124999999999999999999999999 8899998
Q ss_pred hhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC--------cccchhccccCC
Q psy3347 79 IHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN--------SSQEIKLTVNDT 147 (245)
Q Consensus 79 ~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~--------~~~~~~~~~~~~ 147 (245)
+... .+++..+..++.|++.||+|||++||+|| |+||+|| ++....... ...+........
T Consensus 126 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~NI-----ll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (360)
T 3llt_A 126 ITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHT---DLKPENI-----LLDDPYFEKSLITVRRVTDGKKIQIYRTK 197 (360)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE-----EESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC---CCCcccE-----EEccccccccccchhcccccccccccccC
Confidence 8643 48999999999999999999999999999 7777777 322110000 000000000123
Q ss_pred CCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q psy3347 148 EGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND 227 (245)
Q Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (245)
++.+||+|||++..... ......||..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 198 ~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 274 (360)
T 3llt_A 198 STGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274 (360)
T ss_dssp CCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence 78899999999975322 234567899999999999999999999999999999999999999988877777666543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=259.81 Aligned_cols=196 Identities=23% Similarity=0.364 Sum_probs=159.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--------CCeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--------EAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--------~~~~~lv~e~~~~ 72 (245)
||+|+++.+|+.||+|++....... .....+. +++++++.++||||+++++++.. .+..++||||+++
T Consensus 33 V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 108 (351)
T 3mi9_A 33 VFKARHRKTGQKVALKKVLMENEKE-GFPITAL---REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108 (351)
T ss_dssp EEEEEETTTCCEEEEEECCCSSCSS-SSCHHHH---HHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE
T ss_pred EEEEEECCCCCEEEEEEEecccccc-cchHHHH---HHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC
Confidence 7999999999999999997653222 1122333 44677888899999999999976 4578999999986
Q ss_pred Cchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 73 GDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 73 ~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|...+.. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.
T Consensus 109 -~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~---Dlkp~NI----------------------l~~~~~~ 162 (351)
T 3mi9_A 109 -DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR---DMKAANV----------------------LITRDGV 162 (351)
T ss_dssp -EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSC
T ss_pred -CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC---CCCHHHE----------------------EEcCCCC
Confidence 66665533 568999999999999999999999999999 9999999 8888999
Q ss_pred eEEeecCCccCCCC----CCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 151 VKIADFGLCKEGMG----FGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+||+|||++..... .........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999874321 1122345578999999999976 458999999999999999999999999988877777765
Q ss_pred c
Q psy3347 226 N 226 (245)
Q Consensus 226 ~ 226 (245)
.
T Consensus 243 ~ 243 (351)
T 3mi9_A 243 Q 243 (351)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=264.39 Aligned_cols=217 Identities=38% Similarity=0.697 Sum_probs=173.2
Q ss_pred CEeEEEe---cCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR---NTGEYFAIKALKKGDIIA-RDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++. .+|+.||+|+++...... ....+.+.+| +++++.+ +||||+++++++...+..++||||+++++|
T Consensus 70 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 146 (355)
T 1vzo_A 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE---RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146 (355)
T ss_dssp EEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCH---HHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHH---HHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCH
Confidence 7899884 589999999997643211 1122333334 4555555 699999999999999999999999999999
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
.+++. ...+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.+||+
T Consensus 147 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kl~ 201 (355)
T 1vzo_A 147 FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR---DIKLENI----------------------LLDSNGHVVLT 201 (355)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEES
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------EECCCCcEEEe
Confidence 99885 4679999999999999999999999999999 9999999 88889999999
Q ss_pred ecCCccCCCCC-CCCCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcC
Q psy3347 155 DFGLCKEGMGF-GDRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFPGD----DEEEVFDSIVND 227 (245)
Q Consensus 155 Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~~~----~~~~~~~~~~~~ 227 (245)
|||+++..... .......+||..|+|||.+.+ ..++.++|||||||++|+|++|+.||... ...+....+...
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence 99998753222 222345678999999999976 34788999999999999999999999643 345556666667
Q ss_pred cccCCCCCChhHHhhhcC
Q psy3347 228 EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 228 ~~~~p~~~~~~~~~li~~ 245 (245)
..++|..+++.+++||++
T Consensus 282 ~~~~~~~~~~~~~~li~~ 299 (355)
T 1vzo_A 282 EPPYPQEMSALAKDLIQR 299 (355)
T ss_dssp CCCCCTTSCHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHH
Confidence 777888999999998863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=251.09 Aligned_cols=214 Identities=23% Similarity=0.398 Sum_probs=167.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh-HHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE-VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+++.||+|++.......... .+.+....++++.++.++||||+++++++.... ++||||+++++|.+++
T Consensus 35 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l 112 (287)
T 4f0f_A 35 VHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL 112 (287)
T ss_dssp EEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHH
T ss_pred EEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHH
Confidence 7999999999999999997644322211 111123345578888999999999999996665 6999999999998877
Q ss_pred h--hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc-----
Q psy3347 80 H--ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY----- 150 (245)
Q Consensus 80 ~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 150 (245)
. ...+++..+..++.|++.||+|||++| ++|+ |++|+|| +++.++.
T Consensus 113 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~---dikp~Ni----------------------l~~~~~~~~~~~ 167 (287)
T 4f0f_A 113 LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR---DLRSPNI----------------------FLQSLDENAPVC 167 (287)
T ss_dssp HCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCS---CCSGGGE----------------------EESCCCTTCSCC
T ss_pred hcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecC---CCCcceE----------------------EEeccCCCCcee
Confidence 4 346899999999999999999999999 9999 8888888 6666665
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCcccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT--ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE--EVFDSIVN 226 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~--~~~~~~~~ 226 (245)
++|+|||+++... .......|+..|+|||.+. ...++.++||||||+++|+|++|+.||...... .....+..
T Consensus 168 ~kl~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 168 AKVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp EEECCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred EEeCCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 9999999987422 2234567899999999994 455788999999999999999999999765433 33444433
Q ss_pred C--cccCCCCCChhHHhhhc
Q psy3347 227 D--EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 227 ~--~~~~p~~~~~~~~~li~ 244 (245)
. ....|..+++++.++|+
T Consensus 245 ~~~~~~~~~~~~~~l~~li~ 264 (287)
T 4f0f_A 245 EGLRPTIPEDCPPRLRNVIE 264 (287)
T ss_dssp SCCCCCCCTTSCHHHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHH
Confidence 3 33467889999999886
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=252.35 Aligned_cols=211 Identities=22% Similarity=0.372 Sum_probs=175.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. +++.||+|++...... .+.+. ++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 40 V~~~~~~-~~~~vavK~~~~~~~~----~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 111 (283)
T 3gen_A 40 VKYGKWR-GQYDVAIKMIKEGSMS----EDEFI---EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR 111 (283)
T ss_dssp EEEEEET-TTEEEEEEEECTTSBC----HHHHH---HHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHH
T ss_pred EEEEEEc-CCCeEEEEEecCCCCC----HHHHH---HHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHH
Confidence 6889776 6778999999865322 13333 44777888999999999999999999999999999999999985
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 112 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dikp~Ni----------------------li~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR---DLAARNC----------------------LVNDQGVVKVSDFGL 166 (283)
T ss_dssp CGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---SCSGGGE----------------------EECTTSCEEECSTTG
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHCCccCC---CCccceE----------------------EEcCCCCEEEccccc
Confidence 4 579999999999999999999999999999 9999998 888899999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.... ...|..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred cccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcC
Confidence 875322111 1223345678999999988889999999999999999998 999999988888888887664 3457788
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.++|+
T Consensus 247 ~~~l~~li~ 255 (283)
T 3gen_A 247 SEKVYTIMY 255 (283)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 999988875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=256.79 Aligned_cols=210 Identities=22% Similarity=0.301 Sum_probs=160.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++....... ........+ +..+.+..+||||+++++++..++..++||||+ +++|.+++.
T Consensus 73 Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e--~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~ 148 (311)
T 3p1a_A 73 VFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAE--VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE 148 (311)
T ss_dssp EEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHH--HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHH
T ss_pred EEEEEECCCCeEEEEEEecccccCh-HHHHHHHHH--HHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHH
Confidence 7999999999999999987543222 222222222 222334448999999999999999999999999 558877774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|+ |+||+|| +++.++.+||+|||+
T Consensus 149 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dikp~NI----------------------ll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 149 AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL---DVKPANI----------------------FLGPRGRCKLGDFGL 203 (311)
T ss_dssp HHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECGGGCEEECCCTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC---CCCHHHE----------------------EECCCCCEEEcccee
Confidence 3 469999999999999999999999999999 9999998 788889999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc--cCCCCCC
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRFLS 236 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~p~~~~ 236 (245)
+..... ........||+.|+|||.+.+ .++.++||||||+++|+|++|..|+.+... ...+..... .++..++
T Consensus 204 a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 278 (311)
T 3p1a_A 204 LVELGT-AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLS 278 (311)
T ss_dssp CEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSC
T ss_pred eeeccc-CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCC
Confidence 875322 222344568999999999876 689999999999999999999776654322 233333322 2457788
Q ss_pred hhHHhhhc
Q psy3347 237 LEAIAIMR 244 (245)
Q Consensus 237 ~~~~~li~ 244 (245)
+++++||+
T Consensus 279 ~~l~~li~ 286 (311)
T 3p1a_A 279 SELRSVLV 286 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 88888875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=258.27 Aligned_cols=214 Identities=26% Similarity=0.462 Sum_probs=174.0
Q ss_pred CEeEEEe-------cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYR-------NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++. .+++.||+|++.... .....+.+.+| ++.++.+ +||||+++++++...+..++||||+++
T Consensus 51 Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 125 (334)
T 2pvf_A 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSE---MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125 (334)
T ss_dssp EEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTT
T ss_pred EEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHH---HHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCC
Confidence 7889875 467899999998642 22334444444 5666677 899999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
++|.+++... .+++..+..++.|++.||.|||++|++|+ |++|+||
T Consensus 126 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI-------------- 188 (334)
T 2pvf_A 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR---DLAARNV-------------- 188 (334)
T ss_dssp CBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE--------------
T ss_pred CcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCccceE--------------
Confidence 9999998542 37889999999999999999999999999 9999998
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 189 --------ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 189 --------LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp --------EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred --------EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 888899999999999875332221 1233456778999999988889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 213 PGDDEEEVFDSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
.+.+..+....+..+. ...|..+++++.++|+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (334)
T 2pvf_A 261 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293 (334)
T ss_dssp TTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred CcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 9988888877776654 4567889999998875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=253.40 Aligned_cols=214 Identities=28% Similarity=0.471 Sum_probs=168.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+++.||+|.+.... ....+.+. +++..++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 38 Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 111 (295)
T 2clq_A 38 VYAGRDLSNQVRIAIKEIPERD---SRYSQPLH---EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR 111 (295)
T ss_dssp EEEEEETTTCCEEEEEEEECCC---C---HHHH---HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHH
T ss_pred EEEEEECCCCeEEEEEEccCCc---hHHHHHHH---HHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHH
Confidence 7999999999999999997642 22223343 44677888999999999999999999999999999999999886
Q ss_pred hc----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-CCceEEee
Q psy3347 81 AD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-EGYVKIAD 155 (245)
Q Consensus 81 ~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~kl~D 155 (245)
.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++. ++.++|+|
T Consensus 112 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~~kl~D 166 (295)
T 2clq_A 112 SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR---DIKGDNV----------------------LINTYSGVLKISD 166 (295)
T ss_dssp HTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEETTTCCEEECC
T ss_pred hhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEcc---CCChhhE----------------------EEECCCCCEEEee
Confidence 43 45688889999999999999999999999 8888888 6665 78999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH--HhcCccc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDS--IVNDEVR 230 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~--~~~~~~~ 230 (245)
||++..............|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ..... .......
T Consensus 167 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 2clq_A 167 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 246 (295)
T ss_dssp TTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC
T ss_pred cccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc
Confidence 999875433333344567889999999997643 789999999999999999999999754322 22111 2233456
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|..+++++.+||++
T Consensus 247 ~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 247 IPESMSAEAKAFILK 261 (295)
T ss_dssp CCTTSCHHHHHHHHH
T ss_pred ccccCCHHHHHHHHH
Confidence 678899999988863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=267.08 Aligned_cols=192 Identities=25% Similarity=0.421 Sum_probs=161.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc---CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~---~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..+|+.||+|+++... ...+.+.+|.+++..++.. +|+||+++++++...++.++|||++. ++|.+
T Consensus 113 V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 187 (429)
T 3kvw_A 113 VVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYE 187 (429)
T ss_dssp EEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHH
T ss_pred EEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHH
Confidence 7999999999999999997532 2234455565666655544 78899999999999999999999996 58888
Q ss_pred hhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc--eE
Q psy3347 78 HIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY--VK 152 (245)
Q Consensus 78 ~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~k 152 (245)
++... .+++..+..++.|++.||+|||++||+|| |+||+|| +++.++. +|
T Consensus 188 ~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---DlKp~NI----------------------Ll~~~~~~~vk 242 (429)
T 3kvw_A 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC---DLKPENI----------------------LLKQQGRSGIK 242 (429)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECS---CCSGGGE----------------------EESSTTSCCEE
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EEccCCCcceE
Confidence 77543 48999999999999999999999999999 9999998 7777776 99
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|+|||++.... ......+||..|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 243 L~DFG~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 243 VIDFGSSCYEH---QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp ECCCTTCEETT---CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EeecccceecC---CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999987522 22345678999999999999999999999999999999999999999988777666554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=253.48 Aligned_cols=213 Identities=25% Similarity=0.382 Sum_probs=164.1
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..+ +..||+|++.... .....+.+. +++..++.++||||+++++++. ++..++||||+++++|.+
T Consensus 31 Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~ 104 (281)
T 1mp8_A 31 VHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFL---QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRS 104 (281)
T ss_dssp EEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHH---HHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHH
T ss_pred EEEEEEecCCCCceEEEEEeccccC--CHHHHHHHH---HHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHH
Confidence 799988654 5579999987532 222233344 4477788899999999999984 567899999999999999
Q ss_pred hhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|
T Consensus 105 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~D 159 (281)
T 1mp8_A 105 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR---DIAARNV----------------------LVSSNDCVKLGD 159 (281)
T ss_dssp HHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EEEETTEEEECC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc---cccHHHE----------------------EECCCCCEEECc
Confidence 98643 58999999999999999999999999999 9999998 778889999999
Q ss_pred cCCccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 156 FGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+. .+.|
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred cccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence 999875432221 1223345678999999988889999999999999999997 999999888877777776654 4567
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++.++|+
T Consensus 240 ~~~~~~l~~li~ 251 (281)
T 1mp8_A 240 PNCPPTLYSLMT 251 (281)
T ss_dssp TTCCHHHHHHHH
T ss_pred CCCCHHHHHHHH
Confidence 889999999886
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=262.17 Aligned_cols=194 Identities=24% Similarity=0.382 Sum_probs=153.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||+|++..+|+.||+|++.... ......+.+ .+++.+++.++||||+++++++...+ ..++||||+++ +
T Consensus 41 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 115 (371)
T 2xrw_A 41 VCAAYDAILERNVAIKKLSRPF-QNQTHAKRA---YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-N 115 (371)
T ss_dssp EEEEEETTTTEEEEEEEEECTT-SSHHHHHHH---HHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-E
T ss_pred EEEEEECCCCceEEEEEecccc-CChHHHHHH---HHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-C
Confidence 7999999999999999998642 122223333 44577788899999999999997654 78999999975 6
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|.+.+. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 116 l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---Dlkp~NI----------------------l~~~~~~~kl~ 169 (371)
T 2xrw_A 116 LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 169 (371)
T ss_dssp HHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTSCEEEC
T ss_pred HHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecc---cCCHHHE----------------------EEcCCCCEEEE
Confidence 777765 458999999999999999999999999999 9999999 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
|||+++.... ........||..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 170 Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 170 DFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp CCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred Eeeccccccc-ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999875322 2223456789999999999988899999999999999999999999999888777776654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.29 Aligned_cols=215 Identities=26% Similarity=0.447 Sum_probs=169.4
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|++. .+++.||+|++.... .....+.+.+| +..++.+ +||||+++++++...+..++||||+++++
T Consensus 61 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 135 (344)
T 1rjb_A 61 VMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSE---LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135 (344)
T ss_dssp EEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHH---HHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCc
Confidence 7889873 367789999997542 22233444444 6667777 89999999999999999999999999999
Q ss_pred hhhhhhhc------------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhh
Q psy3347 75 LMMHIHAD------------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130 (245)
Q Consensus 75 L~~~~~~~------------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~ 130 (245)
|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 136 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dikp~NI--------- 203 (344)
T 1rjb_A 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR---DLAARNV--------- 203 (344)
T ss_dssp HHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET---TCSGGGE---------
T ss_pred HHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCChhhE---------
Confidence 99988542 27888999999999999999999999999 9999998
Q ss_pred ccccCcccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-
Q psy3347 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV- 207 (245)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~- 207 (245)
+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 204 -------------ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 204 -------------LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp -------------EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred -------------EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 888889999999999875322221 1234456778999999988889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhcC--cccCCCCCChhHHhhhcC
Q psy3347 208 GESPFPGDDEEEVFDSIVND--EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 208 g~~pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 245 (245)
|..||.+....+....+... ....|..+++++.+||++
T Consensus 271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 310 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS 310 (344)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 99999887655444444433 234577889999998863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=254.78 Aligned_cols=212 Identities=24% Similarity=0.405 Sum_probs=165.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEee------CCeEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQT------EAHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~------~~~~~lv~e~~~~~ 73 (245)
||+|++..+|+.||+|++.... ...+.+.+| +..++.+ +||||+++++++.. .+..++||||++++
T Consensus 40 Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e---~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 112 (326)
T 2x7f_A 40 VYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQE---INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112 (326)
T ss_dssp EEEEEETTTCCEEEEEEEECCS----STTHHHHHH---HHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTE
T ss_pred EEEEEECCCCCeEEEEEEecCc----ccHHHHHHH---HHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCC
Confidence 7999999999999999997542 122344444 5556666 79999999999977 46899999999999
Q ss_pred chhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 74 DLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 74 ~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
+|.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.
T Consensus 113 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---dlkp~NI----------------------l~~~~~~ 167 (326)
T 2x7f_A 113 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR---DIKGQNV----------------------LLTENAE 167 (326)
T ss_dssp EHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCSGGGE----------------------EECTTCC
T ss_pred cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCcHHHE----------------------EEcCCCC
Confidence 99999854 468999999999999999999999999999 9999998 8888999
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++|+|||++..............|+..|+|||.+. +..++.++|||||||++|+|++|..||.+.........+.
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp EEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 99999999875433322334557899999999996 4568899999999999999999999998887776666655
Q ss_pred cCccc--CCCCCChhHHhhhc
Q psy3347 226 NDEVR--YPRFLSLEAIAIMR 244 (245)
Q Consensus 226 ~~~~~--~p~~~~~~~~~li~ 244 (245)
....+ .+..+++++++||+
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~ 268 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIE 268 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHH
T ss_pred cCccccCCccccCHHHHHHHH
Confidence 44332 24678888888876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=268.60 Aligned_cols=186 Identities=21% Similarity=0.321 Sum_probs=145.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||||++.... ......+.+ .+++++++.++||||+++++++... +..|+|||+++ ++|
T Consensus 69 V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L 143 (458)
T 3rp9_A 69 VCEAYDKLEKRVVAIKKILRVF-EDLIDCKRI---LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDF 143 (458)
T ss_dssp EEEEEECC--CEEEEEEECSTT-SSHHHHHHH---HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEH
T ss_pred EEEEEECCCCcEEEEEEechhh-cCHHHHHHH---HHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cch
Confidence 7999999999999999997542 122233334 4457778888999999999999443 57999999985 588
Q ss_pred hhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..+++. ..+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 144 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHr---DlKp~NI----------------------Ll~~~~~~kl~ 198 (458)
T 3rp9_A 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR---DLKPANC----------------------LVNQDCSVKVC 198 (458)
T ss_dssp HHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTCCEEEC
T ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCC---CCChhhE----------------------EECCCCCEeec
Confidence 888754 469999999999999999999999999999 9999999 88899999999
Q ss_pred ecCCccCCCCCC---------------------------CCCCcccCCCCcccccccc-CCCCCcchhHHHHHHHHHHHH
Q psy3347 155 DFGLCKEGMGFG---------------------------DRTGTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIFEML 206 (245)
Q Consensus 155 Dfg~~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~ 206 (245)
|||+++...... ......+||+.|+|||++. +..++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 999997542211 1123457899999999874 567999999999999999999
Q ss_pred h-----------CCCCCCCCC
Q psy3347 207 V-----------GESPFPGDD 216 (245)
Q Consensus 207 ~-----------g~~pf~~~~ 216 (245)
+ |+++|++.+
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC---
T ss_pred HhccccccccccccccCCCCc
Confidence 8 788887654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=255.51 Aligned_cols=214 Identities=24% Similarity=0.370 Sum_probs=165.2
Q ss_pred CEeEE----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCc
Q psy3347 1 VILSQ----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~ 74 (245)
||+|+ +..+|+.||+|++... .....+.+. +++++++.++||||+++++++... ...++||||+++++
T Consensus 26 V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 99 (295)
T 3ugc_A 26 VEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFE---REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99 (295)
T ss_dssp EEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHH---HHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCB
T ss_pred EEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHH---HHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCC
Confidence 68888 6678999999999754 233334444 447778899999999999998653 56899999999999
Q ss_pred hhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++.. ..+++..+..++.|++.||+|||++|++|+ |+||+|| +++.++.+|
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dikp~Ni----------------------l~~~~~~~k 154 (295)
T 3ugc_A 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR---DLATRNI----------------------LVENENRVK 154 (295)
T ss_dssp HHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EEEETTEEE
T ss_pred HHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccC---CCCHhhE----------------------EEcCCCeEE
Confidence 9999854 348999999999999999999999999999 9999888 788889999
Q ss_pred EeecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-----------
Q psy3347 153 IADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE----------- 218 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~----------- 218 (245)
|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T 3ugc_A 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234 (295)
T ss_dssp ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT
T ss_pred EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc
Confidence 999999875432221 122334667799999999889999999999999999999999988543211
Q ss_pred -----HHHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 219 -----EVFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 219 -----~~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
.....+... ..+.|..+++++.+||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 267 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE 267 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHH
Confidence 222222222 335678899999998863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=259.95 Aligned_cols=213 Identities=22% Similarity=0.433 Sum_probs=175.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh--------------HHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE--------------VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv 66 (245)
||+|++ +|+.||+|++.......... .+.+. ++++.++.++||||+++++++...+..++|
T Consensus 47 V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 121 (348)
T 2pml_X 47 IILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK---NELQIITDIKNEYCLTCEGIITNYDEVYII 121 (348)
T ss_dssp EEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHH---HHHHHHTTCCCTTBCCCSEEEESSSEEEEE
T ss_pred EEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHH---HHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 799988 89999999998643221111 13444 447778899999999999999999999999
Q ss_pred EeeccCCchhhh------hh---hcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCc
Q psy3347 67 MEYAAGGDLMMH------IH---ADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNS 136 (245)
Q Consensus 67 ~e~~~~~~L~~~------~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~ 136 (245)
|||+++++|.++ +. ...+++..+..++.|++.||.|||+ +|++|+ |++|+||
T Consensus 122 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~---dl~p~Ni--------------- 183 (348)
T 2pml_X 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR---DVKPSNI--------------- 183 (348)
T ss_dssp EECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC---CCCGGGE---------------
T ss_pred EeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec---CCChHhE---------------
Confidence 999999999988 54 3568999999999999999999999 999999 9999998
Q ss_pred ccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCC
Q psy3347 137 SQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTR-AVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 137 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~~l~el~~g~~pf~~ 214 (245)
+++.++.++|+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|+|++|+.||.+
T Consensus 184 -------l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 184 -------LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp -------EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8888999999999998753222 23455788999999999876 5666 99999999999999999999987
Q ss_pred CCH-HHHHHHHhcCcccCC-------------------CCCChhHHhhhcC
Q psy3347 215 DDE-EEVFDSIVNDEVRYP-------------------RFLSLEAIAIMRR 245 (245)
Q Consensus 215 ~~~-~~~~~~~~~~~~~~p-------------------~~~~~~~~~li~~ 245 (245)
... .+....+..+...+| ..+++++.+||++
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 305 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL 305 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHH
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHH
Confidence 766 777777777766666 6688899888863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=251.68 Aligned_cols=213 Identities=24% Similarity=0.397 Sum_probs=174.1
Q ss_pred CEeEEEe--cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYR--NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++ .+++.||+|+++... .....+.+.+ +++.++.++||||+++++++ ..+..++||||+++++|.++
T Consensus 26 Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~ 99 (287)
T 1u59_A 26 VRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR---EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 99 (287)
T ss_dssp EEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHH---HHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHH
T ss_pred EEEeEeccCCCcceEEEEecCCcc--chhHHHHHHH---HHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHH
Confidence 7888754 468899999998642 2233344444 46777888999999999999 55679999999999999998
Q ss_pred hh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+. ...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 100 l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~kl~Df 154 (287)
T 1u59_A 100 LVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR---DLAARNV----------------------LLVNRHYAKISDF 154 (287)
T ss_dssp HTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEEETTEEEECCC
T ss_pred HHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeC---CCchheE----------------------EEcCCCCEEECcc
Confidence 84 3468999999999999999999999999999 9999888 7788899999999
Q ss_pred CCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccC
Q psy3347 157 GLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRY 231 (245)
Q Consensus 157 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~ 231 (245)
|++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+..+. ...
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 234 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence 99875322221 1223345788999999988889999999999999999998 999999888888777776654 456
Q ss_pred CCCCChhHHhhhc
Q psy3347 232 PRFLSLEAIAIMR 244 (245)
Q Consensus 232 p~~~~~~~~~li~ 244 (245)
|..+++++.++|+
T Consensus 235 ~~~~~~~l~~li~ 247 (287)
T 1u59_A 235 PPECPPELYALMS 247 (287)
T ss_dssp CTTCCHHHHHHHH
T ss_pred CCCcCHHHHHHHH
Confidence 7889999999886
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=264.86 Aligned_cols=178 Identities=23% Similarity=0.363 Sum_probs=145.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||||++.... ......+.+ .+++++++.++||||+++++++... +..|+||||+++ +|
T Consensus 42 V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L 116 (432)
T 3n9x_A 42 VYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRI---LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL 116 (432)
T ss_dssp EEEEEETTTTEEEEEEEECSTT-TSHHHHHHH---HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EH
T ss_pred EEEEEECCCCcEEEEEEeCchh-cChHHHHHH---HHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CH
Confidence 7999999999999999997542 122223333 4557788889999999999999766 579999999864 99
Q ss_pred hhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..+++. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 117 ~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHr---Dlkp~NI----------------------Ll~~~~~~kL~ 171 (432)
T 3n9x_A 117 KKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR---DLKPANC----------------------LLNQDCSVKVC 171 (432)
T ss_dssp HHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC---CCCHHHe----------------------EECCCCCEEEc
Confidence 888865 468999999999999999999999999999 9999999 88899999999
Q ss_pred ecCCccCCCCCC----------------------CCCCcccCCCCccccccc-cCCCCCcchhHHHHHHHHHHHHhC
Q psy3347 155 DFGLCKEGMGFG----------------------DRTGTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVG 208 (245)
Q Consensus 155 Dfg~~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~g 208 (245)
|||+++...... ......+||..|+|||.+ .+..++.++|||||||++|||++|
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 999997532221 113566889999999986 456689999999999999999973
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=256.60 Aligned_cols=214 Identities=21% Similarity=0.310 Sum_probs=169.9
Q ss_pred CEeEEEecCC----cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTG----EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.++.++ ..||+|+++... .......+. ++++.++.++||||+++++++...+..++||||+++++|.
T Consensus 60 Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 134 (333)
T 1mqb_A 60 VYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFL---GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 134 (333)
T ss_dssp EEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHH---HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred EEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHH---HHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHH
Confidence 7899887653 469999997542 222333344 4477788899999999999999999999999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.+||+
T Consensus 135 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dikp~NI----------------------l~~~~~~~kl~ 189 (333)
T 1mqb_A 135 KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR---DLAARNI----------------------LVNSNLVCKVS 189 (333)
T ss_dssp HHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCChheE----------------------EECCCCcEEEC
Confidence 99854 468999999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cc
Q psy3347 155 DFGLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EV 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~ 229 (245)
|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+ ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC
Confidence 99998754322211 122234678999999988889999999999999999999 99999988888888877665 34
Q ss_pred cCCCCCChhHHhhhc
Q psy3347 230 RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~~~~~~~~~li~ 244 (245)
+.|..+++++.++|+
T Consensus 270 ~~~~~~~~~l~~li~ 284 (333)
T 1mqb_A 270 PTPMDCPSAIYQLMM 284 (333)
T ss_dssp CCCTTCBHHHHHHHH
T ss_pred CCcccCCHHHHHHHH
Confidence 557788999988875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=253.72 Aligned_cols=216 Identities=24% Similarity=0.369 Sum_probs=174.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe--eCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIA-RDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ--TEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~--~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..+|+.||+|++....... ....+.+ .++++.++.++||||+++++++. ..+..++||||++++ |.+
T Consensus 21 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~ 96 (305)
T 2wtk_C 21 VKEVLDSETLCRRAVKILKKKKLRRIPNGEANV---KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE 96 (305)
T ss_dssp EEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHH---HHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHH
T ss_pred EEEEEECCCCcEEEEEEeccccccccchhHHHH---HHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHH
Confidence 7999999999999999998643221 1222333 44577888999999999999984 456899999999876 555
Q ss_pred hhh---hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 78 HIH---ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 78 ~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++. ...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~---dlkp~NI----------------------l~~~~~~~kl~ 151 (305)
T 2wtk_C 97 MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK---DIKPGNL----------------------LLTTGGTLKIS 151 (305)
T ss_dssp HHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEEC
T ss_pred HHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCcccE----------------------EEcCCCcEEee
Confidence 553 3568999999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCC--CCCCCcccCCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc
Q psy3347 155 DFGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETS--YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR 230 (245)
Q Consensus 155 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (245)
|||++...... ........|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+..+....+......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 231 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC
Confidence 99998753221 11223456889999999997644 367999999999999999999999998888888888888888
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|..+++++.+||++
T Consensus 232 ~~~~~~~~l~~li~~ 246 (305)
T 2wtk_C 232 IPGDCGPPLSDLLKG 246 (305)
T ss_dssp CCSSSCHHHHHHHHH
T ss_pred CCCccCHHHHHHHHH
Confidence 889999999998863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=266.99 Aligned_cols=215 Identities=17% Similarity=0.147 Sum_probs=157.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeee-------EEEeeC-------------
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-------ACFQTE------------- 60 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~-------~~~~~~------------- 60 (245)
||+|+++.+|+.||+|++...........+.+.+|.+++..++. +||||++++ +++...
T Consensus 78 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~ 156 (371)
T 3q60_A 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQD 156 (371)
T ss_dssp EEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC--
T ss_pred EEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcc
Confidence 79999999999999999998654444556667777777888888 899977755 555443
Q ss_pred ----CeEEEEEeeccCCchhhhhhh--cCCChHHH------HHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHh
Q psy3347 61 ----AHVCFVMEYAAGGDLMMHIHA--DVFSEPRA------VFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKV 128 (245)
Q Consensus 61 ----~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~------~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~ 128 (245)
...|+||||++ ++|.+++.. ..++...+ ..++.|++.||+|||++||+|| |+||+||
T Consensus 157 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr---Dikp~NI------- 225 (371)
T 3q60_A 157 DYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG---HFTPDNL------- 225 (371)
T ss_dssp -CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET---TCSGGGE-------
T ss_pred cceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC---cCCHHHE-------
Confidence 34899999998 799999863 34555555 5777999999999999999999 9999999
Q ss_pred hhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHH
Q psy3347 129 QENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEML 206 (245)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~ 206 (245)
+++.++.+||+|||+++... .......++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 226 ---------------ll~~~~~~kL~DFG~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 226 ---------------FIMPDGRLMLGDVSALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp ---------------EECTTSCEEECCGGGEEETT---CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred ---------------EECCCCCEEEEecceeeecC---CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 88899999999999987532 11224456689999999987 67999999999999999999
Q ss_pred hCCCCCCCCCHHHH--HHH---H--hcCcccCC--CCCChhHHhhhcC
Q psy3347 207 VGESPFPGDDEEEV--FDS---I--VNDEVRYP--RFLSLEAIAIMRR 245 (245)
Q Consensus 207 ~g~~pf~~~~~~~~--~~~---~--~~~~~~~p--~~~~~~~~~li~~ 245 (245)
+|+.||.+...... ... . ......+| ..+++++++||++
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHH
Confidence 99999976633211 000 0 11122223 5788999988863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=251.88 Aligned_cols=210 Identities=18% Similarity=0.229 Sum_probs=166.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+|+.||+|++.... ..+.+.+| +..++.+ +|+|++++++++...+..++||||+ +++|.+++
T Consensus 26 V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e---~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 96 (298)
T 1csn_A 26 IFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDE---YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLL 96 (298)
T ss_dssp EEEEEETTTTEEEEEEEEECCT-----TSCCHHHH---HHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred EEEEEECCCCcEEEEEEeccCC-----ccHHHHHH---HHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHH
Confidence 7999999999999999987542 11234444 4445555 6999999999999999999999999 88999998
Q ss_pred hh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc-----eE
Q psy3347 80 HA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY-----VK 152 (245)
Q Consensus 80 ~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~k 152 (245)
.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++. ++
T Consensus 97 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---Dlkp~NI----------------------l~~~~~~~~~~~~k 151 (298)
T 1csn_A 97 DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR---DIKPDNF----------------------LIGRPNSKNANMIY 151 (298)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCCGGGE----------------------EECCSSSTTTTCEE
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EeccCCCCCCCeEE
Confidence 64 468999999999999999999999999999 8888888 6665554 99
Q ss_pred EeecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Q psy3347 153 IADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFD 222 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~---~~~~~~~ 222 (245)
|+|||++........ ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.+. ...+...
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 999999875432221 134557899999999999888999999999999999999999999764 3444444
Q ss_pred HHhcCccc-----CCCCCChhHHhhhc
Q psy3347 223 SIVNDEVR-----YPRFLSLEAIAIMR 244 (245)
Q Consensus 223 ~~~~~~~~-----~p~~~~~~~~~li~ 244 (245)
.+...... .+..+++++.+||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (298)
T 1csn_A 232 RIGEKKQSTPLRELCAGFPEEFYKYMH 258 (298)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred HHHhhccCccHHHHHhhCcHHHHHHHH
Confidence 44333222 23578888888875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.11 Aligned_cols=213 Identities=25% Similarity=0.481 Sum_probs=169.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++.... ....+.+.+ +++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 35 V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 108 (302)
T 2j7t_A 35 VYKAKNKETGALAAAKVIETKS---EEELEDYIV---EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML 108 (302)
T ss_dssp EEEEEETTTCCEEEEEEEC-------CCHHHHHH---HHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHH
T ss_pred EEEEEEcCCCcEEEEEEecCCC---HHHHHHHHH---HHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHH
Confidence 7999999999999999997542 222344444 4667788899999999999999999999999999999998875
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 109 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 109 ELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR---DLKAGNV----------------------LMTLEGDIRLADFGV 163 (302)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCSGGGE----------------------EECTTSCEEECCCHH
T ss_pred hhccCCCHHHHHHHHHHHHHHHHHHhcCCcccC---CCCHHHE----------------------EECCCCCEEEEECCC
Confidence 3569999999999999999999999999999 9999998 888889999999998
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--- 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (245)
+..............|+..|+|||.+. +..++.++||||||+++|+|++|+.||...+..+....+.....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC
Confidence 753211111223456888999999983 567889999999999999999999999988877777666554432
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.++|+
T Consensus 244 ~~~~~~~~l~~li~ 257 (302)
T 2j7t_A 244 TPSKWSVEFRDFLK 257 (302)
T ss_dssp SGGGSCHHHHHHHH
T ss_pred CccccCHHHHHHHH
Confidence 35677888888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=260.56 Aligned_cols=213 Identities=20% Similarity=0.354 Sum_probs=169.9
Q ss_pred CEeEEEecCCcE----EEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEY----FAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+. ||+|.+.... .....+. ..+++..++.++||||+++++++. ++..++||||+.+++|.
T Consensus 29 Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~ 102 (325)
T 3kex_A 29 VHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQA---VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLL 102 (325)
T ss_dssp EEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCS---CCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSH
T ss_pred EEEEEEcCCCceEEEEEEEEeccccc--cHHHHHH---HHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHH
Confidence 799999988886 6667665332 1111222 234467788899999999999986 55689999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 103 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dikp~Ni----------------------l~~~~~~~kl~ 157 (325)
T 3kex_A 103 DHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHR---NLAARNV----------------------LLKSPSQVQVA 157 (325)
T ss_dssp HHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS---CCSSTTE----------------------EESSSSCEEEC
T ss_pred HHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCC---ccchheE----------------------EECCCCeEEEC
Confidence 98854 478999999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+..+. ..
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC
Confidence 9999975432221 2334567778999999998889999999999999999999 999999888777777776653 35
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.++|+
T Consensus 238 ~~~~~~~~~~~li~ 251 (325)
T 3kex_A 238 QPQICTIDVYMVMV 251 (325)
T ss_dssp CCTTBCTTTTHHHH
T ss_pred CCCcCcHHHHHHHH
Confidence 57778888888775
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=269.39 Aligned_cols=211 Identities=26% Similarity=0.417 Sum_probs=174.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+. +++.||||+++... ...+.+.+| +.+++.++||||+++++++. .+..++||||+.+|+|.++++
T Consensus 204 V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E---~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~ 274 (454)
T 1qcf_A 204 VWMATYN-KHTKVAVKTMKPGS----MSVEAFLAE---ANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK 274 (454)
T ss_dssp EEEEEET-TTEEEEEEEECTTS----BCHHHHHHH---HHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHH
T ss_pred EEEEEEC-CccEEEEEEecCCC----ccHHHHHHH---HHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHH
Confidence 7999886 47789999998643 123444444 77788999999999999986 567899999999999999986
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||
T Consensus 275 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~kl~DFG 329 (454)
T 1qcf_A 275 SDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR---DLRAANI----------------------LVSASLVCKIADFG 329 (454)
T ss_dssp SHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---SCSGGGE----------------------EECTTCCEEECSTT
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCCHHHE----------------------EECCCCcEEEeeCC
Confidence 3 368899999999999999999999999999 9999998 88889999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+..+. .+.|..
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 9975322111 1122345678999999988889999999999999999999 999999998888888876653 356788
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.+||++
T Consensus 410 ~~~~l~~li~~ 420 (454)
T 1qcf_A 410 CPEELYNIMMR 420 (454)
T ss_dssp SCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=248.20 Aligned_cols=208 Identities=19% Similarity=0.297 Sum_probs=171.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (245)
||+|++. |+.||+|+++..... ....+.+. +++..++.++||||+++++++... +..+++|||+++++|.++
T Consensus 26 V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 99 (271)
T 3kmu_A 26 LWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFN---EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV 99 (271)
T ss_dssp EEEEEET--TEEEEEEEECCTTCC-HHHHHHHH---HHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHH
T ss_pred EEEEEEC--CeeEEEEEecccccC-HHHHHHHH---HHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHH
Confidence 7899885 889999999865322 22333444 446778899999999999999876 789999999999999999
Q ss_pred hhhc---CCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 79 IHAD---VFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 79 ~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
+... .+++..+..++.|++.||+|||++| ++|+ |++|+|| +++.++.++|
T Consensus 100 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~---dikp~Ni----------------------l~~~~~~~~l 154 (271)
T 3kmu_A 100 LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH---ALNSRSV----------------------MIDEDMTARI 154 (271)
T ss_dssp HHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTC---CCSGGGE----------------------EECTTSCEEE
T ss_pred HhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecC---CCccceE----------------------EEcCCcceeE
Confidence 9653 4899999999999999999999999 9999 9999998 8888999999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc--
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTR---AVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE-- 228 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~-- 228 (245)
+|||++.... .....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (271)
T 3kmu_A 155 SMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229 (271)
T ss_dssp EGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC
T ss_pred Eeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC
Confidence 9998765421 22346788999999998765543 7999999999999999999999888877777765443
Q ss_pred ccCCCCCChhHHhhhc
Q psy3347 229 VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~ 244 (245)
...|..+++++.++|+
T Consensus 230 ~~~~~~~~~~~~~li~ 245 (271)
T 3kmu_A 230 PTIPPGISPHVSKLMK 245 (271)
T ss_dssp CCCCTTCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHH
Confidence 3467889999999886
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=260.06 Aligned_cols=194 Identities=22% Similarity=0.385 Sum_probs=161.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|++..+|+.||+|++.... .....+.+. +++++++.++||||+++++++... ...++|||++++ +|
T Consensus 43 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L 116 (364)
T 3qyz_A 43 VCSAYDNLNKVRVAIKKISPFE--HQTYCQRTL---REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DL 116 (364)
T ss_dssp EEEEEETTTTEEEEEEEECCTT--CHHHHHHHH---HHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EH
T ss_pred EEEEEECCCCeEEEEEEecccc--CcHHHHHHH---HHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CH
Confidence 7999999999999999997532 222233343 457778889999999999999665 378999999975 89
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.++++...+++..+..++.|++.||+|||++||+|+ |++|+|| +++.++.+||+|
T Consensus 117 ~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dikp~NI----------------------l~~~~~~~kl~D 171 (364)
T 3qyz_A 117 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR---DLKPSNL----------------------LLNTTCDLKICD 171 (364)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEECC
T ss_pred HHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCChHhE----------------------EECCCCCEEEEe
Confidence 999988889999999999999999999999999999 9999999 888899999999
Q ss_pred cCCccCCCCCCC---CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 156 FGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 156 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
||++........ .....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 999875332211 1344578999999998755 458999999999999999999999999887766666654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=256.04 Aligned_cols=214 Identities=24% Similarity=0.412 Sum_probs=170.9
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.+ ..+++.||+|++.... .....+.+.+| ++.++.+ +||||+++++++..++..++||||+++++
T Consensus 39 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 113 (313)
T 1t46_A 39 VVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSE---LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113 (313)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred eEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHH---HHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCC
Confidence 688875 4578899999998643 22233444444 6667777 89999999999999999999999999999
Q ss_pred hhhhhhhc-------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 75 LMMHIHAD-------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 75 L~~~~~~~-------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 114 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni-------------- 176 (313)
T 1t46_A 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR---DLAARNI-------------- 176 (313)
T ss_dssp HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE--------------
T ss_pred HHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCccceE--------------
Confidence 99988543 38899999999999999999999999999 9999998
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 177 --------l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 177 --------LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp --------EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred --------EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 788889999999999875433222 1223456778999999988889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHhc-C-cccCCCCCChhHHhhhc
Q psy3347 213 PGDDEEEVFDSIVN-D-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 213 ~~~~~~~~~~~~~~-~-~~~~p~~~~~~~~~li~ 244 (245)
.+............ . ....|..+++++.++|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (313)
T 1t46_A 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK 282 (313)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred CcccchhHHHHHhccCCCCCCcccCCHHHHHHHH
Confidence 87765444444333 2 22346788999998886
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.36 Aligned_cols=212 Identities=23% Similarity=0.396 Sum_probs=170.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..++..||+|++...... ....+.+. +++..++.++||||+++++++.. .+..++||||+++++|.
T Consensus 42 Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (290)
T 1t4h_A 42 VYKGLDTETTVEVAWCELQDRKLT-KSERQRFK---EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117 (290)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHH---HHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHH
T ss_pred EEEeEecCCceEEEEEEecchhhC-HHHHHHHH---HHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHH
Confidence 799999999999999999864322 23333443 45778889999999999999865 35789999999999999
Q ss_pred hhhhh-cCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceE
Q psy3347 77 MHIHA-DVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVK 152 (245)
Q Consensus 77 ~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~k 152 (245)
+++.. ..+++..+..++.|++.||.|||++| ++|+ |++|+|| +++ .++.++
T Consensus 118 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~---dikp~Ni----------------------l~~~~~~~~k 172 (290)
T 1t4h_A 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR---DLKCDNI----------------------FITGPTGSVK 172 (290)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS---CCCGGGE----------------------EESSTTSCEE
T ss_pred HHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEEC---CCCHHHE----------------------EEECCCCCEE
Confidence 99965 67899999999999999999999999 9999 8999888 665 788999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCcc--
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDSIVNDEV-- 229 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~~-- 229 (245)
|+|||++..... .......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.+... ......+.....
T Consensus 173 l~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 173 IGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp ECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EeeCCCcccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc
Confidence 999999864322 22334578999999998864 588999999999999999999999987544 444444444322
Q ss_pred cCCCCCChhHHhhhc
Q psy3347 230 RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~~~~~~~~~li~ 244 (245)
.++...++++.+||+
T Consensus 250 ~~~~~~~~~l~~li~ 264 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIE 264 (290)
T ss_dssp GGGGCCCHHHHHHHH
T ss_pred ccCCCCCHHHHHHHH
Confidence 345677888888875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=276.87 Aligned_cols=213 Identities=26% Similarity=0.408 Sum_probs=173.0
Q ss_pred CEeEEEec--CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRN--TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++. ++..||||+++... .....+.+.+| +++++.++||||+++++++.. +..++||||+.+|+|.++
T Consensus 352 Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E---~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~ 425 (613)
T 2ozo_A 352 VRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMRE---AQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKF 425 (613)
T ss_dssp EEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHH---HHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHH
T ss_pred EEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHH---HHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHH
Confidence 78997764 56789999998642 22234445444 777889999999999999976 569999999999999998
Q ss_pred hh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+||
T Consensus 426 l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr---Dlkp~NI----------------------Ll~~~~~vkL~DF 480 (613)
T 2ozo_A 426 LVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR---NLAARNV----------------------LLVNRHYAKISDF 480 (613)
T ss_dssp HTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EEEETTEEEECCC
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC---cCCHHHE----------------------EEcCCCcEEEeec
Confidence 85 3468999999999999999999999999999 9999898 8888899999999
Q ss_pred CCccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccC
Q psy3347 157 GLCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRY 231 (245)
Q Consensus 157 g~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~ 231 (245)
|+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+..+. .+.
T Consensus 481 Gla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 560 (613)
T 2ozo_A 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560 (613)
T ss_dssp STTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC
T ss_pred cCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999754222111 112234578999999988899999999999999999998 999999988888888887664 356
Q ss_pred CCCCChhHHhhhc
Q psy3347 232 PRFLSLEAIAIMR 244 (245)
Q Consensus 232 p~~~~~~~~~li~ 244 (245)
|..+++++.+||+
T Consensus 561 p~~~~~~l~~li~ 573 (613)
T 2ozo_A 561 PPECPPELYALMS 573 (613)
T ss_dssp CTTCCHHHHHHHH
T ss_pred CCcCCHHHHHHHH
Confidence 8889999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=264.97 Aligned_cols=217 Identities=30% Similarity=0.510 Sum_probs=160.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh--hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD--EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++.+++.||+|++......... .........+++++++.++||||+++++++. .+..++||||+++++|.++
T Consensus 151 V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~ 229 (419)
T 3i6u_A 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDK 229 (419)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGG
T ss_pred EEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHH
Confidence 799999999999999999865322111 1111112234577788999999999999985 4568999999999999888
Q ss_pred hh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCceEEe
Q psy3347 79 IH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGYVKIA 154 (245)
Q Consensus 79 ~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~kl~ 154 (245)
+. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++. ++.+||+
T Consensus 230 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 230 VVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR---DLKPENV----------------------LLSSQEEDCLIKIT 284 (419)
T ss_dssp TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EESSSSSSCCEEEC
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCChHhE----------------------EEecCCCcceEEEe
Confidence 74 4578999999999999999999999999999 8888888 5543 4469999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCccc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDSIVNDEVR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~~~ 230 (245)
|||+++... ........+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+... ......+..+...
T Consensus 285 DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 285 DFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred ecccceecC-CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 999997532 2223445678999999999853 5678899999999999999999999976533 3344445554443
Q ss_pred CC----CCCChhHHhhhc
Q psy3347 231 YP----RFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p----~~~~~~~~~li~ 244 (245)
++ ..+++++++||+
T Consensus 364 ~~~~~~~~~~~~~~~li~ 381 (419)
T 3i6u_A 364 FIPEVWAEVSEKALDLVK 381 (419)
T ss_dssp CCHHHHTTSCHHHHHHHH
T ss_pred CCchhhcccCHHHHHHHH
Confidence 32 568888888875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=247.87 Aligned_cols=226 Identities=23% Similarity=0.254 Sum_probs=164.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||+|++....... .....+.+ ++..+..+ +||||+++++++..++..++||||+++++|.+++
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~---e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (289)
T 1x8b_A 27 VFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALR---EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 102 (289)
T ss_dssp EEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHH---HHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred EEEEEEcCCCceEEEEEeccccccc-HHHHHHHH---HHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHH
Confidence 7999999999999999998643222 22233333 35556666 8999999999999999999999999999999988
Q ss_pred hh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCc--ccchhccccCCCCceE
Q psy3347 80 HA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNS--SQEIKLTVNDTEGYVK 152 (245)
Q Consensus 80 ~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~k 152 (245)
.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| ++...-.... .........+....++
T Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---Dikp~NI-----l~~~~~~~~~~~~~~~~~~~~~~~~~~k 174 (289)
T 1x8b_A 103 SENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHM---DIKPSNI-----FISRTSIPNAASEEGDEDDWASNKVMFK 174 (289)
T ss_dssp HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE-----EEC--------------------CCCEE
T ss_pred HhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeec---CCCHHHE-----EEcCCCCCcccccccccccccCCceEEE
Confidence 53 568999999999999999999999999999 8888887 2211000000 0000000001445799
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-ccc
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND-EVR 230 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~ 230 (245)
|+|||.+...... ....|+..|+|||.+.+. .++.++||||||+++|+|++|.+|+..... ...+..+ ...
T Consensus 175 l~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~ 247 (289)
T 1x8b_A 175 IGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPR 247 (289)
T ss_dssp ECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCCCC
T ss_pred EcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCCCC
Confidence 9999998753222 234588999999999765 566899999999999999999987754432 2333333 345
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
+|..+++++++||++
T Consensus 248 ~~~~~~~~~~~li~~ 262 (289)
T 1x8b_A 248 IPQVLSQEFTELLKV 262 (289)
T ss_dssp CSSCCCHHHHHHHHH
T ss_pred CCcccCHHHHHHHHH
Confidence 678899999998863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=248.62 Aligned_cols=214 Identities=27% Similarity=0.489 Sum_probs=174.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|+++.+|+.||+|++...... ....+.+.+ +++.++.++||||+++++++...+..+++||++++++|.+++
T Consensus 38 V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 113 (287)
T 2wei_A 38 VLKCKDRITQQEYAVKVINKASAK-NKDTSTILR---EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113 (287)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHH---HHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEEcCCCcEEEEEEecccccc-hHHHHHHHH---HHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH
Confidence 799999999999999999764322 222344444 467788899999999999999999999999999999998877
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCceEEeec
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGYVKIADF 156 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~kl~Df 156 (245)
....+++..+..++.|++.||.|||++|++|+ |++|+|| +++. ++.++|+||
T Consensus 114 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~---dl~p~NI----------------------lv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 114 KRKRFSEHDAARIIKQVFSGITYMHKHNIVHR---DLKPENI----------------------LLESKEKDCDIKIIDF 168 (287)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EESCSSTTCCEEECST
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCChhhE----------------------EEecCCCcccEEEecc
Confidence 45679999999999999999999999999999 8888888 5543 457999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|++...... .......++..|+|||.+.+ .++.++|+||||+++|+|++|+.||.+.+..+....+..+...++
T Consensus 169 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T 2wei_A 169 GLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (287)
T ss_dssp TGGGTBCCC-SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred CcceeecCC-CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh
Confidence 998753222 22334457889999999865 488999999999999999999999999888888888877655432
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..++++++++|++
T Consensus 247 ~~~~~~~~~li~~ 259 (287)
T 2wei_A 247 RTISDDAKDLIRK 259 (287)
T ss_dssp TTSCHHHHHHHHH
T ss_pred hhcCHHHHHHHHH
Confidence 5788899888763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.45 Aligned_cols=182 Identities=16% Similarity=0.264 Sum_probs=149.8
Q ss_pred CEeE-----EEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILS-----QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+| .+..+++.||+|+++... ...+.+|.++++.++...|+||+++++++..++..++||||+++|+|
T Consensus 81 Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L 154 (365)
T 3e7e_A 81 VYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154 (365)
T ss_dssp EEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBH
T ss_pred EEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcH
Confidence 7899 577789999999997542 23445555556666666699999999999999999999999999999
Q ss_pred hhhhh------hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC--
Q psy3347 76 MMHIH------ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-- 147 (245)
Q Consensus 76 ~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-- 147 (245)
.+++. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++.
T Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHr---DiKp~NI----------------------ll~~~~ 209 (365)
T 3e7e_A 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG---DIKPDNF----------------------ILGNGF 209 (365)
T ss_dssp HHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCSGGGE----------------------EECGGG
T ss_pred HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecC---CCCHHHE----------------------Eecccc
Confidence 99985 3468999999999999999999999999999 8888888 5555
Q ss_pred ---------CCceEEeecCCccCCC--CCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 148 ---------EGYVKIADFGLCKEGM--GFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 148 ---------~~~~kl~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
++.+||+|||+++... .........+||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 7899999999996422 12223445678999999999999889999999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=250.59 Aligned_cols=194 Identities=25% Similarity=0.397 Sum_probs=158.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe--------------eCCeEEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ--------------TEAHVCFV 66 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~--------------~~~~~~lv 66 (245)
||+|++..+|+.||+|++.... ....+.+. ++++.++.++||||+++++++. ..+..++|
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv 100 (320)
T 2i6l_A 27 VFSAVDNDCDKRVAIKKIVLTD---PQSVKHAL---REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIV 100 (320)
T ss_dssp EEEEEETTTTEEEEEEEEECCS---HHHHHHHH---HHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEE
T ss_pred EEEEEECCCCeEEEEEEEecCC---hHHHHHHH---HHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEE
Confidence 7999999999999999997542 23334444 4477788999999999999873 34688999
Q ss_pred EeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 67 MEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 67 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
|||++ ++|.+++..+.+++..+..++.|++.||+|||++|++|+ |++|+|| +++
T Consensus 101 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~ 154 (320)
T 2i6l_A 101 QEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHR---DLKPANL----------------------FIN 154 (320)
T ss_dssp EECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCSGGGE----------------------EEE
T ss_pred eeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHE----------------------EEc
Confidence 99997 599999988889999999999999999999999999999 8888888 665
Q ss_pred -CCCceEEeecCCccCCCCC---CCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy3347 147 -TEGYVKIADFGLCKEGMGF---GDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221 (245)
Q Consensus 147 -~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~ 221 (245)
.++.+||+|||++...... ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+..
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5678999999998753221 112334467889999999865 67889999999999999999999999988877766
Q ss_pred HHHhc
Q psy3347 222 DSIVN 226 (245)
Q Consensus 222 ~~~~~ 226 (245)
..+..
T Consensus 235 ~~~~~ 239 (320)
T 2i6l_A 235 QLILE 239 (320)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=248.54 Aligned_cols=211 Identities=25% Similarity=0.429 Sum_probs=175.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. +++.||+|++...... .+.+.+ +++.++.++||||+++++++..++..+++|||+++++|.+++.
T Consensus 24 V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 95 (267)
T 3t9t_A 24 VHLGYWL-NKDKVAIKTIREGAMS----EEDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR 95 (267)
T ss_dssp EEEEEET-TTEEEEEEEECTTTBC----HHHHHH---HHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHH
T ss_pred EEEEEec-CCCeEEEEEccccCCC----HHHHHH---HHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHh
Confidence 7899886 6789999999864321 233443 4677888999999999999999999999999999999999986
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 96 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~Ni----------------------li~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 96 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR---DLAARNC----------------------LVGENQVIKVSDFGM 150 (267)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---SCCGGGE----------------------EECGGGCEEECCTTG
T ss_pred hCcccCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCchheE----------------------EECCCCCEEEccccc
Confidence 4 458999999999999999999999999999 8999888 778889999999999
Q ss_pred ccCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 159 CKEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+. ...|..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 230 (267)
T 3t9t_A 151 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 230 (267)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred ccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccC
Confidence 87532211 11223345678999999988889999999999999999999 999999988888888877653 3457788
Q ss_pred ChhHHhhhc
Q psy3347 236 SLEAIAIMR 244 (245)
Q Consensus 236 ~~~~~~li~ 244 (245)
++++.++|+
T Consensus 231 ~~~l~~li~ 239 (267)
T 3t9t_A 231 STHVYQIMN 239 (267)
T ss_dssp CHHHHHHHH
T ss_pred cHHHHHHHH
Confidence 999988875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=246.16 Aligned_cols=214 Identities=24% Similarity=0.391 Sum_probs=170.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++..... ....+.+.+ +++.++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 23 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 97 (276)
T 2yex_A 23 VQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 97 (276)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHH---HHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB
T ss_pred EEEEEECCCCcEEEEEEeeeccc--hhhhHHHHH---HHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh
Confidence 79999999999999999975432 222334444 4677888899999999999999999999999999999999886
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 98 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 98 PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR---DIKPENL----------------------LLDERDNLKISDFGLA 152 (276)
T ss_dssp TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECCCTTC
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhCCeecc---CCChHHE----------------------EEccCCCEEEeeCCCc
Confidence 4 468999999999999999999999999999 9999898 8888899999999998
Q ss_pred cCCCCC--CCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCccc--CCC
Q psy3347 160 KEGMGF--GDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVR--YPR 233 (245)
Q Consensus 160 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~--~p~ 233 (245)
...... ........|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.... .....+...... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh
Confidence 643211 112345578899999999987665 67899999999999999999999765432 223333332222 235
Q ss_pred CCChhHHhhhc
Q psy3347 234 FLSLEAIAIMR 244 (245)
Q Consensus 234 ~~~~~~~~li~ 244 (245)
.+++++++||+
T Consensus 233 ~~~~~~~~li~ 243 (276)
T 2yex_A 233 KIDSAPLALLH 243 (276)
T ss_dssp GSCHHHHHHHH
T ss_pred hcCHHHHHHHH
Confidence 67888888875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=248.59 Aligned_cols=213 Identities=21% Similarity=0.317 Sum_probs=157.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|+++.... ........ .++...++.++||||+++++++..++..++||||+++ +|.+++.
T Consensus 23 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~--~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 97 (290)
T 3fme_A 23 VEKMRHVPSGQIMAVKRIRATVN--SQEQKRLL--MDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYK 97 (290)
T ss_dssp EEEEEETTTTEEEEEEEEC---C--HHHHHHHH--HHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHH
T ss_pred EEEEEecCCCeEEEEEEeecccC--cHHHHHHH--HHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHH
Confidence 79999999999999999976421 12222222 2334457788999999999999999999999999975 7766653
Q ss_pred -----hcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 81 -----ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 81 -----~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
...+++..+..++.|++.||+|||++ |++|+ |++|+|| +++.++.++|+
T Consensus 98 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~ 152 (290)
T 3fme_A 98 QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR---DVKPSNV----------------------LINALGQVKMC 152 (290)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCC---CCSGGGC----------------------EECTTCCEEBC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecC---CCCHHHE----------------------EECCCCCEEEe
Confidence 35799999999999999999999998 99999 9999999 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcC-c
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVL----TETSYTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVND-E 228 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~~g~~pf~~-~~~~~~~~~~~~~-~ 228 (245)
|||++...... .......|++.|+|||.+ .+..++.++||||||+++|+|++|+.||.. ............. .
T Consensus 153 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 153 DFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp CC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred ecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 99998753222 223344688999999996 455788999999999999999999999975 3444444444433 3
Q ss_pred ccC-CCCCChhHHhhhc
Q psy3347 229 VRY-PRFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~~-p~~~~~~~~~li~ 244 (245)
... +..+++++.+||+
T Consensus 232 ~~~~~~~~~~~~~~li~ 248 (290)
T 3fme_A 232 PQLPADKFSAEFVDFTS 248 (290)
T ss_dssp CCCCTTTSCHHHHHHHH
T ss_pred CCcccccCCHHHHHHHH
Confidence 333 3578899998875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=277.91 Aligned_cols=214 Identities=24% Similarity=0.374 Sum_probs=173.1
Q ss_pred CEeEEE--ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQY--RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+ +.+++.||||+++.... .....+.+.+| +++++.++||||+++++++.. +..++||||+++++|.++
T Consensus 385 Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~ 459 (635)
T 4fl3_A 385 VKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAE---ANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKY 459 (635)
T ss_dssp EEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHH---HHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHH
T ss_pred EEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHH---HHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHH
Confidence 789954 45678999999986432 22223445444 677888899999999999964 458899999999999999
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
++. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 460 l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr---DLkp~NI----------------------Ll~~~~~~kL~DFG 514 (635)
T 4fl3_A 460 LQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR---DLAARNV----------------------LLVTQHYAKISDFG 514 (635)
T ss_dssp HHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EEEETTEEEECCTT
T ss_pred HhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCC---CCChHhE----------------------EEeCCCCEEEEEcC
Confidence 864 468999999999999999999999999999 9999998 88888999999999
Q ss_pred CccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 158 LCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 158 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+..+. ...|
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p 594 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 594 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9875332221 1223345678999999998899999999999999999998 999999999888888887664 3568
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++.+||+
T Consensus 595 ~~~~~~l~~li~ 606 (635)
T 4fl3_A 595 AGCPREMYDLMN 606 (635)
T ss_dssp TTCCHHHHHHHH
T ss_pred CCCCHHHHHHHH
Confidence 899999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=256.30 Aligned_cols=212 Identities=17% Similarity=0.255 Sum_probs=160.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-------------------
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------------------- 61 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------------------- 61 (245)
||+|+++.+|+.||||+++... .....+.+. +++++++.++||||++++++|...+
T Consensus 22 V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (332)
T 3qd2_B 22 VFEAKNKVDDCNYAIKRIRLPN--RELAREKVM---REVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTD 96 (332)
T ss_dssp EEEEEETTTCCEEEEEEEECCS--TTTHHHHHH---HHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------
T ss_pred EEEEEEcCCCcEEEEEEeecCC--chhHHHHHH---HHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcccccc
Confidence 7999999999999999998543 222334444 4477888999999999999985543
Q ss_pred --------------------------------------eEEEEEeeccCCchhhhhhhc----CCChHHHHHHHHHHHHH
Q psy3347 62 --------------------------------------HVCFVMEYAAGGDLMMHIHAD----VFSEPRAVFYAACVVLG 99 (245)
Q Consensus 62 --------------------------------------~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~ 99 (245)
+.+++|||+++++|.+++... ..++..+..++.|++.|
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~a 176 (332)
T 3qd2_B 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176 (332)
T ss_dssp -----------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHH
T ss_pred ccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHH
Confidence 489999999999999999653 24555688999999999
Q ss_pred HHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCC------------C
Q psy3347 100 LQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG------------D 167 (245)
Q Consensus 100 l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~ 167 (245)
|+|||++|++|| |+||+|| +++.++.+||+|||+++...... .
T Consensus 177 L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 177 VEFLHSKGLMHR---DLKPSNI----------------------FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp HHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEECCCTTCEECSCC--------------
T ss_pred HHHHHhCCeeec---CCCcccE----------------------EEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 999999999999 9999999 88889999999999987543321 1
Q ss_pred CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc-CCCCCChhHHhhhc
Q psy3347 168 RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLSLEAIAIMR 244 (245)
Q Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~li~ 244 (245)
......||+.|+|||.+.+..++.++||||||+++|+|++|..|+.. .......+.....+ .+...++++++||+
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 307 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQ 307 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHH
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHH
Confidence 22345689999999999998999999999999999999998776522 22222333332221 12344556666654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=261.88 Aligned_cols=189 Identities=16% Similarity=0.189 Sum_probs=150.9
Q ss_pred CEeEEEecC-----CcEEEEEEeecccccchhhHHHHHH-----HHHHHHHHhhcCCCceeeeeEEEeeC----CeEEEE
Q psy3347 1 VILSQYRNT-----GEYFAIKALKKGDIIARDEVESLLS-----EKRIFEVANTMRHPFLVNLFACFQTE----AHVCFV 66 (245)
Q Consensus 1 V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~-----e~~~~~~l~~~~h~ni~~~~~~~~~~----~~~~lv 66 (245)
||+|.++.+ ++.||+|++.........+.+.+.+ ..+++..++.++||||+++++++... .+.++|
T Consensus 51 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv 130 (364)
T 3op5_A 51 IYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130 (364)
T ss_dssp EEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEE
Confidence 799988775 5899999998653221122221111 12334456788999999999998764 568999
Q ss_pred EeeccCCchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 67 MEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 67 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
|||+ +++|.+++.. ..+++..+..++.|++.||+|||++||+|| |+||+|| +
T Consensus 131 ~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHr---Dlkp~Ni----------------------l 184 (364)
T 3op5_A 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHG---DIKASNL----------------------L 184 (364)
T ss_dssp EECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------E
T ss_pred EeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEe---cCCHHHE----------------------E
Confidence 9999 8899999854 569999999999999999999999999999 8999888 6
Q ss_pred cC--CCCceEEeecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 145 ND--TEGYVKIADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 145 ~~--~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
++ .++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 66 789999999999964322211 123445899999999999988999999999999999999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=259.07 Aligned_cols=218 Identities=18% Similarity=0.154 Sum_probs=165.9
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHH-----HHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEe
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLL-----SEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVME 68 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~-----~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e 68 (245)
||+|++.. ++..+|+|++.........+.+.+. ...+++..++.++||||+++++++.. .+..++|||
T Consensus 53 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e 132 (345)
T 2v62_A 53 IYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132 (345)
T ss_dssp EEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEE
T ss_pred EEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEe
Confidence 79999987 8999999999865322111111111 12345677788899999999999987 678999999
Q ss_pred eccCCchhhhhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 69 YAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 69 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
|+ +++|.+++.. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.
T Consensus 133 ~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~ 186 (345)
T 2v62_A 133 RL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHG---DIKAANL----------------------LLGY 186 (345)
T ss_dssp CE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEES
T ss_pred cc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CcCHHHE----------------------EEcc
Confidence 99 8899999854 479999999999999999999999999999 8889888 6666
Q ss_pred CC--ceEEeecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--C
Q psy3347 148 EG--YVKIADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD--D 216 (245)
Q Consensus 148 ~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~--~ 216 (245)
++ .+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+. .
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 66 999999999975322111 113457899999999999888999999999999999999999999642 2
Q ss_pred HHHHHHHHhcCcccCC---------CCCChhHHhhhc
Q psy3347 217 EEEVFDSIVNDEVRYP---------RFLSLEAIAIMR 244 (245)
Q Consensus 217 ~~~~~~~~~~~~~~~p---------~~~~~~~~~li~ 244 (245)
..............+| ..++++++++|+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 303 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLV 303 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHH
T ss_pred cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHH
Confidence 2222222211111222 278888888875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.78 Aligned_cols=215 Identities=21% Similarity=0.367 Sum_probs=166.7
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccC
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~ 72 (245)
||+|++.. +++.||+|+++.... .....+.+. +++..++.++||||+++++++...+ ..+++|||+++
T Consensus 50 V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~ 125 (313)
T 3brb_A 50 VMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFL---SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125 (313)
T ss_dssp EEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHH---HHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTT
T ss_pred EEEEEEeccCCceeEEEEEEEecccc-chhHHHHHH---HHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccC
Confidence 68898775 566899999976432 222333444 4477788999999999999997654 45999999999
Q ss_pred Cchhhhhh-------hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 73 GDLMMHIH-------ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 73 ~~L~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
++|.+++. ...+++..+..++.|++.||.|||++|++|+ |++|+|| ++
T Consensus 126 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---dikp~NI----------------------li 180 (313)
T 3brb_A 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHR---DLAARNC----------------------ML 180 (313)
T ss_dssp CBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCC---CCSGGGE----------------------EE
T ss_pred CCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCcceE----------------------EE
Confidence 99998873 2358999999999999999999999999999 9999999 88
Q ss_pred CCCCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy3347 146 DTEGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFD 222 (245)
Q Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~ 222 (245)
+.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+...
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 889999999999987532221 11223456778999999998899999999999999999999 999999888877777
Q ss_pred HHhcC-cccCCCCCChhHHhhhc
Q psy3347 223 SIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 223 ~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
.+..+ ....|..+++++.++|+
T Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~ 283 (313)
T 3brb_A 261 YLLHGHRLKQPEDCLDELYEIMY 283 (313)
T ss_dssp HHHTTCCCCCBTTCCHHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHH
Confidence 77665 34567889999998875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=251.51 Aligned_cols=214 Identities=24% Similarity=0.356 Sum_probs=171.3
Q ss_pred CEeEEE--ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQY--RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+ ..+++.||+|+++.... .....+.+. ++++.++.++||||+++++++ ..+..++||||+++++|.++
T Consensus 33 Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~ 107 (291)
T 1xbb_A 33 VKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELL---AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY 107 (291)
T ss_dssp EEEEEEECSSSEEEEEEEEEC------CHHHHHHH---HHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHH
T ss_pred eEeeeecCCCceeeEEEEeeccccc-CHHHHHHHH---HHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHH
Confidence 788944 56789999999986432 122233444 447778888999999999999 56678999999999999999
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 108 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~---dikp~Ni----------------------l~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 108 LQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR---DLAARNV----------------------LLVTQHYAKISDFG 162 (291)
T ss_dssp HHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEEETTEEEECCCT
T ss_pred HHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcC---CCCcceE----------------------EEeCCCcEEEccCC
Confidence 864 468999999999999999999999999999 9999888 77888999999999
Q ss_pred CccCCCCCCCC---CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 158 LCKEGMGFGDR---TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+. ...|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 242 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 98753222211 122345678999999988889999999999999999999 999999988888777776654 3567
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++.++|+
T Consensus 243 ~~~~~~l~~li~ 254 (291)
T 1xbb_A 243 AGCPREMYDLMN 254 (291)
T ss_dssp TTCCHHHHHHHH
T ss_pred CCCCHHHHHHHH
Confidence 889999999886
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.66 Aligned_cols=187 Identities=26% Similarity=0.476 Sum_probs=157.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++.... .....+.+ .++++.++.++||||+++++++..++..++||||+++++|.++++
T Consensus 49 V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 123 (360)
T 3eqc_A 49 VFKVSHKPSGLVMARKLIHLEI--KPAIRNQI---IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 123 (360)
T ss_dssp EEEEEETTTCCEEEEEEEECCC--CHHHHHHH---HHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEecccc--CHHHHHHH---HHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHH
Confidence 7999999999999999998642 22223334 344777889999999999999999999999999999999999985
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||.|||+. |++|+ |++|+|| +++.++.++|+|||+
T Consensus 124 ~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 124 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR---DVKPSNI----------------------LVNSRGEIKLCDFGV 178 (360)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCS---CCSGGGE----------------------EECTTCCEEECCCCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcC---CccHHHE----------------------EECCCCCEEEEECCC
Confidence 4 5799999999999999999999996 99999 9999998 888899999999998
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~ 219 (245)
+..... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 179 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 179 SGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp CHHHHH--HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred Cccccc--ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 863211 12334578999999999998899999999999999999999999998765543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=263.69 Aligned_cols=188 Identities=22% Similarity=0.399 Sum_probs=152.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|+++.+|+.||||++...... . .+++++++.++||||++++++|... .+.++||||+++ +
T Consensus 70 Vy~~~~~~~~~~vaiK~~~~~~~~-------~---~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~ 138 (420)
T 1j1b_A 70 VYQAKLCDSGELVAIKKVLQDKRF-------K---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-T 138 (420)
T ss_dssp EEEEEETTTCCEEEEEEEECCTTS-------C---CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-E
T ss_pred EEEEEECCCCcEEEEEEecccchh-------H---HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-c
Confidence 799999999999999999754211 1 2347778899999999999998542 247899999986 4
Q ss_pred hhhhhh-----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-C
Q psy3347 75 LMMHIH-----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-E 148 (245)
Q Consensus 75 L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-~ 148 (245)
+...+. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++. .
T Consensus 139 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------Ll~~~~ 193 (420)
T 1j1b_A 139 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR---DIKPQNL----------------------LLDPDT 193 (420)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS---CCSGGGE----------------------EEETTT
T ss_pred HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc---CCChhhE----------------------EEeCCC
Confidence 544432 3568999999999999999999999999999 8999888 6664 4
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+.+||+|||+++..... ......+||..|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 194 ~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 194 AVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp TEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 67899999999753222 233456789999999999764 68999999999999999999999999988776665554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=257.19 Aligned_cols=181 Identities=23% Similarity=0.315 Sum_probs=149.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|++. |+.||+|++.... .... ...+++..++.++||||+++++++.... ..++||||+++++|.
T Consensus 40 Vy~~~~~--~~~vavK~~~~~~----~~~~---~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 110 (322)
T 3soc_A 40 VWKAQLL--NEYVAVKIFPIQD----KQSW---QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS 110 (322)
T ss_dssp EEEEEET--TEEEEEEEECGGG----HHHH---HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHH
T ss_pred EEEEEEC--CCEEEEEEeecCc----hHHH---HHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHH
Confidence 7999775 8999999997532 1111 1233567788999999999999998743 579999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhhc----------CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHES----------RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----------~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
++++...+++..+..++.|++.||+|||+. |++|| |+||+|| +++
T Consensus 111 ~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~---Dlkp~Ni----------------------ll~ 165 (322)
T 3soc_A 111 DFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHR---DIKSKNV----------------------LLK 165 (322)
T ss_dssp HHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECS---CCSGGGE----------------------EEC
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeC---CCChHhE----------------------EEC
Confidence 999888899999999999999999999999 99999 9999999 888
Q ss_pred CCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 147 TEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTET-----SYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
.++.+||+|||+++....... ......||..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999964322221 23345789999999999763 4557889999999999999999999653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=248.03 Aligned_cols=214 Identities=22% Similarity=0.366 Sum_probs=172.6
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCe-EEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH-VCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~-~~lv~e~~~~~~L~ 76 (245)
||+|++..+++ .||+|++.... .....+.+. ++++.++.++||||+++++++...+. .+++|||+.+++|.
T Consensus 37 Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~ 111 (298)
T 3pls_A 37 VYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFL---REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111 (298)
T ss_dssp EEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHH---HHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHH
T ss_pred EEEEEEecCCCceeeeeeeeccccc--cHHHHHHHH---HHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHH
Confidence 79998776655 89999997532 223334444 44777888999999999999976654 49999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 112 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~---dikp~Ni----------------------li~~~~~~kl~ 166 (298)
T 3pls_A 112 QFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHR---DLAARNC----------------------MLDESFTVKVA 166 (298)
T ss_dssp HHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECTTCCEEEC
T ss_pred HHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCcceE----------------------EEcCCCcEEeC
Confidence 99864 568889999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCC----CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-
Q psy3347 155 DFGLCKEGMGFG----DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE- 228 (245)
Q Consensus 155 Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~- 228 (245)
|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ +.+||...+..+....+....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 999987432211 12334466788999999998899999999999999999999 566677777777777666554
Q ss_pred ccCCCCCChhHHhhhc
Q psy3347 229 VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~ 244 (245)
.+.|..+++++.++|+
T Consensus 247 ~~~~~~~~~~l~~li~ 262 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQ 262 (298)
T ss_dssp CCCCTTCCHHHHHHHH
T ss_pred CCCCccchHHHHHHHH
Confidence 4567888999998875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=256.64 Aligned_cols=213 Identities=22% Similarity=0.350 Sum_probs=164.6
Q ss_pred CEeEEEecCCcEE----EEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYF----AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+.+ |+|.+.... .....+.+. ++++.++.++||||+++++++..++ .++++|++.+++|.
T Consensus 31 Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~ 104 (327)
T 3poz_A 31 VYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEIL---DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 104 (327)
T ss_dssp EEEEEECC----CCEEEEEEEC---------CHHHHH---HHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHH
T ss_pred EEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHH---HHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHH
Confidence 7999998887765 677665321 112233344 4467788889999999999998765 78999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.+||+
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~---Dikp~NI----------------------ll~~~~~~kl~ 159 (327)
T 3poz_A 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR---DLAARNV----------------------LVKTPQHVKIT 159 (327)
T ss_dssp HHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EEEETTEEEEC
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC---CCChheE----------------------EECCCCCEEEc
Confidence 98854 468999999999999999999999999999 9999998 78888999999
Q ss_pred ecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++....... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+. .+
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC
Confidence 9999874322211 1223345778999999999999999999999999999999 999999888777777665553 35
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.++|.
T Consensus 240 ~~~~~~~~~~~li~ 253 (327)
T 3poz_A 240 QPPICTIDVYMIMV 253 (327)
T ss_dssp CCTTBCHHHHHHHH
T ss_pred CCccCCHHHHHHHH
Confidence 67788888888875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=266.77 Aligned_cols=210 Identities=25% Similarity=0.375 Sum_probs=169.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+.. +..||||+++.... ..+.+.+ ++++++.++||||+++++++.. +..++||||+++|+|.++++
T Consensus 200 Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~---E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~ 270 (452)
T 1fmk_A 200 VWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQ---EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK 270 (452)
T ss_dssp EEEEEETT-TEEEEEEECCTTSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHS
T ss_pred EEEEEECC-CceEEEEEeccCCC----CHHHHHH---HHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHH
Confidence 79998875 46799999986432 1234444 4777888999999999999866 67899999999999999985
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++|++|| |++|+|| +++.++.+||+|||
T Consensus 271 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~kl~DfG 325 (452)
T 1fmk_A 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR---DLRAANI----------------------LVGENLVCKVADFG 325 (452)
T ss_dssp HHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECGGGCEEECCCC
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCChhhE----------------------EECCCCCEEECCCc
Confidence 3 458999999999999999999999999999 8889888 77888999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+....+..+. .+.|..
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 405 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 405 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 9975332211 1123345678999999988899999999999999999999 999999998888888876653 356788
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
+++++.+||+
T Consensus 406 ~~~~l~~li~ 415 (452)
T 1fmk_A 406 CPESLHDLMC 415 (452)
T ss_dssp SCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 9999999886
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=250.95 Aligned_cols=197 Identities=25% Similarity=0.376 Sum_probs=162.0
Q ss_pred CEeEEEe-cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe-----eCCeEEEEEeeccCCc
Q psy3347 1 VILSQYR-NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-----TEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~~ 74 (245)
||+|++. .+|+.||+|++...... ......+.+|.+++..+..++||||+++++++. ..+..++||||+. ++
T Consensus 27 V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 104 (326)
T 1blx_A 27 VFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD 104 (326)
T ss_dssp EEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CB
T ss_pred EEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CC
Confidence 7999995 67899999999764321 112234456666666677779999999999987 4568999999997 59
Q ss_pred hhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 75 LMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 75 L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
|.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.+
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~---dlkp~Ni----------------------li~~~~~~ 159 (326)
T 1blx_A 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR---DLKPQNI----------------------LVTSSGQI 159 (326)
T ss_dssp HHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTCCE
T ss_pred HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceec---cCCHHHe----------------------EEcCCCCE
Confidence 9888854 348999999999999999999999999999 9999998 88889999
Q ss_pred EEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 152 KIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+|+|||++..... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 160 kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 160 KLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp EECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEecCcccccccC-CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999999875322 222344578899999999998889999999999999999999999999888777766664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.84 Aligned_cols=191 Identities=25% Similarity=0.427 Sum_probs=156.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeE------EEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHV------CFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~------~lv~e~~~~~~ 74 (245)
||+|+++.+|+.||+|++..... .....+.+ .+++.+++.++||||+++++++...+.. ++||||+. ++
T Consensus 58 Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 132 (371)
T 4exu_A 58 VCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRA---YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TD 132 (371)
T ss_dssp EEEEEETTTTEEEEEEEECSTTS-SHHHHHHH---HHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EE
T ss_pred EEEEEECCCCCEEEEEEeccccc-chhHHHHH---HHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-cc
Confidence 79999999999999999986431 22222333 4457778889999999999999876644 99999997 47
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|...+.. .+++..+..++.|++.||+|||++||+|+ |++|+|| +++.++.+||+
T Consensus 133 l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dikp~NI----------------------ll~~~~~~kL~ 186 (371)
T 4exu_A 133 LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHR---DLKPGNL----------------------AVNEDCELKIL 186 (371)
T ss_dssp HHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCC---CcCHHHe----------------------EECCCCCEEEE
Confidence 8777643 49999999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||+++... .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 187 Dfg~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 187 DFGLARHAD---AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp STTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecCcccccc---cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999987532 22345578999999999977 678999999999999999999999999888777666654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.71 Aligned_cols=188 Identities=23% Similarity=0.422 Sum_probs=151.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||+|++..+++ +|+|++....... .+++++++.++||||++++++|...+ ..++||||++++.
T Consensus 56 V~~a~~~~~~~-~aikk~~~~~~~~----------~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l 124 (394)
T 4e7w_A 56 VFQAKLVESDE-VAIKKVLQDKRFK----------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124 (394)
T ss_dssp EEEEEETTTEE-EEEEEEECCTTSC----------CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEH
T ss_pred EEEEEECCCCe-EEEEEEecCcchH----------HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccH
Confidence 79999987776 8888886532111 23467788999999999999996543 4889999998754
Q ss_pred hhhhhh----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCC
Q psy3347 75 LMMHIH----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEG 149 (245)
Q Consensus 75 L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 149 (245)
+..... ...+++..++.++.|++.||+|||++||+|| |+||+|| +++ .++
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr---Dlkp~Ni----------------------ll~~~~~ 179 (394)
T 4e7w_A 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR---DIKPQNL----------------------LLDPPSG 179 (394)
T ss_dssp HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEETTTT
T ss_pred HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCC---CCCHHHE----------------------EEcCCCC
Confidence 443332 4578999999999999999999999999999 9999888 776 789
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
.+||+|||+++..... .......+|..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 180 ~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~ 255 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII 255 (394)
T ss_dssp EEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999753222 234456789999999999765 58999999999999999999999999988776666554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=253.92 Aligned_cols=214 Identities=22% Similarity=0.333 Sum_probs=170.3
Q ss_pred CEeEE-----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQ-----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|+ +..+++.||+|++.... .......+. +++..++.++||||+++++++...+..++||||+++++|
T Consensus 46 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 120 (327)
T 2yfx_A 46 VYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFL---MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120 (327)
T ss_dssp EEEEEC--------CCEEEEEECCSSC--CHHHHHHHH---HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEH
T ss_pred EEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHH---HHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcH
Confidence 68888 56688999999997432 222333444 446777888999999999999999999999999999999
Q ss_pred hhhhhhc--------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-
Q psy3347 76 MMHIHAD--------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND- 146 (245)
Q Consensus 76 ~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~- 146 (245)
.+++... .+++..+..++.|++.||.|||++|++|+ |++|+|| +++
T Consensus 121 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~---dlkp~NI----------------------li~~ 175 (327)
T 2yfx_A 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR---DIAARNC----------------------LLTC 175 (327)
T ss_dssp HHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EESC
T ss_pred HHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecC---cCCHhHE----------------------EEec
Confidence 9998642 37888999999999999999999999999 8888888 665
Q ss_pred --CCCceEEeecCCccCCCCC--CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy3347 147 --TEGYVKIADFGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVF 221 (245)
Q Consensus 147 --~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~ 221 (245)
.+..++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 3456999999988632111 112334567888999999988889999999999999999998 99999988888888
Q ss_pred HHHhcCc-ccCCCCCChhHHhhhc
Q psy3347 222 DSIVNDE-VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~~-~~~p~~~~~~~~~li~ 244 (245)
..+..+. ...|..+++++.++|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~ 279 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMT 279 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHH
Confidence 7776654 3467789999998885
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.21 Aligned_cols=197 Identities=28% Similarity=0.480 Sum_probs=158.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--eEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~~ 78 (245)
||+|+++.+|+.||+|++..... ....+.+. +++++++.++||||+++++++...+ +.++||||+++++|.++
T Consensus 25 Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 99 (396)
T 4eut_A 25 VFRGRHKKTGDLFAIKVFNNISF--LRPVDVQM---REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTV 99 (396)
T ss_dssp EEEEEETTTCCEEEEEEECGGGG--GSCHHHHH---HHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHH
T ss_pred EEEEEECCCCcEEEEEEeccccc--cchHHHHH---HHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHH
Confidence 79999999999999999985432 12233333 4577788899999999999998755 78999999999999999
Q ss_pred hhhc----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc----CCCCc
Q psy3347 79 IHAD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN----DTEGY 150 (245)
Q Consensus 79 ~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 150 (245)
++.. .+++..+..++.|++.||+|||++||+|| |+||+|| ++ +.++.
T Consensus 100 l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~~~ 154 (396)
T 4eut_A 100 LEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR---NIKPGNI----------------------MRVIGEDGQSV 154 (396)
T ss_dssp TTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EEEECTTSCEE
T ss_pred HHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEEC---CcCHHHE----------------------EEeecCCCcee
Confidence 8542 38999999999999999999999999999 8888888 55 66778
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCC----CCHH
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIFEMLVGESPFPG----DDEE 218 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~~g~~pf~~----~~~~ 218 (245)
+||+|||+++..... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+ ....
T Consensus 155 ~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~ 233 (396)
T 4eut_A 155 YKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233 (396)
T ss_dssp EEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred EEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence 999999999753322 22345678999999999864 4577899999999999999999999964 3344
Q ss_pred HHHHHHhcCc
Q psy3347 219 EVFDSIVNDE 228 (245)
Q Consensus 219 ~~~~~~~~~~ 228 (245)
+....+..+.
T Consensus 234 ~~~~~~~~~~ 243 (396)
T 4eut_A 234 EVMYKIITGK 243 (396)
T ss_dssp HHHHHHHHSC
T ss_pred HHHHHHhcCC
Confidence 5555555443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=255.78 Aligned_cols=214 Identities=27% Similarity=0.460 Sum_probs=170.5
Q ss_pred CEeEEEecCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGE-----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|.+..+++ .||+|++.... .....+.+.+| +..++.+ +||||+++++++..++..++||||+++++
T Consensus 62 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 136 (333)
T 2i1m_A 62 VVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSE---LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136 (333)
T ss_dssp EEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred eEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHH---HHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCc
Confidence 79999877664 79999997643 22333444444 6667777 89999999999999999999999999999
Q ss_pred hhhhhhh---------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccc
Q psy3347 75 LMMHIHA---------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQE 139 (245)
Q Consensus 75 L~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~ 139 (245)
|.+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+||
T Consensus 137 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dlkp~NI------------------ 195 (333)
T 2i1m_A 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR---DVAARNV------------------ 195 (333)
T ss_dssp HHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGC------------------
T ss_pred HHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccC---CcccceE------------------
Confidence 9998853 247889999999999999999999999999 9999888
Q ss_pred hhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy3347 140 IKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDD 216 (245)
Q Consensus 140 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~ 216 (245)
+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 196 ----l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 196 ----LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp ----EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ----EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 778889999999999875322221 1233456778999999988889999999999999999998 999998766
Q ss_pred HHHHHHHHhcCc--ccCCCCCChhHHhhhc
Q psy3347 217 EEEVFDSIVNDE--VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 217 ~~~~~~~~~~~~--~~~p~~~~~~~~~li~ 244 (245)
.......+.... ...|..+++++.+||+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 301 (333)
T 2i1m_A 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ 301 (333)
T ss_dssp SSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hhHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 544444443332 3356778899888875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=254.30 Aligned_cols=193 Identities=23% Similarity=0.369 Sum_probs=157.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-----CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-----AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (245)
||+|++..+|+.||||++.... .......+ .++++.++.++||||+++++++... +..+++||++. ++|
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 100 (353)
T 2b9h_A 27 VCSATHKPTGEIVAIKKIEPFD--KPLFALRT---LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDL 100 (353)
T ss_dssp EEEEEETTTTEEEEEEEECCCS--SHHHHHHH---HHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEH
T ss_pred EEEEEECCCCcEEEEEeecccc--cchHHHHH---HHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccH
Confidence 7999999999999999997432 22222333 3457778888999999999998654 67999999997 589
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
..++....+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~---Dlkp~Ni----------------------l~~~~~~~kl~D 155 (353)
T 2b9h_A 101 HRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR---DLKPSNL----------------------LINSNCDLKVCD 155 (353)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EECTTCCEEECC
T ss_pred HHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------EEcCCCcEEEEe
Confidence 998888889999999999999999999999999999 9999998 888899999999
Q ss_pred cCCccCCCCCCC----------CCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 156 FGLCKEGMGFGD----------RTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 156 fg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
||++........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999875322111 1223467899999998865 67899999999999999999999999988766555443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=253.64 Aligned_cols=213 Identities=23% Similarity=0.362 Sum_probs=166.8
Q ss_pred CEeEEEecCCcEE----EEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYF----AIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+.+ |+|.+.... .....+.+.+ ++..++.++||||+++++++..++ .++++|++.+++|.
T Consensus 31 Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~---E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~ 104 (327)
T 3lzb_A 31 VYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILD---EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLL 104 (327)
T ss_dssp EEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHH---HHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHH
T ss_pred EEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHH---HHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHH
Confidence 7999999888866 555554321 1222334444 477788999999999999997765 88999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++.. ..+++..+..++.|++.||.|||++|++|| |+||+|| +++.++.+||+
T Consensus 105 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---Dikp~NI----------------------l~~~~~~~kL~ 159 (327)
T 3lzb_A 105 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR---DLAARNV----------------------LVKTPQHVKIT 159 (327)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EEEETTEEEEC
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCC---CCCHHHE----------------------EEcCCCCEEEc
Confidence 98854 468999999999999999999999999999 9999998 77888999999
Q ss_pred ecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+.... .+
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999875322211 1223345678999999999999999999999999999999 999999888877777776554 45
Q ss_pred CCCCCChhHHhhhc
Q psy3347 231 YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p~~~~~~~~~li~ 244 (245)
.|..+++++.++|+
T Consensus 240 ~~~~~~~~l~~li~ 253 (327)
T 3lzb_A 240 QPPICTIDVYMIMR 253 (327)
T ss_dssp CCTTBCHHHHHHHH
T ss_pred CCccCCHHHHHHHH
Confidence 67789999998885
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=255.57 Aligned_cols=212 Identities=17% Similarity=0.331 Sum_probs=164.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC--CCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+.. |+.||||++..... .....+.+.+| +++++.++ ||||+++++++..++..++||| +.+++|.++
T Consensus 72 Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~E---i~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~ 145 (390)
T 2zmd_A 72 VFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNE---IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 145 (390)
T ss_dssp EEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHH---HHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHH
T ss_pred EEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHH---HHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHH
Confidence 79998875 99999999976432 23334445555 55666665 5999999999999999999999 567899998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||.|||++||+|| |+||+|| +++ ++.+||+|||
T Consensus 146 l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHr---Dlkp~NI----------------------ll~-~~~~kl~DFG 199 (390)
T 2zmd_A 146 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS---DLKPANF----------------------LIV-DGMLKLIDFG 199 (390)
T ss_dssp HHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCC---CCCGGGE----------------------EES-SSCEEECCCS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCCHHHE----------------------EEE-CCeEEEEecC
Confidence 854 568888999999999999999999999999 8888888 554 4789999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTE-----------TSYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDS 223 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~~g~~pf~~~~-~~~~~~~ 223 (245)
+++....... .....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.. .......
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~ 279 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH
Confidence 9975432221 2345678999999999965 368889999999999999999999997653 3445555
Q ss_pred HhcCc--ccCCCCCChhHHhhhc
Q psy3347 224 IVNDE--VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 224 ~~~~~--~~~p~~~~~~~~~li~ 244 (245)
+.... ..+|...++++.+||+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~li~ 302 (390)
T 2zmd_A 280 IIDPNHEIEFPDIPEKDLQDVLK 302 (390)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHH
T ss_pred HhCccccCCCCccchHHHHHHHH
Confidence 55443 3457777888988875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=252.74 Aligned_cols=217 Identities=31% Similarity=0.521 Sum_probs=162.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccch--hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR--DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|+++.+|+.||+|++........ ..........+++++++.++||||+++++++..++ .++||||+++++|.++
T Consensus 26 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~ 104 (322)
T 2ycf_A 26 VKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDK 104 (322)
T ss_dssp EEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHH
T ss_pred EEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHH
Confidence 79999999999999999976432110 11111122234577788899999999999987665 8999999999999888
Q ss_pred hh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC---ceEEe
Q psy3347 79 IH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG---YVKIA 154 (245)
Q Consensus 79 ~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~kl~ 154 (245)
+. ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++ .+||+
T Consensus 105 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---dlkp~NI----------------------l~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 105 VVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR---DLKPENV----------------------LLSSQEEDCLIKIT 159 (322)
T ss_dssp HSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESSSSSSCCEEEC
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHHHE----------------------EEecCCCCCeEEEc
Confidence 74 4578999999999999999999999999999 8888888 665544 49999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCccc
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~ 230 (245)
|||++..... ........|+..|+|||.+. ...++.++|||||||++|+|++|..||.+.... .....+..+...
T Consensus 160 Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 160 DFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp CCTTCEECCC-CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cCccceeccc-ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 9999875322 11123456899999999974 456889999999999999999999999765332 333444444333
Q ss_pred C----CCCCChhHHhhhc
Q psy3347 231 Y----PRFLSLEAIAIMR 244 (245)
Q Consensus 231 ~----p~~~~~~~~~li~ 244 (245)
+ +..+++++.+||+
T Consensus 239 ~~~~~~~~~~~~~~~li~ 256 (322)
T 2ycf_A 239 FIPEVWAEVSEKALDLVK 256 (322)
T ss_dssp CCHHHHTTSCHHHHHHHH
T ss_pred cCchhhhhcCHHHHHHHH
Confidence 2 2567888888875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=244.80 Aligned_cols=210 Identities=24% Similarity=0.389 Sum_probs=171.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. +++.||+|++..... ..+.+.+ +++.++.++||||+++++++. .+..+++|||+++++|.+++.
T Consensus 29 Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~---E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~ 99 (279)
T 1qpc_A 29 VWMGYYN-GHTKVAVKSLKQGSM----SPDAFLA---EANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK 99 (279)
T ss_dssp EEEEEET-TTEEEEEEEECTTSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTT
T ss_pred EEEEEEc-CCcEEEEEEecCCcc----cHHHHHH---HHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHh
Confidence 7899865 577899999976432 1233444 467788889999999999986 456899999999999999985
Q ss_pred hc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 AD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||
T Consensus 100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR---DLRAANI----------------------LVSDTLSCKIADFG 154 (279)
T ss_dssp SHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTSCEEECCCT
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc---CCCHhhE----------------------EEcCCCCEEECCCc
Confidence 42 69999999999999999999999999999 9999998 88889999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+..+. ...|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T 1qpc_A 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234 (279)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccc
Confidence 9875432211 1223345778999999988889999999999999999999 999999988888877776653 345778
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
+++++.++|+
T Consensus 235 ~~~~l~~li~ 244 (279)
T 1qpc_A 235 CPEELYQLMR 244 (279)
T ss_dssp CCHHHHHHHH
T ss_pred ccHHHHHHHH
Confidence 8999998875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=251.14 Aligned_cols=212 Identities=17% Similarity=0.339 Sum_probs=161.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCC--CceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRH--PFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h--~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+. +++.||+|++..... .....+.+.+| ++.++.++| |||+++++++..++..++||| +.+++|.++
T Consensus 25 Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E---~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~ 98 (343)
T 3dbq_A 25 VFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNE---IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 98 (343)
T ss_dssp EEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHH---HHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHH
T ss_pred EEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHH---HHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHH
Confidence 7999884 689999999986432 22333444444 666666765 999999999999999999999 567799998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||.|||++||+|| |+||+|| +++ ++.+||+|||
T Consensus 99 l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHr---Dikp~NI----------------------ll~-~~~~kl~DFG 152 (343)
T 3dbq_A 99 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS---DLKPANF----------------------LIV-DGMLKLIDFG 152 (343)
T ss_dssp HHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EEE-TTEEEECCCS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCcceE----------------------EEE-CCcEEEeecc
Confidence 854 578999999999999999999999999999 8888888 554 5789999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTE-----------TSYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDS 223 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~~g~~pf~~~~-~~~~~~~ 223 (245)
+++....... .....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.. .......
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 232 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence 9975432221 2335578999999999964 568889999999999999999999997643 3344444
Q ss_pred HhcC--cccCCCCCChhHHhhhc
Q psy3347 224 IVND--EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 224 ~~~~--~~~~p~~~~~~~~~li~ 244 (245)
+... ...+|...++++.+||+
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~ 255 (343)
T 3dbq_A 233 IIDPNHEIEFPDIPEKDLQDVLK 255 (343)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHH
T ss_pred HhcCCcccCCcccCCHHHHHHHH
Confidence 4433 33567888888888875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.13 Aligned_cols=215 Identities=24% Similarity=0.384 Sum_probs=167.6
Q ss_pred CEeEEEec-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRN-TGE--YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++.. +++ .||+|+++..........+.+.+| ++.++.++||||+++++++..++ .+++||++++++|.+
T Consensus 34 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~ 109 (291)
T 1u46_A 34 VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE---VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLD 109 (291)
T ss_dssp CEEEEEECTTSCEEEEEEEC--------CHHHHHHHHH---HHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHH
T ss_pred EEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHH---HHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHH
Confidence 79998754 333 699999986543333344444444 67778889999999999997765 889999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 110 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dikp~Ni----------------------li~~~~~~kl~D 164 (291)
T 1u46_A 110 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR---DLAARNL----------------------LLATRDLVKIGD 164 (291)
T ss_dssp HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EEEETTEEEECC
T ss_pred HHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccC---CCchheE----------------------EEcCCCCEEEcc
Confidence 8853 468999999999999999999999999999 8999888 778889999999
Q ss_pred cCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc--
Q psy3347 156 FGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-- 229 (245)
Q Consensus 156 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-- 229 (245)
||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 999875432221 1223456778999999988888999999999999999999 9999999888888887766543
Q ss_pred cCCCCCChhHHhhhc
Q psy3347 230 RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 ~~p~~~~~~~~~li~ 244 (245)
+.+..+++++.++|+
T Consensus 245 ~~~~~~~~~l~~li~ 259 (291)
T 1u46_A 245 PRPEDCPQDIYNVMV 259 (291)
T ss_dssp CCCTTCCHHHHHHHH
T ss_pred CCCcCcCHHHHHHHH
Confidence 345788999998875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=248.96 Aligned_cols=215 Identities=22% Similarity=0.339 Sum_probs=166.6
Q ss_pred CEeEE----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCc
Q psy3347 1 VILSQ----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~ 74 (245)
||+|+ +..+|+.||+|++.... .....+.+. ++++.++.++||||+++++++... +..++||||+++++
T Consensus 37 V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 111 (302)
T 4e5w_A 37 VELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLK---KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 111 (302)
T ss_dssp EEEEEECTTSSSCSEEEEEEEEC-------CCHHHHH---HHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCB
T ss_pred EEEEEEccccCccCeEEEEEEecccc--cchhHHHHH---HHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCc
Confidence 68888 67789999999998543 222234444 447778889999999999999876 67899999999999
Q ss_pred hhhhhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++. ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++
T Consensus 112 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~k 166 (302)
T 4e5w_A 112 LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR---DLAARNV----------------------LVESEHQVK 166 (302)
T ss_dssp HHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEEETTEEE
T ss_pred HHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccC---CCchheE----------------------EEcCCCCEE
Confidence 999984 3468999999999999999999999999999 9999998 788889999
Q ss_pred EeecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------------
Q psy3347 153 IADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD-------------- 215 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~-------------- 215 (245)
|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 999999875433221 233456777899999998888999999999999999999998875321
Q ss_pred CH-HHHHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 216 DE-EEVFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 216 ~~-~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
.. ......+..+ ..+.|..+++++.+||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 278 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRK 278 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 11 2222223222 334578899999998863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=247.29 Aligned_cols=210 Identities=19% Similarity=0.228 Sum_probs=162.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEE-eeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF-QTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+|+.||+|++...... +.+.+| +..++.++|++++..++.+ ..++..++||||+ +++|.+++
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e---~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 95 (296)
T 3uzp_A 25 IYLGTDIAAGEEVAIKLECVKTKH-----PQLHIE---SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLF 95 (296)
T ss_dssp EEEEEETTTTEEEEEEEEESCSSC-----CHHHHH---HHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred EEEEEEcCCCcEEEEEEecCCcch-----hHHHHH---HHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHH
Confidence 799999999999999998764321 234444 5556677787766666655 6677899999999 88999988
Q ss_pred h--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEe
Q psy3347 80 H--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIA 154 (245)
Q Consensus 80 ~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~ 154 (245)
. ...+++..+..++.|++.||+|||++|++|+ |++|+|| ++ +.++.+||+
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~---dlkp~NI----------------------l~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 96 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR---DVKPDNF----------------------LMGLGKKGNLVYII 150 (296)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EECCGGGTTCEEEC
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCCHHHe----------------------EEecCCCCCeEEEe
Confidence 6 4579999999999999999999999999999 8888888 55 467899999
Q ss_pred ecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH
Q psy3347 155 DFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD---EEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~---~~~~~~~~ 224 (245)
|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.. ..+....+
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 9999875332221 1245578999999999999889999999999999999999999997632 22333333
Q ss_pred hcCcccC-----CCCCChhHHhhhc
Q psy3347 225 VNDEVRY-----PRFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~~~~~-----p~~~~~~~~~li~ 244 (245)
....... +..+++++.++|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~ 255 (296)
T 3uzp_A 231 SEKKMSTPIEVLCKGYPSEFATYLN 255 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred cccccCCchHHHHhhCCHHHHHHHH
Confidence 3322222 3678888888875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=245.36 Aligned_cols=213 Identities=23% Similarity=0.344 Sum_probs=168.6
Q ss_pred CEeEEEec---CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRN---TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++.. ++..||+|++.... .....+.+.+| +..++.++||||+++++++..+ ..+++|||+++++|.+
T Consensus 28 Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~ 101 (281)
T 3cc6_A 28 VYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSE---AVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGH 101 (281)
T ss_dssp EEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHH---HHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHH
T ss_pred EEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHH---HHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHH
Confidence 78998764 34569999998642 22333444444 6667778899999999998654 5689999999999999
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 102 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~D 156 (281)
T 3cc6_A 102 YLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR---DIAVRNI----------------------LVASPECVKLGD 156 (281)
T ss_dssp HHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCSGGGE----------------------EEEETTEEEECC
T ss_pred HHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCccceE----------------------EECCCCcEEeCc
Confidence 9854 358999999999999999999999999999 8999888 778889999999
Q ss_pred cCCccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCC
Q psy3347 156 FGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p 232 (245)
||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+... ..+.|
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 999875332221 1233455778999999988889999999999999999998 99999877777666666554 34567
Q ss_pred CCCChhHHhhhc
Q psy3347 233 RFLSLEAIAIMR 244 (245)
Q Consensus 233 ~~~~~~~~~li~ 244 (245)
..+++++.++|+
T Consensus 237 ~~~~~~l~~li~ 248 (281)
T 3cc6_A 237 DLCPPVLYTLMT 248 (281)
T ss_dssp TTCCHHHHHHHH
T ss_pred CCCCHHHHHHHH
Confidence 889999998876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.27 Aligned_cols=214 Identities=24% Similarity=0.395 Sum_probs=158.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++..... ....+.+ .++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 31 V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 105 (303)
T 2vwi_A 31 VQAAYCAPKKEKVAIKRINLEKC--QTSMDEL---LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK 105 (303)
T ss_dssp EEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEEhhhc--chhHHHH---HHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHH
Confidence 79999999999999999875421 1222333 345777889999999999999999999999999999999998885
Q ss_pred h---------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 81 A---------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 81 ~---------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.+
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dl~p~Ni----------------------l~~~~~~~ 160 (303)
T 2vwi_A 106 HIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR---DVKAGNI----------------------LLGEDGSV 160 (303)
T ss_dssp HHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCSGGGE----------------------EECTTCCE
T ss_pred HHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC---CCChhhE----------------------EEcCCCCE
Confidence 2 358999999999999999999999999999 9999998 88889999
Q ss_pred EEeecCCccCCCCCC-----CCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 152 KIADFGLCKEGMGFG-----DRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+|+|||++....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+......
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 240 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh
Confidence 999999886432211 11234568899999999976 568899999999999999999999998877665555444
Q ss_pred cCccc----------CCCCCChhHHhhhc
Q psy3347 226 NDEVR----------YPRFLSLEAIAIMR 244 (245)
Q Consensus 226 ~~~~~----------~p~~~~~~~~~li~ 244 (245)
....+ .+..+++++++||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 269 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGKSFRKMIS 269 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCHHHHHHHH
T ss_pred ccCCCccccccccchhhhhhhHHHHHHHH
Confidence 33221 12456788888875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=252.66 Aligned_cols=191 Identities=25% Similarity=0.424 Sum_probs=154.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCe------EEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH------VCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~------~~lv~e~~~~~~ 74 (245)
||+|+++.+|+.||||++..... .....+.+ .+++..++.++||||+++++++...+. .+++|||+. ++
T Consensus 40 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 114 (353)
T 3coi_A 40 VCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRA---YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TD 114 (353)
T ss_dssp EEEEEETTTTEEEEEEEESSTTS-SHHHHHHH---HHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EE
T ss_pred EEEEEECCCCCEEEEEEeccccc-chHHHHHH---HHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CC
Confidence 79999999999999999976431 22222333 345777888999999999999977653 599999997 58
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|..++.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+
T Consensus 115 l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~---dlkp~NI----------------------l~~~~~~~kl~ 168 (353)
T 3coi_A 115 LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHR---DLKPGNL----------------------AVNEDCELKIL 168 (353)
T ss_dssp GGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCS---SCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE----------------------eECCCCcEEEe
Confidence 8877754 49999999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||++.... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 169 Dfg~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 169 DFGLARHAD---AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp STTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred ecccccCCC---CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999987532 12334578899999999977 678899999999999999999999999887766655543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=251.89 Aligned_cols=213 Identities=23% Similarity=0.347 Sum_probs=166.2
Q ss_pred EeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC--CeEEEEEeeccCCchhhhh
Q psy3347 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 2 ~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~ 79 (245)
|++.+..+|+.||+|+++... .....+.+.+ ++++++.++||||+++++++... ...++||||+++++|.+++
T Consensus 52 ~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 126 (318)
T 3lxp_A 52 YDPTNDGTGEMVAVKALKADA--GPQHRSGWKQ---EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126 (318)
T ss_dssp ECSCC--CCEEEEEEEECTTC--CHHHHHHHHH---HHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHG
T ss_pred EccCCCCCCcEEEEEEecccc--ChHHHHHHHH---HHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHH
Confidence 334556689999999998642 2233344444 47778888999999999999874 6899999999999999999
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
....+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||++
T Consensus 127 ~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~---Dikp~Ni----------------------l~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 127 PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHR---DLAARNV----------------------LLDNDRLVKIGDFGLA 181 (318)
T ss_dssp GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECCGGGC
T ss_pred hhCCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCchheE----------------------EEcCCCCEEECCcccc
Confidence 88889999999999999999999999999999 9999998 8888999999999998
Q ss_pred cCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHH
Q psy3347 160 KEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEE---------------EVF 221 (245)
Q Consensus 160 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~---------------~~~ 221 (245)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 75432221 123445677899999998888999999999999999999999998643211 112
Q ss_pred HHHhcC-cccCCCCCChhHHhhhc
Q psy3347 222 DSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
..+... ..+.|..+++++.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~ 285 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMK 285 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHH
Confidence 222222 33457889999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=246.98 Aligned_cols=214 Identities=21% Similarity=0.327 Sum_probs=169.2
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEE-eeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF-QTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+..+ +..+|+|.+.... .....+.+.+ +++.++.++||||+++++++ ..++..+++|||+++++|.
T Consensus 41 Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~ 115 (298)
T 3f66_A 41 VYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLT---EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115 (298)
T ss_dssp EEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHH---HHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHH
T ss_pred EEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHH---HHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHH
Confidence 789987643 3368999887532 2333344444 46778899999999999985 4566889999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++++. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+
T Consensus 116 ~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~---dikp~Ni----------------------l~~~~~~~kl~ 170 (298)
T 3f66_A 116 NFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR---DLAARNC----------------------MLDEKFTVKVA 170 (298)
T ss_dssp HHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECTTCCEEEC
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCchheE----------------------EECCCCCEEEC
Confidence 99854 458899999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCCC----CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc
Q psy3347 155 DFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~ 229 (245)
|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+....+....+..+..
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 9999875322211 1223456778999999988889999999999999999999 7788887777777777666544
Q ss_pred -cCCCCCChhHHhhhc
Q psy3347 230 -RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 -~~p~~~~~~~~~li~ 244 (245)
..|..+++++.++|+
T Consensus 251 ~~~~~~~~~~l~~li~ 266 (298)
T 3f66_A 251 LLQPEYCPDPLYEVML 266 (298)
T ss_dssp CCCCTTCCHHHHHHHH
T ss_pred CCCCccCCHHHHHHHH
Confidence 457788999988875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=246.81 Aligned_cols=206 Identities=25% Similarity=0.451 Sum_probs=164.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC-CeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE-AHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++. |+.||+|+++... ..+.+.+ +++.++.++||||+++++++... +..++||||+++++|.+++
T Consensus 37 V~~~~~~--~~~vavK~~~~~~-----~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 106 (278)
T 1byg_A 37 VMLGDYR--GNKVAVKCIKNDA-----TAQAFLA---EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 106 (278)
T ss_dssp EEEEEET--TEEEEEEECCCCC-------HHHHH---THHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHH
T ss_pred EEEEEEc--CCEEEEEEecchh-----HHHHHHH---HHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence 6888774 8999999997542 2234444 47778899999999999987544 5789999999999999988
Q ss_pred hhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+||
T Consensus 107 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~~l~Df 161 (278)
T 1byg_A 107 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR---DLAARNV----------------------LVSEDNVAKVSDF 161 (278)
T ss_dssp HHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECTTSCEEECCC
T ss_pred HhcccccCCHHHHHHHHHHHHHHHHHHHhCCcccc---CCCcceE----------------------EEeCCCcEEEeec
Confidence 542 38899999999999999999999999999 9999998 8888899999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
|++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..+ ....|..
T Consensus 162 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 162 GLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 238 (278)
T ss_dssp CC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred ccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCccc
Confidence 998743221 223356788999999988889999999999999999998 99999988877777777655 3456788
Q ss_pred CChhHHhhhc
Q psy3347 235 LSLEAIAIMR 244 (245)
Q Consensus 235 ~~~~~~~li~ 244 (245)
+++++.++|+
T Consensus 239 ~~~~l~~li~ 248 (278)
T 1byg_A 239 CPPAVYEVMK 248 (278)
T ss_dssp CCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 9999998886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.92 Aligned_cols=214 Identities=21% Similarity=0.315 Sum_probs=163.7
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe-eCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-TEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~-~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+ +..||+|.++... .....+.+.+ ++.+++.++||||+++++++. .++..++||||+++++|.
T Consensus 105 Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~ 179 (373)
T 3c1x_A 105 VYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLT---EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179 (373)
T ss_dssp EEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHH---HHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHH
T ss_pred EEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHH---HHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHH
Confidence 799987654 3468999987532 2233444444 467788999999999999864 456889999999999999
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
++++. ..+++..+..++.|++.||+|||++|++|| |+||+|| +++.++.+||+
T Consensus 180 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kL~ 234 (373)
T 3c1x_A 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR---DLAARNC----------------------MLDEKFTVKVA 234 (373)
T ss_dssp HHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecC---ccchheE----------------------EECCCCCEEEe
Confidence 99964 357888999999999999999999999999 9999998 88889999999
Q ss_pred ecCCccCCCCCCC----CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc
Q psy3347 155 DFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~ 229 (245)
|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+..+..
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~ 314 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence 9999874322111 1223346678999999998899999999999999999999 7889987776666666665543
Q ss_pred -cCCCCCChhHHhhhc
Q psy3347 230 -RYPRFLSLEAIAIMR 244 (245)
Q Consensus 230 -~~p~~~~~~~~~li~ 244 (245)
..|..+++++.++|+
T Consensus 315 ~~~p~~~~~~l~~li~ 330 (373)
T 3c1x_A 315 LLQPEYCPDPLYEVML 330 (373)
T ss_dssp CCCCTTCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHH
Confidence 457889999998885
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=251.55 Aligned_cols=214 Identities=27% Similarity=0.459 Sum_probs=168.5
Q ss_pred CEeEEE-----ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCC-eEEEEEeeccCC
Q psy3347 1 VILSQY-----RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEA-HVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~-~~~lv~e~~~~~ 73 (245)
||+|++ ..+++.||+|++.... .....+.+.+| +..++.+ +||||+++++++...+ ..+++|||++++
T Consensus 43 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~ 117 (316)
T 2xir_A 43 VIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSE---LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117 (316)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTE
T ss_pred EEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHH---HHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCC
Confidence 688985 3578999999998642 22333444444 5566666 6999999999987654 599999999999
Q ss_pred chhhhhhhcC-----------------CChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCc
Q psy3347 74 DLMMHIHADV-----------------FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNS 136 (245)
Q Consensus 74 ~L~~~~~~~~-----------------l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~ 136 (245)
+|.+++.... +++..+..++.|++.||.|||++|++|+ |++|+||
T Consensus 118 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~---dikp~Ni--------------- 179 (316)
T 2xir_A 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR---DLAARNI--------------- 179 (316)
T ss_dssp EHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE---------------
T ss_pred cHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccc---cCccceE---------------
Confidence 9999986432 7888999999999999999999999999 8999888
Q ss_pred ccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy3347 137 SQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFP 213 (245)
Q Consensus 137 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~ 213 (245)
+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 180 -------l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 180 -------LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp -------EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred -------EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 778889999999999875433222 1234456788999999988889999999999999999998 999998
Q ss_pred CCCHH-HHHHHHhcC-cccCCCCCChhHHhhhc
Q psy3347 214 GDDEE-EVFDSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 214 ~~~~~-~~~~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
+.... .....+..+ ....|..+++++.++|.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 285 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285 (316)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred ccchhHHHHHHhccCccCCCCCCCCHHHHHHHH
Confidence 76543 333444433 34567888999988875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=251.31 Aligned_cols=213 Identities=23% Similarity=0.370 Sum_probs=168.9
Q ss_pred CEeEE----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe--eCCeEEEEEeeccCCc
Q psy3347 1 VILSQ----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ--TEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~--~~~~~~lv~e~~~~~~ 74 (245)
||+|+ +..+|+.||+|++.... ....+.+. +++++++.++||||+++++++. ..+..++||||+++++
T Consensus 39 V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 112 (327)
T 3lxl_A 39 VELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQ---REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112 (327)
T ss_dssp EEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHH---HHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCB
T ss_pred EEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHH---HHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCC
Confidence 78898 56789999999997642 22333444 4477788899999999999986 4567999999999999
Q ss_pred hhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++
T Consensus 113 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~---Dikp~NI----------------------l~~~~~~~k 167 (327)
T 3lxl_A 113 LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR---DLAARNI----------------------LVESEAHVK 167 (327)
T ss_dssp HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEEETTEEE
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCChhhE----------------------EECCCCCEE
Confidence 9999854 468999999999999999999999999999 9999998 788889999
Q ss_pred EeecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH------------
Q psy3347 153 IADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE------------ 217 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~------------ 217 (245)
|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 999999875322221 22344577789999999888899999999999999999999999854322
Q ss_pred ---HHHHHHHhcC-cccCCCCCChhHHhhhc
Q psy3347 218 ---EEVFDSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 218 ---~~~~~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
......+..+ ..+.|..+++++.+||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 278 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPAPPACPAEVHELMK 278 (327)
T ss_dssp CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccHHHHHHHhhcccCCCCCCcccHHHHHHHH
Confidence 1222223222 33457789999998886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=247.33 Aligned_cols=210 Identities=19% Similarity=0.226 Sum_probs=160.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEE-eeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF-QTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+|+.||+|++...... +.+.+| .+.++.++|++++..++.+ ...+..+++|||+ +++|.+++
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e---~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 95 (296)
T 4hgt_A 25 IYLGTDIAAGEEVAIKLECVKTKH-----PQLHIE---SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLF 95 (296)
T ss_dssp EEEEEETTTTEEEEEEEEEC---C-----CCHHHH---HHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred EEEEEEcCCCceEEEEeecccccc-----hHHHHH---HHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHH
Confidence 799999999999999987654211 233344 4556666777766666655 6778899999999 88999988
Q ss_pred h--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEe
Q psy3347 80 H--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIA 154 (245)
Q Consensus 80 ~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~ 154 (245)
. ...+++..+..++.|++.||+|||++|++|+ |+||+|| ++ +.++.+||+
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~---Dlkp~NI----------------------l~~~~~~~~~~kL~ 150 (296)
T 4hgt_A 96 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR---DVKPDNF----------------------LMGLGKKGNLVYII 150 (296)
T ss_dssp HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECCGGGTTCEEEC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC---CCCHHHe----------------------eeeccCCCCeEEEe
Confidence 6 4579999999999999999999999999999 8888888 55 678899999
Q ss_pred ecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Q psy3347 155 DFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE---EEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~---~~~~~~~ 224 (245)
|||+++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+... ......+
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 9999875332211 12355789999999999998999999999999999999999999976432 2222333
Q ss_pred hcCcccC-----CCCCChhHHhhhc
Q psy3347 225 VNDEVRY-----PRFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~~~~~-----p~~~~~~~~~li~ 244 (245)
....... +..+++++.+||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~ 255 (296)
T 4hgt_A 231 SEKKMSTPIEVLCKGYPSEFATYLN 255 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred hcccccchhhhhhccCCHHHHHHHH
Confidence 3222222 2667888888775
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=246.98 Aligned_cols=176 Identities=20% Similarity=0.351 Sum_probs=148.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEee--CCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQT--EAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..+|+.||+|+++... .+.+.+| +++++.++ ||||+++++++.. ....+++|||+.+++|..
T Consensus 52 V~~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 122 (330)
T 3nsz_A 52 VFEAINITNNEKVVVKILKPVK------KKKIKRE---IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122 (330)
T ss_dssp EEEEEETTTCCEEEEEEECSCC------HHHHHHH---HHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHH
T ss_pred EEEEEECCCCcEEEEEEecccc------hHHHHHH---HHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHH
Confidence 7999999999999999997532 2334444 55566665 9999999999987 668999999999999998
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-ceEEeec
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG-YVKIADF 156 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Df 156 (245)
+++. +++..+..++.|++.||+|||++|++|+ |+||+|| +++.++ .++|+||
T Consensus 123 ~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dikp~Ni----------------------l~~~~~~~~kl~Df 175 (330)
T 3nsz_A 123 LYQT--LTDYDIRFYMYEILKALDYCHSMGIMHR---DVKPHNV----------------------MIDHEHRKLRLIDW 175 (330)
T ss_dssp HGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEETTTTEEEECCC
T ss_pred HHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeC---CCCHHHE----------------------EEcCCCCEEEEEeC
Confidence 8753 8899999999999999999999999999 8999888 676555 8999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
|+++..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 176 g~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 176 GLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999753222 23445578889999999977 668999999999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=267.78 Aligned_cols=211 Identities=25% Similarity=0.375 Sum_probs=173.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.+.. +..||||+++.... ..+.+.+ ++++++.++||||+++++++.. +..++||||+.+++|.++++
T Consensus 283 Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~---E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~ 353 (535)
T 2h8h_A 283 VWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQ---EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK 353 (535)
T ss_dssp EEEEEETT-TEEEEEEEECTTSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHS
T ss_pred EEEEEECC-CceEEEEEeCCCCC----CHHHHHH---HHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHh
Confidence 79998875 46799999986432 1234444 4777888999999999999866 67899999999999999995
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++||+|| ||+|+|| +++.++.+||+|||
T Consensus 354 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHr---Dlkp~NI----------------------ll~~~~~~kl~DFG 408 (535)
T 2h8h_A 354 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR---DLRAANI----------------------LVGENLVCKVADFG 408 (535)
T ss_dssp HHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECGGGCEEECCTT
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC---CCCHhhE----------------------EEcCCCcEEEcccc
Confidence 3 458999999999999999999999999999 8889888 77888899999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+....+..+. .+.|..
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 488 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 9975322111 1122345678999999988899999999999999999999 999999998888888876653 356788
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++.+||++
T Consensus 489 ~~~~l~~li~~ 499 (535)
T 2h8h_A 489 CPESLHDLMCQ 499 (535)
T ss_dssp CCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=255.65 Aligned_cols=201 Identities=26% Similarity=0.309 Sum_probs=146.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-----CCceeeeeEEEe----eCCeEEEEEeecc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-----HPFLVNLFACFQ----TEAHVCFVMEYAA 71 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-----h~ni~~~~~~~~----~~~~~~lv~e~~~ 71 (245)
||+|++..+|+.||+|++... ....+.+.+|.+++..++... |+||+++++++. ...+.|+||||+.
T Consensus 53 V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 128 (397)
T 1wak_A 53 VWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG 128 (397)
T ss_dssp EEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred EEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC
Confidence 799999999999999999753 233455566655555554433 889999999997 4568999999995
Q ss_pred CCchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccc---------------
Q psy3347 72 GGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYK--------------- 133 (245)
Q Consensus 72 ~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~--------------- 133 (245)
++.+..+.+. ..+++..+..++.|++.||+|||++ ||+|| |+||+|| ++...-.
T Consensus 129 ~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr---Dikp~NI-----ll~~~~~~~~~~~~~~~~~~~~ 200 (397)
T 1wak_A 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT---DIKPENI-----LLSVNEQYIRRLAAEATEWQRS 200 (397)
T ss_dssp CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC---CCSGGGE-----EECCCHHHHHHHHHHHC-----
T ss_pred ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC---CCCHHHe-----eEeccchhhhhhhhhhHHHhhc
Confidence 5444444433 4689999999999999999999998 99999 7777777 3221100
Q ss_pred -----------------cCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHH
Q psy3347 134 -----------------VNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWW 196 (245)
Q Consensus 134 -----------------~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 196 (245)
.................+||+|||++..... ......||..|+|||.+.+..++.++|||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 277 (397)
T 1wak_A 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLEVLIGSGYNTPADIW 277 (397)
T ss_dssp ----------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHHHHHTSCCCTHHHHH
T ss_pred CCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCChhhcCCCCCcHHHHH
Confidence 0000000000001123799999999875322 23445789999999999998899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q psy3347 197 GLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 197 slG~~l~el~~g~~pf~~~~ 216 (245)
||||++|+|++|+.||.+.+
T Consensus 278 slG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 278 STACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHHHHHHHHHSSCSCCCCC
T ss_pred HHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999997644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=252.80 Aligned_cols=193 Identities=25% Similarity=0.374 Sum_probs=153.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-------eEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-------HVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-------~~~lv~e~~~~~ 73 (245)
||+|+++.+|+.||+|++....... . ++.++++.++.++||||++++++|...+ ..++||||++++
T Consensus 39 V~~~~~~~~~~~vavK~~~~~~~~~----~---~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 111 (360)
T 3e3p_A 39 VQLGKEKSTGMSVAIKKVIQDPRFR----N---RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT 111 (360)
T ss_dssp CEEEEETTTCCEEEEEEEECCTTCC----C---HHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB
T ss_pred EEEEEECCCCCEEEEEEEecCcccc----H---HHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccccc
Confidence 8999999999999999987543211 1 2334466677789999999999996543 389999999875
Q ss_pred chhhhh----hhcCCChHHHHHHHHHHHHHHHHhh--hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC
Q psy3347 74 DLMMHI----HADVFSEPRAVFYAACVVLGLQYLH--ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT 147 (245)
Q Consensus 74 ~L~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (245)
.+.... ....+++..+..++.|++.||.||| ++||+|| |+||+|| +++.
T Consensus 112 l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~---Dlkp~NI----------------------ll~~ 166 (360)
T 3e3p_A 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR---DIKPHNV----------------------LVNE 166 (360)
T ss_dssp HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS---CCCGGGE----------------------EEET
T ss_pred HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC---cCCHHHE----------------------EEeC
Confidence 332222 2346888999999999999999999 9999999 8999888 6665
Q ss_pred -CCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 148 -EGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 148 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++.+||+|||++..... ........||..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 167 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSP-SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TTTEEEECCCTTCBCCCT-TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcEEEeeCCCceecCC-CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 88999999999975432 2234455789999999999765 48999999999999999999999999888777776664
Q ss_pred c
Q psy3347 226 N 226 (245)
Q Consensus 226 ~ 226 (245)
.
T Consensus 246 ~ 246 (360)
T 3e3p_A 246 R 246 (360)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=242.73 Aligned_cols=204 Identities=21% Similarity=0.360 Sum_probs=164.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----------------CCeEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----------------EAHVC 64 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----------------~~~~~ 64 (245)
||+|++..+|+.||+|++.... +.+ .++++.++.++||||+++++++.. .+..+
T Consensus 27 V~~~~~~~~~~~vavK~~~~~~-------~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (284)
T 2a19_B 27 VFKAKHRIDGKTYVIKRVKYNN-------EKA---EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96 (284)
T ss_dssp EEEEEETTTCCEEEEEEEECCS-------GGG---HHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEE
T ss_pred EEEEEEcCCCeEEEEEEecccc-------HHH---HHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEE
Confidence 7999999999999999998642 122 234677788899999999999854 44689
Q ss_pred EEEeeccCCchhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchh
Q psy3347 65 FVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIK 141 (245)
Q Consensus 65 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~ 141 (245)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dlkp~Ni-------------------- 153 (284)
T 2a19_B 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINR---DLKPSNI-------------------- 153 (284)
T ss_dssp EEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE--------------------
T ss_pred EEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---cCCHHHE--------------------
Confidence 99999999999999853 468999999999999999999999999999 8999888
Q ss_pred ccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy3347 142 LTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF 221 (245)
Q Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~ 221 (245)
+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||... ....
T Consensus 154 --l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~ 228 (284)
T 2a19_B 154 --FLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFF 228 (284)
T ss_dssp --EEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHH
T ss_pred --EEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHH
Confidence 77888999999999987543322 234456899999999999888999999999999999999999887432 2222
Q ss_pred HHHhcCcccCCCCCChhHHhhhc
Q psy3347 222 DSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 222 ~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
..+.. ..++..++++++++|+
T Consensus 229 ~~~~~--~~~~~~~~~~~~~li~ 249 (284)
T 2a19_B 229 TDLRD--GIISDIFDKKEKTLLQ 249 (284)
T ss_dssp HHHHT--TCCCTTSCHHHHHHHH
T ss_pred HHhhc--ccccccCCHHHHHHHH
Confidence 32322 2355677888888775
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=247.32 Aligned_cols=191 Identities=23% Similarity=0.378 Sum_probs=153.9
Q ss_pred CEeEEE-ecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh---cCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQY-RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT---MRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~---~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.+ +.+|+.||+|+++.. ....+.+.+|.+++..++. ..|++++++++++...++.++||||+ +++|.
T Consensus 30 V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~ 104 (339)
T 1z57_A 30 VVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTY 104 (339)
T ss_dssp EEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHH
Confidence 799988 567999999999753 2233445555444444432 23556999999999999999999999 77998
Q ss_pred hhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC------
Q psy3347 77 MHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT------ 147 (245)
Q Consensus 77 ~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~------ 147 (245)
+++... ++++..+..++.|++.||+|||++|++|+ |+||+|| +++.
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dlkp~Ni----------------------l~~~~~~~~~ 159 (339)
T 1z57_A 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT---DLKPENI----------------------LFVQSDYTEA 159 (339)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESCCCEEEE
T ss_pred HHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCC---CCCHHHE----------------------EEeccccccc
Confidence 888543 58899999999999999999999999999 8888887 4433
Q ss_pred -------------CCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 148 -------------EGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 148 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
++.++|+|||++.... .......||..|+|||.+.+..++.++|||||||++|+|++|..||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDD---EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETT---SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCccccccccccCCCceEeeCcccccCc---cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 6689999999987522 223455789999999999988999999999999999999999999998
Q ss_pred CCHHHHHHHH
Q psy3347 215 DDEEEVFDSI 224 (245)
Q Consensus 215 ~~~~~~~~~~ 224 (245)
.+..+....+
T Consensus 237 ~~~~~~~~~~ 246 (339)
T 1z57_A 237 HDSKEHLAMM 246 (339)
T ss_dssp SCHHHHHHHH
T ss_pred CChHHHHHHH
Confidence 8776655544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=247.83 Aligned_cols=213 Identities=19% Similarity=0.308 Sum_probs=163.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+.||+|++... .....+.+. +++++++.++||||+++++++.. .+..++||||+.+++|.
T Consensus 45 V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 118 (317)
T 2buj_A 45 VDLVEGLHDGHFYALKRILCH---EQQDREEAQ---READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118 (317)
T ss_dssp EEEEEETTTCCEEEEEEEEES---SHHHHHHHH---HHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHH
T ss_pred EEEEEecCCCcEEEEEEEecC---CHHHHHHHH---HHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHH
Confidence 799999999999999998753 223334444 44777888999999999999863 34789999999999999
Q ss_pred hhhhh-----cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 77 MHIHA-----DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 77 ~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+
T Consensus 119 ~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~---dlkp~NI----------------------l~~~~~~~ 173 (317)
T 2buj_A 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR---DLKPTNI----------------------LLGDEGQP 173 (317)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTSCE
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EEcCCCCE
Confidence 88853 568999999999999999999999999999 9999998 88888999
Q ss_pred EEeecCCccCCCCCCCC---------CCcccCCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCC--CH
Q psy3347 152 KIADFGLCKEGMGFGDR---------TGTFCGTPEFLAPEVLTETS---YTRAVDWWGLGVLIFEMLVGESPFPGD--DE 217 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g~~pf~~~--~~ 217 (245)
+|+|||++......... .....|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||... ..
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 99999987643211110 11234688999999997543 688999999999999999999999531 11
Q ss_pred HHHHHHHhcC-cccCCCCCChhHHhhhc
Q psy3347 218 EEVFDSIVND-EVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 218 ~~~~~~~~~~-~~~~p~~~~~~~~~li~ 244 (245)
......+... ..+.+..+++++.++|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~ 281 (317)
T 2buj_A 254 DSVALAVQNQLSIPQSPRHSSALWQLLN 281 (317)
T ss_dssp SCHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred chhhHHhhccCCCCccccCCHHHHHHHH
Confidence 1111222221 22334578888888875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.51 Aligned_cols=211 Identities=20% Similarity=0.388 Sum_probs=155.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. ..||+|+++.... .....+.+. ++++.++.++||||+++++++ ..+..++||||+++++|.+++.
T Consensus 40 Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~ 111 (289)
T 3og7_A 40 VYKGKWH---GDVAVKMLNVTAP-TPQQLQAFK---NEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH 111 (289)
T ss_dssp EEEEESS---SEEEEEEESCSSC-CHHHHHHHH---HHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHT
T ss_pred EEEEEEc---CceEEEEEeccCC-CHHHHHHHH---HHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHh
Confidence 6888764 3599999976432 223334444 447788899999999999965 5567899999999999998884
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++|+|||+
T Consensus 112 ~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~---Dlkp~Ni----------------------l~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 112 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHR---DLKSNNI----------------------FLHEDNTVKIGDFGL 166 (289)
T ss_dssp TC---CCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EEETTTEEEECCCC-
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc---cCccceE----------------------EECCCCCEEEcccee
Confidence 3468999999999999999999999999999 9999998 888889999999999
Q ss_pred ccCCCCC--CCCCCcccCCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcCccc--
Q psy3347 159 CKEGMGF--GDRTGTFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVF-DSIVNDEVR-- 230 (245)
Q Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~-- 230 (245)
+...... ........|+..|+|||.+. +..++.++||||||+++|+|++|+.||.+....+.. ..+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 8743221 11233456899999999996 566888999999999999999999999876554443 333333222
Q ss_pred ---CCCCCChhHHhhhc
Q psy3347 231 ---YPRFLSLEAIAIMR 244 (245)
Q Consensus 231 ---~p~~~~~~~~~li~ 244 (245)
.+..+++++++||+
T Consensus 247 ~~~~~~~~~~~l~~li~ 263 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMA 263 (289)
T ss_dssp TTSSCTTSCHHHHHHHH
T ss_pred hhhccccCCHHHHHHHH
Confidence 23578888888875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=251.50 Aligned_cols=207 Identities=26% Similarity=0.461 Sum_probs=140.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++.+|+.||+|++.... . ..+ ++...++.++||||+++++++.. ++..++||||+++++|.
T Consensus 45 V~~~~~~~~~~~vavK~~~~~~----~----~~~--e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~ 114 (336)
T 3fhr_A 45 VLECFHRRTGQKCALKLLYDSP----K----ARQ--EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114 (336)
T ss_dssp EEEEEETTTCCEEEEEEEESSH----H----HHH--HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHH
T ss_pred EEEEEECCCCCEEEEEEecCcH----H----HHH--HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHH
Confidence 7999999999999999997531 1 111 12233556789999999999976 45689999999999999
Q ss_pred hhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CCc
Q psy3347 77 MHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EGY 150 (245)
Q Consensus 77 ~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 150 (245)
+++... .+++..+..++.|++.||.|||++|++|+ |++|+|| +++. ++.
T Consensus 115 ~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~---dlkp~NI----------------------ll~~~~~~~~ 169 (336)
T 3fhr_A 115 SRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR---DVKPENL----------------------LYTSKEKDAV 169 (336)
T ss_dssp HHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EESCSSTTCC
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC---CCCHHHE----------------------EEEecCCCce
Confidence 998643 58999999999999999999999999999 8888888 5544 566
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhc
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV----FDSIVN 226 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~----~~~~~~ 226 (245)
++|+|||++..... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+...... ...+..
T Consensus 170 ~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 170 LKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp EEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred EEEeccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 99999999875322 223345678999999999888899999999999999999999999976554333 222222
Q ss_pred CcccCC----CCCChhHHhhhc
Q psy3347 227 DEVRYP----RFLSLEAIAIMR 244 (245)
Q Consensus 227 ~~~~~p----~~~~~~~~~li~ 244 (245)
....+| ..+++++++||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~ 269 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIR 269 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHH
T ss_pred cccccCchhhccCCHHHHHHHH
Confidence 222222 568889988876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=255.96 Aligned_cols=183 Identities=25% Similarity=0.377 Sum_probs=142.2
Q ss_pred CEeEEEe--cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYR--NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++ .+++.||+|++...... ..+. +++++++.++||||+++++++.. ....++||||+++ +|.
T Consensus 37 Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~ 107 (405)
T 3rgf_A 37 VYKAKRKDGKDDKDYALKQIEGTGIS-----MSAC---REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLW 107 (405)
T ss_dssp EEEEEESSSSCCCCEEEEECSSSSCC-----HHHH---HHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHH
T ss_pred EEEEEEccCCCCeEEEEEEECCCCCC-----HHHH---HHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHH
Confidence 7999976 57899999999754321 2233 44777888999999999999954 6789999999975 776
Q ss_pred hhhhh----------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-
Q psy3347 77 MHIHA----------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN- 145 (245)
Q Consensus 77 ~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~- 145 (245)
+++.. ..+++..++.++.|++.||+|||++||+|| |+||+|| ++
T Consensus 108 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~---Dlkp~NI----------------------ll~ 162 (405)
T 3rgf_A 108 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR---DLKPANI----------------------LVM 162 (405)
T ss_dssp HHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EEC
T ss_pred HHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCC---CcCHHHe----------------------EEe
Confidence 66532 138999999999999999999999999999 8888888 55
Q ss_pred ---CCCCceEEeecCCccCCCCCC---CCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 146 ---DTEGYVKIADFGLCKEGMGFG---DRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 146 ---~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
+.++.+||+|||+++...... ......+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 163 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 163 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 667899999999997543221 123456789999999999874 589999999999999999999999976543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=246.44 Aligned_cols=210 Identities=19% Similarity=0.316 Sum_probs=144.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC-CCceeeeeEEEe--------eCCeEEEEEeecc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR-HPFLVNLFACFQ--------TEAHVCFVMEYAA 71 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-h~ni~~~~~~~~--------~~~~~~lv~e~~~ 71 (245)
||+|++..+|+.||+|++... .....+.+.+| +..++.+. ||||+++++++. ..+..+++|||+.
T Consensus 44 V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e---~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 117 (337)
T 3ll6_A 44 VYEAQDVGSGREYALKRLLSN---EEEKNRAIIQE---VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117 (337)
T ss_dssp EEEEEETTTCCEEEEEEEEES---SHHHHHHHHHH---HHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS
T ss_pred EEEEEECCCCcEEEEEEecCC---chHHHHHHHHH---HHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC
Confidence 799999999999999998654 22333344444 55566664 999999999984 3446899999996
Q ss_pred CCchhhhhh----hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 72 GGDLMMHIH----ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 72 ~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
|+|.+++. ...+++..+..++.|++.||+|||++| ++|+ |++|+|| ++
T Consensus 118 -g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~---Dikp~NI----------------------l~ 171 (337)
T 3ll6_A 118 -GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR---DLKVENL----------------------LL 171 (337)
T ss_dssp -EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCC---CCCGGGC----------------------EE
T ss_pred -CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEc---cCCcccE----------------------EE
Confidence 58877774 356999999999999999999999999 9999 9999999 88
Q ss_pred CCCCceEEeecCCccCCCCCCC------------CCCcccCCCCccccccc---cCCCCCcchhHHHHHHHHHHHHhCCC
Q psy3347 146 DTEGYVKIADFGLCKEGMGFGD------------RTGTFCGTPEFLAPEVL---TETSYTRAVDWWGLGVLIFEMLVGES 210 (245)
Q Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~~g~~ 210 (245)
+.++.+||+|||++........ ......|++.|+|||.+ .+..++.++||||||+++|+|++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 8899999999999875432211 11134588899999998 45678899999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcCcccCCCCCChhHHhhhc
Q psy3347 211 PFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 211 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
||............. ..+.+...++.+.+||+
T Consensus 252 p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~ 283 (337)
T 3ll6_A 252 PFEDGAKLRIVNGKY--SIPPHDTQYTVFHSLIR 283 (337)
T ss_dssp CC------------C--CCCTTCCSSGGGHHHHH
T ss_pred CCcchhHHHhhcCcc--cCCcccccchHHHHHHH
Confidence 997655443322211 22334566777777765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=248.69 Aligned_cols=183 Identities=26% Similarity=0.401 Sum_probs=153.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ +|+.||+|++.... ....+.+. ++++.++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 55 Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 127 (321)
T 2qkw_B 55 VYKGVLR-DGAKVALKRRTPES---SQGIEEFE---TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127 (321)
T ss_dssp EEEEECT-TCCEEEEEECCSCC---SSHHHHHH---HHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSS
T ss_pred EEEEEEC-CCCEEEEEEecccC---hHHHHHHH---HHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHh
Confidence 7999864 68999999987642 22233443 44778889999999999999999999999999999999999885
Q ss_pred hc-----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 81 AD-----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 81 ~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.+||+|
T Consensus 128 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~D 182 (321)
T 2qkw_B 128 GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR---DVKSINI----------------------LLDENFVPKITD 182 (321)
T ss_dssp SSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCSTTE----------------------EECTTCCEEECC
T ss_pred ccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecC---CCCHHHE----------------------EECCCCCEEEee
Confidence 43 48899999999999999999999999999 8999888 888899999999
Q ss_pred cCCccCCCCC--CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 156 FGLCKEGMGF--GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 156 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
||++...... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 9998743221 11223446789999999998888999999999999999999999999654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=249.46 Aligned_cols=212 Identities=24% Similarity=0.403 Sum_probs=161.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc----CCCceeeeeEEEeeCCeEEEEEee-ccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM----RHPFLVNLFACFQTEAHVCFVMEY-AAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~----~h~ni~~~~~~~~~~~~~~lv~e~-~~~~~L 75 (245)
||+|++..+|+.||+|++..................+++..++.+ +||||+++++++...+..+++||+ +.+++|
T Consensus 47 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L 126 (312)
T 2iwi_A 47 VFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126 (312)
T ss_dssp EEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEH
T ss_pred EEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCH
Confidence 799999999999999999765432211111111222335555555 899999999999999999999999 788999
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceEE
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVKI 153 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~kl 153 (245)
.+++. ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++ .++.++|
T Consensus 127 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~~kl 181 (312)
T 2iwi_A 127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHR---DIKDENI----------------------LIDLRRGCAKL 181 (312)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECC---CCSGGGE----------------------EEETTTTEEEE
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---CCChhhE----------------------EEeCCCCeEEE
Confidence 99885 4569999999999999999999999999999 8889888 676 7889999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
+|||++...... ......|+..|+|||.+.+..+. .++||||||+++|+|++|+.||.+.. .+......+|
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred EEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 999998754322 23455688999999999776654 58999999999999999999997532 2334455677
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..++++++++|++
T Consensus 254 ~~~~~~~~~li~~ 266 (312)
T 2iwi_A 254 AHVSPDCCALIRR 266 (312)
T ss_dssp TTSCHHHHHHHHH
T ss_pred ccCCHHHHHHHHH
Confidence 8889988888763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=245.14 Aligned_cols=180 Identities=24% Similarity=0.410 Sum_probs=145.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|++ +|+.||+|++.... .....+|.+++ ....++||||+++++++.. .+..++||||+++++|.
T Consensus 24 V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~-~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 94 (301)
T 3q4u_A 24 VWRGSW--QGENVAVKIFSSRD------EKSWFRETELY-NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLY 94 (301)
T ss_dssp EEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHH-HHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHH
T ss_pred EEEEEE--CCEEEEEEEecccc------chhhHHHHHHH-HHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHH
Confidence 788877 69999999997531 22333333322 2334789999999998754 34689999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhh--------hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLH--------ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++++...+++..+..++.|++.||+||| ++|++|| |+||+|| +++.+
T Consensus 95 ~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~---Dlkp~Ni----------------------ll~~~ 149 (301)
T 3q4u_A 95 DYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR---DLKSKNI----------------------LVKKN 149 (301)
T ss_dssp HHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS---CCCGGGE----------------------EECTT
T ss_pred HHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC---CCChHhE----------------------EEcCC
Confidence 9998888999999999999999999999 9999999 9999999 88889
Q ss_pred CceEEeecCCccCCCCCCC----CCCcccCCCCccccccccCC------CCCcchhHHHHHHHHHHHHhC----------
Q psy3347 149 GYVKIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTET------SYTRAVDWWGLGVLIFEMLVG---------- 208 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g---------- 208 (245)
+.+||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 9999999999864322211 12334789999999999776 445789999999999999999
Q ss_pred CCCCCC
Q psy3347 209 ESPFPG 214 (245)
Q Consensus 209 ~~pf~~ 214 (245)
..||..
T Consensus 230 ~~pf~~ 235 (301)
T 3q4u_A 230 KPPFYD 235 (301)
T ss_dssp CCTTTT
T ss_pred cccccc
Confidence 888854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=249.34 Aligned_cols=197 Identities=24% Similarity=0.343 Sum_probs=149.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeec
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR-----DEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~ 70 (245)
||+|.+.. |+.||+|++........ .......+..+++++++.++||||+++++++.. ....++||||+
T Consensus 38 V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 116 (362)
T 3pg1_A 38 VCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM 116 (362)
T ss_dssp EEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECC
T ss_pred EEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccC
Confidence 79998865 99999999965332111 011111223445777888999999999999854 34789999999
Q ss_pred cCCchhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 71 AGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 71 ~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++ +|.+++.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++.+
T Consensus 117 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~---Dlkp~NI----------------------l~~~~ 170 (362)
T 3pg1_A 117 RT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHR---DLHPGNI----------------------LLADN 170 (362)
T ss_dssp SE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTT
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEec---CCChHHE----------------------EEcCC
Confidence 84 77777643 368999999999999999999999999999 9999999 88889
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+.++|+|||++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 171 ~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 171 NDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998743222 22344578889999999977 678999999999999999999999999888777766654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=250.45 Aligned_cols=209 Identities=23% Similarity=0.339 Sum_probs=166.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh---hHHHHHHHHHHHHHHhhcC--CCceeeeeEEEeeCCeEEEEEeeccC-Cc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD---EVESLLSEKRIFEVANTMR--HPFLVNLFACFQTEAHVCFVMEYAAG-GD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~--h~ni~~~~~~~~~~~~~~lv~e~~~~-~~ 74 (245)
||+|++..+|+.||+|++......... ..+.+.+| +.+++.++ ||||+++++++...+..+++||++.+ ++
T Consensus 59 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~ 135 (320)
T 3a99_A 59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME---VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD 135 (320)
T ss_dssp EEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHH---HHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEE
T ss_pred EEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHH---HHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCcc
Confidence 799999999999999999865432211 11223333 45555554 69999999999999999999999975 89
Q ss_pred hhhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceE
Q psy3347 75 LMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVK 152 (245)
Q Consensus 75 L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~k 152 (245)
|.+++. ...+++..+..++.|++.||+|||++|++|+ |++|+|| +++ .++.+|
T Consensus 136 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dlkp~NI----------------------ll~~~~~~~k 190 (320)
T 3a99_A 136 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR---DIKDENI----------------------LIDLNRGELK 190 (320)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEETTTTEEE
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeC---CCCHHHE----------------------EEeCCCCCEE
Confidence 998885 4678999999999999999999999999999 8999888 676 678999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY 231 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (245)
|+|||++...... ......|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .+......+
T Consensus 191 L~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~ 262 (320)
T 3a99_A 191 LIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF 262 (320)
T ss_dssp ECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC
T ss_pred EeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc
Confidence 9999998754322 2334568999999999977665 678999999999999999999996532 233445556
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
+..+++++.+||++
T Consensus 263 ~~~~~~~~~~li~~ 276 (320)
T 3a99_A 263 RQRVSSECQHLIRW 276 (320)
T ss_dssp SSCCCHHHHHHHHH
T ss_pred cccCCHHHHHHHHH
Confidence 77888888888763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=246.07 Aligned_cols=213 Identities=23% Similarity=0.372 Sum_probs=147.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|.++.+|+.||+|++.... .......+..+ +..+++.++||||+++++++..++..++||||+++ +|.+++.
T Consensus 38 Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e--~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 112 (327)
T 3aln_A 38 VNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMD--LDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYK 112 (327)
T ss_dssp EEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHH--HHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHH--HHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHH
Confidence 7999999999999999998642 22222233322 23367788999999999999999999999999986 7766664
Q ss_pred ------hcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEE
Q psy3347 81 ------ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKI 153 (245)
Q Consensus 81 ------~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 153 (245)
...+++..+..++.|++.||.|||++ |++|+ |++|+|| +++.++.+||
T Consensus 113 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~---dlkp~NI----------------------ll~~~~~~kl 167 (327)
T 3aln_A 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHR---DIKPSNI----------------------LLDRSGNIKL 167 (327)
T ss_dssp HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCS---CCCGGGE----------------------EEETTTEEEE
T ss_pred HHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeEC---CCCHHHE----------------------EEcCCCCEEE
Confidence 45689999999999999999999999 99999 9999998 8888999999
Q ss_pred eecCCccCCCCCCCCCCcccCCCCccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCc
Q psy3347 154 ADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL----TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE-EEVFDSIVNDE 228 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~-~~~~~~~~~~~ 228 (245)
+|||++....... ......|+..|+|||.+ .+..++.++||||||+++|+|++|+.||.+... .+....+..+.
T Consensus 168 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 168 CDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp CCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred ccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 9999987543222 23334688999999999 456688999999999999999999999976543 23333333332
Q ss_pred cc-CC----CCCChhHHhhhc
Q psy3347 229 VR-YP----RFLSLEAIAIMR 244 (245)
Q Consensus 229 ~~-~p----~~~~~~~~~li~ 244 (245)
.+ ++ ..+++++.+||+
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~ 267 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVN 267 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHH
Confidence 22 22 457888888875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=241.29 Aligned_cols=213 Identities=23% Similarity=0.410 Sum_probs=159.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++..... ........ .++..+++.++||||+++++++..++..++||||+ ++.+.....
T Consensus 41 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~--~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~ 115 (318)
T 2dyl_A 41 VWKMRFRKTGHVIAVKQMRRSGN--KEENKRIL--MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK 115 (318)
T ss_dssp EEEEEETTTCCEEEEEEEETTSC--HHHHHHHH--HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHH
T ss_pred EEEEEEecCCeEEEEEEeccccc--chHHHHHH--HHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHH
Confidence 79999999999999999986532 12222222 22334567789999999999999999999999999 445555543
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
...+++..+..++.|++.||.|||++ |++|+ |++|+|| +++.++.++|+|||
T Consensus 116 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~---dlkp~Ni----------------------l~~~~~~~kl~dfg 170 (318)
T 2dyl_A 116 RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR---DVKPSNI----------------------LLDERGQIKLCDFG 170 (318)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC---CCCGGGE----------------------EECTTSCEEECCCT
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeC---CCCHHHE----------------------EECCCCCEEEEECC
Confidence 36789999999999999999999995 99999 8999998 88889999999999
Q ss_pred CccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCccc-
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPG-DDEEEVFDSIVNDEVR- 230 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (245)
++...... .......++..|+|||.+. ...++.++||||||+++|+|++|+.||.. ....+....+.....+
T Consensus 171 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 171 ISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp TC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred CchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 98653222 2233456889999999994 45678899999999999999999999976 4555666666555433
Q ss_pred CC--CCCChhHHhhhc
Q psy3347 231 YP--RFLSLEAIAIMR 244 (245)
Q Consensus 231 ~p--~~~~~~~~~li~ 244 (245)
.| ..+++++.+||+
T Consensus 250 ~~~~~~~~~~l~~li~ 265 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVK 265 (318)
T ss_dssp CCSSSCCCHHHHHHHH
T ss_pred CCccCCCCHHHHHHHH
Confidence 33 457889988875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=243.46 Aligned_cols=205 Identities=24% Similarity=0.452 Sum_probs=157.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. ++.||+|++... ...+.+.+| ++.++.++||||+++++++. +..++||||+++++|.+++.
T Consensus 24 V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E---~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 91 (307)
T 2eva_A 24 VCKAKWR--AKDVAIKQIESE-----SERKAFIVE---LRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH 91 (307)
T ss_dssp EEEEEET--TEEEEEEECSST-----THHHHHHHH---HHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHH
T ss_pred EEEEEEC--CeeEEEEEecCh-----hHHHHHHHH---HHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHh
Confidence 6888774 889999999743 223344444 67778889999999999886 44799999999999999986
Q ss_pred hc----CCChHHHHHHHHHHHHHHHHhhh---cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc-eE
Q psy3347 81 AD----VFSEPRAVFYAACVVLGLQYLHE---SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY-VK 152 (245)
Q Consensus 81 ~~----~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~k 152 (245)
.. .++...+..++.|++.||+|||+ +|++|+ |++|+|| +++.++. +|
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~---dlkp~NI----------------------ll~~~~~~~k 146 (307)
T 2eva_A 92 GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR---DLKPPNL----------------------LLVAGGTVLK 146 (307)
T ss_dssp CSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCC---CCSGGGE----------------------EEETTTTEEE
T ss_pred ccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecC---CCChhHE----------------------EEeCCCCEEE
Confidence 43 36788999999999999999999 899999 8999888 6666665 79
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcC-cc
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD--DEEEVFDSIVND-EV 229 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~--~~~~~~~~~~~~-~~ 229 (245)
|+|||++..... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||... ........+... ..
T Consensus 147 l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (307)
T 2eva_A 147 ICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223 (307)
T ss_dssp ECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC
T ss_pred Eccccccccccc---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC
Confidence 999999864322 123446899999999999888999999999999999999999999754 333343344333 33
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
+.+..+++++.++|++
T Consensus 224 ~~~~~~~~~l~~li~~ 239 (307)
T 2eva_A 224 PLIKNLPKPIESLMTR 239 (307)
T ss_dssp CCBTTCCHHHHHHHHH
T ss_pred CcccccCHHHHHHHHH
Confidence 4567889999888763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.72 Aligned_cols=207 Identities=21% Similarity=0.252 Sum_probs=159.2
Q ss_pred CEeEEEecC--------CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceee---------------eeEEE
Q psy3347 1 VILSQYRNT--------GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVN---------------LFACF 57 (245)
Q Consensus 1 V~~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~---------------~~~~~ 57 (245)
||+|++..+ ++.||+|++... +.+.+| +++++.++||||++ +++++
T Consensus 58 Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~ 126 (352)
T 2jii_A 58 LYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNE---QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFG 126 (352)
T ss_dssp EEEEEECC-----------CEEEEEEETT--------STHHHH---HHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEE
T ss_pred EEEEeecCCccccccccCceEEEEEeccc--------chHHHH---HHHHHHhcccchhhhhhhhccCCccCccchhhcc
Confidence 799999884 899999999753 223333 55666777888877 67777
Q ss_pred ee-CCeEEEEEeeccCCchhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccc
Q psy3347 58 QT-EAHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYK 133 (245)
Q Consensus 58 ~~-~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~ 133 (245)
.. ++..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||++|++|| |++|+||
T Consensus 127 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~---Dikp~NI------------ 190 (352)
T 2jii_A 127 VHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHG---NVTAENI------------ 190 (352)
T ss_dssp EETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCS---CCCGGGE------------
T ss_pred ccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCC---CCCHHHE------------
Confidence 76 67899999999 8999999964 579999999999999999999999999999 9999888
Q ss_pred cCcccchhccccCCCC--ceEEeecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHH
Q psy3347 134 VNSSQEIKLTVNDTEG--YVKIADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFE 204 (245)
Q Consensus 134 ~~~~~~~~~~~~~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 204 (245)
+++.++ .++|+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|+
T Consensus 191 ----------l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 191 ----------FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp ----------EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 777777 899999999975332211 1234478999999999998889999999999999999
Q ss_pred HHhCCCCCCCCC--HHHHHHHH---hcCcccCC------CCCChhHHhhhc
Q psy3347 205 MLVGESPFPGDD--EEEVFDSI---VNDEVRYP------RFLSLEAIAIMR 244 (245)
Q Consensus 205 l~~g~~pf~~~~--~~~~~~~~---~~~~~~~p------~~~~~~~~~li~ 244 (245)
|++|+.||.+.. ........ ......++ ..+++++.+||+
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 311 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLK 311 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHH
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHH
Confidence 999999997653 32232222 22222222 246888888875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=266.14 Aligned_cols=214 Identities=25% Similarity=0.385 Sum_probs=172.0
Q ss_pred CEeEEEecC---CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT---GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.+..+ +..||+|+++... .....+.+. +++..++.++||||+++++++. ++..++||||+++++|.+
T Consensus 406 Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~ 479 (656)
T 2j0j_A 406 VHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFL---QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRS 479 (656)
T ss_dssp EEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHH---HHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred EEEEEEecCCCccEEEEEEEecccC--CHHHHHHHH---HHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHH
Confidence 799988754 4579999887532 222233444 4477788899999999999985 456899999999999999
Q ss_pred hhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
+++.. .+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.+||+|
T Consensus 480 ~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr---Dikp~NI----------------------Ll~~~~~vkL~D 534 (656)
T 2j0j_A 480 FLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR---DIAARNV----------------------LVSSNDCVKLGD 534 (656)
T ss_dssp HHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EEEETTEEEECC
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc---ccchHhE----------------------EEeCCCCEEEEe
Confidence 98643 58899999999999999999999999999 9999998 888889999999
Q ss_pred cCCccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 156 FGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+..+. .+.|
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999975432221 1223345678999999988899999999999999999997 999999998888888887654 4568
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+++++.+||++
T Consensus 615 ~~~~~~l~~li~~ 627 (656)
T 2j0j_A 615 PNCPPTLYSLMTK 627 (656)
T ss_dssp TTCCHHHHHHHHH
T ss_pred ccccHHHHHHHHH
Confidence 8899999998863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=240.37 Aligned_cols=209 Identities=24% Similarity=0.434 Sum_probs=158.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-------------CCeEEEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-------------EAHVCFVM 67 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-------------~~~~~lv~ 67 (245)
||+|++..+|+.||+|++... ....+.+ .++++.++.++||||+++++++.. .+..++||
T Consensus 22 V~~~~~~~~~~~vaiK~~~~~----~~~~~~~---~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 94 (303)
T 1zy4_A 22 VVKARNALDSRYYAIKKIRHT----EEKLSTI---LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM 94 (303)
T ss_dssp EEEEEETTTCCEEEEEEEEEE----HHHHHHH---HHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEE
T ss_pred EEEEEEcCCCeEEEEEEEecc----HHHHHHH---HHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEE
Confidence 799999999999999999642 2223334 345778889999999999998865 45789999
Q ss_pred eeccCCchhhhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 68 EYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 68 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
||+++++|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+|| ++
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~---dlkp~Ni----------------------l~ 149 (303)
T 1zy4_A 95 EYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHR---DLKPMNI----------------------FI 149 (303)
T ss_dssp ECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EE
T ss_pred ecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecc---cCCHHhE----------------------EE
Confidence 999999999999643 46788899999999999999999999999 9999998 88
Q ss_pred CCCCceEEeecCCccCCCCC--------------CCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCC
Q psy3347 146 DTEGYVKIADFGLCKEGMGF--------------GDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGES 210 (245)
Q Consensus 146 ~~~~~~kl~Dfg~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~ 210 (245)
+.++.++|+|||++...... ........|+..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--- 226 (303)
T 1zy4_A 150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--- 226 (303)
T ss_dssp CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---
T ss_pred cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---
Confidence 88999999999998753221 1122345688899999999764 68899999999999999998
Q ss_pred CCCC-CCHHHHHHHHhcCcccCC----CCCChhHHhhhc
Q psy3347 211 PFPG-DDEEEVFDSIVNDEVRYP----RFLSLEAIAIMR 244 (245)
Q Consensus 211 pf~~-~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~ 244 (245)
||.. .+..+....+......+| ...++.++++|+
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 265 (303)
T 1zy4_A 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR 265 (303)
T ss_dssp CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHH
T ss_pred ccCCchhHHHHHHhccccccccCccccccchHHHHHHHH
Confidence 5543 334455555555444443 445666777775
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=246.06 Aligned_cols=193 Identities=27% Similarity=0.394 Sum_probs=157.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc---CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~---~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||||+++... .......+|.++++.++.. .|++|+++.+++...++.|+||||+++ +|.+
T Consensus 70 V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~ 144 (382)
T 2vx3_A 70 VVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYD 144 (382)
T ss_dssp EEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHH
T ss_pred EEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHH
Confidence 7999999999999999997532 2233444555555544432 234699999999999999999999965 8988
Q ss_pred hhhh---cCCChHHHHHHHHHHHHHHHHhh--hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc--CCCCc
Q psy3347 78 HIHA---DVFSEPRAVFYAACVVLGLQYLH--ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN--DTEGY 150 (245)
Q Consensus 78 ~~~~---~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 150 (245)
++.. ..+++..+..++.|++.||.||| +.||+|| |+||+|| ++ +.++.
T Consensus 145 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHr---Dlkp~NI----------------------ll~~~~~~~ 199 (382)
T 2vx3_A 145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC---DLKPENI----------------------LLCNPKRSA 199 (382)
T ss_dssp HHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECC---CCSGGGE----------------------EESSTTSCC
T ss_pred HHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcC---CCCcccE----------------------EEecCCCCc
Confidence 8854 35899999999999999999999 5799999 8888888 55 45788
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
+||+|||++.... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 200 ~kL~DFG~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 200 IKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp EEECCCTTCEETT---CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEEeccCceecc---cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999997532 223456789999999999998999999999999999999999999999888877777654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=243.97 Aligned_cols=180 Identities=23% Similarity=0.382 Sum_probs=144.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC----CeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE----AHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~----~~~~lv~e~~~~~~L~ 76 (245)
||+|++. |+.||+|++.... .....++.+ +.....++||||+++++++... +..++||||+++++|.
T Consensus 53 V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~-~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 123 (337)
T 3mdy_A 53 VWMGKWR--GEKVAVKVFFTTE------EASWFRETE-IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123 (337)
T ss_dssp EEEEEET--TEEEEEEEEEGGG------HHHHHHHHH-HHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHH
T ss_pred EEEEEEC--CceEEEEEEeccc------cchhhhHHH-HHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHH
Confidence 7899875 8999999996431 122223322 2223345899999999999877 7899999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhhc--------CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHES--------RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++++...+++..+..++.|++.||+|||++ |++|| |+||+|| +++.+
T Consensus 124 ~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~---Dikp~Ni----------------------ll~~~ 178 (337)
T 3mdy_A 124 DYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR---DLKSKNI----------------------LVKKN 178 (337)
T ss_dssp HHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECS---CCCGGGE----------------------EECTT
T ss_pred HHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEec---ccchHHE----------------------EECCC
Confidence 999888899999999999999999999999 99999 9999999 88889
Q ss_pred CceEEeecCCccCCCCCCCC----CCcccCCCCccccccccCCCCCcc------hhHHHHHHHHHHHHhC----------
Q psy3347 149 GYVKIADFGLCKEGMGFGDR----TGTFCGTPEFLAPEVLTETSYTRA------VDWWGLGVLIFEMLVG---------- 208 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~~l~el~~g---------- 208 (245)
+.+||+|||++......... .....||..|+|||.+.+...+.+ +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 99999999998643322221 224578999999999987666554 9999999999999999
Q ss_pred CCCCCC
Q psy3347 209 ESPFPG 214 (245)
Q Consensus 209 ~~pf~~ 214 (245)
..||..
T Consensus 259 ~~p~~~ 264 (337)
T 3mdy_A 259 QLPYHD 264 (337)
T ss_dssp CCTTTT
T ss_pred cccHhh
Confidence 777754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.91 Aligned_cols=183 Identities=25% Similarity=0.343 Sum_probs=146.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc--------CCCceeeeeEEEeeCC----eEEEEEe
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM--------RHPFLVNLFACFQTEA----HVCFVME 68 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~--------~h~ni~~~~~~~~~~~----~~~lv~e 68 (245)
||+|++..+|+.||+|++.... ...+.+.+|.+.+..+... .||||+++++++...+ ..+++||
T Consensus 35 V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e 110 (373)
T 1q8y_A 35 VWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 110 (373)
T ss_dssp EEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred EEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEe
Confidence 7999999999999999997532 2234455555555544422 3899999999997654 7899999
Q ss_pred eccCCchhhhhhh---cCCChHHHHHHHHHHHHHHHHhhhc-CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 69 YAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 69 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
++ +++|.+++.. ..+++..+..++.|++.||+|||++ ||+|+ |+||+|| +
T Consensus 111 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~---Dikp~NI----------------------l 164 (373)
T 1q8y_A 111 VL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT---DIKPENV----------------------L 164 (373)
T ss_dssp CC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS---CCSGGGE----------------------E
T ss_pred cC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEec---CCChHHe----------------------E
Confidence 99 7899888853 4589999999999999999999998 99999 8888888 4
Q ss_pred c------CCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 145 N------DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 145 ~------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
+ +..+.+||+|||++..... ......||..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4 3445799999999875322 2334578999999999999899999999999999999999999997653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.28 Aligned_cols=209 Identities=18% Similarity=0.291 Sum_probs=151.5
Q ss_pred CEeEEEecCC-cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc---CCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTG-EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM---RHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~---~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..++ +.||+|+++... ...+.+.+|.+++..++.. .+++++.+.+++...++.++||||+++ ++.
T Consensus 35 V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 109 (355)
T 2eu9_A 35 VVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTF 109 (355)
T ss_dssp EEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCC-BHH
T ss_pred EEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCC-ChH
Confidence 7999998876 799999997532 2234444554444444322 233499999999999999999999954 565
Q ss_pred hhhh-h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhcccc--CcccchhccccCCCCce
Q psy3347 77 MHIH-A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKV--NSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 77 ~~~~-~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 151 (245)
+++. . ..+++..+..++.|++.||+|||++||+|+ |+||+|| ++...-.. ...........+.++.+
T Consensus 110 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~---Dlkp~NI-----ll~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (355)
T 2eu9_A 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT---DLKPENI-----LFVNSEFETLYNEHKSCEEKSVKNTSI 181 (355)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCCGGGE-----EESCCCEEEEECCC-CCCEEEESCCCE
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC---CCCHHHE-----EEecccccccccccccccccccCCCcE
Confidence 5553 2 368999999999999999999999999999 8888777 22100000 00000000001457889
Q ss_pred EEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 152 KIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
||+|||++.... .......||..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 182 kl~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 182 RVADFGSATFDH---EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp EECCCTTCEETT---SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEeecCcccccc---ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999987522 22345578999999999998899999999999999999999999999887766555543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=245.39 Aligned_cols=214 Identities=23% Similarity=0.353 Sum_probs=165.8
Q ss_pred CEeEE----EecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC--eEEEEEeeccCCc
Q psy3347 1 VILSQ----YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA--HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~ 74 (245)
||+|+ +..+|+.||+|++... .....+.+.+ +++.++.++||||+++++++...+ ..++||||+++++
T Consensus 57 V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 130 (326)
T 2w1i_A 57 VEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130 (326)
T ss_dssp EEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHH---HHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCB
T ss_pred EEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHH---HHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCC
Confidence 68888 4668999999999764 2233344444 477788899999999999986654 7899999999999
Q ss_pred hhhhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
|.+++.. ..+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++.++
T Consensus 131 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---dikp~NI----------------------li~~~~~~k 185 (326)
T 2w1i_A 131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHR---DLATRNI----------------------LVENENRVK 185 (326)
T ss_dssp HHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EEEETTEEE
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEecc---CCCcceE----------------------EEcCCCcEE
Confidence 9999865 358999999999999999999999999999 8999888 778889999
Q ss_pred EeecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH------------
Q psy3347 153 IADFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE------------ 217 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~------------ 217 (245)
|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch
Confidence 999999875433221 12233456779999999888899999999999999999999998753211
Q ss_pred ----HHHHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 218 ----EEVFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 218 ----~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
......+... ..+.|..+++++.+||++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 298 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE 298 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Confidence 0112222222 334578899999998863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=242.45 Aligned_cols=185 Identities=25% Similarity=0.361 Sum_probs=151.8
Q ss_pred CEeEEEecCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII-ARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|.+ +++.||+|++...... .....+.+.+ +++.++.++||||+++++++...+..+++|||+++++|.+++
T Consensus 47 Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 121 (307)
T 2nru_A 47 VYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQ---EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121 (307)
T ss_dssp EEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred EEEEEE--CCceEEEEEEecccCcchHHHHHHHHH---HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHH
Confidence 688876 5889999999754321 2222344444 467788889999999999999999999999999999999888
Q ss_pred h----hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 80 H----ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 80 ~----~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
. ...+++..+..++.|++.||.|||++|++|+ |++|+|| +++.++.++|+|
T Consensus 122 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~---dlkp~Ni----------------------li~~~~~~kl~D 176 (307)
T 2nru_A 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR---DIKSANI----------------------LLDEAFTAKISD 176 (307)
T ss_dssp HTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EECTTCCEEECC
T ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecC---CCCHHHE----------------------EEcCCCcEEEee
Confidence 5 2358999999999999999999999999999 9999998 888899999999
Q ss_pred cCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3347 156 FGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD 216 (245)
Q Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~ 216 (245)
||++........ ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||.+..
T Consensus 177 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999875322211 1334568899999998865 47889999999999999999999997643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=252.76 Aligned_cols=210 Identities=19% Similarity=0.222 Sum_probs=162.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCC-CceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRH-PFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|++..+|+.||||++...... +.+.+| +++++.++| +++..+..++...+..++||||+ +++|.+++
T Consensus 23 Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E---~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll 93 (483)
T 3sv0_A 23 IYLGTNIQTNEEVAIKLENVKTKH-----PQLLYE---SKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLF 93 (483)
T ss_dssp EEEEEETTTCCEEEEEEEETTCSS-----CCHHHH---HHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred EEEEEECCCCcEEEEEEecccccc-----HHHHHH---HHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHH
Confidence 799999999999999988754321 234444 444555655 55666666677888999999999 88999998
Q ss_pred h--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc---CCCCceEEe
Q psy3347 80 H--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN---DTEGYVKIA 154 (245)
Q Consensus 80 ~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~kl~ 154 (245)
. ...+++..+..++.|++.||+|||++||+|| ||||+|| ++ +.++.+||+
T Consensus 94 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr---DIKP~NI----------------------Ll~~~~~~~~vkL~ 148 (483)
T 3sv0_A 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR---DIKPDNF----------------------LMGLGRRANQVYII 148 (483)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECCGGGTTCEEEC
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec---ccCcceE----------------------EEecCCCCCeEEEE
Confidence 6 4579999999999999999999999999999 8888888 55 577899999
Q ss_pred ecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Q psy3347 155 DFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE---EEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~---~~~~~~~ 224 (245)
|||+++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+... .+....+
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 9999975432221 12256789999999999999999999999999999999999999976432 3333333
Q ss_pred hcCcc-----cCCCCCChhHHhhhc
Q psy3347 225 VNDEV-----RYPRFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~~~-----~~p~~~~~~~~~li~ 244 (245)
..... ..+..+++++.+||+
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~ 253 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFH 253 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHH
T ss_pred hhccccccHHHHhcCCcHHHHHHHH
Confidence 22211 233677888888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=245.38 Aligned_cols=182 Identities=26% Similarity=0.341 Sum_probs=151.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++. +|+.||+|++...... .....+ .+++++++.++||||+++++++...+..++||||+++++|.+++.
T Consensus 46 V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 119 (326)
T 3uim_A 46 VYKGRLA-DGTLVAVKRLKEERTQ--GGELQF---QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119 (326)
T ss_dssp EEEECCS-SSCCEEEEECCC-------CCCHH---HHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHH
T ss_pred EEEEEec-CCCEEEEEEeccccCc--hHHHHH---HHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHH
Confidence 7899754 6999999999864321 111233 344777889999999999999999999999999999999999885
Q ss_pred hc-----CCChHHHHHHHHHHHHHHHHhhhc---CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 81 AD-----VFSEPRAVFYAACVVLGLQYLHES---RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 81 ~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
.. .+++..+..++.|++.||+|||++ |++|+ |++|+|| +++.++.++
T Consensus 120 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~---Dlkp~Ni----------------------l~~~~~~~k 174 (326)
T 3uim_A 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR---DVKAANI----------------------LLDEEFEAV 174 (326)
T ss_dssp CCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC---CCSGGGE----------------------EECTTCCEE
T ss_pred hccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC---CCchhhE----------------------EECCCCCEE
Confidence 42 388999999999999999999999 99999 9999998 888899999
Q ss_pred EeecCCccCCCCC-CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 153 IADFGLCKEGMGF-GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 153 l~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
|+|||++...... ........||..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999998753222 222334568999999999988889999999999999999999999995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=243.61 Aligned_cols=178 Identities=23% Similarity=0.336 Sum_probs=142.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~L 75 (245)
||+|++ +|+.||+|++.... ...+..+ +++..+..++||||+++++.+.. ...+++||||+++++|
T Consensus 29 Vy~~~~--~~~~vavK~~~~~~------~~~~~~e-~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L 99 (336)
T 3g2f_A 29 VYKGSL--DERPVAVKVFSFAN------RQNFINE-KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSL 99 (336)
T ss_dssp EEEEEE--TTEEEEEEEEEGGG------HHHHHHH-HHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBH
T ss_pred EEEEEE--CCeEEEEEEeeccc------hhhHHHH-HHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcH
Confidence 788866 68999999997532 1222222 23344556899999999986533 2367999999999999
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhhc---------CccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHES---------RIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
.++++....++..+..++.|++.||+|||+. ||+|| |+||+|| +++
T Consensus 100 ~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~---Dikp~Ni----------------------ll~ 154 (336)
T 3g2f_A 100 XKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR---DLNSRNV----------------------LVK 154 (336)
T ss_dssp HHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECS---SCSGGGE----------------------EEC
T ss_pred HHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeec---ccccceE----------------------EEc
Confidence 9999888889999999999999999999999 99999 9999998 888
Q ss_pred CCCceEEeecCCccCCCCCC--------CCCCcccCCCCccccccccC-------CCCCcchhHHHHHHHHHHHHhCCCC
Q psy3347 147 TEGYVKIADFGLCKEGMGFG--------DRTGTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIFEMLVGESP 211 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~g~~p 211 (245)
.++.+||+|||++....... .......||..|+|||.+.+ ..++.++|||||||++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 88999999999997533211 11234568999999999976 3566789999999999999998666
Q ss_pred C
Q psy3347 212 F 212 (245)
Q Consensus 212 f 212 (245)
|
T Consensus 235 ~ 235 (336)
T 3g2f_A 235 L 235 (336)
T ss_dssp G
T ss_pred C
Confidence 5
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=240.03 Aligned_cols=179 Identities=23% Similarity=0.378 Sum_probs=146.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh--cCCCceeeeeEEEeeCC----eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT--MRHPFLVNLFACFQTEA----HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~ 74 (245)
||+|++ +|+.||+|++.... ...+.+| .+++.. ++||||+++++++...+ ..++||||+++++
T Consensus 58 Vy~~~~--~~~~vavK~~~~~~------~~~~~~e---~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~ 126 (342)
T 1b6c_B 58 VWRGKW--RGEEVAVKIFSSRE------ERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 126 (342)
T ss_dssp EEEEEE--TTEEEEEEEECGGG------HHHHHHH---HHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCB
T ss_pred EEEEEE--cCccEEEEEeCchh------HHHHHHH---HHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCc
Confidence 788887 59999999997431 2334444 333433 78999999999998775 8999999999999
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhh--------hcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLH--------ESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND 146 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~ 146 (245)
|.++++...+++..+..++.|++.||.||| ++|++|+ |++|+|| +++
T Consensus 127 L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~---Dlkp~NI----------------------ll~ 181 (342)
T 1b6c_B 127 LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR---DLKSKNI----------------------LVK 181 (342)
T ss_dssp HHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS---CCSGGGE----------------------EEC
T ss_pred HHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC---CCCHHHE----------------------EEC
Confidence 999998888999999999999999999999 8999999 9999998 888
Q ss_pred CCCceEEeecCCccCCCCCCC----CCCcccCCCCccccccccCC------CCCcchhHHHHHHHHHHHHhC--------
Q psy3347 147 TEGYVKIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTET------SYTRAVDWWGLGVLIFEMLVG-------- 208 (245)
Q Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g-------- 208 (245)
.++.+||+|||++........ ......|+..|+|||.+.+. .++.++||||||+++|+|++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 899999999999864322221 13345789999999999765 233689999999999999999
Q ss_pred --CCCCCCC
Q psy3347 209 --ESPFPGD 215 (245)
Q Consensus 209 --~~pf~~~ 215 (245)
..||...
T Consensus 262 ~~~~p~~~~ 270 (342)
T 1b6c_B 262 DYQLPYYDL 270 (342)
T ss_dssp CCCCTTTTT
T ss_pred ccccCcccc
Confidence 7888653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=233.91 Aligned_cols=212 Identities=17% Similarity=0.333 Sum_probs=159.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC--CCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--HPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.+. +|+.||+|++..... .....+.+.+| ++.++.++ ||||+++++++..++..+++|| +.+++|.++
T Consensus 44 Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E---~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~ 117 (313)
T 3cek_A 44 VFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNE---IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 117 (313)
T ss_dssp EEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHH---HHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHH
T ss_pred EEEEEcC-CCcEEEEEEeccccc-cccchHHHHHH---HHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHH
Confidence 7899885 589999999976432 22334445555 55555665 5999999999999999999999 567899998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
+.. ..+++..+..++.|++.||.|||++|++|+ |++|+|| +++ ++.+||+|||
T Consensus 118 l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~---dlkp~NI----------------------l~~-~~~~kL~Dfg 171 (313)
T 3cek_A 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS---DLKPANF----------------------LIV-DGMLKLIDFG 171 (313)
T ss_dssp HHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EEE-TTEEEECCCS
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceec---CCCcccE----------------------EEE-CCeEEEeecc
Confidence 854 578999999999999999999999999999 8888888 554 4789999999
Q ss_pred CccCCCCCCC--CCCcccCCCCccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q psy3347 158 LCKEGMGFGD--RTGTFCGTPEFLAPEVLTE-----------TSYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDS 223 (245)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~~g~~pf~~~~-~~~~~~~ 223 (245)
++........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... .......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9875322211 1234568899999999965 467889999999999999999999997653 3344444
Q ss_pred HhcCc--ccCCCCCChhHHhhhc
Q psy3347 224 IVNDE--VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 224 ~~~~~--~~~p~~~~~~~~~li~ 244 (245)
+.... ..+|...++++.++|+
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~ 274 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLK 274 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHH
T ss_pred HHhcccccCCcccchHHHHHHHH
Confidence 44332 3457778888888875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.06 Aligned_cols=211 Identities=20% Similarity=0.287 Sum_probs=164.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++.. .+|+|+++..... ....+.+.+ ++..++.++||||+++++++...+..+++|||+++++|.+++.
T Consensus 49 V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~ 121 (319)
T 2y4i_B 49 VYHGRWHG---EVAIRLIDIERDN-EDQLKAFKR---EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121 (319)
T ss_dssp EEEEEESS---SEEEEECCCCSCC-CCCCCCCCT---TGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTT
T ss_pred EEEEEEcC---eEEEEEeecCCCC-HHHHHHHHH---HHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHH
Confidence 68888753 4999999764321 122223333 3667888999999999999999999999999999999999996
Q ss_pred hc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 AD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.. .+++..+..++.|++.||+|||++|++|+ |++|+|| +++ ++.++|+|||+
T Consensus 122 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~---dlkp~NI----------------------l~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK---DLKSKNV----------------------FYD-NGKVVITDFGL 175 (319)
T ss_dssp SSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCC---CCCSTTE----------------------EEC---CCEECCCSC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc---CCChhhE----------------------EEe-CCCEEEeecCC
Confidence 53 58999999999999999999999999999 8888888 665 57899999998
Q ss_pred ccCCCC-----CCCCCCcccCCCCccccccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 159 CKEGMG-----FGDRTGTFCGTPEFLAPEVLTE---------TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 159 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
+..... .........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 764211 1112234457889999999964 34788999999999999999999999988888777777
Q ss_pred hcCcccC--CCCCChhHHhhhc
Q psy3347 225 VNDEVRY--PRFLSLEAIAIMR 244 (245)
Q Consensus 225 ~~~~~~~--p~~~~~~~~~li~ 244 (245)
..+..+. +..+++++.++|+
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~ 277 (319)
T 2y4i_B 256 GTGMKPNLSQIGMGKEISDILL 277 (319)
T ss_dssp HTTCCCCCCCSSCCTTHHHHHH
T ss_pred ccCCCCCCCcCCCCHHHHHHHH
Confidence 6654432 3467888888875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=247.66 Aligned_cols=212 Identities=14% Similarity=0.117 Sum_probs=153.1
Q ss_pred CEeEEEecCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHHHhhc------CCCceeeeeEEE------------
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDII-----ARDEVESLLSEKRIFEVANTM------RHPFLVNLFACF------------ 57 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~------~h~ni~~~~~~~------------ 57 (245)
||+|++ +|+.||+|++...... .....+.+.+|.+++..++.+ +||||+++.+++
T Consensus 36 V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~ 113 (336)
T 2vuw_A 36 VFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLK 113 (336)
T ss_dssp EEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHH
T ss_pred EEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHH
Confidence 799988 6899999999865321 122335556665555444422 366666666654
Q ss_pred -----ee-------------CCeEEEEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhh-hcCccccCCCCCCH
Q psy3347 58 -----QT-------------EAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITK 118 (245)
Q Consensus 58 -----~~-------------~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~~~~~i~~ 118 (245)
.. .+..|+||||+.+|++.+.+....+++..++.++.|++.||+||| ++||+|| |+||
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHr---DlKp 190 (336)
T 2vuw_A 114 AWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR---DLHW 190 (336)
T ss_dssp HHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCS---CCCG
T ss_pred HHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeEC---CCCH
Confidence 22 678999999999997766666677899999999999999999999 9999999 8888
Q ss_pred HHHHHHHHHhhhccccCcccchhccccCCCC--------------------ceEEeecCCccCCCCCCCCCCcccCCCCc
Q psy3347 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEG--------------------YVKIADFGLCKEGMGFGDRTGTFCGTPEF 178 (245)
Q Consensus 119 ~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y 178 (245)
+|| +++.++ .+||+|||+++.... ...+||+.|
T Consensus 191 ~NI----------------------Ll~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y 243 (336)
T 2vuw_A 191 GNV----------------------LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVS 243 (336)
T ss_dssp GGE----------------------EEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCT
T ss_pred HHE----------------------EEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecc
Confidence 888 555554 899999999985322 245789999
Q ss_pred cccccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhcC---cccC----CCCCChhHHhhhcC
Q psy3347 179 LAPEVLTETSYTRAVDWWGLGVL-IFEMLVGESPFPGDDE-EEVFDSIVND---EVRY----PRFLSLEAIAIMRR 245 (245)
Q Consensus 179 ~aPE~~~~~~~~~~~DvwslG~~-l~el~~g~~pf~~~~~-~~~~~~~~~~---~~~~----p~~~~~~~~~li~~ 245 (245)
+|||.+.+.. +.++|||||+++ .+++++|..||.+... ......+... .... +..+++++++||++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHH
Confidence 9999998766 889999998877 6778889999854211 1122232211 1111 23467888888863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=233.90 Aligned_cols=189 Identities=15% Similarity=0.152 Sum_probs=150.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|++..+|+.||+|++........+..+.+.+| ++.++.++||||+++++++..++..|+||||+++++|.++++
T Consensus 47 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 123 (286)
T 3uqc_A 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSR---TLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD 123 (286)
T ss_dssp EEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHH---HHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT
T ss_pred EEEEEecCCCceEEEEEECcccccCHHHHHHHHHH---HHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh
Confidence 79999999999999999987644334444445444 666788999999999999999999999999999999999997
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
.+. ....+.+++.|++.||+|||++||+|| |+||+|| +++.+|.++|+++|
T Consensus 124 ~~~-~~~~~~~i~~ql~~aL~~lH~~givH~---Dikp~NI----------------------ll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 124 TSP-SPVGAIRAMQSLAAAADAAHRAGVALS---IDHPSRV----------------------RVSIDGDVVLAYPA--- 174 (286)
T ss_dssp TCC-CHHHHHHHHHHHHHHHHHHHHTTCCCC---CCSGGGE----------------------EEETTSCEEECSCC---
T ss_pred cCC-ChHHHHHHHHHHHHHHHHHHHCCCccC---CCCcccE----------------------EEcCCCCEEEEecc---
Confidence 654 556788999999999999999999999 9999998 78888999988543
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcCccc----CCC
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD---SIVNDEVR----YPR 233 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~----~p~ 233 (245)
|++ +++.++|||||||++|+|++|+.||.+.+..+... ........ .+.
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR 230 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCT
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhccc
Confidence 222 37889999999999999999999998765433211 11122222 236
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++++++||++
T Consensus 231 ~~~~~l~~li~~ 242 (286)
T 3uqc_A 231 DIPFQISAVAAR 242 (286)
T ss_dssp TSCHHHHHHHHH
T ss_pred CCCHHHHHHHHH
Confidence 788999988863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=243.53 Aligned_cols=180 Identities=21% Similarity=0.288 Sum_probs=137.6
Q ss_pred EEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhc-
Q psy3347 5 QYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHAD- 82 (245)
Q Consensus 5 ~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 82 (245)
+...+|+.||||++...... .. .+++++++.+ +||||+++++++.+.+..|+||||++ ++|.+++...
T Consensus 43 ~~~~~~~~vAvK~~~~~~~~------~~---~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~ 112 (432)
T 3p23_A 43 RGMFDNRDVAVKRILPECFS------FA---DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD 112 (432)
T ss_dssp EEESSSSEEEEEEECTTTEE------EC---HHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSS
T ss_pred EEEeCCeEEEEEEECHHHHH------HH---HHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcC
Confidence 45568999999999754321 12 2335667777 79999999999999999999999996 4999888654
Q ss_pred -CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc-----CCCCceEEeec
Q psy3347 83 -VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN-----DTEGYVKIADF 156 (245)
Q Consensus 83 -~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~kl~Df 156 (245)
..++..+..++.|++.||+|||++||+|| |+||+|| ++ +....++|+||
T Consensus 113 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---DlKp~NI----------------------ll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHR---DLKPHNI----------------------LISMPNAHGKIKAMISDF 167 (432)
T ss_dssp CCCCSSCHHHHHHHHHHHHHHHHHTTCCCC---CCSTTSE----------------------EECCCBTTTBCCEEECCT
T ss_pred CCccchhHHHHHHHHHHHHHHHHHCcCEeC---CCCHHHE----------------------EEecCCCCCceeEEEecc
Confidence 35556778999999999999999999999 8888887 44 23346889999
Q ss_pred CCccCCCCCC---CCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy3347 157 GLCKEGMGFG---DRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219 (245)
Q Consensus 157 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~ 219 (245)
|+++...... .......||+.|+|||.+.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 9987543221 12345678999999999973 567789999999999999999 999996554433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=240.96 Aligned_cols=219 Identities=22% Similarity=0.333 Sum_probs=146.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||.+ ...+|+.||||++.... .+...+| +++++.+ +||||+++++++..++..++||||++ ++|.+++
T Consensus 31 V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E---~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l 99 (434)
T 2rio_A 31 VVFQ-GSFQGRPVAVKRMLIDF------CDIALME---IKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLV 99 (434)
T ss_dssp EEEE-EESSSSEEEEEEEEGGG------HHHHHHH---HHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHH
T ss_pred EEEE-EEECCeEEEEEEEcHHH------HHHHHHH---HHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHH
Confidence 4543 55689999999987532 1233334 5556554 89999999999999999999999996 5999998
Q ss_pred hhcCC--------ChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 80 HADVF--------SEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 80 ~~~~l--------~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
..... ++..+..++.|++.||+|||++||+|| |+||+|| ++...-.. .......+.++.+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr---DLkp~NI-----Ll~~~~~~----~~~~~~~~~~~~~ 167 (434)
T 2rio_A 100 ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR---DLKPQNI-----LVSTSSRF----TADQQTGAENLRI 167 (434)
T ss_dssp HTC------------CCHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE-----EEECCHHH----HSCCTTCCCSCEE
T ss_pred hccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCcccc---CCChHhE-----EEecCccc----ccccccCCCceEE
Confidence 65422 233457899999999999999999999 8888777 22100000 0000001234689
Q ss_pred EEeecCCccCCCCCCC----CCCcccCCCCccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy3347 152 KIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEE 219 (245)
Q Consensus 152 kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~ 219 (245)
||+|||++........ ......||+.|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+....+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999975432221 1234578999999999965 568899999999999999999 999997654333
Q ss_pred HHHHHhcCcccCC-------CCCChhHHhhhc
Q psy3347 220 VFDSIVNDEVRYP-------RFLSLEAIAIMR 244 (245)
Q Consensus 220 ~~~~~~~~~~~~p-------~~~~~~~~~li~ 244 (245)
..+..+....+ ..+++++++||+
T Consensus 248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~ 277 (434)
T 2rio_A 248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277 (434)
T ss_dssp --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHH
T ss_pred --HHHhcCCCCcccccccccccchHHHHHHHH
Confidence 23333322221 123467777775
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=256.16 Aligned_cols=184 Identities=32% Similarity=0.456 Sum_probs=153.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee------CCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT------EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~------~~~~~lv~e~~~~~~ 74 (245)
||+|.+..+|+.||+|++.... .....+.+.+ ++++++.++||||+++++++.. ++..++||||+++++
T Consensus 30 Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~---Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggs 104 (676)
T 3qa8_A 30 VLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCL---EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGD 104 (676)
T ss_dssp CCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHH---HHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCB
T ss_pred EEEEEECCCCcEEEEEEecccC--CHHHHHHHHH---HHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCC
Confidence 7999999999999999987542 2233344444 4677888899999999999765 667899999999999
Q ss_pred hhhhhhhc----CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-
Q psy3347 75 LMMHIHAD----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG- 149 (245)
Q Consensus 75 L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~- 149 (245)
|.+++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++.++
T Consensus 105 L~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHr---DLKP~NI----------------------Ll~~~g~ 159 (676)
T 3qa8_A 105 LRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR---DLKPENI----------------------VLQPGPQ 159 (676)
T ss_dssp HHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCC---CCCSTTE----------------------EEECCSS
T ss_pred HHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC---CCCHHHe----------------------EeecCCC
Confidence 99998642 58899999999999999999999999999 8888888 565444
Q ss_pred --ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 150 --YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 150 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
.++|+|||++..... ........|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.
T Consensus 160 ~~~vKL~DFG~a~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQ-GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp SCEEEECSCCCCCBTTS-CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceeEEEccccccccccc-ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 489999999875322 22344567899999999999889999999999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=227.51 Aligned_cols=186 Identities=26% Similarity=0.474 Sum_probs=144.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHH-hhcCCCceeeeeEEEee----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA-NTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L 75 (245)
||+|.++.+|+.||+|++... ....+| ++.+ +..+||||+++++++.. .+..++||||+++++|
T Consensus 34 V~~~~~~~~~~~vaiK~~~~~--------~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 102 (299)
T 3m2w_A 34 VLQIFNKRTQEKFALKMLQDC--------PKARRE---VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 102 (299)
T ss_dssp EEEEEETTTCCEEEEEEEECS--------HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBH
T ss_pred EEEEEEcCCCcEEEEEEeccc--------HHHHHH---HHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcH
Confidence 799999999999999999743 222333 3333 55689999999999977 6789999999999999
Q ss_pred hhhhhhc---CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC---CC
Q psy3347 76 MMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT---EG 149 (245)
Q Consensus 76 ~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 149 (245)
.+++... .+++..+..++.|++.||+|||++|++|+ |++|+|| +++. ++
T Consensus 103 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~---dlkp~Ni----------------------l~~~~~~~~ 157 (299)
T 3m2w_A 103 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR---DVKPENL----------------------LYTSKRPNA 157 (299)
T ss_dssp HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESSSSTTC
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CCCHHHE----------------------EEecCCCCC
Confidence 9998643 58999999999999999999999999999 8888888 6665 78
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV---- 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~---- 225 (245)
.++|+|||++... .+..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 158 ~~kl~Dfg~a~~~----------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 215 (299)
T 3m2w_A 158 ILKLTDFGFAKET----------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215 (299)
T ss_dssp CEEECCCTTCEEC----------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred cEEEecccccccc----------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence 8999999988632 12457789999999999999999999997765544332222
Q ss_pred cCcccCC----CCCChhHHhhhc
Q psy3347 226 NDEVRYP----RFLSLEAIAIMR 244 (245)
Q Consensus 226 ~~~~~~p----~~~~~~~~~li~ 244 (245)
.....+| ..+++++++||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~ 238 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIR 238 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHH
T ss_pred hccccCCchhcccCCHHHHHHHH
Confidence 2222333 568888888875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=254.13 Aligned_cols=177 Identities=24% Similarity=0.390 Sum_probs=144.7
Q ss_pred CEeEEEec-CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCe-----EEEEEeeccCCc
Q psy3347 1 VILSQYRN-TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAH-----VCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~-----~~lv~e~~~~~~ 74 (245)
||+|.+.. +|+.||||++.... .....+.+. ++++.++.++||||+++++++...+. .|+||||+++++
T Consensus 96 Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~---~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~ 170 (681)
T 2pzi_A 96 IYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAM---AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS 170 (681)
T ss_dssp EEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHH---HHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEE
T ss_pred EEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHH---HHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCc
Confidence 79999987 79999999987532 222333343 44677889999999999999987654 799999999999
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|.+++.. .+++..+..++.|++.||.|||++||+|| |+||+|| +++.+ .+||+
T Consensus 171 L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHr---Dlkp~NI----------------------ll~~~-~~kl~ 223 (681)
T 2pzi_A 171 LKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYN---DLKPENI----------------------MLTEE-QLKLI 223 (681)
T ss_dssp CC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECSS-CEEEC
T ss_pred HHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeec---ccChHHe----------------------EEeCC-cEEEE
Confidence 9988765 79999999999999999999999999999 8999888 66654 89999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPG 214 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~ 214 (245)
|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+
T Consensus 224 DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 224 DLGAVSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp CCTTCEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ecccchhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 99998753222 4557899999999997654 8899999999999999999998854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=242.09 Aligned_cols=207 Identities=17% Similarity=0.151 Sum_probs=147.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCC-Cc---------eeeeeEE------------Ee
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRH-PF---------LVNLFAC------------FQ 58 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h-~n---------i~~~~~~------------~~ 58 (245)
||+|++..+|+.||||++...........+.+.+| +..++.+.| +| ++...+. +.
T Consensus 94 Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (413)
T 3dzo_A 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE---VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170 (413)
T ss_dssp EEEEEETTTCCEEEEEEECCSCC----CCHHHHHH---HHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------
T ss_pred EEEEEecCCCCceEEEEEecCCCccHHHHHHHHHH---HHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccC
Confidence 79999999999999999885433333334455554 445555555 11 1111111 11
Q ss_pred e-----CCeEEEEEeeccCCchhhhhh--------hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHH
Q psy3347 59 T-----EAHVCFVMEYAAGGDLMMHIH--------ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125 (245)
Q Consensus 59 ~-----~~~~~lv~e~~~~~~L~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~ 125 (245)
. ....+++|+.+ +++|.++++ ...+++..+..++.|++.||+|||++||+|| ||||+||
T Consensus 171 ~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr---DiKp~NI---- 242 (413)
T 3dzo_A 171 DERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT---YLRPVDI---- 242 (413)
T ss_dssp ------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----
T ss_pred CCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---CcccceE----
Confidence 1 12467888865 568887774 2346777888999999999999999999999 9999999
Q ss_pred HHhhhccccCcccchhccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccc----------cCCCCCcchhH
Q psy3347 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL----------TETSYTRAVDW 195 (245)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv 195 (245)
+++.++.+||+|||+++..... ....+| ..|+|||.+ .+..++.++||
T Consensus 243 ------------------Ll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 243 ------------------VLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp ------------------EECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred ------------------EEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 8889999999999998753222 344567 899999999 45567889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhHHhhhc
Q psy3347 196 WGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEAIAIMR 244 (245)
Q Consensus 196 wslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 244 (245)
|||||++|+|++|+.||.+.+..+....+.... ..+++++++||+
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 345 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC----KNIPQPVRALLE 345 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC----CCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc----ccCCHHHHHHHH
Confidence 999999999999999998765544333333322 356778888775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=244.87 Aligned_cols=177 Identities=12% Similarity=0.030 Sum_probs=127.9
Q ss_pred eEEEecCCcEEEEEEeecccccc----hhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 3 LSQYRNTGEYFAIKALKKGDIIA----RDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 3 ~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
.++...+|+.||+|++.+..... .....+.....++++.|+++ .|+||+++++++++++..||||||++|++|.+
T Consensus 252 ~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d 331 (569)
T 4azs_A 252 RSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSD 331 (569)
T ss_dssp CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHH
T ss_pred ccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHH
Confidence 34566689999999997643211 12223333445568888888 69999999999999999999999999999999
Q ss_pred hhhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 78 HIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 78 ~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
.+.. +++++ .+|+.||+.||+|+|++||+|| ||||+|| +++.+|.+||+||
T Consensus 332 ~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHR---DIKPeNI----------------------LL~~dg~vKL~DF 383 (569)
T 4azs_A 332 MLAAGEEIDR---EKILGSLLRSLAALEKQGFWHD---DVRPWNV----------------------MVDARQHARLIDF 383 (569)
T ss_dssp HHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEES---CCCGGGE----------------------EECTTSCEEECCC
T ss_pred HHHhCCCCCH---HHHHHHHHHHHHHHHHCCceec---cCchHhE----------------------EECCCCCEEEeec
Confidence 9965 45665 3589999999999999999999 9999999 8899999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG 208 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g 208 (245)
|+++............+||+.|+|||++.+. +..++|+||+|++++++.++
T Consensus 384 GlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 384 GSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp TTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred ccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 9998655554555677899999999999764 56789999999988776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=199.02 Aligned_cols=177 Identities=15% Similarity=0.070 Sum_probs=136.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh--hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD--EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+| ...++.+|+|+.......... ......+..++++++++++||||+++..++...+..|+||||+++++|.++
T Consensus 352 Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~ 429 (540)
T 3en9_A 352 IKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDV 429 (540)
T ss_dssp EEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHH
T ss_pred EEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHH
Confidence 6888 445889999987653322211 111122335557788888999999666666677778999999999999998
Q ss_pred hhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 79 IHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 79 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
++. +..++.|++.||+|||++||+|| |+||+|| +++. .+||+|||+
T Consensus 430 l~~-------~~~i~~qi~~aL~~LH~~gIiHr---DiKp~NI----------------------Ll~~--~~kL~DFGl 475 (540)
T 3en9_A 430 IED-------NLDIAYKIGEIVGKLHKNDVIHN---DLTTSNF----------------------IFDK--DLYIIDFGL 475 (540)
T ss_dssp STT-------CTHHHHHHHHHHHHHHHTTEECT---TCCTTSE----------------------EESS--SEEECCCTT
T ss_pred HHH-------HHHHHHHHHHHHHHHHHCcCccC---CCCHHHE----------------------EECC--eEEEEECcc
Confidence 865 56899999999999999999999 8888888 6666 899999999
Q ss_pred ccCCCCCCCC-------CCcccCCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy3347 159 CKEGMGFGDR-------TGTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIFEMLVGESPFP 213 (245)
Q Consensus 159 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~pf~ 213 (245)
++........ ....+||+.|+|||.+.. ..|+..+|+||.++-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9864332111 135678999999999976 567788899999999988888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=159.01 Aligned_cols=132 Identities=14% Similarity=0.071 Sum_probs=98.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccch---------------hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR---------------DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~l 65 (245)
||+|++ .+|+.||+|+++....... .....+. ++++.++.++ | +++.+++.. +..++
T Consensus 106 Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~---~E~~~l~~l~--~-~~v~~~~~~-~~~~l 177 (282)
T 1zar_A 106 VFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR---NEFRALQKLQ--G-LAVPKVYAW-EGNAV 177 (282)
T ss_dssp EEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHH---HHHHHHHHTT--T-SSSCCEEEE-ETTEE
T ss_pred EEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHH---HHHHHHHhcc--C-CCcCeEEec-cceEE
Confidence 799999 8899999999975321111 1123344 4466677776 5 667776644 45699
Q ss_pred EEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 66 VMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 66 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
||||++|++|.+ +. ...+..++.|++.||.|||++|++|| |+||+|| ++
T Consensus 178 vmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHr---Dlkp~NI----------------------Ll 226 (282)
T 1zar_A 178 LMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHG---DLSQYNV----------------------LV 226 (282)
T ss_dssp EEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECS---CCSTTSE----------------------EE
T ss_pred EEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeC---CCCHHHE----------------------EE
Confidence 999999999987 32 23456799999999999999999999 9999999 77
Q ss_pred CCCCceEEeecCCccCCCCCCCCCCcccCCCCcccccccc
Q psy3347 146 DTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLT 185 (245)
Q Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (245)
+ ++.++|+|||+++. +..++|||.+.
T Consensus 227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 7 89999999999863 33478898884
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=128.36 Aligned_cols=125 Identities=14% Similarity=0.076 Sum_probs=86.3
Q ss_pred CEeEEEecCCcE--EEEEEeecccccch---------------------hhHHHHHHHHHHHHHHhhcCCCce--eeeeE
Q psy3347 1 VILSQYRNTGEY--FAIKALKKGDIIAR---------------------DEVESLLSEKRIFEVANTMRHPFL--VNLFA 55 (245)
Q Consensus 1 V~~a~~~~~~~~--vaiK~~~~~~~~~~---------------------~~~~~~~~e~~~~~~l~~~~h~ni--~~~~~ 55 (245)
||+|.+..+|+. ||||+++....... .....+.+ ++..++.+.|+++ ..+++
T Consensus 63 Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~~~~i~~p~~~~ 139 (258)
T 1zth_A 63 VFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK---EFRNLERAKEAGVSVPQPYT 139 (258)
T ss_dssp EEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH---HHHHHHHHHHTTCCCCCEEE
T ss_pred EEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH---HHHHHHHHHhCCCCCCeEEE
Confidence 799999888999 99999865321100 00113333 4555666666653 33333
Q ss_pred EEeeCCeEEEEEeeccC-C----chhhhhhhcCCChHHHHHHHHHHHHHHHHhh-hcCccccCCCCCCHHHHHHHHHHhh
Q psy3347 56 CFQTEAHVCFVMEYAAG-G----DLMMHIHADVFSEPRAVFYAACVVLGLQYLH-ESRIIYRPQSNITKEEIKRIEAKVQ 129 (245)
Q Consensus 56 ~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~~~~~i~~~~ik~~~~~~~ 129 (245)
. +..++||||+++ | +|.+.... .++..+..++.|++.||.||| ++||+|| |++|+||
T Consensus 140 ~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHr---Dlkp~NI-------- 202 (258)
T 1zth_A 140 Y----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHA---DLSEYNI-------- 202 (258)
T ss_dssp E----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECS---SCSTTSE--------
T ss_pred c----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeC---CCCHHHE--------
Confidence 2 356899999953 4 55554322 235577899999999999999 9999999 8888888
Q ss_pred hccccCcccchhccccCCCCceEEeecCCccC
Q psy3347 130 ENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE 161 (245)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 161 (245)
+++. .++|+|||++..
T Consensus 203 --------------Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 --------------MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp --------------EESS--SEEECCCTTCEE
T ss_pred --------------EEcC--cEEEEECccccc
Confidence 6666 799999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.37 E-value=7.2e-13 Score=112.11 Aligned_cols=128 Identities=13% Similarity=0.084 Sum_probs=80.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccch-----------hhHHHHHH-----HHHHHHHHhhcCCCceeeeeEEEeeCCeEE
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR-----------DEVESLLS-----EKRIFEVANTMRHPFLVNLFACFQTEAHVC 64 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~-----e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~ 64 (245)
||+|.+. +|+.||||+++....... ....+... ..++...|.++.+.++ +....+.... .+
T Consensus 111 VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv-~vp~p~~~~~-~~ 187 (397)
T 4gyi_A 111 IMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF-PVPEPIAQSR-HT 187 (397)
T ss_dssp EEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC-SCCCEEEEET-TE
T ss_pred EEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC-CCCeeeeccC-ce
Confidence 7999885 699999999875321100 00011111 1122333444433222 1111121122 27
Q ss_pred EEEeeccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 65 FVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 65 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
+||||++|++|..... .+.+..++.|++.+|.+||++||+|| |+||.|| +
T Consensus 188 LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHr---DLKp~NI----------------------L 237 (397)
T 4gyi_A 188 IVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHG---DFNEFNI----------------------L 237 (397)
T ss_dssp EEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECS---CCSTTSE----------------------E
T ss_pred EEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCC---CCCHHHE----------------------E
Confidence 9999999988865432 23457789999999999999999999 8888888 5
Q ss_pred cCCCC----------ceEEeecCCccC
Q psy3347 145 NDTEG----------YVKIADFGLCKE 161 (245)
Q Consensus 145 ~~~~~----------~~kl~Dfg~~~~ 161 (245)
++.+| .+.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 55544 388999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=3e-09 Score=85.38 Aligned_cols=94 Identities=11% Similarity=-0.020 Sum_probs=67.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++.. .|+.+++|+...... .....+.+|.+.++.+.. +..+.++++++...+..++|||+++|.+|.....
T Consensus 30 v~~~~~--~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~--~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~ 102 (263)
T 3tm0_A 30 VYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEG--KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp EEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTT--TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC
T ss_pred EEEEEC--CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhc--CCCCCeEEEEEecCCceEEEEEecCCeehhhccC
Confidence 466643 378999999875311 112345566555555543 6778899999999999999999999999876531
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhh
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHE 105 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~ 105 (245)
+......++.+++.+|..||+
T Consensus 103 ----~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 103 ----DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp ----TTTCHHHHHHHHHHHHHHHHH
T ss_pred ----CcccHHHHHHHHHHHHHHHhC
Confidence 223345788899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.74 E-value=3.2e-08 Score=78.83 Aligned_cols=92 Identities=12% Similarity=0.087 Sum_probs=59.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||++.. .+|+.+++|+.... ....+.+|.+.++.+... .-.+.++++++..++..+++||+++|.++. .
T Consensus 36 v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~-~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~- 104 (264)
T 1nd4_A 36 VFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATT-GVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S- 104 (264)
T ss_dssp EEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTT-TCCBCCEEEEEECSSCEEEEEECCSSEETT--T-
T ss_pred EEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhC-CCCCCeEEEeccCCCCCEEEEEecCCcccC--c-
Confidence 466643 45778999987643 113345555555555432 123566888888888899999999998884 1
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcC
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~ 107 (245)
.... ...++.+++..|..+|+..
T Consensus 105 -~~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 105 -SHLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp -SCCC---HHHHHHHHHHHHHHHTTSC
T ss_pred -CcCC---HhHHHHHHHHHHHHHhCCC
Confidence 1111 2356777788888888643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.58 E-value=2.5e-07 Score=77.65 Aligned_cols=99 Identities=13% Similarity=0.181 Sum_probs=64.7
Q ss_pred CEeEEEecCCcEEEEEEee--cccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC---CeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALK--KGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE---AHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~---~~~~lv~e~~~~~~L 75 (245)
||+.... +..+++|+.. .... ......+.+|.+.+..+.. .+..+.+++.++.+. +..++|||+++|..+
T Consensus 54 ~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~-~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l 128 (359)
T 3dxp_A 54 TFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAG-TDVPVAKMYALCEDESVIGRAFYIMEFVSGRVL 128 (359)
T ss_dssp EEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTT-SSSCCCCEEEEECCTTTTSSCEEEEECCCCBCC
T ss_pred EEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhc-CCCCCCcEEEECCCCCccCCeEEEEEecCCeec
Confidence 4555443 5678888776 3221 1122345566566665554 245688888888766 458999999999877
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhh
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHE 105 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 105 (245)
.+... ..++......++.+++..|..||+
T Consensus 129 ~~~~~-~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 129 WDQSL-PGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp CCTTC-TTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcc-ccCCHHHHHHHHHHHHHHHHHHhC
Confidence 54221 236777888899999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.40 E-value=3e-07 Score=75.38 Aligned_cols=90 Identities=13% Similarity=-0.008 Sum_probs=55.5
Q ss_pred cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC---eEEEEEeeccCCchhhhhhhcCCChH
Q psy3347 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA---HVCFVMEYAAGGDLMMHIHADVFSEP 87 (245)
Q Consensus 11 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~l~~~ 87 (245)
+.+++|+.... .....+.+|.+.+..+..-..-.+.+++......+ ..|+||++++|.++..... ..++..
T Consensus 41 ~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-~~l~~~ 114 (304)
T 3sg8_A 41 RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-NNLPKQ 114 (304)
T ss_dssp TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-HTSCHH
T ss_pred CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-ccCCHH
Confidence 56888876532 22345555655444442211112344444433332 4588999999988865332 347777
Q ss_pred HHHHHHHHHHHHHHHhhhc
Q psy3347 88 RAVFYAACVVLGLQYLHES 106 (245)
Q Consensus 88 ~~~~i~~~i~~~l~~lH~~ 106 (245)
+...++.+++..+..||+.
T Consensus 115 ~~~~~~~~l~~~la~LH~~ 133 (304)
T 3sg8_A 115 SQNQAAKDLARFLSELHSI 133 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHcC
Confidence 8888999999999999974
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00026 Score=56.43 Aligned_cols=96 Identities=9% Similarity=0.001 Sum_probs=64.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+......+..+.+|+-... ....+.+|.+.+..+.. +--+.+++.++.+.+..++|||+++|.++.+...
T Consensus 41 v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~--~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 41 IYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTA--FMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp EEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTT--TSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHH
T ss_pred EEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhcc--CCCcCeEEEEEEECCeEEEEEEeeCCcccccccc
Confidence 355555556778889976542 23445556555555542 3336778888888999999999999988876543
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcC
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~ 107 (245)
. .......+..++...|.-||+..
T Consensus 113 ~---~~~~~~~~~~~l~~~L~~Lh~~~ 136 (272)
T 4gkh_A 113 E---YPDSGENIVDALAVFLRRLHSIP 136 (272)
T ss_dssp H---CGGGHHHHHHHHHHHHHHHHTSC
T ss_pred C---CHHHHHHHHHHHHHHHHHhcCCC
Confidence 2 12344567788888899999753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.0007 Score=55.29 Aligned_cols=93 Identities=9% Similarity=-0.028 Sum_probs=59.9
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEe-eCCeEEEEEeeccCCchhhhhhhcCCChHH
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ-TEAHVCFVMEYAAGGDLMMHIHADVFSEPR 88 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~ 88 (245)
|+.+++|+-.. ......+.+|.+.+..+..-..-.+.+++.++. ..+..+++||+++|.++.... -..++...
T Consensus 39 g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~-~~~l~~~~ 112 (306)
T 3tdw_A 39 NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDG-MAVLPDDA 112 (306)
T ss_dssp TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHH-HTTSCHHH
T ss_pred CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhh-hhhCCHHH
Confidence 56788887532 123345666655555554311113556666653 456678999999998886532 13466777
Q ss_pred HHHHHHHHHHHHHHhhhcCc
Q psy3347 89 AVFYAACVVLGLQYLHESRI 108 (245)
Q Consensus 89 ~~~i~~~i~~~l~~lH~~~i 108 (245)
...++.++...|..||+...
T Consensus 113 ~~~~~~~lg~~La~LH~~~~ 132 (306)
T 3tdw_A 113 KDRLALQLAEFMNELSAFPV 132 (306)
T ss_dssp HHHHHHHHHHHHHHHHHSCH
T ss_pred HHHHHHHHHHHHHHHhcCCc
Confidence 78888899999999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0026 Score=52.81 Aligned_cols=98 Identities=11% Similarity=0.028 Sum_probs=57.7
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC---CeEEEEEeeccCCchhhhhh----h-
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE---AHVCFVMEYAAGGDLMMHIH----A- 81 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~----~- 81 (245)
|+.+++|+..............+.+|.+.++.+.....-.+.+++.++... +..+++||+++|.++.+... .
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~~~~~~~~~~ 131 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDN 131 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCBTTBGGGSCS
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhhcCccccccc
Confidence 667888876543200000013345555556666543123466677776554 45789999999987764321 0
Q ss_pred --cCCChHHHHHHHHHHHHHHHHhhhcC
Q psy3347 82 --DVFSEPRAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 82 --~~l~~~~~~~i~~~i~~~l~~lH~~~ 107 (245)
..++......++.+++..|.-||+..
T Consensus 132 ~~~~~~~~~~~~~~~~l~~~La~LH~~~ 159 (357)
T 3ats_A 132 WFADAPAERQRQLQDATVAALATLHSIP 159 (357)
T ss_dssp TTTTSCHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 12455555677888888888888653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.013 Score=49.29 Aligned_cols=71 Identities=11% Similarity=-0.007 Sum_probs=36.5
Q ss_pred CEeEEEecCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDI-IAR---DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~-~~~---~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 73 (245)
||++.+..+++.+++|....... ... ...+....|.+.+..+.......+.+++.+ +....++|||++++.
T Consensus 46 vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 46 VFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp EEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred EEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 57776665678999998653211 000 112334556555555544322234445543 344568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.043 Score=44.76 Aligned_cols=66 Identities=9% Similarity=0.053 Sum_probs=35.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC--CCceeeee-E--EEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--HPFLVNLF-A--CFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--h~ni~~~~-~--~~~~~~~~~lv~e~~~~~~L 75 (245)
||+.... +..+++|+.... . +.+..+.+.++.|...+ -|.++... | +....+..+++|++++|.++
T Consensus 48 ~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~~ 118 (346)
T 2q83_A 48 VWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRPF 118 (346)
T ss_dssp EEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBCC
T ss_pred EEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCccC
Confidence 3554432 345889988752 1 22223444455554322 34443311 1 12346788999999998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.11 Score=42.30 Aligned_cols=81 Identities=7% Similarity=-0.008 Sum_probs=57.0
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCCChHH
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPR 88 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~ 88 (245)
+++.+++|+.... ....+..|.+.+..+.......+.+++.+....+..++|||++++..+..
T Consensus 58 ~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~----------- 120 (312)
T 3jr1_A 58 EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ----------- 120 (312)
T ss_dssp SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT-----------
T ss_pred CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc-----------
Confidence 4678889987642 13455666666666655434568888888888889999999999875421
Q ss_pred HHHHHHHHHHHHHHhhhcCc
Q psy3347 89 AVFYAACVVLGLQYLHESRI 108 (245)
Q Consensus 89 ~~~i~~~i~~~l~~lH~~~i 108 (245)
....++...|+-||+.+.
T Consensus 121 --~~~~~lG~~LA~LH~~~~ 138 (312)
T 3jr1_A 121 --SSFTIFAEKIAQLHQIQG 138 (312)
T ss_dssp --THHHHHHHHHHHHHHCCC
T ss_pred --hhHHHHHHHHHHHHcCCC
Confidence 244678888899998643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.31 E-value=0.071 Score=41.13 Aligned_cols=101 Identities=16% Similarity=0.061 Sum_probs=58.6
Q ss_pred Cchhhhhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCc
Q psy3347 73 GDLMMHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGY 150 (245)
Q Consensus 73 ~~L~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (245)
-+|.+.++ ..++++.+++.++.|.+.+|.-+-...--|.. -+.| ....+..+|.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~--i~~~----------------------~~i~l~~dG~ 88 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHR--VRSA----------------------AQIRVWRDGA 88 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC--CCSG----------------------GGEEEETTSC
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCce--ecCC----------------------cceEEecCCc
Confidence 47888884 56899999999999999988766221000110 0111 1225666777
Q ss_pred eEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy3347 151 VKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESP 211 (245)
Q Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~p 211 (245)
+...+ +.+. .....+.|||... ...+.+.=|||||+++|..+. |-++
T Consensus 89 V~f~~-~~s~------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 89 VTLAP-AADD------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp EEECC-C------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeccc-cccc------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 76554 1110 1122366888762 345578899999999999987 5544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.01 E-value=0.18 Score=40.53 Aligned_cols=83 Identities=14% Similarity=0.035 Sum_probs=40.6
Q ss_pred cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeec-cCCchhhhhhhcCCChHHH
Q psy3347 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYA-AGGDLMMHIHADVFSEPRA 89 (245)
Q Consensus 11 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~l~~~~~ 89 (245)
+.+++|+..... ...-+..+|.+.++.+....-+ .+++..+ ...-++++||+ +|.++...... ..
T Consensus 38 ~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~--P~~~~~~--~~~~~~v~e~i~~g~~l~~~~~~------~~ 103 (301)
T 3dxq_A 38 GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVS--PEVLHVD--PATGVMVTRYIAGAQTMSPEKFK------TR 103 (301)
T ss_dssp TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSS--CCEEEEC--TTTCCEEEECCTTCEECCHHHHH------HS
T ss_pred eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCC--CceEEEE--CCCCEEEEeecCCCccCCHhhHh------hh
Confidence 457777775421 1111223455555556543322 4455443 33346899999 66555321100 00
Q ss_pred HHHHHHHHHHHHHhhhcC
Q psy3347 90 VFYAACVVLGLQYLHESR 107 (245)
Q Consensus 90 ~~i~~~i~~~l~~lH~~~ 107 (245)
..+..+++..|.-+|+.+
T Consensus 104 ~~~~~~~~~~La~lH~~~ 121 (301)
T 3dxq_A 104 PGSPARAGEAFRKLHGSG 121 (301)
T ss_dssp TTHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHHHHHHhCCC
Confidence 124556667777777654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=93.84 E-value=0.22 Score=42.20 Aligned_cols=68 Identities=12% Similarity=0.049 Sum_probs=33.9
Q ss_pred CEeEEEecCCcEEEEEEeecccc-cchh---hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeec-cC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDI-IARD---EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYA-AG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~-~~~~---~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~-~~ 72 (245)
||++.. +++.+++|....... .... .......|.+.+..+.......+.+++.+. .+..++|||++ ++
T Consensus 50 vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~e~l~~g 122 (420)
T 2pyw_A 50 VFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGMRYLEPP 122 (420)
T ss_dssp EEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEECCCCTT
T ss_pred EEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEEeecCCc
Confidence 465533 467899994332110 0000 001112233333333333334566666665 56779999999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.49 E-value=0.33 Score=39.55 Aligned_cols=85 Identities=12% Similarity=0.036 Sum_probs=45.8
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCCChHHH
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRA 89 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~ 89 (245)
|+.+++|...... . +....|.+.+..+.... -.+.+++.+....+ +++||.+++.++..++.......
T Consensus 43 ~~~~vlk~~~~~~---~---~~~~~e~~~l~~L~~~g-~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~--- 110 (333)
T 3csv_A 43 GAKAVLMDWSPEE---G---GDTQPFVDLAQYLRNLD-ISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQE--- 110 (333)
T ss_dssp CCEEEEEECCTTT---T---CCSHHHHHHHHHHHHTT-CBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGH---
T ss_pred CCeEEEEECCCCC---C---ccccHHHHHHHHHHhCC-CCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccH---
Confidence 6677777544321 0 12233444555555432 23555666544444 68999998777766654332211
Q ss_pred HHHHHHHHHHHHHhhhc
Q psy3347 90 VFYAACVVLGLQYLHES 106 (245)
Q Consensus 90 ~~i~~~i~~~l~~lH~~ 106 (245)
.....+++..|.-+|..
T Consensus 111 ~~~~~~~~~~La~lH~~ 127 (333)
T 3csv_A 111 MPLYRAAVDLLIHLHDA 127 (333)
T ss_dssp HHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHhcC
Confidence 34455666666667754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=90.38 E-value=0.9 Score=36.58 Aligned_cols=60 Identities=8% Similarity=-0.003 Sum_probs=31.2
Q ss_pred cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC--CCceeeee-E--EEeeCCeEEEEEeeccCCch
Q psy3347 11 EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--HPFLVNLF-A--CFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 11 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--h~ni~~~~-~--~~~~~~~~~lv~e~~~~~~L 75 (245)
..+++|+..... . .+.+..|.+.++.+...+ -|.++... | +....+..+++|++++|..+
T Consensus 46 g~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~ 110 (322)
T 2ppq_A 46 DPLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWL 110 (322)
T ss_dssp CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCC
T ss_pred ccEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCC
Confidence 368888886521 1 123334555555555422 23333211 1 11235678999999988654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=87.82 E-value=2.5 Score=35.28 Aligned_cols=82 Identities=15% Similarity=0.186 Sum_probs=50.2
Q ss_pred CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCCChHHH
Q psy3347 10 GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRA 89 (245)
Q Consensus 10 ~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~ 89 (245)
++.+++|+.... ........+|.+++..+...+- ..++++.+. +. +||||++|.++..- .+..
T Consensus 82 ~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv--~P~ll~~~~--~g--~v~e~i~G~~l~~~----~l~~--- 144 (379)
T 3feg_A 82 PREVLLRLYGAI----LQGVDSLVLESVMFAILAERSL--GPQLYGVFP--EG--RLEQYIPSRPLKTQ----ELRE--- 144 (379)
T ss_dssp CSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTS--SCCEEEEET--TE--EEEECCSEEECCGG----GGGC---
T ss_pred CCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCC--CCeEEEEcC--Cc--cEEEEecCccCChh----HhCC---
Confidence 578999986331 1223455677777777765433 256666653 32 99999998665421 1111
Q ss_pred HHHHHHHHHHHHHhhhcCc
Q psy3347 90 VFYAACVVLGLQYLHESRI 108 (245)
Q Consensus 90 ~~i~~~i~~~l~~lH~~~i 108 (245)
..+..+++..|+-||+..+
T Consensus 145 p~~~~~ia~~La~LH~~~~ 163 (379)
T 3feg_A 145 PVLSAAIATKMAQFHGMEM 163 (379)
T ss_dssp HHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHhCCCC
Confidence 2356778899999998643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=80.94 E-value=9.3 Score=30.02 Aligned_cols=86 Identities=12% Similarity=-0.014 Sum_probs=46.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+... .+|+.|.+|+-...... ....+..|.+.++.|....---+.+++.+. ..+++||+..++..
T Consensus 31 vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~----- 97 (288)
T 3f7w_A 31 LYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP----- 97 (288)
T ss_dssp EEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC-----
T ss_pred EEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC-----
Confidence 465543 46899999987643211 123345565666666432211233444432 23789999876432
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcC
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESR 107 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~ 107 (245)
.... ..++...|.-+|...
T Consensus 98 ----~~~~----~~~lg~~La~lH~~~ 116 (288)
T 3f7w_A 98 ----TPEA----AERFGHQLAAMHLAG 116 (288)
T ss_dssp ----CHHH----HHHHHHHHHHHHHTC
T ss_pred ----ChHH----HHHHHHHHHhhhhcc
Confidence 2121 235667777888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 245 | ||||
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 0.001 |
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-56
Identities = 108/248 (43%), Positives = 151/248 (60%), Gaps = 32/248 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++++ T ++FAIKALKK ++ D+VE + EKR+ ++ HPFL ++F FQT+
Sbjct: 18 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV--LSLAWEHPFLTHMFCTFQTK 75
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNIT 117
++ FVMEY GGDLM HI + F RA FYAA ++LGLQ+LH I+YR NI
Sbjct: 76 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI- 134
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
+ D +G++KIADFG+CKE M +T TFCGTP+
Sbjct: 135 --------------------------LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD 168
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
++APE+L Y +VDWW GVL++EML+G+SPF G DEEE+F SI D YPR+L
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228
Query: 238 EAIAIMRR 245
EA ++ +
Sbjct: 229 EAKDLLVK 236
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-55
Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ + + A+K L K + L E I + +RHP ++ L+ F
Sbjct: 22 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI---QSHLRHPNILRLYGYFHDA 78
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
V ++EYA G + + F E R Y + L Y H R+I+R
Sbjct: 79 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHR-------- 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + + G +KIADFG R T CGT ++L
Sbjct: 131 DIKP------ENLLL-----------GSAGELKIADFGWSVHAP--SSRRTTLCGTLDYL 171
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
PE++ + VD W LGVL +E LVG+ PF + +E + I E +P F++ A
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231
Query: 240 IAIMRR 245
++ R
Sbjct: 232 RDLISR 237
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-55
Identities = 71/248 (28%), Positives = 121/248 (48%), Gaps = 31/248 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L++ T +AIK L+K II ++V + E+ + + + HPF V L+ FQ +
Sbjct: 24 VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLDHPFFVKLYFTFQDD 80
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ F + YA G+L+ +I F E FY A +V L+YLH II+R
Sbjct: 81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHR-------- 132
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPE 177
++K EN +N + +++I DFG K R +F GT +
Sbjct: 133 DLK------PENILLNE-----------DMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 178 FLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237
+++PE+LTE S ++ D W LG +I++++ G PF +E +F I+ E +P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 238 EAIAIMRR 245
+A ++ +
Sbjct: 236 KARDLVEK 243
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 5e-51
Identities = 63/250 (25%), Positives = 117/250 (46%), Gaps = 33/250 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL++ + T + AIK + K + + S+ +E + + ++HP +V L +++
Sbjct: 25 VILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAV---LHKIKHPNIVALDDIYESG 79
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
H+ +M+ +GG+L I ++E A V+ ++YLH+ I++R
Sbjct: 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR-------- 131
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+ + D + + I+DFGL K G T CGTP ++
Sbjct: 132 --------------DLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYV 176
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FL 235
APEVL + Y++AVD W +GV+ + +L G PF +++ ++F+ I+ E + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 236 SLEAIAIMRR 245
S A +R
Sbjct: 237 SDSAKDFIRH 246
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-50
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 34/248 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + TG+ AI+ + + + E +++E + ++P +VN +
Sbjct: 36 VYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILV---MRENKNPNIVNYLDSYLVG 89
Query: 61 AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEE 120
+ VMEY AGG L + E + + L++LH +++I+R +
Sbjct: 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS----- 144
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
+N + +G VK+ DFG C + + T GTP ++A
Sbjct: 145 ---------DNILLGM-----------DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVND---EVRYPRFLSL 237
PEV+T +Y VD W LG++ EM+ GE P+ ++ I + E++ P LS
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 238 EAIAIMRR 245
+ R
Sbjct: 245 IFRDFLNR 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-49
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 41/255 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V +Q + T A K + +E+E + E I + HP +V L F E
Sbjct: 28 VYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDI---LASCDHPNIVKLLDAFYYE 81
Query: 61 AHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
++ ++E+ AGG + + +E + + L YLH+++II+R
Sbjct: 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR------- 134
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++K N +G +K+ADFG+ + R +F GTP +
Sbjct: 135 -DLK------AGNILF-----------TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 179 LAPEVL-----TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE---VR 230
+APEV+ + Y D W LG+ + EM E P + V I E +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 231 YPRFLSLEAIAIMRR 245
P S +++
Sbjct: 237 QPSRWSSNFKDFLKK 251
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (413), Expect = 2e-49
Identities = 58/251 (23%), Positives = 99/251 (39%), Gaps = 36/251 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + TG F K + + + V K + N + HP L+NL F+ +
Sbjct: 45 VHRCVEKATGRVFVAKFINTPYPLDKYTV------KNEISIMNQLHHPKLINLHDAFEDK 98
Query: 61 AHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ ++E+ +GG+L I A+ SE + Y GL+++HE I++
Sbjct: 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL------- 151
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
+ E + VKI DFGL + + + T EF
Sbjct: 152 ----------------DIKPENIMCETKKASSVKIIDFGLATK-LNPDEIVKVTTATAEF 194
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----F 234
APE++ D W +GVL + +L G SPF G+D+ E ++ + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 235 LSLEAIAIMRR 245
+S EA ++
Sbjct: 255 VSPEAKDFIKN 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-49
Identities = 111/246 (45%), Positives = 150/246 (60%), Gaps = 29/246 (11%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
VIL + + TG Y+A+K L+K IIA+DEV ++E R+ RHPFL L FQT
Sbjct: 21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV---LQNTRHPFLTALKYAFQTH 77
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+CFVMEYA GG+L H+ + VF+E RA FY A +V L+YLH ++YR
Sbjct: 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR-------- 129
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+IK EN + D +G++KI DFGLCKEG+ G TFCGTPE+L
Sbjct: 130 DIK------LENLML-----------DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEVL + Y RAVDWWGLGV+++EM+ G PF D E +F+ I+ +E+R+PR LS EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 240 IAIMRR 245
+++
Sbjct: 233 KSLLAG 238
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (406), Expect = 3e-48
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 40/253 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V R TG FA K + + E++ E + + +RHP LVNL F+ +
Sbjct: 42 VHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQT---MSVLRHPTLVNLHDAFEDD 95
Query: 61 AHVCFVMEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRP--QSNI 116
+ + E+ +GG+L + + SE AV Y V GL ++HE+ ++ NI
Sbjct: 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 155
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
+ +K+ DFGL + GT
Sbjct: 156 -------------------------MFTTKRSNELKLIDFGLTAH-LDPKQSVKVTTGTA 189
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--- 233
EF APEV D W +GVL + +L G SPF G++++E ++ + +
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 234 -FLSLEAIAIMRR 245
+S + +R+
Sbjct: 250 SGISEDGKDFIRK 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-47
Identities = 55/251 (21%), Positives = 102/251 (40%), Gaps = 37/251 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ + + K +K + + E I N RH +++L F++
Sbjct: 21 VHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISI---LNIARHRNILHLHESFESM 73
Query: 61 AHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ + E+ +G D+ I+ +E V Y V LQ+LH I + +I
Sbjct: 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF---DIRP 130
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
E I + +KI +FG ++ + GD PE+
Sbjct: 131 ENI--------------------IYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLFTAPEY 169
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RF 234
APEV + A D W LG L++ +L G +PF + +++ ++I+N E + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 235 LSLEAIAIMRR 245
+S+EA+ + R
Sbjct: 230 ISIEAMDFVDR 240
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 1e-46
Identities = 58/253 (22%), Positives = 94/253 (37%), Gaps = 32/253 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACF--Q 58
+ ++ G+ K L G + E + L+SE + ++HP +V + +
Sbjct: 20 CQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNL---LRELKHPNIVRYYDRIIDR 75
Query: 59 TEAHVCFVMEYAAGGDLMMHIHAD-----VFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
T + VMEY GGDL I E + + L L+ H
Sbjct: 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS---DGG 132
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
+ ++K N + D + VK+ DFGL + F
Sbjct: 133 HTVLHRDLK------PANVFL-----------DGKQNVKLGDFGLARILNHDTSFAKAFV 175
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV-RYP 232
GTP +++PE + SY D W LG L++E+ PF ++E+ I + R P
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235
Query: 233 RFLSLEAIAIMRR 245
S E I+ R
Sbjct: 236 YRYSDELNEIITR 248
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-46
Identities = 53/251 (21%), Positives = 85/251 (33%), Gaps = 38/251 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ E AIK + + ++ + ++ E R +RHP + C+ E
Sbjct: 31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF---LQKLRHPNTIQYRGCYLRE 87
Query: 61 AHVCFVMEYAAGGDL-MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
VMEY G ++ +H E + GL YLH +I+R ++
Sbjct: 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR---DVKAG 144
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
I + G VK+ DFG +F GTP ++
Sbjct: 145 NI----------------------LLSEPGLVKLGDFGSAS----IMAPANSFVGTPYWM 178
Query: 180 APEVL---TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRF 234
APEV+ E Y VD W LG+ E+ + P + I +E
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 235 LSLEAIAIMRR 245
S +
Sbjct: 239 WSEYFRNFVDS 249
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 34/222 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ +G A K + I ++ E ++ + P++V + F ++
Sbjct: 22 VFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQV---LHECNSPYIVGFYGAFYSD 76
Query: 61 AHVCFVMEYAAGGDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHES-RIIYRPQSNITK 118
+ ME+ GG L + A E + V+ GL YL E +I++R
Sbjct: 77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR------- 129
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEF 178
++K N VNS G +K+ DFG+ + + +F GT +
Sbjct: 130 -DVK------PSNILVNS-----------RGEIKLCDFGVSGQLI--DSMANSFVGTRSY 169
Query: 179 LAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEV 220
++PE L T Y+ D W +G+ + EM VG P P D +E+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (379), Expect = 1e-44
Identities = 82/246 (33%), Positives = 131/246 (53%), Gaps = 32/246 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L + R+ G Y+A+K LKK ++ +VE E+ + + + HPF++ ++ FQ
Sbjct: 20 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM---LSIVTHPFIIRMWGTFQDA 76
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ +M+Y GG+L + + F P A FYAA V L L+YLH IIYR
Sbjct: 77 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR-------- 128
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + D G++KI DFG K D T T CGTP+++
Sbjct: 129 DLKP------ENILL-----------DKNGHIKITDFGFAKY---VPDVTYTLCGTPDYI 168
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APEV++ Y +++DWW G+LI+EML G +PF + + ++ I+N E+R+P F + +
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228
Query: 240 IAIMRR 245
++ R
Sbjct: 229 KDLLSR 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 2e-44
Identities = 49/260 (18%), Positives = 101/260 (38%), Gaps = 41/260 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR----HPFLVNLFAC 56
V ++ T + +A+K + + E + + + +R HP ++ L
Sbjct: 19 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 78
Query: 57 FQTEAHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
++T V + G+L ++ V SE ++ + LH+ I++R
Sbjct: 79 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR---- 134
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
++K EN ++ + +K+ DFG + + G++ CGT
Sbjct: 135 ----DLKP------ENILLDD-----------DMNIKLTDFGFSCQ-LDPGEKLREVCGT 172
Query: 176 PEFLAPEVLT------ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV 229
P +LAPE++ Y + VD W GV+++ +L G PF + + I++
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
Query: 230 RYPR----FLSLEAIAIMRR 245
++ S ++ R
Sbjct: 233 QFGSPEWDDYSDTVKDLVSR 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 5e-44
Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 32/250 (12%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + +TG+ +A+K L K I + L+E+ + + +T PF+V + F T
Sbjct: 20 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ F+++ GGDL H+ VFSE FYAA ++LGL+++H ++YR
Sbjct: 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR-------- 131
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K N + D G+V+I+D GL + + GT ++
Sbjct: 132 DLK------PANILL-----------DEHGHVRISDLGLACDFS--KKKPHASVGTHGYM 172
Query: 180 APEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGD---DEEEVFDSIVNDEVRYPRFL 235
APEVL +Y + DW+ LG ++F++L G SPF D+ E+ + V P
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 236 SLEAIAIMRR 245
S E +++
Sbjct: 233 SPELRSLLEG 242
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-43
Identities = 52/255 (20%), Positives = 90/255 (35%), Gaps = 41/255 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT- 59
V T A L+ + + E + E + ++HP +V + +++
Sbjct: 25 VYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEM---LKGLQHPNIVRFYDSWEST 80
Query: 60 ---EAHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHE--SRIIYRPQ 113
+ + V E G L ++ V + ++ GLQ+LH II+R
Sbjct: 81 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR-- 138
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
++K +N + + G VKI D GL +
Sbjct: 139 ------DLK------CDN----------IFITGPTGSVKIGDLGLAT--LKRASFAKAVI 174
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--- 230
GTPEF+APE+ E Y +VD + G+ + EM E P+ V V+
Sbjct: 175 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233
Query: 231 YPRFLSLEAIAIMRR 245
+ + E I+
Sbjct: 234 FDKVAIPEVKEIIEG 248
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-43
Identities = 58/252 (23%), Positives = 99/252 (39%), Gaps = 37/252 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L+ R T E A+K + + D E++ E I + H +V + +
Sbjct: 21 VQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI---NKMLNHENVVKFYGHRREG 75
Query: 61 AHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+EY +GG+L I D+ EP A + ++ G+ YLH I +R
Sbjct: 76 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR-------- 127
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTPE 177
+IK EN ++ +KI+DFGL CGT
Sbjct: 128 DIK------PENLLLDER-----------DNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 178 FLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY---PR 233
++APE+L + VD W G+++ ML GE P+ + S ++ Y +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 234 FLSLEAIAIMRR 245
+ +A++ +
Sbjct: 231 KIDSAPLALLHK 242
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-43
Identities = 61/250 (24%), Positives = 105/250 (42%), Gaps = 27/250 (10%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + ++TG +A K +KK + S +R + ++HP ++ L ++ +
Sbjct: 26 VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
V ++E AGG+L + +E A + ++ G+ YLH +I +
Sbjct: 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDL------ 139
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
EN + N + +KI DFGL + + FG+ GTPEF+
Sbjct: 140 --------KPENIMLLDR-------NVPKPRIKIIDFGLAHK-IDFGNEFKNIFGTPEFV 183
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR----YPRFL 235
APE++ D W +GV+ + +L G SPF GD ++E ++ Y
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 236 SLEAIAIMRR 245
S A +RR
Sbjct: 244 SALAKDFIRR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (360), Expect = 3e-42
Identities = 53/254 (20%), Positives = 95/254 (37%), Gaps = 34/254 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V L++ A+K L+ E + A + HP +V ++ + E
Sbjct: 23 VHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN---AAALNHPAIVAVYDTGEAE 79
Query: 61 AH----VCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
VMEY G L +H + + RA+ A L + H++ II+R
Sbjct: 80 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---- 135
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
++K N ++++ +K+ + +T GT
Sbjct: 136 ----DVKP------ANIMISATNAVKVM--------DFGIARAIADSGNSVTQTAAVIGT 177
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF- 234
++L+PE S D + LG +++E+L GE PF GD V V ++ P
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 235 ---LSLEAIAIMRR 245
LS + A++ +
Sbjct: 238 HEGLSADLDAVVLK 251
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 4e-41
Identities = 91/246 (36%), Positives = 136/246 (55%), Gaps = 32/246 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+L +++ +G ++A+K L K ++ ++E L+EKRI + PFLV L F+
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEFSFKDN 113
Query: 61 AHVCFVMEYAAGGDLMMHIHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+++ VMEY AGG++ H+ FSEP A FYAA +VL +YLH +IYR
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR-------- 165
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
++K EN + D +GY+++ DFG K G RT T CGTPE L
Sbjct: 166 DLKP------ENLLI-----------DQQGYIQVTDFGFAKRVKG---RTWTLCGTPEAL 205
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239
APE++ Y +AVDWW LGVLI+EM G PF D ++++ IV+ +VR+P S +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 240 IAIMRR 245
++R
Sbjct: 266 KDLLRN 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-41
Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 36/245 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ + A+K LK + + LL+E + + +P++V + + E V
Sbjct: 31 KKVVKTVAVKILKN-EANDPALKDELLAEANV---MQQLDNPYIVRMIGICEAE-SWMLV 85
Query: 67 MEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIE 125
ME A G L ++ + + + V +G++YL ES ++R +
Sbjct: 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD--------LA--- 134
Query: 126 AKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGTPEFLAPE 182
++ + L T+ Y KI+DFGL K + ++ APE
Sbjct: 135 -----------ARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 183 VLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDE-VRYPRFLSLEAI 240
+ ++ D W GVL++E G+ P+ G EV + E + P E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 241 AIMRR 245
+M
Sbjct: 241 DLMNL 245
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-40
Identities = 61/260 (23%), Positives = 98/260 (37%), Gaps = 48/260 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT- 59
V+ + T E FA+K L+ R EVE + P +V + ++
Sbjct: 28 VLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRA---------SQCPHIVRIVDVYENL 77
Query: 60 ---EAHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
+ VME GG+L I F+E A + +QYLH I +R
Sbjct: 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR-- 135
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC 173
++K + + T +K+ DFG KE + T C
Sbjct: 136 ------DVK--------------PENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC 174
Query: 174 GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDS----IVNDEV 229
TP ++APEVL Y ++ D W LGV+++ +L G PF + + I +
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
Query: 230 RYPR----FLSLEAIAIMRR 245
+P +S E ++R
Sbjct: 235 EFPNPEWSEVSEEVKMLIRN 254
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-40
Identities = 46/250 (18%), Positives = 87/250 (34%), Gaps = 43/250 (17%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
A+K L ++++ +E + RH ++ + T + V +
Sbjct: 29 WHGDVAVKMLNV-TAPTPQQLQAFKNEVGV---LRKTRHVNILLFM-GYSTAPQLAIVTQ 83
Query: 69 YAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEA 126
+ G L H+H F + + A G+ YLH II+R ++K
Sbjct: 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR--------DLK---- 131
Query: 127 KVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFGDRTGTFCGTPEFLAPEVL 184
S I L + VKI DFGL + G+ ++APEV+
Sbjct: 132 ----------SNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 185 T---ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF------L 235
+ Y+ D + G++++E++ G+ P+ + + +V P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 236 SLEAIAIMRR 245
+M
Sbjct: 239 PKAMKRLMAE 248
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-39
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 38/246 (15%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
R AIK LK+G + + E ++ E +I + + +P++V L Q E + V
Sbjct: 33 RKKQIDVAIKVLKQG--TEKADTEEMMREAQI---MHQLDNPYIVRLIGVCQAE-ALMLV 86
Query: 67 MEYAAGGDLMMHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
ME A GG L + + V +G++YL E ++R ++
Sbjct: 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR--------DLAA- 137
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGTPEFLAP 181
N + + Y KI+DFGL K + ++ AP
Sbjct: 138 -----RNVLLVN-----------RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 182 EVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDE-VRYPRFLSLEA 239
E + ++ D W GV ++E L G+ P+ EV I + + P E
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241
Query: 240 IAIMRR 245
A+M
Sbjct: 242 YALMSD 247
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-38
Identities = 44/250 (17%), Positives = 90/250 (36%), Gaps = 37/250 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--HPFLVNLFACFQ 58
V + AIK ++K I E+ + + + ++ L F+
Sbjct: 20 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79
Query: 59 TEAHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
++E + + E A + V+ +++ H +++R +I
Sbjct: 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR---DI 136
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
E I ++ G +K+ DFG + F GT
Sbjct: 137 KDENI---------------------LIDLNRGELKLIDFGSGA--LLKDTVYTDFDGTR 173
Query: 177 EFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 235
+ PE + + R+ W LG+L+++M+ G+ PF D+E I+ +V + + +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRV 227
Query: 236 SLEAIAIMRR 245
S E ++R
Sbjct: 228 SSECQHLIRW 237
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 7e-38
Identities = 47/247 (19%), Positives = 89/247 (36%), Gaps = 46/247 (18%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCF 65
G A+K +K ++ L+E + +RH LV L + + +
Sbjct: 27 DYRGNKVAVKCIKN-----DATAQAFLAEASV---MTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 66 VMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ--SNITKEE 120
V EY A G L+ ++ + V + ++ V ++YL + ++R N+
Sbjct: 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV---- 134
Query: 121 IKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA 180
+ + K++DFGL KE T ++ A
Sbjct: 135 -----------------------LVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWTA 168
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDE-VRYPRFLSLE 238
PE L E ++ D W G+L++E+ G P+P ++V + + P
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 239 AIAIMRR 245
+M+
Sbjct: 229 VYEVMKN 235
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-37
Identities = 53/253 (20%), Positives = 88/253 (34%), Gaps = 37/253 (14%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
A+K LK + + ++ + E +++ H L+ L+ T
Sbjct: 27 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA---MHSLDHRNLIRLYGVVLTP 83
Query: 61 AHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ V E A G L+ + H F YA V G+ YL R I+R
Sbjct: 84 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD------ 136
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGTFCGT 175
+ N + T VKI DFGL + +
Sbjct: 137 --LA------ARNLLL-----------ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEVRYPR- 233
+ APE L +++ A D W GV ++EM G+ P+ G + ++ I + R PR
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 234 -FLSLEAIAIMRR 245
+ +M +
Sbjct: 238 EDCPQDIYNVMVQ 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-37
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 32/237 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDE--VESLLSEKRIFEVANTMRHPFLVNLFACFQ 58
V ++ +NT + AIK +K G + + L E ++ + HP ++ L F
Sbjct: 14 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL---LQELSHPNIIGLLDAFG 70
Query: 59 TEAHVCFVMEYAAGGDL-MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
++++ V ++ ++ ++ V + Y + GL+YLH+ I++R
Sbjct: 71 HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR------ 124
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPE 177
++K N ++ + G +K+ADFGL K T
Sbjct: 125 --DLK------PNNLLLDEN-----------GVLKLADFGLAKSFGSPNRAYTHQVVTRW 165
Query: 178 FLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 233
+ APE+L Y VD W +G ++ E+L+ PGD + + I
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-36
Identities = 82/248 (33%), Positives = 131/248 (52%), Gaps = 36/248 (14%)
Query: 7 RNTGEYFAIKALKKGDIIARDE-VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
+TG+ +A+K LKK I+ + + E +E+++ E + PFLV L FQTE +
Sbjct: 49 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYAFQTETKLHL 106
Query: 66 VMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
+++Y GG+L H+ F+E Y +VL L++LH+ IIYR +I E I
Sbjct: 107 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR---DIKLENI--- 160
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGF-GDRTGTFCGTPEFLAPEV 183
+ D+ G+V + DFGL KE + +R FCGT E++AP++
Sbjct: 161 -------------------LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 184 L--TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVNDEVRYPRFLSL 237
+ ++ + +AVDWW LGVL++E+L G SPF D E E+ I+ E YP+ +S
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 238 EAIAIMRR 245
A +++R
Sbjct: 262 LAKDLIQR 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-36
Identities = 46/245 (18%), Positives = 89/245 (36%), Gaps = 41/245 (16%)
Query: 8 NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVM 67
AIK +K+G + + + E ++ + H LV L+ + + +
Sbjct: 26 RGQYDVAIKMIKEGSMSEDE----FIEEAKV---MMNLSHEKLVQLYGVCTKQRPIFIIT 78
Query: 68 EYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEIKR 123
EY A G L+ ++ F + + V ++YL + ++R N
Sbjct: 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC------- 131
Query: 124 IEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGT-FCGTPEFLAPE 182
+ + +G VK++DFGL + + + + PE
Sbjct: 132 --------------------LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 183 VLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVND-EVRYPRFLSLEAI 240
VL + ++ D W GVL++E+ +G+ P+ E + I + P S +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231
Query: 241 AIMRR 245
IM
Sbjct: 232 TIMYS 236
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-35
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 58/268 (21%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
A+K LK+ E E+L+SE ++ + H +VNL + +
Sbjct: 64 TGVSIQVAVKMLKEKAD--SSEREALMSELKM--MTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 67 MEYAAGGDLMMHIHA------------------------DVFSEPRAVFYAACVVLGLQY 102
EY GDL+ ++ + +V + + +A V G+++
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 103 LHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEG 162
L ++R ++ + + VKI DFGL ++
Sbjct: 180 LEFKSCVHR---DLAARNV----------------------LVTHGKVVKICDFGLARDI 214
Query: 163 MGFGDRT--GTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEE 219
M + G +++APE L E YT D W G+L++E+ +G +P+PG +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 220 VFDSIVNDEVR--YPRFLSLEAIAIMRR 245
F ++ + + P + + E IM+
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQS 302
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 2e-35
Identities = 44/255 (17%), Positives = 87/255 (34%), Gaps = 38/255 (14%)
Query: 1 VILSQYRNTGEYFAIKALKK-GDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT 59
V + G+ A+K + LSE I HP +++L
Sbjct: 42 VCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI---MGQFDHPNVIHLEGVVTK 98
Query: 60 EAHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
V + E+ G L + + F+ + V + G++YL + ++R ++
Sbjct: 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR---DLA 155
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-----EGMGFGDRTGTF 172
I + ++ K++DFGL +
Sbjct: 156 ARNI----------------------LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDE-VR 230
+ APE + +T A D W G++++E++ GE P+ ++V ++I D +
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253
Query: 231 YPRFLSLEAIAIMRR 245
P +M
Sbjct: 254 PPMDCPSALHQLMLD 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-35
Identities = 51/264 (19%), Positives = 99/264 (37%), Gaps = 47/264 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V+ ++ + G + + ++D+ E + + HP ++NL +
Sbjct: 26 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV--LCKLGHHPNIINLLGACEHR 83
Query: 61 AHVCFVMEYAAGGDLMMHIH-----------------ADVFSEPRAVFYAACVVLGLQYL 103
++ +EYA G+L+ + A S + + +AA V G+ YL
Sbjct: 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 104 HESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGM 163
+ + I+R ++ I + KIADFGL + G
Sbjct: 144 SQKQFIHR---DLAARNI----------------------LVGENYVAKIADFGLSR-GQ 177
Query: 164 GFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFD 222
+ ++A E L + YT D W GVL++E++ G +P+ G E+++
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 223 SIVNDE-VRYPRFLSLEAIAIMRR 245
+ + P E +MR+
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMRQ 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-35
Identities = 51/247 (20%), Positives = 92/247 (37%), Gaps = 41/247 (16%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
Y + AIK +++G + D + E + + HP LV L+ +A +C
Sbjct: 25 YWLNKDKVAIKTIREGAMSEED----FIEEAEV---MMKLSHPKLVQLYGVCLEQAPICL 77
Query: 66 VMEYAAGGDL--MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYR--PQSNITKEEI 121
V E+ G L + +F+ + V G+ YL E+ +I+R N
Sbjct: 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC----- 132
Query: 122 KRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR-TGTFCGTPEFLA 180
+ +K++DFG+ + + + ++ +
Sbjct: 133 ----------------------LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 181 PEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFLSLE 238
PEV + + Y+ D W GVL++E+ G+ P+ EV + I + PR S
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 239 AIAIMRR 245
IM
Sbjct: 231 VYQIMNH 237
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 9e-34
Identities = 45/237 (18%), Positives = 88/237 (37%), Gaps = 46/237 (19%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT- 59
V ++ ++GE AIK + + E++ + + H +V L F +
Sbjct: 36 VYQAKLCDSGELVAIKKVLQDKRFKNRELQIM----------RKLDHCNIVRLRYFFYSS 85
Query: 60 -----EAHVCFVMEYAAGGDLMMHIH----ADVFSEPRAVFYAACVVLGLQYLHESRIIY 110
E ++ V++Y + H Y + L Y+H I +
Sbjct: 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145
Query: 111 RPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
R +I + L ++ +K+ DFG K+ + G+
Sbjct: 146 R---DIKPQ---------------------NLLLDPDTAVLKLCDFGSAKQ-LVRGEPNV 180
Query: 171 TFCGTPEFLAP-EVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
++ + + AP + T YT ++D W G ++ E+L+G+ FPGD + I+
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-33
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 39/251 (15%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EA 61
+N G + A+K ++ S + E + T HP +V LF E
Sbjct: 30 KNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88
Query: 62 HVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V E+ + + ++ GL +LH R+++R
Sbjct: 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD------- 141
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+K +N V S G +K+ADFGL + T + T +
Sbjct: 142 -LK------PQNILVTS-----------SGQIKLADFGLARIYSFQMALT-SVVVTLWYR 182
Query: 180 APEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRF 234
APEVL ++SY VD W +G + EM + F G + + I++ E +PR
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 235 LSLEAIAIMRR 245
++L A +
Sbjct: 243 VALPRQAFHSK 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 4e-33
Identities = 53/268 (19%), Positives = 85/268 (31%), Gaps = 59/268 (22%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
A+K LK+ + D E + +P +V L +C +
Sbjct: 40 YEPFTMVAVKMLKEEA--SADMQADFQREAAL---MAEFDNPNIVKLLGVCAVGKPMCLL 94
Query: 67 MEYAAGGDLMMHIH-------------------------ADVFSEPRAVFYAACVVLGLQ 101
EY A GDL + S + A V G+
Sbjct: 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 154
Query: 102 YLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK- 160
YL E + ++R + ++ + VKIADFGL +
Sbjct: 155 YLSERKFVHRDLA----------------------TRNCLV---GENMVVKIADFGLSRN 189
Query: 161 -EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEE 218
+ G ++ PE + YT D W GV+++E+ G P+ G E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 219 EVFDSIVNDEVR-YPRFLSLEAIAIMRR 245
EV + + + P LE +MR
Sbjct: 250 EVIYYVRDGNILACPENCPLELYNLMRL 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-33
Identities = 46/251 (18%), Positives = 91/251 (36%), Gaps = 47/251 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT- 59
V +++R TG+ A+K + + + +L R ++ ++H +VNL +T
Sbjct: 26 VFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLLKHENVVNLIEICRTK 81
Query: 60 -------EAHVCFVMEYAAGGDLMMHIHADV-FSEPRAVFYAACVVLGLQYLHESRIIYR 111
+ + V ++ + + V F+ ++ GL Y+H ++I++R
Sbjct: 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 141
Query: 112 PQ--SNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE----GMGF 165
+N+ + +G +K+ADFGL +
Sbjct: 142 DMKAANV---------------------------LITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 166 GDRTGTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
+R T + PE+L E Y +D WG G ++ EM G+ E+ I
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 225 VNDEVRYPRFL 235
+
Sbjct: 235 SQLCGSITPEV 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (295), Expect = 2e-32
Identities = 35/232 (15%), Positives = 69/232 (29%), Gaps = 35/232 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
+ + AIK + R + L E R +++ + N++ Q
Sbjct: 21 IFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLA--GCTGIPNVYYFGQEG 73
Query: 61 AHVCFVMEYAAGGDL-MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
H V++ ++ + FS A ++ +Q +HE ++YR +I +
Sbjct: 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR---DIKPD 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-------EGMGFGDRTGTF 172
I + + + DFG+ K +
Sbjct: 131 NFL-----------------IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
GT +++ +R D LG + L G P+ G
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-32
Identities = 55/251 (21%), Positives = 90/251 (35%), Gaps = 40/251 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + + T AIK LK G + E+ L E ++ +RH LV L+A E
Sbjct: 33 VWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQV---MKKLRHEKLVQLYAVVSEE 84
Query: 61 AHVCFVMEYAAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
+ V EY + G L+ + + P+ V AA + G+ Y+ ++R ++
Sbjct: 85 -PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR---DLR 140
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE-GMGFGDRTGTFCGTP 176
I + K+ADFGL +
Sbjct: 141 AANI----------------------LVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 177 EFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234
++ APE +T D W G+L+ E+ G P+PG EV D + + P
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 235 LSLEAIAIMRR 245
+M +
Sbjct: 239 CPESLHDLMCQ 249
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-32
Identities = 42/227 (18%), Positives = 78/227 (34%), Gaps = 38/227 (16%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE----AH 62
+ GE A+K E S E I++ +RH ++ A +
Sbjct: 23 KWRGEEVAVKIFSS------REERSWFREAEIYQTVM-LRHENILGFIAADNKDNGTWTQ 75
Query: 63 VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
+ V +Y G L +++ + + A GL +LH + + + I ++K
Sbjct: 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD----RTGTFCGTPEF 178
S+ I + G IAD GL D GT +
Sbjct: 136 --------------SKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 179 LAPEVLTE------TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEE 219
+APEVL + + D + +G++ +E+ S ++ +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 117 bits (293), Expect = 3e-32
Identities = 46/223 (20%), Positives = 84/223 (37%), Gaps = 31/223 (13%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
N GE FA+K ++ + + + E I ++H +V L+ T+ +
Sbjct: 22 QNNYGETFALKKIRL-EKEDEGIPSTTIREISI---LKELKHSNIVKLYDVIHTKKRLVL 77
Query: 66 VMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRI 124
V E+ + + A + ++ G+ Y H+ R+++R ++K
Sbjct: 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR--------DLKPQ 129
Query: 125 EAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVL 184
+ G +KIADFGL + + T + AP+VL
Sbjct: 130 NLLINRE-----------------GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 185 TETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
+ Y+ +D W +G + EM+ G FPG E + I
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 3e-32
Identities = 55/253 (21%), Positives = 94/253 (37%), Gaps = 42/253 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ A+K LK+ + EVE L E + ++HP LV L E
Sbjct: 33 VYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV---MKEIKHPNLVQLLGVCTRE 85
Query: 61 AHVCFVMEYAAGGDLMMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ--SN 115
+ E+ G+L+ ++ S ++ A + ++YL + I+R N
Sbjct: 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFC-G 174
+ VK+ADFGL + G
Sbjct: 146 C---------------------------LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYP 232
++ APE L ++ D W GVL++E+ G SP+PG D +V++ + D + P
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 233 RFLSLEAIAIMRR 245
+ +MR
Sbjct: 239 EGCPEKVYELMRA 251
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-32
Identities = 51/263 (19%), Positives = 91/263 (34%), Gaps = 53/263 (20%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFV 66
+ A+K LK + E E+L+SE ++ ++ H +VNL +
Sbjct: 50 SDAAMTVAVKMLKPSAHL--TEREALMSELKV--LSYLGNHMNIVNLLGACTIGGPTLVI 105
Query: 67 MEYAAGGDLMMHIHAD-------------------VFSEPRAVFYAACVVLGLQYLHESR 107
EY GDL+ + + ++ V G+ +L
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165
Query: 108 IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD 167
I+R ++ N + KI DFGL ++ +
Sbjct: 166 CIHR--------DLA------ARNILLTH-----------GRITKICDFGLARDIKNDSN 200
Query: 168 R--TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSI 224
G +++APE + YT D W G+ ++E+ +G SP+PG + F +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 225 VNDEVR--YPRFLSLEAIAIMRR 245
+ + R P E IM+
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKT 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-32
Identities = 52/246 (21%), Positives = 96/246 (39%), Gaps = 39/246 (15%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
Y N A+K+LK+G + ++ L+E + ++H LV L+A T+ +
Sbjct: 33 YYNGHTKVAVKSLKQGSM----SPDAFLAEANL---MKQLQHQRLVRLYAVV-TQEPIYI 84
Query: 66 VMEYAAGGDLMMHIHAD---VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIK 122
+ EY G L+ + + + + AA + G+ ++ E I+R +++
Sbjct: 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR--------DLR 136
Query: 123 RIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD-RTGTFCGTPEFLAP 181
+ I + KIADFGL + ++ AP
Sbjct: 137 --------------AANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 182 EVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRFLSLEA 239
E + ++T D W G+L+ E++ G P+PG EV ++ + P E
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 240 IAIMRR 245
+MR
Sbjct: 240 YQLMRL 245
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-32
Identities = 55/253 (21%), Positives = 84/253 (33%), Gaps = 39/253 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEV-ESLLSEKRIFEVANTMRHPFLVNLFACFQT 59
V Y + A+K D V E L E HP +V L T
Sbjct: 23 VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT---MRQFDHPHIVKLIGVI-T 78
Query: 60 EAHVCFVMEYAAGGDLMMHIHADV--FSEPRAVFYAACVVLGLQYLHESRIIYRP--QSN 115
E V +ME G+L + + YA + L YL R ++R N
Sbjct: 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 138
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE-GMGFGDRTGTFCG 174
+ + VK+ DFGL + +
Sbjct: 139 VLV---------------------------SSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232
+++APE + +T A D W GV ++E+L+ G PF G +V I N E + P
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 233 RFLSLEAIAIMRR 245
++M +
Sbjct: 232 PNCPPTLYSLMTK 244
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 8e-32
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 50/261 (19%)
Query: 6 YRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCF 65
N A+K LK ++ L+SE + + +H ++NL + +
Sbjct: 41 KPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM--MKMIGKHKNIINLLGACTQDGPLYV 96
Query: 66 VMEYAAGGDLMMHIH-----------------ADVFSEPRAVFYAACVVLGLQYLHESRI 108
++EYA+ G+L ++ + S V A V G++YL +
Sbjct: 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156
Query: 109 IYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK--EGMGFG 166
I+R ++ N V + +KIADFGL + + +
Sbjct: 157 IHR--------DLA------ARNVLV-----------TEDNVMKIADFGLARDIHHIDYY 191
Query: 167 DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIV 225
+T +++APE L + YT D W GVL++E+ +G SP+PG EE+F +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 226 NDE-VRYPRFLSLEAIAIMRR 245
+ P + E +MR
Sbjct: 252 EGHRMDKPSNCTNELYMMMRD 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 9e-32
Identities = 54/231 (23%), Positives = 86/231 (37%), Gaps = 36/231 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ + TGE A+K ++ D + + E + + HP +V L TE
Sbjct: 18 VYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISL---LKELNHPNIVKLLDVIHTE 73
Query: 61 AHVCFVMEYAAGG--DLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
+ V E+ M P Y ++ GL + H R+++R
Sbjct: 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR------- 126
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTV--NDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++K +TEG +K+ADFGL + T
Sbjct: 127 --------------------DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 177 EFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
+ APE+L Y + AVD W LG + EM+ + FPGD E + I
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-31
Identities = 43/236 (18%), Positives = 86/236 (36%), Gaps = 42/236 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + AIK + + + + L E +I RH ++ + +
Sbjct: 24 VCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILL---RFRHENIIGINDIIRAP 78
Query: 61 AHV----CFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRP--QS 114
+++ + G DL + S ++ ++ GL+Y+H + +++R S
Sbjct: 79 TIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 138
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK---EGMGFGDRTGT 171
N+ + +T +KI DFGL +
Sbjct: 139 NL---------------------------LLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 172 FCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226
+ T + APE++ YT+++D W +G ++ EML FPG + + I+
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-30
Identities = 47/253 (18%), Positives = 95/253 (37%), Gaps = 37/253 (14%)
Query: 1 VILSQYRNTGEYFAIK-ALKK-GDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQ 58
V + GE I A+K+ + + + +L E + ++ +P + L
Sbjct: 25 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM---ASVDNPHVCRLLGICL 81
Query: 59 TEAHVCFVMEYAAGGDLMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNI 116
T V + + G L+ ++ H D + + + G+ YL + R+++R
Sbjct: 82 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR----- 135
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDR--TGTFCG 174
++ ++ + + T +VKI DFGL K
Sbjct: 136 ---DLA--------------ARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDE-VRYP 232
+++A E + YT D W GV ++E++ G P+ G E+ + E + P
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235
Query: 233 RFLSLEAIAIMRR 245
+++ IM +
Sbjct: 236 PICTIDVYMIMVK 248
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (278), Expect = 8e-30
Identities = 39/232 (16%), Positives = 73/232 (31%), Gaps = 43/232 (18%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + E +K LK + + + E +I N P ++ L +
Sbjct: 51 VFEAINITNNEKVVVKILKP------VKKKKIKREIKIL--ENLRGGPNIITLADIVKDP 102
Query: 61 AH--VCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ--SNI 116
V E+ D ++ FY ++ L Y H I++R N+
Sbjct: 103 VSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 160
Query: 117 TKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTP 176
++ +++ D+GL + G +
Sbjct: 161 M--------------------------IDHEHRKLRLIDWGLAEF-YHPGQEYNVRVASR 193
Query: 177 EFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPF-PGDDEEEVFDSIVN 226
F PE+ + Y ++D W LG ++ M+ + PF G D + I
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 1e-29
Identities = 38/261 (14%), Positives = 68/261 (26%), Gaps = 45/261 (17%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
+ L GE AIK + + L E +I+++ + + C
Sbjct: 23 IYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQ--GGVGIPTIRWCGAEG 75
Query: 61 AHVCFVMEYAAGGDLMMHIHAD-VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ VME + FS + A ++ ++Y+H I+R
Sbjct: 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR-------- 127
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK-------EGMGFGDRTGTF 172
+N + + V I DFGL K
Sbjct: 128 ------DVKPDN--------FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 173 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
GT + + +R D LG ++ +G P+ G +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 233 RF--------LSLEAIAIMRR 245
E +
Sbjct: 234 STPIEVLCKGYPSEFATYLNF 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-29
Identities = 48/253 (18%), Positives = 94/253 (37%), Gaps = 39/253 (15%)
Query: 2 ILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTE 60
L + A+K+L + I EV L+E I HP +++L C ++E
Sbjct: 47 TLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGII---MKDFSHPNVLSLLGICLRSE 101
Query: 61 AHVCFVMEYAAGGDLMMHIHADV--FSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITK 118
V+ Y GDL I + + + + V G+++L + ++R ++
Sbjct: 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR---DLAA 158
Query: 119 EEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK----EGMGFGDRTGTFCG 174
+ D + VK+ADFGL + +
Sbjct: 159 RNC----------------------MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232
+++A E L +T D W GVL++E++ G P+P + ++ ++ + P
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256
Query: 233 RFLSLEAIAIMRR 245
+ +M +
Sbjct: 257 EYCPDPLYEVMLK 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-29
Identities = 59/262 (22%), Positives = 104/262 (39%), Gaps = 52/262 (19%)
Query: 7 RNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLF-ACFQTEAHVCF 65
T A+K LK+G E +L+SE +I + + H +VNL AC + +
Sbjct: 40 TATCRTVAVKMLKEGAT--HSEHRALMSELKI--LIHIGHHLNVVNLLGACTKPGGPLMV 95
Query: 66 VMEYAAGGDLMMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRI 108
++E+ G+L ++ + D + + Y+ V G+++L +
Sbjct: 96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 155
Query: 109 IYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD- 167
I+R ++ I + + VKI DFGL ++ D
Sbjct: 156 IHR---DLAARNI----------------------LLSEKNVVKICDFGLARDIYKDPDY 190
Query: 168 -RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG-ESPFPGDDEEEVFDSIV 225
R G +++APE + + YT D W GVL++E+ SP+PG +E F +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 226 NDEVRY--PRFLSLEAIAIMRR 245
+ R P + + E M
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLD 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-28
Identities = 45/252 (17%), Positives = 87/252 (34%), Gaps = 45/252 (17%)
Query: 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68
AIK + + + E L+E + +V L +ME
Sbjct: 49 PETRVAIKTVNEAA--SMRERIEFLNEASV---MKEFNCHHVVRLLGVVSQGQPTLVIME 103
Query: 69 YAAGGDLMMHIH-----------ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNIT 117
GDL ++ S + + A + G+ YL+ ++ ++R
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR------ 157
Query: 118 KEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKE--GMGFGDRTGTFCGT 175
++ N V + VKI DFG+ ++ + + G
Sbjct: 158 --DLA------ARNCMV-----------AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 176 PEFLAPEVLTETSYTRAVDWWGLGVLIFEML-VGESPFPGDDEEEVFDSIVNDEVR-YPR 233
+++PE L + +T D W GV+++E+ + E P+ G E+V ++ + P
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 234 FLSLEAIAIMRR 245
+MR
Sbjct: 259 NCPDMLFELMRM 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 7e-28
Identities = 40/236 (16%), Positives = 80/236 (33%), Gaps = 32/236 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V ++ R T E A+K ++ D S L E + ++H +V L ++
Sbjct: 18 VFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICL---LKELKHKNIVRLHDVLHSD 73
Query: 61 AHVCFVMEYAAGGDLM-MHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKE 119
+ V E+ + ++ GL + H +++R ++ +
Sbjct: 74 KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR---DLKPQ 130
Query: 120 EIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFL 179
+ + + G +K+A+FGL + T +
Sbjct: 131 NL----------------------LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 180 APEVL-TETSYTRAVDWWGLGVLIFEMLVGESP-FPGDDEEEVFDSIVNDEVRYPR 233
P+VL Y+ ++D W G + E+ P FPG+D ++ I
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-27
Identities = 46/251 (18%), Positives = 86/251 (34%), Gaps = 38/251 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + AIK L + + + E + + H +++L F +
Sbjct: 33 VCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVL---MKCVNHKNIISLLNVFTPQ 88
Query: 61 A------HVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
V VME + R + ++ G+++LH + II+R
Sbjct: 89 KTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHR--- 143
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
++K V+ + +KI DFGL + G +
Sbjct: 144 -----DLKPSNIVVKSD-----------------CTLKILDFGLART-AGTSFMMTPYVV 180
Query: 175 TPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF 234
T + APEV+ Y VD W +G ++ EM+ + FPG D + ++ ++
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 235 LSLEAIAIMRR 245
+ +R
Sbjct: 241 FMKKLQPTVRN 251
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-27
Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 40/239 (16%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE 60
V + TG AIK L + + + E R+ + MRH ++ L F +
Sbjct: 34 VCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLK---HMRHENVIGLLDVFTPD 89
Query: 61 ------AHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQS 114
VM + G DL + + E R F ++ GL+Y+H + II+R
Sbjct: 90 ETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 148
Query: 115 NITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCG 174
+ + +KI DFGL ++ +
Sbjct: 149 P-------------------------GNLAVNEDCELKILDFGLARQ---ADSEMTGYVV 180
Query: 175 TPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232
T + APEV+ YT+ VD W +G ++ EM+ G++ F G D + I+ P
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-27
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 38/241 (15%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT- 59
V + TG A+K L + + + E R+ + M+H ++ L F
Sbjct: 34 VCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLK---HMKHENVIGLLDVFTPA 89
Query: 60 ----EAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSN 115
E + +++ + G DL + ++ F ++ GL+Y+H + II+R
Sbjct: 90 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD--- 146
Query: 116 ITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGT 175
+K N + + +KI DFGL D + T
Sbjct: 147 -----LKP------SNL-----------AVNEDCELKILDFGLA---RHTDDEMTGYVAT 181
Query: 176 PEFLAPEV-LTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF 234
+ APE+ L Y + VD W +G ++ E+L G + FPG D + I+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 235 L 235
L
Sbjct: 242 L 242
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-26
Identities = 46/258 (17%), Positives = 81/258 (31%), Gaps = 45/258 (17%)
Query: 1 VILSQYRNTGE----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFAC 56
V + + AIK LK G + L E I H ++ L
Sbjct: 23 VYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGI---MGQFSHHNIIRLEGV 77
Query: 57 FQTEAHVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRP-- 112
+ + EY G L + FS + V + G++YL ++R
Sbjct: 78 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137
Query: 113 QSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTGTF 172
NI + ++ K++DFGL + + T T
Sbjct: 138 ARNI---------------------------LVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 173 C---GTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV 229
+ APE ++ +T A D W G++++E++ + +ND
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 230
Query: 230 R--YPRFLSLEAIAIMRR 245
R P +M +
Sbjct: 231 RLPTPMDCPSAIYQLMMQ 248
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.2 bits (199), Expect = 2e-18
Identities = 45/234 (19%), Positives = 80/234 (34%), Gaps = 31/234 (13%)
Query: 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT----MRHPFLVNLFAC 56
V L++ + A+K ++ + + + +R+ + NT M ++ L
Sbjct: 29 VWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88
Query: 57 FQTEA----HVCFVMEYAAGGDLMMHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIY 110
F + HV V E L + + + ++LGL Y+H
Sbjct: 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH------ 142
Query: 111 RPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGDRTG 170
+ I +IK EN + + + +KIAD G +
Sbjct: 143 -RRCGIIHTDIKP------ENVLMEIVDSPENLIQ-----IKIADLGNACWYD---EHYT 187
Query: 171 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224
T E+ +PEVL + D W LIFE++ G+ F D+
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 36.3 bits (83), Expect = 0.001
Identities = 17/169 (10%), Positives = 39/169 (23%), Gaps = 50/169 (29%)
Query: 6 YRNTGEYFAIKALKKGDIIARD------------EVESLLSEKRIFEVANTMRHPFLVNL 53
Y +K K G + V ++ S + F ++ + +
Sbjct: 20 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79
Query: 54 FACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQ 113
+A +ME + ++ + + I++
Sbjct: 80 YAWEGN----AVLMEL------IDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHG-- 127
Query: 114 SNITKEEIKRIEAKVQENYKVNSSQEIKL-TVNDTEGYVKIADFGLCKE 161
++ V +E + I DF E
Sbjct: 128 -------------------------DLSQYNVLVSEEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 245 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.98 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.78 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=331.14 Aligned_cols=215 Identities=31% Similarity=0.564 Sum_probs=189.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++.+.........+.+. +++++++.++||||+++++++.+++..++||||+++|+|.+++.
T Consensus 22 Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~ 98 (263)
T d2j4za1 22 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 98 (263)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHH---HHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEchHHccChHHHHHHH---HHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh
Confidence 799999999999999999865433333333444 44778889999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 99 ~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHr---DiKp~Ni----------------------ll~~~~~~kl~DFG~a 153 (263)
T d2j4za1 99 KLSKFDEQRTATYITELANALSYCHSKRVIHR---DIKPENL----------------------LLGSAGELKIADFGWS 153 (263)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEECCCCSC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeee---eeccccc----------------------eecCCCCEeeccccee
Confidence 4679999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|+.+|+++
T Consensus 154 ~~~~~--~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 231 (263)
T d2j4za1 154 VHAPS--SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231 (263)
T ss_dssp SCCCC--CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred eecCC--CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence 75432 2344567999999999999999999999999999999999999999999999999999998889999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 232 ~~li~~ 237 (263)
T d2j4za1 232 RDLISR 237 (263)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=338.53 Aligned_cols=217 Identities=50% Similarity=0.928 Sum_probs=194.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++++.........+.+.+| +.+|+.++||||++++++|.+++.+|+||||+++|+|..++.
T Consensus 21 V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~ 97 (337)
T d1o6la_ 21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE---SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH---HHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHH---HHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh
Confidence 79999999999999999987544333344444444 677889999999999999999999999999999999998885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+|
T Consensus 98 ~~~~~~e~~~~~~~~qil~al~ylH~~~iiHR---DlKP~NI----------------------Ll~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYR---DIKLENL----------------------MLDKDGHIKITDFGLC 152 (337)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTTC
T ss_pred cccCCcHHHHHHHHHHHhhhhhhhhhcCcccc---ccCHHHe----------------------EecCCCCEEEeecccc
Confidence 4679999999999999999999999999999 9999999 8899999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+..+.+..+...+|..+|+++
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 232 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHH
Confidence 86555555566778999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 233 ~dli~~ 238 (337)
T d1o6la_ 233 KSLLAG 238 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=333.39 Aligned_cols=217 Identities=32% Similarity=0.569 Sum_probs=188.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++.+.........+.+.+ +++++++++||||++++++|.+++..|+||||+++|+|.+++.
T Consensus 24 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~ 100 (288)
T d1uu3a_ 24 VVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 100 (288)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHH---HHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEehHHccCHHHHHHHHH---HHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh
Confidence 7999999999999999998654333333444544 4777888999999999999999999999999999999998874
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| ||||+|| +++.++.+||+|||++
T Consensus 101 ~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHr---DiKp~NI----------------------ll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 101 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHR---DLKPENI----------------------LLNEDMHIQITDFGTA 155 (288)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHhhccccEEcC---cCCcccc----------------------ccCCCceEEecccccc
Confidence 5689999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCCh
Q psy3347 160 KEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSL 237 (245)
Q Consensus 160 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 237 (245)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++..+...+|+.+++
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 235 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCH
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCH
Confidence 8543222 22345679999999999999999999999999999999999999999999999999999998899999999
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
++++||++
T Consensus 236 ~~~~li~~ 243 (288)
T d1uu3a_ 236 KARDLVEK 243 (288)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 99999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=330.52 Aligned_cols=214 Identities=27% Similarity=0.463 Sum_probs=186.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++..... ..+.+.+ ++++++.++||||++++++|..++..|+||||+++|+|..++.
T Consensus 36 Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~---E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~ 109 (293)
T d1yhwa1 36 VYTAMDVATGQEVAIRQMNLQQQP---KKELIIN---EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109 (293)
T ss_dssp EEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHH---HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEecccCh---HHHHHHH---HHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh
Confidence 799999999999999999864322 2234444 4777889999999999999999999999999999999999988
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCcc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLCK 160 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 160 (245)
...+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+||+|||+++
T Consensus 110 ~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHr---DiKp~NI----------------------Ll~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 110 ETCMDEGQIAAVCRECLQALEFLHSNQVIHR---DIKSDNI----------------------LLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp HSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCCCccc---CCcHHHe----------------------EECCCCcEeeccchhhe
Confidence 8889999999999999999999999999999 9999999 88889999999999998
Q ss_pred CCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCh
Q psy3347 161 EGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---RYPRFLSL 237 (245)
Q Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~p~~~~~ 237 (245)
............+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+..... +.|..+++
T Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 244 (293)
T d1yhwa1 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (293)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCH
T ss_pred eeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCH
Confidence 654444455677899999999999999999999999999999999999999999888777777655432 34678999
Q ss_pred hHHhhhcC
Q psy3347 238 EAIAIMRR 245 (245)
Q Consensus 238 ~~~~li~~ 245 (245)
++++||++
T Consensus 245 ~~~~li~~ 252 (293)
T d1yhwa1 245 IFRDFLNR 252 (293)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-49 Score=328.65 Aligned_cols=214 Identities=37% Similarity=0.752 Sum_probs=189.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++++.........+.+. +++.+++.++||||+++++++.+++..|+||||++||+|..++.
T Consensus 20 Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~---~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~ 96 (316)
T d1fota_ 20 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN---DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96 (316)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHH---HHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchHHccCHHHHHHHH---HHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc
Confidence 899999999999999999865433333344444 44777889999999999999999999999999999999988885
Q ss_pred h-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 A-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 ~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
. ..+++..++.++.|++.||+|||++||+|| ||||+|| +++.+|.+||+|||++
T Consensus 97 ~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHr---DiKp~NI----------------------Ll~~~g~vkL~DFG~a 151 (316)
T d1fota_ 97 KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR---DLKPENI----------------------LLDKNGHIKITDFGFA 151 (316)
T ss_dssp HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCCGGGE----------------------EECTTSCEEECCCSSC
T ss_pred ccccccccHHHHHHHHHHHhhhhhccCcEEcc---ccCchhe----------------------eEcCCCCEEEecCccc
Confidence 4 568899999999999999999999999999 9999999 8899999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..+...+|..+++++
T Consensus 152 ~~~~~---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 228 (316)
T d1fota_ 152 KYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228 (316)
T ss_dssp EECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred eEecc---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 86422 234568999999999999999999999999999999999999999999999999999999888999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
+++|++
T Consensus 229 ~~li~~ 234 (316)
T d1fota_ 229 KDLLSR 234 (316)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=325.28 Aligned_cols=218 Identities=49% Similarity=0.932 Sum_probs=191.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++++.........+...+|..+ +.+.++||||+++++++.+++..|+||||+++|+|.+++.
T Consensus 18 Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~--l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~ 95 (320)
T d1xjda_ 18 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV--LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ 95 (320)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHH--HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHH--HHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh
Confidence 79999999999999999987544334444555555332 3346799999999999999999999999999999999985
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||++
T Consensus 96 ~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHr---Dikp~Ni----------------------L~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 96 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYR---DLKLDNI----------------------LLDKDGHIKIADFGMC 150 (320)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCCGGGE----------------------EECTTSCEEECCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---cCcccce----------------------eecCCCceeccccchh
Confidence 4679999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+............+||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..++...+..+.+.+|..+|+++
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~ 230 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence 86544444555678999999999999999999999999999999999999999999999999999998888999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
++||++
T Consensus 231 ~dli~~ 236 (320)
T d1xjda_ 231 KDLLVK 236 (320)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=324.36 Aligned_cols=214 Identities=26% Similarity=0.436 Sum_probs=182.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++... ....+.+.+ ++++++.++||||+++++++.+++..++||||+++|+|..++.
T Consensus 28 Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~ 101 (288)
T d2jfla1 28 VYKAQNKETSVLAAAKVIDTKS---EEELEDYMV---EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101 (288)
T ss_dssp EEEEEETTTCCEEEEEEEECSS---SGGGGGTHH---HHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH
T ss_pred EEEEEECCCCeEEEEEEECcCC---HHHHHHHHH---HHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHH
Confidence 8999999999999999997642 233344444 4777889999999999999999999999999999999998874
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
..++++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 102 ~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHr---DiKp~NI----------------------ll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHR---DLKAGNI----------------------LFTLDGDIKLADFGV 156 (288)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEe---ecChhhe----------------------eECCCCCEEEEechh
Confidence 3569999999999999999999999999999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc---
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLT-----ETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--- 230 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (245)
|+............+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+....+.....+
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 875333222344568999999999984 456889999999999999999999999998888888888776543
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|..+|+++++||++
T Consensus 237 ~~~~~s~~~~~li~~ 251 (288)
T d2jfla1 237 QPSRWSSNFKDFLKK 251 (288)
T ss_dssp SGGGSCHHHHHHHHH
T ss_pred ccccCCHHHHHHHHH
Confidence 356889999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=318.88 Aligned_cols=216 Identities=25% Similarity=0.413 Sum_probs=173.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--CCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--EAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|+++.+|+.||+|++...... ....+.+. ++++++++++||||+++++++.+ ++.+|+||||+++|+|.++
T Consensus 20 Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~---~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~ 95 (269)
T d2java1 20 CQKIRRKSDGKILVWKELDYGSMT-EAEKQMLV---SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASV 95 (269)
T ss_dssp EEEEEETTTCCEEEEEEECCTTSC-HHHHHHHH---HHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHH
T ss_pred EEEEEECCCCCEEEEEEEChhhCC-HHHHHHHH---HHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHH
Confidence 799999999999999999875432 23334444 45788999999999999999864 4578999999999999988
Q ss_pred hh-----hcCCChHHHHHHHHHHHHHHHHhhhcC-----ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 79 IH-----ADVFSEPRAVFYAACVVLGLQYLHESR-----IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 79 ~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~-----i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
+. ...+++..++.++.|++.||+|||++| |+|| ||||+|| +++.+
T Consensus 96 i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHr---DiKp~NI----------------------ll~~~ 150 (269)
T d2java1 96 ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR---DLKPANV----------------------FLDGK 150 (269)
T ss_dssp HHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------------CCGGGE----------------------EECTT
T ss_pred HHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeC---cCchhhc----------------------CcCCC
Confidence 74 246999999999999999999999976 9999 9999998 88899
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCc
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDE 228 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (245)
+.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..+.
T Consensus 151 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 151 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp SCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred CcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999999865444444556789999999999999899999999999999999999999999999999888887776
Q ss_pred c-cCCCCCChhHHhhhcC
Q psy3347 229 V-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~-~~p~~~~~~~~~li~~ 245 (245)
. ++|..+|+++++||++
T Consensus 231 ~~~~~~~~s~~l~~li~~ 248 (269)
T d2java1 231 FRRIPYRYSDELNEIITR 248 (269)
T ss_dssp CCCCCTTSCHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHH
Confidence 5 4678999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-48 Score=326.68 Aligned_cols=214 Identities=40% Similarity=0.787 Sum_probs=189.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++.+.........+.+. +++++++.++||||+++++++...+..++||||+.+|+|..++.
T Consensus 57 Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~---~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~ 133 (350)
T d1rdqe_ 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHH---HHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchHHccCHHHHHHHH---HHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh
Confidence 899999999999999999865433333344444 44777889999999999999999999999999999999988884
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..++.++.|++.||.|||++||+|| ||||+|| +++.+|.+||+|||++
T Consensus 134 ~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHR---DIKP~NI----------------------Ll~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR---DLKPENL----------------------LIDQQGYIQVTDFGFA 188 (350)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTSCEEECCCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecC---cCCHHHc----------------------ccCCCCCEEeeeceee
Confidence 5689999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCCCChhH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSLEA 239 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 239 (245)
+...+ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|..+++++
T Consensus 189 ~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 265 (350)
T d1rdqe_ 189 KRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265 (350)
T ss_dssp EECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHH
T ss_pred eeccc---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHH
Confidence 86432 234568999999999999999999999999999999999999999999999999999999888999999999
Q ss_pred HhhhcC
Q psy3347 240 IAIMRR 245 (245)
Q Consensus 240 ~~li~~ 245 (245)
.+||++
T Consensus 266 ~~li~~ 271 (350)
T d1rdqe_ 266 KDLLRN 271 (350)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=321.40 Aligned_cols=217 Identities=29% Similarity=0.543 Sum_probs=168.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|++....... ..+.+ .+++.+++.++||||+++++++.+++..|+||||++||+|.+++.
T Consensus 25 Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~---~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~ 99 (307)
T d1a06a_ 25 VILAEDKRTQKLVAIKCIAKKALEG--KEGSM---ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV 99 (307)
T ss_dssp EEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchHHhhh--HHHHH---HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh
Confidence 8999999999999999998654221 12233 345778889999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| ++. ..+.++.+||+|||++
T Consensus 100 ~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHr---DiKp~Ni-----l~~--------------~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 100 EKGFYTERDASRLIFQVLDAVKYLHDLGIVHR---DLKPENL-----LYY--------------SLDEDSKIMISDFGLS 157 (307)
T ss_dssp TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE-----EES--------------SSSTTCCEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHHHhhhhceeeeE---Eecccce-----eec--------------ccCCCceEEEecccee
Confidence 4579999999999999999999999999999 8888888 111 2256789999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----CCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p----~~~ 235 (245)
+.. +........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+..+...++ ..+
T Consensus 158 ~~~-~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 158 KME-DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred EEc-cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 753 223334566899999999999999999999999999999999999999999998888888887766543 578
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
|+++++||++
T Consensus 237 s~~~~~li~~ 246 (307)
T d1a06a_ 237 SDSAKDFIRH 246 (307)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 9999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-48 Score=319.11 Aligned_cols=213 Identities=23% Similarity=0.377 Sum_probs=182.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhh-
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHI- 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~- 79 (245)
||+|+++.+|+.||||++...........+.+.+ +++++++++||||+++++++.+++..|+|||||.+|+|..+.
T Consensus 31 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~---Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~ 107 (309)
T d1u5ra_ 31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 107 (309)
T ss_dssp EEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHH---HHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEchhhccCHHHHHHHHH---HHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH
Confidence 8999999999999999998765444444444544 478889999999999999999999999999999999987665
Q ss_pred hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 80 HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 80 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...++++..+..++.|++.||.|||++||+|| ||||+|| +++.++.+||+|||++
T Consensus 108 ~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHr---DiKp~NI----------------------Ll~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 108 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR---DVKAGNI----------------------LLSEPGLVKLGDFGSA 162 (309)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC---CCSGGGE----------------------EEETTTEEEECCCTTC
T ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc---CCCcceE----------------------EECCCCCEEEeecccc
Confidence 45679999999999999999999999999999 9999999 8888999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCccc--CCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVR--YPRF 234 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~p~~ 234 (245)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+.....+ .+..
T Consensus 163 ~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (309)
T d1u5ra_ 163 SIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (309)
T ss_dssp BSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTT
T ss_pred cccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 85322 335679999999999964 45889999999999999999999999998888888887766543 3457
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+|+++++||++
T Consensus 239 ~s~~~~~li~~ 249 (309)
T d1u5ra_ 239 WSEYFRNFVDS 249 (309)
T ss_dssp SCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 89999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=315.61 Aligned_cols=215 Identities=24% Similarity=0.396 Sum_probs=172.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++..... .+..+.+. +++++++.++||||+++++++.+++..|+||||+++|+|.+++.
T Consensus 21 V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~---~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~ 95 (271)
T d1nvra_ 21 VQLAVNRVTEEAVAVKIVDMKRA--VDCPENIK---KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 95 (271)
T ss_dssp EEEEEETTTCCEEEEEEEECC---------CHH---HHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB
T ss_pred EEEEEECCCCCEEEEEEEehhhc--chHHHHHH---HHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh
Confidence 79999999999999999976432 12223343 45788889999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+|
T Consensus 96 ~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHr---DiKp~NI----------------------Ll~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 96 PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR---DIKPENL----------------------LLDERDNLKISDFGLA 150 (271)
T ss_dssp TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EECTTCCEEECCCTTC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccC---cccHHHE----------------------EECCCCCEEEccchhh
Confidence 4579999999999999999999999999999 9999999 8888999999999999
Q ss_pred cCCCCC--CCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCccc--CCC
Q psy3347 160 KEGMGF--GDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEE-EVFDSIVNDEVR--YPR 233 (245)
Q Consensus 160 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~--~p~ 233 (245)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... .....+...... .+.
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGG
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 854222 222445689999999999988776 57899999999999999999999765433 222333332222 235
Q ss_pred CCChhHHhhhcC
Q psy3347 234 FLSLEAIAIMRR 245 (245)
Q Consensus 234 ~~~~~~~~li~~ 245 (245)
.+++++++||++
T Consensus 231 ~~s~~~~~li~~ 242 (271)
T d1nvra_ 231 KIDSAPLALLHK 242 (271)
T ss_dssp GSCHHHHHHHHH
T ss_pred cCCHHHHHHHHH
Confidence 789999998863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=314.60 Aligned_cols=216 Identities=26% Similarity=0.455 Sum_probs=183.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchh---hHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARD---EVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||||++++....... ..+.+.+ |++++++++||||++++++|.++++.|+|||||++|+|.+
T Consensus 26 Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~---E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~ 102 (293)
T d1jksa_ 26 VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER---EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102 (293)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHH---HHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHH---HHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccc
Confidence 799999999999999999865433222 2334444 4777889999999999999999999999999999999999
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC----ceE
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG----YVK 152 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~k 152 (245)
++. .+.+++..++.++.|++.||+|||++||+|| |+||+|| +++.++ .+|
T Consensus 103 ~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHr---DiKp~Ni----------------------ll~~~~~~~~~vk 157 (293)
T d1jksa_ 103 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF---DLKPENI----------------------MLLDRNVPKPRIK 157 (293)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESCSSSSSCCEE
T ss_pred hhccccccchhHHHHHHHHHHHHHHhhhhcceeec---ccccceE----------------------EEecCCCcccceE
Confidence 885 4679999999999999999999999999999 8888888 555544 599
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP 232 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p 232 (245)
++|||++..... ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......++
T Consensus 158 l~DfG~a~~~~~-~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 158 IIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp ECCCTTCEECTT-SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred ecchhhhhhcCC-CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999999976432 2334456789999999999988899999999999999999999999999999999998888766543
Q ss_pred ----CCCChhHHhhhcC
Q psy3347 233 ----RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ----~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 237 ~~~~~~~s~~~~~li~~ 253 (293)
T d1jksa_ 237 DEYFSNTSALAKDFIRR 253 (293)
T ss_dssp HHHHTTSCHHHHHHHHT
T ss_pred chhcCCCCHHHHHHHHH
Confidence 6789999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-47 Score=321.99 Aligned_cols=218 Identities=31% Similarity=0.561 Sum_probs=186.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.||+.||||++.+...........+.+|.+++.+++.++||||++++++|..++..|+||||+++|+|..++.
T Consensus 20 Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~ 99 (364)
T d1omwa3 20 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 99 (364)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH
Confidence 89999999999999999986554444444556677778889999999999999999999999999999999999999885
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
...+++..+..++.|++.||.|||++||+|| |+||+|| +++.+|.+||+|||+|
T Consensus 100 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHr---DlKP~NI----------------------Ll~~~g~iKl~DFGla 154 (364)
T d1omwa3 100 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYR---DLKPANI----------------------LLDEHGHVRISDLGLA 154 (364)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECSSSCEEECCCTTC
T ss_pred hcccccHHHHHHHHHHHHHHHHHHHHCCccce---eecccee----------------------EEcCCCcEEEeeecee
Confidence 5678999999999999999999999999999 9999999 8889999999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCcccCCCCC
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDE---EEVFDSIVNDEVRYPRFL 235 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~---~~~~~~~~~~~~~~p~~~ 235 (245)
+.... ......+||+.|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+. .+....+......+|..+
T Consensus 155 ~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 155 CDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232 (364)
T ss_dssp EECSS--SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSS
T ss_pred eecCC--CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Confidence 85432 23445689999999999964 5689999999999999999999999976543 344444555666778899
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
|+++++||++
T Consensus 233 s~~~~~li~~ 242 (364)
T d1omwa3 233 SPELRSLLEG 242 (364)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 9999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-47 Score=319.47 Aligned_cols=213 Identities=28% Similarity=0.440 Sum_probs=183.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||+++.... ...+.+ .+|++++++++||||++++++|.+++..|+|||||++|+|.+++.
T Consensus 45 V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~---~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~ 118 (352)
T d1koba_ 45 VHRCVEKATGRVFVAKFINTPYP---LDKYTV---KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118 (352)
T ss_dssp EEEEEETTTCCEEEEEEEECCSH---HHHHHH---HHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT
T ss_pred EEEEEECCCCCEEEEEEECCcch---hHHHHH---HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHH
Confidence 89999999999999999986432 222333 345788899999999999999999999999999999999988774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC--CCCceEEeec
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--TEGYVKIADF 156 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~kl~Df 156 (245)
. .++++..++.++.|++.||+|||++||+|| ||||+|| +++ .++.+||+||
T Consensus 119 ~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHR---DiKp~NI----------------------Ll~~~~~~~vkL~DF 173 (352)
T d1koba_ 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL---DIKPENI----------------------MCETKKASSVKIIDF 173 (352)
T ss_dssp CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSTTCCCEEECCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec---ccccccc----------------------cccccCCCeEEEeec
Confidence 3 368999999999999999999999999999 9999888 554 5789999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|
T Consensus 174 Gla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 252 (352)
T d1koba_ 174 GLATKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252 (352)
T ss_dssp TTCEECCT-TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred ccceecCC-CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 99986432 2234456789999999999999999999999999999999999999999999999999888766554
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 253 ~~~s~~~~~li~~ 265 (352)
T d1koba_ 253 SSVSPEAKDFIKN 265 (352)
T ss_dssp TTSCHHHHHHHHT
T ss_pred cCCCHHHHHHHHH
Confidence 5689999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-47 Score=318.98 Aligned_cols=213 Identities=28% Similarity=0.443 Sum_probs=182.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++.... ....+.+. +++++++.++||||++++++|.+++..|+||||++||+|.+++.
T Consensus 42 Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~---~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~ 115 (350)
T d1koaa2 42 VHRVTERATGNNFAAKFVMTPH---ESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 115 (350)
T ss_dssp EEEEEETTTTEEEEEEEECCCS---HHHHHHHH---HHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT
T ss_pred EEEEEECCCCCEEEEEEEcccc---hhhHHHHH---HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHH
Confidence 8999999999999999997643 22233444 44777888999999999999999999999999999999998883
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc--CCCCceEEeec
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN--DTEGYVKIADF 156 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~kl~Df 156 (245)
.+.+++..+..++.|++.||+|||++||+|| ||||+|| ++ +.++.+||+||
T Consensus 116 ~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHr---DiKp~NI----------------------ll~~~~~~~vkL~DF 170 (350)
T d1koaa2 116 DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL---DLKPENI----------------------MFTTKRSNELKLIDF 170 (350)
T ss_dssp CTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSTTSCCEEECCC
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeee---eechhHe----------------------eeccCCCCeEEEeec
Confidence 4579999999999999999999999999999 8888888 44 34688999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|+++... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|
T Consensus 171 G~a~~~~-~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 171 GLTAHLD-PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp TTCEECC-TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred chheecc-cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 9998532 22334456889999999999999999999999999999999999999999999999999888776554
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 250 ~~~s~~~~~li~~ 262 (350)
T d1koaa2 250 SGISEDGKDFIRK 262 (350)
T ss_dssp GGCCHHHHHHHHH
T ss_pred cCCCHHHHHHHHH
Confidence 4688999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=304.08 Aligned_cols=213 Identities=23% Similarity=0.390 Sum_probs=174.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee----CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++.+++.||+|++..... .....+.+. ++++++++++||||++++++|.. ++.+|+||||+++|+|.
T Consensus 25 Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~---~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~ 100 (270)
T d1t4ha_ 25 VYKGLDTETTVEVAWCELQDRKL-TKSERQRFK---EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 100 (270)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHH---HHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHH
T ss_pred EEEEEECCCCeEEEEEEEchhhC-CHHHHHHHH---HHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHH
Confidence 89999999999999999986532 223334444 45788899999999999999865 35789999999999999
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcC--ccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-CCCceE
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESR--IIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-TEGYVK 152 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~k 152 (245)
++++ ...+++..+..++.|++.||+|||+++ |+|| |+||+|| +++ .++.+|
T Consensus 101 ~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr---DiKp~NI----------------------Ll~~~~~~~K 155 (270)
T d1t4ha_ 101 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR---DLKCDNI----------------------FITGPTGSVK 155 (270)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS---CCCGGGE----------------------EESSTTSCEE
T ss_pred HHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeC---CcChhhc----------------------eeeCCCCCEE
Confidence 9885 467999999999999999999999999 9999 9999998 664 578999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCcc--
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD-EEEVFDSIVNDEV-- 229 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~-~~~~~~~~~~~~~-- 229 (245)
|+|||+++... .......+||+.|+|||.+.+ .++.++|||||||++|||++|+.||.+.. ..+....+..+..
T Consensus 156 l~DFGla~~~~--~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 156 IGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232 (270)
T ss_dssp ECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EeecCcceecc--CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc
Confidence 99999997532 223446689999999999865 59999999999999999999999997654 4555566655443
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
.++..+++++++||++
T Consensus 233 ~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEG 248 (270)
T ss_dssp GGGGCCCHHHHHHHHH
T ss_pred ccCccCCHHHHHHHHH
Confidence 3467789999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.9e-46 Score=301.52 Aligned_cols=219 Identities=22% Similarity=0.379 Sum_probs=183.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccch--hhHH-HHHHHHHHHHHHhhcC-CCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR--DEVE-SLLSEKRIFEVANTMR-HPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~-~~~~e~~~~~~l~~~~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|+++.+|+.||||++++...... +..+ ...+..+++.++++++ ||||+++++++.+++++|+||||+++|+|.
T Consensus 19 V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~ 98 (277)
T d1phka_ 19 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 98 (277)
T ss_dssp EEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred EEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHH
Confidence 79999999999999999987543221 1111 1223455677888886 999999999999999999999999999999
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++++ ++++++..++.++.|++.||+|||++||+|| |+||+|| +++.++.+||+|
T Consensus 99 ~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHr---Dlkp~Ni----------------------ll~~~~~~kl~D 153 (277)
T d1phka_ 99 DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR---DLKPENI----------------------LLDDDMNIKLTD 153 (277)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTCCEEECC
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCccc---ccccceE----------------------EEcCCCCeEEcc
Confidence 9994 5689999999999999999999999999999 9999998 888999999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE------TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~ 229 (245)
||+++.... .......+||..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+..+.+..+..
T Consensus 154 FG~a~~~~~-~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 154 FGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CTTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred chheeEccC-CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 999986433 233455689999999999953 3467899999999999999999999999999888888887765
Q ss_pred cCC----CCCChhHHhhhcC
Q psy3347 230 RYP----RFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p----~~~~~~~~~li~~ 245 (245)
.+| ..+|+++++||++
T Consensus 233 ~~~~~~~~~~s~~~~~li~~ 252 (277)
T d1phka_ 233 QFGSPEWDDYSDTVKDLVSR 252 (277)
T ss_dssp CCCTTTGGGSCHHHHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHH
Confidence 543 3789999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=313.00 Aligned_cols=185 Identities=26% Similarity=0.486 Sum_probs=158.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++... .....+.+. +|+.+++.++||||++++++|.++++.|+||||+++|+|.+++.
T Consensus 22 V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~ 96 (322)
T d1s9ja_ 22 VFKVSHKPSGLVMARKLIHLEI--KPAIRNQII---RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 96 (322)
T ss_dssp EEEEEETTTTEEEEEEEEECCC--CTTHHHHHH---HHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEChhh--CHHHHHHHH---HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh
Confidence 8999999999999999998642 222233444 44777899999999999999999999999999999999999884
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
.+.+++..++.++.|++.||+|||+ +||+|| |+||+|| +++.+|.+||+|||+
T Consensus 97 ~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHR---DiKP~NI----------------------Ll~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 97 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR---DVKPSNI----------------------LVNSRGEIKLCDFGV 151 (322)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCS---CCSGGGE----------------------EECTTCCEEECCCCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcc---ccCHHHe----------------------eECCCCCEEEeeCCC
Confidence 5679999999999999999999997 599999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDE 217 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~ 217 (245)
|+.... ......+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+.
T Consensus 152 a~~~~~--~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 152 SGQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp CHHHHH--HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccCC--CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 985322 223456899999999999999999999999999999999999999976543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=305.21 Aligned_cols=214 Identities=25% Similarity=0.395 Sum_probs=177.7
Q ss_pred CEeEEEec--CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRN--TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++. ++..||||+++... .....+.+.+ +++++++++||||++++|++.. +..|+||||+++|+|.++
T Consensus 25 Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~---E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~ 98 (285)
T d1u59a_ 25 VRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR---EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKF 98 (285)
T ss_dssp EEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHH---HHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHH
T ss_pred EEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHH---HHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHH
Confidence 79997764 45589999997642 2333444544 4777889999999999999865 458999999999999998
Q ss_pred hh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 79 IH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 79 ~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
+. +..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+||
T Consensus 99 l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHr---DlKp~Ni----------------------ll~~~~~~Kl~DF 153 (285)
T d1u59a_ 99 LVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR---DLAARNV----------------------LLVNRHYAKISDF 153 (285)
T ss_dssp HTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEEETTEEEECCC
T ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC---cCchhhe----------------------eeccCCceeeccc
Confidence 74 3579999999999999999999999999999 9999998 8888999999999
Q ss_pred CCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccC
Q psy3347 157 GLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRY 231 (245)
Q Consensus 157 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~ 231 (245)
|+++....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+..+. +++
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99985432221 2334567889999999988899999999999999999998 999999888888888887764 467
Q ss_pred CCCCChhHHhhhcC
Q psy3347 232 PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 p~~~~~~~~~li~~ 245 (245)
|+.+|+++.+||++
T Consensus 234 p~~~~~~l~~li~~ 247 (285)
T d1u59a_ 234 PPECPPELYALMSD 247 (285)
T ss_dssp CTTCCHHHHHHHHH
T ss_pred CCcCCHHHHHHHHH
Confidence 88999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-46 Score=306.93 Aligned_cols=215 Identities=21% Similarity=0.333 Sum_probs=170.3
Q ss_pred CEeEEEecCCc---EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGE---YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+ .||||.+.... .....+.+. ++++++++++||||++++|++..++..++||||+++|+|.+
T Consensus 42 Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~ 116 (299)
T d1jpaa_ 42 VCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFL---SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116 (299)
T ss_dssp EEEEEECC---CCEEEEEEECCSSC--CHHHHHHHH---HHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred EEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHH---HHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCccee
Confidence 79999987765 58888886542 233334454 44788899999999999999999999999999999999998
Q ss_pred hhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++.. +.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|
T Consensus 117 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHr---DlKp~NI----------------------Ll~~~~~~Kl~D 171 (299)
T d1jpaa_ 117 FLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR---DLAARNI----------------------LVNSNLVCKVSD 171 (299)
T ss_dssp HHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEECC
T ss_pred eeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccC---ccccceE----------------------EECCCCcEEECC
Confidence 8854 468999999999999999999999999999 9999999 889999999999
Q ss_pred cCCccCCCCCCCC-----CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-
Q psy3347 156 FGLCKEGMGFGDR-----TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE- 228 (245)
Q Consensus 156 fg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~- 228 (245)
||+++........ .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+..+.
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999854332221 112356889999999998999999999999999999998 899999999988888887664
Q ss_pred ccCCCCCChhHHhhhcC
Q psy3347 229 VRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 229 ~~~p~~~~~~~~~li~~ 245 (245)
.+.|..+++++++||++
T Consensus 252 ~~~~~~~~~~l~~li~~ 268 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLD 268 (299)
T ss_dssp CCCCTTCCHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHH
Confidence 45678899999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5e-46 Score=303.08 Aligned_cols=217 Identities=25% Similarity=0.333 Sum_probs=176.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|+++.+|+.||||+++..........+.+. +++++++.++||||+++++++...+ ..|+||||++|++|.
T Consensus 23 Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~ 99 (277)
T d1o6ya_ 23 VHLARDLRLHRDVAVKVLRADLARDPSFYLRFR---REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 99 (277)
T ss_dssp EEEEEETTTTEEEEEEEECSTTTTCHHHHHHHH---HHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHH
T ss_pred EEEEEECCCCCEEEEEEEchhhccCHHHHHHHH---HHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEeh
Confidence 899999999999999999876544444444444 4477788999999999999997653 489999999999999
Q ss_pred hhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 77 MHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 77 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.++. .+++++..++.++.|++.||+|||++||+|| |+||+|| +++.++..+++|
T Consensus 100 ~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHr---DiKP~NI----------------------ll~~~~~~~l~d 154 (277)
T d1o6ya_ 100 DIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHR---DVKPANI----------------------MISATNAVKVMD 154 (277)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEETTSCEEECC
T ss_pred hhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCc---cccCccc----------------------ccCccccceeeh
Confidence 8874 5679999999999999999999999999999 9999999 888899999999
Q ss_pred cCCccCCCCC---CCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccC-
Q psy3347 156 FGLCKEGMGF---GDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRY- 231 (245)
Q Consensus 156 fg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 231 (245)
||.+...... .......+||+.|+|||++.+..+++++|||||||++|+|++|+.||.+.+..+....+....+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 9987643221 123445679999999999999899999999999999999999999999999888888877765543
Q ss_pred ---CCCCChhHHhhhcC
Q psy3347 232 ---PRFLSLEAIAIMRR 245 (245)
Q Consensus 232 ---p~~~~~~~~~li~~ 245 (245)
+..+|++++++|++
T Consensus 235 ~~~~~~~s~~l~~li~~ 251 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLK 251 (277)
T ss_dssp GGTSSSCCHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHH
Confidence 36789999998863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-46 Score=305.70 Aligned_cols=213 Identities=25% Similarity=0.392 Sum_probs=177.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||+++... ...+.+.+ +++++++++||||++++++|.+++..+++|||+++|+|..++.
T Consensus 33 Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~---E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~ 105 (287)
T d1opja_ 33 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLK---EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 105 (287)
T ss_dssp EEEEEEGGGTEEEEEEECCTTC----SCHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred EEEEEECCCCeEEEEEEECCcc----chHHHHHH---HHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhh
Confidence 8999999999999999997643 22344444 4777889999999999999999999999999999999999885
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 106 ~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHr---DlKp~NI----------------------Ll~~~~~~Kl~DFG 160 (287)
T d1opja_ 106 ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR---DLAARNC----------------------LVGENHLVKVADFG 160 (287)
T ss_dssp HSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECGGGCEEECCCC
T ss_pred hccccchHHHHHHHHHHHHHHHHHHHHHCCcccC---ccccCeE----------------------EECCCCcEEEcccc
Confidence 3 468999999999999999999999999999 9999999 88889999999999
Q ss_pred CccCCCCCCCC-CCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 158 LCKEGMGFGDR-TGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGE-SPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~-~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
+++........ .....|+..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..+..+.+..+ ..+.|+.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence 99864333222 22345788999999999999999999999999999999955 555666666666666554 3456889
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++++||++
T Consensus 241 ~~~~l~~li~~ 251 (287)
T d1opja_ 241 CPEKVYELMRA 251 (287)
T ss_dssp CCHHHHHHHHH
T ss_pred chHHHHHHHHH
Confidence 99999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=301.94 Aligned_cols=215 Identities=24% Similarity=0.355 Sum_probs=175.3
Q ss_pred CEeEEEec--CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRN--TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|.++. +++.||||+++.... .....+.+. ++++++++++||||++++|++..+ ..++||||+++|+|.++
T Consensus 23 Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~---~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~ 97 (277)
T d1xbba_ 23 VKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELL---AEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKY 97 (277)
T ss_dssp EEEEEEECSSSEEEEEEEEEC------CHHHHHHH---HHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHH
T ss_pred EEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHH---HHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHH
Confidence 79997654 568999999976432 222334444 447788899999999999998654 57899999999999998
Q ss_pred hhh-cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IHA-DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
++. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 98 l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr---DlKp~Ni----------------------ll~~~~~~kl~DFG 152 (277)
T d1xbba_ 98 LQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR---DLAARNV----------------------LLVTQHYAKISDFG 152 (277)
T ss_dssp HHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEEETTEEEECCCT
T ss_pred HhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccC---CCcchhh----------------------cccccCcccccchh
Confidence 864 579999999999999999999999999999 9999999 88889999999999
Q ss_pred CccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 158 LCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 158 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
+++....... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+..+. .+.|
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p 232 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9975432221 1234568889999999998899999999999999999998 899999998888888887654 4578
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 233 ~~~~~~~~~li~~ 245 (277)
T d1xbba_ 233 AGCPREMYDLMNL 245 (277)
T ss_dssp TTCCHHHHHHHHH
T ss_pred cccCHHHHHHHHH
Confidence 8999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=305.84 Aligned_cols=212 Identities=25% Similarity=0.436 Sum_probs=182.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++... .....+. +++++|+.++||||++++++|.+++.+|+|||||+||+|.++++
T Consensus 21 Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~---~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~ 93 (321)
T d1tkia_ 21 VHRCVETSSKKTYMAKFVKVKG----TDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN 93 (321)
T ss_dssp EEEEEETTTTEEEEEEEECCCT----HHHHHHH---HHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT
T ss_pred EEEEEECCCCcEEEEEEEcCCc----ccHHHHH---HHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence 7999999999999999998643 1122333 45778889999999999999999999999999999999999985
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC--CCCceEEeec
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND--TEGYVKIADF 156 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~kl~Df 156 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++ ..+.+||+||
T Consensus 94 ~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHr---DlKp~NI----------------------ll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 94 TSAFELNEREIVSYVHQVCEALQFLHSHNIGHF---DIRPENI----------------------IYQTRRSSTIKIIEF 148 (321)
T ss_dssp SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EESSSSCCCEEECCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcc---cccccce----------------------eecCCCceEEEEccc
Confidence 4 368999999999999999999999999999 8888888 554 4458999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCC----
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 232 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p---- 232 (245)
|+++.... .......++++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|
T Consensus 149 G~~~~~~~-~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 149 GQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp TTCEECCT-TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred chhhcccc-CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc
Confidence 99875322 2234456788999999999998999999999999999999999999999999999999988877665
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 228 ~~~s~~~~~li~~ 240 (321)
T d1tkia_ 228 KEISIEAMDFVDR 240 (321)
T ss_dssp TTSCHHHHHHHHT
T ss_pred cCCCHHHHHHHHH
Confidence 4789999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=298.77 Aligned_cols=212 Identities=25% Similarity=0.424 Sum_probs=170.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ +++.||||+++.... ..+.+.+ +++.+++++||||++++|++..++..++||||+++|+|.+++.
T Consensus 21 Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~---E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~ 92 (263)
T d1sm2a_ 21 VHLGYWL-NKDKVAIKTIREGAM----SEEDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR 92 (263)
T ss_dssp EEEEEET-TTEEEEEEECCSSSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred EEEEEEC-CCCEEEEEEECCCcC----cHHHHHH---HHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhh
Confidence 7999886 577899999986432 1234444 4777889999999999999999999999999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|+|+++|+|| |+||+|| +++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr---DlKp~Ni----------------------ll~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 93 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR---DLAARNC----------------------LVGENQVIKVSDFGM 147 (263)
T ss_dssp TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT---TCSGGGE----------------------EECGGGCEEECSCC-
T ss_pred ccccCCCHHHHHHHHHHHHHHHHhhhccceeec---ccchhhe----------------------eecCCCCeEecccch
Confidence 3 468899999999999999999999999999 9999998 888899999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc-cCCCCC
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-RYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~p~~~ 235 (245)
++....... ......||..|+|||.+.+..++.++|||||||++|||+| |.+||...+..+....+..+.. ..|..+
T Consensus 148 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTS
T ss_pred heeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcccc
Confidence 975433322 2234568899999999999999999999999999999999 6888888888888888877643 468889
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++.+||++
T Consensus 228 ~~~l~~li~~ 237 (263)
T d1sm2a_ 228 STHVYQIMNH 237 (263)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 9999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=294.18 Aligned_cols=212 Identities=22% Similarity=0.369 Sum_probs=181.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ +++.||||+++..... .+.+.+ +++.+++++||||++++|++.+++.+++||||+++|+|..++.
T Consensus 20 Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~---Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~ 91 (258)
T d1k2pa_ 20 VKYGKWR-GQYDVAIKMIKEGSMS----EDEFIE---EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR 91 (258)
T ss_dssp EEEEEET-TTEEEEEEEEESSSSC----HHHHHH---HHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHH
T ss_pred EEEEEEC-CCCEEEEEEECcCcCC----HHHHHH---HHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhh
Confidence 7999985 7889999999875432 234444 4778889999999999999999999999999999999988863
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+.+++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~---dlk~~Ni----------------------ll~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 92 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR---DLAARNC----------------------LVNDQGVVKVSDFGL 146 (258)
T ss_dssp SGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCS---CCSGGGE----------------------EECTTCCEEECCCSS
T ss_pred ccccCCcHHHHHHHHHHHHHHHHHHhhcCcccc---cccceeE----------------------EEcCCCcEEECcchh
Confidence 4578999999999999999999999999999 9999888 888999999999999
Q ss_pred ccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q psy3347 159 CKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRFL 235 (245)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~~ 235 (245)
++....... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+..+. .+.|..+
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred heeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 975433222 2234568889999999999999999999999999999998 899999999999888887764 3568899
Q ss_pred ChhHHhhhcC
Q psy3347 236 SLEAIAIMRR 245 (245)
Q Consensus 236 ~~~~~~li~~ 245 (245)
++++++||++
T Consensus 227 ~~~l~~li~~ 236 (258)
T d1k2pa_ 227 SEKVYTIMYS 236 (258)
T ss_dssp CHHHHHHHHH
T ss_pred cHHHHHHHHH
Confidence 9999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=302.46 Aligned_cols=197 Identities=24% Similarity=0.411 Sum_probs=163.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhh--HHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDE--VESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMH 78 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (245)
||+|+++.+|+.||||+++......... .+.+ .+++++++.++||||+++++++..+++.|+||||+.++++...
T Consensus 14 Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~---~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~ 90 (299)
T d1ua2a_ 14 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA---LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII 90 (299)
T ss_dssp EEEEECSSCCSEEEEEEC------------CTHH---HHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHH
T ss_pred EEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHH---HHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhh
Confidence 8999999999999999997643221111 1233 3457788899999999999999999999999999998877766
Q ss_pred hh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 79 IH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 79 ~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
.. ...+++..+..+++|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 91 ~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHr---DiKp~NI----------------------li~~~~~~KL~DFG 145 (299)
T d1ua2a_ 91 KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR---DLKPNNL----------------------LLDENGVLKLADFG 145 (299)
T ss_dssp TTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTCCEEECCCG
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHhhccceecc---cCCcceE----------------------EecCCCccccccCc
Confidence 64 4568999999999999999999999999999 9999999 88999999999999
Q ss_pred CccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 158 LCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
+++............+||+.|+|||.+.+. .++.++|||||||++|||++|.+||.+.+..+....+.
T Consensus 146 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 146 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 998654444445566899999999998754 57899999999999999999999999998888777764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=305.22 Aligned_cols=215 Identities=26% Similarity=0.447 Sum_probs=173.3
Q ss_pred CEeEEEecCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGE-----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|+++.+++ .||+|++.... .......+.+| +..++++ +||||+++++++.+.+..++|||||++|+
T Consensus 53 Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~ 127 (325)
T d1rjba_ 53 VMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSE---LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127 (325)
T ss_dssp EEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHH---HHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCc
Confidence 79999886654 69999987542 22233344444 5556666 79999999999999999999999999999
Q ss_pred hhhhhhhc------------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhh
Q psy3347 75 LMMHIHAD------------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130 (245)
Q Consensus 75 L~~~~~~~------------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~ 130 (245)
|.++++.. .+++..+..++.|++.||+|||++||+|| |+||+||
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR---DlKp~Ni--------- 195 (325)
T d1rjba_ 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR---DLAARNV--------- 195 (325)
T ss_dssp HHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET---TCSGGGE---------
T ss_pred HHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec---cCchhcc---------
Confidence 99998532 37889999999999999999999999999 9999998
Q ss_pred ccccCcccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-
Q psy3347 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV- 207 (245)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~- 207 (245)
+++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 196 -------------ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~ 262 (325)
T d1rjba_ 196 -------------LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262 (325)
T ss_dssp -------------EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred -------------ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence 888899999999999975433322 1234567899999999999999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhcCcc--cCCCCCChhHHhhhcC
Q psy3347 208 GESPFPGDDEEEVFDSIVNDEV--RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 208 g~~pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~ 245 (245)
|+.||.+.+..+....++.... +.|..+|+++++||++
T Consensus 263 g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~ 302 (325)
T d1rjba_ 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS 302 (325)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 8999988776666666655433 4678999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=294.42 Aligned_cols=211 Identities=24% Similarity=0.376 Sum_probs=174.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ +++.||||+++.... ..+.+.+ +++++++++||||++++|++.. +..++||||+++|+|.+++.
T Consensus 29 Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~---E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~ 99 (272)
T d1qpca_ 29 VWMGYYN-GHTKVAVKSLKQGSM----SPDAFLA---EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK 99 (272)
T ss_dssp EEEEEET-TTEEEEEEEECTTSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTT
T ss_pred EEEEEEC-CCCEEEEEEEccCcC----CHHHHHH---HHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHh
Confidence 7999875 678999999976432 2234444 4778889999999999998754 56799999999999988763
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. .++++..+..++.|++.||+|||+++|+|| ||||+|| +++.++.+||+|||
T Consensus 100 ~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHr---DiKp~NI----------------------ll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 100 TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR---DLRAANI----------------------LVSDTLSCKIADFG 154 (272)
T ss_dssp SHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EECTTSCEEECCCT
T ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC---ccchhhe----------------------eeecccceeecccc
Confidence 2 369999999999999999999999999999 9999999 88999999999999
Q ss_pred CccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
+|+....... ......|++.|+|||.+.+..++.++|||||||++|||+| |.+||...+..+..+.+..+. ...|..
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~ 234 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 9986433221 2334568889999999988889999999999999999999 567777788888888887654 456889
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++++||++
T Consensus 235 ~~~~l~~li~~ 245 (272)
T d1qpca_ 235 CPEELYQLMRL 245 (272)
T ss_dssp CCHHHHHHHHH
T ss_pred ChHHHHHHHHH
Confidence 99999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=295.90 Aligned_cols=212 Identities=20% Similarity=0.352 Sum_probs=165.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ ..||||+++..... ....+.+. ++++++++++||||+++++++. ++..++||||+++|+|.+++.
T Consensus 24 Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~---~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~ 95 (276)
T d1uwha_ 24 VYKGKWH---GDVAVKMLNVTAPT-PQQLQAFK---NEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLH 95 (276)
T ss_dssp EEEEESS---SEEEEEECCCSSCC-TTHHHHHH---HHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHH
T ss_pred EEEEEEC---CEEEEEEEEcccCC-HHHHHHHH---HHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHh
Confidence 7899754 46999999765332 23344444 4478889999999999999875 456899999999999999885
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||+
T Consensus 96 ~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHr---DlKp~Ni----------------------Ll~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 96 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR---DLKSNNI----------------------FLHEDLTVKIGDFGL 150 (276)
T ss_dssp TSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EEETTSSEEECCCCC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHhcCCEecc---ccCHHHE----------------------EEcCCCCEEEccccc
Confidence 3 468999999999999999999999999999 9999998 888999999999999
Q ss_pred ccCCCCCC--CCCCcccCCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcc----
Q psy3347 159 CKEGMGFG--DRTGTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEV---- 229 (245)
Q Consensus 159 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~---- 229 (245)
|+...... .......||+.|+|||.+.+ .+++.++|||||||++|||+||+.||.+.+.......+.....
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 97532221 22345678999999999964 3578999999999999999999999988766555444433221
Q ss_pred --cCCCCCChhHHhhhcC
Q psy3347 230 --RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 --~~p~~~~~~~~~li~~ 245 (245)
..+..+++++++||.+
T Consensus 231 ~~~~~~~~~~~l~~li~~ 248 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAE 248 (276)
T ss_dssp GGGSCTTCCHHHHHHHHH
T ss_pred chhccccchHHHHHHHHH
Confidence 2457789999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=302.93 Aligned_cols=208 Identities=28% Similarity=0.485 Sum_probs=166.3
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHH-hhcCCCceeeeeEEEee----CCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVA-NTMRHPFLVNLFACFQT----EAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~h~ni~~~~~~~~~----~~~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||||+++.. ....+| ++++ +..+||||++++++|.+ ++++|+|||||+||+|
T Consensus 28 Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E---~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L 96 (335)
T d2ozaa1 28 VLQIFNKRTQEKFALKMLQDC--------PKARRE---VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 96 (335)
T ss_dssp EEEEEETTTCCEEEEEEEECS--------HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred EEEEEECCCCCEEEEEEECCc--------HHHHHH---HHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcH
Confidence 899999999999999999753 223333 4443 44589999999999975 4679999999999999
Q ss_pred hhhhhh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC---CCC
Q psy3347 76 MMHIHA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND---TEG 149 (245)
Q Consensus 76 ~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 149 (245)
.++++. ..+++..++.++.|++.||+|||++||+|| |+||+|| +++ ..+
T Consensus 97 ~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHR---DiKp~NI----------------------ll~~~~~~~ 151 (335)
T d2ozaa1 97 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR---DVKPENL----------------------LYTSKRPNA 151 (335)
T ss_dssp HHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EESCSSTTC
T ss_pred HHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccc---ccccccc----------------------ccccccccc
Confidence 999854 358999999999999999999999999999 8888888 554 356
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHh
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFD----SIV 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~----~~~ 225 (245)
.+||+|||+++..... ......+||+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+..+... .+.
T Consensus 152 ~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~ 230 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230 (335)
T ss_dssp CEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC
T ss_pred cccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh
Confidence 7999999999754332 33456689999999999999899999999999999999999999997765444333 333
Q ss_pred cCcccCC----CCCChhHHhhhcC
Q psy3347 226 NDEVRYP----RFLSLEAIAIMRR 245 (245)
Q Consensus 226 ~~~~~~p----~~~~~~~~~li~~ 245 (245)
.....+| ..+|+++++||++
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~ 254 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRN 254 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHH
Confidence 4444454 3578999998863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=294.48 Aligned_cols=212 Identities=23% Similarity=0.325 Sum_probs=170.9
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcC--CCceeeeeEEEeeCCeEEEEEeeccC-Cchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMR--HPFLVNLFACFQTEAHVCFVMEYAAG-GDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--h~ni~~~~~~~~~~~~~~lv~e~~~~-~~L~~ 77 (245)
||+|+++.+|+.||||++.+.............+..+++++++.++ ||||+++++++.+++..++||||+.+ +++.+
T Consensus 20 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~ 99 (273)
T d1xwsa_ 20 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 99 (273)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHH
T ss_pred EEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHH
Confidence 7999999999999999998654333222222112233456666665 89999999999999999999999975 57777
Q ss_pred hhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCC-CCceEEee
Q psy3347 78 HIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDT-EGYVKIAD 155 (245)
Q Consensus 78 ~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~kl~D 155 (245)
++. +..+++..++.++.|++.||+|||++||+|| |+||+|| +++. ++.+||+|
T Consensus 100 ~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHr---DiKp~NI----------------------ll~~~~~~vkl~D 154 (273)
T d1xwsa_ 100 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHR---DIKDENI----------------------LIDLNRGELKLID 154 (273)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE----------------------EEETTTTEEEECC
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccc---cCcccce----------------------EEecCCCeEEECc
Confidence 764 5679999999999999999999999999999 9999998 6664 57899999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCcccCCCC
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF 234 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~ 234 (245)
||+++.... .......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+. ..+..+...+|+.
T Consensus 155 FG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~ 226 (273)
T d1xwsa_ 155 FGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR 226 (273)
T ss_dssp CTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSC
T ss_pred cccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCC
Confidence 999975322 23456689999999999987765 57799999999999999999999753 2355667778899
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+|+++++||++
T Consensus 227 ~s~~~~~li~~ 237 (273)
T d1xwsa_ 227 VSSECQHLIRW 237 (273)
T ss_dssp CCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=289.53 Aligned_cols=215 Identities=21% Similarity=0.305 Sum_probs=169.9
Q ss_pred CEeEEEecCC----cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTG----EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|.++.++ ..||||++.... .......+. ++++++++++||||++++|++...+..+++|||+.++++.
T Consensus 23 Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~---~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~ 97 (283)
T d1mqba_ 23 VYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFL---GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 97 (283)
T ss_dssp EEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHH---HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred EEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHH---HHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcch
Confidence 7999988665 479999997542 222333444 4477888999999999999999999999999999999998
Q ss_pred hhhhh--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHA--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+.+.. ..+++..+..++.|++.||+|||+++|+|| |+||+|| +++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHr---DlKp~NI----------------------Ll~~~~~~Kl~ 152 (283)
T d1mqba_ 98 KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR---DLAARNI----------------------LVNSNLVCKVS 152 (283)
T ss_dssp HHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEEC
T ss_pred hhhhcccccccHHHHHHHHHHHHHhhhhccccccccC---ccccceE----------------------EECCCCeEEEc
Confidence 87743 568999999999999999999999999999 9999999 88999999999
Q ss_pred ecCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-c
Q psy3347 155 DFGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-V 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~ 229 (245)
|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+..+. .
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 9999985433222 1223467889999999999999999999999999999999 566667777777877776653 3
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
+.|..+++++++||++
T Consensus 233 ~~~~~~~~~l~~li~~ 248 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQ 248 (283)
T ss_dssp CCCTTCBHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHH
Confidence 5678899999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=289.86 Aligned_cols=214 Identities=25% Similarity=0.377 Sum_probs=167.6
Q ss_pred CEeEEEecCC---cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTG---EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..++ ..||||+++... .....+.+. +++++++.++||||++++|++. ++..++||||+++|+|..
T Consensus 23 Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~---~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~ 96 (273)
T d1mp8a_ 23 VHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFL---QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRS 96 (273)
T ss_dssp EEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHH---HHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHH
T ss_pred EEEEEEecCCceeEEEEEEEecccc--CHHHHHHHH---HHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHh
Confidence 7999887653 468888886532 223334444 4477888999999999999985 567899999999999988
Q ss_pred hhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
++. ...+++..+..++.|++.||.|||+++++|| |+||+|| +++.++.+||+|
T Consensus 97 ~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHr---DlKp~NI----------------------ll~~~~~~Kl~D 151 (273)
T d1mp8a_ 97 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR---DIAARNV----------------------LVSSNDCVKLGD 151 (273)
T ss_dssp HHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EEEETTEEEECC
T ss_pred hhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeecc---ccchhhe----------------------eecCCCcEEEcc
Confidence 764 3468999999999999999999999999999 9999998 888889999999
Q ss_pred cCCccCCCCCCC-CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCC
Q psy3347 156 FGLCKEGMGFGD-RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYP 232 (245)
Q Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p 232 (245)
||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+..+. .++|
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 231 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred chhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999985432222 2344567889999999998999999999999999999998 899999998888888887765 4678
Q ss_pred CCCChhHHhhhcC
Q psy3347 233 RFLSLEAIAIMRR 245 (245)
Q Consensus 233 ~~~~~~~~~li~~ 245 (245)
..+|+++++||++
T Consensus 232 ~~~~~~~~~li~~ 244 (273)
T d1mp8a_ 232 PNCPPTLYSLMTK 244 (273)
T ss_dssp TTCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHH
Confidence 8999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=286.59 Aligned_cols=216 Identities=24% Similarity=0.377 Sum_probs=171.0
Q ss_pred CEeEEEecC-C--cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNT-G--EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|++..+ + ..||||+++.......+..+.+.+| +.++++++||||++++|++.+ +..++||||++++++.+
T Consensus 24 Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~E---i~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~ 99 (273)
T d1u46a_ 24 VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE---VNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLD 99 (273)
T ss_dssp CEEEEEECTTSCEEEEEEEC--------CHHHHHHHHH---HHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHH
T ss_pred EEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHH---HHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhh
Confidence 899987643 3 3789999987554344444555544 677889999999999999965 46789999999999987
Q ss_pred hhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 78 HIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 78 ~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.+. ...+++..+..++.|++.||.|||++||+|| |+||+|| +++.++.+||+|
T Consensus 100 ~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHr---Dikp~NI----------------------ll~~~~~vkl~D 154 (273)
T d1u46a_ 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR---DLAARNL----------------------LLATRDLVKIGD 154 (273)
T ss_dssp HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE----------------------EEEETTEEEECC
T ss_pred hhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeee---eecHHHh----------------------ccccccceeecc
Confidence 763 4569999999999999999999999999999 9999998 888899999999
Q ss_pred cCCccCCCCCCC---CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCcc--
Q psy3347 156 FGLCKEGMGFGD---RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDEV-- 229 (245)
Q Consensus 156 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~-- 229 (245)
||+++....... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+....+.....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC
Confidence 999985433222 2234457788999999999899999999999999999998 8999999999999888876654
Q ss_pred cCCCCCChhHHhhhcC
Q psy3347 230 RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 ~~p~~~~~~~~~li~~ 245 (245)
+.|+.+|+++++||++
T Consensus 235 ~~~~~~~~~l~~li~~ 250 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQ 250 (273)
T ss_dssp CCCTTCCHHHHHHHHH
T ss_pred CCcccccHHHHHHHHH
Confidence 4467899999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=288.97 Aligned_cols=196 Identities=26% Similarity=0.373 Sum_probs=161.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||+|+++.... .....+.+ .+|++++++++||||+++++++.++++.|+||||+.++.+.....
T Consensus 18 Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~---~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~ 93 (298)
T d1gz8a_ 18 VYKARNKLTGEVVALKKIRLDTE-TEGVPSTA---IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA 93 (298)
T ss_dssp EEEEEETTTCCEEEEEEEC--------CCHHH---HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEehhhc-ChHHHHHH---HHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhh
Confidence 79999999999999999975431 12223334 345788899999999999999999999999999997754544332
Q ss_pred --hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCC
Q psy3347 81 --ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGL 158 (245)
Q Consensus 81 --~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 158 (245)
...+++..+..++.|++.||+|||++||+|| ||||+|| +++.++.+||+|||.
T Consensus 94 ~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHr---DiKpeNI----------------------l~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 94 SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR---DLKPQNL----------------------LINTEGAIKLADFGL 148 (298)
T ss_dssp TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTSCEEECSTTH
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEcc---ccCchhe----------------------eecccCcceeccCCc
Confidence 3569999999999999999999999999999 9999999 888899999999999
Q ss_pred ccCCCCCCCCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 159 CKEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
++.............||+.|+|||.+.... ++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~ 216 (298)
T d1gz8a_ 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216 (298)
T ss_dssp HHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence 976544444555668999999999987765 4789999999999999999999999888777766654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=285.04 Aligned_cols=207 Identities=25% Similarity=0.457 Sum_probs=168.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-CCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-EAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++ |+.||||+++.+. ..+.+.+| ++++++++||||++++|++.+ .+.+++||||+++|+|.+++
T Consensus 23 Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E---~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l 92 (262)
T d1byga_ 23 VMLGDYR--GNKVAVKCIKNDA-----TAQAFLAE---ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 92 (262)
T ss_dssp EEEEEET--TEEEEEEECCCCC-------HHHHHT---HHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHH
T ss_pred EEEEEEC--CeEEEEEEECcHH-----HHHHHHHH---HHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHH
Confidence 7999874 8899999997542 22444444 778899999999999999854 46789999999999999998
Q ss_pred hh---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeec
Q psy3347 80 HA---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADF 156 (245)
Q Consensus 80 ~~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 156 (245)
.. ..+++..+.+++.|++.||+|||+++|+|| |++|+|| +++.++.+|++||
T Consensus 93 ~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~---dlkp~Ni----------------------l~~~~~~~kl~df 147 (262)
T d1byga_ 93 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR---DLAARNV----------------------LVSEDNVAKVSDF 147 (262)
T ss_dssp HHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECTTSCEEECCC
T ss_pred HhcCCCCCCHHHHHHHHHHHHhhccccccCceecc---ccchHhh----------------------eecCCCCEeeccc
Confidence 43 358999999999999999999999999999 9999888 8889999999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 234 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~-~~~~p~~ 234 (245)
|+++..... .....++..|+|||.+.+..+++++|||||||++|||+| |++||...+..+....+..+ .+++|..
T Consensus 148 g~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~ 224 (262)
T d1byga_ 148 GLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224 (262)
T ss_dssp CC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred ccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 999753222 334467889999999988899999999999999999998 89999988888888888764 4467889
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++++||++
T Consensus 225 ~~~~~~~li~~ 235 (262)
T d1byga_ 225 CPPAVYEVMKN 235 (262)
T ss_dssp CCHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 99999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=291.85 Aligned_cols=214 Identities=22% Similarity=0.351 Sum_probs=170.2
Q ss_pred CEeEEEecCCc----EEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGE----YFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..+|+ +||+|+++... ..+..+.+.+ +++++++++||||++++|++..+ ..++++|++.+++|.
T Consensus 25 Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~ 98 (317)
T d1xkka_ 25 VYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILD---EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLL 98 (317)
T ss_dssp EEEEEECC----CCEEEEEEEECC------CTHHHHHH---HHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHH
T ss_pred EEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHH---HHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccc
Confidence 89999998877 57888776432 2223344544 47778889999999999999765 567888999999998
Q ss_pred hhhh--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIH--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++. ...+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+
T Consensus 99 ~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr---DlKp~NI----------------------ll~~~~~~kl~ 153 (317)
T d1xkka_ 99 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHR---DLAARNV----------------------LVKTPQHVKIT 153 (317)
T ss_dssp HHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EEEETTEEEEC
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccC---cchhhcc----------------------eeCCCCCeEee
Confidence 8774 3468999999999999999999999999999 9999999 88899999999
Q ss_pred ecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-cc
Q psy3347 155 DFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VR 230 (245)
Q Consensus 155 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~ 230 (245)
|||+++....... ......||..|+|||.+.+..++.++|||||||++|||+| |.+||.+.+..++...+..+. .+
T Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 233 (317)
T d1xkka_ 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233 (317)
T ss_dssp CCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred ccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999985433222 1233467899999999999999999999999999999998 899999988888877777654 45
Q ss_pred CCCCCChhHHhhhcC
Q psy3347 231 YPRFLSLEAIAIMRR 245 (245)
Q Consensus 231 ~p~~~~~~~~~li~~ 245 (245)
.|+.+++++++||++
T Consensus 234 ~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 234 QPPICTIDVYMIMVK 248 (317)
T ss_dssp CCTTBCHHHHHHHHH
T ss_pred CCcccCHHHHHHHHH
Confidence 788999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=288.89 Aligned_cols=198 Identities=23% Similarity=0.337 Sum_probs=163.7
Q ss_pred CEeEEEecC-CcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-----CCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNT-GEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-----EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-----~~~~~lv~e~~~~~~ 74 (245)
||+|++..+ ++.||||+++..... ........+|.++++.++..+||||++++++|.. .++.+++||++.+++
T Consensus 23 V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 101 (305)
T d1blxa_ 23 VFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 101 (305)
T ss_dssp EEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBH
T ss_pred EEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCc
Confidence 899999766 678999999764322 2222345567677777777899999999999853 347899999999887
Q ss_pred hhhhh--hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceE
Q psy3347 75 LMMHI--HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVK 152 (245)
Q Consensus 75 L~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 152 (245)
+.... ....+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.+|
T Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHr---DiKp~NI----------------------Li~~~~~~k 156 (305)
T d1blxa_ 102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR---DLKPQNI----------------------LVTSSGQIK 156 (305)
T ss_dssp HHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTCCEE
T ss_pred hhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEec---CCCccEE----------------------EEcCCCCee
Confidence 65444 34568999999999999999999999999999 9999999 888899999
Q ss_pred EeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 153 IADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|+|||++..... .......+||+.|+|||.+.+.+|+.++||||+||++|||++|+.||.+.+..+....+.
T Consensus 157 l~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 157 LADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp ECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecchhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999875322 233456789999999999999999999999999999999999999999988887777664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=285.97 Aligned_cols=211 Identities=26% Similarity=0.386 Sum_probs=169.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+ +.||||+++.... ..+.+.+ +++++++++||||++++|++.. +..++||||+++|+|..++.
T Consensus 33 Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~---E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~ 103 (285)
T d1fmka3 33 VWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQ---EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK 103 (285)
T ss_dssp EEEEEETTT-EEEEEEECCTTSS----CHHHHHH---HHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHS
T ss_pred EEEEEECCC-CEEEEEEECcccC----CHHHHHH---HHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhh
Confidence 799998765 5699999975432 1234444 4778889999999999999854 55789999999999988874
Q ss_pred h---cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 81 A---DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 81 ~---~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ..+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||
T Consensus 104 ~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~---DlKp~NI----------------------ll~~~~~~kl~DfG 158 (285)
T d1fmka3 104 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR---DLRAANI----------------------LVGENLVCKVADFG 158 (285)
T ss_dssp HHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECGGGCEEECCCC
T ss_pred hcccccchHHHHHHHHHHHHHHHHHHhhhheecc---cccceEE----------------------EECCCCcEEEcccc
Confidence 2 468999999999999999999999999999 9999999 88889999999999
Q ss_pred CccCCCCCC-CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q psy3347 158 LCKEGMGFG-DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPFPGDDEEEVFDSIVNDE-VRYPRF 234 (245)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~-~~~p~~ 234 (245)
+++...... .......||+.|+|||.+....++.++|||||||++|||++ |.+|+.+....+....+..+. .+.|..
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc
Confidence 997532222 12334568899999999999999999999999999999999 566677777778888877653 457889
Q ss_pred CChhHHhhhcC
Q psy3347 235 LSLEAIAIMRR 245 (245)
Q Consensus 235 ~~~~~~~li~~ 245 (245)
+++++++||++
T Consensus 239 ~~~~l~~li~~ 249 (285)
T d1fmka3 239 CPESLHDLMCQ 249 (285)
T ss_dssp SCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-43 Score=286.74 Aligned_cols=215 Identities=25% Similarity=0.383 Sum_probs=178.4
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|+++ .+++.||||+++... ..+..+.+.+| +++++.++||||+++++++...+..+++|||+++|+|
T Consensus 29 Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E---~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L 103 (301)
T d1lufa_ 29 VFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE---AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 103 (301)
T ss_dssp EEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHH---HHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHH---HHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcH
Confidence 7999876 357899999997542 22334445444 7788899999999999999999999999999999999
Q ss_pred hhhhhhc-------------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhh
Q psy3347 76 MMHIHAD-------------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQE 130 (245)
Q Consensus 76 ~~~~~~~-------------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~ 130 (245)
.+++... .+++..+..++.|++.||+|||+++++|| |+||+||
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr---DlKp~NI--------- 171 (301)
T d1lufa_ 104 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR---DLATRNC--------- 171 (301)
T ss_dssp HHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE---------
T ss_pred HHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee---EEcccce---------
Confidence 9988531 37888999999999999999999999999 9999998
Q ss_pred ccccCcccchhccccCCCCceEEeecCCccCCCCCC--CCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC
Q psy3347 131 NYKVNSSQEIKLTVNDTEGYVKIADFGLCKEGMGFG--DRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG 208 (245)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g 208 (245)
+++.++.+||+|||+|+...+.. .......+++.|+|||.+.+..++.++|||||||++|||++|
T Consensus 172 -------------Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 172 -------------LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp -------------EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred -------------EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 88899999999999987432222 123345678899999999999999999999999999999997
Q ss_pred -CCCCCCCCHHHHHHHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 209 -ESPFPGDDEEEVFDSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 209 -~~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
.+||.+.+..+....+..+.. +.|+.+++++.+||++
T Consensus 239 ~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~ 277 (301)
T d1lufa_ 239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 277 (301)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHH
Confidence 578999999999988887654 4688999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=286.34 Aligned_cols=214 Identities=25% Similarity=0.432 Sum_probs=174.3
Q ss_pred CEeEEEecCCcE--EEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEY--FAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (245)
||+|.++.+|.. ||||+++... ..+..+.+.+| ++.+.++ +||||+++++++..++..++||||+++|+|.+
T Consensus 26 Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E---~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~ 100 (309)
T d1fvra_ 26 VLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGE---LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 100 (309)
T ss_dssp EEEEEEEETTEEEEEEEEEEECC--------CHHHHH---HHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred EEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHH---HHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHH
Confidence 799999998875 6677765432 22333445554 6778787 79999999999999999999999999999999
Q ss_pred hhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccch
Q psy3347 78 HIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEI 140 (245)
Q Consensus 78 ~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~ 140 (245)
+++. ..+++..+..++.|++.||.|+|+++|+|| |+||+||
T Consensus 101 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHr---Dlkp~NI------------------- 158 (309)
T d1fvra_ 101 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR---DLAARNI------------------- 158 (309)
T ss_dssp HHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS---CCSGGGE-------------------
T ss_pred HHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccc---ccccceE-------------------
Confidence 8853 358999999999999999999999999999 9999998
Q ss_pred hccccCCCCceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q psy3347 141 KLTVNDTEGYVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG-ESPFPGDDEEE 219 (245)
Q Consensus 141 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~pf~~~~~~~ 219 (245)
+++.++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+
T Consensus 159 ---L~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 159 ---LVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp ---EECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ---EEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 8888899999999999753222 223345688999999999989999999999999999999995 57898889889
Q ss_pred HHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 220 VFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 220 ~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
....+..+ .+++|..+++++++||++
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~~~~li~~ 261 (309)
T d1fvra_ 235 LYEKLPQGYRLEKPLNCDDEVYDLMRQ 261 (309)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 88888765 445678999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=280.36 Aligned_cols=215 Identities=28% Similarity=0.478 Sum_probs=177.2
Q ss_pred CEeEEEecCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccC
Q psy3347 1 VILSQYRNTG-------EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 72 (245)
||+|++..++ ..||||+++... .......+.+| ...+.++ +||||++++++|.+++..++||||+++
T Consensus 29 Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e---~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~ 103 (299)
T d1fgka_ 29 VVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISE---MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103 (299)
T ss_dssp EEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred EEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHH---HHHHHHhcCCCeEEecccccccCCeEEEEEEccCC
Confidence 7999887654 479999997643 22333444444 4445455 799999999999999999999999999
Q ss_pred Cchhhhhhhc-----------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 73 GDLMMHIHAD-----------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 73 ~~L~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
|+|.+++... .+++..+..++.|++.||+|||+++|+|| ||||+||
T Consensus 104 g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr---DiKp~Ni-------------- 166 (299)
T d1fgka_ 104 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR---DLAARNV-------------- 166 (299)
T ss_dssp CBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE--------------
T ss_pred CcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee---eecccce--------------
Confidence 9999988532 47999999999999999999999999999 9999998
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.+||+|||+++...+... ......+++.|+|||.+.+..|+.++||||||+++|||++ |.+||
T Consensus 167 --------Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 167 --------LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp --------EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred --------eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 889999999999999985433222 2344567889999999999999999999999999999998 79999
Q ss_pred CCCCHHHHHHHHhcC-cccCCCCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
.+.+..+....+..+ .++.|..+++++++||++
T Consensus 239 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 272 (299)
T d1fgka_ 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD 272 (299)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHH
Confidence 988888888877665 345688999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.8e-42 Score=278.75 Aligned_cols=195 Identities=24% Similarity=0.351 Sum_probs=159.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++ +|+.||||+++..... ....+.+ .+++.++++++||||+++++++..++..+++||++.++++..+.+
T Consensus 18 Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~---~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~ 92 (286)
T d1ob3a_ 18 VYKAQNN-YGETFALKKIRLEKED-EGIPSTT---IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV 92 (286)
T ss_dssp EEEEEET-TSCEEEEEEECCSSGG-GCCCHHH---HHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT
T ss_pred EEEEEeC-CCCEEEEEEEehhhcC-hHHHHHH---HHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh
Confidence 8999986 7899999999765322 2223344 445788899999999999999999999999999998877777765
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+|++|||.+
T Consensus 93 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHr---DiKp~NI----------------------ll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 93 CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR---DLKPQNL----------------------LINREGELKIADFGLA 147 (286)
T ss_dssp STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTSCEEECCTTHH
T ss_pred hcCCcchhhhHHHHHHHHHHHHHhccCcEEec---CCCCcee----------------------eEcCCCCEEecccccc
Confidence 5679999999999999999999999999999 9999999 8889999999999998
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
..............+++.|+|||.+.+. .++.++|+|||||++|||++|+.||.+.+..+....+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 7543333334555788999999999764 56899999999999999999999999888777766653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=283.76 Aligned_cols=191 Identities=27% Similarity=0.447 Sum_probs=161.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC------eEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA------HVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~------~~~lv~e~~~~~~ 74 (245)
||+|+++.+|+.||||+++... ......+.+. +++++|+.++||||++++++|...+ ++|+||||+ +.+
T Consensus 34 V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~---~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~ 108 (346)
T d1cm8a_ 34 VCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAY---RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD 108 (346)
T ss_dssp EEEEEETTTCCEEEEEECSSTT-SSHHHHHHHH---HHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEE
T ss_pred EEEEEECCCCCEEEEEEEchhh-cChHHHHHHH---HHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-ccc
Confidence 8999999999999999998643 2223333444 4577888999999999999997654 579999999 568
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
|....++..+++..++.++.|++.||+|||++||+|| |+||+|| +++.++.+|++
T Consensus 109 l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHr---DiKp~NI----------------------L~~~~~~~kl~ 163 (346)
T d1cm8a_ 109 LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR---DLKPGNL----------------------AVNEDCELKIL 163 (346)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCccc---ccCcchh----------------------hcccccccccc
Confidence 8888888899999999999999999999999999999 9999999 88899999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
|||+++... .......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 164 Dfg~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~ 231 (346)
T d1cm8a_ 164 DFGLARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231 (346)
T ss_dssp CCTTCEECC---SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccceeccC---CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence 999998632 224456789999999999764 5689999999999999999999999988776665544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=279.75 Aligned_cols=215 Identities=27% Similarity=0.440 Sum_probs=160.7
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh-cCCCceeeeeEEEeeC-CeEEEEEeeccCC
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT-MRHPFLVNLFACFQTE-AHVCFVMEYAAGG 73 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~h~ni~~~~~~~~~~-~~~~lv~e~~~~~ 73 (245)
||+|++.. +++.||||+++... .....+.+.+| ...+.+ .+|+||+.+++++... +..+++||||++|
T Consensus 29 Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e---~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g 103 (299)
T d1ywna1 29 VIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSE---LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 103 (299)
T ss_dssp EEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTC
T ss_pred EEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHH---HHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCC
Confidence 79998764 45789999997543 22333444444 333433 3689999999988654 5789999999999
Q ss_pred chhhhhhh-----------------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCc
Q psy3347 74 DLMMHIHA-----------------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNS 136 (245)
Q Consensus 74 ~L~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~ 136 (245)
+|.++++. ..+++..+..++.|++.||+|||++||+|| |+||+||
T Consensus 104 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr---DlKp~NI--------------- 165 (299)
T d1ywna1 104 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR---DLAARNI--------------- 165 (299)
T ss_dssp BHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE---------------
T ss_pred cHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC---cCCccce---------------
Confidence 99998853 237889999999999999999999999999 9999999
Q ss_pred ccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q psy3347 137 SQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG-ESPFP 213 (245)
Q Consensus 137 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~pf~ 213 (245)
+++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||.
T Consensus 166 -------Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 166 -------LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp -------EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred -------eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 888899999999999975433322 23456789999999999999999999999999999999985 67887
Q ss_pred CCCHHHHHHH-HhcC-cccCCCCCChhHHhhhcC
Q psy3347 214 GDDEEEVFDS-IVND-EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 214 ~~~~~~~~~~-~~~~-~~~~p~~~~~~~~~li~~ 245 (245)
+....+.... +..+ .++.|+.+++++++||.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 272 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 272 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 7654444433 4333 345678899999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-41 Score=275.60 Aligned_cols=215 Identities=20% Similarity=0.304 Sum_probs=168.1
Q ss_pred CEeEEEecCC---cEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee-CCeEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTG---EYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT-EAHVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~ 76 (245)
||+|++..++ ..||||+++.. ......+.+.+| ++++++++||||++++|++.. ++..++|||||++++|.
T Consensus 43 Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E---~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~ 117 (311)
T d1r0pa_ 43 VYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTE---GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117 (311)
T ss_dssp EEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHH---HHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHH
T ss_pred EEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHH---HHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchh
Confidence 7999987643 36999999753 233444555544 778889999999999999765 56899999999999999
Q ss_pred hhhhhc--CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 77 MHIHAD--VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 77 ~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+++... .+++..+..++.|++.||.|+|+.+|+|| |+||+|| ++++++.+||+
T Consensus 118 ~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHr---DLK~~NI----------------------Ll~~~~~~kL~ 172 (311)
T d1r0pa_ 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR---DLAARNC----------------------MLDEKFTVKVA 172 (311)
T ss_dssp HHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE----------------------EECTTCCEEEC
T ss_pred hhhccccccchHHHHHHHHHHHHHhhhhhcccCcccC---CccHHhE----------------------eECCCCCEEEe
Confidence 988643 46778899999999999999999999999 9999999 88999999999
Q ss_pred ecCCccCCCCCCC----CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcCcc
Q psy3347 155 DFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPF-PGDDEEEVFDSIVNDEV 229 (245)
Q Consensus 155 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~~ 229 (245)
|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|..|| ...+..+....+..+..
T Consensus 173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~ 252 (311)
T d1r0pa_ 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252 (311)
T ss_dssp SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC
T ss_pred cccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999985433222 122346788999999998889999999999999999999966555 44455566666666543
Q ss_pred -cCCCCCChhHHhhhcC
Q psy3347 230 -RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 230 -~~p~~~~~~~~~li~~ 245 (245)
..|..+++++.+||++
T Consensus 253 ~~~p~~~~~~l~~li~~ 269 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLK 269 (311)
T ss_dssp CCCCTTCCHHHHHHHHH
T ss_pred CCCcccCcHHHHHHHHH
Confidence 4678899999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-41 Score=280.68 Aligned_cols=189 Identities=23% Similarity=0.416 Sum_probs=154.7
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeC------CeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTE------AHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~------~~~~lv~e~~~~~~ 74 (245)
||+|+++.+|+.||||+++...... .+++++++.++||||++++++|... .+.++||||++++.
T Consensus 36 Vy~a~~~~~~~~vAiK~i~~~~~~~----------~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~ 105 (350)
T d1q5ka_ 36 VYQAKLCDSGELVAIKKVLQDKRFK----------NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV 105 (350)
T ss_dssp EEEEEETTTCCEEEEEEEECCSSSC----------CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEH
T ss_pred EEEEEECCCCCEEEEEEECccchHH----------HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCcc
Confidence 8999999999999999998643211 2346778899999999999998543 36899999998764
Q ss_pred hhhhh----hhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCC-
Q psy3347 75 LMMHI----HADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEG- 149 (245)
Q Consensus 75 L~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~- 149 (245)
+.... ....+++..++.++.|++.||+|||++||+|| ||||+|| +++.++
T Consensus 106 ~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr---DiKp~NI----------------------Ll~~~~~ 160 (350)
T d1q5ka_ 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR---DIKPQNL----------------------LLDPDTA 160 (350)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCCGGGE----------------------EECTTTC
T ss_pred HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc---CCCcceE----------------------EEecCCC
Confidence 44332 23469999999999999999999999999999 9999999 777654
Q ss_pred ceEEeecCCccCCCCCCCCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 150 YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
.+||+|||+++.... .......+|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+....+.
T Consensus 161 ~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 161 VLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CEEECCCTTCEECCT-TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred ceeEecccchhhccC-CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 899999999875432 233455688999999999875 468999999999999999999999999888777666654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=277.44 Aligned_cols=215 Identities=20% Similarity=0.313 Sum_probs=179.0
Q ss_pred CEeEEEec-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRN-----TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|.+.. +++.||||+++... .......+. ++++++++++||||+++++++..++..++||||+.+|+|
T Consensus 36 Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~---~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l 110 (308)
T d1p4oa_ 36 VYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFL---NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110 (308)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHH---HHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHH---HHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCH
Confidence 79998863 46799999997542 223333444 458889999999999999999999999999999999999
Q ss_pred hhhhhh-----------cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccc
Q psy3347 76 MMHIHA-----------DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTV 144 (245)
Q Consensus 76 ~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~ 144 (245)
.+++.. ..+++..+..++.|++.||.|||+++|+|| |+||+|| +
T Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHr---Dlk~~Ni----------------------L 165 (308)
T d1p4oa_ 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR---DLAARNC----------------------M 165 (308)
T ss_dssp HHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS---CCSGGGE----------------------E
T ss_pred HHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeec---eEcCCce----------------------e
Confidence 988742 136788899999999999999999999999 9999999 8
Q ss_pred cCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q psy3347 145 NDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVG-ESPFPGDDEEEVF 221 (245)
Q Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~pf~~~~~~~~~ 221 (245)
++.++++||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..+..
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 89999999999999975433222 23344678999999999999999999999999999999997 6889999999988
Q ss_pred HHHhcCcc-cCCCCCChhHHhhhcC
Q psy3347 222 DSIVNDEV-RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 222 ~~~~~~~~-~~p~~~~~~~~~li~~ 245 (245)
..+..+.. +.|+.+++.+.+||.+
T Consensus 246 ~~i~~~~~~~~p~~~~~~l~~li~~ 270 (308)
T d1p4oa_ 246 RFVMEGGLLDKPDNCPDMLFELMRM 270 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred HHHHhCCCCCCcccchHHHHHHHHH
Confidence 88877654 4678999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=277.63 Aligned_cols=215 Identities=24% Similarity=0.407 Sum_probs=173.7
Q ss_pred CEeEEEe-----cCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeCCeEEEEEeeccCCc
Q psy3347 1 VILSQYR-----NTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTEAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 74 (245)
||+|++. .+++.||||+++... .......+.+| +..++.+ +||||+++++++..++..+++|||+++|+
T Consensus 39 Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E---~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~ 113 (311)
T d1t46a_ 39 VVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSE---LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113 (311)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHH---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred EEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHH---HHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCC
Confidence 7899763 467899999998653 22333445555 5556566 69999999999999999999999999999
Q ss_pred hhhhhhhc-------------------CCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccC
Q psy3347 75 LMMHIHAD-------------------VFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVN 135 (245)
Q Consensus 75 L~~~~~~~-------------------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~ 135 (245)
|.++++.. .+++..+..++.|++.||+|||+++++|| |+||+||
T Consensus 114 l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr---DLKp~NI-------------- 176 (311)
T d1t46a_ 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR---DLAARNI-------------- 176 (311)
T ss_dssp HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCSGGGE--------------
T ss_pred HHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec---ccccccc--------------
Confidence 99988532 48899999999999999999999999999 9999999
Q ss_pred cccchhccccCCCCceEEeecCCccCCCCCCC--CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy3347 136 SSQEIKLTVNDTEGYVKIADFGLCKEGMGFGD--RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLV-GESPF 212 (245)
Q Consensus 136 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~pf 212 (245)
+++.++.++++|||.++....... .....+||+.|+|||.+.+..++.++|||||||++|||+| |.+||
T Consensus 177 --------l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 177 --------LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp --------EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred --------cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 888899999999999986433222 2334578899999999998899999999999999999998 77878
Q ss_pred CCCCHHHHHHHHhcCcc--cCCCCCChhHHhhhcC
Q psy3347 213 PGDDEEEVFDSIVNDEV--RYPRFLSLEAIAIMRR 245 (245)
Q Consensus 213 ~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~ 245 (245)
.+.+..+....+...+. ..|..+++++.+||++
T Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~ 283 (311)
T d1t46a_ 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283 (311)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHH
Confidence 77766665555544333 3567899999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=277.79 Aligned_cols=217 Identities=39% Similarity=0.712 Sum_probs=173.6
Q ss_pred CEeEEE---ecCCcEEEEEEeecccccch-hhHHHHHHHHHHHHHHhhcCC-CceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQY---RNTGEYFAIKALKKGDIIAR-DEVESLLSEKRIFEVANTMRH-PFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~---~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+|++ +.+|+.||||++++...... ...+.+.+| ++++++++| |||+++++++.+.+..+++|||+.+++|
T Consensus 40 Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E---~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L 116 (322)
T d1vzoa_ 40 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE---RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116 (322)
T ss_dssp EEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCH---HHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHH---HHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHH
Confidence 799987 44799999999976543221 222334444 666677766 8999999999999999999999999999
Q ss_pred hhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 76 MMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 76 ~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
..++. .+.+++..+..++.|++.||+|+|++||+|| |+||+|| +++.+|.+||+
T Consensus 117 ~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHr---DiKp~Ni----------------------ll~~~~~vkL~ 171 (322)
T d1vzoa_ 117 FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR---DIKLENI----------------------LLDSNGHVVLT 171 (322)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTSCEEES
T ss_pred HHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEec---cCCccce----------------------eecCCCCEEEe
Confidence 98885 4578899999999999999999999999999 9999999 88899999999
Q ss_pred ecCCccCCCCC-CCCCCcccCCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC
Q psy3347 155 DFGLCKEGMGF-GDRTGTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIFEMLVGESPFPGDDE----EEVFDSIVND 227 (245)
Q Consensus 155 Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~pf~~~~~----~~~~~~~~~~ 227 (245)
|||+++..... ........|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+... ..........
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 99998754322 2234456789999999999764 467899999999999999999999976543 3344444455
Q ss_pred cccCCCCCChhHHhhhcC
Q psy3347 228 EVRYPRFLSLEAIAIMRR 245 (245)
Q Consensus 228 ~~~~p~~~~~~~~~li~~ 245 (245)
..++|..+++++++||++
T Consensus 252 ~~~~~~~~s~~~~~li~~ 269 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQR 269 (322)
T ss_dssp CCCCCTTSCHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHH
Confidence 667788999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=276.55 Aligned_cols=193 Identities=21% Similarity=0.374 Sum_probs=158.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||||+++... .....+.+ .+++++|+.++||||+++++++.... +.|+++ ++.+++|
T Consensus 24 Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~---~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~-~~~~g~L 97 (345)
T d1pmea_ 24 VCSAYDNVNKVRVAIKKISPFE--HQTYCQRT---LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADL 97 (345)
T ss_dssp EEEEEETTTCSEEEEEEECCTT--CHHHHHHH---HHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE-ECCCEEH
T ss_pred EEEEEECCCCcEEEEEEEehhc--ChHHHHHH---HHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE-eecCCch
Confidence 8999999999999999997542 22333344 44577888999999999999996543 355555 5668899
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.++++...+++..++.++.|++.||+|||++||+|| ||||+|| +++.++.+||+|
T Consensus 98 ~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHR---DIKp~NI----------------------Ll~~~~~~kl~D 152 (345)
T d1pmea_ 98 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR---DLKPSNL----------------------LLNTTCDLKICD 152 (345)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTCCEEECC
T ss_pred hhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCC---CCCcceE----------------------EECCCCCEEEcc
Confidence 999988889999999999999999999999999999 9999999 888999999999
Q ss_pred cCCccCCCCCC---CCCCcccCCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy3347 156 FGLCKEGMGFG---DRTGTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSI 224 (245)
Q Consensus 156 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (245)
||++....... ......+|++.|+|||.+.. ..++.++||||+||++|+|++|+.||.+.+..+.....
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~ 225 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence 99987432221 12445678999999999854 56789999999999999999999999888766555544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=273.50 Aligned_cols=197 Identities=21% Similarity=0.334 Sum_probs=157.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee--------CCeEEEEEeeccC
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT--------EAHVCFVMEYAAG 72 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~--------~~~~~lv~e~~~~ 72 (245)
||+|+++.+|+.||||++..... .....+.+.+ ++++|+.++||||+++++++.. +++.|++||++++
T Consensus 26 Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~---E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 101 (318)
T d3blha1 26 VFKARHRKTGQKVALKKVLMENE-KEGFPITALR---EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 101 (318)
T ss_dssp EEEEEETTTCCEEEEEEC----C-TTSSCHHHHH---HHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCE
T ss_pred EEEEEECCCCCEEEEEEEehhhc-chHHHHHHHH---HHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCC
Confidence 89999999999999999876432 1222333444 4777889999999999999854 3568999999988
Q ss_pred Cchhhhhh-hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCce
Q psy3347 73 GDLMMHIH-ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYV 151 (245)
Q Consensus 73 ~~L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (245)
+++..... ...+++..++.+++|++.||.|||++||+|| |+||+|| +++.++.+
T Consensus 102 ~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHr---DlKp~NI----------------------Ll~~~~~~ 156 (318)
T d3blha1 102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR---DMKAANV----------------------LITRDGVL 156 (318)
T ss_dssp EHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCCGGGE----------------------EECTTSCE
T ss_pred CccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEec---CcCchhe----------------------eecCCCcE
Confidence 77765553 4568999999999999999999999999999 9999999 88899999
Q ss_pred EEeecCCccCCCCC----CCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 152 KIADFGLCKEGMGF----GDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 152 kl~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
||+|||+++..... .......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999998643221 1123345789999999999765 689999999999999999999999999888777776644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=264.83 Aligned_cols=195 Identities=19% Similarity=0.316 Sum_probs=162.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||+++.... .....+.+ .+++.+++.++||||+++++++.+....+++++++.++++..+..
T Consensus 18 V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~---~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~ 93 (292)
T d1unla_ 18 VFKAKNRETHEIVALKRVRLDDD-DEGVPSSA---LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93 (292)
T ss_dssp EEEEEETTTCCEEEEEEEESSCS-STTHHHHH---HHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEehhhC-ChHHHHHH---HHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc
Confidence 89999999999999999976532 22223333 455788899999999999999999999999999999988887774
Q ss_pred -hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecCCc
Q psy3347 81 -ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFGLC 159 (245)
Q Consensus 81 -~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 159 (245)
.+.+++..+..++.|++.||+|||++||+|| |+||+|| +++.++.+||+|||.+
T Consensus 94 ~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHr---DiKP~NI----------------------li~~~~~~kl~DFG~a 148 (292)
T d1unla_ 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR---DLKPQNL----------------------LINRNGELKLANFGLA 148 (292)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EECTTCCEEECCCTTC
T ss_pred cccccchhHHHHHHHHHHHHHHHhhcCCEeee---cccCccc----------------------ccccCCceeeeecchh
Confidence 4578999999999999999999999999999 9999999 8888899999999999
Q ss_pred cCCCCCCCCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHH
Q psy3347 160 KEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPF-PGDDEEEVFDSI 224 (245)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf-~~~~~~~~~~~~ 224 (245)
+.............++..|+|||.+.+.. ++.++|||||||++|||++|+.|| .+.+..+....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 86544444444556778899999997765 689999999999999999988875 556666655554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=276.40 Aligned_cols=194 Identities=24% Similarity=0.432 Sum_probs=157.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC-----eEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA-----HVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~-----~~~lv~e~~~~~~L 75 (245)
||+|+++.+|+.||||++++... .....+.+ .+++++++.++||||+++++++.... ..+++|+++.+++|
T Consensus 34 Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~---~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L 109 (348)
T d2gfsa1 34 VCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRT---YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109 (348)
T ss_dssp EEEEEETTTTEEEEEEECSCTTS-SHHHHHHH---HHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEH
T ss_pred EEEEEECCCCCEEEEEEECchhc-ChHHHHHH---HHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCch
Confidence 89999999999999999986432 22223333 45578888999999999999986432 34555667789999
Q ss_pred hhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEee
Q psy3347 76 MMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIAD 155 (245)
Q Consensus 76 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 155 (245)
.+++..+.+++..++.++.|++.||+|||++||+|| |+||+|| +++.+|.+|++|
T Consensus 110 ~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHr---DiKp~NI----------------------Li~~~~~~kl~d 164 (348)
T d2gfsa1 110 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHR---DLKPSNL----------------------AVNEDCELKILD 164 (348)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCC---CCCGGGE----------------------EECTTCCEEECC
T ss_pred hhhcccccccHHHHHHHHHHHHHHHHHHHhCCCccc---ccCCccc----------------------cccccccccccc
Confidence 999988889999999999999999999999999999 9999999 888999999999
Q ss_pred cCCccCCCCCCCCCCcccCCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy3347 156 FGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIVN 226 (245)
Q Consensus 156 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~~ 226 (245)
||++... ........|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 165 fg~a~~~---~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 165 FGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp C----CC---TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cchhccc---CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9998753 22234557888999999987754 68899999999999999999999999888777776643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-39 Score=263.19 Aligned_cols=211 Identities=18% Similarity=0.234 Sum_probs=162.6
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+|+++.+|+.||||++.... . .+.+.+|.+++..+. +|+|++.+++++..+++.++||||+ +++|.++++
T Consensus 21 Vy~a~~~~~~~~vAvK~~~~~~--~---~~~~~~e~~~~~~l~--~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~ 92 (293)
T d1csna_ 21 IFEGTNLLNNQQVAIKFEPRRS--D---APQLRDEYRTYKLLA--GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLD 92 (293)
T ss_dssp EEEEEETTTTEEEEEEEEECCT--T---SCCHHHHHHHHHHTT--TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEcccc--C---cHHHHHHHHHHHHhc--CCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHH
Confidence 8999999999999999986542 1 123444544444333 3589999999999999999999999 568887774
Q ss_pred h--cCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccC-----CCCceEE
Q psy3347 81 A--DVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVND-----TEGYVKI 153 (245)
Q Consensus 81 ~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~kl 153 (245)
. ..++...+..++.|++.||+|||++||+|| |+||+|| +++ .++.++|
T Consensus 93 ~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHr---DiKp~Ni----------------------li~~~~~~~~~~vkl 147 (293)
T d1csna_ 93 LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR---DIKPDNF----------------------LIGRPNSKNANMIYV 147 (293)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC---CCCGGGE----------------------EECCSSSTTTTCEEE
T ss_pred hhccchhhHHHHHHHHHHHHHHHHHHHCCceec---cCCccce----------------------eecCcccccCCceEE
Confidence 3 468999999999999999999999999999 8888888 443 3578999
Q ss_pred eecCCccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH
Q psy3347 154 ADFGLCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDD---EEEVFDS 223 (245)
Q Consensus 154 ~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~---~~~~~~~ 223 (245)
+|||+|+....... .....+||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.. ..+....
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 99999975432211 2335679999999999999999999999999999999999999997543 3333333
Q ss_pred HhcCcc-----cCCCCCChhHHhhhc
Q psy3347 224 IVNDEV-----RYPRFLSLEAIAIMR 244 (245)
Q Consensus 224 ~~~~~~-----~~p~~~~~~~~~li~ 244 (245)
+..... ..+..+|+++.++|+
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~ 253 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMH 253 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred HHhccCCCChHHhcCCCCHHHHHHHH
Confidence 332211 124678888888774
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-39 Score=266.29 Aligned_cols=178 Identities=20% Similarity=0.328 Sum_probs=148.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhc-CCCceeeeeEEEeeC--CeEEEEEeeccCCchhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTM-RHPFLVNLFACFQTE--AHVCFVMEYAAGGDLMM 77 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~h~ni~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 77 (245)
||+|+++.+|+.||||+++... .+.+.+| +++|+.+ +||||++++++|... ++.++||||+.+++|..
T Consensus 51 V~~a~~~~~~~~vAiK~i~~~~------~~~~~~E---i~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~ 121 (328)
T d3bqca1 51 VFEAINITNNEKVVVKILKPVK------KKKIKRE---IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121 (328)
T ss_dssp EEEEEETTTTEEEEEEEECSSC------HHHHHHH---HHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGG
T ss_pred EEEEEECCCCCEEEEEEECHHH------HHHHHHH---HHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHH
Confidence 8999999999999999997532 2344444 5666666 499999999999743 57999999999999987
Q ss_pred hhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC-CceEEeec
Q psy3347 78 HIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE-GYVKIADF 156 (245)
Q Consensus 78 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~kl~Df 156 (245)
.. ..+++..++.+++|++.||+|||++||+|| |+||+|| +++.+ +.+||+||
T Consensus 122 ~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHr---DiKp~NI----------------------Li~~~~~~vkl~DF 174 (328)
T d3bqca1 122 LY--QTLTDYDIRFYMYEILKALDYCHSMGIMHR---DVKPHNV----------------------MIDHEHRKLRLIDW 174 (328)
T ss_dssp TT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECC---CCSGGGE----------------------EEETTTTEEEECCG
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHhhcccccc---cccccce----------------------EEcCCCCeeeeccc
Confidence 65 459999999999999999999999999999 9999998 66654 46999999
Q ss_pred CCccCCCCCCCCCCcccCCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 157 GLCKEGMGFGDRTGTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
|+|+..... ......++|..|+|||.+.+. .++.++||||+||++|+|++|+.||...
T Consensus 175 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 175 GLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp GGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 999754332 334566789999999999775 4789999999999999999999999654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=266.67 Aligned_cols=193 Identities=23% Similarity=0.332 Sum_probs=152.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEee------CCeEEEEEeeccCCc
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQT------EAHVCFVMEYAAGGD 74 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~------~~~~~lv~e~~~~~~ 74 (245)
||+|+|+.||+.||||++..... .......+ .+++.+++.++||||++++++|.. .++.|+||||+.++.
T Consensus 33 V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~---~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l 108 (355)
T d2b1pa1 33 VCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRA---YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 108 (355)
T ss_dssp EEEEEETTTTEEEEEEEEESTTS-SHHHHHHH---HHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEH
T ss_pred EEEEEECCCCCEEEEEEEChhhc-CHHHHHHH---HHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHH
Confidence 89999999999999999986532 22233333 455777888999999999999964 368999999997765
Q ss_pred hhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEe
Q psy3347 75 LMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIA 154 (245)
Q Consensus 75 L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 154 (245)
+... ...+++..++.+++|++.||+|||++||+|| |+||+|| +++.++.++++
T Consensus 109 ~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHr---DlKP~Ni----------------------l~~~~~~~kl~ 161 (355)
T d2b1pa1 109 CQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHR---DLKPSNI----------------------VVKSDCTLKIL 161 (355)
T ss_dssp HHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS---CCCGGGE----------------------EECTTCCEEEC
T ss_pred HHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccc---cCCcccc----------------------ccccccceeee
Confidence 5443 3468999999999999999999999999999 9999999 88889999999
Q ss_pred ecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy3347 155 DFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV 225 (245)
Q Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (245)
|||+++... ........++|..|+|||.+.+..+++++||||+||++|+|++|+.||.+.+.......+.
T Consensus 162 df~~~~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 162 DFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp CCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred chhhhhccc-cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 999887532 2233456678999999999999999999999999999999999999999887776666553
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-39 Score=265.64 Aligned_cols=213 Identities=18% Similarity=0.196 Sum_probs=156.8
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCc-eeeeeEEEeeCCeEEEEEeeccCCchhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPF-LVNLFACFQTEAHVCFVMEYAAGGDLMMHI 79 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~n-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 79 (245)
||+|+++.+|+.||||++..... .+.+.+| .++++.++|+| |+.+.+++..++..++||||+++ ++...+
T Consensus 23 Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E---~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~ 93 (299)
T d1ckia_ 23 IYLGTDIAAGEEVAIKLECVKTK-----HPQLHIE---SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLF 93 (299)
T ss_dssp EEEEEETTTTEEEEEEEEESCTT-----SCCHHHH---HHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchhcc-----CHHHHHH---HHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhh
Confidence 89999999999999999876421 1234444 55666776665 55555666788899999999965 554444
Q ss_pred h--hcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCCCceEEeecC
Q psy3347 80 H--ADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTEGYVKIADFG 157 (245)
Q Consensus 80 ~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 157 (245)
. ...+++..+..++.|++.||+|||++||+|| |+||+|| ++. ..+.+..++++|||
T Consensus 94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHr---DiKp~NI-----l~~--------------~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 94 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR---DVKPDNF-----LMG--------------LGKKGNLVYIIDFG 151 (299)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECS---CCCGGGE-----EEC--------------CGGGTTCEEECCCS
T ss_pred hhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeec---cCCHhhc-----ccc--------------ccCCCceeeeeccC
Confidence 2 4579999999999999999999999999999 8888887 221 23446679999999
Q ss_pred CccCCCCCCC-------CCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cC
Q psy3347 158 LCKEGMGFGD-------RTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGDDEEEVFDSIV---ND 227 (245)
Q Consensus 158 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~~~~~~~~~~~---~~ 227 (245)
+|+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.........+. ..
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 9985432211 1335579999999999999999999999999999999999999997654433322221 11
Q ss_pred c-----ccCCCCCChhHHhhhc
Q psy3347 228 E-----VRYPRFLSLEAIAIMR 244 (245)
Q Consensus 228 ~-----~~~p~~~~~~~~~li~ 244 (245)
. ...+..+|+++.+||+
T Consensus 232 ~~~~~~~~~~~~~p~~~~~li~ 253 (299)
T d1ckia_ 232 KMSTPIEVLCKGYPSEFATYLN 253 (299)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHH
T ss_pred cCCCChhHhccCCCHHHHHHHH
Confidence 1 1234678888888875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-39 Score=262.77 Aligned_cols=178 Identities=22% Similarity=0.322 Sum_probs=145.0
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCC----eEEEEEeeccCCchh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEA----HVCFVMEYAAGGDLM 76 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~----~~~lv~e~~~~~~L~ 76 (245)
||+|++ +|+.||||+++... .+...+| +++..++.++||||+++++++...+ ..|+||||+++|+|.
T Consensus 19 Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e-~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~ 89 (303)
T d1vjya_ 19 VWRGKW--RGEEVAVKIFSSRE------ERSWFRE-AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 89 (303)
T ss_dssp EEEEEE--TTEEEEEEEECGGG------HHHHHHH-HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHH
T ss_pred EEEEEE--CCEEEEEEEECccc------hhHHHHH-HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHH
Confidence 799976 59999999986431 2233333 2345566789999999999997654 689999999999999
Q ss_pred hhhhhcCCChHHHHHHHHHHHHHHHHhhh--------cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 77 MHIHADVFSEPRAVFYAACVVLGLQYLHE--------SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 77 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--------~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
.+++..++++..+.+++.|++.||+|+|+ +||+|| |+||+|| +++.+
T Consensus 90 ~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr---DlKp~NI----------------------Ll~~~ 144 (303)
T d1vjya_ 90 DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR---DLKSKNI----------------------LVKKN 144 (303)
T ss_dssp HHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS---CCCGGGE----------------------EECTT
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc---ccCccce----------------------EEcCC
Confidence 99998889999999999999999999996 599999 9999999 88999
Q ss_pred CceEEeecCCccCCCCCCC----CCCcccCCCCccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCC
Q psy3347 149 GYVKIADFGLCKEGMGFGD----RTGTFCGTPEFLAPEVLTET------SYTRAVDWWGLGVLIFEMLVGESPF 212 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g~~pf 212 (245)
+.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+||..||
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 9999999999875322221 23356789999999999654 2567899999999999999998876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.5e-32 Score=226.87 Aligned_cols=183 Identities=24% Similarity=0.342 Sum_probs=138.2
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhh--------cCCCceeeeeEEEeeC--CeEEEEEeec
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANT--------MRHPFLVNLFACFQTE--AHVCFVMEYA 70 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~--------~~h~ni~~~~~~~~~~--~~~~lv~e~~ 70 (245)
||+|+++.+|+.||||+++.... ..+...+|.++++.+.. +.|+||+++++++... +..+++++++
T Consensus 29 Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~ 104 (362)
T d1q8ya_ 29 VWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104 (362)
T ss_dssp EEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred EEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeec
Confidence 89999999999999999986432 22334444444443332 3578999999998654 5677777776
Q ss_pred cCCch-hhhh---hhcCCChHHHHHHHHHHHHHHHHhhh-cCccccCCCCCCHHHHHHHHHHhhhccccCcccchhcccc
Q psy3347 71 AGGDL-MMHI---HADVFSEPRAVFYAACVVLGLQYLHE-SRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVN 145 (245)
Q Consensus 71 ~~~~L-~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~ 145 (245)
..+.. .... ....+++..++.++.|++.||+|||+ .||+|| |+||+|| ++
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr---DlKp~NI----------------------ll 159 (362)
T d1q8ya_ 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT---DIKPENV----------------------LM 159 (362)
T ss_dssp CCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS---CCSGGGE----------------------EE
T ss_pred ccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc---cCChhHe----------------------ee
Confidence 54433 2222 23468899999999999999999998 899999 8888877 44
Q ss_pred CCCC------ceEEeecCCccCCCCCCCCCCcccCCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy3347 146 DTEG------YVKIADFGLCKEGMGFGDRTGTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIFEMLVGESPFPGD 215 (245)
Q Consensus 146 ~~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~pf~~~ 215 (245)
+.++ .++++|||.+.... ......+||+.|+|||.+.+..++.++|+||+||++++|++|+.||...
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETT---BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eccCcccccceeeEeecccccccc---cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3332 48999999987532 2344567899999999999999999999999999999999999999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=7.4e-20 Score=139.51 Aligned_cols=154 Identities=14% Similarity=0.061 Sum_probs=103.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccch------------hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEe
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR------------DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVME 68 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e 68 (245)
||+|++. +|+.||||+++....... ..........++...+..+.|++++..+++. . .+++||
T Consensus 16 Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme 90 (191)
T d1zara2 16 VFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--G--NAVLME 90 (191)
T ss_dssp EEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEE
T ss_pred EEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--C--CEEEEE
Confidence 7999885 689999998764321100 0011112223456677788899998887663 2 279999
Q ss_pred eccCCchhhhhhhcCCChHHHHHHHHHHHHHHHHhhhcCccccCCCCCCHHHHHHHHHHhhhccccCcccchhccccCCC
Q psy3347 69 YAAGGDLMMHIHADVFSEPRAVFYAACVVLGLQYLHESRIIYRPQSNITKEEIKRIEAKVQENYKVNSSQEIKLTVNDTE 148 (245)
Q Consensus 69 ~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~~~~~i~~~~ik~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (245)
++++..+.. ++...+..++.|++.+++|||++||+|| |+||+|| +++.+
T Consensus 91 ~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHr---DiKP~NI----------------------Lv~~~ 139 (191)
T d1zara2 91 LIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHG---DLSQYNV----------------------LVSEE 139 (191)
T ss_dssp CCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECS---CCSTTSE----------------------EEETT
T ss_pred eeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEc---cCChhhe----------------------eeeCC
Confidence 998865533 4556678899999999999999999999 8889888 66654
Q ss_pred CceEEeecCCccCCCCCCCCCCcccCCCCccc------cccccCCCCCcchhHHHHHH
Q psy3347 149 GYVKIADFGLCKEGMGFGDRTGTFCGTPEFLA------PEVLTETSYTRAVDWWGLGV 200 (245)
Q Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DvwslG~ 200 (245)
.++|+|||++........ ..|.. .+.+ ...|+.++|+||..-
T Consensus 140 -~~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGW--------REILERDVRNIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp -EEEECCCTTCEETTSTTH--------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred -CEEEEECCCcccCCCCCc--------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence 589999999864211110 01111 1111 356788899999763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.43 E-value=0.00028 Score=54.07 Aligned_cols=91 Identities=11% Similarity=0.008 Sum_probs=58.2
Q ss_pred CCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhhhcCCChHH
Q psy3347 9 TGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIHADVFSEPR 88 (245)
Q Consensus 9 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~ 88 (245)
+++.+.+|+...... .....+.+|...+..+.. +--+.+++.+...++..++||++.+|.++...... ...
T Consensus 36 ~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~--~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~----~~~ 106 (263)
T d1j7la_ 36 ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEG--KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED----EQS 106 (263)
T ss_dssp SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTT--TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----CSC
T ss_pred CCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhc--cCCCCcEEEEEecCCceEEEEEecccccccccccc----ccc
Confidence 466788888765321 122334455444554542 33356777888888999999999999887654322 223
Q ss_pred HHHHHHHHHHHHHHhhhcCc
Q psy3347 89 AVFYAACVVLGLQYLHESRI 108 (245)
Q Consensus 89 ~~~i~~~i~~~l~~lH~~~i 108 (245)
...++.++...+..||+...
T Consensus 107 ~~~~~~~l~~~l~~lH~~~~ 126 (263)
T d1j7la_ 107 PEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp HHHHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHHHHHHHhccCc
Confidence 34567778888888997543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.98 E-value=0.0011 Score=50.39 Aligned_cols=91 Identities=12% Similarity=0.084 Sum_probs=55.1
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCchhhhhh
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDLMMHIH 80 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 80 (245)
||+... .+|..+.+|...... ...+..|.+.+..+... .--+.+++.+..+++..+++|++++|.++...
T Consensus 27 v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~-gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~-- 96 (255)
T d1nd4a_ 27 VFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATT-GVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS-- 96 (255)
T ss_dssp EEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTT-TCCBCCEEEEEECSSCEEEEEECCSSEETTTS--
T ss_pred EEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhc-CCCCCceeeecccccceEEEEEeeeccccccc--
Confidence 355533 356678888765432 22344555555555543 23467788888888899999999988766432
Q ss_pred hcCCChHHHHHHHHHHHHHHHHhhhc
Q psy3347 81 ADVFSEPRAVFYAACVVLGLQYLHES 106 (245)
Q Consensus 81 ~~~l~~~~~~~i~~~i~~~l~~lH~~ 106 (245)
..+. .....++...|.-||+.
T Consensus 97 --~~~~---~~~~~~l~~~la~LH~~ 117 (255)
T d1nd4a_ 97 --HLAP---AEKVSIMADAMRRLHTL 117 (255)
T ss_dssp --CCCH---HHHHHHHHHHHHHHTTS
T ss_pred --cccH---HHHHHHHHHHHHHHccC
Confidence 1221 23345666667777753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.07 E-value=0.014 Score=47.27 Aligned_cols=73 Identities=11% Similarity=-0.000 Sum_probs=37.4
Q ss_pred CEeEEEecCCcEEEEEEeecccccch----hhHHHHHHHHHHHHHHhhcCCCceeeeeEEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIAR----DEVESLLSEKRIFEVANTMRHPFLVNLFACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~e~~~~~~l~~~~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 75 (245)
||+..+..+|+.+++|.-...-.... ........|.+.+..+...-...+.+++.+ +....+++||++++..+
T Consensus 42 vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 42 VFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp EEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTSEE
T ss_pred EEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccCCccc
Confidence 57777777788999996543111111 112233445455555544322345555544 45556789999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.78 E-value=0.18 Score=39.22 Aligned_cols=70 Identities=14% Similarity=0.127 Sum_probs=38.5
Q ss_pred CEeEEEecCCcEEEEEEeecccccchhhHHHHHHHHHHHHHHhhcCCC--ceeeee--EEEeeCCeEEEEEeeccCCch
Q psy3347 1 VILSQYRNTGEYFAIKALKKGDIIARDEVESLLSEKRIFEVANTMRHP--FLVNLF--ACFQTEAHVCFVMEYAAGGDL 75 (245)
Q Consensus 1 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~h~--ni~~~~--~~~~~~~~~~lv~e~~~~~~L 75 (245)
||++.. ++|+.|++|+.+.... . .+.+..|.+.+..|...+=| ..+..- ..+...+..+.++++.+|..+
T Consensus 38 vy~v~~-~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 38 VYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp EEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred eEEEEc-CCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 566654 4688999999876432 2 23334444445555543322 111111 123456778999999877443
|